group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00001,1.9347523383535363,FUN_000185-T1,Peve_00037402,Pocillopora_meandrina_HIv1___RNAseq.g28886.t1,three_way,71.059,FUN_000185-T1,Q32LQ0,AMPE_BOVIN,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Bos taurus (Bovine),41.5,881.0,1.4e-197,691.4,sp|Q32LQ0|AMPE_BOVIN Glutamyl aminopeptidase OS=Bos taurus OX=9913 GN=ENPEP PE=2 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00002,1.564359418172944,FUN_000189-T1,Peve_00038462,Pocillopora_meandrina_HIv1___RNAseq.g28888.t3,three_way,68.72583333333334,FUN_000189-T1,Q9DCT6,,,,,38.0,171.0,4.6e-18,92.8,sp|Q9DCT6|BAP18_MOUSE BPTF-associated chromatin complex component 1 OS=Mus musculus OX=10090 GN=Bacc1 PE=1 SV=1,,,,,,
OG_00007,1.153656225659232,FUN_000194-T1,Peve_00038470,Pocillopora_meandrina_HIv1___RNAseq.g28898.t1,three_way,77.11833333333334,FUN_000194-T1,P70182,,,,,60.2,447.0,3.4e-147,523.5,sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2,,,,,,
OG_00016,1.0081856024786524,FUN_000210-T1,Peve_00022649,Pocillopora_meandrina_HIv1___TS.g6133.t2,three_way,62.794,FUN_000210-T1,Q9EQH2,ERAP1_MOUSE,,Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (VEGF-induced aminopeptidase),Mus musculus (Mouse),40.9,694.0,1.1e-145,518.8,sp|Q9EQH2|ERAP1_MOUSE Endoplasmic reticulum aminopeptidase 1 OS=Mus musculus OX=10090 GN=Erap1 PE=1 SV=2,GO:0002250; GO:0004177; GO:0005138; GO:0005576; GO:0005737; GO:0005789; GO:0006508; GO:0006509; GO:0008233; GO:0008235; GO:0008270; GO:0045766,adaptive immune response [GO:0002250]; membrane protein ectodomain proteolysis [GO:0006509]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576],aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0016787; GO:0140096,"immune system process; catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_00017,1.2029999908963418,FUN_000212-T1,Peve_00007289,Pocillopora_meandrina_HIv1___RNAseq.g28915.t1,three_way,63.1635,FUN_000212-T1,Q95334,AMPE_PIG,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Sus scrofa (Pig),37.8,898.0,2.4999999999999997e-173,610.9,sp|Q95334|AMPE_PIG Glutamyl aminopeptidase OS=Sus scrofa OX=9823 GN=ENPEP PE=1 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00018,2.3729460377149096,FUN_000213-T2,Peve_00002451,Pocillopora_meandrina_HIv1___RNAseq.g28916.t1,three_way,60.77916666666667,FUN_000213-T2,Q8LHH9,,,,,38.3,830.0,2.1000000000000001e-134,482.6,sp|Q8LHH9|SHL2_ORYSJ Probable RNA-dependent RNA polymerase SHL2 OS=Oryza sativa subsp. japonica OX=39947 GN=SHL2 PE=2 SV=1,,,,,,
OG_00019,1.970320750294987,FUN_000215-T1,Peve_00002445,Pocillopora_meandrina_HIv1___RNAseq.g28918.t1,three_way,61.82416666666666,FUN_000215-T1,P15541,,,,,34.2,918.0,1.8e-142,508.4,sp|P15541|AMPN_RABIT Aminopeptidase N OS=Oryctolagus cuniculus OX=9986 GN=ANPEP PE=1 SV=4,,,,,,
OG_00020,2.938771082487522,FUN_000216-T1,Peve_00018873,Pocillopora_meandrina_HIv1___RNAseq.g28926.t1,three_way,52.28366666666667,,,,,,,,,,,,,,,,,
OG_00022,1.4084548300476705,FUN_000219-T1,Peve_00019412,Pocillopora_meandrina_HIv1___RNAseq.g28928.t1,three_way,64.90866666666666,,,,,,,,,,,,,,,,,
OG_00024,1.609623703589537,FUN_000223-T1,Peve_00012031,Pocillopora_meandrina_HIv1___RNAseq.g28933.t1,three_way,77.22633333333333,FUN_000223-T1,Q80UY1,,,,,52.0,358.0,2.1e-107,390.6,sp|Q80UY1|CARME_MOUSE Carnosine N-methyltransferase OS=Mus musculus OX=10090 GN=Carnmt1 PE=1 SV=1,,,,,,
OG_00027,1.2860147879187165,FUN_000230-T1,Peve_00012012,Pocillopora_meandrina_HIv1___RNAseq.g28945.t1,three_way,54.19533333333334,FUN_000230-T1,Q5VTE6,ANGE2_HUMAN,,Protein angel homolog 2,Homo sapiens (Human),44.9,254.0,8.199999999999999e-53,209.9,sp|Q5VTE6|ANGE2_HUMAN Protein angel homolog 2 OS=Homo sapiens OX=9606 GN=ANGEL2 PE=1 SV=1,GO:0003730; GO:0003824; GO:0005737; GO:0005739; GO:0005759; GO:0015030; GO:0045930; GO:0070935; GO:0090616,3'-UTR-mediated mRNA stabilization [GO:0070935]; mitochondrial mRNA 3'-end processing [GO:0090616]; negative regulation of mitotic cell cycle [GO:0045930],Cajal body [GO:0015030]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],catalytic activity [GO:0003824]; mRNA 3'-UTR binding [GO:0003730],GO:0003723; GO:0003824; GO:0005739; GO:0016071; GO:0043226; GO:0140053,RNA binding; catalytic activity; mitochondrion; mRNA metabolic process; organelle; mitochondrial gene expression
OG_00028,1.8596459124180968,FUN_000231-T1,Peve_00012025,Pocillopora_meandrina_HIv1___RNAseq.g28946.t1,three_way,54.33083333333334,FUN_000231-T1,Q1ZXH8,GXCDD_DICDI,,Guanine exchange factor for Rac 30,Dictyostelium discoideum (Social amoeba),36.5,203.0,4.3e-26,122.5,sp|Q1ZXH8|GXCDD_DICDI Guanine exchange factor for Rac 30 OS=Dictyostelium discoideum OX=44689 GN=gxcDD PE=4 SV=3,GO:0005085; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005938; GO:0008270; GO:0016020; GO:0030587; GO:0030670; GO:0031152; GO:0031267; GO:0032009; GO:0035556,aggregation involved in sorocarp development [GO:0031152]; intracellular signal transduction [GO:0035556]; sorocarp development [GO:0030587],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early phagosome [GO:0032009]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670],"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0005856; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,cytoskeleton; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_00031,1.545255141721411,FUN_000237-T1,Peve_00033367,Pocillopora_meandrina_HIv1___RNAseq.g28953.t1,three_way,74.7705,FUN_000237-T1,Q2KHR2,RFX7_HUMAN,,DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2),Homo sapiens (Human),45.1,255.0,3.3999999999999997e-47,191.8,sp|Q2KHR2|RFX7_HUMAN DNA-binding protein RFX7 OS=Homo sapiens OX=9606 GN=RFX7 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000979; GO:0000981; GO:0005634; GO:0006357; GO:0045944; GO:1990837,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_00037,1.2068077442056886,FUN_000247-T2,Peve_00033364,Pocillopora_meandrina_HIv1___RNAseq.g28974.t1,three_way,71.2625,FUN_000247-T2,P22045,,,,,36.9,271.0,1.1e-36,157.1,"sp|P22045|PGFS_LEIMA 9,11-endoperoxide prostaglandin H2 reductase OS=Leishmania major OX=5664 GN=P100/11E PE=1 SV=3",,,,,,
OG_00038,1.4378048747522816,FUN_000260-T1,Peve_00027791,Pocillopora_meandrina_HIv1___RNAseq.g28975.t1,three_way,62.275,FUN_000260-T1,Q3KPL3,,,,,33.9,165.0,2.7e-12,74.3,sp|Q3KPL3|LYSM2_XENLA LysM and putative peptidoglycan-binding domain-containing protein 2 OS=Xenopus laevis OX=8355 GN=lysmd2 PE=2 SV=2,,,,,,
OG_00039,1.402570544203745,FUN_000261-T1,Peve_00027784,Pocillopora_meandrina_HIv1___RNAseq.g28976.t1,three_way,77.24933333333334,,,,,,,,,,,,,,,,,
OG_00040,1.7239908541678448,FUN_000263-T1,Peve_00027785,Pocillopora_meandrina_HIv1___RNAseq.g28977.t2,three_way,82.65166666666667,FUN_000263-T1,Q5ZLW3,,,,,49.3,690.0,7.099999999999997e-175,615.5,sp|Q5ZLW3|DYM_CHICK Dymeclin OS=Gallus gallus OX=9031 GN=DYM PE=2 SV=1,,,,,,
OG_00042,1.6953733574236631,FUN_000265-T1,Peve_00027789,Pocillopora_meandrina_HIv1___RNAseq.g28979.t1,three_way,91.153,FUN_000265-T1,P84023,SMAD3_CHICK,,Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3),Gallus gallus (Chicken),74.9,430.0,5.4e-189,661.8,sp|P84023|SMAD3_CHICK Mothers against decapentaplegic homolog 3 OS=Gallus gallus OX=9031 GN=SMAD3 PE=2 SV=1,GO:0000978; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0009653; GO:0030154; GO:0032924; GO:0045944; GO:0046872; GO:0060395; GO:0070411; GO:0071141; GO:0071144,activin receptor signaling pathway [GO:0032924]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_00047,2.4017019137212103,FUN_000283-T1,Peve_00033555,Pocillopora_meandrina_HIv1___RNAseq.g29073.t1,three_way,79.09333333333333,FUN_000283-T1,Q9I8C7,,,,,46.3,322.0,4.6e-86,320.1,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_00051,1.1851007765121446,FUN_000320-T1,Peve_00033574,Pocillopora_meandrina_HIv1___RNAseq.g29014.t1,three_way,81.34316666666668,FUN_000320-T1,Q9Y4E6,,,,,41.7,1189.0,5.3e-228,792.7,sp|Q9Y4E6|WDR7_HUMAN WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=WDR7 PE=1 SV=2,,,,,,
OG_00056,1.348284990910076,FUN_000334-T1,Peve_00033540,Pocillopora_meandrina_HIv1___RNAseq.g29089.t1,three_way,52.14833333333333,FUN_000334-T1,Q6XHB2,ROCO4_DICDI,,Probable serine/threonine-protein kinase roco4 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 4),Dictyostelium discoideum (Social amoeba),25.8,419.0,1.4e-16,90.9,sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum OX=44689 GN=roco4 PE=1 SV=1,GO:0000302; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006120; GO:0007165; GO:0031150; GO:0042331; GO:0106310,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; phototaxis [GO:0042331]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]; sorocarp stalk development [GO:0031150]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005739; GO:0005829; GO:0006091; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; generation of precursor metabolites and energy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00059,1.365732390769834,FUN_000351-T1,Peve_00033536,Pocillopora_meandrina_HIv1___RNAseq.g29115.t1,three_way,75.824,FUN_000351-T1,Q8BLA8,TRPA1_MOUSE,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Mus musculus (Mouse),25.2,1062.0,6.900000000000001e-80,300.8,sp|Q8BLA8|TRPA1_MOUSE Transient receptor potential cation channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Trpa1 PE=1 SV=1,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_00060,1.0514204550192014,FUN_000352-T1,Peve_00033531,Pocillopora_meandrina_HIv1___RNAseq.g29116.t1,three_way,77.85483333333333,FUN_000352-T1,P18395,,,,,46.0,817.0,5.600000000000001e-180,632.9,sp|P18395|CSDE1_RAT Cold shock domain-containing protein E1 OS=Rattus norvegicus OX=10116 GN=Csde1 PE=2 SV=1,,,,,,
OG_00062,1.2900126792002296,FUN_000372-T1,Peve_00033530,Pocillopora_meandrina_HIv1___RNAseq.g29118.t1,three_way,91.26166666666668,FUN_000372-T1,P55258,RAB8A_MOUSE,,Ras-related protein Rab-8A (EC 3.6.5.2) (Oncogene c-mel),Mus musculus (Mouse),79.6,186.0,1.1e-80,300.8,sp|P55258|RAB8A_MOUSE Ras-related protein Rab-8A OS=Mus musculus OX=10090 GN=Rab8a PE=1 SV=2,GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005764; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0010008; GO:0010506; GO:0015629; GO:0019003; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031267; GO:0031489; GO:0032869; GO:0034451; GO:0036064; GO:0043005; GO:0043025; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055037; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098978; GO:0099003; GO:1990782,"autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; regulation of autophagy [GO:0010506]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]",actin cytoskeleton [GO:0015629]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network transport vesicle [GO:0030140],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein tyrosine kinase binding [GO:1990782]; small GTPase binding [GO:0031267],GO:0003824; GO:0003924; GO:0005654; GO:0005730; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0006886; GO:0006914; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0061024; GO:0072659,catalytic activity; GTPase activity; nucleoplasm; nucleolus; lysosome; endosome; vacuole; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; intracellular protein transport; autophagy; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; membrane organization; protein localization to plasma membrane
OG_00063,2.249573013494005,FUN_000374-T1,Peve_00033526,Pocillopora_meandrina_HIv1___TS.g6338.t1,three_way,32.86933333333334,FUN_000374-T1,Q96EQ9,,,,,33.5,254.0,3.2e-30,136.7,sp|Q96EQ9|PRDM9_MOUSE Histone-lysine N-methyltransferase PRDM9 OS=Mus musculus OX=10090 GN=Prdm9 PE=1 SV=2,,,,,,
OG_00067,1.3924513248025412,FUN_000387-T1,Peve_00033598,Pocillopora_meandrina_HIv1___TS.g6342.t3c,three_way,83.94266666666667,FUN_000387-T1,Q64512,PTN13_MOUSE,,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (PTP36) (Protein tyrosine phosphatase DPZPTP) (Protein tyrosine phosphatase PTP-BL) (Protein-tyrosine phosphatase RIP),Mus musculus (Mouse),28.3,1042.0,5.499999999999999e-90,334.0,sp|Q64512|PTN13_MOUSE Tyrosine-protein phosphatase non-receptor type 13 OS=Mus musculus OX=10090 GN=Ptpn13 PE=1 SV=2,GO:0004725; GO:0005634; GO:0005737; GO:0005856; GO:0030027; GO:0030496; GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634],protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005856; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00073,1.9957508101936992,FUN_000397-T1,Peve_00033585,Pocillopora_meandrina_HIv1___RNAseq.g2533.t1a,three_way,50.99,FUN_000397-T1,Q9H792,PEAK1_HUMAN,,Inactive tyrosine-protein kinase PEAK1 (Pseudopodium-enriched atypical kinase 1) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),Homo sapiens (Human),25.8,512.0,3.1e-32,142.9,sp|Q9H792|PEAK1_HUMAN Inactive tyrosine-protein kinase PEAK1 OS=Homo sapiens OX=9606 GN=PEAK1 PE=1 SV=4,GO:0004672; GO:0004715; GO:0005829; GO:0005925; GO:0015629; GO:0016477; GO:0034446; GO:0042802; GO:0046777; GO:0048041; GO:0051893; GO:2000145,cell migration [GO:0016477]; focal adhesion assembly [GO:0048041]; protein autophosphorylation [GO:0046777]; regulation of cell motility [GO:2000145]; regulation of focal adhesion assembly [GO:0051893]; substrate adhesion-dependent cell spreading [GO:0034446],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925],identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672],GO:0003824; GO:0005829; GO:0005856; GO:0007155; GO:0016740; GO:0034330; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; cytosol; cytoskeleton; cell adhesion; transferase activity; cell junction organization; organelle; cell motility; catalytic activity, acting on a protein"
OG_00077,2.70659548764095,FUN_000402-T1,Peve_00033527,Pocillopora_meandrina_HIv1___RNAseq.g2543.t1,three_way,81.73866666666666,FUN_000402-T1,Q9NYL9,,,,,46.9,130.0,2.2e-23,110.2,sp|Q9NYL9|TMOD3_HUMAN Tropomodulin-3 OS=Homo sapiens OX=9606 GN=TMOD3 PE=1 SV=1,,,,,,
OG_00078,1.0676644318493134,FUN_000403-T1,Peve_00033519,Pocillopora_meandrina_HIv1___RNAseq.g2544.t1,three_way,79.21583333333334,FUN_000403-T1,A0A0G2K2P5,ZO1_RAT,,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),Rattus norvegicus (Rat),28.2,1783.0,6.4e-140,500.7,sp|A0A0G2K2P5|ZO1_RAT Tight junction protein ZO-1 OS=Rattus norvegicus OX=10116 GN=Tjp1 PE=1 SV=1,GO:0001825; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005921; GO:0005923; GO:0007605; GO:0008013; GO:0008284; GO:0009410; GO:0009986; GO:0014704; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0031410; GO:0032496; GO:0032991; GO:0034334; GO:0036305; GO:0043066; GO:0043116; GO:0043296; GO:0044325; GO:0045177; GO:0045216; GO:0045471; GO:0046581; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0070830; GO:0071000; GO:0071253; GO:0071277; GO:0071333; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; bicellular tight junction assembly [GO:0070830]; blastocyst formation [GO:0001825]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; intercalated disc [GO:0014704]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; connexin binding [GO:0071253]; kinase activity [GO:0016301]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0003824; GO:0005634; GO:0005886; GO:0007010; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,circulatory system process; catalytic activity; nucleus; plasma membrane; cytoskeleton organization; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_00079,2.120913525062217,FUN_000407-T2,Peve_00033597,Pocillopora_meandrina_HIv1___RNAseq.g2545.t1,three_way,54.79116666666667,FUN_000407-T2,Q92859,NEO1_HUMAN,,Neogenin (Immunoglobulin superfamily DCC subclass member 2),Homo sapiens (Human),29.2,991.0,3.1e-102,374.8,sp|Q92859|NEO1_HUMAN Neogenin OS=Homo sapiens OX=9606 GN=NEO1 PE=1 SV=2,GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007155; GO:0007411; GO:0007520; GO:0009306; GO:0009986; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0045296; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550,"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; protein secretion [GO:0009306]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550]",cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839],BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023],GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0007155; GO:0023052; GO:0043226; GO:0048870; GO:0060089,nucleoplasm; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cell adhesion; signaling; organelle; cell motility; molecular transducer activity
OG_00080,1.4533510339807614,FUN_000408-T1,Peve_00033593,Pocillopora_meandrina_HIv1___RNAseq.g2518.t1,three_way,59.73233333333334,FUN_000408-T1,Q8BP40,,,,,33.6,390.0,5.7e-51,203.4,sp|Q8BP40|PPA6_MOUSE Lysophosphatidic acid phosphatase type 6 OS=Mus musculus OX=10090 GN=Acp6 PE=1 SV=1,,,,,,
OG_00081,2.600091197508408,FUN_000409-T1,Peve_00033505,Pocillopora_meandrina_HIv1___RNAseq.g2517.t1,three_way,55.74733333333334,FUN_000409-T1,Q6A044,,,,,26.9,312.0,9.8e-18,93.2,sp|Q6A044|EREP2_MOUSE Protein ENTREP2 OS=Mus musculus OX=10090 GN=Entrep2 PE=2 SV=3,,,,,,
OG_00085,1.913004059710847,FUN_000433-T1,Peve_00011195,Pocillopora_meandrina_HIv1___RNAseq.g2325.t1,three_way,73.84433333333334,FUN_000433-T1,P26714,,,,,33.7,291.0,2.3e-51,204.9,sp|P26714|GBRB_LYMST Gamma-aminobutyric acid receptor subunit beta OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_00087,2.562945813337824,FUN_000440-T1,Peve_00003439,Pocillopora_meandrina_HIv1___RNAseq.g2328.t2,three_way,87.82716666666667,FUN_000440-T1,P11029,,,,,63.2,2251.0,0.0,2921.0,sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1,,,,,,
OG_00091,1.1161950162057444,FUN_000449-T1,Peve_00019109,Pocillopora_meandrina_HIv1___RNAseq.g2337.t1,three_way,66.32566666666666,FUN_000449-T1,Q64378,FKBP5_MOUSE,,Peptidyl-prolyl cis-trans isomerase FKBP5 (PPIase FKBP5) (EC 5.2.1.8) (51 kDa FK506-binding protein) (51 kDa FKBP) (FKBP-51) (FK506-binding protein 5) (FKBP-5) (Rotamase),Mus musculus (Mouse),33.8,272.0,1.4000000000000001e-28,128.3,sp|Q64378|FKBP5_MOUSE Peptidyl-prolyl cis-trans isomerase FKBP5 OS=Mus musculus OX=10090 GN=Fkbp5 PE=1 SV=1,GO:0003755; GO:0005654; GO:0005829; GO:0009617; GO:0030674; GO:0031072; GO:0042220; GO:0061077; GO:0097305,chaperone-mediated protein folding [GO:0061077]; response to alcohol [GO:0097305]; response to bacterium [GO:0009617]; response to cocaine [GO:0042220],cytosol [GO:0005829]; nucleoplasm [GO:0005654],heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005654; GO:0005829; GO:0016853; GO:0060090; GO:0140096,"catalytic activity; nucleoplasm; cytosol; isomerase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_00092,1.427218280198847,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),34.1,695.0,4.9e-100,368.2,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00092,1.427218280198847,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),47.9,71.0,4.6e-13,79.3,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00100,1.507768309415359,FUN_000483-T1,Peve_00038235,Pocillopora_meandrina_HIv1___RNAseq.g2342.t1,three_way,68.861,FUN_000483-T1,Q8CFV2,,,,,27.0,559.0,5.399999999999999e-31,137.5,sp|Q8CFV2|F149A_MOUSE Protein FAM149A OS=Mus musculus OX=10090 GN=Fam149a PE=2 SV=1,,,,,,
OG_00103,1.3545056097848165,FUN_000489-T1,Peve_00043825,Pocillopora_meandrina_HIv1___TS.g4918.t1,three_way,64.97083333333333,FUN_000489-T1,Q12923,,,,,26.7,2887.0,7.2e-210,733.8,sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2,,,,,,
OG_00104,1.1808588207004345,FUN_000490-T1,Peve_00043823,Pocillopora_meandrina_HIv1___RNAseq.g2411.t1,three_way,66.018,,,,,,,,,,,,,,,,,
OG_00107,1.9286457950829432,FUN_000499-T1,Peve_00024155,Pocillopora_meandrina_HIv1___RNAseq.g2414.t1,three_way,82.06683333333332,FUN_000499-T1,Q14432,PDE3A_HUMAN,,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)",Homo sapiens (Human),37.6,1034.0,2.2e-143,511.5,"sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A OS=Homo sapiens OX=9606 GN=PDE3A PE=1 SV=3",GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162,apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; membrane [GO:0016020],"3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284]",GO:0003013; GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0022414; GO:0060089; GO:0140110,circulatory system process; catalytic activity; cytosol; lipid metabolic process; hydrolase activity; reproductive process; molecular transducer activity; transcription regulator activity
OG_00111,1.2896086375048204,FUN_000503-T1,Peve_00043531,Pocillopora_meandrina_HIv1___RNAseq.g18598.t1,three_way,56.31033333333333,,,,,,,,,,,,,,,,,
OG_00115,2.735353763531144,FUN_000533-T1,Peve_00039811,Pocillopora_meandrina_HIv1___RNAseq.g2384.t1,three_way,81.9405,FUN_000533-T1,P20693,,,,,34.0,147.0,3.6e-17,94.0,sp|P20693|FCER2_MOUSE Low affinity immunoglobulin epsilon Fc receptor OS=Mus musculus OX=10090 GN=Fcer2 PE=1 SV=1,,,,,,
OG_00117,1.1273293485142872,FUN_000535-T1,Peve_00039805,Pocillopora_meandrina_HIv1___TS.g4883.t1,three_way,45.208,FUN_000535-T1,Q9Z2D7,,,,,27.8,399.0,2.5e-21,104.4,sp|Q9Z2D7|MBD4_MOUSE Methyl-CpG-binding domain protein 4 OS=Mus musculus OX=10090 GN=Mbd4 PE=1 SV=1,,,,,,
OG_00119,2.9014863125194887,FUN_000537-T1,Peve_00039797,Pocillopora_meandrina_HIv1___RNAseq.g2375.t1,three_way,66.51866666666668,FUN_000537-T1,Q56A06,,,,,51.3,710.0,5.7e-140,500.0,sp|Q56A06|TMTC2_MOUSE Protein O-mannosyl-transferase TMTC2 OS=Mus musculus OX=10090 GN=Tmtc2 PE=2 SV=1,,,,,,
OG_00122,1.6792422833888083,FUN_000542-T1,Peve_00039829,Pocillopora_meandrina_HIv1___RNAseq.g2370.t1,three_way,61.55866666666667,FUN_000542-T1,P40657,,,,,45.3,148.0,5.2e-26,120.2,sp|P40657|SOX15_DROME Putative transcription factor SOX-15 OS=Drosophila melanogaster OX=7227 GN=Sox15 PE=2 SV=2,,,,,,
OG_00126,1.1350062392907283,FUN_000550-T1,Peve_00039823,Pocillopora_meandrina_HIv1___RNAseq.g2362.t1,three_way,66.874,FUN_000550-T1,Q923Y6,,,,,23.8,332.0,7.3e-11,69.7,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_00127,1.8044823944527548,FUN_000554-T1,Peve_00039816,Pocillopora_meandrina_HIv1___RNAseq.g2466.t1,three_way,58.334,,,,,,,,,,,,,,,,,
OG_00133,1.5125548400124955,FUN_000564-T1,Peve_00041880,Pocillopora_meandrina_HIv1___TS.g4968.t1,three_way,70.89666666666666,,,,,,,,,,,,,,,,,
OG_00134,1.0904061301647507,FUN_000568-T1,Peve_00034143,Pocillopora_meandrina_HIv1___RNAseq.g2453.t1,three_way,59.7515,FUN_000568-T1,Q99816,TS101_HUMAN,,Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101),Homo sapiens (Human),36.5,307.0,1e-30,135.6,sp|Q99816|TS101_HUMAN Tumor susceptibility gene 101 protein OS=Homo sapiens OX=9606 GN=TSG101 PE=1 SV=2,GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005813; GO:0005829; GO:0005886; GO:0006858; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0016236; GO:0019076; GO:0030216; GO:0031625; GO:0031901; GO:0031902; GO:0036211; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043328; GO:0043405; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090148; GO:0090543; GO:0097352; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397,autophagosome maturation [GO:0097352]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein modification process [GO:0036211]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790],GO:0003677; GO:0005730; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0006914; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0140110,DNA binding; nucleolus; endosome; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; autophagy; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; transcription regulator activity
OG_00137,1.0064769666186562,FUN_000574-T1,Peve_00034745,Pocillopora_meandrina_HIv1___TS.g4950.t1,three_way,68.503,FUN_000574-T1,Q54KD0,,,,,25.7,904.0,1.7e-76,289.7,sp|Q54KD0|Y7407_DICDI TPR repeat-containing protein DDB_G0287407 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0287407 PE=4 SV=1,,,,,,
OG_00138,1.2846664758830466,FUN_000576-T1,Peve_00034748,Pocillopora_meandrina_HIv1___RNAseq.g2437.t1,three_way,77.08166666666666,FUN_000576-T1,Q9Z2D5,,,,,34.0,247.0,6.199999999999997e-29,129.4,sp|Q9Z2D5|NPY2R_CAVPO Neuropeptide Y receptor type 2 OS=Cavia porcellus OX=10141 GN=NPY2R PE=3 SV=1,,,,,,
OG_00139,1.274234392248565,FUN_000577-T1,Peve_00034749,Pocillopora_meandrina_HIv1___RNAseq.g2436.t1,three_way,60.07216666666667,,,,,,,,,,,,,,,,,
OG_00143,1.5860881772588484,FUN_000585-T1,Peve_00034705,Pocillopora_meandrina_HIv1___RNAseq.g29297.t1,three_way,50.52733333333334,FUN_000585-T1,Q6TLH3,,,,,33.4,326.0,2.6999999999999997e-31,137.5,sp|Q6TLH3|CUED2_DANRE CUE domain-containing protein 2 OS=Danio rerio OX=7955 GN=cuedc2 PE=2 SV=1,,,,,,
OG_00144,1.6077628139517366,FUN_000586-T1,Peve_00025314,Pocillopora_meandrina_HIv1___TS.g6498.t2,three_way,63.92666666666666,FUN_000586-T1,O00339,MATN2_HUMAN,,Matrilin-2,Homo sapiens (Human),30.2,192.0,2.3e-14,82.4,sp|O00339|MATN2_HUMAN Matrilin-2 OS=Homo sapiens OX=9606 GN=MATN2 PE=1 SV=4,GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_00145,2.192796239314324,FUN_000588-T1,Peve_00025320,Pocillopora_meandrina_HIv1___RNAseq.g29293.t3,three_way,87.40333333333334,FUN_000588-T1,P28347,TEAD1_HUMAN,,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),Homo sapiens (Human),65.6,450.0,3.6000000000000002e-146,519.6,sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837,embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_00152,1.1091826037090298,FUN_000606-T1,Peve_00041267,Pocillopora_meandrina_HIv1___RNAseq.13383_t,three_way,76.453,FUN_000606-T1,Q9DA37,SAMD8_MOUSE,,Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8),Mus musculus (Mouse),52.1,411.0,1.9e-114,414.1,sp|Q9DA37|SAMD8_MOUSE Sphingomyelin synthase-related protein 1 OS=Mus musculus OX=10090 GN=Samd8 PE=1 SV=1,GO:0002950; GO:0005789; GO:0006686; GO:0016020; GO:0046513; GO:1905373; GO:2000303,ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingomyelin biosynthetic process [GO:0006686],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],ceramide phosphoethanolamine synthase activity [GO:0002950],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_00157,1.2152978736964657,FUN_000612-T1,Peve_00023943,Pocillopora_meandrina_HIv1___RNAseq.g1719.t1,three_way,81.25433333333334,FUN_000612-T1,Q8N7B6,PACRL_HUMAN,,PACRG-like protein,Homo sapiens (Human),61.2,206.0,1.6e-61,237.3,sp|Q8N7B6|PACRL_HUMAN PACRG-like protein OS=Homo sapiens OX=9606 GN=PACRGL PE=1 SV=2,,,,,,
OG_00158,1.156727382832418,FUN_000614-T1,Peve_00036774,Pocillopora_meandrina_HIv1___RNAseq.g1715.t1,three_way,67.67916666666667,FUN_000614-T1,Q5ZLL7,,,,,44.8,397.0,5.2999999999999996e-92,340.1,sp|Q5ZLL7|WDR91_CHICK WD repeat-containing protein 91 OS=Gallus gallus OX=9031 GN=WDR91 PE=2 SV=1,,,,,,
OG_00159,1.5143687132432606,FUN_000616-T1,Peve_00036773,Pocillopora_meandrina_HIv1___RNAseq.g1713.t1,three_way,72.57533333333333,FUN_000616-T1,P31729,,,,,58.0,162.0,2.7e-51,203.0,sp|P31729|OV16_ONCVO OV-16 antigen OS=Onchocerca volvulus OX=6282 GN=OV16 PE=2 SV=2,,,,,,
OG_00164,2.149057575549382,FUN_000639-T1,Peve_00011494,Pocillopora_meandrina_HIv1___RNAseq.g1868.t2,three_way,79.212,FUN_000639-T1,Q9EQQ9,,,,,39.0,918.0,1.2000000000000001e-180,635.2,sp|Q9EQQ9|OGA_MOUSE Protein O-GlcNAcase OS=Mus musculus OX=10090 GN=Oga PE=1 SV=2,,,,,,
OG_00166,1.924013135568937,FUN_000641-T1,Peve_00012249,Pocillopora_meandrina_HIv1___TS.g17921.t4,three_way,55.0825,FUN_000641-T1,A6QLA0,,,,,45.6,780.0,1.1e-188,662.1,sp|A6QLA0|NFX1_BOVIN Transcriptional repressor NF-X1 OS=Bos taurus OX=9913 GN=NFX1 PE=2 SV=1,,,,,,
OG_00171,1.293525321305809,FUN_000857-T1,Peve_00004526,Pocillopora_meandrina_HIv1___RNAseq.g1863.t1,three_way,95.30166666666666,FUN_000857-T1,P61162,,,,,85.9,376.0,7.4e-198,691.0,sp|P61162|ACTZ_CANLF Alpha-centractin OS=Canis lupus familiaris OX=9615 GN=ACTR1A PE=2 SV=1,,,,,,
OG_00173,1.073997077609381,FUN_000861-T1,Peve_00004523,Pocillopora_meandrina_HIv1___RNAseq.g1861.t1,three_way,52.99133333333333,,,,,,,,,,,,,,,,,
OG_00174,1.5718235875265754,FUN_000862-T1,Peve_00004534,Pocillopora_meandrina_HIv1___RNAseq.g1860.t1,three_way,73.89966666666666,FUN_000862-T1,Q9NTM9,CUTC_HUMAN,,Copper homeostasis protein cutC homolog,Homo sapiens (Human),62.0,245.0,3.3e-85,316.2,sp|Q9NTM9|CUTC_HUMAN Copper homeostasis protein cutC homolog OS=Homo sapiens OX=9606 GN=CUTC PE=1 SV=1,GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070,copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],copper ion binding [GO:0005507],GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0043226; GO:0065003,nucleus; nucleoplasm; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_00177,1.0728990830335048,FUN_000870-T1,Peve_00002066,Pocillopora_meandrina_HIv1___RNAseq.g1813.t1,three_way,92.69433333333332,FUN_000870-T1,P55039,DRG2_HUMAN,,Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-),Homo sapiens (Human),78.6,364.0,2.1000000000000002e-165,583.2,sp|P55039|DRG2_HUMAN Developmentally-regulated GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=DRG2 PE=1 SV=1,GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0043231; GO:0046872,cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],GO:0002181; GO:0003723; GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226,cytoplasmic translation; RNA binding; catalytic activity; GTPase activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle
OG_00178,1.5790181028586514,FUN_000871-T1,Peve_00002056,Pocillopora_meandrina_HIv1___RNAseq.g1814.t1,three_way,62.229,FUN_000871-T1,A6QPC8,,,,,34.4,323.0,5.6e-35,149.8,sp|A6QPC8|EID3_BOVIN EP300-interacting inhibitor of differentiation 3 OS=Bos taurus OX=9913 GN=EID3 PE=2 SV=1,,,,,,
OG_00181,1.200558983074237,FUN_000876-T1,Peve_00039671,Pocillopora_meandrina_HIv1___RNAseq.g29425.t1,three_way,67.38333333333334,FUN_000876-T1,Q6PFL8,,,,,72.5,171.0,1.4e-71,270.8,sp|Q6PFL8|THYN1_DANRE Thymocyte nuclear protein 1 OS=Danio rerio OX=7955 GN=thyn1 PE=2 SV=1,,,,,,
OG_00182,1.1169214632021218,FUN_000877-T1,Peve_00039677,Pocillopora_meandrina_HIv1___RNAseq.g29428.t1,three_way,82.03933333333333,FUN_000877-T1,Q86AQ7,,,,,42.2,211.0,5.0000000000000005e-37,156.0,sp|Q86AQ7|VAM7B_DICDI Vesicle-associated membrane protein 7B OS=Dictyostelium discoideum OX=44689 GN=vamp7B PE=3 SV=1,,,,,,
OG_00186,1.42574690812714,FUN_000885-T1,Peve_00029323,Pocillopora_meandrina_HIv1___RNAseq.g29436.t1,three_way,58.51866666666667,,,,,,,,,,,,,,,,,
OG_00188,1.4307641140478082,FUN_000892-T1,Peve_00026758,Pocillopora_meandrina_HIv1___RNAseq.g29444.t1,three_way,81.38833333333334,,,,,,,,,,,,,,,,,
OG_00191,1.247781865628223,FUN_000896-T1,Peve_00009744,Pocillopora_meandrina_HIv1___TS.g6634.t1,three_way,41.8635,,,,,,,,,,,,,,,,,
OG_00195,2.0763523610985635,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00196,2.1297920726660187,FUN_000908-T1,Peve_00010044,Pocillopora_meandrina_HIv1___RNAseq.g29495.t1,three_way,77.85966666666667,FUN_000908-T1,Q8QG61,,,,,64.7,499.0,3.3e-210,732.6,sp|Q8QG61|CRY1_CHICK Cryptochrome-1 OS=Gallus gallus OX=9031 GN=CRY1 PE=2 SV=1,,,,,,
OG_00199,1.2942852701141818,FUN_000912-T1,Peve_00010054,Pocillopora_meandrina_HIv1___RNAseq.g29489.t1,three_way,68.19866666666667,FUN_000912-T1,Q8BSF5,,,,,22.8,479.0,1.7e-26,122.9,sp|Q8BSF5|KLH38_MOUSE Kelch-like protein 38 OS=Mus musculus OX=10090 GN=Klhl38 PE=2 SV=1,,,,,,
OG_00201,2.435703649032081,FUN_000915-T1,Peve_00044966,Pocillopora_meandrina_HIv1___RNAseq.g29485.t1,three_way,71.85666666666667,,,,,,,,,,,,,,,,,
OG_00203,1.3448933433903958,FUN_000918-T1,Peve_00044972,Pocillopora_meandrina_HIv1___RNAseq.g29483.t1,three_way,64.11866666666667,,,,,,,,,,,,,,,,,
OG_00207,1.6132945955296063,FUN_000926-T1,Peve_00009718,Pocillopora_meandrina_HIv1___RNAseq.g29467.t1,three_way,63.42333333333334,FUN_000926-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),29.5,319.0,9.100000000000001e-33,142.9,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_00212,1.5394946014783424,FUN_000931-T1,Peve_00009723,Pocillopora_meandrina_HIv1___RNAseq.g29462.t1,three_way,72.855,FUN_000931-T1,Q5E9J5,DHCR7_BOVIN,,"7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Cholesterol-5,6-epoxide hydrolase subunit DHCR7) (EC 3.3.2.11) (Sterol Delta(7)-reductase)",Bos taurus (Bovine),50.6,437.0,1.1000000000000002e-124,448.4,sp|Q5E9J5|DHCR7_BOVIN 7-dehydrocholesterol reductase OS=Bos taurus OX=9913 GN=DHCR7 PE=2 SV=1,GO:0005640; GO:0005789; GO:0006695; GO:0033490; GO:0033963; GO:0047598; GO:0050661; GO:0160020,cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via lathosterol [GO:0033490]; positive regulation of ferroptosis [GO:0160020],endoplasmic reticulum membrane [GO:0005789]; nuclear outer membrane [GO:0005640],"7-dehydrocholesterol reductase activity [GO:0047598]; cholesterol-5,6-oxide hydrolase activity [GO:0033963]; NADP binding [GO:0050661]",GO:0003824; GO:0006629; GO:0016491; GO:0016787,catalytic activity; lipid metabolic process; oxidoreductase activity; hydrolase activity
OG_00213,2.1121971261741423,FUN_000932-T1,Peve_00009724,Pocillopora_meandrina_HIv1___RNAseq.g29460.t1,three_way,85.761,FUN_000932-T1,P00516,,,,,65.8,619.0,1.3e-240,833.9,sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus OX=9913 GN=PRKG1 PE=1 SV=2,,,,,,
OG_00214,1.4581602863577805,FUN_000933-T1,Peve_00009727,Pocillopora_meandrina_HIv1___RNAseq.g29459.t1,three_way,43.35483333333333,,,,,,,,,,,,,,,,,
OG_00215,2.1033569925625883,FUN_000934-T1,Peve_00009728,Pocillopora_meandrina_HIv1___RNAseq.g29458.t1,three_way,74.37933333333334,FUN_000934-T1,Q9BW85,YJU2_HUMAN,,Splicing factor YJU2 (Coiled-coil domain-containing protein 94),Homo sapiens (Human),68.8,173.0,7.7e-64,245.7,sp|Q9BW85|YJU2_HUMAN Splicing factor YJU2 OS=Homo sapiens OX=9606 GN=YJU2 PE=1 SV=1,GO:0000349; GO:0005654; GO:0008380; GO:0043518; GO:0046872; GO:0071006,"generation of catalytic spliceosome for first transesterification step [GO:0000349]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]",nucleoplasm [GO:0005654]; U2-type catalytic step 1 spliceosome [GO:0071006],metal ion binding [GO:0046872],GO:0005654; GO:0065003,nucleoplasm; protein-containing complex assembly
OG_00216,1.1529991133138944,FUN_000935-T1,Peve_00009730,Pocillopora_meandrina_HIv1___RNAseq.g29457.t1,three_way,84.785,FUN_000935-T1,Q5ZL33,STRAP_CHICK,,Serine-threonine kinase receptor-associated protein,Gallus gallus (Chicken),63.8,304.0,4.3e-114,412.5,sp|Q5ZL33|STRAP_CHICK Serine-threonine kinase receptor-associated protein OS=Gallus gallus OX=9031 GN=STRAP PE=2 SV=2,GO:0000122; GO:0000380; GO:0000387; GO:0003723; GO:0003729; GO:0005102; GO:0005634; GO:0005829; GO:0030182; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:1990447,"alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; spliceosomal snRNP assembly [GO:0000387]",cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; U2 snRNP binding [GO:1990447],GO:0003723; GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0022600; GO:0030154; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; digestive system process; cell differentiation; organelle; protein-containing complex assembly
OG_00226,1.3368293569669971,FUN_000961-T1,Peve_00008026,Pocillopora_meandrina_HIv1___TS.g5059.t2,three_way,69.25816666666667,FUN_000961-T1,Q26613,,,,,43.4,632.0,3.5e-159,563.9,sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1,,,,,,
OG_00227,1.8078822219396105,FUN_000962-T1,Peve_00008025,Pocillopora_meandrina_HIv1___TS.g5027.t1,three_way,64.00016666666667,FUN_000962-T1,O73606,,,,,40.3,77.0,1.3e-06,56.2,sp|O73606|KCNG2_CHICK Voltage-gated potassium channel regulatory subunit KCNG2 OS=Gallus gallus OX=9031 GN=KCNG2 PE=2 SV=1,,,,,,
OG_00234,3.079332511162163,FUN_000988-T1,Peve_00022149,Pocillopora_meandrina_HIv1___RNAseq.g29209.t1,three_way,82.41166666666666,FUN_000988-T1,Q92828,,,,,47.6,401.0,3.4e-101,370.5,sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2,,,,,,
OG_00237,1.6284387997077543,FUN_000992-T1,Peve_00004455,Pocillopora_meandrina_HIv1___RNAseq.g29194.t1,three_way,92.068,FUN_000992-T1,P82471,GNAQ_RAT,,Guanine nucleotide-binding protein G(q) subunit alpha (EC 3.6.5.-) (Guanine nucleotide-binding protein alpha-q),Rattus norvegicus (Rat),82.2,353.0,8.9e-169,594.3,sp|P82471|GNAQ_RAT Guanine nucleotide-binding protein G(q) subunit alpha OS=Rattus norvegicus OX=10116 GN=Gnaq PE=2 SV=2,GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0003925; GO:0005096; GO:0005525; GO:0005737; GO:0005794; GO:0005834; GO:0005886; GO:0005901; GO:0007186; GO:0007189; GO:0007200; GO:0007206; GO:0007207; GO:0007208; GO:0007215; GO:0007218; GO:0007507; GO:0008217; GO:0009791; GO:0010543; GO:0016020; GO:0016322; GO:0021884; GO:0030234; GO:0030425; GO:0031683; GO:0031965; GO:0032024; GO:0034695; GO:0042711; GO:0042733; GO:0043066; GO:0043267; GO:0044297; GO:0044877; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0050821; GO:0060158; GO:0060828; GO:0086100; GO:0098793; GO:0099524; GO:1904888; GO:1990806,action potential [GO:0001508]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; endothelin receptor signaling pathway [GO:0086100]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; ligand-gated ion channel signaling pathway [GO:1990806]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; neuron remodeling [GO:0016322]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of insulin secretion [GO:0032024]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of blood pressure [GO:0008217]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; regulation of platelet activation [GO:0010543]; response to prostaglandin E [GO:0034695]; skeletal system development [GO:0001501],caveola [GO:0005901]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynapse [GO:0098793],alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; enzyme regulator activity [GO:0030234]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_00238,2.0243811763947392,FUN_000994-T1,Peve_00004444,Pocillopora_meandrina_HIv1___RNAseq.g29192.t1,three_way,83.734,,,,,,,,,,,,,,,,,
OG_00240,2.119391503176017,FUN_000996-T1,Peve_00004446,Pocillopora_meandrina_HIv1___RNAseq.g29189.t1,three_way,48.307833333333335,,,,,,,,,,,,,,,,,
OG_00242,1.1993519440021536,FUN_001005-T1,Peve_00015285,Pocillopora_meandrina_HIv1___TS.g6390.t1,three_way,40.208,,,,,,,,,,,,,,,,,
OG_00243,2.025295158921338,FUN_001006-T1,Peve_00015278,Pocillopora_meandrina_HIv1___RNAseq.g29174.t1,three_way,60.991,FUN_001006-T1,Q498G2,,,,,27.4,727.0,1.3e-40,171.0,sp|Q498G2|CE152_XENLA Centrosomal protein of 152 kDa OS=Xenopus laevis OX=8355 GN=cep152 PE=2 SV=1,,,,,,
OG_00245,1.5767124652548237,FUN_001008-T1,Peve_00015281,Pocillopora_meandrina_HIv1___RNAseq.g29171.t1,three_way,51.759,,,,,,,,,,,,,,,,,
OG_00246,1.7635536763404556,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_00248,1.440264816934773,FUN_001011-T1,Peve_00041060,Pocillopora_meandrina_HIv1___RNAseq.g29164.t1,three_way,70.763,FUN_001011-T1,Q6ZUX7,LHPL2_HUMAN,,LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein),Homo sapiens (Human),43.1,232.0,6.4e-43,175.6,sp|Q6ZUX7|LHPL2_HUMAN LHFPL tetraspan subfamily member 2 protein OS=Homo sapiens OX=9606 GN=LHFPL2 PE=1 SV=2,GO:0005886; GO:0007338; GO:0016020; GO:0031092; GO:0046545; GO:0046546; GO:1905516,development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338],membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092],,GO:0005886; GO:0022414,plasma membrane; reproductive process
OG_00249,1.3278804208249324,FUN_001012-T1,Peve_00041036,Pocillopora_meandrina_HIv1___TS.g6378.t1,three_way,76.26333333333334,FUN_001012-T1,P49641,MA2A2_HUMAN,,"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",Homo sapiens (Human),44.9,1158.0,9.3e-292,1004.6,sp|P49641|MA2A2_HUMAN Alpha-mannosidase 2x OS=Homo sapiens OX=9606 GN=MAN2A2 PE=1 SV=3,GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0016799; GO:0030246; GO:0046872,mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486],Golgi membrane [GO:0000139],"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]",GO:0003824; GO:0005975; GO:0006486; GO:0009101; GO:0016787; GO:1901135,catalytic activity; carbohydrate metabolic process; protein glycosylation; glycoprotein biosynthetic process; hydrolase activity; carbohydrate derivative metabolic process
OG_00250,1.102265532322988,FUN_001013-T1,Peve_00041041,Pocillopora_meandrina_HIv1___RNAseq.g29162.t1,three_way,71.989,FUN_001013-T1,Q5R6Z8,CYBP_PONAB,,Calcyclin-binding protein (CacyBP),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),42.5,221.0,1.6000000000000001e-38,161.0,sp|Q5R6Z8|CYBP_PONAB Calcyclin-binding protein OS=Pongo abelii OX=9601 GN=CACYBP PE=2 SV=1,GO:0005634; GO:0005737; GO:0007507; GO:0015631; GO:0031625; GO:0044548,heart development [GO:0007507],cytoplasm [GO:0005737]; nucleus [GO:0005634],S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0008092; GO:0043226; GO:0048856,nucleus; cytoskeletal protein binding; organelle; anatomical structure development
OG_00252,2.849491717014613,FUN_001016-T1,Peve_00041043,Pocillopora_meandrina_HIv1___RNAseq.g29160.t1,three_way,48.55133333333333,FUN_001016-T1,Q0IHU9,,,,,42.9,203.0,7.6e-44,180.6,sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1,,,,,,
OG_00253,1.761413414610798,FUN_001017-T2,Peve_00041044,Pocillopora_meandrina_HIv1___RNAseq.g29159.t1,three_way,66.55,,,,,,,,,,,,,,,,,
OG_00255,1.544765608919337,FUN_001019-T1,Peve_00041047,Pocillopora_meandrina_HIv1___RNAseq.g29550.t1,three_way,74.728,FUN_001019-T1,E1C1R4,,,,,44.2,1361.0,1.6999999999999999e-301,1036.9,sp|E1C1R4|UBP47_CHICK Ubiquitin carboxyl-terminal hydrolase 47 OS=Gallus gallus OX=9031 GN=USP47 PE=3 SV=1,,,,,,
OG_00258,2.728355180019045,FUN_001025-T1,Peve_00041055,Pocillopora_meandrina_HIv1___RNAseq.g16888.t1,three_way,40.96733333333333,,,,,,,,,,,,,,,,,
OG_00259,2.3643211629582903,FUN_001028-T1,Peve_00041059,Pocillopora_meandrina_HIv1___RNAseq.g29614.t1,three_way,51.323,,,,,,,,,,,,,,,,,
OG_00260,1.4738143663267402,FUN_001031-T1,Peve_00041063,Pocillopora_meandrina_HIv1___RNAseq.g29618.t2,three_way,62.334,,,,,,,,,,,,,,,,,
OG_00266,1.8768543697527784,FUN_001044-T1,Peve_00041039,Pocillopora_meandrina_HIv1___TS.g6802.t1a,three_way,45.7765,,,,,,,,,,,,,,,,,
OG_00267,1.361862397739952,FUN_001046-T1,Peve_00041040,Pocillopora_meandrina_HIv1___TS.g6802.t1b,three_way,57.10733333333334,,,,,,,,,,,,,,,,,
OG_00270,1.20372435496331,FUN_001049-T1,Peve_00021554,Pocillopora_meandrina_HIv1___RNAseq.g29627.t1,three_way,71.21166666666667,FUN_001049-T1,P28039,AOAH_HUMAN,,Acyloxyacyl hydrolase (EC 3.1.1.77) [Cleaved into: Acyloxyacyl hydrolase small subunit; Acyloxyacyl hydrolase large subunit],Homo sapiens (Human),42.7,583.0,9.299999999999999e-139,495.4,sp|P28039|AOAH_HUMAN Acyloxyacyl hydrolase OS=Homo sapiens OX=9606 GN=AOAH PE=1 SV=1,GO:0005509; GO:0005576; GO:0006631; GO:0009104; GO:0031410; GO:0050528; GO:0050728,fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]; negative regulation of inflammatory response [GO:0050728],cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576],acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509],GO:0003824; GO:0005576; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:1901135,catalytic activity; extracellular region; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; carbohydrate derivative metabolic process
OG_00271,1.2796510467539235,FUN_001051-T1,Peve_00021557,Pocillopora_meandrina_HIv1___RNAseq.g29625.t1,three_way,81.868,FUN_001051-T1,Q92738,US6NL_HUMAN,,USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre),Homo sapiens (Human),57.3,372.0,8.9e-118,425.6,sp|Q92738|US6NL_HUMAN USP6 N-terminal-like protein OS=Homo sapiens OX=9606 GN=USP6NL PE=1 SV=3,GO:0005096; GO:0005829; GO:0005886; GO:0007030; GO:0019068; GO:0031267; GO:0031410; GO:0032588; GO:0035526; GO:0043547; GO:0048227; GO:1903358,"Golgi organization [GO:0007030]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]",cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_00274,1.0299383394114698,FUN_001054-T1,Peve_00023871,Pocillopora_meandrina_HIv1___RNAseq.g29645.t1,three_way,68.80666666666667,,,,,,,,,,,,,,,,,
OG_00276,1.1076670831314683,FUN_001061-T2,Peve_00005407,Pocillopora_meandrina_HIv1___RNAseq.g29648.t1,three_way,69.14066666666666,FUN_001061-T2,P22758,,,,,40.8,686.0,2.1999999999999998e-142,508.1,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00279,2.3950700381812005,FUN_001064-T1,Peve_00005413,Pocillopora_meandrina_HIv1___RNAseq.g29653.t1,three_way,61.42933333333333,FUN_001064-T1,P22758,,,,,41.1,671.0,1.3e-132,475.3,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00280,2.339985608200888,FUN_001066-T1,Peve_00018849,Pocillopora_meandrina_HIv1___RNAseq.g29655.t1,three_way,63.10516666666666,FUN_001066-T1,P22758,,,,,39.4,695.0,3.2e-132,474.2,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00281,1.7995678242428936,FUN_001067-T1,Peve_00029706,Pocillopora_meandrina_HIv1___RNAseq.g29656.t1,three_way,64.9165,FUN_001067-T1,A0AVK6,E2F8_HUMAN,,Transcription factor E2F8 (E2F-8),Homo sapiens (Human),40.1,304.0,1.1e-41,173.3,sp|A0AVK6|E2F8_HUMAN Transcription factor E2F8 OS=Homo sapiens OX=9606 GN=E2F8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0048144; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837,cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0000278; GO:0003677; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,mitotic cell cycle; DNA binding; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00286,2.1254578124357373,FUN_001076-T1,Peve_00037405,Pocillopora_meandrina_HIv1___RNAseq.g2716.t1,three_way,76.12899999999999,FUN_001076-T1,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.4,850.0,1.3999999999999999e-187,658.3,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_00287,1.1746752717141145,FUN_001077-T1,Peve_00037392,Pocillopora_meandrina_HIv1___TS.g5224.t1,three_way,47.706,FUN_001077-T1,P13233,CN37_RAT,,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",Rattus norvegicus (Rat),28.8,416.0,1e-38,162.9,"sp|P13233|CN37_RAT 2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Rattus norvegicus OX=10116 GN=Cnp PE=1 SV=2",GO:0003723; GO:0004113; GO:0005615; GO:0005737; GO:0005741; GO:0005743; GO:0005902; GO:0007409; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0042995; GO:0043209; GO:0046902; GO:0048471; GO:0048709,adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143],"2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]",GO:0003723; GO:0003824; GO:0005615; GO:0007005; GO:0016787; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:0061024,RNA binding; catalytic activity; extracellular space; mitochondrion organization; hydrolase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; membrane organization
OG_00290,1.2609810244492423,FUN_001081-T1,Peve_00037397,Pocillopora_meandrina_HIv1___RNAseq.g2712.t1,three_way,88.91366666666667,FUN_001081-T1,Q13557,,,,,72.0,468.0,8.2e-197,688.0,sp|Q13557|KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens OX=9606 GN=CAMK2D PE=1 SV=3,,,,,,
OG_00291,1.758672085688746,FUN_001082-T1,Peve_00037398,Pocillopora_meandrina_HIv1___RNAseq.g2711.t1,three_way,87.09333333333333,FUN_001082-T1,Q6DKC0,,,,,71.6,327.0,1.3000000000000002e-124,447.6,sp|Q6DKC0|ERL2B_XENLA Erlin-2-B OS=Xenopus laevis OX=8355 GN=erlin2-b PE=2 SV=1,,,,,,
OG_00304,1.1782486055284342,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_00305,1.106468207034024,FUN_001107-T1,Peve_00029366,Pocillopora_meandrina_HIv1___RNAseq.g29366.t1,three_way,86.59933333333333,FUN_001107-T1,Q9GZN1,ARP6_HUMAN,,Actin-related protein 6 (hArp6) (hARPX),Homo sapiens (Human),60.3,398.0,3.2e-143,509.6,sp|Q9GZN1|ARP6_HUMAN Actin-related protein 6 OS=Homo sapiens OX=9606 GN=ACTR6 PE=1 SV=1,GO:0000786; GO:0000812; GO:0005634; GO:0005730; GO:0005737; GO:0005856; GO:0006338; GO:0006355; GO:0007000; GO:0016479; GO:0031491; GO:0045943,chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleolus organization [GO:0007000]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of DNA-templated transcription [GO:0006355],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812],nucleosome binding [GO:0031491],GO:0005634; GO:0005730; GO:0005856; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleolus; cytoskeleton; chromatin organization; regulation of DNA-templated transcription; organelle
OG_00308,3.2662295766794736,FUN_001110-T1,Peve_00029335,Pocillopora_meandrina_HIv1___RNAseq.g29363.t1,three_way,71.534,FUN_001110-T1,P15384,,,,,49.9,407.0,2.3e-84,314.7,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_00313,1.2519462144621796,FUN_001116-T2,Peve_00029365,Pocillopora_meandrina_HIv1___RNAseq.g29354.t1,three_way,60.4465,FUN_001116-T2,Q12912,IRAG2_HUMAN,,"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2]",Homo sapiens (Human),29.0,217.0,9e-15,84.7,"sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3",GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577,immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0002376; GO:0005635; GO:0005694; GO:0005815; GO:0005886; GO:0008092; GO:0022414; GO:0043226; GO:0061024,immune system process; nuclear envelope; chromosome; microtubule organizing center; plasma membrane; cytoskeletal protein binding; reproductive process; organelle; membrane organization
OG_00315,1.343269840356845,FUN_001122-T1,Peve_00029372,Pocillopora_meandrina_HIv1___TS.g6543.t1,three_way,62.12316666666666,FUN_001122-T1,O75691,UTP20_HUMAN,,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),Homo sapiens (Human),32.2,1710.0,8.1e-220,766.1,sp|O75691|UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens OX=9606 GN=UTP20 PE=1 SV=3,GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040; GO:0042274,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]",RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0005730; GO:0005886; GO:0043226,RNA binding; nucleoplasm; nucleolus; plasma membrane; organelle
OG_00319,1.35247858813904,FUN_001137-T1,Peve_00029385,Pocillopora_meandrina_HIv1___RNAseq.g29339.t1,three_way,81.55166666666666,FUN_001137-T1,Q9Y345,,,,,44.3,625.0,1.2e-152,541.6,sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3,,,,,,
OG_00320,1.3912167643615314,FUN_001139-T1,Peve_00029334,Pocillopora_meandrina_HIv1___RNAseq.g29336.t1,three_way,78.20866666666667,FUN_001139-T1,Q761V0,SC6A5_MOUSE,,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Mus musculus (Mouse),46.3,609.0,5.5e-158,559.3,sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1,GO:0001504; GO:0005886; GO:0015375; GO:0046872; GO:0098690; GO:0098793; GO:0098810,neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504],glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynapse [GO:0098793],glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_00322,1.1196422992184554,FUN_001141-T1,Peve_00029338,Pocillopora_meandrina_HIv1___RNAseq.g29333.t1,three_way,78.69883333333334,FUN_001141-T1,Q8WML3,,,,,47.3,752.0,2.700000000000001e-186,654.1,sp|Q8WML3|KAT6B_MACFA Histone acetyltransferase KAT6B OS=Macaca fascicularis OX=9541 GN=KAT6B PE=2 SV=1,,,,,,
OG_00323,1.252337544251099,FUN_001142-T1,Peve_00029340,Pocillopora_meandrina_HIv1___RNAseq.g29332.t1,three_way,72.95883333333333,FUN_001142-T1,Q91827,,,,,38.8,178.0,1.4999999999999998e-24,114.4,sp|Q91827|AR1_XENLA Apoptosis regulator R1 (Fragment) OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_00327,1.0288659367199944,FUN_001147-T1,Peve_00029344,Pocillopora_meandrina_HIv1___TS.g6522.t1,three_way,73.868,FUN_001147-T1,Q17QK3,CBPQ_BOVIN,,Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase),Bos taurus (Bovine),57.9,470.0,3.5e-152,539.7,sp|Q17QK3|CBPQ_BOVIN Carboxypeptidase Q OS=Bos taurus OX=9913 GN=CPQ PE=2 SV=1,GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0006590; GO:0042246; GO:0042803; GO:0043171; GO:0046872; GO:0070573,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764],carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0006575; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; modified amino acid metabolic process; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00328,1.8260483806510344,FUN_001148-T1,Peve_00002869,Pocillopora_meandrina_HIv1___RNAseq.g29326.t1,three_way,83.11733333333333,FUN_001148-T1,Q99LI7,,,,,55.9,709.0,2.5e-234,813.1,sp|Q99LI7|CSTF3_MOUSE Cleavage stimulation factor subunit 3 OS=Mus musculus OX=10090 GN=Cstf3 PE=1 SV=1,,,,,,
OG_00330,1.5160184685600329,FUN_001151-T1,Peve_00002867,Pocillopora_meandrina_HIv1___RNAseq.g29324.t1,three_way,82.99033333333333,FUN_001151-T1,Q6TEM9,MYLIA_DANRE,,E3 ubiquitin-protein ligase MYLIP-A (EC 2.3.2.27) (Myosin regulatory light chain-interacting protein A) (MIR-A) (RING-type E3 ubiquitin transferase MYLIP-A),Danio rerio (Zebrafish) (Brachydanio rerio),31.2,480.0,1.4999999999999998e-62,241.9,sp|Q6TEM9|MYLIA_DANRE E3 ubiquitin-protein ligase MYLIP-A OS=Danio rerio OX=7955 GN=mylipa PE=1 SV=2,GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0006511; GO:0007369; GO:0008270; GO:0016567; GO:0030178,gastrulation [GO:0007369]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005856; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00334,1.3431434502917607,FUN_001155-T1,Peve_00002861,Pocillopora_meandrina_HIv1___RNAseq.g29319.t1,three_way,85.69133333333333,FUN_001155-T1,O08734,BAK_MOUSE,,Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK),Mus musculus (Mouse),46.4,112.0,3.0999999999999997e-24,113.2,sp|O08734|BAK_MOUSE Bcl-2 homologous antagonist/killer OS=Mus musculus OX=10090 GN=Bak1 PE=1 SV=3,GO:0001776; GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0031966; GO:0032471; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0048872; GO:0050673; GO:0051087; GO:0051400; GO:0051649; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097145; GO:0097192; GO:1901029; GO:1901030; GO:1902262,animal organ regeneration [GO:0031100]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; epithelial cell proliferation [GO:0050673]; establishment of localization in cell [GO:0051649]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; homeostasis of number of cells [GO:0048872]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; leukocyte homeostasis [GO:0001776]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],BAK complex [GO:0097145]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930],BH domain binding [GO:0051400]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0005215; GO:0005739; GO:0005783; GO:0005829; GO:0007005; GO:0012501; GO:0022414; GO:0043226; GO:0048856; GO:0055085; GO:0061024,immune system process; transporter activity; mitochondrion; endoplasmic reticulum; cytosol; mitochondrion organization; programmed cell death; reproductive process; organelle; anatomical structure development; transmembrane transport; membrane organization
OG_00338,1.4567358646569588,FUN_001160-T1,Peve_00043472,Pocillopora_meandrina_HIv1___RNAseq.g29219.t1,three_way,80.853,FUN_001160-T1,P50416,CPT1A_HUMAN,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Homo sapiens (Human),40.4,798.0,1.7e-154,548.1,"sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0010883; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0055085; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; transmembrane transport; molecular adaptor activity
OG_00342,1.9914802368225604,FUN_001167-T1,Peve_00015996,Pocillopora_meandrina_HIv1___RNAseq.g29154.t1,three_way,76.15266666666666,FUN_001167-T1,Q01617,,,,,51.7,172.0,6.1e-35,149.4,sp|Q01617|CPO_DROME Protein couch potato OS=Drosophila melanogaster OX=7227 GN=cpo PE=2 SV=4,,,,,,
OG_00348,2.0703380838913312,FUN_001175-T1,Peve_00015994,Pocillopora_meandrina_HIv1___RNAseq.g29156.t1,three_way,64.6045,FUN_001175-T1,Q1LUQ4,,,,,24.8,568.0,1.6e-35,152.5,sp|Q1LUQ4|MFD6A_DANRE Major facilitator superfamily domain-containing protein 6-A OS=Danio rerio OX=7955 GN=mfsd6a PE=3 SV=1,,,,,,
OG_00349,1.0467198059222778,FUN_001176-T1,Peve_00015993,Pocillopora_meandrina_HIv1___TS.g6373.t1,three_way,71.25133333333333,FUN_001176-T1,O43451,MGA_HUMAN,,"Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20)",Homo sapiens (Human),48.8,853.0,2.6e-247,856.7,sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6,GO:0000025; GO:0003824; GO:0004339; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027,dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821],"alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; oligo-1,6-glucosidase activity [GO:0004574]",GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0043226,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; organelle
OG_00352,1.861340649278816,FUN_001180-T1,Peve_00018946,Pocillopora_meandrina_HIv1___RNAseq.g29544.t1,three_way,57.39666666666667,FUN_001180-T1,E9Q7E2,ARID2_MOUSE,,AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200),Mus musculus (Mouse),33.1,834.0,1.3e-106,390.2,sp|E9Q7E2|ARID2_MOUSE AT-rich interactive domain-containing protein 2 OS=Mus musculus OX=10090 GN=Arid2 PE=1 SV=1,GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005667; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008270; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0045944; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:0072359; GO:1905168; GO:2000045; GO:2000781; GO:2000819,cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0005886; GO:0006325; GO:0006355; GO:0043226; GO:0048856,DNA binding; nucleoplasm; plasma membrane; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development
OG_00355,1.4877495105024834,FUN_001185-T1,Peve_00040986,Pocillopora_meandrina_HIv1___RNAseq.g29540.t1,three_way,52.84166666666667,FUN_001185-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),41.7,412.0,3.4e-63,245.0,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_00357,1.4957937355084483,FUN_001189-T1,Peve_00009676,Pocillopora_meandrina_HIv1___RNAseq.g29537.t1,three_way,76.39316666666667,FUN_001189-T1,Q93063,EXT2_HUMAN,,Exostosin-2 (EC 2.4.1.224) (Exostosin glycosyltransferase 2) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Heparan sulfate co-polymerase subunit EXT1) (Multiple exostoses protein 2),Homo sapiens (Human),50.1,711.0,2.0000000000000002e-212,740.3,sp|Q93063|EXT2_HUMAN Exostosin-2 OS=Homo sapiens OX=9606 GN=EXT2 PE=1 SV=1,GO:0000139; GO:0000271; GO:0001503; GO:0001707; GO:0002062; GO:0005783; GO:0005794; GO:0006024; GO:0006487; GO:0008217; GO:0010467; GO:0015012; GO:0015020; GO:0016020; GO:0016757; GO:0030210; GO:0042044; GO:0042311; GO:0042328; GO:0043541; GO:0044344; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0051923; GO:0055078; GO:0060047; GO:0060350; GO:0070062; GO:1902494,cellular response to fibroblast growth factor stimulus [GO:0044344]; chondrocyte differentiation [GO:0002062]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal-level water homeostasis [GO:0050891]; ossification [GO:0001503]; polysaccharide biosynthetic process [GO:0000271]; protein N-linked glycosylation [GO:0006487]; regulation of blood pressure [GO:0008217]; sodium ion homeostasis [GO:0055078]; sulfation [GO:0051923]; vasodilation [GO:0042311],catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541],glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982],GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006790; GO:0009101; GO:0016740; GO:0030154; GO:0043226; GO:1901135,circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; cell differentiation; organelle; carbohydrate derivative metabolic process
OG_00360,1.8509441145551635,FUN_001193-T1,Peve_00006937,Pocillopora_meandrina_HIv1___RNAseq.g29527.t1,three_way,63.272,FUN_001193-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),34.4,326.0,6.6e-40,166.4,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_00361,2.6155272078842726,FUN_001195-T1,Peve_00006935,Pocillopora_meandrina_HIv1___RNAseq.g29525.t1,three_way,41.97683333333333,,,,,,,,,,,,,,,,,
OG_00370,1.0171846656550134,FUN_001211-T1,Peve_00033815,Pocillopora_meandrina_HIv1___RNAseq.g29514.t2c,three_way,72.93533333333333,FUN_001211-T1,Q9VZS6,,,,,40.4,275.0,2.8e-55,217.6,sp|Q9VZS6|NSMA_DROME Putative neutral sphingomyelinase OS=Drosophila melanogaster OX=7227 GN=nSMase PE=2 SV=2,,,,,,
OG_00371,1.0983177324564544,FUN_001212-T1,Peve_00033814,Pocillopora_meandrina_HIv1___RNAseq.g29513.t1,three_way,80.26333333333334,,,,,,,,,,,,,,,,,
OG_00374,1.1680555617821615,FUN_001217-T1,Peve_00035371,Pocillopora_meandrina_HIv1___RNAseq.g2551.t1,three_way,78.48366666666666,FUN_001217-T1,Q8BGF9,,,,,38.9,306.0,9.1e-58,225.3,sp|Q8BGF9|S2544_MOUSE Solute carrier family 25 member 44 OS=Mus musculus OX=10090 GN=Slc25a44 PE=1 SV=1,,,,,,
OG_00376,1.4144251039641496,FUN_001219-T1,Peve_00035350,Pocillopora_meandrina_HIv1___RNAseq.g2554.t1,three_way,81.54166666666667,FUN_001219-T1,Q8BGF9,,,,,47.2,307.0,1.1e-74,281.6,sp|Q8BGF9|S2544_MOUSE Solute carrier family 25 member 44 OS=Mus musculus OX=10090 GN=Slc25a44 PE=1 SV=1,,,,,,
OG_00381,1.881044457900101,FUN_001233-T1,Peve_00022952,Pocillopora_meandrina_HIv1___RNAseq.g29020.t1,three_way,84.606,FUN_001233-T1,Q32L68,,,,,36.4,349.0,3.4e-46,187.2,sp|Q32L68|HM20B_BOVIN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related OS=Bos taurus OX=9913 GN=HMG20B PE=2 SV=1,,,,,,
OG_00383,1.2552928435742547,FUN_001235-T1,Peve_00002839,Pocillopora_meandrina_HIv1___TS.g5021.t3,three_way,88.22116666666666,FUN_001235-T1,Q60520,SIN3A_MOUSE,,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),Mus musculus (Mouse),56.3,1191.0,0.0,1134.4,sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3,GO:0000122; GO:0000776; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351,activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337],kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416],GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006325; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; nucleolus; DNA replication; chromatin organization; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_00386,1.3415431423182247,FUN_001238-T1,Peve_00002842,Pocillopora_meandrina_HIv1___RNAseq.g2515.t2,three_way,45.375,FUN_001238-T1,Q8IVU1,,,,,32.5,517.0,1.1e-67,260.4,sp|Q8IVU1|IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens OX=9606 GN=IGDCC3 PE=1 SV=2,,,,,,
OG_00388,1.5189879133845765,FUN_001241-T1,Peve_00022814,Pocillopora_meandrina_HIv1___TS.g4819.t1,three_way,90.189,FUN_001241-T1,Q5BJ41,CNOT6_XENLA,,CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase),Xenopus laevis (African clawed frog),59.0,558.0,8e-140,498.8,sp|Q5BJ41|CNOT6_XENLA CCR4-NOT transcription complex subunit 6 OS=Xenopus laevis OX=8355 GN=cnot6 PE=1 SV=1,GO:0000175; GO:0000289; GO:0003713; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0035279; GO:0046872; GO:0070966,"miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]",CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_00389,1.1375219040927778,FUN_001244-T1,Peve_00037040,Pocillopora_meandrina_HIv1___RNAseq.g2296.t1,three_way,77.55366666666667,FUN_001244-T1,Q5MNH6,,,,,28.5,253.0,1e-20,102.1,sp|Q5MNH6|LOLO2_EPIUN 2-oxoglutarate-dependent dioxygenase lolO2 OS=Epichloe uncinata OX=5050 GN=lolO2 PE=1 SV=1,,,,,,
OG_00394,1.215743068888615,FUN_001255-T1,Peve_00008793,Pocillopora_meandrina_HIv1___RNAseq.g2172.t1,three_way,80.75366666666667,FUN_001255-T1,Q6P2B1,TNPO3_MOUSE,,Transportin-3,Mus musculus (Mouse),46.8,921.0,1.1999999999999999e-244,847.8,sp|Q6P2B1|TNPO3_MOUSE Transportin-3 OS=Mus musculus OX=10090 GN=Tnpo3 PE=1 SV=1,GO:0005635; GO:0005642; GO:0005654; GO:0005829; GO:0006606; GO:0031267; GO:0042802,protein import into nucleus [GO:0006606],annulate lamellae [GO:0005642]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654],identical protein binding [GO:0042802]; small GTPase binding [GO:0031267],GO:0005635; GO:0005654; GO:0005829; GO:0006886; GO:0006913,nuclear envelope; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_00399,1.0332630141854464,FUN_001270-T1,Peve_00008764,Pocillopora_meandrina_HIv1___RNAseq.g2183.t1,three_way,76.675,FUN_001270-T1,Q9NWT6,HIF1N_HUMAN,,Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase),Homo sapiens (Human),59.9,319.0,1.2e-120,434.5,sp|Q9NWT6|HIF1N_HUMAN Hypoxia-inducible factor 1-alpha inhibitor OS=Homo sapiens OX=9606 GN=HIF1AN PE=1 SV=2,GO:0000122; GO:0003714; GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0019826; GO:0030947; GO:0031406; GO:0036139; GO:0036140; GO:0042803; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0061629; GO:0062101; GO:0071532; GO:2001214,negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],[protein]-asparagine 3-dioxygenase activity [GO:0036140]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0016491; GO:0060090; GO:0098772; GO:0140096; GO:0140110; GO:0140299,"catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; oxidoreductase activity; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity; molecular sensor activity"
OG_00400,1.727563110937094,FUN_001271-T1,Peve_00008757,Pocillopora_meandrina_HIv1___RNAseq.g2184.t1,three_way,83.30966666666667,FUN_001271-T1,P0C605,KGP1_MOUSE,,cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI),Mus musculus (Mouse),58.6,630.0,9.7e-210,731.5,sp|P0C605|KGP1_MOUSE cGMP-dependent protein kinase 1 OS=Mus musculus OX=10090 GN=Prkg1 PE=1 SV=1,GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0006468; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043087; GO:0045986; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0106310; GO:1904706; GO:1904753; GO:2000224,cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003012; GO:0003824; GO:0005654; GO:0005794; GO:0005886; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0098772; GO:0140096,"muscle system process; catalytic activity; nucleoplasm; Golgi apparatus; plasma membrane; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00402,1.0157992382486851,FUN_001289-T1,Peve_00037015,Pocillopora_meandrina_HIv1___TS.g4708.t1a,three_way,81.49916666666667,FUN_001289-T1,Q9ULJ6,,,,,45.5,1166.0,3.5e-155,550.8,sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3,,,,,,
OG_00404,1.1537856139656557,FUN_001292-T1,Peve_00037004,Pocillopora_meandrina_HIv1___RNAseq.g2226.t1,three_way,63.83866666666667,,,,,,,,,,,,,,,,,
OG_00409,1.0999305063815878,FUN_001299-T1,Peve_00036999,Pocillopora_meandrina_HIv1___RNAseq.g2232.t1,three_way,50.557,,,,,,,,,,,,,,,,,
OG_00412,1.40326969556259,FUN_001310-T1,Peve_00036984,Pocillopora_meandrina_HIv1___RNAseq.g2249.t1,three_way,83.714,FUN_001310-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),38.1,252.0,1.3e-50,201.4,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_00414,2.044268632154665,FUN_001316-T1,Peve_00036964,Pocillopora_meandrina_HIv1___RNAseq.g2261.t1,three_way,53.97383333333333,FUN_001316-T1,Q8IVL1,,,,,36.1,388.0,7.2e-66,255.0,sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3,,,,,,
OG_00415,1.0349515381975052,FUN_001317-T1,Peve_00036963,Pocillopora_meandrina_HIv1___TS.g4770.t2,three_way,81.075,FUN_001317-T1,Q8WU76,,,,,35.4,675.0,5.7e-108,393.3,sp|Q8WU76|SCFD2_HUMAN Sec1 family domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCFD2 PE=1 SV=2,,,,,,
OG_00417,1.8418936455947343,FUN_001320-T1,Peve_00005008,Pocillopora_meandrina_HIv1___RNAseq.g5443.t1,three_way,65.57416666666667,,,,,,,,,,,,,,,,,
OG_00418,1.3948785755891369,FUN_001323-T1,Peve_00036961,Pocillopora_meandrina_HIv1___RNAseq.g2265.t1,three_way,51.98283333333333,,,,,,,,,,,,,,,,,
OG_00421,1.4980990319031704,FUN_001328-T1,Peve_00036956,Pocillopora_meandrina_HIv1___RNAseq.g2270.t1b,three_way,79.90283333333333,FUN_001328-T1,Q5F471,,,,,41.4,903.0,8.500000000000001e-174,612.5,sp|Q5F471|PP6R3_CHICK Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Gallus gallus OX=9031 GN=PPP6R3 PE=2 SV=1,,,,,,
OG_00430,1.4859100411144606,FUN_001338-T1,Peve_00036941,Pocillopora_meandrina_HIv1___TS.g4798.t2,three_way,67.19033333333333,FUN_001338-T1,Q8C9W3,ATS2_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI),Mus musculus (Mouse),31.2,954.0,4.4e-135,484.6,sp|Q8C9W3|ATS2_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Mus musculus OX=10090 GN=Adamts2 PE=1 SV=2,GO:0004222; GO:0005576; GO:0007283; GO:0008233; GO:0008270; GO:0016485; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588,collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_00434,2.235152396956446,FUN_001344-T1,Peve_00037041,Pocillopora_meandrina_HIv1___TS.g4804.t1,three_way,84.807,FUN_001344-T1,Q9DGA5,CDK1_ORYCU,,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),Oryzias curvinotus (Hynann ricefish) (Aplocheilus curvinotus),68.6,299.0,4.0999999999999997e-120,432.6,sp|Q9DGA5|CDK1_ORYCU Cyclin-dependent kinase 1 OS=Oryzias curvinotus OX=104658 GN=cdk1 PE=2 SV=1,GO:0000086; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007095; GO:0008353; GO:0051301; GO:0106310,cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic G2 DNA damage checkpoint signaling [GO:0007095],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00436,1.8384420491257072,FUN_001347-T1,Peve_00023385,Pocillopora_meandrina_HIv1___RNAseq.g1879.t1,three_way,63.254,FUN_001347-T1,Q3TCJ1,ABRX2_MOUSE,,BRISC complex subunit Abraxas 2 (Abraxas brother protein 1) (Protein FAM175B),Mus musculus (Mouse),29.9,274.0,4.2e-25,117.5,sp|Q3TCJ1|ABRX2_MOUSE BRISC complex subunit Abraxas 2 OS=Mus musculus OX=10090 GN=Abraxas2 PE=1 SV=1,GO:0000278; GO:0000922; GO:0002931; GO:0005634; GO:0005737; GO:0005874; GO:0007059; GO:0008017; GO:0008608; GO:0031593; GO:0043066; GO:0051301; GO:0070536; GO:0070552; GO:0071497; GO:0090307,attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to freezing [GO:0071497]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931],BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922],microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593],GO:0000278; GO:0005634; GO:0007010; GO:0007059; GO:0008092; GO:0043226,mitotic cell cycle; nucleus; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; organelle
OG_00439,1.904365923037977,FUN_001350-T1,Peve_00023405,Pocillopora_meandrina_HIv1___RNAseq.g1875.t1,three_way,48.55,FUN_001350-T1,Q8BM75,ARI5B_MOUSE,,AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (Developmentally and sexually retarded with transient immune abnormalities protein) (Desrt) (MRF1-like) (Modulator recognition factor protein 2) (MRF-2),Mus musculus (Mouse),24.0,758.0,3.2999999999999998e-43,179.1,sp|Q8BM75|ARI5B_MOUSE AT-rich interactive domain-containing protein 5B OS=Mus musculus OX=10090 GN=Arid5b PE=1 SV=3,GO:0000122; GO:0000976; GO:0001822; GO:0003713; GO:0005634; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830,adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705],nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_00441,1.2897564631950813,FUN_001354-T1,Peve_00028939,Pocillopora_meandrina_HIv1___RNAseq.g1872.t2,three_way,86.42,FUN_001354-T1,Q6PFX9,TNKS1_MOUSE,,Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1),Mus musculus (Mouse),72.8,1146.0,4.9e-232,806.2,sp|Q6PFX9|TNKS1_MOUSE Poly [ADP-ribose] polymerase tankyrase-1 OS=Mus musculus OX=10090 GN=Tnks PE=1 SV=1,GO:0000139; GO:0000209; GO:0000781; GO:0003950; GO:0005643; GO:0005794; GO:0005813; GO:0005829; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0016779; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051301; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:0140806; GO:0140807; GO:1904355; GO:1904357; GO:1904908; GO:1990404,"cell division [GO:0051301]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; Wnt signaling pathway [GO:0016055]","centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]",histone binding [GO:0042393]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005815; GO:0005829; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_00442,1.1654870454671236,FUN_001355-T1,Peve_00028946,Pocillopora_meandrina_HIv1___TS.g4661.t1a,three_way,69.34483333333333,FUN_001355-T1,Q3UDE2,,,,,45.6,654.0,3.9e-159,563.1,sp|Q3UDE2|TTL12_MOUSE Tubulin--tyrosine ligase-like protein 12 OS=Mus musculus OX=10090 GN=Ttll12 PE=1 SV=1,,,,,,
OG_00443,1.1722244312128334,FUN_001356-T1,Peve_00005527,Pocillopora_meandrina_HIv1___RNAseq.g2154.t1,three_way,89.02,FUN_001356-T1,Q571I9,,,,,42.8,828.0,1.5e-185,651.4,sp|Q571I9|A16A1_MOUSE Aldehyde dehydrogenase family 16 member A1 OS=Mus musculus OX=10090 GN=Aldh16a1 PE=1 SV=2,,,,,,
OG_00449,1.4169221669171577,FUN_001369-T1,Peve_00035683,Pocillopora_meandrina_HIv1___RNAseq.g2141.t1,three_way,82.50766666666667,FUN_001369-T1,A0A1L8F5J9,NMDZ1_XENLA,,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",Xenopus laevis (African clawed frog),50.5,876.0,2.8e-243,843.2,"sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1",GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839,calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725],neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_00456,1.4147772201745672,FUN_001385-T1,Peve_00019351,Pocillopora_meandrina_HIv1___RNAseq.g2129.t1,three_way,85.12266666666667,FUN_001385-T1,O75398,DEAF1_HUMAN,,Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5),Homo sapiens (Human),43.0,291.0,1.5e-50,202.2,sp|O75398|DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens OX=9606 GN=DEAF1 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0001662; GO:0001843; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0007281; GO:0008270; GO:0008542; GO:0009653; GO:0033599; GO:0045892; GO:0045893; GO:0048706; GO:0090575,anatomical structure morphogenesis [GO:0009653]; behavioral fear response [GO:0001662]; embryonic skeletal system development [GO:0048706]; germ cell development [GO:0007281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542],chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005576; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0050877; GO:0140110,DNA binding; extracellular region; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_00460,2.343273831352745,FUN_001392-T1,Peve_00019358,Pocillopora_meandrina_HIv1___RNAseq.g2123.t1,three_way,90.084,,,,,,,,,,,,,,,,,
OG_00465,1.06449121038782,FUN_001401-T1,Peve_00008770,Pocillopora_meandrina_HIv1___RNAseq.g2113.t1,three_way,79.55216666666666,FUN_001401-T1,Q8C8M1,SHCAF_MOUSE,,SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein),Mus musculus (Mouse),43.0,235.0,2.4e-40,167.2,sp|Q8C8M1|SHCAF_MOUSE SIN3-HDAC complex-associated factor OS=Mus musculus OX=10090 GN=Sinhcaf PE=1 SV=1,GO:0000122; GO:0005634; GO:0008284; GO:0030336; GO:0030512; GO:0045596; GO:0070822; GO:1902455; GO:1902459,negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459],nucleus [GO:0005634]; Sin3-type complex [GO:0070822],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_00466,1.2427113197664126,FUN_001402-T1,Peve_00008766,Pocillopora_meandrina_HIv1___TS.g4618.t1,three_way,89.81483333333334,FUN_001402-T1,P38976,,,,,74.9,195.0,1.2000000000000001e-74,280.8,sp|P38976|RAS2_HYDVU Ras-like protein RAS2 OS=Hydra vulgaris OX=6087 GN=RAS2 PE=2 SV=1,,,,,,
OG_00475,1.9142131233097035,FUN_001414-T1,Peve_00008747,Pocillopora_meandrina_HIv1___RNAseq.g2100.t1,three_way,79.928,FUN_001414-T1,P50553,ASCL1_HUMAN,,Achaete-scute homolog 1 (ASH-1) (hASH1) (Class A basic helix-loop-helix protein 46) (bHLHa46),Homo sapiens (Human),60.3,63.0,3.9e-13,76.6,sp|P50553|ASCL1_HUMAN Achaete-scute homolog 1 OS=Homo sapiens OX=9606 GN=ASCL1 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003358; GO:0003359; GO:0003676; GO:0003682; GO:0003700; GO:0005634; GO:0007219; GO:0007346; GO:0007400; GO:0007405; GO:0007423; GO:0007507; GO:0010468; GO:0014003; GO:0021527; GO:0021530; GO:0021750; GO:0021892; GO:0021902; GO:0021954; GO:0021987; GO:0022008; GO:0030182; GO:0030856; GO:0032526; GO:0042802; GO:0043025; GO:0043066; GO:0043425; GO:0043525; GO:0045665; GO:0045666; GO:0045747; GO:0045787; GO:0045892; GO:0045944; GO:0046983; GO:0048469; GO:0048485; GO:0048663; GO:0048665; GO:0048666; GO:0048935; GO:0050767; GO:0050769; GO:0050883; GO:0051593; GO:0060163; GO:0060165; GO:0060166; GO:0060487; GO:0060579; GO:0061100; GO:0061102; GO:0061103; GO:0061104; GO:0061549; GO:0070849; GO:0070888; GO:0071259; GO:0090575; GO:0097475; GO:1990837; GO:2000179,"adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; motor neuron migration [GO:0097475]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]",chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_00477,2.011325821372409,FUN_001416-T1,Peve_00008744,Pocillopora_meandrina_HIv1___RNAseq.g2098.t1,three_way,82.74133333333333,FUN_001416-T1,Q924X7,STK33_MOUSE,,Serine/threonine-protein kinase 33 (EC 2.7.11.1),Mus musculus (Mouse),54.2,345.0,2e-101,370.9,sp|Q924X7|STK33_MOUSE Serine/threonine-protein kinase 33 OS=Mus musculus OX=10090 GN=Stk33 PE=1 SV=2,GO:0002177; GO:0004674; GO:0005524; GO:0007283; GO:0046777; GO:0048471; GO:0106310; GO:1905198,manchette assembly [GO:1905198]; protein autophosphorylation [GO:0046777]; spermatogenesis [GO:0007283],manchette [GO:0002177]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0140096,"catalytic activity; transferase activity; reproductive process; catalytic activity, acting on a protein"
OG_00478,1.127080554426959,FUN_001417-T1,Peve_00008743,Pocillopora_meandrina_HIv1___RNAseq.g2096.t1,three_way,84.827,FUN_001417-T1,Q8C5L3,CNOT2_MOUSE,,CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2),Mus musculus (Mouse),43.2,562.0,2.8e-94,347.8,sp|Q8C5L3|CNOT2_MOUSE CCR4-NOT transcription complex subunit 2 OS=Mus musculus OX=10090 GN=Cnot2 PE=1 SV=2,GO:0000122; GO:0001222; GO:0001829; GO:0004535; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006417; GO:0010606; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:2000036,negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829],CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],poly(A)-specific ribonuclease activity [GO:0004535]; transcription corepressor binding [GO:0001222],GO:0003824; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0031047; GO:0140098,"catalytic activity; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; regulatory ncRNA-mediated gene silencing; catalytic activity, acting on RNA"
OG_00479,1.314222631248258,FUN_001418-T1,Peve_00008742,Pocillopora_meandrina_HIv1___RNAseq.g2097.t1,three_way,81.65133333333334,FUN_001418-T1,P32198,CPT1A_RAT,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Rattus norvegicus (Rat),49.2,765.0,3.5e-218,759.6,"sp|P32198|CPT1A_RAT Carnitine O-palmitoyltransferase 1, liver isoform OS=Rattus norvegicus OX=10116 GN=Cpt1a PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0007584; GO:0009410; GO:0009437; GO:0030674; GO:0030855; GO:0031667; GO:0031998; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0046320; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity
OG_00482,1.152668223362182,FUN_001424-T1,Peve_00008792,Pocillopora_meandrina_HIv1___TS.g4679.t3,three_way,67.32566666666666,,,,,,,,,,,,,,,,,
OG_00485,1.0787678896836077,FUN_001450-T1,Peve_00018452,Pocillopora_meandrina_HIv1___RNAseq.g1956.t1,three_way,82.06483333333334,FUN_001450-T1,Q804S6,,,,,65.5,58.0,1.1e-12,74.7,sp|Q804S6|EMX1_DANRE Homeobox protein EMX1 OS=Danio rerio OX=7955 GN=emx1 PE=2 SV=1,,,,,,
OG_00493,2.212660391124057,FUN_001463-T1,Peve_00027128,Pocillopora_meandrina_HIv1___RNAseq.g1963.t1,three_way,62.418,FUN_001463-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),28.8,2337.0,8.6e-257,889.4,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00500,1.826917683135195,FUN_001473-T1,Peve_00029354,Pocillopora_meandrina_HIv1___TS.g4480.t1,three_way,91.325,FUN_001473-T1,Q5ZLT0,,,,,70.9,1080.0,0.0,1511.1,sp|Q5ZLT0|XPO7_CHICK Exportin-7 OS=Gallus gallus OX=9031 GN=XPO7 PE=2 SV=1,,,,,,
OG_00514,2.325677844679831,FUN_001507-T1,Peve_00012118,Pocillopora_meandrina_HIv1___TS.g4396.t1a,three_way,54.123666666666665,FUN_001507-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),42.2,398.0,5.3e-88,328.2,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_00522,1.845832608733614,FUN_001522-T1,Peve_00042518,Pocillopora_meandrina_HIv1___RNAseq.g2040.t1,three_way,96.534,FUN_001522-T1,B1WBM3,,,,,57.6,99.0,1e-20,100.9,sp|B1WBM3|TM138_RAT Transmembrane protein 138 OS=Rattus norvegicus OX=10116 GN=Tmem138 PE=2 SV=1,,,,,,
OG_00525,2.049547486753379,FUN_001529-T3,Peve_00000626,Pocillopora_meandrina_HIv1___RNAseq.g2044.t1,three_way,76.09666666666666,FUN_001529-T3,O75912,DGKI_HUMAN,,Diacylglycerol kinase iota (DAG kinase iota) (DGK-iota) (EC 2.7.1.107),Homo sapiens (Human),45.7,999.0,2.3e-238,827.0,sp|O75912|DGKI_HUMAN Diacylglycerol kinase iota OS=Homo sapiens OX=9606 GN=DGKI PE=1 SV=2,GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0014069; GO:0030168; GO:0030424; GO:0030672; GO:0032991; GO:0035556; GO:0043197; GO:0045202; GO:0046339; GO:0046834; GO:0097060; GO:0098978,diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:0043226,catalytic activity; nucleus; cytosol; plasma membrane; lipid metabolic process; transferase activity; organelle
OG_00527,1.0936123284896453,FUN_001531-T1,Peve_00000632,Pocillopora_meandrina_HIv1___RNAseq.g2047.t1,three_way,79.239,FUN_001531-T1,A2RSQ0,,,,,43.6,1377.0,1.4e-312,1074.7,sp|A2RSQ0|DEN5B_MOUSE DENN domain-containing protein 5B OS=Mus musculus OX=10090 GN=Dennd5b PE=1 SV=2,,,,,,
OG_00530,2.1647090245272373,FUN_001535-T1,Peve_00014195,Pocillopora_meandrina_HIv1___RNAseq.g2057.t1,three_way,71.78833333333333,FUN_001535-T1,Q9Y4D2,,,,,34.3,829.0,1.0999999999999999e-127,459.5,sp|Q9Y4D2|DGLA_HUMAN Diacylglycerol lipase-alpha OS=Homo sapiens OX=9606 GN=DAGLA PE=1 SV=3,,,,,,
OG_00533,1.3985121126307207,FUN_001547-T1,Peve_00020470,Pocillopora_meandrina_HIv1___RNAseq.g2064.t1,three_way,91.406,FUN_001547-T1,E9Q8T7,DYH1_MOUSE,,Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7),Mus musculus (Mouse),64.2,4208.0,0.0,5480.6,sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1,GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0007288; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288],extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; isomerase activity; reproductive process; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_00535,1.3243503349741372,FUN_001550-T1,Peve_00003916,Pocillopora_meandrina_HIv1___RNAseq.g2091.t1,three_way,65.51033333333334,FUN_001550-T1,Q54I58,,,,,32.0,219.0,6.2e-26,119.4,sp|Q54I58|NIPSN_DICDI Protein NipSnap homolog OS=Dictyostelium discoideum OX=44689 GN=nipsnap PE=3 SV=1,,,,,,
OG_00537,1.6374292900768803,FUN_001553-T1,Peve_00003908,Pocillopora_meandrina_HIv1___RNAseq.g1998.t1,three_way,60.30766666666667,FUN_001553-T1,Q9UQF2,JIP1_HUMAN,,C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1),Homo sapiens (Human),40.5,242.0,1.5e-50,201.8,sp|Q9UQF2|JIP1_HUMAN C-Jun-amino-terminal kinase-interacting protein 1 OS=Homo sapiens OX=9606 GN=MAPK8IP1 PE=1 SV=1,GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007254; GO:0008432; GO:0016192; GO:0019894; GO:0031434; GO:0031435; GO:0031966; GO:0043025; GO:0043508; GO:0044294; GO:0044295; GO:0044302; GO:0045202; GO:0046328; GO:0046330; GO:0048471; GO:2000564; GO:2001243,"JNK cascade [GO:0007254]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of DNA-templated transcription [GO:0006355]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]",axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202],JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase inhibitor activity [GO:0004860],GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0008092; GO:0016192; GO:0043226; GO:0060090; GO:0098772,nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; organelle; molecular adaptor activity; molecular function regulator activity
OG_00542,1.064101139002999,FUN_001573-T1,Peve_00010783,Pocillopora_meandrina_HIv1___RNAseq.g2028.t1,three_way,70.1815,FUN_001573-T1,A7T1N0,TMP2L_NEMVE,,Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2),Nematostella vectensis (Starlet sea anemone),30.8,1292.0,5.1e-158,560.5,sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1,GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604,calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725],plasma membrane [GO:0005886],ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872],GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085,catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport
OG_00543,1.2647046711691268,FUN_001577-T1,Peve_00010785,Pocillopora_meandrina_HIv1___RNAseq.g2029.t1,three_way,69.47,FUN_001577-T1,Q6A039,,,,,55.0,453.0,3.1e-134,480.7,sp|Q6A039|TBC12_MOUSE TBC1 domain family member 12 OS=Mus musculus OX=10090 GN=Tbc1d12 PE=1 SV=2,,,,,,
OG_00547,1.0539892080187183,FUN_001583-T1,Peve_00005423,Pocillopora_meandrina_HIv1___RNAseq.g2035.t1,three_way,72.56533333333333,,,,,,,,,,,,,,,,,
OG_00549,1.5776543860569652,FUN_001590-T1,Peve_00023229,Pocillopora_meandrina_HIv1___RNAseq.g1994.t1,three_way,58.80866666666667,FUN_001590-T1,Q9VAN6,SLBP_DROME,,Histone RNA hairpin-binding protein (Histone stem-loop-binding protein),Drosophila melanogaster (Fruit fly),46.8,79.0,1.9e-16,88.2,sp|Q9VAN6|SLBP_DROME Histone RNA hairpin-binding protein OS=Drosophila melanogaster OX=7227 GN=Slbp PE=1 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0006398; GO:0007076; GO:0035613; GO:0051028; GO:0071204; GO:0071207; GO:1990825,mitotic chromosome condensation [GO:0007076]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028],cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleus [GO:0005634],histone pre-mRNA stem-loop binding [GO:0071207]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_00551,1.416173414520836,FUN_001592-T1,Peve_00023231,Pocillopora_meandrina_HIv1___RNAseq.g1991.t1,three_way,51.281666666666666,FUN_001592-T1,O35144,TERF2_MOUSE,,Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein),Mus musculus (Mouse),20.8,457.0,4.8e-06,54.3,sp|O35144|TERF2_MOUSE Telomeric repeat-binding factor 2 OS=Mus musculus OX=10090 GN=Terf2 PE=1 SV=3,GO:0000723; GO:0000781; GO:0000782; GO:0001673; GO:0001701; GO:0003691; GO:0003720; GO:0005654; GO:0016233; GO:0016604; GO:0019899; GO:0030424; GO:0031627; GO:0031848; GO:0032206; GO:0032208; GO:0032211; GO:0042162; GO:0042803; GO:0044877; GO:0061820; GO:0070187; GO:0070198; GO:0098505; GO:0099088; GO:1904354; GO:1904430; GO:1905839; GO:2000773,"axonal transport of messenger ribonucleoprotein complex [GO:0099088]; in utero embryonic development [GO:0001701]; negative regulation of cellular senescence [GO:2000773]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere capping [GO:1904354]; negative regulation of telomere maintenance via recombination [GO:0032208]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]; telomeric loop formation [GO:0031627]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; telomere cap complex [GO:0000782]",double-stranded telomeric DNA binding [GO:0003691]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomerase activity [GO:0003720]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0007018; GO:0016740; GO:0032200; GO:0043226; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule-based movement; transferase activity; telomere organization; organelle; anatomical structure development; catalytic activity, acting on DNA"
OG_00554,1.7909750811164271,FUN_001599-T1,Peve_00004146,Pocillopora_meandrina_HIv1___RNAseq.g1982.t1,three_way,81.72066666666667,FUN_001599-T1,Q9Y2D4,EXC6B_HUMAN,,Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2),Homo sapiens (Human),50.0,800.0,4.7e-223,775.8,sp|Q9Y2D4|EXC6B_HUMAN Exocyst complex component 6B OS=Homo sapiens OX=9606 GN=EXOC6B PE=1 SV=3,GO:0000145; GO:0000281; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522],exocyst [GO:0000145],,GO:0000910; GO:0006886; GO:0016192; GO:0061024,cytokinesis; intracellular protein transport; vesicle-mediated transport; membrane organization
OG_00556,1.126460014076537,FUN_001608-T2,Peve_00045305,Pocillopora_meandrina_HIv1___RNAseq.g1923.t1,three_way,86.59616666666666,FUN_001608-T2,Q5W8I8,VGL2A_DANRE,,Vesicular glutamate transporter 2.1 (Protein blumenkohl) (Solute carrier family 17 member 6-B) (Vesicular glutamate transporter 2-A),Danio rerio (Zebrafish) (Brachydanio rerio),43.0,470.0,2e-108,394.4,sp|Q5W8I8|VGL2A_DANRE Vesicular glutamate transporter 2.1 OS=Danio rerio OX=7955 GN=slc17a6b PE=2 SV=2,GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006817; GO:0007268; GO:0007601; GO:0008021; GO:0015386; GO:0015813; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0140788,"chemical synaptic transmission [GO:0007268]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]; visual perception [GO:0007601]",chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; signaling; cytoplasmic vesicle; organelle; nervous system process; transmembrane transport
OG_00559,1.0682477155246937,FUN_001613-T1,Peve_00045310,Pocillopora_meandrina_HIv1___TS.g4484.t1,three_way,71.21433333333333,FUN_001613-T1,P97931,UNG_MOUSE,,Uracil-DNA glycosylase (UDG) (EC 3.2.2.27),Mus musculus (Mouse),55.3,311.0,6.6e-91,335.5,sp|P97931|UNG_MOUSE Uracil-DNA glycosylase OS=Mus musculus OX=10090 GN=Ung PE=1 SV=3,GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0016446; GO:0016447; GO:0043024; GO:0045190; GO:0097510,"base-excision repair, AP site formation via deaminated base removal [GO:0097510]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]",mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_00565,1.5284245768096207,FUN_001621-T1,Peve_00012529,Pocillopora_meandrina_HIv1___RNAseq.g1948.t1,three_way,82.54650000000001,FUN_001621-T1,Q8VCD6,,,,,61.8,152.0,1.3000000000000001e-48,194.5,sp|Q8VCD6|REEP2_MOUSE Receptor expression-enhancing protein 2 OS=Mus musculus OX=10090 GN=Reep2 PE=1 SV=2,,,,,,
OG_00570,2.7425464790015432,FUN_001628-T1,Peve_00009929,Pocillopora_meandrina_HIv1___RNAseq.g2165.t1,three_way,85.88366666666667,FUN_001628-T1,P49706,,,,,57.9,290.0,2.8e-88,326.6,sp|P49706|CCND2_CHICK G1/S-specific cyclin-D2 OS=Gallus gallus OX=9031 GN=CCND2 PE=3 SV=1,,,,,,
OG_00571,2.587548789613599,FUN_001630-T1,Peve_00009934,Pocillopora_meandrina_HIv1___RNAseq.g2163.t1,three_way,60.408,FUN_001630-T1,Q7KM13,,,,,40.7,167.0,8.1e-17,90.1,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_00575,1.4903612934217991,FUN_001636-T1,Peve_00030249,Pocillopora_meandrina_HIv1___RNAseq.g2156.t1,three_way,45.20433333333334,,,,,,,,,,,,,,,,,
OG_00587,1.3351752846561102,FUN_001665-T1,Peve_00038394,Pocillopora_meandrina_HIv1___RNAseq.g29391.t1,three_way,65.37583333333333,FUN_001665-T1,C3ZQF9,,,,,34.8,339.0,8.8e-39,162.5,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_00588,2.6515125091424494,FUN_001671-T2,Peve_00038393,Pocillopora_meandrina_HIv1___RNAseq.g29390.t1,three_way,54.833666666666666,FUN_001671-T2,O60293,,,,,28.7,1468.0,5.8000000000000005e-133,478.0,sp|O60293|ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens OX=9606 GN=ZFC3H1 PE=1 SV=3,,,,,,
OG_00592,1.4919620593766134,FUN_001727-T3,Peve_00007898,Pocillopora_meandrina_HIv1___RNAseq.g2700.t1,three_way,82.50633333333333,FUN_001727-T3,P32297,ACHA3_HUMAN,,Neuronal acetylcholine receptor subunit alpha-3,Homo sapiens (Human),37.1,472.0,2.7000000000000003e-87,324.3,sp|P32297|ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens OX=9606 GN=CHRNA3 PE=1 SV=4,GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0014056; GO:0015276; GO:0015464; GO:0016020; GO:0016607; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0043231; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098878; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005730; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; nucleolus; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; signaling; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_00596,2.258401097714308,FUN_001733-T1,Peve_00007896,Pocillopora_meandrina_HIv1___RNAseq.g2642.t1,three_way,61.95166666666667,FUN_001733-T1,P27544,CERS1_HUMAN,,Ceramide synthase 1 (CerS1) (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299),Homo sapiens (Human),43.5,269.0,6.9e-55,216.1,sp|P27544|CERS1_HUMAN Ceramide synthase 1 OS=Homo sapiens OX=9606 GN=CERS1 PE=1 SV=1,GO:0005783; GO:0005789; GO:0007420; GO:0010614; GO:0016020; GO:0030148; GO:0036146; GO:0043231; GO:0046325; GO:0046513; GO:0050291; GO:0071466; GO:0071492; GO:0072721; GO:1901526,brain development [GO:0007420]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of D-glucose import [GO:0046325]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],sphingosine N-acyltransferase activity [GO:0050291],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226; GO:0048856,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle; anatomical structure development
OG_00597,1.0405876942469536,FUN_001735-T1,Peve_00025009,Pocillopora_meandrina_HIv1___RNAseq.g2644.t1,three_way,79.81366666666666,FUN_001735-T1,P04464,,,,,36.7,147.0,4e-22,105.9,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_00598,1.0496303753885852,FUN_001739-T1,Peve_00025011,Pocillopora_meandrina_HIv1___RNAseq.g2646.t1,three_way,73.694,FUN_001739-T1,A7S4N4,,,,,41.6,267.0,9.2e-50,199.5,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_00599,1.9816716374292136,FUN_001747-T1,Peve_00023224,Pocillopora_meandrina_HIv1___RNAseq.13551_t,three_way,50.601,,,,,,,,,,,,,,,,,
OG_00608,1.007700177826074,FUN_001771-T1,Peve_00035574,Pocillopora_meandrina_HIv1___RNAseq.g2680.t1,three_way,97.479,FUN_001771-T1,Q6P4J8,,,,,83.6,482.0,7.6e-166,585.1,sp|Q6P4J8|SMU1_XENTR WD40 repeat-containing protein SMU1 OS=Xenopus tropicalis OX=8364 GN=smu1 PE=2 SV=1,,,,,,
OG_00609,1.4359416043737627,FUN_001772-T1,Peve_00035573,Pocillopora_meandrina_HIv1___RNAseq.g2681.t1,three_way,55.65416666666667,,,,,,,,,,,,,,,,,
OG_00612,1.0454426515294155,FUN_001778-T1,Peve_00035593,Pocillopora_meandrina_HIv1___RNAseq.g2685.t1,three_way,54.77516666666666,FUN_001778-T1,Q80VL1,TDRKH_MOUSE,,Tudor and KH domain-containing protein (Tudor domain-containing protein 2),Mus musculus (Mouse),31.1,549.0,2.7e-66,255.4,sp|Q80VL1|TDRKH_MOUSE Tudor and KH domain-containing protein OS=Mus musculus OX=10090 GN=Tdrkh PE=1 SV=1,GO:0003723; GO:0005737; GO:0005739; GO:0005829; GO:0007140; GO:0007283; GO:0009566; GO:0030154; GO:0034587; GO:0071546; GO:0071547,cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; pi-body [GO:0071546]; piP-body [GO:0071547],RNA binding [GO:0003723],GO:0003723; GO:0005739; GO:0005829; GO:0022414; GO:0030154; GO:0043226; GO:0140013,RNA binding; mitochondrion; cytosol; reproductive process; cell differentiation; organelle; meiotic nuclear division
OG_00618,1.421391694148243,FUN_001784-T1,Peve_00011611,Pocillopora_meandrina_HIv1___RNAseq.g2640.t1a,three_way,76.89133333333334,FUN_001784-T1,Q91ZR4,NEK8_MOUSE,,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8),Mus musculus (Mouse),40.8,650.0,1.2e-118,429.9,sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310,animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00619,1.3097841252700404,FUN_001787-T1,Peve_00008715,Pocillopora_meandrina_HIv1___RNAseq.g2639.t1,three_way,71.26766666666667,FUN_001787-T1,Q9HCE0,EPG5_HUMAN,,Ectopic P granules protein 5 homolog,Homo sapiens (Human),30.6,2484.0,0.0,1120.1,sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2,GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786,autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],,GO:0002376; GO:0005764; GO:0005773; GO:0006954; GO:0012501; GO:0016192; GO:0030154; GO:0043226,immune system process; lysosome; vacuole; inflammatory response; programmed cell death; vesicle-mediated transport; cell differentiation; organelle
OG_00622,1.9544047688745207,FUN_001793-T1,Peve_00008718,Pocillopora_meandrina_HIv1___RNAseq.g2635.t1a,three_way,54.11416666666666,FUN_001793-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.2,112.0,1.9e-13,79.3,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_00623,1.9322489315995832,FUN_001794-T1,Peve_00037091,Pocillopora_meandrina_HIv1___RNAseq.g15131.t1,three_way,57.70583333333334,FUN_001794-T1,P05183,CP3A2_RAT,,Cytochrome P450 3A2 (EC 1.14.14.1) (CYPIIIA2) (Cytochrome P450-PCN2) (Cytochrome P450/6-beta-A) (Testosterone 6-beta-hydroxylase),Rattus norvegicus (Rat),39.3,504.0,7.0000000000000015e-90,332.8,sp|P05183|CP3A2_RAT Cytochrome P450 3A2 OS=Rattus norvegicus OX=10116 GN=Cyp3a2 PE=1 SV=2,GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006706; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0032451; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021,alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789],"1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity
OG_00627,1.578125343062447,FUN_001845-T1,Peve_00006788,Pocillopora_meandrina_HIv1___RNAseq.g2618.t1,three_way,61.23066666666666,FUN_001845-T1,Q13395,TARB1_HUMAN,,tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 (EC 2.1.1.34) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185),Homo sapiens (Human),29.4,1429.0,3.8e-169,597.8,sp|Q13395|TARB1_HUMAN tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 OS=Homo sapiens OX=9606 GN=TARBP1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488; GO:0141100,regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488],nucleus [GO:0005634],RNA binding [GO:0003723]; tRNA (guanine(18)-2'-O)-methyltransferase activity [GO:0141100]; tRNA (guanine) methyltransferase activity [GO:0016423],GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_00629,2.8605892702800304,FUN_001847-T1,Peve_00025829,Pocillopora_meandrina_HIv1___RNAseq.g2613.t1,three_way,82.766,FUN_001847-T1,O88576,S6A18_MOUSE,,Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3),Mus musculus (Mouse),51.0,486.0,7.500000000000001e-145,515.4,sp|O88576|S6A18_MOUSE Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Mus musculus OX=10090 GN=Slc6a18 PE=1 SV=1,GO:0003333; GO:0005886; GO:0006836; GO:0015175; GO:0015804; GO:0016324; GO:0031526; GO:0140931; GO:1990297,amino acid transmembrane transport [GO:0003333]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; renal amino acid absorption [GO:1990297],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],neutral L-amino acid transmembrane transporter activity [GO:0015175]; neutral L-amino acid:sodium:chloride symporter activity [GO:0140931],GO:0003014; GO:0005215; GO:0005886; GO:0055085,renal system process; transporter activity; plasma membrane; transmembrane transport
OG_00630,1.5682105138781506,FUN_001848-T1,Peve_00018077,Pocillopora_meandrina_HIv1___RNAseq.g2612.t1a,three_way,57.900333333333336,FUN_001848-T1,Q9NH13,,,,,25.7,346.0,5.4e-20,100.9,sp|Q9NH13|RP43_RIFPA Exoskeleton protein RP43 OS=Riftia pachyptila OX=6426 PE=1 SV=1,,,,,,
OG_00631,2.4363674763141936,FUN_001853-T1,Peve_00018078,Pocillopora_meandrina_HIv1___RNAseq.g2603.t1,three_way,57.54833333333333,FUN_001853-T1,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),32.9,237.0,3.9e-29,130.6,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_00644,1.088345100087078,FUN_001889-T1,Peve_00030492,Pocillopora_meandrina_HIv1___RNAseq.g2578.t2,three_way,70.65033333333334,,,,,,,,,,,,,,,,,
OG_00649,1.1676606815371382,FUN_001904-T1,Peve_00013091,Pocillopora_meandrina_HIv1___RNAseq.g2569.t1,three_way,67.893,FUN_001904-T1,Q9SF91,,,,,41.7,211.0,8.3e-40,165.2,sp|Q9SF91|RAE1E_ARATH Ras-related protein RABE1e OS=Arabidopsis thaliana OX=3702 GN=RABE1E PE=1 SV=1,,,,,,
OG_00654,1.842803139000237,FUN_001940-T1,Peve_00024481,Pocillopora_meandrina_HIv1___RNAseq.20168_t,three_way,77.20733333333334,FUN_001940-T1,Q87PP5,,,,,35.6,547.0,4.6e-98,360.5,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_00656,1.0359551477965785,FUN_001943-T1,Peve_00041248,Pocillopora_meandrina_HIv1___RNAseq.g2485.t1,three_way,67.74316666666667,FUN_001943-T1,Q3TC46,PATL1_MOUSE,,Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b),Mus musculus (Mouse),27.4,602.0,3.4e-40,168.3,sp|Q3TC46|PATL1_MOUSE Protein PAT1 homolog 1 OS=Mus musculus OX=10090 GN=Patl1 PE=1 SV=2,GO:0000290; GO:0000932; GO:0002151; GO:0003723; GO:0005737; GO:0005829; GO:0008266; GO:0016605; GO:0016607; GO:0017148; GO:0030014; GO:0030371; GO:0033962; GO:0034046,deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962],CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605],G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371],GO:0003723; GO:0005829; GO:0016071; GO:0043226; GO:0045182,RNA binding; cytosol; mRNA metabolic process; organelle; translation regulator activity
OG_00662,1.0422449356433603,FUN_001955-T1,Peve_00041246,Pocillopora_meandrina_HIv1___RNAseq.g2487.t1,three_way,54.437666666666665,,,,,,,,,,,,,,,,,
OG_00664,1.0363055046613765,FUN_001957-T1,Peve_00041244,Pocillopora_meandrina_HIv1___RNAseq.g2489.t1,three_way,78.50733333333334,FUN_001957-T1,Q8CHW4,EI2BE_MOUSE,,Translation initiation factor eIF2B subunit epsilon (eIF2B GDP-GTP exchange factor subunit epsilon),Mus musculus (Mouse),41.6,671.0,1e-123,445.7,sp|Q8CHW4|EI2BE_MOUSE Translation initiation factor eIF2B subunit epsilon OS=Mus musculus OX=10090 GN=Eif2b5 PE=1 SV=1,GO:0001541; GO:0002183; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045948; GO:0048708; GO:0050852,astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634],guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0005634; GO:0005829; GO:0030154; GO:0043226; GO:0048856; GO:0098772,immune system process; nucleus; cytosol; cell differentiation; organelle; anatomical structure development; molecular function regulator activity
OG_00667,1.549667050897088,FUN_001966-T1,Peve_00041285,Pocillopora_meandrina_HIv1___RNAseq.g2492.t1,three_way,65.555,,,,,,,,,,,,,,,,,
OG_00670,1.4982379179397478,FUN_002073-T1,Peve_00013323,Pocillopora_meandrina_HIv1___RNAseq.g1722.t1,three_way,64.35900000000001,FUN_002073-T1,Q8C206,,,,,33.9,289.0,6.599999999999997e-41,169.5,sp|Q8C206|GP157_MOUSE G-protein coupled receptor 157 OS=Mus musculus OX=10090 GN=Gpr157 PE=1 SV=1,,,,,,
OG_00671,1.5181163473291373,FUN_002079-T1,Peve_00036467,Pocillopora_meandrina_HIv1___RNAseq.g1723.t1,three_way,66.33500000000001,FUN_002079-T1,Q99614,,,,,45.6,160.0,7.2e-36,152.5,sp|Q99614|TTC1_HUMAN Tetratricopeptide repeat protein 1 OS=Homo sapiens OX=9606 GN=TTC1 PE=1 SV=1,,,,,,
OG_00673,1.0461836976739292,FUN_002084-T1,Peve_00006417,Pocillopora_meandrina_HIv1___RNAseq.g1717.t2,three_way,43.899,FUN_002084-T1,P37237,FGF8_MOUSE,,Fibroblast growth factor 8 (FGF-8) (Androgen-induced growth factor) (AIGF) (Heparin-binding growth factor 8) (HBGF-8),Mus musculus (Mouse),31.5,143.0,7.9e-17,89.0,sp|P37237|FGF8_MOUSE Fibroblast growth factor 8 OS=Mus musculus OX=10090 GN=Fgf8 PE=1 SV=1,GO:0000165; GO:0001569; GO:0001656; GO:0001658; GO:0001759; GO:0001822; GO:0001839; GO:0001947; GO:0001974; GO:0003007; GO:0003148; GO:0003151; GO:0003198; GO:0005576; GO:0006915; GO:0006979; GO:0007368; GO:0007507; GO:0008045; GO:0008078; GO:0008083; GO:0008283; GO:0008284; GO:0008406; GO:0008543; GO:0009410; GO:0009792; GO:0009897; GO:0010628; GO:0021537; GO:0021543; GO:0021544; GO:0021798; GO:0021846; GO:0021884; GO:0023019; GO:0030324; GO:0030539; GO:0030878; GO:0030916; GO:0030917; GO:0033563; GO:0035050; GO:0035108; GO:0035116; GO:0035265; GO:0035909; GO:0042056; GO:0042472; GO:0042476; GO:0042487; GO:0043066; GO:0043524; GO:0045165; GO:0045745; GO:0045840; GO:0046622; GO:0048699; GO:0048702; GO:0048853; GO:0051402; GO:0051781; GO:0055026; GO:0060037; GO:0060128; GO:0060129; GO:0060348; GO:0060425; GO:0060445; GO:0070374; GO:0071542; GO:0072089; GO:0090134; GO:0120223; GO:0140014; GO:2000648,aorta morphogenesis [GO:0035909]; apoptotic process [GO:0006915]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell fate commitment [GO:0045165]; cell migration involved in mesendoderm migration [GO:0090134]; cell population proliferation [GO:0008283]; cell proliferation in forebrain [GO:0021846]; corticotropin hormone secreting cell differentiation [GO:0060128]; determination of left/right symmetry [GO:0007368]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axon guidance [GO:0033563]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic neurocranium morphogenesis [GO:0048702]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; forebrain neuron development [GO:0021884]; generation of neurons [GO:0048699]; gonad development [GO:0008406]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; larynx morphogenesis [GO:0120223]; limb morphogenesis [GO:0035108]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesodermal cell migration [GO:0008078]; metanephros development [GO:0001656]; midbrain-hindbrain boundary development [GO:0030917]; mitotic nuclear division [GO:0140014]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle tissue development [GO:0055026]; negative regulation of neuron apoptotic process [GO:0043524]; neural plate morphogenesis [GO:0001839]; neuron apoptotic process [GO:0051402]; odontogenesis [GO:0042476]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pallium development [GO:0021543]; pharyngeal system development [GO:0060037]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of organ growth [GO:0046622]; positive regulation of stem cell proliferation [GO:2000648]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell proliferation [GO:0072089]; subpallium development [GO:0021544]; telencephalon development [GO:0021537]; thyroid gland development [GO:0030878]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129],external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083],GO:0005576; GO:0012501; GO:0022414; GO:0030154; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140014,extracellular region; programmed cell death; reproductive process; cell differentiation; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; mitotic nuclear division
OG_00674,1.6918536004953268,FUN_002085-T1,Peve_00006425,Pocillopora_meandrina_HIv1___RNAseq.g1726.t1,three_way,71.64233333333334,FUN_002085-T1,O60258,FGF17_HUMAN,,Fibroblast growth factor 17 (FGF-17),Homo sapiens (Human),35.8,173.0,5e-23,109.8,sp|O60258|FGF17_HUMAN Fibroblast growth factor 17 OS=Homo sapiens OX=9606 GN=FGF17 PE=1 SV=1,GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0008543; GO:0022008; GO:0030334; GO:0043410,cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0005576; GO:0005615; GO:0023052; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; signaling; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_00675,1.1954693502734364,FUN_002087-T1,Peve_00006424,Pocillopora_meandrina_HIv1___RNAseq.g1727.t1,three_way,59.805,FUN_002087-T1,Q90722,FGF8_CHICK,,Fibroblast growth factor 8 (FGF-8) (Heparin-binding growth factor 8) (HBGF-8),Gallus gallus (Chicken),38.4,177.0,1.2e-24,115.2,sp|Q90722|FGF8_CHICK Fibroblast growth factor 8 OS=Gallus gallus OX=9031 GN=FGF8 PE=2 SV=1,GO:0005105; GO:0005111; GO:0005615; GO:0005737; GO:0008083; GO:0008284; GO:0008543; GO:0009880; GO:0009953; GO:0010628; GO:0022008; GO:0030177; GO:0030334; GO:0043410; GO:0045893; GO:0045944; GO:0051781; GO:0060173; GO:0060174; GO:0060684,dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; epithelial-mesenchymal cell signaling [GO:0060684]; fibroblast growth factor receptor signaling pathway [GO:0008543]; limb bud formation [GO:0060174]; limb development [GO:0060173]; neurogenesis [GO:0022008]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334],cytoplasm [GO:0005737]; extracellular space [GO:0005615],growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0005615; GO:0006355; GO:0023052; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; signaling; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_00677,1.17933677690097,FUN_002092-T1,Peve_00004296,Pocillopora_meandrina_HIv1___RNAseq.g1730.t2,three_way,68.856,FUN_002092-T1,H3BCW1,ADPRS_LATCH,,ADP-ribosylhydrolase ARH3 (ADP-ribose glycohydrolase ARH3) (LchARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-),Latimeria chalumnae (Coelacanth),40.8,355.0,2.2e-61,237.7,sp|H3BCW1|ADPRS_LATCH ADP-ribosylhydrolase ARH3 OS=Latimeria chalumnae OX=7897 GN=adprs PE=1 SV=1,GO:0000287; GO:0004649; GO:0005634; GO:0005694; GO:0005759; GO:0006281; GO:0060546; GO:0140290; GO:0140292,DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine ADP-deribosylation [GO:0140290],chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634],ADP-ribosylserine hydrolase activity [GO:0140292]; magnesium ion binding [GO:0000287]; poly(ADP-ribose) glycohydrolase activity [GO:0004649],GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; DNA repair; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00678,1.7347107782369315,FUN_002093-T1,Peve_00004291,Pocillopora_meandrina_HIv1___RNAseq.g1731.t2,three_way,44.53733333333333,,,,,,,,,,,,,,,,,
OG_00679,2.8485272690509333,FUN_002102-T1,Peve_00004294,Pocillopora_meandrina_HIv1___RNAseq.g1737.t1,three_way,59.12716666666666,FUN_002102-T1,P18461,,,,,37.9,833.0,3.8e-141,503.8,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_00682,1.7397448714766743,FUN_002200-T1,Peve_00043658,Pocillopora_meandrina_HIv1___RNAseq.g30301.t1,three_way,78.49766666666667,FUN_002200-T1,Q14746,,,,,39.1,750.0,7.1e-144,512.7,sp|Q14746|COG2_HUMAN Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens OX=9606 GN=COG2 PE=1 SV=1,,,,,,
OG_00684,1.42051738772259,FUN_002351-T2,Peve_00035726,Pocillopora_meandrina_HIv1___RNAseq.g32.t1,three_way,66.9635,FUN_002351-T2,Q5XIX3,DCR1C_RAT,,Protein artemis (EC 3.1.-.-) (DNA cross-link repair 1C protein) (SNM1-like protein),Rattus norvegicus (Rat),42.9,371.0,2.4e-87,324.7,sp|Q5XIX3|DCR1C_RAT Protein artemis OS=Rattus norvegicus OX=10116 GN=Dclre1c PE=1 SV=1,GO:0000014; GO:0000723; GO:0002250; GO:0003684; GO:0005634; GO:0006302; GO:0006303; GO:0006310; GO:0008409; GO:0010212; GO:0030183; GO:0033151; GO:0035312; GO:0036297; GO:0051276; GO:0070419,adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromosome organization [GO:0051276]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]; V(D)J recombination [GO:0033151],nonhomologous end joining complex [GO:0070419]; nucleus [GO:0005634],5'-3' DNA exonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0030154; GO:0032200; GO:0043226; GO:0140097,"immune system process; DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; cell differentiation; telomere organization; organelle; catalytic activity, acting on DNA"
OG_00692,1.2747690804025509,FUN_002379-T1,Peve_00034020,Pocillopora_meandrina_HIv1___RNAseq.g20.t2,three_way,83.75166666666667,FUN_002379-T1,Q00537,CDK17_HUMAN,,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),Homo sapiens (Human),57.9,525.0,3.6e-160,566.2,sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens OX=9606 GN=CDK17 PE=1 SV=2,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310; GO:1901987,protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00695,1.3818693794265786,FUN_002406-T1,Peve_00034029,Pocillopora_meandrina_HIv1___RNAseq.g14842.t1,three_way,82.38833333333334,FUN_002406-T1,Q86TL2,STIMA_HUMAN,,Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110),Homo sapiens (Human),50.2,259.0,2.8000000000000002e-59,230.3,sp|Q86TL2|STIMA_HUMAN Store-operated calcium entry regulator STIMATE OS=Homo sapiens OX=9606 GN=STIMATE PE=1 SV=1,GO:0002115; GO:0005246; GO:0005789; GO:0016020; GO:0032237; GO:0032541; GO:0140268,activation of store-operated calcium channel activity [GO:0032237]; store-operated calcium entry [GO:0002115],cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020],calcium channel regulator activity [GO:0005246],GO:0098772,molecular function regulator activity
OG_00701,1.361880900974649,FUN_002451-T1,Peve_00043794,Pocillopora_meandrina_HIv1___RNAseq.g14889.t1,three_way,85.959,FUN_002451-T1,P47897,SYQ_HUMAN,,Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS),Homo sapiens (Human),62.5,778.0,1.2e-290,1000.3,sp|P47897|SYQ_HUMAN Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1,GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006418; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234,brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860],GO:0003824; GO:0005829; GO:0006355; GO:0006399; GO:0006520; GO:0016874; GO:0048856; GO:0098772; GO:0140098,"catalytic activity; cytosol; regulation of DNA-templated transcription; tRNA metabolic process; amino acid metabolic process; ligase activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on RNA"
OG_00704,1.2580049740115682,FUN_002454-T2,Peve_00023669,Pocillopora_meandrina_HIv1___RNAseq.g14892.t1,three_way,71.75366666666666,FUN_002454-T2,Q9N0P9,,,,,51.2,254.0,6.2e-71,269.6,sp|Q9N0P9|PIM1_BOVIN Serine/threonine-protein kinase pim-1 OS=Bos taurus OX=9913 GN=PIM1 PE=2 SV=1,,,,,,
OG_00706,1.7322864129483129,FUN_002463-T1,Peve_00034010,Pocillopora_meandrina_HIv1___RNAseq.g14902.t1,three_way,92.76133333333334,FUN_002463-T1,P55861,,,,,73.9,789.0,7.3e-312,1070.8,sp|P55861|MCM2_XENLA DNA replication licensing factor mcm2 OS=Xenopus laevis OX=8355 GN=mcm2 PE=1 SV=2,,,,,,
OG_00708,1.4539323655141698,FUN_002469-T1,Peve_00034012,Pocillopora_meandrina_HIv1___TS.g4051.t1,three_way,74.81733333333334,FUN_002469-T1,Q7TMY8,HUWE1_MOUSE,,"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (E3Histone) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",Mus musculus (Mouse),41.0,4757.0,0.0,2664.4,sp|Q7TMY8|HUWE1_MOUSE E3 ubiquitin-protein ligase HUWE1 OS=Mus musculus OX=10090 GN=Huwe1 PE=1 SV=5,GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006284; GO:0006513; GO:0030154; GO:0031398; GO:0032922; GO:0035359; GO:0043123; GO:0043161; GO:0061630; GO:0070936; GO:0140852; GO:0141198,base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; transferase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_00714,1.3505053249941494,FUN_002582-T1,Peve_00002778,Pocillopora_meandrina_HIv1___RNAseq.g25727.t1,three_way,60.239666666666665,,,,,,,,,,,,,,,,,
OG_00721,1.4409081977723528,FUN_002661-T1,Peve_00043790,Pocillopora_meandrina_HIv1___RNAseq.g14882.t1a,three_way,78.43133333333333,FUN_002661-T1,Q00709,,,,,40.5,116.0,4.1e-20,99.8,sp|Q00709|BCL2_CHICK Apoptosis regulator Bcl-2 OS=Gallus gallus OX=9031 GN=BCL2 PE=2 SV=1,,,,,,
OG_00727,2.375711085305166,FUN_002690-T1,Peve_00009951,Pocillopora_meandrina_HIv1___RNAseq.g20729.t1,three_way,49.989,FUN_002690-T1,Q3ZBG4,HES1_BOVIN,,Transcription factor HES-1 (Hairy and enhancer of split 1),Bos taurus (Bovine),59.4,64.0,4.6e-11,69.7,sp|Q3ZBG4|HES1_BOVIN Transcription factor HES-1 OS=Bos taurus OX=9913 GN=HES1 PE=2 SV=1,GO:0000122; GO:0001227; GO:0005634; GO:0007219; GO:0021861; GO:0042531; GO:0042803; GO:0043388; GO:0043565; GO:0045665; GO:0045892; GO:0046425; GO:0046427; GO:0048711; GO:0048715; GO:0050767; GO:0060253; GO:0065003; GO:0070888; GO:0071820; GO:2000974; GO:2000978,forebrain radial glial cell differentiation [GO:0021861]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of DNA binding [GO:0043388]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of neurogenesis [GO:0050767]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425],nucleus [GO:0005634],"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0065003; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; protein-containing complex assembly; transcription regulator activity
OG_00729,1.415808682911858,FUN_002695-T1,Peve_00009946,Pocillopora_meandrina_HIv1___RNAseq.g20725.t1,three_way,61.78816666666667,FUN_002695-T1,Q90VV1,HES4B_XENLA,,Transcription factor HES-4-B (Hairy and enhancer of split 4-B) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2b),Xenopus laevis (African clawed frog),37.6,194.0,7.2e-20,99.0,sp|Q90VV1|HES4B_XENLA Transcription factor HES-4-B OS=Xenopus laevis OX=8355 GN=hes4-b PE=1 SV=1,GO:0000122; GO:0000978; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0014029; GO:0021501; GO:0033504; GO:0043066; GO:0043565; GO:0045892; GO:0046982; GO:0048642; GO:0050767,floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; prechordal plate formation [GO:0021501]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_00732,2.231545207151835,FUN_002698-T1,Peve_00034497,Pocillopora_meandrina_HIv1___RNAseq.g20728.t1,three_way,72.25633333333333,FUN_002698-T1,Q6IRB2,HES1A_XENLA,,Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1),Xenopus laevis (African clawed frog),39.2,245.0,2.4e-26,120.6,sp|Q6IRB2|HES1A_XENLA Transcription factor HES-1-A OS=Xenopus laevis OX=8355 GN=hes1-a PE=1 SV=1,GO:0000122; GO:0000978; GO:0005634; GO:0007219; GO:0043425; GO:0043565; GO:0045665; GO:0045892; GO:0046982; GO:0048635; GO:0050767,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],bHLH transcription factor binding [GO:0043425]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_00734,1.0128900418625433,FUN_002714-T1,Peve_00027875,Pocillopora_meandrina_HIv1___TS.g27685.t1,three_way,53.21833333333333,,,,,,,,,,,,,,,,,
OG_00735,1.055562973303561,FUN_002716-T1,Peve_00027493,Pocillopora_meandrina_HIv1___RNAseq.g20658.t1,three_way,59.64266666666666,,,,,,,,,,,,,,,,,
OG_00736,1.5565766234605107,FUN_002718-T1,Peve_00025049,Pocillopora_meandrina_HIv1___RNAseq.g20657.t1,three_way,73.45766666666667,FUN_002718-T1,Q66H43,,,,,48.1,104.0,2.7999999999999998e-24,113.6,sp|Q66H43|BORC6_RAT BLOC-1-related complex subunit 6 OS=Rattus norvegicus OX=10116 GN=Borcs6 PE=2 SV=2,,,,,,
OG_00746,1.1754197587070303,FUN_002736-T1,Peve_00041437,Pocillopora_meandrina_HIv1___RNAseq.g14951.t1,three_way,65.202,FUN_002736-T1,Q9BXT6,M10L1_HUMAN,,RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1),Homo sapiens (Human),39.3,1153.0,1.3999999999999999e-221,771.5,sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196,germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; cytosol; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00749,1.2412473997282325,FUN_002806-T2,Peve_00044239,Pocillopora_meandrina_HIv1___RNAseq.g14970.t1b,three_way,71.58233333333334,,,,,,,,,,,,,,,,,
OG_00754,1.3270397567388048,FUN_002813-T1,Peve_00044244,Pocillopora_meandrina_HIv1___RNAseq.g14958.t1,three_way,72.313,FUN_002813-T1,C4A0D9,BAP1_BRAFL,,Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1),Branchiostoma floridae (Florida lancelet) (Amphioxus),39.8,694.0,2.9999999999999997e-97,357.5,sp|C4A0D9|BAP1_BRAFL Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Branchiostoma floridae OX=7739 GN=BAP1 PE=3 SV=1,GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0016579; GO:0031507; GO:0035517; GO:0045892; GO:0051726; GO:0071108,heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517],chromatin binding [GO:0003682]; cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00757,1.4880741831734283,FUN_003163-T1,Peve_00013072,Pocillopora_meandrina_HIv1___RNAseq.g6226.t1,three_way,84.06066666666666,FUN_003163-T1,P54996,,,,,66.8,479.0,3.9e-200,699.1,sp|P54996|G6PD_TAKRU Glucose-6-phosphate 1-dehydrogenase OS=Takifugu rubripes OX=31033 GN=g6pd PE=3 SV=1,,,,,,
OG_00765,1.459809858936508,FUN_003434-T1,Peve_00010306,Pocillopora_meandrina_HIv1___RNAseq.g9162.t1,three_way,49.788,,,,,,,,,,,,,,,,,
OG_00769,2.1367861981940663,FUN_003713-T1,Peve_00001357,Pocillopora_meandrina_HIv1___RNAseq.g17373.t2,three_way,74.59033333333333,FUN_003713-T1,A7RX69,TIKI1_NEMVE,,Metalloprotease TIKI homolog (EC 3.4.-.-),Nematostella vectensis (Starlet sea anemone),59.5,373.0,5.4999999999999996e-129,462.6,sp|A7RX69|TIKI1_NEMVE Metalloprotease TIKI homolog OS=Nematostella vectensis OX=45351 GN=v1g27680 PE=2 SV=2,GO:0004222; GO:0006508; GO:0016020; GO:0030178; GO:0046872,negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508],membrane [GO:0016020],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00771,1.648744285729329,FUN_003839-T1,Peve_00042654,Pocillopora_meandrina_HIv1___RNAseq.g11160.t1,three_way,68.94483333333334,FUN_003839-T1,Q9Z254,GIPC1_RAT,,PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin),Rattus norvegicus (Rat),59.0,290.0,3.8e-93,343.2,sp|Q9Z254|GIPC1_RAT PDZ domain-containing protein GIPC1 OS=Rattus norvegicus OX=10116 GN=Gipc1 PE=1 SV=2,GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005903; GO:0005938; GO:0006605; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030139; GO:0030165; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0048023; GO:0048167; GO:0098685; GO:0098761; GO:0098793; GO:0098794; GO:0098978; GO:0099171,cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167],brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506],actin binding [GO:0003779]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102],GO:0005829; GO:0008092; GO:0023052; GO:0031410; GO:0043226; GO:0048870,cytosol; cytoskeletal protein binding; signaling; cytoplasmic vesicle; organelle; cell motility
OG_00772,3.2073177359851623,FUN_003840-T1,Peve_00003890,Pocillopora_meandrina_HIv1___RNAseq.g11708.t1,three_way,63.461333333333336,FUN_003840-T1,A7MBJ4,PTPRF_BOVIN,,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),Bos taurus (Bovine),31.0,1540.0,1.8000000000000001e-162,575.5,sp|A7MBJ4|PTPRF_BOVIN Receptor-type tyrosine-protein phosphatase F OS=Bos taurus OX=9913 GN=PTPRF PE=2 SV=1,GO:0004725; GO:0007165; GO:0008201; GO:0016020; GO:0016477; GO:0035335; GO:0099560; GO:1900121,cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560],membrane [GO:0016020],heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007155; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; cell adhesion; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_00775,1.5280796725662709,FUN_003847-T1,Peve_00009243,Pocillopora_meandrina_HIv1___RNAseq.g11165.t1,three_way,62.71566666666666,FUN_003847-T1,Q80TL4,PHF24_MOUSE,,PHD finger protein 24,Mus musculus (Mouse),30.2,268.0,2.8e-31,137.9,sp|Q80TL4|PHF24_MOUSE PHD finger protein 24 OS=Mus musculus OX=10090 GN=Phf24 PE=1 SV=2,GO:0007214; GO:0008270; GO:0008277; GO:0030672; GO:0032228; GO:0050966; GO:0098978,"detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic transmission, GABAergic [GO:0032228]",glutamatergic synapse [GO:0098978]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0023052,signaling
OG_00776,1.4257645570066573,FUN_003849-T2,Peve_00018009,Pocillopora_meandrina_HIv1___RNAseq.g16676.t1,three_way,81.325,FUN_003849-T2,Q8R1A4,DOCK7_MOUSE,,Dedicator of cytokinesis protein 7 (Protein moonlight),Mus musculus (Mouse),52.9,2155.0,0.0,2026.1,sp|Q8R1A4|DOCK7_MOUSE Dedicator of cytokinesis protein 7 OS=Mus musculus OX=10090 GN=Dock7 PE=1 SV=3,GO:0002244; GO:0005085; GO:0007264; GO:0022027; GO:0030424; GO:0031267; GO:0031594; GO:0043473; GO:0050767; GO:0098698; GO:0120163,hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; negative regulation of cold-induced thermogenesis [GO:0120163]; pigmentation [GO:0043473]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase-mediated signal transduction [GO:0007264],axon [GO:0030424]; neuromuscular junction [GO:0031594],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0030154; GO:0098772,cell differentiation; molecular function regulator activity
OG_00778,1.9541441489861453,FUN_003852-T2,Peve_00012768,Pocillopora_meandrina_HIv1___RNAseq.g11582.t1,three_way,50.0285,FUN_003852-T2,Q9QYT7,,,,,39.9,318.0,3.4e-54,214.5,sp|Q9QYT7|PIGQ_MOUSE Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Mus musculus OX=10090 GN=Pigq PE=1 SV=3,,,,,,
OG_00781,1.303625506016823,FUN_003881-T1,Peve_00023686,Pocillopora_meandrina_HIv1___RNAseq.g11577.t1,three_way,74.771,FUN_003881-T1,Q66KE8,,,,,30.9,459.0,4.3e-50,201.4,sp|Q66KE8|CCD78_XENLA Coiled-coil domain-containing protein 78 OS=Xenopus laevis OX=8355 GN=ccdc78 PE=2 SV=1,,,,,,
OG_00784,1.0070827064163157,FUN_003894-T1,Peve_00015142,Pocillopora_meandrina_HIv1___RNAseq.g11707.t1,three_way,79.82766666666667,FUN_003894-T1,P35574,,,,,51.0,1345.0,0.0,1379.0,sp|P35574|GDE_RABIT Glycogen debranching enzyme OS=Oryctolagus cuniculus OX=9986 GN=AGL PE=1 SV=1,,,,,,
OG_00787,2.2349789451082995,FUN_003900-T1,Peve_00025157,Pocillopora_meandrina_HIv1___RNAseq.g17184.t1,three_way,80.535,FUN_003900-T1,Q69ZJ7,RIC1_MOUSE,,Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1),Mus musculus (Mouse),40.0,1396.0,3.9000000000000003e-284,979.5,sp|Q69ZJ7|RIC1_MOUSE Guanine nucleotide exchange factor subunit RIC1 OS=Mus musculus OX=10090 GN=Ric1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547,"intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005829; GO:0006886; GO:0016192; GO:0098772,cytosol; intracellular protein transport; vesicle-mediated transport; molecular function regulator activity
OG_00792,2.981442006350673,FUN_003938-T1,Peve_00041389,Pocillopora_meandrina_HIv1___TS.g7868.t1,three_way,40.8085,,,,,,,,,,,,,,,,,
OG_00793,1.1036768615492585,FUN_003940-T1,Peve_00038457,Pocillopora_meandrina_HIv1___RNAseq.g11757.t1,three_way,58.294,FUN_003940-T1,Q6DG99,,,,,53.7,95.0,7.6e-19,96.3,sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1,,,,,,
OG_00796,1.1415236599538257,FUN_003982-T1,Peve_00038451,Pocillopora_meandrina_HIv1___TS.g7876.t1,three_way,62.93233333333333,,,,,,,,,,,,,,,,,
OG_00799,1.0834059167539716,FUN_003992-T1,Peve_00038456,Pocillopora_meandrina_HIv1___RNAseq.g17199.t1,three_way,69.46000000000001,FUN_003992-T1,Q0GGW5,STK11_CHICK,,Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1 homolog) (LKB1),Gallus gallus (Chicken),45.7,234.0,4.6999999999999995e-49,196.4,sp|Q0GGW5|STK11_CHICK Serine/threonine-protein kinase STK11 OS=Gallus gallus OX=9031 GN=STK11 PE=2 SV=1,GO:0000287; GO:0001558; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006470; GO:0006974; GO:0007165; GO:0009267; GO:0009410; GO:0010212; GO:0016020; GO:0019901; GO:0030010; GO:0030111; GO:0030295; GO:0030308; GO:0032147; GO:0042593; GO:0046777; GO:0072332; GO:0090090; GO:0106310; GO:1901610,activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; positive regulation of vesicle transport along microtubule [GO:1901610]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of Wnt signaling pathway [GO:0030111]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; vasculature development [GO:0001944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0007163; GO:0016740; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; nucleus; mitochondrion; cytosol; establishment or maintenance of cell polarity; transferase activity; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00800,1.2431307459961742,FUN_003996-T1,Peve_00038453,Pocillopora_meandrina_HIv1___RNAseq.g17200.t1,three_way,59.2325,FUN_003996-T1,P24524,GLRA3_RAT,,Glycine receptor subunit alpha-3,Rattus norvegicus (Rat),27.8,399.0,5.9e-36,153.3,sp|P24524|GLRA3_RAT Glycine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Glra3 PE=1 SV=1,GO:0004888; GO:0005886; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0042734; GO:0043204; GO:0046872; GO:0051260; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099171; GO:0099634; GO:1902476,cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734],extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888],GO:0005215; GO:0005886; GO:0055085; GO:0060089; GO:0065003,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity; protein-containing complex assembly
OG_00801,1.289637372983844,FUN_003999-T1,Peve_00034334,Pocillopora_meandrina_HIv1___RNAseq.g11693.t1,three_way,63.882666666666665,FUN_003999-T1,P21956,MFGM_MOUSE,,Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47),Mus musculus (Mouse),32.1,346.0,3.3e-32,141.0,sp|P21956|MFGM_MOUSE Lactadherin OS=Mus musculus OX=10090 GN=Mfge8 PE=1 SV=3,GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0043277; GO:0050766; GO:0062023,"angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]",acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615],integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786],GO:0005615; GO:0007155; GO:0008289; GO:0016192; GO:0022414; GO:0061024,extracellular space; cell adhesion; lipid binding; vesicle-mediated transport; reproductive process; membrane organization
OG_00802,1.0804768224254566,FUN_004000-T1,Peve_00034331,Pocillopora_meandrina_HIv1___RNAseq.g11698.t1,three_way,63.14333333333333,FUN_004000-T1,Q8CJ12,AGRG2_MOUSE,,"Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Mouse epididymis-specific protein 6) (Me6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)]",Mus musculus (Mouse),34.0,379.0,1.9e-50,203.4,sp|Q8CJ12|AGRG2_MOUSE Adhesion G-protein coupled receptor G2 OS=Mus musculus OX=10090 GN=Adgrg2 PE=1 SV=1,GO:0004930; GO:0005829; GO:0007166; GO:0007189; GO:0007286; GO:0016324,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; spermatid development [GO:0007286],apical plasma membrane [GO:0016324]; cytosol [GO:0005829],G protein-coupled receptor activity [GO:0004930],GO:0005829; GO:0022414; GO:0048856; GO:0060089,cytosol; reproductive process; anatomical structure development; molecular transducer activity
OG_00803,1.1221054448849528,FUN_004001-T1,Peve_00034328,Pocillopora_meandrina_HIv1___RNAseq.g11699.t1,three_way,70.47566666666667,FUN_004001-T1,Q90240,CBPD_ANAPL,,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) (p170),Anas platyrhynchos (Mallard) (Anas boschas),54.0,376.0,4.3e-119,430.3,sp|Q90240|CBPD_ANAPL Carboxypeptidase D OS=Anas platyrhynchos OX=8839 GN=CPD PE=1 SV=1,GO:0004181; GO:0005615; GO:0005886; GO:0006508; GO:0006518; GO:0008270; GO:0016020; GO:0016485,peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_00807,2.158268240349176,FUN_004006-T1,Peve_00044933,Pocillopora_meandrina_HIv1___RNAseq.g11690.t1,three_way,87.45700000000001,FUN_004006-T1,P03967,RASD_DICDI,,Ras-like protein rasD (EC 3.6.5.2) (Transforming protein p23 homolog),Dictyostelium discoideum (Social amoeba),39.9,193.0,7.1e-35,148.7,sp|P03967|RASD_DICDI Ras-like protein rasD OS=Dictyostelium discoideum OX=44689 GN=rasD PE=1 SV=2,GO:0000281; GO:0003924; GO:0003925; GO:0004860; GO:0005525; GO:0005811; GO:0005829; GO:0005886; GO:0006935; GO:0009617; GO:0019003; GO:0019887; GO:0031005; GO:0042331; GO:0043052; GO:0043422; GO:0046956; GO:0051019; GO:0070371; GO:0070685; GO:0140582; GO:1905301,adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway [GO:0140582]; chemotaxis [GO:0006935]; ERK1 and ERK2 cascade [GO:0070371]; mitotic cytokinesis [GO:0000281]; phototaxis [GO:0042331]; positive phototaxis [GO:0046956]; regulation of macropinocytosis [GO:1905301]; response to bacterium [GO:0009617]; thermotaxis [GO:0043052],cytosol [GO:0005829]; lipid droplet [GO:0005811]; macropinocytic cup [GO:0070685]; plasma membrane [GO:0005886],filamin binding [GO:0031005]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase B binding [GO:0043422]; protein kinase inhibitor activity [GO:0004860]; protein kinase regulator activity [GO:0019887],GO:0000910; GO:0003824; GO:0003924; GO:0005811; GO:0005829; GO:0005886; GO:0008092; GO:0016787; GO:0043226; GO:0098772,cytokinesis; catalytic activity; GTPase activity; lipid droplet; cytosol; plasma membrane; cytoskeletal protein binding; hydrolase activity; organelle; molecular function regulator activity
OG_00808,1.7607423225094994,FUN_004007-T1,Peve_00044893,Pocillopora_meandrina_HIv1___RNAseq.g11703.t1b,three_way,74.065,FUN_004007-T1,O95405,,,,,43.3,743.0,2.8000000000000003e-161,571.2,sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2,,,,,,
OG_00810,2.1781041619711883,FUN_004010-T1,Peve_00044898,Pocillopora_meandrina_HIv1___RNAseq.g11691.t1,three_way,58.72366666666667,FUN_004010-T1,Q9BYK8,,,,,26.8,1587.0,5.9e-113,411.4,sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7,,,,,,
OG_00811,1.9150054529772509,FUN_004011-T1,Peve_00044901,Pocillopora_meandrina_HIv1___RNAseq.g24674.t1,three_way,43.192,,,,,,,,,,,,,,,,,
OG_00816,1.5096371594881788,FUN_004029-T1,Peve_00003922,Pocillopora_meandrina_HIv1___TS.g18515.t2,three_way,93.10066666666664,FUN_004029-T1,Q9R050,,,,,40.6,414.0,1.6999999999999998e-53,211.5,sp|Q9R050|SSBP3_RAT Single-stranded DNA-binding protein 3 OS=Rattus norvegicus OX=10116 GN=Ssbp3 PE=1 SV=1,,,,,,
OG_00820,1.338471697117804,FUN_004038-T1,Peve_00008961,Pocillopora_meandrina_HIv1___RNAseq.g11549.t1,three_way,96.45366666666666,FUN_004038-T1,Q2KJ81,AP1M1_BOVIN,,AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin),Bos taurus (Bovine),81.5,422.0,8.299999999999998e-206,717.6,sp|Q2KJ81|AP1M1_BOVIN AP-1 complex subunit mu-1 OS=Bos taurus OX=9913 GN=AP1M1 PE=1 SV=3,GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0035615,intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794],clathrin adaptor activity [GO:0035615],GO:0005794; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090,Golgi apparatus; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_00821,1.8106038390432848,FUN_004039-T1,Peve_00008962,Pocillopora_meandrina_HIv1___RNAseq.g11550.t1,three_way,79.03166666666667,FUN_004039-T1,D3YXK1,SAMD1_MOUSE,,Sterile alpha motif domain-containing protein 1 (SAM domain-containing protein 1) (Atherin),Mus musculus (Mouse),54.7,75.0,7.5e-17,90.1,sp|D3YXK1|SAMD1_MOUSE Sterile alpha motif domain-containing protein 1 OS=Mus musculus OX=10090 GN=Samd1 PE=1 SV=1,GO:0000122; GO:0003677; GO:0003682; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0030169; GO:0034439; GO:0051260; GO:0090077; GO:0160217,chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription initiation-coupled chromatin remodeling [GO:0160217]; protein homooligomerization [GO:0051260],chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; low-density lipoprotein particle binding [GO:0030169],GO:0003677; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0043226; GO:0065003,DNA binding; extracellular space; nucleus; chromosome; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_00825,1.1082861247662403,FUN_004054-T1,Peve_00003957,Pocillopora_meandrina_HIv1___RNAseq.g12636.t1,three_way,93.765,FUN_004054-T1,Q28DV3,HDAC3_XENTR,,Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),70.9,423.0,2.2e-182,639.8,sp|Q28DV3|HDAC3_XENTR Histone deacetylase 3 OS=Xenopus tropicalis OX=8364 GN=hdac3 PE=2 SV=1,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0005737; GO:0005829; GO:0017053; GO:0032922; GO:0033558; GO:0042752; GO:0046872; GO:0141221; GO:0160008; GO:0160009; GO:0160010; GO:0160216,circadian regulation of gene expression [GO:0032922]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone decrotonylase activity [GO:0160009]; metal ion binding [GO:0046872]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein decrotonylase activity [GO:0160008]; protein lysine deacetylase activity [GO:0033558]; protein lysine delactylase activity [GO:0160216]; transcription corepressor activity [GO:0003714]",GO:0003824; GO:0005634; GO:0005694; GO:0005829; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; cytosol; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_00827,1.608063946236394,FUN_004056-T1,Peve_00007130,Pocillopora_meandrina_HIv1___TS.g18499.t1,three_way,72.9045,FUN_004056-T1,Q6P0Q8,MAST2_HUMAN,,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),Homo sapiens (Human),43.5,1429.0,1.8999999999999997e-236,821.2,sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310,cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_00833,1.8660777699844884,FUN_004078-T1,Peve_00006662,Pocillopora_meandrina_HIv1___RNAseq.g17237.t1,three_way,69.94466666666666,FUN_004078-T1,B1AS42,NB5R5_MOUSE,,NADH-cytochrome b5 reductase-like (EC 1.6.2.2),Mus musculus (Mouse),39.5,311.0,9.999999999999999e-64,245.4,sp|B1AS42|NB5R5_MOUSE NADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1,GO:0004128; GO:0005654; GO:0005789,,endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]",GO:0003824; GO:0005654; GO:0016491,catalytic activity; nucleoplasm; oxidoreductase activity
OG_00834,1.7188834834656417,FUN_004079-T1,Peve_00007133,Pocillopora_meandrina_HIv1___RNAseq.g17243.t1,three_way,61.05466666666667,FUN_004079-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),36.1,651.0,7.7e-94,347.4,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_00835,1.2197751975306723,FUN_004084-T1,Peve_00006656,Pocillopora_meandrina_HIv1___RNAseq.g17235.t1,three_way,83.86,FUN_004084-T1,Q8IWG1,DNAI3_HUMAN,,Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63),Homo sapiens (Human),48.8,801.0,4.1e-223,776.2,sp|Q8IWG1|DNAI3_HUMAN Dynein axonemal intermediate chain 3 OS=Homo sapiens OX=9606 GN=DNAI3 PE=1 SV=1,GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933,cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669],axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156],Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503],GO:0007018; GO:0065003,microtubule-based movement; protein-containing complex assembly
OG_00838,1.7768606070301904,FUN_004088-T1,Peve_00024024,Pocillopora_meandrina_HIv1___RNAseq.29948_t,three_way,59.1695,FUN_004088-T1,Q0KIA2,,,,,44.8,232.0,3.5e-49,197.6,sp|Q0KIA2|Y9801_DROME PP2C-like domain-containing protein CG9801 OS=Drosophila melanogaster OX=7227 GN=CG9801 PE=2 SV=1,,,,,,
OG_00843,2.8031490996269506,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_00844,1.7768670711752474,FUN_004095-T1,Peve_00028986,Pocillopora_meandrina_HIv1___RNAseq.g11568.t1,three_way,55.16966666666666,FUN_004095-T1,Q96S53,TESK2_HUMAN,,Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2),Homo sapiens (Human),50.5,287.0,5.2e-76,287.0,sp|Q96S53|TESK2_HUMAN Dual specificity testis-specific protein kinase 2 OS=Homo sapiens OX=9606 GN=TESK2 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007283; GO:0016604; GO:0030036; GO:0046872; GO:0048041; GO:0106310,actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0007010; GO:0016740; GO:0022414; GO:0034330; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton organization; transferase activity; reproductive process; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_00849,1.0211542619322225,FUN_004100-T1,Peve_00030718,Pocillopora_meandrina_HIv1___RNAseq.g11660.t1,three_way,75.31516666666667,FUN_004100-T1,Q32NH8,PLCD4_XENLA,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4)",Xenopus laevis (African clawed frog),41.4,749.0,1.0000000000000001e-145,518.8,"sp|Q32NH8|PLCD4_XENLA 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 OS=Xenopus laevis OX=8355 GN=plcd4 PE=2 SV=1",GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0005886; GO:0016042; GO:0035556,intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005634; GO:0005783; GO:0005886; GO:0006629; GO:0016787; GO:0043226,catalytic activity; nucleus; endoplasmic reticulum; plasma membrane; lipid metabolic process; hydrolase activity; organelle
OG_00854,1.4469800666879398,FUN_004117-T1,Peve_00038521,Pocillopora_meandrina_HIv1___RNAseq.g11674.t1,three_way,85.43533333333333,FUN_004117-T1,F1Q8K0,RAD54_DANRE,,DNA repair and recombination protein RAD54-like (EC 3.6.4.12),Danio rerio (Zebrafish) (Brachydanio rerio),66.8,744.0,3.7000000000000004e-292,1005.4,sp|F1Q8K0|RAD54_DANRE DNA repair and recombination protein RAD54-like OS=Danio rerio OX=7955 GN=rad54l PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0008094; GO:0015616; GO:0016787; GO:0045003,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131],nucleus [GO:0005634],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]",GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_00858,1.2353744540536722,FUN_004121-T2,Peve_00029608,Pocillopora_meandrina_HIv1___RNAseq.g11680.t2,three_way,75.833,FUN_004121-T2,Q6DCG4,RHBGB_XENLA,,Ammonium transporter Rh type B-B (Rhesus blood group family type B glycoprotein B) (Rh family type B glycoprotein B) (Rh type B glycoprotein B),Xenopus laevis (African clawed frog),48.8,445.0,2e-110,401.0,sp|Q6DCG4|RHBGB_XENLA Ammonium transporter Rh type B-B OS=Xenopus laevis OX=8355 GN=rhbg-b PE=2 SV=1,GO:0005886; GO:0008519; GO:0016323; GO:0030659; GO:0072488; GO:0097272,ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488],basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886],ammonium channel activity [GO:0008519],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_00862,1.1074994037764898,FUN_004127-T1,Peve_00004367,Pocillopora_meandrina_HIv1___RNAseq.g11562.t1,three_way,66.90633333333334,FUN_004127-T1,Q2I327,,,,,32.2,357.0,2.5e-27,124.8,sp|Q2I327|DMTA2_XIPMA Doublesex- and mab-3-related transcription factor A2 OS=Xiphophorus maculatus OX=8083 GN=dmrta2 PE=2 SV=1,,,,,,
OG_00863,1.5583771974528573,FUN_004128-T1,Peve_00021772,Pocillopora_meandrina_HIv1___RNAseq.g16786.t1,three_way,47.478,,,,,,,,,,,,,,,,,
OG_00866,2.3410283666069125,FUN_004140-T2,Peve_00009429,Pocillopora_meandrina_HIv1___RNAseq.g11564.t1,three_way,92.6315,FUN_004140-T2,Q07343,PDE4B_HUMAN,,"3',5'-cyclic-AMP phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32) (cAMP-specific phosphodiesterase 4B)",Homo sapiens (Human),56.3,551.0,1.1000000000000001e-168,595.1,"sp|Q07343|PDE4B_HUMAN 3',5'-cyclic-AMP phosphodiesterase 4B OS=Homo sapiens OX=9606 GN=PDE4B PE=1 SV=1",GO:0000930; GO:0001780; GO:0004115; GO:0005246; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0008021; GO:0014069; GO:0019933; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0047555; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071466; GO:0071872; GO:0071878; GO:0086004; GO:1901898; GO:1902514,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; leukocyte migration [GO:0050900]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of type II interferon production [GO:0032729]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell contraction [GO:0086004]; T cell receptor signaling pathway [GO:0050852],centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium channel regulator activity [GO:0005246]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]",GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0048870; GO:0055086; GO:0098772; GO:1901135,immune system process; catalytic activity; microtubule organizing center; cytosol; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; cell motility; nucleobase-containing small molecule metabolic process; molecular function regulator activity; carbohydrate derivative metabolic process
OG_00867,1.5527549173526412,FUN_004142-T1,Peve_00004368,Pocillopora_meandrina_HIv1___RNAseq.g144.t1,three_way,51.94683333333333,FUN_004142-T1,Q5T890,ER6L2_HUMAN,,DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like) (Excision repair cross-complementation group 6-like 2),Homo sapiens (Human),31.5,1000.0,5.9999999999999986e-93,344.0,sp|Q5T890|ER6L2_HUMAN DNA excision repair protein ERCC-6-like 2 OS=Homo sapiens OX=9606 GN=ERCC6L2 PE=1 SV=3,GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0097680,cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0006281; GO:0016787; GO:0016853; GO:0043226; GO:0140657,DNA binding; catalytic activity; nucleus; mitochondrion; microtubule organizing center; DNA repair; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_00868,1.199973206374069,FUN_004150-T1,Peve_00021770,Pocillopora_meandrina_HIv1___RNAseq.g16785.t1,three_way,52.79866666666667,,,,,,,,,,,,,,,,,
OG_00872,2.03577388973399,FUN_004160-T1,Peve_00031557,Pocillopora_meandrina_HIv1___RNAseq.g16770.t1,three_way,82.089,FUN_004160-T1,Q6QI06,RICTR_MOUSE,,Rapamycin-insensitive companion of mTOR (AVO3 homolog) (mAVO3) (Protein pianissimo),Mus musculus (Mouse),48.6,1035.0,4.7e-280,966.5,sp|Q6QI06|RICTR_MOUSE Rapamycin-insensitive companion of mTOR OS=Mus musculus OX=10090 GN=Rictor PE=1 SV=2,GO:0001932; GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0038203; GO:0043022; GO:0043066; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0140767; GO:1902554; GO:2000114,actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein phosphorylation [GO:0001932]; TORC2 signaling [GO:0038203],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; serine/threonine protein kinase complex [GO:1902554]; TORC2 complex [GO:0031932],ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270],GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0006629; GO:0007010; GO:0043226; GO:0048856; GO:0060090; GO:0098772,lysosome; vacuole; endoplasmic reticulum; plasma membrane; lipid metabolic process; cytoskeleton organization; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_00873,1.3289681665188031,FUN_004162-T1,Peve_00031559,Pocillopora_meandrina_HIv1___RNAseq.24438_t,three_way,37.080333333333336,,,,,,,,,,,,,,,,,
OG_00876,1.3654379798948444,FUN_004165-T1,Peve_00031563,Pocillopora_meandrina_HIv1___RNAseq.g16742.t1,three_way,88.557,FUN_004165-T1,Q8N6S4,AN13C_HUMAN,,Ankyrin repeat domain-containing protein 13C,Homo sapiens (Human),64.4,430.0,1.1000000000000002e-165,584.3,sp|Q8N6S4|AN13C_HUMAN Ankyrin repeat domain-containing protein 13C OS=Homo sapiens OX=9606 GN=ANKRD13C PE=1 SV=2,GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006612; GO:0006621; GO:0048471; GO:0071799; GO:0140597; GO:2000209,cellular response to prostaglandin D stimulus [GO:0071799]; protein retention in ER lumen [GO:0006621]; protein targeting to membrane [GO:0006612]; regulation of anoikis [GO:2000209],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471],protein carrier chaperone [GO:0140597]; signaling receptor binding [GO:0005102],GO:0005783; GO:0043226; GO:0140104,endoplasmic reticulum; organelle; molecular carrier activity
OG_00879,1.631261426766371,FUN_004172-T1,Peve_00035080,Pocillopora_meandrina_HIv1___TS.g17566.t1,three_way,84.42933333333333,FUN_004172-T1,Q9H841,,,,,50.5,291.0,9.2e-76,285.4,sp|Q9H841|NPAL2_HUMAN NIPA-like protein 2 OS=Homo sapiens OX=9606 GN=NIPAL2 PE=1 SV=2,,,,,,
OG_00880,2.494844787970123,FUN_004174-T1,Peve_00019597,Pocillopora_meandrina_HIv1___TS.g17559.t2,three_way,57.525333333333336,FUN_004174-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),35.1,1661.0,5.0999999999999996e-250,867.1,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_00881,1.2273844546977528,FUN_004196-T2,Peve_00030899,Pocillopora_meandrina_HIv1___RNAseq.g17013.t1,three_way,51.406666666666666,FUN_004196-T2,Q60988,STIL_MOUSE,,SCL-interrupting locus protein homolog,Mus musculus (Mouse),25.4,1322.0,1.7e-66,256.5,sp|Q60988|STIL_MOUSE SCL-interrupting locus protein homolog OS=Mus musculus OX=10090 GN=Stil PE=1 SV=2,GO:0000578; GO:0001701; GO:0001843; GO:0001947; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005938; GO:0006915; GO:0007052; GO:0007224; GO:0007368; GO:0021915; GO:0030900; GO:0030903; GO:0033504; GO:0035264; GO:0043066; GO:0046599; GO:0046601; GO:0051298; GO:0060236; GO:0071539; GO:0120099; GO:1900087; GO:1905515; GO:1905832,apoptotic process [GO:0006915]; centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224],cell cortex [GO:0005938]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; procentriole replication complex [GO:0120099],,GO:0005815; GO:0005829; GO:0007010; GO:0012501; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytosol; cytoskeleton organization; programmed cell death; organelle; cilium organization; anatomical structure development
OG_00882,1.2101076384055347,FUN_004197-T1,Peve_00030901,Pocillopora_meandrina_HIv1___RNAseq.g17019.t1,three_way,60.303666666666665,FUN_004197-T1,Q9H6X5,,,,,37.4,147.0,5.9e-19,97.1,sp|Q9H6X5|CS044_HUMAN Uncharacterized protein C19orf44 OS=Homo sapiens OX=9606 GN=C19orf44 PE=1 SV=1,,,,,,
OG_00887,3.504542369126642,FUN_004202-T1,Peve_00008456,Pocillopora_meandrina_HIv1___RNAseq.g16814.t1,three_way,83.68566666666666,FUN_004202-T1,Q91W43,GCSP_MOUSE,,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))",Mus musculus (Mouse),66.0,968.0,0.0,1327.0,"sp|Q91W43|GCSP_MOUSE Glycine dehydrogenase (decarboxylating), mitochondrial OS=Mus musculus OX=10090 GN=Gldc PE=1 SV=1",GO:0004375; GO:0005654; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0065003; GO:0070280; GO:1903442; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein-containing complex assembly [GO:0065003]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005886; GO:0006520; GO:0016491; GO:0016829; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; plasma membrane; amino acid metabolic process; oxidoreductase activity; lyase activity; organelle; protein-containing complex assembly
OG_00889,1.0696483393400915,FUN_004204-T1,Peve_00018652,Pocillopora_meandrina_HIv1___RNAseq.g16708.t1,three_way,74.196,FUN_004204-T1,Q96LT7,CI072_HUMAN,,Guanine nucleotide exchange factor C9orf72,Homo sapiens (Human),32.5,459.0,9.2e-60,232.6,sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange factor C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2,GO:0000932; GO:0001933; GO:0005085; GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005776; GO:0005829; GO:0006897; GO:0006914; GO:0010494; GO:0010506; GO:0016239; GO:0030425; GO:0031267; GO:0031965; GO:0032045; GO:0032880; GO:0034063; GO:0043204; GO:0043231; GO:0044295; GO:0044304; GO:0045920; GO:0048675; GO:0050777; GO:0061909; GO:0090543; GO:0098686; GO:0098693; GO:0098794; GO:0098978; GO:0099523; GO:0110053; GO:1902774; GO:1903432; GO:2000785,autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of protein localization [GO:0032880]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063],autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005615; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0098772,extracellular space; nucleus; lysosome; endosome; vacuole; cytosol; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; molecular function regulator activity
OG_00890,1.1151180819793616,FUN_004205-T1,Peve_00027996,Pocillopora_meandrina_HIv1___RNAseq.g11214.t1,three_way,62.80466666666667,FUN_004205-T1,Q8WWF8,,,,,38.6,184.0,4.4e-29,129.4,sp|Q8WWF8|CAPSL_HUMAN Calcyphosin-like protein OS=Homo sapiens OX=9606 GN=CAPSL PE=1 SV=4,,,,,,
OG_00893,2.3802363994113693,FUN_004208-T2,Peve_00011048,Pocillopora_meandrina_HIv1___RNAseq.g11218.t1,three_way,83.40266666666666,FUN_004208-T2,P51688,SPHM_HUMAN,,N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase),Homo sapiens (Human),63.4,432.0,4.3e-168,592.4,sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062,determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_00898,1.2676276443216683,FUN_004213-T1,Peve_00008868,Pocillopora_meandrina_HIv1___RNAseq.g11223.t1,three_way,82.36266666666667,FUN_004213-T1,Q16739,CEGT_HUMAN,,Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase),Homo sapiens (Human),43.0,386.0,1e-91,338.6,sp|Q16739|CEGT_HUMAN Ceramide glucosyltransferase OS=Homo sapiens OX=9606 GN=UGCG PE=1 SV=1,GO:0000139; GO:0006497; GO:0006679; GO:0006688; GO:0008120; GO:0008544; GO:0009966; GO:0016020; GO:0030154; GO:0030216; GO:0033210; GO:0048666; GO:0061436; GO:0098856; GO:1903575,cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid biosynthetic process [GO:0006688]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966],Golgi membrane [GO:0000139]; membrane [GO:0016020],ceramide glucosyltransferase activity [GO:0008120],GO:0003824; GO:0006629; GO:0016740; GO:0022600; GO:0030154; GO:0048856; GO:0061024; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; digestive system process; cell differentiation; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_00903,1.18857394757121,FUN_004226-T1,Peve_00012172,Pocillopora_meandrina_HIv1___RNAseq.g11228.t1,three_way,71.90066666666667,FUN_004226-T1,Q5EA53,T2FA_BOVIN,,General transcription factor IIF subunit 1 (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha),Bos taurus (Bovine),51.5,546.0,1.4e-43,179.1,sp|Q5EA53|T2FA_BOVIN General transcription factor IIF subunit 1 OS=Bos taurus OX=9913 GN=GTF2F1 PE=2 SV=1,GO:0001096; GO:0003677; GO:0005669; GO:0005674; GO:0006367; GO:0006368; GO:0009615; GO:0016251; GO:0019211; GO:0019903; GO:0019904; GO:0030054; GO:0032091; GO:0032968; GO:0045944; GO:1990841,negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; response to virus [GO:0009615]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367],cell junction [GO:0030054]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674],DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096],GO:0003677; GO:0006355; GO:0098772; GO:0140223,DNA binding; regulation of DNA-templated transcription; molecular function regulator activity; general transcription initiation factor activity
OG_00906,1.1878718534252568,FUN_004233-T1,Peve_00004620,Pocillopora_meandrina_HIv1___RNAseq.g12556.t1,three_way,86.73,FUN_004233-T1,P80363,,,,,44.2,199.0,5.6999999999999995e-46,185.7,sp|P80363|CCB23_FAXLI Crustacean calcium-binding protein 23 OS=Faxonius limosus OX=28379 PE=1 SV=1,,,,,,
OG_00909,1.0748852839280785,FUN_004237-T1,Peve_00017641,Pocillopora_meandrina_HIv1___RNAseq.g11534.t1,three_way,79.0,,,,,,,,,,,,,,,,,
OG_00910,1.4711429656310442,FUN_004238-T1,Peve_00006799,Pocillopora_meandrina_HIv1___RNAseq.g11533.t1,three_way,59.7285,,,,,,,,,,,,,,,,,
OG_00913,2.071015391256675,FUN_004247-T1,Peve_00019440,Pocillopora_meandrina_HIv1___RNAseq.g11529.t1,three_way,67.11033333333333,FUN_004247-T1,P41233,,,,,40.9,2521.0,0.0,1671.4,sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4,,,,,,
OG_00920,1.7498559345343934,FUN_004261-T1,Peve_00008971,Pocillopora_meandrina_HIv1___RNAseq.g11410.t1,three_way,69.04033333333334,FUN_004261-T1,Q2F7Z7,,,,,32.3,297.0,9.2e-29,129.0,sp|Q2F7Z7|TMM59_PIG Transmembrane protein 59 OS=Sus scrofa OX=9823 GN=TMEM59 PE=2 SV=1,,,,,,
OG_00921,1.0002547982218726,FUN_004263-T1,Peve_00008934,Pocillopora_meandrina_HIv1___RNAseq.g11364.t1,three_way,72.5965,,,,,,,,,,,,,,,,,
OG_00930,1.5450945389825144,FUN_004275-T1,Peve_00008946,Pocillopora_meandrina_HIv1___RNAseq.g12553.t1,three_way,69.154,FUN_004275-T1,Q7ZVP8,TM38B_DANRE,,Trimeric intracellular cation channel type B (TRIC-B) (TRICB) (Transmembrane protein 38B),Danio rerio (Zebrafish) (Brachydanio rerio),35.1,251.0,9.999999999999999e-32,138.7,sp|Q7ZVP8|TM38B_DANRE Trimeric intracellular cation channel type B OS=Danio rerio OX=7955 GN=tmem38b PE=2 SV=1,GO:0005267; GO:0005783; GO:0005789; GO:0030500; GO:0031101; GO:0042802; GO:0051279; GO:1903010,fin regeneration [GO:0031101]; regulation of bone development [GO:1903010]; regulation of bone mineralization [GO:0030500]; regulation of release of sequestered calcium ion into cytosol [GO:0051279],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],identical protein binding [GO:0042802]; potassium channel activity [GO:0005267],GO:0005215; GO:0005783; GO:0043226; GO:0048856,transporter activity; endoplasmic reticulum; organelle; anatomical structure development
OG_00938,1.5808482839092386,FUN_004288-T1,Peve_00029197,Pocillopora_meandrina_HIv1___RNAseq.g11767.t1,three_way,35.059,,,,,,,,,,,,,,,,,
OG_00941,1.193948208752982,FUN_004292-T1,Peve_00008379,Pocillopora_meandrina_HIv1___RNAseq.g11770.t1,three_way,65.67333333333333,FUN_004292-T1,Q08CD5,RXLT1_DANRE,,"Ribitol-5-phosphate xylosyltransferase 1 (EC 2.4.2.61) (Transmembrane protein 5) (UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,332.0,1.6e-100,367.9,sp|Q08CD5|RXLT1_DANRE Ribitol-5-phosphate xylosyltransferase 1 OS=Danio rerio OX=7955 GN=rxylt1 PE=2 SV=2,GO:0000139; GO:0005794; GO:0035269; GO:0120053,protein O-linked mannosylation [GO:0035269],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],"ribitol beta-1,4-xylosyltransferase activity [GO:0120053]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_00942,1.555514563804971,FUN_004293-T1,Peve_00008382,Pocillopora_meandrina_HIv1___RNAseq.g11771.t1,three_way,62.1905,FUN_004293-T1,A2A9C3,SZT2_MOUSE,,KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR),Mus musculus (Mouse),30.2,3639.0,0.0,1353.6,sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1,GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667],GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777],,GO:0005777; GO:0043226; GO:0048856,peroxisome; organelle; anatomical structure development
OG_00944,1.3466797138287394,FUN_004298-T1,Peve_00018886,Pocillopora_meandrina_HIv1___RNAseq.g11773.t1,three_way,95.47533333333332,FUN_004298-T1,P25228,RAB3_DROME,,Ras-related protein Rab-3,Drosophila melanogaster (Fruit fly),80.5,221.0,7.7e-102,371.3,sp|P25228|RAB3_DROME Ras-related protein Rab-3 OS=Drosophila melanogaster OX=7227 GN=Rab3 PE=1 SV=1,GO:0000287; GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0007269; GO:0008021; GO:0015031; GO:0016192; GO:0031489; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0046718; GO:0046928; GO:0048172; GO:0048786; GO:0048789; GO:0048790,cytoskeletal matrix organization at active zone [GO:0048789]; exocytosis [GO:0006887]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; symbiont entry into host cell [GO:0046718]; vesicle-mediated transport [GO:0016192],endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; myosin V binding [GO:0031489],GO:0003824; GO:0003924; GO:0005768; GO:0005886; GO:0007010; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0034330; GO:0043226,catalytic activity; GTPase activity; endosome; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; cell junction organization; organelle
OG_00945,1.483062299395859,FUN_004302-T1,Peve_00033935,Pocillopora_meandrina_HIv1___RNAseq.g11774.t1,three_way,84.65366666666667,FUN_004302-T1,Q90988,SMC2_CHICK,,Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome scaffold protein ScII),Gallus gallus (Chicken),61.0,1173.0,6.6999999999999996e-264,912.1,sp|Q90988|SMC2_CHICK Structural maintenance of chromosomes protein 2 OS=Gallus gallus OX=9031 GN=SMC2 PE=2 SV=1,GO:0000785; GO:0000793; GO:0000796; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0007076; GO:0016887; GO:0051301,cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682],GO:0003824; GO:0005634; GO:0005694; GO:0016787; GO:0043226,catalytic activity; nucleus; chromosome; hydrolase activity; organelle
OG_00946,2.131291176342886,FUN_004303-T1,Peve_00033932,Pocillopora_meandrina_HIv1___RNAseq.g11775.t1,three_way,66.79366666666667,FUN_004303-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),39.8,698.0,4.9e-140,500.0,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00953,2.995065009373937,FUN_004313-T1,Peve_00033929,Pocillopora_meandrina_HIv1___RNAseq.g16987.t1,three_way,67.48483333333334,FUN_004313-T1,Q90693,,,,,37.8,1339.0,2e-235,817.8,sp|Q90693|PTC1_CHICK Protein patched homolog 1 OS=Gallus gallus OX=9031 GN=PTCH1 PE=1 SV=1,,,,,,
OG_00957,1.9016940556547828,FUN_004321-T1,Peve_00016506,Pocillopora_meandrina_HIv1___RNAseq.g11786.t1,three_way,75.91266666666667,FUN_004321-T1,P54357,,,,,42.0,143.0,3.7e-23,109.4,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_00961,1.790094799012253,FUN_004330-T1,Peve_00016550,Pocillopora_meandrina_HIv1___RNAseq.g12529.t1,three_way,89.566,FUN_004330-T1,A6QPA3,,,,,37.2,277.0,1.1999999999999999e-41,171.8,sp|A6QPA3|BTBDJ_BOVIN BTB/POZ domain-containing protein 19 OS=Bos taurus OX=9913 GN=BTBD19 PE=2 SV=1,,,,,,
OG_00962,1.2268098095648414,FUN_004331-T1,Peve_00016476,Pocillopora_meandrina_HIv1___TS.g18404.t1,three_way,55.634,FUN_004331-T1,Q9V9S7,,,,,33.4,347.0,5.9e-43,177.9,sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2,,,,,,
OG_00963,2.088024571161115,FUN_004332-T1,Peve_00016477,Pocillopora_meandrina_HIv1___RNAseq.g12532.t1,three_way,86.59233333333333,FUN_004332-T1,Q9UNH5,CC14A_HUMAN,,Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A),Homo sapiens (Human),60.3,459.0,1.4000000000000002e-161,570.9,sp|Q9UNH5|CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens OX=9606 GN=CDC14A PE=1 SV=1,GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686; GO:1902636,cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005730; GO:0005783; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0016787; GO:0043226; GO:0044782; GO:0050877; GO:0140096,"catalytic activity; nucleoplasm; nucleolus; endoplasmic reticulum; microtubule organizing center; cytosol; cilium; cytoskeleton organization; hydrolase activity; organelle; cilium organization; nervous system process; catalytic activity, acting on a protein"
OG_00969,1.3543581244089866,FUN_004342-T1,Peve_00016486,Pocillopora_meandrina_HIv1___RNAseq.g12543.t1,three_way,62.193333333333335,FUN_004342-T1,Q9Y5Q9,,,,,36.5,824.0,3.8999999999999996e-142,507.3,sp|Q9Y5Q9|TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens OX=9606 GN=GTF3C3 PE=1 SV=1,,,,,,
OG_00972,1.0707059073738414,FUN_004346-T1,Peve_00016493,Pocillopora_meandrina_HIv1___RNAseq.g16896.t1,three_way,82.173,FUN_004346-T1,Q8BRK8,AAPK2_MOUSE,,5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31),Mus musculus (Mouse),58.6,561.0,3.1e-179,629.8,sp|Q8BRK8|AAPK2_MOUSE 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Mus musculus OX=10090 GN=Prkaa2 PE=1 SV=3,GO:0003682; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010468; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0036064; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:0140823; GO:1903829; GO:1903944; GO:1904262; GO:1904428; GO:1905691; GO:1990044,autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634],[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712],GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; lipid metabolic process; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00974,1.312496367770326,FUN_004350-T1,Peve_00016543,Pocillopora_meandrina_HIv1___RNAseq.g12505.t1,three_way,81.94066666666667,FUN_004350-T1,P28288,ABCD3_HUMAN,,ATP-binding cassette sub-family D member 3 (EC 3.1.2.-) (EC 7.6.2.-) (70 kDa peroxisomal membrane protein) (PMP70),Homo sapiens (Human),66.0,617.0,2.2999999999999998e-245,849.7,sp|P28288|ABCD3_HUMAN ATP-binding cassette sub-family D member 3 OS=Homo sapiens OX=9606 GN=ABCD3 PE=1 SV=1,GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0006699; GO:0007031; GO:0009410; GO:0015721; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0047617; GO:0140359; GO:1903512,bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_00977,1.1271697640018528,FUN_004356-T1,Peve_00016494,Pocillopora_meandrina_HIv1___RNAseq.g12547.t1,three_way,92.93433333333331,FUN_004356-T1,Q9R1K5,FZR1_MOUSE,,Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog),Mus musculus (Mouse),72.8,500.0,3.4e-203,709.1,sp|Q9R1K5|FZR1_MOUSE Fizzy-related protein homolog OS=Mus musculus OX=10090 GN=Fzr1 PE=1 SV=1,GO:0005654; GO:0006281; GO:0007095; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0051301; GO:0051603; GO:0070306; GO:0097027; GO:1904668; GO:1990756; GO:2000773,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of meiotic nuclear division [GO:0040020],nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654],anaphase-promoting complex binding [GO:0010997]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005654; GO:0006281; GO:0030154; GO:0030163; GO:0060090; GO:0098772,nucleoplasm; DNA repair; cell differentiation; protein catabolic process; molecular adaptor activity; molecular function regulator activity
OG_00986,3.0672332162373164,FUN_004373-T2,Peve_00007253,Pocillopora_meandrina_HIv1___TS.g17451.t1,three_way,60.50866666666667,FUN_004373-T2,P16621,,,,,38.6,2020.0,0.0,1295.0,sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2,,,,,,
OG_00994,1.0242664224216522,FUN_004402-T1,Peve_00009341,Pocillopora_meandrina_HIv1___TS.g8719.t1,three_way,63.466166666666666,FUN_004402-T1,F4JG10,,,,,38.8,366.0,3.3e-66,254.2,"sp|F4JG10|XYN3_ARATH Endo-1,4-beta-xylanase 3 OS=Arabidopsis thaliana OX=3702 GN=XYN3 PE=2 SV=1",,,,,,
OG_00997,1.986581058888895,FUN_004406-T1,Peve_00017185,Pocillopora_meandrina_HIv1___RNAseq.g4937.t1,three_way,59.73633333333333,FUN_004406-T1,Q9BUJ2,,,,,50.9,389.0,1.8e-111,404.8,sp|Q9BUJ2|HNRL1_HUMAN Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Homo sapiens OX=9606 GN=HNRNPUL1 PE=1 SV=2,,,,,,
OG_00998,1.4068856140514383,FUN_004407-T1,Peve_00017184,Pocillopora_meandrina_HIv1___RNAseq.g4936.t1,three_way,80.429,FUN_004407-T1,Q96KB5,,,,,50.2,303.0,6.2e-71,269.2,sp|Q96KB5|TOPK_HUMAN Lymphokine-activated killer T-cell-originated protein kinase OS=Homo sapiens OX=9606 GN=PBK PE=1 SV=3,,,,,,
OG_01002,2.646391753307573,FUN_004421-T1,Peve_00026932,Pocillopora_meandrina_HIv1___RNAseq.g16665.t1,three_way,58.136,FUN_004421-T1,F1NWE3,,,,,29.1,1542.0,2.5e-170,601.7,sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3,,,,,,
OG_01007,1.921086727028031,FUN_004431-T1,Peve_00033220,Pocillopora_meandrina_HIv1___RNAseq.g11379.t1,three_way,81.504,FUN_004431-T1,Q7ZW46,,,,,57.3,321.0,2.5e-101,370.2,sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1,,,,,,
OG_01008,1.0216923102769273,FUN_004432-T1,Peve_00033218,Pocillopora_meandrina_HIv1___RNAseq.g11372.t1,three_way,78.27866666666667,FUN_004432-T1,Q6YC49,,,,,66.1,316.0,2.6e-109,396.7,sp|Q6YC49|S35A3_BOVIN UDP-N-acetylglucosamine transporter OS=Bos taurus OX=9913 GN=SLC35A3 PE=1 SV=1,,,,,,
OG_01009,1.517766186709118,FUN_004436-T1,Peve_00033216,Pocillopora_meandrina_HIv1___RNAseq.g11488.t1,three_way,71.79266666666666,FUN_004436-T1,Q9H3R0,,,,,38.8,1037.0,4.0999999999999996e-191,669.8,sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2,,,,,,
OG_01014,2.360079257269377,FUN_004442-T1,Peve_00033209,Pocillopora_meandrina_HIv1___RNAseq.g11479.t1,three_way,73.821,FUN_004442-T1,A7MB63,CTNS_BOVIN,,Cystinosin,Bos taurus (Bovine),50.5,333.0,2.9e-91,337.0,sp|A7MB63|CTNS_BOVIN Cystinosin OS=Bos taurus OX=9913 GN=CTNS PE=2 SV=1,GO:0005765; GO:0015031; GO:0015184; GO:0015295; GO:0015811; GO:0033162; GO:0042438; GO:0042470; GO:0048021,L-cystine transport [GO:0015811]; melanin biosynthetic process [GO:0042438]; protein transport [GO:0015031]; regulation of melanin biosynthetic process [GO:0048021],lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162],L-cystine transmembrane transporter activity [GO:0015184]; solute:proton symporter activity [GO:0015295],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_01017,2.25218986757815,FUN_004446-T1,Peve_00024328,Pocillopora_meandrina_HIv1___RNAseq.g12519.t3,three_way,72.83733333333333,FUN_004446-T1,Q6DCD1,,,,,55.2,554.0,3.5000000000000005e-180,632.9,sp|Q6DCD1|FGGY_XENLA FGGY carbohydrate kinase domain-containing protein OS=Xenopus laevis OX=8355 GN=fggy PE=2 SV=2,,,,,,
OG_01018,1.941907562062405,FUN_004447-T1,Peve_00024327,Pocillopora_meandrina_HIv1___RNAseq.g11246.t1,three_way,84.03683333333333,FUN_004447-T1,Q9UPU5,UBP24_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),Homo sapiens (Human),45.2,2673.0,0.0,2190.2,sp|Q9UPU5|UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3,GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0016579; GO:0031647,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01023,1.5754744123697422,FUN_004455-T1,Peve_00024319,Pocillopora_meandrina_HIv1___RNAseq.g4970.t1,three_way,67.10066666666667,FUN_004455-T1,Q16651,PRSS8_HUMAN,,Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain],Homo sapiens (Human),39.0,249.0,2.0999999999999999e-41,173.3,sp|Q16651|PRSS8_HUMAN Prostasin OS=Homo sapiens OX=9606 GN=PRSS8 PE=1 SV=1,GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0010765; GO:0070062,positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005576; GO:0005615; GO:0005886; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; plasma membrane; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01024,1.555169183211372,FUN_004456-T1,Peve_00028023,Pocillopora_meandrina_HIv1___RNAseq.g4969.t1,three_way,72.8845,FUN_004456-T1,A2VDD2,,,,,28.7,178.0,1.5e-13,77.8,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_01027,2.3049231898883864,FUN_004461-T1,Peve_00023630,Pocillopora_meandrina_HIv1___RNAseq.g4962.t1,three_way,86.20783333333334,FUN_004461-T1,E7FDB3,,,,,57.7,71.0,3.2e-18,93.6,sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1,,,,,,
OG_01031,1.616379753827947,FUN_004466-T1,Peve_00007163,Pocillopora_meandrina_HIv1___RNAseq.g4955.t1,three_way,66.68966666666667,,,,,,,,,,,,,,,,,
OG_01033,1.4339036433305885,FUN_004468-T1,Peve_00007166,Pocillopora_meandrina_HIv1___RNAseq.g4953.t1,three_way,63.32233333333333,FUN_004468-T1,P23727,P85A_BOVIN,,Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha),Bos taurus (Bovine),32.1,636.0,1.2e-79,299.7,sp|P23727|P85A_BOVIN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Bos taurus OX=9913 GN=PIK3R1 PE=1 SV=1,GO:0001678; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005942; GO:0005943; GO:0008286; GO:0015031; GO:0032869; GO:0033120; GO:0034446; GO:0034976; GO:0035014; GO:0042307; GO:0042802; GO:0043066; GO:0043125; GO:0043491; GO:0043548; GO:0043560; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0140767; GO:0141038; GO:1900103; GO:1903078,cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular glucose homeostasis [GO:0001678]; negative regulation of apoptotic process [GO:0043066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446],"nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]",1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; enzyme-substrate adaptor activity [GO:0140767]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0005634; GO:0006355; GO:0006629; GO:0007155; GO:0043226; GO:0060090; GO:0098772,nucleus; regulation of DNA-templated transcription; lipid metabolic process; cell adhesion; organelle; molecular adaptor activity; molecular function regulator activity
OG_01037,1.1788021535825737,FUN_004472-T1,Peve_00007171,Pocillopora_meandrina_HIv1___RNAseq.g4949.t1,three_way,82.363,FUN_004472-T1,Q13042,,,,,53.3,533.0,1.6e-165,584.3,sp|Q13042|CDC16_HUMAN Cell division cycle protein 16 homolog OS=Homo sapiens OX=9606 GN=CDC16 PE=1 SV=2,,,,,,
OG_01038,1.0241626623883031,FUN_004473-T1,Peve_00007172,Pocillopora_meandrina_HIv1___RNAseq.g4948.t1,three_way,45.68216666666667,FUN_004473-T1,P98081,DAB_DROME,,Protein disabled,Drosophila melanogaster (Fruit fly),41.4,157.0,2.5e-28,129.4,sp|P98081|DAB_DROME Protein disabled OS=Drosophila melanogaster OX=7227 GN=Dab PE=1 SV=2,GO:0005118; GO:0005829; GO:0006898; GO:0007349; GO:0007391; GO:0008045; GO:0016319; GO:0017124; GO:0030424; GO:0035591; GO:0042051; GO:0045874; GO:0048488; GO:0072583; GO:0098793,cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; positive regulation of sevenless signaling pathway [GO:0045874]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488],axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793],sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591],GO:0005829; GO:0016192; GO:0048856; GO:0060090,cytosol; vesicle-mediated transport; anatomical structure development; molecular adaptor activity
OG_01041,1.167198984880264,FUN_004481-T1,Peve_00008403,Pocillopora_meandrina_HIv1___RNAseq.g11617.t2,three_way,80.77366666666667,FUN_004481-T1,Q96LB3,,,,,39.8,553.0,9.4e-89,329.3,sp|Q96LB3|IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens OX=9606 GN=IFT74 PE=1 SV=1,,,,,,
OG_01045,1.2462228342069026,FUN_004491-T1,Peve_00003206,Pocillopora_meandrina_HIv1___RNAseq.g11626.t1,three_way,79.37166666666667,FUN_004491-T1,Q9NXG6,,,,,38.8,361.0,2.6e-64,247.7,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_01054,1.645317533412139,FUN_004506-T1,Peve_00044059,Pocillopora_meandrina_HIv1___RNAseq.g11391.t1,three_way,79.72433333333333,FUN_004506-T1,Q96NR8,RDH12_HUMAN,,Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2),Homo sapiens (Human),54.7,298.0,9.599999999999999e-82,305.1,sp|Q96NR8|RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens OX=9606 GN=RDH12 PE=1 SV=3,GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0102354; GO:0110095,cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342],11-cis-retinol dehydrogenase activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0006629; GO:0016491; GO:0050877; GO:0098754,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process; detoxification
OG_01060,1.0089475181102572,FUN_004515-T1,Peve_00044063,Pocillopora_meandrina_HIv1___RNAseq.g11318.t1,three_way,65.01150000000001,FUN_004515-T1,Q9Z1P7,,,,,39.5,253.0,1.3e-45,186.8,sp|Q9Z1P7|KANK3_MOUSE KN motif and ankyrin repeat domain-containing protein 3 OS=Mus musculus OX=10090 GN=Kank3 PE=1 SV=1,,,,,,
OG_01062,1.665192428475538,FUN_004517-T1,Peve_00044062,Pocillopora_meandrina_HIv1___RNAseq.g11317.t1,three_way,69.30250000000001,FUN_004517-T1,Q5R5M5,ENPP3_PONAB,,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Dinucleoside polyphosphatase) (EC 3.6.1.-) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.5,766.0,1.2e-133,478.8,sp|Q5R5M5|ENPP3_PONAB Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Pongo abelii OX=9601 GN=ENPP3 PE=2 SV=1,GO:0002276; GO:0003676; GO:0004081; GO:0004528; GO:0005509; GO:0005524; GO:0005576; GO:0005886; GO:0006220; GO:0008270; GO:0009143; GO:0009897; GO:0016324; GO:0033007; GO:0034432; GO:0036219; GO:0036221; GO:0046034; GO:0047429; GO:0047693; GO:0047710; GO:0050728; GO:0070667,ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; pyrimidine nucleotide metabolic process [GO:0006220],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; calcium ion binding [GO:0005509]; GTP diphosphatase activity [GO:0036219]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; UTP diphosphatase activity [GO:0036221]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0055086; GO:1901135,immune system process; catalytic activity; extracellular region; plasma membrane; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01063,1.0595754039422345,FUN_004519-T1,Peve_00044060,Pocillopora_meandrina_HIv1___RNAseq.g11313.t1,three_way,81.71333333333332,FUN_004519-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),48.6,395.0,8.699999999999999e-94,345.5,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_01065,1.0515892942166445,FUN_004525-T1,Peve_00003214,Pocillopora_meandrina_HIv1___RNAseq.g11634.t1,three_way,83.67433333333334,FUN_004525-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),49.4,857.0,3.6999999999999996e-242,839.3,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_01072,1.7917830680639588,FUN_004554-T1,Peve_00016046,Pocillopora_meandrina_HIv1___RNAseq.g8234.t1,three_way,72.76433333333334,FUN_004554-T1,P20700,LMNB1_HUMAN,,Lamin-B1,Homo sapiens (Human),33.0,542.0,1.7e-60,235.3,sp|P20700|LMNB1_HUMAN Lamin-B1 OS=Homo sapiens OX=9606 GN=LMNB1 PE=1 SV=2,GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0007097; GO:0016020; GO:0016363; GO:0031507; GO:0031965; GO:0043274; GO:0051664; GO:0090435; GO:0160123; GO:1990837,heterochromatin formation [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435],lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of nuclear lamina [GO:0160123],GO:0003677; GO:0005198; GO:0005634; GO:0005635; GO:0005654; GO:0006325; GO:0043226; GO:0061024,DNA binding; structural molecule activity; nucleus; nuclear envelope; nucleoplasm; chromatin organization; organelle; membrane organization
OG_01078,1.177036512937619,FUN_004566-T1,Peve_00016038,Pocillopora_meandrina_HIv1___RNAseq.g8224.t1,three_way,70.882,FUN_004566-T1,P16393,,,,,46.1,915.0,5.000000000000001e-208,726.1,sp|P16393|HMDH_STRPU 3-hydroxy-3-methylglutaryl-coenzyme A reductase OS=Strongylocentrotus purpuratus OX=7668 GN=HMGCR PE=2 SV=2,,,,,,
OG_01081,1.5131983257153063,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),27.6,757.0,3.2999999999999997e-41,172.6,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01081,1.5131983257153063,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),34.8,224.0,3.6e-27,125.9,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01082,1.856988569262178,FUN_004570-T1,Peve_00041478,Pocillopora_meandrina_HIv1___RNAseq.g6646.t1a,three_way,78.209,FUN_004570-T1,Q6NRZ4,,,,,43.9,640.0,5.6e-150,532.7,sp|Q6NRZ4|CERT_XENLA Ceramide transfer protein OS=Xenopus laevis OX=8355 GN=cert1 PE=2 SV=1,,,,,,
OG_01088,1.0164817484613304,FUN_004581-T1,Peve_00012389,Pocillopora_meandrina_HIv1___RNAseq.g6605.t2,three_way,90.10633333333334,FUN_004581-T1,Q9D0R2,SYTC_MOUSE,,"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)",Mus musculus (Mouse),72.3,678.0,3.7e-307,1055.0,"sp|Q9D0R2|SYTC_MOUSE Threonine--tRNA ligase 1, cytoplasmic OS=Mus musculus OX=10090 GN=Tars1 PE=1 SV=2",GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0008270; GO:0042802,threonyl-tRNA aminoacylation [GO:0006435],cytoplasm [GO:0005737],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270],GO:0003824; GO:0006399; GO:0006520; GO:0016874; GO:0140098,"catalytic activity; tRNA metabolic process; amino acid metabolic process; ligase activity; catalytic activity, acting on RNA"
OG_01092,1.3538546980823702,FUN_004588-T1,Peve_00012396,Pocillopora_meandrina_HIv1___RNAseq.g6598.t1,three_way,60.343833333333336,,,,,,,,,,,,,,,,,
OG_01100,1.2285271922535987,FUN_004601-T1,Peve_00020781,Pocillopora_meandrina_HIv1___RNAseq.g6777.t1,three_way,49.251333333333335,,,,,,,,,,,,,,,,,
OG_01105,1.8466742216385827,FUN_004624-T1,Peve_00039250,Pocillopora_meandrina_HIv1___RNAseq.g8088.t1,three_way,67.861,FUN_004624-T1,Q3UHC2,LRRK1_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1),Mus musculus (Mouse),29.8,1808.0,4.400000000000001e-211,737.6,sp|Q3UHC2|LRRK1_MOUSE Leucine-rich repeat serine/threonine-protein kinase 1 OS=Mus musculus OX=10090 GN=Lrrk1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533,bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005739; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; plasma membrane; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01107,1.628765938005262,FUN_004626-T1,Peve_00039247,Pocillopora_meandrina_HIv1___TS.g19833.t1,three_way,41.262166666666666,,,,,,,,,,,,,,,,,
OG_01113,1.5022428734039257,FUN_004652-T1,Peve_00035139,Pocillopora_meandrina_HIv1___RNAseq.g8739.t1,three_way,72.61366666666666,,,,,,,,,,,,,,,,,
OG_01118,1.4945599498368225,FUN_004663-T1,Peve_00035116,Pocillopora_meandrina_HIv1___RNAseq.g8745.t1,three_way,40.65533333333333,,,,,,,,,,,,,,,,,
OG_01119,1.014060991627477,FUN_004681-T1,Peve_00035120,Pocillopora_meandrina_HIv1___RNAseq.g8769.t1,three_way,60.601333333333336,,,,,,,,,,,,,,,,,
OG_01121,1.5431956469996924,FUN_004684-T1,Peve_00035122,Pocillopora_meandrina_HIv1___RNAseq.g8765.t1,three_way,65.35983333333333,FUN_004684-T1,Q07008,NOTC1_RAT,,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Rattus norvegicus (Rat),42.2,628.0,7.7e-77,291.2,sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3,GO:0000122; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006915; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008283; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003677; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006954; GO:0012501; GO:0016192; GO:0022414; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; inflammatory response; programmed cell death; vesicle-mediated transport; reproductive process; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular transducer activity; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_01124,1.5189156045354515,FUN_004693-T1,Peve_00003276,Pocillopora_meandrina_HIv1___RNAseq.g8747.t1,three_way,73.396,,,,,,,,,,,,,,,,,
OG_01126,1.503231712969209,FUN_004695-T1,Peve_00044672,Pocillopora_meandrina_HIv1___RNAseq.g8771.t1,three_way,71.41250000000001,,,,,,,,,,,,,,,,,
OG_01127,1.4384106883363723,FUN_004696-T1,Peve_00044673,Pocillopora_meandrina_HIv1___RNAseq.g8775.t1,three_way,45.049,,,,,,,,,,,,,,,,,
OG_01134,1.237547099683108,FUN_004711-T1,Peve_00005084,Pocillopora_meandrina_HIv1___RNAseq.g8798.t1,three_way,84.41083333333333,FUN_004711-T1,Q8CFW7,C2D2A_MOUSE,,Coiled-coil and C2 domain-containing protein 2A,Mus musculus (Mouse),42.9,1526.0,8.4e-310,1065.1,sp|Q8CFW7|C2D2A_MOUSE Coiled-coil and C2 domain-containing protein 2A OS=Mus musculus OX=10090 GN=Cc2d2a PE=1 SV=1,GO:0001822; GO:0001843; GO:0005737; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224],ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; MKS complex [GO:0036038],,GO:0005856; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_01136,1.1534793026150143,FUN_004714-T1,Peve_00005079,Pocillopora_meandrina_HIv1___RNAseq.g8807.t1,three_way,78.63366666666667,FUN_004714-T1,Q5R5N8,,,,,54.3,1021.0,0.0,1082.0,sp|Q5R5N8|DI3L1_PONAB DIS3-like exonuclease 1 OS=Pongo abelii OX=9601 GN=DIS3L PE=2 SV=1,,,,,,
OG_01138,1.402593928584583,FUN_004718-T1,Peve_00011539,Pocillopora_meandrina_HIv1___RNAseq.g8832.t1,three_way,75.06166666666667,FUN_004718-T1,Q92546,RGP1_HUMAN,,RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog),Homo sapiens (Human),41.7,405.0,1.1e-80,302.0,sp|Q92546|RGP1_HUMAN RAB6A-GEF complex partner protein 2 OS=Homo sapiens OX=9606 GN=RGP1 PE=1 SV=1,GO:0000139; GO:0005085; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547,"negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005829; GO:0005886; GO:0016192; GO:0098772,cytosol; plasma membrane; vesicle-mediated transport; molecular function regulator activity
OG_01141,3.0938847017472013,FUN_004721-T1,Peve_00005068,Pocillopora_meandrina_HIv1___RNAseq.g8837.t2,three_way,47.232,,,,,,,,,,,,,,,,,
OG_01147,2.4889331318570416,FUN_004740-T1,Peve_00007775,Pocillopora_meandrina_HIv1___RNAseq.g8829.t1,three_way,86.16033333333334,FUN_004740-T1,Q92963,RIT1_HUMAN,,GTP-binding protein Rit1 (EC 3.6.5.2) (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1),Homo sapiens (Human),61.7,196.0,1.0999999999999999e-62,241.1,sp|Q92963|RIT1_HUMAN GTP-binding protein Rit1 OS=Homo sapiens OX=9606 GN=RIT1 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0007265; GO:0019003,Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165],plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; plasma membrane; hydrolase activity; molecular function regulator activity
OG_01148,1.3142800036595494,FUN_004747-T1,Peve_00007770,Pocillopora_meandrina_HIv1___RNAseq.g8813.t1,three_way,66.33366666666667,,,,,,,,,,,,,,,,,
OG_01156,1.4046963334438487,FUN_004767-T1,Peve_00007781,Pocillopora_meandrina_HIv1___RNAseq.g6697.t1,three_way,76.52799999999999,FUN_004767-T1,O57457,,,,,44.1,474.0,3.5e-96,354.4,sp|O57457|E41LA_DANRE Band 4.1-like protein 4 OS=Danio rerio OX=7955 GN=epb41l4a PE=2 SV=1,,,,,,
OG_01159,1.9912421661417856,FUN_004777-T1,Peve_00037749,Pocillopora_meandrina_HIv1___RNAseq.g6694.t2,three_way,76.02633333333334,FUN_004777-T1,P46859,,,,,34.6,179.0,1.2e-21,104.8,sp|P46859|GNTK_ECOLI Thermoresistant gluconokinase OS=Escherichia coli (strain K12) OX=83333 GN=gntK PE=1 SV=4,,,,,,
OG_01160,2.367030211136107,FUN_004779-T1,Peve_00037747,Pocillopora_meandrina_HIv1___RNAseq.g6693.t1,three_way,80.62566666666666,FUN_004779-T1,A2A2Y4,FRMD3_HUMAN,,FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O),Homo sapiens (Human),49.3,341.0,6.399999999999999e-96,352.8,sp|A2A2Y4|FRMD3_HUMAN FERM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FRMD3 PE=1 SV=1,GO:0005856; GO:0008092; GO:0016020; GO:0031032,actomyosin structure organization [GO:0031032],cytoskeleton [GO:0005856]; membrane [GO:0016020],cytoskeletal protein binding [GO:0008092],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_01162,1.053797559305303,FUN_004781-T1,Peve_00037742,Pocillopora_meandrina_HIv1___RNAseq.g6688.t1,three_way,84.00166666666667,FUN_004781-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),31.8,534.0,1.1e-64,249.6,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01165,1.2173965979903616,FUN_004785-T1,Peve_00037753,Pocillopora_meandrina_HIv1___RNAseq.g27039.t1,three_way,60.36183333333333,FUN_004785-T1,Q9CQX4,PAF15_MOUSE,,PCNA-associated factor (HCV NS5A-transactivated protein 9 homolog) (PCNA-associated factor of 15 kDa) (PAF15) (p15PAF) (PCNA-clamp-associated factor),Mus musculus (Mouse),37.6,109.0,9e-08,57.8,sp|Q9CQX4|PAF15_MOUSE PCNA-associated factor OS=Mus musculus OX=10090 GN=Pclaf PE=1 SV=1,GO:0003682; GO:0005634; GO:0005813; GO:0006260; GO:0006974; GO:0007098; GO:0009411; GO:0019985; GO:0048471; GO:0051726; GO:0060090,centrosome cycle [GO:0007098]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985],centrosome [GO:0005813]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090],GO:0005634; GO:0005815; GO:0006260; GO:0006281; GO:0043226; GO:0060090,nucleus; microtubule organizing center; DNA replication; DNA repair; organelle; molecular adaptor activity
OG_01167,1.6263656696372182,FUN_004787-T1,Peve_00010251,Pocillopora_meandrina_HIv1___RNAseq.g8521.t1,three_way,75.73400000000001,FUN_004787-T1,Q6TFL3,,,,,37.2,807.0,6.2e-84,313.9,sp|Q6TFL3|CC171_HUMAN Coiled-coil domain-containing protein 171 OS=Homo sapiens OX=9606 GN=CCDC171 PE=1 SV=1,,,,,,
OG_01168,3.1262216077953697,FUN_004791-T1,Peve_00010255,Pocillopora_meandrina_HIv1___RNAseq.g8522.t1,three_way,63.762,FUN_004791-T1,P56705,WNT4_HUMAN,,Protein Wnt-4,Homo sapiens (Human),39.4,322.0,1.8999999999999998e-62,241.1,sp|P56705|WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens OX=9606 GN=WNT4 PE=1 SV=4,GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008543; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0035567; GO:0040037; GO:0042445; GO:0043410; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060008; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:0097190; GO:0140013; GO:1904238; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234,adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048018; GO:0048856; GO:0060090; GO:0098772; GO:0140013; GO:0140110,immune system process; extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity; meiotic nuclear division; transcription regulator activity
OG_01172,1.6395973326661863,FUN_004797-T1,Peve_00010271,Pocillopora_meandrina_HIv1___RNAseq.g8564.t1,three_way,55.6755,FUN_004797-T1,Q9DBN1,STR6L_MOUSE,,Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2),Mus musculus (Mouse),28.0,633.0,1.8e-62,242.3,sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1,GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939,establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939],plasma membrane [GO:0005886],retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_01173,1.219822927647096,FUN_004799-T1,Peve_00027138,Pocillopora_meandrina_HIv1___TS.g20303.t1b,three_way,56.354,FUN_004799-T1,Q9UKP4,ATS7_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-),Homo sapiens (Human),29.2,343.0,6.6e-28,127.9,sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2,GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773,cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0140096; GO:1901135,"catalytic activity; extracellular region; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01183,1.5861914818710503,FUN_004833-T1,Peve_00041797,Pocillopora_meandrina_HIv1___RNAseq.g8607.t1,three_way,66.8355,FUN_004833-T1,Q6JAN0,AGRV1_DANRE,,Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,6348.0,0.0,2524.2,sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1,GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007194; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264,cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171],adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787],GO:0003824; GO:0016787; GO:0048856; GO:0050877; GO:0060089; GO:0098772,catalytic activity; hydrolase activity; anatomical structure development; nervous system process; molecular transducer activity; molecular function regulator activity
OG_01184,1.250339260027734,FUN_004834-T1,Peve_00019417,Pocillopora_meandrina_HIv1___RNAseq.g8609.t1,three_way,70.38799999999999,FUN_004834-T1,Q9UKP4,ATS7_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-),Homo sapiens (Human),45.7,924.0,7.5e-249,862.1,sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2,GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773,cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0140096; GO:1901135,"catalytic activity; extracellular region; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01187,1.7738839236520862,FUN_004838-T1,Peve_00019421,Pocillopora_meandrina_HIv1___RNAseq.g8612.t1b,three_way,74.21666666666667,FUN_004838-T1,P43681,ACHA4_HUMAN,,Neuronal acetylcholine receptor subunit alpha-4,Homo sapiens (Human),41.8,325.0,5.9e-75,283.1,sp|P43681|ACHA4_HUMAN Neuronal acetylcholine receptor subunit alpha-4 OS=Homo sapiens OX=9606 GN=CHRNA4 PE=1 SV=2,GO:0001508; GO:0001666; GO:0005886; GO:0005892; GO:0006281; GO:0006811; GO:0006816; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0009897; GO:0014059; GO:0015276; GO:0015464; GO:0016020; GO:0019233; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042113; GO:0042166; GO:0042391; GO:0042734; GO:0043005; GO:0043025; GO:0045202; GO:0045211; GO:0050877; GO:0050890; GO:0051899; GO:0060080; GO:0095500; GO:0098878,"acetylcholine receptor signaling pathway [GO:0095500]; action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; inhibitory postsynaptic potential [GO:0060080]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0002376; GO:0005215; GO:0005886; GO:0006281; GO:0023052; GO:0050877; GO:0055085; GO:0060089,immune system process; transporter activity; plasma membrane; DNA repair; signaling; nervous system process; transmembrane transport; molecular transducer activity
OG_01188,2.860130234269866,FUN_004841-T1,Peve_00019429,Pocillopora_meandrina_HIv1___RNAseq.g8617.t1,three_way,76.224,FUN_004841-T1,P32297,ACHA3_HUMAN,,Neuronal acetylcholine receptor subunit alpha-3,Homo sapiens (Human),35.1,490.0,2.6e-86,320.9,sp|P32297|ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens OX=9606 GN=CHRNA3 PE=1 SV=4,GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0014056; GO:0015276; GO:0015464; GO:0016020; GO:0016607; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0043231; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098878; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005730; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; nucleolus; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; signaling; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_01193,2.423090887606853,FUN_004851-T1,Peve_00043739,Pocillopora_meandrina_HIv1___RNAseq.g8640.t1,three_way,62.76883333333333,FUN_004851-T1,Q04912,RON_HUMAN,,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],Homo sapiens (Human),35.8,293.0,2.2e-49,198.7,sp|Q04912|RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens OX=9606 GN=MST1R PE=1 SV=3,GO:0001725; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009986; GO:0016477; GO:0019899; GO:0043235; GO:0043406; GO:0045087; GO:0051897,cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338],cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005773; GO:0005886; GO:0016192; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0098542; GO:0140096,"immune system process; catalytic activity; vacuole; plasma membrane; vesicle-mediated transport; transferase activity; reproductive process; organelle; anatomical structure development; cell motility; molecular transducer activity; defense response to other organism; catalytic activity, acting on a protein"
OG_01199,1.304251573760242,FUN_004862-T1,Peve_00043709,Pocillopora_meandrina_HIv1___RNAseq.g8631.t2,three_way,66.93066666666667,FUN_004862-T1,Q9JJQ0,,,,,43.5,540.0,3.3e-122,440.3,"sp|Q9JJQ0|PIGB_MOUSE GPI alpha-1,2-mannosyltransferase 3 OS=Mus musculus OX=10090 GN=Pigb PE=2 SV=2",,,,,,
OG_01201,2.368111186030226,FUN_004865-T1,Peve_00043712,Pocillopora_meandrina_HIv1___RNAseq.g8628.t1,three_way,55.48716666666667,FUN_004865-T1,Q5F416,,,,,38.2,228.0,8.000000000000001e-29,129.8,sp|Q5F416|TIPIN_CHICK TIMELESS-interacting protein OS=Gallus gallus OX=9031 GN=TIPIN PE=2 SV=1,,,,,,
OG_01202,1.6565250087047991,FUN_004866-T1,Peve_00043716,Pocillopora_meandrina_HIv1___RNAseq.g8626.t1,three_way,62.815333333333335,FUN_004866-T1,Q1JV40,HVCN1_CIOIN,,Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1) (Voltage sensor domain-only protein),Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis),45.6,114.0,9.8e-18,91.7,sp|Q1JV40|HVCN1_CIOIN Voltage-gated hydrogen channel 1 OS=Ciona intestinalis OX=7719 GN=HVCN1 PE=2 SV=1,GO:0005886; GO:0030171; GO:0034702; GO:0071294; GO:0071467; GO:1902600,cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600],monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],voltage-gated proton channel activity [GO:0030171],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01204,1.0067430666203276,FUN_004870-T1,Peve_00043738,Pocillopora_meandrina_HIv1___RNAseq.g8641.t1,three_way,89.86433333333333,FUN_004870-T1,Q1ZXJ0,,,,,32.5,873.0,3.9e-114,414.1,sp|Q1ZXJ0|CLCD_DICDI Chloride channel protein D OS=Dictyostelium discoideum OX=44689 GN=clcD PE=3 SV=1,,,,,,
OG_01210,5.237730272671915,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01219,1.202966677070165,FUN_004900-T1,Peve_00015870,Pocillopora_meandrina_HIv1___TS.g20400.t1,three_way,76.45466666666667,FUN_004900-T1,Q9QYV8,DPOG1_RAT,,DNA polymerase subunit gamma-1 (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (5'-deoxyribose-phosphate lyase) (EC 4.2.99.-) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha),Rattus norvegicus (Rat),49.4,1219.0,0.0,1146.7,sp|Q9QYV8|DPOG1_RAT DNA polymerase subunit gamma-1 OS=Rattus norvegicus OX=10116 GN=Polg PE=2 SV=1,GO:0000262; GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0004527; GO:0005739; GO:0005759; GO:0005760; GO:0006261; GO:0006264; GO:0006284; GO:0006287; GO:0008310; GO:0008340; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0045004; GO:0046872; GO:0051575; GO:0055093; GO:0071333,"base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; determination of adult lifespan [GO:0008340]; DNA replication proofreading [GO:0045004]; DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]",gamma DNA polymerase complex [GO:0005760]; mitochondrial chromosome [GO:0000262]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195],3'-5' exonuclease activity [GO:0008408]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],GO:0003677; GO:0003824; GO:0005694; GO:0005739; GO:0006260; GO:0006281; GO:0016740; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; chromosome; mitochondrion; DNA replication; DNA repair; transferase activity; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_01222,1.0037792095664928,FUN_004904-T1,Peve_00028659,Pocillopora_meandrina_HIv1___RNAseq.g8332.t1,three_way,63.89233333333333,FUN_004904-T1,Q8BGZ3,DCA12_MOUSE,,DDB1- and CUL4-associated factor 12 (WD repeat-containing protein 40A),Mus musculus (Mouse),41.8,411.0,4.5e-81,303.1,sp|Q8BGZ3|DCA12_MOUSE DDB1- and CUL4-associated factor 12 OS=Mus musculus OX=10090 GN=Dcaf12 PE=2 SV=1,GO:0005634; GO:0005813; GO:0005829; GO:0010506; GO:0016567; GO:0042110; GO:0080008; GO:0140627; GO:1990756,protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleus [GO:0005634],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0005634; GO:0005815; GO:0005829; GO:0030163; GO:0043226; GO:0060090,immune system process; nucleus; microtubule organizing center; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_01223,1.819045830965044,FUN_004905-T1,Peve_00028658,Pocillopora_meandrina_HIv1___RNAseq.g8333.t1,three_way,69.76066666666667,FUN_004905-T1,Q61555,FBN2_MOUSE,,Fibrillin-2 [Cleaved into: Placensin],Mus musculus (Mouse),53.2,2537.0,9.1e-126,454.5,sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2,GO:0001527; GO:0005179; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023,bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527],calcium ion binding [GO:0005509]; hormone activity [GO:0005179],GO:0005576; GO:0048018; GO:0048856; GO:0098772,extracellular region; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01228,1.2325157843890984,FUN_004910-T1,Peve_00028228,Pocillopora_meandrina_HIv1___TS.g20086.t1,three_way,85.51783333333333,FUN_004910-T1,Q16959,,,,,63.3,654.0,2.4999999999999998e-231,803.1,"sp|Q16959|DYI2_HELCR Dynein intermediate chain 2, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1",,,,,,
OG_01235,1.2338548947310737,FUN_004920-T1,Peve_00044504,Pocillopora_meandrina_HIv1___RNAseq.g8353.t1,three_way,57.138666666666666,FUN_004920-T1,Q06441,,,,,45.8,938.0,1.4e-86,322.8,sp|Q06441|TSP4_XENLA Thrombospondin-4 OS=Xenopus laevis OX=8355 GN=thbs4 PE=2 SV=1,,,,,,
OG_01237,1.4326378143088254,FUN_004923-T2,Peve_00034765,Pocillopora_meandrina_HIv1___RNAseq.g8361.t1,three_way,65.8205,FUN_004923-T2,Q9Z1T2,TSP4_MOUSE,,Thrombospondin-4,Mus musculus (Mouse),47.5,927.0,1e-105,386.3,sp|Q9Z1T2|TSP4_MOUSE Thrombospondin-4 OS=Mus musculus OX=10090 GN=Thbs4 PE=1 SV=1,GO:0001938; GO:0005178; GO:0005509; GO:0005604; GO:0005615; GO:0005783; GO:0006986; GO:0008083; GO:0008201; GO:0016525; GO:0016529; GO:0034103; GO:0034976; GO:0048266; GO:0048771; GO:0051451; GO:0051781; GO:0062023; GO:0071603; GO:0090023,behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178],GO:0005615; GO:0005783; GO:0007155; GO:0030312; GO:0031012; GO:0043226; GO:0048018; GO:0048870; GO:0098772,extracellular space; endoplasmic reticulum; cell adhesion; external encapsulating structure; extracellular matrix; organelle; receptor ligand activity; cell motility; molecular function regulator activity
OG_01241,1.7725379175362443,FUN_004929-T1,Peve_00034771,Pocillopora_meandrina_HIv1___RNAseq.g8368.t1,three_way,72.67233333333333,,,,,,,,,,,,,,,,,
OG_01242,1.5048974643394046,FUN_004932-T1,Peve_00034773,Pocillopora_meandrina_HIv1___RNAseq.g8372.t1,three_way,69.01916666666666,,,,,,,,,,,,,,,,,
OG_01243,1.2949299788092967,FUN_004933-T1,Peve_00014403,Pocillopora_meandrina_HIv1___RNAseq.g8373.t1,three_way,72.1075,,,,,,,,,,,,,,,,,
OG_01244,1.94761286928272,FUN_004939-T1,Peve_00014400,Pocillopora_meandrina_HIv1___RNAseq.g8389.t1,three_way,65.75466666666667,,,,,,,,,,,,,,,,,
OG_01248,1.057949209043225,FUN_004947-T1,Peve_00043267,Pocillopora_meandrina_HIv1___RNAseq.g8394.t1,three_way,76.3205,FUN_004947-T1,Q9BY12,SCAPE_HUMAN,,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),Homo sapiens (Human),41.5,1440.0,9.2e-140,500.0,sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2,GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917,antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0005654; GO:0005783; GO:0005829; GO:0022414; GO:0043226; GO:0048856,nucleoplasm; endoplasmic reticulum; cytosol; reproductive process; organelle; anatomical structure development
OG_01250,1.1351746904029407,FUN_004969-T1,Peve_00043270,Pocillopora_meandrina_HIv1___TS.g20136.t1,three_way,49.14716666666666,,,,,,,,,,,,,,,,,
OG_01251,1.2602825358130354,FUN_004979-T1,Peve_00031942,Pocillopora_meandrina_HIv1___TS.g20137.t4,three_way,53.51116666666667,FUN_004979-T1,Q13332,,,,,34.1,249.0,7.1e-29,131.3,sp|Q13332|PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens OX=9606 GN=PTPRS PE=1 SV=3,,,,,,
OG_01254,1.654040923913236,FUN_004985-T1,Peve_00015857,Pocillopora_meandrina_HIv1___RNAseq.g7568.t1,three_way,84.217,FUN_004985-T1,Q6TGY8,,,,,57.4,282.0,9.5e-87,321.6,sp|Q6TGY8|EMC2_DANRE ER membrane protein complex subunit 2 OS=Danio rerio OX=7955 GN=emc2 PE=2 SV=1,,,,,,
OG_01255,1.0141871585263849,FUN_004986-T1,Peve_00015856,Pocillopora_meandrina_HIv1___RNAseq.g7569.t1,three_way,84.39133333333334,FUN_004986-T1,P97390,,,,,66.1,564.0,1.8000000000000003e-214,746.9,sp|P97390|VPS45_MOUSE Vacuolar protein sorting-associated protein 45 OS=Mus musculus OX=10090 GN=Vps45 PE=1 SV=1,,,,,,
OG_01261,2.825897563394865,FUN_005023-T1,Peve_00028649,Pocillopora_meandrina_HIv1___RNAseq.g8329.t1,three_way,83.2865,FUN_005023-T1,A2BEA6,,,,,62.1,195.0,1.3e-58,228.8,sp|A2BEA6|ARI3A_DANRE AT-rich interactive domain-containing protein 3A OS=Danio rerio OX=7955 GN=arid3a PE=1 SV=1,,,,,,
OG_01262,1.4681576370475828,FUN_005024-T1,Peve_00028650,Pocillopora_meandrina_HIv1___RNAseq.g8327.t1,three_way,62.04933333333333,,,,,,,,,,,,,,,,,
OG_01266,1.063460494378164,FUN_005033-T1,Peve_00016746,Pocillopora_meandrina_HIv1___RNAseq.g8318.t1,three_way,64.74883333333332,FUN_005033-T1,Q91XE9,CR3L3_MOUSE,,Cyclic AMP-responsive element-binding protein 3-like protein 3 (cAMP-responsive element-binding protein 3-like protein 3) (Transcription factor CREB-H) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 3],Mus musculus (Mouse),44.7,152.0,6.2e-22,106.7,sp|Q91XE9|CR3L3_MOUSE Cyclic AMP-responsive element-binding protein 3-like protein 3 OS=Mus musculus OX=10090 GN=Creb3l3 PE=1 SV=1,GO:0000977; GO:0001228; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0006986; GO:0016020; GO:0034976; GO:0042803; GO:0045944; GO:0046982,positive regulation of transcription by RNA polymerase II [GO:0045944]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_01268,1.8848761847652045,FUN_005036-T1,Peve_00016743,Pocillopora_meandrina_HIv1___RNAseq.g8315.t1,three_way,67.82966666666667,FUN_005036-T1,Q99853,FOXB1_HUMAN,,Forkhead box protein B1 (Transcription factor FKH-5),Homo sapiens (Human),61.9,181.0,2.2999999999999998e-55,217.2,sp|Q99853|FOXB1_HUMAN Forkhead box protein B1 OS=Homo sapiens OX=9606 GN=FOXB1 PE=1 SV=3,GO:0000785; GO:0000978; GO:0000981; GO:0001655; GO:0001756; GO:0005634; GO:0006357; GO:0007412; GO:0007595; GO:0008542; GO:0009653; GO:0021510; GO:0021767; GO:0021794; GO:0021855; GO:0022029; GO:0030154; GO:0030901; GO:0033504; GO:0043524; GO:0043565; GO:0061030; GO:0061374; GO:0061377; GO:0061379; GO:0061381; GO:1990837,anatomical structure morphogenesis [GO:0009653]; axon target recognition [GO:0007412]; cell differentiation [GO:0030154]; cell migration in diencephalon [GO:0061381]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; floor plate development [GO:0033504]; hypothalamus cell migration [GO:0021855]; inferior colliculus development [GO:0061379]; lactation [GO:0007595]; mammary gland lobule development [GO:0061377]; mammillary body development [GO:0021767]; mammillothalamic axonal tract development [GO:0061374]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]; visual learning [GO:0008542],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_01276,2.3100954253001493,FUN_005056-T1,Peve_00016747,Pocillopora_meandrina_HIv1___RNAseq.g8303.t1,three_way,56.921,FUN_005056-T1,P42568,AF9_HUMAN,,Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3),Homo sapiens (Human),38.0,92.0,2.1e-09,65.1,sp|P42568|AF9_HUMAN Protein AF-9 OS=Homo sapiens OX=9606 GN=MLLT3 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007379; GO:0008023; GO:0009952; GO:0010467; GO:0042393; GO:0045893; GO:0060090; GO:0060218; GO:0070062; GO:0070577; GO:0090090; GO:0140030; GO:0140044; GO:0140072; GO:0140119; GO:1902275; GO:2000035; GO:2000096,"anterior/posterior pattern specification [GO:0009952]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of chromatin organization [GO:1902275]; regulation of stem cell division [GO:2000035]; segment specification [GO:0007379]",chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; histone H3K9ac reader activity [GO:0140072]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; molecular adaptor activity [GO:0060090],GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0060090,DNA binding; nucleus; nucleoplasm; chromosome; cytosol; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; molecular adaptor activity
OG_01277,2.842897841705226,FUN_005057-T1,Peve_00016734,Pocillopora_meandrina_HIv1___RNAseq.g8302.t1,three_way,72.20533333333333,FUN_005057-T1,Q8K596,NAC2_MOUSE,,Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2),Mus musculus (Mouse),37.3,499.0,1.4e-72,275.8,sp|Q8K596|NAC2_MOUSE Sodium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc8a2 PE=1 SV=1,GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015085; GO:0016323; GO:0035725; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070588; GO:0098815; GO:0099608; GO:0106056; GO:1902533; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of intracellular signal transduction [GO:1902533]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808],axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],calcium ion transmembrane transporter activity [GO:0015085]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; cell junction organization; organelle; nervous system process; transmembrane transport
OG_01278,1.174462819592825,FUN_005058-T1,Peve_00016724,Pocillopora_meandrina_HIv1___RNAseq.g8301.t1,three_way,65.66266666666667,,,,,,,,,,,,,,,,,
OG_01282,1.4582028410171792,FUN_005063-T1,Peve_00030190,Pocillopora_meandrina_HIv1___RNAseq.g8293.t1,three_way,74.4175,FUN_005063-T1,B2RR83,YTDC2_MOUSE,,3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2),Mus musculus (Mouse),47.1,1526.0,0.0,1282.7,sp|B2RR83|YTDC2_MOUSE 3'-5' RNA helicase YTHDC2 OS=Mus musculus OX=10090 GN=Ythdc2 PE=1 SV=1,GO:0003723; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247,"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063],GO:0003723; GO:0003824; GO:0005783; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0140098; GO:0140657,"RNA binding; catalytic activity; endoplasmic reticulum; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01283,1.5437687351482057,FUN_005101-T1,Peve_00007482,Pocillopora_meandrina_HIv1___RNAseq.g8276.t1,three_way,63.833666666666666,FUN_005101-T1,P20585,MSH3_HUMAN,,DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1),Homo sapiens (Human),44.8,859.0,3.4e-194,680.2,sp|P20585|MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens OX=9606 GN=MSH3 PE=1 SV=4,GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0140664,DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; somatic recombination of immunoglobulin gene segments [GO:0016447],membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01287,2.711846803880256,FUN_005108-T1,Peve_00007468,Pocillopora_meandrina_HIv1___RNAseq.g8270.t1,three_way,63.20066666666666,FUN_005108-T1,Q96B86,,,,,35.5,361.0,3.8e-52,207.2,sp|Q96B86|RGMA_HUMAN Repulsive guidance molecule A OS=Homo sapiens OX=9606 GN=RGMA PE=1 SV=4,,,,,,
OG_01290,1.3835201687633487,FUN_005113-T1,Peve_00007463,Pocillopora_meandrina_HIv1___RNAseq.g8268.t1,three_way,72.56616666666666,FUN_005113-T1,O15945,ARNT_DROME,,Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango),Drosophila melanogaster (Fruit fly),57.4,378.0,5.4e-115,416.8,sp|O15945|ARNT_DROME Aryl hydrocarbon receptor nuclear translocator homolog OS=Drosophila melanogaster OX=7227 GN=tgo PE=1 SV=3,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575,appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_01291,1.490069686030224,FUN_005114-T1,Peve_00007462,Pocillopora_meandrina_HIv1___RNAseq.g8267.t1,three_way,89.027,FUN_005114-T1,Q9Y6I4,UBP3_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3),Homo sapiens (Human),49.9,531.0,1.3e-149,531.2,sp|Q9Y6I4|UBP3_HUMAN Ubiquitin carboxyl-terminal hydrolase 3 OS=Homo sapiens OX=9606 GN=USP3 PE=1 SV=2,GO:0000785; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006508; GO:0008270; GO:0016579; GO:0036464; GO:0042393; GO:0090543; GO:0140861; GO:0140936; GO:0140950,DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0016787; GO:0042393; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; hydrolase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_01292,2.4956064245091305,FUN_005115-T1,Peve_00007461,Pocillopora_meandrina_HIv1___RNAseq.g8266.t1,three_way,64.81533333333333,FUN_005115-T1,Q8BUN9,NCKX2_MOUSE,,Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2),Mus musculus (Mouse),44.7,622.0,6.2e-134,479.6,sp|Q8BUN9|NCKX2_MOUSE Sodium/potassium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc24a2 PE=1 SV=1,GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007602; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0016020; GO:0034220; GO:0036368; GO:0051649; GO:0060291; GO:0060292; GO:0070050; GO:0071486; GO:0098703; GO:0098793; GO:0098794,calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; establishment of localization in cell [GO:0051649]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; neuron cellular homeostasis [GO:0070050]; phototransduction [GO:0007602],membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_01293,1.5758194780220731,FUN_005117-T1,Peve_00007460,Pocillopora_meandrina_HIv1___RNAseq.g8265.t1,three_way,71.62033333333333,FUN_005117-T1,O88801,HOME2_RAT,,Homer protein homolog 2 (Homer-2) (Cupidin) (VASP/Ena-related gene up-regulated during seizure and LTP 2) (Vesl-2),Rattus norvegicus (Rat),49.3,221.0,4.7e-47,190.3,sp|O88801|HOME2_RAT Homer protein homolog 2 OS=Rattus norvegicus OX=10116 GN=Homer2 PE=1 SV=1,GO:0003779; GO:0005737; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0019722; GO:0019904; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035254; GO:0035256; GO:0042802; GO:0043025; GO:0043229; GO:0044877; GO:0045177; GO:0048148; GO:0070885; GO:0098978; GO:2001256,behavioral response to cocaine [GO:0048148]; calcium-mediated signaling [GO:0019722]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; synaptic receptor adaptor activity [GO:0030160],GO:0005886; GO:0008092; GO:0043226; GO:0050877; GO:0060090,plasma membrane; cytoskeletal protein binding; organelle; nervous system process; molecular adaptor activity
OG_01298,1.8283223196046696,FUN_005132-T1,Peve_00026674,Pocillopora_meandrina_HIv1___TS.g20000.t1,three_way,85.70366666666666,FUN_005132-T1,Q91348,,,,,60.1,439.0,3.7e-156,552.7,"sp|Q91348|F26L_CHICK 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase OS=Gallus gallus OX=9031 PE=2 SV=2",,,,,,
OG_01299,2.0432904771619675,FUN_005133-T1,Peve_00026671,Pocillopora_meandrina_HIv1___RNAseq.g8258.t1,three_way,85.96366666666667,FUN_005133-T1,Q05116,,,,,70.0,377.0,4.3e-148,525.8,sp|Q05116|MP2K1_XENLA Dual specificity mitogen-activated protein kinase kinase 1 OS=Xenopus laevis OX=8355 GN=map2k1 PE=1 SV=2,,,,,,
OG_01301,1.7126401892446756,FUN_005155-T1,Peve_00014626,Pocillopora_meandrina_HIv1___RNAseq.g8081.t2,three_way,50.48,,,,,,,,,,,,,,,,,
OG_01312,1.8596150770808448,FUN_005175-T1,Peve_00011874,Pocillopora_meandrina_HIv1___RNAseq.g7581.t1,three_way,61.32216666666667,FUN_005175-T1,Q9VW71,,,,,22.0,2889.0,4.9e-74,283.1,sp|Q9VW71|FAT2_DROME Fat-like cadherin-related tumor suppressor homolog OS=Drosophila melanogaster OX=7227 GN=kug PE=2 SV=3,,,,,,
OG_01314,1.0314835957504036,FUN_005177-T1,Peve_00022720,Pocillopora_meandrina_HIv1___RNAseq.g7584.t1,three_way,78.689,FUN_005177-T1,Q7Z401,MYCPP_HUMAN,,C-myc promoter-binding protein (DENN domain-containing protein 4A),Homo sapiens (Human),34.8,1885.0,8.6e-282,971.8,sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2,GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483,regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_01315,1.52779017693623,FUN_005178-T1,Peve_00022721,Pocillopora_meandrina_HIv1___RNAseq.g7585.t1,three_way,63.69316666666666,FUN_005178-T1,Q5ZM55,,,,,28.4,627.0,5.7e-31,137.5,sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1,,,,,,
OG_01317,2.666389005135227,FUN_005182-T1,Peve_00023411,Pocillopora_meandrina_HIv1___RNAseq.g8094.t1,three_way,60.54366666666667,FUN_005182-T1,Q9UGM3,,,,,32.5,830.0,4.1999999999999995e-95,352.1,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_01330,2.7945387982082264,FUN_005220-T1,Peve_00035492,Pocillopora_meandrina_HIv1___TS.g19865.t1,three_way,97.09066666666666,FUN_005220-T1,Q9TTR8,,,,,73.7,266.0,5e-111,402.1,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_01332,1.0779462969421545,FUN_005226-T1,Peve_00035495,Pocillopora_meandrina_HIv1___RNAseq.g8118.t1,three_way,70.23566666666666,FUN_005226-T1,Q91W67,,,,,35.7,336.0,9.3e-22,105.9,sp|Q91W67|UBL7_MOUSE Ubiquitin-like protein 7 OS=Mus musculus OX=10090 GN=Ubl7 PE=1 SV=2,,,,,,
OG_01333,1.595487301011957,FUN_005230-T1,Peve_00042881,Pocillopora_meandrina_HIv1___RNAseq.g8115.t1,three_way,67.631,FUN_005230-T1,Q8C9M2,,,,,67.3,49.0,1.1e-13,79.7,sp|Q8C9M2|CCD15_MOUSE Coiled-coil domain-containing protein 15 OS=Mus musculus OX=10090 GN=Ccdc15 PE=2 SV=2,,,,,,
OG_01340,1.3525048997463816,FUN_005239-T1,Peve_00014036,Pocillopora_meandrina_HIv1___RNAseq.g8108.t1,three_way,64.7975,FUN_005239-T1,Q6GPB8,,,,,46.3,549.0,2.3e-128,460.7,sp|Q6GPB8|DBR1A_XENLA Lariat debranching enzyme A OS=Xenopus laevis OX=8355 GN=dbr1-a PE=2 SV=1,,,,,,
OG_01343,1.7032983711870404,FUN_005244-T1,Peve_00003366,Pocillopora_meandrina_HIv1___RNAseq.g8140.t2,three_way,77.56250000000001,FUN_005244-T1,Q8TDJ6,,,,,34.9,3319.0,0.0,1533.5,sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2,,,,,,
OG_01349,1.3439416714412558,FUN_005251-T1,Peve_00003359,Pocillopora_meandrina_HIv1___RNAseq.g8148.t1,three_way,73.81333333333333,FUN_005251-T1,A4UTP7,MEF2C_PIG,,Myocyte-specific enhancer factor 2C,Sus scrofa (Pig),48.2,305.0,3.9e-58,227.3,sp|A4UTP7|MEF2C_PIG Myocyte-specific enhancer factor 2C OS=Sus scrofa OX=9823 GN=MEF2C PE=2 SV=1,GO:0000122; GO:0000165; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001649; GO:0001782; GO:0001947; GO:0001958; GO:0001974; GO:0002062; GO:0002467; GO:0002634; GO:0003138; GO:0003139; GO:0003151; GO:0003185; GO:0003211; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006959; GO:0007507; GO:0007519; GO:0007521; GO:0007611; GO:0010628; GO:0010629; GO:0014033; GO:0016528; GO:0016607; GO:0030182; GO:0030220; GO:0030279; GO:0030318; GO:0030501; GO:0030890; GO:0032991; GO:0035051; GO:0035984; GO:0042100; GO:0043524; GO:0045652; GO:0045663; GO:0045666; GO:0045669; GO:0045893; GO:0045944; GO:0046983; GO:0048643; GO:0048666; GO:0050853; GO:0051145; GO:0055012; GO:0060025; GO:0060045; GO:0061333; GO:0071222; GO:0071277; GO:0071374; GO:0071466; GO:0071498; GO:0071560; GO:0072102; GO:0072160; GO:2000111; GO:2000727; GO:2000987; GO:2001013; GO:2001016,B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cardiocyte differentiation [GO:0035051]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule epithelial cell differentiation [GO:0072160]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary heart field specification [GO:0003138]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of synaptic activity [GO:0060025]; renal tubule morphogenesis [GO:0061333]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]",GO:0002376; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140110,immune system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_01350,1.1161369305588538,FUN_005253-T1,Peve_00003358,Pocillopora_meandrina_HIv1___RNAseq.g8149.t1,three_way,40.75233333333333,,,,,,,,,,,,,,,,,
OG_01351,2.0989694783928545,FUN_005258-T1,Peve_00003357,Pocillopora_meandrina_HIv1___RNAseq.g8150.t1,three_way,89.47800000000001,FUN_005258-T1,Q7ZYG4,,,,,59.9,212.0,7.4e-46,185.3,sp|Q7ZYG4|OSTF1_XENLA Osteoclast-stimulating factor 1 OS=Xenopus laevis OX=8355 GN=ostf1 PE=2 SV=1,,,,,,
OG_01352,1.093735146605053,FUN_005260-T1,Peve_00003354,Pocillopora_meandrina_HIv1___RNAseq.g8151.t1,three_way,68.60516666666666,FUN_005260-T1,Q6PCN7,HLTF_MOUSE,,Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (P113) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3) (TNF-response element-binding protein),Mus musculus (Mouse),43.8,843.0,2.9e-177,624.4,sp|Q6PCN7|HLTF_MOUSE Helicase-like transcription factor OS=Mus musculus OX=10090 GN=Hltf PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0006325; GO:0008094; GO:0008270; GO:0016363; GO:0016567; GO:0016740; GO:0016818; GO:0031625; GO:0042789; GO:0045944; GO:0050767; GO:0090575,chromatin organization [GO:0006325]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005654; GO:0005730; GO:0006325; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; nucleolus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_01353,1.2562579629666375,FUN_005265-T1,Peve_00003353,Pocillopora_meandrina_HIv1___RNAseq.g8152.t1,three_way,57.54216666666667,FUN_005265-T1,Q8BH97,RCN3_MOUSE,,Reticulocalbin-3,Mus musculus (Mouse),34.2,149.0,1.2e-11,72.0,sp|Q8BH97|RCN3_MOUSE Reticulocalbin-3 OS=Mus musculus OX=10090 GN=Rcn3 PE=1 SV=1,GO:0005509; GO:0005783; GO:0005788; GO:0009306; GO:0010952; GO:0015031; GO:0032964; GO:0036503; GO:0043129; GO:0051896; GO:0055091; GO:0060428,collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; positive regulation of peptidase activity [GO:0010952]; protein secretion [GO:0009306]; protein transport [GO:0015031]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; surfactant homeostasis [GO:0043129],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509],GO:0005783; GO:0030163; GO:0043226; GO:0048856,endoplasmic reticulum; protein catabolic process; organelle; anatomical structure development
OG_01366,2.3570273229824537,FUN_005313-T1,Peve_00003312,Pocillopora_meandrina_HIv1___RNAseq.g8174.t1,three_way,94.14516666666668,FUN_005313-T1,Q04727,TLE4_HUMAN,,Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4),Homo sapiens (Human),84.8,356.0,3.9e-180,632.1,sp|Q04727|TLE4_HUMAN Transducin-like enhancer protein 4 OS=Homo sapiens OX=9606 GN=TLE4 PE=1 SV=3,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055],beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_01367,1.1497244632743884,FUN_005315-T1,Peve_00003311,Pocillopora_meandrina_HIv1___RNAseq.g8175.t1,three_way,70.18966666666667,FUN_005315-T1,Q9UPR3,SMG5_HUMAN,,Nonsense-mediated mRNA decay factor SMG5 (EST1-like protein B) (LPTS-RP1) (LPTS-interacting protein) (SMG-5 homolog) (hSMG-5),Homo sapiens (Human),31.7,851.0,3.6e-72,274.6,sp|Q9UPR3|SMG5_HUMAN Nonsense-mediated mRNA decay factor SMG5 OS=Homo sapiens OX=9606 GN=SMG5 PE=1 SV=3,GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0031625; GO:0032204; GO:0032210; GO:0035303; GO:0036464; GO:0042162; GO:0042826; GO:0051721; GO:0070034,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0006913; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; cytosol; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_01370,1.2986356955401983,FUN_005320-T1,Peve_00003308,Pocillopora_meandrina_HIv1___RNAseq.g8181.t1,three_way,77.714,FUN_005320-T1,Q9GZV8,PRD14_HUMAN,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Homo sapiens (Human),41.4,116.0,6.2e-22,107.1,sp|Q9GZV8|PRD14_HUMAN PR domain zinc finger protein 14 OS=Homo sapiens OX=9606 GN=PRDM14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0030718; GO:0031490; GO:0032259; GO:0040037; GO:0043231; GO:0045814; GO:0048873; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]",intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_01375,1.1477868253373416,FUN_005331-T1,Peve_00003302,Pocillopora_meandrina_HIv1___TS.g19933.t1,three_way,77.45716666666667,FUN_005331-T1,A0JN62,CE120_BOVIN,,Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100),Bos taurus (Bovine),42.1,525.0,8.4e-83,309.3,sp|A0JN62|CE120_BOVIN Centrosomal protein of 120 kDa OS=Bos taurus OX=9913 GN=CEP120 PE=2 SV=2,GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:1903724; GO:1904951,astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737],,GO:0005815; GO:0007010; GO:0030154; GO:0043226; GO:0048856,microtubule organizing center; cytoskeleton organization; cell differentiation; organelle; anatomical structure development
OG_01376,1.0600238780717934,FUN_005333-T1,Peve_00003300,Pocillopora_meandrina_HIv1___RNAseq.g8193.t1,three_way,71.21333333333332,,,,,,,,,,,,,,,,,
OG_01379,1.362317525239521,FUN_005336-T1,Peve_00003298,Pocillopora_meandrina_HIv1___RNAseq.g8196.t1,three_way,77.24866666666667,FUN_005336-T1,Q5ZK14,,,,,57.0,100.0,7e-21,101.3,sp|Q5ZK14|DDA1_CHICK DET1- and DDB1-associated protein 1 OS=Gallus gallus OX=9031 GN=DDA1 PE=3 SV=1,,,,,,
OG_01384,1.4765318255974194,FUN_005352-T1,Peve_00016030,Pocillopora_meandrina_HIv1___TS.g19950.t1,three_way,73.10666666666667,FUN_005352-T1,A2ASI5,SCN3A_MOUSE,,Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3),Mus musculus (Mouse),34.4,1484.0,1.1e-178,629.4,sp|A2ASI5|SCN3A_MOUSE Sodium channel protein type 3 subunit alpha OS=Mus musculus OX=10090 GN=Scn3a PE=1 SV=1,GO:0001518; GO:0005248; GO:0005272; GO:0005886; GO:0009925; GO:0016020; GO:0016528; GO:0048266; GO:0086010,behavioral response to pain [GO:0048266]; membrane depolarization during action potential [GO:0086010],basal plasma membrane [GO:0009925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasm [GO:0016528]; voltage-gated sodium channel complex [GO:0001518],sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_01385,1.237200859299159,FUN_005354-T1,Peve_00016052,Pocillopora_meandrina_HIv1___TS.g19952.t1,three_way,78.38366666666667,FUN_005354-T1,A4FUY7,,,,,63.4,145.0,1.7e-48,193.7,sp|A4FUY7|MOC2B_BOVIN Molybdopterin synthase catalytic subunit OS=Bos taurus OX=9913 GN=MOCS2 PE=2 SV=2,,,,,,
OG_01389,1.683125034238817,FUN_005363-T1,Peve_00016035,Pocillopora_meandrina_HIv1___RNAseq.g8221.t1,three_way,93.72233333333334,FUN_005363-T1,Q7L5Y6,DET1_HUMAN,,DET1 homolog (De-etiolated-1 homolog),Homo sapiens (Human),66.1,481.0,1.1e-185,651.0,sp|Q7L5Y6|DET1_HUMAN DET1 homolog OS=Homo sapiens OX=9606 GN=DET1 PE=1 SV=2,GO:0005634; GO:0016567; GO:0031461; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleus [GO:0005634],protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0043226; GO:0060090; GO:0065003,nucleus; organelle; molecular adaptor activity; protein-containing complex assembly
OG_01392,1.225444562984594,FUN_005367-T1,Peve_00041491,Pocillopora_meandrina_HIv1___RNAseq.g6637.t3,three_way,81.581,,,,,,,,,,,,,,,,,
OG_01393,1.085217270922854,FUN_005369-T1,Peve_00041469,Pocillopora_meandrina_HIv1___RNAseq.g6632.t2,three_way,79.86133333333333,FUN_005369-T1,Q9UPW5,CBPC1_HUMAN,,Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog) (Protein deglutamylase CCP1),Homo sapiens (Human),42.5,1201.0,9.6e-233,808.5,sp|Q9UPW5|CBPC1_HUMAN Cytosolic carboxypeptidase 1 OS=Homo sapiens OX=9606 GN=AGTPBP1 PE=1 SV=3,GO:0001754; GO:0004181; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006508; GO:0007005; GO:0007628; GO:0008270; GO:0008285; GO:0015630; GO:0015631; GO:0021702; GO:0021772; GO:0021954; GO:0034451; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0050905; GO:0060041; GO:0098957; GO:0098958; GO:1904115; GO:2000060,adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958],axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007005; GO:0007018; GO:0008092; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; mitochondrion organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_01400,1.403981310795389,FUN_005389-T1,Peve_00042934,Pocillopora_meandrina_HIv1___RNAseq.g7680.t1,three_way,74.071,,,,,,,,,,,,,,,,,
OG_01405,1.4615374353598276,FUN_005473-T1,Peve_00002044,Pocillopora_meandrina_HIv1___RNAseq.g6627.t2,three_way,52.35033333333333,FUN_005473-T1,Q5N8Z0,,,,,28.4,278.0,5.1e-06,55.1,sp|Q5N8Z0|DRB1_ORYSJ Double-stranded RNA-binding protein 1 OS=Oryza sativa subsp. japonica OX=39947 GN=DRB1 PE=2 SV=1,,,,,,
OG_01407,2.7600781597924917,FUN_005476-T1,Peve_00041489,Pocillopora_meandrina_HIv1___RNAseq.g6630.t1,three_way,45.82566666666667,,,,,,,,,,,,,,,,,
OG_01408,1.404827023042028,FUN_005479-T1,Peve_00001976,Pocillopora_meandrina_HIv1___RNAseq.g6643.t1,three_way,83.39633333333333,FUN_005479-T1,P50904,,,,,47.7,900.0,1.4e-237,824.3,sp|P50904|RASA1_RAT Ras GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1,,,,,,
OG_01409,2.221841689217272,FUN_005480-T1,Peve_00001975,Pocillopora_meandrina_HIv1___RNAseq.g6644.t1,three_way,42.841166666666666,,,,,,,,,,,,,,,,,
OG_01411,1.3898172044317827,FUN_005697-T1,Peve_00008482,Pocillopora_meandrina_HIv1___RNAseq.g19565.t1,three_way,83.81866666666667,FUN_005697-T1,O93308,,,,,50.9,1241.0,1.7e-278,960.7,sp|O93308|SMC1A_XENLA Structural maintenance of chromosomes protein 1A OS=Xenopus laevis OX=8355 GN=smc1a PE=1 SV=1,,,,,,
OG_01413,1.9966811988263284,FUN_005700-T1,Peve_00008485,Pocillopora_meandrina_HIv1___RNAseq.g19563.t1,three_way,75.503,FUN_005700-T1,Q9Z2V9,,,,,40.4,213.0,5.4e-36,152.9,sp|Q9Z2V9|CCNI_MOUSE Cyclin-I OS=Mus musculus OX=10090 GN=Ccni PE=2 SV=4,,,,,,
OG_01418,1.684412146178753,FUN_005725-T1,Peve_00039545,Pocillopora_meandrina_HIv1___RNAseq.g19424.t1,three_way,40.257666666666665,,,,,,,,,,,,,,,,,
OG_01419,2.629110439487123,FUN_005730-T1,Peve_00004979,Pocillopora_meandrina_HIv1___RNAseq.3034_t,three_way,61.8795,FUN_005730-T1,Q6BEA0,PLXA4_DANRE,,Plexin-A4,Danio rerio (Zebrafish) (Brachydanio rerio),37.4,1904.0,3.2e-310,1066.6,sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1,GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526,axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416],membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116],semaphorin receptor activity [GO:0017154],GO:0005886; GO:0034330; GO:0060089,plasma membrane; cell junction organization; molecular transducer activity
OG_01421,1.5150325760377712,FUN_005749-T1,Peve_00020858,Pocillopora_meandrina_HIv1___RNAseq.g19556.t1,three_way,50.93933333333333,,,,,,,,,,,,,,,,,
OG_01424,1.072226499550578,FUN_005808-T1,Peve_00004975,Pocillopora_meandrina_HIv1___RNAseq.g19447.t1,three_way,71.41199999999999,FUN_005808-T1,Q2HJE4,UBP15_BOVIN,,Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15),Bos taurus (Bovine),56.1,919.0,3.100000000000001e-277,956.1,sp|Q2HJE4|UBP15_BOVIN Ubiquitin carboxyl-terminal hydrolase 15 OS=Bos taurus OX=9913 GN=USP15 PE=2 SV=1,GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005739; GO:0006508; GO:0030509; GO:0030512; GO:0035520; GO:0140673; GO:1905035; GO:1990167,BMP signaling pathway [GO:0030509]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein K27-linked deubiquitination [GO:1990167]; proteolysis [GO:0006508]; transcription elongation-coupled chromatin remodeling [GO:0140673],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005739; GO:0006325; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; mitochondrion; chromatin organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01425,1.4781916043795795,FUN_005812-T1,Peve_00039600,Pocillopora_meandrina_HIv1___RNAseq.g19558.t1,three_way,91.84433333333334,FUN_005812-T1,Q8WXX0,DYH7_HUMAN,,Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2),Homo sapiens (Human),54.7,4000.0,0.0,4338.5,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0016887; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729,cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_01426,1.0639484331611195,FUN_005814-T1,Peve_00004967,Pocillopora_meandrina_HIv1___RNAseq.g19530.t1,three_way,80.68183333333334,FUN_005814-T1,Q06187,BTK_HUMAN,,Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase),Homo sapiens (Human),41.3,658.0,7.8e-147,522.3,sp|Q06187|BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens OX=9606 GN=BTK PE=1 SV=3,GO:0001780; GO:0001805; GO:0001812; GO:0002250; GO:0002344; GO:0002553; GO:0002639; GO:0002721; GO:0002755; GO:0002902; GO:0004713; GO:0004715; GO:0005524; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007498; GO:0008270; GO:0016004; GO:0018108; GO:0019722; GO:0030167; GO:0030889; GO:0030890; GO:0031410; GO:0032496; GO:0032693; GO:0032755; GO:0032760; GO:0034614; GO:0035556; GO:0038095; GO:0042113; GO:0042802; GO:0043123; GO:0043274; GO:0045087; GO:0045121; GO:0045579; GO:0048469; GO:0048471; GO:0050766; GO:0050852; GO:0050853; GO:0051092; GO:0061516; GO:0071226; GO:0097190; GO:0098761; GO:0141111; GO:0150153; GO:1900227; GO:1901647; GO:1990959,adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; eosinophil homeostasis [GO:1990959]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; monocyte proliferation [GO:0061516]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; neutrophil homeostasis [GO:0001780]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17A production [GO:0150153]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of phagocytosis [GO:0050766]; positive regulation of synoviocyte proliferation [GO:1901647]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; proteoglycan catabolic process [GO:0030167]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]; response to lipopolysaccharide [GO:0032496]; T cell receptor signaling pathway [GO:0050852],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0008289; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0098542; GO:0098772; GO:0140096; GO:1901135,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid binding; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01428,1.6092515728856027,FUN_005821-T1,Peve_00034064,Pocillopora_meandrina_HIv1___TS.g29038.t2,three_way,69.24366666666667,FUN_005821-T1,Q9JLG8,,,,,50.0,640.0,1.2000000000000001e-182,641.7,sp|Q9JLG8|CAN15_MOUSE Calpain-15 OS=Mus musculus OX=10090 GN=Capn15 PE=1 SV=1,,,,,,
OG_01433,1.658004517941918,FUN_005832-T2,Peve_00034054,Pocillopora_meandrina_HIv1___RNAseq.g19672.t1,three_way,60.95,FUN_005832-T2,Q3L254,WNT7B_CHICK,,Protein Wnt-7b,Gallus gallus (Chicken),47.4,333.0,2.7e-88,327.0,sp|Q3L254|WNT7B_CHICK Protein Wnt-7b OS=Gallus gallus OX=9031 GN=WNT7B PE=2 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0021871; GO:0030182; GO:0045165; GO:0046330; GO:0048144; GO:0060070; GO:0070307; GO:0071300; GO:0072089,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089],extracellular space [GO:0005615],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01435,1.6590085469741305,FUN_005856-T1,Peve_00034053,Pocillopora_meandrina_HIv1___TS.g29054.t1,three_way,52.05916666666666,FUN_005856-T1,P41221,WNT5A_HUMAN,,Protein Wnt-5a,Homo sapiens (Human),41.0,376.0,1.5e-79,298.1,sp|P41221|WNT5A_HUMAN Protein Wnt-5a OS=Homo sapiens OX=9606 GN=WNT5A PE=1 SV=2,GO:0001736; GO:0001756; GO:0001822; GO:0001837; GO:0001843; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002720; GO:0003138; GO:0003139; GO:0003281; GO:0003283; GO:0003323; GO:0003344; GO:0003408; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006954; GO:0007200; GO:0007223; GO:0007254; GO:0007411; GO:0007442; GO:0007494; GO:0008104; GO:0008543; GO:0008584; GO:0008595; GO:0009986; GO:0010463; GO:0010595; GO:0010628; GO:0010631; GO:0010742; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030509; GO:0030514; GO:0030666; GO:0030669; GO:0031012; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0043410; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048846; GO:0048850; GO:0050680; GO:0050727; GO:0050729; GO:0050807; GO:0051216; GO:0051885; GO:0051897; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060809; GO:0060907; GO:0061036; GO:0062009; GO:0070062; GO:0070242; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090090; GO:0090103; GO:0097325; GO:0098685; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099170; GO:0099175; GO:0099566; GO:0140013; GO:0150012; GO:1900020; GO:1902035; GO:1902379; GO:1902474; GO:1904861; GO:1904862; GO:1904934; GO:1904948; GO:2000049; GO:2000052; GO:2001235,"anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to calcium ion [GO:0071277]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to type II interferon [GO:0071346]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell migration [GO:0010631]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inflammatory response [GO:0006954]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; meiotic nuclear division [GO:0140013]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation [GO:0010463]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midbrain dopaminergic neuron differentiation [GO:1904948]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; pericardium morphogenesis [GO:0003344]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type II interferon production [GO:0032729]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein localization [GO:0008104]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; thymocyte apoptotic process [GO:0070242]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventricular septum development [GO:0003281]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]",cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115],GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0006954; GO:0007163; GO:0008289; GO:0012501; GO:0022414; GO:0023052; GO:0030154; GO:0030312; GO:0031012; GO:0034330; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140013,extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; inflammatory response; establishment or maintenance of cell polarity; lipid binding; programmed cell death; reproductive process; signaling; cell differentiation; external encapsulating structure; extracellular matrix; cell junction organization; wound healing; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; meiotic nuclear division
OG_01436,1.7536076974847203,FUN_005858-T1,Peve_00015774,Pocillopora_meandrina_HIv1___RNAseq.g19665.t1,three_way,77.938,FUN_005858-T1,Q8IV35,,,,,25.4,906.0,2.2e-77,292.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_01437,3.3055027568321544,FUN_005873-T1,Peve_00015756,Pocillopora_meandrina_HIv1___RNAseq.g19664.t1,three_way,58.21833333333333,,,,,,,,,,,,,,,,,
OG_01442,1.026835566362995,FUN_005882-T1,Peve_00015765,Pocillopora_meandrina_HIv1___RNAseq.g19676.t1,three_way,71.35633333333334,,,,,,,,,,,,,,,,,
OG_01443,1.6807013918466955,FUN_005883-T1,Peve_00015767,Pocillopora_meandrina_HIv1___RNAseq.g19677.t1,three_way,79.88083333333334,FUN_005883-T1,Q6XPS3,TPTE2_HUMAN,,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)",Homo sapiens (Human),46.4,468.0,6e-103,376.3,"sp|Q6XPS3|TPTE2_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 OS=Homo sapiens OX=9606 GN=TPTE2 PE=1 SV=2",GO:0000139; GO:0005216; GO:0005737; GO:0005789; GO:0005829; GO:0006661; GO:0016314; GO:0051800,phosphatidylinositol biosynthetic process [GO:0006661],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],"monoatomic ion channel activity [GO:0005216]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]",GO:0003824; GO:0005215; GO:0005829; GO:0006629; GO:0016787,catalytic activity; transporter activity; cytosol; lipid metabolic process; hydrolase activity
OG_01445,1.5376769309036236,FUN_005893-T1,Peve_00015773,Pocillopora_meandrina_HIv1___RNAseq.g19681.t1,three_way,81.42,FUN_005893-T1,G5EBX9,PPE_CAEEL,,Serine/threonine-protein phosphatase with EF-hands pef-1 (CePPEF) (EC 3.1.3.16) (Phosphatase with EF hands 1),Caenorhabditis elegans,49.7,580.0,1.8000000000000001e-162,574.3,sp|G5EBX9|PPE_CAEEL Serine/threonine-protein phosphatase with EF-hands pef-1 OS=Caenorhabditis elegans OX=6239 GN=pef-1 PE=1 SV=1,GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0030145; GO:0030424; GO:0030425; GO:0043025; GO:0043204; GO:0050906,detection of stimulus involved in sensory perception [GO:0050906],axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; cilium; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01446,1.021094215562901,FUN_005894-T1,Peve_00035818,Pocillopora_meandrina_HIv1___RNAseq.g19682.t1,three_way,75.725,FUN_005894-T1,Q9BVK2,ALG8_HUMAN,,"Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)",Homo sapiens (Human),55.1,296.0,6.5e-84,312.4,"sp|Q9BVK2|ALG8_HUMAN Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG8 PE=1 SV=2",GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0018279; GO:0042283; GO:0098553,dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553],"dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_01447,2.64805745440436,FUN_005896-T1,Peve_00035817,Pocillopora_meandrina_HIv1___RNAseq.3177_t,three_way,67.3925,FUN_005896-T1,Q8K2Y0,,,,,39.0,141.0,1.2e-15,86.3,sp|Q8K2Y0|OBI1_MOUSE ORC ubiquitin ligase 1 OS=Mus musculus OX=10090 GN=Obi1 PE=1 SV=2,,,,,,
OG_01448,1.7361095043591672,FUN_005899-T1,Peve_00035816,Pocillopora_meandrina_HIv1___RNAseq.3178_t,three_way,96.55533333333334,FUN_005899-T1,Q15319,PO4F3_HUMAN,,"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C)",Homo sapiens (Human),59.5,259.0,1.4e-66,254.6,"sp|Q15319|PO4F3_HUMAN POU domain, class 4, transcription factor 3 OS=Homo sapiens OX=9606 GN=POU4F3 PE=1 SV=1",GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402; GO:1990837,axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_01451,1.077853296427337,FUN_005905-T1,Peve_00033233,Pocillopora_meandrina_HIv1___RNAseq.g19576.t1,three_way,48.1295,FUN_005905-T1,Q8JI28,,,,,24.0,271.0,2.7e-13,77.8,sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1,,,,,,
OG_01452,2.094599746345813,FUN_005908-T1,Peve_00038389,Pocillopora_meandrina_HIv1___RNAseq.g19573.t1,three_way,84.7165,FUN_005908-T1,P23634,AT2B4_HUMAN,,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),Homo sapiens (Human),59.0,1089.0,0.0,1226.8,sp|P23634|AT2B4_HUMAN Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens OX=9606 GN=ATP2B4 PE=1 SV=2,GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0005901; GO:0005929; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145,calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832],basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080],GO:0003012; GO:0003013; GO:0003824; GO:0005215; GO:0005739; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0098772; GO:0140657,muscle system process; circulatory system process; catalytic activity; transporter activity; mitochondrion; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; microtubule-based movement; hydrolase activity; reproductive process; organelle; anatomical structure development; cell motility; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_01454,1.4547021916438752,FUN_005910-T1,Peve_00038357,Pocillopora_meandrina_HIv1___TS.g28951.t2,three_way,53.465833333333336,FUN_005910-T1,Q4AC94,C2CD3_HUMAN,,C2 domain-containing protein 3,Homo sapiens (Human),31.7,1538.0,2.5e-185,651.7,sp|Q4AC94|C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=C2CD3 PE=1 SV=4,GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0060271; GO:0061511; GO:0071539; GO:1905515,brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815],,GO:0005815; GO:0005829; GO:0043226; GO:0044782; GO:0048856; GO:0051604,microtubule organizing center; cytosol; organelle; cilium organization; anatomical structure development; protein maturation
OG_01457,1.7135989902463498,FUN_005931-T1,Peve_00011544,Pocillopora_meandrina_HIv1___TS.g26522.t1,three_way,59.55316666666667,,,,,,,,,,,,,,,,,
OG_01460,1.1437265824559804,FUN_005994-T2,Peve_00008882,Pocillopora_meandrina_HIv1___RNAseq.g19943.t1,three_way,67.73166666666667,FUN_005994-T2,Q6YBV0,S36A4_HUMAN,,Neutral amino acid uniporter 4 (Solute carrier family 36 member 4),Homo sapiens (Human),43.1,418.0,7.6e-86,319.3,sp|Q6YBV0|S36A4_HUMAN Neutral amino acid uniporter 4 OS=Homo sapiens OX=9606 GN=SLC36A4 PE=1 SV=1,GO:0003333; GO:0005765; GO:0005774; GO:0005886; GO:0015180; GO:0015193; GO:0015196; GO:0015293; GO:0015808; GO:0015824; GO:0015827; GO:1904271; GO:1904556,amino acid transmembrane transport [GO:0003333]; L-alanine transport [GO:0015808]; L-proline import across plasma membrane [GO:1904271]; L-tryptophan transmembrane transport [GO:1904556]; proline transport [GO:0015824]; tryptophan transport [GO:0015827],lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774],L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; L-tryptophan transmembrane transporter activity [GO:0015196]; symporter activity [GO:0015293],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01462,1.374135944476341,FUN_005996-T1,Peve_00036051,Pocillopora_meandrina_HIv1___TS.g29328.t1,three_way,73.044,FUN_005996-T1,Q6GMK0,MGT4B_DANRE,,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,508.0,6e-143,509.2,"sp|Q6GMK0|MGT4B_DANRE Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B OS=Danio rerio OX=7955 GN=mgat4bQ9UQ53 PE=2 SV=1",GO:0000139; GO:0005783; GO:0005793; GO:0005795; GO:0006486; GO:0006487; GO:0008375; GO:0008454; GO:0046872,protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]",GO:0003824; GO:0005783; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01463,1.5334246279495385,FUN_005998-T1,Peve_00036045,Pocillopora_meandrina_HIv1___RNAseq.g19934.t1,three_way,70.90683333333334,FUN_005998-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),50.4,625.0,1.3e-181,637.9,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_01474,1.1830981460668852,FUN_006026-T1,Peve_00043468,Pocillopora_meandrina_HIv1___RNAseq.g11262.t1,three_way,44.10966666666667,FUN_006026-T1,Q07409,,,,,29.4,282.0,1.1e-22,110.5,sp|Q07409|CNTN3_MOUSE Contactin-3 OS=Mus musculus OX=10090 GN=Cntn3 PE=1 SV=2,,,,,,
OG_01475,2.219071568357987,FUN_006038-T1,Peve_00023433,Pocillopora_meandrina_HIv1___RNAseq.g20251.t1,three_way,65.71133333333333,FUN_006038-T1,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),37.0,686.0,1.8e-115,418.3,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01479,1.4794185058830571,FUN_006042-T1,Peve_00017140,Pocillopora_meandrina_HIv1___RNAseq.g20180.t1,three_way,75.429,FUN_006042-T1,Q99JW2,,,,,59.5,393.0,1.2e-140,501.1,sp|Q99JW2|ACY1_MOUSE Aminoacylase-1 OS=Mus musculus OX=10090 GN=Acy1 PE=1 SV=1,,,,,,
OG_01480,1.1699720919545342,FUN_006106-T1,Peve_00034999,Pocillopora_meandrina_HIv1___TS.g16643.t1,three_way,41.91333333333333,,,,,,,,,,,,,,,,,
OG_01489,3.0169645330238906,FUN_006165-T1,Peve_00023607,Pocillopora_meandrina_HIv1___RNAseq.g20426.t1,three_way,60.60533333333333,FUN_006165-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),33.7,5014.0,0.0,2299.2,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_01491,1.632393106014495,FUN_006167-T2,Peve_00021030,Pocillopora_meandrina_HIv1___RNAseq.g20429.t1,three_way,75.59433333333334,FUN_006167-T2,Q06S87,,,,,54.3,116.0,2.3e-27,125.6,sp|Q06S87|HIUH_DANRE 5-hydroxyisourate hydrolase OS=Danio rerio OX=7955 GN=urah PE=1 SV=1,,,,,,
OG_01492,1.281994142132125,FUN_006168-T1,Peve_00021029,Pocillopora_meandrina_HIv1___RNAseq.g20428.t1,three_way,70.18666666666667,FUN_006168-T1,Q07G10,,,,,42.8,661.0,8.4e-152,538.9,sp|Q07G10|ALKB8_XENTR tRNA (carboxymethyluridine(34)-5-O)-methyltransferase alkbh8 OS=Xenopus tropicalis OX=8364 GN=alkbh8 PE=2 SV=2,,,,,,
OG_01496,2.0516681552437266,FUN_006220-T1,Peve_00020217,Pocillopora_meandrina_HIv1___RNAseq.g20437.t1,three_way,69.87716666666667,FUN_006220-T1,P83094,STIM_DROME,,Stromal interaction molecule homolog,Drosophila melanogaster (Fruit fly),37.4,390.0,8.200000000000001e-59,229.9,sp|P83094|STIM_DROME Stromal interaction molecule homolog OS=Drosophila melanogaster OX=7227 GN=Stim PE=1 SV=1,GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0007476; GO:0012505; GO:0015279; GO:0016020; GO:0022416; GO:0048763; GO:0051924; GO:0140268,chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular calcium ion homeostasis [GO:0006874]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; store-operated calcium channel activity [GO:0015279],GO:0005215; GO:0005783; GO:0005886; GO:0043226; GO:0048856; GO:0098772,transporter activity; endoplasmic reticulum; plasma membrane; organelle; anatomical structure development; molecular function regulator activity
OG_01498,2.3953503264845564,FUN_006222-T1,Peve_00020211,Pocillopora_meandrina_HIv1___RNAseq.g20439.t1,three_way,85.01766666666667,FUN_006222-T1,P56560,,,,,53.5,505.0,2.2e-152,540.4,sp|P56560|AOFB_BOVIN Amine oxidase [flavin-containing] B OS=Bos taurus OX=9913 GN=MAOB PE=1 SV=4,,,,,,
OG_01503,2.398646911908887,FUN_006230-T1,Peve_00002942,Pocillopora_meandrina_HIv1___RNAseq.g20449.t1,three_way,69.12416666666667,FUN_006230-T1,Q5SZK8,FREM2_HUMAN,,FRAS1-related extracellular matrix protein 2 (ECM3 homolog),Homo sapiens (Human),41.5,1242.0,4.8e-265,916.0,sp|Q5SZK8|FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens OX=9606 GN=FREM2 PE=1 SV=3,GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0009653; GO:0042733; GO:0046872; GO:0048839; GO:0062023; GO:0070062,anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],metal ion binding [GO:0046872],GO:0005886; GO:0007155; GO:0030312; GO:0031012; GO:0043226; GO:0048856,plasma membrane; cell adhesion; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_01504,1.629107500817126,FUN_006236-T1,Peve_00011453,Pocillopora_meandrina_HIv1___RNAseq.g20448.t1,three_way,65.54733333333333,,,,,,,,,,,,,,,,,
OG_01506,1.543028703143803,FUN_006238-T1,Peve_00011450,Pocillopora_meandrina_HIv1___RNAseq.g20446.t1,three_way,77.295,FUN_006238-T1,P52875,,,,,63.8,229.0,1.2e-68,261.5,sp|P52875|TM165_MOUSE Putative divalent cation/proton antiporter TMEM165 OS=Mus musculus OX=10090 GN=Tmem165 PE=1 SV=2,,,,,,
OG_01507,2.0616235695291145,FUN_006242-T1,Peve_00011455,Pocillopora_meandrina_HIv1___RNAseq.g20444.t1,three_way,65.56483333333334,FUN_006242-T1,Q6GQJ2,JADE1_XENLA,,Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17),Xenopus laevis (African clawed frog),44.8,511.0,5.6e-120,433.7,sp|Q6GQJ2|JADE1_XENLA Protein Jade-1 OS=Xenopus laevis OX=8355 GN=jade1 PE=2 SV=1,GO:0000123; GO:0005634; GO:0005737; GO:0005856; GO:0006357; GO:0006915; GO:0008270; GO:0042995,apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0005856; GO:0006355; GO:0012501; GO:0043226,nucleus; cytoskeleton; regulation of DNA-templated transcription; programmed cell death; organelle
OG_01510,2.604942690601055,FUN_006245-T1,Peve_00002946,Pocillopora_meandrina_HIv1___RNAseq.g20390.t1b,three_way,45.26566666666667,,,,,,,,,,,,,,,,,
OG_01514,1.0825017398643293,FUN_006253-T1,Peve_00012679,Pocillopora_meandrina_HIv1___RNAseq.g20382.t1,three_way,89.648,FUN_006253-T1,P37235,HPCL1_HUMAN,,Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3),Homo sapiens (Human),51.6,188.0,6.6e-52,205.3,sp|P37235|HPCL1_HUMAN Hippocalcin-like protein 1 OS=Homo sapiens OX=9606 GN=HPCAL1 PE=1 SV=3,GO:0005509; GO:0009966; GO:0016020,regulation of signal transduction [GO:0009966],membrane [GO:0016020],calcium ion binding [GO:0005509],,
OG_01520,1.2403156797542487,FUN_006266-T1,Peve_00019724,Pocillopora_meandrina_HIv1___RNAseq.g20372.t1,three_way,75.93266666666666,,,,,,,,,,,,,,,,,
OG_01521,1.0858478030012038,FUN_006275-T1,Peve_00019725,Pocillopora_meandrina_HIv1___RNAseq.g20370.t1,three_way,75.4355,FUN_006275-T1,Q8R3S6,,,,,43.7,924.0,1.3e-200,701.4,sp|Q8R3S6|EXOC1_MOUSE Exocyst complex component 1 OS=Mus musculus OX=10090 GN=Exoc1 PE=1 SV=4,,,,,,
OG_01522,1.3499403008914517,FUN_006276-T1,Peve_00031100,Pocillopora_meandrina_HIv1___RNAseq.g20369.t1,three_way,84.9125,FUN_006276-T1,Q8K5C0,GRHL2_MOUSE,,Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3),Mus musculus (Mouse),32.7,620.0,2.6999999999999998e-70,268.1,sp|Q8K5C0|GRHL2_MOUSE Grainyhead-like protein 2 homolog OS=Mus musculus OX=10090 GN=Grhl2 PE=2 SV=1,GO:0001161; GO:0001228; GO:0001701; GO:0001843; GO:0003208; GO:0003382; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006355; GO:0006357; GO:0007155; GO:0007420; GO:0008544; GO:0010468; GO:0016020; GO:0021915; GO:0030216; GO:0030323; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0048568; GO:0048701; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132; GO:0140297,anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323],cell-cell junction [GO:0005911]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007155; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell adhesion; cell differentiation; cell junction organization; organelle; anatomical structure development; transcription regulator activity
OG_01523,1.3043425568502631,FUN_006278-T1,Peve_00018295,Pocillopora_meandrina_HIv1___RNAseq.g20361.t1,three_way,65.20033333333333,FUN_006278-T1,A1Z7G7,LPHN_DROME,,Latrophilin Cirl,Drosophila melanogaster (Fruit fly),22.5,329.0,7e-12,74.7,sp|A1Z7G7|LPHN_DROME Latrophilin Cirl OS=Drosophila melanogaster OX=7227 GN=Cirl PE=1 SV=2,GO:0004888; GO:0004930; GO:0005886; GO:0007166; GO:0008344; GO:0019230; GO:0030246; GO:0140897,adult locomotory behavior [GO:0008344]; cell surface receptor signaling pathway [GO:0007166]; proprioception [GO:0019230],plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; mechanoreceptor activity [GO:0140897]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_01524,1.5407989508283186,FUN_006320-T1,Peve_00021264,Pocillopora_meandrina_HIv1___RNAseq.g20359.t1,three_way,67.9575,FUN_006320-T1,Q8BV79,,,,,30.9,2660.0,1.4999999999999998e-286,988.8,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_01527,1.048397102289367,FUN_006323-T1,Peve_00012583,Pocillopora_meandrina_HIv1___RNAseq.g20356.t1,three_way,61.63033333333333,,,,,,,,,,,,,,,,,
OG_01529,1.1101138744934804,FUN_006328-T1,Peve_00012587,Pocillopora_meandrina_HIv1___RNAseq.g20352.t1,three_way,90.09566666666666,FUN_006328-T1,O43772,MCAT_HUMAN,,Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (Solute carrier family 25 member 20),Homo sapiens (Human),61.7,298.0,5.4e-109,395.6,sp|O43772|MCAT_HUMAN Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens OX=9606 GN=SLC25A20 PE=1 SV=1,GO:0001701; GO:0005476; GO:0005739; GO:0005740; GO:0005743; GO:0005829; GO:0006839; GO:0006853; GO:0015227; GO:1902603,carnitine shuttle [GO:0006853]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839],cytosol [GO:0005829]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],carnitine:O-acyl-L-carnitine antiporter activity [GO:0005476]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227],GO:0005215; GO:0005739; GO:0005829; GO:0043226; GO:0048856; GO:0055085,transporter activity; mitochondrion; cytosol; organelle; anatomical structure development; transmembrane transport
OG_01531,1.5439946519033032,FUN_006330-T1,Peve_00012584,Pocillopora_meandrina_HIv1___TS.g29728.t1,three_way,74.3075,FUN_006330-T1,Q8IZ81,,,,,46.7,289.0,6.6e-67,255.8,sp|Q8IZ81|ELMD2_HUMAN ELMO domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ELMOD2 PE=1 SV=1,,,,,,
OG_01533,1.1103871036675497,FUN_006336-T1,Peve_00026066,Pocillopora_meandrina_HIv1___TS.g29722.t1,three_way,94.48533333333332,FUN_006336-T1,Q3ZC01,CNOT7_BOVIN,,CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1),Bos taurus (Bovine),73.1,208.0,6.8000000000000015e-87,321.6,sp|Q3ZC01|CNOT7_BOVIN CCR4-NOT transcription complex subunit 7 OS=Bos taurus OX=9913 GN=CNOT7 PE=2 SV=1,GO:0000175; GO:0000288; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0004532; GO:0004535; GO:0006417; GO:0008284; GO:0008285; GO:0016607; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0034584; GO:0035279; GO:0045070; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0140297; GO:0140991; GO:1900153,"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]",CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932],3'-5'-RNA exonuclease activity [GO:0000175]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA exonuclease activity [GO:0004532]; transcription corepressor activity [GO:0003714],GO:0003723; GO:0003824; GO:0006355; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_01534,2.32906007421026,FUN_006339-T1,Peve_00026068,Pocillopora_meandrina_HIv1___RNAseq.g20341.t1,three_way,67.9555,FUN_006339-T1,Q8NHP6,MSPD2_HUMAN,,Motile sperm domain-containing protein 2,Homo sapiens (Human),34.7,473.0,2.8e-65,251.5,sp|Q8NHP6|MSPD2_HUMAN Motile sperm domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MOSPD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0006935; GO:0012505; GO:0016020; GO:0033149; GO:0035579; GO:0044232; GO:0051260; GO:0090023; GO:0090026; GO:0140042; GO:0140284,chemotaxis [GO:0006935]; lipid droplet formation [GO:0140042]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein homooligomerization [GO:0051260],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],FFAT motif binding [GO:0033149],GO:0005783; GO:0005886; GO:0043226; GO:0065003,endoplasmic reticulum; plasma membrane; organelle; protein-containing complex assembly
OG_01536,1.995784826893667,FUN_006367-T1,Peve_00007381,Pocillopora_meandrina_HIv1___TS.g29719.t1,three_way,89.19266666666667,FUN_006367-T1,Q6DKM1,,,,,59.0,261.0,2.3e-78,293.5,sp|Q6DKM1|UN50A_XENLA Protein unc-50 homolog A OS=Xenopus laevis OX=8355 GN=unc50-a PE=2 SV=1,,,,,,
OG_01541,1.206489035345341,FUN_006411-T1,Peve_00018195,Pocillopora_meandrina_HIv1___RNAseq.g20262.t1,three_way,76.773,FUN_006411-T1,Q9NTJ4,,,,,49.9,1007.0,1.9e-293,1010.0,sp|Q9NTJ4|MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens OX=9606 GN=MAN2C1 PE=1 SV=1,,,,,,
OG_01544,2.144944992743474,FUN_006418-T1,Peve_00043553,Pocillopora_meandrina_HIv1___RNAseq.g20277.t1,three_way,85.8545,FUN_006418-T1,Q1KL12,,,,,61.2,80.0,1.7e-18,94.4,sp|Q1KL12|HXA3A_TAKRU Homeobox protein Hox-A3a OS=Takifugu rubripes OX=31033 GN=hoxa3a PE=3 SV=1,,,,,,
OG_01550,2.16317702879274,FUN_006425-T1,Peve_00043546,Pocillopora_meandrina_HIv1___TS.g29666.t1,three_way,69.39816666666667,FUN_006425-T1,Q96P50,,,,,30.0,253.0,1.1e-26,124.4,"sp|Q96P50|ACAP3_HUMAN Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ACAP3 PE=1 SV=2",,,,,,
OG_01551,1.4547677356569926,FUN_006427-T1,Peve_00043545,Pocillopora_meandrina_HIv1___RNAseq.g20285.t1,three_way,86.59366666666666,FUN_006427-T1,Q2TA46,,,,,66.7,108.0,2.7e-35,149.4,sp|Q2TA46|UBL3_BOVIN Ubiquitin-like protein 3 OS=Bos taurus OX=9913 GN=UBL3 PE=3 SV=1,,,,,,
OG_01555,2.49423353026624,FUN_006435-T1,Peve_00024931,Pocillopora_meandrina_HIv1___RNAseq.g20292.t1,three_way,81.35366666666667,FUN_006435-T1,Q9ULJ7,,,,,44.8,542.0,4.500000000000001e-130,467.6,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_01556,1.3655380953170142,FUN_006436-T1,Peve_00024930,Pocillopora_meandrina_HIv1___RNAseq.g20293.t1,three_way,69.03933333333335,FUN_006436-T1,Q8BW70,,,,,34.7,1038.0,8.4e-156,552.7,sp|Q8BW70|UBP38_MOUSE Ubiquitin carboxyl-terminal hydrolase 38 OS=Mus musculus OX=10090 GN=Usp38 PE=1 SV=2,,,,,,
OG_01557,1.3338647146086182,FUN_006438-T1,Peve_00038436,Pocillopora_meandrina_HIv1___RNAseq.g20295.t1,three_way,78.40966666666667,FUN_006438-T1,P29146,,,,,49.8,566.0,8.6e-155,548.9,sp|P29146|NECA_HYDVU PC3-like endoprotease variant A OS=Hydra vulgaris OX=6087 PE=2 SV=1,,,,,,
OG_01558,1.5302730389908232,FUN_006439-T1,Peve_00038430,Pocillopora_meandrina_HIv1___RNAseq.g20296.t1,three_way,83.673,,,,,,,,,,,,,,,,,
OG_01561,1.036138956547631,FUN_006442-T1,Peve_00038427,Pocillopora_meandrina_HIv1___RNAseq.g20301.t1,three_way,91.59233333333331,FUN_006442-T1,Q9DF58,ILK_CHICK,,Scaffold protein ILK (ILK-1) (ILK-2) (Inactive integrin-linked kinase) (p59ILK),Gallus gallus (Chicken),62.6,449.0,7.4e-112,405.6,sp|Q9DF58|ILK_CHICK Scaffold protein ILK OS=Gallus gallus OX=9031 GN=ILK PE=1 SV=1,GO:0000287; GO:0000785; GO:0000902; GO:0001658; GO:0003151; GO:0004672; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007052; GO:0007165; GO:0007229; GO:0008284; GO:0010761; GO:0015629; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0043123; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0061351; GO:0070836; GO:0072697; GO:0090263; GO:1900026; GO:2000178,branching involved in ureteric bud morphogenesis [GO:0001658]; caveola assembly [GO:0070836]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; mitotic spindle organization [GO:0007052]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; neural precursor cell proliferation [GO:0061351]; outflow tract morphogenesis [GO:0003151]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell cortex [GO:0072697]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017],ATP binding [GO:0005524]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901],GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0007163; GO:0016740; GO:0043226; GO:0048856; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; transferase activity; organelle; anatomical structure development; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_01566,1.509868155928476,FUN_006448-T1,Peve_00038420,Pocillopora_meandrina_HIv1___RNAseq.g20307.t1a,three_way,70.55933333333333,,,,,,,,,,,,,,,,,
OG_01567,1.5332111607856054,FUN_006449-T1,Peve_00038439,Pocillopora_meandrina_HIv1___RNAseq.g20307.t1b,three_way,72.05333333333333,FUN_006449-T1,Q6ZWJ1,STXB4_HUMAN,,Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip),Homo sapiens (Human),28.6,768.0,1.2e-64,250.0,sp|Q6ZWJ1|STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens OX=9606 GN=STXBP4 PE=1 SV=2,GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:1902808,cellular response to type II interferon [GO:0071346]; DNA damage response [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178],cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335],syntaxin binding [GO:0019905],GO:0031410; GO:0043226,cytoplasmic vesicle; organelle
OG_01573,1.352102227394972,FUN_006573-T1,Peve_00011457,Pocillopora_meandrina_HIv1___RNAseq.g20313.t1,three_way,82.19833333333334,FUN_006573-T1,P46850,RTCB_ECOLI,,RNA-splicing ligase RtcB (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase),Escherichia coli (strain K12),60.3,401.0,8.1e-135,481.9,sp|P46850|RTCB_ECOLI RNA-splicing ligase RtcB OS=Escherichia coli (strain K12) OX=83333 GN=rtcB PE=1 SV=3,GO:0003909; GO:0005525; GO:0006281; GO:0006396; GO:0006974; GO:0030145; GO:0042245; GO:0170057,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; RNA processing [GO:0006396]; RNA repair [GO:0042245],,DNA ligase activity [GO:0003909]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; RNA ligase (GTP) activity [GO:0170057],GO:0003824; GO:0006281; GO:0016874; GO:0140097; GO:0140098,"catalytic activity; DNA repair; ligase activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_01575,1.9118454376212013,FUN_006580-T1,Peve_00015619,Pocillopora_meandrina_HIv1___RNAseq.g20273.t1,three_way,43.7885,FUN_006580-T1,Q04589,FGFR1_RAT,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Rattus norvegicus (Rat),33.2,675.0,2.7000000000000002e-89,332.8,sp|Q04589|FGFR1_RAT Fibroblast growth factor receptor 1 OS=Rattus norvegicus OX=10116 GN=Fgfr1 PE=1 SV=1,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0002931; GO:0004713; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007565; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010966; GO:0010976; GO:0017134; GO:0019827; GO:0021769; GO:0021827; GO:0021847; GO:0021954; GO:0022028; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0031667; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0043536; GO:0043583; GO:0044344; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050839; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0071222; GO:0071344; GO:0071420; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:1990090; GO:2000491; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to histamine [GO:0071420]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nerve growth factor stimulus [GO:1990090]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; female pregnancy [GO:0007565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postnatal olfactory bulb interneuron migration [GO:0021827]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; regulation of stem cell proliferation [GO:0072091]; response to ischemia [GO:0002931]; response to nutrient levels [GO:0031667]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0022414; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; reproductive process; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_01579,1.3609753708260903,FUN_006613-T2,Peve_00023430,Pocillopora_meandrina_HIv1___RNAseq.g20254.t1,three_way,74.73116666666667,FUN_006613-T2,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),34.5,730.0,3.7e-114,414.1,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01589,2.2252799789023903,FUN_006629-T1,Peve_00040873,Pocillopora_meandrina_HIv1___RNAseq.g20167.t1,three_way,52.60733333333334,,,,,,,,,,,,,,,,,
OG_01591,1.275167566770812,FUN_006631-T1,Peve_00040841,Pocillopora_meandrina_HIv1___TS.g29548.t1a,three_way,67.0835,,,,,,,,,,,,,,,,,
OG_01593,2.527222120135799,FUN_006634-T1,Peve_00040843,Pocillopora_meandrina_HIv1___TS.g29546.t1b,three_way,57.3695,FUN_006634-T1,Q9NY47,,,,,30.1,951.0,1.1e-87,326.2,sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2,,,,,,
OG_01595,1.0632177209694478,FUN_006637-T1,Peve_00024050,Pocillopora_meandrina_HIv1___RNAseq.g20237.t1,three_way,73.5665,FUN_006637-T1,Q9P2Q2,FRM4A_HUMAN,,FERM domain-containing protein 4A,Homo sapiens (Human),44.8,504.0,7.7000000000000005e-118,426.4,sp|Q9P2Q2|FRM4A_HUMAN FERM domain-containing protein 4A OS=Homo sapiens OX=9606 GN=FRMD4A PE=1 SV=3,GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162,establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],protein-macromolecule adaptor activity [GO:0030674],GO:0005856; GO:0007163; GO:0043226; GO:0060090,cytoskeleton; establishment or maintenance of cell polarity; organelle; molecular adaptor activity
OG_01602,1.4174762268562215,FUN_006645-T1,Peve_00029047,Pocillopora_meandrina_HIv1___RNAseq.g19947.t1,three_way,43.628166666666665,,,,,,,,,,,,,,,,,
OG_01603,1.389424919376428,FUN_006646-T1,Peve_00029030,Pocillopora_meandrina_HIv1___RNAseq.g19948.t1,three_way,55.7015,FUN_006646-T1,Q9BY77,PDIP3_HUMAN,,Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein) (p46) (S6K1 Aly/REF-like target) (SKAR),Homo sapiens (Human),50.7,69.0,2.3e-13,78.2,sp|Q9BY77|PDIP3_HUMAN Polymerase delta-interacting protein 3 OS=Homo sapiens OX=9606 GN=POLDIP3 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016607; GO:0016973; GO:0036464; GO:0044877; GO:0045727,poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006913; GO:0043226,RNA binding; nucleus; nucleoplasm; cytosol; nucleocytoplasmic transport; organelle
OG_01606,1.4934594557220218,FUN_006650-T1,Peve_00029034,Pocillopora_meandrina_HIv1___RNAseq.g19953.t1,three_way,78.253,FUN_006650-T1,Q9UI36,DACH1_HUMAN,,Dachshund homolog 1 (Dach1),Homo sapiens (Human),27.6,479.0,9.2e-19,96.7,sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279,development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0022414; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle; transcription regulator activity
OG_01608,1.9880388419532464,FUN_006652-T1,Peve_00029039,Pocillopora_meandrina_HIv1___RNAseq.g19955.t1,three_way,64.58433333333333,FUN_006652-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),32.4,1666.0,2.3000000000000004e-224,781.6,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_01612,1.389376077574276,FUN_006692-T1,Peve_00029050,Pocillopora_meandrina_HIv1___RNAseq.g19966.t1,three_way,46.55916666666666,,,,,,,,,,,,,,,,,
OG_01615,1.0846431180604772,FUN_006706-T1,Peve_00022745,Pocillopora_meandrina_HIv1___RNAseq.g19996.t1,three_way,57.7245,FUN_006706-T1,Q8VE88,,,,,36.3,411.0,8e-51,203.4,sp|Q8VE88|F1142_MOUSE Protein FAM114A2 OS=Mus musculus OX=10090 GN=Fam114a2 PE=1 SV=2,,,,,,
OG_01618,1.3341096288285827,FUN_006727-T1,Peve_00039555,Pocillopora_meandrina_HIv1___RNAseq.g20013.t1,three_way,71.43566666666666,FUN_006727-T1,Q3UTQ8,CDKL5_MOUSE,,Cyclin-dependent kinase-like 5 (EC 2.7.11.22),Mus musculus (Mouse),44.0,616.0,8.800000000000001e-125,449.5,sp|Q3UTQ8|CDKL5_MOUSE Cyclin-dependent kinase-like 5 OS=Mus musculus OX=10090 GN=Cdkl5 PE=1 SV=1,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0016301; GO:0034504; GO:0036064; GO:0097542; GO:0106310; GO:1902017,protein localization to nucleus [GO:0034504]; regulation of cilium assembly [GO:1902017],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01619,1.5399386121430028,FUN_006728-T1,Peve_00039557,Pocillopora_meandrina_HIv1___RNAseq.g20014.t1,three_way,68.159,,,,,,,,,,,,,,,,,
OG_01620,2.5715428862290928,FUN_006729-T1,Peve_00039560,Pocillopora_meandrina_HIv1___RNAseq.g20015.t1,three_way,68.16666666666667,FUN_006729-T1,O55240,RDH5_MOUSE,,Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (Cis-retinol dehydrogenase),Mus musculus (Mouse),44.6,285.0,1.7999999999999994e-68,261.2,sp|O55240|RDH5_MOUSE Retinol dehydrogenase 5 OS=Mus musculus OX=10090 GN=Rdh5 PE=1 SV=1,GO:0001523; GO:0004745; GO:0005788; GO:0005789; GO:0007601; GO:0008202; GO:0042572; GO:0042803; GO:0044297; GO:0047023; GO:0047044; GO:0106429,retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; visual perception [GO:0007601],cell body [GO:0044297]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],"11-cis-retinol dehydrogenase [GO:0106429]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0006629; GO:0016491; GO:0050877,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process
OG_01621,1.8206295210902448,FUN_006730-T1,Peve_00039561,Pocillopora_meandrina_HIv1___TS.g29404.t2,three_way,70.635,FUN_006730-T1,Q9CQF6,,,,,50.4,254.0,2.0000000000000002e-72,273.9,sp|Q9CQF6|ADPPT_MOUSE L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase OS=Mus musculus OX=10090 GN=Aasdhppt PE=1 SV=1,,,,,,
OG_01630,2.34258648728093,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_01632,1.6308297630822906,FUN_006750-T1,Peve_00029281,Pocillopora_meandrina_HIv1___RNAseq.g20533.t1,three_way,80.3975,FUN_006750-T1,Q9H3E2,,,,,37.7,871.0,3.8e-161,570.5,sp|Q9H3E2|SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens OX=9606 GN=SNX25 PE=1 SV=2,,,,,,
OG_01636,3.030934121573191,FUN_006769-T1,Peve_00027411,Pocillopora_meandrina_HIv1___RNAseq.g20028.t1,three_way,57.7305,FUN_006769-T1,Q9Y2U8,MAN1_HUMAN,,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),Homo sapiens (Human),42.9,317.0,7.4e-55,216.9,sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446,negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446],GO:0003677,DNA binding
OG_01637,1.9321351955586672,FUN_006771-T1,Peve_00027409,Pocillopora_meandrina_HIv1___RNAseq.g20026.t1,three_way,45.833333333333336,,,,,,,,,,,,,,,,,
OG_01641,1.0119729049739097,FUN_006778-T1,Peve_00042981,Pocillopora_meandrina_HIv1___TS.g29885.t1,three_way,45.0235,FUN_006778-T1,P16092,FGFR1_MOUSE,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Mus musculus (Mouse),33.7,784.0,2.6e-100,368.6,sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus OX=10090 GN=Fgfr1 PE=1 SV=2,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010966; GO:0010976; GO:0017134; GO:0021769; GO:0021847; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042803; GO:0043235; GO:0043536; GO:0043583; GO:0045666; GO:0045787; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_01648,1.8175022986195128,FUN_006802-T1,Peve_00040415,Pocillopora_meandrina_HIv1___RNAseq.g15311.t1,three_way,49.62916666666666,FUN_006802-T1,Q9UBM8,MGT4C_HUMAN,,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-acetylglucosaminyltransferase IV homolog) (hGnT-IV-H) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GlcNAc-T IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)",Homo sapiens (Human),32.2,410.0,6.4e-54,213.4,"sp|Q9UBM8|MGT4C_HUMAN Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Homo sapiens OX=9606 GN=MGAT4C PE=2 SV=2",GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0019082; GO:0046872,protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082],Golgi membrane [GO:0000139],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]",GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01649,1.3773995686948732,FUN_006803-T2,Peve_00029309,Pocillopora_meandrina_HIv1___RNAseq.g20491.t1,three_way,82.40566666666668,FUN_006803-T2,A1L1C7,PAN3_XENTR,,PAN2-PAN3 deadenylation complex subunit pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),51.1,626.0,6.2e-166,585.9,sp|A1L1C7|PAN3_XENTR PAN2-PAN3 deadenylation complex subunit pan3 OS=Xenopus tropicalis OX=8364 GN=pan3 PE=2 SV=1,GO:0000289; GO:0000932; GO:0003723; GO:0004672; GO:0005524; GO:0006397; GO:0008270; GO:0010606; GO:0031251,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],P-body [GO:0000932]; PAN complex [GO:0031251],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01653,1.5673927225719158,FUN_006821-T1,Peve_00023763,Pocillopora_meandrina_HIv1___RNAseq.g20482.t1,three_way,90.73766666666668,FUN_006821-T1,Q9HD45,,,,,69.3,554.0,6.7e-206,718.4,sp|Q9HD45|TM9S3_HUMAN Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2,,,,,,
OG_01656,2.1101970030937807,FUN_006826-T1,Peve_00023770,Pocillopora_meandrina_HIv1___RNAseq.g20475.t1,three_way,76.18166666666667,,,,,,,,,,,,,,,,,
OG_01657,1.507590397758612,FUN_006827-T2,Peve_00023772,Pocillopora_meandrina_HIv1___RNAseq.g20474.t1,three_way,59.91866666666667,FUN_006827-T2,Q566X8,DMX1B_DANRE,,Diencephalon/mesencephalon homeobox protein 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),60.8,97.0,1.8e-21,104.4,sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074,midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01658,1.107991090412782,FUN_006829-T1,Peve_00023773,Pocillopora_meandrina_HIv1___RNAseq.g20472.t1,three_way,62.132333333333335,FUN_006829-T1,Q566X8,DMX1B_DANRE,,Diencephalon/mesencephalon homeobox protein 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),50.8,122.0,1e-21,105.1,sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074,midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01659,2.8855877205212965,FUN_006830-T1,Peve_00023775,Pocillopora_meandrina_HIv1___RNAseq.g20471.t1,three_way,73.49133333333333,FUN_006830-T1,Q9U637,,,,,37.9,198.0,7.3e-17,89.0,sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1,,,,,,
OG_01661,1.089608981257638,FUN_006844-T1,Peve_00023779,Pocillopora_meandrina_HIv1___RNAseq.g20468.t1,three_way,65.999,,,,,,,,,,,,,,,,,
OG_01662,1.670159056134913,FUN_006845-T1,Peve_00023780,Pocillopora_meandrina_HIv1___RNAseq.g20467.t2,three_way,74.246,FUN_006845-T1,Q8AWB5,,,,,49.5,386.0,1.9e-105,384.4,sp|Q8AWB5|OFUT3_CHICK GDP-fucose protein O-fucosyltransferase 3 OS=Gallus gallus OX=9031 GN=FUT10 PE=2 SV=2,,,,,,
OG_01663,1.0192244339460768,FUN_006846-T1,Peve_00023781,Pocillopora_meandrina_HIv1___RNAseq.g20466.t1,three_way,87.019,FUN_006846-T1,Q6AYU1,,,,,50.3,316.0,2.6e-84,313.5,sp|Q6AYU1|MO4L1_RAT Mortality factor 4-like protein 1 OS=Rattus norvegicus OX=10116 GN=Morf4l1 PE=2 SV=1,,,,,,
OG_01665,1.007904501151398,FUN_006848-T1,Peve_00023783,Pocillopora_meandrina_HIv1___RNAseq.g20485.t1,three_way,69.09166666666667,,,,,,,,,,,,,,,,,
OG_01669,1.8978819971505951,FUN_006856-T1,Peve_00016201,Pocillopora_meandrina_HIv1___RNAseq.g19911.t1,three_way,74.561,FUN_006856-T1,P24861,,,,,48.5,454.0,1.7e-95,351.3,sp|P24861|CCNA_PATVU G2/mitotic-specific cyclin-A OS=Patella vulgata OX=6465 PE=2 SV=1,,,,,,
OG_01670,1.36439238269638,FUN_006857-T1,Peve_00016203,Pocillopora_meandrina_HIv1___RNAseq.g19910.t1b,three_way,63.460166666666666,FUN_006857-T1,B9EJ80,PDZD8_MOUSE,,PDZ domain-containing protein 8,Mus musculus (Mouse),28.5,1009.0,2.5000000000000004e-80,302.0,sp|B9EJ80|PDZD8_MOUSE PDZ domain-containing protein 8 OS=Mus musculus OX=10090 GN=Pdzd8 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008270; GO:0008289; GO:0022604; GO:0044233; GO:0051560; GO:1990456,cytoskeleton organization [GO:0007010]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604],endoplasmic reticulum membrane [GO:0005789]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; zinc ion binding [GO:0008270],GO:0005739; GO:0007010; GO:0008289; GO:0043226,mitochondrion; cytoskeleton organization; lipid binding; organelle
OG_01671,1.0320397175294749,FUN_006858-T1,Peve_00006602,Pocillopora_meandrina_HIv1___RNAseq.g19910.t1a,three_way,92.78333333333332,FUN_006858-T1,Q27802,,,,,65.6,4362.0,0.0,5570.0,sp|Q27802|DYHC2_TRIGR Cytoplasmic dynein 2 heavy chain 1 OS=Tripneustes gratilla OX=7673 GN=DYH1B PE=2 SV=2,,,,,,
OG_01677,1.1228587086848898,FUN_006885-T1,Peve_00009911,Pocillopora_meandrina_HIv1___RNAseq.g19833.t1,three_way,60.03416666666667,FUN_006885-T1,O94966,,,,,42.5,738.0,3.1999999999999995e-151,537.7,sp|O94966|UBP19_HUMAN Ubiquitin carboxyl-terminal hydrolase 19 OS=Homo sapiens OX=9606 GN=USP19 PE=1 SV=2,,,,,,
OG_01679,1.291683139784781,FUN_006889-T1,Peve_00009369,Pocillopora_meandrina_HIv1___RNAseq.g19815.t1,three_way,70.95,FUN_006889-T1,P61328,FGF12_HUMAN,,Fibroblast growth factor 12 (FGF-12) (Fibroblast growth factor homologous factor 1) (FHF-1) (Myocyte-activating factor),Homo sapiens (Human),29.0,131.0,3.1e-16,87.0,sp|P61328|FGF12_HUMAN Fibroblast growth factor 12 OS=Homo sapiens OX=9606 GN=FGF12 PE=1 SV=1,GO:0005615; GO:0005634; GO:0005737; GO:0007165; GO:0007254; GO:0007267; GO:0007268; GO:0007399; GO:0007507; GO:0008083; GO:0008201; GO:0008344; GO:0010765; GO:0017080; GO:0022008; GO:0044325; GO:0045202; GO:0050905; GO:0086002; GO:0098908; GO:1902305; GO:1905150,adult locomotory behavior [GO:0008344]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; heart development [GO:0007507]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuromuscular process [GO:0050905]; positive regulation of sodium ion transport [GO:0010765]; regulation of neuronal action potential [GO:0098908]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; synapse [GO:0045202],growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],GO:0005615; GO:0005634; GO:0023052; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0050877; GO:0098772,extracellular space; nucleus; signaling; cell differentiation; organelle; receptor ligand activity; anatomical structure development; nervous system process; molecular function regulator activity
OG_01680,2.0554512482619005,FUN_006890-T1,Peve_00009370,Pocillopora_meandrina_HIv1___RNAseq.g19814.t1,three_way,60.797666666666665,FUN_006890-T1,Q19791,GON1_CAEEL,,A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1),Caenorhabditis elegans,25.1,338.0,3.3e-18,94.4,sp|Q19791|GON1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs gon-1 OS=Caenorhabditis elegans OX=6239 GN=gon-1 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005604; GO:0005783; GO:0005794; GO:0006508; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607,cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]; proteolysis [GO:0006508],basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0016192; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; vesicle-mediated transport; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_01683,1.1710792900903346,FUN_006901-T1,Peve_00044416,Pocillopora_meandrina_HIv1___RNAseq.g19809.t1,three_way,59.586,,,,,,,,,,,,,,,,,
OG_01698,1.1663130672828657,FUN_006941-T1,Peve_00042016,Pocillopora_meandrina_HIv1___RNAseq.g20150.t1,three_way,80.58666666666667,FUN_006941-T1,Q32N90,,,,,36.0,566.0,4.4000000000000003e-100,367.9,sp|Q32N90|MBTD1_XENLA MBT domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=mbtd1 PE=2 SV=1,,,,,,
OG_01699,1.008002735938916,FUN_006942-T1,Peve_00014295,Pocillopora_meandrina_HIv1___RNAseq.g20148.t2,three_way,70.609,FUN_006942-T1,P23770,,,,,42.9,385.0,1.3e-66,255.4,sp|P23770|GATA2_XENLA GATA-binding factor 2 OS=Xenopus laevis OX=8355 GN=gata2 PE=2 SV=1,,,,,,
OG_01701,1.558844380761903,FUN_006944-T1,Peve_00020225,Pocillopora_meandrina_HIv1___TS.g29510.t1,three_way,85.65633333333334,FUN_006944-T1,Q96P70,IPO9_HUMAN,,Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9),Homo sapiens (Human),60.4,916.0,2.2e-310,1066.2,sp|Q96P70|IPO9_HUMAN Importin-9 OS=Homo sapiens OX=9606 GN=IPO9 PE=1 SV=3,GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0016020; GO:0031144; GO:0031267; GO:0042393; GO:0061608; GO:0140713,proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654],histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267],GO:0005635; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0042393; GO:0140104,nuclear envelope; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; histone binding; molecular carrier activity
OG_01703,1.7440145822379285,FUN_006948-T1,Peve_00001502,Pocillopora_meandrina_HIv1___RNAseq.g20123.t1,three_way,82.16266666666667,FUN_006948-T1,Q9GZQ3,COMD5_HUMAN,,COMM domain-containing protein 5 (Hypertension-related calcium-regulated gene protein) (HCaRG),Homo sapiens (Human),47.3,201.0,1.8e-42,174.1,sp|Q9GZQ3|COMD5_HUMAN COMM domain-containing protein 5 OS=Homo sapiens OX=9606 GN=COMMD5 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005829; GO:0043226,nucleus; nucleoplasm; cytosol; organelle
OG_01704,1.846276089580713,FUN_006949-T1,Peve_00001501,Pocillopora_meandrina_HIv1___RNAseq.g20122.t1,three_way,65.41066666666667,FUN_006949-T1,Q9D4H7,,,,,35.5,617.0,9e-100,365.9,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_01709,2.429504247915653,FUN_006982-T1,Peve_00045260,Pocillopora_meandrina_HIv1___TS.g29608.t2b,three_way,78.57366666666667,FUN_006982-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),44.9,187.0,1.9e-40,167.5,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_01710,1.732425404321415,FUN_006983-T1,Peve_00045259,Pocillopora_meandrina_HIv1___RNAseq.3765_t,three_way,61.745333333333335,FUN_006983-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),38.7,248.0,5.7e-40,166.0,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_01711,1.1396686293728582,FUN_006985-T1,Peve_00045265,Pocillopora_meandrina_HIv1___RNAseq.g20222.t1,three_way,77.84,FUN_006985-T1,Q05086,UBE3A_HUMAN,,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54),Homo sapiens (Human),53.1,755.0,9.8e-221,768.1,sp|Q05086|UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens OX=9606 GN=UBE3A PE=1 SV=4,GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0008021; GO:0008270; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042752; GO:0043161; GO:0045944; GO:0048167; GO:0048511; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061630; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:2000058,androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021],transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016192; GO:0016740; GO:0022414; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; vesicle-mediated transport; transferase activity; reproductive process; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_01713,1.411310248457721,FUN_006988-T1,Peve_00009621,Pocillopora_meandrina_HIv1___RNAseq.g20160.t1,three_way,80.87866666666667,FUN_006988-T1,P57760,STK16_RAT,,Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2),Rattus norvegicus (Rat),40.4,297.0,1.4999999999999999e-55,218.0,sp|P57760|STK16_RAT Serine/threonine-protein kinase 16 OS=Rattus norvegicus OX=10116 GN=Stk16 PE=2 SV=2,GO:0000978; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0016604; GO:0045944; GO:0048471; GO:0071560; GO:0106310,cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"DNA binding; catalytic activity; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_01715,1.479259884164345,FUN_006995-T1,Peve_00035637,Pocillopora_meandrina_HIv1___RNAseq.g20064.t1,three_way,61.722166666666666,,,,,,,,,,,,,,,,,
OG_01721,1.9934455701511768,FUN_007008-T1,Peve_00044388,Pocillopora_meandrina_HIv1___TS.g27386.t2,three_way,40.379333333333335,FUN_007008-T1,Q6UW56,ARAID_HUMAN,,All-trans retinoic acid-induced differentiation factor (Apoptosis-related protein 3) (APR-3) (p18),Homo sapiens (Human),32.0,203.0,1.6e-20,101.3,sp|Q6UW56|ARAID_HUMAN All-trans retinoic acid-induced differentiation factor OS=Homo sapiens OX=9606 GN=ATRAID PE=1 SV=2,GO:0005635; GO:0005765; GO:0005886; GO:0006855; GO:0010468; GO:0030154; GO:0030501; GO:0033689; GO:0042177; GO:0042910; GO:0043231; GO:0045669; GO:0048471,cell differentiation [GO:0030154]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]; xenobiotic transmembrane transport [GO:0006855],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005635; GO:0005886; GO:0030154; GO:0043226; GO:0055085,transporter activity; nuclear envelope; plasma membrane; cell differentiation; organelle; transmembrane transport
OG_01723,1.2529058803129325,FUN_007011-T1,Peve_00021642,Pocillopora_meandrina_HIv1___RNAseq.g20537.t1,three_way,77.91333333333333,FUN_007011-T1,Q9Y2L1,RRP44_HUMAN,,Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44),Homo sapiens (Human),56.1,547.0,7.1e-173,608.6,sp|Q9Y2L1|RRP44_HUMAN Exosome complex exonuclease RRP44 OS=Homo sapiens OX=9606 GN=DIS3 PE=1 SV=2,GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000288; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0016075; GO:0071031; GO:0071034,"CUT catabolic process [GO:0071034]; nuclear mRNA surveillance of mRNA 3'-end processing [GO:0071031]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]",cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0098772; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; mRNA metabolic process; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on RNA"
OG_01724,1.127935861151692,FUN_007013-T1,Peve_00021641,Pocillopora_meandrina_HIv1___RNAseq.g20538.t1,three_way,66.045,,,,,,,,,,,,,,,,,
OG_01728,3.496803678098737,FUN_007020-T1,Peve_00037180,Pocillopora_meandrina_HIv1___RNAseq.g20542.t1,three_way,63.67233333333333,FUN_007020-T1,Q6ZZY0,,,,,46.9,497.0,1.3e-139,499.6,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_01729,1.824328620128589,FUN_007023-T2,Peve_00032897,Pocillopora_meandrina_HIv1___RNAseq.g20021.t2,three_way,56.138,,,,,,,,,,,,,,,,,
OG_01734,1.284515244365435,FUN_007053-T1,Peve_00003800,Pocillopora_meandrina_HIv1___RNAseq.g20070.t1,three_way,78.94083333333333,FUN_007053-T1,Q8VDL9,GLIS2_MOUSE,,Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein) (Zinc finger protein GLI5),Mus musculus (Mouse),53.3,90.0,4.900000000000003e-22,107.1,sp|Q8VDL9|GLIS2_MOUSE Zinc finger protein GLIS2 OS=Mus musculus OX=10090 GN=Glis2 PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0001227; GO:0001228; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007399; GO:0008270; GO:0016607; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0061005; GO:0061484; GO:0097730; GO:1900182,cell differentiation involved in kidney development [GO:0061005]; hematopoietic stem cell homeostasis [GO:0061484]; kidney development [GO:0001822]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005929; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cilium; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01735,1.8116064490810009,FUN_007054-T1,Peve_00003799,Pocillopora_meandrina_HIv1___RNAseq.g20071.t1,three_way,78.438,FUN_007054-T1,Q01664,TFAP4_HUMAN,,Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41),Homo sapiens (Human),53.6,140.0,7.5e-27,122.5,sp|Q01664|TFAP4_HUMAN Transcription factor AP-4 OS=Homo sapiens OX=9606 GN=TFAP4 PE=1 SV=2,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008285; GO:0010629; GO:0017053; GO:0030330; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071549; GO:1901990; GO:1990837,"cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0043226; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; transcription regulator activity
OG_01736,1.3830600853497073,FUN_007055-T1,Peve_00003798,Pocillopora_meandrina_HIv1___RNAseq.g20072.t1,three_way,88.616,FUN_007055-T1,Q5SQX6,CYFP2_MOUSE,,Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121),Mus musculus (Mouse),61.2,1252.0,0.0,1540.4,sp|Q5SQX6|CYFP2_MOUSE Cytoplasmic FMR1-interacting protein 2 OS=Mus musculus OX=10090 GN=Cyfip2 PE=1 SV=2,GO:0005634; GO:0005737; GO:0006915; GO:0030833; GO:0031175; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0097484; GO:0098609; GO:0150052,apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202],small GTPase binding [GO:0031267],GO:0005634; GO:0007155; GO:0012501; GO:0043226,nucleus; cell adhesion; programmed cell death; organelle
OG_01739,1.2968951429523978,FUN_007060-T1,Peve_00022328,Pocillopora_meandrina_HIv1___TS.g29460.t1,three_way,77.21333333333334,FUN_007060-T1,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),28.9,308.0,3.5999999999999997e-35,150.6,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_01740,2.9008323622493584,FUN_007062-T1,Peve_00025326,Pocillopora_meandrina_HIv1___RNAseq.g20109.t1,three_way,70.79983333333334,FUN_007062-T1,Q8IX03,KIBRA_HUMAN,,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),Homo sapiens (Human),29.0,1136.0,8.3e-51,204.1,sp|Q8IX03|KIBRA_HUMAN Protein KIBRA OS=Homo sapiens OX=9606 GN=WWC1 PE=1 SV=1,GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0043410; GO:0046621; GO:0048471; GO:0060090,cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0007163; GO:0043226; GO:0048870; GO:0060090; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_01745,1.1492273188956517,FUN_007069-T1,Peve_00019900,Pocillopora_meandrina_HIv1___RNAseq.g20089.t1,three_way,62.687666666666665,,,,,,,,,,,,,,,,,
OG_01748,1.143160611089694,FUN_007075-T1,Peve_00019894,Pocillopora_meandrina_HIv1___RNAseq.g20079.t1,three_way,81.41866666666667,FUN_007075-T1,B2RQR8,ECE2_MOUSE,,Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71),Mus musculus (Mouse),39.7,685.0,3.2e-147,523.9,sp|B2RQR8|ECE2_MOUSE Endothelin-converting enzyme 2 OS=Mus musculus OX=10090 GN=Ece2 PE=1 SV=1,GO:0000139; GO:0004222; GO:0005802; GO:0016486; GO:0030658; GO:0046872,peptide hormone processing [GO:0016486],Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_01752,1.570246079587593,FUN_007092-T1,Peve_00019879,Pocillopora_meandrina_HIv1___RNAseq.g19058.t1,three_way,57.32516666666667,FUN_007092-T1,Q8CDI6,,,,,27.6,174.0,1.1e-07,61.2,sp|Q8CDI6|CD158_MOUSE Coiled-coil domain-containing protein 158 OS=Mus musculus OX=10090 GN=Ccdc158 PE=2 SV=1,,,,,,
OG_01757,1.10890678279364,FUN_007100-T1,Peve_00033790,Pocillopora_meandrina_HIv1___RNAseq.g19049.t1b,three_way,84.0445,FUN_007100-T1,O95714,HERC2_HUMAN,,E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2),Homo sapiens (Human),53.6,4960.0,0.0,4944.0,sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; plasma membrane; DNA repair; intracellular protein transport; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01778,1.516421922340861,FUN_007150-T1,Peve_00028250,Pocillopora_meandrina_HIv1___RNAseq.g19714.t1,three_way,81.34100000000001,FUN_007150-T1,Q96DB2,HDA11_HUMAN,,Histone deacetylase 11 (HD11) (EC 3.5.1.98),Homo sapiens (Human),63.6,319.0,6.7e-119,428.7,sp|Q96DB2|HDA11_HUMAN Histone deacetylase 11 OS=Homo sapiens OX=9606 GN=HDAC11 PE=1 SV=1,GO:0000118; GO:0004407; GO:0005634; GO:0005886; GO:0006325; GO:0040029; GO:0140297; GO:0141221,chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; chromatin organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01782,1.9607525689939256,FUN_007155-T1,Peve_00028244,Pocillopora_meandrina_HIv1___TS.g29111.t1,three_way,72.6365,FUN_007155-T1,Q9PT84,,,,,43.9,471.0,5.1e-99,363.6,sp|Q9PT84|KCNH6_CHICK Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Gallus gallus OX=9031 GN=KCNH6 PE=2 SV=2,,,,,,
OG_01788,1.6500916536380446,FUN_007166-T1,Peve_00042484,Pocillopora_meandrina_HIv1___RNAseq.g19745.t1,three_way,75.658,FUN_007166-T1,P57695,,,,,37.9,457.0,8.7e-76,285.8,sp|P57695|GLRA1_BOVIN Glycine receptor subunit alpha-1 OS=Bos taurus OX=9913 GN=GLRA1 PE=1 SV=1,,,,,,
OG_01789,1.1022241714642813,FUN_007169-T1,Peve_00026948,Pocillopora_meandrina_HIv1___RNAseq.g19749.t1,three_way,52.4205,FUN_007169-T1,P51587,BRCA2_HUMAN,,Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein),Homo sapiens (Human),31.1,1439.0,3.1e-152,542.3,sp|P51587|BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens OX=9606 GN=BRCA2 PE=1 SV=4,GO:0000152; GO:0000722; GO:0000724; GO:0000781; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0007141; GO:0007283; GO:0007420; GO:0008585; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030141; GO:0030330; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0042771; GO:0042802; GO:0043015; GO:0045893; GO:0045931; GO:0051298; GO:0070200; GO:0071425; GO:0071479; GO:0090398; GO:1990391; GO:1990426; GO:2000001,"brain development [GO:0007420]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of cytokinesis [GO:0032465]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA-templated transcription [GO:0006355]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]","BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; lateral element [GO:0000800]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]",gamma-tubulin binding [GO:0043015]; histone H3 acetyltransferase activity [GO:0010484]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006355; GO:0008092; GO:0016740; GO:0022414; GO:0031410; GO:0032200; GO:0043226; GO:0048856; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; DNA recombination; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; reproductive process; cytoplasmic vesicle; telomere organization; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on a protein"
OG_01791,1.473212617405766,FUN_007171-T1,Peve_00019731,Pocillopora_meandrina_HIv1___RNAseq.g19751.t1,three_way,75.6985,FUN_007171-T1,Q7ZW24,,,,,56.6,498.0,2e-160,567.4,"sp|Q7ZW24|ALG11_DANRE GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase OS=Danio rerio OX=7955 GN=alg11 PE=2 SV=2",,,,,,
OG_01795,1.1531781368485483,FUN_007180-T1,Peve_00042731,Pocillopora_meandrina_HIv1___RNAseq.g19780.t1,three_way,75.47366666666666,FUN_007180-T1,P95329,,,,,40.0,475.0,2.5e-97,357.5,sp|P95329|MASY_MYXXD Malate synthase OS=Myxococcus xanthus (strain DK1622) OX=246197 GN=mls PE=3 SV=2,,,,,,
OG_01808,1.0757635764937032,FUN_007607-T1,Peve_00034273,Pocillopora_meandrina_HIv1___RNAseq.g5809.t1,three_way,55.49466666666667,FUN_007607-T1,Q8R2S1,,,,,31.8,525.0,3.5e-63,245.0,sp|Q8R2S1|RPKL1_MOUSE Ribosomal protein S6 kinase-like 1 OS=Mus musculus OX=10090 GN=Rps6kl1 PE=1 SV=1,,,,,,
OG_01810,2.215441628191425,FUN_007645-T1,Peve_00034272,Pocillopora_meandrina_HIv1___RNAseq.g5810.t1,three_way,52.86483333333334,FUN_007645-T1,O16099,,,,,36.6,503.0,1.0000000000000001e-81,305.8,sp|O16099|MAL2_DROVI Maltase 2 OS=Drosophila virilis OX=7244 GN=Mal-B2 PE=3 SV=2,,,,,,
OG_01817,1.7505910913201193,FUN_007690-T1,Peve_00012973,Pocillopora_meandrina_HIv1___RNAseq.g18009.t1b,three_way,56.254666666666665,,,,,,,,,,,,,,,,,
OG_01820,1.0314160117515097,FUN_007693-T1,Peve_00026595,Pocillopora_meandrina_HIv1___RNAseq.g18006.t2,three_way,58.693666666666665,FUN_007693-T1,B0BM95,ACTMP_XENTR,,Actin maturation protease (EC 3.4.11.-) (Actin aminopeptidase ACTMAP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),38.7,261.0,1.1e-41,171.8,sp|B0BM95|ACTMP_XENTR Actin maturation protease OS=Xenopus tropicalis OX=8364 GN=actmap PE=2 SV=2,GO:0004239; GO:0005737; GO:0016485,protein processing [GO:0016485],cytoplasm [GO:0005737],initiator methionyl aminopeptidase activity [GO:0004239],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_01821,1.8696905838080835,FUN_007694-T1,Peve_00026596,Pocillopora_meandrina_HIv1___RNAseq.g18005.t1,three_way,80.34066666666666,FUN_007694-T1,Q9H307,,,,,52.2,274.0,2.5e-25,117.9,sp|Q9H307|PININ_HUMAN Pinin OS=Homo sapiens OX=9606 GN=PNN PE=1 SV=5,,,,,,
OG_01822,1.069288878030445,FUN_007695-T1,Peve_00026597,Pocillopora_meandrina_HIv1___RNAseq.g18003.t1,three_way,72.62466666666667,,,,,,,,,,,,,,,,,
OG_01825,1.0662647691026372,FUN_007699-T1,Peve_00030615,Pocillopora_meandrina_HIv1___RNAseq.g17995.t1,three_way,69.25383333333333,FUN_007699-T1,G3M4F8,,,,,26.0,315.0,2.5e-17,91.3,sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1,,,,,,
OG_01837,1.222417243111475,FUN_007773-T1,Peve_00036438,Pocillopora_meandrina_HIv1___RNAseq.g5836.t1,three_way,57.734,FUN_007773-T1,Q8JFW4,,,,,39.7,378.0,5.499999999999999e-63,243.0,sp|Q8JFW4|ADAT3_DANRE Probable inactive tRNA-specific adenosine deaminase-like protein 3 OS=Danio rerio OX=7955 GN=adat3 PE=2 SV=2,,,,,,
OG_01838,1.299609282471849,FUN_007775-T1,Peve_00032268,Pocillopora_meandrina_HIv1___TS.g24628.t2,three_way,66.44866666666667,FUN_007775-T1,Q9HAV4,XPO5_HUMAN,,Exportin-5 (Exp5) (Ran-binding protein 21),Homo sapiens (Human),34.6,1233.0,3.5e-196,687.2,sp|Q9HAV4|XPO5_HUMAN Exportin-5 OS=Homo sapiens OX=9606 GN=XPO5 PE=1 SV=1,GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1905172,miRNA metabolic process [GO:0010586]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565],mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0140104,RNA binding; nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular carrier activity
OG_01839,2.3626975642604555,FUN_007785-T1,Peve_00032269,Pocillopora_meandrina_HIv1___RNAseq.g5904.t3,three_way,77.73566666666667,FUN_007785-T1,Q7ZZC8,NEK9_XENLA,,Serine/threonine-protein kinase Nek9 (xNek9) (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9),Xenopus laevis (African clawed frog),45.7,637.0,6e-157,556.2,sp|Q7ZZC8|NEK9_XENLA Serine/threonine-protein kinase Nek9 OS=Xenopus laevis OX=8355 GN=nek9 PE=2 SV=1,GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310,cell division [GO:0051301]; mitotic cell cycle [GO:0000278],centrosome [GO:0005813]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005815; GO:0016740; GO:0098772; GO:0140096,"mitotic cell cycle; catalytic activity; microtubule organizing center; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01840,2.1273576044123947,FUN_007786-T1,Peve_00022059,Pocillopora_meandrina_HIv1___RNAseq.g5903.t1,three_way,66.8125,,,,,,,,,,,,,,,,,
OG_01843,1.2551113887950711,FUN_007789-T1,Peve_00022037,Pocillopora_meandrina_HIv1___RNAseq.g5900.t1,three_way,86.02133333333333,FUN_007789-T1,Q9NZ32,,,,,56.1,155.0,3.4e-44,179.5,sp|Q9NZ32|ARP10_HUMAN Actin-related protein 10 OS=Homo sapiens OX=9606 GN=ACTR10 PE=1 SV=1,,,,,,
OG_01844,1.6508845613293917,FUN_007790-T1,Peve_00022038,Pocillopora_meandrina_HIv1___RNAseq.g5899.t1,three_way,82.86166666666666,FUN_007790-T1,Q8R1Q9,,,,,56.1,305.0,1.3000000000000001e-89,331.3,sp|Q8R1Q9|RBSK_MOUSE Ribokinase OS=Mus musculus OX=10090 GN=Rbks PE=1 SV=1,,,,,,
OG_01845,1.726063890534011,FUN_007791-T1,Peve_00022040,Pocillopora_meandrina_HIv1___TS.g24621.t1,three_way,47.446,FUN_007791-T1,Q9UHC1,MLH3_HUMAN,,DNA mismatch repair protein Mlh3 (MutL protein homolog 3),Homo sapiens (Human),27.8,1446.0,1.3e-121,439.5,sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3,GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664,female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130],chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0043226; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; hydrolase activity; reproductive process; organelle; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01846,2.0184867231770425,FUN_007795-T1,Peve_00022050,Pocillopora_meandrina_HIv1___TS.g21334.t1,three_way,60.86366666666667,FUN_007795-T1,Q9NR09,BIRC6_HUMAN,,Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),Homo sapiens (Human),29.0,4083.0,0.0,1173.3,sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3,GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237,apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802],cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; nucleus; endosome; microtubule organizing center; cytosol; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01848,1.5815413245667014,FUN_007798-T1,Peve_00022052,Pocillopora_meandrina_HIv1___RNAseq.g18342.t1,three_way,82.26133333333333,FUN_007798-T1,Q9UGV2,,,,,42.5,325.0,1.2e-66,255.0,sp|Q9UGV2|NDRG3_HUMAN Protein NDRG3 OS=Homo sapiens OX=9606 GN=NDRG3 PE=1 SV=2,,,,,,
OG_01849,1.597433030547485,FUN_007799-T1,Peve_00022053,Pocillopora_meandrina_HIv1___RNAseq.g18341.t1,three_way,65.1245,FUN_007799-T1,Q9UHY8,FEZ2_HUMAN,,Fasciculation and elongation protein zeta-2 (Zygin II) (Zygin-2),Homo sapiens (Human),30.6,268.0,2e-21,104.8,sp|Q9UHY8|FEZ2_HUMAN Fasciculation and elongation protein zeta-2 OS=Homo sapiens OX=9606 GN=FEZ2 PE=1 SV=2,GO:0005737; GO:0007165; GO:0007399; GO:0007411; GO:0030424; GO:1902902,axon guidance [GO:0007411]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; signal transduction [GO:0007165],axon [GO:0030424]; cytoplasm [GO:0005737],,GO:0048856,anatomical structure development
OG_01851,1.0149705066555594,FUN_007801-T1,Peve_00022055,Pocillopora_meandrina_HIv1___RNAseq.g18338.t1,three_way,56.8715,,,,,,,,,,,,,,,,,
OG_01852,1.2086705968132088,FUN_007803-T2,Peve_00022056,Pocillopora_meandrina_HIv1___RNAseq.g18339.t1,three_way,75.05483333333333,FUN_007803-T2,Q96JM7,,,,,34.7,862.0,6.800000000000001e-134,479.9,sp|Q96JM7|LMBL3_HUMAN Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens OX=9606 GN=L3MBTL3 PE=1 SV=2,,,,,,
OG_01853,1.752595380269667,FUN_007804-T1,Peve_00022057,Pocillopora_meandrina_HIv1___RNAseq.g18346.t1,three_way,62.281666666666666,,,,,,,,,,,,,,,,,
OG_01862,1.1579730824570764,FUN_007821-T1,Peve_00038746,Pocillopora_meandrina_HIv1___RNAseq.g18388.t1,three_way,57.14966666666667,,,,,,,,,,,,,,,,,
OG_01863,2.244551105356524,FUN_007823-T1,Peve_00038744,Pocillopora_meandrina_HIv1___RNAseq.21899_t,three_way,75.6335,FUN_007823-T1,Q3U1V8,M3K9_MOUSE,,Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25),Mus musculus (Mouse),51.9,617.0,1.8999999999999998e-138,495.0,sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus OX=10090 GN=Map3k9 PE=2 SV=2,GO:0004709; GO:0005524; GO:0006915; GO:0106310,apoptotic process [GO:0006915],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_01866,1.5200425027842537,FUN_007832-T1,Peve_00003986,Pocillopora_meandrina_HIv1___RNAseq.g29997.t1,three_way,76.73700000000001,FUN_007832-T1,Q7Q107,,,,,61.9,202.0,2.9e-67,256.9,sp|Q7Q107|MED6_ANOGA Mediator of RNA polymerase II transcription subunit 6 OS=Anopheles gambiae OX=7165 GN=MED6 PE=3 SV=3,,,,,,
OG_01869,2.262173439315464,FUN_007836-T1,Peve_00019311,Pocillopora_meandrina_HIv1___RNAseq.g18432.t1a,three_way,61.774,FUN_007836-T1,E7FEV0,,,,,27.2,2195.0,1e-187,659.8,sp|E7FEV0|WDR81_DANRE WD repeat-containing protein 81 OS=Danio rerio OX=7955 GN=wdr81 PE=2 SV=1,,,,,,
OG_01870,1.037030813330465,FUN_007837-T1,Peve_00019310,Pocillopora_meandrina_HIv1___RNAseq.g18433.t1,three_way,78.51033333333334,FUN_007837-T1,Q1L9A2,OPA3_DANRE,,Optic atrophy 3 protein homolog,Danio rerio (Zebrafish) (Brachydanio rerio),48.6,148.0,5.8e-32,138.7,sp|Q1L9A2|OPA3_DANRE Optic atrophy 3 protein homolog OS=Danio rerio OX=7955 GN=opa3 PE=3 SV=1,GO:0005739; GO:0007626; GO:0019216; GO:0031413; GO:0050881,locomotory behavior [GO:0007626]; musculoskeletal movement [GO:0050881]; regulation of buoyancy [GO:0031413]; regulation of lipid metabolic process [GO:0019216],mitochondrion [GO:0005739],,GO:0005739; GO:0043226; GO:0050877,mitochondrion; organelle; nervous system process
OG_01873,1.0247130389815615,FUN_007842-T1,Peve_00040457,Pocillopora_meandrina_HIv1___RNAseq.21938_t,three_way,93.767,FUN_007842-T1,Q7SXL3,,,,,89.7,214.0,4.7e-92,339.0,sp|Q7SXL3|TBP_DANRE TATA-box-binding protein OS=Danio rerio OX=7955 GN=tbp PE=1 SV=1,,,,,,
OG_01874,1.9490641119227008,FUN_007846-T1,Peve_00014226,Pocillopora_meandrina_HIv1___RNAseq.g20393.t1,three_way,68.34366666666666,FUN_007846-T1,Q9TTR8,,,,,36.1,382.0,1.5e-58,228.4,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_01876,1.8249764803966992,FUN_007849-T1,Peve_00039898,Pocillopora_meandrina_HIv1___RNAseq.g18286.t1,three_way,90.37933333333334,FUN_007849-T1,O00470,MEIS1_HUMAN,,Homeobox protein Meis1,Homo sapiens (Human),58.7,349.0,4.1e-94,347.1,sp|O00470|MEIS1_HUMAN Homeobox protein Meis1 OS=Homo sapiens OX=9606 GN=MEIS1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001654; GO:0002089; GO:0003677; GO:0003682; GO:0005634; GO:0005667; GO:0007420; GO:0007626; GO:0008284; GO:0009880; GO:0009887; GO:0030097; GO:0035855; GO:0045638; GO:0045665; GO:0045944; GO:0060216; GO:0061049,angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell growth involved in cardiac muscle cell development [GO:0061049]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01877,1.2605260826662523,FUN_007850-T1,Peve_00021800,Pocillopora_meandrina_HIv1___RNAseq.g18287.t1,three_way,66.41766666666666,,,,,,,,,,,,,,,,,
OG_01880,1.964195344598176,FUN_007856-T1,Peve_00021797,Pocillopora_meandrina_HIv1___RNAseq.g18293.t1,three_way,48.038,,,,,,,,,,,,,,,,,
OG_01885,1.5610952386016888,FUN_007864-T1,Peve_00044449,Pocillopora_meandrina_HIv1___RNAseq.g18299.t1,three_way,76.96966666666667,FUN_007864-T1,Q96P50,,,,,44.0,209.0,1.4999999999999999e-40,169.5,"sp|Q96P50|ACAP3_HUMAN Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ACAP3 PE=1 SV=2",,,,,,
OG_01886,1.2005303643547294,FUN_007865-T1,Peve_00044450,Pocillopora_meandrina_HIv1___RNAseq.g18300.t1,three_way,55.03033333333333,,,,,,,,,,,,,,,,,
OG_01888,1.4544761780383986,FUN_007869-T1,Peve_00009888,Pocillopora_meandrina_HIv1___RNAseq.g18305.t1,three_way,80.55466666666666,,,,,,,,,,,,,,,,,
OG_01889,1.9858184021184824,FUN_007871-T1,Peve_00009886,Pocillopora_meandrina_HIv1___RNAseq.g18307.t1,three_way,66.36216666666667,FUN_007871-T1,Q13613,,,,,32.8,466.0,6.600000000000003e-60,234.2,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_01893,1.239325756306508,FUN_007891-T1,Peve_00009872,Pocillopora_meandrina_HIv1___RNAseq.g18248.t1,three_way,58.57216666666667,,,,,,,,,,,,,,,,,
OG_01895,1.706962695883822,FUN_007895-T1,Peve_00009865,Pocillopora_meandrina_HIv1___RNAseq.g18241.t1a,three_way,47.54166666666666,,,,,,,,,,,,,,,,,
OG_01896,1.395341491204202,FUN_007896-T1,Peve_00040697,Pocillopora_meandrina_HIv1___RNAseq.g30048.t1,three_way,77.057,FUN_007896-T1,Q96BY7,ATG2B_HUMAN,,Autophagy-related protein 2 homolog B,Homo sapiens (Human),38.0,2230.0,0.0,1251.9,sp|Q96BY7|ATG2B_HUMAN Autophagy-related protein 2 homolog B OS=Homo sapiens OX=9606 GN=ATG2B PE=1 SV=5,GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005783; GO:0005789; GO:0005811; GO:0032266; GO:0034045; GO:0034727; GO:0043231; GO:0043495; GO:0061709; GO:0061723; GO:0061908; GO:0120013,autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; phagophore [GO:0061908]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-membrane adaptor activity [GO:0043495],GO:0005215; GO:0005783; GO:0005811; GO:0005975; GO:0006091; GO:0006914; GO:0008289; GO:0043226; GO:0060090,transporter activity; endoplasmic reticulum; lipid droplet; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lipid binding; organelle; molecular adaptor activity
OG_01904,1.6803090460944023,FUN_007918-T1,Peve_00040674,Pocillopora_meandrina_HIv1___RNAseq.g30119.t1,three_way,52.329166666666666,FUN_007918-T1,Q9D6X6,,,,,34.3,289.0,4.4e-36,153.7,sp|Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musculus OX=10090 GN=Prss23 PE=2 SV=2,,,,,,
OG_01905,1.0807082372624832,FUN_007919-T1,Peve_00040675,Pocillopora_meandrina_HIv1___RNAseq.g30121.t1,three_way,90.73183333333331,FUN_007919-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),63.3,608.0,1.6e-207,724.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01906,1.0183651016860729,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),61.6,620.0,3.3e-199,697.6,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01906,1.0183651016860729,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),40.4,146.0,3.1999999999999997e-29,132.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01908,1.6135690505107014,FUN_007922-T1,Peve_00040679,Pocillopora_meandrina_HIv1___RNAseq.g30087.t1,three_way,86.508,FUN_007922-T1,Q4V7N3,,,,,63.6,162.0,2.0999999999999998e-55,216.9,sp|Q4V7N3|STYXA_XENLA Serine/threonine/tyrosine-interacting protein A OS=Xenopus laevis OX=8355 GN=styx-a PE=2 SV=1,,,,,,
OG_01911,2.171025900987692,FUN_007927-T1,Peve_00040689,Pocillopora_meandrina_HIv1___RNAseq.g18108.t1,three_way,68.03966666666666,FUN_007927-T1,Q10AZ7,GPA3_ORYSJ,,Protein GLUTELIN PRECURSOR ACCUMULATION 3,Oryza sativa subsp. japonica (Rice),24.2,194.0,2.9e-12,75.1,sp|Q10AZ7|GPA3_ORYSJ Protein GLUTELIN PRECURSOR ACCUMULATION 3 OS=Oryza sativa subsp. japonica OX=39947 GN=GPA3 PE=1 SV=1,GO:0000325; GO:0000326; GO:0005802; GO:0006886,intracellular protein transport [GO:0006886],plant-type vacuole [GO:0000325]; protein storage vacuole [GO:0000326]; trans-Golgi network [GO:0005802],,GO:0005773; GO:0006886; GO:0043226,vacuole; intracellular protein transport; organelle
OG_01912,1.404917906935231,FUN_007928-T1,Peve_00040690,Pocillopora_meandrina_HIv1___RNAseq.g18109.t1,three_way,62.142833333333336,,,,,,,,,,,,,,,,,
OG_01916,1.0102320655951365,FUN_007943-T1,Peve_00040696,Pocillopora_meandrina_HIv1___RNAseq.g18120.t1,three_way,83.53,FUN_007943-T1,Q9NW15,,,,,28.6,623.0,1.9e-60,235.3,sp|Q9NW15|ANO10_HUMAN Anoctamin-10 OS=Homo sapiens OX=9606 GN=ANO10 PE=1 SV=2,,,,,,
OG_01919,1.7197241183632237,FUN_007948-T1,Peve_00044442,Pocillopora_meandrina_HIv1___RNAseq.g18135.t1,three_way,64.81733333333334,FUN_007948-T1,Q3TTY0,PLB1_MOUSE,,"Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3)",Mus musculus (Mouse),39.7,345.0,6.200000000000003e-66,253.4,"sp|Q3TTY0|PLB1_MOUSE Phospholipase B1, membrane-associated OS=Mus musculus OX=10090 GN=Plb1 PE=1 SV=2",GO:0004622; GO:0004806; GO:0016324; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344,diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; positive regulation of acrosome reaction [GO:2000344]; triglyceride catabolic process [GO:0019433],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526],calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_01923,1.4895470537946207,FUN_007957-T1,Peve_00039189,Pocillopora_meandrina_HIv1___RNAseq.g30070.t1,three_way,65.248,FUN_007957-T1,P25703,,,,,42.9,403.0,6.099999999999999e-75,282.7,sp|P25703|BMP2A_XENLA Bone morphogenetic protein 2-A OS=Xenopus laevis OX=8355 GN=bmp2-a PE=2 SV=1,,,,,,
OG_01926,2.60778791724204,FUN_007963-T1,Peve_00030095,Pocillopora_meandrina_HIv1___RNAseq.g30028.t1,three_way,80.453,FUN_007963-T1,Q6PBN2,AIDA_DANRE,,"Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)",Danio rerio (Zebrafish) (Brachydanio rerio),45.6,307.0,7.1e-71,268.9,"sp|Q6PBN2|AIDA_DANRE Axin interactor, dorsalization-associated protein OS=Danio rerio OX=7955 GN=aida PE=1 SV=1",GO:0009953; GO:0016020; GO:0031333; GO:0035091; GO:0043508; GO:0046329; GO:0048264; GO:2000016,determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333],membrane [GO:0016020],phosphatidylinositol binding [GO:0035091],GO:0008289,lipid binding
OG_01927,1.7317898634079862,FUN_007964-T1,Peve_00030094,Pocillopora_meandrina_HIv1___RNAseq.g30026.t1,three_way,69.93233333333333,FUN_007964-T1,Q66HG4,,,,,48.8,281.0,1.6e-70,267.7,sp|Q66HG4|GALM_RAT Galactose mutarotase OS=Rattus norvegicus OX=10116 GN=Galm PE=1 SV=1,,,,,,
OG_01928,1.0910518906190054,FUN_007965-T1,Peve_00030093,Pocillopora_meandrina_HIv1___RNAseq.g30027.t1,three_way,56.10933333333333,,,,,,,,,,,,,,,,,
OG_01934,1.4666895124955135,FUN_007973-T1,Peve_00030074,Pocillopora_meandrina_HIv1___RNAseq.g30008.t1,three_way,60.6855,FUN_007973-T1,Q9TTK4,,,,,27.2,4160.0,0.0,1187.2,sp|Q9TTK4|LYST_BOVIN Lysosomal-trafficking regulator OS=Bos taurus OX=9913 GN=LYST PE=1 SV=1,,,,,,
OG_01935,1.1696700941336453,FUN_007976-T1,Peve_00040181,Pocillopora_meandrina_HIv1___RNAseq.g18173.t1,three_way,73.17483333333334,FUN_007976-T1,P14866,HNRPL_HUMAN,,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),Homo sapiens (Human),43.1,450.0,3.8e-87,323.6,sp|P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2,GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0016020; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0070062; GO:0097157; GO:1990904,"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; synapse [GO:0045202],mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_01938,1.0658341008946275,FUN_007980-T1,Peve_00040185,Pocillopora_meandrina_HIv1___RNAseq.g18169.t1,three_way,77.59366666666666,FUN_007980-T1,B6NXD5,BABA2_BRAFL,,BRISC and BRCA1-A complex member 2 (BRCA1-A complex subunit BRE) (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein),Branchiostoma floridae (Florida lancelet) (Amphioxus),43.6,381.0,4.2e-92,339.7,sp|B6NXD5|BABA2_BRAFL BRISC and BRCA1-A complex member 2 OS=Branchiostoma floridae OX=7739 GN=BABAM2 PE=3 SV=1,GO:0005634; GO:0005737; GO:0006302; GO:0006325; GO:0006915; GO:0007095; GO:0010212; GO:0031593; GO:0045739; GO:0051301; GO:0070531; GO:0070552,apoptotic process [GO:0006915]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212],BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634],polyubiquitin modification-dependent protein binding [GO:0031593],GO:0005634; GO:0006281; GO:0006325; GO:0012501; GO:0043226,nucleus; DNA repair; chromatin organization; programmed cell death; organelle
OG_01939,1.8513101915350751,FUN_007981-T1,Peve_00040186,Pocillopora_meandrina_HIv1___RNAseq.g18168.t2,three_way,61.64066666666667,FUN_007981-T1,Q8CIF6,SIDT2_MOUSE,,SID1 transmembrane family member 2,Mus musculus (Mouse),26.6,418.0,4.3999999999999995e-25,118.2,sp|Q8CIF6|SIDT2_MOUSE SID1 transmembrane family member 2 OS=Mus musculus OX=10090 GN=Sidt2 PE=1 SV=1,GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0061178,cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032],GO:0003677; GO:0003723; GO:0005215; GO:0005764; GO:0005773; GO:0005886; GO:0043226; GO:0048856,DNA binding; RNA binding; transporter activity; lysosome; vacuole; plasma membrane; organelle; anatomical structure development
OG_01941,3.165839627206812,FUN_007993-T1,Peve_00018053,Pocillopora_meandrina_HIv1___RNAseq.g5090.t1,three_way,42.72566666666666,FUN_007993-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),25.9,587.0,7.1e-39,163.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_01942,2.72992294814377,FUN_007995-T1,Peve_00018055,Pocillopora_meandrina_HIv1___RNAseq.g18162.t1,three_way,60.7,FUN_007995-T1,Q13308,,,,,32.5,1058.0,5.8e-147,523.5,sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,,,,,,
OG_01946,1.2281106802659312,FUN_008001-T1,Peve_00006650,Pocillopora_meandrina_HIv1___TS.g21139.t2b,three_way,61.92966666666666,FUN_008001-T1,Q8IWY9,CDAN1_HUMAN,,Codanin-1,Homo sapiens (Human),30.4,1310.0,1.6e-117,426.0,sp|Q8IWY9|CDAN1_HUMAN Codanin-1 OS=Homo sapiens OX=9606 GN=CDAN1 PE=1 SV=4,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0008104; GO:0012505; GO:0051170,chromatin organization [GO:0006325]; import into nucleus [GO:0051170]; protein localization [GO:0008104],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005829; GO:0005886; GO:0006325; GO:0006913; GO:0043226,nucleus; cytosol; plasma membrane; chromatin organization; nucleocytoplasmic transport; organelle
OG_01951,1.6283488782207949,FUN_008016-T1,Peve_00031315,Pocillopora_meandrina_HIv1___RNAseq.g30338.t1,three_way,69.895,FUN_008016-T1,Q6GYQ0,RGPA1_HUMAN,,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),Homo sapiens (Human),36.5,2122.0,0.0,1175.6,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630,activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; nucleus [GO:0005634],GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_01954,2.0201504254368863,FUN_008020-T1,Peve_00031302,Pocillopora_meandrina_HIv1___RNAseq.g30341.t1,three_way,85.20216666666667,FUN_008020-T1,P27448,MARK3_HUMAN,,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),Homo sapiens (Human),52.2,826.0,3.2000000000000005e-201,703.4,sp|P27448|MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens OX=9606 GN=MARK3 PE=1 SV=5,GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0048156; GO:0050321; GO:0070062; GO:0106310; GO:1900181,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005829; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01957,1.928424234623408,FUN_008025-T1,Peve_00011341,Pocillopora_meandrina_HIv1___RNAseq.g30350.t1,three_way,62.04266666666667,,,,,,,,,,,,,,,,,
OG_01963,1.187035436024739,FUN_008046-T1,Peve_00045145,Pocillopora_meandrina_HIv1___RNAseq.g30363.t1,three_way,54.59633333333333,,,,,,,,,,,,,,,,,
OG_01964,1.1159716274436602,FUN_008047-T1,Peve_00045146,Pocillopora_meandrina_HIv1___RNAseq.g30362.t2,three_way,56.651333333333326,,,,,,,,,,,,,,,,,
OG_01966,2.154605193555794,FUN_008049-T1,Peve_00045150,Pocillopora_meandrina_HIv1___RNAseq.g30360.t1,three_way,52.505,,,,,,,,,,,,,,,,,
OG_01968,1.3275165294457156,FUN_008058-T1,Peve_00017188,Pocillopora_meandrina_HIv1___RNAseq.g17900.t1,three_way,70.506,FUN_008058-T1,Q8AWD2,MOCS3_DANRE,,Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)],Danio rerio (Zebrafish) (Brachydanio rerio),53.7,492.0,1e-135,485.0,sp|Q8AWD2|MOCS3_DANRE Adenylyltransferase and sulfurtransferase MOCS3 OS=Danio rerio OX=7955 GN=mocs3 PE=2 SV=1,GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605,Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292],GO:0003824; GO:0005829; GO:0006399; GO:0016740; GO:0016874; GO:0140096; GO:0140657,"catalytic activity; cytosol; tRNA metabolic process; transferase activity; ligase activity; catalytic activity, acting on a protein; ATP-dependent activity"
OG_01969,1.89021784874205,FUN_008060-T1,Peve_00017191,Pocillopora_meandrina_HIv1___RNAseq.g17907.t1,three_way,77.13,,,,,,,,,,,,,,,,,
OG_01974,1.028349162698993,FUN_008079-T1,Peve_00041217,Pocillopora_meandrina_HIv1___RNAseq.g30082.t1,three_way,88.34400000000001,FUN_008079-T1,Q9Z2Q4,,,,,69.2,1253.0,0.0,1754.2,sp|Q9Z2Q4|METH_RAT Methionine synthase OS=Rattus norvegicus OX=10116 GN=Mtr PE=1 SV=1,,,,,,
OG_01982,1.0163432748243135,FUN_008090-T1,Peve_00033656,Pocillopora_meandrina_HIv1___RNAseq.g30101.t1,three_way,80.22983333333333,FUN_008090-T1,P58405,STRN3_RAT,,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),Rattus norvegicus (Rat),44.9,824.0,2.0999999999999996e-171,604.4,sp|P58405|STRN3_RAT Striatin-3 OS=Rattus norvegicus OX=10116 GN=Strn3 PE=1 SV=2,GO:0005516; GO:0005654; GO:0005794; GO:0005886; GO:0019901; GO:0030425; GO:0030674; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0035331; GO:0043025; GO:0044877; GO:0045892; GO:0051721; GO:0070016; GO:0090443; GO:0098794,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; response to estradiol [GO:0032355],dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0043226; GO:0060090,nucleoplasm; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_01985,1.0710209412658651,FUN_008093-T1,Peve_00038989,Pocillopora_meandrina_HIv1___RNAseq.g30098.t1,three_way,63.867666666666665,FUN_008093-T1,Q8BGQ1,SPE39_MOUSE,,Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction),Mus musculus (Mouse),38.4,385.0,1.5e-67,258.8,sp|Q8BGQ1|SPE39_MOUSE Spermatogenesis-defective protein 39 homolog OS=Mus musculus OX=10090 GN=Vipas39 PE=1 SV=1,GO:0005737; GO:0005769; GO:0005770; GO:0005794; GO:0006886; GO:0007283; GO:0008333; GO:0030154; GO:0030199; GO:0032963; GO:0043687; GO:0044877; GO:0055037; GO:0099023,cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023],protein-containing complex binding [GO:0044877],GO:0005768; GO:0005794; GO:0006886; GO:0016192; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle
OG_01990,1.351388833574416,FUN_008098-T1,Peve_00038884,Pocillopora_meandrina_HIv1___RNAseq.g30141.t1,three_way,74.036,FUN_008098-T1,Q9NQC3,RTN4_HUMAN,,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),Homo sapiens (Human),38.9,190.0,1.3e-26,121.7,sp|Q9NQC3|RTN4_HUMAN Reticulon-4 OS=Homo sapiens OX=9606 GN=RTN4 PE=1 SV=2,GO:0001825; GO:0002523; GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0007029; GO:0007413; GO:0007420; GO:0010634; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030182; GO:0030308; GO:0030334; GO:0030517; GO:0031625; GO:0033601; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042981; GO:0043005; GO:0043025; GO:0045202; GO:0045296; GO:0045766; GO:0046872; GO:0050804; GO:0050821; GO:0051292; GO:0051897; GO:0060317; GO:0060907; GO:0061462; GO:0070161; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0098978; GO:0120078; GO:0150052; GO:1902430; GO:1902624; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1990809; GO:2000172; GO:2000347; GO:2001213,apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; brain development [GO:0007420]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; intracellular sphingolipid homeostasis [GO:0090156]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; neuron differentiation [GO:0030182]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]; regulation of postsynapse assembly [GO:0150052],anchoring junction [GO:0070161]; cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0003723; GO:0005635; GO:0005783; GO:0005886; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0061024; GO:0065003,immune system process; RNA binding; nuclear envelope; endoplasmic reticulum; plasma membrane; cell adhesion; programmed cell death; cell differentiation; organelle; anatomical structure development; cell motility; membrane organization; protein-containing complex assembly
OG_01992,1.3612402245357187,FUN_008100-T1,Peve_00038880,Pocillopora_meandrina_HIv1___RNAseq.g30139.t1,three_way,44.18833333333333,,,,,,,,,,,,,,,,,
OG_01994,2.1313054448692337,FUN_008103-T1,Peve_00017193,Pocillopora_meandrina_HIv1___RNAseq.g17899.t1,three_way,61.52516666666666,FUN_008103-T1,Q3T1I9,,,,,33.8,1354.0,5.6000000000000005e-182,640.2,sp|Q3T1I9|RPAP1_RAT RNA polymerase II-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Rpap1 PE=1 SV=1,,,,,,
OG_01996,1.948212224734472,FUN_008107-T1,Peve_00019589,Pocillopora_meandrina_HIv1___RNAseq.21377_t,three_way,82.86116666666668,FUN_008107-T1,Q2PFW9,,,,,36.0,458.0,2.5000000000000002e-58,227.6,sp|Q2PFW9|NOVA1_MACFA RNA-binding protein Nova-1 OS=Macaca fascicularis OX=9541 GN=NOVA1 PE=2 SV=1,,,,,,
OG_01997,1.2482541729428211,FUN_008108-T1,Peve_00019590,Pocillopora_meandrina_HIv1___RNAseq.g17896.t1,three_way,76.08733333333333,FUN_008108-T1,P31669,,,,,54.0,985.0,1.6999999999999996e-286,986.9,sp|P31669|PARP1_XENLA Poly [ADP-ribose] polymerase 1 (Fragment) OS=Xenopus laevis OX=8355 GN=parp1 PE=2 SV=1,,,,,,
OG_01999,1.5390769062876364,FUN_008110-T1,Peve_00006537,Pocillopora_meandrina_HIv1___RNAseq.g17894.t1,three_way,57.97233333333333,FUN_008110-T1,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),34.8,310.0,1.3e-45,187.2,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_02000,2.809689925852242,FUN_008111-T1,Peve_00022340,Pocillopora_meandrina_HIv1___RNAseq.g17893.t1,three_way,53.2585,FUN_008111-T1,B3EWY9,,,,,33.3,1402.0,3.9e-139,498.4,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02003,1.4231810085292054,FUN_008117-T1,Peve_00022344,Pocillopora_meandrina_HIv1___RNAseq.21365_t,three_way,73.45166666666667,FUN_008117-T1,Q08DJ7,,,,,45.6,215.0,1.3000000000000002e-44,181.0,sp|Q08DJ7|AAR2_BOVIN Protein AAR2 homolog OS=Bos taurus OX=9913 GN=AAR2 PE=2 SV=1,,,,,,
OG_02004,2.256433365477644,FUN_008119-T1,Peve_00022345,Pocillopora_meandrina_HIv1___RNAseq.g17886.t1,three_way,94.39433333333334,,,,,,,,,,,,,,,,,
OG_02007,1.18044755636578,FUN_008122-T1,Peve_00022348,Pocillopora_meandrina_HIv1___RNAseq.g17883.t1,three_way,77.1465,FUN_008122-T1,Q8R4P9,MRP7_MOUSE,,ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7),Mus musculus (Mouse),49.7,1236.0,0.0,1107.0,sp|Q8R4P9|MRP7_MOUSE ATP-binding cassette sub-family C member 10 OS=Mus musculus OX=10090 GN=Abcc10 PE=1 SV=1,GO:0005524; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0016323; GO:0016887; GO:0071716; GO:0140359,leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869],basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323],ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0016787; GO:0140657,catalytic activity; transporter activity; hydrolase activity; ATP-dependent activity
OG_02015,1.3924884083521425,FUN_008188-T1,Peve_00010859,Pocillopora_meandrina_HIv1___RNAseq.g29996.t1,three_way,81.78566666666667,FUN_008188-T1,Q99NB1,ACS2L_MOUSE,,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)",Mus musculus (Mouse),62.1,612.0,1.7e-229,797.0,"sp|Q99NB1|ACS2L_MOUSE Acetyl-coenzyme A synthetase 2-like, mitochondrial OS=Mus musculus OX=10090 GN=Acss1 PE=1 SV=1",GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218,acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0005739; GO:0006629; GO:0006790; GO:0016874; GO:0043226; GO:0055086; GO:0140657,catalytic activity; mitochondrion; lipid metabolic process; sulfur compound metabolic process; ligase activity; organelle; nucleobase-containing small molecule metabolic process; ATP-dependent activity
OG_02017,1.0848789232201317,FUN_008194-T1,Peve_00022158,Pocillopora_meandrina_HIv1___RNAseq.g30170.t1,three_way,74.29066666666667,FUN_008194-T1,Q99538,LGMN_HUMAN,,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (AEP) (Protease, cysteine 1)",Homo sapiens (Human),62.9,280.0,2.7e-100,366.7,sp|Q99538|LGMN_HUMAN Legumain OS=Homo sapiens OX=9606 GN=LGMN PE=1 SV=1,GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0019886; GO:0032801; GO:0035729; GO:0036021; GO:0040015; GO:0042359; GO:0043202; GO:0043524; GO:0045177; GO:0045931; GO:0048156; GO:0048471; GO:0051603; GO:0051604; GO:0061133; GO:0070062; GO:0071277; GO:0090026; GO:0097061; GO:1900273; GO:1901185; GO:1904646; GO:2001028,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156],GO:0002376; GO:0003014; GO:0003824; GO:0005576; GO:0005764; GO:0005768; GO:0005773; GO:0006629; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0050877; GO:0051604; GO:0098772; GO:0140096,"immune system process; renal system process; catalytic activity; extracellular region; lysosome; endosome; vacuole; lipid metabolic process; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; nervous system process; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02024,1.556108919075319,FUN_008214-T1,Peve_00005268,Pocillopora_meandrina_HIv1___RNAseq.g30183.t1,three_way,49.18816666666667,FUN_008214-T1,A0A8J1LLF7,DICRS_XENLA,,Endoribonuclease Dicer-S (EC 3.1.26.3),Xenopus laevis (African clawed frog),28.8,2019.0,7.3e-172,607.1,sp|A0A8J1LLF7|DICRS_XENLA Endoribonuclease Dicer-S OS=Xenopus laevis OX=8355 GN=dicer1.S PE=3 SV=1,GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0030422; GO:0031054; GO:0070578,apoptotic DNA fragmentation [GO:0006309]; pre-miRNA processing [GO:0031054]; siRNA processing [GO:0030422],cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578],ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02031,2.3116735673577664,FUN_008232-T1,Peve_00039956,Pocillopora_meandrina_HIv1___RNAseq.g30199.t1,three_way,66.05233333333334,FUN_008232-T1,Q6DC37,,,,,28.3,304.0,4e-22,107.1,sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1,,,,,,
OG_02032,1.0827194328481886,FUN_008233-T1,Peve_00039958,Pocillopora_meandrina_HIv1___RNAseq.21398_t,three_way,65.03,FUN_008233-T1,Q90964,FOXG1_CHICK,,Forkhead box protein G1 (FoxG1) (Brain factor 1) (BF-1) (BF1) (cBF-1) (CEQ 3-1) (Forkhead-related protein FKHL1) (N-62-5) (Proto-oncogene C-QIN),Gallus gallus (Chicken),61.5,187.0,2.1999999999999997e-53,211.1,sp|Q90964|FOXG1_CHICK Forkhead box protein G1 OS=Gallus gallus OX=9031 GN=FOXG1 PE=2 SV=1,GO:0000122; GO:0002052; GO:0003700; GO:0005634; GO:0006357; GO:0007346; GO:0007405; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0045665; GO:0045666; GO:0045787; GO:0048664; GO:1990837,axon midline choice point recognition [GO:0016199]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; sequence-specific double-stranded DNA binding [GO:1990837],GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cell motility; transcription regulator activity
OG_02036,1.0185463118926288,FUN_008238-T1,Peve_00003880,Pocillopora_meandrina_HIv1___RNAseq.g17929.t1,three_way,69.81566666666667,FUN_008238-T1,Q8R2K4,TAF6L_MOUSE,,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha),Mus musculus (Mouse),43.2,472.0,5.600000000000001e-89,330.1,sp|Q8R2K4|TAF6L_MOUSE TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L OS=Mus musculus OX=10090 GN=Taf6l PE=1 SV=1,GO:0000124; GO:0005634; GO:0005669; GO:0006282; GO:0006355; GO:0006367; GO:0016251; GO:0043484; GO:0045893; GO:0046695; GO:0046982; GO:1904672,positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; transcription initiation at RNA polymerase II promoter [GO:0006367],nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669],protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0005634; GO:0006355; GO:0043226; GO:0140223,nucleus; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_02043,2.5479737430668656,FUN_008248-T1,Peve_00031792,Pocillopora_meandrina_HIv1___RNAseq.g17952.t2,three_way,55.662,FUN_008248-T1,P83618,,,,,25.9,185.0,9.7e-14,78.6,sp|P83618|RN28_PANGI Ribonuclease-like storage protein OS=Panax ginseng OX=4054 PE=1 SV=2,,,,,,
OG_02049,2.343819844010692,FUN_008259-T1,Peve_00042075,Pocillopora_meandrina_HIv1___RNAseq.g17963.t1,three_way,74.48566666666667,FUN_008259-T1,O88559,MEN1_MOUSE,,Menin,Mus musculus (Mouse),42.6,599.0,3.6e-116,420.2,sp|O88559|MEN1_MOUSE Menin OS=Mus musculus OX=10090 GN=Men1 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000976; GO:0001216; GO:0001503; GO:0001776; GO:0002051; GO:0002076; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006338; GO:0008283; GO:0008285; GO:0010468; GO:0010628; GO:0017053; GO:0030097; GO:0035097; GO:0035265; GO:0043565; GO:0044342; GO:0044346; GO:0045668; GO:0045669; GO:0045815; GO:0045893; GO:0045944; GO:0046621; GO:0048144; GO:0048147; GO:0048704; GO:0048863; GO:0051301; GO:0051781; GO:0060021; GO:0060135; GO:0072089; GO:1904691; GO:2000045; GO:2000271; GO:2000647; GO:2000738,cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; embryonic skeletal system morphogenesis [GO:0048704]; fibroblast apoptotic process [GO:0044346]; fibroblast proliferation [GO:0048144]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; organ growth [GO:0035265]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of cell division [GO:0051781]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription initiation-coupled chromatin remodeling [GO:0045815]; type B pancreatic cell proliferation [GO:0044342],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976],GO:0002376; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02055,1.3312380149348693,FUN_008266-T1,Peve_00000650,Pocillopora_meandrina_HIv1___RNAseq.g17976.t1,three_way,56.130833333333335,FUN_008266-T1,Q64LD2,WDR25_HUMAN,,WD repeat-containing protein 25,Homo sapiens (Human),42.7,309.0,5.1e-77,290.0,sp|Q64LD2|WDR25_HUMAN WD repeat-containing protein 25 OS=Homo sapiens OX=9606 GN=WDR25 PE=1 SV=3,,,,,,
OG_02058,2.1688763944442715,FUN_008272-T1,Peve_00001961,Pocillopora_meandrina_HIv1___RNAseq.g17980.t1,three_way,78.47733333333333,FUN_008272-T1,P55807,,,,,29.5,237.0,2.9e-15,84.7,sp|P55807|NRT2_CHICK NAD(P)(+)--arginine ADP-ribosyltransferase 2 OS=Gallus gallus OX=9031 PE=2 SV=1,,,,,,
OG_02067,2.399250852973947,FUN_008281-T1,Peve_00001962,Pocillopora_meandrina_HIv1___RNAseq.g17989.t1,three_way,70.79683333333334,,,,,,,,,,,,,,,,,
OG_02068,1.2016939009302432,FUN_008282-T1,Peve_00022943,Pocillopora_meandrina_HIv1___RNAseq.g17990.t1,three_way,61.2045,FUN_008282-T1,A0A974H8H3,DICRL_XENLA,,Endoribonuclease Dicer-L (EC 3.1.26.3),Xenopus laevis (African clawed frog),31.1,1891.0,3.0000000000000003e-224,780.8,sp|A0A974H8H3|DICRL_XENLA Endoribonuclease Dicer-L OS=Xenopus laevis OX=8355 GN=dicer1.L PE=2 SV=1,GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0030422; GO:0031054; GO:0070578,apoptotic DNA fragmentation [GO:0006309]; pre-miRNA processing [GO:0031054]; siRNA processing [GO:0030422],cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578],ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02069,1.2028041029260297,FUN_008283-T1,Peve_00038050,Pocillopora_meandrina_HIv1___RNAseq.g17993.t1,three_way,71.20333333333333,FUN_008283-T1,Q6P158,DHX57_HUMAN,,Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57),Homo sapiens (Human),45.4,1347.0,2.2e-308,1060.1,sp|Q6P158|DHX57_HUMAN Putative ATP-dependent RNA helicase DHX57 OS=Homo sapiens OX=9606 GN=DHX57 PE=1 SV=2,GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0008270; GO:0016887,,,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016787; GO:0016853; GO:0140098; GO:0140657,"RNA binding; catalytic activity; hydrolase activity; isomerase activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02074,1.532331415986821,FUN_008290-T1,Peve_00018505,Pocillopora_meandrina_HIv1___RNAseq.g18018.t1,three_way,70.76516666666666,FUN_008290-T1,Q5PRF9,SMAG2_HUMAN,,Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B),Homo sapiens (Human),32.0,719.0,1.7e-72,275.4,sp|Q5PRF9|SMAG2_HUMAN Protein Smaug homolog 2 OS=Homo sapiens OX=9606 GN=SAMD4B PE=1 SV=1,GO:0000289; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0030371,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289],cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0045182,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; translation regulator activity
OG_02090,4.582629554619443,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02091,1.579630238974889,FUN_008329-T1,Peve_00007606,Pocillopora_meandrina_HIv1___RNAseq.g5444.t1,three_way,68.1515,FUN_008329-T1,Q80TN7,NAV3_MOUSE,,Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1),Mus musculus (Mouse),34.7,101.0,5e-13,78.2,sp|Q80TN7|NAV3_MOUSE Neuron navigator 3 OS=Mus musculus OX=10090 GN=Nav3 PE=1 SV=2,GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0016887; GO:0022008,neurogenesis [GO:0022008],nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005634; GO:0005635; GO:0016787; GO:0030154; GO:0043226,catalytic activity; nucleus; nuclear envelope; hydrolase activity; cell differentiation; organelle
OG_02092,1.514249199111638,FUN_008331-T3,Peve_00007611,Pocillopora_meandrina_HIv1___RNAseq.g5441.t1,three_way,61.8445,FUN_008331-T3,O15040,TCPR2_HUMAN,,Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297),Homo sapiens (Human),24.6,1344.0,7.3e-81,304.3,sp|O15040|TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=TECPR2 PE=1 SV=4,GO:0005737; GO:0006914; GO:0032527,autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527],cytoplasm [GO:0005737],,GO:0006886; GO:0006914,intracellular protein transport; autophagy
OG_02095,1.5734624996429742,FUN_008367-T1,Peve_00014479,Pocillopora_meandrina_HIv1___RNAseq.g5715.t1,three_way,60.782,FUN_008367-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),21.4,1717.0,2.7e-72,276.6,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02098,1.2397266090335646,FUN_008370-T1,Peve_00007056,Pocillopora_meandrina_HIv1___RNAseq.g5701.t1,three_way,69.50716666666666,FUN_008370-T1,F1QCP6,TAZ_DANRE,,Tafazzin (Taz) (EC 2.3.1.-),Danio rerio (Zebrafish) (Brachydanio rerio),48.6,220.0,8.700000000000001e-58,226.1,sp|F1QCP6|TAZ_DANRE Tafazzin OS=Danio rerio OX=7955 GN=tafazzin PE=2 SV=1,GO:0001947; GO:0005739; GO:0005741; GO:0005743; GO:0007007; GO:0007507; GO:0031966; GO:0035965; GO:0045823; GO:0047184,cardiolipin acyl-chain remodeling [GO:0035965]; heart development [GO:0007507]; heart looping [GO:0001947]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of heart contraction [GO:0045823],mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184],GO:0003824; GO:0005739; GO:0006629; GO:0007005; GO:0016740; GO:0043226; GO:0048856; GO:0061024,catalytic activity; mitochondrion; lipid metabolic process; mitochondrion organization; transferase activity; organelle; anatomical structure development; membrane organization
OG_02101,2.9338168655162127,FUN_008377-T1,Peve_00024686,Pocillopora_meandrina_HIv1___RNAseq.g18396.t1,three_way,53.3375,,,,,,,,,,,,,,,,,
OG_02102,1.1776800572955854,FUN_008381-T1,Peve_00002115,Pocillopora_meandrina_HIv1___RNAseq.g18435.t2,three_way,41.09916666666667,FUN_008381-T1,Q8IW19,APLF_HUMAN,,Aprataxin and PNK-like factor (EC 3.1.-.-) (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1),Homo sapiens (Human),30.1,522.0,2.7e-22,109.0,sp|Q8IW19|APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens OX=9606 GN=APLF PE=1 SV=1,GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006974; GO:0007566; GO:0008270; GO:0008408; GO:0010717; GO:0035861; GO:0042393; GO:0044183; GO:0045191; GO:0071168; GO:0072572; GO:0090734; GO:0140713; GO:0140861; GO:0160002,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryo implantation [GO:0007566]; protein localization to chromatin [GO:0071168]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861],3'-5' exonuclease activity [GO:0008408]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose binding [GO:0072572]; protein folding chaperone [GO:0044183]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006325; GO:0016787; GO:0022414; GO:0042393; GO:0043226; GO:0044183; GO:0140097; GO:0140104,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; chromatin organization; hydrolase activity; reproductive process; histone binding; organelle; protein folding chaperone; catalytic activity, acting on DNA; molecular carrier activity"
OG_02103,1.8380280162984164,FUN_008382-T1,Peve_00002119,Pocillopora_meandrina_HIv1___TS.g21432.t1,three_way,43.963,FUN_008382-T1,Q9Y3Q0,NALD2_HUMAN,,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),Homo sapiens (Human),31.3,747.0,3.3999999999999998e-68,261.2,sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129,carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508],membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_02107,1.0554442018041486,FUN_008390-T1,Peve_00028171,Pocillopora_meandrina_HIv1___RNAseq.12433_t,three_way,87.16266666666667,FUN_008390-T1,Q54BM3,,,,,41.3,300.0,1.1e-64,248.4,sp|Q54BM3|MCFG_DICDI Mitochondrial substrate carrier family protein G OS=Dictyostelium discoideum OX=44689 GN=mcfG PE=2 SV=1,,,,,,
OG_02114,1.5390672323724253,FUN_008399-T1,Peve_00043600,Pocillopora_meandrina_HIv1___RNAseq.g6181.t1,three_way,83.61133333333333,FUN_008399-T1,P41823,,,,,35.0,300.0,9.3e-43,176.4,sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2,,,,,,
OG_02121,1.120270549422178,FUN_008408-T1,Peve_00031489,Pocillopora_meandrina_HIv1___RNAseq.g18028.t1,three_way,87.17083333333333,FUN_008408-T1,Q3B7D2,SPTC2_RAT,,Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Serine-palmitoyl-CoA transferase 2) (SPT 2),Rattus norvegicus (Rat),68.8,487.0,1.2999999999999998e-198,694.1,sp|Q3B7D2|SPTC2_RAT Serine palmitoyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Sptlc2 PE=1 SV=1,GO:0004758; GO:0005789; GO:0006686; GO:0017059; GO:0030148; GO:0030170; GO:0035902; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504,adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; response to immobilization stress [GO:0035902]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0006629; GO:0016740; GO:0048856,catalytic activity; lipid metabolic process; transferase activity; anatomical structure development
OG_02122,1.0381453984398172,FUN_008415-T1,Peve_00015094,Pocillopora_meandrina_HIv1___RNAseq.g18042.t1,three_way,72.59683333333334,FUN_008415-T1,Q9H2M9,RBGPR_HUMAN,,Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit),Homo sapiens (Human),37.2,1459.0,3.6999999999999996e-242,840.1,sp|Q9H2M9|RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP2 PE=1 SV=1,GO:0005096; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0016236; GO:0030234; GO:0031267; GO:0032991; GO:0042734; GO:0043087; GO:0097051; GO:0099536; GO:1903061; GO:1903373; GO:2000786,establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]; synaptic signaling [GO:0099536],autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991],enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0023052; GO:0043226; GO:0098772,vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; signaling; organelle; molecular function regulator activity
OG_02124,1.3345345530926374,FUN_008418-T1,Peve_00009794,Pocillopora_meandrina_HIv1___RNAseq.g18045.t1,three_way,95.60633333333334,FUN_008418-T1,P53488,,,,,89.1,359.0,1.2e-192,673.7,sp|P53488|ARP2_CHICK Actin-related protein 2 OS=Gallus gallus OX=9031 GN=ACTR2 PE=2 SV=1,,,,,,
OG_02132,1.551981980090166,FUN_008436-T1,Peve_00003898,Pocillopora_meandrina_HIv1___RNAseq.g18055.t1,three_way,83.60333333333334,FUN_008436-T1,Q07889,SOS1_HUMAN,,Son of sevenless homolog 1 (SOS-1),Homo sapiens (Human),56.7,1047.0,0.0,1162.9,sp|Q07889|SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens OX=9606 GN=SOS1 PE=1 SV=1,GO:0001782; GO:0001942; GO:0002931; GO:0003209; GO:0003344; GO:0005085; GO:0005096; GO:0005154; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0008543; GO:0014044; GO:0014069; GO:0017124; GO:0019221; GO:0019901; GO:0033081; GO:0035264; GO:0038095; GO:0042110; GO:0042127; GO:0042129; GO:0042552; GO:0043025; GO:0045742; GO:0046982; GO:0048009; GO:0048011; GO:0048514; GO:0050853; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:0098978; GO:0140693; GO:1904693; GO:1905360; GO:2000973,axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vitellogenesis [GO:0007296],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular condensate scaffold activity [GO:0140693]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],GO:0002376; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0098772,immune system process; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; anatomical structure development; cell motility; molecular adaptor activity; molecular function regulator activity
OG_02133,1.0865384293494311,FUN_008438-T1,Peve_00024973,Pocillopora_meandrina_HIv1___RNAseq.g18056.t1,three_way,83.8915,FUN_008438-T1,A7SMW7,,,,,69.4,448.0,5.4e-187,655.2,"sp|A7SMW7|L2HDH_NEMVE L-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g172254 PE=3 SV=1",,,,,,
OG_02134,1.9260531841102395,FUN_008440-T1,Peve_00024976,Pocillopora_meandrina_HIv1___RNAseq.g18057.t1,three_way,74.42933333333333,FUN_008440-T1,Q8CDU6,,,,,34.3,685.0,9.799999999999999e-96,353.2,sp|Q8CDU6|HECD2_MOUSE Probable E3 ubiquitin-protein ligase HECTD2 OS=Mus musculus OX=10090 GN=Hectd2 PE=1 SV=2,,,,,,
OG_02136,1.0491343446528458,FUN_008442-T1,Peve_00024978,Pocillopora_meandrina_HIv1___RNAseq.g18060.t1,three_way,83.17033333333333,FUN_008442-T1,Q9C026,TRIM9_HUMAN,,E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9),Homo sapiens (Human),44.3,704.0,9.099999999999999e-175,615.1,sp|Q9C026|TRIM9_HUMAN E3 ubiquitin-protein ligase TRIM9 OS=Homo sapiens OX=9606 GN=TRIM9 PE=1 SV=1,GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0016567; GO:0019904; GO:0030425; GO:0042803; GO:0043161; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021],protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_02145,1.2710326098611615,FUN_008451-T1,Peve_00015483,Pocillopora_meandrina_HIv1___RNAseq.g18071.t1,three_way,76.60533333333333,,,,,,,,,,,,,,,,,
OG_02146,1.051999134836633,FUN_008453-T1,Peve_00031938,Pocillopora_meandrina_HIv1___RNAseq.g18072.t1,three_way,62.222166666666666,FUN_008453-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),43.1,218.0,9.7e-57,221.9,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_02148,1.1894350371484896,FUN_008456-T1,Peve_00011006,Pocillopora_meandrina_HIv1___TS.g21065.t1,three_way,57.86566666666666,FUN_008456-T1,Q7TN88,,,,,24.0,1765.0,2.0000000000000002e-126,456.4,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_02149,1.6612277074670674,FUN_008469-T2,Peve_00028805,Pocillopora_meandrina_HIv1___TS.g21072.t1,three_way,57.63733333333333,FUN_008469-T2,B8UU59,PK1L_ACRMI,,Polycystin-1-related protein (Polycystic kidney disease 1-related protein),Acropora millepora (Staghorn coral) (Heteropora millepora),33.5,373.0,5e-53,212.2,sp|B8UU59|PK1L_ACRMI Polycystin-1-related protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005261; GO:0005886; GO:0005929; GO:0006816,calcium ion transport [GO:0006816],cilium [GO:0005929]; plasma membrane [GO:0005886],monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_02157,1.652266656809123,FUN_008489-T1,Peve_00028786,Pocillopora_meandrina_HIv1___RNAseq.g30382.t1,three_way,82.557,FUN_008489-T1,O77475,,,,,27.0,281.0,3.2000000000000003e-27,124.0,sp|O77475|CPESY_DROME Ceramide phosphoethanolamine synthase OS=Drosophila melanogaster OX=7227 GN=Cpes PE=1 SV=1,,,,,,
OG_02159,1.8375603070416344,FUN_008493-T1,Peve_00043695,Pocillopora_meandrina_HIv1___RNAseq.g6186.t1,three_way,78.713,FUN_008493-T1,B9U3F2,DISP3_CHICK,,Protein dispatched homolog 3 (Patched domain-containing protein 2) (Thyroid hormone receptor up-regulated protein 1) (TRUP1),Gallus gallus (Chicken),24.4,504.0,1.5e-19,100.1,sp|B9U3F2|DISP3_CHICK Protein dispatched homolog 3 OS=Gallus gallus OX=9031 GN=DISP3 PE=1 SV=1,GO:0005737; GO:0005783; GO:0005789; GO:0008203; GO:0009725; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0042632; GO:0045665; GO:0045834; GO:2000179,cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; response to hormone [GO:0009725],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965],,GO:0005783; GO:0006629; GO:0030154; GO:0043226,endoplasmic reticulum; lipid metabolic process; cell differentiation; organelle
OG_02168,1.081654803374276,FUN_008517-T1,Peve_00042434,Pocillopora_meandrina_HIv1___TS.g3919.t1b,three_way,62.54983333333333,FUN_008517-T1,Q9ESJ4,,,,,38.8,402.0,5.6e-78,293.5,sp|Q9ESJ4|SPN90_MOUSE NCK-interacting protein with SH3 domain OS=Mus musculus OX=10090 GN=Nckipsd PE=1 SV=2,,,,,,
OG_02172,1.6452870295360478,FUN_008521-T1,Peve_00023090,Pocillopora_meandrina_HIv1___RNAseq.24125_t,three_way,85.33366666666667,FUN_008521-T1,A6QL50,,,,,52.4,143.0,2.4999999999999997e-43,176.4,sp|A6QL50|FA72A_BOVIN Protein FAM72A OS=Bos taurus OX=9913 GN=FAM72A PE=1 SV=1,,,,,,
OG_02173,1.8873722929422367,FUN_008522-T1,Peve_00012217,Pocillopora_meandrina_HIv1___RNAseq.g14762.t2,three_way,80.53666666666668,FUN_008522-T1,Q9UPE1,,,,,59.4,547.0,7.599999999999999e-136,485.7,sp|Q9UPE1|SRPK3_HUMAN SRSF protein kinase 3 OS=Homo sapiens OX=9606 GN=SRPK3 PE=1 SV=2,,,,,,
OG_02175,1.3555723315245207,FUN_008524-T1,Peve_00027673,Pocillopora_meandrina_HIv1___RNAseq.g14752.t1,three_way,75.38833333333334,FUN_008524-T1,Q4R6K2,ZNT1_MACFA,,Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),39.8,462.0,2.9e-73,277.3,sp|Q4R6K2|ZNT1_MACFA Proton-coupled zinc antiporter SLC30A1 OS=Macaca fascicularis OX=9541 GN=SLC30A1 PE=2 SV=1,GO:0000139; GO:0005789; GO:0005886; GO:0006882; GO:0010312; GO:0016323; GO:0019855; GO:0030659; GO:0031965; GO:0042742; GO:0046872; GO:0062111; GO:0140826; GO:0140882,defense response to bacterium [GO:0042742]; detoxification of zinc ion [GO:0010312]; intracellular zinc ion homeostasis [GO:0006882]; zinc export across plasma membrane [GO:0140882]; zinc ion import into organelle [GO:0062111],basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],calcium channel inhibitor activity [GO:0019855]; metal ion binding [GO:0046872]; zinc:proton antiporter activity [GO:0140826],GO:0005215; GO:0005886; GO:0055085; GO:0098754; GO:0098772,transporter activity; plasma membrane; transmembrane transport; detoxification; molecular function regulator activity
OG_02176,1.9225752850661952,FUN_008525-T2,Peve_00019201,Pocillopora_meandrina_HIv1___TS.g3901.t1,three_way,50.440666666666665,FUN_008525-T2,Q9P2N4,ATS9_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-),Homo sapiens (Human),35.7,1772.0,0.0,1103.6,sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4,GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671,aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005783; GO:0007155; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; endoplasmic reticulum; cell adhesion; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02181,1.4111173111987256,FUN_008534-T1,Peve_00014007,Pocillopora_meandrina_HIv1___RNAseq.g14740.t1,three_way,62.36966666666667,FUN_008534-T1,Q28E45,MCM10_XENTR,,Protein MCM10 homolog,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),36.7,645.0,4.0999999999999996e-92,340.9,sp|Q28E45|MCM10_XENTR Protein MCM10 homolog OS=Xenopus tropicalis OX=8364 GN=mcm10 PE=2 SV=1,GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0008270,DNA damage response [GO:0006974]; DNA replication initiation [GO:0006270],nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0043226,DNA binding; nucleus; organelle
OG_02184,1.8890246485868625,FUN_008537-T1,Peve_00044625,Pocillopora_meandrina_HIv1___RNAseq.g14737.t1,three_way,73.81949999999999,FUN_008537-T1,Q7Z6B7,SRGP1_HUMAN,,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),Homo sapiens (Human),33.9,834.0,3.3e-120,434.5,sp|Q7Z6B7|SRGP1_HUMAN SLIT-ROBO Rho GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=SRGAP1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0007266; GO:0016477; GO:0030336; GO:0031267,cell migration [GO:0016477]; negative regulation of cell migration [GO:0030336]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0048870; GO:0098772,cytosol; cell motility; molecular function regulator activity
OG_02185,1.090419300331568,FUN_008538-T1,Peve_00014613,Pocillopora_meandrina_HIv1___RNAseq.g14663.t1,three_way,63.84633333333333,FUN_008538-T1,A4QND0,,,,,39.7,131.0,4.6e-20,99.0,sp|A4QND0|UBL4A_XENTR Ubiquitin-like protein 4A OS=Xenopus tropicalis OX=8364 GN=ubl4a PE=2 SV=1,,,,,,
OG_02194,1.3684851945082823,FUN_008549-T1,Peve_00035549,Pocillopora_meandrina_HIv1___RNAseq.g6325.t1,three_way,84.30933333333333,FUN_008549-T1,B2RRD7,BRPF1_MOUSE,,Peregrin (Bromodomain and PHD finger-containing protein 1),Mus musculus (Mouse),45.3,1287.0,2.5999999999999998e-250,867.1,sp|B2RRD7|BRPF1_MOUSE Peregrin OS=Mus musculus OX=10090 GN=Brpf1 PE=1 SV=1,GO:0000123; GO:0001570; GO:0001841; GO:0003677; GO:0005634; GO:0005737; GO:0006338; GO:0008270; GO:0010698; GO:0035726; GO:0048145; GO:0070776,chromatin remodeling [GO:0006338]; common myeloid progenitor cell proliferation [GO:0035726]; neural tube formation [GO:0001841]; regulation of fibroblast proliferation [GO:0048145]; vasculogenesis [GO:0001570],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleus [GO:0005634],acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0030154; GO:0043226; GO:0098772,DNA binding; nucleus; chromatin organization; cell differentiation; organelle; molecular function regulator activity
OG_02196,1.0109534062864067,FUN_008558-T1,Peve_00044735,Pocillopora_meandrina_HIv1___RNAseq.g69.t1,three_way,76.34233333333333,FUN_008558-T1,F1MUG2,,,,,47.2,212.0,1.6e-43,177.9,sp|F1MUG2|CEP41_BOVIN Centrosomal protein of 41 kDa OS=Bos taurus OX=9913 GN=CEP41 PE=3 SV=2,,,,,,
OG_02197,1.0462658262772806,FUN_008561-T1,Peve_00044734,Pocillopora_meandrina_HIv1___RNAseq.g70.t1,three_way,79.849,FUN_008561-T1,Q07646,,,,,48.7,318.0,3.7e-84,313.2,sp|Q07646|MEST_MOUSE Mesoderm-specific transcript protein OS=Mus musculus OX=10090 GN=Mest PE=2 SV=1,,,,,,
OG_02200,2.5746975780439287,FUN_008569-T1,Peve_00044727,Pocillopora_meandrina_HIv1___RNAseq.g12789.t1,three_way,62.34433333333333,,,,,,,,,,,,,,,,,
OG_02201,1.789208895924392,FUN_008576-T1,Peve_00044725,Pocillopora_meandrina_HIv1___RNAseq.g12787.t1,three_way,63.60733333333333,,,,,,,,,,,,,,,,,
OG_02207,1.7716341040598516,FUN_008583-T1,Peve_00028408,Pocillopora_meandrina_HIv1___RNAseq.g12778.t1,three_way,81.406,FUN_008583-T1,Q5RB35,MKLN1_PONAB,,Muskelin,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),61.2,738.0,2.1e-273,943.0,sp|Q5RB35|MKLN1_PONAB Muskelin OS=Pongo abelii OX=9601 GN=MKLN1 PE=2 SV=1,GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030036; GO:0042803; GO:0098895; GO:0098968; GO:0098982; GO:0099003; GO:0099164,actin cytoskeleton organization [GO:0030036]; cell-matrix adhesion [GO:0007160]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport in synapse [GO:0099003],cell cortex [GO:0005938]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; nucleoplasm [GO:0005654]; postsynaptic endosome membrane [GO:0098895]; postsynaptic specialization membrane of symmetric synapse [GO:0099164]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151],protein homodimerization activity [GO:0042803],GO:0005654; GO:0005829; GO:0007010; GO:0007155; GO:0016192,nucleoplasm; cytosol; cytoskeleton organization; cell adhesion; vesicle-mediated transport
OG_02210,1.2908342338406211,FUN_008586-T1,Peve_00028409,Pocillopora_meandrina_HIv1___RNAseq.g12772.t1,three_way,68.07300000000001,FUN_008586-T1,Q8K0U4,,,,,37.4,623.0,1.5e-107,391.7,sp|Q8K0U4|HS12A_MOUSE Heat shock 70 kDa protein 12A OS=Mus musculus OX=10090 GN=Hspa12a PE=1 SV=1,,,,,,
OG_02211,1.3161673483460177,FUN_008587-T1,Peve_00028398,Pocillopora_meandrina_HIv1___RNAseq.g12773.t1,three_way,39.733,,,,,,,,,,,,,,,,,
OG_02212,1.614925796776462,FUN_008594-T1,Peve_00002263,Pocillopora_meandrina_HIv1___RNAseq.g12762.t1,three_way,68.02633333333334,FUN_008594-T1,P02469,LAMB1_MOUSE,,Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta),Mus musculus (Mouse),43.3,1409.0,5.4e-246,853.2,sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3,GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007566; GO:0007611; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046,cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637],enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178],GO:0005198; GO:0005576; GO:0005615; GO:0005634; GO:0007155; GO:0008289; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048870; GO:0050877,structural molecule activity; extracellular region; extracellular space; nucleus; cell adhesion; lipid binding; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; cell motility; nervous system process
OG_02216,2.548833459221804,FUN_008605-T1,Peve_00020826,Pocillopora_meandrina_HIv1___RNAseq.g12755.t1,three_way,59.71116666666666,FUN_008605-T1,Q4V8X0,,,,,39.7,267.0,3e-41,170.6,sp|Q4V8X0|TPRA1_DANRE Transmembrane protein adipocyte-associated 1 homolog OS=Danio rerio OX=7955 GN=tpra1 PE=2 SV=1,,,,,,
OG_02220,2.638471346830483,FUN_008615-T1,Peve_00015389,Pocillopora_meandrina_HIv1___RNAseq.g12744.t1,three_way,73.05916666666667,FUN_008615-T1,O35161,CELR1_MOUSE,,Cadherin EGF LAG seven-pass G-type receptor 1,Mus musculus (Mouse),33.5,2618.0,0.0,1375.5,sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3,GO:0001736; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007166; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475,anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell surface receptor signaling pathway [GO:0007166]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060],membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005886; GO:0007155; GO:0042060; GO:0048856; GO:0048870; GO:0060089,nucleoplasm; plasma membrane; cell adhesion; wound healing; anatomical structure development; cell motility; molecular transducer activity
OG_02223,1.0971925890149192,FUN_008619-T1,Peve_00015390,Pocillopora_meandrina_HIv1___RNAseq.g6258.t1,three_way,84.62133333333334,FUN_008619-T1,Q9HC24,LFG4_HUMAN,,Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein),Homo sapiens (Human),54.6,227.0,5.3e-64,245.7,sp|Q9HC24|LFG4_HUMAN Protein lifeguard 4 OS=Homo sapiens OX=9606 GN=TMBIM4 PE=1 SV=3,GO:0000139; GO:0005262; GO:0005789; GO:0005795; GO:0006915; GO:0007626; GO:0016020; GO:0030968; GO:0043066; GO:0043524; GO:0050848,apoptotic process [GO:0006915]; endoplasmic reticulum unfolded protein response [GO:0030968]; locomotory behavior [GO:0007626]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of calcium-mediated signaling [GO:0050848],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020],calcium channel activity [GO:0005262],GO:0005215; GO:0012501,transporter activity; programmed cell death
OG_02224,1.5716610408342169,FUN_008623-T1,Peve_00015387,Pocillopora_meandrina_HIv1___RNAseq.g6256.t1,three_way,65.94366666666667,,,,,,,,,,,,,,,,,
OG_02226,1.4835409277858504,FUN_008631-T1,Peve_00012388,Pocillopora_meandrina_HIv1___RNAseq.g14912.t1,three_way,62.56166666666666,,,,,,,,,,,,,,,,,
OG_02227,2.48950660419286,FUN_008633-T1,Peve_00012386,Pocillopora_meandrina_HIv1___RNAseq.g14915.t1,three_way,74.2705,FUN_008633-T1,Q8VDT1,,,,,45.9,573.0,4.5e-140,500.0,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_02228,2.3155276162955523,FUN_008634-T1,Peve_00021941,Pocillopora_meandrina_HIv1___RNAseq.g14919.t2,three_way,51.94316666666667,FUN_008634-T1,P42166,LAP2A_HUMAN,,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]",Homo sapiens (Human),35.0,197.0,9.1e-16,85.9,"sp|P42166|LAP2A_HUMAN Lamina-associated polypeptide 2, isoform alpha OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2",GO:0000785; GO:0003677; GO:0005521; GO:0005634; GO:0005635; GO:0045296,,chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nucleus [GO:0005634],cadherin binding [GO:0045296]; DNA binding [GO:0003677]; lamin binding [GO:0005521],GO:0003677; GO:0005634; GO:0005635; GO:0043226,DNA binding; nucleus; nuclear envelope; organelle
OG_02231,1.3301077256097975,FUN_008641-T1,Peve_00021174,Pocillopora_meandrina_HIv1___RNAseq.30196_t,three_way,85.19133333333333,FUN_008641-T1,A6QP15,,,,,63.5,469.0,9.1e-177,621.3,"sp|A6QP15|HOT_BOVIN Hydroxyacid-oxoacid transhydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ADHFE1 PE=2 SV=1",,,,,,
OG_02236,1.4675536605720592,FUN_008648-T1,Peve_00021173,Pocillopora_meandrina_HIv1___RNAseq.g14.t1,three_way,67.93333333333332,,,,,,,,,,,,,,,,,
OG_02237,1.0060944643982803,FUN_008649-T1,Peve_00035682,Pocillopora_meandrina_HIv1___RNAseq.g15.t1,three_way,97.37233333333332,FUN_008649-T1,Q32LN1,UBE2H_BOVIN,,Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (Ubiquitin carrier protein H) (Ubiquitin-protein ligase H),Bos taurus (Bovine),73.8,183.0,4.0000000000000004e-72,272.3,sp|Q32LN1|UBE2H_BOVIN Ubiquitin-conjugating enzyme E2 H OS=Bos taurus OX=9913 GN=UBE2H PE=2 SV=1,GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02242,1.0463872952563928,FUN_008659-T1,Peve_00016766,Pocillopora_meandrina_HIv1___RNAseq.g14869.t1,three_way,64.205,FUN_008659-T1,Q8NA03,,,,,27.0,359.0,3e-08,61.6,sp|Q8NA03|FSIP1_HUMAN Fibrous sheath-interacting protein 1 OS=Homo sapiens OX=9606 GN=FSIP1 PE=1 SV=1,,,,,,
OG_02246,1.0078213382643029,FUN_008663-T1,Peve_00044714,Pocillopora_meandrina_HIv1___RNAseq.g14878.t1,three_way,73.19,FUN_008663-T1,P13439,UMPS_MOUSE,,Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMPdecase)],Mus musculus (Mouse),52.2,467.0,2.1e-133,477.2,sp|P13439|UMPS_MOUSE Uridine 5'-monophosphate synthase OS=Mus musculus OX=10090 GN=Umps PE=1 SV=3,GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0044205,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; nucleus [GO:0005634],orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590],GO:0003824; GO:0005634; GO:0016740; GO:0016829; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; transferase activity; lyase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02248,1.780730331362092,FUN_008665-T1,Peve_00044711,Pocillopora_meandrina_HIv1___RNAseq.g64.t1,three_way,73.61466666666666,FUN_008665-T1,Q6RHR9,,,,,33.7,1372.0,3.9e-185,650.6,"sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1",,,,,,
OG_02249,1.056704924480308,FUN_008668-T1,Peve_00044707,Pocillopora_meandrina_HIv1___RNAseq.g67.t1,three_way,96.41,FUN_008668-T1,Q6NZW8,,,,,86.2,130.0,1.0999999999999999e-62,240.7,sp|Q6NZW8|AR8BA_DANRE ADP-ribosylation factor-like protein 8B-A OS=Danio rerio OX=7955 GN=arl8ba PE=2 SV=1,,,,,,
OG_02255,1.1540600811259407,FUN_008701-T1,Peve_00034980,Pocillopora_meandrina_HIv1___RNAseq.g25726.t1,three_way,81.37066666666666,FUN_008701-T1,Q925U4,,,,,59.6,530.0,3.8e-185,649.4,sp|Q925U4|EDEM1_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 1 OS=Mus musculus OX=10090 GN=Edem1 PE=1 SV=1,,,,,,
OG_02258,1.1526440929107298,FUN_008705-T1,Peve_00034987,Pocillopora_meandrina_HIv1___RNAseq.g25667.t1,three_way,69.49066666666667,,,,,,,,,,,,,,,,,
OG_02260,1.7316634930862993,FUN_008707-T1,Peve_00034989,Pocillopora_meandrina_HIv1___TS.g9102.t1,three_way,77.2585,FUN_008707-T1,Q99246,,,,,52.7,1458.0,0.0,1323.9,sp|Q99246|CAC1D_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1D OS=Mus musculus OX=10090 GN=Cacna1d PE=1 SV=3,,,,,,
OG_02265,1.5876551337461715,FUN_008713-T2,Peve_00025642,Pocillopora_meandrina_HIv1___RNAseq.g25652.t1,three_way,84.41833333333334,FUN_008713-T2,Q8BW96,KCC1D_MOUSE,,Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM-KI delta) (CaMKI delta) (CaM kinase ID) (CaMKI-like protein kinase) (CKLiK) (mCKLiK),Mus musculus (Mouse),68.4,329.0,5.4e-129,462.2,sp|Q8BW96|KCC1D_MOUSE Calcium/calmodulin-dependent protein kinase type 1D OS=Mus musculus OX=10090 GN=Camk1d PE=1 SV=2,GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006954; GO:0007399; GO:0010976; GO:0032793; GO:0043065; GO:0043066; GO:0050766; GO:0050773; GO:0060267; GO:0071622; GO:0090023; GO:0106310,inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis [GO:0050766]; positive regulation of respiratory burst [GO:0060267]; regulation of dendrite development [GO:0050773]; regulation of granulocyte chemotaxis [GO:0071622],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0006355; GO:0006954; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; inflammatory response; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02271,1.046856855908699,FUN_008740-T1,Peve_00013702,Pocillopora_meandrina_HIv1___RNAseq.g12735.t1,three_way,71.64699999999999,,,,,,,,,,,,,,,,,
OG_02272,1.1725572634064687,FUN_008748-T1,Peve_00015782,Pocillopora_meandrina_HIv1___RNAseq.g12748.t1,three_way,61.57383333333333,,,,,,,,,,,,,,,,,
OG_02277,1.3429438929578643,FUN_008768-T1,Peve_00036720,Pocillopora_meandrina_HIv1___RNAseq.g12705.t1,three_way,76.76466666666667,FUN_008768-T1,Q1LXK4,,,,,38.7,1047.0,7.500000000000001e-184,646.0,sp|Q1LXK4|M10B1_DANRE Putative helicase mov-10-B.1 OS=Danio rerio OX=7955 GN=mov10b.1 PE=2 SV=2,,,,,,
OG_02278,1.1781451814980108,FUN_008769-T1,Peve_00036718,Pocillopora_meandrina_HIv1___RNAseq.g12704.t1,three_way,66.35966666666667,FUN_008769-T1,Q9JHZ4,GRAP1_RAT,,GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)],Rattus norvegicus (Rat),33.5,179.0,7.9e-18,94.4,sp|Q9JHZ4|GRAP1_RAT GRIP1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Gripap1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910,"negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]",axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255],GO:0005654; GO:0005829; GO:0098772,nucleoplasm; cytosol; molecular function regulator activity
OG_02279,1.121039885729435,FUN_008771-T1,Peve_00036717,Pocillopora_meandrina_HIv1___RNAseq.g12703.t1,three_way,83.727,FUN_008771-T1,Q95LL3,,,,,53.3,510.0,1.5e-138,494.6,sp|Q95LL3|TB22B_MACFA TBC1 domain family member 22B OS=Macaca fascicularis OX=9541 GN=TBC1D22B PE=2 SV=1,,,,,,
OG_02280,2.4582640229583816,FUN_008772-T1,Peve_00036716,Pocillopora_meandrina_HIv1___RNAseq.g12702.t1,three_way,55.00416666666666,FUN_008772-T1,P30974,,,,,26.0,412.0,1.6e-18,95.9,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_02288,1.803753645405444,FUN_008795-T1,Peve_00042598,Pocillopora_meandrina_HIv1___RNAseq.g12685.t1a,three_way,70.187,FUN_008795-T1,Q8IYQ7,,,,,47.4,685.0,3.8e-168,593.2,sp|Q8IYQ7|THNS1_HUMAN Threonine synthase-like 1 OS=Homo sapiens OX=9606 GN=THNSL1 PE=1 SV=2,,,,,,
OG_02292,1.6900405444151103,FUN_008860-T1,Peve_00002936,Pocillopora_meandrina_HIv1___RNAseq.g30.t1,three_way,63.93383333333333,FUN_008860-T1,Q96M96,,,,,41.2,556.0,2.9e-110,401.4,"sp|Q96M96|FGD4_HUMAN FYVE, RhoGEF and PH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FGD4 PE=1 SV=2",,,,,,
OG_02293,1.6101664447743125,FUN_008871-T1,Peve_00000781,Pocillopora_meandrina_HIv1___RNAseq.g4009.t1,three_way,72.09516666666667,FUN_008871-T1,Q5RID7,,,,,45.6,401.0,2.6000000000000002e-110,400.6,sp|Q5RID7|SNX17_DANRE Sorting nexin-17 OS=Danio rerio OX=7955 GN=snx17 PE=2 SV=1,,,,,,
OG_02294,2.8380653416261423,FUN_008872-T1,Peve_00000784,Pocillopora_meandrina_HIv1___RNAseq.g4010.t1,three_way,45.396166666666666,,,,,,,,,,,,,,,,,
OG_02296,2.434761119586795,FUN_008874-T1,Peve_00000786,Pocillopora_meandrina_HIv1___RNAseq.g4012.t1,three_way,67.04350000000001,,,,,,,,,,,,,,,,,
OG_02298,1.461617493871223,FUN_008877-T1,Peve_00043352,Pocillopora_meandrina_HIv1___TS.g30031.t1,three_way,72.87216666666667,FUN_008877-T1,Q8IZQ1,WDFY3_HUMAN,,WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy),Homo sapiens (Human),36.1,2785.0,0.0,1567.7,sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2,GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204,aggrephagy [GO:0035973],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605],1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270],GO:0005635; GO:0005654; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006914; GO:0008289; GO:0043226,nuclear envelope; nucleoplasm; nucleolus; vacuole; cytosol; plasma membrane; autophagy; lipid binding; organelle
OG_02300,2.0603930320599098,FUN_008879-T1,Peve_00043354,Pocillopora_meandrina_HIv1___RNAseq.g14471.t1,three_way,77.52583333333332,FUN_008879-T1,O93310,,,,,39.9,642.0,2.8e-79,297.7,sp|O93310|RAD21_XENLA Double-strand-break repair protein rad21 homolog OS=Xenopus laevis OX=8355 GN=rad21 PE=1 SV=1,,,,,,
OG_02302,1.053559462900283,FUN_008881-T1,Peve_00032861,Pocillopora_meandrina_HIv1___RNAseq.g14469.t1,three_way,94.62233333333332,FUN_008881-T1,Q96DI7,SNR40_HUMAN,,U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57),Homo sapiens (Human),68.7,345.0,7.6e-96,352.1,sp|Q96DI7|SNR40_HUMAN U5 small nuclear ribonucleoprotein 40 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP40 PE=1 SV=1,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0046540; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; cytosol; mRNA metabolic process; organelle
OG_02303,1.3266217886731757,FUN_008882-T1,Peve_00032041,Pocillopora_meandrina_HIv1___RNAseq.g14468.t1,three_way,62.712,FUN_008882-T1,Q32KN7,,,,,41.7,192.0,3.3e-26,120.9,sp|Q32KN7|ZC21B_BOVIN Zinc finger C2HC domain-containing protein 1B OS=Bos taurus OX=9913 GN=ZC2HC1B PE=2 SV=1,,,,,,
OG_02305,1.548176165588521,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,42.3,137.0,2.1e-31,140.2,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_02305,1.548176165588521,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,46.9,128.0,2.5e-29,133.3,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_02312,1.006136876716238,FUN_008903-T1,Peve_00013993,Pocillopora_meandrina_HIv1___RNAseq.g4000.t1,three_way,73.99,FUN_008903-T1,Q9VU77,JMJD7_DROME,,Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 (EC 1.14.11.63) (EC 3.4.-.-) (Jumonji domain containing protein 7),Drosophila melanogaster (Fruit fly),29.7,296.0,2.5e-29,131.3,sp|Q9VU77|JMJD7_DROME Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 OS=Drosophila melanogaster OX=7227 GN=JMJD7 PE=1 SV=1,GO:0004175; GO:0005634; GO:0005737; GO:0008198; GO:0016706; GO:0042802; GO:0048512; GO:0106155,circadian behavior [GO:0048512],cytoplasm [GO:0005737]; nucleus [GO:0005634],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; endopeptidase activity [GO:0004175]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; peptidyl-lysine 3-dioxygenase activity [GO:0106155],GO:0003824; GO:0005634; GO:0016491; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; oxidoreductase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02316,1.737131095853055,FUN_008907-T1,Peve_00027548,Pocillopora_meandrina_HIv1___RNAseq.g3972.t1,three_way,56.05233333333333,FUN_008907-T1,Q8CH34,ZP4_RAT,,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],Rattus norvegicus (Rat),27.7,332.0,4.3e-14,80.5,sp|Q8CH34|ZP4_RAT Zona pellucida sperm-binding protein 4 OS=Rattus norvegicus OX=10116 GN=Zp4 PE=2 SV=1,GO:0002922; GO:0005576; GO:0005886; GO:0007339; GO:0032190; GO:0035804; GO:0035805; GO:0042102; GO:0042802; GO:0060468; GO:0060478; GO:0062023; GO:2000344; GO:2000360,acrosomal vesicle exocytosis [GO:0060478]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of humoral immune response [GO:0002922]; positive regulation of T cell proliferation [GO:0042102]; prevention of polyspermy [GO:0060468],collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],acrosin binding [GO:0032190]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804],GO:0005198; GO:0005576; GO:0005886; GO:0016192; GO:0030312; GO:0031012,structural molecule activity; extracellular region; plasma membrane; vesicle-mediated transport; external encapsulating structure; extracellular matrix
OG_02317,3.762073852327448,FUN_008908-T1,Peve_00017912,Pocillopora_meandrina_HIv1___TS.g30016.t1,three_way,61.309333333333335,FUN_008908-T1,G8HTB6,,,,,95.7,349.0,1.3e-187,657.1,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02318,1.4487797513853249,FUN_008909-T1,Peve_00017911,Pocillopora_meandrina_HIv1___RNAseq.g3974.t1,three_way,62.283166666666666,FUN_008909-T1,Q9EQZ7,,,,,32.2,1005.0,1.6e-93,346.7,sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1,,,,,,
OG_02319,1.606312706375328,FUN_008911-T1,Peve_00019472,Pocillopora_meandrina_HIv1___RNAseq.g3976.t1,three_way,68.34216666666667,FUN_008911-T1,O60266,ADCY3_HUMAN,,"Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)",Homo sapiens (Human),39.5,1100.0,4.3e-204,713.4,sp|O60266|ADCY3_HUMAN Adenylate cyclase type 3 OS=Homo sapiens OX=9606 GN=ADCY3 PE=1 SV=3,GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:1904322,acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338],ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886],adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0005886; GO:0005929; GO:0007018; GO:0009975; GO:0016829; GO:0022414; GO:0043226; GO:0048870; GO:0050877; GO:0055086; GO:1901135,catalytic activity; Golgi apparatus; plasma membrane; cilium; microtubule-based movement; cyclase activity; lyase activity; reproductive process; organelle; cell motility; nervous system process; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02324,1.0601981331856147,FUN_008916-T1,Peve_00033003,Pocillopora_meandrina_HIv1___RNAseq.g3981.t1,three_way,69.72566666666667,FUN_008916-T1,Q8JHF4,,,,,30.0,120.0,1.1e-07,59.3,sp|Q8JHF4|PAL1A_DANRE Protein PALS1 OS=Danio rerio OX=7955 GN=pals1a PE=1 SV=2,,,,,,
OG_02336,1.742268090538213,FUN_008931-T1,Peve_00036391,Pocillopora_meandrina_HIv1___RNAseq.g14259.t1,three_way,74.031,FUN_008931-T1,Q8BSY0,ASPH_MOUSE,,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),Mus musculus (Mouse),55.5,429.0,5.6e-143,509.2,sp|Q8BSY0|ASPH_MOUSE Aspartyl/asparaginyl beta-hydroxylase OS=Mus musculus OX=10090 GN=Asph PE=1 SV=1,GO:0005737; GO:0005886; GO:0007389; GO:0008283; GO:0008285; GO:0016020; GO:0031647; GO:0032541; GO:0033017; GO:0035108; GO:0045862; GO:0046872; GO:0060021; GO:0060325; GO:0062101; GO:1901879,cell population proliferation [GO:0008283]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; positive regulation of proteolysis [GO:0045862]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; roof of mouth development [GO:0060021],cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],metal ion binding [GO:0046872]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101],GO:0003824; GO:0005886; GO:0016491; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; oxidoreductase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02337,1.356905518642202,FUN_008933-T1,Peve_00036390,Pocillopora_meandrina_HIv1___RNAseq.g14258.t1,three_way,90.02433333333333,FUN_008933-T1,A6QQY2,,,,,39.1,92.0,1.2e-09,65.5,sp|A6QQY2|KLH13_BOVIN Kelch-like protein 13 OS=Bos taurus OX=9913 GN=KLHL13 PE=2 SV=1,,,,,,
OG_02338,1.5657968539837186,FUN_008934-T1,Peve_00036402,Pocillopora_meandrina_HIv1___RNAseq.g14257.t1,three_way,76.08966666666667,FUN_008934-T1,A5D7I4,EXT1_BOVIN,,Exostosin-1 (EC 2.4.1.225) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase),Bos taurus (Bovine),50.3,749.0,7.999999999999999e-217,755.0,sp|A5D7I4|EXT1_BOVIN Exostosin-1 OS=Bos taurus OX=9913 GN=EXT1 PE=2 SV=1,GO:0000139; GO:0000271; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0010803; GO:0014033; GO:0015012; GO:0015020; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1902494; GO:1904888; GO:1990823,"antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; polysaccharide biosynthetic process [GO:0000271]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synapse [GO:0045202],acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006790; GO:0006954; GO:0007155; GO:0009101; GO:0016740; GO:0023052; GO:0030154; GO:0030163; GO:0030198; GO:0034330; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:1901135,immune system process; circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; sulfur compound metabolic process; inflammatory response; cell adhesion; glycoprotein biosynthetic process; transferase activity; signaling; cell differentiation; protein catabolic process; extracellular matrix organization; cell junction organization; wound healing; organelle; anatomical structure development; cell motility; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_02339,1.3964153765710996,FUN_008935-T1,Peve_00036395,Pocillopora_meandrina_HIv1___TS.g5740.t1,three_way,79.28566666666667,FUN_008935-T1,A0JM56,,,,,51.8,1431.0,1.4000000000000001e-186,655.6,sp|A0JM56|LRRC9_XENTR Leucine-rich repeat-containing protein 9 OS=Xenopus tropicalis OX=8364 GN=lrrc9 PE=2 SV=2,,,,,,
OG_02340,1.2677777142897555,FUN_008938-T1,Peve_00007199,Pocillopora_meandrina_HIv1___RNAseq.g4080.t1,three_way,43.816833333333335,FUN_008938-T1,Q5F4A1,,,,,43.0,300.0,1.6000000000000001e-71,272.3,sp|Q5F4A1|G2E3_CHICK G2/M phase-specific E3 ubiquitin-protein ligase OS=Gallus gallus OX=9031 GN=G2E3 PE=2 SV=1,,,,,,
OG_02341,2.3149108318510287,FUN_008940-T1,Peve_00007194,Pocillopora_meandrina_HIv1___TS.g30103.t1,three_way,71.29533333333333,FUN_008940-T1,P31422,GRM3_RAT,,Metabotropic glutamate receptor 3 (mGluR3),Rattus norvegicus (Rat),41.0,808.0,1.2999999999999998e-173,611.7,sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_02346,1.0392294774224382,FUN_008947-T1,Peve_00011183,Pocillopora_meandrina_HIv1___RNAseq.g4057.t1,three_way,74.78516666666667,,,,,,,,,,,,,,,,,
OG_02351,1.7603839780893509,FUN_008952-T1,Peve_00037679,Pocillopora_meandrina_HIv1___RNAseq.g4051.t1,three_way,70.46833333333333,FUN_008952-T1,Q8TDM6,,,,,31.0,1363.0,9.8e-134,480.3,sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4,,,,,,
OG_02352,1.3191758955749515,FUN_008953-T2,Peve_00037684,Pocillopora_meandrina_HIv1___TS.g30089.t1,three_way,80.953,FUN_008953-T2,G5E8K5,ANK3_MOUSE,,Ankyrin-3 (ANK-3) (Ankyrin-G),Mus musculus (Mouse),36.2,624.0,2.2000000000000001e-100,369.4,sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1,GO:0005764; GO:0005886; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043194; GO:0043266; GO:0044325; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0090314; GO:0098794; GO:0099103; GO:0099612; GO:1900827; GO:1902260,axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018],cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; transmembrane transporter binding [GO:0044325],GO:0005764; GO:0005773; GO:0005783; GO:0005856; GO:0005886; GO:0008092; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659; GO:0098772,lysosome; vacuole; endoplasmic reticulum; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane; molecular function regulator activity
OG_02352,1.3191758955749515,FUN_008953-T2,Peve_00037684,Pocillopora_meandrina_HIv1___TS.g30089.t1,three_way,80.953,FUN_008953-T2,G5E8K5,ANK3_MOUSE,,Ankyrin-3 (ANK-3) (Ankyrin-G),Mus musculus (Mouse),57.1,42.0,3.5e-05,53.1,sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1,GO:0005764; GO:0005886; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043194; GO:0043266; GO:0044325; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0090314; GO:0098794; GO:0099103; GO:0099612; GO:1900827; GO:1902260,axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018],cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; transmembrane transporter binding [GO:0044325],GO:0005764; GO:0005773; GO:0005783; GO:0005856; GO:0005886; GO:0008092; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659; GO:0098772,lysosome; vacuole; endoplasmic reticulum; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane; molecular function regulator activity
OG_02353,2.0667857945066075,FUN_008955-T1,Peve_00037682,Pocillopora_meandrina_HIv1___RNAseq.g4048.t1,three_way,75.81333333333333,FUN_008955-T1,Q149N8,,,,,35.5,1772.0,5.0000000000000005e-278,959.5,sp|Q149N8|SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens OX=9606 GN=SHPRH PE=1 SV=2,,,,,,
OG_02354,1.0670252162006342,FUN_008956-T1,Peve_00021626,Pocillopora_meandrina_HIv1___RNAseq.g4047.t1,three_way,86.82350000000001,FUN_008956-T1,Q9NV58,,,,,68.9,360.0,7.5e-154,545.4,sp|Q9NV58|RN19A_HUMAN E3 ubiquitin-protein ligase RNF19A OS=Homo sapiens OX=9606 GN=RNF19A PE=1 SV=3,,,,,,
OG_02358,1.567125731693959,FUN_008961-T1,Peve_00006948,Pocillopora_meandrina_HIv1___RNAseq.g4042.t1,three_way,60.446,,,,,,,,,,,,,,,,,
OG_02359,1.9956243236827609,FUN_008962-T1,Peve_00007353,Pocillopora_meandrina_HIv1___RNAseq.g3914.t1,three_way,53.4015,FUN_008962-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),31.7,489.0,3.1e-54,214.9,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02362,1.411724890142882,FUN_008967-T1,Peve_00007330,Pocillopora_meandrina_HIv1___RNAseq.g14273.t1,three_way,70.74066666666667,FUN_008967-T1,Q9UBI4,,,,,35.1,350.0,6.9e-45,183.0,sp|Q9UBI4|STML1_HUMAN Stomatin-like protein 1 OS=Homo sapiens OX=9606 GN=STOML1 PE=1 SV=1,,,,,,
OG_02365,1.530861927789238,FUN_008972-T1,Peve_00025074,Pocillopora_meandrina_HIv1___RNAseq.g14268.t1,three_way,56.09883333333333,FUN_008972-T1,Q9BXT4,TDRD1_HUMAN,,Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1),Homo sapiens (Human),22.4,961.0,1.8999999999999998e-35,153.3,sp|Q9BXT4|TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TDRD1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02369,2.370201182205249,FUN_008978-T1,Peve_00017852,Pocillopora_meandrina_HIv1___RNAseq.g14265.t1,three_way,33.91433333333333,,,,,,,,,,,,,,,,,
OG_02372,1.8538534707988843,FUN_008981-T1,Peve_00017856,Pocillopora_meandrina_HIv1___RNAseq.g3907.t1,three_way,83.092,FUN_008981-T1,Q9UK96,,,,,33.1,505.0,5.8e-66,254.2,sp|Q9UK96|FBX10_HUMAN F-box only protein 10 OS=Homo sapiens OX=9606 GN=FBXO10 PE=1 SV=3,,,,,,
OG_02374,1.7823339479899825,FUN_008984-T1,Peve_00029644,Pocillopora_meandrina_HIv1___RNAseq.g3905.t1,three_way,78.63966666666667,FUN_008984-T1,Q9NSN8,,,,,34.6,448.0,3e-69,264.2,sp|Q9NSN8|SNTG1_HUMAN Gamma-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTG1 PE=1 SV=1,,,,,,
OG_02381,1.852464273696877,FUN_008994-T1,Peve_00013183,Pocillopora_meandrina_HIv1___RNAseq.g3910.t1,three_way,75.73266666666666,FUN_008994-T1,Q5ZM65,,,,,54.3,411.0,3.8e-123,443.4,sp|Q5ZM65|PTSS1_CHICK Phosphatidylserine synthase 1 OS=Gallus gallus OX=9031 GN=PTDSS1 PE=2 SV=2,,,,,,
OG_02384,1.8300500944367373,FUN_009006-T1,Peve_00029130,Pocillopora_meandrina_HIv1___RNAseq.g14283.t1,three_way,69.471,FUN_009006-T1,Q96RG2,,,,,34.2,1207.0,2.8e-153,544.7,sp|Q96RG2|PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=PASK PE=1 SV=3,,,,,,
OG_02385,1.3866790834199203,FUN_009007-T1,Peve_00029131,Pocillopora_meandrina_HIv1___RNAseq.g14284.t1,three_way,70.31566666666667,,,,,,,,,,,,,,,,,
OG_02390,1.3735979722750562,FUN_009014-T1,Peve_00021062,Pocillopora_meandrina_HIv1___RNAseq.g14291.t1,three_way,68.24033333333333,FUN_009014-T1,Q3U0M1,TPPC9_MOUSE,,Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein),Mus musculus (Mouse),31.7,1140.0,3e-141,504.6,sp|Q3U0M1|TPPC9_MOUSE Trafficking protein particle complex subunit 9 OS=Mus musculus OX=10090 GN=Trappc9 PE=1 SV=2,GO:0005737; GO:0005783; GO:0006888; GO:0006901; GO:0021987; GO:0030182; GO:0099022; GO:1990071,cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; TRAPPII protein complex [GO:1990071],,GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048856,endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development
OG_02393,1.138755596195141,FUN_009021-T1,Peve_00044339,Pocillopora_meandrina_HIv1___RNAseq.g3922.t1,three_way,71.4215,,,,,,,,,,,,,,,,,
OG_02400,2.5089179610730965,FUN_009039-T1,Peve_00033720,Pocillopora_meandrina_HIv1___RNAseq.g14374.t1,three_way,60.694,,,,,,,,,,,,,,,,,
OG_02402,2.3677251069422307,FUN_009043-T1,Peve_00033724,Pocillopora_meandrina_HIv1___RNAseq.g14380.t1,three_way,66.07533333333333,FUN_009043-T1,Q6P3K3,FBX9_DANRE,,F-box only protein 9,Danio rerio (Zebrafish) (Brachydanio rerio),39.8,437.0,1.3e-81,305.1,sp|Q6P3K3|FBX9_DANRE F-box only protein 9 OS=Danio rerio OX=7955 GN=fbxo9 PE=2 SV=1,GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006,protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005],,GO:0030163,protein catabolic process
OG_02404,1.258011434705271,FUN_009053-T1,Peve_00032043,Pocillopora_meandrina_HIv1___RNAseq.g14499.t1,three_way,60.631166666666665,FUN_009053-T1,Q68FD7,FNIP1_MOUSE,,Folliculin-interacting protein 1,Mus musculus (Mouse),29.9,1162.0,7.4e-115,416.8,sp|Q68FD7|FNIP1_MOUSE Folliculin-interacting protein 1 OS=Mus musculus OX=10090 GN=Fnip1 PE=1 SV=1,GO:0000122; GO:0001783; GO:0002327; GO:0002904; GO:0005737; GO:0005765; GO:0005829; GO:0008047; GO:0008285; GO:0009267; GO:0019899; GO:0031334; GO:0031929; GO:0032007; GO:0032008; GO:0042030; GO:0051087; GO:1904263; GO:1905672; GO:2000973,B cell apoptotic process [GO:0001783]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of lysosome organization [GO:1905672]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of pro-B cell differentiation [GO:2000973]; TOR signaling [GO:0031929],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765],ATPase inhibitor activity [GO:0042030]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; protein-folding chaperone binding [GO:0051087],GO:0002376; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0098772,immune system process; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; molecular function regulator activity
OG_02405,1.0781154825831447,FUN_009054-T1,Peve_00032030,Pocillopora_meandrina_HIv1___RNAseq.g14498.t1,three_way,59.42516666666667,FUN_009054-T1,Q9WVK8,CP46A_MOUSE,,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1),Mus musculus (Mouse),32.7,493.0,1.3000000000000001e-67,258.8,sp|Q9WVK8|CP46A_MOUSE Cholesterol 24-hydroxylase OS=Mus musculus OX=10090 GN=Cyp46a1 PE=1 SV=1,GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044,cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805],dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793],cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_02406,1.517777101783405,FUN_009055-T1,Peve_00032032,Pocillopora_meandrina_HIv1___RNAseq.g14497.t1,three_way,46.194,,,,,,,,,,,,,,,,,
OG_02408,1.2003723978887657,FUN_009228-T2,Peve_00014803,Pocillopora_meandrina_HIv1___RNAseq.g6343.t1,three_way,63.64683333333333,FUN_009228-T2,Q24JV9,,,,,50.0,106.0,4.5000000000000003e-23,113.6,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02409,1.2408369224653102,FUN_009268-T1,Peve_00032035,Pocillopora_meandrina_HIv1___RNAseq.g3994.t1,three_way,78.74633333333333,FUN_009268-T1,Q4R516,ELOV5_MACFA,,Very long chain fatty acid elongase 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Elongation of very long chain fatty acids protein 5) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),35.5,231.0,4.8e-25,116.3,sp|Q4R516|ELOV5_MACFA Very long chain fatty acid elongase 5 OS=Macaca fascicularis OX=9541 GN=ELOVL5 PE=2 SV=1,GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0043025; GO:0097447,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",dendrite [GO:0030425]; dendritic tree [GO:0097447]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_02411,1.1888791463483166,FUN_009270-T1,Peve_00032038,Pocillopora_meandrina_HIv1___RNAseq.g3996.t1,three_way,56.53483333333333,,,,,,,,,,,,,,,,,
OG_02415,1.2228555340992726,FUN_009296-T1,Peve_00041170,Pocillopora_meandrina_HIv1___RNAseq.g14453.t3,three_way,46.81766666666667,,,,,,,,,,,,,,,,,
OG_02416,1.4399811112290857,FUN_009298-T1,Peve_00041169,Pocillopora_meandrina_HIv1___RNAseq.g14449.t1,three_way,55.967,,,,,,,,,,,,,,,,,
OG_02417,1.9378934209422392,FUN_009301-T1,Peve_00025384,Pocillopora_meandrina_HIv1___RNAseq.g14448.t1,three_way,83.23466666666667,FUN_009301-T1,Q867C9,,,,,59.6,757.0,8.799999999999999e-268,924.5,"sp|Q867C9|PFKAM_HORSE ATP-dependent 6-phosphofructokinase, muscle type OS=Equus caballus OX=9796 GN=PFKM PE=2 SV=3",,,,,,
OG_02421,1.0376649296641107,FUN_009312-T2,Peve_00021837,Pocillopora_meandrina_HIv1___RNAseq.g14441.t1,three_way,44.22516666666667,,,,,,,,,,,,,,,,,
OG_02424,2.052167822231227,FUN_009349-T1,Peve_00038081,Pocillopora_meandrina_HIv1___RNAseq.g14427.t2,three_way,67.24183333333333,,,,,,,,,,,,,,,,,
OG_02428,1.1329094409027862,FUN_009369-T1,Peve_00011042,Pocillopora_meandrina_HIv1___RNAseq.g14409.t1,three_way,62.123666666666665,FUN_009369-T1,A8KBE0,,,,,31.3,823.0,3.5e-86,321.2,sp|A8KBE0|OXR1_XENTR Oxidation resistance protein 1 OS=Xenopus tropicalis OX=8364 GN=oxr1 PE=2 SV=2,,,,,,
OG_02430,2.040659952549684,FUN_009383-T1,Peve_00026822,Pocillopora_meandrina_HIv1___RNAseq.g14536.t2,three_way,52.69433333333333,FUN_009383-T1,O57382,,,,,33.2,238.0,1.9e-27,125.9,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_02432,1.7183010069261655,FUN_009438-T1,Peve_00031029,Pocillopora_meandrina_HIv1___RNAseq.g25068.t1,three_way,73.89733333333334,,,,,,,,,,,,,,,,,
OG_02435,1.0703194723211304,FUN_009441-T1,Peve_00031034,Pocillopora_meandrina_HIv1___RNAseq.g25070.t1,three_way,55.70133333333333,,,,,,,,,,,,,,,,,
OG_02439,2.14576493779392,FUN_009459-T2,Peve_00010355,Pocillopora_meandrina_HIv1___RNAseq.g25133.t1,three_way,61.281333333333336,FUN_009459-T2,Q24JV9,,,,,58.1,105.0,3.1999999999999997e-31,139.0,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02441,1.1292382543433317,FUN_009464-T1,Peve_00031025,Pocillopora_meandrina_HIv1___RNAseq.g25059.t1,three_way,87.40733333333333,FUN_009464-T1,Q6IML7,,,,,66.2,260.0,1.6e-101,370.5,sp|Q6IML7|DJC27_RAT DnaJ homolog subfamily C member 27 OS=Rattus norvegicus OX=10116 GN=Dnajc27 PE=2 SV=1,,,,,,
OG_02443,1.7619116489524838,FUN_009512-T1,Peve_00040630,Pocillopora_meandrina_HIv1___TS.g24209.t1,three_way,57.00666666666667,FUN_009512-T1,A6LX31,,,,,46.4,252.0,2.1e-56,221.5,sp|A6LX31|Y2760_CLOB8 Putative hydro-lyase Cbei_2760 OS=Clostridium beijerinckii (strain ATCC 51743 / NCIMB 8052) OX=290402 GN=Cbei_2760 PE=3 SV=1,,,,,,
OG_02448,1.1551725062205842,FUN_009519-T1,Peve_00014186,Pocillopora_meandrina_HIv1___RNAseq.g24501.t1,three_way,81.64666666666666,FUN_009519-T1,Q02874,H2AY_RAT,,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y),Rattus norvegicus (Rat),55.9,381.0,1.7e-101,370.9,sp|Q02874|H2AY_RAT Core histone macro-H2A.1 OS=Rattus norvegicus OX=10116 GN=Macroh2a1 PE=1 SV=5,GO:0000122; GO:0000182; GO:0000228; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0001740; GO:0002082; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006281; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0030527; GO:0031490; GO:0031492; GO:0031507; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0071169; GO:0072570; GO:0090734; GO:0160002; GO:1901837; GO:1902688; GO:1902750; GO:1902882; GO:1903226; GO:1904815; GO:1990841,"DNA repair [GO:0006281]; epigenetic regulation of gene expression [GO:0040029]; establishment of protein localization to chromatin [GO:0071169]; heterochromatin formation [GO:0031507]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of NAD metabolic process [GO:1902688]; regulation of oxidative phosphorylation [GO:0002082]; regulation of response to oxidative stress [GO:1902882]; sex-chromosome dosage compensation [GO:0007549]; transcription initiation-coupled chromatin remodeling [GO:0045815]",Barr body [GO:0001740]; chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734],ADP-D-ribose binding [GO:0072570]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976],GO:0000228; GO:0003677; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0043226; GO:0065003; GO:0098772,nuclear chromosome; DNA binding; structural molecule activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; molecular function regulator activity
OG_02452,1.5880367022185355,FUN_009530-T1,Peve_00009552,Pocillopora_meandrina_HIv1___RNAseq.g24495.t1,three_way,46.4995,FUN_009530-T1,Q460N3,PAR15_HUMAN,,Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15),Homo sapiens (Human),27.4,201.0,6.3e-14,80.9,sp|Q460N3|PAR15_HUMAN Protein mono-ADP-ribosyltransferase PARP15 OS=Homo sapiens OX=9606 GN=PARP15 PE=1 SV=2,GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0010629; GO:0016779; GO:0070212; GO:0070403; GO:0140806; GO:0140807; GO:1990404,negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein poly-ADP-ribosylation [GO:0070212],cytoplasm [GO:0005737]; nucleus [GO:0005634],NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02457,1.0456353111323706,FUN_009641-T1,Peve_00021801,Pocillopora_meandrina_HIv1___RNAseq.g24616.t1,three_way,92.12033333333332,FUN_009641-T1,A6N6J5,WDR35_RAT,,WD repeat-containing protein 35 (Naofen),Rattus norvegicus (Rat),68.2,1188.0,0.0,1680.6,sp|A6N6J5|WDR35_RAT WD repeat-containing protein 35 OS=Rattus norvegicus OX=10116 GN=Wdr35 PE=1 SV=1,GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0045019; GO:0045907; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0071466; GO:0090200; GO:0097421; GO:1990830; GO:2001238,cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vasoconstriction [GO:0045907]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; intraciliary transport particle A [GO:0030991],,GO:0003013; GO:0005815; GO:0007018; GO:0044782; GO:0048856,circulatory system process; microtubule organizing center; microtubule-based movement; cilium organization; anatomical structure development
OG_02459,1.160923340172602,FUN_009649-T1,Peve_00003562,Pocillopora_meandrina_HIv1___RNAseq.g24589.t1,three_way,62.382666666666665,FUN_009649-T1,P48442,CASR_RAT,,Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR),Rattus norvegicus (Rat),26.8,892.0,1e-78,296.6,sp|P48442|CASR_RAT Extracellular calcium-sensing receptor OS=Rattus norvegicus OX=10116 GN=Casr PE=1 SV=1,GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0005886; GO:0048856; GO:0055085; GO:0060089,circulatory system process; plasma membrane; anatomical structure development; transmembrane transport; molecular transducer activity
OG_02464,1.047324451703035,FUN_009655-T1,Peve_00003554,Pocillopora_meandrina_HIv1___RNAseq.g24582.t1,three_way,64.32866666666666,,,,,,,,,,,,,,,,,
OG_02468,1.4568744456547638,FUN_009667-T1,Peve_00009664,Pocillopora_meandrina_HIv1___RNAseq.g24575.t1,three_way,87.4595,,,,,,,,,,,,,,,,,
OG_02472,1.042309350642988,FUN_009674-T1,Peve_00009258,Pocillopora_meandrina_HIv1___RNAseq.g24570.t1,three_way,65.10866666666666,FUN_009674-T1,Q7ZW47,,,,,34.7,625.0,1.4e-71,272.3,sp|Q7ZW47|STAU2_DANRE Double-stranded RNA-binding protein Staufen homolog 2 OS=Danio rerio OX=7955 GN=stau2 PE=2 SV=2,,,,,,
OG_02475,1.685236563904614,FUN_009736-T1,Peve_00033566,Pocillopora_meandrina_HIv1___RNAseq.g29063.t1,three_way,57.04183333333333,FUN_009736-T1,G5EBQ8,CHS2_CAEEL,,Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2),Caenorhabditis elegans,32.1,764.0,9.100000000000001e-104,380.6,sp|G5EBQ8|CHS2_CAEEL Chitin synthase chs-2 OS=Caenorhabditis elegans OX=6239 GN=chs-2 PE=1 SV=1,GO:0004100; GO:0005886; GO:0006031; GO:0061063,chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063],plasma membrane [GO:0005886],chitin synthase activity [GO:0004100],GO:0003824; GO:0005886; GO:0016740; GO:1901135,catalytic activity; plasma membrane; transferase activity; carbohydrate derivative metabolic process
OG_02483,2.6659546929092715,FUN_009777-T1,Peve_00002096,Pocillopora_meandrina_HIv1___RNAseq.g24558.t1,three_way,79.21533333333333,FUN_009777-T1,Q9JID6,,,,,48.5,699.0,9.999999999999999e-193,674.9,sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1,,,,,,
OG_02484,2.680288137041405,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_02485,1.0781902030864303,FUN_009817-T1,Peve_00020547,Pocillopora_meandrina_HIv1___RNAseq.g24553.t1,three_way,74.48683333333334,FUN_009817-T1,Q3UQI9,,,,,37.9,771.0,2.3e-118,427.9,sp|Q3UQI9|MINY4_MOUSE Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 OS=Mus musculus OX=10090 GN=Mindy4 PE=1 SV=1,,,,,,
OG_02494,1.16844457259687,FUN_009828-T1,Peve_00042906,Pocillopora_meandrina_HIv1___TS.g12483.t2,three_way,70.49633333333334,FUN_009828-T1,Q58D00,,,,,50.3,344.0,1e-50,202.2,sp|Q58D00|FBXW2_BOVIN F-box/WD repeat-containing protein 2 OS=Bos taurus OX=9913 GN=FBXW2 PE=2 SV=1,,,,,,
OG_02495,1.104958515083559,FUN_009829-T1,Peve_00042905,Pocillopora_meandrina_HIv1___RNAseq.g24536.t1,three_way,71.46266666666666,FUN_009829-T1,Q9VKA4,,,,,35.4,539.0,1.8e-89,332.0,sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3,,,,,,
OG_02496,1.5254830296573765,FUN_009830-T2,Peve_00034091,Pocillopora_meandrina_HIv1___RNAseq.g24529.t1,three_way,75.58566666666667,,,,,,,,,,,,,,,,,
OG_02501,1.330500256387201,FUN_009856-T1,Peve_00009092,Pocillopora_meandrina_HIv1___RNAseq.g24507.t1,three_way,69.30833333333334,,,,,,,,,,,,,,,,,
OG_02505,2.010385738839991,FUN_009961-T1,Peve_00036464,Pocillopora_meandrina_HIv1___RNAseq.g24242.t1,three_way,77.88566666666667,FUN_009961-T1,Q90ZC7,KCMA1_XENLA,,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (xSlo)",Xenopus laevis (African clawed frog),45.5,1111.0,7.3e-262,905.2,sp|Q90ZC7|KCMA1_XENLA Calcium-activated potassium channel subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kcnma1 PE=2 SV=1,GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805,potassium ion transmembrane transport [GO:0071805],monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211],large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_02507,1.5470061537743975,FUN_010019-T1,Peve_00036456,Pocillopora_meandrina_HIv1___TS.g12195.t1a,three_way,70.6275,FUN_010019-T1,Q7Z5K2,WAPL_HUMAN,,Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor),Homo sapiens (Human),38.7,545.0,3.8e-92,340.9,sp|Q7Z5K2|WAPL_HUMAN Wings apart-like protein homolog OS=Homo sapiens OX=9606 GN=WAPL PE=1 SV=1,GO:0000070; GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0035562; GO:0043231; GO:0045171; GO:0045875; GO:0051301; GO:0071168; GO:0072686; GO:0140083,cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; protein localization to chromatin [GO:0071168],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP-dependent protein-DNA unloader activity [GO:0140083],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007059; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; chromosome segregation; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02508,1.478829118832672,FUN_010020-T1,Peve_00036457,Pocillopora_meandrina_HIv1___RNAseq.g24255.t1,three_way,74.96866666666666,FUN_010020-T1,Q7ZWN6,Z703A_XENLA,,Zinc finger protein 703-A,Xenopus laevis (African clawed frog),29.2,517.0,1.9e-22,108.6,sp|Q7ZWN6|Z703A_XENLA Zinc finger protein 703-A OS=Xenopus laevis OX=8355 GN=znf703-a PE=2 SV=2,GO:0005634; GO:0005737; GO:0008270; GO:0016363; GO:0017015; GO:0030335; GO:0034111; GO:0034333; GO:0045892; GO:0051726; GO:0060828,adherens junction assembly [GO:0034333]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0006355; GO:0034330; GO:0043226,nucleus; regulation of DNA-templated transcription; cell junction organization; organelle
OG_02512,1.0318302816328808,FUN_010555-T1,Peve_00032733,Pocillopora_meandrina_HIv1___RNAseq.g21411.t1,three_way,87.566,FUN_010555-T1,Q9R244,TRPC2_MOUSE,,Short transient receptor potential channel 2 (TrpC2) (Transient receptor protein 2) (TRP-2) (mTrp2),Mus musculus (Mouse),25.4,508.0,1.8e-30,137.1,sp|Q9R244|TRPC2_MOUSE Short transient receptor potential channel 2 OS=Mus musculus OX=10090 GN=Trpc2 PE=2 SV=2,GO:0000012; GO:0000139; GO:0002118; GO:0002121; GO:0002124; GO:0003684; GO:0005516; GO:0005634; GO:0005635; GO:0005789; GO:0005886; GO:0006816; GO:0007204; GO:0007340; GO:0008050; GO:0010468; GO:0012505; GO:0015279; GO:0019236; GO:0019992; GO:0032590; GO:0048047; GO:0070679; GO:1902436,"acrosome reaction [GO:0007340]; aggressive behavior [GO:0002118]; calcium ion transport [GO:0006816]; female courtship behavior [GO:0008050]; inter-male aggressive behavior [GO:0002121]; mating behavior, sex discrimination [GO:0048047]; negative regulation of male mating behavior [GO:1902436]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of gene expression [GO:0010468]; response to pheromone [GO:0019236]; single strand break repair [GO:0000012]; territorial aggressive behavior [GO:0002124]",dendrite membrane [GO:0032590]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calmodulin binding [GO:0005516]; damaged DNA binding [GO:0003684]; diacylglycerol binding [GO:0019992]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0003677; GO:0005215; GO:0005634; GO:0005635; GO:0005886; GO:0006281; GO:0008289; GO:0022414; GO:0043226,DNA binding; transporter activity; nucleus; nuclear envelope; plasma membrane; DNA repair; lipid binding; reproductive process; organelle
OG_02514,1.01256998900753,FUN_010558-T3,Peve_00032721,Pocillopora_meandrina_HIv1___RNAseq.g21414.t1,three_way,80.07333333333334,FUN_010558-T3,Q3KQ80,,,,,42.1,316.0,9.999999999999999e-57,222.2,sp|Q3KQ80|STPG1_XENLA O(6)-methylguanine-induced apoptosis 2 OS=Xenopus laevis OX=8355 GN=stpg1 PE=2 SV=1,,,,,,
OG_02516,2.428609112155395,FUN_010575-T1,Peve_00032734,Pocillopora_meandrina_HIv1___RNAseq.g21523.t1,three_way,73.19066666666667,FUN_010575-T1,Q9C091,GRB1L_HUMAN,,GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein),Homo sapiens (Human),33.4,1940.0,6.8e-250,866.3,sp|Q9C091|GRB1L_HUMAN GREB1-like protein OS=Homo sapiens OX=9606 GN=GREB1L PE=1 SV=2,GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0061205; GO:0072177,branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065],membrane [GO:0016020],,GO:0022414; GO:0030154; GO:0042254; GO:0048856,reproductive process; cell differentiation; ribosome biogenesis; anatomical structure development
OG_02517,1.097978468154343,FUN_010576-T1,Peve_00032735,Pocillopora_meandrina_HIv1___RNAseq.g21522.t1,three_way,61.242666666666665,,,,,,,,,,,,,,,,,
OG_02519,1.214566490270525,FUN_010579-T1,Peve_00032738,Pocillopora_meandrina_HIv1___RNAseq.g21519.t1,three_way,42.1245,FUN_010579-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),23.7,329.0,4.3e-11,71.2,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_02521,1.3519974366598977,FUN_010586-T1,Peve_00032749,Pocillopora_meandrina_HIv1___RNAseq.g21514.t1,three_way,59.089333333333336,FUN_010586-T1,Q28EM3,PARI_XENTR,,PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),24.7,636.0,5.9000000000000005e-30,134.0,sp|Q28EM3|PARI_XENTR PCNA-interacting partner OS=Xenopus tropicalis OX=8364 GN=parpbp PE=2 SV=2,GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:2000042,DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0006281; GO:0043226,DNA binding; nucleus; DNA repair; organelle
OG_02522,1.2647304290686276,FUN_010588-T1,Peve_00032700,Pocillopora_meandrina_HIv1___RNAseq.g21512.t1,three_way,83.79533333333333,FUN_010588-T1,Q6INX4,,,,,58.8,434.0,3.0000000000000003e-161,569.7,sp|Q6INX4|ENOF1_XENLA Mitochondrial enolase superfamily member 1 OS=Xenopus laevis OX=8355 GN=enosf1 PE=2 SV=1,,,,,,
OG_02526,2.2051923507889164,FUN_010598-T1,Peve_00032709,Pocillopora_meandrina_HIv1___RNAseq.g21501.t1,three_way,41.12233333333334,FUN_010598-T1,O82504,,,,,24.5,420.0,8.599999999999999e-24,113.6,sp|O82504|RDR2_ARATH RNA-dependent RNA polymerase 2 OS=Arabidopsis thaliana OX=3702 GN=RDR2 PE=1 SV=1,,,,,,
OG_02527,1.7692689455439263,FUN_010601-T1,Peve_00032713,Pocillopora_meandrina_HIv1___RNAseq.g21495.t1,three_way,71.13166666666666,,,,,,,,,,,,,,,,,
OG_02529,1.090792830727207,FUN_010604-T1,Peve_00032717,Pocillopora_meandrina_HIv1___RNAseq.g21493.t1,three_way,50.83316666666667,,,,,,,,,,,,,,,,,
OG_02532,2.2361536929904715,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_02534,1.0417478832202225,FUN_010613-T1,Peve_00013441,Pocillopora_meandrina_HIv1___RNAseq.g21489.t1,three_way,59.64266666666666,FUN_010613-T1,Q569U0,,,,,43.5,835.0,1.6000000000000002e-170,601.7,sp|Q569U0|MYO19_XENLA Unconventional myosin-XIX OS=Xenopus laevis OX=8355 GN=myo19 PE=2 SV=1,,,,,,
OG_02536,1.5870438817469636,FUN_010615-T1,Peve_00013370,Pocillopora_meandrina_HIv1___RNAseq.g21487.t1,three_way,60.214333333333336,FUN_010615-T1,Q8HZ58,,,,,23.2,293.0,1.3e-09,67.0,sp|Q8HZ58|CCHCR_PONPY Coiled-coil alpha-helical rod protein 1 OS=Pongo pygmaeus OX=9600 GN=CCHCR1 PE=3 SV=1,,,,,,
OG_02537,1.5837707683908104,FUN_010620-T1,Peve_00031460,Pocillopora_meandrina_HIv1___TS.g26115.t1,three_way,50.77283333333333,FUN_010620-T1,O14514,AGRB1_HUMAN,,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],Homo sapiens (Human),29.6,659.0,1.9999999999999999e-63,246.9,sp|O14514|AGRB1_HUMAN Adhesion G protein-coupled receptor B1 OS=Homo sapiens OX=9606 GN=ADGRB1 PE=1 SV=2,GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016020; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]",cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786],GO:0002376; GO:0005615; GO:0005886; GO:0007155; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0060089; GO:0061024; GO:0098542,immune system process; extracellular space; plasma membrane; cell adhesion; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; molecular transducer activity; membrane organization; defense response to other organism
OG_02539,1.1697373490849892,FUN_010622-T1,Peve_00010090,Pocillopora_meandrina_HIv1___RNAseq.g20925.t1,three_way,73.781,,,,,,,,,,,,,,,,,
OG_02540,1.9322328147237773,FUN_010623-T1,Peve_00004505,Pocillopora_meandrina_HIv1___RNAseq.g21294.t1,three_way,68.17916666666667,FUN_010623-T1,Q91VZ6,SMAP1_MOUSE,,Stromal membrane-associated protein 1,Mus musculus (Mouse),63.0,138.0,4.2999999999999996e-46,187.2,sp|Q91VZ6|SMAP1_MOUSE Stromal membrane-associated protein 1 OS=Mus musculus OX=10090 GN=Smap1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005886; GO:0008270; GO:0030276; GO:0045648; GO:2000369,positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_02543,1.0086747904079008,FUN_010626-T1,Peve_00004474,Pocillopora_meandrina_HIv1___RNAseq.g21298.t1,three_way,89.19266666666667,FUN_010626-T1,Q91YL3,,,,,66.8,400.0,5.5e-149,528.9,sp|Q91YL3|UCKL1_MOUSE Uridine-cytidine kinase-like 1 OS=Mus musculus OX=10090 GN=Uckl1 PE=1 SV=1,,,,,,
OG_02546,1.449290026361467,FUN_010633-T1,Peve_00004481,Pocillopora_meandrina_HIv1___RNAseq.g21305.t1,three_way,37.91866666666667,FUN_010633-T1,Q6P0J3,SP8_DANRE,,Transcription factor Sp8,Danio rerio (Zebrafish) (Brachydanio rerio),48.8,84.0,4.1e-15,84.7,sp|Q6P0J3|SP8_DANRE Transcription factor Sp8 OS=Danio rerio OX=7955 GN=sp8b PE=2 SV=1,GO:0000978; GO:0000981; GO:0003690; GO:0005634; GO:0006357; GO:0008270; GO:0030326; GO:0035118; GO:0045743,embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_02548,1.632247899438997,FUN_010635-T1,Peve_00009633,Pocillopora_meandrina_HIv1___RNAseq.g21307.t2,three_way,60.11416666666666,FUN_010635-T1,P07996,TSP1_HUMAN,,Thrombospondin-1 (Glycoprotein G),Homo sapiens (Human),59.6,525.0,5.4e-56,221.5,sp|P07996|TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens OX=9606 GN=THBS1 PE=1 SV=2,GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002020; GO:0002040; GO:0002544; GO:0002581; GO:0002605; GO:0004866; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006915; GO:0006954; GO:0006955; GO:0006986; GO:0007155; GO:0008201; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032693; GO:0032695; GO:0032720; GO:0032760; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0038060; GO:0040037; GO:0042327; GO:0042803; GO:0043032; GO:0043066; GO:0043236; GO:0043394; GO:0043410; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237,apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide-cGMP-mediated signaling [GO:0038060]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141],calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; endopeptidase inhibitor activity [GO:0004866]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431],GO:0002376; GO:0005198; GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0008289; GO:0012501; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048870; GO:0061024; GO:0098772,immune system process; structural molecule activity; extracellular region; extracellular space; endoplasmic reticulum; inflammatory response; cell adhesion; lipid binding; programmed cell death; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; cell motility; membrane organization; molecular function regulator activity
OG_02550,1.9009382267459376,FUN_010638-T1,Peve_00009636,Pocillopora_meandrina_HIv1___RNAseq.g21309.t1,three_way,85.60366666666667,FUN_010638-T1,P79733,RIR2_DANRE,,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),Danio rerio (Zebrafish) (Brachydanio rerio),79.4,335.0,5.3e-151,535.4,sp|P79733|RIR2_DANRE Ribonucleoside-diphosphate reductase subunit M2 OS=Danio rerio OX=7955 GN=rrm2 PE=1 SV=1,GO:0004748; GO:0005829; GO:0009263; GO:0046872,deoxyribonucleotide biosynthetic process [GO:0009263],cytosol [GO:0005829],"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",GO:0003824; GO:0005829; GO:0016491; GO:0055086; GO:1901135,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02557,1.3343913168504864,FUN_010654-T1,Peve_00031468,Pocillopora_meandrina_HIv1___RNAseq.g21322.t1,three_way,49.04883333333333,FUN_010654-T1,Q5FWF5,ESCO1_HUMAN,,N-acetyltransferase ESCO1 (EC 2.3.1.-) (CTF7 homolog 1) (Establishment factor-like protein 1) (EFO1) (EFO1p) (hEFO1) (Establishment of cohesion 1 homolog 1) (ECO1 homolog 1) (ESO1 homolog 1),Homo sapiens (Human),47.1,240.0,5.2e-58,227.3,sp|Q5FWF5|ESCO1_HUMAN N-acetyltransferase ESCO1 OS=Homo sapiens OX=9606 GN=ESCO1 PE=1 SV=3,GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0007062; GO:0007064; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733,mitotic sister chromatid cohesion [GO:0007064]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062],chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; protein-lysine-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02563,1.5220182537007894,FUN_010662-T1,Peve_00031441,Pocillopora_meandrina_HIv1___RNAseq.g21360.t1,three_way,72.268,FUN_010662-T1,Q8BZT9,LACC1_MOUSE,,Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28),Mus musculus (Mouse),42.9,266.0,7.3e-54,213.0,sp|Q8BZT9|LACC1_MOUSE Purine nucleoside phosphorylase LACC1 OS=Mus musculus OX=10090 GN=Lacc1 PE=1 SV=1,GO:0002221; GO:0002720; GO:0004000; GO:0004731; GO:0005634; GO:0005737; GO:0005777; GO:0005783; GO:0006954; GO:0017061; GO:0030641; GO:0045087; GO:0046872; GO:0047975; GO:0050727; GO:0070431; GO:1900542,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; peroxisome [GO:0005777],adenosine deaminase activity [GO:0004000]; guanosine phosphorylase activity [GO:0047975]; metal ion binding [GO:0046872]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061],GO:0002376; GO:0003824; GO:0005634; GO:0005777; GO:0005783; GO:0006954; GO:0016740; GO:0016787; GO:0043226; GO:0098542,immune system process; catalytic activity; nucleus; peroxisome; endoplasmic reticulum; inflammatory response; transferase activity; hydrolase activity; organelle; defense response to other organism
OG_02564,1.6387843196668992,FUN_010663-T1,Peve_00031442,Pocillopora_meandrina_HIv1___RNAseq.g21359.t1,three_way,44.581500000000005,FUN_010663-T1,Q99MV1,TDRD1_MOUSE,,Tudor domain-containing protein 1,Mus musculus (Mouse),28.6,814.0,2.1e-72,277.7,sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02568,1.0102067746078276,FUN_010668-T1,Peve_00031448,Pocillopora_meandrina_HIv1___RNAseq.g21354.t1,three_way,71.776,FUN_010668-T1,Q6GLL2,ABH6A_XENLA,,Monoacylglycerol lipase abhd6-A (EC 3.1.1.23) (Abhydrolase domain-containing protein 6-A),Xenopus laevis (African clawed frog),39.1,289.0,3.3e-56,220.3,sp|Q6GLL2|ABH6A_XENLA Monoacylglycerol lipase abhd6-A OS=Xenopus laevis OX=8355 GN=abhd6-a PE=2 SV=1,GO:0005765; GO:0016020; GO:0031902; GO:0031966; GO:0032281; GO:0046464; GO:0047372; GO:0052651; GO:2001311,acylglycerol catabolic process [GO:0046464]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651],AMPA glutamate receptor complex [GO:0032281]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966],monoacylglycerol lipase activity [GO:0047372],GO:0003824; GO:0006629; GO:0016787; GO:1901135,catalytic activity; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_02570,1.0344285555114905,FUN_010672-T1,Peve_00031451,Pocillopora_meandrina_HIv1___RNAseq.g21351.t1,three_way,71.39183333333334,FUN_010672-T1,Q9UL68,,,,,56.0,175.0,1.5e-17,93.2,sp|Q9UL68|MYT1L_HUMAN Myelin transcription factor 1-like protein OS=Homo sapiens OX=9606 GN=MYT1L PE=1 SV=3,,,,,,
OG_02570,1.0344285555114905,FUN_010672-T1,Peve_00031451,Pocillopora_meandrina_HIv1___RNAseq.g21351.t1,three_way,71.39183333333334,FUN_010672-T1,Q9UL68,,,,,73.0,37.0,1.8e-10,69.7,sp|Q9UL68|MYT1L_HUMAN Myelin transcription factor 1-like protein OS=Homo sapiens OX=9606 GN=MYT1L PE=1 SV=3,,,,,,
OG_02570,1.0344285555114905,FUN_010672-T1,Peve_00031451,Pocillopora_meandrina_HIv1___RNAseq.g21351.t1,three_way,71.39183333333334,FUN_010672-T1,Q9UL68,,,,,51.2,41.0,3e-05,52.4,sp|Q9UL68|MYT1L_HUMAN Myelin transcription factor 1-like protein OS=Homo sapiens OX=9606 GN=MYT1L PE=1 SV=3,,,,,,
OG_02571,1.6104977489149577,FUN_010674-T1,Peve_00044786,Pocillopora_meandrina_HIv1___RNAseq.g21350.t1,three_way,81.68766666666667,FUN_010674-T1,O75116,ROCK2_HUMAN,,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",Homo sapiens (Human),50.3,445.0,8.199999999999999e-109,396.7,sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4,GO:0000281; GO:0001837; GO:0001934; GO:0002020; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007266; GO:0008270; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061133; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; zinc ion binding [GO:0008270],GO:0000910; GO:0003012; GO:0003013; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0030154; GO:0043226; GO:0072659; GO:0098772; GO:0140096,"cytokinesis; muscle system process; circulatory system process; RNA binding; catalytic activity; structural molecule activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; cell differentiation; organelle; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02580,1.486971886698619,FUN_010696-T1,Peve_00040382,Pocillopora_meandrina_HIv1___RNAseq.g6938.t1,three_way,55.94833333333333,FUN_010696-T1,F4JTS8,NOV_ARATH,,Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597),Arabidopsis thaliana (Mouse-ear cress),26.4,2000.0,7.3e-152,541.2,sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1,GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364,auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827],nucleus [GO:0005634],,GO:0005634; GO:0022414; GO:0043226; GO:0048856,nucleus; reproductive process; organelle; anatomical structure development
OG_02584,2.226749394575489,FUN_010703-T1,Peve_00022609,Pocillopora_meandrina_HIv1___TS.g25727.t1,three_way,70.271,,,,,,,,,,,,,,,,,
OG_02589,1.352230931704307,FUN_010709-T1,Peve_00022594,Pocillopora_meandrina_HIv1___RNAseq.g20962.t1,three_way,45.36966666666667,FUN_010709-T1,Q21313,EPI1_CAEEL,,Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1),Caenorhabditis elegans,29.1,110.0,3.4e-06,55.1,sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1,GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0022414; GO:0040017; GO:0042127; GO:0051788; GO:0071711,animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; reproductive process [GO:0022414]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888],basement membrane [GO:0005604]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0007155; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; cell adhesion; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_02594,1.0579467440660326,FUN_010714-T1,Peve_00022559,Pocillopora_meandrina_HIv1___RNAseq.g20957.t1,three_way,53.61783333333334,FUN_010714-T1,Q8WV22,NSE1_HUMAN,,Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27),Homo sapiens (Human),34.5,258.0,3.2e-35,150.2,sp|Q8WV22|NSE1_HUMAN Non-structural maintenance of chromosomes element 1 homolog OS=Homo sapiens OX=9606 GN=NSMCE1 PE=1 SV=5,GO:0000724; GO:0000775; GO:0000781; GO:0004842; GO:0005634; GO:0005654; GO:0006974; GO:0008270; GO:0016925; GO:0030915; GO:0032204; GO:0043231; GO:0046983; GO:0061630; GO:0097431; GO:0140588,chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204],"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]",protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02595,1.0340696655011434,FUN_010716-T1,Peve_00022598,Pocillopora_meandrina_HIv1___RNAseq.g20955.t1,three_way,82.276,FUN_010716-T1,P17713,,,,,64.1,512.0,3.7e-192,672.5,sp|P17713|STK_HYDVU Tyrosine-protein kinase STK OS=Hydra vulgaris OX=6087 GN=STK PE=2 SV=1,,,,,,
OG_02596,1.2869064437952091,FUN_010717-T1,Peve_00022590,Pocillopora_meandrina_HIv1___RNAseq.g20954.t1,three_way,77.32616666666667,FUN_010717-T1,Q9V9J3,SRC42_DROME,,Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41),Drosophila melanogaster (Fruit fly),57.2,530.0,1.7e-168,594.0,sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1,GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136; GO:0106016,"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005886; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; cytosol; plasma membrane; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_02599,3.1199385858409743,FUN_010720-T1,Peve_00029905,Pocillopora_meandrina_HIv1___RNAseq.g20949.t2,three_way,83.7885,FUN_010720-T1,P58197,AP2A_RAT,,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),Rattus norvegicus (Rat),63.4,227.0,3.3e-68,260.8,sp|P58197|AP2A_RAT Transcription factor AP-2-alpha OS=Rattus norvegicus OX=10116 GN=Tfap2a PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001501; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:1990837; GO:2000378,anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559],clathrin-coated pit [GO:0005905]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0012501; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; extracellular matrix organization; organelle; anatomical structure development; cell motility; nervous system process; molecular adaptor activity; transcription regulator activity
OG_02600,2.157198663117496,FUN_010726-T1,Peve_00038971,Pocillopora_meandrina_HIv1___RNAseq.g20947.t1,three_way,72.91166666666666,FUN_010726-T1,Q17QM4,EPT1_BOVIN,,Ethanolaminephosphotransferase 1 (EC 2.7.8.1) (Selenoprotein I) (SelI),Bos taurus (Bovine),44.5,380.0,3.2999999999999996e-90,333.6,sp|Q17QM4|EPT1_BOVIN Ethanolaminephosphotransferase 1 OS=Bos taurus OX=9913 GN=SELENOI PE=2 SV=3,GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0008611; GO:0042552; GO:0046872,ether lipid biosynthetic process [GO:0008611]; myelination [GO:0042552]; phosphatidylethanolamine biosynthetic process [GO:0006646],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0006629; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; lipid metabolic process; transferase activity; organelle
OG_02606,1.4388468972847182,FUN_010735-T1,Peve_00038977,Pocillopora_meandrina_HIv1___RNAseq.g20941.t1,three_way,82.79933333333334,FUN_010735-T1,Q9V9J3,SRC42_DROME,,Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41),Drosophila melanogaster (Fruit fly),64.1,468.0,4.3999999999999985e-177,622.5,sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1,GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136; GO:0106016,"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005886; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; cytosol; plasma membrane; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_02607,1.1888020817012932,FUN_010736-T1,Peve_00038978,Pocillopora_meandrina_HIv1___RNAseq.g20940.t1,three_way,50.23233333333334,FUN_010736-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),28.3,762.0,9.3e-88,327.4,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_02612,1.2174428714926215,FUN_010746-T1,Peve_00038410,Pocillopora_meandrina_HIv1___RNAseq.g20932.t1,three_way,83.767,FUN_010746-T1,Q96QK8,,,,,62.9,70.0,3.9e-19,95.1,sp|Q96QK8|SIM14_HUMAN Small integral membrane protein 14 OS=Homo sapiens OX=9606 GN=SMIM14 PE=1 SV=1,,,,,,
OG_02614,1.5688907687110094,FUN_010753-T1,Peve_00004503,Pocillopora_meandrina_HIv1___RNAseq.g21292.t1,three_way,87.76683333333334,FUN_010753-T1,Q9NV56,,,,,61.1,90.0,1.4e-26,120.9,sp|Q9NV56|MRGBP_HUMAN MRG/MORF4L-binding protein OS=Homo sapiens OX=9606 GN=MRGBP PE=1 SV=1,,,,,,
OG_02616,1.7344205257570462,FUN_010755-T1,Peve_00008039,Pocillopora_meandrina_HIv1___RNAseq.g20929.t1,three_way,67.73883333333333,FUN_010755-T1,A7RM45,,,,,60.1,552.0,4.8e-161,569.3,sp|A7RM45|LMBD1_NEMVE Probable lysosomal cobalamin transporter OS=Nematostella vectensis OX=45351 GN=v1g160387 PE=3 SV=1,,,,,,
OG_02620,1.6333256500014866,FUN_010763-T1,Peve_00008038,Pocillopora_meandrina_HIv1___RNAseq.g20924.t1,three_way,83.1185,FUN_010763-T1,O46382,,,,,58.7,1985.0,0.0,2090.5,sp|O46382|BIG1_BOVIN Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Bos taurus OX=9913 GN=ARFGEF1 PE=1 SV=1,,,,,,
OG_02625,1.6224337178505517,FUN_010775-T1,Peve_00004492,Pocillopora_meandrina_HIv1___RNAseq.g21202.t1,three_way,84.75166666666667,FUN_010775-T1,Q15560,TCEA2_HUMAN,,Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l),Homo sapiens (Human),48.7,306.0,6.9e-69,262.3,sp|Q15560|TCEA2_HUMAN Transcription elongation factor A protein 2 OS=Homo sapiens OX=9606 GN=TCEA2 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005654; GO:0005813; GO:0006354; GO:0006357; GO:0006368; GO:0008023; GO:0008270; GO:0032784; GO:0036064,DNA-templated transcription elongation [GO:0006354]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; microtubule organizing center; regulation of DNA-templated transcription; organelle
OG_02626,1.80760335288082,FUN_010776-T1,Peve_00004491,Pocillopora_meandrina_HIv1___RNAseq.g21203.t1,three_way,66.07983333333334,,,,,,,,,,,,,,,,,
OG_02627,1.3043704866898531,FUN_010779-T1,Peve_00004487,Pocillopora_meandrina_HIv1___TS.g25955.t1,three_way,91.82266666666666,FUN_010779-T1,Q9D1P2,KAT8_MOUSE,,"Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Males-absent on the first protein homolog) (mMof) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-)",Mus musculus (Mouse),76.1,397.0,6.4e-180,631.7,sp|Q9D1P2|KAT8_MOUSE Histone acetyltransferase KAT8 OS=Mus musculus OX=10090 GN=Kat8 PE=1 SV=1,GO:0000123; GO:0000776; GO:0003713; GO:0005634; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010506; GO:0010719; GO:0016363; GO:0016407; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0035166; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:1902726; GO:1903108; GO:1990841,dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; mitochondrion; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02631,1.1260341282514958,FUN_010784-T1,Peve_00004483,Pocillopora_meandrina_HIv1___RNAseq.g21211.t1,three_way,60.87499999999999,,,,,,,,,,,,,,,,,
OG_02639,1.2840845811756485,FUN_010807-T1,Peve_00006506,Pocillopora_meandrina_HIv1___RNAseq.g20902.t1,three_way,83.408,FUN_010807-T1,Q9QXG4,ACSA_MOUSE,,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)",Mus musculus (Mouse),65.8,679.0,2.1999999999999999e-280,966.1,"sp|Q9QXG4|ACSA_MOUSE Acetyl-coenzyme A synthetase, cytoplasmic OS=Mus musculus OX=10090 GN=Acss2 PE=1 SV=2",GO:0003682; GO:0003713; GO:0003987; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006085; GO:0006629; GO:0007616; GO:0050218,acetyl-CoA biosynthetic process [GO:0006085]; lipid metabolic process [GO:0006629]; long-term memory [GO:0007616],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; propionate-CoA ligase activity [GO:0050218]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005829; GO:0006629; GO:0006790; GO:0016874; GO:0043226; GO:0050877; GO:0055086; GO:0060090; GO:0140110; GO:0140657,catalytic activity; nucleus; cytosol; lipid metabolic process; sulfur compound metabolic process; ligase activity; organelle; nervous system process; nucleobase-containing small molecule metabolic process; molecular adaptor activity; transcription regulator activity; ATP-dependent activity
OG_02641,1.5478176593132325,FUN_010809-T1,Peve_00034256,Pocillopora_meandrina_HIv1___TS.g25664.t1,three_way,62.525333333333336,FUN_010809-T1,Q49LS8,,,,,33.2,365.0,2.1e-46,188.3,sp|Q49LS8|XKR6_TETNG XK-related protein 6 OS=Tetraodon nigroviridis OX=99883 GN=xkr6 PE=2 SV=1,,,,,,
OG_02642,1.9709318201955173,FUN_010810-T1,Peve_00006510,Pocillopora_meandrina_HIv1___RNAseq.g20905.t1,three_way,54.041,FUN_010810-T1,Q49LS8,,,,,31.2,420.0,1e-51,207.2,sp|Q49LS8|XKR6_TETNG XK-related protein 6 OS=Tetraodon nigroviridis OX=99883 GN=xkr6 PE=2 SV=1,,,,,,
OG_02645,2.40581090586202,FUN_010818-T1,Peve_00006523,Pocillopora_meandrina_HIv1___RNAseq.g20909.t1,three_way,90.38933333333334,FUN_010818-T1,Q8R4V0,SGK3_RAT,,Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like),Rattus norvegicus (Rat),62.1,451.0,9.6e-163,574.7,sp|Q8R4V0|SGK3_RAT Serine/threonine-protein kinase Sgk3 OS=Rattus norvegicus OX=10116 GN=Sgk3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005769; GO:0015459; GO:0031410; GO:0035091; GO:0035556; GO:0055037; GO:0060090; GO:0106310; GO:2001240,intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240],cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; recycling endosome [GO:0055037],ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005768; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0060090; GO:0098772; GO:0140096,"catalytic activity; endosome; lipid binding; transferase activity; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02652,1.1114479546728608,FUN_010835-T1,Peve_00030776,Pocillopora_meandrina_HIv1___RNAseq.g20920.t1,three_way,69.44516666666667,FUN_010835-T1,Q8BFW9,,,,,39.7,574.0,5.3e-110,399.8,"sp|Q8BFW9|GTR12_MOUSE Solute carrier family 2, facilitated glucose transporter member 12 OS=Mus musculus OX=10090 GN=Slc2a12 PE=2 SV=1",,,,,,
OG_02655,1.0936495277914229,FUN_010838-T1,Peve_00014585,Pocillopora_meandrina_HIv1___RNAseq.g21010.t1,three_way,86.72466666666666,FUN_010838-T1,Q4V7Z0,,,,,63.6,280.0,6.3e-101,368.6,sp|Q4V7Z0|GPN3_XENLA GPN-loop GTPase 3 OS=Xenopus laevis OX=8355 GN=gpn3 PE=2 SV=1,,,,,,
OG_02657,1.325379004814405,FUN_010840-T3,Peve_00014596,Pocillopora_meandrina_HIv1___RNAseq.g21008.t1,three_way,71.34866666666667,FUN_010840-T3,Q05B79,DHX36_BOVIN,,ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein),Bos taurus (Bovine),49.9,1010.0,5.3e-265,915.6,sp|Q05B79|DHX36_BOVIN ATP-dependent DNA/RNA helicase DHX36 OS=Bos taurus OX=9913 GN=DHX36 PE=1 SV=1,GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:0140640; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]",GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0098542; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02658,1.3196284704361616,FUN_010841-T1,Peve_00024826,Pocillopora_meandrina_HIv1___RNAseq.g21007.t1,three_way,64.80283333333334,FUN_010841-T1,Q8NDL9,CBPC5_HUMAN,,Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5),Homo sapiens (Human),47.5,703.0,2.5e-179,630.9,sp|Q8NDL9|CBPC5_HUMAN Cytosolic carboxypeptidase-like protein 5 OS=Homo sapiens OX=9606 GN=AGBL5 PE=1 SV=1,GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686,C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02663,1.449462800635388,FUN_010879-T1,Peve_00035832,Pocillopora_meandrina_HIv1___RNAseq.g21030.t1,three_way,86.78866666666667,FUN_010879-T1,Q2KJI3,CYRIB_BOVIN,,CYFIP-related Rac1 interactor B (Protein FAM49B),Bos taurus (Bovine),65.7,327.0,8.4e-116,418.3,sp|Q2KJI3|CYRIB_BOVIN CYFIP-related Rac1 interactor B OS=Bos taurus OX=9913 GN=CYRIB PE=2 SV=1,GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568,cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of type II interferon production [GO:0032729]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140],cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739],"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; small GTPase binding [GO:0031267]",GO:0005739; GO:0005929; GO:0043226,mitochondrion; cilium; organelle
OG_02664,1.2168659375888982,FUN_010883-T1,Peve_00035843,Pocillopora_meandrina_HIv1___RNAseq.g21034.t1,three_way,65.3205,,,,,,,,,,,,,,,,,
OG_02668,1.2221167121742251,FUN_010887-T1,Peve_00035839,Pocillopora_meandrina_HIv1___RNAseq.g21002.t1,three_way,87.91066666666666,FUN_010887-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),67.4,307.0,5e-129,463.0,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_02669,1.3150713826130656,FUN_010888-T1,Peve_00035840,Pocillopora_meandrina_HIv1___RNAseq.g21001.t1,three_way,71.89333333333333,FUN_010888-T1,Q8VCM5,MUL1_MOUSE,,Mitochondrial ubiquitin ligase activator of NFKB 1 (EC 2.3.2.27) (E3 ubiquitin-protein ligase MUL1) (Growth inhibition and death E3 ligase) (Protein Hades) (RING-type E3 ubiquitin transferase NFKB 1),Mus musculus (Mouse),34.8,339.0,9.3e-59,228.8,sp|Q8VCM5|MUL1_MOUSE Mitochondrial ubiquitin ligase activator of NFKB 1 OS=Mus musculus OX=10090 GN=Mul1 PE=1 SV=2,GO:0000209; GO:0000266; GO:0002039; GO:0005739; GO:0005741; GO:0005777; GO:0006915; GO:0008270; GO:0010637; GO:0016567; GO:0016925; GO:0019789; GO:0030424; GO:0031625; GO:0031647; GO:0031648; GO:0033235; GO:0042802; GO:0043025; GO:0043123; GO:0045824; GO:0050689; GO:0050821; GO:0051646; GO:0051881; GO:0051898; GO:0060339; GO:0061630; GO:0071360; GO:0071650; GO:0090141; GO:1901028; GO:1903861; GO:1905091,apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of innate immune response [GO:0045824]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite extension [GO:1903861]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of protein stability [GO:0031647],axon [GO:0030424]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777],identical protein binding [GO:0042802]; p53 binding [GO:0002039]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0005777; GO:0007005; GO:0012501; GO:0016740; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; mitochondrion; peroxisome; mitochondrion organization; programmed cell death; transferase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_02671,2.210959984154575,FUN_010896-T1,Peve_00044943,Pocillopora_meandrina_HIv1___RNAseq.g20992.t1,three_way,75.72,FUN_010896-T1,Q10075,PCS_SCHPO,,Glutathione gamma-glutamylcysteinyltransferase (EC 2.3.2.15) (Phytochelatin synthase),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),44.3,235.0,1.8e-53,211.1,sp|Q10075|PCS_SCHPO Glutathione gamma-glutamylcysteinyltransferase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC3H1.10 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0010273; GO:0016756; GO:0046870; GO:0046938; GO:0071276; GO:0098849,cellular detoxification of cadmium ion [GO:0098849]; cellular response to cadmium ion [GO:0071276]; detoxification of copper ion [GO:0010273]; phytochelatin biosynthetic process [GO:0046938],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cadmium ion binding [GO:0046870]; glutathione gamma-glutamylcysteinyltransferase activity [GO:0016756],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0098754,catalytic activity; nucleus; cytosol; transferase activity; organelle; detoxification
OG_02676,1.1675254653184717,FUN_010925-T1,Peve_00005955,Pocillopora_meandrina_HIv1___RNAseq.g21797.t1,three_way,57.31033333333333,,,,,,,,,,,,,,,,,
OG_02679,1.4670865505398547,FUN_010929-T1,Peve_00005959,Pocillopora_meandrina_HIv1___RNAseq.g20983.t1,three_way,77.19966666666666,FUN_010929-T1,Q29RS4,IN80E_BOVIN,,INO80 complex subunit E (Coiled-coil domain-containing protein 95),Bos taurus (Bovine),70.3,64.0,1.3e-16,88.6,sp|Q29RS4|IN80E_BOVIN INO80 complex subunit E OS=Bos taurus OX=9913 GN=INO80E PE=2 SV=1,GO:0006281; GO:0006310; GO:0006338; GO:0031011,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],Ino80 complex [GO:0031011],,GO:0006281; GO:0006310; GO:0006325,DNA repair; DNA recombination; chromatin organization
OG_02683,1.6397973542697228,FUN_010941-T1,Peve_00005967,Pocillopora_meandrina_HIv1___RNAseq.g21806.t1,three_way,91.54933333333334,FUN_010941-T1,E2QWQ2,NLK_CANLF,,Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase),Canis lupus familiaris (Dog) (Canis familiaris),72.8,390.0,1.6000000000000002e-164,580.5,sp|E2QWQ2|NLK_CANLF Serine/threonine-protein kinase NLK OS=Canis lupus familiaris OX=9615 GN=NLK PE=3 SV=1,GO:0000287; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0007179; GO:0016055; GO:0030178; GO:0031625; GO:0035556; GO:0042169; GO:0050821; GO:0071470; GO:0106310; GO:0140297; GO:1904262; GO:1904894,cellular response to osmotic stress [GO:0071470]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH2 domain binding [GO:0042169]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02684,1.4410660186732522,FUN_010942-T2,Peve_00040402,Pocillopora_meandrina_HIv1___RNAseq.g21807.t1,three_way,57.24416666666667,FUN_010942-T2,Q9EST3,4ET_MOUSE,,Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (CD40 ligand-activated specific transcript 4) (Eukaryotic translation initiation factor 4E nuclear import factor 1),Mus musculus (Mouse),25.5,842.0,3.2999999999999997e-29,132.5,sp|Q9EST3|4ET_MOUSE Eukaryotic translation initiation factor 4E transporter OS=Mus musculus OX=10090 GN=Eif4enif1 PE=1 SV=2,GO:0000932; GO:0003729; GO:0005049; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006606; GO:0016605; GO:0016607; GO:0017148; GO:0019827; GO:0019900; GO:0030182; GO:0033962; GO:0035278; GO:0045665; GO:0048255; GO:0060213; GO:0106289,miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA stabilization [GO:0048255]; negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106289]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; P-body assembly [GO:0033962]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein import into nucleus [GO:0006606]; stem cell population maintenance [GO:0019827]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; PML body [GO:0016605],kinase binding [GO:0019900]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049],GO:0003723; GO:0005634; GO:0005829; GO:0006886; GO:0006913; GO:0030154; GO:0031047; GO:0043226; GO:0140104,RNA binding; nucleus; cytosol; intracellular protein transport; nucleocytoplasmic transport; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular carrier activity
OG_02690,2.466449049873523,FUN_010950-T1,Peve_00040405,Pocillopora_meandrina_HIv1___RNAseq.g21821.t1,three_way,69.54883333333333,FUN_010950-T1,Q7TN88,,,,,38.0,403.0,5.7e-77,292.4,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_02694,1.2008696741952625,FUN_010957-T1,Peve_00035899,Pocillopora_meandrina_HIv1___RNAseq.g21825.t1,three_way,53.990833333333335,,,,,,,,,,,,,,,,,
OG_02696,1.2001893628740683,FUN_010960-T1,Peve_00007918,Pocillopora_meandrina_HIv1___RNAseq.g21827.t1,three_way,80.13816666666666,FUN_010960-T1,Q5F259,AN13B_MOUSE,,Ankyrin repeat domain-containing protein 13B,Mus musculus (Mouse),45.7,532.0,1.2e-126,455.3,sp|Q5F259|AN13B_MOUSE Ankyrin repeat domain-containing protein 13B OS=Mus musculus OX=10090 GN=Ankrd13b PE=2 SV=1,GO:0002091; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0048471; GO:0140036,negative regulation of receptor internalization [GO:0002091],cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ubiquitin-modified protein reader activity [GO:0140036],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0060090,endosome; plasma membrane; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_02704,1.190698027966443,FUN_010979-T2,Peve_00013382,Pocillopora_meandrina_HIv1___RNAseq.g22013.t1,three_way,50.22,,,,,,,,,,,,,,,,,
OG_02707,1.4542935554299086,FUN_010984-T1,Peve_00013386,Pocillopora_meandrina_HIv1___RNAseq.g22009.t1,three_way,79.6975,FUN_010984-T1,Q7Z3V4,UBE3B_HUMAN,,Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B),Homo sapiens (Human),50.4,1075.0,3.1e-310,1065.8,sp|Q7Z3V4|UBE3B_HUMAN Ubiquitin-protein ligase E3B OS=Homo sapiens OX=9606 GN=UBE3B PE=1 SV=3,GO:0000209; GO:0005739; GO:0006511; GO:0014069; GO:0061630; GO:0098978; GO:0150052,protein polyubiquitination [GO:0000209]; regulation of postsynapse assembly [GO:0150052]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; postsynaptic density [GO:0014069],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02709,1.178490273541137,FUN_010986-T1,Peve_00013392,Pocillopora_meandrina_HIv1___RNAseq.g22007.t2,three_way,74.76766666666667,FUN_010986-T1,Q96LW2,,,,,38.4,315.0,3.4e-61,237.3,sp|Q96LW2|KS6R_HUMAN Ribosomal protein S6 kinase-related protein OS=Homo sapiens OX=9606 GN=RSKR PE=1 SV=3,,,,,,
OG_02712,1.4323554730330486,FUN_010990-T1,Peve_00013396,Pocillopora_meandrina_HIv1___TS.g29847.t1,three_way,54.55116666666667,FUN_010990-T1,Q6J4K2,NCLX_HUMAN,,"Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",Homo sapiens (Human),39.1,539.0,1.6e-99,365.2,sp|Q6J4K2|NCLX_HUMAN Mitochondrial sodium/calcium exchanger protein OS=Homo sapiens OX=9606 GN=SLC8B1 PE=1 SV=2,GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006811; GO:0006851; GO:0006874; GO:0015368; GO:0016020; GO:0030061; GO:0031966; GO:0042383; GO:0042593; GO:0042803; GO:0050796; GO:0051480; GO:0051560; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256,calcium export from the mitochondrion [GO:0099093]; glucose homeostasis [GO:0042593]; intracellular calcium ion homeostasis [GO:0006874]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; monoatomic ion transport [GO:0006811]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256],membrane [GO:0016020]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_02714,1.1750000193942247,FUN_010997-T1,Peve_00013403,Pocillopora_meandrina_HIv1___RNAseq.g22025.t1,three_way,73.773,FUN_010997-T1,P78330,SERB_HUMAN,,Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase),Homo sapiens (Human),57.1,219.0,8.8e-70,265.0,sp|P78330|SERB_HUMAN Phosphoserine phosphatase OS=Homo sapiens OX=9606 GN=PSPH PE=1 SV=2,GO:0000287; GO:0001701; GO:0005737; GO:0005829; GO:0006563; GO:0006564; GO:0009612; GO:0031667; GO:0033574; GO:0036424; GO:0042802; GO:0042803,in utero embryonic development [GO:0001701]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574],cytoplasm [GO:0005737]; cytosol [GO:0005829],identical protein binding [GO:0042802]; L-phosphoserine phosphatase activity [GO:0036424]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016787; GO:0048856,catalytic activity; cytosol; amino acid metabolic process; hydrolase activity; anatomical structure development
OG_02718,2.593542860454211,FUN_011001-T1,Peve_00013415,Pocillopora_meandrina_HIv1___RNAseq.g22019.t1,three_way,62.246,FUN_011001-T1,A8WFU8,KIF22_DANRE,,Kinesin-like protein KIF22,Danio rerio (Zebrafish) (Brachydanio rerio),41.6,632.0,3.4e-120,433.7,sp|A8WFU8|KIF22_DANRE Kinesin-like protein KIF22 OS=Danio rerio OX=7955 GN=kif22 PE=2 SV=1,GO:0001756; GO:0001966; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007409; GO:0007420; GO:0008017; GO:0016887; GO:0021952; GO:0048592,axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; eye morphogenesis [GO:0048592]; microtubule-based movement [GO:0007018]; somitogenesis [GO:0001756]; thigmotaxis [GO:0001966],cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003677; GO:0003774; GO:0003824; GO:0005634; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0140657,DNA binding; cytoskeletal motor activity; catalytic activity; nucleus; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; anatomical structure development; ATP-dependent activity
OG_02720,2.2899505446760218,FUN_011048-T1,Peve_00013435,Pocillopora_meandrina_HIv1___RNAseq.g21483.t1,three_way,68.41766666666666,FUN_011048-T1,Q5PQT2,MTMR3_RAT,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase)",Rattus norvegicus (Rat),37.4,1193.0,2.4e-206,720.7,"sp|Q5PQT2|MTMR3_RAT Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Rattus norvegicus OX=10116 GN=Mtmr3 PE=1 SV=1",GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016020; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785,cellular response to glucose starvation [GO:0042149]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],"molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0060090; GO:0061024; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; hydrolase activity; molecular adaptor activity; membrane organization; catalytic activity, acting on a protein"
OG_02723,1.3472466911643963,FUN_011058-T1,Peve_00009503,Pocillopora_meandrina_HIv1___RNAseq.g22353.t1,three_way,79.46733333333333,FUN_011058-T1,P57772,SELB_HUMAN,,"Selenocysteine-specific elongation factor (EC 3.6.5.-) (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific)",Homo sapiens (Human),58.6,594.0,1.7999999999999998e-190,667.2,sp|P57772|SELB_HUMAN Selenocysteine-specific elongation factor OS=Homo sapiens OX=9606 GN=EEFSEC PE=1 SV=4,GO:0000049; GO:0001514; GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0035368; GO:0043021; GO:1990904,selenocysteine incorporation [GO:0001514],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0003924; GO:0005634; GO:0016787; GO:0043226,RNA binding; catalytic activity; GTPase activity; nucleus; hydrolase activity; organelle
OG_02727,1.5618178854203406,FUN_011179-T1,Peve_00006850,Pocillopora_meandrina_HIv1___RNAseq.g22322.t1,three_way,55.33916666666666,FUN_011179-T1,Q0V9E9,KMT5A_XENTR,,N-lysine methyltransferase KMT5A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine-specific methylase 5A) (SET domain-containing protein 8),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),50.6,174.0,1.2999999999999998e-47,191.8,sp|Q0V9E9|KMT5A_XENTR N-lysine methyltransferase KMT5A OS=Xenopus tropicalis OX=8364 GN=kmt5a PE=2 SV=1,GO:0005634; GO:0005694; GO:0032259; GO:0042054; GO:0051301; GO:0140944,cell division [GO:0051301]; methylation [GO:0032259],chromosome [GO:0005694]; nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054],GO:0003824; GO:0005634; GO:0005694; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02728,1.6241376326360877,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_02730,1.1679321312472448,FUN_011258-T1,Peve_00030534,Pocillopora_meandrina_HIv1___RNAseq.g22312.t1,three_way,68.89616666666667,FUN_011258-T1,A7MBS7,THS7A_DANRE,,Thrombospondin type-1 domain-containing protein 7A,Danio rerio (Zebrafish) (Brachydanio rerio),37.6,85.0,3.7e-08,60.5,sp|A7MBS7|THS7A_DANRE Thrombospondin type-1 domain-containing protein 7A OS=Danio rerio OX=7955 GN=thsd7aa PE=1 SV=2,GO:0001525; GO:0002040; GO:0003094; GO:0005886; GO:0008593; GO:0030036; GO:0032835; GO:0042995; GO:0043534; GO:0048675; GO:0072015,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerulus development [GO:0032835]; podocyte development [GO:0072015]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040],cell projection [GO:0042995]; plasma membrane [GO:0005886],,GO:0003014; GO:0005886; GO:0007010; GO:0048856; GO:0048870,renal system process; plasma membrane; cytoskeleton organization; anatomical structure development; cell motility
OG_02741,2.3301898084596973,FUN_011284-T1,Peve_00033625,Pocillopora_meandrina_HIv1___RNAseq.g22145.t2,three_way,53.47266666666667,FUN_011284-T1,Q5M775,CYTSB_HUMAN,,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),Homo sapiens (Human),46.2,106.0,1.9e-21,106.3,sp|Q5M775|CYTSB_HUMAN Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177,actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824],apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0048856; GO:0050877,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; organelle; anatomical structure development; nervous system process
OG_02743,1.1439751666016356,FUN_011307-T1,Peve_00042903,Pocillopora_meandrina_HIv1___RNAseq.g22315.t1,three_way,85.486,FUN_011307-T1,Q07994,,,,,59.8,478.0,1.3e-170,600.9,sp|Q07994|NCPR_MUSDO NADPH--cytochrome P450 reductase OS=Musca domestica OX=7370 PE=2 SV=1,,,,,,
OG_02744,3.1720993947677187,FUN_011308-T1,Peve_00024988,Pocillopora_meandrina_HIv1___RNAseq.g22351.t1,three_way,73.087,FUN_011308-T1,Q8L7W2,,,,,39.7,214.0,6.0999999999999996e-43,176.0,sp|Q8L7W2|NUDT8_ARATH Nudix hydrolase 8 OS=Arabidopsis thaliana OX=3702 GN=NUDT8 PE=2 SV=2,,,,,,
OG_02748,1.5452761558009207,FUN_011416-T1,Peve_00033619,Pocillopora_meandrina_HIv1___TS.g27041.t2,three_way,80.652,FUN_011416-T1,Q14165,MLEC_HUMAN,,Malectin,Homo sapiens (Human),54.3,245.0,9.6e-67,255.0,sp|Q14165|MLEC_HUMAN Malectin OS=Homo sapiens OX=9606 GN=MLEC PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0008250; GO:0016020; GO:0019899; GO:0030246; GO:0035579,,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899],GO:0005783; GO:0005886; GO:0043226,endoplasmic reticulum; plasma membrane; organelle
OG_02752,1.1104994493827107,FUN_011681-T1,Peve_00027007,Pocillopora_meandrina_HIv1___RNAseq.g23914.t1,three_way,78.4315,FUN_011681-T1,Q13492,,,,,59.6,349.0,2e-112,407.5,sp|Q13492|PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens OX=9606 GN=PICALM PE=1 SV=2,,,,,,
OG_02754,1.1916989790246708,FUN_011684-T1,Peve_00027010,Pocillopora_meandrina_HIv1___RNAseq.g23917.t1b,three_way,67.25733333333334,FUN_011684-T1,Q9KX40,,,,,31.0,187.0,4.1e-13,78.2,sp|Q9KX40|ESTB_BURGA Esterase EstB OS=Burkholderia gladioli OX=28095 GN=estB PE=1 SV=1,,,,,,
OG_02756,1.1715774336981306,FUN_011693-T1,Peve_00027018,Pocillopora_meandrina_HIv1___RNAseq.g23907.t1,three_way,70.913,FUN_011693-T1,Q96A49,SYAP1_HUMAN,,Synapse-associated protein 1 (BSD domain-containing signal transducer and Akt interactor protein) (BSTA),Homo sapiens (Human),41.0,346.0,6.2e-48,193.0,sp|Q96A49|SYAP1_HUMAN Synapse-associated protein 1 OS=Homo sapiens OX=9606 GN=SYAP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0009898; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0032869; GO:0036120; GO:0038203; GO:0042734; GO:0043204; GO:0045202; GO:0045211; GO:0045600; GO:0048172; GO:0048471; GO:0070062; GO:0071364; GO:0071902; GO:1990314,cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; TORC2 signaling [GO:0038203],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202],,GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0030154; GO:0043226,nucleus; nucleoplasm; Golgi apparatus; cytosol; cell differentiation; organelle
OG_02759,1.901426113655727,FUN_011696-T1,Peve_00010715,Pocillopora_meandrina_HIv1___RNAseq.g23904.t1,three_way,73.33366666666667,FUN_011696-T1,A8XJZ8,,,,,45.2,93.0,1.1e-14,83.2,sp|A8XJZ8|LST2_CAEBR Lateral signaling target protein 2 OS=Caenorhabditis briggsae OX=6238 GN=lst-2 PE=3 SV=1,,,,,,
OG_02761,1.669460443465978,FUN_011698-T1,Peve_00018061,Pocillopora_meandrina_HIv1___RNAseq.g23828.t1,three_way,91.74833333333332,FUN_011698-T1,P31365,,,,,51.6,320.0,9.500000000000001e-71,268.9,"sp|P31365|P3F2A_XENLA POU domain, class 3, transcription factor 2-A OS=Xenopus laevis OX=8355 GN=pou3f2-a PE=2 SV=2",,,,,,
OG_02765,1.0647843527814167,FUN_011703-T1,Peve_00025150,Pocillopora_meandrina_HIv1___RNAseq.g23822.t1,three_way,80.578,FUN_011703-T1,Q7TQE7,,,,,32.6,334.0,7.4e-35,149.8,sp|Q7TQE7|MACA2_MOUSE Putative tyrosine carboxypeptidase MATCAP2 OS=Mus musculus OX=10090 GN=Matcap2 PE=2 SV=2,,,,,,
OG_02767,1.7385690927778787,FUN_011706-T2,Peve_00025155,Pocillopora_meandrina_HIv1___RNAseq.g23820.t1,three_way,66.33966666666666,FUN_011706-T2,O95835,LATS1_HUMAN,,Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts),Homo sapiens (Human),38.3,1163.0,3.9e-172,607.1,sp|O95835|LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens OX=9606 GN=LATS1 PE=1 SV=1,GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033146; GO:0035329; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051301; GO:0060644; GO:0090090; GO:0098794; GO:0098978; GO:0099151; GO:0106310; GO:1900181; GO:1900227; GO:2000058,cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0007059; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; chromosome segregation; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_02770,1.2915520185381653,FUN_011709-T1,Peve_00025138,Pocillopora_meandrina_HIv1___RNAseq.g23817.t1,three_way,57.62166666666666,,,,,,,,,,,,,,,,,
OG_02771,1.3889646016515556,FUN_011710-T1,Peve_00025140,Pocillopora_meandrina_HIv1___RNAseq.g23816.t1,three_way,86.54816666666667,FUN_011710-T1,Q9JJ31,CUL5_RAT,,Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1),Rattus norvegicus (Rat),71.6,784.0,0.0,1121.3,sp|Q9JJ31|CUL5_RAT Cullin-5 OS=Rattus norvegicus OX=10116 GN=Cul5 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005000; GO:0005634; GO:0016567; GO:0019005; GO:0021799; GO:0021942; GO:0030674; GO:0031146; GO:0031466; GO:0031625; GO:0038026; GO:0043161; GO:0051480; GO:0070979; GO:0090734; GO:0160072; GO:2001222,cerebral cortex radially oriented cell migration [GO:0021799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; reelin-mediated signaling pathway [GO:0038026]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of neuron migration [GO:2001222]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul5-RING ubiquitin ligase complex [GO:0031466]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734],protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; vasopressin receptor activity [GO:0005000],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0048870; GO:0060089; GO:0060090; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; cell motility; molecular transducer activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02773,1.0075886202516202,FUN_011716-T1,Peve_00039703,Pocillopora_meandrina_HIv1___TS.g16734.t1,three_way,63.82533333333333,FUN_011716-T1,Q9UBS5,,,,,31.7,715.0,1.3e-98,362.5,sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1,,,,,,
OG_02776,1.0069549341813522,FUN_011724-T1,Peve_00039706,Pocillopora_meandrina_HIv1___RNAseq.g23851.t1,three_way,75.24866666666667,FUN_011724-T1,Q6ZV70,,,,,39.1,238.0,1.7999999999999998e-35,151.0,sp|Q6ZV70|LANC3_HUMAN LanC-like protein 3 OS=Homo sapiens OX=9606 GN=LANCL3 PE=1 SV=2,,,,,,
OG_02777,1.3347321838844548,FUN_011725-T1,Peve_00039709,Pocillopora_meandrina_HIv1___RNAseq.g23849.t1,three_way,80.71566666666666,FUN_011725-T1,Q4R918,KIF25_MACFA,,Kinesin-like protein KIF25,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),41.1,604.0,4.1000000000000004e-111,403.7,sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647,establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; protein-containing complex assembly; ATP-dependent activity
OG_02779,1.980929840274152,FUN_011729-T1,Peve_00001119,Pocillopora_meandrina_HIv1___RNAseq.g23842.t1,three_way,77.98466666666667,FUN_011729-T1,Q9Y233,PDE10_HUMAN,,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17)",Homo sapiens (Human),39.8,757.0,1.0000000000000001e-159,565.5,"sp|Q9Y233|PDE10_HUMAN cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A OS=Homo sapiens OX=9606 GN=PDE10A PE=1 SV=2",GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0010754; GO:0019933; GO:0030552; GO:0030553; GO:0046069; GO:0046872; GO:0047555; GO:0098978; GO:0106070; GO:0141161,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of cAMP/PKA signal transduction [GO:0141161],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02782,1.0938128507954232,FUN_011733-T1,Peve_00001121,Pocillopora_meandrina_HIv1___RNAseq.g23840.t2,three_way,53.03233333333333,FUN_011733-T1,Q6ZPR6,,,,,30.4,1491.0,1.3e-160,569.3,sp|Q6ZPR6|IBTK_MOUSE Inhibitor of Bruton tyrosine kinase OS=Mus musculus OX=10090 GN=Ibtk PE=1 SV=3,,,,,,
OG_02789,1.2057681166771326,FUN_011745-T1,Peve_00034105,Pocillopora_meandrina_HIv1___RNAseq.g23887.t1,three_way,65.875,FUN_011745-T1,P49406,,,,,41.1,168.0,1.7e-21,104.8,sp|P49406|RM19_HUMAN Large ribosomal subunit protein bL19m OS=Homo sapiens OX=9606 GN=MRPL19 PE=1 SV=2,,,,,,
OG_02791,1.1912559790306765,FUN_011747-T1,Peve_00034099,Pocillopora_meandrina_HIv1___RNAseq.9509_t,three_way,56.78566666666666,FUN_011747-T1,C5H5C4,NOT1A_DANRE,,Palmitoleoyl-protein carboxylesterase notum1a (EC 3.1.1.98),Danio rerio (Zebrafish) (Brachydanio rerio),40.0,417.0,7.7e-82,305.8,sp|C5H5C4|NOT1A_DANRE Palmitoleoyl-protein carboxylesterase notum1a OS=Danio rerio OX=7955 GN=notum1a PE=2 SV=1,GO:0004621; GO:0005576; GO:0009952; GO:0016055; GO:0021532; GO:0030178; GO:0090090; GO:1990697; GO:1990699,anterior/posterior pattern specification [GO:0009952]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005576; GO:0016787; GO:0030163,catalytic activity; extracellular region; hydrolase activity; protein catabolic process
OG_02795,1.723323293378334,FUN_011758-T1,Peve_00037784,Pocillopora_meandrina_HIv1___RNAseq.g23896.t1,three_way,91.42466666666668,FUN_011758-T1,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),63.4,4613.0,0.0,5645.5,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_02811,1.160224018620034,FUN_011794-T1,Peve_00034591,Pocillopora_meandrina_HIv1___RNAseq.g23258.t1a,three_way,52.43483333333333,,,,,,,,,,,,,,,,,
OG_02815,2.0928024731516093,FUN_011802-T1,Peve_00028440,Pocillopora_meandrina_HIv1___RNAseq.g23252.t1,three_way,63.55466666666666,FUN_011802-T1,B9FAF3,KN14E_ORYSJ,,Kinesin-like protein KIN-14E,Oryza sativa subsp. japonica (Rice),45.6,377.0,1.2e-84,316.2,sp|B9FAF3|KN14E_ORYSJ Kinesin-like protein KIN-14E OS=Oryza sativa subsp. japonica OX=39947 GN=KIN14E PE=2 SV=1,GO:0003777; GO:0005524; GO:0005874; GO:0007017; GO:0007018; GO:0008017; GO:0015630,microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017],microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005856; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; ATP-dependent activity
OG_02820,1.0346805517685405,FUN_011808-T1,Peve_00020938,Pocillopora_meandrina_HIv1___RNAseq.g23246.t1,three_way,76.82233333333333,,,,,,,,,,,,,,,,,
OG_02821,1.2802482819591805,FUN_011809-T1,Peve_00020918,Pocillopora_meandrina_HIv1___RNAseq.g23245.t1b,three_way,79.96799999999999,FUN_011809-T1,Q5TH69,,,,,30.1,2503.0,1.9e-256,888.3,sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3,,,,,,
OG_02822,1.070682381835728,FUN_011810-T1,Peve_00020919,Pocillopora_meandrina_HIv1___RNAseq.g23237.t1,three_way,64.20366666666666,,,,,,,,,,,,,,,,,
OG_02831,1.3417705297598117,FUN_011846-T1,Peve_00034370,Pocillopora_meandrina_HIv1___RNAseq.g23376.t1,three_way,70.376,,,,,,,,,,,,,,,,,
OG_02834,1.163564838297838,FUN_011851-T1,Peve_00034359,Pocillopora_meandrina_HIv1___TS.g16263.t1,three_way,69.67533333333333,FUN_011851-T1,Q9PWH2,,,,,45.6,572.0,1.3999999999999999e-140,501.5,sp|Q9PWH2|FZD10_CHICK Frizzled-10 OS=Gallus gallus OX=9031 GN=FZD10 PE=1 SV=1,,,,,,
OG_02835,1.0844370705004571,FUN_011853-T1,Peve_00034403,Pocillopora_meandrina_HIv1___RNAseq.g23381.t1,three_way,67.724,FUN_011853-T1,Q3ZBE6,,,,,37.9,443.0,1.8e-72,274.6,sp|Q3ZBE6|TM135_BOVIN Transmembrane protein 135 OS=Bos taurus OX=9913 GN=TMEM135 PE=2 SV=1,,,,,,
OG_02843,1.3864812759951612,FUN_011867-T1,Peve_00005279,Pocillopora_meandrina_HIv1___RNAseq.g26657.t1,three_way,72.6535,,,,,,,,,,,,,,,,,
OG_02845,1.898470135145628,FUN_011871-T1,Peve_00018844,Pocillopora_meandrina_HIv1___RNAseq.g23396.t1,three_way,78.22483333333334,FUN_011871-T1,Q9UA35,,,,,47.3,545.0,2e-125,451.1,sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1,,,,,,
OG_02846,1.0146942525684124,FUN_011873-T1,Peve_00018843,Pocillopora_meandrina_HIv1___TS.g16282.t1,three_way,69.31633333333333,FUN_011873-T1,Q9C0E2,XPO4_HUMAN,,Exportin-4 (Exp4),Homo sapiens (Human),41.9,1157.0,2.2000000000000003e-253,877.1,sp|Q9C0E2|XPO4_HUMAN Exportin-4 OS=Homo sapiens OX=9606 GN=XPO4 PE=1 SV=2,GO:0005049; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0031267; GO:0046827,positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267],GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0140104,nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular carrier activity
OG_02853,3.2189909279848745,FUN_011890-T1,Peve_00042786,Pocillopora_meandrina_HIv1___RNAseq.g13675.t1,three_way,73.18133333333333,FUN_011890-T1,Q9ULI1,,,,,28.0,898.0,2.4e-78,296.2,sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3,,,,,,
OG_02857,1.520662553081367,FUN_011899-T1,Peve_00010113,Pocillopora_meandrina_HIv1___RNAseq.g23787.t1,three_way,67.8275,FUN_011899-T1,Q5R9B8,DCAF6_PONAB,,DDB1- and CUL4-associated factor 6 (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),39.1,843.0,7.8e-144,512.7,sp|Q5R9B8|DCAF6_PONAB DDB1- and CUL4-associated factor 6 OS=Pongo abelii OX=9601 GN=DCAF6 PE=2 SV=2,GO:0005634; GO:0005737; GO:0016567; GO:0045944; GO:0080008,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_02858,1.455219428822417,FUN_011900-T1,Peve_00010115,Pocillopora_meandrina_HIv1___RNAseq.g23788.t1,three_way,86.81633333333333,FUN_011900-T1,Q9GRC0,,,,,48.8,256.0,1.1e-61,238.4,sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1,,,,,,
OG_02859,1.7555665036084476,FUN_011901-T1,Peve_00032854,Pocillopora_meandrina_HIv1___TS.g16663.t2,three_way,70.4165,FUN_011901-T1,A7MBI0,PACN1_BOVIN,,Protein kinase C and casein kinase substrate in neurons protein 1,Bos taurus (Bovine),33.7,306.0,7.9e-41,169.5,sp|A7MBI0|PACN1_BOVIN Protein kinase C and casein kinase substrate in neurons protein 1 OS=Bos taurus OX=9913 GN=PACSIN1 PE=2 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043679; GO:0048488; GO:0048812; GO:0072657; GO:0097320; GO:1900006,actin filament organization [GO:0007015]; cytoskeleton organization [GO:0007010]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488],axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; ruffle membrane [GO:0032587],phospholipid binding [GO:0005543],GO:0005768; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_02861,1.2024240670649533,FUN_011906-T1,Peve_00026367,Pocillopora_meandrina_HIv1___RNAseq.g23365.t1,three_way,91.1335,FUN_011906-T1,Q61371,,,,,70.8,718.0,5.900000000000001e-170,599.4,sp|Q61371|IFT88_MOUSE Intraflagellar transport protein 88 homolog OS=Mus musculus OX=10090 GN=Ift88 PE=1 SV=2,,,,,,
OG_02865,1.4053184265997136,FUN_011912-T1,Peve_00020699,Pocillopora_meandrina_HIv1___RNAseq.g23360.t1,three_way,69.96266666666666,FUN_011912-T1,Q92562,FIG4_HUMAN,,"Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16)",Homo sapiens (Human),45.8,1014.0,7.2e-216,752.3,sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1,GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037,locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033],early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037],"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722]",GO:0003824; GO:0005768; GO:0005811; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endosome; lipid droplet; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02877,1.0434964391955834,FUN_011927-T1,Peve_00039378,Pocillopora_meandrina_HIv1___RNAseq.g23328.t1,three_way,81.451,FUN_011927-T1,O60476,MA1A2_HUMAN,,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)",Homo sapiens (Human),52.3,623.0,1e-183,644.8,"sp|O60476|MA1A2_HUMAN Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB OS=Homo sapiens OX=9606 GN=MAN1A2 PE=1 SV=1",GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0036503; GO:0048286; GO:0070062; GO:1904381,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585],endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0009101; GO:0016787; GO:0030163; GO:0043226; GO:0048856; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; glycoprotein biosynthetic process; hydrolase activity; protein catabolic process; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_02878,1.0874667033084795,FUN_011928-T1,Peve_00039387,Pocillopora_meandrina_HIv1___RNAseq.g23329.t1,three_way,69.43666666666667,FUN_011928-T1,Q5E9H9,ABHDA_BOVIN,,"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)",Bos taurus (Bovine),44.6,251.0,9.7e-64,245.0,"sp|Q5E9H9|ABHDA_BOVIN Palmitoyl-protein thioesterase ABHD10, mitochondrial OS=Bos taurus OX=9913 GN=ABHD10 PE=2 SV=1",GO:0002084; GO:0004553; GO:0005739; GO:0008474; GO:0102390,protein depalmitoylation [GO:0002084],mitochondrion [GO:0005739],"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; palmitoyl-(protein) hydrolase activity [GO:0008474]",GO:0003824; GO:0005739; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02879,1.0567273317797894,FUN_011929-T1,Peve_00039637,Pocillopora_meandrina_HIv1___RNAseq.g23330.t1,three_way,69.50066666666667,FUN_011929-T1,Q54MF3,CANB2_DICDI,,Calcineurin subunit B type 2 (Calcineurin regulatory subunit 2) (Protein phosphatase 2B regulatory subunit 2),Dictyostelium discoideum (Social amoeba),24.2,161.0,1e-11,71.6,sp|Q54MF3|CANB2_DICDI Calcineurin subunit B type 2 OS=Dictyostelium discoideum OX=44689 GN=cnbB PE=3 SV=1,GO:0005509; GO:0005955; GO:0008597; GO:0019902; GO:0097720,calcineurin-mediated signaling [GO:0097720],calcineurin complex [GO:0005955],calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902],GO:0098772,molecular function regulator activity
OG_02883,1.5436621060747933,FUN_011933-T1,Peve_00039642,Pocillopora_meandrina_HIv1___RNAseq.g23334.t1,three_way,74.492,FUN_011933-T1,Q9TZM3,,,,,26.5,2417.0,9.3e-178,627.1,sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6,,,,,,
OG_02886,1.4135593748099706,FUN_011936-T1,Peve_00015901,Pocillopora_meandrina_HIv1___TS.g16218.t1,three_way,61.47666666666667,FUN_011936-T1,Q9GLP1,,,,,36.6,186.0,4.7e-22,107.8,sp|Q9GLP1|FA5_PIG Coagulation factor V OS=Sus scrofa OX=9823 GN=F5 PE=2 SV=1,,,,,,
OG_02890,1.445500950353345,FUN_011945-T1,Peve_00016921,Pocillopora_meandrina_HIv1___RNAseq.g9189.t2,three_way,87.27733333333333,FUN_011945-T1,Q9YH18,,,,,42.9,324.0,4.7e-59,229.6,sp|Q9YH18|QKI_CHICK KH domain-containing RNA-binding protein QKI OS=Gallus gallus OX=9031 GN=QKI PE=2 SV=2,,,,,,
OG_02902,1.4062164722386847,FUN_011961-T1,Peve_00032575,Pocillopora_meandrina_HIv1___RNAseq.g12963.t1,three_way,70.89166666666667,FUN_011961-T1,Q5ZID0,,,,,42.0,300.0,3.1e-64,246.9,sp|Q5ZID0|NMRL1_CHICK NmrA-like family domain-containing protein 1 OS=Gallus gallus OX=9031 GN=NMRAL1 PE=2 SV=1,,,,,,
OG_02903,1.8603219522705696,FUN_011973-T1,Peve_00001000,Pocillopora_meandrina_HIv1___RNAseq.g23724.t1,three_way,61.82216666666667,FUN_011973-T1,Q54G43,SHKE_DICDI,,Dual specificity protein kinase shkE (EC 2.7.11.1) (SH2 domain-containing protein 5) (SH2 domain-containing protein E),Dictyostelium discoideum (Social amoeba),31.5,251.0,1.8e-23,113.2,sp|Q54G43|SHKE_DICDI Dual specificity protein kinase shkE OS=Dictyostelium discoideum OX=44689 GN=shkE PE=3 SV=1,GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0106310,signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_02904,1.0651103957456265,FUN_011974-T1,Peve_00000999,Pocillopora_meandrina_HIv1___RNAseq.g23723.t1,three_way,49.84633333333333,FUN_011974-T1,Q9BQF6,SENP7_HUMAN,,Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7),Homo sapiens (Human),48.3,321.0,1.3e-68,263.1,sp|Q9BQF6|SENP7_HUMAN Sentrin-specific protease 7 OS=Homo sapiens OX=9606 GN=SENP7 PE=1 SV=4,GO:0005634; GO:0005737; GO:0006508; GO:0016926; GO:0070139; GO:0099523; GO:0099524; GO:0140374,antiviral innate immune response [GO:0140374]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523],SUMO-specific endopeptidase activity [GO:0070139],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; hydrolase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_02908,2.0040703475506207,FUN_011985-T1,Peve_00000524,Pocillopora_meandrina_HIv1___RNAseq.g23714.t1,three_way,77.837,FUN_011985-T1,P21872,,,,,57.5,1039.0,0.0,1168.3,sp|P21872|PUR2_CHICK Trifunctional purine biosynthetic protein adenosine-3 OS=Gallus gallus OX=9031 GN=GART PE=1 SV=1,,,,,,
OG_02912,2.4346719380707453,FUN_011991-T1,Peve_00000528,Pocillopora_meandrina_HIv1___RNAseq.g23706.t1,three_way,78.50233333333333,FUN_011991-T1,P11620,,,,,48.9,174.0,5.2e-39,162.5,sp|P11620|YPT1_SCHPO GTP-binding protein ypt1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ypt1 PE=1 SV=2,,,,,,
OG_02922,1.9584462379412213,FUN_012008-T1,Peve_00016374,Pocillopora_meandrina_HIv1___RNAseq.g24029.t1,three_way,89.249,FUN_012008-T1,Q17QU4,RB39B_BOVIN,,Ras-related protein Rab-39B (EC 3.6.5.2),Bos taurus (Bovine),54.0,187.0,9.1e-56,218.4,sp|Q17QU4|RB39B_BOVIN Ras-related protein Rab-39B OS=Bos taurus OX=9913 GN=RAB39B PE=2 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0005886; GO:0006914; GO:0010506; GO:0015031; GO:0016192; GO:0030659; GO:0031489; GO:0032482; GO:0043005; GO:0050808,autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192],cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489],GO:0003824; GO:0003924; GO:0005794; GO:0005886; GO:0006914; GO:0008092; GO:0016192; GO:0016787; GO:0034330; GO:0043226; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; plasma membrane; autophagy; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell junction organization; organelle; molecular function regulator activity
OG_02925,1.6097778385759536,FUN_012012-T1,Peve_00030428,Pocillopora_meandrina_HIv1___RNAseq.g24037.t1,three_way,73.38199999999999,FUN_012012-T1,O95935,TBX18_HUMAN,,T-box transcription factor TBX18 (T-box protein 18),Homo sapiens (Human),53.3,336.0,4e-86,320.1,sp|O95935|TBX18_HUMAN T-box transcription factor TBX18 OS=Homo sapiens OX=9606 GN=TBX18 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001708; GO:0001756; GO:0003163; GO:0005634; GO:0005654; GO:0006357; GO:0016331; GO:0021999; GO:0042803; GO:0045893; GO:0051145; GO:0060930; GO:0060931; GO:0072189; GO:0090090; GO:0090103; GO:0090571; GO:0098907; GO:1990837,cell fate specification [GO:0001708]; cochlea morphogenesis [GO:0090103]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate anterior/posterior regionalization [GO:0021999]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of SA node cell action potential [GO:0098907]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node cell development [GO:0060931]; sinoatrial node cell fate commitment [GO:0060930]; sinoatrial node development [GO:0003163]; smooth muscle cell differentiation [GO:0051145]; somitogenesis [GO:0001756]; ureter development [GO:0072189],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02930,2.140892253280097,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_02939,1.2621888673224455,FUN_012046-T1,Peve_00013730,Pocillopora_meandrina_HIv1___TS.g16525.t1,three_way,75.98333333333333,FUN_012046-T1,Q9Y5B6,PAXB1_HUMAN,,PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1),Homo sapiens (Human),38.1,839.0,2.6e-119,431.4,sp|Q9Y5B6|PAXB1_HUMAN PAX3- and PAX7-binding protein 1 OS=Homo sapiens OX=9606 GN=PAXBP1 PE=1 SV=2,GO:0000398; GO:0003677; GO:0005634; GO:0005829; GO:0006366; GO:0007517; GO:0014842; GO:0045944; GO:1990226; GO:2000288,"mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; transcription by RNA polymerase II [GO:0006366]",cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226],GO:0003677; GO:0005634; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0043226; GO:0048856,DNA binding; nucleus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; organelle; anatomical structure development
OG_02940,1.4055252197088848,FUN_012049-T1,Peve_00004088,Pocillopora_meandrina_HIv1___RNAseq.g23650.t3,three_way,68.88266666666667,FUN_012049-T1,E7EZG2,MY9AA_DANRE,,Unconventional myosin-IXAa (Myosin IXAa),Danio rerio (Zebrafish) (Brachydanio rerio),33.3,2215.0,4.1e-257,890.2,sp|E7EZG2|MY9AA_DANRE Unconventional myosin-IXAa OS=Danio rerio OX=7955 GN=myo9aa PE=3 SV=1,GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0008270; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0044295; GO:0045198; GO:0045202; GO:0048675; GO:0051015; GO:0061564; GO:0098529,"axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; swimming behavior [GO:0036269]",actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; membrane [GO:0016020]; myosin complex [GO:0016459]; synapse [GO:0045202],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270],GO:0003774; GO:0003824; GO:0007163; GO:0008092; GO:0016853; GO:0030154; GO:0034330; GO:0098772; GO:0140657,cytoskeletal motor activity; catalytic activity; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; cell differentiation; cell junction organization; molecular function regulator activity; ATP-dependent activity
OG_02941,1.486299921579857,FUN_012050-T2,Peve_00004087,Pocillopora_meandrina_HIv1___RNAseq.g23649.t1,three_way,70.43433333333333,,,,,,,,,,,,,,,,,
OG_02949,3.737317283285862,FUN_012067-T1,Peve_00004104,Pocillopora_meandrina_HIv1___RNAseq.g23636.t1,three_way,67.023,FUN_012067-T1,Q7Z020,,,,,28.6,553.0,9.3e-45,184.1,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02957,1.2795421324775968,FUN_012102-T1,Peve_00007426,Pocillopora_meandrina_HIv1___RNAseq.g23946.t1,three_way,60.24616666666667,FUN_012102-T1,P18956,GGT_ECOLI,,Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (GGT) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain],Escherichia coli (strain K12),30.7,267.0,7.9000000000000025e-22,107.5,sp|P18956|GGT_ECOLI Glutathione hydrolase proenzyme OS=Escherichia coli (strain K12) OX=83333 GN=ggt PE=1 SV=1,GO:0006750; GO:0006751; GO:0030288; GO:0034722; GO:0036374; GO:0042597; GO:0043102; GO:0097264; GO:0103068,amino acid salvage [GO:0043102]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; self proteolysis [GO:0097264],outer membrane-bounded periplasmic space [GO:0030288]; periplasmic space [GO:0042597],gamma-glutamyl-peptidase activity [GO:0034722]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068],GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0016740; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_02959,2.03517644478041,FUN_012105-T1,Peve_00000984,Pocillopora_meandrina_HIv1___RNAseq.9341_t,three_way,72.279,,,,,,,,,,,,,,,,,
OG_02966,2.450770718514673,FUN_012120-T1,Peve_00035447,Pocillopora_meandrina_HIv1___TS.g16803.t2,three_way,75.527,FUN_012120-T1,Q8VIH3,S28A3_RAT,,Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (rCNT3),Rattus norvegicus (Rat),47.3,499.0,1.3e-119,431.8,sp|Q8VIH3|S28A3_RAT Solute carrier family 28 member 3 OS=Rattus norvegicus OX=10116 GN=Slc28a3 PE=2 SV=1,GO:0001895; GO:0005886; GO:0015213; GO:0015389; GO:0015390; GO:0015860; GO:0015862; GO:0015864; GO:0031526; GO:0072531; GO:1901642,nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; retina homeostasis [GO:0001895]; uridine transmembrane transport [GO:0015862],brush border membrane [GO:0031526]; plasma membrane [GO:0005886],purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenosine-specific:sodium symporter activity [GO:0015389]; uridine transmembrane transporter activity [GO:0015213],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_02968,1.88993373663534,FUN_012130-T1,Peve_00035469,Pocillopora_meandrina_HIv1___RNAseq.g23786.t1,three_way,43.8205,FUN_012130-T1,Q5R7K9,,,,,32.1,156.0,7.5e-10,66.6,sp|Q5R7K9|EDIL3_PONAB EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Pongo abelii OX=9601 GN=EDIL3 PE=2 SV=1,,,,,,
OG_02969,2.250699495831234,FUN_012132-T1,Peve_00035465,Pocillopora_meandrina_HIv1___RNAseq.g23782.t1,three_way,56.359,FUN_012132-T1,Q07113,MPRI_MOUSE,,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),Mus musculus (Mouse),30.7,2462.0,7.5e-280,966.1,sp|Q07113|MPRI_MOUSE Cation-independent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=Igf2r PE=1 SV=1,GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005520; GO:0005537; GO:0005615; GO:0005634; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005802; GO:0007041; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030139; GO:0030140; GO:0031100; GO:0031995; GO:0032526; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:1904772; GO:1905394,animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023],GO:0005615; GO:0005634; GO:0005768; GO:0008289; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060089,extracellular space; nucleus; endosome; lipid binding; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity
OG_02978,1.0967114974941627,FUN_012145-T1,Peve_00033299,Pocillopora_meandrina_HIv1___RNAseq.g23871.t1,three_way,72.78233333333333,FUN_012145-T1,Q9Y6R4,M3K4_HUMAN,,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),Homo sapiens (Human),35.0,1732.0,4.6e-247,856.7,sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2,GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745,chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_02980,1.3202315489674077,FUN_012150-T1,Peve_00035454,Pocillopora_meandrina_HIv1___RNAseq.9397_t,three_way,84.231,FUN_012150-T1,Q00796,DHSO_HUMAN,,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)",Homo sapiens (Human),58.6,263.0,1.2e-85,317.8,sp|Q00796|DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens OX=9606 GN=SORD PE=1 SV=4,GO:0000721; GO:0003939; GO:0005615; GO:0005829; GO:0006006; GO:0006062; GO:0008270; GO:0016020; GO:0019640; GO:0030246; GO:0030317; GO:0031514; GO:0031966; GO:0042802; GO:0046370; GO:0046526; GO:0047833; GO:0050255; GO:0051160; GO:0051164; GO:0051287; GO:0070062,D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; sorbitol catabolic process [GO:0006062]; xylitol catabolic process [GO:0051160]; xylitol metabolic process [GO:0051164],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514],"(R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase (NAD+) activity [GO:0050255]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005615; GO:0005829; GO:0005929; GO:0005975; GO:0007018; GO:0016491; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; extracellular space; cytosol; cilium; carbohydrate metabolic process; microtubule-based movement; oxidoreductase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_02981,1.2194734338631803,FUN_012151-T1,Peve_00035456,Pocillopora_meandrina_HIv1___RNAseq.g23773.t1,three_way,68.10066666666667,FUN_012151-T1,Q91W96,,,,,33.8,769.0,1.4999999999999999e-92,342.4,sp|Q91W96|APC4_MOUSE Anaphase-promoting complex subunit 4 OS=Mus musculus OX=10090 GN=Anapc4 PE=1 SV=1,,,,,,
OG_02982,2.445255413307887,FUN_012152-T1,Peve_00035458,Pocillopora_meandrina_HIv1___TS.g16648.t1,three_way,75.35416666666667,FUN_012152-T1,Q8NEN0,,,,,32.3,885.0,5.2000000000000004e-117,423.7,sp|Q8NEN0|ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=ARMC2 PE=1 SV=4,,,,,,
OG_02983,1.08978444392668,FUN_012153-T1,Peve_00040788,Pocillopora_meandrina_HIv1___RNAseq.g23437.t1,three_way,74.26066666666667,FUN_012153-T1,Q5EA89,,,,,36.4,308.0,8e-20,99.4,sp|Q5EA89|FA76A_BOVIN Protein FAM76A OS=Bos taurus OX=9913 GN=FAM76A PE=2 SV=1,,,,,,
OG_02985,1.727129424406305,FUN_012155-T1,Peve_00040791,Pocillopora_meandrina_HIv1___RNAseq.g23435.t1,three_way,55.4285,FUN_012155-T1,E7FA21,,,,,24.2,854.0,6.6e-38,161.0,sp|E7FA21|SMR8A_DANRE Guanine nucleotide exchange protein smcr8a OS=Danio rerio OX=7955 GN=smcr8a PE=3 SV=1,,,,,,
OG_02997,1.7012239499528108,FUN_012176-T1,Peve_00040994,Pocillopora_meandrina_HIv1___RNAseq.g23858.t1,three_way,63.23466666666666,FUN_012176-T1,Q709C8,VP13C_HUMAN,,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),Homo sapiens (Human),24.7,4222.0,0.0,1083.2,sp|Q709C8|VP13C_HUMAN Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090,Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741],,GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0007005; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; mitochondrion organization; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03001,1.301609669458522,FUN_012180-T1,Peve_00020513,Pocillopora_meandrina_HIv1___RNAseq.g23512.t1,three_way,61.40383333333333,FUN_012180-T1,J9HGJ1,,,,,34.1,88.0,9.7e-08,59.3,sp|J9HGJ1|LTRIN_AEDAE Lymphotoxin beta receptor inhibitor OS=Aedes aegypti OX=7159 GN=AaeL_AAEL017253 PE=1 SV=1,,,,,,
OG_03003,1.2696008129037788,FUN_012187-T2,Peve_00027771,Pocillopora_meandrina_HIv1___RNAseq.g23457.t1,three_way,57.22,,,,,,,,,,,,,,,,,
OG_03004,1.0583671023364645,FUN_012192-T1,Peve_00013741,Pocillopora_meandrina_HIv1___RNAseq.g23419.t1,three_way,64.87933333333334,FUN_012192-T1,Q9NFP5,,,,,41.6,101.0,5.9e-11,68.2,sp|Q9NFP5|SH3BG_DROME SH3 domain-binding glutamic acid-rich protein homolog OS=Drosophila melanogaster OX=7227 GN=Sh3beta PE=1 SV=2,,,,,,
OG_03005,1.3720128723467235,FUN_012193-T1,Peve_00013740,Pocillopora_meandrina_HIv1___RNAseq.g23420.t1,three_way,60.66016666666667,FUN_012193-T1,Q91VW3,,,,,44.8,87.0,1.9e-17,89.7,sp|Q91VW3|SH3L3_MOUSE SH3 domain-binding glutamic acid-rich-like protein 3 OS=Mus musculus OX=10090 GN=Sh3bgrl3 PE=1 SV=1,,,,,,
OG_03006,1.4524869397630542,FUN_012194-T1,Peve_00013739,Pocillopora_meandrina_HIv1___RNAseq.g23421.t2,three_way,77.17933333333333,FUN_012194-T1,Q6NYU7,,,,,59.0,249.0,1.1e-77,291.2,sp|Q6NYU7|UPP_DANRE Uracil phosphoribosyltransferase homolog OS=Danio rerio OX=7955 GN=uprt PE=2 SV=1,,,,,,
OG_03008,2.181649885378583,FUN_012217-T1,Peve_00005368,Pocillopora_meandrina_HIv1___RNAseq.g23434.t1,three_way,65.92999999999999,,,,,,,,,,,,,,,,,
OG_03009,1.441333043344733,FUN_012218-T1,Peve_00005373,Pocillopora_meandrina_HIv1___TS.g16318.t1,three_way,65.238,FUN_012218-T1,Q008S8,,,,,35.3,405.0,6.800000000000001e-58,226.5,sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2,,,,,,
OG_03011,1.2684933732397528,FUN_012229-T2,Peve_00020576,Pocillopora_meandrina_HIv1___TS.g16417.t1,three_way,92.94133333333332,FUN_012229-T2,Q9TTF0,,,,,47.9,378.0,1.1e-92,341.7,sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2,,,,,,
OG_03019,1.2290628835385764,FUN_012239-T1,Peve_00020584,Pocillopora_meandrina_HIv1___TS.g16406.t3,three_way,55.63166666666667,FUN_012239-T1,Q8BGT0,OSTM1_MOUSE,,Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit) (Grey-lethal protein),Mus musculus (Mouse),27.2,239.0,1.4e-20,101.7,sp|Q8BGT0|OSTM1_MOUSE Osteopetrosis-associated transmembrane protein 1 OS=Mus musculus OX=10090 GN=Ostm1 PE=1 SV=1,GO:0005765; GO:0005829; GO:0030316; GO:0030321; GO:0034707,osteoclast differentiation [GO:0030316]; transepithelial chloride transport [GO:0030321],chloride channel complex [GO:0034707]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765],,GO:0005829; GO:0030154,cytosol; cell differentiation
OG_03021,1.2878022619888387,FUN_012241-T1,Peve_00018303,Pocillopora_meandrina_HIv1___RNAseq.g23522.t2,three_way,67.49,FUN_012241-T1,O14497,ARI1A_HUMAN,,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",Homo sapiens (Human),36.1,711.0,1.3e-109,400.2,sp|O14497|ARI1A_HUMAN AT-rich interactive domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ARID1A PE=1 SV=3,GO:0000785; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_03024,1.572852110494352,FUN_012250-T1,Peve_00020519,Pocillopora_meandrina_HIv1___RNAseq.g23517.t1,three_way,75.335,FUN_012250-T1,Q5T5C0,STXB5_HUMAN,,Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1),Homo sapiens (Human),38.5,1156.0,1.5999999999999999e-208,728.0,sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807],acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],GO:0005829; GO:0005886; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_03028,1.4251752794135375,FUN_012254-T1,Peve_00036363,Pocillopora_meandrina_HIv1___RNAseq.g23560.t1a,three_way,48.51266666666667,FUN_012254-T1,Q6NV72,,,,,22.0,641.0,1.3e-16,89.7,sp|Q6NV72|WDCP_MOUSE WD repeat and coiled-coil-containing protein OS=Mus musculus OX=10090 GN=Wdcp PE=2 SV=2,,,,,,
OG_03029,1.0163179347153066,FUN_012257-T2,Peve_00036357,Pocillopora_meandrina_HIv1___TS.g16433.t1,three_way,75.69800000000001,FUN_012257-T2,Q795M8,,,,,37.6,93.0,5.2e-06,54.3,sp|Q795M8|YUGO_BACSU Putative potassium channel protein YugO OS=Bacillus subtilis (strain 168) OX=224308 GN=yugO PE=4 SV=2,,,,,,
OG_03036,1.269318045444397,FUN_012274-T1,Peve_00026376,Pocillopora_meandrina_HIv1___RNAseq.g23878.t1,three_way,73.09366666666666,FUN_012274-T1,Q76I89,NDC80_CHICK,,Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2),Gallus gallus (Chicken),35.0,491.0,2.9e-69,264.6,sp|Q76I89|NDC80_CHICK Kinetochore protein NDC80 homolog OS=Gallus gallus OX=9031 GN=NDC80 PE=1 SV=1,GO:0000132; GO:0000776; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0008017; GO:0008315; GO:0014841; GO:0016607; GO:0030332; GO:0031262; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase chromosome alignment [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle assembly involved in female meiosis I [GO:0007057],centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; nuclear speck [GO:0016607],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; microtubule binding [GO:0008017],GO:0005815; GO:0005829; GO:0007010; GO:0007059; GO:0008092; GO:0022414; GO:0043226; GO:0060090,microtubule organizing center; cytosol; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; reproductive process; organelle; molecular adaptor activity
OG_03037,1.4397007285384078,FUN_012275-T1,Peve_00012592,Pocillopora_meandrina_HIv1___RNAseq.g23879.t1,three_way,84.85633333333332,FUN_012275-T1,Q63481,RAB7L_RAT,,Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29),Rattus norvegicus (Rat),28.6,213.0,8.6e-15,83.2,sp|Q63481|RAB7L_RAT Ras-related protein Rab-7L1 OS=Rattus norvegicus OX=10116 GN=Rab29 PE=1 SV=1,GO:0000139; GO:0001921; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0031965; GO:0031982; GO:0032438; GO:0042110; GO:0042147; GO:0042470; GO:0044788; GO:0048471; GO:0050862; GO:0055037; GO:0060271; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1903441; GO:1905279; GO:1990748,"cell differentiation [GO:0030154]; cellular detoxification [GO:1990748]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; modulation by host of viral process [GO:0044788]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]",cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; vesicle [GO:0031982],dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005739; GO:0005768; GO:0005773; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0008092; GO:0016192; GO:0016787; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0044782; GO:0098754,immune system process; catalytic activity; GTPase activity; nucleoplasm; mitochondrion; endosome; vacuole; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; intracellular protein transport; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; cilium organization; detoxification
OG_03042,1.0314362075456385,FUN_012281-T1,Peve_00024232,Pocillopora_meandrina_HIv1___RNAseq.g23579.t1,three_way,65.3465,FUN_012281-T1,Q5TB80,CE162_HUMAN,,Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog),Homo sapiens (Human),31.5,791.0,2.9e-91,339.0,sp|Q5TB80|CE162_HUMAN Centrosomal protein of 162 kDa OS=Homo sapiens OX=9606 GN=CEP162 PE=1 SV=2,GO:0005654; GO:0005794; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0034451; GO:0036064; GO:0043231; GO:0060271,cilium assembly [GO:0060271],axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; spindle [GO:0005819],,GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0043226; GO:0044782,nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; organelle; cilium organization
OG_03046,1.108783473806487,FUN_012292-T1,Peve_00036368,Pocillopora_meandrina_HIv1___RNAseq.g23561.t1,three_way,74.99983333333333,FUN_012292-T1,Q20191,,,,,45.5,189.0,7.3e-45,183.0,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_03047,1.2087871243425368,FUN_012293-T1,Peve_00036366,Pocillopora_meandrina_HIv1___RNAseq.g23562.t1,three_way,84.339,FUN_012293-T1,Q96JB1,,,,,26.2,4649.0,0.0,1572.4,sp|Q96JB1|DYH8_HUMAN Dynein axonemal heavy chain 8 OS=Homo sapiens OX=9606 GN=DNAH8 PE=1 SV=2,,,,,,
OG_03048,1.5037085799395618,FUN_012295-T1,Peve_00036365,Pocillopora_meandrina_HIv1___RNAseq.g23560.t1b,three_way,72.36266666666667,FUN_012295-T1,D3ZGS3,OCRL_RAT,,"Inositol polyphosphate 5-phosphatase OCRL (EC 3.1.3.36) (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase OCRL-1) (OCRL-1) (Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase) (EC 3.1.3.86)",Rattus norvegicus (Rat),48.5,616.0,3.2e-174,613.6,sp|D3ZGS3|OCRL_RAT Inositol polyphosphate 5-phosphatase OCRL OS=Rattus norvegicus OX=10116 GN=Ocrl PE=1 SV=1,GO:0001701; GO:0001750; GO:0004439; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005802; GO:0005886; GO:0005905; GO:0007165; GO:0016020; GO:0030136; GO:0030670; GO:0031267; GO:0031901; GO:0034485; GO:0043005; GO:0046856; GO:0052658; GO:0052659; GO:0052745; GO:0060271,cilium assembly [GO:0060271]; in utero embryonic development [GO:0001701]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],"GTPase activator activity [GO:0005096]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; small GTPase binding [GO:0031267]",GO:0003824; GO:0005634; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0098772,catalytic activity; nucleus; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_03052,1.4146908978212724,FUN_012299-T1,Peve_00038613,Pocillopora_meandrina_HIv1___RNAseq.g23767.t1,three_way,72.542,,,,,,,,,,,,,,,,,
OG_03061,2.365765077318672,FUN_012325-T1,Peve_00022885,Pocillopora_meandrina_HIv1___RNAseq.g23751.t1,three_way,82.00566666666667,FUN_012325-T1,Q8R3S2,TSN33_MOUSE,,Tetraspanin-33 (Tspan-33) (Penumbra) (mPen) (Proerythroblast new membrane),Mus musculus (Mouse),45.7,258.0,7.699999999999999e-56,218.8,sp|Q8R3S2|TSN33_MOUSE Tetraspanin-33 OS=Mus musculus OX=10090 GN=Tspan33 PE=1 SV=1,GO:0005737; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197,pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197],enzyme binding [GO:0019899],GO:0051604; GO:0065003; GO:0072659,protein maturation; protein-containing complex assembly; protein localization to plasma membrane
OG_03066,1.1221309114052127,FUN_012333-T1,Peve_00028481,Pocillopora_meandrina_HIv1___RNAseq.g23758.t1,three_way,69.9595,FUN_012333-T1,O43524,,,,,35.0,546.0,2e-50,201.8,sp|O43524|FOXO3_HUMAN Forkhead box protein O3 OS=Homo sapiens OX=9606 GN=FOXO3 PE=1 SV=1,,,,,,
OG_03068,1.4756965279741237,FUN_012338-T1,Peve_00021550,Pocillopora_meandrina_HIv1___RNAseq.g24073.t1,three_way,51.0305,,,,,,,,,,,,,,,,,
OG_03076,1.893020456978199,FUN_012348-T1,Peve_00029070,Pocillopora_meandrina_HIv1___RNAseq.g24069.t1,three_way,66.19800000000001,FUN_012348-T1,P0C8E4,M3K7_RAT,,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25),Rattus norvegicus (Rat),36.2,796.0,1.6e-112,408.7,sp|P0C8E4|M3K7_RAT Mitogen-activated protein kinase kinase kinase 7 OS=Rattus norvegicus OX=10116 GN=Map3k7 PE=1 SV=1,GO:0000165; GO:0000287; GO:0001223; GO:0001525; GO:0001649; GO:0001666; GO:0001841; GO:0002726; GO:0004674; GO:0004707; GO:0004708; GO:0004709; GO:0005114; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006955; GO:0007179; GO:0007249; GO:0007252; GO:0007254; GO:0008349; GO:0010508; GO:0010629; GO:0014069; GO:0016239; GO:0030971; GO:0031625; GO:0032743; GO:0034142; GO:0035173; GO:0038066; GO:0038172; GO:0038173; GO:0042742; GO:0042802; GO:0043123; GO:0043276; GO:0043410; GO:0043507; GO:0045787; GO:0045793; GO:0046330; GO:0051403; GO:0060348; GO:0060546; GO:0070498; GO:0071356; GO:0071456; GO:0071560; GO:0097110; GO:0097190; GO:0106310; GO:0120283; GO:0140297; GO:0140672; GO:1901224; GO:1902443; GO:1904385; GO:1904707; GO:1904754; GO:1990450; GO:1990776; GO:2000377; GO:2000378; GO:2001234,angiogenesis [GO:0001525]; anoikis [GO:0043276]; apoptotic signaling pathway [GO:0097190]; bone development [GO:0060348]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; defense response to bacterium [GO:0042742]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression [GO:0010629]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; osteoblast differentiation [GO:0001649]; p38MAPK cascade [GO:0038066]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to angiotensin [GO:1990776]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179],ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0006954; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; inflammatory response; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03078,1.2574364113936851,FUN_012350-T1,Peve_00042525,Pocillopora_meandrina_HIv1___RNAseq.g23281.t1,three_way,96.66666666666669,FUN_012350-T1,Q5ZI57,,,,,72.2,180.0,6.499999999999999e-75,281.6,sp|Q5ZI57|TPPC3_CHICK Trafficking protein particle complex subunit 3 OS=Gallus gallus OX=9031 GN=TRAPPC3 PE=2 SV=1,,,,,,
OG_03081,1.6767756101261548,FUN_012353-T1,Peve_00042562,Pocillopora_meandrina_HIv1___RNAseq.g23278.t2,three_way,88.492,FUN_012353-T1,Q6ZQ88,KDM1A_MOUSE,,Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),Mus musculus (Mouse),68.2,692.0,4.4000000000000004e-274,945.3,sp|Q6ZQ88|KDM1A_MOUSE Lysine-specific histone demethylase 1A OS=Mus musculus OX=10090 GN=Kdm1a PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0006366; GO:0010569; GO:0010718; GO:0010725; GO:0016491; GO:0019899; GO:0021983; GO:0030154; GO:0030851; GO:0031398; GO:0032452; GO:0032453; GO:0032454; GO:0032880; GO:0032991; GO:0034644; GO:0043426; GO:0045648; GO:0045654; GO:0045944; GO:0050660; GO:0050681; GO:0050767; GO:0050768; GO:0055001; GO:0061629; GO:0071480; GO:0106222; GO:0120162; GO:0140297; GO:0140682; GO:0140684; GO:0140861; GO:0160217; GO:1990138; GO:1990391; GO:1990841; GO:2000179; GO:2000648,cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA repair-dependent chromatin remodeling [GO:0140861]; granulocyte differentiation [GO:0030851]; muscle cell development [GO:0055001]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription initiation-coupled chromatin remodeling [GO:0160217]; neuron projection extension [GO:1990138]; pituitary gland development [GO:0021983]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neurogenesis [GO:0050767]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; DNA repair complex [GO:1990391]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; FAD-dependent H3K4me/H3K4me3 demethylase activity [GO:0140682]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone H3K4 demethylase activity [GO:0032453]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me2/H3K9me3 demethylase activity [GO:0140684]; lncRNA binding [GO:0106222]; MRF binding [GO:0043426]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity [GO:0016491]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"DNA binding; RNA binding; catalytic activity; nucleus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_03084,1.11055020462987,FUN_012357-T1,Peve_00042558,Pocillopora_meandrina_HIv1___TS.g16156.t2,three_way,49.562333333333335,,,,,,,,,,,,,,,,,
OG_03088,2.5199647371293654,FUN_012361-T1,Peve_00042554,Pocillopora_meandrina_HIv1___RNAseq.g23270.t1,three_way,67.283,FUN_012361-T1,Q8BUB6,,,,,41.5,277.0,8.2e-60,232.3,sp|Q8BUB6|UST_MOUSE Uronyl 2-sulfotransferase OS=Mus musculus OX=10090 GN=Ust PE=2 SV=3,,,,,,
OG_03093,1.1408445795437203,FUN_012378-T1,Peve_00042531,Pocillopora_meandrina_HIv1___RNAseq.g23353.t1,three_way,64.31700000000001,FUN_012378-T1,Q9JKK0,,,,,34.0,194.0,7.4e-20,99.0,sp|Q9JKK0|RCAN3_MOUSE Calcipressin-3 OS=Mus musculus OX=10090 GN=Rcan3 PE=2 SV=1,,,,,,
OG_03094,1.5189364178736169,FUN_012379-T1,Peve_00042533,Pocillopora_meandrina_HIv1___TS.g16234.t1b,three_way,77.48716666666667,FUN_012379-T1,P91620,SIF2_DROME,,"Protein still life, isoforms C/SIF type 2",Drosophila melanogaster (Fruit fly),32.8,1044.0,4.7e-133,477.6,"sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2",GO:0005085; GO:0007264; GO:0016020; GO:0030036; GO:0045202; GO:0050770; GO:0050772; GO:0050803; GO:0051491,actin cytoskeleton organization [GO:0030036]; positive regulation of axonogenesis [GO:0050772]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264],membrane [GO:0016020]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0007010; GO:0098772,cytoskeleton organization; molecular function regulator activity
OG_03099,2.585722774327587,FUN_012386-T1,Peve_00030648,Pocillopora_meandrina_HIv1___RNAseq.g23347.t1,three_way,52.83716666666666,,,,,,,,,,,,,,,,,
OG_03101,1.290283092383595,FUN_012388-T1,Peve_00029782,Pocillopora_meandrina_HIv1___RNAseq.g23654.t1,three_way,67.31333333333333,,,,,,,,,,,,,,,,,
OG_03106,2.22632514580728,FUN_012402-T1,Peve_00023469,Pocillopora_meandrina_HIv1___RNAseq.g23670.t1,three_way,45.885,FUN_012402-T1,Q6UXI7,VITRN_HUMAN,,Vitrin,Homo sapiens (Human),28.8,184.0,5.1e-15,84.7,sp|Q6UXI7|VITRN_HUMAN Vitrin OS=Homo sapiens OX=9606 GN=VIT PE=1 SV=1,GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198,extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510],extracellular region [GO:0005576]; interstitial matrix [GO:0005614],glycosaminoglycan binding [GO:0005539],GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_03108,2.6445036601104857,FUN_012405-T1,Peve_00002856,Pocillopora_meandrina_HIv1___RNAseq.g9951.t1,three_way,66.98066666666666,,,,,,,,,,,,,,,,,
OG_03117,1.5111074767109869,FUN_012465-T1,Peve_00000724,Pocillopora_meandrina_HIv1___RNAseq.g24004.t1,three_way,90.188,FUN_012465-T1,P63030,,,,,73.1,78.0,2.8999999999999997e-29,129.0,sp|P63030|MPC1_MOUSE Mitochondrial pyruvate carrier 1 OS=Mus musculus OX=10090 GN=Mpc1 PE=1 SV=1,,,,,,
OG_03118,2.124349791792352,FUN_012466-T1,Peve_00034217,Pocillopora_meandrina_HIv1___RNAseq.g24003.t1,three_way,65.63133333333333,FUN_012466-T1,P46029,,,,,41.7,672.0,1.1e-136,488.8,sp|P46029|S15A2_RABIT Solute carrier family 15 member 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC15A2 PE=1 SV=1,,,,,,
OG_03119,1.0660110080423464,FUN_012467-T1,Peve_00007948,Pocillopora_meandrina_HIv1___RNAseq.g23979.t1,three_way,72.50066666666666,FUN_012467-T1,Q9HF54,,,,,41.9,186.0,3.7e-35,150.2,sp|Q9HF54|RHO1_EREGS GTP-binding protein RHO1 OS=Eremothecium gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=RHO1 PE=3 SV=1,,,,,,
OG_03122,2.071248693221205,FUN_012476-T1,Peve_00004005,Pocillopora_meandrina_HIv1___RNAseq.g23990.t1,three_way,74.48633333333333,FUN_012476-T1,O15247,CLIC2_HUMAN,,Chloride intracellular channel protein 2 (Glutaredoxin-like oxidoreductase CLIC2) (EC 1.8.-.-) (Glutaredoxin-like peroxidase CLIC2) (EC 1.11.1.-) (XAP121),Homo sapiens (Human),31.7,230.0,1.5e-23,111.3,sp|O15247|CLIC2_HUMAN Chloride intracellular channel protein 2 OS=Homo sapiens OX=9606 GN=CLIC2 PE=1 SV=3,GO:0004602; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707,chloride transport [GO:0006821]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602],GO:0003824; GO:0005215; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016209; GO:0016491; GO:0043226,catalytic activity; transporter activity; nucleus; nucleoplasm; cytosol; plasma membrane; antioxidant activity; oxidoreductase activity; organelle
OG_03123,1.1263080730034625,FUN_012477-T1,Peve_00004006,Pocillopora_meandrina_HIv1___RNAseq.g23991.t1,three_way,62.38933333333333,,,,,,,,,,,,,,,,,
OG_03126,1.7876757308817244,FUN_012482-T1,Peve_00004001,Pocillopora_meandrina_HIv1___RNAseq.g23996.t2,three_way,49.154,FUN_012482-T1,O15287,FANCG_HUMAN,,Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9),Homo sapiens (Human),26.7,243.0,4.6e-08,61.6,sp|O15287|FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens OX=9606 GN=FANCG PE=1 SV=1,GO:0000785; GO:0001541; GO:0003684; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006974; GO:0007005; GO:0007286; GO:0009314; GO:0016607; GO:0036297; GO:0043240,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; response to radiation [GO:0009314]; spermatid development [GO:0007286],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],damaged DNA binding [GO:0003684],GO:0003677; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0007005; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleoplasm; mitochondrion; cytosol; DNA repair; mitochondrion organization; reproductive process; organelle; anatomical structure development
OG_03130,1.6086283417702358,FUN_012490-T1,Peve_00007944,Pocillopora_meandrina_HIv1___RNAseq.g23964.t1,three_way,84.40183333333333,FUN_012490-T1,E9PZZ1,PRD13_MOUSE,,PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13),Mus musculus (Mouse),55.2,87.0,6.6e-20,100.1,sp|E9PZZ1|PRD13_MOUSE PR domain zinc finger protein 13 OS=Mus musculus OX=10090 GN=Prdm13 PE=2 SV=1,GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0021979; GO:0022008; GO:0032259; GO:0042054; GO:0061629; GO:0097154,GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_03132,1.355921156066091,FUN_012494-T1,Peve_00007950,Pocillopora_meandrina_HIv1___RNAseq.g23966.t1,three_way,73.58933333333333,FUN_012494-T1,A1ZAY1,DLISH_DROME,,SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains),Drosophila melanogaster (Fruit fly),30.5,419.0,7.6e-41,169.5,sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1,GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219,establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251],apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219],cadherin binding [GO:0045296],GO:0005929; GO:0007163; GO:0043226,cilium; establishment or maintenance of cell polarity; organelle
OG_03141,1.154301031775703,FUN_012525-T1,Peve_00019857,Pocillopora_meandrina_HIv1___RNAseq.g23978.t1,three_way,41.14233333333333,FUN_012525-T1,Q9H4Q3,PRD13_HUMAN,,PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13),Homo sapiens (Human),58.3,84.0,7.9999999999999985e-25,117.1,sp|Q9H4Q3|PRD13_HUMAN PR domain zinc finger protein 13 OS=Homo sapiens OX=9606 GN=PRDM13 PE=1 SV=2,GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0010468; GO:0021979; GO:0032259; GO:0042054; GO:0061629; GO:0097154,GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468],nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_03146,1.6465732895258107,FUN_012532-T1,Peve_00013905,Pocillopora_meandrina_HIv1___RNAseq.g23955.t1,three_way,55.178666666666665,,,,,,,,,,,,,,,,,
OG_03147,2.131772868837224,FUN_012533-T1,Peve_00034230,Pocillopora_meandrina_HIv1___RNAseq.g23954.t1,three_way,57.28066666666667,,,,,,,,,,,,,,,,,
OG_03153,1.185814831914064,FUN_012542-T1,Peve_00034213,Pocillopora_meandrina_HIv1___RNAseq.g23623.t1,three_way,74.7105,FUN_012542-T1,O15442,,,,,51.8,251.0,1.3e-72,274.6,sp|O15442|MPPD1_HUMAN Metallophosphoesterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MPPED1 PE=1 SV=3,,,,,,
OG_03158,1.95976491376456,FUN_012554-T1,Peve_00030421,Pocillopora_meandrina_HIv1___RNAseq.g23587.t2,three_way,58.8805,,,,,,,,,,,,,,,,,
OG_03161,2.720383905206717,FUN_012557-T1,Peve_00030425,Pocillopora_meandrina_HIv1___TS.g16464.t1,three_way,86.991,FUN_012557-T1,Q8IZN3,ZDH14_HUMAN,,Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14),Homo sapiens (Human),65.3,303.0,6.5e-121,435.6,sp|Q8IZN3|ZDH14_HUMAN Palmitoyltransferase ZDHHC14 OS=Homo sapiens OX=9606 GN=ZDHHC14 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580,peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0003824; GO:0005783; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03165,1.3940978015502044,FUN_012571-T1,Peve_00015689,Pocillopora_meandrina_HIv1___RNAseq.g12855.t1,three_way,43.12116666666667,FUN_012571-T1,P0C6Y7,PRDM9_RAT,,Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361),Rattus norvegicus (Rat),40.5,173.0,1.4e-32,143.3,sp|P0C6Y7|PRDM9_RAT Histone-lysine N-methyltransferase PRDM9 OS=Rattus norvegicus OX=10116 GN=Prdm9 PE=3 SV=1,GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0045944; GO:0046975; GO:0048232; GO:0060903; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; nucleus [GO:0005634],histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_03166,1.1692228112300742,FUN_012588-T1,Peve_00038785,Pocillopora_meandrina_HIv1___TS.g2635.t1,three_way,81.07383333333334,FUN_012588-T1,Q18297,TRPA1_CAEEL,,Transient receptor potential cation channel subfamily A member 1 homolog,Caenorhabditis elegans,30.8,568.0,2.3e-54,216.1,sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5,GO:0005216; GO:0005886; GO:0043025; GO:0097730,,neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],monoatomic ion channel activity [GO:0005216],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_03168,1.4652619477715905,FUN_012590-T1,Peve_00038782,Pocillopora_meandrina_HIv1___RNAseq.g13637.t1,three_way,72.70233333333334,FUN_012590-T1,Q53FA7,QORX_HUMAN,,Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein),Homo sapiens (Human),53.7,322.0,9.4e-97,355.1,sp|Q53FA7|QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2,GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0048038; GO:0070402,NADP metabolic process [GO:0006739],cytosol [GO:0005829],NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038],GO:0003824; GO:0005829; GO:0016491; GO:0055086,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_03172,1.0936570781067958,FUN_012595-T1,Peve_00042401,Pocillopora_meandrina_HIv1___TS.g2626.t1,three_way,93.69466666666666,FUN_012595-T1,Q8BWD8,,,,,81.7,367.0,3.4e-181,636.0,sp|Q8BWD8|CDK19_MOUSE Cyclin-dependent kinase 19 OS=Mus musculus OX=10090 GN=Cdk19 PE=2 SV=1,,,,,,
OG_03180,1.05776201470927,FUN_012628-T1,Peve_00040111,Pocillopora_meandrina_HIv1___RNAseq.g13728.t1,three_way,73.136,FUN_012628-T1,Q5BKR2,SL9B2_MOUSE,,Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Mus musculus (Mouse),50.6,451.0,9.2e-114,412.1,sp|Q5BKR2|SL9B2_MOUSE Sodium/hydrogen exchanger 9B2 OS=Mus musculus OX=10090 GN=Slc9b2 PE=1 SV=2,GO:0005765; GO:0005886; GO:0010008; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0046872; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:2001206,clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; lithium ion transport [GO:0010351]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672],identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; metal ion binding [GO:0046872]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005768; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endosome; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_03181,1.6185896713775776,FUN_012630-T1,Peve_00040109,Pocillopora_meandrina_HIv1___RNAseq.g22915.t2,three_way,37.121,,,,,,,,,,,,,,,,,
OG_03184,1.4728487643554722,FUN_012639-T1,Peve_00036806,Pocillopora_meandrina_HIv1___RNAseq.g22909.t1,three_way,74.95033333333333,FUN_012639-T1,Q5THJ4,VP13D_HUMAN,,Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D),Homo sapiens (Human),35.7,4659.0,0.0,2452.2,sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2,GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526,lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623],extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],,GO:0005739; GO:0006886; GO:0007005; GO:0043226,mitochondrion; intracellular protein transport; mitochondrion organization; organelle
OG_03186,1.1707561317694488,FUN_012655-T1,Peve_00022124,Pocillopora_meandrina_HIv1___RNAseq.g22896.t1,three_way,83.30833333333334,FUN_012655-T1,B3TP03,CTR2_CHICK,,Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),Gallus gallus (Chicken),41.7,653.0,5.0000000000000004e-130,466.5,sp|B3TP03|CTR2_CHICK Cationic amino acid transporter 2 OS=Gallus gallus OX=9031 GN=SLC7A2 PE=2 SV=1,GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352,L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],GO:0005215; GO:0005794; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_03189,1.5597756340832765,FUN_012660-T1,Peve_00020497,Pocillopora_meandrina_HIv1___RNAseq.g22893.t1,three_way,86.607,FUN_012660-T1,Q8C811,,,,,49.4,265.0,7.899999999999999e-62,238.8,sp|Q8C811|S35E2_MOUSE Solute carrier family 35 member E2A OS=Mus musculus OX=10090 GN=Slc35e2a PE=2 SV=1,,,,,,
OG_03190,1.601761848148609,FUN_012662-T1,Peve_00020495,Pocillopora_meandrina_HIv1___RNAseq.g22891.t1,three_way,60.961666666666666,FUN_012662-T1,Q8BZ20,,,,,32.8,649.0,2e-78,295.0,sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3,,,,,,
OG_03192,1.53049464205196,FUN_012668-T1,Peve_00008661,Pocillopora_meandrina_HIv1___RNAseq.g22886.t1,three_way,85.77733333333333,,,,,,,,,,,,,,,,,
OG_03193,2.626107888281336,FUN_012670-T1,Peve_00008660,Pocillopora_meandrina_HIv1___RNAseq.g22885.t1,three_way,76.15866666666666,FUN_012670-T1,Q5F464,,,,,48.0,256.0,2.8e-72,273.5,sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1,,,,,,
OG_03201,1.1831852874750806,FUN_012687-T1,Peve_00022398,Pocillopora_meandrina_HIv1___RNAseq.g22871.t1,three_way,44.837833333333336,,,,,,,,,,,,,,,,,
OG_03203,1.4664063761901815,FUN_012689-T1,Peve_00016816,Pocillopora_meandrina_HIv1___RNAseq.g22864.t1,three_way,78.05083333333333,FUN_012689-T1,Q9YHY6,,,,,42.0,1454.0,3.1999999999999995e-300,1033.1,sp|Q9YHY6|CND1_XENLA Condensin complex subunit 1 OS=Xenopus laevis OX=8355 GN=ncapd2 PE=1 SV=1,,,,,,
OG_03204,1.2722492985097418,FUN_012693-T1,Peve_00016824,Pocillopora_meandrina_HIv1___TS.g15743.t1,three_way,82.26066666666667,FUN_012693-T1,Q7L8C5,SYT13_HUMAN,,Synaptotagmin-13 (Synaptotagmin XIII) (SytXIII),Homo sapiens (Human),29.4,194.0,6.1e-11,70.5,sp|Q7L8C5|SYT13_HUMAN Synaptotagmin-13 OS=Homo sapiens OX=9606 GN=SYT13 PE=1 SV=1,GO:0000149; GO:0005544; GO:0005886; GO:0016192; GO:0017158; GO:0030133; GO:0030424; GO:0030672; GO:0031045; GO:0043231; GO:0061891; GO:0070382; GO:0099502; GO:2000300,calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of synaptic vesicle exocytosis [GO:2000300]; vesicle-mediated transport [GO:0016192],axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; transport vesicle [GO:0030133],calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149],GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_03207,1.13419050204019,FUN_012699-T1,Peve_00016830,Pocillopora_meandrina_HIv1___RNAseq.g22854.t1,three_way,70.60966666666667,FUN_012699-T1,O94923,GLCE_HUMAN,,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),Homo sapiens (Human),44.1,612.0,9.099999999999999e-137,488.8,sp|O94923|GLCE_HUMAN D-glucuronyl C5-epimerase OS=Homo sapiens OX=9606 GN=GLCE PE=1 SV=3,GO:0000139; GO:0005509; GO:0005794; GO:0008284; GO:0015012; GO:0016857; GO:0030210; GO:0031345; GO:0042803; GO:0047464; GO:0060391,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; negative regulation of cell projection organization [GO:0031345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of SMAD protein signal transduction [GO:0060391],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]",GO:0003824; GO:0005794; GO:0009101; GO:0016853; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; isomerase activity; organelle; carbohydrate derivative metabolic process
OG_03208,1.707976080703372,FUN_012700-T1,Peve_00016832,Pocillopora_meandrina_HIv1___RNAseq.g12826.t1,three_way,67.51966666666667,FUN_012700-T1,Q12794,,,,,39.9,353.0,2.5000000000000002e-73,278.1,sp|Q12794|HYAL1_HUMAN Hyaluronidase-1 OS=Homo sapiens OX=9606 GN=HYAL1 PE=1 SV=2,,,,,,
OG_03209,1.7639588415191856,FUN_012701-T1,Peve_00016835,Pocillopora_meandrina_HIv1___RNAseq.g12828.t1,three_way,66.00966666666667,,,,,,,,,,,,,,,,,
OG_03211,1.0619691256056218,FUN_012707-T1,Peve_00004150,Pocillopora_meandrina_HIv1___RNAseq.g12831.t1,three_way,67.89066666666668,FUN_012707-T1,A7YY53,ADPRM_BOVIN,,Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase (EC 3.6.1.13) (EC 3.6.1.16) (EC 3.6.1.53) (ADPRibase-Mn) (CDP-choline phosphohydrolase),Bos taurus (Bovine),41.1,333.0,1.1e-70,268.5,sp|A7YY53|ADPRM_BOVIN Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase OS=Bos taurus OX=9913 GN=ADPRM PE=2 SV=2,GO:0008663; GO:0030145; GO:0047631; GO:0047734,,,"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]",GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_03212,1.0341029949585638,FUN_012708-T1,Peve_00004160,Pocillopora_meandrina_HIv1___RNAseq.g12832.t1,three_way,54.59816666666666,,,,,,,,,,,,,,,,,
OG_03213,1.0541416893191566,FUN_012710-T1,Peve_00004152,Pocillopora_meandrina_HIv1___RNAseq.g12834.t1,three_way,52.82866666666666,,,,,,,,,,,,,,,,,
OG_03216,1.400434823174819,FUN_012740-T1,Peve_00045176,Pocillopora_meandrina_HIv1___RNAseq.g23183.t1a,three_way,66.55333333333333,,,,,,,,,,,,,,,,,
OG_03218,1.3341118138314032,FUN_012742-T1,Peve_00045169,Pocillopora_meandrina_HIv1___RNAseq.g23181.t1,three_way,60.48133333333333,,,,,,,,,,,,,,,,,
OG_03220,2.028278337319429,FUN_012757-T1,Peve_00044225,Pocillopora_meandrina_HIv1___TS.g16058.t1,three_way,41.0565,,,,,,,,,,,,,,,,,
OG_03221,1.0779033701115994,FUN_012758-T1,Peve_00010982,Pocillopora_meandrina_HIv1___RNAseq.g23173.t2,three_way,87.95,FUN_012758-T1,Q7TNL3,STK40_MOUSE,,Serine/threonine-protein kinase 40 (EC 2.7.11.1) (Serine/threonine-protein kinase lyk4),Mus musculus (Mouse),58.1,454.0,1.5e-136,487.6,sp|Q7TNL3|STK40_MOUSE Serine/threonine-protein kinase 40 OS=Mus musculus OX=10090 GN=Stk40 PE=1 SV=1,GO:0003016; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0010468; GO:0030324; GO:0035264; GO:0043066; GO:0043408; GO:0048286; GO:0060425; GO:0106310,glycogen metabolic process [GO:0005977]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]; respiratory system process [GO:0003016],cytosol [GO:0005829]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003016; GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0048856; GO:0140096,"respiratory system process; catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_03224,1.1452667531971297,FUN_012764-T2,Peve_00006134,Pocillopora_meandrina_HIv1___TS.g16045.t1,three_way,49.54133333333333,FUN_012764-T2,Q5RFG8,UBE3D_PONAB,,E3 ubiquitin-protein ligase E3D (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase E3D) (UbcH10-binding protein with a HECT-like domain) (Ubiquitin-conjugating enzyme E2C-binding protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,359.0,8.100000000000001e-28,126.3,sp|Q5RFG8|UBE3D_PONAB E3 ubiquitin-protein ligase E3D OS=Pongo abelii OX=9601 GN=UBE3D PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005829; GO:0006513; GO:0030332; GO:0031624; GO:0043161; GO:0051865; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],cyclin binding [GO:0030332]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03225,2.165624321088869,FUN_012766-T1,Peve_00026363,Pocillopora_meandrina_HIv1___RNAseq.g23151.t1c,three_way,53.47366666666667,,,,,,,,,,,,,,,,,
OG_03227,1.2886639960720074,FUN_012769-T1,Peve_00016323,Pocillopora_meandrina_HIv1___RNAseq.g13659.t1,three_way,77.668,FUN_012769-T1,Q68EJ0,NB5R4_RAT,,Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R),Rattus norvegicus (Rat),42.8,544.0,7.9e-116,419.1,sp|Q68EJ0|NB5R4_RAT Cytochrome b5 reductase 4 OS=Rattus norvegicus OX=10116 GN=Cyb5r4 PE=1 SV=2,GO:0003958; GO:0004128; GO:0005737; GO:0005783; GO:0006739; GO:0006801; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0050660; GO:0072593,cell development [GO:0048468]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; NADP metabolic process [GO:0006739]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]",GO:0003824; GO:0005783; GO:0016491; GO:0043226; GO:0048856; GO:0055086,catalytic activity; endoplasmic reticulum; oxidoreductase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_03231,1.5219287644793589,FUN_012774-T1,Peve_00007593,Pocillopora_meandrina_HIv1___RNAseq.g13651.t1,three_way,88.069,FUN_012774-T1,O43741,,,,,45.0,280.0,3.1e-60,233.4,sp|O43741|AAKB2_HUMAN 5'-AMP-activated protein kinase subunit beta-2 OS=Homo sapiens OX=9606 GN=PRKAB2 PE=1 SV=1,,,,,,
OG_03234,1.19307393335286,FUN_012779-T1,Peve_00017054,Pocillopora_meandrina_HIv1___RNAseq.g12883.t1,three_way,75.45166666666667,FUN_012779-T1,Q9WVK0,ATRAP_MOUSE,,Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein),Mus musculus (Mouse),46.3,121.0,1.7000000000000002e-22,107.5,sp|Q9WVK0|ATRAP_MOUSE Type-1 angiotensin II receptor-associated protein OS=Mus musculus OX=10090 GN=Agtrap PE=1 SV=2,GO:0000139; GO:0001666; GO:0004945; GO:0005789; GO:0005886; GO:0005938; GO:0008217; GO:0030659,regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666],cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],angiotensin type II receptor activity [GO:0004945],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_03236,2.2067345462908783,FUN_012786-T1,Peve_00018304,Pocillopora_meandrina_HIv1___RNAseq.g12888.t1,three_way,86.545,FUN_012786-T1,Q6IWH7,ANO7_HUMAN,,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),Homo sapiens (Human),45.7,879.0,2.2e-213,743.8,sp|Q6IWH7|ANO7_HUMAN Anoctamin-7 OS=Homo sapiens OX=9606 GN=ANO7 PE=1 SV=2,GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476,calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; organelle; transmembrane transport; membrane organization
OG_03237,1.007092303938973,FUN_012787-T1,Peve_00023538,Pocillopora_meandrina_HIv1___TS.g1877.t1,three_way,62.16516666666666,FUN_012787-T1,Q920Q2,REV1_MOUSE,,DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase),Mus musculus (Mouse),33.0,1286.0,1.2e-152,542.3,sp|Q920Q2|REV1_MOUSE DNA repair protein REV1 OS=Mus musculus OX=10090 GN=Rev1 PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0009411; GO:0017125; GO:0042276; GO:0046872,error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_03238,1.0399339786004205,FUN_012788-T1,Peve_00010079,Pocillopora_meandrina_HIv1___RNAseq.g12891.t1,three_way,80.43083333333334,FUN_012788-T1,Q5RCR5,,,,,56.2,274.0,4.7e-94,345.9,sp|Q5RCR5|SUMF2_PONAB Inactive C-alpha-formylglycine-generating enzyme 2 OS=Pongo abelii OX=9601 GN=SUMF2 PE=2 SV=1,,,,,,
OG_03241,1.0096812777260051,FUN_012795-T1,Peve_00022361,Pocillopora_meandrina_HIv1___TS.g1884.t1,three_way,59.97133333333333,FUN_012795-T1,Q05793,PGBM_MOUSE,,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) [Cleaved into: Endorepellin; LG3 peptide],Mus musculus (Mouse),32.0,1366.0,6.4e-204,713.0,sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1,GO:0001525; GO:0001958; GO:0002020; GO:0002062; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007420; GO:0008104; GO:0030198; GO:0031012; GO:0048704; GO:0048738; GO:0060351; GO:0062023,angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796],calcium ion binding [GO:0005509]; protease binding [GO:0002020],GO:0005576; GO:0016192; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; vesicle-mediated transport; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_03242,1.0785179359308623,FUN_012801-T1,Peve_00019853,Pocillopora_meandrina_HIv1___RNAseq.g12895.t1,three_way,85.11566666666667,FUN_012801-T1,Q9WUA2,,,,,60.4,589.0,2.1000000000000002e-213,743.4,sp|Q9WUA2|SYFB_MOUSE Phenylalanine--tRNA ligase beta subunit OS=Mus musculus OX=10090 GN=Farsb PE=1 SV=2,,,,,,
OG_03252,1.8486269127726136,FUN_012983-T1,Peve_00028830,Pocillopora_meandrina_HIv1___RNAseq.g30380.t2,three_way,73.10633333333334,,,,,,,,,,,,,,,,,
OG_03254,1.6884468879746948,FUN_013022-T1,Peve_00032576,Pocillopora_meandrina_HIv1___RNAseq.g12959.t1,three_way,71.19483333333334,FUN_013022-T1,Q674X7,KAZRN_HUMAN,,Kazrin,Homo sapiens (Human),35.2,693.0,1.8e-94,348.6,sp|Q674X7|KAZRN_HUMAN Kazrin OS=Homo sapiens OX=9606 GN=KAZN PE=1 SV=2,GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0031424,keratinization [GO:0031424],cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0043226,nucleoplasm; cytosol; cytoskeleton; plasma membrane; organelle
OG_03255,1.753866545735408,FUN_013023-T1,Peve_00032574,Pocillopora_meandrina_HIv1___RNAseq.g12958.t1,three_way,85.64083333333333,,,,,,,,,,,,,,,,,
OG_03256,1.0792544773606745,FUN_013024-T1,Peve_00032573,Pocillopora_meandrina_HIv1___RNAseq.g12957.t1,three_way,92.86466666666666,FUN_013024-T1,Q9UNL4,,,,,66.7,93.0,4.8e-28,125.2,sp|Q9UNL4|ING4_HUMAN Inhibitor of growth protein 4 OS=Homo sapiens OX=9606 GN=ING4 PE=1 SV=1,,,,,,
OG_03257,1.1872479618574294,FUN_013027-T2,Peve_00032585,Pocillopora_meandrina_HIv1___RNAseq.g12956.t1,three_way,68.18766666666667,FUN_013027-T2,P47736,RPGP1_HUMAN,,Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1),Homo sapiens (Human),48.6,414.0,2.6e-101,371.7,sp|P47736|RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RAP1GAP PE=1 SV=2,GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006909; GO:0007165; GO:0016020; GO:0022409; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:0051649; GO:0098609; GO:1903697; GO:1904442; GO:1990792,adaptive immune response [GO:0002250]; cell-cell adhesion [GO:0098609]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; establishment of localization in cell [GO:0051649]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; phagocytosis [GO:0006909]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025],GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],GO:0002376; GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0007155; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0098772,immune system process; catalytic activity; GTPase activity; endosome; cytosol; cell adhesion; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_03260,1.5161338717880697,FUN_013083-T1,Peve_00027384,Pocillopora_meandrina_HIv1___RNAseq.g13104.t1,three_way,71.1305,FUN_013083-T1,Q6ZUK4,,,,,31.6,367.0,9.999999999999999e-33,142.5,sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1,,,,,,
OG_03261,1.5986513073607511,FUN_013085-T1,Peve_00027392,Pocillopora_meandrina_HIv1___RNAseq.g13092.t2,three_way,58.874,FUN_013085-T1,Q8IZH2,XRN1_HUMAN,,5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog),Homo sapiens (Human),45.9,1541.0,0.0,1238.8,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:1905795,cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; rRNA catabolic process [GO:0016075],cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886],5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; plasma membrane; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03263,1.2768324993712254,FUN_013089-T1,Peve_00034077,Pocillopora_meandrina_HIv1___RNAseq.g216.t1,three_way,78.51933333333334,FUN_013089-T1,Q8WXG1,RSAD2_HUMAN,,"S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (EC 4.2.-.-) (Cytomegalovirus-induced gene 5 protein) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin)",Homo sapiens (Human),74.7,292.0,4.3000000000000004e-134,479.2,sp|Q8WXG1|RSAD2_HUMAN S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 OS=Homo sapiens OX=9606 GN=RSAD2 PE=1 SV=1,GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553,"CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],"4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]",GO:0002376; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005811; GO:0016829; GO:0030154; GO:0043226; GO:0098542,immune system process; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; lipid droplet; lyase activity; cell differentiation; organelle; defense response to other organism
OG_03264,1.1020621027293578,FUN_013106-T1,Peve_00027393,Pocillopora_meandrina_HIv1___RNAseq.g13093.t1,three_way,69.684,FUN_013106-T1,Q6P1B1,,,,,47.2,494.0,6.899999999999999e-127,455.7,sp|Q6P1B1|XPP1_MOUSE Xaa-Pro aminopeptidase 1 OS=Mus musculus OX=10090 GN=Xpnpep1 PE=1 SV=1,,,,,,
OG_03270,1.1438312104863928,FUN_013139-T1,Peve_00042385,Pocillopora_meandrina_HIv1___RNAseq.g23012.t1,three_way,50.720333333333336,FUN_013139-T1,Q63341,MMP12_RAT,,Macrophage metalloelastase (MME) (EC 3.4.24.65) (Matrix metalloproteinase-12) (MMP-12),Rattus norvegicus (Rat),36.7,267.0,1.2e-34,148.7,sp|Q63341|MMP12_RAT Macrophage metalloelastase OS=Rattus norvegicus OX=10116 GN=Mmp12 PE=2 SV=1,GO:0000122; GO:0001046; GO:0001666; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0009410; GO:0010628; GO:0030198; GO:0030574; GO:0031012; GO:0032727; GO:0035313; GO:0043565; GO:0045944; GO:0048286; GO:0050679; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0060435; GO:0098586; GO:1901163; GO:1904905,"bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; regulation of trophoblast cell migration [GO:1901163]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; wound healing, spreading of epidermal cells [GO:0035313]",cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005615; GO:0005634; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030163; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096; GO:1901135,"DNA binding; catalytic activity; extracellular space; nucleus; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; protein catabolic process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03272,1.4307728539345854,FUN_013145-T1,Peve_00027383,Pocillopora_meandrina_HIv1___RNAseq.g13822.t1,three_way,65.41383333333333,FUN_013145-T1,Q01780,EXOSX_HUMAN,,Exosome complex component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2),Homo sapiens (Human),45.4,707.0,2.4e-159,564.3,sp|Q01780|EXOSX_HUMAN Exosome complex component 10 OS=Homo sapiens OX=9606 GN=EXOSC10 PE=1 SV=2,GO:0000166; GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000791; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0032040; GO:0032211; GO:0042274; GO:0046872; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071051; GO:0101019; GO:1904872; GO:1905746,"CUT catabolic process [GO:0071034]; DNA repair [GO:0006281]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; ribosomal small subunit biogenesis [GO:0042274]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]",cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006399; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; tRNA metabolic process; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03273,1.7577454418290468,FUN_013146-T1,Peve_00024360,Pocillopora_meandrina_HIv1___RNAseq.g13823.t1,three_way,75.41933333333333,FUN_013146-T1,Q5U247,,,,,34.6,673.0,1e-96,355.9,sp|Q5U247|EXOC8_XENLA Exocyst complex component 8 OS=Xenopus laevis OX=8355 GN=exoc8 PE=2 SV=1,,,,,,
OG_03281,1.7844876605586413,FUN_013162-T1,Peve_00022440,Pocillopora_meandrina_HIv1___RNAseq.g13110.t3,three_way,66.35566666666666,FUN_013162-T1,Q924H0,,,,,27.5,360.0,9.1e-18,92.8,sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2,,,,,,
OG_03282,1.093335662955322,FUN_013314-T1,Peve_00022437,Pocillopora_meandrina_HIv1___RNAseq.g12993.t1,three_way,71.73,FUN_013314-T1,Q5XF89,AT133_MOUSE,,Polyamine-transporting ATPase 13A3 (Putrescine transporting ATPase) (EC 7.6.2.16),Mus musculus (Mouse),47.0,1186.0,5.3999999999999995e-279,962.2,sp|Q5XF89|AT133_MOUSE Polyamine-transporting ATPase 13A3 OS=Mus musculus OX=10090 GN=Atp13a3 PE=1 SV=1,GO:0005524; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358,,early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038],ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358],GO:0003824; GO:0005215; GO:0016787; GO:0140657,catalytic activity; transporter activity; hydrolase activity; ATP-dependent activity
OG_03284,1.6473247398895217,FUN_013321-T1,Peve_00022436,Pocillopora_meandrina_HIv1___RNAseq.g12987.t1,three_way,43.632333333333335,,,,,,,,,,,,,,,,,
OG_03285,1.0186801960615024,FUN_013323-T1,Peve_00027397,Pocillopora_meandrina_HIv1___RNAseq.g941.t1,three_way,74.55333333333333,FUN_013323-T1,Q9D2I5,ARMC9_MOUSE,,LisH domain-containing protein ARMC9,Mus musculus (Mouse),50.8,675.0,6.9e-166,585.9,sp|Q9D2I5|ARMC9_MOUSE LisH domain-containing protein ARMC9 OS=Mus musculus OX=10090 GN=Armc9 PE=1 SV=1,GO:0005737; GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542,cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005815; GO:0005929; GO:0043226; GO:0044782,microtubule organizing center; cilium; organelle; cilium organization
OG_03289,1.89132389942755,FUN_013330-T1,Peve_00022425,Pocillopora_meandrina_HIv1___RNAseq.g12990.t1a,three_way,66.249,FUN_013330-T1,P42893,,,,,37.2,686.0,2.6000000000000003e-133,477.6,sp|P42893|ECE1_RAT Endothelin-converting enzyme 1 OS=Rattus norvegicus OX=10116 GN=Ece1 PE=1 SV=2,,,,,,
OG_03291,1.7055597757074834,FUN_013350-T1,Peve_00041996,Pocillopora_meandrina_HIv1___TS.g2168.t1a,three_way,66.735,FUN_013350-T1,Q8CBF3,EPHB1_MOUSE,,Ephrin type-B receptor 1 (EC 2.7.10.1),Mus musculus (Mouse),38.3,975.0,3.2e-176,620.5,sp|Q8CBF3|EPHB1_MOUSE Ephrin type-B receptor 1 OS=Mus musculus OX=10090 GN=Ephb1 PE=1 SV=1,GO:0001525; GO:0001771; GO:0005005; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007411; GO:0008046; GO:0014719; GO:0016020; GO:0021545; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070372; GO:0098978; GO:1902723; GO:1902725,angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; cranial nerve development [GO:0021545]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein-containing complex binding [GO:0044877]; transmembrane-ephrin receptor activity [GO:0005005],GO:0003824; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007163; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endoplasmic reticulum; cytosol; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; transferase activity; cell differentiation; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_03298,1.1833196701798443,FUN_013365-T1,Peve_00001191,Pocillopora_meandrina_HIv1___RNAseq.g13342.t1,three_way,66.11066666666666,FUN_013365-T1,Q8IS64,,,,,46.9,685.0,1.8e-185,651.0,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_03300,1.2443709228289728,FUN_013368-T1,Peve_00001209,Pocillopora_meandrina_HIv1___RNAseq.g13344.t1,three_way,89.73183333333333,FUN_013368-T1,Q96C19,,,,,64.6,161.0,5.9e-50,198.7,sp|Q96C19|EFHD2_HUMAN EF-hand domain-containing protein D2 OS=Homo sapiens OX=9606 GN=EFHD2 PE=1 SV=1,,,,,,
OG_03310,1.4123970880924823,FUN_013387-T1,Peve_00034571,Pocillopora_meandrina_HIv1___RNAseq.g22979.t1,three_way,82.8835,FUN_013387-T1,Q3UY96,,,,,33.7,1633.0,7.6e-245,849.4,sp|Q3UY96|CFA74_MOUSE Cilia- and flagella-associated protein 74 OS=Mus musculus OX=10090 GN=Cfap74 PE=2 SV=3,,,,,,
OG_03311,2.0038241204717986,FUN_013389-T1,Peve_00031288,Pocillopora_meandrina_HIv1___TS.g15861.t1,three_way,67.08366666666667,,,,,,,,,,,,,,,,,
OG_03314,1.9012520872271632,FUN_013392-T1,Peve_00028094,Pocillopora_meandrina_HIv1___RNAseq.g22974.t2,three_way,67.61166666666666,,,,,,,,,,,,,,,,,
OG_03315,1.7755260738490637,FUN_013393-T2,Peve_00028093,Pocillopora_meandrina_HIv1___TS.g15814.t1,three_way,82.98983333333334,FUN_013393-T2,Q9WU45,CLCN2_CAVPO,,Chloride channel protein 2 (ClC-2),Cavia porcellus (Guinea pig),49.5,831.0,5.4e-204,712.6,sp|Q9WU45|CLCN2_CAVPO Chloride channel protein 2 OS=Cavia porcellus OX=10141 GN=CLCN2 PE=1 SV=1,GO:0005247; GO:0005886; GO:0016323; GO:0030424; GO:0032347; GO:0032591; GO:0034707; GO:0045211,regulation of aldosterone biosynthetic process [GO:0032347],axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; dendritic spine membrane [GO:0032591]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],voltage-gated chloride channel activity [GO:0005247],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_03332,2.051288139745293,FUN_013545-T1,Peve_00038572,Pocillopora_meandrina_HIv1___RNAseq.g22955.t1a,three_way,83.74533333333333,FUN_013545-T1,Q99570,PI3R4_HUMAN,,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),Homo sapiens (Human),51.6,1405.0,0.0,1382.1,sp|Q99570|PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PIK3R4 PE=1 SV=3,GO:0000425; GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005929; GO:0005930; GO:0006468; GO:0006622; GO:0006623; GO:0010506; GO:0015630; GO:0016020; GO:0016241; GO:0030670; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0036064; GO:0036092; GO:0042149; GO:0043231; GO:0043491; GO:0045022; GO:0045171; GO:0045324; GO:0071561; GO:0097352; GO:0106310,autophagosome maturation [GO:0097352]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; pexophagy [GO:0000425]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241],"autophagosome [GO:0005776]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]",ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005768; GO:0005773; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; vacuole; microtubule organizing center; cytosol; cytoskeleton; cilium; lipid metabolic process; intracellular protein transport; autophagy; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_03336,1.4662321257007571,FUN_013557-T1,Peve_00038567,Pocillopora_meandrina_HIv1___RNAseq.g22961.t1,three_way,93.49333333333334,FUN_013557-T1,Q62074,KPCI_MOUSE,,Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (nPKC-iota),Mus musculus (Mouse),69.2,591.0,1.4999999999999999e-245,850.1,sp|Q62074|KPCI_MOUSE Protein kinase C iota type OS=Mus musculus OX=10090 GN=Prkci PE=1 SV=3,GO:0000139; GO:0004672; GO:0004674; GO:0004699; GO:0005524; GO:0005543; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005903; GO:0005923; GO:0005929; GO:0007015; GO:0008270; GO:0010976; GO:0015630; GO:0016324; GO:0016477; GO:0031252; GO:0032869; GO:0034351; GO:0035089; GO:0042462; GO:0043220; GO:0043524; GO:0045171; GO:0045177; GO:0045197; GO:0045216; GO:0046326; GO:0048194; GO:0051092; GO:0060252; GO:0070555; GO:0098685; GO:0098978; GO:0099072; GO:0106310; GO:0120157; GO:1903078; GO:2000353,actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to insulin stimulus [GO:0032869]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220],"ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005634; GO:0005768; GO:0005829; GO:0005856; GO:0005929; GO:0006355; GO:0007163; GO:0008289; GO:0016740; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; nucleus; endosome; cytosol; cytoskeleton; cilium; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; lipid binding; transferase activity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_03340,1.3540976954818915,FUN_013570-T1,Peve_00018159,Pocillopora_meandrina_HIv1___RNAseq.g13476.t1,three_way,85.26566666666666,FUN_013570-T1,Q9CPV0,TM107_MOUSE,,Transmembrane protein 107,Mus musculus (Mouse),52.7,129.0,1.4e-32,140.6,sp|Q9CPV0|TM107_MOUSE Transmembrane protein 107 OS=Mus musculus OX=10090 GN=Tmem107 PE=1 SV=1,GO:0003127; GO:0007368; GO:0010468; GO:0016020; GO:0021532; GO:0035869; GO:0036038; GO:0042733; GO:0044782; GO:0060021; GO:0060271; GO:0097094; GO:1904491; GO:1905515,cilium assembly [GO:0060271]; cilium organization [GO:0044782]; craniofacial suture morphogenesis [GO:0097094]; detection of nodal flow [GO:0003127]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021],ciliary transition zone [GO:0035869]; membrane [GO:0016020]; MKS complex [GO:0036038],,GO:0044782; GO:0048856,cilium organization; anatomical structure development
OG_03346,1.0657882942720556,FUN_013582-T1,Peve_00018189,Pocillopora_meandrina_HIv1___RNAseq.g13504.t1,three_way,62.93,,,,,,,,,,,,,,,,,
OG_03348,1.08424407170868,FUN_013584-T1,Peve_00018186,Pocillopora_meandrina_HIv1___RNAseq.g13502.t1,three_way,72.53633333333333,,,,,,,,,,,,,,,,,
OG_03349,2.7905045356488247,FUN_013585-T1,Peve_00018185,Pocillopora_meandrina_HIv1___RNAseq.g13501.t1,three_way,78.13466666666666,FUN_013585-T1,O35454,CLCN6_MOUSE,,H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6),Mus musculus (Mouse),54.1,857.0,1.0999999999999999e-249,864.4,sp|O35454|CLCN6_MOUSE H(+)/Cl(-) exchange transporter 6 OS=Mus musculus OX=10090 GN=Clcn6 PE=1 SV=1,GO:0005247; GO:0005524; GO:0006821; GO:0015297; GO:0031902,chloride transport [GO:0006821],late endosome membrane [GO:0031902],antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247],GO:0005215,transporter activity
OG_03350,1.362948175442595,FUN_013586-T1,Peve_00018184,Pocillopora_meandrina_HIv1___TS.g2494.t1,three_way,61.21066666666667,,,,,,,,,,,,,,,,,
OG_03357,1.6035006933852385,FUN_013594-T1,Peve_00029572,Pocillopora_meandrina_HIv1___RNAseq.g6546.t1,three_way,67.05166666666666,,,,,,,,,,,,,,,,,
OG_03362,1.9063833195069333,FUN_013601-T1,Peve_00018166,Pocillopora_meandrina_HIv1___RNAseq.g13480.t1,three_way,70.76016666666666,,,,,,,,,,,,,,,,,
OG_03368,1.641543257141876,FUN_013613-T1,Peve_00002659,Pocillopora_meandrina_HIv1___RNAseq.g13533.t1,three_way,54.56916666666667,FUN_013613-T1,Q9P2K9,DISP3_HUMAN,,Protein dispatched homolog 3 (Patched domain-containing protein 2),Homo sapiens (Human),35.0,1203.0,7.2e-160,566.6,sp|Q9P2K9|DISP3_HUMAN Protein dispatched homolog 3 OS=Homo sapiens OX=9606 GN=DISP3 PE=1 SV=2,GO:0005737; GO:0005783; GO:0005789; GO:0007224; GO:0008203; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0032368; GO:0042632; GO:0045665; GO:0045834; GO:2000179,cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of lipid transport [GO:0032368]; smoothened signaling pathway [GO:0007224],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965],,GO:0005783; GO:0006629; GO:0030154; GO:0043226,endoplasmic reticulum; lipid metabolic process; cell differentiation; organelle
OG_03370,1.2810292322499073,FUN_013616-T1,Peve_00002647,Pocillopora_meandrina_HIv1___RNAseq.g13535.t1,three_way,68.612,FUN_013616-T1,Q9Y2G8,DJC16_HUMAN,,DnaJ homolog subfamily C member 16 (Endoplasmic reticulum DNA J domain-containing protein 8) (ER-resident protein ERdj8) (ERdj8),Homo sapiens (Human),31.9,781.0,3.7e-95,350.9,sp|Q9Y2G8|DJC16_HUMAN DnaJ homolog subfamily C member 16 OS=Homo sapiens OX=9606 GN=DNAJC16 PE=1 SV=3,GO:0005789; GO:0016243,regulation of autophagosome size [GO:0016243],endoplasmic reticulum membrane [GO:0005789],,,
OG_03374,1.0342122915040035,FUN_013620-T1,Peve_00014987,Pocillopora_meandrina_HIv1___RNAseq.g13541.t1,three_way,88.12266666666667,FUN_013620-T1,B9GCH9,UREA_ORYSJ,,Urease (EC 3.5.1.5) (Urea amidohydrolase),Oryza sativa subsp. japonica (Rice),62.3,862.0,3.4e-307,1055.4,sp|B9GCH9|UREA_ORYSJ Urease OS=Oryza sativa subsp. japonica OX=39947 GN=Os12g0234800 PE=3 SV=2,GO:0009039; GO:0016151; GO:0035550; GO:0043419,urea catabolic process [GO:0043419],urease complex [GO:0035550],nickel cation binding [GO:0016151]; urease activity [GO:0009039],GO:0003824; GO:0016787; GO:0071941,catalytic activity; hydrolase activity; nitrogen cycle metabolic process
OG_03377,1.2063531036416837,FUN_013623-T1,Peve_00014994,Pocillopora_meandrina_HIv1___RNAseq.g13544.t1,three_way,69.24266666666666,FUN_013623-T1,A9GP79,,,,,32.0,256.0,1.0999999999999998e-24,115.5,sp|A9GP79|URED_SORC5 Urease accessory protein UreD OS=Sorangium cellulosum (strain So ce56) OX=448385 GN=ureD PE=3 SV=2,,,,,,
OG_03378,1.5397368158535103,FUN_013626-T1,Peve_00013600,Pocillopora_meandrina_HIv1___RNAseq.g13546.t1,three_way,86.476,FUN_013626-T1,P49915,GUAA_HUMAN,,GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase),Homo sapiens (Human),65.0,666.0,4.9e-264,911.8,sp|P49915|GUAA_HUMAN GMP synthase [glutamine-hydrolyzing] OS=Homo sapiens OX=9606 GN=GMPS PE=1 SV=1,GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0009113; GO:0009168,GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168],cytosol [GO:0005829],ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921],GO:0003824; GO:0005829; GO:0016874; GO:0055086; GO:1901135,catalytic activity; cytosol; ligase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03379,1.2765355344464364,FUN_013627-T1,Peve_00018598,Pocillopora_meandrina_HIv1___RNAseq.g13548.t1,three_way,66.10166666666667,,,,,,,,,,,,,,,,,
OG_03381,1.1783715633258809,FUN_013631-T1,Peve_00039074,Pocillopora_meandrina_HIv1___RNAseq.g13554.t1,three_way,65.295,FUN_013631-T1,Q6PBI8,,,,,24.7,296.0,4.9e-17,90.1,sp|Q6PBI8|TM177_DANRE Transmembrane protein 177 OS=Danio rerio OX=7955 GN=tmem177 PE=2 SV=1,,,,,,
OG_03386,1.1056387101446998,FUN_013641-T1,Peve_00019982,Pocillopora_meandrina_HIv1___RNAseq.g13568.t1,three_way,45.04066666666667,,,,,,,,,,,,,,,,,
OG_03389,1.7311100777198458,FUN_014089-T1,Peve_00007744,Pocillopora_meandrina_HIv1___RNAseq.g15612.t1,three_way,71.63983333333333,FUN_014089-T1,Q91VS8,FARP2_MOUSE,,"FERM, ARHGEF and pleckstrin domain-containing protein 2 (FERM domain including RhoGEF) (FIR) (FERM, RhoGEF and pleckstrin domain-containing protein 2)",Mus musculus (Mouse),36.0,1242.0,1.5999999999999998e-191,671.8,"sp|Q91VS8|FARP2_MOUSE FERM, ARHGEF and pleckstrin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Farp2 PE=1 SV=2",GO:0005085; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0008092; GO:0016322; GO:0016601; GO:0022405; GO:0030036; GO:0030316; GO:0033623; GO:0071526; GO:0071800,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; semaphorin-plexin signaling pathway [GO:0071526],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829],cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005856; GO:0007010; GO:0007155; GO:0008092; GO:0030154; GO:0043226; GO:0065003; GO:0098772,cytosol; cytoskeleton; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; cell differentiation; organelle; protein-containing complex assembly; molecular function regulator activity
OG_03394,1.0807820057496935,FUN_014166-T1,Peve_00026508,Pocillopora_meandrina_HIv1___RNAseq.g7362.t1,three_way,57.504,FUN_014166-T1,Q9H2K2,,,,,28.4,211.0,3.9e-08,62.0,sp|Q9H2K2|TNKS2_HUMAN Poly [ADP-ribose] polymerase tankyrase-2 OS=Homo sapiens OX=9606 GN=TNKS2 PE=1 SV=1,,,,,,
OG_03398,1.337571954325535,FUN_014264-T1,Peve_00021332,Pocillopora_meandrina_HIv1___RNAseq.g16097.t2,three_way,75.2415,FUN_014264-T1,Q32KU6,,,,,36.5,244.0,9.7e-39,162.2,sp|Q32KU6|TSN6_BOVIN Tetraspanin-6 OS=Bos taurus OX=9913 GN=TSPAN6 PE=2 SV=1,,,,,,
OG_03399,1.7039073754552447,FUN_014438-T1,Peve_00020049,Pocillopora_meandrina_HIv1___RNAseq.g24661.t1,three_way,86.73333333333333,FUN_014438-T1,Q0VG85,,,,,31.7,944.0,1.5000000000000001e-123,446.8,sp|Q0VG85|CC162_MOUSE Coiled-coil domain-containing protein 162 OS=Mus musculus OX=10090 GN=Ccdc162 PE=1 SV=4,,,,,,
OG_03401,1.5780448448157698,FUN_014440-T1,Peve_00002505,Pocillopora_meandrina_HIv1___TS.g8856.t1b,three_way,69.38566666666667,FUN_014440-T1,Q692V3,,,,,30.4,918.0,3e-104,381.7,sp|Q692V3|TTC41_MOUSE Tetratricopeptide repeat protein 41 OS=Mus musculus OX=10090 GN=Ttc41 PE=1 SV=1,,,,,,
OG_03402,1.0876079757949757,FUN_014441-T1,Peve_00009614,Pocillopora_meandrina_HIv1___RNAseq.g22836.t1,three_way,66.44333333333333,FUN_014441-T1,Q6PDY2,AEDO_MOUSE,,2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase),Mus musculus (Mouse),34.8,264.0,2.0000000000000002e-29,131.0,sp|Q6PDY2|AEDO_MOUSE 2-aminoethanethiol dioxygenase OS=Mus musculus OX=10090 GN=Ado PE=1 SV=2,GO:0005506; GO:0005739; GO:0047800; GO:0071456,cellular response to hypoxia [GO:0071456],mitochondrion [GO:0005739],cysteamine dioxygenase activity [GO:0047800]; iron ion binding [GO:0005506],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_03403,1.2354726187104037,FUN_014442-T1,Peve_00009611,Pocillopora_meandrina_HIv1___RNAseq.g22833.t1,three_way,60.98433333333333,FUN_014442-T1,Q55C17,,,,,27.9,247.0,2.8e-16,87.4,sp|Q55C17|TECR_DICDI Very-long-chain enoyl-CoA reductase OS=Dictyostelium discoideum OX=44689 GN=gpsn2 PE=3 SV=1,,,,,,
OG_03406,2.016443035698216,FUN_014449-T1,Peve_00009606,Pocillopora_meandrina_HIv1___RNAseq.1985_t,three_way,77.316,FUN_014449-T1,Q54BU4,ABCB1_DICDI,,ABC transporter B family member 1 (ABC transporter ABCB.1),Dictyostelium discoideum (Social amoeba),51.9,620.0,1.3e-162,575.1,sp|Q54BU4|ABCB1_DICDI ABC transporter B family member 1 OS=Dictyostelium discoideum OX=44689 GN=abcB1 PE=3 SV=1,GO:0005524; GO:0006935; GO:0006972; GO:0016020; GO:0016887; GO:0031154; GO:0042626; GO:0055085; GO:0140359,chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085],membrane [GO:0016020],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626],GO:0003824; GO:0005215; GO:0016787; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_03407,1.3894366958815547,FUN_014451-T1,Peve_00009605,Pocillopora_meandrina_HIv1___RNAseq.g22828.t1,three_way,66.653,FUN_014451-T1,O88831,KKCC2_RAT,,Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta),Rattus norvegicus (Rat),42.3,220.0,2.2e-29,131.0,sp|O88831|KKCC2_RAT Calcium/calmodulin-dependent protein kinase kinase 2 OS=Rattus norvegicus OX=10116 GN=Camkk2 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0030295; GO:0043005; GO:0046777; GO:0061762; GO:0106310,CAMKK-AMPK signaling cascade [GO:0061762]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03409,1.863502385661939,FUN_014456-T1,Peve_00009600,Pocillopora_meandrina_HIv1___RNAseq.g22824.t1,three_way,65.45816666666667,FUN_014456-T1,O35551,RABE1_MOUSE,,Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha),Mus musculus (Mouse),33.5,367.0,7.700000000000001e-38,160.6,sp|O35551|RABE1_MOUSE Rab GTPase-binding effector protein 1 OS=Mus musculus OX=10090 GN=Rabep1 PE=1 SV=2,GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0055037; GO:0098978; GO:0099149; GO:1903441,apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037],growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803],GO:0005768; GO:0005829; GO:0012501; GO:0016192; GO:0031410; GO:0043226; GO:0048018; GO:0098772,endosome; cytosol; programmed cell death; vesicle-mediated transport; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_03420,1.098958746282288,FUN_014474-T1,Peve_00030525,Pocillopora_meandrina_HIv1___TS.g27573.t1,three_way,70.30083333333333,FUN_014474-T1,Q00174,LAMA_DROME,,Laminin subunit alpha (Laminin A chain),Drosophila melanogaster (Fruit fly),35.5,3904.0,3.4e-306,1054.3,sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2,GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711,"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021],extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048856; GO:0098542,immune system process; structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism
OG_03424,1.056245047029826,FUN_014478-T1,Peve_00037305,Pocillopora_meandrina_HIv1___RNAseq.g22816.t2,three_way,65.88550000000001,,,,,,,,,,,,,,,,,
OG_03426,1.6598213043235122,FUN_014481-T1,Peve_00037299,Pocillopora_meandrina_HIv1___RNAseq.g22814.t1,three_way,43.44533333333333,,,,,,,,,,,,,,,,,
OG_03427,1.413192912456556,FUN_014483-T1,Peve_00037300,Pocillopora_meandrina_HIv1___RNAseq.g22813.t2,three_way,92.40566666666666,FUN_014483-T1,Q6NVL5,ELP3_XENTR,,Elongator complex protein 3 (EC 2.3.1.311) (tRNA uridine(34) acetyltransferase),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),81.4,532.0,7.4e-262,904.0,sp|Q6NVL5|ELP3_XENTR Elongator complex protein 3 OS=Xenopus tropicalis OX=8364 GN=elp3 PE=2 SV=1,GO:0000049; GO:0001755; GO:0002098; GO:0005634; GO:0005737; GO:0006357; GO:0008607; GO:0031397; GO:0046872; GO:0050821; GO:0051539; GO:0106261,negative regulation of protein ubiquitination [GO:0031397]; neural crest cell migration [GO:0001755]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]",GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0006399; GO:0016740; GO:0043226; GO:0048870; GO:0098772; GO:0140098,"RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; cell motility; molecular function regulator activity; catalytic activity, acting on RNA"
OG_03428,1.4033906323167928,FUN_014484-T1,Peve_00037302,Pocillopora_meandrina_HIv1___RNAseq.g22812.t1,three_way,51.21066666666667,FUN_014484-T1,Q84JS1,,,,,35.1,365.0,1.5e-57,226.1,sp|Q84JS1|PAE6_ARATH Pectin acetylesterase 6 OS=Arabidopsis thaliana OX=3702 GN=PAE6 PE=2 SV=1,,,,,,
OG_03429,2.464901135691997,FUN_014485-T1,Peve_00037303,Pocillopora_meandrina_HIv1___RNAseq.g22811.t1,three_way,75.97416666666666,FUN_014485-T1,O35887,,,,,29.0,155.0,5.5e-09,63.5,sp|O35887|CALU_MOUSE Calumenin OS=Mus musculus OX=10090 GN=Calu PE=1 SV=1,,,,,,
OG_03435,1.1519964743057134,FUN_014492-T1,Peve_00024063,Pocillopora_meandrina_HIv1___RNAseq.g22516.t1,three_way,57.00866666666666,FUN_014492-T1,Q9DB28,,,,,38.6,145.0,4.2e-26,119.4,sp|Q9DB28|POP5_MOUSE Ribonuclease P/MRP protein subunit POP5 OS=Mus musculus OX=10090 GN=Pop5 PE=1 SV=1,,,,,,
OG_03438,1.4125639027635415,FUN_014497-T1,Peve_00037310,Pocillopora_meandrina_HIv1___RNAseq.1964_t,three_way,81.125,FUN_014497-T1,Q5R8D0,,,,,65.0,343.0,1.3e-132,474.2,sp|Q5R8D0|GALE_PONAB UDP-glucose 4-epimerase OS=Pongo abelii OX=9601 GN=GALE PE=2 SV=1,,,,,,
OG_03439,1.8986128391782244,FUN_014498-T1,Peve_00013882,Pocillopora_meandrina_HIv1___RNAseq.g22640.t1,three_way,72.19283333333334,,,,,,,,,,,,,,,,,
OG_03440,1.2046555774227468,FUN_014499-T1,Peve_00013881,Pocillopora_meandrina_HIv1___TS.g27403.t1,three_way,65.235,FUN_014499-T1,Q6DE37,GXLT2_XENLA,,Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4),Xenopus laevis (African clawed frog),52.9,280.0,3.6000000000000004e-86,320.1,sp|Q6DE37|GXLT2_XENLA Glucoside xylosyltransferase 2 OS=Xenopus laevis OX=8355 GN=gxylt2 PE=2 SV=1,GO:0016020; GO:0016266; GO:0035252; GO:0140563,O-glycan processing [GO:0016266],membrane [GO:0016020],"UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity [GO:0140563]; UDP-xylosyltransferase activity [GO:0035252]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_03444,1.75034880870543,FUN_014506-T1,Peve_00015332,Pocillopora_meandrina_HIv1___RNAseq.g22634.t1,three_way,64.51866666666666,FUN_014506-T1,Q5XHG1,NSMA3_XENLA,,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),Xenopus laevis (African clawed frog),32.9,828.0,6.3e-106,386.7,sp|Q5XHG1|NSMA3_XENLA Sphingomyelin phosphodiesterase 4 OS=Xenopus laevis OX=8355 GN=smpd4 PE=2 SV=2,GO:0000139; GO:0004767; GO:0005635; GO:0005783; GO:0005789; GO:0006685; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356,cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; sarcolemma [GO:0042383],metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290],GO:0003824; GO:0005635; GO:0005783; GO:0005886; GO:0006629; GO:0016787; GO:0043226,catalytic activity; nuclear envelope; endoplasmic reticulum; plasma membrane; lipid metabolic process; hydrolase activity; organelle
OG_03446,1.0165107030188456,FUN_014510-T1,Peve_00024077,Pocillopora_meandrina_HIv1___RNAseq.g22630.t1,three_way,76.287,FUN_014510-T1,Q8CG45,ARK72_RAT,,Aflatoxin B1 aldehyde reductase member 2 (rAFAR2) (EC 1.1.1.n11) (Succinic semialdehyde reductase) (SSA reductase),Rattus norvegicus (Rat),52.2,322.0,1.1e-94,348.2,sp|Q8CG45|ARK72_RAT Aflatoxin B1 aldehyde reductase member 2 OS=Rattus norvegicus OX=10116 GN=Akr7a2 PE=1 SV=2,GO:0004032; GO:0004033; GO:0005635; GO:0005737; GO:0005739; GO:0005795; GO:0006629; GO:0019119; GO:0044597; GO:0044598,daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629],cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635],"aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]",GO:0003824; GO:0005635; GO:0005739; GO:0006629; GO:0016491; GO:0016787; GO:0043226; GO:1901135,catalytic activity; nuclear envelope; mitochondrion; lipid metabolic process; oxidoreductase activity; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_03451,1.808338280588079,FUN_014525-T1,Peve_00044380,Pocillopora_meandrina_HIv1___RNAseq.g22618.t1,three_way,89.524,FUN_014525-T1,Q7PPA5,,,,,70.7,996.0,0.0,1408.7,sp|Q7PPA5|ATC1_ANOGA Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type OS=Anopheles gambiae OX=7165 GN=SERCA PE=3 SV=5,,,,,,
OG_03452,2.565056038745197,FUN_014527-T1,Peve_00044379,Pocillopora_meandrina_HIv1___RNAseq.g22617.t1,three_way,81.44616666666667,FUN_014527-T1,O15297,PPM1D_HUMAN,,Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1),Homo sapiens (Human),51.3,277.0,1.2e-79,298.5,sp|O15297|PPM1D_HUMAN Protein phosphatase 1D OS=Homo sapiens OX=9606 GN=PPM1D PE=1 SV=1,GO:0000086; GO:0004674; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006346; GO:0006470; GO:0008285; GO:0009267; GO:0009314; GO:0009617; GO:0030330; GO:0035970; GO:0045814; GO:0046872; GO:0051019; GO:0060260; GO:1902531,"cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; regulation of intracellular signal transduction [GO:1902531]; regulation of transcription initiation by RNA polymerase II [GO:0060260]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]",cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03453,1.107219221376709,FUN_014528-T1,Peve_00044378,Pocillopora_meandrina_HIv1___RNAseq.g22616.t1,three_way,85.47933333333333,FUN_014528-T1,P56839,,,,,81.2,292.0,4.7e-137,488.8,sp|P56839|PEPM_MYTED Phosphoenolpyruvate phosphomutase OS=Mytilus edulis OX=6550 PE=1 SV=3,,,,,,
OG_03454,1.1775489428190675,FUN_014529-T1,Peve_00044375,Pocillopora_meandrina_HIv1___RNAseq.g22615.t1,three_way,84.25116666666666,FUN_014529-T1,P61267,,,,,57.3,267.0,9.1e-74,278.5,sp|P61267|STX1B_BOVIN Syntaxin-1B OS=Bos taurus OX=9913 GN=STX1B PE=1 SV=1,,,,,,
OG_03459,1.437706975883911,FUN_014536-T1,Peve_00040838,Pocillopora_meandrina_HIv1___RNAseq.g22607.t1,three_way,36.9925,,,,,,,,,,,,,,,,,
OG_03462,1.793412905613332,FUN_014543-T1,Peve_00035998,Pocillopora_meandrina_HIv1___RNAseq.g22595.t1,three_way,76.62,FUN_014543-T1,Q7K556,TTD14_DROME,,TRPL translocation defect protein 14,Drosophila melanogaster (Fruit fly),53.4,294.0,5.800000000000001e-89,328.9,sp|Q7K556|TTD14_DROME TRPL translocation defect protein 14 OS=Drosophila melanogaster OX=7227 GN=Ttd14 PE=1 SV=1,GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300,photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031],cytosol [GO:0005829],GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0008289,cytosol; lipid binding
OG_03468,1.8717286497798988,FUN_014553-T1,Peve_00035991,Pocillopora_meandrina_HIv1___RNAseq.g22697.t1,three_way,82.49233333333333,FUN_014553-T1,P29674,,,,,52.4,315.0,1.2000000000000001e-80,301.6,sp|P29674|LHX1_XENLA LIM/homeobox protein Lhx1 OS=Xenopus laevis OX=8355 GN=lhx1 PE=1 SV=1,,,,,,
OG_03470,1.7811399544927682,FUN_014556-T1,Peve_00035993,Pocillopora_meandrina_HIv1___RNAseq.g22695.t1,three_way,72.46883333333334,FUN_014556-T1,E1BLT8,ZDHC5_BOVIN,,Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5),Bos taurus (Bovine),52.3,243.0,9.599999999999999e-70,265.4,sp|E1BLT8|ZDHC5_BOVIN Palmitoyltransferase ZDHHC5 OS=Bos taurus OX=9913 GN=ZDHHC5 PE=3 SV=1,GO:0005654; GO:0005886; GO:0006869; GO:0016409; GO:0019706; GO:0030425; GO:0045087; GO:0045335; GO:0062208; GO:0072659; GO:0098794; GO:0098978; GO:0140639; GO:1900227; GO:1903078; GO:1905171,innate immune response [GO:0045087]; lipid transport [GO:0006869]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to plasma membrane [GO:0072659],dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0002376; GO:0003824; GO:0005654; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0072659; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleoplasm; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; defense response to other organism; catalytic activity, acting on a protein"
OG_03472,1.4040750709169938,FUN_014560-T1,Peve_00009691,Pocillopora_meandrina_HIv1___RNAseq.g22702.t1,three_way,77.68633333333334,FUN_014560-T1,Q96NN9,,,,,45.9,510.0,5.4e-137,489.6,sp|Q96NN9|AIFM3_HUMAN Apoptosis-inducing factor 3 OS=Homo sapiens OX=9606 GN=AIFM3 PE=1 SV=1,,,,,,
OG_03473,1.4985696903830328,FUN_014561-T1,Peve_00023543,Pocillopora_meandrina_HIv1___RNAseq.g22703.t1,three_way,65.42583333333333,FUN_014561-T1,Q96S52,PIGS_HUMAN,,GPI-anchor transamidase component PIGS (Phosphatidylinositol-glycan biosynthesis class S protein),Homo sapiens (Human),36.6,508.0,2.9e-81,304.3,sp|Q96S52|PIGS_HUMAN GPI-anchor transamidase component PIGS OS=Homo sapiens OX=9606 GN=PIGS PE=1 SV=3,GO:0005789; GO:0006506; GO:0016020; GO:0016255; GO:0042765; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046],endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020],,GO:0006629; GO:0051604; GO:1901135,lipid metabolic process; protein maturation; carbohydrate derivative metabolic process
OG_03479,1.1730447105233313,FUN_014573-T3,Peve_00027630,Pocillopora_meandrina_HIv1___RNAseq.g22711.t1,three_way,76.72633333333333,FUN_014573-T3,Q6DFR1,,,,,31.8,494.0,5.1e-54,213.8,sp|Q6DFR1|S22AF_XENTR Solute carrier family 22 member 15 OS=Xenopus tropicalis OX=8364 GN=slc22a15 PE=2 SV=2,,,,,,
OG_03481,1.0750044726611356,FUN_014575-T1,Peve_00037170,Pocillopora_meandrina_HIv1___RNAseq.g22712.t1,three_way,86.77133333333333,FUN_014575-T1,Q0IIF2,,,,,60.7,300.0,5.3e-94,345.9,sp|Q0IIF2|EI2BA_BOVIN Translation initiation factor eIF2B subunit alpha OS=Bos taurus OX=9913 GN=EIF2B1 PE=2 SV=1,,,,,,
OG_03482,1.4237660884564751,FUN_014584-T1,Peve_00001487,Pocillopora_meandrina_HIv1___RNAseq.g22720.t1,three_way,49.659333333333336,FUN_014584-T1,Q1L5Z9,LONF2_HUMAN,,LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192),Homo sapiens (Human),31.0,625.0,2.6999999999999997e-68,261.5,sp|Q1L5Z9|LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 OS=Homo sapiens OX=9606 GN=LONRF2 PE=1 SV=3,GO:0005737; GO:0006515; GO:0008270; GO:0021522; GO:0031175; GO:0043021; GO:0043524; GO:0050905; GO:0051402; GO:0051787; GO:0061630; GO:0061744,motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737],misfolded protein binding [GO:0051787]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0012501; GO:0016740; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; programmed cell death; transferase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_03486,1.1783073201229983,FUN_014589-T1,Peve_00011858,Pocillopora_meandrina_HIv1___TS.g27493.t1,three_way,81.65599999999999,FUN_014589-T1,O43147,,,,,45.5,1038.0,4.3e-227,789.6,sp|O43147|SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens OX=9606 GN=SGSM2 PE=1 SV=4,,,,,,
OG_03492,2.5412499714640617,FUN_014601-T1,Peve_00034546,Pocillopora_meandrina_HIv1___RNAseq.g22743.t1,three_way,50.54366666666667,,,,,,,,,,,,,,,,,
OG_03495,1.0764296069471924,FUN_014604-T1,Peve_00028205,Pocillopora_meandrina_HIv1___RNAseq.g22749.t1,three_way,70.68266666666666,FUN_014604-T1,A2BGR3,,,,,54.5,635.0,3.2000000000000004e-185,650.2,sp|A2BGR3|ERC6L_DANRE DNA excision repair protein ERCC-6-like OS=Danio rerio OX=7955 GN=ercc6l PE=1 SV=1,,,,,,
OG_03496,1.177741630432874,FUN_014605-T1,Peve_00001902,Pocillopora_meandrina_HIv1___RNAseq.g22752.t1,three_way,91.59133333333334,FUN_014605-T1,Q14254,FLOT2_HUMAN,,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),Homo sapiens (Human),58.5,417.0,1.6999999999999998e-105,384.4,sp|Q14254|FLOT2_HUMAN Flotillin-2 OS=Homo sapiens OX=9606 GN=FLOT2 PE=1 SV=2,GO:0001931; GO:0002020; GO:0002080; GO:0005768; GO:0005886; GO:0005901; GO:0005912; GO:0005925; GO:0007155; GO:0008544; GO:0010629; GO:0016020; GO:0016323; GO:0016600; GO:0030027; GO:0030139; GO:0031410; GO:0031982; GO:0032839; GO:0043123; GO:0043231; GO:0044291; GO:0044860; GO:0045661; GO:0048471; GO:0050821; GO:0070062; GO:0072659; GO:0098937; GO:0098978; GO:0099072; GO:1902992; GO:1903905,anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of establishment of T cell polarity [GO:1903905]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982],protease binding [GO:0002020],GO:0005768; GO:0005886; GO:0007018; GO:0007155; GO:0031410; GO:0043226; GO:0048856; GO:0072659,endosome; plasma membrane; microtubule-based movement; cell adhesion; cytoplasmic vesicle; organelle; anatomical structure development; protein localization to plasma membrane
OG_03498,1.3924223866761398,FUN_014607-T1,Peve_00002391,Pocillopora_meandrina_HIv1___RNAseq.g22765.t1,three_way,71.34233333333333,FUN_014607-T1,Q4QMZ7,,,,,31.5,127.0,8.9e-10,65.9,"sp|Q4QMZ7|APAH_HAEI8 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical OS=Haemophilus influenzae (strain 86-028NP) OX=281310 GN=apaH PE=3 SV=1",,,,,,
OG_03499,1.464224750058552,FUN_014608-T1,Peve_00002424,Pocillopora_meandrina_HIv1___RNAseq.g22764.t1,three_way,78.122,FUN_014608-T1,Q8SX37,CDIPT_DROME,,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (CDIPT) (EC 2.7.8.11) (Phosphatidylinositol synthase),Drosophila melanogaster (Fruit fly),44.0,84.0,1.2e-09,65.1,sp|Q8SX37|CDIPT_DROME CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Drosophila melanogaster OX=7227 GN=Pis PE=1 SV=1,GO:0003881; GO:0005794; GO:0006661; GO:0007602; GO:0016324; GO:0016328; GO:0046872; GO:0071711,basement membrane organization [GO:0071711]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602],apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328],CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0006629; GO:0016740; GO:0030198; GO:0043226,catalytic activity; Golgi apparatus; lipid metabolic process; transferase activity; extracellular matrix organization; organelle
OG_03500,3.615084752332184,FUN_014610-T1,Peve_00027567,Pocillopora_meandrina_HIv1___TS.g27529.t1,three_way,75.49566666666666,FUN_014610-T1,P27465,,,,,48.5,361.0,3.7e-97,356.7,"sp|P27465|PISD_CRIGR Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Cricetulus griseus OX=10029 GN=Pisd PE=1 SV=2",,,,,,
OG_03506,1.332174474266945,FUN_014616-T1,Peve_00001903,Pocillopora_meandrina_HIv1___RNAseq.g22756.t1,three_way,96.60133333333332,FUN_014616-T1,Q6IP91,,,,,90.6,309.0,1.3e-168,593.6,sp|Q6IP91|PP4C_XENLA Serine/threonine-protein phosphatase 4 catalytic subunit OS=Xenopus laevis OX=8355 GN=ppp4c PE=2 SV=1,,,,,,
OG_03509,1.5177065598926534,FUN_014619-T1,Peve_00002405,Pocillopora_meandrina_HIv1___RNAseq.g22775.t1,three_way,73.92766666666667,,,,,,,,,,,,,,,,,
OG_03510,1.2107080900839509,FUN_014621-T1,Peve_00002408,Pocillopora_meandrina_HIv1___RNAseq.g22778.t1,three_way,70.79983333333334,FUN_014621-T1,A4QNN3,UBP30_XENTR,,Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),39.8,450.0,2.7e-74,280.8,sp|A4QNN3|UBP30_XENTR Ubiquitin carboxyl-terminal hydrolase 30 OS=Xenopus tropicalis OX=8364 GN=usp30 PE=2 SV=1,GO:0000422; GO:0004197; GO:0004843; GO:0005739; GO:0005741; GO:0006508; GO:0008053; GO:0016579; GO:0035871; GO:0044313,autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; proteolysis [GO:0006508],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005739; GO:0006914; GO:0007005; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; autophagy; mitochondrion organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03513,2.14831430766195,FUN_014624-T1,Peve_00002411,Pocillopora_meandrina_HIv1___RNAseq.g22781.t1,three_way,98.58133333333332,FUN_014624-T1,P48727,,,,,90.4,332.0,5e-182,638.3,sp|P48727|GLC7B_CAEEL Serine/threonine-protein phosphatase PP1-beta OS=Caenorhabditis elegans OX=6239 GN=gsp-2 PE=1 SV=1,,,,,,
OG_03514,2.2491574776312957,FUN_014625-T1,Peve_00002412,Pocillopora_meandrina_HIv1___TS.g27550.t1,three_way,56.03566666666666,,,,,,,,,,,,,,,,,
OG_03515,1.4645575894903429,FUN_014626-T1,Peve_00002414,Pocillopora_meandrina_HIv1___RNAseq.g22784.t1,three_way,94.20133333333334,FUN_014626-T1,Q3MHR3,,,,,94.4,89.0,2.3e-44,179.5,"sp|Q3MHR3|DYL2_BOVIN Dynein light chain 2, cytoplasmic OS=Bos taurus OX=9913 GN=DYNLL2 PE=3 SV=1",,,,,,
OG_03517,2.224305858206281,FUN_014630-T1,Peve_00002417,Pocillopora_meandrina_HIv1___RNAseq.g22787.t1,three_way,63.39333333333334,FUN_014630-T1,Q5R5S1,,,,,31.7,612.0,1.1999999999999999e-75,285.8,sp|Q5R5S1|FBX21_PONAB F-box only protein 21 OS=Pongo abelii OX=9601 GN=FBXO21 PE=2 SV=1,,,,,,
OG_03526,1.159380644552727,FUN_014641-T1,Peve_00002430,Pocillopora_meandrina_HIv1___RNAseq.g22798.t1,three_way,72.066,FUN_014641-T1,Q96CM3,,,,,36.0,250.0,5.5e-33,142.9,"sp|Q96CM3|RUSD4_HUMAN Pseudouridylate synthase RPUSD4, mitochondrial OS=Homo sapiens OX=9606 GN=RPUSD4 PE=1 SV=1",,,,,,
OG_03528,1.3906258799892723,FUN_014643-T1,Peve_00002386,Pocillopora_meandrina_HIv1___RNAseq.g22800.t1,three_way,82.04466666666667,FUN_014643-T1,Q9DAX9,,,,,52.4,435.0,1.7e-119,431.0,sp|Q9DAX9|APBP2_MOUSE Amyloid protein-binding protein 2 OS=Mus musculus OX=10090 GN=Appbp2 PE=2 SV=1,,,,,,
OG_03532,1.5365909295457678,FUN_014647-T1,Peve_00007619,Pocillopora_meandrina_HIv1___RNAseq.g22685.t1,three_way,82.742,FUN_014647-T1,A0JPI9,,,,,44.3,79.0,3.8e-13,77.8,sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1,,,,,,
OG_03534,1.7107992141495276,FUN_014653-T1,Peve_00007592,Pocillopora_meandrina_HIv1___TS.g27445.t1,three_way,63.556,FUN_014653-T1,Q2KHM9,MOONR_HUMAN,,Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein),Homo sapiens (Human),26.4,982.0,3.3e-31,138.7,sp|Q2KHM9|MOONR_HUMAN Protein moonraker OS=Homo sapiens OX=9606 GN=KIAA0753 PE=1 SV=3,GO:0005783; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0005929; GO:0007099; GO:0034451; GO:0036064; GO:0046872; GO:0051537; GO:0060271; GO:0061824; GO:0071539,centriole replication [GO:0007099]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; protein localization to centrosome [GO:0071539],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; microtubule organizing center [GO:0005815],"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]",GO:0005783; GO:0005815; GO:0005829; GO:0005929; GO:0043226; GO:0044782,endoplasmic reticulum; microtubule organizing center; cytosol; cilium; organelle; cilium organization
OG_03540,1.280045909511592,FUN_014660-T1,Peve_00032454,Pocillopora_meandrina_HIv1___RNAseq.g22661.t1,three_way,97.681,FUN_014660-T1,Q2YDI3,,,,,92.9,113.0,1.6e-58,226.5,sp|Q2YDI3|YPEL2_BOVIN Protein yippee-like 2 OS=Bos taurus OX=9913 GN=YPEL2 PE=3 SV=1,,,,,,
OG_03544,1.4783667850294255,FUN_014670-T1,Peve_00030803,Pocillopora_meandrina_HIv1___RNAseq.g22675.t1,three_way,86.73983333333334,FUN_014670-T1,Q13356,PPIL2_HUMAN,,RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2),Homo sapiens (Human),58.3,527.0,1.1e-178,627.9,sp|Q13356|PPIL2_HUMAN RING-type E3 ubiquitin-protein ligase PPIL2 OS=Homo sapiens OX=9606 GN=PPIL2 PE=1 SV=1,GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006397; GO:0006457; GO:0008380; GO:0034450; GO:0061630; GO:0071013; GO:0072659,mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; RNA splicing [GO:0008380],catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0006457; GO:0016071; GO:0016740; GO:0043226; GO:0072659; GO:0140096,"catalytic activity; nucleus; nucleoplasm; plasma membrane; protein folding; mRNA metabolic process; transferase activity; organelle; protein localization to plasma membrane; catalytic activity, acting on a protein"
OG_03546,2.482409742046149,FUN_014673-T1,Peve_00013033,Pocillopora_meandrina_HIv1___RNAseq.g22680.t1,three_way,77.56683333333334,FUN_014673-T1,Q96AY4,TTC28_HUMAN,,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),Homo sapiens (Human),44.3,828.0,5.7e-171,604.4,sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4,GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301,cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922],kinase binding [GO:0019900],GO:0005815,microtubule organizing center
OG_03554,1.804451741694968,FUN_014690-T1,Peve_00028116,Pocillopora_meandrina_HIv1___RNAseq.g22821.t1,three_way,83.69500000000001,FUN_014690-T1,Q8NFA0,UBP32_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),Homo sapiens (Human),44.8,1747.0,0.0,1401.3,sp|Q8NFA0|UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1,GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263,positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005794; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03563,1.4631907382832536,FUN_014712-T1,Peve_00028586,Pocillopora_meandrina_HIv1___RNAseq.g22528.t1,three_way,51.81133333333333,,,,,,,,,,,,,,,,,
OG_03564,1.2116981181913071,FUN_014713-T1,Peve_00028587,Pocillopora_meandrina_HIv1___RNAseq.g22527.t1,three_way,84.00266666666667,FUN_014713-T1,Q96DM3,,,,,53.3,647.0,7.699999999999999e-198,691.8,sp|Q96DM3|RMC1_HUMAN Regulator of MON1-CCZ1 complex OS=Homo sapiens OX=9606 GN=RMC1 PE=1 SV=2,,,,,,
OG_03565,1.0240269932737245,FUN_014714-T1,Peve_00023481,Pocillopora_meandrina_HIv1___RNAseq.g22526.t1,three_way,80.59266666666667,FUN_014714-T1,Q6GQN5,PPR42_DANRE,,Protein phosphatase 1 regulatory subunit 42 (Leucine-rich repeat-containing protein 67),Danio rerio (Zebrafish) (Brachydanio rerio),66.7,252.0,2.1e-35,151.4,sp|Q6GQN5|PPR42_DANRE Protein phosphatase 1 regulatory subunit 42 OS=Danio rerio OX=7955 GN=ppp1r42 PE=2 SV=1,GO:0002177; GO:0003779; GO:0005737; GO:0005813; GO:0005815; GO:0015630; GO:0015631; GO:0070840,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815],actin binding [GO:0003779]; dynein complex binding [GO:0070840]; tubulin binding [GO:0015631],GO:0005815; GO:0005856; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton; cytoskeletal protein binding; organelle
OG_03566,1.5149182415619518,FUN_014715-T1,Peve_00023482,Pocillopora_meandrina_HIv1___RNAseq.g22525.t1,three_way,70.94933333333333,FUN_014715-T1,Q5RA75,,,,,35.2,1159.0,4.4e-158,560.5,sp|Q5RA75|F135A_PONAB Protein FAM135A OS=Pongo abelii OX=9601 GN=FAM135A PE=2 SV=1,,,,,,
OG_03567,1.1217820408044012,FUN_014716-T2,Peve_00022399,Pocillopora_meandrina_HIv1___RNAseq.g22524.t1,three_way,51.833666666666666,FUN_014716-T2,P49791,,,,,27.7,285.0,6.9e-16,88.6,sp|P49791|NU153_RAT Nuclear pore complex protein Nup153 OS=Rattus norvegicus OX=10116 GN=Nup153 PE=1 SV=1,,,,,,
OG_03578,1.0860103665959355,FUN_014733-T1,Peve_00010436,Pocillopora_meandrina_HIv1___RNAseq.g22485.t1,three_way,84.49266666666666,FUN_014733-T1,A5D7E2,TM9S4_BOVIN,,Transmembrane 9 superfamily member 4,Bos taurus (Bovine),59.6,596.0,1.1e-203,711.1,sp|A5D7E2|TM9S4_BOVIN Transmembrane 9 superfamily member 4 OS=Bos taurus OX=9913 GN=TM9SF4 PE=2 SV=2,GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010,cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],,GO:0005768; GO:0005794; GO:0007155; GO:0016192; GO:0031410; GO:0043226; GO:0065003,endosome; Golgi apparatus; cell adhesion; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_03582,2.249341527501937,FUN_014737-T1,Peve_00010440,Pocillopora_meandrina_HIv1___RNAseq.g22480.t1c,three_way,64.17166666666667,FUN_014737-T1,Q6PAY6,,,,,40.4,421.0,2.1e-80,301.2,sp|Q6PAY6|HYPDH_XENLA Hydroxyproline dehydrogenase OS=Xenopus laevis OX=8355 GN=prodh2 PE=2 SV=1,,,,,,
OG_03586,1.731525243134744,FUN_014742-T1,Peve_00036169,Pocillopora_meandrina_HIv1___RNAseq.g22472.t1,three_way,71.57566666666666,FUN_014742-T1,Q502L2,PGAM5_DANRE,,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Phosphoglycerate mutase family member 5)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,233.0,2.1e-67,257.3,"sp|Q502L2|PGAM5_DANRE Serine/threonine-protein phosphatase PGAM5, mitochondrial OS=Danio rerio OX=7955 GN=pgam5 PE=2 SV=2",GO:0004722; GO:0005739; GO:0005741; GO:0012501; GO:0090141,positive regulation of mitochondrial fission [GO:0090141]; programmed cell death [GO:0012501],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005739; GO:0012501; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03593,1.3123254143722596,FUN_014751-T1,Peve_00039157,Pocillopora_meandrina_HIv1___RNAseq.g22448.t2,three_way,67.324,,,,,,,,,,,,,,,,,
OG_03596,1.1142165788632952,FUN_014755-T1,Peve_00039152,Pocillopora_meandrina_HIv1___RNAseq.g22443.t1,three_way,62.79233333333333,FUN_014755-T1,Q9CQK1,,,,,36.1,144.0,2.5e-17,90.1,sp|Q9CQK1|ZNHI3_MOUSE Zinc finger HIT domain-containing protein 3 OS=Mus musculus OX=10090 GN=Znhit3 PE=1 SV=1,,,,,,
OG_03597,1.4755093130721382,FUN_014756-T1,Peve_00039153,Pocillopora_meandrina_HIv1___RNAseq.g22442.t1,three_way,67.01416666666667,FUN_014756-T1,Q07066,,,,,38.9,180.0,1.1e-35,151.4,sp|Q07066|PXMP2_RAT Peroxisomal membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Pxmp2 PE=1 SV=2,,,,,,
OG_03599,1.0794859312800724,FUN_014758-T1,Peve_00039156,Pocillopora_meandrina_HIv1___RNAseq.g22440.t1,three_way,60.02083333333333,,,,,,,,,,,,,,,,,
OG_03600,1.0943981394442122,FUN_014764-T1,Peve_00000342,Pocillopora_meandrina_HIv1___RNAseq.g22434.t1,three_way,79.31733333333334,FUN_014764-T1,P70645,,,,,53.3,465.0,1.3e-151,537.7,sp|P70645|BLMH_RAT Bleomycin hydrolase OS=Rattus norvegicus OX=10116 GN=Blmh PE=1 SV=1,,,,,,
OG_03603,2.1064212935013247,FUN_014770-T1,Peve_00014608,Pocillopora_meandrina_HIv1___RNAseq.g22567.t1,three_way,76.14166666666667,FUN_014770-T1,A2BFP5,,,,,43.0,900.0,7.000000000000001e-186,652.5,sp|A2BFP5|S12A9_DANRE Solute carrier family 12 member 9 OS=Danio rerio OX=7955 GN=slc12a9 PE=3 SV=1,,,,,,
OG_03604,1.224815599906672,FUN_014771-T1,Peve_00014607,Pocillopora_meandrina_HIv1___RNAseq.g22566.t1,three_way,79.51866666666668,FUN_014771-T1,Q8K370,,,,,57.8,1018.0,0.0,1177.2,sp|Q8K370|ACD10_MOUSE Acyl-CoA dehydrogenase family member 10 OS=Mus musculus OX=10090 GN=Acad10 PE=1 SV=1,,,,,,
OG_03607,1.1131845600926351,FUN_014783-T1,Peve_00014593,Pocillopora_meandrina_HIv1___RNAseq.g22511.t1,three_way,54.09,FUN_014783-T1,B3EWZ8,,,,,39.9,158.0,6.1e-23,110.9,sp|B3EWZ8|ECT_ACRMI Ectin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_03608,1.4841980151457006,FUN_014785-T2,Peve_00001849,Pocillopora_meandrina_HIv1___RNAseq.g22512.t1a,three_way,42.24616666666667,,,,,,,,,,,,,,,,,
OG_03614,1.3630267699578678,FUN_014796-T1,Peve_00026742,Pocillopora_meandrina_HIv1___RNAseq.g22420.t1,three_way,83.09333333333333,FUN_014796-T1,Q8CFG5,CA2D3_RAT,,Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3],Rattus norvegicus (Rat),26.6,632.0,1.9e-50,203.0,sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1,GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314,calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174],GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891],calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0098772,transporter activity; molecular function regulator activity
OG_03623,1.692972619582464,FUN_014810-T1,Peve_00022206,Pocillopora_meandrina_HIv1___RNAseq.g22405.t1,three_way,74.15333333333334,FUN_014810-T1,Q9NXZ2,,,,,46.8,577.0,2.1e-146,521.2,sp|Q9NXZ2|DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens OX=9606 GN=DDX43 PE=1 SV=2,,,,,,
OG_03631,1.6801569167039785,FUN_014848-T1,Peve_00038810,Pocillopora_meandrina_HIv1___RNAseq.g22383.t1,three_way,69.762,FUN_014848-T1,Q9SJM7,URH1_ARATH,,Uridine nucleosidase 1 (EC 3.2.2.3) (Adenosine nucleosidase) (EC 3.2.2.7) (Inosine nucleosidase) (EC 3.2.2.2) (Nucleoside hydrolase 1) (Uridine ribohydrolase 1) (Xanthosine nucleosidase) (EC 3.2.2.-),Arabidopsis thaliana (Mouse-ear cress),34.5,287.0,1.8e-32,141.4,sp|Q9SJM7|URH1_ARATH Uridine nucleosidase 1 OS=Arabidopsis thaliana OX=3702 GN=URH1 PE=1 SV=2,GO:0005829; GO:0006152; GO:0006218; GO:0042802; GO:0042803; GO:0045437; GO:0046982; GO:0047622; GO:0047724; GO:0072585,purine nucleoside catabolic process [GO:0006152]; uridine catabolic process [GO:0006218],cytosol [GO:0005829],adenosine nucleosidase activity [GO:0047622]; identical protein binding [GO:0042802]; inosine nucleosidase activity [GO:0047724]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; uridine nucleosidase activity [GO:0045437]; xanthosine nucleotidase activity [GO:0072585],GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03633,1.380185583534909,FUN_014852-T1,Peve_00038812,Pocillopora_meandrina_HIv1___RNAseq.g22380.t1b,three_way,70.72466666666666,FUN_014852-T1,Q9BW91,NUDT9_HUMAN,,"ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)",Homo sapiens (Human),52.1,317.0,2.1e-89,330.5,"sp|Q9BW91|NUDT9_HUMAN ADP-ribose pyrophosphatase, mitochondrial OS=Homo sapiens OX=9606 GN=NUDT9 PE=1 SV=1",GO:0005739; GO:0005759; GO:0005829; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0046032; GO:0047631; GO:0055086; GO:0070062,ADP catabolic process [GO:0046032]; nucleobase-containing small molecule metabolic process [GO:0055086],cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965],ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144],GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03635,1.0718904123534998,FUN_014855-T1,Peve_00038800,Pocillopora_meandrina_HIv1___RNAseq.g22371.t1,three_way,96.05733333333332,FUN_014855-T1,Q6P2Q9,PRP8_HUMAN,,Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220),Homo sapiens (Human),92.1,2321.0,0.0,4492.2,sp|Q6P2Q9|PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2,GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157,"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03639,2.0529385199664296,FUN_014861-T1,Peve_00016000,Pocillopora_meandrina_HIv1___RNAseq.g22368.t1,three_way,62.06,FUN_014861-T1,Q69ZM6,STK36_MOUSE,,Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog),Mus musculus (Mouse),25.5,1026.0,5.9e-57,224.6,sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus OX=10090 GN=Stk36 PE=1 SV=3,GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007224; GO:0007420; GO:0009791; GO:0035082; GO:0042995; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310,axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222],GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005856; GO:0006355; GO:0007010; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0140096,"catalytic activity; extracellular region; nucleus; cytosol; cytoskeleton; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; catalytic activity, acting on a protein"
OG_03643,2.004416086632254,FUN_014871-T1,Peve_00012980,Pocillopora_meandrina_HIv1___RNAseq.g21043.t2a,three_way,72.989,FUN_014871-T1,Q05B54,,,,,27.7,213.0,3.2e-12,73.6,sp|Q05B54|TM134_BOVIN Transmembrane protein 134 OS=Bos taurus OX=9913 GN=TMEM134 PE=2 SV=2,,,,,,
OG_03646,1.069967616368861,FUN_014877-T1,Peve_00013644,Pocillopora_meandrina_HIv1___RNAseq.g21046.t1,three_way,63.173,,,,,,,,,,,,,,,,,
OG_03650,1.2995349445948656,FUN_014882-T1,Peve_00013645,Pocillopora_meandrina_HIv1___RNAseq.g21054.t1,three_way,56.43533333333333,FUN_014882-T1,Q5SSG4,GA2L2_MOUSE,,GAS2-like protein 2 (Growth arrest-specific protein 2-like 2),Mus musculus (Mouse),35.9,473.0,1.6999999999999998e-53,213.0,sp|Q5SSG4|GA2L2_MOUSE GAS2-like protein 2 OS=Mus musculus OX=10090 GN=Gas2l2 PE=1 SV=1,GO:0001578; GO:0001725; GO:0001965; GO:0005737; GO:0005884; GO:0005886; GO:0007026; GO:0008017; GO:0008093; GO:0035371; GO:0036064; GO:0045745; GO:0051015; GO:0060296; GO:1904825,microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; plasma membrane [GO:0005886]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017],GO:0005815; GO:0005886; GO:0007010; GO:0008092; GO:0060090,microtubule organizing center; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; molecular adaptor activity
OG_03651,1.4010729555711736,FUN_014883-T1,Peve_00032212,Pocillopora_meandrina_HIv1___RNAseq.g21057.t1,three_way,86.76933333333334,FUN_014883-T1,A1L0Y5,,,,,78.5,288.0,2.8e-130,466.5,sp|A1L0Y5|SEP2B_XENTR Septin-2B OS=Xenopus tropicalis OX=8364 GN=sept2-B PE=2 SV=1,,,,,,
OG_03653,1.4347524237587324,FUN_014886-T1,Peve_00003525,Pocillopora_meandrina_HIv1___RNAseq.g21061.t1,three_way,63.435833333333335,FUN_014886-T1,P53668,LIMK1_MOUSE,,LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (KIZ-1),Mus musculus (Mouse),37.8,521.0,1.1e-85,318.9,sp|P53668|LIMK1_MOUSE LIM domain kinase 1 OS=Mus musculus OX=10090 GN=Limk1 PE=1 SV=1,GO:0001673; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0016020; GO:0016607; GO:0030027; GO:0031072; GO:0031625; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051496; GO:0098794; GO:0098978; GO:0106310; GO:1990948,axon extension [GO:0048675]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; stress fiber assembly [GO:0043149],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03657,1.879107047570325,FUN_014893-T1,Peve_00003548,Pocillopora_meandrina_HIv1___RNAseq.g21106.t1,three_way,54.15466666666666,,,,,,,,,,,,,,,,,
OG_03658,2.803530843176788,FUN_014895-T1,Peve_00003547,Pocillopora_meandrina_HIv1___RNAseq.g21105.t1,three_way,67.7525,FUN_014895-T1,Q0VH32,,,,,50.8,122.0,6.3999999999999975e-25,116.3,sp|Q0VH32|MNT_XENLA Max-binding protein MNT OS=Xenopus laevis OX=8355 GN=mnt PE=2 SV=1,,,,,,
OG_03662,1.637810040113468,FUN_014900-T1,Peve_00003542,Pocillopora_meandrina_HIv1___RNAseq.g21067.t1,three_way,61.59133333333333,FUN_014900-T1,Q9WVS8,,,,,64.2,355.0,5.6999999999999994e-129,463.8,sp|Q9WVS8|MK07_MOUSE Mitogen-activated protein kinase 7 OS=Mus musculus OX=10090 GN=Mapk7 PE=1 SV=1,,,,,,
OG_03666,1.2745745982264551,FUN_014905-T1,Peve_00003537,Pocillopora_meandrina_HIv1___RNAseq.g21071.t1,three_way,89.49799999999999,FUN_014905-T1,P14866,HNRPL_HUMAN,,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),Homo sapiens (Human),46.7,210.0,4.3e-39,163.7,sp|P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2,GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0016020; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0070062; GO:0097157; GO:1990904,"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; synapse [GO:0045202],mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_03671,1.294997634620905,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_03674,1.292049122011354,FUN_014925-T1,Peve_00006270,Pocillopora_meandrina_HIv1___RNAseq.g21082.t1,three_way,77.86116666666666,FUN_014925-T1,Q9I9E0,,,,,43.7,581.0,9.9e-52,206.5,sp|Q9I9E0|TAOK3_CHICK Serine/threonine-protein kinase TAO3 OS=Gallus gallus OX=9031 GN=TAOK3 PE=2 SV=2,,,,,,
OG_03677,1.2411876425965125,FUN_014931-T1,Peve_00037145,Pocillopora_meandrina_HIv1___RNAseq.g21089.t1,three_way,68.721,FUN_014931-T1,Q4FAT7,,,,,40.9,580.0,7.9e-123,442.6,sp|Q4FAT7|BGLR_PIG Beta-glucuronidase OS=Sus scrofa OX=9823 GN=GUSB PE=3 SV=1,,,,,,
OG_03678,2.147085254075788,FUN_014932-T1,Peve_00037144,Pocillopora_meandrina_HIv1___RNAseq.g21090.t2,three_way,93.364,FUN_014932-T1,P26818,,,,,66.9,680.0,9.099999999999999e-271,934.1,sp|P26818|ARBK2_BOVIN G protein-coupled receptor kinase 3 OS=Bos taurus OX=9913 GN=GRK3 PE=2 SV=1,,,,,,
OG_03682,1.806065632457382,FUN_014941-T2,Peve_00037149,Pocillopora_meandrina_HIv1___RNAseq.g21098.t1,three_way,78.08300000000001,FUN_014941-T2,O43435,TBX1_HUMAN,,T-box transcription factor TBX1 (T-box protein 1) (Testis-specific T-box protein),Homo sapiens (Human),74.4,203.0,2.7e-85,317.4,sp|O43435|TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens OX=9606 GN=TBX1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001708; GO:0001755; GO:0001934; GO:0001945; GO:0002053; GO:0003007; GO:0003148; GO:0003151; GO:0003677; GO:0005634; GO:0006357; GO:0007368; GO:0007389; GO:0007498; GO:0007507; GO:0007517; GO:0007605; GO:0008283; GO:0008284; GO:0009952; GO:0021644; GO:0030855; GO:0030878; GO:0035019; GO:0035176; GO:0035909; GO:0042471; GO:0042472; GO:0042473; GO:0042474; GO:0042475; GO:0042693; GO:0042803; GO:0043410; GO:0043565; GO:0043587; GO:0044344; GO:0045596; GO:0045893; GO:0045944; GO:0046983; GO:0048384; GO:0048514; GO:0048538; GO:0048644; GO:0048701; GO:0048703; GO:0048752; GO:0048844; GO:0050679; GO:0060017; GO:0060023; GO:0060037; GO:0060325; GO:0060415; GO:0060982; GO:0070166; GO:0071300; GO:0090103; GO:0097152; GO:1990837; GO:2000027; GO:2001037; GO:2001054,angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_03683,1.697250114194355,FUN_014942-T1,Peve_00037148,Pocillopora_meandrina_HIv1___RNAseq.g21099.t1,three_way,86.43466666666666,FUN_014942-T1,Q8AX98,TBX1A_XENLA,,T-box transcription factor TBX1-A (T-box protein 1-A),Xenopus laevis (African clawed frog),74.0,196.0,1.3e-84,315.1,sp|Q8AX98|TBX1A_XENLA T-box transcription factor TBX1-A OS=Xenopus laevis OX=8355 GN=tbx1-a PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006357; GO:0045944; GO:0050793; GO:0060788; GO:0071300,cell fate specification [GO:0001708]; cellular response to retinoic acid [GO:0071300]; ectodermal placode formation [GO:0060788]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_03684,1.5374159599508943,FUN_014944-T1,Peve_00037147,Pocillopora_meandrina_HIv1___RNAseq.g21100.t1,three_way,64.583,,,,,,,,,,,,,,,,,
OG_03686,1.840321406065564,FUN_014948-T1,Peve_00024855,Pocillopora_meandrina_HIv1___RNAseq.g21115.t1,three_way,80.74033333333334,FUN_014948-T1,Q04336,,,,,46.8,939.0,1.3999999999999998e-250,867.5,sp|Q04336|YM54_YEAST Uncharacterized protein YMR196W OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YMR196W PE=1 SV=1,,,,,,
OG_03687,1.4314086744696064,FUN_014949-T1,Peve_00006235,Pocillopora_meandrina_HIv1___RNAseq.g21116.t1,three_way,79.29216666666667,FUN_014949-T1,Q9Y6J0,,,,,36.0,1819.0,9e-282,972.2,sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1,,,,,,
OG_03690,1.7076107013778583,FUN_014952-T1,Peve_00006246,Pocillopora_meandrina_HIv1___RNAseq.g21119.t1,three_way,65.61866666666666,,,,,,,,,,,,,,,,,
OG_03691,1.5613302118358665,FUN_014954-T1,Peve_00006248,Pocillopora_meandrina_HIv1___RNAseq.g21121.t1,three_way,69.067,,,,,,,,,,,,,,,,,
OG_03695,1.4588768390427889,FUN_014964-T1,Peve_00006258,Pocillopora_meandrina_HIv1___RNAseq.g21128.t1,three_way,88.101,FUN_014964-T1,A7S338,LIS1_NEMVE,,Lissencephaly-1 homolog,Nematostella vectensis (Starlet sea anemone),86.2,348.0,4.0000000000000006e-80,300.1,sp|A7S338|LIS1_NEMVE Lissencephaly-1 homolog OS=Nematostella vectensis OX=45351 GN=v1g242515 PE=3 SV=1,GO:0000132; GO:0000776; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0007097; GO:0031023; GO:0047496; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1990234,cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; vesicle transport along microtubule [GO:0047496],centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; nuclear envelope [GO:0005635]; transferase complex [GO:1990234],dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010],GO:0005635; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0043226,nuclear envelope; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; organelle
OG_03698,1.346023746190705,FUN_014969-T1,Peve_00006263,Pocillopora_meandrina_HIv1___RNAseq.g21132.t2,three_way,67.03883333333333,FUN_014969-T1,B2RXZ1,PNDC1_MOUSE,,Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1),Mus musculus (Mouse),35.4,463.0,4.3e-65,250.4,sp|B2RXZ1|PNDC1_MOUSE Poly(A)-specific ribonuclease PNLDC1 OS=Mus musculus OX=10090 GN=Pnldc1 PE=1 SV=1,GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005783; GO:0005789; GO:0007283; GO:0034587; GO:0046872,"blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005783; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; endoplasmic reticulum; mRNA metabolic process; hydrolase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_03703,1.039833299475274,FUN_014975-T1,Peve_00024846,Pocillopora_meandrina_HIv1___RNAseq.g21114.t1,three_way,68.426,FUN_014975-T1,Q6DGR4,,,,,47.2,343.0,1.5e-86,321.2,sp|Q6DGR4|HGH1_DANRE Protein HGH1 homolog OS=Danio rerio OX=7955 GN=hgh1 PE=2 SV=1,,,,,,
OG_03704,1.3258036524978083,FUN_014977-T1,Peve_00024843,Pocillopora_meandrina_HIv1___RNAseq.g21138.t1,three_way,72.322,FUN_014977-T1,Q2XWK0,,,,,47.3,461.0,2.1e-115,417.5,sp|Q2XWK0|SVOP_XENLA Synaptic vesicle 2-related protein OS=Xenopus laevis OX=8355 GN=svop PE=2 SV=1,,,,,,
OG_03705,1.264249180087361,FUN_014978-T1,Peve_00024839,Pocillopora_meandrina_HIv1___RNAseq.g21140.t1,three_way,50.67916666666667,,,,,,,,,,,,,,,,,
OG_03707,2.457923720743357,FUN_014980-T3,Peve_00024829,Pocillopora_meandrina_HIv1___RNAseq.g21142.t1,three_way,72.68066666666667,FUN_014980-T3,P51577,,,,,52.3,392.0,5.2000000000000004e-110,399.4,sp|P51577|P2RX4_RAT P2X purinoceptor 4 OS=Rattus norvegicus OX=10116 GN=P2rx4 PE=1 SV=1,,,,,,
OG_03713,1.0086759131757903,FUN_014987-T1,Peve_00039946,Pocillopora_meandrina_HIv1___RNAseq.g21150.t1,three_way,82.91666666666667,FUN_014987-T1,O14874,,,,,55.7,368.0,1.4e-109,397.9,sp|O14874|BCKD_HUMAN Branched-chain alpha-ketoacid dehydrogenase kinase OS=Homo sapiens OX=9606 GN=BCKDK PE=1 SV=2,,,,,,
OG_03719,1.6481534187341322,FUN_014995-T1,Peve_00010955,Pocillopora_meandrina_HIv1___RNAseq.g21158.t1,three_way,83.375,FUN_014995-T1,Q23979,MY61F_DROME,,Unconventional myosin IC (MyoIC) (Brush border myosin IB) (BBMIB) (Myosin-IB) (MIB) (Unconventional myosin 1C) (Myo1C),Drosophila melanogaster (Fruit fly),55.3,1014.0,0.0,1112.4,sp|Q23979|MY61F_DROME Unconventional myosin IC OS=Drosophila melanogaster OX=7227 GN=Myo61F PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030048; GO:0032528; GO:0042742; GO:0048803; GO:0051015,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; endocytosis [GO:0006897]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0003774; GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0016192; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; isomerase activity; reproductive process; organelle; anatomical structure development; ATP-dependent activity
OG_03721,1.6090149512236147,FUN_015006-T1,Peve_00034682,Pocillopora_meandrina_HIv1___RNAseq.352_t,three_way,82.70633333333333,FUN_015006-T1,Q96QT6,PHF12_HUMAN,,PHD finger protein 12 (PHD factor 1) (Pf1),Homo sapiens (Human),31.1,1037.0,1.8e-99,365.5,sp|Q96QT6|PHF12_HUMAN PHD finger protein 12 OS=Homo sapiens OX=9606 GN=PHF12 PE=1 SV=2,GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053],phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0008289; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; lipid binding; organelle; molecular adaptor activity; transcription regulator activity
OG_03722,1.6470945611324963,FUN_015007-T1,Peve_00034683,Pocillopora_meandrina_HIv1___RNAseq.g21247.t1,three_way,90.045,FUN_015007-T1,A6NIH7,U119B_HUMAN,,Protein unc-119 homolog B,Homo sapiens (Human),68.4,193.0,2.3000000000000002e-74,280.0,sp|A6NIH7|U119B_HUMAN Protein unc-119 homolog B OS=Homo sapiens OX=9606 GN=UNC119B PE=1 SV=1,GO:0005829; GO:0005929; GO:0007399; GO:0008289; GO:0035869; GO:0042953; GO:0060271,cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytosol; cilium; lipid binding; organelle; cilium organization; anatomical structure development
OG_03724,1.82883193749282,FUN_015009-T1,Peve_00034685,Pocillopora_meandrina_HIv1___RNAseq.g21245.t1,three_way,73.11366666666666,,,,,,,,,,,,,,,,,
OG_03728,1.1433095457988127,FUN_015021-T2,Peve_00034691,Pocillopora_meandrina_HIv1___RNAseq.g21238.t1,three_way,93.31283333333334,FUN_015021-T2,Q8IVF4,DYH10_HUMAN,,Dynein axonemal heavy chain 10 (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10),Homo sapiens (Human),64.5,4571.0,0.0,5881.6,sp|Q8IVF4|DYH10_HUMAN Dynein axonemal heavy chain 10 OS=Homo sapiens OX=9606 GN=DNAH10 PE=1 SV=4,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_03733,1.6241067321219411,FUN_015026-T1,Peve_00004782,Pocillopora_meandrina_HIv1___RNAseq.g21178.t1,three_way,77.89583333333333,FUN_015026-T1,A4FU69,EFCB5_HUMAN,,EF-hand calcium-binding domain-containing protein 5,Homo sapiens (Human),28.9,1341.0,1.9e-133,478.8,sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3,GO:0005509,,,calcium ion binding [GO:0005509],,
OG_03736,1.5305268916129533,FUN_015036-T1,Peve_00024712,Pocillopora_meandrina_HIv1___RNAseq.g21165.t1,three_way,78.18966666666667,FUN_015036-T1,Q9BZ72,PITM2_HUMAN,,"Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3)",Homo sapiens (Human),42.6,1386.0,1.2e-287,991.1,sp|Q9BZ72|PITM2_HUMAN Membrane-associated phosphatidylinositol transfer protein 2 OS=Homo sapiens OX=9606 GN=PITPNM2 PE=1 SV=1,GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0016020; GO:0030971; GO:0031210; GO:0035091,phosphatidylinositol biosynthetic process [GO:0006661],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020],calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971],GO:0005215; GO:0005829; GO:0006629; GO:0008289,transporter activity; cytosol; lipid metabolic process; lipid binding
OG_03737,1.3189883522714942,FUN_015038-T1,Peve_00024408,Pocillopora_meandrina_HIv1___RNAseq.g21253.t1,three_way,68.02199999999999,FUN_015038-T1,P11023,RAB3A_BOVIN,,Ras-related protein Rab-3A (EC 3.6.5.2) (SMG P25A),Bos taurus (Bovine),45.0,171.0,1.1e-41,171.4,sp|P11023|RAB3A_BOVIN Ras-related protein Rab-3A OS=Bos taurus OX=9913 GN=RAB3A PE=1 SV=3,GO:0003016; GO:0003924; GO:0005525; GO:0005764; GO:0005768; GO:0005829; GO:0005886; GO:0007005; GO:0007274; GO:0007409; GO:0008021; GO:0009791; GO:0015031; GO:0016020; GO:0016079; GO:0016188; GO:0017157; GO:0030324; GO:0030424; GO:0030672; GO:0031489; GO:0031630; GO:0048786; GO:0048790; GO:0050975; GO:0051602; GO:0060478; GO:0098793; GO:0098794,acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; lung development [GO:0030324]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; post-embryonic development [GO:0009791]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188],axon [GO:0030424]; cytosol [GO:0005829]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489],GO:0003016; GO:0003824; GO:0003924; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0007005; GO:0008092; GO:0016192; GO:0016787; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,respiratory system process; catalytic activity; GTPase activity; lysosome; endosome; vacuole; cytosol; plasma membrane; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_03752,1.5516032852532766,FUN_015061-T1,Peve_00015752,Pocillopora_meandrina_HIv1___RNAseq.g21278.t1,three_way,60.377,FUN_015061-T1,Q9UH36,,,,,47.6,187.0,2.4e-42,174.1,sp|Q9UH36|SRR1L_HUMAN SRR1-like protein OS=Homo sapiens OX=9606 GN=SRRD PE=1 SV=1,,,,,,
OG_03753,1.187637835490741,FUN_015062-T1,Peve_00015751,Pocillopora_meandrina_HIv1___RNAseq.g21279.t1,three_way,81.46366666666667,FUN_015062-T1,Q9H773,DCTP1_HUMAN,,dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein),Homo sapiens (Human),58.9,141.0,2.9e-39,162.9,sp|Q9H773|DCTP1_HUMAN dCTP pyrophosphatase 1 OS=Homo sapiens OX=9606 GN=DCTPP1 PE=1 SV=1,GO:0000287; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840,dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03764,2.008908582804082,FUN_015089-T1,Peve_00010705,Pocillopora_meandrina_HIv1___RNAseq.g21187.t1,three_way,72.56533333333334,FUN_015089-T1,Q71F56,MD13L_HUMAN,,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),Homo sapiens (Human),29.0,2382.0,7.899999999999999e-204,713.4,sp|Q71F56|MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens OX=9606 GN=MED13L PE=1 SV=1,GO:0003713; GO:0005654; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592]; nucleoplasm [GO:0005654],transcription coactivator activity [GO:0003713],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_03765,2.2508083116173507,FUN_015090-T1,Peve_00010706,Pocillopora_meandrina_HIv1___RNAseq.g21186.t1,three_way,63.61833333333333,FUN_015090-T1,Q8HZ69,,,,,41.6,505.0,3.8e-115,416.8,sp|Q8HZ69|FMO2_GORGO Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Gorilla gorilla gorilla OX=9595 GN=FMO2 PE=3 SV=3,,,,,,
OG_03766,1.9626634790828177,FUN_015091-T1,Peve_00010707,Pocillopora_meandrina_HIv1___RNAseq.g21185.t1,three_way,59.72,,,,,,,,,,,,,,,,,
OG_03767,1.7789004122736711,FUN_015095-T1,Peve_00043821,Pocillopora_meandrina_HIv1___RNAseq.g22283.t1,three_way,81.09083333333334,FUN_015095-T1,Q8IZ69,TRM2A_HUMAN,,tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.35) (mRNA (uracil-5-)-methyltransferase TRMT2A) (EC 2.1.1.-),Homo sapiens (Human),40.3,618.0,9.4e-120,432.6,sp|Q8IZ69|TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens OX=9606 GN=TRMT2A PE=1 SV=2,GO:0003723; GO:0005829; GO:0006397; GO:0008033; GO:0008169; GO:0030697; GO:0032259,methylation [GO:0032259]; mRNA processing [GO:0006397]; tRNA processing [GO:0008033],cytosol [GO:0005829],"C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697]",GO:0003723; GO:0003824; GO:0005829; GO:0006399; GO:0016071; GO:0016740; GO:0140098,"RNA binding; catalytic activity; cytosol; tRNA metabolic process; mRNA metabolic process; transferase activity; catalytic activity, acting on RNA"
OG_03768,1.438083675987085,FUN_015096-T1,Peve_00043816,Pocillopora_meandrina_HIv1___RNAseq.g22282.t2,three_way,74.82266666666666,,,,,,,,,,,,,,,,,
OG_03770,1.1625730307866535,FUN_015099-T1,Peve_00029475,Pocillopora_meandrina_HIv1___RNAseq.g22142.t1,three_way,61.8635,FUN_015099-T1,P27615,SCRB2_RAT,,Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36),Rattus norvegicus (Rat),35.1,450.0,3e-80,300.8,sp|P27615|SCRB2_RAT Lysosome membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Scarb2 PE=1 SV=2,GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0007605; GO:0010976; GO:0015485; GO:0015917; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0099638,aminophospholipid transport [GO:0015917]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; sensory perception of sound [GO:0007605],endocytic vesicle membrane [GO:0030666]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044],GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0038024; GO:0050877; GO:0072659,plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cargo receptor activity; nervous system process; protein localization to plasma membrane
OG_03771,1.5105251634010983,FUN_015100-T1,Peve_00027023,Pocillopora_meandrina_HIv1___RNAseq.g22141.t1,three_way,83.81099999999999,FUN_015100-T1,Q5U3N5,,,,,51.7,238.0,6.2e-63,242.3,sp|Q5U3N5|PPTC7_DANRE Protein phosphatase PTC7 homolog OS=Danio rerio OX=7955 GN=pptc7 PE=2 SV=1,,,,,,
OG_03772,2.053034133052728,FUN_015101-T1,Peve_00027022,Pocillopora_meandrina_HIv1___RNAseq.g22124.t1,three_way,62.69583333333333,FUN_015101-T1,P47708,RP3A_MOUSE,,Rabphilin-3A (Exophilin-1),Mus musculus (Mouse),37.0,683.0,1.8e-109,398.3,sp|P47708|RP3A_MOUSE Rabphilin-3A OS=Mus musculus OX=10090 GN=Rph3a PE=1 SV=2,GO:0005509; GO:0005544; GO:0005546; GO:0006886; GO:0008270; GO:0008430; GO:0016082; GO:0019898; GO:0030141; GO:0030672; GO:0031267; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070679,intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle priming [GO:0016082],dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0006886; GO:0008289; GO:0031410; GO:0043226; GO:0065003,intracellular protein transport; lipid binding; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_03773,1.160591943233257,FUN_015102-T1,Peve_00036873,Pocillopora_meandrina_HIv1___RNAseq.g22122.t1,three_way,57.66816666666666,,,,,,,,,,,,,,,,,
OG_03774,1.6260223647386176,FUN_015103-T1,Peve_00036870,Pocillopora_meandrina_HIv1___RNAseq.g22120.t1,three_way,72.14483333333332,FUN_015103-T1,Q9CWK3,,,,,38.8,343.0,6.8e-44,179.5,sp|Q9CWK3|CD2B2_MOUSE CD2 antigen cytoplasmic tail-binding protein 2 OS=Mus musculus OX=10090 GN=Cd2bp2 PE=1 SV=1,,,,,,
OG_03775,1.2016749767848598,FUN_015104-T1,Peve_00036871,Pocillopora_meandrina_HIv1___RNAseq.g22119.t3,three_way,78.71466666666666,FUN_015104-T1,Q5ZKJ5,,,,,31.5,496.0,7.6e-55,216.5,sp|Q5ZKJ5|MF13A_CHICK Transmembrane protein 180 OS=Gallus gallus OX=9031 GN=MFSD13A PE=2 SV=1,,,,,,
OG_03777,1.9440835865241293,FUN_015107-T1,Peve_00036875,Pocillopora_meandrina_HIv1___TS.g26879.t1,three_way,68.18,FUN_015107-T1,Q86YT5,S13A5_HUMAN,,Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5),Homo sapiens (Human),45.1,618.0,1.4e-138,495.0,sp|Q86YT5|S13A5_HUMAN Na(+)/citrate cotransporter OS=Homo sapiens OX=9606 GN=SLC13A5 PE=1 SV=1,GO:0005343; GO:0005654; GO:0005829; GO:0005886; GO:0015137; GO:0015141; GO:0015729; GO:0015741; GO:0015742; GO:0015744; GO:0015746; GO:0017153; GO:0042802; GO:0055085; GO:0071285,alpha-ketoglutarate transport [GO:0015742]; cellular response to lithium ion [GO:0071285]; citrate transport [GO:0015746]; fumarate transport [GO:0015741]; oxaloacetate transport [GO:0015729]; succinate transport [GO:0015744]; transmembrane transport [GO:0055085],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],citrate transmembrane transporter activity [GO:0015137]; identical protein binding [GO:0042802]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141],GO:0005215; GO:0005654; GO:0005829; GO:0005886; GO:0055085,transporter activity; nucleoplasm; cytosol; plasma membrane; transmembrane transport
OG_03779,3.0340050371667195,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_03780,1.88171875025579,FUN_015110-T1,Peve_00024794,Pocillopora_meandrina_HIv1___RNAseq.g7729.t1,three_way,38.797,FUN_015110-T1,P82596,,,,,31.1,135.0,1e-08,65.5,sp|P82596|PLC_HALLA Perlucin OS=Haliotis laevigata OX=36097 PE=1 SV=3,,,,,,
OG_03781,1.0308381017731143,FUN_015136-T1,Peve_00001089,Pocillopora_meandrina_HIv1___RNAseq.g21740.t1,three_way,78.34933333333333,FUN_015136-T1,A1L2R7,,,,,47.0,230.0,7.499999999999999e-53,208.8,sp|A1L2R7|TACAN_XENLA Transmembrane protein 120A OS=Xenopus laevis OX=8355 GN=tmem120a.L PE=2 SV=1,,,,,,
OG_03784,1.1858006302992157,FUN_015140-T1,Peve_00001082,Pocillopora_meandrina_HIv1___RNAseq.g21745.t1,three_way,84.37516666666667,FUN_015140-T1,Q9U6B8,,,,,57.0,193.0,1.6e-51,204.1,sp|Q9U6B8|ORAI1_DROME Calcium release-activated calcium channel protein 1 OS=Drosophila melanogaster OX=7227 GN=Orai PE=1 SV=1,,,,,,
OG_03786,1.1071726078377468,FUN_015146-T1,Peve_00001085,Pocillopora_meandrina_HIv1___TS.g26499.t3,three_way,47.95283333333333,,,,,,,,,,,,,,,,,
OG_03790,1.3427428565163373,FUN_015155-T1,Peve_00001868,Pocillopora_meandrina_HIv1___RNAseq.g21762.t1,three_way,71.99633333333334,FUN_015155-T1,B6NK32,,,,,57.8,64.0,4.8e-15,81.6,sp|B6NK32|LYRM9_BRAFL LYR motif-containing protein 9 OS=Branchiostoma floridae OX=7739 GN=LYRM9 PE=3 SV=1,,,,,,
OG_03792,2.393221594781976,FUN_015158-T1,Peve_00001862,Pocillopora_meandrina_HIv1___RNAseq.g21765.t1,three_way,81.74516666666666,FUN_015158-T1,Q96DH6,,,,,47.2,335.0,2.3e-67,257.7,sp|Q96DH6|MSI2H_HUMAN RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1,,,,,,
OG_03793,2.3237814690701764,FUN_015164-T1,Peve_00001860,Pocillopora_meandrina_HIv1___TS.g25730.t1,three_way,68.88416666666667,FUN_015164-T1,Q14667,,,,,30.3,2363.0,1.9999999999999998e-285,984.6,sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3,,,,,,
OG_03799,1.1604210515932911,FUN_015179-T1,Peve_00001854,Pocillopora_meandrina_HIv1___RNAseq.g21786.t1,three_way,59.745333333333335,,,,,,,,,,,,,,,,,
OG_03801,1.401356020011168,FUN_015184-T1,Peve_00023889,Pocillopora_meandrina_HIv1___RNAseq.g22343.t1,three_way,40.410833333333336,FUN_015184-T1,P34331,PLK1_CAEEL,,Serine/threonine-protein kinase plk-1 (EC 2.7.11.21) (Polo-like kinase 1),Caenorhabditis elegans,29.1,292.0,1.2e-19,100.1,sp|P34331|PLK1_CAEEL Serine/threonine-protein kinase plk-1 OS=Caenorhabditis elegans OX=6239 GN=plk-1 PE=1 SV=4,GO:0000776; GO:0000793; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0007077; GO:0007098; GO:0007147; GO:0030496; GO:0040038; GO:0045132; GO:0051233; GO:0051726; GO:0106310; GO:0110039,centrosome cycle [GO:0007098]; female meiosis II [GO:0007147]; meiotic chromosome segregation [GO:0045132]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; regulation of cell cycle [GO:0051726],centrosome [GO:0005813]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005634; GO:0005694; GO:0005815; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0061024; GO:0140013; GO:0140096,"cytokinesis; catalytic activity; nucleus; chromosome; microtubule organizing center; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; membrane organization; meiotic nuclear division; catalytic activity, acting on a protein"
OG_03802,1.0915048172362196,FUN_015186-T1,Peve_00019714,Pocillopora_meandrina_HIv1___RNAseq.g22308.t1,three_way,66.40933333333334,,,,,,,,,,,,,,,,,
OG_03803,1.1389643293986886,FUN_015187-T1,Peve_00013021,Pocillopora_meandrina_HIv1___RNAseq.g22307.t1,three_way,65.45766666666667,FUN_015187-T1,O88845,AKA10_MOUSE,,"A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10)",Mus musculus (Mouse),33.2,596.0,9.3e-79,296.2,"sp|O88845|AKA10_MOUSE A-kinase anchor protein 10, mitochondrial OS=Mus musculus OX=10090 GN=Akap10 PE=1 SV=3",GO:0005739; GO:0005829; GO:0005886; GO:0008104; GO:0032991; GO:0051018,protein localization [GO:0008104],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],protein kinase A binding [GO:0051018],GO:0005739; GO:0005829; GO:0005886; GO:0043226,mitochondrion; cytosol; plasma membrane; organelle
OG_03806,1.1028983462102755,FUN_015193-T1,Peve_00013020,Pocillopora_meandrina_HIv1___RNAseq.g22296.t1,three_way,76.85266666666666,FUN_015193-T1,Q6PCX9,TRI37_MOUSE,,E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37),Mus musculus (Mouse),79.4,447.0,4.6e-210,733.0,sp|Q6PCX9|TRI37_MOUSE E3 ubiquitin-protein ligase TRIM37 OS=Mus musculus OX=10090 GN=Trim37 PE=1 SV=1,GO:0000122; GO:0003682; GO:0003713; GO:0005164; GO:0005694; GO:0005737; GO:0005778; GO:0005829; GO:0006513; GO:0008270; GO:0016235; GO:0016558; GO:0031625; GO:0035098; GO:0042803; GO:0045814; GO:0046600; GO:0048471; GO:0050821; GO:0051865; GO:0061630; GO:0070842; GO:0140862,"aggresome assembly [GO:0070842]; negative regulation of centriole replication [GO:0046600]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]",aggresome [GO:0016235]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778],chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005694; GO:0005829; GO:0006325; GO:0006355; GO:0006886; GO:0007031; GO:0016740; GO:0043226; GO:0055085; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; chromosome; cytosol; chromatin organization; regulation of DNA-templated transcription; intracellular protein transport; peroxisome organization; transferase activity; organelle; transmembrane transport; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_03810,1.0751830499444264,FUN_015219-T1,Peve_00023888,Pocillopora_meandrina_HIv1___RNAseq.g22336.t1,three_way,80.74166666666666,FUN_015219-T1,Q6GM71,LRWD1_XENLA,,Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein),Xenopus laevis (African clawed frog),26.8,728.0,4.2e-63,244.2,sp|Q6GM71|LRWD1_XENLA Leucine-rich repeat and WD repeat-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrwd1 PE=2 SV=1,GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005737; GO:0005813; GO:0006260; GO:0006325; GO:0008327; GO:0061628; GO:0071169,chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]",chromatin binding [GO:0003682]; histone H3K27me3 reader activity [GO:0061628]; methyl-CpG binding [GO:0008327],GO:0003677; GO:0005634; GO:0005815; GO:0006260; GO:0006325; GO:0043226; GO:0060090,DNA binding; nucleus; microtubule organizing center; DNA replication; chromatin organization; organelle; molecular adaptor activity
OG_03812,1.3673673140830602,FUN_015222-T1,Peve_00013653,Pocillopora_meandrina_HIv1___RNAseq.g22187.t1,three_way,59.37533333333334,FUN_015222-T1,Q9UHJ6,SHPK_HUMAN,,Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein),Homo sapiens (Human),41.5,472.0,3.3e-94,347.1,sp|Q9UHJ6|SHPK_HUMAN Sedoheptulokinase OS=Homo sapiens OX=9606 GN=SHPK PE=1 SV=4,GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0016310; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353,"carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]",cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03813,1.7135536163156735,FUN_015223-T1,Peve_00013652,Pocillopora_meandrina_HIv1___RNAseq.g22186.t1,three_way,75.90233333333333,FUN_015223-T1,Q8K4C0,FMO5_RAT,,Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1),Rattus norvegicus (Rat),49.9,539.0,1.1999999999999998e-153,544.7,sp|Q8K4C0|FMO5_RAT Flavin-containing monooxygenase 5 OS=Rattus norvegicus OX=10116 GN=Fmo5 PE=1 SV=3,GO:0004031; GO:0004497; GO:0004499; GO:0005789; GO:0006629; GO:0006805; GO:0050660; GO:0050661; GO:0090181; GO:0106294,lipid metabolic process [GO:0006629]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"aldehyde oxidase activity [GO:0004031]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_03818,1.4786637041913833,FUN_015229-T1,Peve_00016434,Pocillopora_meandrina_HIv1___RNAseq.g22180.t1,three_way,49.66866666666667,,,,,,,,,,,,,,,,,
OG_03825,1.0179430167857924,FUN_015245-T1,Peve_00003467,Pocillopora_meandrina_HIv1___RNAseq.g22163.t1,three_way,72.38283333333334,FUN_015245-T1,Q6VAB6,KSR2_HUMAN,,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),Homo sapiens (Human),33.3,953.0,6.5e-104,380.2,sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2,GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162,calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_03827,1.6916814816832637,FUN_015257-T1,Peve_00014297,Pocillopora_meandrina_HIv1___RNAseq.g22208.t1,three_way,54.744,,,,,,,,,,,,,,,,,
OG_03828,1.264218637445064,FUN_015258-T1,Peve_00014298,Pocillopora_meandrina_HIv1___RNAseq.g22209.t1,three_way,46.362,FUN_015258-T1,Q8BHE0,,,,,37.9,145.0,7e-15,83.2,sp|Q8BHE0|PRR11_MOUSE Proline-rich protein 11 OS=Mus musculus OX=10090 GN=Prr11 PE=2 SV=1,,,,,,
OG_03830,1.4758705563709704,FUN_015263-T1,Peve_00044771,Pocillopora_meandrina_HIv1___RNAseq.g22216.t1,three_way,70.697,FUN_015263-T1,Q9CQM5,,,,,45.2,115.0,2.1e-22,106.7,sp|Q9CQM5|TXD17_MOUSE Thioredoxin domain-containing protein 17 OS=Mus musculus OX=10090 GN=Txndc17 PE=1 SV=1,,,,,,
OG_03839,1.0061255136350054,FUN_015298-T1,Peve_00004801,Pocillopora_meandrina_HIv1___RNAseq.g22106.t1,three_way,63.3705,FUN_015298-T1,Q8QFX1,,,,,28.4,1242.0,2.3999999999999997e-83,313.2,sp|Q8QFX1|RIMB2_CHICK RIMS-binding protein 2 OS=Gallus gallus OX=9031 GN=RIMBP2 PE=1 SV=1,,,,,,
OG_03843,1.4576688571959815,FUN_015308-T1,Peve_00024022,Pocillopora_meandrina_HIv1___RNAseq.g21734.t1,three_way,74.93433333333334,FUN_015308-T1,Q9WU01,KHDR2_MOUSE,,"KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1) (SLM-1) (mSLM-1)",Mus musculus (Mouse),53.1,226.0,9.8e-56,218.8,"sp|Q9WU01|KHDR2_MOUSE KH domain-containing, RNA-binding, signal transduction-associated protein 2 OS=Mus musculus OX=10090 GN=Khdrbs2 PE=1 SV=1",GO:0005634; GO:0006397; GO:0008143; GO:0008266; GO:0017124; GO:0042169; GO:0048024,"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]",nucleus [GO:0005634],poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_03845,2.9080591998669463,FUN_015318-T1,Peve_00023982,Pocillopora_meandrina_HIv1___RNAseq.g21728.t1,three_way,82.93366666666667,FUN_015318-T1,Q5QNI2,,,,,31.0,532.0,4.7999999999999997e-54,213.8,sp|Q5QNI2|NCL1_ORYSJ Sodium/calcium exchanger NCL1 OS=Oryza sativa subsp. japonica OX=39947 GN=NCL1 PE=2 SV=1,,,,,,
OG_03846,1.0717442962883297,FUN_015325-T1,Peve_00023983,Pocillopora_meandrina_HIv1___RNAseq.g21727.t1,three_way,67.91250000000001,FUN_015325-T1,Q9VKJ9,C2D1_DROME,,Coiled-coil and C2 domain-containing protein 1-like (Lethal (2) giant discs 1 protein),Drosophila melanogaster (Fruit fly),40.0,758.0,1e-103,379.8,sp|Q9VKJ9|C2D1_DROME Coiled-coil and C2 domain-containing protein 1-like OS=Drosophila melanogaster OX=7227 GN=l(2)gd1 PE=1 SV=1,GO:0000281; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006357; GO:0006886; GO:0007219; GO:0007423; GO:0007472; GO:0008586; GO:0010008; GO:0016197; GO:0016327; GO:0032509; GO:0045035; GO:0045746; GO:0048132; GO:0048749; GO:0098592; GO:1901981; GO:1905367,compound eye development [GO:0048749]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of intralumenal vesicle formation [GO:1905367]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472],apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidylinositol phosphate binding [GO:1901981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0000910; GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0006886; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0140110,cytokinesis; DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; transcription regulator activity
OG_03847,1.328831976919183,FUN_015338-T2,Peve_00023985,Pocillopora_meandrina_HIv1___RNAseq.g21723.t1,three_way,71.78633333333333,FUN_015338-T2,Q5BJE1,CC178_HUMAN,,Coiled-coil domain-containing protein 178,Homo sapiens (Human),30.5,131.0,2.5e-09,66.2,sp|Q5BJE1|CC178_HUMAN Coiled-coil domain-containing protein 178 OS=Homo sapiens OX=9606 GN=CCDC178 PE=1 SV=3,GO:0036064,,ciliary basal body [GO:0036064],,GO:0005815,microtubule organizing center
OG_03848,1.327982391378291,FUN_015339-T1,Peve_00023987,Pocillopora_meandrina_HIv1___TS.g26471.t1,three_way,94.288,FUN_015339-T1,Q6PC72,CIB2_DANRE,,Calcium and integrin-binding family member 2,Danio rerio (Zebrafish) (Brachydanio rerio),47.3,188.0,1.6000000000000002e-44,180.6,sp|Q6PC72|CIB2_DANRE Calcium and integrin-binding family member 2 OS=Danio rerio OX=7955 GN=cib2 PE=2 SV=1,GO:0000287; GO:0001750; GO:0001917; GO:0005509; GO:0005737; GO:0007638; GO:0032420; GO:0042383; GO:0043010; GO:0048884; GO:0055074; GO:0071944,calcium ion homeostasis [GO:0055074]; camera-type eye development [GO:0043010]; mechanosensory behavior [GO:0007638]; neuromast development [GO:0048884],cell periphery [GO:0071944]; cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; sarcolemma [GO:0042383]; stereocilium [GO:0032420],calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287],GO:0005886; GO:0048856,plasma membrane; anatomical structure development
OG_03856,1.1070698468784006,FUN_015349-T1,Peve_00017518,Pocillopora_meandrina_HIv1___RNAseq.g21711.t1,three_way,74.874,FUN_015349-T1,Q54TR1,CFAD_DICDI,,Counting factor associated protein D,Dictyostelium discoideum (Social amoeba),29.7,528.0,3.8000000000000003e-59,231.1,sp|Q54TR1|CFAD_DICDI Counting factor associated protein D OS=Dictyostelium discoideum OX=44689 GN=cfaD PE=1 SV=1,GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0031288; GO:0031410; GO:0072659; GO:0140986; GO:1903665; GO:2001235,G protein-coupled chemorepellent receptor signaling pathway [GO:0140986]; immune response [GO:0006955]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; sorocarp morphogenesis [GO:0031288],cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764],,GO:0002376; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0031410; GO:0043226; GO:0072659,immune system process; extracellular region; extracellular space; lysosome; vacuole; cytoplasmic vesicle; organelle; protein localization to plasma membrane
OG_03857,1.562606161376711,FUN_015350-T1,Peve_00017519,Pocillopora_meandrina_HIv1___RNAseq.g21710.t1,three_way,76.06583333333333,FUN_015350-T1,P13277,,,,,36.8,321.0,1.5999999999999998e-49,199.1,sp|P13277|CYSP1_HOMAM Digestive cysteine proteinase 1 OS=Homarus americanus OX=6706 GN=LCP1 PE=1 SV=2,,,,,,
OG_03858,1.0444205756406724,FUN_015352-T1,Peve_00017515,Pocillopora_meandrina_HIv1___RNAseq.g21698.t1,three_way,68.03,FUN_015352-T1,P07098,LIPF_HUMAN,,Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3),Homo sapiens (Human),53.2,370.0,9.900000000000001e-111,401.7,sp|P07098|LIPF_HUMAN Gastric triacylglycerol lipase OS=Homo sapiens OX=9606 GN=LIPF PE=1 SV=1,GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0006641; GO:0008289; GO:0016042; GO:0016615; GO:0043231,lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]; triglyceride metabolic process [GO:0006641],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; malate dehydrogenase activity [GO:0016615]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005576; GO:0005739; GO:0006629; GO:0008289; GO:0016491; GO:0016787; GO:0043226,catalytic activity; extracellular region; mitochondrion; lipid metabolic process; lipid binding; oxidoreductase activity; hydrolase activity; organelle
OG_03864,1.9453842066028573,FUN_015372-T1,Peve_00000220,Pocillopora_meandrina_HIv1___RNAseq.g21694.t1,three_way,63.956,FUN_015372-T1,Q9H6I2,SOX17_HUMAN,,Transcription factor SOX-17,Homo sapiens (Human),47.8,178.0,6.5e-29,129.8,sp|Q9H6I2|SOX17_HUMAN Transcription factor SOX-17 OS=Homo sapiens OX=9606 GN=SOX17 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001570; GO:0001656; GO:0001706; GO:0001714; GO:0001828; GO:0001947; GO:0003142; GO:0003143; GO:0003151; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007493; GO:0007507; GO:0008013; GO:0010467; GO:0010628; GO:0016055; GO:0021903; GO:0023019; GO:0030308; GO:0031648; GO:0035050; GO:0042074; GO:0043279; GO:0045732; GO:0045893; GO:0045944; GO:0045995; GO:0048617; GO:0048866; GO:0050821; GO:0060214; GO:0060913; GO:0060914; GO:0060956; GO:0061009; GO:0061010; GO:0061031; GO:0061629; GO:0072091; GO:0072189; GO:0090090; GO:1903226; GO:1990830; GO:2000035; GO:2000043; GO:2000738,angiogenesis [GO:0001525]; cardiac cell fate determination [GO:0060913]; cardiogenic plate morphogenesis [GO:0003142]; cell migration involved in gastrulation [GO:0042074]; cellular response to leukemia inhibitory factor [GO:1990830]; common bile duct development [GO:0061009]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cell differentiation [GO:0060956]; endocardium formation [GO:0060214]; endoderm formation [GO:0001706]; endodermal cell fate determination [GO:0007493]; endodermal cell fate specification [GO:0001714]; endodermal digestive tract morphogenesis [GO:0061031]; gallbladder development [GO:0061010]; gene expression [GO:0010467]; heart development [GO:0007507]; heart formation [GO:0060914]; heart looping [GO:0001947]; inner cell mass cellular morphogenesis [GO:0001828]; metanephros development [GO:0001656]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; outflow tract morphogenesis [GO:0003151]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of cardiac cell fate specification [GO:2000043]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of stem cell division [GO:2000035]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; rostrocaudal neural tube patterning [GO:0021903]; signal transduction involved in regulation of gene expression [GO:0023019]; spermatogenesis [GO:0007283]; stem cell fate specification [GO:0048866]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_03865,1.0349414140213886,FUN_015373-T1,Peve_00000221,Pocillopora_meandrina_HIv1___RNAseq.g10184.t1,three_way,76.64383333333333,FUN_015373-T1,Q01320,TOP2A_MOUSE,,"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)",Mus musculus (Mouse),67.5,1208.0,0.0,1654.4,sp|Q01320|TOP2A_MOUSE DNA topoisomerase 2-alpha OS=Mus musculus OX=10090 GN=Top2a PE=1 SV=2,GO:0000228; GO:0000287; GO:0000775; GO:0000793; GO:0001673; GO:0002244; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006265; GO:0006325; GO:0006974; GO:0007059; GO:0007143; GO:0008301; GO:0009330; GO:0030261; GO:0030263; GO:0040016; GO:0042752; GO:0042803; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:0051309; GO:1990904,apoptotic chromosome condensation [GO:0030263]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511],"centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]","ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]",GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006355; GO:0007059; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140097; GO:0140657,"nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; isomerase activity; reproductive process; cell differentiation; organelle; meiotic nuclear division; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03867,1.0213383183301772,FUN_015377-T1,Peve_00000222,Pocillopora_meandrina_HIv1___RNAseq.g21693.t1,three_way,79.768,FUN_015377-T1,Q32LJ2,ARFRP_BOVIN,,ADP-ribosylation factor-related protein 1 (ARF-related protein 1),Bos taurus (Bovine),58.2,201.0,7.3e-67,255.0,sp|Q32LJ2|ARFRP_BOVIN ADP-ribosylation factor-related protein 1 OS=Bos taurus OX=9913 GN=ARFRP1 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0034067; GO:0043001,Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067],Golgi apparatus [GO:0005794],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0006886; GO:0016192; GO:0016787; GO:0043226; GO:0072659,catalytic activity; GTPase activity; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; hydrolase activity; organelle; protein localization to plasma membrane
OG_03874,1.829979559836846,FUN_015405-T1,Peve_00000200,Pocillopora_meandrina_HIv1___RNAseq.g21681.t1,three_way,86.47533333333334,FUN_015405-T1,Q26619,,,,,47.3,383.0,1.5e-89,331.3,sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_03878,1.3575755341394409,FUN_015411-T1,Peve_00026943,Pocillopora_meandrina_HIv1___RNAseq.g21674.t1,three_way,92.28733333333334,FUN_015411-T1,Q7ZVM1,WASC5_DANRE,,WASH complex subunit 5 (WASH complex subunit strumpellin),Danio rerio (Zebrafish) (Brachydanio rerio),67.2,1161.0,0.0,1580.8,sp|Q7ZVM1|WASC5_DANRE WASH complex subunit 5 OS=Danio rerio OX=7955 GN=washc5 PE=2 SV=1,GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0048738; GO:0051125; GO:0060047; GO:0071203; GO:0140285; GO:1905304,actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; cardiac muscle tissue development [GO:0048738]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of cardiac myofibril assembly [GO:1905304],early endosome [GO:0005769]; endosome [GO:0005768]; WASH complex [GO:0071203],,GO:0003013; GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0065003,circulatory system process; endosome; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly
OG_03881,1.1518622867266315,FUN_015423-T1,Peve_00011818,Pocillopora_meandrina_HIv1___RNAseq.g21657.t1,three_way,82.22166666666666,FUN_015423-T1,Q5E9X1,,,,,78.6,140.0,3.3000000000000004e-57,223.8,sp|Q5E9X1|NFYC_BOVIN Nuclear transcription factor Y subunit gamma OS=Bos taurus OX=9913 GN=NFYC PE=2 SV=1,,,,,,
OG_03884,1.3496173422843527,FUN_015429-T1,Peve_00033649,Pocillopora_meandrina_HIv1___RNAseq.g22262.t1,three_way,84.209,FUN_015429-T1,Q5ZI89,,,,,48.9,1121.0,0.0,1077.0,sp|Q5ZI89|TPC11_CHICK Trafficking protein particle complex subunit 11 OS=Gallus gallus OX=9031 GN=TRAPPC11 PE=2 SV=1,,,,,,
OG_03887,1.0333925685503849,FUN_015436-T1,Peve_00033643,Pocillopora_meandrina_HIv1___RNAseq.g22285.t1,three_way,77.14,FUN_015436-T1,O55125,,,,,51.8,247.0,4.6e-75,282.7,sp|O55125|NIPS1_MOUSE Protein NipSnap homolog 1 OS=Mus musculus OX=10090 GN=Nipsnap1 PE=1 SV=1,,,,,,
OG_03890,1.2411696231797371,FUN_015443-T1,Peve_00013024,Pocillopora_meandrina_HIv1___RNAseq.g22268.t1,three_way,73.08466666666666,FUN_015443-T1,A7S4N4,,,,,57.8,455.0,6.6e-129,462.2,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_03891,1.1580064152463847,FUN_015445-T1,Peve_00013658,Pocillopora_meandrina_HIv1___TS.g26948.t2,three_way,62.11333333333334,FUN_015445-T1,O75140,DEPD5_HUMAN,,GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5),Homo sapiens (Human),33.7,1699.0,4.9e-238,826.6,sp|O75140|DEPD5_HUMAN GATOR1 complex protein DEPDC5 OS=Homo sapiens OX=9606 GN=DEPDC5 PE=1 SV=2,GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508],cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267],GO:0005764; GO:0005773; GO:0005829; GO:0043226; GO:0098772,lysosome; vacuole; cytosol; organelle; molecular function regulator activity
OG_03896,1.6849271547290623,FUN_015474-T1,Peve_00009512,Pocillopora_meandrina_HIv1___TS.g26531.t2,three_way,73.673,FUN_015474-T1,Q14CX7,NAA25_HUMAN,,"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)",Homo sapiens (Human),36.3,980.0,6.4000000000000005e-161,569.7,"sp|Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1",GO:0005737; GO:0005794; GO:0005829; GO:0007010; GO:0010698; GO:0031416,cytoskeleton organization [GO:0007010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416],acetyltransferase activator activity [GO:0010698],GO:0005794; GO:0005829; GO:0007010; GO:0043226; GO:0098772,Golgi apparatus; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_03898,1.0314826282882663,FUN_015476-T1,Peve_00040441,Pocillopora_meandrina_HIv1___RNAseq.g18726.t1,three_way,63.078333333333326,,,,,,,,,,,,,,,,,
OG_03903,2.562661308329269,FUN_015977-T1,Peve_00032728,Pocillopora_meandrina_HIv1___RNAseq.g21409.t1,three_way,72.505,,,,,,,,,,,,,,,,,
OG_03906,2.8205621677267363,FUN_015982-T1,Peve_00024012,Pocillopora_meandrina_HIv1___RNAseq.g21404.t2,three_way,57.955,FUN_015982-T1,Q00174,LAMA_DROME,,Laminin subunit alpha (Laminin A chain),Drosophila melanogaster (Fruit fly),29.8,729.0,2.6e-88,330.1,sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2,GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711,"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021],extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048856; GO:0098542,immune system process; structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism
OG_03907,1.3409834711972577,FUN_015983-T2,Peve_00024011,Pocillopora_meandrina_HIv1___RNAseq.g21403.t1,three_way,53.04383333333333,FUN_015983-T2,Q99575,POP1_HUMAN,,Ribonucleases P/MRP protein subunit POP1 (hPOP1),Homo sapiens (Human),29.6,1024.0,4.0000000000000003e-104,380.9,sp|Q99575|POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens OX=9606 GN=POP1 PE=1 SV=2,GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005615; GO:0005654; GO:0005655; GO:0005730; GO:0008033; GO:0016078; GO:0030681; GO:0033204,tRNA 5'-leader removal [GO:0001682]; tRNA decay [GO:0016078]; tRNA processing [GO:0008033],extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172],ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005615; GO:0005654; GO:0005730; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; extracellular space; nucleoplasm; nucleolus; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03908,1.0161723487633636,FUN_015984-T1,Peve_00024010,Pocillopora_meandrina_HIv1___RNAseq.g21402.t1,three_way,68.71833333333333,FUN_015984-T1,Q9WTL7,LYPA2_MOUSE,,Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) (mLyso II) (Palmitoyl-protein hydrolase) (EC 3.1.2.22),Mus musculus (Mouse),52.0,229.0,5.7e-64,245.7,sp|Q9WTL7|LYPA2_MOUSE Acyl-protein thioesterase 2 OS=Mus musculus OX=10090 GN=Lypla2 PE=1 SV=1,GO:0002084; GO:0004622; GO:0005654; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0008474; GO:0046464; GO:1905344,acylglycerol catabolic process [GO:0046464]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleoplasm [GO:0005654],lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; nucleoplasm; cytosol; lipid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03911,2.7660900714100007,FUN_015990-T1,Peve_00023998,Pocillopora_meandrina_HIv1___RNAseq.g21387.t1,three_way,69.50233333333334,FUN_015990-T1,Q5BIM1,,,,,25.3,490.0,3.2e-30,135.2,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_03913,1.0415462511308218,FUN_015994-T1,Peve_00023995,Pocillopora_meandrina_HIv1___RNAseq.g21381.t1,three_way,89.52166666666666,FUN_015994-T1,Q9ULC3,RAB23_HUMAN,,Ras-related protein Rab-23 (EC 3.6.5.2),Homo sapiens (Human),67.2,232.0,1.1e-80,301.2,sp|Q9ULC3|RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens OX=9606 GN=RAB23 PE=1 SV=1,GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0006968; GO:0010008; GO:0012505; GO:0030054; GO:0030670; GO:0036064; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094,autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308],autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005773; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0055086; GO:1901135,catalytic activity; GTPase activity; vacuole; microtubule organizing center; cytosol; plasma membrane; cilium; intracellular protein transport; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03923,1.1421445627246238,FUN_016033-T1,Peve_00011813,Pocillopora_meandrina_HIv1___RNAseq.g21653.t1,three_way,71.436,FUN_016033-T1,P31422,GRM3_RAT,,Metabotropic glutamate receptor 3 (mGluR3),Rattus norvegicus (Rat),38.0,839.0,6.400000000000001e-158,559.7,sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_03926,2.520085140822266,FUN_016038-T1,Peve_00011807,Pocillopora_meandrina_HIv1___RNAseq.g21648.t2,three_way,64.21833333333333,FUN_016038-T1,Q8TDN4,CABL1_HUMAN,,CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1),Homo sapiens (Human),43.4,295.0,2.7e-61,237.7,sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2,GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726,cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0043226; GO:0048856,nucleus; cytosol; organelle; anatomical structure development
OG_03928,2.3239973551904165,FUN_016043-T1,Peve_00011803,Pocillopora_meandrina_HIv1___RNAseq.g21644.t1,three_way,70.11666666666666,,,,,,,,,,,,,,,,,
OG_03929,1.6372551000132256,FUN_016044-T1,Peve_00011802,Pocillopora_meandrina_HIv1___RNAseq.g21643.t1,three_way,75.492,,,,,,,,,,,,,,,,,
OG_03940,1.058291363832368,FUN_016075-T1,Peve_00021919,Pocillopora_meandrina_HIv1___RNAseq.g21617.t1,three_way,62.84066666666667,FUN_016075-T1,Q43470,,,,,64.7,238.0,7.3e-72,271.9,sp|Q43470|1433B_HORVU 14-3-3-like protein B OS=Hordeum vulgare OX=4513 PE=2 SV=1,,,,,,
OG_03943,1.1980332191928025,FUN_016078-T1,Peve_00021923,Pocillopora_meandrina_HIv1___RNAseq.g21614.t1,three_way,69.4695,FUN_016078-T1,P16388,KCNA1_MOUSE,,Potassium voltage-gated channel subfamily A member 1 (MBK1) (MKI) (Voltage-gated potassium channel subunit Kv1.1),Mus musculus (Mouse),49.0,396.0,4.9e-75,283.5,sp|P16388|KCNA1_MOUSE Potassium voltage-gated channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Kcna1 PE=1 SV=1,GO:0001964; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0007420; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030424; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0086011; GO:0097718,brain development [GO:0007420]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; membrane repolarization during action potential [GO:0086011]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; juxtaparanode region of axon [GO:0044224]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; protein-containing complex assembly
OG_03944,1.1913460883617348,FUN_016081-T1,Peve_00021927,Pocillopora_meandrina_HIv1___RNAseq.g21612.t1,three_way,72.43566666666666,,,,,,,,,,,,,,,,,
OG_03945,1.115880965510669,FUN_016082-T1,Peve_00021929,Pocillopora_meandrina_HIv1___RNAseq.g21611.t1,three_way,89.665,FUN_016082-T1,Q8CCB4,,,,,60.6,830.0,1.8000000000000002e-273,943.3,sp|Q8CCB4|VPS53_MOUSE Vacuolar protein sorting-associated protein 53 homolog OS=Mus musculus OX=10090 GN=Vps53 PE=1 SV=1,,,,,,
OG_03946,2.111669481139119,FUN_016083-T1,Peve_00021930,Pocillopora_meandrina_HIv1___RNAseq.g21608.t1,three_way,63.108,FUN_016083-T1,Q503L9,NXN_DANRE,,Nucleoredoxin (EC 1.8.1.8),Danio rerio (Zebrafish) (Brachydanio rerio),44.6,413.0,5.8e-95,349.4,sp|Q503L9|NXN_DANRE Nucleoredoxin OS=Danio rerio OX=7955 GN=nxn PE=2 SV=1,GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0072359,cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634],thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005829; GO:0016209; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; antioxidant activity; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03949,2.315397283896872,FUN_016088-T1,Peve_00010756,Pocillopora_meandrina_HIv1___RNAseq.g21605.t1,three_way,64.84400000000001,FUN_016088-T1,A6NFN9,,,,,31.8,466.0,7.399999999999999e-56,220.3,sp|A6NFN9|ANKUB_HUMAN Protein ANKUB1 OS=Homo sapiens OX=9606 GN=ANKUB1 PE=2 SV=3,,,,,,
OG_03950,1.1842581739210336,FUN_016089-T1,Peve_00013364,Pocillopora_meandrina_HIv1___RNAseq.g21562.t1,three_way,69.75566666666667,FUN_016089-T1,Q4V9Y5,,,,,40.3,201.0,9.1e-34,146.4,sp|Q4V9Y5|CRLD2_XENTR Cysteine-rich secretory protein LCCL domain-containing 2 OS=Xenopus tropicalis OX=8364 GN=crispld2 PE=2 SV=1,,,,,,
OG_03955,1.195948082380805,FUN_016100-T1,Peve_00010771,Pocillopora_meandrina_HIv1___RNAseq.g21590.t1,three_way,83.7185,FUN_016100-T1,Q13948,,,,,48.2,676.0,4.2e-151,536.6,sp|Q13948|CASP_HUMAN Protein CASP OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=2,,,,,,
OG_03960,1.684287333289089,FUN_016106-T1,Peve_00010760,Pocillopora_meandrina_HIv1___TS.g26345.t1,three_way,78.27083333333333,FUN_016106-T1,P07314,GGT1_RAT,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Rattus norvegicus (Rat),45.9,536.0,3.6e-125,450.3,sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_03962,1.2695250928997768,FUN_016111-T1,Peve_00013359,Pocillopora_meandrina_HIv1___RNAseq.g21553.t2,three_way,68.24533333333333,FUN_016111-T1,Q8WXX7,,,,,35.2,162.0,1.2e-07,60.5,sp|Q8WXX7|AUTS2_HUMAN Autism susceptibility gene 2 protein OS=Homo sapiens OX=9606 GN=AUTS2 PE=1 SV=1,,,,,,
OG_03963,1.8423238615990776,FUN_016112-T1,Peve_00013360,Pocillopora_meandrina_HIv1___RNAseq.g21551.t1,three_way,44.34066666666666,,,,,,,,,,,,,,,,,
OG_03966,1.4247861558039057,FUN_016115-T1,Peve_00013352,Pocillopora_meandrina_HIv1___RNAseq.g21556.t1,three_way,63.22466666666667,FUN_016115-T1,Q9H9H4,VP37B_HUMAN,,Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B),Homo sapiens (Human),36.6,82.0,2.4e-06,53.1,sp|Q9H9H4|VP37B_HUMAN Vacuolar protein sorting-associated protein 37B OS=Homo sapiens OX=9606 GN=VPS37B PE=1 SV=1,GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0019076; GO:0030496; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0048306; GO:0070062; GO:0090148; GO:1903774,macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306],GO:0005768; GO:0005886; GO:0006886; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; plasma membrane; intracellular protein transport; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_03967,1.4636774571665994,FUN_016116-T1,Peve_00013351,Pocillopora_meandrina_HIv1___TS.g26292.t1a,three_way,59.283,FUN_016116-T1,Q01097,NMDE2_MOUSE,,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B)",Mus musculus (Mouse),22.8,689.0,2.1e-31,139.0,"sp|Q01097|NMDE2_MOUSE Glutamate receptor ionotropic, NMDA 2B OS=Mus musculus OX=10090 GN=Grin2b PE=1 SV=3",GO:0001662; GO:0001701; GO:0001964; GO:0001967; GO:0004972; GO:0005261; GO:0005262; GO:0005764; GO:0005770; GO:0005789; GO:0005856; GO:0005886; GO:0006812; GO:0006816; GO:0007268; GO:0007423; GO:0007611; GO:0007612; GO:0007613; GO:0008021; GO:0008270; GO:0009986; GO:0014069; GO:0016020; GO:0016595; GO:0017146; GO:0022849; GO:0030425; GO:0030658; GO:0035235; GO:0042596; GO:0042734; GO:0043005; GO:0045202; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0048266; GO:0050966; GO:0051290; GO:0051968; GO:0060078; GO:0060079; GO:0060291; GO:0097060; GO:0097553; GO:0098655; GO:0098794; GO:0098839; GO:0098978; GO:0141161; GO:1902951; GO:1904062; GO:2000463,"behavioral fear response [GO:0001662]; behavioral response to pain [GO:0048266]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; excitatory postsynaptic potential [GO:0060079]; fear response [GO:0042596]; in utero embryonic development [GO:0001701]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; sensory organ development [GO:0007423]; startle response [GO:0001964]; suckling behavior [GO:0001967]",cell surface [GO:0009986]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; transport vesicle membrane [GO:0030658],calcium channel activity [GO:0005262]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005856; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0060089; GO:0065003,transporter activity; lysosome; endosome; vacuole; cytoskeleton; plasma membrane; signaling; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly
OG_03968,1.7364223069924758,FUN_016122-T1,Peve_00013455,Pocillopora_meandrina_HIv1___RNAseq.g21534.t1,three_way,49.625,,,,,,,,,,,,,,,,,
OG_03978,1.4582017405946783,FUN_016132-T1,Peve_00022580,Pocillopora_meandrina_HIv1___RNAseq.g22029.t1,three_way,56.699000000000005,FUN_016132-T1,Q8N4B1,SESQ1_HUMAN,,Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase-interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1),Homo sapiens (Human),45.7,127.0,1.2000000000000001e-30,135.6,sp|Q8N4B1|SESQ1_HUMAN Sesquipedalian-1 OS=Homo sapiens OX=9606 GN=PHETA1 PE=1 SV=1,GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037,"endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],protein homodimerization activity [GO:0042803],GO:0005768; GO:0005829; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03982,1.8345068824811608,FUN_016141-T1,Peve_00013437,Pocillopora_meandrina_HIv1___TS.g26796.t1c,three_way,79.88266666666667,FUN_016141-T1,O14578,,,,,35.7,1950.0,1.8999999999999999e-239,831.6,sp|O14578|CTRO_HUMAN Citron Rho-interacting kinase OS=Homo sapiens OX=9606 GN=CIT PE=1 SV=2,,,,,,
OG_03985,1.3754035728418736,FUN_016150-T1,Peve_00013422,Pocillopora_meandrina_HIv1___RNAseq.g22094.t1,three_way,87.48066666666666,,,,,,,,,,,,,,,,,
OG_03987,1.1791184345293424,FUN_016152-T1,Peve_00022569,Pocillopora_meandrina_HIv1___RNAseq.g21229.t1,three_way,62.593833333333336,FUN_016152-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),47.1,425.0,5.6e-104,380.9,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03988,2.536945404855345,FUN_016154-T1,Peve_00004478,Pocillopora_meandrina_HIv1___RNAseq.g21231.t1,three_way,69.62266666666667,,,,,,,,,,,,,,,,,
OG_03991,2.1106908037203245,FUN_016163-T1,Peve_00022617,Pocillopora_meandrina_HIv1___RNAseq.g21016.t1,three_way,65.033,FUN_016163-T1,Q9ULI0,ATD2B_HUMAN,,ATPase family AAA domain-containing protein 2B,Homo sapiens (Human),42.8,1254.0,1.0999999999999999e-249,865.1,sp|Q9ULI0|ATD2B_HUMAN ATPase family AAA domain-containing protein 2B OS=Homo sapiens OX=9606 GN=ATAD2B PE=1 SV=4,GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0016887; GO:0042393; GO:0045815; GO:0070577,nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; transcription initiation-coupled chromatin remodeling [GO:0045815],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016787; GO:0042393; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; chromatin organization; hydrolase activity; histone binding; organelle; protein-containing complex assembly
OG_03996,1.299772765281318,FUN_016280-T2,Peve_00003392,Pocillopora_meandrina_HIv1___RNAseq.g403.t1,three_way,76.21483333333333,FUN_016280-T2,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),42.5,742.0,6.9e-166,585.9,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03997,1.998912089992992,FUN_016284-T1,Peve_00024280,Pocillopora_meandrina_HIv1___RNAseq.g401.t2,three_way,83.84983333333334,FUN_016284-T1,Q61084,M3K3_MOUSE,,Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3),Mus musculus (Mouse),43.4,677.0,4.9000000000000005e-123,443.4,sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus OX=10090 GN=Map3k3 PE=1 SV=1,GO:0001568; GO:0004672; GO:0004709; GO:0005524; GO:0035556; GO:0043123; GO:0046872; GO:0106310; GO:1900745,blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_03998,1.385687458163984,FUN_016286-T1,Peve_00027223,Pocillopora_meandrina_HIv1___RNAseq.g400.t1,three_way,87.92383333333333,FUN_016286-T1,O46470,,,,,56.8,458.0,9e-137,488.4,sp|O46470|RGS7_BOVIN Regulator of G-protein signaling 7 OS=Bos taurus OX=9913 GN=RGS7 PE=1 SV=1,,,,,,
OG_04006,1.9942094947388715,FUN_016305-T1,Peve_00032293,Pocillopora_meandrina_HIv1___RNAseq.g10040.t1,three_way,94.53566666666669,FUN_016305-T1,Q6NZ04,SIX1B_DANRE,,Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,285.0,6.9e-92,338.6,sp|Q6NZ04|SIX1B_DANRE Homeobox protein six1b OS=Danio rerio OX=7955 GN=six1b PE=1 SV=1,GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0048741; GO:0048839; GO:0048935; GO:0051146,adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; chordate pharyngeal muscle development [GO:0043282]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; peripheral nervous system neuron development [GO:0048935]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04010,1.7512869751616122,FUN_016311-T1,Peve_00032324,Pocillopora_meandrina_HIv1___RNAseq.g10035.t1,three_way,78.09949999999999,FUN_016311-T1,Q76L87,,,,,37.8,259.0,3.8e-27,124.0,sp|Q76L87|DMTA2_ORYLA Doublesex- and mab-3-related transcription factor A2 OS=Oryzias latipes OX=8090 GN=dmrta2 PE=3 SV=1,,,,,,
OG_04019,1.4160400299883371,FUN_016324-T1,Peve_00009565,Pocillopora_meandrina_HIv1___TS.g23223.t1,three_way,71.28433333333334,,,,,,,,,,,,,,,,,
OG_04024,1.2933937710881982,FUN_016330-T1,Peve_00032370,Pocillopora_meandrina_HIv1___RNAseq.g9857.t2,three_way,82.74833333333333,FUN_016330-T1,Q9NRC6,SPTN5_HUMAN,,"Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)",Homo sapiens (Human),28.1,3578.0,0.0,1392.1,"sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2",GO:0002046; GO:0003779; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007030; GO:0007041; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030054; GO:0030507; GO:0030864; GO:0032029; GO:0032391; GO:0034452; GO:0042802; GO:0042995; GO:0045179; GO:0045505; GO:0051015; GO:0051693; GO:0097381,actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041],apical cortex [GO:0045179]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; spectrin binding [GO:0030507],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_04025,1.0596811404409752,FUN_016332-T1,Peve_00044544,Pocillopora_meandrina_HIv1___RNAseq.g9841.t1,three_way,43.75183333333334,,,,,,,,,,,,,,,,,
OG_04026,1.766556625116365,FUN_016333-T1,Peve_00044546,Pocillopora_meandrina_HIv1___TS.g23374.t1,three_way,71.42983333333333,FUN_016333-T1,P35869,AHR_HUMAN,,Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76),Homo sapiens (Human),40.4,381.0,7.4e-62,240.4,sp|P35869|AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens OX=9606 GN=AHR PE=1 SV=2,GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001094; GO:0001223; GO:0001568; GO:0002819; GO:0002841; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006805; GO:0006915; GO:0009410; GO:0009636; GO:0010468; GO:0017025; GO:0030888; GO:0032922; GO:0032991; GO:0034751; GO:0034752; GO:0034753; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837,"apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]",aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic aryl hydrocarbon receptor complex [GO:0034752]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_04029,1.402945817659113,FUN_016337-T1,Peve_00044566,Pocillopora_meandrina_HIv1___RNAseq.g9732.t1,three_way,81.75833333333334,,,,,,,,,,,,,,,,,
OG_04035,1.0876979890865743,FUN_016343-T1,Peve_00044581,Pocillopora_meandrina_HIv1___RNAseq.g9724.t1,three_way,79.218,FUN_016343-T1,Q28DS0,,,,,49.7,342.0,5.4e-94,345.9,sp|Q28DS0|SAE1_XENTR SUMO-activating enzyme subunit 1 OS=Xenopus tropicalis OX=8364 GN=sae1 PE=2 SV=1,,,,,,
OG_04038,2.022083973258613,FUN_016346-T2,Peve_00004339,Pocillopora_meandrina_HIv1___TS.g23215.t1,three_way,85.454,FUN_016346-T2,Q6NW96,SP9_DANRE,,Transcription factor Sp9,Danio rerio (Zebrafish) (Brachydanio rerio),39.6,341.0,1.2999999999999998e-43,178.7,sp|Q6NW96|SP9_DANRE Transcription factor Sp9 OS=Danio rerio OX=7955 GN=sp9 PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0030326; GO:0035118; GO:0045743,embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04039,2.795365491721393,FUN_016347-T1,Peve_00004355,Pocillopora_meandrina_HIv1___RNAseq.g9679.t1,three_way,82.813,FUN_016347-T1,Q9JHX2,,,,,31.5,321.0,1.9e-18,95.1,sp|Q9JHX2|SP5_MOUSE Transcription factor Sp5 OS=Mus musculus OX=10090 GN=Sp5 PE=2 SV=1,,,,,,
OG_04040,1.0698434277676017,FUN_016349-T1,Peve_00004360,Pocillopora_meandrina_HIv1___RNAseq.g9678.t1,three_way,89.957,FUN_016349-T1,Q7ZU42,,,,,75.0,388.0,1.4e-166,587.4,sp|Q7ZU42|OLA1_DANRE Obg-like ATPase 1 OS=Danio rerio OX=7955 GN=ola1 PE=2 SV=1,,,,,,
OG_04041,3.3957279014948374,FUN_016350-T1,Peve_00004331,Pocillopora_meandrina_HIv1___RNAseq.16312_t,three_way,70.639,FUN_016350-T1,Q90WR8,SP3_CHICK,,Transcription factor Sp3,Gallus gallus (Chicken),48.7,117.0,7.9e-20,100.1,sp|Q90WR8|SP3_CHICK Transcription factor Sp3 OS=Gallus gallus OX=9031 GN=SP3 PE=1 SV=1,GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001889; GO:0002318; GO:0003682; GO:0005829; GO:0006357; GO:0008270; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0043353; GO:0045944; GO:0048596; GO:0048706; GO:0060216; GO:0061629,B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; myeloid progenitor cell differentiation [GO:0002318]; natural killer cell differentiation [GO:0001779]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217],cytosol [GO:0005829]; PML body [GO:0016605]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04048,1.3429806207851414,FUN_016362-T1,Peve_00004341,Pocillopora_meandrina_HIv1___RNAseq.g9604.t1,three_way,75.83800000000001,FUN_016362-T1,Q9D1Q6,ERP44_MOUSE,,Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4),Mus musculus (Mouse),47.8,427.0,4.6e-111,402.9,sp|Q9D1Q6|ERP44_MOUSE Endoplasmic reticulum resident protein 44 OS=Mus musculus OX=10090 GN=Erp44 PE=1 SV=1,GO:0003756; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976,glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793],protein disulfide isomerase activity [GO:0003756],GO:0003824; GO:0006457; GO:0016853; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; protein folding; isomerase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04049,1.9907392477547887,FUN_016365-T1,Peve_00004342,Pocillopora_meandrina_HIv1___RNAseq.g9605.t1,three_way,60.6625,FUN_016365-T1,Q58D84,,,,,40.3,72.0,1.4e-09,67.0,sp|Q58D84|FSTL1_BOVIN Follistatin-related protein 1 OS=Bos taurus OX=9913 GN=FSTL1 PE=2 SV=1,,,,,,
OG_04050,2.330331369717437,FUN_016368-T2,Peve_00004346,Pocillopora_meandrina_HIv1___RNAseq.g9681.t1,three_way,71.802,FUN_016368-T2,Q8NEV4,MYO3A_HUMAN,,Myosin-IIIa (EC 2.7.11.1),Homo sapiens (Human),49.4,1096.0,9.1e-305,1048.1,sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2,GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310,cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0008092; GO:0016740; GO:0016787; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytoskeletal protein binding; transferase activity; hydrolase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_04052,1.0107673398996715,FUN_016371-T1,Peve_00022927,Pocillopora_meandrina_HIv1___RNAseq.g9747.t1,three_way,64.89166666666667,FUN_016371-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),56.4,133.0,4.6e-27,123.2,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04054,1.214605737379594,FUN_016373-T1,Peve_00022923,Pocillopora_meandrina_HIv1___RNAseq.g9745.t1,three_way,73.565,FUN_016373-T1,P42587,,,,,58.7,75.0,4.2e-17,89.7,sp|P42587|HNK2_XENLA Homeobox protein XENK-2 OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_04055,1.400846570142821,FUN_016374-T1,Peve_00022922,Pocillopora_meandrina_HIv1___RNAseq.g9744.t1,three_way,74.13233333333334,FUN_016374-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,207.0,5.3e-32,139.4,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04056,1.25213325399053,FUN_016375-T1,Peve_00022921,Pocillopora_meandrina_HIv1___RNAseq.16382_t,three_way,83.09666666666666,FUN_016375-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),65.5,87.0,8.3e-25,115.5,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04057,1.1217890009829972,FUN_016377-T1,Peve_00022920,Pocillopora_meandrina_HIv1___RNAseq.g9741.t1,three_way,46.54933333333334,FUN_016377-T1,Q03372,HMSH_DROME,,Muscle segmentation homeobox (Protein drop) (Protein msh),Drosophila melanogaster (Fruit fly),36.9,111.0,7e-08,59.3,sp|Q03372|HMSH_DROME Muscle segmentation homeobox OS=Drosophila melanogaster OX=7227 GN=Dr PE=1 SV=2,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007389; GO:0007398; GO:0007400; GO:0007417; GO:0007419; GO:0007420; GO:0007450; GO:0007476; GO:0007485; GO:0007517; GO:0009953; GO:0010629; GO:0021782; GO:0035222; GO:0035309; GO:0042659; GO:0043565; GO:0048598,"brain development [GO:0007420]; central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic morphogenesis [GO:0048598]; glial cell development [GO:0021782]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing morphogenesis [GO:0007476]; muscle organ development [GO:0007517]; negative regulation of gene expression [GO:0010629]; neuroblast fate determination [GO:0007400]; pattern specification process [GO:0007389]; regulation of cell fate specification [GO:0042659]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; wing and notum subfield formation [GO:0035309]; wing disc pattern formation [GO:0035222]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04059,1.0410003676498898,FUN_016379-T1,Peve_00022918,Pocillopora_meandrina_HIv1___RNAseq.g9739.t1,three_way,48.443333333333335,FUN_016379-T1,P02836,HMEN_DROME,,Segmentation polarity homeobox protein engrailed,Drosophila melanogaster (Fruit fly),42.7,96.0,4.6e-09,63.2,sp|P02836|HMEN_DROME Segmentation polarity homeobox protein engrailed OS=Drosophila melanogaster OX=7227 GN=en PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007367; GO:0007386; GO:0007388; GO:0007400; GO:0007411; GO:0007418; GO:0007472; GO:0007474; GO:0007487; GO:0008406; GO:0010468; GO:0010629; GO:0035215; GO:0035224; GO:0035277; GO:0035288; GO:0035289; GO:0035290; GO:0043524; GO:0043565; GO:0045944; GO:0048099; GO:0048100,"analia development [GO:0007487]; anterior head segmentation [GO:0035288]; anterior/posterior lineage restriction, imaginal disc [GO:0048099]; axon guidance [GO:0007411]; compartment pattern specification [GO:0007386]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc development [GO:0035215]; gonad development [GO:0008406]; imaginal disc-derived wing vein specification [GO:0007474]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior compartment specification [GO:0007388]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; trunk segmentation [GO:0035290]; ventral midline development [GO:0007418]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04061,1.683118421123966,FUN_016381-T1,Peve_00022915,Pocillopora_meandrina_HIv1___RNAseq.g9749.t1,three_way,68.01166666666667,,,,,,,,,,,,,,,,,
OG_04075,2.207932825316772,FUN_016400-T1,Peve_00006411,Pocillopora_meandrina_HIv1___RNAseq.g9752.t1,three_way,83.30466666666666,FUN_016400-T1,Q6NUP7,PP4R4_HUMAN,,Serine/threonine-protein phosphatase 4 regulatory subunit 4,Homo sapiens (Human),46.8,667.0,3.4e-166,587.0,sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1,GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064; GO:0043231,blastocyst hatching [GO:0001835],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase complex [GO:0008287],protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005815; GO:0005829; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cilium; organelle; molecular function regulator activity
OG_04077,2.083116698224637,FUN_016402-T1,Peve_00028063,Pocillopora_meandrina_HIv1___RNAseq.g9780.t1,three_way,62.028666666666666,FUN_016402-T1,Q9Y2I7,FYV1_HUMAN,,1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1),Homo sapiens (Human),31.1,2630.0,2.5e-294,1014.2,sp|Q9Y2I7|FYV1_HUMAN 1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3,GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]",cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506],"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005829; GO:0006629; GO:0016192; GO:0016740; GO:0016787; GO:0031410; GO:0043226; GO:0048870; GO:0061024; GO:0140096,"immune system process; catalytic activity; cytosol; lipid metabolic process; vesicle-mediated transport; transferase activity; hydrolase activity; cytoplasmic vesicle; organelle; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_04078,1.6003163199162689,FUN_016408-T1,Peve_00018205,Pocillopora_meandrina_HIv1___TS.g23317.t1,three_way,74.89666666666666,FUN_016408-T1,Q98TY9,,,,,63.8,469.0,2.1e-170,600.1,sp|Q98TY9|AKT1_XENLA RAC-alpha serine/threonine-protein kinase OS=Xenopus laevis OX=8355 GN=akt1 PE=2 SV=1,,,,,,
OG_04085,1.5842483176721314,FUN_016421-T1,Peve_00023006,Pocillopora_meandrina_HIv1___RNAseq.g9803.t1,three_way,72.968,FUN_016421-T1,Q9P2G1,AKIB1_HUMAN,,Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31),Homo sapiens (Human),50.3,746.0,6.800000000000001e-211,735.7,sp|Q9P2G1|AKIB1_HUMAN Ankyrin repeat and IBR domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKIB1 PE=1 SV=3,GO:0000151; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0061630,protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04086,1.3801446525111962,FUN_016422-T1,Peve_00004363,Pocillopora_meandrina_HIv1___RNAseq.g9804.t1,three_way,88.40866666666666,FUN_016422-T1,P62490,,,,,67.1,207.0,2e-70,266.9,sp|P62490|RB11A_CANLF Ras-related protein Rab-11A OS=Canis lupus familiaris OX=9615 GN=RAB11A PE=2 SV=3,,,,,,
OG_04088,1.4364109661662834,FUN_016425-T1,Peve_00004359,Pocillopora_meandrina_HIv1___TS.g23342.t4,three_way,52.22683333333333,,,,,,,,,,,,,,,,,
OG_04089,2.340603777665263,FUN_016428-T1,Peve_00004356,Pocillopora_meandrina_HIv1___RNAseq.g9809.t1,three_way,74.45816666666666,FUN_016428-T1,Q15147,,,,,38.6,1257.0,9.2e-231,802.4,"sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3",,,,,,
OG_04090,1.214812659353526,FUN_016429-T1,Peve_00004354,Pocillopora_meandrina_HIv1___RNAseq.g9810.t1,three_way,71.03866666666667,FUN_016429-T1,Q642M9,,,,,44.1,331.0,4.8e-79,296.2,"sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2",,,,,,
OG_04097,1.4604364534397276,FUN_016439-T1,Peve_00013822,Pocillopora_meandrina_HIv1___RNAseq.g9838.t1,three_way,64.92133333333334,FUN_016439-T1,O54928,SOCS5_MOUSE,,Suppressor of cytokine signaling 5 (SOCS-5) (Cytokine-inducible SH2-containing protein 5),Mus musculus (Mouse),47.5,219.0,2.9e-47,191.0,sp|O54928|SOCS5_MOUSE Suppressor of cytokine signaling 5 OS=Mus musculus OX=10090 GN=Socs5 PE=1 SV=2,GO:0005154; GO:0005737; GO:0007173; GO:0007175; GO:0007259; GO:0009968; GO:0016567; GO:0019210; GO:0019221; GO:0030971; GO:0032436; GO:0032715; GO:0035556; GO:0045627; GO:0045629; GO:0050728; GO:0071404; GO:0071638; GO:0097699; GO:1904988,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of endothelial cell activation [GO:1904988]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of signal transduction [GO:0009968]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; protein ubiquitination [GO:0016567]; vascular endothelial cell response to fluid shear stress [GO:0097699],cytoplasm [GO:0005737],epidermal growth factor receptor binding [GO:0005154]; kinase inhibitor activity [GO:0019210]; receptor tyrosine kinase binding [GO:0030971],GO:0098772,molecular function regulator activity
OG_04101,1.1612762511073098,FUN_016452-T1,Peve_00016427,Pocillopora_meandrina_HIv1___RNAseq.g9832.t1,three_way,79.55466666666666,FUN_016452-T1,Q8TD10,MIPO1_HUMAN,,Mirror-image polydactyly gene 1 protein,Homo sapiens (Human),26.7,322.0,5.4e-17,90.5,sp|Q8TD10|MIPO1_HUMAN Mirror-image polydactyly gene 1 protein OS=Homo sapiens OX=9606 GN=MIPOL1 PE=1 SV=1,GO:0005634; GO:0042802,,nucleus [GO:0005634],identical protein binding [GO:0042802],GO:0005634; GO:0043226,nucleus; organelle
OG_04105,1.442533013572287,FUN_016469-T1,Peve_00015303,Pocillopora_meandrina_HIv1___RNAseq.g100.t1,three_way,99.05466666666666,FUN_016469-T1,Q17QC5,AP2S1_BOVIN,,AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin),Bos taurus (Bovine),92.3,142.0,1.4e-69,263.5,sp|Q17QC5|AP2S1_BOVIN AP-2 complex subunit sigma OS=Bos taurus OX=9913 GN=AP2S1 PE=2 SV=1,GO:0006886; GO:0016192; GO:0030122; GO:0035615; GO:0043231; GO:0072583,clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231],clathrin adaptor activity [GO:0035615],GO:0006886; GO:0016192; GO:0043226; GO:0060090,intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity
OG_04106,1.9484938214046168,FUN_016470-T1,Peve_00015304,Pocillopora_meandrina_HIv1___RNAseq.g101.t1,three_way,67.28366666666666,FUN_016470-T1,Q6P4F7,RHGBA_HUMAN,,Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A),Homo sapiens (Human),37.3,260.0,1.6999999999999996e-31,139.0,sp|Q6P4F7|RHGBA_HUMAN Rho GTPase-activating protein 11A OS=Homo sapiens OX=9606 GN=ARHGAP11A PE=1 SV=2,GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056,positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleus [GO:0005634],GTPase activator activity [GO:0005096],GO:0005634; GO:0005829; GO:0043226; GO:0098772,nucleus; cytosol; organelle; molecular function regulator activity
OG_04108,1.447427337122028,FUN_016473-T1,Peve_00015306,Pocillopora_meandrina_HIv1___RNAseq.g145.t1,three_way,60.1465,FUN_016473-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),81.0,58.0,5e-21,102.8,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04109,1.866324853051428,FUN_016475-T1,Peve_00040144,Pocillopora_meandrina_HIv1___RNAseq.g10194.t1,three_way,66.4755,FUN_016475-T1,P0C5Y8,ALS2_RAT,,Alsin (Amyotrophic lateral sclerosis 2 protein homolog),Rattus norvegicus (Rat),30.6,1765.0,3.8e-188,661.0,sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1,GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072,"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267],GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_04113,1.3581562417217397,FUN_016489-T1,Peve_00001327,Pocillopora_meandrina_HIv1___RNAseq.g9629.t1,three_way,83.481,FUN_016489-T1,Q8R5L3,,,,,52.2,596.0,7.399999999999999e-171,602.1,sp|Q8R5L3|VPS39_MOUSE Vam6/Vps39-like protein OS=Mus musculus OX=10090 GN=Vps39 PE=1 SV=1,,,,,,
OG_04116,1.8138759886286409,FUN_016492-T1,Peve_00042752,Pocillopora_meandrina_HIv1___RNAseq.g179.t1,three_way,63.57866666666666,FUN_016492-T1,Q8L706,,,,,24.4,312.0,1.1e-15,87.4,sp|Q8L706|SYT5_ARATH Synaptotagmin-5 OS=Arabidopsis thaliana OX=3702 GN=SYT5 PE=2 SV=1,,,,,,
OG_04117,1.2896185826752609,FUN_016493-T1,Peve_00042754,Pocillopora_meandrina_HIv1___RNAseq.g178.t1,three_way,75.77766666666666,FUN_016493-T1,P54357,,,,,44.8,145.0,1.8e-29,130.6,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_04121,1.1948175332154989,FUN_016502-T1,Peve_00002862,Pocillopora_meandrina_HIv1___RNAseq.g26039.t1,three_way,58.61033333333333,,,,,,,,,,,,,,,,,
OG_04125,1.011594647568333,FUN_016508-T1,Peve_00042768,Pocillopora_meandrina_HIv1___TS.g23255.t1,three_way,68.21666666666667,FUN_016508-T1,Q6PUF4,,,,,41.6,267.0,2.1e-49,197.6,sp|Q6PUF4|DHI1L_CHICK Hydroxysteroid 11-beta-dehydrogenase 1-like protein OS=Gallus gallus OX=9031 GN=HSD11B1L PE=2 SV=1,,,,,,
OG_04129,1.588351951745146,FUN_016578-T1,Peve_00002516,Pocillopora_meandrina_HIv1___RNAseq.g9694.t1,three_way,71.17683333333333,FUN_016578-T1,Q8K4Q6,NEIL1_MOUSE,,Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (Nei homolog 1) (NEH1) (Nei-like protein 1),Mus musculus (Mouse),49.5,307.0,1.9000000000000002e-80,301.2,sp|Q8K4Q6|NEIL1_MOUSE Endonuclease 8-like 1 OS=Mus musculus OX=10090 GN=Neil1 PE=2 SV=3,GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0006281; GO:0006284; GO:0006979; GO:0008270; GO:0016829; GO:0019104; GO:0140078,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; lyase activity [GO:0016829]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; microtubule organizing center; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_04130,1.2690123960066078,FUN_016580-T1,Peve_00002515,Pocillopora_meandrina_HIv1___RNAseq.g9696.t1,three_way,53.467,,,,,,,,,,,,,,,,,
OG_04131,1.4427420091804108,FUN_016583-T1,Peve_00016678,Pocillopora_meandrina_HIv1___RNAseq.g418.t1,three_way,41.5285,,,,,,,,,,,,,,,,,
OG_04132,1.171009761504753,FUN_016586-T1,Peve_00015488,Pocillopora_meandrina_HIv1___RNAseq.g471.t1,three_way,72.66883333333334,FUN_016586-T1,Q08CH3,,,,,37.6,540.0,7.2e-91,336.3,sp|Q08CH3|MPND_DANRE MPN domain-containing protein OS=Danio rerio OX=7955 GN=mpnd PE=2 SV=1,,,,,,
OG_04133,2.052175671548059,FUN_016587-T1,Peve_00000800,Pocillopora_meandrina_HIv1___RNAseq.g2974.t1,three_way,65.638,FUN_016587-T1,Q92900,RENT1_HUMAN,,Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1),Homo sapiens (Human),38.4,440.0,3.5999999999999997e-69,265.8,sp|Q92900|RENT1_HUMAN Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1 PE=1 SV=2,GO:0000184; GO:0000781; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0044877; GO:0048471; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347; GO:1905746,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006913; GO:0016071; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA replication; DNA repair; nucleocytoplasmic transport; mRNA metabolic process; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04134,1.4160822980034642,FUN_016588-T1,Peve_00000798,Pocillopora_meandrina_HIv1___RNAseq.g2973.t1,three_way,71.725,,,,,,,,,,,,,,,,,
OG_04137,1.7815106656583828,FUN_016591-T1,Peve_00005997,Pocillopora_meandrina_HIv1___RNAseq.g474.t1,three_way,70.59733333333334,FUN_016591-T1,Q4KLE6,,,,,47.7,241.0,2.5999999999999998e-61,236.9,sp|Q4KLE6|NT1AB_XENLA N-terminal Xaa-Pro-Lys N-methyltransferase 1-B OS=Xenopus laevis OX=8355 GN=ntmt1-b PE=2 SV=1,,,,,,
OG_04146,1.9313754600048427,FUN_016608-T1,Peve_00010249,Pocillopora_meandrina_HIv1___RNAseq.g9623.t1b,three_way,79.465,FUN_016608-T1,P58465,,,,,63.3,270.0,1.5e-89,330.9,sp|P58465|CTDSL_MOUSE CTD small phosphatase-like protein OS=Mus musculus OX=10090 GN=Ctdspl PE=2 SV=3,,,,,,
OG_04147,1.307461893225511,FUN_016609-T2,Peve_00010250,Pocillopora_meandrina_HIv1___RNAseq.g9614.t1,three_way,73.77483333333333,FUN_016609-T2,Q9EQD2,NPFF2_RAT,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),Rattus norvegicus (Rat),35.0,303.0,4.8e-38,160.2,sp|Q9EQD2|NPFF2_RAT Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_04156,1.1095108739370576,FUN_016623-T1,Peve_00026347,Pocillopora_meandrina_HIv1___RNAseq.g9627.t1,three_way,60.69583333333333,FUN_016623-T1,P97718,ADA1A_MOUSE,,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor),Mus musculus (Mouse),24.1,316.0,5.3e-23,110.2,sp|P97718|ADA1A_MOUSE Alpha-1A adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1a PE=1 SV=3,GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007512; GO:0008217; GO:0010507; GO:0010613; GO:0016020; GO:0019229; GO:0031965; GO:0035024; GO:0035265; GO:0043410; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0071875; GO:0097195; GO:0150099,adrenergic receptor signaling pathway [GO:0071875]; adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982],GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0060089,circulatory system process; nucleus; nucleoplasm; cytosol; plasma membrane; signaling; organelle; anatomical structure development; molecular transducer activity
OG_04159,2.179572647586232,FUN_016636-T2,Peve_00026358,Pocillopora_meandrina_HIv1___RNAseq.g103.t1,three_way,71.86316666666667,FUN_016636-T2,O46680,TGFR1_BOVIN,,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Bos taurus (Bovine),56.6,486.0,9e-146,518.5,sp|O46680|TGFR1_BOVIN TGF-beta receptor type-1 OS=Bos taurus OX=9913 GN=TGFBR1 PE=2 SV=1,GO:0001938; GO:0005025; GO:0005524; GO:0005634; GO:0005768; GO:0005886; GO:0005923; GO:0006915; GO:0007179; GO:0007399; GO:0007507; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0016020; GO:0016361; GO:0032924; GO:0035556; GO:0042118; GO:0045121; GO:0045893; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0060317; GO:0071363; GO:0071560; GO:0101023,activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; endothelial cell activation [GO:0042118]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial cell proliferation [GO:0101023],activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]",GO:0003824; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0012501; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; programmed cell death; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_04160,1.954031080759,FUN_016638-T1,Peve_00026352,Pocillopora_meandrina_HIv1___RNAseq.g102.t1,three_way,61.59666666666666,FUN_016638-T1,Q62136,,,,,27.0,1183.0,6.6999999999999995e-90,333.6,sp|Q62136|PTN21_MOUSE Tyrosine-protein phosphatase non-receptor type 21 OS=Mus musculus OX=10090 GN=Ptpn21 PE=1 SV=1,,,,,,
OG_04167,1.8804528216934493,FUN_016648-T1,Peve_00042742,Pocillopora_meandrina_HIv1___RNAseq.g197.t1,three_way,86.58166666666666,FUN_016648-T1,A8QCE4,,,,,45.3,64.0,6.8e-15,83.6,sp|A8QCE4|LST2_BRUMA Lateral signaling target protein 2 homolog OS=Brugia malayi OX=6279 GN=Bm5439 PE=3 SV=1,,,,,,
OG_04170,1.883418140233612,FUN_016651-T1,Peve_00042780,Pocillopora_meandrina_HIv1___TS.g6961.t1,three_way,81.653,FUN_016651-T1,Q6TMK4,POXA_DICDI,,Peroxinectin A (EC 1.11.1.7),Dictyostelium discoideum (Social amoeba),34.7,521.0,3.3e-86,322.0,sp|Q6TMK4|POXA_DICDI Peroxinectin A OS=Dictyostelium discoideum OX=44689 GN=poxA PE=1 SV=1,GO:0004447; GO:0004601; GO:0005576; GO:0005783; GO:0006955; GO:0006979; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0140825,defense response to bacterium [GO:0042742]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; response to oxidative stress [GO:0006979],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; lactoperoxidase activity [GO:0140825]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393],GO:0002376; GO:0003824; GO:0005576; GO:0005783; GO:0016209; GO:0016491; GO:0043226,immune system process; catalytic activity; extracellular region; endoplasmic reticulum; antioxidant activity; oxidoreductase activity; organelle
OG_04179,1.3030873931816052,FUN_016671-T1,Peve_00034246,Pocillopora_meandrina_HIv1___TS.g7272.t1b,three_way,52.63633333333333,FUN_016671-T1,Q28C74,,,,,26.6,992.0,1.1e-15,87.4,"sp|Q28C74|LPPRC_XENTR Leucine-rich PPR motif-containing protein, mitochondrial OS=Xenopus tropicalis OX=8364 GN=lrpprc PE=2 SV=1",,,,,,
OG_04180,1.5830259640365627,FUN_016676-T1,Peve_00013936,Pocillopora_meandrina_HIv1___RNAseq.g504.t1,three_way,57.66266666666667,FUN_016676-T1,Q96L42,,,,,50.7,213.0,2.8999999999999996e-55,218.8,sp|Q96L42|KCNH8_HUMAN Voltage-gated delayed rectifier potassium channel KCNH8 OS=Homo sapiens OX=9606 GN=KCNH8 PE=1 SV=2,,,,,,
OG_04181,1.3972084690793225,FUN_016677-T1,Peve_00035082,Pocillopora_meandrina_HIv1___RNAseq.g388.t3,three_way,77.881,FUN_016677-T1,A2RUC4,TYW5_HUMAN,,tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase),Homo sapiens (Human),64.9,302.0,2.1999999999999998e-116,420.2,sp|A2RUC4|TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens OX=9606 GN=TYW5 PE=1 SV=1,GO:0000049; GO:0005506; GO:0005737; GO:0031591; GO:0042803; GO:0102524,wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524],GO:0003723; GO:0003824; GO:0006399; GO:0016491; GO:0140098; GO:1901135,"RNA binding; catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_04183,1.965747777657878,FUN_016701-T1,Peve_00004837,Pocillopora_meandrina_HIv1___RNAseq.g279.t1,three_way,55.42366666666667,,,,,,,,,,,,,,,,,
OG_04185,1.48011362785676,FUN_016705-T1,Peve_00004831,Pocillopora_meandrina_HIv1___RNAseq.g281.t1,three_way,77.65433333333333,FUN_016705-T1,Q9SB50,,,,,48.3,292.0,1.1e-71,271.6,sp|Q9SB50|AP4M_ARATH AP-4 complex subunit mu OS=Arabidopsis thaliana OX=3702 GN=AP4M PE=2 SV=1,,,,,,
OG_04186,2.1357060757304387,FUN_016706-T1,Peve_00034244,Pocillopora_meandrina_HIv1___RNAseq.g282.t2,three_way,70.44399999999999,FUN_016706-T1,Q8VDM6,HNRL1_MOUSE,,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Mus musculus (Mouse),50.9,399.0,8.3e-112,406.4,sp|Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Mus musculus OX=10090 GN=Hnrnpul1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005654; GO:0019899; GO:0045202; GO:1990904,,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],enzyme binding [GO:0019899]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0043226,RNA binding; nucleus; nucleoplasm; organelle
OG_04188,1.1616843181094818,FUN_016709-T1,Peve_00024195,Pocillopora_meandrina_HIv1___RNAseq.g276.t1,three_way,51.529833333333336,FUN_016709-T1,P79763,,,,,33.7,543.0,6e-73,277.3,sp|P79763|FSHR_CHICK Follicle-stimulating hormone receptor OS=Gallus gallus OX=9031 GN=FSHR PE=2 SV=1,,,,,,
OG_04189,2.553248850524396,FUN_016710-T1,Peve_00024194,Pocillopora_meandrina_HIv1___RNAseq.g275.t1,three_way,50.513666666666666,,,,,,,,,,,,,,,,,
OG_04195,2.8655806828181776,FUN_016720-T1,Peve_00014673,Pocillopora_meandrina_HIv1___RNAseq.g230.t1,three_way,61.32066666666666,FUN_016720-T1,Q64729,TGFR1_MOUSE,,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Mus musculus (Mouse),38.4,487.0,5.7e-74,280.0,sp|Q64729|TGFR1_MOUSE TGF-beta receptor type-1 OS=Mus musculus OX=10090 GN=Tgfbr1 PE=1 SV=1,GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001935; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006915; GO:0007179; GO:0007507; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016020; GO:0030199; GO:0030307; GO:0030335; GO:0030336; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046847; GO:0046872; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0050431; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071560; GO:1901203; GO:1902462; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237,activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021],"ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005929; GO:0006355; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; nucleoplasm; endosome; plasma membrane; cilium; regulation of DNA-templated transcription; programmed cell death; transferase activity; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04202,1.0851724741341755,FUN_016744-T1,Peve_00025013,Pocillopora_meandrina_HIv1___RNAseq.g9954.t1,three_way,80.80783333333333,FUN_016744-T1,Q9P2K3,RCOR3_HUMAN,,REST corepressor 3,Homo sapiens (Human),45.4,443.0,7.8e-93,342.8,sp|Q9P2K3|RCOR3_HUMAN REST corepressor 3 OS=Homo sapiens OX=9606 GN=RCOR3 PE=1 SV=2,GO:0000118; GO:0003714; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0045892,negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],transcription corepressor activity [GO:0003714],GO:0005654; GO:0005829; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; cytosol; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_04204,2.605910367253253,FUN_016759-T1,Peve_00003676,Pocillopora_meandrina_HIv1___RNAseq.g14956.t1,three_way,68.49566666666666,FUN_016759-T1,Q2QUN2,,,,,25.6,629.0,2.7e-41,172.6,sp|Q2QUN2|LAC24_ORYSJ Laccase-24 OS=Oryza sativa subsp. japonica OX=39947 GN=LAC24 PE=2 SV=1,,,,,,
OG_04205,2.3957255307013887,FUN_016777-T1,Peve_00032303,Pocillopora_meandrina_HIv1___RNAseq.g10047.t1,three_way,85.97500000000001,FUN_016777-T1,Q86SR1,GLT10_HUMAN,,Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10),Homo sapiens (Human),41.8,584.0,1.1e-123,445.3,sp|Q86SR1|GLT10_HUMAN Polypeptide N-acetylgalactosaminyltransferase 10 OS=Homo sapiens OX=9606 GN=GALNT10 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04207,2.427465411018326,FUN_016779-T1,Peve_00032301,Pocillopora_meandrina_HIv1___RNAseq.g10031.t1,three_way,80.821,FUN_016779-T1,Q8BTW9,PAK4_MOUSE,,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),Mus musculus (Mouse),45.4,597.0,1.4e-119,431.4,sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus OX=10090 GN=Pak4 PE=1 SV=1,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0045766; GO:0060996; GO:0106310; GO:2000352,apoptotic process [GO:0006915]; dendritic spine development [GO:0060996]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766],cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0012501; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; programmed cell death; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04211,2.091864746843144,FUN_016798-T1,Peve_00023973,Pocillopora_meandrina_HIv1___RNAseq.g242.t1,three_way,87.46816666666666,FUN_016798-T1,Q9Y2E4,,,,,56.7,1558.0,0.0,1701.0,sp|Q9Y2E4|DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens OX=9606 GN=DIP2C PE=1 SV=2,,,,,,
OG_04212,1.4821385739825157,FUN_016801-T1,Peve_00018618,Pocillopora_meandrina_HIv1___RNAseq.g243.t1,three_way,58.68683333333333,FUN_016801-T1,Q7Z5N4,SDK1_HUMAN,,Protein sidekick-1,Homo sapiens (Human),25.9,942.0,8.3e-57,224.2,sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998,behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_04217,1.5959839531802502,FUN_016964-T1,Peve_00025247,Pocillopora_meandrina_HIv1___RNAseq.g9909.t1,three_way,65.26533333333333,FUN_016964-T1,P24540,,,,,60.2,98.0,9.2e-26,117.5,sp|P24540|ACYP1_PIG Acylphosphatase-1 OS=Sus scrofa OX=9823 GN=ACYP1 PE=1 SV=2,,,,,,
OG_04219,1.4871705592807378,FUN_016970-T1,Peve_00025293,Pocillopora_meandrina_HIv1___RNAseq.g9903.t2,three_way,56.20816666666666,,,,,,,,,,,,,,,,,
OG_04223,1.4103083646750476,FUN_016984-T1,Peve_00025278,Pocillopora_meandrina_HIv1___TS.g23429.t1,three_way,66.937,FUN_016984-T1,Q96GW7,,,,,31.6,133.0,2.6e-11,71.6,sp|Q96GW7|PGCB_HUMAN Brevican core protein OS=Homo sapiens OX=9606 GN=BCAN PE=1 SV=2,,,,,,
OG_04224,1.5669109485816195,FUN_016988-T1,Peve_00025276,Pocillopora_meandrina_HIv1___RNAseq.g9895.t1,three_way,70.32283333333334,FUN_016988-T1,Q8CJ69,BMPER_MOUSE,,BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (mCV2),Mus musculus (Mouse),37.7,446.0,2.6e-92,340.9,sp|Q8CJ69|BMPER_MOUSE BMP-binding endothelial regulator protein OS=Mus musculus OX=10090 GN=Bmper PE=1 SV=1,GO:0001657; GO:0002043; GO:0005576; GO:0005615; GO:0010594; GO:0030509; GO:0030514; GO:0032880; GO:0042118; GO:0048839; GO:0060391; GO:0060395; GO:0062023; GO:0070374; GO:1903672,blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization [GO:0032880]; SMAD protein signal transduction [GO:0060395]; ureteric bud development [GO:0001657],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615],,GO:0005576; GO:0005615; GO:0048856,extracellular region; extracellular space; anatomical structure development
OG_04226,1.249161071753638,FUN_017004-T1,Peve_00025258,Pocillopora_meandrina_HIv1___RNAseq.g9892.t1,three_way,79.81666666666666,FUN_017004-T1,Q9TTF0,,,,,43.8,393.0,4e-82,306.6,sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2,,,,,,
OG_04227,1.76689002632822,FUN_017022-T1,Peve_00018298,Pocillopora_meandrina_HIv1___RNAseq.g20360.t1,three_way,58.69716666666667,FUN_017022-T1,Q8BV79,,,,,28.2,2731.0,2.9e-254,881.7,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_04232,1.647038541834396,FUN_017709-T1,Peve_00022746,Pocillopora_meandrina_HIv1___RNAseq.g19535.t1,three_way,68.68633333333334,FUN_017709-T1,Q12931,TRAP1_HUMAN,,"Heat shock protein 75 kDa, mitochondrial (HSP 75) (Heat shock protein family C member 5) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)",Homo sapiens (Human),50.5,661.0,7.799999999999998e-177,622.1,"sp|Q12931|TRAP1_HUMAN Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens OX=9606 GN=TRAP1 PE=1 SV=3",GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0016887; GO:0019901; GO:0051082; GO:0061077; GO:0140662; GO:1901856; GO:1903427; GO:1903751,chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0140657,RNA binding; catalytic activity; nucleoplasm; mitochondrion; protein folding; hydrolase activity; organelle; protein folding chaperone; ATP-dependent activity
OG_04235,2.553830923367954,FUN_017756-T1,Peve_00030017,Pocillopora_meandrina_HIv1___RNAseq.g15152.t1,three_way,86.29766666666667,FUN_017756-T1,Q3ZBG9,,,,,63.9,233.0,3.8e-92,339.3,sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1,,,,,,
OG_04240,1.456047145913672,FUN_017761-T1,Peve_00003284,Pocillopora_meandrina_HIv1___RNAseq.g440.t1,three_way,66.74333333333334,FUN_017761-T1,Q8C1A9,,,,,42.5,457.0,1.5e-98,361.3,sp|Q8C1A9|ABD18_MOUSE Protein ABHD18 OS=Mus musculus OX=10090 GN=Abhd18 PE=2 SV=1,,,,,,
OG_04241,1.3253391928523854,FUN_017762-T1,Peve_00003285,Pocillopora_meandrina_HIv1___RNAseq.g441.t1,three_way,80.27833333333334,FUN_017762-T1,Q8BPM2,,,,,46.1,857.0,7.6e-203,708.8,sp|Q8BPM2|M4K5_MOUSE Mitogen-activated protein kinase kinase kinase kinase 5 OS=Mus musculus OX=10090 GN=Map4k5 PE=1 SV=2,,,,,,
OG_04243,2.0746716991634573,FUN_017765-T1,Peve_00003282,Pocillopora_meandrina_HIv1___RNAseq.g446.t1,three_way,79.75516666666667,FUN_017765-T1,Q5RD44,B3A2_PONAB,,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Solute carrier family 4 member 2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),43.1,1043.0,1.9e-207,724.5,sp|Q5RD44|B3A2_PONAB Anion exchange protein 2 OS=Pongo abelii OX=9601 GN=SLC4A2 PE=2 SV=2,GO:0016323; GO:0016324; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0051453; GO:0140900; GO:2000565,"negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]",apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323],chloride:bicarbonate antiporter activity [GO:0140900],GO:0005215; GO:0030154,transporter activity; cell differentiation
OG_04244,1.444547244012839,FUN_017766-T1,Peve_00035953,Pocillopora_meandrina_HIv1___RNAseq.g462.t1,three_way,86.78283333333333,FUN_017766-T1,P19517,,,,,56.8,405.0,1.8e-114,414.5,sp|P19517|CACB1_RABIT Voltage-dependent L-type calcium channel subunit beta-1 OS=Oryctolagus cuniculus OX=9986 GN=CACNB1 PE=1 SV=1,,,,,,
OG_04249,1.049475907470689,FUN_017777-T1,Peve_00006865,Pocillopora_meandrina_HIv1___RNAseq.g9511.t1,three_way,83.44666666666667,FUN_017777-T1,Q6IMK3,,,,,38.7,168.0,6.9e-33,142.1,sp|Q6IMK3|DJC27_DANRE DnaJ homolog subfamily C member 27 OS=Danio rerio OX=7955 GN=dnajc27 PE=2 SV=1,,,,,,
OG_04254,1.2665805543257906,FUN_017784-T1,Peve_00040540,Pocillopora_meandrina_HIv1___RNAseq.g9518.t1,three_way,64.44666666666666,FUN_017784-T1,P29351,,,,,35.2,105.0,2.7e-10,67.0,sp|P29351|PTN6_MOUSE Tyrosine-protein phosphatase non-receptor type 6 OS=Mus musculus OX=10090 GN=Ptpn6 PE=1 SV=2,,,,,,
OG_04255,1.1231075268396122,FUN_017786-T1,Peve_00040532,Pocillopora_meandrina_HIv1___RNAseq.g9521.t1,three_way,78.56866666666667,FUN_017786-T1,A0A455ZMR3,,,,,31.7,322.0,3.7999999999999996e-35,150.2,sp|A0A455ZMR3|PPZD_METMF 2-oxoglutarate-Fe(II) type oxidoreductase ppzD OS=Metarhizium majus (strain ARSEF 297) OX=1276143 GN=ppzD PE=1 SV=1,,,,,,
OG_04261,1.244175865583121,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,54.0,767.0,3.7e-223,777.3,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_04261,1.244175865583121,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,38.5,78.0,0.002,47.4,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_04265,2.2176204117821903,FUN_017815-T1,Peve_00006859,Pocillopora_meandrina_HIv1___RNAseq.g9541.t1,three_way,67.37566666666666,FUN_017815-T1,P22727,WNT6_MOUSE,,Protein Wnt-6,Mus musculus (Mouse),41.3,366.0,3e-82,307.0,sp|P22727|WNT6_MOUSE Protein Wnt-6 OS=Mus musculus OX=10090 GN=Wnt6 PE=1 SV=2,GO:0001658; GO:0005102; GO:0005576; GO:0005788; GO:0007165; GO:0007267; GO:0009798; GO:0009887; GO:0009986; GO:0010628; GO:0016055; GO:0031012; GO:0042475; GO:0045893; GO:0060684; GO:0070172; GO:0072079; GO:0072080,animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],signaling receptor binding [GO:0005102],GO:0005576; GO:0006355; GO:0023052; GO:0030312; GO:0031012; GO:0048856,extracellular region; regulation of DNA-templated transcription; signaling; external encapsulating structure; extracellular matrix; anatomical structure development
OG_04266,1.5920344958463362,FUN_017816-T1,Peve_00006857,Pocillopora_meandrina_HIv1___RNAseq.g9540.t1,three_way,72.20233333333334,FUN_017816-T1,Q2LMP1,WNT3A_CHICK,,Protein Wnt-3a,Gallus gallus (Chicken),41.7,314.0,2.3000000000000002e-71,270.8,sp|Q2LMP1|WNT3A_CHICK Protein Wnt-3a OS=Gallus gallus OX=9031 GN=WNT3A PE=1 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0005640; GO:0005783; GO:0005829; GO:0005886; GO:0009953; GO:0010628; GO:0010831; GO:0030182; GO:0030509; GO:0035108; GO:0040036; GO:0042472; GO:0045165; GO:0045663; GO:0045743; GO:0045944; GO:0048263; GO:0050679; GO:0060070; GO:0060173; GO:0060828; GO:0061303; GO:0090263,BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cornea development in camera-type eye [GO:0061303]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; endoplasmic reticulum; cytosol; plasma membrane; regulation of DNA-templated transcription; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_04269,1.788303290968222,FUN_017827-T1,Peve_00032668,Pocillopora_meandrina_HIv1___TS.g23180.t1,three_way,68.87883333333333,FUN_017827-T1,Q6NVP8,FUT8_XENTR,,"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)",Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),41.7,434.0,3.2e-91,337.0,"sp|Q6NVP8|FUT8_XENTR Alpha-(1,6)-fucosyltransferase OS=Xenopus tropicalis OX=8364 GN=fut8 PE=2 SV=1",GO:0008424; GO:0017124; GO:0018279; GO:0032580; GO:0046368,GDP-L-fucose metabolic process [GO:0046368]; protein N-linked glycosylation via asparagine [GO:0018279],Golgi cisterna membrane [GO:0032580],glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124],GO:0003824; GO:0009101; GO:0016740; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04270,1.764848955311493,FUN_017828-T1,Peve_00032669,Pocillopora_meandrina_HIv1___RNAseq.g9643.t1,three_way,84.98966666666666,FUN_017828-T1,P52162,,,,,65.5,139.0,1.8e-38,160.6,sp|P52162|MAX_CHICK Protein max OS=Gallus gallus OX=9031 GN=MAX PE=3 SV=1,,,,,,
OG_04271,1.4551970681352595,FUN_017829-T1,Peve_00029495,Pocillopora_meandrina_HIv1___RNAseq.g9642.t1,three_way,83.37966666666667,FUN_017829-T1,Q9NES8,,,,,59.1,477.0,9.1e-164,578.2,sp|Q9NES8|PPP5_CAEEL Serine/threonine-protein phosphatase 5 OS=Caenorhabditis elegans OX=6239 GN=pph-5 PE=1 SV=2,,,,,,
OG_04272,1.1941465409184644,FUN_017831-T1,Peve_00029496,Pocillopora_meandrina_HIv1___TS.g23177.t1,three_way,86.089,,,,,,,,,,,,,,,,,
OG_04275,2.062147598083292,FUN_017834-T1,Peve_00009484,Pocillopora_meandrina_HIv1___RNAseq.g9635.t1,three_way,60.010333333333335,FUN_017834-T1,Q9H3U7,,,,,30.4,214.0,7e-14,80.9,sp|Q9H3U7|SMOC2_HUMAN SPARC-related modular calcium-binding protein 2 OS=Homo sapiens OX=9606 GN=SMOC2 PE=1 SV=2,,,,,,
OG_04276,1.67736383788784,FUN_017835-T1,Peve_00027711,Pocillopora_meandrina_HIv1___RNAseq.g9593.t1,three_way,65.258,FUN_017835-T1,E1C1L6,ENTP5_CHICK,,Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5),Gallus gallus (Chicken),47.1,380.0,1.0000000000000001e-88,328.6,sp|E1C1L6|ENTP5_CHICK Ectonucleoside triphosphate diphosphohydrolase 5 OS=Gallus gallus OX=9031 GN=ENTPD5 PE=3 SV=1,GO:0004382; GO:0005576; GO:0005783; GO:0006011; GO:0006256; GO:0006487; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003,'de novo' post-translational protein folding [GO:0051084]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-alpha-D-glucose metabolic process [GO:0006011],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],ADP phosphatase activity [GO:0043262]; CDP phosphatase activity [GO:0036384]; GDP phosphatase activity [GO:0004382]; IDP phosphatase activity [GO:1990003]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0005576; GO:0005783; GO:0006457; GO:0009101; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; extracellular region; endoplasmic reticulum; protein folding; glycoprotein biosynthetic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04279,1.5232801098699034,FUN_017840-T1,Peve_00011468,Pocillopora_meandrina_HIv1___RNAseq.g9633.t1,three_way,76.64583333333333,FUN_017840-T1,F4JYJ3,,,,,35.1,225.0,6.599999999999997e-29,129.8,sp|F4JYJ3|SFH11_ARATH Phosphatidylinositol/phosphatidylcholine transfer protein SFH11 OS=Arabidopsis thaliana OX=3702 GN=SFH11 PE=3 SV=1,,,,,,
OG_04281,1.4874828214593894,FUN_017843-T1,Peve_00018632,Pocillopora_meandrina_HIv1___RNAseq.g9587.t3,three_way,50.5255,,,,,,,,,,,,,,,,,
OG_04282,1.815220013553066,FUN_017845-T1,Peve_00018633,Pocillopora_meandrina_HIv1___RNAseq.g9586.t1,three_way,63.23116666666667,,,,,,,,,,,,,,,,,
OG_04285,3.1446210517387496,FUN_017848-T2,Peve_00013267,Pocillopora_meandrina_HIv1___RNAseq.g9584.t1a,three_way,68.80566666666667,FUN_017848-T2,Q09328,MGT5A_HUMAN,,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",Homo sapiens (Human),37.0,873.0,6.1e-166,586.3,"sp|Q09328|MGT5A_HUMAN Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Homo sapiens OX=9606 GN=MGAT5 PE=1 SV=1",GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1904894,positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04287,1.1329173489153532,FUN_017850-T1,Peve_00019991,Pocillopora_meandrina_HIv1___RNAseq.g9582.t1,three_way,53.20133333333334,FUN_017850-T1,C5FWH1,,,,,34.9,146.0,8.9e-14,79.7,sp|C5FWH1|LIS1_ARTOC Nuclear distribution protein PAC1 OS=Arthroderma otae (strain ATCC MYA-4605 / CBS 113480) OX=554155 GN=PAC1 PE=3 SV=1,,,,,,
OG_04292,1.5025600495436742,FUN_017858-T1,Peve_00032944,Pocillopora_meandrina_HIv1___RNAseq.g9575.t1,three_way,75.3595,FUN_017858-T1,Q9GLM4,,,,,46.3,428.0,1.5e-111,404.8,sp|Q9GLM4|TENS1_BOVIN Tensin-1 OS=Bos taurus OX=9913 GN=TNS1 PE=2 SV=2,,,,,,
OG_04293,2.0189538817252197,FUN_017859-T1,Peve_00014752,Pocillopora_meandrina_HIv1___RNAseq.g9574.t2,three_way,59.749500000000005,FUN_017859-T1,Q04205,,,,,47.0,285.0,3.1e-68,261.9,sp|Q04205|TENS1_CHICK Tensin-1 OS=Gallus gallus OX=9031 GN=TNS1 PE=1 SV=3,,,,,,
OG_04296,1.0928658182758082,FUN_017862-T1,Peve_00016055,Pocillopora_meandrina_HIv1___RNAseq.g9571.t1,three_way,53.224,,,,,,,,,,,,,,,,,
OG_04297,1.2557132952225352,FUN_017864-T1,Peve_00018760,Pocillopora_meandrina_HIv1___RNAseq.g9560.t1,three_way,71.19116666666666,FUN_017864-T1,Q9VM21,,,,,27.0,629.0,9.8e-54,213.4,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04299,1.1961337730391528,FUN_017868-T1,Peve_00020409,Pocillopora_meandrina_HIv1___RNAseq.g9556.t1,three_way,92.76516666666666,FUN_017868-T1,Q6DKN2,,,,,73.3,86.0,6.7e-28,125.6,sp|Q6DKN2|OTX2B_XENLA Homeobox protein OTX2-B OS=Xenopus laevis OX=8355 GN=otx2-b PE=2 SV=1,,,,,,
OG_04302,1.3648209200402812,FUN_017878-T1,Peve_00021114,Pocillopora_meandrina_HIv1___TS.g7116.t1,three_way,74.763,FUN_017878-T1,P97259,,,,,45.1,587.0,8.600000000000001e-145,515.4,"sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1",,,,,,
OG_04305,1.0007545970264629,FUN_017890-T1,Peve_00019164,Pocillopora_meandrina_HIv1___RNAseq.g9666.t1,three_way,81.693,FUN_017890-T1,Q5EAB6,PMGT1_BOVIN,,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)",Bos taurus (Bovine),52.1,657.0,1.9e-201,703.7,"sp|Q5EAB6|PMGT1_BOVIN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Bos taurus OX=9913 GN=POMGNT1 PE=2 SV=1",GO:0000139; GO:0006493; GO:0008375; GO:0016020; GO:0016266; GO:0030145; GO:0030246; GO:0047223,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139]; membrane [GO:0016020],"acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]",GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04309,1.403406263896217,FUN_017897-T1,Peve_00000237,Pocillopora_meandrina_HIv1___RNAseq.g343.t1,three_way,80.214,FUN_017897-T1,Q6AXJ9,,,,,63.9,352.0,1.4000000000000001e-126,454.1,sp|Q6AXJ9|CDKL1_DANRE Cyclin-dependent kinase-like 1 OS=Danio rerio OX=7955 GN=cdkl1 PE=2 SV=1,,,,,,
OG_04313,1.6260914200732963,FUN_017901-T1,Peve_00000244,Pocillopora_meandrina_HIv1___RNAseq.g335.t1,three_way,71.97016666666667,FUN_017901-T1,A7J1T0,M313B_XENLA,,Mitogen-activated protein kinase kinase kinase 13-B (EC 2.7.11.25),Xenopus laevis (African clawed frog),67.4,387.0,1.3e-155,551.6,sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis OX=8355 GN=map3k13-b PE=2 SV=1,GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0007254; GO:0016020; GO:0060255; GO:0080090; GO:0106310,JNK cascade [GO:0007254]; regulation of macromolecule metabolic process [GO:0060255]; regulation of primary metabolic process [GO:0080090],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04314,1.219261865843884,FUN_017902-T1,Peve_00025079,Pocillopora_meandrina_HIv1___RNAseq.g336.t1,three_way,54.62016666666666,FUN_017902-T1,Q9HBW9,AGRL4_HUMAN,,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",Homo sapiens (Human),25.4,268.0,1.3e-09,67.8,sp|Q9HBW9|AGRL4_HUMAN Adhesion G protein-coupled receptor L4 OS=Homo sapiens OX=9606 GN=ADGRL4 PE=1 SV=3,GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0031410,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0031410; GO:0043226; GO:0060089,plasma membrane; cytoplasmic vesicle; organelle; molecular transducer activity
OG_04318,1.1023734201876283,FUN_017918-T1,Peve_00013068,Pocillopora_meandrina_HIv1___RNAseq.g326.t1,three_way,47.547,,,,,,,,,,,,,,,,,
OG_04319,2.537553823657916,FUN_017919-T1,Peve_00005940,Pocillopora_meandrina_HIv1___RNAseq.g312.t1,three_way,45.6825,FUN_017919-T1,O88488,PTPRQ_RAT,,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.36) (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q),Rattus norvegicus (Rat),26.4,1078.0,1.7e-50,203.8,sp|O88488|PTPRQ_RAT Phosphatidylinositol phosphatase PTPRQ OS=Rattus norvegicus OX=10116 GN=Ptprq PE=1 SV=1,GO:0002244; GO:0004439; GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0032421; GO:0034485; GO:0042472; GO:0043235; GO:0043813; GO:0045598; GO:0050885; GO:0050910; GO:0052629; GO:0060116; GO:0120044,detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044]; stereocilium bundle [GO:0032421],"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]",GO:0003824; GO:0016787; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; hydrolase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_04322,1.1060344412464498,FUN_017924-T1,Peve_00035877,Pocillopora_meandrina_HIv1___TS.g7056.t1,three_way,80.122,FUN_017924-T1,Q1JQD7,MOCS1_BOVIN,,"Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]",Bos taurus (Bovine),70.1,344.0,5.9999999999999995e-142,505.4,sp|Q1JQD7|MOCS1_BOVIN Molybdenum cofactor biosynthesis protein 1 OS=Bos taurus OX=9913 GN=MOCS1 PE=2 SV=2,GO:0005525; GO:0006777; GO:0046872; GO:0051539; GO:0061798; GO:0061799,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],,"4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]",GO:0003824; GO:0016829,catalytic activity; lyase activity
OG_04324,2.1660933328754117,FUN_017926-T2,Peve_00001604,Pocillopora_meandrina_HIv1___RNAseq.g288.t1,three_way,71.02733333333333,FUN_017926-T2,Q7TNC6,KI26B_MOUSE,,Kinesin-like protein KIF26B,Mus musculus (Mouse),39.8,814.0,1.3e-130,469.9,sp|Q7TNC6|KI26B_MOUSE Kinesin-like protein KIF26B OS=Mus musculus OX=10090 GN=Kif26b PE=1 SV=3,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0022409; GO:0030010; GO:0072092,establishment of cell polarity [GO:0030010]; microtubule-based movement [GO:0007018]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092],cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0007018; GO:0007163; GO:0008092; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule-based movement; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_04325,1.2328174399163017,FUN_017927-T2,Peve_00001600,Pocillopora_meandrina_HIv1___TS.g7049.t1,three_way,73.92666666666668,FUN_017927-T2,A0A8V0ZB02,TM63B_CHICK,,Mechanosensitive cation channel TMEM63B (Transmembrane protein 63B),Gallus gallus (Chicken),39.6,700.0,1.6e-133,478.4,sp|A0A8V0ZB02|TM63B_CHICK Mechanosensitive cation channel TMEM63B OS=Gallus gallus OX=9031 GN=TMEM63B PE=3 SV=1,GO:0005227; GO:0005765; GO:0005886; GO:0007605; GO:0015629; GO:0017128; GO:0031901; GO:0036335; GO:0042756; GO:0120019; GO:0140135; GO:0140338; GO:0160069; GO:1990760,drinking behavior [GO:0042756]; intestinal stem cell homeostasis [GO:0036335]; sensory perception of sound [GO:0007605]; surfactant secretion [GO:0160069],actin cytoskeleton [GO:0015629]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],calcium-activated cation channel activity [GO:0005227]; mechanosensitive monoatomic cation channel activity [GO:0140135]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; phosphatidylcholine transfer activity [GO:0120019]; phospholipid scramblase activity [GO:0017128]; sphingomyelin transfer activity [GO:0140338],GO:0005215; GO:0005856; GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772; GO:0140299,transporter activity; cytoskeleton; plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity; molecular sensor activity
OG_04326,1.470946108296284,FUN_017929-T1,Peve_00001599,Pocillopora_meandrina_HIv1___RNAseq.g283.t1,three_way,89.11483333333334,FUN_017929-T1,O75165,DJC13_HUMAN,,DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8),Homo sapiens (Human),66.3,1643.0,0.0,2240.3,sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5,GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641,endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667],,GO:0005829; GO:0005886; GO:0016192; GO:0030154; GO:0043226,cytosol; plasma membrane; vesicle-mediated transport; cell differentiation; organelle
OG_04330,1.0707444380502005,FUN_017938-T1,Peve_00001589,Pocillopora_meandrina_HIv1___RNAseq.g218.t1,three_way,75.231,FUN_017938-T1,Q7TPM9,,,,,34.7,507.0,4.4e-71,270.8,sp|Q7TPM9|MTMRA_MOUSE Myotubularin-related protein 10 OS=Mus musculus OX=10090 GN=Mtmr10 PE=1 SV=2,,,,,,
OG_04331,1.7126483954574732,FUN_017939-T1,Peve_00001588,Pocillopora_meandrina_HIv1___RNAseq.g219.t1,three_way,53.27133333333334,FUN_017939-T1,Q6P0D7,,,,,42.1,449.0,7.2e-89,330.1,sp|Q6P0D7|MPP7_DANRE MAGUK p55 subfamily member 7 OS=Danio rerio OX=7955 GN=mpp7 PE=1 SV=1,,,,,,
OG_04335,2.673286305710733,FUN_017947-T1,Peve_00000380,Pocillopora_meandrina_HIv1___RNAseq.g25233.t1,three_way,66.458,FUN_017947-T1,F1M0Z1,TRIO_RAT,,Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein),Rattus norvegicus (Rat),44.3,314.0,2.1999999999999998e-69,265.8,sp|F1M0Z1|TRIO_RAT Triple functional domain protein OS=Rattus norvegicus OX=10116 GN=Trio PE=1 SV=4,GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310,axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04336,3.336505346933347,FUN_017948-T1,Peve_00000381,Pocillopora_meandrina_HIv1___RNAseq.g25232.t1,three_way,82.87233333333333,,,,,,,,,,,,,,,,,
OG_04338,2.297478684168848,FUN_017952-T1,Peve_00001586,Pocillopora_meandrina_HIv1___RNAseq.g224.t1,three_way,96.399,FUN_017952-T1,Q7T1R4,,,,,91.5,117.0,8.8e-61,235.3,sp|Q7T1R4|FOXA2_XENTR Forkhead box protein A2 OS=Xenopus tropicalis OX=8364 GN=foxa2 PE=2 SV=1,,,,,,
OG_04340,1.709150875966987,FUN_017955-T1,Peve_00000384,Pocillopora_meandrina_HIv1___RNAseq.g25234.t1,three_way,69.41033333333334,FUN_017955-T1,Q6GLK6,,,,,52.1,530.0,4.1e-155,549.7,"sp|Q6GLK6|ACSF3_XENLA Malonate--CoA ligase ACSF3, mitochondrial OS=Xenopus laevis OX=8355 GN=acsf3 PE=2 SV=1",,,,,,
OG_04343,1.3778295573484054,FUN_017964-T1,Peve_00000391,Pocillopora_meandrina_HIv1___TS.g25524.t1,three_way,75.0295,FUN_017964-T1,O00409,FOXN3_HUMAN,,Forkhead box protein N3 (Checkpoint suppressor 1),Homo sapiens (Human),44.8,281.0,4.799999999999999e-53,210.3,sp|O00409|FOXN3_HUMAN Forkhead box protein N3 OS=Homo sapiens OX=9606 GN=FOXN3 PE=1 SV=1,GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006355; GO:0007095; GO:0045892; GO:0097094,craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],chromatin [GO:0000785]; nucleus [GO:0005634],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04346,1.5866830825276597,FUN_017970-T1,Peve_00000395,Pocillopora_meandrina_HIv1___TS.g25528.t2,three_way,63.346833333333336,FUN_017970-T1,Q9VM21,,,,,33.0,624.0,2.1999999999999997e-53,212.2,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04348,1.3532039005299032,FUN_017974-T1,Peve_00027236,Pocillopora_meandrina_HIv1___RNAseq.g25289.t1,three_way,57.09133333333333,,,,,,,,,,,,,,,,,
OG_04351,1.4704438599350418,FUN_017990-T1,Peve_00037470,Pocillopora_meandrina_HIv1___RNAseq.g25285.t1,three_way,80.066,FUN_017990-T1,Q16665,,,,,40.2,388.0,3.2e-77,291.2,sp|Q16665|HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens OX=9606 GN=HIF1A PE=1 SV=1,,,,,,
OG_04359,1.6132331152205732,FUN_018010-T1,Peve_00000404,Pocillopora_meandrina_HIv1___RNAseq.g25255.t4,three_way,81.14033333333334,FUN_018010-T1,A2CG49,,,,,35.3,3036.0,0.0,1707.6,sp|A2CG49|KALRN_MOUSE Kalirin OS=Mus musculus OX=10090 GN=Kalrn PE=1 SV=1,,,,,,
OG_04365,1.107030105178863,FUN_018018-T2,Peve_00026633,Pocillopora_meandrina_HIv1___RNAseq.g25292.t1,three_way,78.64166666666667,FUN_018018-T2,P30260,CDC27_HUMAN,,Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC),Homo sapiens (Human),51.0,843.0,4.8e-117,423.7,sp|P30260|CDC27_HUMAN Cell division cycle protein 27 homolog OS=Homo sapiens OX=9606 GN=CDC27 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0019903; GO:0031145; GO:0031175; GO:0051301; GO:0051445; GO:0070936; GO:0070979; GO:0072686; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; neuron projection development [GO:0031175]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],protein phosphatase binding [GO:0019903],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; microtubule organizing center; cytosol; protein catabolic process; organelle
OG_04367,2.115363797472,FUN_018023-T1,Peve_00005730,Pocillopora_meandrina_HIv1___RNAseq.g25298.t1,three_way,70.57966666666667,FUN_018023-T1,Q9WU06,AVIL_RAT,,Advillin (Peripheral nervous system villin-like protein) (Pervin),Rattus norvegicus (Rat),40.0,834.0,9e-156,552.4,sp|Q9WU06|AVIL_RAT Advillin OS=Rattus norvegicus OX=10116 GN=Avil PE=2 SV=2,GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480,actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005856; GO:0008092; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeletal protein binding; lipid binding; organelle; cilium organization; anatomical structure development
OG_04369,1.0016169124728873,FUN_018027-T1,Peve_00005736,Pocillopora_meandrina_HIv1___TS.g25576.t2,three_way,66.2555,FUN_018027-T1,A5D7P8,SOSB2_BOVIN,,SOSS complex subunit B2 (Nucleic acid-binding protein 1) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2A) (Sensor of single-strand DNA complex subunit B2) (Sensor of ssDNA subunit B2) (SOSS-B2) (Single-stranded DNA-binding protein 2),Bos taurus (Bovine),54.7,139.0,6.3e-40,166.0,sp|A5D7P8|SOSB2_BOVIN SOSS complex subunit B2 OS=Bos taurus OX=9913 GN=NABP1 PE=2 SV=1,GO:0000724; GO:0003677; GO:0010212; GO:0044818; GO:0070876,double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212],SOSS complex [GO:0070876],DNA binding [GO:0003677],GO:0003677; GO:0006281; GO:0006310,DNA binding; DNA repair; DNA recombination
OG_04372,1.4356570064361796,FUN_018031-T1,Peve_00025689,Pocillopora_meandrina_HIv1___RNAseq.g25357.t1,three_way,55.23,FUN_018031-T1,O35206,COFA1_MOUSE,,Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV)],Mus musculus (Mouse),35.1,239.0,3.9999999999999994e-28,127.5,sp|O35206|COFA1_MOUSE Collagen alpha-1(XV) chain OS=Mus musculus OX=10090 GN=Col15a1 PE=1 SV=2,GO:0005581; GO:0005604; GO:0005615; GO:0005783; GO:0007155; GO:0062023,cell adhesion [GO:0007155],basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],,GO:0005615; GO:0005783; GO:0007155; GO:0030312; GO:0031012; GO:0043226,extracellular space; endoplasmic reticulum; cell adhesion; external encapsulating structure; extracellular matrix; organelle
OG_04373,1.854690645717756,FUN_018033-T1,Peve_00020008,Pocillopora_meandrina_HIv1___TS.g25636.t1,three_way,60.77283333333334,,,,,,,,,,,,,,,,,
OG_04378,1.4878870667685002,FUN_018044-T1,Peve_00021778,Pocillopora_meandrina_HIv1___RNAseq.g25351.t1,three_way,82.307,FUN_018044-T1,Q3ZCH9,,,,,61.7,248.0,2.0000000000000001e-88,327.0,sp|Q3ZCH9|HDHD2_BOVIN Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Bos taurus OX=9913 GN=HDHD2 PE=2 SV=1,,,,,,
OG_04381,1.5328955337317078,FUN_018086-T1,Peve_00021774,Pocillopora_meandrina_HIv1___RNAseq.g25348.t1,three_way,67.76233333333333,FUN_018086-T1,A0JM23,,,,,37.7,1131.0,2.1e-142,508.4,sp|A0JM23|NPHP3_XENTR Nephrocystin-3 OS=Xenopus tropicalis OX=8364 GN=nphp3 PE=2 SV=2,,,,,,
OG_04383,1.6723269507316056,FUN_018089-T1,Peve_00034409,Pocillopora_meandrina_HIv1___RNAseq.g25344.t1,three_way,74.77966666666667,FUN_018089-T1,A6QQX9,TM163_BOVIN,,Transmembrane protein 163,Bos taurus (Bovine),35.8,215.0,2.7e-29,130.6,sp|A6QQX9|TM163_BOVIN Transmembrane protein 163 OS=Bos taurus OX=9913 GN=TMEM163 PE=2 SV=1,GO:0005765; GO:0005886; GO:0008270; GO:0030672; GO:0031901; GO:0031902; GO:0042552; GO:0140882,myelination [GO:0042552]; zinc export across plasma membrane [GO:0140882],early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0005886; GO:0055085,plasma membrane; transmembrane transport
OG_04385,1.7292950560010152,FUN_018091-T1,Peve_00001666,Pocillopora_meandrina_HIv1___TS.g25577.t1,three_way,73.79583333333333,FUN_018091-T1,Q6ZS30,,,,,36.6,2500.0,0.0,1536.9,sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3,,,,,,
OG_04387,1.0462699606539665,FUN_018138-T1,Peve_00001660,Pocillopora_meandrina_HIv1___RNAseq.g25310.t1,three_way,71.25666666666666,FUN_018138-T1,Q9Y6B7,AP4B1_HUMAN,,AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin),Homo sapiens (Human),38.5,748.0,2.7000000000000003e-133,477.6,sp|Q9Y6B7|AP4B1_HUMAN AP-4 complex subunit beta-1 OS=Homo sapiens OX=9606 GN=AP4B1 PE=1 SV=2,GO:0005802; GO:0005829; GO:0006605; GO:0006886; GO:0008104; GO:0016192; GO:0030124; GO:0030131; GO:0030276; GO:0031904; GO:0032588; GO:0061938; GO:0098541,intracellular protein transport [GO:0006886]; protein localization [GO:0008104]; protein localization to somatodendritic compartment [GO:0061938]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192],AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic side of trans-Golgi network transport vesicle membrane [GO:0098541]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],clathrin binding [GO:0030276],GO:0005829; GO:0006886; GO:0016192,cytosol; intracellular protein transport; vesicle-mediated transport
OG_04393,1.4115340216258492,FUN_018395-T1,Peve_00031706,Pocillopora_meandrina_HIv1___RNAseq.16757_t,three_way,77.64733333333334,,,,,,,,,,,,,,,,,
OG_04394,1.44007401079752,FUN_018397-T1,Peve_00031707,Pocillopora_meandrina_HIv1___RNAseq.g10093.t1,three_way,92.263,FUN_018397-T1,O35819,,,,,45.6,294.0,3.2000000000000003e-28,127.1,sp|O35819|KLF6_RAT Krueppel-like factor 6 OS=Rattus norvegicus OX=10116 GN=Klf6 PE=2 SV=2,,,,,,
OG_04395,1.1027160095631858,FUN_018398-T1,Peve_00032288,Pocillopora_meandrina_HIv1___TS.g23627.t2,three_way,73.27966666666667,FUN_018398-T1,P70168,IMB1_MOUSE,,Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG),Mus musculus (Mouse),64.6,878.0,0.0,1105.5,sp|P70168|IMB1_MOUSE Importin subunit beta-1 OS=Mus musculus OX=10090 GN=Kpnb1 PE=1 SV=2,GO:0005654; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0010494; GO:0019904; GO:0030953; GO:0031267; GO:0031965; GO:0032991; GO:0040001; GO:0042564; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307,astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267],GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0007010; GO:0007018; GO:0043226; GO:0140104,nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; microtubule-based movement; organelle; molecular carrier activity
OG_04397,2.5715192261258646,FUN_018402-T1,Peve_00033494,Pocillopora_meandrina_HIv1___RNAseq.16819_t,three_way,58.857,FUN_018402-T1,Q8BVT6,,,,,27.0,429.0,2.6e-26,122.1,sp|Q8BVT6|PP2D1_MOUSE Protein phosphatase 2C-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pp2d1 PE=2 SV=1,,,,,,
OG_04399,1.0208521594433466,FUN_018404-T1,Peve_00031698,Pocillopora_meandrina_HIv1___RNAseq.g10163.t1,three_way,62.86966666666667,FUN_018404-T1,Q5S006,LRRK2_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-),Mus musculus (Mouse),31.9,138.0,7.2e-09,64.7,sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2,GO:0000139; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0007005; GO:0007029; GO:0007030; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031410; GO:0031647; GO:0031965; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034614; GO:0035556; GO:0035564; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042802; GO:0042803; GO:0043068; GO:0043195; GO:0043204; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; multivesicular body, internal vesicle [GO:0097487]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; nucleoplasm; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04403,1.2116353190962414,FUN_018416-T1,Peve_00031691,Pocillopora_meandrina_HIv1___RNAseq.g10170.t1,three_way,54.97866666666667,FUN_018416-T1,Q49A88,CCD14_HUMAN,,Coiled-coil domain-containing protein 14,Homo sapiens (Human),29.7,229.0,3.1e-18,95.5,sp|Q49A88|CCD14_HUMAN Coiled-coil domain-containing protein 14 OS=Homo sapiens OX=9606 GN=CCDC14 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005929; GO:0015630; GO:0021762; GO:0034451; GO:0036064; GO:0071539,protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630],,GO:0005815; GO:0005856; GO:0005929; GO:0043226; GO:0048856,microtubule organizing center; cytoskeleton; cilium; organelle; anatomical structure development
OG_04405,1.1337711612788397,FUN_018423-T1,Peve_00031689,Pocillopora_meandrina_HIv1___RNAseq.g10176.t1,three_way,63.1915,,,,,,,,,,,,,,,,,
OG_04409,1.9049697261793537,FUN_018428-T1,Peve_00007315,Pocillopora_meandrina_HIv1___TS.g23705.t3,three_way,65.60566666666666,FUN_018428-T1,P97321,SEPR_MOUSE,,"Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]",Mus musculus (Mouse),35.3,787.0,7.4e-134,479.6,sp|P97321|SEPR_MOUSE Prolyl endopeptidase FAP OS=Mus musculus OX=10090 GN=Fap PE=1 SV=1,GO:0001525; GO:0002020; GO:0004252; GO:0005178; GO:0005615; GO:0005886; GO:0006508; GO:0007155; GO:0008233; GO:0008236; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0031258; GO:0032587; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0051726; GO:0060244; GO:0070161; GO:0097325; GO:1900119; GO:1902362; GO:1903054; GO:1905368,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710],anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; extracellular space [GO:0005615]; lamellipodium membrane [GO:0031258]; peptidase complex [GO:1905368]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],dipeptidyl-peptidase activity [GO:0008239]; integrin binding [GO:0005178]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005615; GO:0005886; GO:0007155; GO:0012501; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; extracellular space; plasma membrane; cell adhesion; programmed cell death; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_04412,1.3022185458114457,FUN_018519-T1,Peve_00007317,Pocillopora_meandrina_HIv1___TS.g23707.t1,three_way,53.989333333333335,FUN_018519-T1,Q0Z7W6,TMX1_BOVIN,,Thioredoxin-related transmembrane protein 1 (Protein disulfide-isomerase TMX1) (EC 5.3.4.1) (Thioredoxin domain-containing protein 1),Bos taurus (Bovine),40.5,195.0,6.0999999999999996e-43,176.0,sp|Q0Z7W6|TMX1_BOVIN Thioredoxin-related transmembrane protein 1 OS=Bos taurus OX=9913 GN=TMX1 PE=2 SV=1,GO:0003756; GO:0004857; GO:0005576; GO:0005789; GO:0010868; GO:0012505; GO:0015035; GO:0015036; GO:0031966; GO:0034976; GO:0044233; GO:0051924; GO:0090331; GO:1904294,negative regulation of platelet aggregation [GO:0090331]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of ERAD pathway [GO:1904294]; regulation of calcium ion transport [GO:0051924]; response to endoplasmic reticulum stress [GO:0034976],endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966],disulfide oxidoreductase activity [GO:0015036]; enzyme inhibitor activity [GO:0004857]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],GO:0003824; GO:0005576; GO:0016491; GO:0016853; GO:0098772; GO:0140096,"catalytic activity; extracellular region; oxidoreductase activity; isomerase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04415,1.5352814460099573,FUN_018522-T1,Peve_00007314,Pocillopora_meandrina_HIv1___RNAseq.g10182.t2,three_way,59.49766666666667,,,,,,,,,,,,,,,,,
OG_04417,1.15051105396015,FUN_018525-T1,Peve_00039210,Pocillopora_meandrina_HIv1___RNAseq.g10001.t1,three_way,54.96333333333333,,,,,,,,,,,,,,,,,
OG_04418,1.266106029924825,FUN_018526-T1,Peve_00039209,Pocillopora_meandrina_HIv1___TS.g23531.t1,three_way,63.84433333333334,,,,,,,,,,,,,,,,,
OG_04421,1.741769736953566,FUN_018530-T2,Peve_00039202,Pocillopora_meandrina_HIv1___RNAseq.g9980.t1,three_way,91.0425,FUN_018530-T2,Q01082,SPTB2_HUMAN,,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",Homo sapiens (Human),49.4,2310.0,0.0,2035.0,"sp|Q01082|SPTB2_HUMAN Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTBN1 PE=1 SV=2",GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007009; GO:0007417; GO:0008091; GO:0014069; GO:0014731; GO:0021556; GO:0030036; GO:0030054; GO:0030506; GO:0030673; GO:0030864; GO:0031430; GO:0032437; GO:0032743; GO:0042995; GO:0043001; GO:0045296; GO:0051015; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:0098978; GO:1903076; GO:1903078,actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; central nervous system development [GO:0007417]; central nervous system formation [GO:0021556]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200],GO:0000910; GO:0003723; GO:0005198; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0061024; GO:0072659,cytokinesis; RNA binding; structural molecule activity; nucleolus; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; membrane organization; protein localization to plasma membrane
OG_04422,1.2409122829464674,FUN_018531-T1,Peve_00039201,Pocillopora_meandrina_HIv1___RNAseq.g9981.t1,three_way,73.98216666666667,FUN_018531-T1,Q9H9S5,FKRP_HUMAN,,Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase),Homo sapiens (Human),44.4,522.0,2.4e-120,434.1,sp|Q9H9S5|FKRP_HUMAN Ribitol 5-phosphate transferase FKRP OS=Homo sapiens OX=9606 GN=FKRP PE=1 SV=1,GO:0000139; GO:0001701; GO:0001764; GO:0002162; GO:0003007; GO:0003016; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0006096; GO:0006600; GO:0006629; GO:0006936; GO:0006954; GO:0007420; GO:0007628; GO:0009410; GO:0010001; GO:0014823; GO:0016485; GO:0016780; GO:0017038; GO:0019321; GO:0019519; GO:0030282; GO:0035269; GO:0035437; GO:0036058; GO:0038026; GO:0042383; GO:0042802; GO:0043010; GO:0043236; GO:0043403; GO:0043491; GO:0046872; GO:0050905; GO:0051262; GO:0051384; GO:0051674; GO:0060539; GO:0061448; GO:0071711; GO:0072592; GO:0097305; GO:0097709; GO:0098528; GO:0098723,adult walking behavior [GO:0007628]; basement membrane organization [GO:0071711]; bone mineralization [GO:0030282]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; connective tissue development [GO:0061448]; connective tissue replacement [GO:0097709]; creatine metabolic process [GO:0006600]; diaphragm development [GO:0060539]; filtration diaphragm assembly [GO:0036058]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; localization of cell [GO:0051674]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; muscle contraction [GO:0006936]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; oxygen metabolic process [GO:0072592]; pentitol metabolic process [GO:0019519]; pentose metabolic process [GO:0019321]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein import [GO:0017038]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]; reelin-mediated signaling pathway [GO:0038026]; respiratory system process [GO:0003016]; response to activity [GO:0014823]; response to alcohol [GO:0097305]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue regeneration [GO:0043403],cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; skeletal muscle myofibril [GO:0098723],"dystroglycan binding [GO:0002162]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",GO:0003012; GO:0003016; GO:0003824; GO:0005615; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0006575; GO:0006629; GO:0006954; GO:0009101; GO:0016740; GO:0030154; GO:0030198; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0051604; GO:0055086; GO:0065003; GO:1901135,muscle system process; respiratory system process; catalytic activity; extracellular space; nucleoplasm; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; modified amino acid metabolic process; lipid metabolic process; inflammatory response; glycoprotein biosynthetic process; transferase activity; cell differentiation; extracellular matrix organization; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; protein maturation; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_04423,1.9253648819722984,FUN_018532-T1,Peve_00039214,Pocillopora_meandrina_HIv1___RNAseq.g9982.t1,three_way,57.187333333333335,,,,,,,,,,,,,,,,,
OG_04427,1.5188717516960828,FUN_018550-T1,Peve_00032304,Pocillopora_meandrina_HIv1___RNAseq.g10049.t1,three_way,68.13333333333334,FUN_018550-T1,Q5BLD8,,,,,33.1,166.0,2.1e-17,90.9,sp|Q5BLD8|MT21A_DANRE Protein N-lysine methyltransferase METTL21A OS=Danio rerio OX=7955 GN=mettl21a PE=2 SV=1,,,,,,
OG_04430,1.5846995968771758,FUN_018596-T1,Peve_00043163,Pocillopora_meandrina_HIv1___RNAseq.g501.t1,three_way,71.55466666666666,,,,,,,,,,,,,,,,,
OG_04432,1.2729968025158558,FUN_018599-T1,Peve_00043159,Pocillopora_meandrina_HIv1___RNAseq.g10033.t1,three_way,85.14233333333334,FUN_018599-T1,F1MKX4,,,,,48.8,1856.0,0.0,1741.9,sp|F1MKX4|PSME4_BOVIN Proteasome activator complex subunit 4 OS=Bos taurus OX=9913 GN=PSME4 PE=1 SV=1,,,,,,
OG_04434,1.1261288221961518,FUN_018790-T1,Peve_00013151,Pocillopora_meandrina_HIv1___RNAseq.g14712.t1,three_way,68.35233333333333,,,,,,,,,,,,,,,,,
OG_04437,1.7810878985426313,FUN_018822-T1,Peve_00035783,Pocillopora_meandrina_HIv1___RNAseq.g9871.t1,three_way,38.3045,FUN_018822-T1,Q9Y2C9,TLR6_HUMAN,,Toll-like receptor 6 (CD antigen CD286),Homo sapiens (Human),36.5,148.0,1.2e-13,79.7,sp|Q9Y2C9|TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens OX=9606 GN=TLR6 PE=1 SV=2,GO:0001540; GO:0001774; GO:0002224; GO:0002755; GO:0004888; GO:0005102; GO:0005794; GO:0005886; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0010628; GO:0030670; GO:0032717; GO:0032720; GO:0032731; GO:0032755; GO:0034136; GO:0035355; GO:0035663; GO:0035666; GO:0038023; GO:0038124; GO:0042496; GO:0042498; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043507; GO:0045087; GO:0045121; GO:0045429; GO:0046209; GO:0046982; GO:0050729; GO:0061809; GO:0071723; GO:0071726; GO:0140052; GO:1900017; GO:1900227; GO:1903428; GO:1904646; GO:2001238,activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide metabolic process [GO:0046209]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355],"amyloid-beta binding [GO:0001540]; diacyl lipopeptide binding [GO:0042498]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_04439,3.521082145676015,FUN_018835-T2,Peve_00035787,Pocillopora_meandrina_HIv1___RNAseq.g9856.t1,three_way,77.22033333333333,FUN_018835-T2,Q9C0G6,DYH6_HUMAN,,Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6),Homo sapiens (Human),37.1,4337.0,0.0,2654.0,sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_04443,1.680523813463955,FUN_018864-T3,Peve_00035796,Pocillopora_meandrina_HIv1___RNAseq.g371.t1,three_way,60.120666666666665,FUN_018864-T3,G3V928,LRP1_RAT,,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],Rattus norvegicus (Rat),36.6,3344.0,4.5e-259,897.9,sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1,GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005815; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010951; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032374; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587,amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104],apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235],alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102],GO:0002376; GO:0003013; GO:0005634; GO:0005768; GO:0005794; GO:0005815; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0060089,immune system process; circulatory system process; nucleus; endosome; Golgi apparatus; microtubule organizing center; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; molecular transducer activity
OG_04454,2.3781553724934974,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,2.3781553724934974,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04458,1.2568382365145614,FUN_019330-T1,Peve_00032905,Pocillopora_meandrina_HIv1___RNAseq.g19534.t1,three_way,82.16766666666666,FUN_019330-T1,Q8VXY7,,,,,26.4,390.0,3.3e-19,97.8,sp|Q8VXY7|ENT1_ARATH Equilibrative nucleotide transporter 1 OS=Arabidopsis thaliana OX=3702 GN=ENT1 PE=1 SV=1,,,,,,
OG_04474,1.5118625505243255,FUN_020855-T1,Peve_00032916,Pocillopora_meandrina_HIv1___RNAseq.g20813.t1,three_way,66.00766666666667,,,,,,,,,,,,,,,,,
OG_04477,1.3437405046385682,FUN_021107-T1,Peve_00008862,Pocillopora_meandrina_HIv1___RNAseq.g4370.t1,three_way,74.41733333333333,FUN_021107-T1,Q5FVN8,,,,,34.2,325.0,2.8e-38,161.4,"sp|Q5FVN8|WSDU1_RAT WD repeat, SAM and U-box domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Wdsub1 PE=2 SV=1",,,,,,
OG_04487,1.402344817360583,FUN_021608-T1,Peve_00002684,Pocillopora_meandrina_HIv1___RNAseq.g2921.t1,three_way,51.73733333333333,FUN_021608-T1,A0JPF9,ISPD_DANRE,,D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein),Danio rerio (Zebrafish) (Brachydanio rerio),46.1,323.0,1e-73,278.9,sp|A0JPF9|ISPD_DANRE D-ribitol-5-phosphate cytidylyltransferase OS=Danio rerio OX=7955 GN=crppa PE=2 SV=2,GO:0005829; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0048854; GO:0055001; GO:0060049; GO:0070567,brain morphogenesis [GO:0048854]; isoprenoid biosynthetic process [GO:0008299]; muscle cell development [GO:0055001]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049],cytosol [GO:0005829],cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006629; GO:0009101; GO:0016740; GO:0048856; GO:1901135,catalytic activity; cytosol; lipid metabolic process; glycoprotein biosynthetic process; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_04496,2.596578602424905,FUN_021928-T1,Peve_00023935,Pocillopora_meandrina_HIv1___RNAseq.g2913.t1,three_way,79.017,FUN_021928-T1,O81884,,,,,44.3,316.0,7.099999999999999e-70,265.8,sp|O81884|GALDH_ARATH L-galactose dehydrogenase OS=Arabidopsis thaliana OX=3702 GN=LGALDH PE=1 SV=1,,,,,,
OG_04498,1.6770834704005968,FUN_021934-T1,Peve_00023932,Pocillopora_meandrina_HIv1___RNAseq.g2962.t1,three_way,57.409666666666666,,,,,,,,,,,,,,,,,
OG_04499,1.3506612910906997,FUN_021937-T1,Peve_00023931,Pocillopora_meandrina_HIv1___RNAseq.g2961.t1,three_way,82.98416666666667,FUN_021937-T1,P50549,ETV1_HUMAN,,ETS translocation variant 1 (Ets-related protein 81),Homo sapiens (Human),35.8,477.0,1.3e-58,228.8,sp|P50549|ETV1_HUMAN ETS translocation variant 1 OS=Homo sapiens OX=9606 GN=ETV1 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935; GO:1990837,axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04500,1.6976074732180086,FUN_021938-T1,Peve_00023930,Pocillopora_meandrina_HIv1___RNAseq.g2960.t2,three_way,73.7475,FUN_021938-T1,Q4W5Z4,DNM3A_CHICK,,DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-),Gallus gallus (Chicken),47.0,651.0,6.4e-174,612.5,sp|Q4W5Z4|DNM3A_CHICK DNA (cytosine-5)-methyltransferase 3A OS=Gallus gallus OX=9031 GN=DNMT3A PE=2 SV=1,GO:0000791; GO:0001046; GO:0003886; GO:0005634; GO:0005737; GO:0008270; GO:0009408; GO:0016363; GO:0032259; GO:0044027; GO:0045892; GO:0071774; GO:0106363,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; response to fibroblast growth factor [GO:0071774]; response to heat [GO:0009408],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],core promoter sequence-specific DNA binding [GO:0001046]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; protein-cysteine methyltransferase activity [GO:0106363]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0140096; GO:0140097,"DNA binding; catalytic activity; nucleus; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_04503,1.4303906021254371,FUN_022013-T1,Peve_00042673,Pocillopora_meandrina_HIv1___RNAseq.g3139.t1,three_way,74.30833333333334,FUN_022013-T1,Q05360,,,,,43.6,676.0,1.9e-149,531.2,sp|Q05360|WHITE_LUCCU Protein white OS=Lucilia cuprina OX=7375 GN=W PE=2 SV=2,,,,,,
OG_04504,1.4371211193032716,FUN_022016-T1,Peve_00042666,Pocillopora_meandrina_HIv1___RNAseq.g3182.t2,three_way,75.399,FUN_022016-T1,P07228,,,,,38.2,808.0,2.6e-144,514.2,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_04513,1.6237340782871652,FUN_022046-T1,Peve_00007833,Pocillopora_meandrina_HIv1___RNAseq.g9288.t1,three_way,85.22166666666666,FUN_022046-T1,Q8WVP7,LMBR1_HUMAN,,Limb region 1 protein homolog (Differentiation-related gene 14 protein),Homo sapiens (Human),51.5,464.0,4.4000000000000006e-118,426.4,sp|Q8WVP7|LMBR1_HUMAN Limb region 1 protein homolog OS=Homo sapiens OX=9606 GN=LMBR1 PE=1 SV=1,GO:0004888; GO:0005886; GO:0007165; GO:0042733,embryonic digit morphogenesis [GO:0042733]; signal transduction [GO:0007165],plasma membrane [GO:0005886],transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_04515,1.3103237058612198,FUN_022048-T1,Peve_00017132,Pocillopora_meandrina_HIv1___RNAseq.g4598.t1,three_way,56.047666666666665,FUN_022048-T1,Q7TN88,,,,,27.8,1834.0,3.2e-182,642.5,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_04516,1.232429177205641,FUN_022049-T1,Peve_00032394,Pocillopora_meandrina_HIv1___RNAseq.g4599.t1,three_way,67.69266666666667,FUN_022049-T1,Q9C098,DCLK3_HUMAN,,Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3),Homo sapiens (Human),59.1,269.0,2e-91,338.6,sp|Q9C098|DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens OX=9606 GN=DCLK3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0034504; GO:0106310,protein localization to nucleus [GO:0034504],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04523,1.033630081024046,FUN_022057-T1,Peve_00014939,Pocillopora_meandrina_HIv1___RNAseq.g4608.t1,three_way,86.64366666666668,FUN_022057-T1,M0RDU0,,,,,37.1,350.0,4.3e-50,199.9,sp|M0RDU0|HAP40_RAT 40-kDa huntingtin-associated protein OS=Rattus norvegicus OX=10116 GN=F8a1 PE=1 SV=1,,,,,,
OG_04524,1.025536157719922,FUN_022059-T1,Peve_00014932,Pocillopora_meandrina_HIv1___RNAseq.g4610.t1,three_way,48.778,FUN_022059-T1,Q9NVV4,PAPD1_HUMAN,,"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)",Homo sapiens (Human),35.3,292.0,4.3e-40,167.9,"sp|Q9NVV4|PAPD1_HUMAN Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1",GO:0000287; GO:0000965; GO:0002134; GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0006397; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0043231; GO:0071044; GO:1990817,histone mRNA catabolic process [GO:0071044]; mitochondrial RNA 3'-end processing [GO:0000965]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123],intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; poly(A) RNA polymerase activity [GO:1990817]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140053,RNA binding; catalytic activity; nucleoplasm; mitochondrion; mRNA metabolic process; transferase activity; organelle; mitochondrial gene expression
OG_04531,1.986425345556314,FUN_022075-T1,Peve_00038290,Pocillopora_meandrina_HIv1___RNAseq.g9321.t1,three_way,59.58166666666667,,,,,,,,,,,,,,,,,
OG_04533,2.562353479043269,FUN_022079-T1,Peve_00038279,Pocillopora_meandrina_HIv1___TS.g19620.t1,three_way,56.668,FUN_022079-T1,Q3TZ87,MARH9_MOUSE,,E3 ubiquitin-protein ligase MARCHF9 (EC 2.3.2.27) (Membrane-associated RING finger protein 9) (Membrane-associated RING-CH protein IX) (MARCH-IX) (RING-type E3 ubiquitin transferase MARCHF9),Mus musculus (Mouse),33.2,187.0,1.4e-21,105.5,sp|Q3TZ87|MARH9_MOUSE E3 ubiquitin-protein ligase MARCHF9 OS=Mus musculus OX=10090 GN=Marchf9 PE=2 SV=1,GO:0000139; GO:0004842; GO:0005765; GO:0005795; GO:0005802; GO:0008270; GO:0016567,protein ubiquitination [GO:0016567],Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; trans-Golgi network [GO:0005802],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04536,1.2704786140874194,FUN_022092-T1,Peve_00038684,Pocillopora_meandrina_HIv1___RNAseq.g4111.t1,three_way,48.881,,,,,,,,,,,,,,,,,
OG_04538,2.669771430490107,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_04542,1.2208539451138332,FUN_022103-T1,Peve_00009716,Pocillopora_meandrina_HIv1___RNAseq.g4105.t1,three_way,85.40766666666667,FUN_022103-T1,A6H779,FBXL2_BOVIN,,F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2),Bos taurus (Bovine),69.6,102.0,2.1e-37,158.3,sp|A6H779|FBXL2_BOVIN F-box/LRR-repeat protein 2 OS=Bos taurus OX=9913 GN=FBXL2 PE=2 SV=1,GO:0005516; GO:0006513; GO:0010506; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830; GO:0050727; GO:0051896; GO:1900226; GO:1990756,modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005],calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_04544,2.234527121463558,FUN_022106-T1,Peve_00025701,Pocillopora_meandrina_HIv1___RNAseq.g9229.t1,three_way,68.26433333333333,FUN_022106-T1,Q5E9J9,,,,,39.2,375.0,1.3e-70,268.5,sp|Q5E9J9|STRAA_BOVIN STE20-related kinase adapter protein alpha OS=Bos taurus OX=9913 GN=STRADA PE=2 SV=1,,,,,,
OG_04545,2.009646657903404,FUN_022110-T1,Peve_00020403,Pocillopora_meandrina_HIv1___RNAseq.g9226.t1,three_way,64.77066666666667,FUN_022110-T1,Q9FN03,,,,,33.7,347.0,2.7e-51,204.9,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_04547,1.7512012563676134,FUN_022170-T1,Peve_00036602,Pocillopora_meandrina_HIv1___RNAseq.g4779.t1,three_way,50.17433333333334,FUN_022170-T1,B8UU78,,,,,90.7,1117.0,0.0,1992.2,sp|B8UU78|ELP_ACRMI EGF and laminin G domain-containing protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_04554,1.0966500979152418,FUN_022185-T2,Peve_00014941,Pocillopora_meandrina_HIv1___RNAseq.g4790.t1,three_way,68.66233333333334,FUN_022185-T2,P34147,,,,,27.5,632.0,8.3e-64,246.5,sp|P34147|RACA_DICDI Rho-related protein racA OS=Dictyostelium discoideum OX=44689 GN=racA PE=1 SV=2,,,,,,
OG_04555,1.5865733916537663,FUN_022186-T1,Peve_00018623,Pocillopora_meandrina_HIv1___RNAseq.g4791.t1,three_way,75.88,FUN_022186-T1,O08539,BIN1_MOUSE,,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Bridging integrator 1) (SH3 domain-containing protein 9),Mus musculus (Mouse),31.9,593.0,2e-57,224.9,sp|O08539|BIN1_MOUSE Myc box-dependent-interacting protein 1 OS=Mus musculus OX=10090 GN=Bin1 PE=1 SV=1,GO:0000122; GO:0005634; GO:0005635; GO:0005768; GO:0005874; GO:0010564; GO:0019828; GO:0030018; GO:0030100; GO:0030315; GO:0030424; GO:0030425; GO:0030838; GO:0031674; GO:0031982; GO:0032496; GO:0033268; GO:0033292; GO:0035591; GO:0042692; GO:0043065; GO:0043194; GO:0045202; GO:0045664; GO:0048156; GO:0048488; GO:0048711; GO:0051647; GO:0060987; GO:0060988; GO:0086091; GO:0090571; GO:0098793; GO:0098794; GO:0098978; GO:1901380; GO:1902430; GO:1903946; GO:1904878,lipid tube assembly [GO:0060988]; muscle cell differentiation [GO:0042692]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell cycle process [GO:0010564]; regulation of endocytosis [GO:0030100]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; response to lipopolysaccharide [GO:0032496]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292],axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; microtubule [GO:0005874]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; RNA polymerase II transcription repressor complex [GO:0090571]; synapse [GO:0045202]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018],aspartic-type endopeptidase inhibitor activity [GO:0019828]; signaling adaptor activity [GO:0035591]; tau protein binding [GO:0048156],GO:0005634; GO:0005635; GO:0005768; GO:0006355; GO:0008092; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0065003; GO:0098772,nucleus; nuclear envelope; endosome; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity
OG_04559,1.1533349031715807,FUN_022198-T1,Peve_00038010,Pocillopora_meandrina_HIv1___RNAseq.g4797.t1,three_way,68.02633333333333,,,,,,,,,,,,,,,,,
OG_04560,2.6708112378122744,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_04566,1.1758938192219637,FUN_022209-T1,Peve_00008601,Pocillopora_meandrina_HIv1___RNAseq.g4801.t1,three_way,46.54666666666667,FUN_022209-T1,Q7KM13,,,,,52.7,91.0,2.1e-14,81.3,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_04567,1.0199157239233343,FUN_022210-T1,Peve_00008600,Pocillopora_meandrina_HIv1___RNAseq.g4765.t1,three_way,84.062,FUN_022210-T1,Q8HYI9,,,,,45.7,138.0,1.9e-30,133.7,sp|Q8HYI9|PFD5_BOVIN Prefoldin subunit 5 OS=Bos taurus OX=9913 GN=PFDN5 PE=2 SV=1,,,,,,
OG_04575,1.0251144831806782,FUN_022225-T1,Peve_00008146,Pocillopora_meandrina_HIv1___RNAseq.g4746.t1b,three_way,48.185,FUN_022225-T1,P35448,,,,,39.9,158.0,7.7e-07,57.8,sp|P35448|TSP1_XENLA Thrombospondin-1 OS=Xenopus laevis OX=8355 GN=thbs1 PE=2 SV=1,,,,,,
OG_04579,1.5412199385491576,FUN_022242-T1,Peve_00037424,Pocillopora_meandrina_HIv1___TS.g22171.t1,three_way,87.71433333333333,FUN_022242-T1,E7F590,VPS41_DANRE,,Vacuolar protein sorting-associated protein 41 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),53.6,823.0,8.099999999999999e-251,868.2,sp|E7F590|VPS41_DANRE Vacuolar protein sorting-associated protein 41 homolog OS=Danio rerio OX=7955 GN=vps41 PE=1 SV=1,GO:0005765; GO:0005770; GO:0005794; GO:0005829; GO:0006623; GO:0008270; GO:0008333; GO:0009267; GO:0016236; GO:0030136; GO:0030897; GO:0031901; GO:0031902; GO:0034058,cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623],clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],zinc ion binding [GO:0008270],GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; Golgi apparatus; cytosol; intracellular protein transport; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_04580,1.2628554383434123,FUN_022243-T2,Peve_00037426,Pocillopora_meandrina_HIv1___RNAseq.g4758.t1,three_way,80.60083333333333,FUN_022243-T2,Q9H2F5,,,,,46.3,555.0,5.4e-117,423.3,sp|Q9H2F5|EPC1_HUMAN Enhancer of polycomb homolog 1 OS=Homo sapiens OX=9606 GN=EPC1 PE=1 SV=1,,,,,,
OG_04581,1.2282286542241678,FUN_022244-T1,Peve_00037427,Pocillopora_meandrina_HIv1___RNAseq.g4759.t1,three_way,49.892,,,,,,,,,,,,,,,,,
OG_04582,1.1006457967834722,FUN_022245-T1,Peve_00037428,Pocillopora_meandrina_HIv1___RNAseq.g4760.t1,three_way,54.247166666666665,FUN_022245-T1,Q96DN6,MBD6_HUMAN,,Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6),Homo sapiens (Human),41.4,99.0,6.5e-16,88.6,sp|Q96DN6|MBD6_HUMAN Methyl-CpG-binding domain protein 6 OS=Homo sapiens OX=9606 GN=MBD6 PE=1 SV=2,GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0010369,,chromocenter [GO:0010369]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005654; GO:0005694; GO:0043226,nucleus; nucleoplasm; chromosome; organelle
OG_04584,1.1390603029515685,FUN_022249-T1,Peve_00021283,Pocillopora_meandrina_HIv1___RNAseq.g4723.t1,three_way,79.9,FUN_022249-T1,Q1ECX4,TLK2_DANRE,,Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2),Danio rerio (Zebrafish) (Brachydanio rerio),51.9,697.0,1.7e-174,614.4,sp|Q1ECX4|TLK2_DANRE Serine/threonine-protein kinase tousled-like 2 OS=Danio rerio OX=7955 GN=tlk2 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0035556; GO:0048471; GO:0106310,chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556],cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton; chromosome segregation; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04595,1.1344680686133577,FUN_022279-T1,Peve_00022093,Pocillopora_meandrina_HIv1___RNAseq.g4703.t2,three_way,75.602,FUN_022279-T1,Q7ZWS1,DUS3L_XENLA,,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like),Xenopus laevis (African clawed frog),54.4,634.0,7.399999999999997e-190,665.2,sp|Q7ZWS1|DUS3L_XENLA tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Xenopus laevis OX=8355 GN=dus3l PE=2 SV=1,GO:0002943; GO:0003723; GO:0006397; GO:0006417; GO:0008270; GO:0017150; GO:0050660; GO:0102265; GO:0106414,mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943],,flavin adenine dinucleotide binding [GO:0050660]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine47 synthase activity [GO:0102265]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0006399; GO:0016071; GO:0016491; GO:0140098,"RNA binding; catalytic activity; tRNA metabolic process; mRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA"
OG_04596,2.197221700013538,FUN_022280-T1,Peve_00022092,Pocillopora_meandrina_HIv1___RNAseq.g4702.t1,three_way,79.605,FUN_022280-T1,Q0V9W6,,,,,40.9,423.0,5.6e-88,326.2,sp|Q0V9W6|BTBD6_XENTR BTB/POZ domain-containing protein 6 OS=Xenopus tropicalis OX=8364 GN=btbd6 PE=2 SV=2,,,,,,
OG_04601,1.329865435361193,FUN_022288-T1,Peve_00003595,Pocillopora_meandrina_HIv1___RNAseq.g4695.t1,three_way,67.76066666666667,FUN_022288-T1,Q9Z340,PARD3_RAT,,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Atypical PKC-specific-binding protein) (ASBP),Rattus norvegicus (Rat),32.5,805.0,1.7e-76,289.7,sp|Q9Z340|PARD3_RAT Partitioning defective 3 homolog OS=Rattus norvegicus OX=10116 GN=Pard3 PE=1 SV=1,GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007155; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0120157,"apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]",adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; PAR polarity complex [GO:0120157]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]",GO:0007010; GO:0007155; GO:0007163; GO:0008289; GO:0034330; GO:0043226; GO:0048870,cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell junction organization; organelle; cell motility
OG_04604,1.9557632462880823,FUN_022293-T1,Peve_00003688,Pocillopora_meandrina_HIv1___RNAseq.g4691.t1,three_way,65.73366666666666,,,,,,,,,,,,,,,,,
OG_04609,1.5224778808014965,FUN_022305-T1,Peve_00003816,Pocillopora_meandrina_HIv1___RNAseq.g3971.t1,three_way,36.00233333333333,,,,,,,,,,,,,,,,,
OG_04610,1.4696220897373111,FUN_022307-T1,Peve_00021671,Pocillopora_meandrina_HIv1___RNAseq.g4623.t1,three_way,86.57633333333334,FUN_022307-T1,Q8VEE0,,,,,65.1,212.0,1e-75,284.6,sp|Q8VEE0|RPE_MOUSE Ribulose-phosphate 3-epimerase OS=Mus musculus OX=10090 GN=Rpe PE=1 SV=1,,,,,,
OG_04611,1.4378663651812105,FUN_022308-T1,Peve_00021683,Pocillopora_meandrina_HIv1___RNAseq.g4624.t1,three_way,85.60266666666666,FUN_022308-T1,Q3TZZ7,ESYT2_MOUSE,,Extended synaptotagmin-2 (E-Syt2),Mus musculus (Mouse),35.6,793.0,2.9e-132,474.2,sp|Q3TZZ7|ESYT2_MOUSE Extended synaptotagmin-2 OS=Mus musculus OX=10090 GN=Esyt2 PE=1 SV=1,GO:0005509; GO:0005789; GO:0005829; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268,endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232],calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0008289; GO:0016192,cytosol; lipid binding; vesicle-mediated transport
OG_04615,2.827840045625797,FUN_022314-T1,Peve_00021691,Pocillopora_meandrina_HIv1___TS.g22047.t1,three_way,61.79866666666667,,,,,,,,,,,,,,,,,
OG_04616,1.079516319221977,FUN_022315-T1,Peve_00021692,Pocillopora_meandrina_HIv1___RNAseq.g4632.t1,three_way,88.54166666666667,FUN_022315-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.0,218.0,3.2e-15,83.6,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_04620,1.5170113028277763,FUN_022322-T1,Peve_00021644,Pocillopora_meandrina_HIv1___RNAseq.g4643.t1,three_way,86.02233333333332,,,,,,,,,,,,,,,,,
OG_04621,1.879089995983381,FUN_022323-T1,Peve_00021645,Pocillopora_meandrina_HIv1___RNAseq.g4644.t1,three_way,86.14483333333334,,,,,,,,,,,,,,,,,
OG_04625,1.4049976196389096,FUN_022333-T1,Peve_00028601,Pocillopora_meandrina_HIv1___RNAseq.g4652.t1,three_way,61.93866666666667,FUN_022333-T1,Q92609,TBCD5_HUMAN,,TBC1 domain family member 5,Homo sapiens (Human),37.5,610.0,3.2e-104,381.3,sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1,GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:1905394,"autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]",autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904],AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394],GO:0005773; GO:0005794; GO:0005829; GO:0006914; GO:0016192; GO:0043226; GO:0098772,vacuole; Golgi apparatus; cytosol; autophagy; vesicle-mediated transport; organelle; molecular function regulator activity
OG_04627,2.028799764697859,FUN_022340-T1,Peve_00028608,Pocillopora_meandrina_HIv1___RNAseq.g4654.t1,three_way,62.08733333333333,FUN_022340-T1,Q63258,ITA7_RAT,,Integrin alpha-7 (H36-alpha7) [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],Rattus norvegicus (Rat),27.7,1149.0,3.1e-87,325.1,sp|Q63258|ITA7_RAT Integrin alpha-7 OS=Rattus norvegicus OX=10116 GN=Itga7 PE=1 SV=2,GO:0005178; GO:0005737; GO:0005927; GO:0007155; GO:0007229; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016477; GO:0031594; GO:0033627; GO:0034113; GO:0034677; GO:0035987; GO:0042383; GO:0043236; GO:0044877; GO:0046872; GO:0048514; GO:0050839; GO:0050900; GO:0098609,blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519],cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integrin alpha7-beta1 complex [GO:0034677]; integrin complex [GO:0008305]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383],cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0002376; GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0048870,immune system process; plasma membrane; cell adhesion; cell differentiation; anatomical structure development; cell motility
OG_04630,1.1871234814899432,FUN_022343-T1,Peve_00028597,Pocillopora_meandrina_HIv1___RNAseq.g4657.t1,three_way,58.79733333333333,,,,,,,,,,,,,,,,,
OG_04635,1.9701038684659105,FUN_022357-T1,Peve_00021682,Pocillopora_meandrina_HIv1___RNAseq.g4585.t1,three_way,74.13533333333334,FUN_022357-T1,P55011,S12A2_HUMAN,,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (hNKCC1),Homo sapiens (Human),45.9,1014.0,4e-238,826.2,sp|P55011|S12A2_HUMAN Solute carrier family 12 member 2 OS=Homo sapiens OX=9606 GN=SLC12A2 PE=1 SV=1,GO:0005886; GO:0006811; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015377; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0031253; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0044298; GO:0045795; GO:0046873; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0061044; GO:0070062; GO:0070634; GO:0071944; GO:0072488; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:0150104; GO:1902476; GO:1903561; GO:1904450; GO:1904464; GO:1990573; GO:1990869,ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; monoatomic ion transport [GO:0006811]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ammonium channel activity [GO:0008519]; chloride:monoatomic cation symporter activity [GO:0015377]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]; protein-folding chaperone binding [GO:0051087]; sodium:potassium:chloride symporter activity [GO:0008511],GO:0002376; GO:0003013; GO:0005215; GO:0005886; GO:0023052; GO:0043226; GO:0048870; GO:0055085,immune system process; circulatory system process; transporter activity; plasma membrane; signaling; organelle; cell motility; transmembrane transport
OG_04637,1.3008503722399054,FUN_022363-T1,Peve_00021993,Pocillopora_meandrina_HIv1___RNAseq.g4594.t1,three_way,86.07533333333333,FUN_022363-T1,Q7Z5J8,,,,,48.0,1367.0,3.1e-212,740.7,sp|Q7Z5J8|ANKAR_HUMAN Ankyrin and armadillo repeat-containing protein OS=Homo sapiens OX=9606 GN=ANKAR PE=1 SV=3,,,,,,
OG_04638,2.1929169054381195,FUN_022364-T3,Peve_00021992,Pocillopora_meandrina_HIv1___RNAseq.g4595.t2,three_way,67.867,FUN_022364-T3,P18461,,,,,32.1,808.0,7.1e-87,323.6,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_04639,1.851111713130284,FUN_022365-T1,Peve_00021988,Pocillopora_meandrina_HIv1___TS.g22011.t1,three_way,64.79716666666667,FUN_022365-T1,A2RRU4,SCAP_RAT,,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),Rattus norvegicus (Rat),35.1,1375.0,2.4999999999999998e-147,525.0,sp|A2RRU4|SCAP_RAT Sterol regulatory element-binding protein cleavage-activating protein OS=Rattus norvegicus OX=10116 GN=Scap PE=2 SV=1,GO:0000139; GO:0001666; GO:0005789; GO:0006629; GO:0006955; GO:0008203; GO:0012507; GO:0019217; GO:0032868; GO:0032933; GO:0032934; GO:0032936; GO:0032991; GO:0033552; GO:0042304; GO:0044877; GO:0045540; GO:0045542; GO:0090110,cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; lipid metabolic process [GO:0006629]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin B3 [GO:0033552]; SREBP signaling pathway [GO:0032933],endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; protein-containing complex [GO:0032991]; SREBP-SCAP complex [GO:0032936],protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934],GO:0002376; GO:0006629; GO:0008289,immune system process; lipid metabolic process; lipid binding
OG_04642,1.8565477159432044,FUN_022368-T1,Peve_00013237,Pocillopora_meandrina_HIv1___RNAseq.g9293.t2,three_way,55.12766666666666,FUN_022368-T1,B2GV47,,,,,31.2,523.0,1.9000000000000001e-66,255.8,sp|B2GV47|RADX_RAT RPA-related protein RADX OS=Rattus norvegicus OX=10116 GN=Radx PE=2 SV=1,,,,,,
OG_04643,1.0107494011096212,FUN_022369-T1,Peve_00013236,Pocillopora_meandrina_HIv1___RNAseq.g9295.t1,three_way,77.29733333333333,FUN_022369-T1,Q8NCL4,GALT6_HUMAN,,Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6),Homo sapiens (Human),52.4,450.0,6.6e-132,472.6,sp|Q8NCL4|GALT6_HUMAN Polypeptide N-acetylgalactosaminyltransferase 6 OS=Homo sapiens OX=9606 GN=GALNT6 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0018243; GO:0030246; GO:0046872; GO:0048471,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04644,2.041353322517812,FUN_022371-T1,Peve_00013234,Pocillopora_meandrina_HIv1___RNAseq.g9296.t1,three_way,87.35,FUN_022371-T1,Q6WV17,GALT5_DROME,,Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5),Drosophila melanogaster (Fruit fly),52.9,442.0,3.5e-128,460.3,sp|Q6WV17|GALT5_DROME Polypeptide N-acetylgalactosaminyltransferase 5 OS=Drosophila melanogaster OX=7227 GN=Pgant5 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006493; GO:0012505; GO:0030246; GO:0046872,protein O-linked glycosylation [GO:0006493],endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04646,1.1290236069416753,FUN_022378-T1,Peve_00013226,Pocillopora_meandrina_HIv1___RNAseq.g9303.t1,three_way,49.90833333333334,,,,,,,,,,,,,,,,,
OG_04649,1.4714838983361789,FUN_022382-T1,Peve_00013222,Pocillopora_meandrina_HIv1___RNAseq.g9307.t1,three_way,66.057,FUN_022382-T1,O93366,,,,,50.0,76.0,4.7e-14,79.7,sp|O93366|TLX1_CHICK T-cell leukemia homeobox protein 1 OS=Gallus gallus OX=9031 GN=TLX1 PE=2 SV=1,,,,,,
OG_04650,1.5010837703494162,FUN_022383-T1,Peve_00013221,Pocillopora_meandrina_HIv1___RNAseq.g9308.t1,three_way,67.081,FUN_022383-T1,P20009,DLL_DROME,,Homeotic protein distal-less (Protein brista),Drosophila melanogaster (Fruit fly),47.1,174.0,6.900000000000001e-28,125.9,sp|P20009|DLL_DROME Homeotic protein distal-less OS=Drosophila melanogaster OX=7227 GN=Dll PE=2 SV=3,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007449; GO:0007469; GO:0007479; GO:0007480; GO:0007485; GO:0007487; GO:0008587; GO:0010092; GO:0010629; GO:0016319; GO:0030154; GO:0035114; GO:0035215; GO:0045893; GO:0048264; GO:0048728,"analia development [GO:0007487]; antennal development [GO:0007469]; cell differentiation [GO:0030154]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; positive regulation of DNA-templated transcription [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04652,1.773532519412176,FUN_022389-T1,Peve_00037602,Pocillopora_meandrina_HIv1___TS.g19607.t1,three_way,66.46,FUN_022389-T1,D3Z2X2,DNHD1_MOUSE,,Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein),Mus musculus (Mouse),22.8,4456.0,4.4999999999999995e-257,891.3,sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3,GO:0005524; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0045505; GO:0051959; GO:0120316,flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316],dynein complex [GO:0030286]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; isomerase activity; reproductive process; organelle; cilium organization; cell motility; ATP-dependent activity
OG_04657,1.1933722793647423,FUN_022397-T1,Peve_00037595,Pocillopora_meandrina_HIv1___RNAseq.g9319.t1a,three_way,71.057,,,,,,,,,,,,,,,,,
OG_04661,1.485742587410839,FUN_022406-T1,Peve_00037585,Pocillopora_meandrina_HIv1___TS.g21958.t2,three_way,79.75416666666666,FUN_022406-T1,Q8BXK8,AGAP1_MOUSE,,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP-1) (Centaurin-gamma-2) (Cnt-g2)",Mus musculus (Mouse),46.3,525.0,1e-111,405.6,"sp|Q8BXK8|AGAP1_MOUSE Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 OS=Mus musculus OX=10090 GN=Agap1 PE=1 SV=1",GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0008270; GO:0015031,protein transport [GO:0015031],cytosol [GO:0005829],GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270],GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0098772,catalytic activity; GTPase activity; cytosol; hydrolase activity; molecular function regulator activity
OG_04662,2.052795130528354,FUN_022408-T1,Peve_00037583,Pocillopora_meandrina_HIv1___RNAseq.g4541.t1,three_way,68.21366666666667,FUN_022408-T1,F1QJX5,UBR3_DANRE,,E3 ubiquitin-protein ligase ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase ubr3),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,844.0,4.4000000000000004e-125,451.1,sp|F1QJX5|UBR3_DANRE E3 ubiquitin-protein ligase ubr3 OS=Danio rerio OX=7955 GN=ubr3 PE=2 SV=2,GO:0000151; GO:0005737; GO:0008270; GO:0016567; GO:0048592; GO:0061630; GO:0071596,eye morphogenesis [GO:0048592]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04669,1.265344381562284,FUN_022425-T1,Peve_00037613,Pocillopora_meandrina_HIv1___RNAseq.g4349.t1,three_way,66.758,,,,,,,,,,,,,,,,,
OG_04672,1.27004490750883,FUN_022430-T1,Peve_00037605,Pocillopora_meandrina_HIv1___RNAseq.g4343.t1,three_way,55.87566666666667,FUN_022430-T1,P07106,,,,,46.6,131.0,5.1e-28,127.5,sp|P07106|ACBD5_BOVIN Acyl-CoA-binding domain-containing protein 5 OS=Bos taurus OX=9913 GN=ACBD5 PE=2 SV=2,,,,,,
OG_04675,1.2875476659043958,FUN_022437-T1,Peve_00017892,Pocillopora_meandrina_HIv1___RNAseq.g4335.t1,three_way,81.93833333333333,FUN_022437-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),42.7,450.0,4.5e-92,340.1,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_04684,1.0275489996337002,FUN_022475-T1,Peve_00020972,Pocillopora_meandrina_HIv1___RNAseq.g4305.t1,three_way,57.77916666666667,,,,,,,,,,,,,,,,,
OG_04686,1.3018242781670042,FUN_022477-T1,Peve_00002918,Pocillopora_meandrina_HIv1___RNAseq.g4303.t1,three_way,85.38066666666667,FUN_022477-T1,Q32L53,LFG1_BOVIN,,Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit),Bos taurus (Bovine),46.4,220.0,5.999999999999997e-47,189.1,sp|Q32L53|LFG1_BOVIN Protein lifeguard 1 OS=Bos taurus OX=9913 GN=GRINA PE=2 SV=1,GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0043524; GO:0097190; GO:1902042,apoptotic signaling pathway [GO:0097190]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],calcium channel activity [GO:0005262],GO:0005215; GO:0005783; GO:0005794; GO:0043226,transporter activity; endoplasmic reticulum; Golgi apparatus; organelle
OG_04689,1.0598302774675965,FUN_022480-T1,Peve_00002919,Pocillopora_meandrina_HIv1___RNAseq.g4299.t1,three_way,73.78766666666667,FUN_022480-T1,Q9UH92,MLX_HUMAN,,Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4),Homo sapiens (Human),61.2,188.0,1.8e-56,220.7,sp|Q9UH92|MLX_HUMAN Max-like protein X OS=Homo sapiens OX=9606 GN=MLX PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:0061629; GO:1990837,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04690,1.38181347188881,FUN_022481-T1,Peve_00002920,Pocillopora_meandrina_HIv1___RNAseq.g4298.t1,three_way,71.46483333333333,FUN_022481-T1,Q99MZ8,LASP1_RAT,,LIM and SH3 domain protein 1 (LASP-1),Rattus norvegicus (Rat),56.1,264.0,1.0999999999999999e-53,211.5,sp|Q99MZ8|LASP1_RAT LIM and SH3 domain protein 1 OS=Rattus norvegicus OX=10116 GN=Lasp1 PE=1 SV=1,GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0046872; GO:0051015; GO:0098794,monoatomic ion transport [GO:0006811],cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; postsynapse [GO:0098794],actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; monoatomic ion transmembrane transporter activity [GO:0015075],GO:0005215; GO:0005856; GO:0008092; GO:0043226,transporter activity; cytoskeleton; cytoskeletal protein binding; organelle
OG_04691,1.0606281587720856,FUN_022482-T1,Peve_00002923,Pocillopora_meandrina_HIv1___RNAseq.g4296.t1,three_way,79.319,FUN_022482-T1,O14929,HAT1_HUMAN,,Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1),Homo sapiens (Human),48.1,401.0,2.5e-106,387.1,sp|O14929|HAT1_HUMAN Histone acetyltransferase type B catalytic subunit OS=Homo sapiens OX=9606 GN=HAT1 PE=1 SV=2,GO:0000781; GO:0000785; GO:0004402; GO:0005634; GO:0005654; GO:0005739; GO:0006334; GO:0006475; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043997; GO:0051276,chromosome organization [GO:0051276]; internal protein amino acid acetylation [GO:0006475]; nucleosome assembly [GO:0006334]; subtelomeric heterochromatin formation [GO:0031509],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K12 acetyltransferase activity [GO:0043997],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006325; GO:0016740; GO:0042393; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; chromatin organization; transferase activity; histone binding; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_04692,1.687160614814182,FUN_022484-T1,Peve_00002924,Pocillopora_meandrina_HIv1___RNAseq.g4295.t1,three_way,86.47083333333333,FUN_022484-T1,Q8VID6,PDE11_RAT,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)",Rattus norvegicus (Rat),47.6,930.0,9.3e-242,838.2,"sp|Q8VID6|PDE11_RAT Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Rattus norvegicus OX=10116 GN=Pde11a PE=1 SV=1",GO:0004115; GO:0004118; GO:0005829; GO:0010754; GO:0019933; GO:0030553; GO:0043204; GO:0046872; GO:0047555; GO:0141162,cAMP-mediated signaling [GO:0019933]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754],cytosol [GO:0005829]; perikaryon [GO:0043204],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787,catalytic activity; cytosol; hydrolase activity
OG_04694,1.0700903327376914,FUN_022486-T1,Peve_00002926,Pocillopora_meandrina_HIv1___RNAseq.g4292.t1,three_way,75.504,FUN_022486-T1,P15882,CHIN_HUMAN,,N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin) (NC) (Rho GTPase-activating protein 2),Homo sapiens (Human),55.8,457.0,7e-142,505.4,sp|P15882|CHIN_HUMAN N-chimaerin OS=Homo sapiens OX=9606 GN=CHN1 PE=1 SV=3,GO:0005096; GO:0005829; GO:0008045; GO:0008270; GO:0046875; GO:0048013; GO:0050770; GO:0051056,ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of small GTPase mediated signal transduction [GO:0051056],cytosol [GO:0005829],ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_04697,1.2962616748843232,FUN_022494-T1,Peve_00043030,Pocillopora_meandrina_HIv1___TS.18734_t,three_way,69.23266666666666,,,,,,,,,,,,,,,,,
OG_04699,2.0449905170873617,FUN_022499-T1,Peve_00033031,Pocillopora_meandrina_HIv1___RNAseq.g4275.t1,three_way,69.74766666666667,FUN_022499-T1,A4IH82,,,,,29.7,290.0,3.3e-22,107.8,sp|A4IH82|3BP5L_XENTR SH3 domain-binding protein 5-like OS=Xenopus tropicalis OX=8364 GN=sh3bp5l PE=2 SV=1,,,,,,
OG_04708,1.1634632871678618,FUN_022512-T3,Peve_00029626,Pocillopora_meandrina_HIv1___RNAseq.g4258.t2,three_way,80.24166666666667,FUN_022512-T3,P49282,NRAM2_MOUSE,,Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2),Mus musculus (Mouse),65.1,504.0,1.1e-179,631.3,sp|P49282|NRAM2_MOUSE Natural resistance-associated macrophage protein 2 OS=Mus musculus OX=10090 GN=Slc11a2 PE=1 SV=2,GO:0005375; GO:0005381; GO:0005384; GO:0005634; GO:0005741; GO:0005765; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005903; GO:0006778; GO:0006779; GO:0006783; GO:0006824; GO:0006826; GO:0007611; GO:0009986; GO:0010039; GO:0012505; GO:0015078; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015295; GO:0016324; GO:0031526; GO:0031901; GO:0031902; GO:0033212; GO:0045178; GO:0046870; GO:0048471; GO:0048813; GO:0048821; GO:0051649; GO:0055037; GO:0055038; GO:0060586; GO:0070574; GO:0070826; GO:1902600; GO:1903561,cadmium ion transmembrane transport [GO:0070574]; cobalt ion transport [GO:0006824]; dendrite morphogenesis [GO:0048813]; erythrocyte development [GO:0048821]; establishment of localization in cell [GO:0051649]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transport [GO:0006826]; learning or memory [GO:0007611]; multicellular organismal-level iron ion homeostasis [GO:0060586]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; proton transmembrane transport [GO:1902600]; response to iron ion [GO:0010039],apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; proton transmembrane transporter activity [GO:0015078]; solute:proton symporter activity [GO:0015295],GO:0005215; GO:0005634; GO:0005768; GO:0005794; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,transporter activity; nucleus; endosome; Golgi apparatus; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_04717,1.1805115034882387,FUN_022539-T2,Peve_00025372,Pocillopora_meandrina_HIv1___RNAseq.g4147.t1,three_way,68.20566666666667,,,,,,,,,,,,,,,,,
OG_04722,1.806799133219993,FUN_022580-T1,Peve_00020261,Pocillopora_meandrina_HIv1___RNAseq.g4432.t1,three_way,74.89066666666666,FUN_022580-T1,Q5F3W2,,,,,42.0,205.0,8.4e-46,185.3,sp|Q5F3W2|INSI2_CHICK Insulin-induced gene 2 protein OS=Gallus gallus OX=9031 GN=INSIG2 PE=2 SV=2,,,,,,
OG_04723,1.837840131896134,FUN_022586-T1,Peve_00020593,Pocillopora_meandrina_HIv1___RNAseq.g4434.t2,three_way,67.00133333333333,FUN_022586-T1,Q9BE31,,,,,29.9,632.0,8e-77,289.7,sp|Q9BE31|RHG12_MACFA Rho GTPase-activating protein 12 OS=Macaca fascicularis OX=9541 GN=ARHGAP12 PE=2 SV=1,,,,,,
OG_04731,1.822514709250365,FUN_022599-T1,Peve_00012273,Pocillopora_meandrina_HIv1___RNAseq.g4424.t2,three_way,83.4855,FUN_022599-T1,F1LZW6,S2513_RAT,,"Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Solute carrier family 25 member 13)",Rattus norvegicus (Rat),51.9,671.0,7.100000000000001e-186,652.1,"sp|F1LZW6|S2513_RAT Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial OS=Rattus norvegicus OX=10116 GN=Slc25a13 PE=3 SV=4",GO:0000514; GO:0000515; GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006094; GO:0006754; GO:0015172; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592,aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],"3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]",GO:0005215; GO:0005739; GO:0005975; GO:0006091; GO:0043226; GO:0055085; GO:0055086; GO:1901135,transporter activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04737,4.764645763634374,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_04739,2.4449432735274947,FUN_022615-T1,Peve_00012268,Pocillopora_meandrina_HIv1___RNAseq.g4395.t1,three_way,62.804,FUN_022615-T1,P79691,SHH_CARAU,,Sonic hedgehog protein (SHHA) (EC 3.1.-.-) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) [Cleaved into: Sonic hedgehog protein A N-product (Shh N-terminal processed signaling domains) (ShhNp) (Sonic hedgehog protein N-product) (ShhN)],Carassius auratus (Goldfish),44.2,398.0,9.4e-82,305.4,sp|P79691|SHH_CARAU Sonic hedgehog protein OS=Carassius auratus OX=7957 GN=shha PE=3 SV=3,GO:0000139; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005789; GO:0005886; GO:0007224; GO:0007267; GO:0007389; GO:0008233; GO:0009888; GO:0010468; GO:0016539; GO:0016540; GO:0030182; GO:0035295; GO:0042127; GO:0045880; GO:0048468; GO:0048513; GO:0048709; GO:0050793; GO:0097264; GO:0140853,animal organ development [GO:0048513]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; pattern specification process [GO:0007389]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of cell population proliferation [GO:0042127]; regulation of developmental process [GO:0050793]; regulation of gene expression [GO:0010468]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888]; tube development [GO:0035295],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233],GO:0003824; GO:0005615; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0030154; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; transferase activity; hydrolase activity; signaling; cell differentiation; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_04748,1.2788453013528875,FUN_022631-T1,Peve_00012222,Pocillopora_meandrina_HIv1___RNAseq.g2907.t1,three_way,61.568000000000005,FUN_022631-T1,C3ZQF9,,,,,31.4,322.0,7.4e-33,143.3,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_04754,2.2859990072984857,FUN_022639-T1,Peve_00022141,Pocillopora_meandrina_HIv1___RNAseq.g9366.t2,three_way,68.227,FUN_022639-T1,Q9H330,,,,,37.4,854.0,4.4999999999999997e-129,463.8,sp|Q9H330|TM245_HUMAN Transmembrane protein 245 OS=Homo sapiens OX=9606 GN=TMEM245 PE=1 SV=3,,,,,,
OG_04755,1.8154393127496995,FUN_022640-T1,Peve_00022140,Pocillopora_meandrina_HIv1___RNAseq.g9367.t1,three_way,76.032,FUN_022640-T1,P49356,FNTB_HUMAN,,Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta),Homo sapiens (Human),54.6,388.0,6.6e-122,438.7,sp|P49356|FNTB_HUMAN Protein farnesyltransferase subunit beta OS=Homo sapiens OX=9606 GN=FNTB PE=1 SV=1,GO:0004660; GO:0005829; GO:0005875; GO:0005965; GO:0006629; GO:0008270; GO:0008284; GO:0010698; GO:0018343; GO:0019899; GO:0042277; GO:0045787; GO:0060632,lipid metabolic process [GO:0006629]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; protein farnesylation [GO:0018343]; regulation of microtubule-based movement [GO:0060632],cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965],acetyltransferase activator activity [GO:0010698]; enzyme binding [GO:0019899]; peptide binding [GO:0042277]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006629; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04756,1.146427478726187,FUN_022642-T1,Peve_00044337,Pocillopora_meandrina_HIv1___RNAseq.g9369.t1,three_way,57.92616666666667,FUN_022642-T1,Q14517,,,,,26.9,334.0,2.4e-19,100.1,sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2,,,,,,
OG_04758,2.2981182989111804,FUN_022647-T1,Peve_00036577,Pocillopora_meandrina_HIv1___RNAseq.g4454.t1,three_way,72.587,FUN_022647-T1,Q15434,,,,,61.2,232.0,9.8e-69,262.7,"sp|Q15434|RBMS2_HUMAN RNA-binding motif, single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1",,,,,,
OG_04762,1.0289670886077924,FUN_022662-T1,Peve_00027940,Pocillopora_meandrina_HIv1___RNAseq.g3157.t1b,three_way,84.34933333333333,FUN_022662-T1,Q5ZLC8,,,,,47.4,137.0,1.4e-25,120.2,sp|Q5ZLC8|ANR52_CHICK Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Gallus gallus OX=9031 GN=ANKRD52 PE=2 SV=1,,,,,,
OG_04765,2.3919252827396176,FUN_022665-T1,Peve_00036260,Pocillopora_meandrina_HIv1___RNAseq.g3193.t1,three_way,60.42666666666667,,,,,,,,,,,,,,,,,
OG_04768,1.3504566720964524,FUN_022670-T1,Peve_00003746,Pocillopora_meandrina_HIv1___RNAseq.g4535.t1,three_way,78.69650000000001,FUN_022670-T1,Q05096,MYO1B_RAT,,Unconventional myosin-Ib (Myosin I alpha) (MMI-alpha) (MMIa) (Myosin heavy chain myr 1),Rattus norvegicus (Rat),57.9,1094.0,2.4e-300,1033.1,sp|Q05096|MYO1B_RAT Unconventional myosin-Ib OS=Rattus norvegicus OX=10116 GN=Myo1b PE=1 SV=1,GO:0000146; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0006892; GO:0006897; GO:0007015; GO:0007399; GO:0010008; GO:0015629; GO:0016459; GO:0030048; GO:0030175; GO:0032588; GO:0033572; GO:0045177; GO:0048471; GO:0051015; GO:0051017; GO:0071944,actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0003774; GO:0003824; GO:0005768; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0016192; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_04780,1.147611255244758,FUN_022689-T1,Peve_00045106,Pocillopora_meandrina_HIv1___RNAseq.g4835.t1,three_way,78.04266666666666,FUN_022689-T1,Q8NKE2,,,,,44.2,278.0,4.999999999999999e-62,239.6,"sp|Q8NKE2|AOX_CRYNH Alternative oxidase, mitochondrial OS=Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) OX=235443 GN=AOX1 PE=3 SV=2",,,,,,
OG_04785,2.0015066420148195,FUN_022697-T1,Peve_00045103,Pocillopora_meandrina_HIv1___RNAseq.g4828.t1,three_way,67.73633333333333,FUN_022697-T1,Q9XJ54,,,,,53.3,120.0,8.5e-26,117.9,sp|Q9XJ54|NTF2_ORYSJ Nuclear transport factor 2 OS=Oryza sativa subsp. japonica OX=39947 GN=NTF2 PE=2 SV=1,,,,,,
OG_04788,1.3336292297781365,FUN_022702-T1,Peve_00018685,Pocillopora_meandrina_HIv1___TS.g22237.t2,three_way,74.7355,FUN_022702-T1,Q3MJK5,CDK12_RAT,,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (Protein kinase for splicing component)",Rattus norvegicus (Rat),77.8,334.0,3.2e-159,564.3,sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus OX=10116 GN=Cdk12 PE=1 SV=1,GO:0002944; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0006397; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019901; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0043484; GO:0045944; GO:0106310; GO:2000737,mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],cyclin K-CDK12 complex [GO:0002944]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04791,1.1789663475008365,FUN_022707-T1,Peve_00006887,Pocillopora_meandrina_HIv1___RNAseq.g4819.t1a,three_way,61.56366666666667,FUN_022707-T1,O60294,TYW4_HUMAN,,tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase),Homo sapiens (Human),32.6,242.0,5.8e-26,119.4,sp|O60294|TYW4_HUMAN tRNA wybutosine-synthesizing protein 4 OS=Homo sapiens OX=9606 GN=LCMT2 PE=1 SV=3,GO:0005737; GO:0006400; GO:0008175; GO:0030488; GO:0031591,tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],tRNA methyltransferase activity [GO:0008175],GO:0003824; GO:0006399; GO:0016740; GO:0140098; GO:1901135,"catalytic activity; tRNA metabolic process; transferase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_04794,1.3554566620882562,FUN_022710-T1,Peve_00006885,Pocillopora_meandrina_HIv1___RNAseq.g4817.t1,three_way,81.13166666666666,FUN_022710-T1,Q3T904,ATG9A_BOVIN,,Autophagy-related protein 9A (APG9-like 1) (Autophagy protein 9),Bos taurus (Bovine),54.5,462.0,1.2e-152,541.6,sp|Q3T904|ATG9A_BOVIN Autophagy-related protein 9A OS=Bos taurus OX=9913 GN=ATG9A PE=2 SV=1,GO:0000045; GO:0000139; GO:0000407; GO:0000421; GO:0000423; GO:0005739; GO:0005776; GO:0005789; GO:0005794; GO:0005802; GO:0017128; GO:0031902; GO:0031966; GO:0034045; GO:0034497; GO:0034727; GO:0055038; GO:0060349; GO:0061709; GO:0097300,autophagosome assembly [GO:0000045]; bone morphogenesis [GO:0060349]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; programmed necrotic cell death [GO:0097300]; protein localization to phagophore assembly site [GO:0034497]; reticulophagy [GO:0061709],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802],phospholipid scramblase activity [GO:0017128],GO:0005215; GO:0005739; GO:0005773; GO:0005794; GO:0006914; GO:0012501; GO:0043226,transporter activity; mitochondrion; vacuole; Golgi apparatus; autophagy; programmed cell death; organelle
OG_04795,1.7612442373517083,FUN_022711-T1,Peve_00006886,Pocillopora_meandrina_HIv1___TS.g22231.t1,three_way,42.857,,,,,,,,,,,,,,,,,
OG_04802,1.824641162930915,FUN_022761-T1,Peve_00006882,Pocillopora_meandrina_HIv1___RNAseq.g4814.t1,three_way,80.2745,,,,,,,,,,,,,,,,,
OG_04805,1.2132011835207002,FUN_022764-T1,Peve_00014654,Pocillopora_meandrina_HIv1___RNAseq.g4808.t1,three_way,73.40683333333334,FUN_022764-T1,Q6QHK4,FIGLA_HUMAN,,Factor in the germline alpha (FIGalpha) (Class C basic helix-loop-helix protein 8) (bHLHc8) (Folliculogenesis-specific basic helix-loop-helix protein) (Transcription factor FIGa),Homo sapiens (Human),45.3,64.0,1.6e-08,61.2,sp|Q6QHK4|FIGLA_HUMAN Factor in the germline alpha OS=Homo sapiens OX=9606 GN=FIGLA PE=1 SV=2,GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0032502; GO:0043425; GO:0046983; GO:0048599; GO:1990837,developmental process [GO:0032502]; oocyte development [GO:0048599]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04806,1.95752274648075,FUN_022765-T1,Peve_00014656,Pocillopora_meandrina_HIv1___RNAseq.g4805.t1,three_way,83.05433333333333,FUN_022765-T1,P13903,,,,,77.5,89.0,1.1e-31,137.5,sp|P13903|TWIST_XENLA Twist-related protein OS=Xenopus laevis OX=8355 GN=twist1 PE=2 SV=1,,,,,,
OG_04808,1.7079899418732976,FUN_022767-T1,Peve_00014658,Pocillopora_meandrina_HIv1___RNAseq.g4729.t1,three_way,73.63166666666666,FUN_022767-T1,Q7ZX22,WDR24_XENLA,,GATOR2 complex protein WDR24 (EC 2.3.2.27),Xenopus laevis (African clawed frog),38.4,799.0,4.6e-160,566.6,sp|Q7ZX22|WDR24_XENLA GATOR2 complex protein WDR24 OS=Xenopus laevis OX=8355 GN=wdr24 PE=2 SV=1,GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0008270; GO:0016239; GO:0031669; GO:0034198; GO:0061630; GO:0061700; GO:0085020; GO:1904263,autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; protein K6-linked ubiquitination [GO:0085020],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016740; GO:0140096,"catalytic activity; cytosol; autophagy; transferase activity; catalytic activity, acting on a protein"
OG_04809,1.4663959099014896,FUN_022771-T1,Peve_00043386,Pocillopora_meandrina_HIv1___RNAseq.g4766.t1,three_way,62.87,FUN_022771-T1,P49442,,,,,39.7,393.0,1.5e-66,255.0,sp|P49442|INPP_MOUSE Inositol polyphosphate 1-phosphatase OS=Mus musculus OX=10090 GN=Inpp1 PE=1 SV=2,,,,,,
OG_04813,1.3462641122672794,FUN_022777-T1,Peve_00021164,Pocillopora_meandrina_HIv1___RNAseq.g4771.t1,three_way,52.269,,,,,,,,,,,,,,,,,
OG_04814,1.9442159045506129,FUN_022778-T1,Peve_00021168,Pocillopora_meandrina_HIv1___RNAseq.g4772.t1,three_way,76.42866666666667,,,,,,,,,,,,,,,,,
OG_04818,1.7535586858134304,FUN_022804-T1,Peve_00024731,Pocillopora_meandrina_HIv1___RNAseq.g3480.t1,three_way,66.91633333333334,FUN_022804-T1,Q9NQZ5,STAR7_HUMAN,,"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)",Homo sapiens (Human),44.1,247.0,7.6000000000000005e-59,229.2,"sp|Q9NQZ5|STAR7_HUMAN StAR-related lipid transfer protein 7, mitochondrial OS=Homo sapiens OX=9606 GN=STARD7 PE=1 SV=2",GO:0001773; GO:0005576; GO:0005739; GO:0005741; GO:0006744; GO:0006954; GO:0008289; GO:0042092; GO:0061436; GO:0120013; GO:0120197; GO:0140104,establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; mucociliary clearance [GO:0120197]; myeloid dendritic cell activation [GO:0001773]; type 2 immune response [GO:0042092]; ubiquinone biosynthetic process [GO:0006744],extracellular region [GO:0005576]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; lipid transfer activity [GO:0120013]; molecular carrier activity [GO:0140104],GO:0002376; GO:0003016; GO:0005215; GO:0005576; GO:0005739; GO:0006954; GO:0007018; GO:0008289; GO:0043226; GO:0048856; GO:0140104,immune system process; respiratory system process; transporter activity; extracellular region; mitochondrion; inflammatory response; microtubule-based movement; lipid binding; organelle; anatomical structure development; molecular carrier activity
OG_04819,1.492835855767363,FUN_022805-T1,Peve_00018106,Pocillopora_meandrina_HIv1___RNAseq.g3479.t1,three_way,60.698,,,,,,,,,,,,,,,,,
OG_04825,1.231217617509088,FUN_022817-T1,Peve_00014997,Pocillopora_meandrina_HIv1___TS.g9632.t1,three_way,48.804,,,,,,,,,,,,,,,,,
OG_04829,2.0196393276980795,FUN_022823-T1,Peve_00027665,Pocillopora_meandrina_HIv1___RNAseq.g3439.t1,three_way,69.43183333333333,FUN_022823-T1,A8MU46,SMTL1_HUMAN,,Smoothelin-like protein 1,Homo sapiens (Human),49.5,101.0,9.6e-22,106.7,sp|A8MU46|SMTL1_HUMAN Smoothelin-like protein 1 OS=Homo sapiens OX=9606 GN=SMTNL1 PE=1 SV=2,GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0008157; GO:0009410; GO:0014823; GO:0031430; GO:0031674; GO:0042310; GO:0043292; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718,muscle organ morphogenesis [GO:0048644]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310],contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; I band [GO:0031674]; M band [GO:0031430]; nucleus [GO:0005634],calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523],GO:0003013; GO:0005634; GO:0006355; GO:0008092; GO:0043226,circulatory system process; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; organelle
OG_04831,1.206303339216506,FUN_022825-T1,Peve_00028904,Pocillopora_meandrina_HIv1___RNAseq.g3433.t1,three_way,66.04366666666667,FUN_022825-T1,O43156,TTI1_HUMAN,,TELO2-interacting protein 1 homolog (Protein SMG10),Homo sapiens (Human),33.4,1144.0,2.5e-172,607.8,sp|O43156|TTI1_HUMAN TELO2-interacting protein 1 homolog OS=Homo sapiens OX=9606 GN=TTI1 PE=1 SV=3,GO:0005634; GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0050821; GO:0110078; GO:2000003,positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006],cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT Hsp90 cochaperone complex [GO:0110078],,GO:0005634; GO:0043226,nucleus; organelle
OG_04834,1.2581432297847173,FUN_022832-T1,Peve_00028897,Pocillopora_meandrina_HIv1___RNAseq.g3430.t1,three_way,80.637,FUN_022832-T1,Q8WXB1,MT21A_HUMAN,,Protein N-lysine methyltransferase METTL21A (EC 2.1.1.-) (HSPA lysine methyltransferase) (HSPA-KMT) (Hepatocellular carcinoma-associated antigen 557b) (Methyltransferase-like protein 21A),Homo sapiens (Human),53.4,161.0,2.2e-38,160.2,sp|Q8WXB1|MT21A_HUMAN Protein N-lysine methyltransferase METTL21A OS=Homo sapiens OX=9606 GN=METTL21A PE=1 SV=2,GO:0005654; GO:0005829; GO:0006479; GO:0008276; GO:0016279; GO:0030544; GO:0031072; GO:0032991; GO:0051117; GO:1903645,negative regulation of chaperone-mediated protein folding [GO:1903645]; protein methylation [GO:0006479],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_04835,1.313031404583766,FUN_022833-T1,Peve_00028896,Pocillopora_meandrina_HIv1___RNAseq.g3429.t1,three_way,83.13033333333334,FUN_022833-T1,Q969Q5,RAB24_HUMAN,,Ras-related protein Rab-24 (EC 3.6.5.2),Homo sapiens (Human),69.6,171.0,4.8e-66,252.3,sp|Q969Q5|RAB24_HUMAN Ras-related protein Rab-24 OS=Homo sapiens OX=9606 GN=RAB24 PE=1 SV=1,GO:0000421; GO:0001556; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0008608; GO:0012505; GO:0030139; GO:0030667; GO:0048471; GO:0140013,attachment of spindle microtubules to kinetochore [GO:0008608]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; meiotic nuclear division [GO:0140013]; oocyte maturation [GO:0001556],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle [GO:0005819],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0098772; GO:0140013,catalytic activity; GTPase activity; mitochondrion; endosome; vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity; meiotic nuclear division
OG_04836,1.0275991958804005,FUN_022834-T1,Peve_00028894,Pocillopora_meandrina_HIv1___RNAseq.g3426.t1,three_way,70.747,FUN_022834-T1,P57775,,,,,34.0,391.0,1.3e-56,221.9,sp|P57775|FBXW4_HUMAN F-box/WD repeat-containing protein 4 OS=Homo sapiens OX=9606 GN=FBXW4 PE=1 SV=1,,,,,,
OG_04846,1.1124603296772746,FUN_022856-T1,Peve_00004026,Pocillopora_meandrina_HIv1___RNAseq.g3389.t1,three_way,83.74,FUN_022856-T1,A2TLM1,,,,,67.5,194.0,8.9e-66,251.5,sp|A2TLM1|RPIA_PIG Ribose-5-phosphate isomerase OS=Sus scrofa OX=9823 GN=RPIA PE=2 SV=1,,,,,,
OG_04849,1.8249735684503232,FUN_022861-T1,Peve_00025611,Pocillopora_meandrina_HIv1___RNAseq.g3605.t1,three_way,79.88833333333334,FUN_022861-T1,O55003,BNIP3_MOUSE,,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,Mus musculus (Mouse),33.5,188.0,1.5e-15,84.3,sp|O55003|BNIP3_MOUSE BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 OS=Mus musculus OX=10090 GN=Bnip3 PE=1 SV=1,GO:0000423; GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005789; GO:0006915; GO:0009617; GO:0010637; GO:0010659; GO:0010666; GO:0010917; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043069; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0061709; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097193; GO:0097345; GO:0140506; GO:0140507; GO:0140580; GO:1902109; GO:1903599; GO:1990144,apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; mitophagy [GO:0000423]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of programmed cell death [GO:0043069]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane permeability [GO:0046902]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; reticulophagy [GO:0061709],cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; mitochondrion autophagosome adaptor activity [GO:0140580]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0006914; GO:0007005; GO:0012501; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0061024,nucleus; nuclear envelope; nucleoplasm; mitochondrion; autophagy; mitochondrion organization; programmed cell death; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; membrane organization
OG_04851,1.2228565161173706,FUN_022863-T1,Peve_00025604,Pocillopora_meandrina_HIv1___RNAseq.g3607.t1,three_way,83.18433333333333,FUN_022863-T1,Q5F450,PAN2_CHICK,,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2),Gallus gallus (Chicken),51.1,1129.0,0.0,1086.6,sp|Q5F450|PAN2_CHICK PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Gallus gallus OX=9031 GN=PAN2 PE=2 SV=1,GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535],GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_04852,1.2532476149930487,FUN_022864-T1,Peve_00025619,Pocillopora_meandrina_HIv1___TS.g9783.t1,three_way,69.89,FUN_022864-T1,Q9BSG0,,,,,43.6,165.0,7.2e-38,158.7,sp|Q9BSG0|PADC1_HUMAN Protease-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PRADC1 PE=1 SV=1,,,,,,
OG_04854,1.6163725665194524,FUN_022868-T1,Peve_00012303,Pocillopora_meandrina_HIv1___RNAseq.g3613.t1,three_way,73.38633333333333,FUN_022868-T1,Q804R0,LBX2_DANRE,,Transcription factor LBX2 (Ladybird homeobox 2) (Ladybird homeobox protein homolog 2),Danio rerio (Zebrafish) (Brachydanio rerio),46.3,177.0,4.2e-30,132.9,sp|Q804R0|LBX2_DANRE Transcription factor LBX2 OS=Danio rerio OX=7955 GN=lbx2 PE=1 SV=1,GO:0000578; GO:0000981; GO:0005634; GO:0006357; GO:0042692; GO:0048920; GO:0048922; GO:0055001; GO:0060828; GO:1904105; GO:1990837; GO:2000052,embryonic axis specification [GO:0000578]; muscle cell development [GO:0055001]; muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; posterior lateral line neuromast deposition [GO:0048922]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04856,1.3124606468529467,FUN_022870-T1,Peve_00012300,Pocillopora_meandrina_HIv1___RNAseq.g3615.t1,three_way,81.07966666666667,FUN_022870-T1,P70061,,,,,67.0,106.0,5.3e-32,139.4,sp|P70061|NKX32_XENLA Homeobox protein Nkx-3.2 OS=Xenopus laevis OX=8355 GN=nkx3-2 PE=2 SV=1,,,,,,
OG_04857,1.1513683776573898,FUN_022871-T1,Peve_00012299,Pocillopora_meandrina_HIv1___RNAseq.g3616.t1,three_way,89.286,FUN_022871-T1,Q90788,NKX25_CHICK,,Homeobox protein Nkx-2.5 (cNKx-2.5) (Homeobox protein NK-2 homolog E),Gallus gallus (Chicken),52.2,159.0,1.2e-33,145.2,sp|Q90788|NKX25_CHICK Homeobox protein Nkx-2.5 OS=Gallus gallus OX=9031 GN=NKX-2.5 PE=2 SV=1,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001947; GO:0003148; GO:0003166; GO:0003168; GO:0003211; GO:0003221; GO:0003222; GO:0003228; GO:0003278; GO:0003285; GO:0003342; GO:0003350; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007512; GO:0010628; GO:0010667; GO:0010765; GO:0010832; GO:0030097; GO:0030154; GO:0030855; GO:0030878; GO:0032991; GO:0032993; GO:0042803; GO:0045666; GO:0045823; GO:0048536; GO:0050673; GO:0050679; GO:0051891; GO:0055005; GO:0055117; GO:0060037; GO:0060038; GO:0060043; GO:0060048; GO:0060261; GO:0060347; GO:0060412; GO:0060413; GO:0060928; GO:0060929; GO:0060971; GO:0061629; GO:0071772; GO:0090090; GO:1903779; GO:1904019; GO:1904036; GO:1990664,adult heart development [GO:0007512]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; bundle of His development [GO:0003166]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; response to BMP [GO:0071772]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytosol [GO:0005829]; Nkx-2.5 complex [GO:1990664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007010; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04858,2.204119915953756,FUN_022873-T1,Peve_00012298,Pocillopora_meandrina_HIv1___RNAseq.g3617.t1,three_way,80.57066666666667,FUN_022873-T1,P13297,MSX1_MOUSE,,Homeobox protein MSX-1 (Homeobox protein Hox-7) (Hox-7.1) (Msh homeobox 1-like protein),Mus musculus (Mouse),65.8,149.0,1e-41,171.8,sp|P13297|MSX1_MOUSE Homeobox protein MSX-1 OS=Mus musculus OX=10090 GN=Msx1 PE=1 SV=4,GO:0000122; GO:0000902; GO:0000976; GO:0000977; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001701; GO:0001837; GO:0002039; GO:0003007; GO:0003198; GO:0005634; GO:0005654; GO:0005667; GO:0006366; GO:0007507; GO:0007517; GO:0008285; GO:0009952; GO:0010463; GO:0010629; GO:0021983; GO:0023019; GO:0030308; GO:0030326; GO:0030509; GO:0030513; GO:0030900; GO:0030901; GO:0034399; GO:0034504; GO:0035115; GO:0035116; GO:0035880; GO:0042474; GO:0042475; GO:0042476; GO:0042481; GO:0042482; GO:0042733; GO:0043066; GO:0043565; GO:0043584; GO:0045787; GO:0045892; GO:0045944; GO:0048839; GO:0048863; GO:0050821; GO:0051154; GO:0060021; GO:0060325; GO:0060349; GO:0060536; GO:0061180; GO:0061311; GO:0071316; GO:0090427; GO:0097152; GO:1901330; GO:1902255; GO:2001055,activation of meiosis [GO:0090427]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; bone morphogenesis [GO:0060349]; cartilage morphogenesis [GO:0060536]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway involved in heart development [GO:0061311]; cellular response to nicotine [GO:0071316]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic nail plate morphogenesis [GO:0035880]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; mammary gland epithelium development [GO:0061180]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of odontoblast differentiation [GO:1901330]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nose development [GO:0043584]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; pituitary gland development [GO:0021983]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell cycle [GO:0045787]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of odontogenesis [GO:0042482]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of odontogenesis [GO:0042481]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366],nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04860,1.2880597291814002,FUN_022877-T1,Peve_00012293,Pocillopora_meandrina_HIv1___RNAseq.g3620.t1,three_way,78.91933333333333,FUN_022877-T1,Q9BRF8,CPPED_HUMAN,,Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1),Homo sapiens (Human),48.3,294.0,1.3e-80,301.2,sp|Q9BRF8|CPPED_HUMAN Serine/threonine-protein phosphatase CPPED1 OS=Homo sapiens OX=9606 GN=CPPED1 PE=1 SV=3,GO:0004722; GO:0005576; GO:0005829; GO:0005886; GO:0035578; GO:0046872,,azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005576; GO:0005829; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular region; cytosol; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_04861,1.3584756784697578,FUN_022878-T1,Peve_00012292,Pocillopora_meandrina_HIv1___RNAseq.g3621.t1,three_way,69.06,,,,,,,,,,,,,,,,,
OG_04868,1.3384147906323658,FUN_022895-T1,Peve_00001718,Pocillopora_meandrina_HIv1___RNAseq.g3694.t1,three_way,68.29366666666667,FUN_022895-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),39.7,715.0,1.4e-142,508.4,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04869,2.102821253879349,FUN_022896-T1,Peve_00001719,Pocillopora_meandrina_HIv1___RNAseq.g3697.t1,three_way,53.845,,,,,,,,,,,,,,,,,
OG_04870,1.4166182230388178,FUN_022897-T1,Peve_00001717,Pocillopora_meandrina_HIv1___RNAseq.g3698.t1,three_way,60.53266666666666,FUN_022897-T1,Q0VCR4,PPR3C_BOVIN,,Protein phosphatase 1 regulatory subunit 3C (Protein phosphatase 1 regulatory subunit 5) (PP1 subunit R5) (Protein targeting to glycogen) (PTG),Bos taurus (Bovine),35.8,176.0,3e-26,120.2,sp|Q0VCR4|PPR3C_BOVIN Protein phosphatase 1 regulatory subunit 3C OS=Bos taurus OX=9913 GN=PPP1R3C PE=2 SV=1,GO:0000164; GO:0005829; GO:0005977; GO:0005978; GO:0005979; GO:0008157; GO:0019903; GO:0060090; GO:2001069,glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979],cytosol [GO:0005829]; protein phosphatase type 1 complex [GO:0000164],glycogen binding [GO:2001069]; molecular adaptor activity [GO:0060090]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903],GO:0005829; GO:0005975; GO:0006091; GO:0060090,cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; molecular adaptor activity
OG_04874,2.1676837079040343,FUN_022903-T1,Peve_00001842,Pocillopora_meandrina_HIv1___RNAseq.g3702.t1,three_way,81.031,FUN_022903-T1,Q6ZQN7,SO4C1_HUMAN,,Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (OATP-H) (Organic anion transporter M1) (OATP-M1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20),Homo sapiens (Human),35.1,615.0,6.1e-111,403.3,sp|Q6ZQN7|SO4C1_HUMAN Solute carrier organic anion transporter family member 4C1 OS=Homo sapiens OX=9606 GN=SLCO4C1 PE=1 SV=1,GO:0005886; GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0016323; GO:0030154; GO:0035577; GO:0035579; GO:0043252; GO:0070062,cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283],azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347],GO:0005215; GO:0005886; GO:0022414; GO:0030154; GO:0043226,transporter activity; plasma membrane; reproductive process; cell differentiation; organelle
OG_04875,1.3714673842720544,FUN_022906-T1,Peve_00001841,Pocillopora_meandrina_HIv1___RNAseq.g3703.t1,three_way,76.03683333333333,,,,,,,,,,,,,,,,,
OG_04877,1.5392502605923564,FUN_022908-T1,Peve_00001834,Pocillopora_meandrina_HIv1___RNAseq.g3705.t1,three_way,83.53733333333334,FUN_022908-T1,Q08DA5,,,,,59.4,360.0,8.9e-119,428.3,sp|Q08DA5|PANK3_BOVIN Pantothenate kinase 3 OS=Bos taurus OX=9913 GN=PANK3 PE=2 SV=1,,,,,,
OG_04880,1.736632445913082,FUN_022914-T1,Peve_00001826,Pocillopora_meandrina_HIv1___RNAseq.g3710.t1,three_way,80.40933333333334,FUN_022914-T1,Q63028,ADDA_RAT,,Alpha-adducin (Erythrocyte adducin subunit alpha),Rattus norvegicus (Rat),47.2,375.0,3.7e-87,323.9,sp|Q63028|ADDA_RAT Alpha-adducin OS=Rattus norvegicus OX=10116 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008290; GO:0014069; GO:0016020; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0046983; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393,actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608],GO:0005198; GO:0005634; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nucleus; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_04882,1.5559900291498292,FUN_022916-T1,Peve_00001780,Pocillopora_meandrina_HIv1___RNAseq.g3712.t1,three_way,72.08516666666667,,,,,,,,,,,,,,,,,
OG_04885,2.363674406980884,FUN_022922-T1,Peve_00008665,Pocillopora_meandrina_HIv1___RNAseq.g3726.t1,three_way,68.77866666666667,FUN_022922-T1,Q58A42,DD3_DICDI,,Protein DD3-3,Dictyostelium discoideum (Social amoeba),33.6,661.0,3e-82,307.8,sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_04889,1.235285466054585,FUN_022930-T1,Peve_00032135,Pocillopora_meandrina_HIv1___RNAseq.g3729.t1,three_way,70.59166666666667,,,,,,,,,,,,,,,,,
OG_04890,1.1832564313789309,FUN_022933-T1,Peve_00016029,Pocillopora_meandrina_HIv1___RNAseq.g3734.t1,three_way,55.45366666666667,,,,,,,,,,,,,,,,,
OG_04895,2.373522481726617,FUN_022939-T1,Peve_00026755,Pocillopora_meandrina_HIv1___RNAseq.g3742.t1,three_way,61.73183333333333,FUN_022939-T1,A8WG21,,,,,39.9,153.0,2.9e-19,97.1,sp|A8WG21|SNXAB_DANRE Sorting nexin-10B OS=Danio rerio OX=7955 GN=snx10b PE=2 SV=1,,,,,,
OG_04896,1.319370848637836,FUN_022940-T1,Peve_00001686,Pocillopora_meandrina_HIv1___RNAseq.g3744.t1,three_way,83.253,FUN_022940-T1,Q9JJX8,,,,,59.5,375.0,1.900000000000001e-130,467.2,sp|Q9JJX8|ST32B_MOUSE Serine/threonine-protein kinase 32B OS=Mus musculus OX=10090 GN=Stk32b PE=2 SV=2,,,,,,
OG_04897,1.172559830105423,FUN_022941-T1,Peve_00001690,Pocillopora_meandrina_HIv1___RNAseq.g3745.t1,three_way,72.69833333333334,FUN_022941-T1,Q9HDY1,,,,,24.5,575.0,2.9e-24,115.2,sp|Q9HDY1|ASE1_SCHPO Anaphase spindle elongation protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ase1 PE=1 SV=1,,,,,,
OG_04898,1.7384357044073664,FUN_022942-T2,Peve_00001683,Pocillopora_meandrina_HIv1___RNAseq.g3746.t1,three_way,53.5425,FUN_022942-T2,Q76NI1,KNDC1_HUMAN,,Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2),Homo sapiens (Human),29.4,901.0,7e-79,298.5,sp|Q76NI1|KNDC1_HUMAN Kinase non-catalytic C-lobe domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KNDC1 PE=1 SV=2,GO:0001934; GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773,cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase-mediated signal transduction [GO:0007264],dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0030154; GO:0098772,cell differentiation; molecular function regulator activity
OG_04900,1.85364558027191,FUN_022945-T1,Peve_00015105,Pocillopora_meandrina_HIv1___RNAseq.g3748.t1,three_way,90.02333333333334,FUN_022945-T1,E7FDB3,,,,,59.2,76.0,2e-20,100.9,sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1,,,,,,
OG_04903,2.1302409746910045,FUN_022949-T1,Peve_00005144,Pocillopora_meandrina_HIv1___TS.g9923.t1,three_way,70.34633333333333,FUN_022949-T1,Q9JIP0,TRPV5_RAT,,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transporter 2) (CaT2) (Epithelial calcium channel 1) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),Rattus norvegicus (Rat),27.3,598.0,1.4999999999999998e-43,179.5,sp|Q9JIP0|TRPV5_RAT Transient receptor potential cation channel subfamily V member 5 OS=Rattus norvegicus OX=10116 GN=Trpv5 PE=1 SV=1,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809],apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003014; GO:0005215; GO:0005886; GO:0055085; GO:0065003,renal system process; transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_04912,1.1854265202161964,FUN_022965-T1,Peve_00011899,Pocillopora_meandrina_HIv1___RNAseq.g3764.t1,three_way,81.05166666666666,FUN_022965-T1,Q6NTV9,,,,,55.1,98.0,1.2e-22,107.5,sp|Q6NTV9|NHP2_XENLA H/ACA ribonucleoprotein complex subunit 2-like protein OS=Xenopus laevis OX=8355 GN=nhp2 PE=2 SV=1,,,,,,
OG_04914,1.370645384900522,FUN_022968-T1,Peve_00011901,Pocillopora_meandrina_HIv1___RNAseq.g3762.t1,three_way,74.65283333333333,FUN_022968-T1,Q14185,,,,,47.2,1635.0,0.0,1488.4,sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2,,,,,,
OG_04916,1.1439709124165427,FUN_022970-T1,Peve_00011906,Pocillopora_meandrina_HIv1___RNAseq.17380_t,three_way,66.845,FUN_022970-T1,Q9QYC0,ADDA_MOUSE,,Alpha-adducin (Erythrocyte adducin subunit alpha),Mus musculus (Mouse),34.7,395.0,3.5e-58,227.6,sp|Q9QYC0|ADDA_MOUSE Alpha-adducin OS=Mus musculus OX=10090 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0003779; GO:0005200; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006884; GO:0016020; GO:0016604; GO:0020027; GO:0030218; GO:0035264; GO:0045202; GO:0048873; GO:0071277; GO:1903142; GO:1903393,cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_04920,1.596556846517741,FUN_022978-T1,Peve_00027960,Pocillopora_meandrina_HIv1___RNAseq.g3754.t1,three_way,71.34933333333333,FUN_022978-T1,Q28FF3,,,,,41.1,436.0,3.3e-92,340.5,sp|Q28FF3|S49A3_XENTR Solute carrier family 49 member A3 OS=Xenopus tropicalis OX=8364 GN=slc49a3 PE=2 SV=2,,,,,,
OG_04928,2.059619915360535,FUN_022993-T1,Peve_00043404,Pocillopora_meandrina_HIv1___RNAseq.g3789.t1,three_way,71.83366666666667,,,,,,,,,,,,,,,,,
OG_04931,1.0304924635095118,FUN_022998-T1,Peve_00006898,Pocillopora_meandrina_HIv1___RNAseq.g3792.t1,three_way,50.482,,,,,,,,,,,,,,,,,
OG_04942,1.4998690351344244,FUN_023017-T1,Peve_00010018,Pocillopora_meandrina_HIv1___RNAseq.g3833.t1,three_way,60.31033333333333,FUN_023017-T1,Q1PSW8,LIN41_MOUSE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Mus musculus (Mouse),21.1,313.0,9.5e-09,63.2,sp|Q1PSW8|LIN41_MOUSE E3 ubiquitin-protein ligase TRIM71 OS=Mus musculus OX=10090 GN=Trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637,3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04944,1.220850206533199,FUN_023023-T1,Peve_00010022,Pocillopora_meandrina_HIv1___RNAseq.g3837.t1,three_way,74.59233333333333,FUN_023023-T1,Q91175,,,,,31.2,333.0,6e-37,156.4,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_04946,2.229734219729101,FUN_023033-T1,Peve_00008499,Pocillopora_meandrina_HIv1___RNAseq.g3855.t2,three_way,61.9305,FUN_023033-T1,O14924,,,,,29.3,1289.0,6.6e-108,394.4,sp|O14924|RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens OX=9606 GN=RGS12 PE=1 SV=1,,,,,,
OG_04948,1.0992558499451748,FUN_023038-T1,Peve_00008502,Pocillopora_meandrina_HIv1___RNAseq.17481_t,three_way,82.503,,,,,,,,,,,,,,,,,
OG_04949,1.4100438410065956,FUN_023039-T1,Peve_00008503,Pocillopora_meandrina_HIv1___RNAseq.g3858.t1,three_way,73.10366666666667,FUN_023039-T1,B5FYQ0,ARL3_TAEGU,,ADP-ribosylation factor-like protein 3,Taeniopygia guttata (Zebra finch) (Poephila guttata),70.2,181.0,1.6e-68,260.4,sp|B5FYQ0|ARL3_TAEGU ADP-ribosylation factor-like protein 3 OS=Taeniopygia guttata OX=59729 GN=ARL3 PE=2 SV=1,GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0015031; GO:0019003; GO:0030496; GO:0032391; GO:0036064; GO:0042073; GO:0042461; GO:0060271; GO:1903441,cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017],GO:0000910; GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005929; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0043226; GO:0044782; GO:0048856,cytokinesis; catalytic activity; GTPase activity; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cilium; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; organelle; cilium organization; anatomical structure development
OG_04957,1.0469465621700569,FUN_023047-T1,Peve_00008514,Pocillopora_meandrina_HIv1___RNAseq.g3871.t1,three_way,45.82666666666667,FUN_023047-T1,Q6NUJ5,PWP2B_HUMAN,,PWWP domain-containing protein 2B,Homo sapiens (Human),48.9,92.0,3.3e-17,91.7,sp|Q6NUJ5|PWP2B_HUMAN PWWP domain-containing protein 2B OS=Homo sapiens OX=9606 GN=PWWP2B PE=1 SV=3,GO:0005634; GO:0005654; GO:0006338; GO:0032968; GO:0120161; GO:0120325,chromatin remodeling [GO:0006338]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cold-induced thermogenesis [GO:0120161],nucleoplasm [GO:0005654]; nucleus [GO:0005634],NuRD complex binding [GO:0120325],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_04959,1.2662554380067133,FUN_023050-T1,Peve_00008516,Pocillopora_meandrina_HIv1___RNAseq.g3873.t1,three_way,85.382,FUN_023050-T1,Q7M760,ZRAN1_MOUSE,,Ubiquitin thioesterase Zranb1 (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1),Mus musculus (Mouse),46.4,724.0,1.2e-185,651.4,sp|Q7M760|ZRAN1_MOUSE Ubiquitin thioesterase Zranb1 OS=Mus musculus OX=10090 GN=Zranb1 PE=2 SV=1,GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0008270; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0035523; GO:0070530; GO:0070536; GO:0071947; GO:1990168,cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0007010; GO:0016787; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton organization; hydrolase activity; organelle; cell motility; catalytic activity, acting on a protein"
OG_04961,1.9233494390780088,FUN_023053-T1,Peve_00027088,Pocillopora_meandrina_HIv1___RNAseq.g13314.t1,three_way,61.67966666666666,,,,,,,,,,,,,,,,,
OG_04962,1.409802370678577,FUN_023054-T2,Peve_00008519,Pocillopora_meandrina_HIv1___RNAseq.g3877.t1,three_way,70.94933333333334,FUN_023054-T2,Q9BPW9,DHRS9_HUMAN,,Dehydrogenase/reductase SDR family member 9 (EC 1.1.1.209) (EC 1.1.1.53) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15) (EC 1.1.1.105) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),Homo sapiens (Human),45.9,305.0,1.2e-66,255.0,sp|Q9BPW9|DHRS9_HUMAN Dehydrogenase/reductase SDR family member 9 OS=Homo sapiens OX=9606 GN=DHRS9 PE=1 SV=1,GO:0004022; GO:0004745; GO:0005789; GO:0008202; GO:0008209; GO:0016491; GO:0016854; GO:0030855; GO:0042448; GO:0042572; GO:0042904; GO:0043231; GO:0047023; GO:0047035; GO:0047044,9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"alcohol dehydrogenase (NAD+) activity [GO:0004022]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; oxidoreductase activity [GO:0016491]; racemase and epimerase activity [GO:0016854]; testosterone dehydrogenase (NAD+) activity [GO:0047035]",GO:0003824; GO:0006629; GO:0016491; GO:0016853; GO:0030154; GO:0043226,catalytic activity; lipid metabolic process; oxidoreductase activity; isomerase activity; cell differentiation; organelle
OG_04965,1.5711473935398517,FUN_023064-T1,Peve_00024668,Pocillopora_meandrina_HIv1___RNAseq.g3883.t1,three_way,87.05566666666667,FUN_023064-T1,P43249,,,,,62.2,566.0,1.8e-203,710.3,sp|P43249|GRK5_BOVIN G protein-coupled receptor kinase 5 OS=Bos taurus OX=9913 GN=GRK5 PE=1 SV=1,,,,,,
OG_04966,1.1666424104010025,FUN_023066-T1,Peve_00024667,Pocillopora_meandrina_HIv1___RNAseq.g3884.t2,three_way,87.49933333333333,FUN_023066-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),46.5,2103.0,0.0,1895.2,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_04968,1.452418811972301,FUN_023073-T1,Peve_00014063,Pocillopora_meandrina_HIv1___RNAseq.g1646.t2,three_way,77.28333333333333,FUN_023073-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),42.4,2171.0,0.0,1587.8,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_04969,1.7983540699894192,FUN_023074-T1,Peve_00014065,Pocillopora_meandrina_HIv1___RNAseq.g1647.t1,three_way,71.61066666666666,FUN_023074-T1,Q8NBF2,,,,,51.1,704.0,3.9e-195,682.9,sp|Q8NBF2|NHLC2_HUMAN NHL repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=NHLRC2 PE=1 SV=1,,,,,,
OG_04976,1.3341255767162636,FUN_023085-T1,Peve_00027837,Pocillopora_meandrina_HIv1___RNAseq.g1661.t1,three_way,55.247166666666665,FUN_023085-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),30.7,313.0,4.7e-31,137.1,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_04979,1.4235687355977509,FUN_023099-T1,Peve_00006979,Pocillopora_meandrina_HIv1___TS.g4182.t1,three_way,64.4485,FUN_023099-T1,P55115,,,,,34.9,278.0,7e-41,171.0,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_04981,1.46551484671099,FUN_023108-T1,Peve_00038931,Pocillopora_meandrina_HIv1___RNAseq.g1687.t1,three_way,51.39366666666667,FUN_023108-T1,Q9JME2,CHSTB_MOUSE,,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),Mus musculus (Mouse),37.0,265.0,1.1e-43,178.7,sp|Q9JME2|CHSTB_MOUSE Carbohydrate sulfotransferase 11 OS=Mus musculus OX=10090 GN=Chst11 PE=2 SV=1,GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216,apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179],Golgi membrane [GO:0000139],chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005975; GO:0009101; GO:0012501; GO:0016740; GO:0048856; GO:1901135,catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; programmed cell death; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_04982,1.2418632427492835,FUN_023109-T1,Peve_00001973,Pocillopora_meandrina_HIv1___RNAseq.g1688.t1,three_way,60.158,FUN_023109-T1,Q5VV63,ATRN1_HUMAN,,Attractin-like protein 1,Homo sapiens (Human),32.3,1320.0,4.1e-183,643.7,sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2,GO:0005112; GO:0007186; GO:0016020; GO:0030246,G protein-coupled receptor signaling pathway [GO:0007186],membrane [GO:0016020],carbohydrate binding [GO:0030246]; Notch binding [GO:0005112],,
OG_04985,1.3585956756052286,FUN_023112-T1,Peve_00045022,Pocillopora_meandrina_HIv1___RNAseq.g1699.t1,three_way,49.251,,,,,,,,,,,,,,,,,
OG_04986,1.914744149767585,FUN_023113-T1,Peve_00045019,Pocillopora_meandrina_HIv1___RNAseq.g1698.t1,three_way,71.10633333333334,FUN_023113-T1,Q5ZJN2,RB11A_CHICK,,Ras-related protein Rab-11A (EC 3.6.5.2),Gallus gallus (Chicken),52.4,233.0,3.7999999999999996e-62,239.6,sp|Q5ZJN2|RB11A_CHICK Ras-related protein Rab-11A OS=Gallus gallus OX=9031 GN=RAB11A PE=2 SV=1,GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0006887; GO:0030133; GO:0030666; GO:0032154; GO:0032402; GO:0032588; GO:0045335; GO:0055038; GO:0061512; GO:0098837; GO:0098887; GO:1902017; GO:1902954; GO:1904779; GO:2001135,"exocytosis [GO:0006887]; melanosome transport [GO:0032402]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of early endosome to recycling endosome transport [GO:1902954]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to centrosome [GO:1904779]",cleavage furrow [GO:0032154]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0072659; GO:0098772,catalytic activity; GTPase activity; endosome; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; molecular function regulator activity
OG_04987,1.251662972965679,FUN_023115-T1,Peve_00045026,Pocillopora_meandrina_HIv1___RNAseq.g1697.t1,three_way,82.82133333333333,,,,,,,,,,,,,,,,,
OG_04988,1.1421610427924382,FUN_023118-T1,Peve_00045010,Pocillopora_meandrina_HIv1___RNAseq.g1695.t1,three_way,60.8045,FUN_023118-T1,Q80UN9,MOD5_MOUSE,,tRNA dimethylallyltransferase (EC 2.5.1.75) (Isopentenyl-diphosphate:tRNA isopentenyltransferase) (IPP transferase) (IPPT) (tRNA isopentenyltransferase) (IPTase),Mus musculus (Mouse),39.0,516.0,1.6e-92,341.7,sp|Q80UN9|MOD5_MOUSE tRNA dimethylallyltransferase OS=Mus musculus OX=10090 GN=Trit1 PE=1 SV=2,GO:0005524; GO:0005634; GO:0005739; GO:0006400; GO:0008270; GO:0052381; GO:0070900,mitochondrial tRNA modification [GO:0070900]; tRNA modification [GO:0006400],mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; tRNA dimethylallyltransferase activity [GO:0052381]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005739; GO:0006399; GO:0016740; GO:0043226; GO:0140053; GO:0140098,"catalytic activity; nucleus; mitochondrion; tRNA metabolic process; transferase activity; organelle; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_04989,1.948696198559308,FUN_023119-T1,Peve_00021102,Pocillopora_meandrina_HIv1___RNAseq.g1692.t1,three_way,61.756166666666665,FUN_023119-T1,Q92547,TOPB1_HUMAN,,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),Homo sapiens (Human),33.8,1669.0,2e-207,724.9,sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3,GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166,broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212],actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922],chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0000228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0005856; GO:0005886; GO:0006281; GO:0006310; GO:0043226; GO:0060090; GO:0098772,nuclear chromosome; DNA binding; nucleus; nucleoplasm; chromosome; microtubule organizing center; cytoskeleton; plasma membrane; DNA repair; DNA recombination; organelle; molecular adaptor activity; molecular function regulator activity
OG_04990,1.2050700996667965,FUN_023120-T1,Peve_00021101,Pocillopora_meandrina_HIv1___RNAseq.g1691.t1,three_way,66.651,,,,,,,,,,,,,,,,,
OG_04992,1.6452560661264308,FUN_023122-T1,Peve_00021098,Pocillopora_meandrina_HIv1___RNAseq.g1689.t1,three_way,60.922666666666665,FUN_023122-T1,Q9VY86,,,,,61.6,151.0,2.1e-52,206.8,sp|Q9VY86|TM2D2_DROME TM2 domain-containing protein amaretto OS=Drosophila melanogaster OX=7227 GN=amrt PE=2 SV=3,,,,,,
OG_04995,1.1674748408632525,FUN_023127-T1,Peve_00011778,Pocillopora_meandrina_HIv1___RNAseq.g1757.t1,three_way,70.8965,FUN_023127-T1,P42859,,,,,34.8,3196.0,0.0,1587.0,sp|P42859|HD_MOUSE Huntingtin OS=Mus musculus OX=10090 GN=Htt PE=1 SV=2,,,,,,
OG_04996,1.6398036447547637,FUN_023129-T1,Peve_00011777,Pocillopora_meandrina_HIv1___RNAseq.g1756.t1,three_way,68.69866666666667,,,,,,,,,,,,,,,,,
OG_04998,1.5035299883628734,FUN_023133-T1,Peve_00008525,Pocillopora_meandrina_HIv1___RNAseq.g1754.t1,three_way,68.886,FUN_023133-T1,Q9EPZ8,,,,,36.0,663.0,6.6e-106,386.3,sp|Q9EPZ8|RN103_RAT E3 ubiquitin-protein ligase RNF103 OS=Rattus norvegicus OX=10116 GN=Rnf103 PE=2 SV=1,,,,,,
OG_04999,1.8927164212485623,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05000,2.1530354000351237,FUN_023136-T1,Peve_00008523,Pocillopora_meandrina_HIv1___RNAseq.g1752.t1,three_way,64.003,,,,,,,,,,,,,,,,,
OG_05003,1.1847867589029233,FUN_023139-T1,Peve_00042477,Pocillopora_meandrina_HIv1___RNAseq.g1749.t1,three_way,49.72316666666666,FUN_023139-T1,P70399,TP53B_MOUSE,,TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),Mus musculus (Mouse),27.4,559.0,4.7999999999999996e-43,179.1,sp|P70399|TP53B_MOUSE TP53-binding protein 1 OS=Mus musculus OX=10090 GN=Tp53bp1 PE=1 SV=3,GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005657; GO:0005737; GO:0006281; GO:0006303; GO:0006355; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0043565; GO:0045830; GO:0045944; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:0097680; GO:0140005; GO:0140941; GO:1990166; GO:1990391; GO:2000042,cellular response to X-ray [GO:0071481]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; protein localization to site of double-strand break [GO:1990166]; regulation of DNA-templated transcription [GO:0006355],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",damaged DNA binding [GO:0003684]; histone H4K20me methyltransferase activity [GO:0140941]; histone H4K20me2 reader activity [GO:0140005]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin-modified histone reader activity [GO:0061649],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; DNA repair; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_05005,2.105933208262301,FUN_023153-T1,Peve_00014158,Pocillopora_meandrina_HIv1___RNAseq.g17694.t1,three_way,72.7995,FUN_023153-T1,Q9Y2H2,SAC2_HUMAN,,Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2),Homo sapiens (Human),48.1,774.0,2e-204,714.5,sp|Q9Y2H2|SAC2_HUMAN Phosphatidylinositide phosphatase SAC2 OS=Homo sapiens OX=9606 GN=INPP5F PE=1 SV=3,GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043491; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135,adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135],axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037],inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803],GO:0003012; GO:0003824; GO:0005768; GO:0006629; GO:0016192; GO:0016787; GO:0031410; GO:0043226,muscle system process; catalytic activity; endosome; lipid metabolic process; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_05008,1.5341262503217317,FUN_023159-T1,Peve_00018798,Pocillopora_meandrina_HIv1___RNAseq.g640.t1,three_way,86.96466666666667,FUN_023159-T1,O00909,ARF1_DICDI,,ADP-ribosylation factor 1 (EC 3.6.5.2),Dictyostelium discoideum (Social amoeba),82.2,180.0,4.5e-84,312.0,sp|O00909|ARF1_DICDI ADP-ribosylation factor 1 OS=Dictyostelium discoideum OX=44689 GN=arfA PE=1 SV=3,GO:0000281; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0045335; GO:0048471; GO:0051489; GO:0140220,intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; regulation of filopodium assembly [GO:0051489]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; pathogen-containing vacuole [GO:0140220]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0000910; GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226,cytokinesis; catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_05009,1.912968311040168,FUN_023160-T2,Peve_00018797,Pocillopora_meandrina_HIv1___RNAseq.g641.t1,three_way,62.85266666666667,,,,,,,,,,,,,,,,,
OG_05011,1.8821966522332456,FUN_023163-T1,Peve_00018795,Pocillopora_meandrina_HIv1___TS.g25340.t2c,three_way,74.67866666666667,FUN_023163-T1,Q8K4G5,ABLM1_MOUSE,,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1),Mus musculus (Mouse),48.6,253.0,8.9e-78,292.0,sp|Q8K4G5|ABLM1_MOUSE Actin-binding LIM protein 1 OS=Mus musculus OX=10090 GN=Ablim1 PE=1 SV=1,GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0060271,axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725],actin binding [GO:0003779]; metal ion binding [GO:0046872],GO:0005856; GO:0006351; GO:0006355; GO:0007010; GO:0008092; GO:0043226; GO:0044782,cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_05016,1.726055654893078,FUN_023178-T1,Peve_00009977,Pocillopora_meandrina_HIv1___RNAseq.g659.t2,three_way,55.161,FUN_023178-T1,Q8WY21,SORC1_HUMAN,,VPS10 domain-containing receptor SorCS1 (hSorCS),Homo sapiens (Human),28.4,989.0,4.4e-95,351.3,sp|Q8WY21|SORC1_HUMAN VPS10 domain-containing receptor SorCS1 OS=Homo sapiens OX=9606 GN=SORCS1 PE=1 SV=3,GO:0005794; GO:0006892; GO:0007218; GO:0008188; GO:0016020,neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892],Golgi apparatus [GO:0005794]; membrane [GO:0016020],neuropeptide receptor activity [GO:0008188],GO:0005794; GO:0016192; GO:0043226; GO:0060089,Golgi apparatus; vesicle-mediated transport; organelle; molecular transducer activity
OG_05017,1.1777694607883809,FUN_023180-T1,Peve_00009979,Pocillopora_meandrina_HIv1___RNAseq.g661.t1,three_way,65.57166666666666,FUN_023180-T1,Q2NL37,BCCIP_BOVIN,,BRCA2 and CDKN1A-interacting protein,Bos taurus (Bovine),30.5,272.0,2.3000000000000002e-30,134.4,sp|Q2NL37|BCCIP_BOVIN BRCA2 and CDKN1A-interacting protein OS=Bos taurus OX=9913 GN=BCCIP PE=2 SV=1,GO:0000226; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0006281; GO:0007052; GO:0034453; GO:0090307; GO:0097431,DNA repair [GO:0006281]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634],,GO:0005634; GO:0005815; GO:0006281; GO:0007010; GO:0043226,nucleus; microtubule organizing center; DNA repair; cytoskeleton organization; organelle
OG_05018,1.6301222819611547,FUN_023181-T1,Peve_00009980,Pocillopora_meandrina_HIv1___RNAseq.g662.t1,three_way,72.565,FUN_023181-T1,Q8R0X2,,,,,46.7,225.0,3.5999999999999986e-55,216.5,sp|Q8R0X2|CACL1_MOUSE CDK2-associated and cullin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cacul1 PE=2 SV=1,,,,,,
OG_05021,1.022001018769835,FUN_023184-T1,Peve_00027670,Pocillopora_meandrina_HIv1___RNAseq.g665.t1,three_way,47.4835,,,,,,,,,,,,,,,,,
OG_05024,1.054786117388452,FUN_023187-T1,Peve_00009989,Pocillopora_meandrina_HIv1___RNAseq.g669.t1,three_way,73.152,FUN_023187-T1,F1Q8J0,RNPC3_DANRE,,RNA-binding region-containing protein 3 (RNA-binding protein 40),Danio rerio (Zebrafish) (Brachydanio rerio),44.0,489.0,1.1999999999999999e-75,285.4,sp|F1Q8J0|RNPC3_DANRE RNA-binding region-containing protein 3 OS=Danio rerio OX=7955 GN=rnpc3 PE=2 SV=1,GO:0000398; GO:0001889; GO:0005689; GO:0030626; GO:0031016; GO:0048565; GO:0097157,"digestive tract development [GO:0048565]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; pancreas development [GO:0031016]",U12-type spliceosomal complex [GO:0005689],pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626],GO:0003723; GO:0016071; GO:0048856,RNA binding; mRNA metabolic process; anatomical structure development
OG_05025,1.1150738726532443,FUN_023188-T1,Peve_00009990,Pocillopora_meandrina_HIv1___RNAseq.g670.t1,three_way,70.7675,,,,,,,,,,,,,,,,,
OG_05026,1.355531497894675,FUN_023189-T1,Peve_00009992,Pocillopora_meandrina_HIv1___TS.g25367.t1,three_way,58.125,FUN_023189-T1,O43490,,,,,27.2,751.0,1.8e-53,212.6,sp|O43490|PROM1_HUMAN Prominin-1 OS=Homo sapiens OX=9606 GN=PROM1 PE=1 SV=1,,,,,,
OG_05030,1.4475560742083264,FUN_023202-T1,Peve_00010001,Pocillopora_meandrina_HIv1___RNAseq.g680.t1,three_way,51.176,FUN_023202-T1,Q9Z0R0,,,,,46.0,339.0,2e-82,308.5,sp|Q9Z0R0|HASP_MOUSE Serine/threonine-protein kinase haspin OS=Mus musculus OX=10090 GN=Haspin PE=1 SV=3,,,,,,
OG_05031,2.3330422986824164,FUN_023205-T1,Peve_00010002,Pocillopora_meandrina_HIv1___RNAseq.g681.t2,three_way,61.8175,FUN_023205-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),41.3,150.0,3.5e-26,119.8,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_05033,1.073071766067766,FUN_023213-T1,Peve_00010009,Pocillopora_meandrina_HIv1___RNAseq.g689.t1,three_way,68.199,FUN_023213-T1,Q8IUR5,,,,,44.5,456.0,6e-86,320.9,sp|Q8IUR5|TMTC1_HUMAN Protein O-mannosyl-transferase TMTC1 OS=Homo sapiens OX=9606 GN=TMTC1 PE=1 SV=3,,,,,,
OG_05034,1.596935693668144,FUN_023215-T1,Peve_00029821,Pocillopora_meandrina_HIv1___RNAseq.g690.t1,three_way,75.65683333333334,FUN_023215-T1,Q75W95,,,,,43.3,224.0,6.5e-31,136.0,sp|Q75W95|NKX11_DANRE NK1 transcription factor-related protein 1 OS=Danio rerio OX=7955 GN=nkx1.2lb PE=2 SV=1,,,,,,
OG_05035,1.754086298542603,FUN_023216-T1,Peve_00029820,Pocillopora_meandrina_HIv1___RNAseq.g691.t1,three_way,77.107,FUN_023216-T1,Q90XN9,,,,,68.3,126.0,2e-36,154.1,sp|Q90XN9|HMX3B_ORYLA Homeobox protein HMX3-B OS=Oryzias latipes OX=8090 GN=hmx3b PE=2 SV=1,,,,,,
OG_05047,1.2880298217781652,FUN_023236-T1,Peve_00029852,Pocillopora_meandrina_HIv1___TS.g16967.t1,three_way,66.868,FUN_023236-T1,Q8AW42,,,,,44.2,353.0,1.7e-70,268.1,sp|Q8AW42|S39AD_DANRE Zinc transporter ZIP13 OS=Danio rerio OX=7955 GN=slc39a13 PE=2 SV=1,,,,,,
OG_05050,1.777009527453944,FUN_023240-T1,Peve_00029849,Pocillopora_meandrina_HIv1___RNAseq.g17391.t1,three_way,69.214,FUN_023240-T1,Q6Y685,TACC1_MOUSE,,Transforming acidic coiled-coil-containing protein 1,Mus musculus (Mouse),43.0,193.0,1.1e-29,133.3,sp|Q6Y685|TACC1_MOUSE Transforming acidic coiled-coil-containing protein 1 OS=Mus musculus OX=10090 GN=Tacc1 PE=1 SV=1,GO:0000226; GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0008283; GO:0019904; GO:0021987; GO:0022008; GO:0022027; GO:0030331; GO:0030496; GO:0032886; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301,cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; regulation of microtubule-based process [GO:0032886],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634],nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005815; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; microtubule organizing center; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_05053,2.166903245525061,FUN_023249-T1,Peve_00019252,Pocillopora_meandrina_HIv1___TS.g16979.t2,three_way,58.003,,,,,,,,,,,,,,,,,
OG_05059,1.425428638556332,FUN_023256-T1,Peve_00019260,Pocillopora_meandrina_HIv1___TS.g25273.t1,three_way,37.922666666666665,,,,,,,,,,,,,,,,,
OG_05062,1.7214089808491435,FUN_023259-T1,Peve_00019266,Pocillopora_meandrina_HIv1___RNAseq.g574.t1,three_way,69.79666666666667,,,,,,,,,,,,,,,,,
OG_05063,1.1260262067398337,FUN_023260-T1,Peve_00019268,Pocillopora_meandrina_HIv1___RNAseq.g578.t1,three_way,89.18833333333333,FUN_023260-T1,Q9W676,,,,,61.8,382.0,2.4e-114,413.7,sp|Q9W676|LDB2_CHICK LIM domain-binding protein 2 OS=Gallus gallus OX=9031 GN=LDB2 PE=2 SV=1,,,,,,
OG_05066,1.1726372518352997,FUN_023269-T1,Peve_00019482,Pocillopora_meandrina_HIv1___TS.g17377.t1a,three_way,74.93916666666667,FUN_023269-T1,Q9PVF8,CTNA1_DANRE,,Catenin alpha-1 (Alpha E-catenin),Danio rerio (Zebrafish) (Brachydanio rerio),23.7,628.0,5.3e-38,162.2,sp|Q9PVF8|CTNA1_DANRE Catenin alpha-1 OS=Danio rerio OX=7955 GN=ctnna1 PE=1 SV=1,GO:0001894; GO:0005198; GO:0005634; GO:0005902; GO:0005911; GO:0005912; GO:0005938; GO:0008013; GO:0015629; GO:0016342; GO:0016477; GO:0034334; GO:0043009; GO:0045296; GO:0051015; GO:0098609,adherens junction maintenance [GO:0034334]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; chordate embryonic development [GO:0043009]; tissue homeostasis [GO:0001894],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; microvillus [GO:0005902]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0034330; GO:0043226; GO:0048856; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; cell junction organization; organelle; anatomical structure development; cell motility
OG_05069,1.9863561462007435,FUN_023272-T1,Peve_00031864,Pocillopora_meandrina_HIv1___RNAseq.g17803.t1,three_way,64.60916666666667,FUN_023272-T1,Q9Z1Z1,E2AK3_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2),Rattus norvegicus (Rat),35.6,1035.0,9.7e-144,512.7,sp|Q9Z1Z1|E2AK3_RAT Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Rattus norvegicus OX=10116 GN=Eif2ak3 PE=1 SV=1,GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006446; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0017148; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032933; GO:0034198; GO:0034976; GO:0036499; GO:0036503; GO:0042149; GO:0042802; GO:0043066; GO:0044233; GO:0044322; GO:0045444; GO:0045943; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:0106310; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990737,angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005783; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05074,1.412650434879314,FUN_023300-T1,Peve_00041309,Pocillopora_meandrina_HIv1___RNAseq.g17778.t1,three_way,86.52966666666667,FUN_023300-T1,Q3ZCF5,,,,,75.7,276.0,3.2e-128,459.5,"sp|Q3ZCF5|OAT_BOVIN Ornithine aminotransferase, mitochondrial OS=Bos taurus OX=9913 GN=OAT PE=2 SV=1",,,,,,
OG_05075,2.030027722759128,FUN_023301-T1,Peve_00041311,Pocillopora_meandrina_HIv1___RNAseq.g17777.t1,three_way,77.84916666666666,FUN_023301-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),31.5,371.0,1.6000000000000001e-38,162.5,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_05078,1.344448049540142,FUN_023307-T1,Peve_00041315,Pocillopora_meandrina_HIv1___RNAseq.g17774.t1,three_way,62.178,FUN_023307-T1,Q9QXT1,,,,,36.0,86.0,3.4e-10,67.4,sp|Q9QXT1|DAPP1_MOUSE Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide OS=Mus musculus OX=10090 GN=Dapp1 PE=1 SV=1,,,,,,
OG_05079,1.3371961355007322,FUN_023308-T1,Peve_00041319,Pocillopora_meandrina_HIv1___RNAseq.g17773.t1,three_way,65.986,FUN_023308-T1,Q80YG3,,,,,38.9,378.0,3.6e-73,276.9,sp|Q80YG3|KLDC1_MOUSE Kelch domain-containing protein 1 OS=Mus musculus OX=10090 GN=Klhdc1 PE=2 SV=1,,,,,,
OG_05080,1.9104689861332664,FUN_023309-T1,Peve_00041320,Pocillopora_meandrina_HIv1___RNAseq.g17772.t1,three_way,73.30616666666667,FUN_023309-T1,P52732,KIF11_HUMAN,,Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5) (TR-interacting protein 5) (TRIP-5),Homo sapiens (Human),51.0,755.0,1.2e-171,605.5,sp|P52732|KIF11_HUMAN Kinesin-like protein KIF11 OS=Homo sapiens OX=9606 GN=KIF11 PE=1 SV=2,GO:0000278; GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007051; GO:0007052; GO:0007100; GO:0008017; GO:0008574; GO:0016020; GO:0019901; GO:0032991; GO:0036064; GO:0043231; GO:0046602; GO:0051231; GO:0051301; GO:0072686; GO:0090307,cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; spindle elongation [GO:0051231]; spindle organization [GO:0007051],ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901],GO:0000278; GO:0003774; GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0140657,mitotic cell cycle; cytoskeletal motor activity; catalytic activity; nucleus; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; ATP-dependent activity
OG_05081,1.095254416634834,FUN_023311-T1,Peve_00011528,Pocillopora_meandrina_HIv1___RNAseq.g17770.t1,three_way,61.54116666666667,FUN_023311-T1,Q13332,,,,,29.5,742.0,1.1999999999999999e-61,240.4,sp|Q13332|PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens OX=9606 GN=PTPRS PE=1 SV=3,,,,,,
OG_05082,2.139038455693976,FUN_023314-T1,Peve_00017882,Pocillopora_meandrina_HIv1___RNAseq.g17767.t1,three_way,79.65150000000001,FUN_023314-T1,P47870,GBRB2_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Homo sapiens (Human),40.5,321.0,5.9e-61,236.5,sp|P47870|GBRB2_HUMAN Gamma-aminobutyric acid receptor subunit beta-2 OS=Homo sapiens OX=9606 GN=GABRB2 PE=1 SV=2,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0022851; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0051932; GO:0060119; GO:0060384; GO:0070062; GO:0071420; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05083,2.5892498162516797,FUN_023316-T2,Peve_00017883,Pocillopora_meandrina_HIv1___RNAseq.g17768.t1,three_way,78.326,FUN_023316-T2,P63138,GBRB2_RAT,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Rattus norvegicus (Rat),32.2,391.0,1.6000000000000002e-48,194.9,sp|P63138|GBRB2_RAT Gamma-aminobutyric acid receptor subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gabrb2 PE=1 SV=1,GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0007214; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0048666; GO:0048787; GO:0051932; GO:0060119; GO:0060384; GO:0071420; GO:0090102; GO:0098978; GO:0098982; GO:0099507; GO:0099634; GO:1902476; GO:1902710; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; neuron development [GO:0048666]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated monoatomic ion channel activity [GO:0005237]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05087,1.0074552821510223,FUN_023324-T2,Peve_00004283,Pocillopora_meandrina_HIv1___RNAseq.g17837.t1,three_way,49.6935,FUN_023324-T2,Q9D733,GP2_MOUSE,,Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2),Mus musculus (Mouse),35.4,164.0,5.600000000000001e-23,111.3,sp|Q9D733|GP2_MOUSE Pancreatic secretory granule membrane major glycoprotein GP2 OS=Mus musculus OX=10090 GN=Gp2 PE=1 SV=3,GO:0002412; GO:0003823; GO:0005615; GO:0005768; GO:0009897; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:0051649,antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; establishment of localization in cell [GO:0051649]; innate immune response [GO:0045087],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; zymogen granule membrane [GO:0042589],antigen binding [GO:0003823],GO:0002376; GO:0005615; GO:0005768; GO:0016192; GO:0031410; GO:0043226; GO:0098542,immune system process; extracellular space; endosome; vesicle-mediated transport; cytoplasmic vesicle; organelle; defense response to other organism
OG_05090,1.686946414947592,FUN_023334-T1,Peve_00001906,Pocillopora_meandrina_HIv1___RNAseq.g17417.t1,three_way,76.06566666666667,FUN_023334-T1,Q9HB40,,,,,53.6,379.0,2.3e-114,413.7,sp|Q9HB40|RISC_HUMAN Retinoid-inducible serine carboxypeptidase OS=Homo sapiens OX=9606 GN=SCPEP1 PE=1 SV=1,,,,,,
OG_05092,1.7057502909983382,FUN_023338-T1,Peve_00001905,Pocillopora_meandrina_HIv1___RNAseq.g17419.t1,three_way,63.309333333333335,FUN_023338-T1,Q9HB40,,,,,47.1,408.0,6.6e-100,365.9,sp|Q9HB40|RISC_HUMAN Retinoid-inducible serine carboxypeptidase OS=Homo sapiens OX=9606 GN=SCPEP1 PE=1 SV=1,,,,,,
OG_05093,1.089903689841025,FUN_023339-T1,Peve_00001913,Pocillopora_meandrina_HIv1___RNAseq.g17420.t1,three_way,51.641666666666666,FUN_023339-T1,Q91ZV2,,,,,33.3,168.0,2.7e-14,82.0,"sp|Q91ZV2|DCBD2_RAT Discoidin, CUB and LCCL domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Dcbld2 PE=2 SV=1",,,,,,
OG_05094,2.922291612027553,FUN_023341-T1,Peve_00023294,Pocillopora_meandrina_HIv1___RNAseq.g17422.t2,three_way,63.56933333333334,FUN_023341-T1,O15066,KIF3B_HUMAN,,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",Homo sapiens (Human),28.9,557.0,1.3000000000000002e-44,183.7,sp|O15066|KIF3B_HUMAN Kinesin-like protein KIF3B OS=Homo sapiens OX=9606 GN=KIF3B PE=1 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016192; GO:0016887; GO:0016939; GO:0030425; GO:0030496; GO:0031267; GO:0032467; GO:0032839; GO:0036372; GO:0042073; GO:0043197; GO:0060271; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0098971; GO:0098978; GO:0120170; GO:1904115,anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_05097,1.1385494441638722,FUN_023345-T1,Peve_00035609,Pocillopora_meandrina_HIv1___RNAseq.g17425.t1,three_way,45.39233333333333,FUN_023345-T1,Q06615,,,,,58.5,65.0,2.9e-11,70.5,sp|Q06615|NOTO_XENLA Homeobox protein notochord OS=Xenopus laevis OX=8355 GN=noto PE=2 SV=1,,,,,,
OG_05099,2.2180945491445847,FUN_023351-T1,Peve_00035607,Pocillopora_meandrina_HIv1___RNAseq.g17430.t1,three_way,83.50133333333333,FUN_023351-T1,Q802G6,MSB1A_DANRE,,Methionine-R-sulfoxide reductase B1-A (MsrB) (MsrB1-A) (EC 1.8.4.12) (EC 1.8.4.14) (Selenoprotein X-A) (SePR) (SelX-A),Danio rerio (Zebrafish) (Brachydanio rerio),58.6,99.0,5.799999999999997e-29,128.3,sp|Q802G6|MSB1A_DANRE Methionine-R-sulfoxide reductase B1-A OS=Danio rerio OX=7955 GN=msrb1 PE=2 SV=3,GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0030041; GO:0030091; GO:0033743; GO:0033745; GO:0045087; GO:0046872,actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743],GO:0002376; GO:0003824; GO:0005634; GO:0005856; GO:0008092; GO:0016491; GO:0043226; GO:0065003; GO:0098542,immune system process; catalytic activity; nucleus; cytoskeleton; cytoskeletal protein binding; oxidoreductase activity; organelle; protein-containing complex assembly; defense response to other organism
OG_05103,1.7711843421469595,FUN_023358-T2,Peve_00005335,Pocillopora_meandrina_HIv1___TS.g17018.t1,three_way,80.87916666666666,FUN_023358-T2,Q96A58,RERG_HUMAN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Homo sapiens (Human),36.9,160.0,2.8000000000000002e-28,127.1,sp|Q96A58|RERG_HUMAN Ras-related and estrogen-regulated growth inhibitor OS=Homo sapiens OX=9606 GN=RERG PE=1 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007264; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear estrogen receptor binding [GO:0030331],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; nucleus; nucleoplasm; cytosol; plasma membrane; hydrolase activity; organelle; molecular function regulator activity
OG_05104,1.2308707495328337,FUN_023360-T1,Peve_00005336,Pocillopora_meandrina_HIv1___TS.g17019.t1,three_way,64.49333333333334,FUN_023360-T1,Q0VCJ7,RERG_BOVIN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Bos taurus (Bovine),38.9,193.0,1.5999999999999999e-29,131.3,sp|Q0VCJ7|RERG_BOVIN Ras-related and estrogen-regulated growth inhibitor OS=Bos taurus OX=9913 GN=RERG PE=2 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005829; GO:0005886; GO:0008285; GO:0009725; GO:0019003; GO:0030308,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; nucleoplasm; cytosol; plasma membrane; hydrolase activity; molecular function regulator activity
OG_05117,1.0027760535843226,FUN_023378-T1,Peve_00005367,Pocillopora_meandrina_HIv1___RNAseq.g17524.t1,three_way,84.52566666666667,FUN_023378-T1,Q6GLB9,,,,,40.1,192.0,1.6000000000000002e-23,110.9,sp|Q6GLB9|EMX1_XENTR Homeobox protein EMX1 OS=Xenopus tropicalis OX=8364 GN=emx1 PE=2 SV=1,,,,,,
OG_05119,1.594635843384554,FUN_023381-T1,Peve_00030697,Pocillopora_meandrina_HIv1___RNAseq.g17515.t1,three_way,64.44500000000001,FUN_023381-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),32.7,428.0,4.3e-52,207.2,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05123,1.1281238815017811,FUN_023386-T1,Peve_00004633,Pocillopora_meandrina_HIv1___RNAseq.g17450.t1,three_way,75.50966666666666,FUN_023386-T1,Q8R367,,,,,33.6,137.0,4.7e-16,85.9,sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1,,,,,,
OG_05128,1.2690325355240624,FUN_023393-T2,Peve_00038660,Pocillopora_meandrina_HIv1___RNAseq.g17626.t1,three_way,95.275,FUN_023393-T2,O43143,DHX15_HUMAN,,ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15) (Splicing factor Prp43) (hPrp43),Homo sapiens (Human),81.6,674.0,0.0,1121.3,sp|O43143|DHX15_HUMAN ATP-dependent RNA helicase DHX15 OS=Homo sapiens OX=9606 GN=DHX15 PE=1 SV=2,GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008186; GO:0008380; GO:0009636; GO:0016607; GO:0016887; GO:0042742; GO:0043123; GO:0043279; GO:0051607; GO:0140374,"antiviral innate immune response [GO:0140374]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]",nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]",GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0098542; GO:0140098; GO:0140657,"immune system process; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05130,1.2580872671072807,FUN_023398-T1,Peve_00004631,Pocillopora_meandrina_HIv1___RNAseq.g17445.t1,three_way,65.884,FUN_023398-T1,Q9BW72,,,,,47.9,71.0,1.4e-12,74.3,"sp|Q9BW72|HIG2A_HUMAN HIG1 domain family member 2A, mitochondrial OS=Homo sapiens OX=9606 GN=HIGD2A PE=1 SV=1",,,,,,
OG_05135,1.6213510677897285,FUN_023406-T1,Peve_00016101,Pocillopora_meandrina_HIv1___RNAseq.g17553.t1,three_way,88.30066666666667,FUN_023406-T1,P24844,MYL9_HUMAN,,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",Homo sapiens (Human),59.1,171.0,2.5e-52,206.5,sp|P24844|MYL9_HUMAN Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4,GO:0001725; GO:0005200; GO:0005509; GO:0005737; GO:0005829; GO:0005859; GO:0005938; GO:0006937; GO:0008307; GO:0016460; GO:0030016; GO:0030018; GO:0030239; GO:0032036; GO:0043149; GO:0070527,myofibril assembly [GO:0030239]; platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937]; stress fiber assembly [GO:0043149],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0005829; GO:0007010; GO:0007155; GO:0008092; GO:0043226,structural molecule activity; cytosol; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle
OG_05136,2.167185567871972,FUN_023407-T1,Peve_00016102,Pocillopora_meandrina_HIv1___RNAseq.g17552.t1,three_way,89.46416666666667,FUN_023407-T1,P24032,,,,,63.5,170.0,1.6e-54,213.8,"sp|P24032|MLRN_CHICK Myosin regulatory light chain 2, smooth muscle minor isoform OS=Gallus gallus OX=9031 PE=1 SV=2",,,,,,
OG_05138,1.1411728082596304,FUN_023410-T1,Peve_00017394,Pocillopora_meandrina_HIv1___RNAseq.g17575.t1,three_way,54.03783333333333,FUN_023410-T1,Q1LYG0,,,,,34.5,313.0,3.9e-50,201.8,sp|Q1LYG0|SPD2A_DANRE SH3 and PX domain-containing protein 2A OS=Danio rerio OX=7955 GN=sh3pxd2a PE=3 SV=2,,,,,,
OG_05140,1.8938585560328272,FUN_023416-T1,Peve_00017406,Pocillopora_meandrina_HIv1___RNAseq.g17587.t2,three_way,86.484,FUN_023416-T1,Q9UHX1,,,,,45.5,569.0,4.5e-115,416.8,sp|Q9UHX1|PUF60_HUMAN Poly(U)-binding-splicing factor PUF60 OS=Homo sapiens OX=9606 GN=PUF60 PE=1 SV=1,,,,,,
OG_05146,1.4861937942588177,FUN_023423-T1,Peve_00019215,Pocillopora_meandrina_HIv1___RNAseq.g583.t1,three_way,90.14433333333334,FUN_023423-T1,Q5R416,CTNA2_PONAB,,Catenin alpha-2 (Alpha N-catenin),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),41.2,1200.0,2.9000000000000003e-214,747.3,sp|Q5R416|CTNA2_PONAB Catenin alpha-2 OS=Pongo abelii OX=9601 GN=CTNNA2 PE=2 SV=3,GO:0005198; GO:0005634; GO:0005737; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222,axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0043226; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; organelle; cell motility
OG_05147,1.8868754085596304,FUN_023426-T1,Peve_00019216,Pocillopora_meandrina_HIv1___RNAseq.g584.t1,three_way,75.90066666666667,FUN_023426-T1,Q6P4Q7,CNNM4_HUMAN,,Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4),Homo sapiens (Human),52.5,537.0,1.7e-155,550.8,sp|Q6P4Q7|CNNM4_HUMAN Metal transporter CNNM4 OS=Homo sapiens OX=9606 GN=CNNM4 PE=1 SV=3,GO:0005886; GO:0007601; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016323; GO:0030003; GO:0032991; GO:0070166,enamel mineralization [GO:0070166]; intracellular monoatomic cation homeostasis [GO:0030003]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; visual perception [GO:0007601],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081],GO:0005215; GO:0005886; GO:0048856; GO:0050877,transporter activity; plasma membrane; anatomical structure development; nervous system process
OG_05150,2.37892092122415,FUN_023433-T1,Peve_00019225,Pocillopora_meandrina_HIv1___TS.g25287.t1,three_way,71.47266666666667,FUN_023433-T1,Q9UBG0,MRC2_HUMAN,,C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280),Homo sapiens (Human),32.6,132.0,8.5e-14,80.5,sp|Q9UBG0|MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2,GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0030246; GO:0030574; GO:0038023,collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649],focal adhesion [GO:0005925]; membrane [GO:0016020],carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023],GO:0016192; GO:0030154; GO:0060089,vesicle-mediated transport; cell differentiation; molecular transducer activity
OG_05155,1.3749017937040928,FUN_023442-T1,Peve_00019240,Pocillopora_meandrina_HIv1___RNAseq.g17640.t2,three_way,86.21766666666667,FUN_023442-T1,I6LDA6,,,,,61.0,520.0,2.4e-183,643.3,"sp|I6LDA6|GPMI_ONCVO 2,3-bisphosphoglycerate-independent phosphoglycerate mutase OS=Onchocerca volvulus OX=6282 GN=ipgm-1 PE=1 SV=1",,,,,,
OG_05157,1.557074871906725,FUN_023446-T1,Peve_00019244,Pocillopora_meandrina_HIv1___RNAseq.g17636.t1,three_way,73.13333333333333,FUN_023446-T1,Q708S6,ASI1C_DANRE,,"Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3)",Danio rerio (Zebrafish) (Brachydanio rerio),32.2,457.0,5.9999999999999996e-55,216.9,sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1,GO:0005261; GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128,cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725],dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05158,1.5118453159862886,FUN_023447-T1,Peve_00019245,Pocillopora_meandrina_HIv1___RNAseq.g17633.t1,three_way,62.09233333333333,FUN_023447-T1,Q708S6,ASI1C_DANRE,,"Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3)",Danio rerio (Zebrafish) (Brachydanio rerio),26.3,457.0,1.1e-37,159.5,sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1,GO:0005261; GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128,cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725],dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05159,1.0637820692364248,FUN_023449-T1,Peve_00037222,Pocillopora_meandrina_HIv1___RNAseq.g17631.t2,three_way,40.68716666666667,,,,,,,,,,,,,,,,,
OG_05161,1.3805687895980114,FUN_023459-T1,Peve_00037224,Pocillopora_meandrina_HIv1___RNAseq.g17544.t1,three_way,95.354,FUN_023459-T1,O75643,U520_HUMAN,,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),Homo sapiens (Human),74.1,2143.0,0.0,3215.6,sp|O75643|U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens OX=9606 GN=SNRNP200 PE=1 SV=2,GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005886; GO:0005929; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013,"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]",catalytic step 2 spliceosome [GO:0071013]; cilium [GO:0005929]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0005929; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; plasma membrane; cilium; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05165,1.004015270762722,FUN_023489-T1,Peve_00017466,Pocillopora_meandrina_HIv1___RNAseq.g544.t1,three_way,67.37633333333333,FUN_023489-T1,P56484,,,,,25.7,319.0,2.9e-16,87.8,sp|P56484|CCR8_MOUSE C-C chemokine receptor type 8 OS=Mus musculus OX=10090 GN=Ccr8 PE=2 SV=1,,,,,,
OG_05167,1.2451439303634375,FUN_023494-T1,Peve_00017462,Pocillopora_meandrina_HIv1___RNAseq.g542.t1,three_way,88.889,FUN_023494-T1,P51157,RAB28_HUMAN,,Ras-related protein Rab-28 (EC 3.6.5.2),Homo sapiens (Human),59.4,224.0,2.6e-73,276.6,sp|P51157|RAB28_HUMAN Ras-related protein Rab-28 OS=Homo sapiens OX=9606 GN=RAB28 PE=1 SV=2,GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005886; GO:0006886; GO:0012505; GO:0019003; GO:0035253; GO:0036064,intracellular protein transport [GO:0006886],ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005815; GO:0005886; GO:0006886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; microtubule organizing center; plasma membrane; intracellular protein transport; hydrolase activity; molecular function regulator activity
OG_05173,1.6043821569394912,FUN_023501-T1,Peve_00017454,Pocillopora_meandrina_HIv1___RNAseq.g534.t1,three_way,56.98533333333334,,,,,,,,,,,,,,,,,
OG_05175,1.4261164779869286,FUN_023503-T1,Peve_00017430,Pocillopora_meandrina_HIv1___RNAseq.g531.t2,three_way,72.32416666666667,FUN_023503-T1,Q3UUG6,TBC24_MOUSE,,TBC1 domain family member 24,Mus musculus (Mouse),28.8,539.0,1.3e-52,209.1,sp|Q3UUG6|TBC24_MOUSE TBC1 domain family member 24 OS=Mus musculus OX=10090 GN=Tbc1d24 PE=1 SV=2,GO:0005096; GO:0005886; GO:0016358; GO:0030659; GO:0031175; GO:0031594; GO:0034599; GO:0043195; GO:0048488; GO:0050775; GO:0061564; GO:1900408; GO:2000463; GO:2001224,axon development [GO:0061564]; cellular response to oxidative stress [GO:0034599]; dendrite development [GO:0016358]; negative regulation of cellular response to oxidative stress [GO:1900408]; neuron projection development [GO:0031175]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron migration [GO:2001224]; synaptic vesicle endocytosis [GO:0048488],cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195],GTPase activator activity [GO:0005096],GO:0005886; GO:0016192; GO:0048856; GO:0098772,plasma membrane; vesicle-mediated transport; anatomical structure development; molecular function regulator activity
OG_05177,1.2915294333335938,FUN_023507-T1,Peve_00005822,Pocillopora_meandrina_HIv1___RNAseq.g568.t1,three_way,58.58383333333333,,,,,,,,,,,,,,,,,
OG_05183,1.3123963367271103,FUN_023529-T1,Peve_00044316,Pocillopora_meandrina_HIv1___TS.g7657.t1,three_way,73.594,,,,,,,,,,,,,,,,,
OG_05184,1.071671522177992,FUN_023550-T1,Peve_00041532,Pocillopora_meandrina_HIv1___RNAseq.g11206.t1a,three_way,67.22466666666666,FUN_023550-T1,Q5SSH8,NEUFC_MOUSE,,Neuferricin (Cytochrome b5 domain-containing protein 2),Mus musculus (Mouse),43.9,223.0,2.5000000000000002e-58,227.3,sp|Q5SSH8|NEUFC_MOUSE Neuferricin OS=Mus musculus OX=10090 GN=Cyb5d2 PE=1 SV=1,GO:0005576; GO:0020037; GO:0030182; GO:0045666,neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666],extracellular region [GO:0005576],heme binding [GO:0020037],GO:0005576; GO:0030154,extracellular region; cell differentiation
OG_05185,1.0382125899794097,FUN_023551-T1,Peve_00009052,Pocillopora_meandrina_HIv1___RNAseq.g3556.t1,three_way,81.81566666666666,FUN_023551-T1,Q4R4Q3,,,,,32.7,297.0,1.1e-40,168.7,sp|Q4R4Q3|NDRG1_MACFA Protein NDRG1 OS=Macaca fascicularis OX=9541 GN=Ndrg1 PE=2 SV=1,,,,,,
OG_05187,1.230966245229009,FUN_023553-T1,Peve_00009074,Pocillopora_meandrina_HIv1___RNAseq.g3589.t1,three_way,89.21216666666666,FUN_023553-T1,Q8NE35,CPEB3_HUMAN,,Cytoplasmic polyadenylation element-binding protein 3 (CPE-BP3) (CPE-binding protein 3) (hCPEB-3),Homo sapiens (Human),70.5,369.0,1.6e-146,521.2,sp|Q8NE35|CPEB3_HUMAN Cytoplasmic polyadenylation element-binding protein 3 OS=Homo sapiens OX=9606 GN=CPEB3 PE=1 SV=2,GO:0000122; GO:0000900; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007616; GO:0008135; GO:0014069; GO:0017148; GO:0030014; GO:0030425; GO:0030496; GO:0035613; GO:0035925; GO:0043005; GO:0043022; GO:0045202; GO:0045727; GO:0048167; GO:0060213; GO:0060998; GO:0060999; GO:0061158; GO:0071230; GO:0097440; GO:1900153; GO:1900248; GO:2000766,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; long-term memory [GO:0007616]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; regulation of dendritic spine development [GO:0060998]; regulation of synaptic plasticity [GO:0048167]",apical dendrite [GO:0097440]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],"mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; translation factor activity, RNA binding [GO:0008135]",GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0045182; GO:0050877,RNA binding; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; translation regulator activity; nervous system process
OG_05188,1.359616497691439,FUN_023554-T1,Peve_00024945,Pocillopora_meandrina_HIv1___RNAseq.g3590.t1,three_way,88.87966666666667,FUN_023554-T1,Q6GM44,,,,,63.3,275.0,7.8e-104,378.3,sp|Q6GM44|MARH5_XENLA E3 ubiquitin-protein ligase MARCHF5 OS=Xenopus laevis OX=8355 GN=marchf5 PE=2 SV=1,,,,,,
OG_05189,1.8662625802991648,FUN_023555-T1,Peve_00009058,Pocillopora_meandrina_HIv1___RNAseq.g3555.t1,three_way,64.18966666666667,FUN_023555-T1,Q9UIF7,MUTYH_HUMAN,,Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (hMYH),Homo sapiens (Human),47.7,472.0,1.2e-110,401.7,sp|Q9UIF7|MUTYH_HUMAN Adenine DNA glycosylase OS=Homo sapiens OX=9606 GN=MUTYH PE=1 SV=1,GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539; GO:0060546,base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; negative regulation of necroptotic process [GO:0060546],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_05190,1.2518283526577625,FUN_023556-T1,Peve_00037254,Pocillopora_meandrina_HIv1___RNAseq.g521.t1,three_way,64.69166666666666,FUN_023556-T1,Q9NYF3,,,,,25.5,318.0,2.4e-07,58.2,sp|Q9NYF3|FA53C_HUMAN Protein FAM53C OS=Homo sapiens OX=9606 GN=FAM53C PE=1 SV=1,,,,,,
OG_05191,1.4191981824978115,FUN_023557-T1,Peve_00037255,Pocillopora_meandrina_HIv1___RNAseq.g520.t1,three_way,63.37466666666667,FUN_023557-T1,Q5TEA3,,,,,35.3,1191.0,5.8e-204,713.0,sp|Q5TEA3|DAAF9_HUMAN Dynein axonemal assembly factor 9 OS=Homo sapiens OX=9606 GN=DNAAF9 PE=1 SV=1,,,,,,
OG_05194,3.067748329808832,FUN_023565-T2,Peve_00037262,Pocillopora_meandrina_HIv1___RNAseq.g514.t1,three_way,79.68733333333333,FUN_023565-T2,Q14642,,,,,45.9,386.0,2e-98,360.9,sp|Q14642|I5P1_HUMAN Inositol polyphosphate-5-phosphatase A OS=Homo sapiens OX=9606 GN=INPP5A PE=1 SV=1,,,,,,
OG_05198,2.253288544702738,FUN_023578-T1,Peve_00035142,Pocillopora_meandrina_HIv1___RNAseq.g3534.t2,three_way,64.644,FUN_023578-T1,O95786,RIGI_HUMAN,,Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),Homo sapiens (Human),35.5,716.0,2.1e-106,388.7,sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2,GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005829; GO:0005856; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; cytosol; cytoskeleton; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; molecular transducer activity; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05200,1.4221283723371054,FUN_023581-T1,Peve_00035146,Pocillopora_meandrina_HIv1___RNAseq.g3529.t1,three_way,51.781333333333336,,,,,,,,,,,,,,,,,
OG_05207,1.597674223492605,FUN_023591-T1,Peve_00023917,Pocillopora_meandrina_HIv1___RNAseq.g3310.t1,three_way,53.26583333333333,FUN_023591-T1,A7Z035,EPN4_BOVIN,,Clathrin interactor 1 (Epsin-4),Bos taurus (Bovine),38.2,626.0,8.3e-77,289.7,sp|A7Z035|EPN4_BOVIN Clathrin interactor 1 OS=Bos taurus OX=9913 GN=CLINT1 PE=2 SV=1,GO:0005543; GO:0005654; GO:0005768; GO:0005798; GO:0005802; GO:0005886; GO:0006897; GO:0030125; GO:0030276; GO:0048471,endocytosis [GO:0006897],clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],clathrin binding [GO:0030276]; phospholipid binding [GO:0005543],GO:0005654; GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_05208,3.0708129054069038,FUN_023592-T1,Peve_00023919,Pocillopora_meandrina_HIv1___RNAseq.g3311.t1,three_way,44.60383333333333,FUN_023592-T1,E9PVX6,KI67_MOUSE,,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog),Mus musculus (Mouse),42.2,135.0,5.7e-18,95.9,sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1,GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072089; GO:0072574; GO:0140693; GO:1902275; GO:1990705,cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088]; stem cell proliferation [GO:0072089],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0007059; GO:0022414; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; chromosome; nucleolus; chromosome segregation; reproductive process; organelle; molecular adaptor activity
OG_05215,1.2206282969844082,FUN_023623-T1,Peve_00010900,Pocillopora_meandrina_HIv1___RNAseq.g3525.t1,three_way,73.34016666666666,FUN_023623-T1,Q90W58,,,,,46.8,308.0,4.4e-68,260.0,sp|Q90W58|DUS1B_XENLA Dual specificity protein phosphatase 1-B OS=Xenopus laevis OX=8355 GN=dusp1-b PE=2 SV=1,,,,,,
OG_05217,1.785421860344964,FUN_023627-T2,Peve_00037251,Pocillopora_meandrina_HIv1___RNAseq.g523.t1,three_way,55.51683333333334,FUN_023627-T2,Q9JIC3,,,,,30.6,1016.0,8.3e-114,412.9,sp|Q9JIC3|DCR1A_MOUSE DNA cross-link repair 1A protein OS=Mus musculus OX=10090 GN=Dclre1a PE=1 SV=2,,,,,,
OG_05219,1.1409869724261228,FUN_023631-T1,Peve_00017456,Pocillopora_meandrina_HIv1___RNAseq.g526.t1,three_way,75.54283333333333,FUN_023631-T1,P57073,SOX8_HUMAN,,Transcription factor SOX-8,Homo sapiens (Human),59.1,110.0,6.7e-28,126.7,sp|P57073|SOX8_HUMAN Transcription factor SOX-8 OS=Homo sapiens OX=9606 GN=SOX8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001649; GO:0001701; GO:0001755; GO:0002009; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0007165; GO:0007283; GO:0007422; GO:0008584; GO:0010628; GO:0010817; GO:0014015; GO:0014032; GO:0033690; GO:0035914; GO:0043066; GO:0045165; GO:0045444; GO:0045662; GO:0045892; GO:0045893; GO:0045944; GO:0046533; GO:0048469; GO:0048484; GO:0048709; GO:0060009; GO:0060018; GO:0060041; GO:0060221; GO:0060612; GO:0061138; GO:0072034; GO:0072197; GO:0072289; GO:0090184; GO:0090190; GO:0140297; GO:1990837,adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hormone levels [GO:0010817]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_05220,2.3079832544957597,FUN_023632-T1,Peve_00017477,Pocillopora_meandrina_HIv1___RNAseq.g527.t1,three_way,59.04733333333333,,,,,,,,,,,,,,,,,
OG_05224,1.4432323481237028,FUN_023636-T1,Peve_00027831,Pocillopora_meandrina_HIv1___RNAseq.g17813.t1,three_way,85.25933333333333,,,,,,,,,,,,,,,,,
OG_05225,1.2586866577425952,FUN_023638-T1,Peve_00027830,Pocillopora_meandrina_HIv1___RNAseq.g17814.t1a,three_way,68.096,FUN_023638-T1,Q975N4,,,,,30.1,349.0,1.4000000000000001e-33,145.2,sp|Q975N4|METE_SULTO Methionine synthase OS=Sulfurisphaera tokodaii (strain DSM 16993 / JCM 10545 / NBRC 100140 / 7) OX=273063 GN=metE PE=3 SV=1,,,,,,
OG_05229,1.312439582732607,FUN_023642-T1,Peve_00027826,Pocillopora_meandrina_HIv1___RNAseq.g17815.t1,three_way,79.919,FUN_023642-T1,P06798,,,,,55.1,107.0,5.1e-20,99.8,sp|P06798|HXA4_MOUSE Homeobox protein Hox-A4 OS=Mus musculus OX=10090 GN=Hoxa4 PE=2 SV=4,,,,,,
OG_05232,1.6535708902207942,FUN_023647-T1,Peve_00027823,Pocillopora_meandrina_HIv1___RNAseq.23947_t,three_way,76.041,FUN_023647-T1,Q6PCJ9,,,,,50.9,287.0,2.7e-78,293.5,sp|Q6PCJ9|PPT2A_XENLA Lysosomal thioesterase PPT2-A OS=Xenopus laevis OX=8355 GN=ppt2-a PE=2 SV=1,,,,,,
OG_05247,1.774240098626723,FUN_023693-T1,Peve_00014155,Pocillopora_meandrina_HIv1___RNAseq.g17720.t1,three_way,64.13166666666666,FUN_023693-T1,Q5YCC5,,,,,29.7,660.0,6.2e-79,297.0,sp|Q5YCC5|TMC7_CHICK Transmembrane channel-like protein 7 OS=Gallus gallus OX=9031 GN=Tmc7 PE=2 SV=1,,,,,,
OG_05248,1.357964836982824,FUN_023694-T1,Peve_00017435,Pocillopora_meandrina_HIv1___RNAseq.g17612.t1,three_way,85.42266666666667,FUN_023694-T1,Q28G26,P4K2B_XENTR,,Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),61.3,434.0,4.4e-152,539.3,sp|Q28G26|P4K2B_XENTR Phosphatidylinositol 4-kinase type 2-beta OS=Xenopus tropicalis OX=8364 GN=pi4k2b PE=2 SV=1,GO:0000139; GO:0004430; GO:0005524; GO:0005789; GO:0005829; GO:0005886; GO:0031901; GO:0046854,phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016740,catalytic activity; cytosol; plasma membrane; lipid metabolic process; transferase activity
OG_05253,1.23135103712028,FUN_023701-T1,Peve_00017415,Pocillopora_meandrina_HIv1___RNAseq.g17594.t1,three_way,79.94866666666667,FUN_023701-T1,Q8IYX7,SAXO1_HUMAN,,Stabilizer of axonemal microtubules 1,Homo sapiens (Human),21.5,498.0,2.4e-12,75.1,sp|Q8IYX7|SAXO1_HUMAN Stabilizer of axonemal microtubules 1 OS=Homo sapiens OX=9606 GN=SAXO1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0036064; GO:0036126; GO:0045724; GO:0050821; GO:0070417,cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821],axonemal microtubule [GO:0005879]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],microtubule binding [GO:0008017],GO:0005815; GO:0005856; GO:0005929; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton; cilium; cytoskeletal protein binding; organelle
OG_05254,1.7831726334247708,FUN_023702-T1,Peve_00017411,Pocillopora_meandrina_HIv1___RNAseq.g17589.t1,three_way,69.48033333333333,FUN_023702-T1,Q3KP44,ANR55_HUMAN,,Ankyrin repeat domain-containing protein 55,Homo sapiens (Human),25.1,259.0,1.5e-16,89.0,sp|Q3KP44|ANR55_HUMAN Ankyrin repeat domain-containing protein 55 OS=Homo sapiens OX=9606 GN=ANKRD55 PE=1 SV=3,,,,,,
OG_05256,3.1814492715053797,FUN_023759-T1,Peve_00044461,Pocillopora_meandrina_HIv1___RNAseq.g3497.t1,three_way,51.79566666666666,FUN_023759-T1,E7FBY6,AGRA2_DANRE,,Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124),Danio rerio (Zebrafish) (Brachydanio rerio),26.0,889.0,4.7e-66,255.4,sp|E7FBY6|AGRA2_DANRE Adhesion G protein-coupled receptor A2 OS=Danio rerio OX=7955 GN=adgra2 PE=1 SV=2,GO:0001525; GO:0004930; GO:0005886; GO:0007399; GO:0060070; GO:1990909,angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; nervous system development [GO:0007399],plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_05259,1.1318928101950567,FUN_023765-T1,Peve_00030839,Pocillopora_meandrina_HIv1___TS.g9692.t1a,three_way,65.00833333333333,FUN_023765-T1,P17453,,,,,32.3,473.0,4.500000000000001e-65,250.4,sp|P17453|BPI_BOVIN Bactericidal permeability-increasing protein OS=Bos taurus OX=9913 GN=BPI PE=2 SV=2,,,,,,
OG_05261,1.354180378132787,FUN_023772-T1,Peve_00039442,Pocillopora_meandrina_HIv1___RNAseq.g3603.t1,three_way,71.67933333333333,FUN_023772-T1,Q4JIM5,ABL2_MOUSE,,Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG),Mus musculus (Mouse),40.5,74.0,4.7e-08,60.8,sp|Q4JIM5|ABL2_MOUSE Tyrosine-protein kinase ABL2 OS=Mus musculus OX=10090 GN=Abl2 PE=1 SV=1,GO:0000287; GO:0001843; GO:0001891; GO:0002118; GO:0004713; GO:0004715; GO:0005524; GO:0006468; GO:0006909; GO:0006930; GO:0007015; GO:0007173; GO:0007200; GO:0007204; GO:0007249; GO:0007266; GO:0007612; GO:0007628; GO:0008104; GO:0008542; GO:0009791; GO:0010976; GO:0015629; GO:0016322; GO:0018108; GO:0021587; GO:0022408; GO:0030027; GO:0030036; GO:0030145; GO:0030182; GO:0031223; GO:0031410; GO:0032729; GO:0032743; GO:0035024; GO:0035264; GO:0035640; GO:0043123; GO:0043197; GO:0046632; GO:0048008; GO:0048813; GO:0050885; GO:0051017; GO:0051649; GO:0060020; GO:0060074; GO:0060563; GO:0070374; GO:0072359; GO:0097062; GO:0098609; GO:0098794; GO:0098978; GO:1903053; GO:1903905; GO:1904157; GO:2000096; GO:2000352; GO:2000406,"actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; adult walking behavior [GO:0007628]; aggressive behavior [GO:0002118]; alpha-beta T cell differentiation [GO:0046632]; auditory behavior [GO:0031223]; Bergmann glial cell differentiation [GO:0060020]; canonical NF-kappaB signal transduction [GO:0007249]; cell-cell adhesion [GO:0098609]; cerebellum morphogenesis [GO:0021587]; circulatory system development [GO:0072359]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; DN4 thymocyte differentiation [GO:1904157]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of localization in cell [GO:0051649]; exploration behavior [GO:0035640]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of Rho protein signal transduction [GO:0035024]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuron remodeling [GO:0016322]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell migration [GO:2000406]; positive regulation of type II interferon production [GO:0032729]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of extracellular matrix organization [GO:1903053]; Rho protein signal transduction [GO:0007266]; substrate-dependent cell migration, cell extension [GO:0006930]; synapse maturation [GO:0060074]; visual learning [GO:0008542]",actin cytoskeleton [GO:0015629]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; postsynapse [GO:0098794],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713],GO:0002376; GO:0003824; GO:0005856; GO:0007010; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"immune system process; catalytic activity; cytoskeleton; cytoskeleton organization; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05265,1.0593754716402637,FUN_023795-T1,Peve_00039445,Pocillopora_meandrina_HIv1___RNAseq.g5766.t1,three_way,90.22266666666668,FUN_023795-T1,Q91VN6,DDX41_MOUSE,,Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41),Mus musculus (Mouse),76.5,548.0,1.1e-243,844.0,sp|Q91VN6|DDX41_MOUSE Probable ATP-dependent RNA helicase DDX41 OS=Mus musculus OX=10090 GN=Ddx41 PE=1 SV=2,GO:0000398; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005783; GO:0005829; GO:0008270; GO:0008283; GO:0016887; GO:0030154; GO:0035458; GO:0045944; GO:0051607; GO:0071013; GO:0140896,"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005783; GO:0005829; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; endoplasmic reticulum; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05268,2.4952878195840023,FUN_023921-T1,Peve_00026572,Pocillopora_meandrina_HIv1___TS.g27910.t1,three_way,65.93933333333332,,,,,,,,,,,,,,,,,
OG_05274,2.005550331161093,FUN_023928-T1,Peve_00026565,Pocillopora_meandrina_HIv1___TS.g27906.t1a,three_way,36.54933333333333,FUN_023928-T1,Q3V2Q8,N42L1_MOUSE,,NEDD4-binding protein 2-like 1,Mus musculus (Mouse),51.4,175.0,3.6999999999999997e-41,172.2,sp|Q3V2Q8|N42L1_MOUSE NEDD4-binding protein 2-like 1 OS=Mus musculus OX=10090 GN=N4bp2l1 PE=1 SV=1,,,,,,
OG_05275,1.202255069356202,FUN_023933-T1,Peve_00017668,Pocillopora_meandrina_HIv1___TS.g28130.t1b,three_way,81.382,FUN_023933-T1,Q6P0U0,,,,,51.3,398.0,7.3e-117,422.2,sp|Q6P0U0|NAGA_DANRE N-acetylglucosamine-6-phosphate deacetylase OS=Danio rerio OX=7955 GN=amdhd2 PE=2 SV=1,,,,,,
OG_05280,1.4155380940360354,FUN_023942-T1,Peve_00023221,Pocillopora_meandrina_HIv1___RNAseq.g18858.t1,three_way,53.260666666666665,,,,,,,,,,,,,,,,,
OG_05283,1.8808299823854835,FUN_023945-T1,Peve_00010787,Pocillopora_meandrina_HIv1___RNAseq.g18863.t1,three_way,91.15233333333332,FUN_023945-T1,Q6NYV5,SP30L_DANRE,,Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like),Danio rerio (Zebrafish) (Brachydanio rerio),62.1,174.0,1.5e-54,213.8,sp|Q6NYV5|SP30L_DANRE Histone deacetylase complex subunit SAP30L OS=Danio rerio OX=7955 GN=sap30l PE=1 SV=1,GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0003712; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273,heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355],histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005730; GO:0006355; GO:0008289; GO:0042393; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleolus; regulation of DNA-templated transcription; lipid binding; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_05286,3.0666300358589025,FUN_023949-T1,Peve_00016150,Pocillopora_meandrina_HIv1___RNAseq.2014_t,three_way,80.2065,FUN_023949-T1,P51830,,,,,39.3,1189.0,3.8999999999999997e-205,716.8,sp|P51830|ADCY9_MOUSE Adenylate cyclase type 9 OS=Mus musculus OX=10090 GN=Adcy9 PE=1 SV=1,,,,,,
OG_05288,1.2796261244113178,FUN_023952-T1,Peve_00017998,Pocillopora_meandrina_HIv1___RNAseq.g18523.t1,three_way,45.82333333333333,,,,,,,,,,,,,,,,,
OG_05290,1.7889569127430156,FUN_023956-T1,Peve_00017997,Pocillopora_meandrina_HIv1___RNAseq.g18522.t1,three_way,84.48,FUN_023956-T1,O60271,,,,,49.1,642.0,1.4e-149,531.2,sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4,,,,,,
OG_05301,1.508932554429806,FUN_023971-T1,Peve_00025477,Pocillopora_meandrina_HIv1___RNAseq.g18534.t1,three_way,57.55416666666667,FUN_023971-T1,P15384,,,,,33.7,395.0,9.300000000000001e-57,222.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_05303,1.3808090002001088,FUN_023974-T2,Peve_00002583,Pocillopora_meandrina_HIv1___RNAseq.g19437.t1,three_way,55.776333333333326,FUN_023974-T2,P98069,,,,,30.9,282.0,2e-35,152.1,sp|P98069|BMPH_STRPU Bone morphogenetic protein 1 homolog OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_05304,2.824008294583848,FUN_023976-T1,Peve_00020879,Pocillopora_meandrina_HIv1___RNAseq.g19436.t1,three_way,62.5495,FUN_023976-T1,Q9HBW9,AGRL4_HUMAN,,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",Homo sapiens (Human),37.6,93.0,1.4e-08,65.1,sp|Q9HBW9|AGRL4_HUMAN Adhesion G protein-coupled receptor L4 OS=Homo sapiens OX=9606 GN=ADGRL4 PE=1 SV=3,GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0031410,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0031410; GO:0043226; GO:0060089,plasma membrane; cytoplasmic vesicle; organelle; molecular transducer activity
OG_05305,2.75501625403498,FUN_023978-T1,Peve_00020874,Pocillopora_meandrina_HIv1___RNAseq.g19435.t1,three_way,47.72816666666667,,,,,,,,,,,,,,,,,
OG_05309,1.329005308960563,FUN_023983-T1,Peve_00020889,Pocillopora_meandrina_HIv1___RNAseq.g19410.t1,three_way,79.52850000000001,FUN_023983-T1,Q5R754,CDKL2_PONAB,,Cyclin-dependent kinase-like 2 (EC 2.7.11.22),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),66.5,328.0,2.6e-132,474.2,sp|Q5R754|CDKL2_PONAB Cyclin-dependent kinase-like 2 OS=Pongo abelii OX=9601 GN=CDKL2 PE=2 SV=1,GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0106310,,cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05314,1.154637009853584,FUN_023999-T1,Peve_00034191,Pocillopora_meandrina_HIv1___RNAseq.g19353.t1,three_way,71.23733333333334,FUN_023999-T1,Q3USF0,,,,,34.5,264.0,2.6e-31,137.9,"sp|Q3USF0|B3GN6_MOUSE Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase OS=Mus musculus OX=10090 GN=B3gnt6 PE=2 SV=2",,,,,,
OG_05316,1.5587287404959835,FUN_024001-T1,Peve_00034187,Pocillopora_meandrina_HIv1___RNAseq.g19350.t1,three_way,77.74116666666666,FUN_024001-T1,P15056,BRAF_HUMAN,,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),Homo sapiens (Human),47.0,743.0,1.8999999999999998e-173,610.9,sp|P15056|BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens OX=9606 GN=BRAF PE=1 SV=4,GO:0000165; GO:0002318; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007173; GO:0008270; GO:0008542; GO:0009887; GO:0010628; GO:0010764; GO:0010828; GO:0016079; GO:0030878; GO:0033077; GO:0033138; GO:0034446; GO:0034451; GO:0035019; GO:0036064; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043149; GO:0043231; GO:0043367; GO:0043369; GO:0043524; GO:0044297; GO:0045580; GO:0048538; GO:0048680; GO:0050772; GO:0050852; GO:0051496; GO:0060291; GO:0060323; GO:0060324; GO:0070371; GO:0070374; GO:0071277; GO:0071466; GO:0072577; GO:0090150; GO:0097110; GO:0098793; GO:0098794; GO:0098978; GO:0099170; GO:0106310; GO:1900026; GO:2000301; GO:2000352,"animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; visual learning [GO:0008542]",cell body [GO:0044297]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007155; GO:0012501; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; cell adhesion; programmed cell death; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05321,1.1677431614493703,FUN_024010-T1,Peve_00042605,Pocillopora_meandrina_HIv1___RNAseq.g7352.t1,three_way,64.49566666666666,,,,,,,,,,,,,,,,,
OG_05326,1.7364497488211543,FUN_024018-T1,Peve_00023795,Pocillopora_meandrina_HIv1___RNAseq.g19283.t1,three_way,81.60583333333334,FUN_024018-T1,Q96T37,RBM15_HUMAN,,RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),Homo sapiens (Human),35.3,835.0,2.1e-99,365.2,sp|Q96T37|RBM15_HUMAN RNA-binding protein 15 OS=Homo sapiens OX=9606 GN=RBM15 PE=1 SV=2,GO:0000381; GO:0001510; GO:0001569; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0007221; GO:0009048; GO:0016607; GO:0031965; GO:0036396; GO:0038163; GO:0045638; GO:0045652; GO:0048536; GO:0060412; GO:0060674,"branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]",nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0048856,RNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development
OG_05330,1.28129794430989,FUN_024034-T1,Peve_00020334,Pocillopora_meandrina_HIv1___RNAseq.g19276.t1,three_way,96.28633333333332,FUN_024034-T1,P30676,,,,,85.9,354.0,2e-176,619.8,sp|P30676|GNAI_PATPE Guanine nucleotide-binding protein G(i) subunit alpha OS=Patiria pectinifera OX=7594 PE=1 SV=3,,,,,,
OG_05331,1.1464978636252603,FUN_024037-T1,Peve_00020333,Pocillopora_meandrina_HIv1___RNAseq.g19274.t1,three_way,74.21233333333333,FUN_024037-T1,O00462,MANBA_HUMAN,,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase),Homo sapiens (Human),47.2,885.0,1.1999999999999998e-243,844.3,sp|O00462|MANBA_HUMAN Beta-mannosidase OS=Homo sapiens OX=9606 GN=MANBA PE=1 SV=3,GO:0004567; GO:0005886; GO:0006516; GO:0009313; GO:0035577; GO:0036211; GO:0043202; GO:0043231,glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]; protein modification process [GO:0036211],azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886],beta-mannosidase activity [GO:0004567],GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05333,1.591586100520641,FUN_024043-T1,Peve_00020342,Pocillopora_meandrina_HIv1___RNAseq.g19269.t1,three_way,88.07966666666667,FUN_024043-T1,Q5T0T0,MARH8_HUMAN,,E3 ubiquitin-protein ligase MARCHF8 (EC 2.3.2.27) (Cellular modulator of immune recognition) (c-MIR) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING finger protein 178) (RING-type E3 ubiquitin transferase MARCHF8),Homo sapiens (Human),59.5,237.0,4.300000000000001e-74,279.3,sp|Q5T0T0|MARH8_HUMAN E3 ubiquitin-protein ligase MARCHF8 OS=Homo sapiens OX=9606 GN=MARCHF8 PE=1 SV=1,GO:0000139; GO:0000209; GO:0002250; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005789; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0042287; GO:0061630,adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"immune system process; catalytic activity; lysosome; endosome; vacuole; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05334,1.2111532888720995,FUN_024044-T4,Peve_00020349,Pocillopora_meandrina_HIv1___RNAseq.g19263.t1,three_way,44.71333333333334,,,,,,,,,,,,,,,,,
OG_05335,1.149683117933379,FUN_024047-T1,Peve_00020347,Pocillopora_meandrina_HIv1___RNAseq.g19265.t1,three_way,76.87566666666666,FUN_024047-T1,Q99MB5,,,,,60.5,124.0,1.3000000000000002e-44,180.6,sp|Q99MB5|LMO3_RAT LIM domain only protein 3 OS=Rattus norvegicus OX=10116 GN=Lmo3 PE=2 SV=2,,,,,,
OG_05337,1.980173232164804,FUN_024053-T1,Peve_00000160,Pocillopora_meandrina_HIv1___RNAseq.g19257.t2,three_way,68.68216666666666,FUN_024053-T1,Q8CIQ7,DOCK3_MOUSE,,Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP),Mus musculus (Mouse),42.0,1682.0,0.0,1276.5,sp|Q8CIQ7|DOCK3_MOUSE Dedicator of cytokinesis protein 3 OS=Mus musculus OX=10090 GN=Dock3 PE=1 SV=1,GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007264; GO:0017124,small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_05342,1.4595746758586683,FUN_024071-T1,Peve_00014630,Pocillopora_meandrina_HIv1___RNAseq.23622_t,three_way,47.72133333333333,,,,,,,,,,,,,,,,,
OG_05348,2.0492831943509526,FUN_024111-T1,Peve_00000186,Pocillopora_meandrina_HIv1___RNAseq.g19189.t1,three_way,75.39166666666667,FUN_024111-T1,O00408,PDE2A_HUMAN,,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)",Homo sapiens (Human),45.4,868.0,9.700000000000001e-196,685.3,"sp|O00408|PDE2A_HUMAN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Homo sapiens OX=9606 GN=PDE2A PE=1 SV=1",GO:0000122; GO:0000287; GO:0003170; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0008270; GO:0010628; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0097011; GO:0097060; GO:0106072; GO:1904613,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; ventricular septum development [GO:0003281]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]",GO:0003013; GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:1901135,circulatory system process; catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05350,1.4294508635471432,FUN_024113-T1,Peve_00000184,Pocillopora_meandrina_HIv1___RNAseq.g19187.t1,three_way,78.90166666666667,FUN_024113-T1,Q9UI95,MD2L2_HUMAN,,Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2) (REV7 homolog) (hREV7),Homo sapiens (Human),55.6,160.0,4.5e-44,179.1,sp|Q9UI95|MD2L2_HUMAN Mitotic spindle assembly checkpoint protein MAD2B OS=Homo sapiens OX=9606 GN=MAD2L2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0001558; GO:0002208; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0006302; GO:0007015; GO:0007094; GO:0008432; GO:0010719; GO:0010944; GO:0016035; GO:0033138; GO:0035861; GO:0042177; GO:0042276; GO:0042772; GO:0043247; GO:0045830; GO:0045893; GO:0051301; GO:0061629; GO:0090090; GO:1904667; GO:2000042; GO:2000048; GO:2001034,"actin filament organization [GO:0007015]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; error-prone translesion synthesis [GO:0042276]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell growth [GO:0001558]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247]",chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035],JUN kinase binding [GO:0008432]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006355; GO:0032200; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; nucleoplasm; chromosome; DNA repair; regulation of DNA-templated transcription; telomere organization; organelle; molecular adaptor activity; transcription regulator activity
OG_05354,1.636155939775178,FUN_024126-T1,Peve_00000142,Pocillopora_meandrina_HIv1___RNAseq.g19899.t1,three_way,63.01416666666667,FUN_024126-T1,A6QQL0,S15A4_BOVIN,,Solute carrier family 15 member 4 (Peptide/histidine transporter 1),Bos taurus (Bovine),30.3,545.0,1.1999999999999999e-54,216.1,sp|A6QQL0|S15A4_BOVIN Solute carrier family 15 member 4 OS=Bos taurus OX=9913 GN=SLC15A4 PE=2 SV=2,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_05356,1.0175847938967129,FUN_024129-T1,Peve_00005110,Pocillopora_meandrina_HIv1___RNAseq.g19897.t1,three_way,72.21683333333333,FUN_024129-T1,F1MDL2,,,,,35.2,899.0,1.6e-142,508.4,sp|F1MDL2|INTU_BOVIN Protein inturned OS=Bos taurus OX=9913 GN=INTU PE=3 SV=2,,,,,,
OG_05361,1.311428580660322,FUN_024136-T1,Peve_00020658,Pocillopora_meandrina_HIv1___RNAseq.g19872.t1,three_way,70.992,FUN_024136-T1,A7SNN5,PLK4_NEMVE,,Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4),Nematostella vectensis (Starlet sea anemone),55.1,1013.0,1.3999999999999998e-280,967.2,sp|A7SNN5|PLK4_NEMVE Serine/threonine-protein kinase PLK4 OS=Nematostella vectensis OX=45351 GN=v1g246408 PE=3 SV=1,GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0106310,,centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05376,1.4814158299094156,FUN_024192-T1,Peve_00018693,Pocillopora_meandrina_HIv1___RNAseq.g18883.t1,three_way,75.952,FUN_024192-T1,Q921D9,GRHL1_MOUSE,,Grainyhead-like protein 1 homolog (Transcription factor CP2-like 2) (Transcription factor LBP-32),Mus musculus (Mouse),33.3,93.0,6.4e-10,65.5,sp|Q921D9|GRHL1_MOUSE Grainyhead-like protein 1 homolog OS=Mus musculus OX=10090 GN=Grhl1 PE=1 SV=1,GO:0000976; GO:0000978; GO:0001228; GO:0002934; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0008544; GO:0031490; GO:0042803; GO:0043565; GO:0045616; GO:0045944; GO:0061436; GO:0140297,desmosome organization [GO:0002934]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of keratinocyte differentiation [GO:0045616],nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0034330; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell junction organization; organelle; anatomical structure development; transcription regulator activity
OG_05378,1.075809383865448,FUN_024195-T1,Peve_00018698,Pocillopora_meandrina_HIv1___RNAseq.g18880.t1,three_way,77.08933333333333,FUN_024195-T1,Q96NL6,SCLT1_HUMAN,,Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1),Homo sapiens (Human),27.6,613.0,2.3999999999999998e-54,215.3,sp|Q96NL6|SCLT1_HUMAN Sodium channel and clathrin linker 1 OS=Homo sapiens OX=9606 GN=SCLT1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0015630; GO:0017080; GO:0030276; GO:0036064; GO:0045162; GO:0060271; GO:0071439; GO:0097539,cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630],clathrin binding [GO:0030276]; sodium channel regulator activity [GO:0017080],GO:0005815; GO:0005829; GO:0005856; GO:0043226; GO:0044782; GO:0061024; GO:0098772,microtubule organizing center; cytosol; cytoskeleton; organelle; cilium organization; membrane organization; molecular function regulator activity
OG_05380,1.1297743671904386,FUN_024197-T1,Peve_00025330,Pocillopora_meandrina_HIv1___RNAseq.g3316.t1,three_way,57.18566666666667,FUN_024197-T1,Q6PBQ2,,,,,33.5,388.0,6.1e-54,213.4,sp|Q6PBQ2|CHMP7_DANRE Charged multivesicular body protein 7 OS=Danio rerio OX=7955 GN=chmp7 PE=2 SV=1,,,,,,
OG_05382,2.1057096645716884,FUN_024199-T1,Peve_00031882,Pocillopora_meandrina_HIv1___RNAseq.g18898.t1,three_way,95.62316666666666,FUN_024199-T1,A5WWB0,,,,,75.2,375.0,3.8e-162,572.4,sp|A5WWB0|UBP46_DANRE Ubiquitin carboxyl-terminal hydrolase 46 OS=Danio rerio OX=7955 GN=usp46 PE=3 SV=2,,,,,,
OG_05384,1.5212856133679016,FUN_024201-T1,Peve_00031885,Pocillopora_meandrina_HIv1___RNAseq.g18895.t1,three_way,52.33616666666667,FUN_024201-T1,Q5RG49,,,,,28.2,1294.0,6.1e-121,437.2,sp|Q5RG49|ACSF4_DANRE Beta-alanine-activating enzyme OS=Danio rerio OX=7955 GN=aasdh PE=3 SV=1,,,,,,
OG_05397,2.0091907740738493,FUN_024224-T1,Peve_00031887,Pocillopora_meandrina_HIv1___TS.g28304.t1,three_way,65.771,FUN_024224-T1,O60343,TBCD4_HUMAN,,TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160),Homo sapiens (Human),33.6,1274.0,8.199999999999999e-148,526.6,sp|O60343|TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens OX=9606 GN=TBC1D4 PE=1 SV=2,GO:0005096; GO:0005794; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869,cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],GTPase activator activity [GO:0005096],GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_05398,1.1232324335512025,FUN_024327-T2,Peve_00016300,Pocillopora_meandrina_HIv1___RNAseq.g18921.t1,three_way,43.888,FUN_024327-T2,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),38.0,108.0,1.7e-11,71.6,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_05400,2.125654148421103,FUN_024330-T1,Peve_00016319,Pocillopora_meandrina_HIv1___RNAseq.g18926.t1,three_way,76.277,FUN_024330-T1,O89023,TPP1_MOUSE,,Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I),Mus musculus (Mouse),50.2,562.0,2.3e-155,550.4,sp|O89023|TPP1_MOUSE Tripeptidyl-peptidase 1 OS=Mus musculus OX=10090 GN=Tpp1 PE=1 SV=2,GO:0004175; GO:0004252; GO:0005739; GO:0005764; GO:0005794; GO:0006508; GO:0007040; GO:0007399; GO:0008233; GO:0008236; GO:0008240; GO:0030855; GO:0035727; GO:0042470; GO:0043171; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070198; GO:0120146; GO:1905146,"bone resorption [GO:0045453]; epithelial cell differentiation [GO:0030855]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]",Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; recycling endosome [GO:0055037],endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240],GO:0003824; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0007040; GO:0008289; GO:0016787; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; mitochondrion; lysosome; endosome; vacuole; Golgi apparatus; lysosome organization; lipid binding; hydrolase activity; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05403,1.5807871553130015,FUN_024334-T1,Peve_00016307,Pocillopora_meandrina_HIv1___RNAseq.g18941.t1,three_way,70.359,FUN_024334-T1,Q99MK9,,,,,38.3,313.0,2e-57,224.9,sp|Q99MK9|RASF1_MOUSE Ras association domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rassf1 PE=1 SV=1,,,,,,
OG_05404,1.08868727272677,FUN_024335-T1,Peve_00016306,Pocillopora_meandrina_HIv1___TS.g28328.t1c,three_way,80.27,FUN_024335-T1,O75896,TUSC2_HUMAN,,Tumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2),Homo sapiens (Human),55.6,72.0,2.7e-17,89.4,sp|O75896|TUSC2_HUMAN Tumor suppressor candidate 2 OS=Homo sapiens OX=9606 GN=TUSC2 PE=1 SV=3,GO:0001779; GO:0005739; GO:0006909; GO:0006954; GO:0032700; GO:0032733; GO:0048469; GO:0051881; GO:0070945; GO:2000377,cell maturation [GO:0048469]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377],mitochondrion [GO:0005739],,GO:0002376; GO:0005739; GO:0006954; GO:0016192; GO:0030154; GO:0043226; GO:0098542,immune system process; mitochondrion; inflammatory response; vesicle-mediated transport; cell differentiation; organelle; defense response to other organism
OG_05416,1.332214221127208,FUN_024354-T1,Peve_00024185,Pocillopora_meandrina_HIv1___RNAseq.g18690.t1,three_way,66.696,FUN_024354-T1,Q5I0M0,SETMR_RAT,,Histone-lysine N-methyltransferase SETMAR (EC 2.1.1.357) (SET domain and mariner transposase fusion protein homolog),Rattus norvegicus (Rat),46.7,289.0,3.1000000000000003e-66,253.4,sp|Q5I0M0|SETMR_RAT Histone-lysine N-methyltransferase SETMAR OS=Rattus norvegicus OX=10116 GN=Setmar PE=2 SV=1,GO:0000014; GO:0000729; GO:0000793; GO:0003677; GO:0003690; GO:0003697; GO:0004519; GO:0005634; GO:0006303; GO:0006308; GO:0008270; GO:0008283; GO:0015074; GO:0031297; GO:0032259; GO:0035861; GO:0042054; GO:0042800; GO:0042803; GO:0044547; GO:0044774; GO:0045814; GO:0045892; GO:0046975; GO:0140954; GO:2001034; GO:2001251,"cell population proliferation [GO:0008283]; DNA catabolic process [GO:0006308]; DNA double-strand break processing [GO:0000729]; DNA integration [GO:0015074]; double-strand break repair via nonhomologous end joining [GO:0006303]; methylation [GO:0032259]; mitotic DNA integrity checkpoint signaling [GO:0044774]; negative regulation of chromosome organization [GO:2001251]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; replication fork processing [GO:0031297]",condensed chromosome [GO:0000793]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 methyltransferase activity [GO:0042800]; histone methyltransferase activity [GO:0042054]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0043226; GO:0140096; GO:0140097,"DNA binding; catalytic activity; nucleus; chromosome; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_05424,1.2728041194809945,FUN_024369-T1,Peve_00003574,Pocillopora_meandrina_HIv1___RNAseq.g19084.t1,three_way,59.029,,,,,,,,,,,,,,,,,
OG_05426,1.1425784710239146,FUN_024371-T1,Peve_00003576,Pocillopora_meandrina_HIv1___RNAseq.g19086.t1,three_way,85.09433333333334,FUN_024371-T1,Q80UU9,PGRC2_MOUSE,,Membrane-associated progesterone receptor component 2,Mus musculus (Mouse),61.1,131.0,5.5e-37,155.6,sp|Q80UU9|PGRC2_MOUSE Membrane-associated progesterone receptor component 2 OS=Mus musculus OX=10090 GN=Pgrmc2 PE=1 SV=2,GO:0005496; GO:0005576; GO:0005635; GO:0005783; GO:0015232; GO:0015886; GO:0016020; GO:0020037; GO:0045202; GO:0060612; GO:0098978,adipose tissue development [GO:0060612]; heme transport [GO:0015886],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; synapse [GO:0045202],heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; steroid binding [GO:0005496],GO:0005215; GO:0005576; GO:0005635; GO:0005783; GO:0008289; GO:0043226; GO:0048856,transporter activity; extracellular region; nuclear envelope; endoplasmic reticulum; lipid binding; organelle; anatomical structure development
OG_05432,1.2256905482168694,FUN_024378-T1,Peve_00020233,Pocillopora_meandrina_HIv1___RNAseq.g18603.t1,three_way,84.493,FUN_024378-T1,P94598,,,,,60.0,440.0,7.3e-161,568.5,sp|P94598|DHE3_BACTN Glutamate dehydrogenase OS=Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50) OX=226186 GN=gdhA PE=3 SV=2,,,,,,
OG_05436,2.9120289350555337,FUN_024389-T1,Peve_00018044,Pocillopora_meandrina_HIv1___RNAseq.g18620.t1,three_way,74.58266666666667,FUN_024389-T1,O70433,,,,,39.0,269.0,1.3e-68,262.3,sp|O70433|FHL2_MOUSE Four and a half LIM domains protein 2 OS=Mus musculus OX=10090 GN=Fhl2 PE=1 SV=1,,,,,,
OG_05437,1.9387385771822776,FUN_024390-T2,Peve_00018042,Pocillopora_meandrina_HIv1___RNAseq.g18621.t1,three_way,74.62266666666667,FUN_024390-T2,Q80VL3,,,,,50.8,413.0,3e-126,454.1,sp|Q80VL3|PRIC3_MOUSE Prickle planar cell polarity protein 3 OS=Mus musculus OX=10090 GN=Prickle3 PE=1 SV=1,,,,,,
OG_05443,2.192384977650997,FUN_024398-T2,Peve_00021812,Pocillopora_meandrina_HIv1___RNAseq.g18631.t1,three_way,82.838,FUN_024398-T2,Q66GS9,CP135_HUMAN,,Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4),Homo sapiens (Human),37.8,566.0,6.9e-91,337.4,sp|Q66GS9|CP135_HUMAN Centrosomal protein of 135 kDa OS=Homo sapiens OX=9606 GN=CEP135 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008017; GO:0010457; GO:0015631; GO:0042802; GO:0042803; GO:1902857; GO:1904951,centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631],GO:0005815; GO:0005829; GO:0008092; GO:0043226,microtubule organizing center; cytosol; cytoskeletal protein binding; organelle
OG_05444,1.2947936918472855,FUN_024399-T1,Peve_00021813,Pocillopora_meandrina_HIv1___RNAseq.g18632.t1,three_way,82.354,FUN_024399-T1,Q9QZN3,,,,,52.8,267.0,1.5e-81,304.3,sp|Q9QZN3|FBX8_MOUSE F-box only protein 8 OS=Mus musculus OX=10090 GN=Fbxo8 PE=2 SV=2,,,,,,
OG_05445,3.252801996435162,FUN_024401-T1,Peve_00033232,Pocillopora_meandrina_HIv1___RNAseq.g18633.t1,three_way,75.52233333333334,FUN_024401-T1,P20595,GCYB1_RAT,,Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit),Rattus norvegicus (Rat),46.0,620.0,2.1e-138,494.6,sp|P20595|GCYB1_RAT Guanylate cyclase soluble subunit beta-1 OS=Rattus norvegicus OX=10116 GN=Gucy1b1 PE=1 SV=2,GO:0004383; GO:0005525; GO:0005829; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0032991; GO:0038060; GO:0044877; GO:0046872; GO:0051879; GO:0070026; GO:0070482; GO:0071732; GO:0098831; GO:0098978,cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482],"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone cytoplasmic component [GO:0098831]; protein-containing complex [GO:0032991]",GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005829; GO:0009975; GO:0016829; GO:0055086; GO:1901135,catalytic activity; cytosol; cyclase activity; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05446,2.41533964216458,FUN_024402-T1,Peve_00007147,Pocillopora_meandrina_HIv1___RNAseq.g18634.t1,three_way,78.25166666666667,FUN_024402-T1,O54865,,,,,51.5,532.0,1.4e-146,521.2,sp|O54865|GCYB1_MOUSE Guanylate cyclase soluble subunit beta-1 OS=Mus musculus OX=10090 GN=Gucy1b1 PE=1 SV=1,,,,,,
OG_05450,2.521783228357512,FUN_024408-T1,Peve_00015478,Pocillopora_meandrina_HIv1___TS.g28030.t1,three_way,67.57766666666666,FUN_024408-T1,Q8I719,KGP_PLAF7,,cGMP-dependent protein kinase (EC 2.7.11.12) (PfPKG),Plasmodium falciparum (isolate 3D7),26.9,245.0,7.8e-13,77.4,sp|Q8I719|KGP_PLAF7 cGMP-dependent protein kinase OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=PKG PE=1 SV=1,GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005952; GO:0006468; GO:0007165; GO:0007276; GO:0019898; GO:0030553; GO:0046872; GO:0106310,gamete generation [GO:0007276]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898],ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005783; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_05453,2.3195829728457893,FUN_024411-T1,Peve_00011775,Pocillopora_meandrina_HIv1___RNAseq.g18636.t1,three_way,77.30883333333334,FUN_024411-T1,Q7T163,KDISB_DANRE,,Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B),Danio rerio (Zebrafish) (Brachydanio rerio),35.3,893.0,4.3999999999999996e-141,504.6,sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3,GO:0005770; GO:0007399; GO:0019887; GO:0030165; GO:0031902; GO:0038180,nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399],late endosome [GO:0005770]; late endosome membrane [GO:0031902],PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887],GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0098772,endosome; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_05455,1.3866125695277125,FUN_024413-T1,Peve_00029254,Pocillopora_meandrina_HIv1___TS.g28094.t1,three_way,72.38216666666666,FUN_024413-T1,Q08874,MITF_MOUSE,,Microphthalmia-associated transcription factor,Mus musculus (Mouse),41.5,366.0,1.1e-46,189.1,sp|Q08874|MITF_MOUSE Microphthalmia-associated transcription factor OS=Mus musculus OX=10090 GN=Mitf PE=1 SV=4,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0006357; GO:0010468; GO:0010628; GO:0016055; GO:0030154; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0043066; GO:0043473; GO:0043565; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:1902362; GO:2000144,bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; melanocyte apoptotic process [GO:1902362]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; pigmentation [GO:0043473]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_05460,1.5467873576871722,FUN_024439-T1,Peve_00004162,Pocillopora_meandrina_HIv1___RNAseq.g18714.t1,three_way,80.35366666666667,FUN_024439-T1,Q9Z206,ARHG8_MOUSE,,Neuroepithelial cell-transforming gene 1 protein (Rho guanine nucleotide exchange factor 8),Mus musculus (Mouse),45.5,444.0,1.8000000000000002e-104,381.3,sp|Q9Z206|ARHG8_MOUSE Neuroepithelial cell-transforming gene 1 protein OS=Mus musculus OX=10090 GN=Net1 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005737; GO:0005886; GO:0031267; GO:0035556; GO:0043065; GO:0043547; GO:0051451; GO:0070301; GO:0071479; GO:1900026,cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005634; GO:0005886; GO:0043226; GO:0048870; GO:0098772,nucleus; plasma membrane; organelle; cell motility; molecular function regulator activity
OG_05462,1.385161585192473,FUN_024445-T1,Peve_00025478,Pocillopora_meandrina_HIv1___RNAseq.g18708.t1,three_way,87.55799999999999,FUN_024445-T1,Q14643,,,,,59.9,2841.0,0.0,3137.1,"sp|Q14643|ITPR1_HUMAN Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1 OS=Homo sapiens OX=9606 GN=ITPR1 PE=1 SV=3",,,,,,
OG_05465,2.1261896932294837,FUN_024448-T1,Peve_00025474,Pocillopora_meandrina_HIv1___RNAseq.g18705.t1,three_way,56.5495,FUN_024448-T1,Q96RY5,,,,,49.1,228.0,3.2e-52,208.8,sp|Q96RY5|CRML_HUMAN Protein cramped-like OS=Homo sapiens OX=9606 GN=CRAMP1 PE=1 SV=3,,,,,,
OG_05467,1.6434218372266012,FUN_024450-T1,Peve_00025472,Pocillopora_meandrina_HIv1___RNAseq.g18853.t1,three_way,86.50233333333333,FUN_024450-T1,P51790,CLCN3_HUMAN,,H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3),Homo sapiens (Human),61.5,808.0,1.8e-281,969.9,sp|P51790|CLCN3_HUMAN H(+)/Cl(-) exchange transporter 3 OS=Homo sapiens OX=9606 GN=CLCN3 PE=1 SV=2,GO:0000139; GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0006885; GO:0006911; GO:0008021; GO:0008344; GO:0009897; GO:0009986; GO:0010008; GO:0012506; GO:0015297; GO:0016020; GO:0030141; GO:0030165; GO:0030672; GO:0031410; GO:0031901; GO:0031902; GO:0032587; GO:0035249; GO:0042581; GO:0043231; GO:0043679; GO:0045335; GO:0045494; GO:0045794; GO:0048388; GO:0051932; GO:0055037; GO:0062158; GO:0072320; GO:0097401; GO:0098978; GO:0098982; GO:1902476; GO:1903428,"adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; endosomal lumen acidification [GO:0048388]; negative regulation of cell volume [GO:0045794]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of pH [GO:0006885]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401]",axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle membrane [GO:0012506],antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride:proton antiporter activity [GO:0062158]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]; volume-sensitive chloride channel activity [GO:0072320],GO:0005215; GO:0005768; GO:0005794; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0055085; GO:0061024,transporter activity; endosome; Golgi apparatus; plasma membrane; signaling; cytoplasmic vesicle; organelle; transmembrane transport; membrane organization
OG_05468,1.1218292192735266,FUN_024451-T1,Peve_00003482,Pocillopora_meandrina_HIv1___RNAseq.g18852.t1,three_way,84.42533333333333,FUN_024451-T1,Q6P5I8,,,,,47.8,228.0,1.8e-45,184.1,sp|Q6P5I8|YIPF5_DANRE Protein YIPF5 OS=Danio rerio OX=7955 GN=yipf5 PE=2 SV=1,,,,,,
OG_05469,1.7159464624933027,FUN_024452-T1,Peve_00010318,Pocillopora_meandrina_HIv1___TS.g27970.t1,three_way,82.02633333333333,FUN_024452-T1,Q9SVG0,,,,,34.9,415.0,2.3e-51,204.5,sp|Q9SVG0|AVT3C_ARATH Amino acid transporter AVT3C OS=Arabidopsis thaliana OX=3702 GN=AVT3C PE=1 SV=1,,,,,,
OG_05471,2.2229083036294752,FUN_024454-T1,Peve_00010316,Pocillopora_meandrina_HIv1___RNAseq.g18577.t1,three_way,67.4025,FUN_024454-T1,Q5DTZ6,,,,,45.4,273.0,1.5e-58,228.4,sp|Q5DTZ6|RN150_MOUSE RING finger protein 150 OS=Mus musculus OX=10090 GN=Rnf150 PE=2 SV=2,,,,,,
OG_05473,2.327044977334571,FUN_024456-T1,Peve_00010312,Pocillopora_meandrina_HIv1___RNAseq.g18574.t1,three_way,77.98883333333333,FUN_024456-T1,A7S6A1,,,,,59.2,903.0,2.2000000000000002e-272,939.9,sp|A7S6A1|U518_NEMVE FHIP family protein v1g243165 OS=Nematostella vectensis OX=45351 GN=v1g243165 PE=3 SV=1,,,,,,
OG_05474,1.5112961587476854,FUN_024457-T1,Peve_00010311,Pocillopora_meandrina_HIv1___TS.g27964.t1,three_way,63.876,FUN_024457-T1,Q9H8H3,TMT1A_HUMAN,,Thiol S-methyltransferase TMT1A (EC 2.1.1.9) (Methyltransferase-like protein 7A) (N6-adenosine-methyltransferase TMT1A) (EC 2.1.1.348) (Protein AAM-B) (Thiol methyltransferase 1A),Homo sapiens (Human),40.7,216.0,1.1e-40,168.3,sp|Q9H8H3|TMT1A_HUMAN Thiol S-methyltransferase TMT1A OS=Homo sapiens OX=9606 GN=TMT1A PE=1 SV=1,GO:0001649; GO:0001734; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0008168; GO:0008173; GO:0016020; GO:0018708; GO:0032259; GO:0042476; GO:0180035; GO:1904724,lncRNA processing [GO:0180035]; methylation [GO:0032259]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724],methyltransferase activity [GO:0008168]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA methyltransferase activity [GO:0008173]; thiol S-methyltransferase activity [GO:0018708],GO:0003824; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0016740; GO:0030154; GO:0043226; GO:0140098,"catalytic activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; transferase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_05476,2.0135820416291783,FUN_024466-T1,Peve_00026420,Pocillopora_meandrina_HIv1___RNAseq.g18562.t1,three_way,72.03833333333334,FUN_024466-T1,J7GQ11,,,,,35.2,495.0,1e-70,270.0,sp|J7GQ11|TYRDC_LEVBR L-tyrosine decarboxylase OS=Levilactobacillus brevis OX=1580 GN=tdc PE=1 SV=1,,,,,,
OG_05484,1.6078672799991818,FUN_024481-T1,Peve_00016898,Pocillopora_meandrina_HIv1___RNAseq.g19066.t2,three_way,65.00099999999999,FUN_024481-T1,Q92870,APBB2_HUMAN,,Amyloid beta precursor protein binding family B member 2 (Amyloid-beta (A4) precursor protein-binding family B member 2) (Protein Fe65-like 1),Homo sapiens (Human),36.6,331.0,3.8e-55,218.8,sp|Q92870|APBB2_HUMAN Amyloid beta precursor protein binding family B member 2 OS=Homo sapiens OX=9606 GN=APBB2 PE=1 SV=3,GO:0000122; GO:0001540; GO:0001764; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0006355; GO:0006939; GO:0007411; GO:0016020; GO:0030027; GO:0030198; GO:0030426; GO:0035556; GO:0036438; GO:0043065; GO:0043066; GO:0045202; GO:0045944; GO:0050808; GO:0060090; GO:1901988,axon guidance [GO:0007411]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808],cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202],amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090],GO:0003012; GO:0005634; GO:0005768; GO:0005783; GO:0005794; GO:0006355; GO:0030198; GO:0031410; GO:0034330; GO:0043226; GO:0048870; GO:0060090,muscle system process; nucleus; endosome; endoplasmic reticulum; Golgi apparatus; regulation of DNA-templated transcription; extracellular matrix organization; cytoplasmic vesicle; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_05485,1.8693473011064512,FUN_024482-T1,Peve_00010582,Pocillopora_meandrina_HIv1___RNAseq.g19067.t1,three_way,60.68966666666667,,,,,,,,,,,,,,,,,
OG_05489,1.05829706329545,FUN_024487-T1,Peve_00042022,Pocillopora_meandrina_HIv1___RNAseq.g18539.t1,three_way,70.27733333333333,FUN_024487-T1,A2BGL3,,,,,31.5,111.0,1.6e-08,60.8,sp|A2BGL3|WSCD2_DANRE Sialate:O-sulfotransferase 2 OS=Danio rerio OX=7955 GN=wscd2 PE=3 SV=1,,,,,,
OG_05492,1.0290856256123255,FUN_024524-T1,Peve_00034558,Pocillopora_meandrina_HIv1___RNAseq.g18542.t1,three_way,74.3655,FUN_024524-T1,Q96PY6,NEK1_HUMAN,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55),Homo sapiens (Human),32.6,1424.0,3.4000000000000003e-128,461.5,sp|Q96PY6|NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens OX=9606 GN=NEK1 PE=1 SV=2,GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310,cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_05498,2.2750103986102603,FUN_024557-T1,Peve_00039513,Pocillopora_meandrina_HIv1___RNAseq.g18656.t1,three_way,51.671,,,,,,,,,,,,,,,,,
OG_05500,1.0370204006229178,FUN_024559-T1,Peve_00039516,Pocillopora_meandrina_HIv1___RNAseq.g18658.t1,three_way,92.67866666666669,FUN_024559-T1,P70340,SMAD1_MOUSE,,Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (Dwarfin-A) (Dwf-A) (Mothers-against-DPP-related 1) (Mad-related protein 1) (mMad1) (SMAD family member 1) (SMAD 1) (Smad1),Mus musculus (Mouse),70.4,467.0,2.5e-184,646.4,sp|P70340|SMAD1_MOUSE Mothers against decapentaplegic homolog 1 OS=Mus musculus OX=10090 GN=Smad1 PE=1 SV=2,GO:0000165; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0001657; GO:0001673; GO:0001710; GO:0002051; GO:0003700; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0006351; GO:0006357; GO:0006366; GO:0006879; GO:0006954; GO:0007179; GO:0007276; GO:0008283; GO:0008285; GO:0009880; GO:0010628; GO:0017151; GO:0019901; GO:0030509; GO:0030901; GO:0030902; GO:0031625; GO:0032991; GO:0042592; GO:0042802; GO:0043565; GO:0045669; GO:0045944; GO:0046872; GO:0048863; GO:0051148; GO:0051216; GO:0060038; GO:0060348; GO:0060395; GO:0061036; GO:0070410; GO:0070411; GO:0070878; GO:0071142; GO:0071144; GO:1902895; GO:1903672,BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; DNA-templated transcription [GO:0006351]; embryonic pattern specification [GO:0009880]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; intracellular iron ion homeostasis [GO:0006879]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell differentiation [GO:0051148]; osteoblast differentiation [GO:0001649]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],chromatin [GO:0000785]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; male germ cell nucleus [GO:0001673]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase binding [GO:0031625]",GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0006954; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; RNA binding; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; inflammatory response; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05501,1.4029457814812565,FUN_024564-T1,Peve_00009968,Pocillopora_meandrina_HIv1___RNAseq.g18662.t1,three_way,88.02933333333334,,,,,,,,,,,,,,,,,
OG_05503,1.0464456742126915,FUN_024567-T1,Peve_00036070,Pocillopora_meandrina_HIv1___RNAseq.g19088.t1,three_way,78.1325,FUN_024567-T1,Q8WXW3,PIBF1_HUMAN,,Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90),Homo sapiens (Human),39.1,713.0,3.8000000000000003e-119,430.6,sp|Q8WXW3|PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens OX=9606 GN=PIBF1 PE=1 SV=2,GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0036064; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515,activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],interleukin-4 receptor binding [GO:0005136],GO:0002376; GO:0005615; GO:0005634; GO:0005815; GO:0007010; GO:0043226; GO:0044782,immune system process; extracellular space; nucleus; microtubule organizing center; cytoskeleton organization; organelle; cilium organization
OG_05505,1.8187206202580464,FUN_024577-T1,Peve_00007643,Pocillopora_meandrina_HIv1___TS.g28491.t1,three_way,74.36816666666667,FUN_024577-T1,Q2LD37,BLTP1_HUMAN,,Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein),Homo sapiens (Human),29.4,5271.0,0.0,1751.9,sp|Q2LD37|BLTP1_HUMAN Bridge-like lipid transfer protein family member 1 OS=Homo sapiens OX=9606 GN=BLTP1 PE=1 SV=2,GO:0001558; GO:0005634; GO:0005789; GO:0005886; GO:0006909; GO:0016020; GO:0016197; GO:0030856; GO:0031966; GO:0032456; GO:0048488; GO:0098793; GO:0120009; GO:0140268; GO:1904121,endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intermembrane lipid transfer [GO:0120009]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793],phosphatidylethanolamine transfer activity [GO:1904121],GO:0005215; GO:0005634; GO:0005886; GO:0016192; GO:0043226; GO:0061024,transporter activity; nucleus; plasma membrane; vesicle-mediated transport; organelle; membrane organization
OG_05510,1.555951958426239,FUN_024593-T1,Peve_00037920,Pocillopora_meandrina_HIv1___RNAseq.g19123.t1,three_way,88.745,,,,,,,,,,,,,,,,,
OG_05514,2.7309249137868563,FUN_024614-T1,Peve_00041134,Pocillopora_meandrina_HIv1___RNAseq.g19147.t1,three_way,72.74433333333333,FUN_024614-T1,B3EWZ9,HEPHL_ACRMI,,Hephaestin-like protein (EC 1.-.-.-),Acropora millepora (Staghorn coral) (Heteropora millepora),96.7,1114.0,0.0,2249.2,sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491,copper ion transport [GO:0006825]; iron ion transport [GO:0006826],plasma membrane [GO:0005886],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005886; GO:0016491,catalytic activity; plasma membrane; oxidoreductase activity
OG_05518,1.2952554752215484,FUN_024618-T1,Peve_00027329,Pocillopora_meandrina_HIv1___RNAseq.g19153.t1,three_way,82.87033333333333,FUN_024618-T1,Q9VJ79,PDE11_DROME,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11) (PDE11)",Drosophila melanogaster (Fruit fly),51.3,915.0,3.4e-254,879.4,"sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster OX=7227 GN=Pde11 PE=1 SV=4",GO:0004115; GO:0005829; GO:0019933; GO:0046058; GO:0046068; GO:0046872; GO:0047555,cAMP metabolic process [GO:0046058]; cAMP-mediated signaling [GO:0019933]; cGMP metabolic process [GO:0046068],cytosol [GO:0005829],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05522,2.224554610236684,FUN_024625-T1,Peve_00012720,Pocillopora_meandrina_HIv1___TS.g28341.t1,three_way,37.063,,,,,,,,,,,,,,,,,
OG_05523,1.2930172449249229,FUN_024629-T1,Peve_00012710,Pocillopora_meandrina_HIv1___RNAseq.g18959.t1,three_way,61.03916666666667,,,,,,,,,,,,,,,,,
OG_05524,1.414734822619077,FUN_024632-T1,Peve_00012707,Pocillopora_meandrina_HIv1___RNAseq.g18962.t1,three_way,81.95866666666667,FUN_024632-T1,P07742,,,,,75.2,793.0,0.0,1231.5,sp|P07742|RIR1_MOUSE Ribonucleoside-diphosphate reductase large subunit OS=Mus musculus OX=10090 GN=Rrm1 PE=1 SV=2,,,,,,
OG_05528,1.3818809523540985,FUN_024671-T1,Peve_00032976,Pocillopora_meandrina_HIv1___RNAseq.g18966.t1,three_way,60.04133333333333,FUN_024671-T1,Q5BK09,,,,,25.9,263.0,2.8e-13,77.4,sp|Q5BK09|DRAM2_RAT DNA damage-regulated autophagy modulator protein 2 OS=Rattus norvegicus OX=10116 GN=Dram2 PE=2 SV=1,,,,,,
OG_05529,1.3608739771430085,FUN_024672-T1,Peve_00027344,Pocillopora_meandrina_HIv1___RNAseq.g19161.t1,three_way,74.23133333333334,,,,,,,,,,,,,,,,,
OG_05533,2.063377246715527,FUN_024719-T1,Peve_00012704,Pocillopora_meandrina_HIv1___RNAseq.g18947.t1,three_way,64.05266666666667,FUN_024719-T1,A7MBB3,,,,,31.4,175.0,8.8e-10,65.9,sp|A7MBB3|T150B_BOVIN Modulator of macroautophagy TMEM150B OS=Bos taurus OX=9913 GN=TMEM150B PE=2 SV=1,,,,,,
OG_05535,1.0481428463974105,FUN_024724-T1,Peve_00012714,Pocillopora_meandrina_HIv1___RNAseq.g18835.t1,three_way,82.242,FUN_024724-T1,Q9EPW0,INP4A_MOUSE,,"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Inositol polyphosphate 4-phosphatase-1) (4-Ptase-1) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)",Mus musculus (Mouse),37.1,911.0,3.5e-154,547.4,sp|Q9EPW0|INP4A_MOUSE Inositol polyphosphate-4-phosphatase type I A OS=Mus musculus OX=10090 GN=Inpp4a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0006798; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0052828; GO:0055038; GO:0098978; GO:0099072,polyphosphate catabolic process [GO:0006798]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038],"inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]",GO:0003824; GO:0005634; GO:0005886; GO:0016787; GO:0043226,catalytic activity; nucleus; plasma membrane; hydrolase activity; organelle
OG_05537,1.0114257197078669,FUN_024726-T1,Peve_00029154,Pocillopora_meandrina_HIv1___RNAseq.g18837.t1,three_way,72.15833333333333,FUN_024726-T1,A0A1J6KGJ9,,,,,30.6,563.0,1e-55,219.5,sp|A0A1J6KGJ9|JAR4_NICAT Jasmonoyl--L-amino acid synthetase JAR4 OS=Nicotiana attenuata OX=49451 GN=JAR4 PE=1 SV=1,,,,,,
OG_05539,1.248026910242378,FUN_024741-T1,Peve_00026308,Pocillopora_meandrina_HIv1___RNAseq.g18839.t1,three_way,45.45766666666667,FUN_024741-T1,Q8NB91,FANCB_HUMAN,,Fanconi anemia group B protein (Protein FACB) (Fanconi anemia-associated polypeptide of 95 kDa) (FAAP95),Homo sapiens (Human),20.2,643.0,3.7e-10,68.6,sp|Q8NB91|FANCB_HUMAN Fanconi anemia group B protein OS=Homo sapiens OX=9606 GN=FANCB PE=1 SV=1,GO:0000785; GO:0005654; GO:0005829; GO:0036297; GO:0043240; GO:1905168; GO:1990414; GO:2000042,interstrand cross-link repair [GO:0036297]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829; GO:0006281; GO:0006310,nucleoplasm; cytosol; DNA repair; DNA recombination
OG_05540,1.5845310159275534,FUN_024742-T1,Peve_00005934,Pocillopora_meandrina_HIv1___TS.g28230.t1,three_way,61.432,FUN_024742-T1,Q865W2,,,,,26.7,217.0,2e-10,69.3,sp|Q865W2|TRI50_PIG E3 ubiquitin-protein ligase TRIM50 OS=Sus scrofa OX=9823 GN=TRIM50 PE=2 SV=1,,,,,,
OG_05542,1.3230871158766566,FUN_024748-T1,Peve_00005930,Pocillopora_meandrina_HIv1___RNAseq.g18844.t2,three_way,45.1395,,,,,,,,,,,,,,,,,
OG_05547,1.9790379181422249,FUN_024754-T1,Peve_00041144,Pocillopora_meandrina_HIv1___RNAseq.g18833.t1,three_way,62.28083333333333,FUN_024754-T1,Q9NXR5,,,,,41.9,93.0,3.5e-12,73.9,sp|Q9NXR5|ANR10_HUMAN Ankyrin repeat domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ANKRD10 PE=1 SV=2,,,,,,
OG_05548,2.6337941060823744,FUN_024755-T1,Peve_00041143,Pocillopora_meandrina_HIv1___RNAseq.2312_t,three_way,71.259,FUN_024755-T1,P22304,IDS_HUMAN,,Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain],Homo sapiens (Human),52.4,510.0,3.2e-146,520.0,sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1,GO:0004423; GO:0005509; GO:0005737; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202,dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200],cytoplasm [GO:0005737]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05549,1.0312991837560088,FUN_024756-T1,Peve_00027351,Pocillopora_meandrina_HIv1___RNAseq.g18828.t1,three_way,51.74283333333333,FUN_024756-T1,Q9P0M2,AKA7G_HUMAN,,A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma),Homo sapiens (Human),39.0,205.0,7.9e-36,153.3,sp|Q9P0M2|AKA7G_HUMAN A-kinase anchor protein 7 isoform gamma OS=Homo sapiens OX=9606 GN=AKAP7 PE=1 SV=2,GO:0000166; GO:0005634; GO:0005829; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686,modulation of chemical synaptic transmission [GO:0050804],cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901],GO:0005634; GO:0005829; GO:0043226,nucleus; cytosol; organelle
OG_05551,2.2929123690293656,FUN_024758-T1,Peve_00027326,Pocillopora_meandrina_HIv1___RNAseq.g18826.t1,three_way,87.74933333333333,,,,,,,,,,,,,,,,,
OG_05554,1.0263353491136076,FUN_024762-T1,Peve_00020489,Pocillopora_meandrina_HIv1___RNAseq.g18822.t1,three_way,75.65866666666666,FUN_024762-T1,Q5U3V7,,,,,46.3,341.0,4.3e-72,273.1,sp|Q5U3V7|S2543_DANRE Solute carrier family 25 member 43 OS=Danio rerio OX=7955 GN=slc25a43 PE=2 SV=1,,,,,,
OG_05557,3.0756861602213905,FUN_024775-T1,Peve_00033053,Pocillopora_meandrina_HIv1___RNAseq.g18815.t1,three_way,70.15433333333333,FUN_024775-T1,Q92629,,,,,40.8,265.0,5.6999999999999996e-49,196.1,sp|Q92629|SGCD_HUMAN Delta-sarcoglycan OS=Homo sapiens OX=9606 GN=SGCD PE=1 SV=2,,,,,,
OG_05559,1.592722013216047,FUN_024777-T1,Peve_00029133,Pocillopora_meandrina_HIv1___RNAseq.g18813.t1,three_way,71.3975,FUN_024777-T1,Q5T8P6,RBM26_HUMAN,,RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26),Homo sapiens (Human),31.9,1043.0,1e-47,193.7,sp|Q5T8P6|RBM26_HUMAN RNA-binding protein 26 OS=Homo sapiens OX=9606 GN=RBM26 PE=1 SV=3,GO:0003723; GO:0005634; GO:0008270,,nucleus [GO:0005634],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005634; GO:0043226,RNA binding; nucleus; organelle
OG_05561,1.7206433196987454,FUN_024780-T1,Peve_00015072,Pocillopora_meandrina_HIv1___RNAseq.g18803.t1,three_way,84.27633333333333,FUN_024780-T1,Q9CXV9,DCNL5_MOUSE,,DCN1-like protein 5 (DCNL5) (DCUN1 domain-containing protein 5) (Defective in cullin neddylation protein 1-like protein 5) (Squamous cell carcinoma-related oncogene 5),Mus musculus (Mouse),51.8,168.0,1.3e-42,174.5,sp|Q9CXV9|DCNL5_MOUSE DCN1-like protein 5 OS=Mus musculus OX=10090 GN=Dcun1d5 PE=1 SV=1,GO:0001558; GO:0005634; GO:0005737; GO:0005819; GO:0006974; GO:0097602; GO:2000434; GO:2000436,DNA damage response [GO:0006974]; positive regulation of protein neddylation [GO:2000436]; regulation of cell growth [GO:0001558]; regulation of protein neddylation [GO:2000434],cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819],cullin family protein binding [GO:0097602],GO:0005634; GO:0043226,nucleus; organelle
OG_05562,1.5475204190327596,FUN_024781-T1,Peve_00015076,Pocillopora_meandrina_HIv1___TS.g28189.t2,three_way,75.94966666666666,FUN_024781-T1,Q5F3U9,,,,,42.0,1148.0,3.5999999999999997e-242,840.1,sp|Q5F3U9|PDS5B_CHICK Sister chromatid cohesion protein PDS5 homolog B OS=Gallus gallus OX=9031 GN=PDS5B PE=2 SV=3,,,,,,
OG_05566,1.337270629854616,FUN_024796-T1,Peve_00007042,Pocillopora_meandrina_HIv1___RNAseq.g18794.t1,three_way,55.33416666666667,,,,,,,,,,,,,,,,,
OG_05571,1.6861527094231537,FUN_024814-T1,Peve_00026077,Pocillopora_meandrina_HIv1___RNAseq.g18773.t1,three_way,88.77166666666666,FUN_024814-T1,Q4GZT3,PKD2_BOVIN,,Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2),Bos taurus (Bovine),54.5,751.0,1.4999999999999999e-215,751.1,sp|Q4GZT3|PKD2_BOVIN Polycystin-2 OS=Bos taurus OX=9913 GN=PKD2 PE=2 SV=1,GO:0002133; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006813; GO:0006814; GO:0006816; GO:0007166; GO:0015271; GO:0016020; GO:0016323; GO:0030659; GO:0034703; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070062; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0140494,calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; release of sequestered calcium ion into cytosol [GO:0051209]; sodium ion transport [GO:0006814],basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; migrasome [GO:0140494]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0008092; GO:0043226; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; Golgi apparatus; plasma membrane; cilium; cytoskeletal protein binding; organelle; transmembrane transport; protein-containing complex assembly
OG_05572,3.165589292143443,FUN_024815-T1,Peve_00026076,Pocillopora_meandrina_HIv1___RNAseq.g18772.t1,three_way,69.34433333333334,FUN_024815-T1,Q96PE2,ARHGH_HUMAN,,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),Homo sapiens (Human),40.1,1066.0,9.2e-179,630.2,sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056,actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0007010; GO:0098772,cytosol; cytoskeleton organization; molecular function regulator activity
OG_05576,1.0402985158178866,FUN_024871-T1,Peve_00016134,Pocillopora_meandrina_HIv1___RNAseq.g18750.t1,three_way,55.18966666666667,FUN_024871-T1,P39022,,,,,68.3,161.0,3.8e-60,233.8,sp|P39022|RAD52_CHICK DNA repair protein RAD52 homolog OS=Gallus gallus OX=9031 GN=RAD52 PE=2 SV=1,,,,,,
OG_05581,1.126821753496816,FUN_024905-T1,Peve_00016139,Pocillopora_meandrina_HIv1___RNAseq.g18746.t1,three_way,52.13,FUN_024905-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),36.1,280.0,9.9e-38,160.2,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_05582,2.522947849498289,FUN_024906-T1,Peve_00038387,Pocillopora_meandrina_HIv1___RNAseq.g19419.t1,three_way,66.53216666666667,FUN_024906-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),24.3,382.0,1.2000000000000001e-30,135.6,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05586,1.1928040372136473,FUN_024942-T1,Peve_00038386,Pocillopora_meandrina_HIv1___RNAseq.g19445.t1,three_way,68.45700000000001,FUN_024942-T1,A8MXD5,GRCR1_HUMAN,,Glutaredoxin domain-containing cysteine-rich protein 1,Homo sapiens (Human),35.3,190.0,2.1e-28,127.5,sp|A8MXD5|GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens OX=9606 GN=GRXCR1 PE=1 SV=1,GO:0005902; GO:0006887; GO:0007009; GO:0007605; GO:0032420; GO:0051592; GO:0051649; GO:0060088; GO:0060091; GO:0060118; GO:0060119; GO:0060122; GO:0070588; GO:0090102; GO:1905144,auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transmembrane transport [GO:0070588]; cochlea development [GO:0090102]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; plasma membrane organization [GO:0007009]; response to acetylcholine [GO:1905144]; response to calcium ion [GO:0051592]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118],kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420],,GO:0005929; GO:0016192; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0061024,cilium; vesicle-mediated transport; organelle; anatomical structure development; nervous system process; transmembrane transport; membrane organization
OG_05588,1.5916326146953126,FUN_025031-T1,Peve_00004654,Pocillopora_meandrina_HIv1___TS.g28790.t2,three_way,69.56233333333333,FUN_025031-T1,Q6R1L1,,,,,55.9,195.0,5.1999999999999996e-46,186.4,sp|Q6R1L1|TAF7_CRIGR Transcription initiation factor TFIID subunit 7 OS=Cricetulus griseus OX=10029 GN=TAF7 PE=1 SV=1,,,,,,
OG_05593,1.193895601617278,FUN_025100-T1,Peve_00038383,Pocillopora_meandrina_HIv1___RNAseq.g19443.t1,three_way,68.198,FUN_025100-T1,Q8C8U0,,,,,33.6,961.0,3.5e-107,391.0,sp|Q8C8U0|LIPB1_MOUSE Liprin-beta-1 OS=Mus musculus OX=10090 GN=Ppfibp1 PE=1 SV=3,,,,,,
OG_05595,1.2935628555787968,FUN_025109-T1,Peve_00038375,Pocillopora_meandrina_HIv1___RNAseq.g19429.t1,three_way,81.03466666666667,FUN_025109-T1,P23935,,,,,54.4,114.0,4.2e-27,122.1,sp|P23935|NDUA5_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 OS=Bos taurus OX=9913 GN=NDUFA5 PE=1 SV=3,,,,,,
OG_05602,1.577274516532455,FUN_025259-T1,Peve_00031195,Pocillopora_meandrina_HIv1___TS.g2586.t1,three_way,76.54266666666668,FUN_025259-T1,Q8NCX0,,,,,27.3,956.0,1.9e-10,70.1,sp|Q8NCX0|CC150_HUMAN Coiled-coil domain-containing protein 150 OS=Homo sapiens OX=9606 GN=CCDC150 PE=1 SV=2,,,,,,
OG_05606,1.2929354940764926,FUN_025266-T1,Peve_00030516,Pocillopora_meandrina_HIv1___RNAseq.g13584.t1,three_way,92.62,FUN_025266-T1,O70475,,,,,71.9,481.0,2.8e-197,689.5,sp|O70475|UGDH_MOUSE UDP-glucose 6-dehydrogenase OS=Mus musculus OX=10090 GN=Ugdh PE=1 SV=1,,,,,,
OG_05613,1.6768295350268576,FUN_025299-T1,Peve_00040950,Pocillopora_meandrina_HIv1___RNAseq.g13465.t1,three_way,63.21666666666667,,,,,,,,,,,,,,,,,
OG_05616,2.304200962598559,FUN_025304-T1,Peve_00040949,Pocillopora_meandrina_HIv1___RNAseq.g13460.t1,three_way,85.93833333333333,FUN_025304-T1,Q9I7S6,,,,,53.0,372.0,3.1e-112,407.1,"sp|Q9I7S6|PDE9A_DROME High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Drosophila melanogaster OX=7227 GN=Pde9 PE=2 SV=2",,,,,,
OG_05618,1.2492136733858057,FUN_025308-T1,Peve_00027048,Pocillopora_meandrina_HIv1___RNAseq.g13453.t1,three_way,61.894,,,,,,,,,,,,,,,,,
OG_05619,1.332808985958818,FUN_025309-T1,Peve_00027055,Pocillopora_meandrina_HIv1___RNAseq.g13452.t2,three_way,92.745,FUN_025309-T1,Q9XT54,,,,,80.8,146.0,2e-66,253.1,"sp|Q9XT54|PDE6D_CANLF Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta OS=Canis lupus familiaris OX=9615 GN=PDE6D PE=2 SV=1",,,,,,
OG_05620,1.5990781084017278,FUN_025310-T1,Peve_00027063,Pocillopora_meandrina_HIv1___RNAseq.g13451.t1,three_way,53.777,,,,,,,,,,,,,,,,,
OG_05621,1.0750378833085623,FUN_025314-T1,Peve_00027075,Pocillopora_meandrina_HIv1___RNAseq.g13449.t1,three_way,74.45566666666667,FUN_025314-T1,Q5U458,DJC11_MOUSE,,DnaJ homolog subfamily C member 11,Mus musculus (Mouse),47.5,558.0,2e-135,484.2,sp|Q5U458|DJC11_MOUSE DnaJ homolog subfamily C member 11 OS=Mus musculus OX=10090 GN=Dnajc11 PE=1 SV=2,GO:0001401; GO:0005739; GO:0005743; GO:0016607; GO:0042407; GO:0061617,cristae formation [GO:0042407],MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; SAM complex [GO:0001401],,GO:0005739; GO:0007005; GO:0043226; GO:0061024,mitochondrion; mitochondrion organization; organelle; membrane organization
OG_05627,1.5812144063699844,FUN_025322-T1,Peve_00027091,Pocillopora_meandrina_HIv1___RNAseq.g13422.t1,three_way,87.86033333333333,FUN_025322-T1,Q6PAX2,,,,,62.0,574.0,2.0000000000000005e-165,583.9,sp|Q6PAX2|ATD3B_XENLA ATPase family AAA domain-containing protein 3-B OS=Xenopus laevis OX=8355 GN=atad3-b PE=2 SV=1,,,,,,
OG_05629,1.6453651838854386,FUN_025324-T1,Peve_00027096,Pocillopora_meandrina_HIv1___RNAseq.g13420.t1,three_way,68.96249999999999,FUN_025324-T1,Q9Y6Y1,CMTA1_HUMAN,,Calmodulin-binding transcription activator 1,Homo sapiens (Human),29.5,1137.0,2.1e-90,335.9,sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4,GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886,neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712],GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; nervous system process; molecular adaptor activity; transcription regulator activity
OG_05631,1.3597785664637545,FUN_025328-T1,Peve_00027062,Pocillopora_meandrina_HIv1___RNAseq.g13406.t1,three_way,70.02683333333333,FUN_025328-T1,Q9H3D4,,,,,34.9,272.0,1.1999999999999999e-35,152.5,sp|Q9H3D4|P63_HUMAN Tumor protein 63 OS=Homo sapiens OX=9606 GN=TP63 PE=1 SV=1,,,,,,
OG_05632,1.2400146898468587,FUN_025330-T1,Peve_00027061,Pocillopora_meandrina_HIv1___RNAseq.g13405.t1,three_way,58.849,,,,,,,,,,,,,,,,,
OG_05636,1.922871860408383,FUN_025335-T1,Peve_00027053,Pocillopora_meandrina_HIv1___RNAseq.g13400.t1,three_way,76.48966666666666,FUN_025335-T1,Q5ZK62,ACAP2_CHICK,,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",Gallus gallus (Chicken),42.7,858.0,2.3000000000000002e-170,600.9,"sp|Q5ZK62|ACAP2_CHICK Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ACAP2 PE=2 SV=1",GO:0005096; GO:0005886; GO:0008270; GO:0010008; GO:0032456; GO:1990090,cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005886; GO:0016192; GO:0098772,plasma membrane; vesicle-mediated transport; molecular function regulator activity
OG_05638,1.6520270590407653,FUN_025342-T1,Peve_00027052,Pocillopora_meandrina_HIv1___RNAseq.g13380.t1,three_way,69.806,FUN_025342-T1,Q7RYI0,,,,,42.1,57.0,4.4e-06,52.4,sp|Q7RYI0|MIC10_NEUCR MICOS complex subunit mic10 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=mic10 PE=3 SV=1,,,,,,
OG_05640,2.6543163456888244,FUN_025348-T1,Peve_00004327,Pocillopora_meandrina_HIv1___TS.g2360.t1a,three_way,40.693666666666665,,,,,,,,,,,,,,,,,
OG_05645,2.7109407486757733,FUN_025363-T1,Peve_00040516,Pocillopora_meandrina_HIv1___RNAseq.g13346.t1,three_way,65.52933333333334,FUN_025363-T1,Q9ER65,CSTN2_MOUSE,,Calsyntenin-2,Mus musculus (Mouse),27.8,856.0,4.6e-77,291.2,sp|Q9ER65|CSTN2_MOUSE Calsyntenin-2 OS=Mus musculus OX=10090 GN=Clstn2 PE=1 SV=2,GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0008306; GO:0009986; GO:0014069; GO:0030425; GO:0045211; GO:0050806; GO:0051965; GO:0098839; GO:0098978; GO:1904862,associative learning [GO:0008306]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inhibitory synapse assembly [GO:1904862]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806],cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211],calcium ion binding [GO:0005509],GO:0007155; GO:0034330; GO:0043226; GO:0050877,cell adhesion; cell junction organization; organelle; nervous system process
OG_05648,2.056327878983799,FUN_025368-T1,Peve_00040520,Pocillopora_meandrina_HIv1___RNAseq.g13331.t1,three_way,95.874,FUN_025368-T1,Q6PH57,,,,,91.4,339.0,2.9e-140,499.6,sp|Q6PH57|GBB1_DANRE Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1,,,,,,
OG_05649,2.165067160934378,FUN_025372-T1,Peve_00040522,Pocillopora_meandrina_HIv1___RNAseq.g13329.t1,three_way,85.562,FUN_025372-T1,Q92997,DVL3_HUMAN,,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),Homo sapiens (Human),61.0,485.0,3.2e-124,447.2,sp|Q92997|DVL3_HUMAN Segment polarity protein dishevelled homolog DVL-3 OS=Homo sapiens OX=9606 GN=DVL3 PE=1 SV=2,GO:0000785; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0009410; GO:0031267; GO:0032880; GO:0032956; GO:0035556; GO:0035567; GO:0043547; GO:0045893; GO:0045944; GO:0046330; GO:0050821; GO:0060070; GO:0060071; GO:0150012,"canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein localization [GO:0032880]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",chromatin [GO:0000785]; cytosol [GO:0005829],beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267],GO:0005829; GO:0006355,cytosol; regulation of DNA-templated transcription
OG_05650,1.1644018905923068,FUN_025373-T1,Peve_00040523,Pocillopora_meandrina_HIv1___RNAseq.g13328.t1,three_way,60.128166666666665,FUN_025373-T1,A1L0Y2,,,,,39.5,1520.0,7.3e-307,1055.0,sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1,,,,,,
OG_05652,2.242477892496572,FUN_025393-T1,Peve_00031004,Pocillopora_meandrina_HIv1___RNAseq.g13303.t1,three_way,60.83166666666666,FUN_025393-T1,Q9NH13,,,,,29.0,352.0,1.2e-32,142.9,sp|Q9NH13|RP43_RIFPA Exoskeleton protein RP43 OS=Riftia pachyptila OX=6426 PE=1 SV=1,,,,,,
OG_05654,1.0295557594200035,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_05666,1.861098700345973,FUN_025441-T1,Peve_00029478,Pocillopora_meandrina_HIv1___RNAseq.g13294.t1,three_way,72.48916666666666,FUN_025441-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),45.7,361.0,2.8e-94,349.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_05669,3.341450316952202,FUN_025459-T1,Peve_00005466,Pocillopora_meandrina_HIv1___RNAseq.g13245.t1,three_way,94.06666666666666,FUN_025459-T1,Q2KJ93,CDC42_BOVIN,,Cell division control protein 42 homolog (EC 3.6.5.2),Bos taurus (Bovine),90.6,191.0,9e-99,360.9,sp|Q2KJ93|CDC42_BOVIN Cell division control protein 42 homolog OS=Bos taurus OX=9913 GN=CDC42 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005813; GO:0005886; GO:0006897; GO:0006911; GO:0007015; GO:0007165; GO:0007264; GO:0016020; GO:0019901; GO:0030010; GO:0030425; GO:0030496; GO:0031258; GO:0032467; GO:0034329; GO:0045198; GO:0048549; GO:0051233; GO:0051489; GO:0051491; GO:0051988; GO:0060997; GO:0072686; GO:1900026,"actin filament organization [GO:0007015]; cell junction assembly [GO:0034329]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of pinocytosis [GO:0048549]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005815; GO:0005886; GO:0007163; GO:0016192; GO:0016787; GO:0030154; GO:0034330; GO:0043226; GO:0061024; GO:0098772,catalytic activity; GTPase activity; microtubule organizing center; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; hydrolase activity; cell differentiation; cell junction organization; organelle; membrane organization; molecular function regulator activity
OG_05671,2.2527431543198357,FUN_025464-T1,Peve_00043839,Pocillopora_meandrina_HIv1___RNAseq.g13242.t1,three_way,70.53633333333333,FUN_025464-T1,P60763,RAC3_HUMAN,,Ras-related C3 botulinum toxin substrate 3 (EC 3.6.5.2) (p21-Rac3),Homo sapiens (Human),39.2,153.0,6.8e-23,111.7,sp|P60763|RAC3_HUMAN Ras-related C3 botulinum toxin substrate 3 OS=Homo sapiens OX=9606 GN=RAC3 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0012505; GO:0014041; GO:0016055; GO:0016601; GO:0019901; GO:0021894; GO:0030027; GO:0030031; GO:0030036; GO:0030426; GO:0030865; GO:0031410; GO:0031941; GO:0032956; GO:0033630; GO:0035556; GO:0043005; GO:0043020; GO:0043025; GO:0045730; GO:0048306; GO:0048471; GO:0048873; GO:0050885; GO:0051932; GO:0060326; GO:0070062; GO:0071944; GO:0098794; GO:0098974; GO:0098978; GO:0150052; GO:1900026; GO:1902622,"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell chemotaxis [GO:0060326]; cell projection assembly [GO:0030031]; cerebral cortex GABAergic interneuron development [GO:0021894]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neuron maturation [GO:0014041]; regulation of neutrophil migration [GO:1902622]; regulation of postsynapse assembly [GO:0150052]; respiratory burst [GO:0045730]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway [GO:0016055]",cell periphery [GO:0071944]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; NADPH oxidase complex [GO:0043020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],calcium-dependent protein binding [GO:0048306]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0016787; GO:0023052; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0098772,catalytic activity; GTPase activity; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; hydrolase activity; signaling; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; nervous system process; molecular function regulator activity
OG_05678,2.090108032883907,FUN_025511-T1,Peve_00002249,Pocillopora_meandrina_HIv1___RNAseq.g13212.t1,three_way,56.655,FUN_025511-T1,Q8TCQ1,MARH1_HUMAN,,E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCHF1),Homo sapiens (Human),28.2,206.0,7.7e-14,79.7,sp|Q8TCQ1|MARH1_HUMAN E3 ubiquitin-protein ligase MARCHF1 OS=Homo sapiens OX=9606 GN=MARCHF1 PE=1 SV=1,GO:0000209; GO:0002495; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0043231; GO:0061630,antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"immune system process; catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05679,2.261493365677704,FUN_025516-T1,Peve_00002247,Pocillopora_meandrina_HIv1___RNAseq.g13210.t1,three_way,89.46916666666667,,,,,,,,,,,,,,,,,
OG_05680,1.7062834929290942,FUN_025517-T1,Peve_00020632,Pocillopora_meandrina_HIv1___RNAseq.14497_t,three_way,51.73233333333334,,,,,,,,,,,,,,,,,
OG_05681,1.3949094237547122,FUN_025518-T1,Peve_00031512,Pocillopora_meandrina_HIv1___RNAseq.g13207.t1,three_way,87.27499999999999,FUN_025518-T1,O95140,,,,,51.6,744.0,3.3999999999999997e-205,716.5,sp|O95140|MFN2_HUMAN Mitofusin-2 OS=Homo sapiens OX=9606 GN=MFN2 PE=1 SV=3,,,,,,
OG_05683,2.1598883472577213,FUN_025520-T1,Peve_00024301,Pocillopora_meandrina_HIv1___RNAseq.g13205.t1,three_way,68.23033333333333,,,,,,,,,,,,,,,,,
OG_05685,1.71230694749725,FUN_025530-T1,Peve_00009476,Pocillopora_meandrina_HIv1___TS.g2807.t1,three_way,91.53566666666669,FUN_025530-T1,Q5U395,,,,,73.8,244.0,2.7000000000000002e-104,379.8,sp|Q5U395|CNEPA_DANRE CTD nuclear envelope phosphatase 1A OS=Danio rerio OX=7955 GN=ctdnep1a PE=2 SV=1,,,,,,
OG_05691,2.775457844346216,FUN_025542-T1,Peve_00032958,Pocillopora_meandrina_HIv1___RNAseq.g13798.t1,three_way,69.249,,,,,,,,,,,,,,,,,
OG_05693,1.2126018202113158,FUN_025544-T1,Peve_00032952,Pocillopora_meandrina_HIv1___TS.g2798.t1,three_way,69.56033333333333,FUN_025544-T1,O60308,CE104_HUMAN,,Centrosomal protein of 104 kDa (Cep104),Homo sapiens (Human),38.5,925.0,9.3e-159,562.4,sp|O60308|CE104_HUMAN Centrosomal protein of 104 kDa OS=Homo sapiens OX=9606 GN=CEP104 PE=1 SV=1,GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0005929,,centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_05695,1.4951667689605952,FUN_025556-T1,Peve_00017520,Pocillopora_meandrina_HIv1___RNAseq.g13790.t1,three_way,77.30333333333333,FUN_025556-T1,Q5SRE5,NU188_HUMAN,,Nucleoporin NUP188 (hNup188),Homo sapiens (Human),37.0,1762.0,5.6e-296,1019.2,sp|Q5SRE5|NU188_HUMAN Nucleoporin NUP188 OS=Homo sapiens OX=9606 GN=NUP188 PE=1 SV=1,GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0044611; GO:0051028,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006886; GO:0006913,structural molecule activity; nuclear envelope; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_05698,3.4125466500090167,FUN_025561-T1,Peve_00019806,Pocillopora_meandrina_HIv1___TS.g2789.t1,three_way,87.92233333333333,FUN_025561-T1,Q6VFT7,FOXL2_BOVIN,,Forkhead box protein L2,Bos taurus (Bovine),89.7,107.0,1.9e-52,207.6,sp|Q6VFT7|FOXL2_BOVIN Forkhead box protein L2 OS=Bos taurus OX=9913 GN=FOXL2 PE=2 SV=1,GO:0000978; GO:0000981; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006309; GO:0006357; GO:0009653; GO:0019101; GO:0030154; GO:0031624; GO:0043028; GO:0043065; GO:0045892; GO:0045893; GO:0045944; GO:0048048; GO:0060014; GO:0090543,anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of DNA-templated transcription [GO:0045892]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin conjugating enzyme binding [GO:0031624]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_05721,1.4030748003491835,FUN_025629-T1,Peve_00032155,Pocillopora_meandrina_HIv1___TS.g16003.t1,three_way,70.9745,FUN_025629-T1,A2AP18,,,,,46.6,736.0,4.500000000000001e-186,652.9,"sp|A2AP18|PLCH2_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 OS=Mus musculus OX=10090 GN=Plch2 PE=1 SV=2",,,,,,
OG_05723,1.6091296988331216,FUN_025642-T1,Peve_00039651,Pocillopora_meandrina_HIv1___RNAseq.g23097.t1,three_way,81.889,FUN_025642-T1,Q5I598,MTHR_BOVIN,,Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53),Bos taurus (Bovine),63.3,602.0,5.7e-238,825.1,sp|Q5I598|MTHR_BOVIN Methylenetetrahydrofolate reductase (NADPH) OS=Bos taurus OX=9913 GN=MTHFR PE=2 SV=1,GO:0004489; GO:0009086; GO:0035999; GO:0071949; GO:0106313,methionine biosynthetic process [GO:0009086]; tetrahydrofolate interconversion [GO:0035999],,FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase (NADPH) activity [GO:0106313],GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0016491,catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity
OG_05727,1.6477566947275284,FUN_025650-T1,Peve_00002528,Pocillopora_meandrina_HIv1___RNAseq.g23087.t2a,three_way,85.454,,,,,,,,,,,,,,,,,
OG_05728,1.2766708787496035,FUN_025651-T1,Peve_00002530,Pocillopora_meandrina_HIv1___RNAseq.g23086.t1,three_way,78.245,FUN_025651-T1,Q9Z1L0,PK3CB_RAT,,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1)",Rattus norvegicus (Rat),46.3,1059.0,4.4e-264,912.5,"sp|Q9Z1L0|PK3CB_RAT Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform OS=Rattus norvegicus OX=10116 GN=Pik3cb PE=2 SV=1",GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0007156; GO:0010595; GO:0010628; GO:0016303; GO:0016477; GO:0030168; GO:0031526; GO:0033031; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0042267; GO:0043409; GO:0043491; GO:0043560; GO:0045429; GO:0046854; GO:0046934; GO:0048015; GO:0051898; GO:0060055; GO:0106310; GO:1900747; GO:1903298; GO:1903671,angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intracellular calcium ion homeostasis [GO:0006874]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; response to ischemia [GO:0002931]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376],"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]","1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein serine kinase activity [GO:0106310]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006629; GO:0006914; GO:0007155; GO:0016192; GO:0016740; GO:0043226; GO:0048870; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; lipid metabolic process; autophagy; cell adhesion; vesicle-mediated transport; transferase activity; organelle; cell motility; defense response to other organism; catalytic activity, acting on a protein"
OG_05731,2.134168156165163,FUN_025657-T1,Peve_00042176,Pocillopora_meandrina_HIv1___RNAseq.g23075.t1,three_way,71.07683333333333,FUN_025657-T1,P17863,,,,,33.1,341.0,1.1e-45,186.4,sp|P17863|SKI_AVIES Transforming protein Ski OS=Avian erythroblastosis virus (strain Sloan-Kettering) OX=11862 GN=V-SKI PE=1 SV=1,,,,,,
OG_05732,1.7671707363032694,FUN_025658-T1,Peve_00042175,Pocillopora_meandrina_HIv1___RNAseq.g23074.t1,three_way,65.081,FUN_025658-T1,Q8C033,ARHGA_MOUSE,,Rho guanine nucleotide exchange factor 10,Mus musculus (Mouse),34.0,920.0,1.1e-133,479.9,sp|Q8C033|ARHGA_MOUSE Rho guanine nucleotide exchange factor 10 OS=Mus musculus OX=10090 GN=Arhgef10 PE=1 SV=2,GO:0005085; GO:0005813; GO:0019894; GO:0022011; GO:0035025; GO:0051298; GO:0051496; GO:0090307,centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496],centrosome [GO:0005813],guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894],GO:0005815; GO:0007010; GO:0008092; GO:0098772,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; molecular function regulator activity
OG_05734,1.6415641398321523,FUN_025660-T1,Peve_00042171,Pocillopora_meandrina_HIv1___RNAseq.g23068.t1,three_way,78.61866666666667,FUN_025660-T1,B0DOB4,NPHP4_XENLA,,Nephrocystin-4,Xenopus laevis (African clawed frog),41.9,1048.0,1.8e-222,774.2,sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1,GO:0005737; GO:0035869; GO:0036064; GO:0090090; GO:0097546; GO:0097730; GO:1904491,negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein localization to ciliary transition zone [GO:1904491],ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_05737,1.0478241978888512,FUN_025663-T1,Peve_00042168,Pocillopora_meandrina_HIv1___RNAseq.g23062.t1,three_way,73.4105,FUN_025663-T1,Q9UPW0,FOXJ3_HUMAN,,Forkhead box protein J3,Homo sapiens (Human),43.9,321.0,8.1e-57,223.0,sp|Q9UPW0|FOXJ3_HUMAN Forkhead box protein J3 OS=Homo sapiens OX=9606 GN=FOXJ3 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007141; GO:0007283; GO:0030154; GO:0043565; GO:0045944; GO:1990837,cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; meiotic nuclear division; transcription regulator activity
OG_05745,1.0817532353952173,FUN_025672-T1,Peve_00042189,Pocillopora_meandrina_HIv1___RNAseq.g23055.t1,three_way,85.41666666666667,FUN_025672-T1,Q7F0J0,,,,,45.2,146.0,7.6e-31,135.6,sp|Q7F0J0|CML13_ORYSJ Probable calcium-binding protein CML13 OS=Oryza sativa subsp. japonica OX=39947 GN=CML13 PE=2 SV=1,,,,,,
OG_05746,1.3419050884618755,FUN_025673-T1,Peve_00023389,Pocillopora_meandrina_HIv1___RNAseq.g1882.t1,three_way,79.89666666666666,FUN_025673-T1,C3YWU0,FUCO_BRAFL,,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),Branchiostoma floridae (Florida lancelet) (Amphioxus),62.1,449.0,3.8000000000000004e-180,632.5,sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2,GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139,fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],extracellular region [GO:0005576]; lysosome [GO:0005764],alpha-L-fucosidase activity [GO:0004560],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005975; GO:0016787; GO:0043226; GO:1901135,catalytic activity; extracellular region; lysosome; vacuole; carbohydrate metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_05748,1.317608036110847,FUN_025680-T1,Peve_00000465,Pocillopora_meandrina_HIv1___RNAseq.g13116.t1,three_way,73.074,FUN_025680-T1,P49338,,,,,57.1,347.0,9.599999999999999e-115,414.8,sp|P49338|WNT4_XENLA Protein Wnt-4 OS=Xenopus laevis OX=8355 GN=wnt4 PE=2 SV=1,,,,,,
OG_05751,1.1540449025017314,FUN_025683-T2,Peve_00000457,Pocillopora_meandrina_HIv1___RNAseq.g13113.t1,three_way,56.72566666666667,FUN_025683-T2,O57460,TLL1_DANRE,,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),Danio rerio (Zebrafish) (Brachydanio rerio),34.0,141.0,1.2e-16,89.7,sp|O57460|TLL1_DANRE Dorsal-ventral patterning tolloid-like protein 1 OS=Danio rerio OX=7955 GN=tll1 PE=2 SV=1,GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264,blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_05753,1.1116513646395232,FUN_025686-T1,Peve_00022755,Pocillopora_meandrina_HIv1___RNAseq.g13112.t1,three_way,71.20066666666666,FUN_025686-T1,O76075,,,,,35.7,328.0,1.5999999999999999e-55,218.0,sp|O76075|DFFB_HUMAN DNA fragmentation factor subunit beta OS=Homo sapiens OX=9606 GN=DFFB PE=1 SV=1,,,,,,
OG_05757,2.7252233722188235,FUN_025692-T1,Peve_00005578,Pocillopora_meandrina_HIv1___RNAseq.g13161.t2,three_way,54.39333333333333,,,,,,,,,,,,,,,,,
OG_05760,1.0766434129409876,FUN_025701-T1,Peve_00026329,Pocillopora_meandrina_HIv1___RNAseq.g13828.t1,three_way,85.17516666666667,FUN_025701-T1,Q8K268,,,,,58.7,715.0,2.7e-228,793.1,sp|Q8K268|ABCF3_MOUSE ATP-binding cassette sub-family F member 3 OS=Mus musculus OX=10090 GN=Abcf3 PE=1 SV=1,,,,,,
OG_05761,2.35791624621278,FUN_025702-T1,Peve_00004694,Pocillopora_meandrina_HIv1___RNAseq.g13827.t1,three_way,44.88766666666667,FUN_025702-T1,Q08D19,,,,,43.6,110.0,8.7e-14,80.1,sp|Q08D19|GOLI4_XENTR Golgi integral membrane protein 4 OS=Xenopus tropicalis OX=8364 GN=golim4 PE=2 SV=2,,,,,,
OG_05762,1.0162424607171554,FUN_025716-T1,Peve_00001130,Pocillopora_meandrina_HIv1___RNAseq.g10446.t1,three_way,60.85233333333333,,,,,,,,,,,,,,,,,
OG_05764,1.0668056537931403,FUN_025722-T1,Peve_00014085,Pocillopora_meandrina_HIv1___RNAseq.g10452.t1,three_way,58.814,FUN_025722-T1,A8MY62,,,,,29.3,447.0,1.5e-46,188.7,sp|A8MY62|BLML_HUMAN Putative beta-lactamase-like 1 OS=Homo sapiens OX=9606 GN=LACTBL1 PE=1 SV=2,,,,,,
OG_05765,1.27785301877865,FUN_025723-T1,Peve_00001126,Pocillopora_meandrina_HIv1___RNAseq.g10454.t2,three_way,89.69200000000001,FUN_025723-T1,Q14566,MCM6_HUMAN,,DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM),Homo sapiens (Human),70.7,808.0,0.0,1134.0,sp|Q14566|MCM6_HUMAN DNA replication licensing factor MCM6 OS=Homo sapiens OX=9606 GN=MCM6 PE=1 SV=1,GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0042802; GO:0071162; GO:1902969,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-templated DNA replication initiation [GO:0030174],"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_05766,1.6217676478556065,FUN_025724-T1,Peve_00001160,Pocillopora_meandrina_HIv1___RNAseq.g10456.t1,three_way,61.71366666666667,FUN_025724-T1,Q5NUA6,NF2L2_BOVIN,,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2)",Bos taurus (Bovine),43.4,122.0,1e-17,93.2,sp|Q5NUA6|NF2L2_BOVIN Nuclear factor erythroid 2-related factor 2 OS=Bos taurus OX=9913 GN=NFE2L2 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0010499; GO:0016567; GO:0034599; GO:0043161; GO:0043565; GO:0045088; GO:0045454; GO:0045944; GO:0071498; GO:0110076,cell redox homeostasis [GO:0045454]; cellular response to fluid shear stress [GO:0071498]; cellular response to oxidative stress [GO:0034599]; negative regulation of ferroptosis [GO:0110076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of innate immune response [GO:0045088]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; transcription regulator activity
OG_05767,1.888774541029007,FUN_025725-T1,Peve_00001159,Pocillopora_meandrina_HIv1___RNAseq.g10457.t1,three_way,72.23316666666668,FUN_025725-T1,Q9NZI7,UBIP1_HUMAN,,Upstream-binding protein 1 (Transcription factor LBP-1),Homo sapiens (Human),36.7,586.0,8.2e-89,329.3,sp|Q9NZI7|UBIP1_HUMAN Upstream-binding protein 1 OS=Homo sapiens OX=9606 GN=UBP1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0032897; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_05769,2.201750760699712,FUN_025728-T1,Peve_00024169,Pocillopora_meandrina_HIv1___RNAseq.g10438.t1,three_way,70.458,FUN_025728-T1,Q8WZA2,RPGF4_HUMAN,,Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII),Homo sapiens (Human),49.9,351.0,4.2e-105,382.9,sp|Q8WZA2|RPGF4_HUMAN Rap guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=RAPGEF4 PE=1 SV=1,GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0030674; GO:0031267; GO:0032024; GO:0050796; GO:0098686; GO:0098693,adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of insulin secretion [GO:0050796]; regulation of synaptic vesicle cycle [GO:0098693],cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886],cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0002376; GO:0005829; GO:0005886; GO:0016192; GO:0060090; GO:0098772,immune system process; cytosol; plasma membrane; vesicle-mediated transport; molecular adaptor activity; molecular function regulator activity
OG_05775,1.2712885772207776,FUN_025738-T1,Peve_00008539,Pocillopora_meandrina_HIv1___RNAseq.g30315.t1,three_way,59.97833333333333,,,,,,,,,,,,,,,,,
OG_05776,2.850328224160143,FUN_025745-T1,Peve_00008538,Pocillopora_meandrina_HIv1___TS.g13844.t2,three_way,50.434333333333335,FUN_025745-T1,Q86XL3,ANKL2_HUMAN,,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),Homo sapiens (Human),28.6,889.0,7.4e-84,313.5,sp|Q86XL3|ANKL2_HUMAN Ankyrin repeat and LEM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ANKLE2 PE=1 SV=4,GO:0004860; GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721,cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; regulation of catalytic activity [GO:0050790],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],protein kinase inhibitor activity [GO:0004860]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888],GO:0005783; GO:0043226; GO:0048856; GO:0061024; GO:0098772,endoplasmic reticulum; organelle; anatomical structure development; membrane organization; molecular function regulator activity
OG_05777,1.074801410607889,FUN_025746-T1,Peve_00008534,Pocillopora_meandrina_HIv1___RNAseq.g10426.t1,three_way,57.30083333333333,FUN_025746-T1,Q6P132,,,,,40.8,152.0,1.9999999999999998e-32,142.9,sp|Q6P132|TXB1B_DANRE Tax1-binding protein 1 homolog B OS=Danio rerio OX=7955 GN=tax1bp1b PE=2 SV=3,,,,,,
OG_05778,1.457706682441031,FUN_025748-T1,Peve_00014397,Pocillopora_meandrina_HIv1___RNAseq.g10413.t1,three_way,92.053,FUN_025748-T1,Q66KB0,,,,,76.1,222.0,9.1e-102,371.3,sp|Q66KB0|UBE2Z_XENTR Ubiquitin-conjugating enzyme E2 Z OS=Xenopus tropicalis OX=8364 GN=ube2z PE=2 SV=2,,,,,,
OG_05779,2.6544457976288407,FUN_025750-T1,Peve_00007726,Pocillopora_meandrina_HIv1___RNAseq.g10411.t1,three_way,86.325,FUN_025750-T1,O57656,,,,,52.3,392.0,2.1999999999999998e-107,390.6,"sp|O57656|GPDA_TAKRU Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic OS=Takifugu rubripes OX=31033 GN=gpd1 PE=3 SV=1",,,,,,
OG_05780,1.5674258321774546,FUN_025751-T1,Peve_00007731,Pocillopora_meandrina_HIv1___RNAseq.g10407.t1,three_way,81.0305,FUN_025751-T1,A2A935,PRD16_MOUSE,,Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.367) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1),Mus musculus (Mouse),24.8,298.0,1.1e-20,103.2,sp|A2A935|PRD16_MOUSE Histone-lysine N-methyltransferase PRDM16 OS=Mus musculus OX=10090 GN=Prdm16 PE=1 SV=1,GO:0000122; GO:0001228; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0008270; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0032259; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162; GO:0140947; GO:0140948,brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; histone H3K9me2 methyltransferase activity [GO:0140947]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_05781,1.3070720417213737,FUN_025755-T1,Peve_00040610,Pocillopora_meandrina_HIv1___RNAseq.g10416.t1,three_way,76.434,FUN_025755-T1,A7T1N0,TMP2L_NEMVE,,Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2),Nematostella vectensis (Starlet sea anemone),60.0,1583.0,0.0,1838.2,sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1,GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604,calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725],plasma membrane [GO:0005886],ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872],GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085,catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport
OG_05782,1.7849181004657089,FUN_025756-T1,Peve_00040609,Pocillopora_meandrina_HIv1___RNAseq.26310_t,three_way,71.92066666666666,FUN_025756-T1,Q91ZS8,RED1_MOUSE,,Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase),Mus musculus (Mouse),46.2,643.0,3.6e-145,516.9,sp|Q91ZS8|RED1_MOUSE Double-stranded RNA-specific editase 1 OS=Mus musculus OX=10090 GN=Adarb1 PE=1 SV=1,GO:0003723; GO:0003725; GO:0003726; GO:0004000; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008285; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049,adenosine to inosine editing [GO:0006382]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202],adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0012501; GO:0016071; GO:0016787; GO:0023052; GO:0043226; GO:0050877,RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; programmed cell death; mRNA metabolic process; hydrolase activity; signaling; organelle; nervous system process
OG_05784,1.1909100273780406,FUN_025758-T1,Peve_00040618,Pocillopora_meandrina_HIv1___RNAseq.g10419.t1,three_way,66.84783333333333,FUN_025758-T1,Q3TVI4,,,,,39.1,169.0,3.4e-16,87.4,sp|Q3TVI4|HEXI2_MOUSE Protein HEXIM2 OS=Mus musculus OX=10090 GN=Hexim2 PE=1 SV=1,,,,,,
OG_05785,1.4396741432825964,FUN_025760-T1,Peve_00041463,Pocillopora_meandrina_HIv1___RNAseq.g10421.t1,three_way,74.163,FUN_025760-T1,Q566I1,,,,,31.3,518.0,1.4e-47,193.0,sp|Q566I1|IN80D_XENLA INO80 complex subunit D OS=Xenopus laevis OX=8355 GN=ino80d PE=2 SV=1,,,,,,
OG_05786,1.2208025211361444,FUN_025762-T1,Peve_00041464,Pocillopora_meandrina_HIv1___RNAseq.g10422.t1,three_way,66.92333333333333,FUN_025762-T1,Q6PFM4,,,,,42.4,361.0,1.3999999999999999e-61,238.4,sp|Q6PFM4|LNPB_DANRE Endoplasmic reticulum junction formation protein lunapark-B OS=Danio rerio OX=7955 GN=lnpkb PE=2 SV=2,,,,,,
OG_05799,1.040975301308671,FUN_025784-T1,Peve_00003062,Pocillopora_meandrina_HIv1___TS.g13806.t1,three_way,71.1365,FUN_025784-T1,Q80TG1,KANL1_MOUSE,,KAT8 regulatory NSL complex subunit 1 (NSL complex protein NSL1) (Non-specific lethal 1 homolog),Mus musculus (Mouse),27.1,535.0,5e-21,105.1,sp|Q80TG1|KANL1_MOUSE KAT8 regulatory NSL complex subunit 1 OS=Mus musculus OX=10090 GN=Kansl1 PE=1 SV=1,GO:0000123; GO:0000776; GO:0005739; GO:0006325; GO:0044545; GO:0045893; GO:0071339; GO:1903108,chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545],,GO:0005739; GO:0006325; GO:0006355; GO:0043226,mitochondrion; chromatin organization; regulation of DNA-templated transcription; organelle
OG_05805,1.5281793057264557,FUN_025800-T1,Peve_00017926,Pocillopora_meandrina_HIv1___RNAseq.g10386.t2,three_way,84.613,FUN_025800-T1,Q8VDT1,,,,,52.0,666.0,8.599999999999999e-189,661.8,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_05808,1.5715208605749524,FUN_025806-T1,Peve_00017932,Pocillopora_meandrina_HIv1___RNAseq.g10347.t1,three_way,73.36699999999999,FUN_025806-T1,Q95245,,,,,44.4,169.0,4.999999999999999e-32,139.0,sp|Q95245|CY561_PIG Transmembrane ascorbate-dependent reductase CYB561 OS=Sus scrofa OX=9823 GN=CYB561 PE=2 SV=1,,,,,,
OG_05809,1.5738839751535674,FUN_025809-T2,Peve_00017944,Pocillopora_meandrina_HIv1___TS.g19642.t2,three_way,56.2395,FUN_025809-T2,Q08EN7,,,,,29.7,286.0,1.6e-26,122.5,sp|Q08EN7|ZCPW2_MOUSE Zinc finger CW-type PWWP domain protein 2 homolog OS=Mus musculus OX=10090 GN=Zcwpw2 PE=2 SV=2,,,,,,
OG_05815,1.2451179891357618,FUN_025821-T1,Peve_00036285,Pocillopora_meandrina_HIv1___RNAseq.g9341.t1,three_way,70.9975,FUN_025821-T1,Q9TUI4,,,,,51.1,924.0,2.8e-231,803.5,sp|Q9TUI4|KCNH2_PIG Voltage-gated inwardly rectifying potassium channel KCNH2 OS=Sus scrofa OX=9823 GN=KCNH2 PE=2 SV=2,,,,,,
OG_05817,2.3669105547153912,FUN_025824-T1,Peve_00036284,Pocillopora_meandrina_HIv1___RNAseq.g9344.t1,three_way,88.77216666666666,FUN_025824-T1,Q9GM70,,,,,50.4,282.0,9e-78,292.0,sp|Q9GM70|ST17A_RABIT Serine/threonine-protein kinase 17A OS=Oryctolagus cuniculus OX=9986 GN=STK17A PE=2 SV=1,,,,,,
OG_05818,1.1444231568940528,FUN_025825-T2,Peve_00036287,Pocillopora_meandrina_HIv1___RNAseq.g9345.t1,three_way,78.706,FUN_025825-T2,P54513,,,,,32.3,195.0,9.9e-15,83.6,sp|P54513|YQHO_BACSU Uncharacterized protein YqhO OS=Bacillus subtilis (strain 168) OX=224308 GN=yqhO PE=3 SV=1,,,,,,
OG_05819,1.5469897346156398,FUN_025826-T1,Peve_00036290,Pocillopora_meandrina_HIv1___RNAseq.g9346.t1,three_way,60.5495,FUN_025826-T1,B8V7Q1,,,,,39.9,3257.0,0.0,2112.0,sp|B8V7Q1|PCDL_ACRMI Protocadherin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05821,1.525037394874574,FUN_025836-T1,Peve_00028304,Pocillopora_meandrina_HIv1___RNAseq.g10325.t1b,three_way,67.41033333333334,FUN_025836-T1,Q9DBC0,SELO_MOUSE,,"Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.108) (Selenoprotein O) (SelO)",Mus musculus (Mouse),46.7,642.0,4.0999999999999995e-148,526.6,"sp|Q9DBC0|SELO_MOUSE Protein adenylyltransferase SelO, mitochondrial OS=Mus musculus OX=10090 GN=Selenoo PE=1 SV=4",GO:0005524; GO:0005694; GO:0005739; GO:0046872; GO:0070733,,chromosome [GO:0005694]; mitochondrion [GO:0005739],AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],GO:0003824; GO:0005694; GO:0005739; GO:0016740; GO:0043226,catalytic activity; chromosome; mitochondrion; transferase activity; organelle
OG_05822,1.2828976086199706,FUN_025838-T1,Peve_00028309,Pocillopora_meandrina_HIv1___RNAseq.g10332.t1,three_way,68.98100000000001,FUN_025838-T1,Q14957,NMDE3_HUMAN,,"Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C)",Homo sapiens (Human),25.0,472.0,4.799999999999997e-41,171.4,"sp|Q14957|NMDE3_HUMAN Glutamate receptor ionotropic, NMDA 2C OS=Homo sapiens OX=9606 GN=GRIN2C PE=1 SV=3",GO:0004972; GO:0005261; GO:0005789; GO:0005886; GO:0007215; GO:0007420; GO:0009611; GO:0017146; GO:0033058; GO:0035235; GO:0035249; GO:0042177; GO:0045211; GO:0048167; GO:0048168; GO:0050885; GO:0051968; GO:0060079; GO:0060291; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:1903539; GO:1904062; GO:1904315; GO:2000463,"brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; directional locomotion [GO:0033058]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic potentiation [GO:0060291]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process controlling balance [GO:0050885]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611]; synaptic transmission, glutamatergic [GO:0035249]",endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211],monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_05824,1.5346132585685817,FUN_025841-T1,Peve_00028314,Pocillopora_meandrina_HIv1___RNAseq.g10337.t1,three_way,68.842,FUN_025841-T1,Q921L8,GLT11_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11),Mus musculus (Mouse),52.4,553.0,7.5e-165,582.0,sp|Q921L8|GLT11_MOUSE Polypeptide N-acetylgalactosaminyltransferase 11 OS=Mus musculus OX=10090 GN=Galnt11 PE=1 SV=1,GO:0000139; GO:0004653; GO:0005112; GO:0007220; GO:0007368; GO:0008593; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314,cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593],Golgi membrane [GO:0000139],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0016740; GO:0044782; GO:0140096,"catalytic activity; transferase activity; cilium organization; catalytic activity, acting on a protein"
OG_05825,1.1341374636357142,FUN_025842-T1,Peve_00028315,Pocillopora_meandrina_HIv1___TS.g13751.t1,three_way,74.87866666666667,FUN_025842-T1,Q91WG5,AAKG2_MOUSE,,5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2),Mus musculus (Mouse),61.1,314.0,5.6e-108,392.9,sp|Q91WG5|AAKG2_MOUSE 5'-AMP-activated protein kinase subunit gamma-2 OS=Mus musculus OX=10090 GN=Prkag2 PE=1 SV=2,GO:0004679; GO:0004862; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0006110; GO:0006633; GO:0008607; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0031669; GO:0035556; GO:0043531,cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588],ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887],GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0006629; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; lipid metabolic process; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05826,1.6062973432627436,FUN_025843-T1,Peve_00028316,Pocillopora_meandrina_HIv1___RNAseq.g10339.t1,three_way,66.52566666666667,,,,,,,,,,,,,,,,,
OG_05828,1.0333891988874682,FUN_025845-T1,Peve_00012183,Pocillopora_meandrina_HIv1___RNAseq.g10340.t2b,three_way,73.04216666666667,FUN_025845-T1,P42768,WASP_HUMAN,,Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp),Homo sapiens (Human),38.9,293.0,2.1000000000000005e-44,181.8,sp|P42768|WASP_HUMAN Actin nucleation-promoting factor WAS OS=Homo sapiens OX=9606 GN=WAS PE=1 SV=4,GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146,actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506],actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],GO:0002376; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0048856; GO:0065003; GO:0098772,immune system process; nucleus; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_05829,1.3491629629351174,FUN_025847-T1,Peve_00012182,Pocillopora_meandrina_HIv1___TS.g13754.t1,three_way,63.074,FUN_025847-T1,Q9NZA1,CLIC5_HUMAN,,Chloride intracellular channel protein 5 (Glutaredoxin-like oxidoreductase CLIC5) (EC 1.8.-.-),Homo sapiens (Human),34.1,223.0,1.5e-20,101.3,sp|Q9NZA1|CLIC5_HUMAN Chloride intracellular channel protein 5 OS=Homo sapiens OX=9606 GN=CLIC5 PE=1 SV=3,GO:0005254; GO:0005739; GO:0005794; GO:0005813; GO:0005938; GO:0006821; GO:0007565; GO:0007601; GO:0007605; GO:0015629; GO:0016324; GO:0016491; GO:0032420; GO:0034707; GO:0070062,chloride transport [GO:0006821]; female pregnancy [GO:0007565]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; stereocilium [GO:0032420],chloride channel activity [GO:0005254]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005215; GO:0005739; GO:0005794; GO:0005815; GO:0005856; GO:0016491; GO:0022414; GO:0043226; GO:0050877,catalytic activity; transporter activity; mitochondrion; Golgi apparatus; microtubule organizing center; cytoskeleton; oxidoreductase activity; reproductive process; organelle; nervous system process
OG_05833,1.3527897701214855,FUN_025877-T1,Peve_00006434,Pocillopora_meandrina_HIv1___RNAseq.g9351.t1c,three_way,59.905,FUN_025877-T1,Q91ZV7,PLDX1_MOUSE,,Plexin domain-containing protein 1 (Tumor endothelial marker 7),Mus musculus (Mouse),38.3,295.0,4.2e-53,210.3,sp|Q91ZV7|PLDX1_MOUSE Plexin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Plxdc1 PE=1 SV=2,GO:0005576; GO:0005737; GO:0005886; GO:0005923; GO:0021510; GO:0030425; GO:0043025; GO:0043235,spinal cord development [GO:0021510],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],,GO:0005576; GO:0005886; GO:0048856,extracellular region; plasma membrane; anatomical structure development
OG_05841,2.038083587053048,FUN_025889-T1,Peve_00024284,Pocillopora_meandrina_HIv1___RNAseq.g10542.t1,three_way,53.60116666666666,FUN_025889-T1,Q5ZM41,,,,,29.0,728.0,7.4e-64,247.3,sp|Q5ZM41|TEX10_CHICK Testis-expressed protein 10 homolog OS=Gallus gallus OX=9031 GN=TEX10 PE=2 SV=1,,,,,,
OG_05845,2.007585399888326,FUN_025914-T1,Peve_00010173,Pocillopora_meandrina_HIv1___TS.g13966.t1,three_way,69.57366666666667,,,,,,,,,,,,,,,,,
OG_05846,1.094572754329308,FUN_025915-T1,Peve_00010172,Pocillopora_meandrina_HIv1___RNAseq.g10468.t1,three_way,86.59700000000001,FUN_025915-T1,Q6DDF0,,,,,41.7,489.0,1.6999999999999998e-96,354.8,sp|Q6DDF0|WDR37_XENLA WD repeat-containing protein 37 OS=Xenopus laevis OX=8355 GN=wdr37 PE=2 SV=1,,,,,,
OG_05848,1.351928301754904,FUN_025917-T1,Peve_00001158,Pocillopora_meandrina_HIv1___RNAseq.g10466.t1,three_way,67.06833333333333,FUN_025917-T1,Q8C6G1,CF410_MOUSE,,Cilia- and flagella-associated protein 410,Mus musculus (Mouse),38.9,265.0,4.6e-38,159.8,sp|Q8C6G1|CF410_MOUSE Cilia- and flagella-associated protein 410 OS=Mus musculus OX=10090 GN=Cfap410 PE=1 SV=1,GO:0001750; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006974; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0036064; GO:0060271; GO:0097733,cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886],,GO:0005654; GO:0005739; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0043226; GO:0044782,nucleoplasm; mitochondrion; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; organelle; cilium organization
OG_05850,2.175421791766562,FUN_025923-T1,Peve_00018907,Pocillopora_meandrina_HIv1___TS.g13940.t2,three_way,74.94983333333333,FUN_025923-T1,A1A5K2,CLA1B_XENLA,,CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP),Xenopus laevis (African clawed frog),42.2,756.0,1.2e-134,482.3,sp|A1A5K2|CLA1B_XENLA CLIP-associating protein 1-B OS=Xenopus laevis OX=8355 GN=clasp1b PE=1 SV=1,GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307; GO:1902903,cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of supramolecular fiber organization [GO:1902903],basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876],kinetochore binding [GO:0043515]; microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0007010; GO:0008092; GO:0043226,Golgi apparatus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_05851,2.105203862660915,FUN_025924-T1,Peve_00027741,Pocillopora_meandrina_HIv1___RNAseq.g10523.t1,three_way,81.66433333333333,FUN_025924-T1,Q80TV8,CLAP1_MOUSE,,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1),Mus musculus (Mouse),41.3,726.0,1.1e-131,472.2,sp|Q80TV8|CLAP1_MOUSE CLIP-associating protein 1 OS=Mus musculus OX=10090 GN=Clasp1 PE=1 SV=2,GO:0000776; GO:0005794; GO:0005813; GO:0005819; GO:0005874; GO:0005938; GO:0007020; GO:0007026; GO:0008017; GO:0015630; GO:0016477; GO:0030010; GO:0031023; GO:0034453; GO:0051294; GO:0051301,cell division [GO:0051301]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; establishment of spindle orientation [GO:0051294]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; negative regulation of microtubule depolymerization [GO:0007026],cell cortex [GO:0005938]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0043226; GO:0048870,Golgi apparatus; microtubule organizing center; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle; cell motility
OG_05856,1.3660321071569714,FUN_025935-T1,Peve_00027752,Pocillopora_meandrina_HIv1___RNAseq.g13629.t2,three_way,63.209,FUN_025935-T1,Q4PZA2,ECE1_MOUSE,,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),Mus musculus (Mouse),35.1,701.0,2.4e-126,454.5,sp|Q4PZA2|ECE1_MOUSE Endothelin-converting enzyme 1 OS=Mus musculus OX=10090 GN=Ece1 PE=1 SV=1,GO:0001921; GO:0004222; GO:0005768; GO:0005794; GO:0007411; GO:0008270; GO:0009897; GO:0009986; GO:0010467; GO:0010814; GO:0010815; GO:0010816; GO:0016486; GO:0031175; GO:0033093; GO:0034959; GO:0035050; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0060385; GO:0097492; GO:1902287,axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492],cell surface [GO:0009986]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Weibel-Palade body [GO:0033093],metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; endosome; Golgi apparatus; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_05860,1.5918945427500568,FUN_025963-T1,Peve_00015816,Pocillopora_meandrina_HIv1___RNAseq.g10514.t1,three_way,62.4445,,,,,,,,,,,,,,,,,
OG_05861,1.3444028880036267,FUN_025968-T1,Peve_00015812,Pocillopora_meandrina_HIv1___RNAseq.g10513.t1,three_way,76.54333333333334,FUN_025968-T1,Q8IZ52,CHSS2_HUMAN,,Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2),Homo sapiens (Human),31.2,794.0,3.2e-100,367.9,sp|Q8IZ52|CHSS2_HUMAN Chondroitin sulfate synthase 2 OS=Homo sapiens OX=9606 GN=CHPF PE=1 SV=2,GO:0000139; GO:0005759; GO:0005829; GO:0032580; GO:0046872; GO:0047238; GO:0050510; GO:0050650,chondroitin sulfate proteoglycan biosynthetic process [GO:0050650],cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; mitochondrial matrix [GO:0005759],glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],GO:0003824; GO:0005829; GO:0009101; GO:0016740; GO:1901135,catalytic activity; cytosol; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_05864,1.58201602454755,FUN_025971-T1,Peve_00002910,Pocillopora_meandrina_HIv1___RNAseq.g10510.t1,three_way,71.926,FUN_025971-T1,Q6XYQ8,SYT10_HUMAN,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Homo sapiens (Human),34.1,229.0,9.900000000000001e-28,125.2,sp|Q6XYQ8|SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens OX=9606 GN=SYT10 PE=1 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0006887; GO:0007268; GO:0007608; GO:0016192; GO:0017158; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0061891; GO:0070382; GO:0098793; GO:0098978,chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process; molecular function regulator activity; molecular sensor activity
OG_05865,1.9815480499157787,FUN_025974-T1,Peve_00002327,Pocillopora_meandrina_HIv1___RNAseq.g10508.t1,three_way,78.03366666666666,,,,,,,,,,,,,,,,,
OG_05866,2.102876790152111,FUN_025975-T1,Peve_00002326,Pocillopora_meandrina_HIv1___RNAseq.g10507.t1,three_way,57.90466666666666,,,,,,,,,,,,,,,,,
OG_05867,2.6249633866909887,FUN_025976-T1,Peve_00002325,Pocillopora_meandrina_HIv1___RNAseq.g10506.t1,three_way,64.18716666666667,FUN_025976-T1,Q13873,BMPR2_HUMAN,,Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II),Homo sapiens (Human),38.1,494.0,1.9e-88,328.2,sp|Q13873|BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens OX=9606 GN=BMPR2 PE=1 SV=2,GO:0001568; GO:0001649; GO:0001707; GO:0001893; GO:0001935; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005886; GO:0005901; GO:0005905; GO:0005912; GO:0007178; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010628; GO:0010634; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030154; GO:0030166; GO:0030308; GO:0030424; GO:0030425; GO:0030501; GO:0030509; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048662; GO:0048842; GO:0048863; GO:0051148; GO:0060173; GO:0060350; GO:0060391; GO:0060412; GO:0060413; GO:0060426; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782,anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lung vasculature development [GO:0060426]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; stem cell differentiation [GO:0048863]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235],"activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta receptor activity [GO:0005024]",GO:0003013; GO:0003824; GO:0005615; GO:0005654; GO:0005886; GO:0006355; GO:0009101; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140096; GO:1901135,"circulatory system process; catalytic activity; extracellular space; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; glycoprotein biosynthetic process; programmed cell death; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05868,1.0187667034687415,FUN_025977-T1,Peve_00002324,Pocillopora_meandrina_HIv1___RNAseq.g10505.t1,three_way,91.186,FUN_025977-T1,P43450,,,,,76.2,294.0,7.8e-134,478.0,sp|P43450|CDK2_CARAU Cyclin-dependent kinase 2 OS=Carassius auratus OX=7957 GN=cdk2 PE=1 SV=1,,,,,,
OG_05870,1.3528688455784112,FUN_025985-T1,Peve_00002331,Pocillopora_meandrina_HIv1___RNAseq.g10502.t1,three_way,56.960166666666666,,,,,,,,,,,,,,,,,
OG_05872,2.157955607318631,FUN_026014-T1,Peve_00004062,Pocillopora_meandrina_HIv1___RNAseq.g10490.t1,three_way,68.83616666666667,FUN_026014-T1,Q61122,,,,,30.6,317.0,1.0999999999999998e-24,116.3,sp|Q61122|NAB1_MOUSE NGFI-A-binding protein 1 OS=Mus musculus OX=10090 GN=Nab1 PE=1 SV=2,,,,,,
OG_05874,1.9053779055747613,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_05875,1.563001184682682,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_05881,1.1279779304058533,FUN_026034-T1,Peve_00022184,Pocillopora_meandrina_HIv1___RNAseq.g10547.t1,three_way,87.94766666666666,FUN_026034-T1,P29074,PTN4_HUMAN,,Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1),Homo sapiens (Human),43.1,929.0,2e-217,757.3,sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1,GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254,protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05886,1.2725068466432847,FUN_026049-T1,Peve_00022189,Pocillopora_meandrina_HIv1___TS.g13972.t1,three_way,66.42933333333333,FUN_026049-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),35.0,537.0,5.4e-80,300.1,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05887,1.3403549537583794,FUN_026051-T1,Peve_00022190,Pocillopora_meandrina_HIv1___RNAseq.g10553.t1,three_way,59.20016666666667,FUN_026051-T1,Q8NFZ3,,,,,33.3,631.0,7.6e-91,336.3,"sp|Q8NFZ3|NLGNY_HUMAN Neuroligin-4, Y-linked OS=Homo sapiens OX=9606 GN=NLGN4Y PE=1 SV=1",,,,,,
OG_05888,1.3707521350498464,FUN_026052-T1,Peve_00022191,Pocillopora_meandrina_HIv1___RNAseq.g10554.t1,three_way,94.17266666666669,,,,,,,,,,,,,,,,,
OG_05891,1.2317302921460718,FUN_026057-T1,Peve_00022193,Pocillopora_meandrina_HIv1___RNAseq.g10569.t1,three_way,81.50766666666667,FUN_026057-T1,Q66I12,CCD47_DANRE,,PAT complex subunit CCDC47 (Coiled-coil domain-containing protein 47),Danio rerio (Zebrafish) (Brachydanio rerio),44.5,321.0,3.9e-74,280.4,sp|Q66I12|CCD47_DANRE PAT complex subunit CCDC47 OS=Danio rerio OX=7955 GN=ccdc47 PE=2 SV=1,GO:0005509; GO:0005783; GO:0005789; GO:0030867; GO:0032469; GO:0043022; GO:0044183; GO:0045048; GO:0160063; GO:0160064,endoplasmic reticulum calcium ion homeostasis [GO:0032469]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; protein insertion into ER membrane [GO:0045048],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064]; rough endoplasmic reticulum membrane [GO:0030867],calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022],GO:0005783; GO:0043226; GO:0044183,endoplasmic reticulum; organelle; protein folding chaperone
OG_05899,1.5871190730687028,FUN_026076-T1,Peve_00002022,Pocillopora_meandrina_HIv1___RNAseq.g10561.t1,three_way,58.79216666666667,FUN_026076-T1,Q9NVE5,,,,,35.0,1254.0,1.6e-196,688.3,sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3,,,,,,
OG_05902,2.279487249561462,FUN_026081-T1,Peve_00004132,Pocillopora_meandrina_HIv1___RNAseq.g10570.t1,three_way,97.37833333333332,FUN_026081-T1,Q96KC2,,,,,79.0,176.0,5.6e-79,295.0,sp|Q96KC2|ARL5B_HUMAN ADP-ribosylation factor-like protein 5B OS=Homo sapiens OX=9606 GN=ARL5B PE=1 SV=1,,,,,,
OG_05903,1.6482419504603114,FUN_026088-T1,Peve_00004126,Pocillopora_meandrina_HIv1___RNAseq.g10571.t1,three_way,73.563,FUN_026088-T1,Q5FVG2,E41L5_RAT,,Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5),Rattus norvegicus (Rat),47.5,358.0,2.8e-86,321.6,sp|Q5FVG2|E41L5_RAT Band 4.1-like protein 5 OS=Rattus norvegicus OX=10116 GN=Epb41l5 PE=1 SV=2,GO:0000902; GO:0001701; GO:0001756; GO:0001837; GO:0001839; GO:0001917; GO:0001954; GO:0003382; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007498; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0030036; GO:0031032; GO:0031252; GO:0032525; GO:0032587; GO:0048318; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560,"actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis [GO:0000902]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]",adherens junction [GO:0005912]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904],GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0048870,nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; cell motility
OG_05904,1.8560107477960848,FUN_026090-T1,Peve_00004127,Pocillopora_meandrina_HIv1___TS.g13992.t1,three_way,76.80466666666666,FUN_026090-T1,Q08D64,ABCB6_XENTR,,ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6) (EC 7.6.2.5),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),55.9,755.0,4.0999999999999995e-234,812.8,sp|Q08D64|ABCB6_XENTR ATP-binding cassette sub-family B member 6 OS=Xenopus tropicalis OX=8364 GN=abcb6 PE=2 SV=1,GO:0000139; GO:0005524; GO:0005739; GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0006778; GO:0006878; GO:0015439; GO:0016887; GO:0031901; GO:0031902; GO:0032585; GO:0033013; GO:0033162; GO:0035351; GO:0036020; GO:0042168; GO:0046906; GO:0070062; GO:0098849; GO:0140359; GO:1903232,cellular detoxification of cadmium ion [GO:0098849]; heme metabolic process [GO:0042168]; heme transmembrane transport [GO:0035351]; intracellular copper ion homeostasis [GO:0006878]; melanosome assembly [GO:1903232]; porphyrin-containing compound metabolic process [GO:0006778]; tetrapyrrole metabolic process [GO:0033013],early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type heme transporter activity [GO:0015439]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; tetrapyrrole binding [GO:0046906],GO:0003824; GO:0005215; GO:0005739; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0098754; GO:0140657,catalytic activity; transporter activity; mitochondrion; Golgi apparatus; plasma membrane; hydrolase activity; organelle; transmembrane transport; detoxification; ATP-dependent activity
OG_05905,1.005712882314602,FUN_026091-T1,Peve_00017829,Pocillopora_meandrina_HIv1___RNAseq.g10573.t1,three_way,33.376,,,,,,,,,,,,,,,,,
OG_05910,1.2048596282305666,FUN_026101-T1,Peve_00013338,Pocillopora_meandrina_HIv1___RNAseq.g10579.t1,three_way,87.09166666666667,FUN_026101-T1,Q96JG6,,,,,51.6,965.0,9.3e-269,927.9,sp|Q96JG6|VPS50_HUMAN Syndetin OS=Homo sapiens OX=9606 GN=VPS50 PE=1 SV=3,,,,,,
OG_05915,1.6085741986231996,FUN_026107-T1,Peve_00044186,Pocillopora_meandrina_HIv1___RNAseq.g10322.t1,three_way,90.69366666666669,FUN_026107-T1,P22033,MUTA_HUMAN,,"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)",Homo sapiens (Human),74.7,732.0,0.0,1115.5,"sp|P22033|MUTA_HUMAN Methylmalonyl-CoA mutase, mitochondrial OS=Homo sapiens OX=9606 GN=MMUT PE=1 SV=4",GO:0003924; GO:0004494; GO:0005737; GO:0005739; GO:0005759; GO:0009791; GO:0019678; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341; GO:1901290,"homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; propionate metabolic process, methylmalonyl pathway [GO:0019678]; succinyl-CoA biosynthetic process [GO:1901290]",cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0006520; GO:0006629; GO:0006790; GO:0016787; GO:0016853; GO:0043226; GO:0055086,catalytic activity; GTPase activity; mitochondrion; amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; hydrolase activity; isomerase activity; organelle; nucleobase-containing small molecule metabolic process
OG_05917,1.7084724025497842,FUN_026112-T1,Peve_00014998,Pocillopora_meandrina_HIv1___TS.g13728.t1,three_way,36.16533333333333,,,,,,,,,,,,,,,,,
OG_05918,1.2140791621687486,FUN_026113-T1,Peve_00013996,Pocillopora_meandrina_HIv1___RNAseq.g10315.t1,three_way,80.111,FUN_026113-T1,Q642F4,,,,,39.4,307.0,4.7e-54,213.0,sp|Q642F4|SC22A_RAT Vesicle-trafficking protein SEC22a OS=Rattus norvegicus OX=10116 GN=Sec22a PE=2 SV=1,,,,,,
OG_05925,1.448897914397335,FUN_026148-T1,Peve_00014875,Pocillopora_meandrina_HIv1___RNAseq.g3232.t1,three_way,87.95866666666667,FUN_026148-T1,Q64261,CDK6_MOUSE,,Cyclin-dependent kinase 6 (EC 2.7.11.22) (CR2 protein kinase) (CRK2) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE),Mus musculus (Mouse),68.0,222.0,6.7e-85,315.1,sp|Q64261|CDK6_MOUSE Cyclin-dependent kinase 6 OS=Mus musculus OX=10090 GN=Cdk6 PE=1 SV=2,GO:0000082; GO:0000122; GO:0001726; GO:0001954; GO:0002244; GO:0003323; GO:0004693; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0006974; GO:0007219; GO:0009615; GO:0010628; GO:0016301; GO:0030097; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0050680; GO:0051301; GO:0060218; GO:0097131; GO:0097132; GO:0097133; GO:0098770; GO:0106310; GO:1902036; GO:2000773,cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; DNA damage response [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; regulation of erythrocyte differentiation [GO:0045646]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],centrosome [GO:0005813]; cyclin D1-CDK6 complex [GO:0097131]; cyclin D2-CDK6 complex [GO:0097132]; cyclin D3-CDK6 complex [GO:0097133]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310],GO:0002376; GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0016740; GO:0030154; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; transferase activity; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_05926,1.7024548569863915,FUN_026150-T1,Peve_00020731,Pocillopora_meandrina_HIv1___RNAseq.g3216.t1,three_way,83.78333333333333,FUN_026150-T1,Q9UJ83,HACL1_HUMAN,,2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2),Homo sapiens (Human),60.0,578.0,2.3e-206,719.9,sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2,GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:0106359; GO:0106376; GO:1903512,fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0005654; GO:0005777; GO:0005829; GO:0006629; GO:0016829; GO:0043226,catalytic activity; nucleoplasm; peroxisome; cytosol; lipid metabolic process; lyase activity; organelle
OG_05934,1.0750484913412373,FUN_026162-T1,Peve_00006896,Pocillopora_meandrina_HIv1___RNAseq.g3201.t1,three_way,64.434,FUN_026162-T1,Q5RAP8,,,,,35.1,211.0,1.4000000000000002e-23,111.3,sp|Q5RAP8|TSN31_PONAB Tetraspanin-31 OS=Pongo abelii OX=9601 GN=TSPAN31 PE=2 SV=1,,,,,,
OG_05935,1.295612581008,FUN_026165-T1,Peve_00008133,Pocillopora_meandrina_HIv1___RNAseq.g3173.t1,three_way,63.327666666666666,FUN_026165-T1,Q5NU32,AOFA_HORSE,,Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A),Equus caballus (Horse),37.2,468.0,2.9e-77,290.8,sp|Q5NU32|AOFA_HORSE Amine oxidase [flavin-containing] A OS=Equus caballus OX=9796 GN=MAOA PE=2 SV=1,GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0050660; GO:0097621,catecholamine metabolic process [GO:0006584],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_05936,1.6382323577305549,FUN_026166-T1,Peve_00008132,Pocillopora_meandrina_HIv1___RNAseq.g3195.t1,three_way,97.83466666666666,FUN_026166-T1,P62194,,,,,91.0,400.0,1.9e-205,716.5,sp|P62194|PRS8_BOVIN 26S proteasome regulatory subunit 8 OS=Bos taurus OX=9913 GN=PSMC5 PE=2 SV=1,,,,,,
OG_05938,1.895324864336769,FUN_026173-T1,Peve_00039168,Pocillopora_meandrina_HIv1___RNAseq.g3177.t1,three_way,35.60133333333333,FUN_026173-T1,P24668,MPRD_MOUSE,,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),Mus musculus (Mouse),51.8,56.0,7e-07,56.2,sp|P24668|MPRD_MOUSE Cation-dependent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=M6pr PE=1 SV=1,GO:0005765; GO:0005768; GO:0005770; GO:0005794; GO:0006622; GO:0006886; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394,intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471],protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394],GO:0005768; GO:0005794; GO:0006886; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; cytoplasmic vesicle; organelle
OG_05940,1.2575372051419529,FUN_026177-T2,Peve_00012697,Pocillopora_meandrina_HIv1___RNAseq.g3032.t1,three_way,74.30799999999999,FUN_026177-T2,P83038,HDAC4_CHICK,,Histone deacetylase 4 (HD4) (EC 3.5.1.98),Gallus gallus (Chicken),58.6,486.0,8e-161,569.7,sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1,GO:0000118; GO:0000122; GO:0004407; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221,B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399],histone deacetylase complex [GO:0000118],"DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872]",GO:0002376; GO:0003824; GO:0006325; GO:0006355; GO:0006954; GO:0016787; GO:0030154; GO:0048856; GO:0140096,"immune system process; catalytic activity; chromatin organization; regulation of DNA-templated transcription; inflammatory response; hydrolase activity; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_05942,2.664066970875372,FUN_026179-T1,Peve_00012698,Pocillopora_meandrina_HIv1___RNAseq.g3034.t1,three_way,82.133,FUN_026179-T1,O02695,,,,,58.0,440.0,8.500000000000001e-133,476.1,sp|O02695|PTPR2_MACNE Receptor-type tyrosine-protein phosphatase N2 OS=Macaca nemestrina OX=9545 GN=PTPRN2 PE=2 SV=1,,,,,,
OG_05945,1.9379825471899177,FUN_026188-T1,Peve_00007220,Pocillopora_meandrina_HIv1___RNAseq.g9603.t1,three_way,49.890166666666666,,,,,,,,,,,,,,,,,
OG_05947,1.98234792970861,FUN_026194-T1,Peve_00016690,Pocillopora_meandrina_HIv1___TS.g18158.t1,three_way,54.12983333333333,,,,,,,,,,,,,,,,,
OG_05949,1.1922168912819828,FUN_026199-T1,Peve_00010232,Pocillopora_meandrina_HIv1___RNAseq.g3044.t1,three_way,45.858,,,,,,,,,,,,,,,,,
OG_05952,1.3923756978267547,FUN_026214-T1,Peve_00004859,Pocillopora_meandrina_HIv1___TS.g18166.t1,three_way,63.017,FUN_026214-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,371.0,3.5e-20,102.4,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_05956,1.429163344447484,FUN_026300-T1,Peve_00030624,Pocillopora_meandrina_HIv1___RNAseq.g3055.t1,three_way,48.91783333333333,,,,,,,,,,,,,,,,,
OG_05958,1.5466286662302295,FUN_026305-T1,Peve_00025709,Pocillopora_meandrina_HIv1___RNAseq.g3058.t1,three_way,89.43866666666666,FUN_026305-T1,P21613,,,,,58.8,972.0,2.4e-239,830.5,sp|P21613|KINH_DORPE Kinesin heavy chain OS=Doryteuthis pealeii OX=1051067 PE=1 SV=1,,,,,,
OG_05961,1.2872088560163728,FUN_026308-T1,Peve_00023863,Pocillopora_meandrina_HIv1___RNAseq.g3063.t1,three_way,52.47083333333333,,,,,,,,,,,,,,,,,
OG_05963,1.135035750023964,FUN_026310-T1,Peve_00036855,Pocillopora_meandrina_HIv1___RNAseq.g3065.t1,three_way,55.12266666666667,FUN_026310-T1,A0A1L8F5J9,NMDZ1_XENLA,,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",Xenopus laevis (African clawed frog),26.6,549.0,1.2e-49,199.9,"sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1",GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839,calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725],neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_05972,1.0646412783306465,FUN_026388-T1,Peve_00032419,Pocillopora_meandrina_HIv1___RNAseq.g2952.t1,three_way,95.50233333333334,FUN_026388-T1,Q9D1K2,,,,,70.7,116.0,7.8e-43,174.5,sp|Q9D1K2|VATF_MOUSE V-type proton ATPase subunit F OS=Mus musculus OX=10090 GN=Atp6v1f PE=1 SV=2,,,,,,
OG_05973,1.5500398872650596,FUN_026389-T1,Peve_00032417,Pocillopora_meandrina_HIv1___RNAseq.g2951.t1,three_way,65.594,FUN_026389-T1,Q54UT2,DGK_DICDI,,Deoxyguanosine kinase (dGK) (EC 2.7.1.113) (DddGK),Dictyostelium discoideum (Social amoeba),46.5,217.0,9e-51,202.2,sp|Q54UT2|DGK_DICDI Deoxyguanosine kinase OS=Dictyostelium discoideum OX=44689 GN=dgk PE=1 SV=2,GO:0004138; GO:0005524; GO:0005737; GO:0005739; GO:0006120; GO:0006180; GO:0045271,"deoxyguanosine salvage [GO:0006180]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271],ATP binding [GO:0005524]; deoxyguanosine kinase activity [GO:0004138],GO:0003824; GO:0005739; GO:0006091; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; generation of precursor metabolites and energy; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05976,1.0232482366040103,FUN_026399-T1,Peve_00028956,Pocillopora_meandrina_HIv1___TS.g18054.t2,three_way,70.44033333333333,FUN_026399-T1,P02720,,,,,49.0,206.0,3.5e-53,209.9,sp|P02720|PPCT_BOVIN Phosphatidylcholine transfer protein OS=Bos taurus OX=9913 GN=PCTP PE=1 SV=1,,,,,,
OG_05977,1.1941935763802964,FUN_026406-T1,Peve_00000795,Pocillopora_meandrina_HIv1___RNAseq.g2938.t1,three_way,71.30283333333334,,,,,,,,,,,,,,,,,
OG_05983,2.925332433594146,FUN_026415-T1,Peve_00006089,Pocillopora_meandrina_HIv1___RNAseq.g3014.t1,three_way,79.76233333333333,FUN_026415-T1,Q9EPR4,S23A2_MOUSE,,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2),Mus musculus (Mouse),54.1,549.0,1.1e-163,578.2,sp|Q9EPR4|S23A2_MOUSE Solute carrier family 23 member 2 OS=Mus musculus OX=10090 GN=Slc23a2 PE=1 SV=2,GO:0005737; GO:0006979; GO:0007155; GO:0008015; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0071361; GO:1903861,blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229],GO:0003013; GO:0005215; GO:0005975; GO:0007155; GO:0055085,circulatory system process; transporter activity; carbohydrate metabolic process; cell adhesion; transmembrane transport
OG_05986,1.408992510434901,FUN_026472-T1,Peve_00002340,Pocillopora_meandrina_HIv1___TS.g21592.t2,three_way,76.41433333333333,FUN_026472-T1,Q8K3I9,,,,,36.6,306.0,1.1000000000000001e-27,125.9,sp|Q8K3I9|GLCI1_MOUSE Glucocorticoid-induced transcript 1 protein OS=Mus musculus OX=10090 GN=Glcci1 PE=1 SV=1,,,,,,
OG_05987,1.987790507546545,FUN_026473-T1,Peve_00002338,Pocillopora_meandrina_HIv1___RNAseq.g4184.t1,three_way,47.833,,,,,,,,,,,,,,,,,
OG_05988,1.957588082552948,FUN_026474-T1,Peve_00002337,Pocillopora_meandrina_HIv1___RNAseq.g4183.t1,three_way,68.71333333333334,FUN_026474-T1,P35244,RFA3_HUMAN,,Replication protein A 14 kDa subunit (RP-A p14) (Replication factor A protein 3) (RF-A protein 3),Homo sapiens (Human),38.3,107.0,2.6e-13,76.3,sp|P35244|RFA3_HUMAN Replication protein A 14 kDa subunit OS=Homo sapiens OX=9606 GN=RPA3 PE=1 SV=1,GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005654; GO:0005662; GO:0006260; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0007346; GO:0035861; GO:0042127,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; regulation of cell population proliferation [GO:0042127]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723],DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861],damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0005654; GO:0006260; GO:0006281; GO:0006310; GO:0032200,DNA binding; nucleoplasm; DNA replication; DNA repair; DNA recombination; telomere organization
OG_05989,1.1725158887825404,FUN_026475-T1,Peve_00002335,Pocillopora_meandrina_HIv1___RNAseq.g4182.t1,three_way,75.23366666666666,FUN_026475-T1,Q802U2,MIOS_DANRE,,GATOR2 complex protein MIOS,Danio rerio (Zebrafish) (Brachydanio rerio),45.1,443.0,7.2e-107,389.0,sp|Q802U2|MIOS_DANRE GATOR2 complex protein MIOS OS=Danio rerio OX=7955 GN=mios PE=2 SV=1,GO:0005737; GO:0005765; GO:0008270; GO:0031669; GO:0034198; GO:0060047; GO:0060841; GO:0061700; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; heart contraction [GO:0060047]; positive regulation of TORC1 signaling [GO:1904263]; venous blood vessel development [GO:0060841],cytoplasm [GO:0005737]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765],zinc ion binding [GO:0008270],GO:0003013; GO:0048856,circulatory system process; anatomical structure development
OG_05992,1.0114724068800565,FUN_026481-T1,Peve_00002333,Pocillopora_meandrina_HIv1___RNAseq.g4177.t1,three_way,82.02083333333333,FUN_026481-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),34.3,414.0,6.6e-58,226.5,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05993,1.3860973420796707,FUN_026482-T1,Peve_00002332,Pocillopora_meandrina_HIv1___RNAseq.g4176.t1,three_way,69.22866666666667,FUN_026482-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),30.8,402.0,2.2999999999999998e-55,218.0,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05995,1.4592422471609063,FUN_026484-T1,Peve_00022075,Pocillopora_meandrina_HIv1___RNAseq.g4174.t1,three_way,66.93066666666667,FUN_026484-T1,Q8N5B7,CERS5_HUMAN,,Ceramide synthase 5 (CerS5) (LAG1 longevity assurance homolog 5) (Sphingoid base N-palmitoyltransferase CERS5) (EC 2.3.1.291) (Sphingosine N-acyltransferase CERS5) (EC 2.3.1.24),Homo sapiens (Human),41.5,347.0,8.999999999999999e-71,268.9,sp|Q8N5B7|CERS5_HUMAN Ceramide synthase 5 OS=Homo sapiens OX=9606 GN=CERS5 PE=1 SV=1,GO:0003677; GO:0005789; GO:0014003; GO:0030148; GO:0046513; GO:0050291,ceramide biosynthetic process [GO:0046513]; oligodendrocyte development [GO:0014003]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum membrane [GO:0005789],DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291],GO:0003677; GO:0003824; GO:0006629; GO:0016740; GO:0048856,DNA binding; catalytic activity; lipid metabolic process; transferase activity; anatomical structure development
OG_05996,1.261345240375686,FUN_026485-T1,Peve_00030055,Pocillopora_meandrina_HIv1___RNAseq.g4173.t1,three_way,93.52966666666669,FUN_026485-T1,Q9CZQ9,,,,,78.2,335.0,3.5e-154,545.8,sp|Q9CZQ9|BBS5_MOUSE BBSome complex member BBS5 OS=Mus musculus OX=10090 GN=Bbs5 PE=1 SV=1,,,,,,
OG_05997,1.618912809421116,FUN_026486-T1,Peve_00037221,Pocillopora_meandrina_HIv1___RNAseq.g4172.t1,three_way,92.45966666666668,FUN_026486-T1,Q8N138,ORML3_HUMAN,,ORM1-like protein 3,Homo sapiens (Human),59.0,144.0,3.2e-46,186.0,sp|Q8N138|ORML3_HUMAN ORM1-like protein 3 OS=Homo sapiens OX=9606 GN=ORMDL3 PE=1 SV=1,GO:0002903; GO:0005783; GO:0005789; GO:0005886; GO:0006672; GO:0006686; GO:0006940; GO:0010508; GO:0017059; GO:0030148; GO:0030667; GO:0035579; GO:0042552; GO:0061744; GO:0090156; GO:1900060; GO:1900182,ceramide metabolic process [GO:0006672]; intracellular sphingolipid homeostasis [GO:0090156]; motor behavior [GO:0061744]; myelination [GO:0042552]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of ceramide biosynthetic process [GO:1900060]; positive regulation of autophagy [GO:0010508]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of smooth muscle contraction [GO:0006940]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine palmitoyltransferase complex [GO:0017059]; specific granule membrane [GO:0035579],,GO:0005783; GO:0005886; GO:0006629; GO:0043226,endoplasmic reticulum; plasma membrane; lipid metabolic process; organelle
OG_05999,1.2406834858802598,FUN_026488-T1,Peve_00030554,Pocillopora_meandrina_HIv1___RNAseq.g4190.t1,three_way,72.27866666666667,,,,,,,,,,,,,,,,,
OG_06004,1.398580973073839,FUN_026494-T1,Peve_00004180,Pocillopora_meandrina_HIv1___RNAseq.g4199.t1,three_way,63.488,FUN_026494-T1,Q71M21,,,,,28.2,1343.0,2.3000000000000001e-88,329.7,sp|Q71M21|RH21B_XENLA Rho GTPase-activating protein 21-B OS=Xenopus laevis OX=8355 GN=arhgap21-b PE=2 SV=1,,,,,,
OG_06005,2.0464875542921925,FUN_026501-T1,Peve_00004184,Pocillopora_meandrina_HIv1___TS.g21607.t1,three_way,44.153333333333336,FUN_026501-T1,Q9VTT0,SEM5C_DROME,,Semaphorin 5c,Drosophila melanogaster (Fruit fly),27.1,630.0,1.7e-51,206.1,sp|Q9VTT0|SEM5C_DROME Semaphorin 5c OS=Drosophila melanogaster OX=7227 GN=Sema5c PE=1 SV=3,GO:0001700; GO:0005768; GO:0005886; GO:0007411; GO:0016324; GO:0016328; GO:0030215; GO:0030335; GO:0042048; GO:0045499; GO:0048036; GO:0071526,axon guidance [GO:0007411]; central complex development [GO:0048036]; embryonic development via the syncytial blastoderm [GO:0001700]; olfactory behavior [GO:0042048]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0048018; GO:0048856; GO:0098772,endosome; plasma membrane; cytoplasmic vesicle; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06006,1.1251477201640356,FUN_026511-T1,Peve_00034433,Pocillopora_meandrina_HIv1___RNAseq.g4202.t1,three_way,85.81833333333333,FUN_026511-T1,Q9H269,VPS16_HUMAN,,Vacuolar protein sorting-associated protein 16 homolog (hVPS16),Homo sapiens (Human),48.9,630.0,2.5e-166,587.0,sp|Q9H269|VPS16_HUMAN Vacuolar protein sorting-associated protein 16 homolog OS=Homo sapiens OX=9606 GN=VPS16 PE=1 SV=2,GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0010008; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0042144; GO:0043025; GO:0051015; GO:0055037; GO:0097352; GO:0098793,"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]",autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; recycling endosome [GO:0055037],actin binding [GO:0003779]; actin filament binding [GO:0051015],GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0061024,lysosome; endosome; vacuole; intracellular protein transport; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_06009,1.132791978066925,FUN_026529-T1,Peve_00021569,Pocillopora_meandrina_HIv1___RNAseq.g4217.t1,three_way,74.87133333333334,FUN_026529-T1,Q9JIT1,,,,,47.4,369.0,1.4000000000000001e-89,331.3,sp|Q9JIT1|RNF32_MOUSE RING finger protein 32 OS=Mus musculus OX=10090 GN=Rnf32 PE=1 SV=1,,,,,,
OG_06015,1.5823401787633975,FUN_026542-T1,Peve_00020320,Pocillopora_meandrina_HIv1___RNAseq.g4239.t1,three_way,82.803,FUN_026542-T1,Q8BHN5,,,,,39.6,493.0,2.8000000000000003e-80,300.8,sp|Q8BHN5|RBM45_MOUSE RNA-binding protein 45 OS=Mus musculus OX=10090 GN=Rbm45 PE=1 SV=1,,,,,,
OG_06016,1.9874860617099988,FUN_026543-T1,Peve_00020319,Pocillopora_meandrina_HIv1___RNAseq.g4238.t1,three_way,56.20633333333333,,,,,,,,,,,,,,,,,
OG_06022,1.0256690412026244,FUN_026564-T1,Peve_00043274,Pocillopora_meandrina_HIv1___RNAseq.g4519.t1,three_way,45.92583333333333,FUN_026564-T1,Q9DD78,,,,,32.7,107.0,3.3e-12,75.1,sp|Q9DD78|TLR21_CHICK Toll-like receptor 2 type-1 OS=Gallus gallus OX=9031 GN=TLR2-1 PE=2 SV=1,,,,,,
OG_06030,1.817015238669409,FUN_026591-T1,Peve_00035407,Pocillopora_meandrina_HIv1___RNAseq.g4496.t1,three_way,59.29,,,,,,,,,,,,,,,,,
OG_06032,1.0733384071672236,FUN_026617-T1,Peve_00043915,Pocillopora_meandrina_HIv1___RNAseq.g4482.t1,three_way,86.23883333333333,FUN_026617-T1,A0A8I5ZNK2,OXSR1_RAT,,Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein),Rattus norvegicus (Rat),54.0,522.0,8.8e-151,535.0,sp|A0A8I5ZNK2|OXSR1_RAT Serine/threonine-protein kinase OSR1 OS=Rattus norvegicus OX=10116 GN=Oxsr1 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006884; GO:0006979; GO:0007165; GO:0007231; GO:0009410; GO:0010820; GO:0019901; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0070294; GO:0071474; GO:0071476; GO:1901380; GO:1990869,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; osmosensory signaling pathway [GO:0007231]; positive regulation of T cell chemotaxis [GO:0010820]; renal sodium ion absorption [GO:0070294]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674],GO:0003014; GO:0003824; GO:0005829; GO:0016740; GO:0140096,"renal system process; catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_06033,1.7375155882856768,FUN_026619-T1,Peve_00043889,Pocillopora_meandrina_HIv1___RNAseq.g4478.t1a,three_way,66.35766666666667,FUN_026619-T1,Q8BHC4,,,,,46.8,222.0,1.7e-51,204.1,sp|Q8BHC4|DCAKD_MOUSE Dephospho-CoA kinase domain-containing protein OS=Mus musculus OX=10090 GN=Dcakd PE=1 SV=1,,,,,,
OG_06035,1.009353213940807,FUN_026628-T1,Peve_00030693,Pocillopora_meandrina_HIv1___RNAseq.g4477.t1,three_way,52.323,FUN_026628-T1,Q86VD9,PIGZ_HUMAN,,"GPI alpha-1,2-mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3)",Homo sapiens (Human),34.0,556.0,2.2e-66,255.0,"sp|Q86VD9|PIGZ_HUMAN GPI alpha-1,2-mannosyltransferase 4 OS=Homo sapiens OX=9606 GN=PIGZ PE=1 SV=4",GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506,GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],"alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]",GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_06039,1.092662327176093,FUN_026686-T1,Peve_00036588,Pocillopora_meandrina_HIv1___RNAseq.g4458.t1,three_way,77.316,FUN_026686-T1,Q91ZR4,NEK8_MOUSE,,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8),Mus musculus (Mouse),53.2,710.0,1.2e-204,714.5,sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310,animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06044,1.4077360405436496,FUN_026709-T1,Peve_00018525,Pocillopora_meandrina_HIv1___RNAseq.g9380.t1,three_way,64.574,,,,,,,,,,,,,,,,,
OG_06066,1.841998325900617,FUN_026909-T1,Peve_00021653,Pocillopora_meandrina_HIv1___TS.g19726.t1,three_way,61.72833333333333,FUN_026909-T1,Q66J01,,,,,30.8,910.0,4e-101,370.9,sp|Q66J01|PGAP1_XENLA GPI inositol-deacylase OS=Xenopus laevis OX=8355 GN=pgap1 PE=2 SV=1,,,,,,
OG_06068,1.928495799585952,FUN_026916-T1,Peve_00014703,Pocillopora_meandrina_HIv1___RNAseq.g11017.t1,three_way,54.9965,,,,,,,,,,,,,,,,,
OG_06072,1.1764865262533033,FUN_026981-T1,Peve_00013217,Pocillopora_meandrina_HIv1___RNAseq.g9421.t1,three_way,51.642,,,,,,,,,,,,,,,,,
OG_06074,1.1175478607420606,FUN_026983-T1,Peve_00013214,Pocillopora_meandrina_HIv1___RNAseq.g9418.t1,three_way,73.671,FUN_026983-T1,Q6ZQ18,,,,,39.6,818.0,8e-149,529.3,sp|Q6ZQ18|EFR3B_MOUSE Protein EFR3 homolog B OS=Mus musculus OX=10090 GN=Efr3b PE=1 SV=2,,,,,,
OG_06080,1.3385734952812611,FUN_027065-T1,Peve_00012227,Pocillopora_meandrina_HIv1___RNAseq.g2816.t1,three_way,66.86916666666667,FUN_027065-T1,A2AG06,MEIOC_MOUSE,,Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein),Mus musculus (Mouse),46.5,114.0,4.8e-14,80.9,sp|A2AG06|MEIOC_MOUSE Meiosis-specific coiled-coil domain-containing protein MEIOC OS=Mus musculus OX=10090 GN=Meioc PE=1 SV=1,GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192,"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase chromosome alignment [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]",cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006281; GO:0022414; GO:0043226; GO:0048856; GO:0140013,nucleus; DNA repair; reproductive process; organelle; anatomical structure development; meiotic nuclear division
OG_06084,1.0694614708268209,FUN_027072-T1,Peve_00012231,Pocillopora_meandrina_HIv1___RNAseq.g2813.t1,three_way,68.39233333333333,FUN_027072-T1,P26797,,,,,38.5,91.0,5.9e-11,69.3,sp|P26797|HM19_CAEEL Homeobox protein ceh-19 OS=Caenorhabditis elegans OX=6239 GN=ceh-19 PE=2 SV=2,,,,,,
OG_06085,1.0104427645277716,FUN_027075-T1,Peve_00012235,Pocillopora_meandrina_HIv1___RNAseq.g2812.t1,three_way,70.49183333333333,FUN_027075-T1,Q14549,,,,,69.1,97.0,4.5000000000000004e-30,132.9,sp|Q14549|GBX1_HUMAN Homeobox protein GBX-1 OS=Homo sapiens OX=9606 GN=GBX1 PE=1 SV=2,,,,,,
OG_06089,1.545392783652893,FUN_027127-T1,Peve_00039622,Pocillopora_meandrina_HIv1___RNAseq.g15332.t1,three_way,58.584833333333336,FUN_027127-T1,Q8K245,UVRAG_MOUSE,,UV radiation resistance-associated protein,Mus musculus (Mouse),43.1,450.0,5.2e-84,313.9,sp|Q8K245|UVRAG_MOUSE UV radiation resistance-associated protein OS=Mus musculus OX=10090 GN=Uvrag PE=1 SV=2,GO:0000149; GO:0000421; GO:0000775; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0007051; GO:0007059; GO:0007098; GO:0010506; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035032; GO:0035493; GO:0036092; GO:0045335; GO:0046718; GO:0051684; GO:0070418; GO:0097352; GO:0097680,"autophagosome maturation [GO:0097352]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; symbiont entry into host cell [GO:0046718]","autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; protein-containing complex [GO:0032991]",SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005815; GO:0006281; GO:0006629; GO:0007010; GO:0007059; GO:0016192; GO:0031410; GO:0043226; GO:0065003,lysosome; endosome; vacuole; endoplasmic reticulum; microtubule organizing center; DNA repair; lipid metabolic process; cytoskeleton organization; chromosome segregation; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_06090,1.5251969882010012,FUN_027128-T1,Peve_00039620,Pocillopora_meandrina_HIv1___TS.g10360.t2,three_way,69.8775,FUN_027128-T1,O60244,MED14_HUMAN,,Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150),Homo sapiens (Human),36.0,1532.0,7.500000000000001e-225,782.7,sp|O60244|MED14_HUMAN Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2,GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847,positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_06092,1.8991101839109288,FUN_027218-T1,Peve_00018289,Pocillopora_meandrina_HIv1___RNAseq.g15249.t1,three_way,69.15166666666667,FUN_027218-T1,Q8IW92,,,,,43.8,665.0,4.3e-148,526.6,sp|Q8IW92|GLBL2_HUMAN Beta-galactosidase-1-like protein 2 OS=Homo sapiens OX=9606 GN=GLB1L2 PE=1 SV=1,,,,,,
OG_06096,1.1479174288886405,FUN_027270-T1,Peve_00018292,Pocillopora_meandrina_HIv1___TS.g10917.t1,three_way,87.52583333333334,FUN_027270-T1,Q80W99,CTSR3_MOUSE,,Cation channel sperm-associated protein 3 (CatSper3),Mus musculus (Mouse),34.5,383.0,1.4e-53,211.8,sp|Q80W99|CTSR3_MOUSE Cation channel sperm-associated protein 3 OS=Mus musculus OX=10090 GN=Catsper3 PE=1 SV=2,GO:0001669; GO:0005245; GO:0005783; GO:0006814; GO:0030317; GO:0031514; GO:0036128; GO:0048240; GO:0051649,establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240],acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; endoplasmic reticulum [GO:0005783]; motile cilium [GO:0031514],voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005783; GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endoplasmic reticulum; cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_06098,1.5271220954674367,FUN_027734-T1,Peve_00036493,Pocillopora_meandrina_HIv1___RNAseq.g13905.t1,three_way,66.03566666666666,FUN_027734-T1,Q86YF9,DZIP1_HUMAN,,Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1),Homo sapiens (Human),28.4,334.0,1.3e-27,127.1,sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0043231; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140706; GO:1903566,ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; reproductive process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_06099,1.1724306357667746,FUN_027735-T1,Peve_00036492,Pocillopora_meandrina_HIv1___RNAseq.g13904.t1,three_way,70.82816666666666,FUN_027735-T1,O94888,UBXN7_HUMAN,,UBX domain-containing protein 7,Homo sapiens (Human),41.6,500.0,1e-93,345.5,sp|O94888|UBXN7_HUMAN UBX domain-containing protein 7 OS=Homo sapiens OX=9606 GN=UBXN7 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005829; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_06104,1.575348724396075,FUN_027805-T1,Peve_00036485,Pocillopora_meandrina_HIv1___RNAseq.g13898.t1,three_way,81.17733333333334,FUN_027805-T1,Q8BHJ5,TBL1R_MOUSE,,F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1),Mus musculus (Mouse),58.4,514.0,4.8e-120,433.0,sp|Q8BHJ5|TBL1R_MOUSE F-box-like/WD repeat-containing protein TBL1XR1 OS=Mus musculus OX=10090 GN=Tbl1xr1 PE=1 SV=1,GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0008013; GO:0010468; GO:0016042; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045944; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263,adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; fat pad development [GO:0060613]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0030163; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; protein catabolic process; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06107,1.049848155708584,FUN_027811-T1,Peve_00036479,Pocillopora_meandrina_HIv1___RNAseq.g13893.t1,three_way,68.13966666666667,,,,,,,,,,,,,,,,,
OG_06109,1.242452986652945,FUN_027814-T1,Peve_00036499,Pocillopora_meandrina_HIv1___RNAseq.g13890.t1,three_way,84.264,FUN_027814-T1,O00571,DDX3X_HUMAN,,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)",Homo sapiens (Human),71.5,425.0,1.6999999999999996e-177,623.6,sp|O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=3,GO:0002753; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010628; GO:0010629; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031252; GO:0031333; GO:0031369; GO:0032481; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035591; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043186; GO:0043273; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070131; GO:0071243; GO:0071470; GO:0071651; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243,cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055],cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; signaling adaptor activity [GO:0035591]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; GTPase activity; extracellular region; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06110,2.0858354727444066,FUN_027815-T1,Peve_00036487,Pocillopora_meandrina_HIv1___RNAseq.g13889.t2,three_way,90.976,FUN_027815-T1,Q23356,MIG15_CAEEL,,Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15),Caenorhabditis elegans,44.9,1094.0,1.7e-240,833.9,sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans OX=6239 GN=mig-15 PE=2 SV=3,GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0022414; GO:0030334; GO:0032228; GO:0033563; GO:0043408; GO:0048812; GO:0106310,"body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of MAPK cascade [GO:0043408]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproductive process [GO:0022414]",cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_06111,1.3104764014666948,FUN_027817-T1,Peve_00042678,Pocillopora_meandrina_HIv1___TS.g22877.t1b,three_way,64.28866666666667,,,,,,,,,,,,,,,,,
OG_06114,1.9883289523849308,FUN_027831-T1,Peve_00020551,Pocillopora_meandrina_HIv1___RNAseq.g13868.t1,three_way,74.62966666666667,FUN_027831-T1,Q9H892,,,,,27.8,753.0,8.2e-63,243.4,sp|Q9H892|TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens OX=9606 GN=TTC12 PE=1 SV=2,,,,,,
OG_06115,1.3452114539991156,FUN_027832-T1,Peve_00020550,Pocillopora_meandrina_HIv1___TS.g11651.t1a,three_way,84.66816666666666,FUN_027832-T1,Q6NRH1,,,,,58.3,408.0,3.2e-139,496.5,sp|Q6NRH1|DCAF8_XENLA DDB1- and CUL4-associated factor 8 OS=Xenopus laevis OX=8355 GN=dcaf8 PE=2 SV=1,,,,,,
OG_06118,1.0746595981541096,FUN_027849-T2,Peve_00024334,Pocillopora_meandrina_HIv1___RNAseq.g13871.t1,three_way,64.28016666666666,FUN_027849-T2,Q9QZS7,,,,,24.7,522.0,3.9e-26,122.5,sp|Q9QZS7|NPHN_MOUSE Nephrin OS=Mus musculus OX=10090 GN=Nphs1 PE=1 SV=2,,,,,,
OG_06120,1.869892072700087,FUN_027852-T2,Peve_00031657,Pocillopora_meandrina_HIv1___TS.g11671.t1,three_way,59.174166666666665,,,,,,,,,,,,,,,,,
OG_06121,1.262238035643377,FUN_027853-T1,Peve_00020102,Pocillopora_meandrina_HIv1___RNAseq.g13886.t1,three_way,89.03033333333333,FUN_027853-T1,Q8CI04,,,,,48.8,818.0,1.5000000000000002e-211,737.6,sp|Q8CI04|COG3_MOUSE Conserved oligomeric Golgi complex subunit 3 OS=Mus musculus OX=10090 GN=Cog3 PE=1 SV=3,,,,,,
OG_06122,1.063841766014557,FUN_027899-T1,Peve_00020103,Pocillopora_meandrina_HIv1___RNAseq.g13885.t1,three_way,50.3325,,,,,,,,,,,,,,,,,
OG_06124,2.572426241985371,FUN_027902-T1,Peve_00020105,Pocillopora_meandrina_HIv1___RNAseq.g13882.t1,three_way,48.062,,,,,,,,,,,,,,,,,
OG_06125,2.420883175000536,FUN_027903-T1,Peve_00020107,Pocillopora_meandrina_HIv1___RNAseq.g13881.t1,three_way,48.315666666666665,FUN_027903-T1,O75487,GPC4_HUMAN,,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],Homo sapiens (Human),33.5,507.0,6.5e-73,276.6,sp|O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens OX=9606 GN=GPC4 PE=1 SV=4,GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0015026; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1905606,cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],coreceptor activity [GO:0015026],GO:0005634; GO:0005886; GO:0007155; GO:0043226; GO:0048870; GO:0060089,nucleus; plasma membrane; cell adhesion; organelle; cell motility; molecular transducer activity
OG_06133,1.7697533800004832,FUN_027939-T1,Peve_00023148,Pocillopora_meandrina_HIv1___RNAseq.g14031.t1,three_way,77.95766666666667,FUN_027939-T1,Q18120,TWK18_CAEEL,,TWiK family of potassium channels protein 18,Caenorhabditis elegans,35.9,192.0,7.4e-23,109.8,sp|Q18120|TWK18_CAEEL TWiK family of potassium channels protein 18 OS=Caenorhabditis elegans OX=6239 GN=twk-18 PE=1 SV=2,GO:0005886; GO:0006813; GO:0006936; GO:0015271; GO:0016020; GO:0022841; GO:0040011; GO:0071805,locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813],membrane [GO:0016020]; plasma membrane [GO:0005886],outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841],GO:0003012; GO:0005215; GO:0005886; GO:0055085,muscle system process; transporter activity; plasma membrane; transmembrane transport
OG_06136,1.2645314230642994,FUN_027947-T1,Peve_00034209,Pocillopora_meandrina_HIv1___RNAseq.g14034.t1,three_way,76.312,,,,,,,,,,,,,,,,,
OG_06137,1.0346782482582315,FUN_027950-T1,Peve_00021880,Pocillopora_meandrina_HIv1___RNAseq.g14040.t1,three_way,82.44316666666667,FUN_027950-T1,Q58EK3,,,,,36.9,306.0,1.3e-53,211.8,sp|Q58EK3|PLCX3_DANRE PI-PLC X domain-containing protein 3 OS=Danio rerio OX=7955 GN=plcxd3 PE=2 SV=1,,,,,,
OG_06138,1.1525335629188116,FUN_027960-T1,Peve_00017205,Pocillopora_meandrina_HIv1___RNAseq.g14049.t1,three_way,88.88733333333333,,,,,,,,,,,,,,,,,
OG_06139,1.0783625006812436,FUN_027961-T1,Peve_00021881,Pocillopora_meandrina_HIv1___RNAseq.g14050.t1,three_way,83.93933333333334,FUN_027961-T1,P47791,,,,,60.3,461.0,1.9e-158,560.5,"sp|P47791|GSHR_MOUSE Glutathione reductase, mitochondrial OS=Mus musculus OX=10090 GN=Gsr PE=1 SV=3",,,,,,
OG_06141,1.0087936484593485,FUN_027963-T1,Peve_00031347,Pocillopora_meandrina_HIv1___RNAseq.g14047.t1,three_way,67.17033333333333,FUN_027963-T1,P16333,NCK1_HUMAN,,SH2/SH3 adapter protein NCK1 (Cytoplasmic protein NCK1) (NCK adapter protein 1) (Nck-1) (SH2/SH3 adapter protein NCK-alpha),Homo sapiens (Human),41.3,380.0,7e-76,285.8,sp|P16333|NCK1_HUMAN SH2/SH3 adapter protein NCK1 OS=Homo sapiens OX=9606 GN=NCK1 PE=1 SV=1,GO:0000122; GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007172; GO:0008093; GO:0010976; GO:0012506; GO:0016477; GO:0019904; GO:0030032; GO:0030159; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0034976; GO:0035591; GO:0036491; GO:0036493; GO:0042102; GO:0042110; GO:0045296; GO:0045944; GO:0046627; GO:0046875; GO:0048013; GO:0050860; GO:0071074; GO:0140311; GO:0140374; GO:0140693; GO:1902237; GO:1903676; GO:1903679; GO:1903898,"actin filament organization [GO:0007015]; antiviral innate immune response [GO:0140374]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036491]; response to endoplasmic reticulum stress [GO:0034976]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]",cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506],cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; molecular condensate scaffold activity [GO:0140693]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159],GO:0002376; GO:0005634; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0006355; GO:0043226; GO:0048870; GO:0060090; GO:0065003; GO:0098542; GO:0098772; GO:0140313,immune system process; nucleus; endoplasmic reticulum; cytosol; ribosome; plasma membrane; regulation of DNA-templated transcription; organelle; cell motility; molecular adaptor activity; protein-containing complex assembly; defense response to other organism; molecular function regulator activity; molecular sequestering activity
OG_06144,1.011046083740557,FUN_027971-T1,Peve_00031357,Pocillopora_meandrina_HIv1___RNAseq.g14053.t1,three_way,64.43966666666667,FUN_027971-T1,Q7PCJ9,,,,,47.6,168.0,1.4e-37,157.5,sp|Q7PCJ9|SAT2_PIG Thialysine N-epsilon-acetyltransferase OS=Sus scrofa OX=9823 GN=SAT2 PE=2 SV=1,,,,,,
OG_06147,1.133946002791838,FUN_027977-T1,Peve_00031366,Pocillopora_meandrina_HIv1___RNAseq.g14058.t1,three_way,74.97666666666666,FUN_027977-T1,Q9Z2F6,,,,,44.0,175.0,4.2000000000000005e-33,143.7,sp|Q9Z2F6|BCL3_MOUSE B-cell lymphoma 3 protein homolog OS=Mus musculus OX=10090 GN=Bcl3 PE=1 SV=2,,,,,,
OG_06150,1.1139041604428075,FUN_027982-T1,Peve_00033314,Pocillopora_meandrina_HIv1___RNAseq.g14062.t1,three_way,57.83766666666667,FUN_027982-T1,O88623,UBP2_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2),Mus musculus (Mouse),50.1,385.0,1.5999999999999999e-96,355.1,sp|O88623|UBP2_MOUSE Ubiquitin carboxyl-terminal hydrolase 2 OS=Mus musculus OX=10090 GN=Usp2 PE=1 SV=3,GO:0000122; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005938; GO:0006508; GO:0007517; GO:0016020; GO:0016579; GO:0030332; GO:0031625; GO:0032922; GO:0042802; GO:0043153; GO:0045475; GO:0045931; GO:0046872; GO:0048471; GO:0048512; GO:0050821; GO:0051926,circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508],cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],cyclin binding [GO:0030332]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06152,2.4983759765453075,FUN_027984-T2,Peve_00011299,Pocillopora_meandrina_HIv1___RNAseq.g13864.t1,three_way,75.97583333333333,,,,,,,,,,,,,,,,,
OG_06154,3.817252084668996,FUN_027987-T1,Peve_00023127,Pocillopora_meandrina_HIv1___RNAseq.g14022.t1,three_way,64.95433333333334,,,,,,,,,,,,,,,,,
OG_06162,1.1132080418347263,FUN_028008-T1,Peve_00008115,Pocillopora_meandrina_HIv1___RNAseq.g14077.t1,three_way,56.86366666666667,FUN_028008-T1,D8VNS7,,,,,46.8,231.0,2.2e-52,208.8,sp|D8VNS7|FCNV1_CERRY Ryncolin-1 OS=Cerberus rynchops OX=46267 PE=1 SV=1,,,,,,
OG_06163,1.485633254585507,FUN_028014-T1,Peve_00008114,Pocillopora_meandrina_HIv1___RNAseq.g14103.t1,three_way,86.13066666666667,FUN_028014-T1,Q66HG5,,,,,64.5,639.0,2e-238,826.6,sp|Q66HG5|TM9S2_RAT Transmembrane 9 superfamily member 2 OS=Rattus norvegicus OX=10116 GN=Tm9sf2 PE=2 SV=1,,,,,,
OG_06166,1.2484936106517015,FUN_028019-T1,Peve_00036500,Pocillopora_meandrina_HIv1___RNAseq.g13910.t1,three_way,60.98683333333333,FUN_028019-T1,Q6DCD5,TMTC2_XENLA,,Protein O-mannosyl-transferase tmtc2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2),Xenopus laevis (African clawed frog),36.7,581.0,5.800000000000001e-86,320.5,sp|Q6DCD5|TMTC2_XENLA Protein O-mannosyl-transferase tmtc2 OS=Xenopus laevis OX=8355 GN=tmtc2 PE=2 SV=1,GO:0000030; GO:0004169; GO:0005789; GO:0035269,protein O-linked mannosylation [GO:0035269],endoplasmic reticulum membrane [GO:0005789],dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030],GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06169,1.2881391855236333,FUN_028022-T1,Peve_00010821,Pocillopora_meandrina_HIv1___RNAseq.g13913.t1,three_way,64.496,FUN_028022-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),32.9,434.0,7.4999999999999994e-62,239.6,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_06177,1.8694702409758768,FUN_028040-T1,Peve_00020094,Pocillopora_meandrina_HIv1___RNAseq.g13938.t1,three_way,66.845,,,,,,,,,,,,,,,,,
OG_06179,1.018954890700554,FUN_028042-T1,Peve_00020097,Pocillopora_meandrina_HIv1___RNAseq.g15391.t1,three_way,65.06816666666667,FUN_028042-T1,Q568J8,,,,,41.3,104.0,2.5e-07,55.8,sp|Q568J8|TM256_DANRE Transmembrane protein 256 OS=Danio rerio OX=7955 GN=tmem256 PE=3 SV=1,,,,,,
OG_06181,1.541805825292702,FUN_028088-T1,Peve_00031660,Pocillopora_meandrina_HIv1___TS.g11574.t1,three_way,88.21483333333333,FUN_028088-T1,P18907,,,,,76.6,988.0,0.0,1502.3,sp|P18907|AT1A1_HORSE Sodium/potassium-transporting ATPase subunit alpha-1 OS=Equus caballus OX=9796 GN=ATP1A1 PE=3 SV=1,,,,,,
OG_06182,1.1887332824643415,FUN_028092-T1,Peve_00031646,Pocillopora_meandrina_HIv1___RNAseq.g16567.t1,three_way,76.8695,FUN_028092-T1,Q5F364,MRP1_CHICK,,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),Gallus gallus (Chicken),53.1,1353.0,0.0,1347.0,sp|Q5F364|MRP1_CHICK Multidrug resistance-associated protein 1 OS=Gallus gallus OX=9031 GN=ABCC1 PE=2 SV=1,GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729,cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],basolateral plasma membrane [GO:0016323],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; glutathione transmembrane transporter activity [GO:0034634],GO:0003824; GO:0005215; GO:0016787; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_06183,1.0769300274291695,FUN_028093-T1,Peve_00022235,Pocillopora_meandrina_HIv1___RNAseq.g15583.t1,three_way,71.7505,FUN_028093-T1,Q6DDH6,,,,,27.4,394.0,2.4e-21,105.9,sp|Q6DDH6|SP13A_XENLA Histone deacetylase complex subunit SAP130-A OS=Xenopus laevis OX=8355 GN=sap130-a PE=2 SV=1,,,,,,
OG_06186,2.641935507895714,FUN_028098-T1,Peve_00026162,Pocillopora_meandrina_HIv1___RNAseq.g15579.t1b,three_way,70.61933333333333,FUN_028098-T1,Q08D62,,,,,33.1,350.0,9e-46,186.4,sp|Q08D62|MAEL_XENTR Protein maelstrom homolog OS=Xenopus tropicalis OX=8364 GN=mael PE=2 SV=1,,,,,,
OG_06188,1.6822722143266775,FUN_028103-T1,Peve_00032588,Pocillopora_meandrina_HIv1___RNAseq.g15573.t1,three_way,47.289,,,,,,,,,,,,,,,,,
OG_06195,1.1695179909162614,FUN_028120-T1,Peve_00033839,Pocillopora_meandrina_HIv1___TS.g10588.t1b,three_way,59.40266666666667,,,,,,,,,,,,,,,,,
OG_06197,1.634709048673152,FUN_028122-T1,Peve_00004261,Pocillopora_meandrina_HIv1___RNAseq.g15557.t2,three_way,43.58133333333333,FUN_028122-T1,P36335,,,,,26.3,598.0,1.3e-35,152.9,sp|P36335|NCA12_XENLA Neural cell adhesion molecule 1-B OS=Xenopus laevis OX=8355 GN=ncam1-b PE=2 SV=1,,,,,,
OG_06198,2.556955860334742,FUN_028130-T1,Peve_00004260,Pocillopora_meandrina_HIv1___RNAseq.g15556.t1,three_way,59.60266666666666,FUN_028130-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),26.8,276.0,4.9e-14,81.6,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_06203,2.557496323203531,FUN_028139-T1,Peve_00025714,Pocillopora_meandrina_HIv1___RNAseq.g16451.t1,three_way,81.30433333333333,FUN_028139-T1,A1L3P4,SL9A6_MOUSE,,Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Sodium/hydrogen exchanger) (Solute carrier family 9 member 6),Mus musculus (Mouse),55.7,587.0,3.3e-153,543.5,sp|A1L3P4|SL9A6_MOUSE Sodium/hydrogen exchanger 6 OS=Mus musculus OX=10090 GN=Slc9a6 PE=1 SV=1,GO:0005739; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0015385; GO:0015386; GO:0030010; GO:0030425; GO:0031410; GO:0031547; GO:0031901; GO:0031902; GO:0043679; GO:0044308; GO:0045202; GO:0048675; GO:0048812; GO:0050808; GO:0051386; GO:0051453; GO:0055037; GO:0055038; GO:0060996; GO:0097484; GO:0098685; GO:0098978; GO:0099072; GO:1902600,axon extension [GO:0048675]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; dendrite extension [GO:0097484]; dendritic spine development [GO:0060996]; establishment of cell polarity [GO:0030010]; neuron projection morphogenesis [GO:0048812]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; synapse organization [GO:0050808],axon terminus [GO:0043679]; axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005739; GO:0005768; GO:0005886; GO:0007163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0055085,transporter activity; mitochondrion; endosome; plasma membrane; establishment or maintenance of cell polarity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; transmembrane transport
OG_06211,1.5862089106968706,FUN_028150-T1,Peve_00042832,Pocillopora_meandrina_HIv1___RNAseq.g15551.t1,three_way,65.80033333333333,FUN_028150-T1,Q68J42,LIPS_PIG,,Hormone-sensitive lipase (HSL) (EC 3.1.1.79) (Monoacylglycerol lipase LIPE) (EC 3.1.1.23) (Retinyl ester hydrolase) (REH),Sus scrofa (Pig),33.3,816.0,3.4e-115,417.5,sp|Q68J42|LIPS_PIG Hormone-sensitive lipase OS=Sus scrofa OX=9823 GN=LIPE PE=2 SV=1,GO:0004771; GO:0004806; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016020; GO:0016042; GO:0019433; GO:0042134; GO:0046340; GO:0046485; GO:0047372; GO:0047376; GO:0050253; GO:0120516,cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],"all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diacylglycerol lipase activity [GO:0120516]; monoacylglycerol lipase activity [GO:0047372]; retinyl-palmitate esterase activity [GO:0050253]; rRNA primary transcript binding [GO:0042134]; sterol ester esterase activity [GO:0004771]; triacylglycerol lipase activity [GO:0004806]",GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016787; GO:0043226,RNA binding; catalytic activity; nucleus; mitochondrion; lipid droplet; cytosol; lipid metabolic process; hydrolase activity; organelle
OG_06212,1.1493893586346775,FUN_028151-T1,Peve_00037724,Pocillopora_meandrina_HIv1___RNAseq.g16452.t1,three_way,82.02066666666667,FUN_028151-T1,Q9TTF0,,,,,43.1,415.0,1.5e-82,308.1,sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2,,,,,,
OG_06215,1.5779128482998164,FUN_028156-T1,Peve_00027512,Pocillopora_meandrina_HIv1___RNAseq.g16461.t1,three_way,34.681666666666665,,,,,,,,,,,,,,,,,
OG_06225,1.3930812787504387,FUN_028170-T1,Peve_00044582,Pocillopora_meandrina_HIv1___RNAseq.g16470.t1,three_way,67.04516666666666,,,,,,,,,,,,,,,,,
OG_06227,1.5312487717516583,FUN_028173-T1,Peve_00024812,Pocillopora_meandrina_HIv1___RNAseq.g16502.t1,three_way,60.945166666666665,FUN_028173-T1,P50534,MSL2_DROME,,E3 ubiquitin-protein ligase msl-2 (EC 2.3.2.27) (Protein male-specific lethal-2),Drosophila melanogaster (Fruit fly),40.9,88.0,2.8e-11,71.2,sp|P50534|MSL2_DROME E3 ubiquitin-protein ligase msl-2 OS=Drosophila melanogaster OX=7227 GN=msl-2 PE=1 SV=2,GO:0000209; GO:0000228; GO:0000805; GO:0003677; GO:0003682; GO:0005694; GO:0007549; GO:0008270; GO:0009047; GO:0016456; GO:0016567; GO:0046536; GO:0061630; GO:0071168; GO:0072487; GO:0106222; GO:0140463; GO:0140517; GO:0140693; GO:0141054; GO:1990837,dosage compensation by hyperactivation of X chromosome [GO:0009047]; protein localization to chromatin [GO:0071168]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sex-chromosome dosage compensation [GO:0007549],"chromosome [GO:0005694]; dosage compensation complex [GO:0046536]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]",chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; histone H2B ubiquitin ligase activity [GO:0141054]; lncRNA binding [GO:0106222]; molecular condensate scaffold activity [GO:0140693]; protein-RNA adaptor activity [GO:0140517]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0000228; GO:0003677; GO:0003723; GO:0003824; GO:0005694; GO:0006325; GO:0016740; GO:0043226; GO:0060090; GO:0140096,"nuclear chromosome; DNA binding; RNA binding; catalytic activity; chromosome; chromatin organization; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein"
OG_06232,1.3019014833098492,FUN_028185-T1,Peve_00001293,Pocillopora_meandrina_HIv1___TS.g11524.t1,three_way,76.6565,FUN_028185-T1,Q86YW9,MD12L_HUMAN,,Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like),Homo sapiens (Human),39.9,1865.0,0.0,1122.5,sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2,GO:0003713; GO:0008013; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592],beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713],GO:0006355; GO:0060090; GO:0140110,regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_06234,2.457725177818648,FUN_028187-T1,Peve_00000861,Pocillopora_meandrina_HIv1___RNAseq.g16542.t1,three_way,56.39333333333333,FUN_028187-T1,Q9YH85,,,,,27.1,284.0,4.2e-15,84.0,sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1,,,,,,
OG_06236,1.6920963468001948,FUN_028192-T1,Peve_00001297,Pocillopora_meandrina_HIv1___TS.g11527.t1,three_way,50.75,FUN_028192-T1,Q91X17,UROM_MOUSE,,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",Mus musculus (Mouse),37.5,144.0,6.5e-21,104.0,sp|Q91X17|UROM_MOUSE Uromodulin OS=Mus musculus OX=10090 GN=Umod PE=1 SV=1,GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033554; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266,antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to stress [GO:0033554]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]; IgG binding [GO:0019864],GO:0002376; GO:0003014; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007155; GO:0012501; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0061024; GO:0098542,immune system process; renal system process; extracellular space; endoplasmic reticulum; plasma membrane; cilium; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; cell adhesion; programmed cell death; protein catabolic process; organelle; anatomical structure development; cell motility; transmembrane transport; membrane organization; defense response to other organism
OG_06241,1.0663539161193971,FUN_028229-T1,Peve_00015265,Pocillopora_meandrina_HIv1___TS.g10556.t1,three_way,86.2135,FUN_028229-T1,Q9H172,ABCG4_HUMAN,,ATP-binding cassette sub-family G member 4 (EC 7.6.2.-),Homo sapiens (Human),58.5,602.0,8.9e-191,668.3,sp|Q9H172|ABCG4_HUMAN ATP-binding cassette sub-family G member 4 OS=Homo sapiens OX=9606 GN=ABCG4 PE=1 SV=2,GO:0005524; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0055085; GO:0071403; GO:1990830,cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of DNA-templated transcription [GO:0006355]; transmembrane transport [GO:0055085],cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005886; GO:0006355; GO:0016787; GO:0031410; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_06244,1.408125246821582,FUN_028236-T1,Peve_00015260,Pocillopora_meandrina_HIv1___TS.g10553.t1,three_way,56.52033333333333,,,,,,,,,,,,,,,,,
OG_06246,2.1563816991855367,FUN_028241-T1,Peve_00019542,Pocillopora_meandrina_HIv1___RNAseq.g15522.t1,three_way,71.78316666666666,FUN_028241-T1,Q155Q3,DIXC1_HUMAN,,Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1),Homo sapiens (Human),41.1,725.0,4.900000000000001e-71,270.8,sp|Q155Q3|DIXC1_HUMAN Dixin OS=Homo sapiens OX=9606 GN=DIXDC1 PE=1 SV=2,GO:0001725; GO:0003779; GO:0005829; GO:0005925; GO:0019904; GO:0021799; GO:0021869; GO:0030177; GO:0032956; GO:0043015; GO:0045665; GO:0060070; GO:0070507; GO:0098794; GO:0098885; GO:0098978,canonical Wnt signaling pathway [GO:0060070]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; stress fiber [GO:0001725],actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904],GO:0005829; GO:0008092; GO:0034330; GO:0048870,cytosol; cytoskeletal protein binding; cell junction organization; cell motility
OG_06250,1.517433953457896,FUN_028247-T1,Peve_00017261,Pocillopora_meandrina_HIv1___RNAseq.g15518.t1,three_way,77.46416666666667,,,,,,,,,,,,,,,,,
OG_06262,1.1010413127036471,FUN_028287-T1,Peve_00003672,Pocillopora_meandrina_HIv1___RNAseq.g15495.t1,three_way,73.47366666666667,FUN_028287-T1,Q8K1K9,HINFP_MOUSE,,Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein),Mus musculus (Mouse),50.1,413.0,4.2e-106,386.7,sp|Q8K1K9|HINFP_MOUSE Histone H4 transcription factor OS=Mus musculus OX=10090 GN=Hinfp PE=2 SV=3,GO:0000077; GO:0000082; GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0008270; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044843; GO:0045184; GO:0045445; GO:0045892; GO:0045893,cell cycle G1/S phase transition [GO:0044843]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355],Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; anatomical structure development; transcription regulator activity
OG_06266,1.4804674375024094,FUN_028293-T1,Peve_00000716,Pocillopora_meandrina_HIv1___TS.g10567.t1,three_way,55.41733333333333,FUN_028293-T1,G5EBF1,SAX3_CAEEL,,Protein sax-3 (Sensory axon guidance 3),Caenorhabditis elegans,24.9,887.0,4.3e-42,175.6,sp|G5EBF1|SAX3_CAEEL Protein sax-3 OS=Caenorhabditis elegans OX=6239 GN=sax-3 PE=2 SV=1,GO:0001764; GO:0005829; GO:0005886; GO:0007411; GO:0008046; GO:0030424; GO:0033563; GO:0035385; GO:0097374; GO:0098609; GO:1905489,axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; Roundabout signaling pathway [GO:0035385]; sensory neuron axon guidance [GO:0097374],axon [GO:0030424]; cytosol [GO:0005829]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046],GO:0005829; GO:0005886; GO:0007155; GO:0048870; GO:0060089,cytosol; plasma membrane; cell adhesion; cell motility; molecular transducer activity
OG_06269,1.8478396695608783,FUN_028300-T1,Peve_00000713,Pocillopora_meandrina_HIv1___RNAseq.g15543.t1,three_way,84.12116666666667,FUN_028300-T1,Q80Z96,,,,,42.7,461.0,2.0999999999999998e-94,347.8,sp|Q80Z96|VANG1_MOUSE Vang-like protein 1 OS=Mus musculus OX=10090 GN=Vangl1 PE=1 SV=2,,,,,,
OG_06270,1.2795099295455328,FUN_028301-T1,Peve_00000714,Pocillopora_meandrina_HIv1___TS.g10572.t1,three_way,51.42816666666666,FUN_028301-T1,D3ZSP7,TTC3_RAT,,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D),Rattus norvegicus (Rat),27.5,741.0,7.4e-62,241.5,sp|D3ZSP7|TTC3_RAT E3 ubiquitin-protein ligase TTC3 OS=Rattus norvegicus OX=10116 GN=Ttc3 PE=3 SV=3,GO:0004842; GO:0005634; GO:0005773; GO:0005794; GO:0006511; GO:0008270; GO:0030517; GO:0045665; GO:0070936,negative regulation of axon extension [GO:0030517]; negative regulation of neuron differentiation [GO:0045665]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; vacuole [GO:0005773],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005773; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vacuole; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06273,1.3701608875537603,FUN_028309-T1,Peve_00037726,Pocillopora_meandrina_HIv1___RNAseq.g16424.t1,three_way,73.845,FUN_028309-T1,O15550,KDM6A_HUMAN,,Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A),Homo sapiens (Human),40.4,1012.0,2.5e-115,418.3,sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2,GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558,chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468],histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06280,1.5374613232851506,FUN_028449-T1,Peve_00031080,Pocillopora_meandrina_HIv1___TS.g11207.t1,three_way,39.0405,FUN_028449-T1,Q62718,NTRI_RAT,,Neurotrimin (GP65),Rattus norvegicus (Rat),31.4,204.0,2.4e-18,95.9,sp|Q62718|NTRI_RAT Neurotrimin OS=Rattus norvegicus OX=10116 GN=Ntm PE=1 SV=1,GO:0005615; GO:0007155; GO:0009986; GO:0010976; GO:0010977; GO:0021549; GO:0030424; GO:0032355; GO:0042802; GO:0048471; GO:0048787; GO:0060076; GO:0060253; GO:0071392; GO:0098552; GO:0098686; GO:0098839; GO:1900149,cell adhesion [GO:0007155]; cellular response to estradiol stimulus [GO:0071392]; cerebellum development [GO:0021549]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron projection development [GO:0010977]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Schwann cell migration [GO:1900149]; response to estradiol [GO:0032355],axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; side of membrane [GO:0098552],identical protein binding [GO:0042802],GO:0005615; GO:0007155; GO:0048856,extracellular space; cell adhesion; anatomical structure development
OG_06281,2.330890303634729,FUN_028450-T1,Peve_00002378,Pocillopora_meandrina_HIv1___RNAseq.g16191.t1,three_way,41.13883333333333,FUN_028450-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),28.0,168.0,1.3e-08,62.8,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_06283,2.2066997087820206,FUN_028468-T1,Peve_00036785,Pocillopora_meandrina_HIv1___RNAseq.g16127.t1,three_way,61.769666666666666,FUN_028468-T1,Q17LW0,,,,,35.2,577.0,2.8e-92,340.9,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_06284,2.0802170854108573,FUN_028470-T1,Peve_00036788,Pocillopora_meandrina_HIv1___RNAseq.g16126.t1,three_way,85.66233333333334,FUN_028470-T1,Q17LW0,,,,,59.3,1107.0,1.4e-292,1007.3,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_06285,1.4711903972754747,FUN_028472-T1,Peve_00036790,Pocillopora_meandrina_HIv1___RNAseq.g16124.t1,three_way,53.61833333333333,,,,,,,,,,,,,,,,,
OG_06289,1.1340945027668905,FUN_028484-T1,Peve_00023662,Pocillopora_meandrina_HIv1___RNAseq.g16115.t1,three_way,73.85666666666667,FUN_028484-T1,Q9NYR8,,,,,33.7,264.0,2.2e-31,137.9,sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1,,,,,,
OG_06291,2.910130107388978,FUN_028486-T1,Peve_00039740,Pocillopora_meandrina_HIv1___TS.g11105.t3a,three_way,50.81666666666667,FUN_028486-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),33.2,368.0,2.2e-41,172.6,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06295,1.4300438933500323,FUN_028495-T1,Peve_00019600,Pocillopora_meandrina_HIv1___RNAseq.g16122.t1,three_way,80.23233333333333,FUN_028495-T1,Q9CQ92,FIS1_MOUSE,,Mitochondrial fission 1 protein (FIS1 homolog) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11),Mus musculus (Mouse),46.9,147.0,1.1e-32,141.0,sp|Q9CQ92|FIS1_MOUSE Mitochondrial fission 1 protein OS=Mus musculus OX=10090 GN=Fis1 PE=1 SV=1,GO:0000266; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0006626; GO:0006915; GO:0007005; GO:0016559; GO:0032991; GO:0042802; GO:1903579; GO:2000192; GO:2001244,apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of fatty acid transport [GO:2000192]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein targeting to mitochondrion [GO:0006626],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],identical protein binding [GO:0042802],GO:0005739; GO:0005777; GO:0007005; GO:0012501; GO:0043226,mitochondrion; peroxisome; mitochondrion organization; programmed cell death; organelle
OG_06305,1.0843451461572746,FUN_028511-T1,Peve_00008102,Pocillopora_meandrina_HIv1___RNAseq.g14117.t1,three_way,72.03616666666667,FUN_028511-T1,Q6GLC9,FMR1_XENTR,,Fragile X messenger ribonucleoprotein 1 homolog (XtFmrp),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.6,377.0,2e-87,324.7,sp|Q6GLC9|FMR1_XENTR Fragile X messenger ribonucleoprotein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fmr1 PE=2 SV=1,GO:0000381; GO:0000775; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006281; GO:0006397; GO:0006406; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0010629; GO:0014069; GO:0017148; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0032433; GO:0033592; GO:0034046; GO:0034063; GO:0035195; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042803; GO:0042995; GO:0043005; GO:0043197; GO:0043204; GO:0043232; GO:0043488; GO:0043679; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048471; GO:0051028; GO:0051489; GO:0051491; GO:0060538; GO:0060965; GO:0060998; GO:0060999; GO:0070840; GO:0071598; GO:0097386; GO:0098793; GO:0098794; GO:0098908; GO:0140006; GO:0140693; GO:0140694; GO:1900453; GO:1901386; GO:1901800; GO:1902737; GO:1990247; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766,"DNA repair [GO:0006281]; glutamate receptor signaling pathway [GO:0007215]; membraneless organelle assembly [GO:0140694]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of receptor internalization [GO:0002092]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]; skeletal muscle organ development [GO:0060538]; stress granule assembly [GO:0034063]","axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; intracellular membraneless organelle [GO:0043232]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]",chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; histone H3 reader activity [GO:0140006]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation repressor activity [GO:0030371],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006913; GO:0008092; GO:0016071; GO:0016853; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0060090; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; nucleocytoplasmic transport; cytoskeletal protein binding; mRNA metabolic process; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA"
OG_06310,2.9908413290154066,FUN_028549-T1,Peve_00000746,Pocillopora_meandrina_HIv1___RNAseq.g6218.t1,three_way,56.03633333333333,FUN_028549-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),30.5,285.0,4.8e-29,131.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_06313,1.6091917754549403,FUN_028553-T1,Peve_00000750,Pocillopora_meandrina_HIv1___TS.g15553.t2,three_way,74.64583333333333,FUN_028553-T1,A2AT37,RENT2_MOUSE,,Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog) (Upf2),Mus musculus (Mouse),48.4,1041.0,5e-267,922.5,sp|A2AT37|RENT2_MOUSE Regulator of nonsense transcripts 2 OS=Mus musculus OX=10090 GN=Upf2 PE=1 SV=1,GO:0000184; GO:0001889; GO:0003723; GO:0005737; GO:0005829; GO:0006986; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471,"animal organ regeneration [GO:0031100]; liver development [GO:0001889]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to unfolded protein [GO:0006986]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; perinuclear region of cytoplasm [GO:0048471],RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005829; GO:0016071; GO:0043226; GO:0048856,DNA binding; RNA binding; cytosol; mRNA metabolic process; organelle; anatomical structure development
OG_06314,1.3881476631354797,FUN_028554-T1,Peve_00002501,Pocillopora_meandrina_HIv1___RNAseq.g20706.t2,three_way,70.67833333333333,FUN_028554-T1,A8MWY0,ELAP2_HUMAN,,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L),Homo sapiens (Human),35.5,1029.0,1.2e-176,622.1,sp|A8MWY0|ELAP2_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Homo sapiens OX=9606 GN=ELAPOR2 PE=1 SV=2,GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700,negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684],membrane [GO:0016020]; plasma membrane [GO:0005886],BMP receptor binding [GO:0070700],GO:0005886,plasma membrane
OG_06316,1.1535684037573726,FUN_028658-T1,Peve_00027144,Pocillopora_meandrina_HIv1___TS.g27058.t1,three_way,39.778333333333336,,,,,,,,,,,,,,,,,
OG_06318,1.1823477883454954,FUN_028794-T1,Peve_00000751,Pocillopora_meandrina_HIv1___RNAseq.g20732.t1,three_way,77.11333333333333,FUN_028794-T1,Q9W352,,,,,39.9,313.0,1.9e-21,104.8,sp|Q9W352|CXXC1_DROME CXXC-type zinc finger protein 1 OS=Drosophila melanogaster OX=7227 GN=Cfp1 PE=1 SV=1,,,,,,
OG_06319,2.1894426848315427,FUN_028795-T1,Peve_00000745,Pocillopora_meandrina_HIv1___RNAseq.g20731.t1,three_way,70.815,FUN_028795-T1,P52756,RBM5_HUMAN,,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),Homo sapiens (Human),39.6,768.0,1.8e-75,285.8,sp|P52756|RBM5_HUMAN RNA-binding protein 5 OS=Homo sapiens OX=9606 GN=RBM5 PE=1 SV=2,GO:0000245; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0006915; GO:0008270; GO:0008285; GO:0043065; GO:0043231,"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]",cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0012501; GO:0016071; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; cytosol; programmed cell death; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06322,1.2002258479369357,FUN_028819-T1,Peve_00031680,Pocillopora_meandrina_HIv1___RNAseq.g20707.t1,three_way,83.64516666666667,FUN_028819-T1,Q3U2S4,OTUD5_MOUSE,,OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA),Mus musculus (Mouse),44.3,447.0,2.4e-87,324.3,sp|Q3U2S4|OTUD5_MOUSE OTU domain-containing protein 5 OS=Mus musculus OX=10090 GN=Otud5 PE=1 SV=2,GO:0004843; GO:0005634; GO:0014033; GO:0016579; GO:0031647; GO:0032496; GO:0032700; GO:0043161; GO:0043374; GO:0061578; GO:0070536; GO:0071108; GO:0072540; GO:0101005; GO:1990380; GO:2000316,"CD8-positive, alpha-beta T cell differentiation [GO:0043374]; negative regulation of interleukin-17 production [GO:0032700]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein stability [GO:0031647]; regulation of T-helper 17 type immune response [GO:2000316]; response to lipopolysaccharide [GO:0032496]; T-helper 17 cell lineage commitment [GO:0072540]",nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578],GO:0002376; GO:0003824; GO:0005634; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; hydrolase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06323,2.8367806141242413,FUN_028831-T1,Peve_00024573,Pocillopora_meandrina_HIv1___RNAseq.g20708.t1,three_way,60.382666666666665,FUN_028831-T1,Q9NVH0,EXD2_HUMAN,,Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2),Homo sapiens (Human),34.2,669.0,3.8e-100,367.5,sp|Q9NVH0|EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2,GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090304; GO:0090734,DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],GO:0003824; GO:0005634; GO:0005739; GO:0005856; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; mitochondrion; cytoskeleton; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_06325,1.812636553846438,FUN_028843-T1,Peve_00024571,Pocillopora_meandrina_HIv1___RNAseq.g20712.t1,three_way,79.26683333333334,FUN_028843-T1,Q32M08,DUS4L_MOUSE,,tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like (EC 1.3.1.90) (tRNA-dihydrouridine synthase 4-like),Mus musculus (Mouse),60.2,299.0,5e-110,399.1,sp|Q32M08|DUS4L_MOUSE tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like OS=Mus musculus OX=10090 GN=Dus4l PE=2 SV=1,GO:0002943; GO:0050660; GO:0102266; GO:0102267,tRNA dihydrouridine synthesis [GO:0002943],,flavin adenine dinucleotide binding [GO:0050660]; tRNA-dihydrouridine20a synthase activity [GO:0102266]; tRNA-dihydrouridine20b synthase activity [GO:0102267],GO:0003824; GO:0006399; GO:0016491; GO:0140098,"catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA"
OG_06327,1.0774485795621709,FUN_028847-T1,Peve_00044608,Pocillopora_meandrina_HIv1___RNAseq.g12800.t1,three_way,69.94233333333334,,,,,,,,,,,,,,,,,
OG_06338,1.1813856135663237,FUN_028897-T1,Peve_00027290,Pocillopora_meandrina_HIv1___RNAseq.g25674.t1,three_way,93.493,FUN_028897-T1,A8WIP6,CDK20_DANRE,,Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20),Danio rerio (Zebrafish) (Brachydanio rerio),79.6,334.0,1.2e-152,540.8,sp|A8WIP6|CDK20_DANRE Cyclin-dependent kinase 20 OS=Danio rerio OX=7955 GN=cdk20 PE=2 SV=1,GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0051301; GO:0060271; GO:0106310,cell division [GO:0051301]; cilium assembly [GO:0060271],cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; cilium; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_06340,1.0114789093491154,FUN_028905-T1,Peve_00042688,Pocillopora_meandrina_HIv1___RNAseq.g25682.t1,three_way,65.59266666666667,,,,,,,,,,,,,,,,,
OG_06347,1.0176371048335944,FUN_028913-T1,Peve_00028026,Pocillopora_meandrina_HIv1___RNAseq.g20741.t2a,three_way,84.06333333333333,FUN_028913-T1,Q8IV35,,,,,40.4,1045.0,5.2e-223,776.2,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_06348,1.0133372470769682,FUN_028918-T1,Peve_00028028,Pocillopora_meandrina_HIv1___TS.g9367.t1,three_way,84.30666666666667,FUN_028918-T1,A7RX26,HUTI_NEMVE,,Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog),Nematostella vectensis (Starlet sea anemone),71.0,317.0,6.6e-131,468.4,sp|A7RX26|HUTI_NEMVE Probable imidazolonepropionase OS=Nematostella vectensis OX=45351 GN=amdhd1 PE=3 SV=1,GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480,L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557],cytoplasm [GO:0005737],imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872],GO:0003824; GO:0006520; GO:0016787,catalytic activity; amino acid metabolic process; hydrolase activity
OG_06349,1.1916099437229353,FUN_028919-T1,Peve_00028034,Pocillopora_meandrina_HIv1___RNAseq.g20741.t2b,three_way,74.77233333333334,FUN_028919-T1,Q28107,FA5_BOVIN,,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],Bos taurus (Bovine),36.2,160.0,5e-24,112.5,sp|Q28107|FA5_BOVIN Coagulation factor V OS=Bos taurus OX=9913 GN=F5 PE=1 SV=1,GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091,blood circulation [GO:0008015]; blood coagulation [GO:0007596],extracellular region [GO:0005576]; platelet alpha granule [GO:0031091],copper ion binding [GO:0005507],GO:0003013; GO:0005576; GO:0031410; GO:0043226,circulatory system process; extracellular region; cytoplasmic vesicle; organelle
OG_06353,1.489140980256359,FUN_028946-T1,Peve_00026868,Pocillopora_meandrina_HIv1___RNAseq.g25583.t1,three_way,40.32216666666666,,,,,,,,,,,,,,,,,
OG_06354,1.0692085084130265,FUN_028947-T1,Peve_00026866,Pocillopora_meandrina_HIv1___RNAseq.g25582.t1,three_way,71.633,FUN_028947-T1,Q9NSA2,KCND1_HUMAN,,A-type voltage-gated potassium channel KCND1 (Potassium voltage-gated channel subfamily D member 1) (Shal-type potassium channel KCND1) (Voltage-gated potassium channel subunit Kv4.1),Homo sapiens (Human),39.5,390.0,6.4e-67,256.1,sp|Q9NSA2|KCND1_HUMAN A-type voltage-gated potassium channel KCND1 OS=Homo sapiens OX=9606 GN=KCND1 PE=1 SV=2,GO:0001508; GO:0005250; GO:0005886; GO:0008076; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_06365,1.1993200219885554,FUN_028969-T1,Peve_00029302,Pocillopora_meandrina_HIv1___TS.g9014.t1a,three_way,92.622,FUN_028969-T1,Q69ZQ2,ISY1_MOUSE,,Pre-mRNA-splicing factor ISY1 homolog,Mus musculus (Mouse),65.4,286.0,9.199999999999999e-92,338.2,sp|Q69ZQ2|ISY1_MOUSE Pre-mRNA-splicing factor ISY1 homolog OS=Mus musculus OX=10090 GN=Isy1 PE=1 SV=2,GO:0000350; GO:0000398; GO:0005634; GO:0071006; GO:0071013,"generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006],,GO:0005634; GO:0016071; GO:0043226; GO:0065003,nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06367,1.625631690723793,FUN_028971-T1,Peve_00006112,Pocillopora_meandrina_HIv1___RNAseq.g25601.t1,three_way,69.34566666666667,FUN_028971-T1,Q80TM9,NISCH_MOUSE,,Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor I-1-like protein) (Imidazoline-1 receptor) (I1R),Mus musculus (Mouse),25.1,343.0,6e-15,85.5,sp|Q80TM9|NISCH_MOUSE Nischarin OS=Mus musculus OX=10090 GN=Nisch PE=1 SV=2,GO:0005178; GO:0005654; GO:0005769; GO:0005829; GO:0005886; GO:0006915; GO:0015630; GO:0016601; GO:0030036; GO:0030336; GO:0035091; GO:0042802; GO:0045171; GO:0055037,actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601],cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091],GO:0005654; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008289; GO:0012501; GO:0031410; GO:0043226,nucleoplasm; endosome; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; lipid binding; programmed cell death; cytoplasmic vesicle; organelle
OG_06369,1.3286550622540507,FUN_028973-T1,Peve_00031293,Pocillopora_meandrina_HIv1___RNAseq.g25606.t1,three_way,43.651833333333336,,,,,,,,,,,,,,,,,
OG_06373,3.063649685927989,FUN_028978-T1,Peve_00029291,Pocillopora_meandrina_HIv1___RNAseq.g25600.t1,three_way,57.49583333333333,FUN_028978-T1,P35331,,,,,29.0,978.0,1.4e-95,352.8,sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06375,1.5684958828844062,FUN_028980-T1,Peve_00015446,Pocillopora_meandrina_HIv1___RNAseq.g25620.t1,three_way,72.642,FUN_028980-T1,Q9UHQ4,BAP29_HUMAN,,B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29),Homo sapiens (Human),47.0,168.0,9.6e-32,138.7,sp|Q9UHQ4|BAP29_HUMAN B-cell receptor-associated protein 29 OS=Homo sapiens OX=9606 GN=BCAP29 PE=1 SV=2,GO:0001649; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0016020; GO:0070973,apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],,GO:0006886; GO:0012501; GO:0016192; GO:0030154,intracellular protein transport; programmed cell death; vesicle-mediated transport; cell differentiation
OG_06384,1.6435420183760645,FUN_029014-T1,Peve_00003118,Pocillopora_meandrina_HIv1___TS.g9087.t1,three_way,52.617,FUN_029014-T1,B8VIW9,,,,,40.2,1040.0,3.2999999999999996e-188,660.6,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_06389,2.035662683752629,FUN_029032-T2,Peve_00006767,Pocillopora_meandrina_HIv1___RNAseq.g20772.t1,three_way,92.37233333333332,FUN_029032-T2,Q9C0G6,DYH6_HUMAN,,Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6),Homo sapiens (Human),66.1,4022.0,0.0,5300.7,sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_06392,2.0174237307280385,FUN_029040-T1,Peve_00026015,Pocillopora_meandrina_HIv1___RNAseq.g20769.t1,three_way,90.76433333333334,FUN_029040-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),57.2,568.0,1.8000000000000004e-164,580.9,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06400,2.885426276540544,FUN_029061-T1,Peve_00043258,Pocillopora_meandrina_HIv1___RNAseq.g25810.t1,three_way,65.944,FUN_029061-T1,A8MTJ6,FOXI3_HUMAN,,Forkhead box protein I3,Homo sapiens (Human),42.1,145.0,1.6e-20,101.7,sp|A8MTJ6|FOXI3_HUMAN Forkhead box protein I3 OS=Homo sapiens OX=9606 GN=FOXI3 PE=1 SV=3,GO:0000978; GO:0000981; GO:0001942; GO:0005634; GO:0006357; GO:0009653; GO:0009957; GO:0030154; GO:0042475; GO:0048538; GO:0060017; GO:0060037; GO:1905040,anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; epidermal cell fate specification [GO:0009957]; hair follicle development [GO:0001942]; odontogenesis of dentin-containing tooth [GO:0042475]; otic placode development [GO:1905040]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; regulation of transcription by RNA polymerase II [GO:0006357]; thymus development [GO:0048538],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06401,1.8877930144787296,FUN_029062-T1,Peve_00043257,Pocillopora_meandrina_HIv1___RNAseq.g25809.t1,three_way,72.04133333333333,FUN_029062-T1,Q02360,,,,,47.4,114.0,6.8e-21,104.0,sp|Q02360|FOXL1_DROME Fork head domain-containing protein L1 OS=Drosophila melanogaster OX=7227 GN=FoxL1 PE=1 SV=2,,,,,,
OG_06403,2.178432931426818,FUN_029065-T1,Peve_00043255,Pocillopora_meandrina_HIv1___RNAseq.g25804.t1,three_way,71.726,,,,,,,,,,,,,,,,,
OG_06406,1.0003645796136449,FUN_029080-T1,Peve_00012860,Pocillopora_meandrina_HIv1___RNAseq.g25461.t1,three_way,67.50433333333334,FUN_029080-T1,Q6IQ20,NAPEP_HUMAN,,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54),Homo sapiens (Human),54.1,344.0,7.000000000000003e-110,398.7,sp|Q6IQ20|NAPEP_HUMAN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Homo sapiens OX=9606 GN=NAPEPLD PE=1 SV=2,GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0030868; GO:0031901; GO:0032052; GO:0035900; GO:0042622; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0098686; GO:1903999,host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; temperature homeostasis [GO:0001659],cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; smooth endoplasmic reticulum membrane [GO:0030868],bile acid binding [GO:0032052]; identical protein binding [GO:0042802]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],GO:0003824; GO:0005635; GO:0005654; GO:0005768; GO:0005794; GO:0006629; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nuclear envelope; nucleoplasm; endosome; Golgi apparatus; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_06409,1.688517979440897,FUN_029091-T1,Peve_00033472,Pocillopora_meandrina_HIv1___RNAseq.g25753.t1,three_way,63.12366666666667,FUN_029091-T1,Q8R4U0,STAB2_MOUSE,,"Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) [Cleaved into: Short form stabilin-2]",Mus musculus (Mouse),35.9,2141.0,2.6e-153,545.8,sp|Q8R4U0|STAB2_MOUSE Stabilin-2 OS=Mus musculus OX=10090 GN=Stab2 PE=1 SV=1,GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0030169; GO:0030214; GO:0038024; GO:0050830,cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],cytosol [GO:0005829]; external side of plasma membrane [GO:0009897],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044],GO:0005829; GO:0007155; GO:0016192; GO:0038024; GO:1901135,cytosol; cell adhesion; vesicle-mediated transport; cargo receptor activity; carbohydrate derivative metabolic process
OG_06411,1.0887935675677425,FUN_029094-T1,Peve_00033474,Pocillopora_meandrina_HIv1___RNAseq.g25750.t1,three_way,77.252,FUN_029094-T1,Q8N468,,,,,33.0,479.0,7.7e-58,226.5,sp|Q8N468|MFD4A_HUMAN Major facilitator superfamily domain-containing protein 4A OS=Homo sapiens OX=9606 GN=MFSD4A PE=1 SV=3,,,,,,
OG_06412,1.3109458261056384,FUN_029095-T1,Peve_00007830,Pocillopora_meandrina_HIv1___RNAseq.g25749.t1,three_way,83.04316666666666,FUN_029095-T1,Q6PDC8,,,,,35.7,487.0,2.5000000000000003e-67,258.1,sp|Q6PDC8|MFD4A_MOUSE Major facilitator superfamily domain-containing protein 4A OS=Mus musculus OX=10090 GN=Mfsd4a PE=2 SV=2,,,,,,
OG_06415,1.1136628518537235,FUN_029098-T1,Peve_00038059,Pocillopora_meandrina_HIv1___RNAseq.g25745.t1,three_way,75.214,FUN_029098-T1,Q9QUQ5,TRPC4_MOUSE,,Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel Trp4) (Receptor-activated cation channel TRP4),Mus musculus (Mouse),33.1,708.0,3e-95,351.3,sp|Q9QUQ5|TRPC4_MOUSE Short transient receptor potential channel 4 OS=Mus musculus OX=10090 GN=Trpc4 PE=1 SV=1,GO:0005886; GO:0005901; GO:0005911; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0032991; GO:0034704; GO:0045121; GO:0045296; GO:0048709; GO:0070509; GO:0070679,calcium ion import [GO:0070509]; gamma-aminobutyric acid secretion [GO:0014051]; oligodendrocyte differentiation [GO:0048709],basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],"beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0005215; GO:0005856; GO:0005886; GO:0030154; GO:0043226,transporter activity; cytoskeleton; plasma membrane; cell differentiation; organelle
OG_06420,1.024435364527405,FUN_029108-T1,Peve_00017655,Pocillopora_meandrina_HIv1___RNAseq.g25465.t1,three_way,91.391,FUN_029108-T1,Q3SZ71,MPPB_BOVIN,,Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP),Bos taurus (Bovine),69.1,469.0,1.3000000000000006e-186,654.1,sp|Q3SZ71|MPPB_BOVIN Mitochondrial-processing peptidase subunit beta OS=Bos taurus OX=9913 GN=PMPCB PE=2 SV=1,GO:0004222; GO:0005739; GO:0005759; GO:0006627; GO:0046872,protein processing involved in protein targeting to mitochondrion [GO:0006627],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_06421,2.274148822177847,FUN_029110-T1,Peve_00004670,Pocillopora_meandrina_HIv1___RNAseq.g25754.t1,three_way,87.27333333333334,FUN_029110-T1,Q99LW6,,,,,52.4,143.0,9.8e-29,127.9,sp|Q99LW6|YAF2_MOUSE YY1-associated factor 2 OS=Mus musculus OX=10090 GN=Yaf2 PE=1 SV=1,,,,,,
OG_06433,2.008507365761546,FUN_029127-T1,Peve_00004665,Pocillopora_meandrina_HIv1___RNAseq.g25779.t1,three_way,50.135333333333335,,,,,,,,,,,,,,,,,
OG_06436,1.220770065390858,FUN_029130-T1,Peve_00033155,Pocillopora_meandrina_HIv1___RNAseq.g25785.t1,three_way,48.33016666666666,,,,,,,,,,,,,,,,,
OG_06438,1.4265145902816063,FUN_029139-T1,Peve_00041022,Pocillopora_meandrina_HIv1___TS.g9187.t2,three_way,76.01066666666667,FUN_029139-T1,Q9H1D0,TRPV6_HUMAN,,Transient receptor potential cation channel subfamily V member 6 (TrpV6) (CaT-like) (CaT-L) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2),Homo sapiens (Human),27.6,566.0,5.5e-48,194.1,sp|Q9H1D0|TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens OX=9606 GN=TRPV6 PE=1 SV=3,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0017158; GO:0034704; GO:0035898; GO:0042802; GO:0046872; GO:0051592; GO:0055074; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592],calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06440,1.5358195043674885,FUN_029144-T1,Peve_00000512,Pocillopora_meandrina_HIv1___RNAseq.g25729.t1,three_way,75.978,FUN_029144-T1,Q14BN4,,,,,59.9,289.0,1.6e-89,332.4,sp|Q14BN4|SLMAP_HUMAN Sarcolemmal membrane-associated protein OS=Homo sapiens OX=9606 GN=SLMAP PE=1 SV=1,,,,,,
OG_06441,1.1192601543305594,FUN_029145-T1,Peve_00000511,Pocillopora_meandrina_HIv1___RNAseq.g25730.t1,three_way,65.79666666666667,,,,,,,,,,,,,,,,,
OG_06442,1.0935289235069507,FUN_029149-T1,Peve_00000508,Pocillopora_meandrina_HIv1___RNAseq.g25732.t1,three_way,83.18866666666666,FUN_029149-T1,Q62717,,,,,54.3,1182.0,0.0,1248.0,sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1,,,,,,
OG_06445,1.403587270615182,FUN_029156-T1,Peve_00041032,Pocillopora_meandrina_HIv1___RNAseq.g25738.t1,three_way,72.0625,FUN_029156-T1,Q6DEZ2,,,,,32.0,977.0,4.3e-129,464.2,sp|Q6DEZ2|F120A_XENTR Constitutive coactivator of PPAR-gamma-like protein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fam120a PE=2 SV=1,,,,,,
OG_06446,1.300794300213839,FUN_029165-T1,Peve_00003759,Pocillopora_meandrina_HIv1___RNAseq.g25482.t1,three_way,60.49966666666667,FUN_029165-T1,Q91035,SHH_CHICK,,Sonic hedgehog protein (SHH) (EC 3.1.-.-) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) [Cleaved into: Sonic hedgehog protein N-product (ShhN) (Shh N-terminal processed signaling domains) (ShhNp)],Gallus gallus (Chicken),43.2,410.0,2.9999999999999997e-83,310.5,sp|Q91035|SHH_CHICK Sonic hedgehog protein OS=Gallus gallus OX=9031 GN=SHH PE=1 SV=1,GO:0000139; GO:0001708; GO:0001709; GO:0001895; GO:0003406; GO:0003408; GO:0003430; GO:0005113; GO:0005509; GO:0005576; GO:0005615; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0008270; GO:0009880; GO:0009888; GO:0009949; GO:0009951; GO:0009952; GO:0010468; GO:0010628; GO:0016015; GO:0016539; GO:0016540; GO:0021508; GO:0021513; GO:0021631; GO:0023052; GO:0030326; GO:0030514; GO:0032526; GO:0042733; GO:0043066; GO:0045880; GO:0048709; GO:0048877; GO:0060059; GO:0060573; GO:0060591; GO:0060785; GO:0060786; GO:0061075; GO:0071679; GO:0090269; GO:0097190; GO:0097264; GO:0140853; GO:2000177,anterior/posterior pattern specification [GO:0009952]; apoptotic signaling pathway [GO:0097190]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell fate specification involved in pattern specification [GO:0060573]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; commissural neuron axon guidance [GO:0071679]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; fibroblast growth factor production [GO:0090269]; floor plate formation [GO:0021508]; growth plate cartilage chondrocyte growth [GO:0003430]; homeostasis of number of retina cells [GO:0048877]; intein-mediated protein splicing [GO:0016539]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; oligodendrocyte differentiation [GO:0048709]; optic cup formation involved in camera-type eye development [GO:0003408]; optic nerve morphogenesis [GO:0021631]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of gene expression [GO:0010628]; positive regulation of neural retina development [GO:0061075]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of cell differentiation involved in tissue homeostasis [GO:0060786]; regulation of gene expression [GO:0010468]; regulation of neural precursor cell proliferation [GO:2000177]; response to retinoic acid [GO:0032526]; retina homeostasis [GO:0001895]; retinal pigment epithelium development [GO:0003406]; self proteolysis [GO:0097264]; signaling [GO:0023052]; smoothened signaling pathway [GO:0007224]; spinal cord dorsal/ventral patterning [GO:0021513]; tissue development [GO:0009888],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; extracellular region; extracellular space; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; hydrolase activity; signaling; cell differentiation; organelle; receptor ligand activity; anatomical structure development; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06447,1.9518057755823848,FUN_029166-T1,Peve_00027805,Pocillopora_meandrina_HIv1___RNAseq.g25481.t1,three_way,75.72866666666667,FUN_029166-T1,P50395,GDIB_HUMAN,,Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2),Homo sapiens (Human),62.2,442.0,6.8e-166,585.1,sp|P50395|GDIB_HUMAN Rab GDP dissociation inhibitor beta OS=Homo sapiens OX=9606 GN=GDI2 PE=1 SV=2,GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0031267; GO:0031982; GO:0034774; GO:0035578; GO:0045202; GO:0070062; GO:1902018; GO:1903565,negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0003723; GO:0005576; GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,RNA binding; extracellular region; Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_06451,1.6616815701622671,FUN_029171-T1,Peve_00042456,Pocillopora_meandrina_HIv1___RNAseq.g25478.t1,three_way,65.962,FUN_029171-T1,Q9UHD2,TBK1_HUMAN,,Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1),Homo sapiens (Human),42.0,628.0,2.1000000000000002e-125,451.4,sp|Q9UHD2|TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens OX=9606 GN=TBK1 PE=1 SV=1,GO:0002218; GO:0002753; GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010508; GO:0010629; GO:0016236; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0034142; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060337; GO:0060340; GO:0061470; GO:0061629; GO:0106310; GO:0140374; GO:0140896; GO:1902554; GO:1904262; GO:1904263; GO:1904417; GO:1904515,activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of gene expression [GO:0010629]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; T follicular helper cell differentiation [GO:0061470]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0002376; GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0006914; GO:0006954; GO:0016740; GO:0030154; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; autophagy; inflammatory response; transferase activity; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_06453,1.644559074846606,FUN_029174-T1,Peve_00015171,Pocillopora_meandrina_HIv1___TS.g8934.t1,three_way,64.79366666666667,FUN_029174-T1,Q62277,SYPH_MOUSE,,Synaptophysin (BM89 antigen) (Major synaptic vesicle protein p38),Mus musculus (Mouse),30.8,240.0,2.2000000000000004e-28,127.5,sp|Q62277|SYPH_MOUSE Synaptophysin OS=Mus musculus OX=10090 GN=Syp PE=1 SV=2,GO:0006897; GO:0007268; GO:0008021; GO:0010807; GO:0015485; GO:0016020; GO:0017075; GO:0030672; GO:0031594; GO:0042169; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044306; GO:0045202; GO:0048169; GO:0048172; GO:0048471; GO:0048786; GO:0050804; GO:0060076; GO:0060203; GO:0098685; GO:0098793; GO:2000474,chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; modulation of chemical synaptic transmission [GO:0050804]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807],clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; excitatory synapse [GO:0060076]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195],cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; syntaxin-1 binding [GO:0017075],GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226,lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle
OG_06454,2.426122052632802,FUN_029175-T1,Peve_00015172,Pocillopora_meandrina_HIv1___RNAseq.g25499.t1,three_way,65.24666666666667,FUN_029175-T1,B2GUB3,TTLL3_XENTR,,Tubulin tyrosine ligase 3 (EC 6.3.2.-) (Tubulin--tyrosine ligase protein 3),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),49.2,659.0,3.6e-156,554.3,sp|B2GUB3|TTLL3_XENTR Tubulin tyrosine ligase 3 OS=Xenopus tropicalis OX=8364 GN=ttll3 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005874; GO:0018094; GO:0031514; GO:0046872; GO:0070736,protein polyglycylation [GO:0018094],cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity, initiating [GO:0070736]",GO:0003824; GO:0005929; GO:0016874; GO:0043226; GO:0140096,"catalytic activity; cilium; ligase activity; organelle; catalytic activity, acting on a protein"
OG_06455,1.0722237360540077,FUN_029177-T1,Peve_00031203,Pocillopora_meandrina_HIv1___TS.g8937.t1,three_way,73.50366666666666,FUN_029177-T1,Q9DC53,,,,,63.0,519.0,6.399999999999999e-190,665.2,sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3,,,,,,
OG_06457,1.1911311134379772,FUN_029186-T1,Peve_00031210,Pocillopora_meandrina_HIv1___RNAseq.g25503.t1,three_way,70.64266666666667,FUN_029186-T1,Q8R4I1,ATX7_MOUSE,,Ataxin-7 (Spinocerebellar ataxia type 7 protein homolog),Mus musculus (Mouse),32.3,470.0,2.7e-26,122.5,sp|Q8R4I1|ATX7_MOUSE Ataxin-7 OS=Mus musculus OX=10090 GN=Atxn7 PE=1 SV=2,GO:0000124; GO:0003682; GO:0005634; GO:0005730; GO:0005737; GO:0005856; GO:0006282; GO:0006357; GO:0006366; GO:0016363; GO:0033276; GO:0043484; GO:0043569; GO:0045893; GO:0045944; GO:0048009,insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],chromatin binding [GO:0003682],GO:0005634; GO:0005730; GO:0005856; GO:0006351; GO:0006355; GO:0043226,nucleus; nucleolus; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; organelle
OG_06458,1.798330633434402,FUN_029187-T1,Peve_00031211,Pocillopora_meandrina_HIv1___RNAseq.g25505.t1,three_way,77.81533333333333,FUN_029187-T1,Q63481,RAB7L_RAT,,Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29),Rattus norvegicus (Rat),52.6,209.0,3e-57,223.4,sp|Q63481|RAB7L_RAT Ras-related protein Rab-7L1 OS=Rattus norvegicus OX=10116 GN=Rab29 PE=1 SV=1,GO:0000139; GO:0001921; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0031965; GO:0031982; GO:0032438; GO:0042110; GO:0042147; GO:0042470; GO:0044788; GO:0048471; GO:0050862; GO:0055037; GO:0060271; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1903441; GO:1905279; GO:1990748,"cell differentiation [GO:0030154]; cellular detoxification [GO:1990748]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; modulation by host of viral process [GO:0044788]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]",cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; vesicle [GO:0031982],dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005739; GO:0005768; GO:0005773; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0008092; GO:0016192; GO:0016787; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0044782; GO:0098754,immune system process; catalytic activity; GTPase activity; nucleoplasm; mitochondrion; endosome; vacuole; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; intracellular protein transport; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; cilium organization; detoxification
OG_06459,1.284232189221906,FUN_029188-T1,Peve_00031212,Pocillopora_meandrina_HIv1___RNAseq.g25507.t1,three_way,58.37133333333333,FUN_029188-T1,P70677,,,,,38.7,261.0,3.4999999999999996e-43,177.2,sp|P70677|CASP3_MOUSE Caspase-3 OS=Mus musculus OX=10090 GN=Casp3 PE=1 SV=1,,,,,,
OG_06464,1.5299492234620289,FUN_029195-T1,Peve_00025427,Pocillopora_meandrina_HIv1___RNAseq.g25521.t1,three_way,69.22866666666667,,,,,,,,,,,,,,,,,
OG_06465,1.5065741570834177,FUN_029196-T1,Peve_00004309,Pocillopora_meandrina_HIv1___RNAseq.g25522.t1,three_way,39.9695,FUN_029196-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),29.6,213.0,2.1e-13,79.3,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_06467,1.0182964404883357,FUN_029198-T1,Peve_00004307,Pocillopora_meandrina_HIv1___RNAseq.g25525.t1,three_way,50.453833333333336,,,,,,,,,,,,,,,,,
OG_06469,1.615233062724935,FUN_029208-T1,Peve_00013633,Pocillopora_meandrina_HIv1___RNAseq.g25538.t1,three_way,48.8415,,,,,,,,,,,,,,,,,
OG_06470,1.2365627995715696,FUN_029211-T1,Peve_00024515,Pocillopora_meandrina_HIv1___RNAseq.g25545.t1,three_way,61.35433333333333,,,,,,,,,,,,,,,,,
OG_06472,1.007959591272767,FUN_029234-T1,Peve_00045061,Pocillopora_meandrina_HIv1___RNAseq.g25553.t1,three_way,64.42733333333334,FUN_029234-T1,O15427,MOT4_HUMAN,,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),Homo sapiens (Human),27.4,398.0,5.9999999999999996e-40,166.8,sp|O15427|MOT4_HUMAN Monocarboxylate transporter 4 OS=Homo sapiens OX=9606 GN=SLC16A3 PE=1 SV=1,GO:0003723; GO:0005886; GO:0008028; GO:0015650; GO:0015718; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0031965; GO:0035873; GO:0035879; GO:0042867; GO:0050833; GO:1901475,lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],lactate:proton symporter activity [GO:0015650]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; RNA binding [GO:0003723],GO:0003723; GO:0005215; GO:0005886; GO:0055085,RNA binding; transporter activity; plasma membrane; transmembrane transport
OG_06474,1.610304659463916,FUN_029241-T1,Peve_00013753,Pocillopora_meandrina_HIv1___RNAseq.g25410.t1,three_way,73.27116666666666,FUN_029241-T1,Q9D8P7,,,,,39.5,119.0,5.8e-17,88.6,sp|Q9D8P7|TF3C6_MOUSE General transcription factor 3C polypeptide 6 OS=Mus musculus OX=10090 GN=Gtf3c6 PE=2 SV=1,,,,,,
OG_06478,1.7090145789488955,FUN_029246-T1,Peve_00013747,Pocillopora_meandrina_HIv1___RNAseq.g25404.t1,three_way,78.42166666666667,FUN_029246-T1,Q9Y2I9,TBC30_HUMAN,,TBC1 domain family member 30,Homo sapiens (Human),49.0,569.0,8.899999999999999e-139,496.1,sp|Q9Y2I9|TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens OX=9606 GN=TBC1D30 PE=1 SV=2,GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0016604; GO:0031267; GO:0036064; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; nuclear body [GO:0016604]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; plasma membrane; cilium; organelle; molecular function regulator activity
OG_06479,1.191951805147601,FUN_029247-T1,Peve_00013745,Pocillopora_meandrina_HIv1___TS.g9395.t1,three_way,61.76716666666667,FUN_029247-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),37.3,496.0,4.5e-84,314.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_06485,1.0832838391544686,FUN_029259-T1,Peve_00024365,Pocillopora_meandrina_HIv1___RNAseq.g15031.t1b,three_way,71.01783333333333,FUN_029259-T1,Q6DN90,IQEC1_HUMAN,,IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2),Homo sapiens (Human),42.1,447.0,1.1e-74,283.1,sp|Q6DN90|IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IQSEC1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0051549; GO:0060996; GO:0120183,actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012],centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_06489,1.4389862252093646,FUN_029264-T1,Peve_00030745,Pocillopora_meandrina_HIv1___RNAseq.g15034.t1,three_way,71.40766666666667,,,,,,,,,,,,,,,,,
OG_06494,1.7557213373505265,FUN_029275-T1,Peve_00030743,Pocillopora_meandrina_HIv1___RNAseq.g15044.t1,three_way,76.801,FUN_029275-T1,Q9SLX0,,,,,29.3,188.0,5.7e-16,86.7,sp|Q9SLX0|IMA1B_ORYSJ Importin subunit alpha-1b OS=Oryza sativa subsp. japonica OX=39947 GN=Os05g0155601 PE=1 SV=2,,,,,,
OG_06496,1.784376154159167,FUN_029277-T1,Peve_00030739,Pocillopora_meandrina_HIv1___RNAseq.g25413.t1,three_way,84.80083333333334,FUN_029277-T1,Q16829,DUS7_HUMAN,,Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2),Homo sapiens (Human),44.7,358.0,9e-73,275.4,sp|Q16829|DUS7_HUMAN Dual specificity protein phosphatase 7 OS=Homo sapiens OX=9606 GN=DUSP7 PE=1 SV=4,GO:0000165; GO:0004722; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008138; GO:0008330; GO:0017017; GO:0033550; GO:0035335; GO:0043407; GO:0070371; GO:0070373,ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; catalytic activity, acting on a protein"
OG_06499,1.505665869369892,FUN_029290-T1,Peve_00036558,Pocillopora_meandrina_HIv1___RNAseq.g11162.t1,three_way,72.6425,FUN_029290-T1,O95602,RPA1_HUMAN,,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),Homo sapiens (Human),50.1,1092.0,2e-264,913.7,sp|O95602|RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens OX=9606 GN=POLR1A PE=1 SV=2,GO:0000287; GO:0000785; GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005739; GO:0006360; GO:0008270; GO:0071667; GO:1904750,negative regulation of protein localization to nucleolus [GO:1904750]; transcription by RNA polymerase I [GO:0006360],chromatin [GO:0000785]; chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005694; GO:0005739; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"DNA binding; catalytic activity; nucleoplasm; chromosome; mitochondrion; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_06502,1.3165088870488524,FUN_029296-T1,Peve_00040801,Pocillopora_meandrina_HIv1___RNAseq.g12593.t1,three_way,55.744,FUN_029296-T1,Q8TE60,,,,,30.5,1022.0,6.6e-110,401.0,sp|Q8TE60|ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens OX=9606 GN=ADAMTS18 PE=1 SV=3,,,,,,
OG_06507,1.4674061152037046,FUN_029301-T1,Peve_00040808,Pocillopora_meandrina_HIv1___RNAseq.g12585.t1,three_way,51.386,FUN_029301-T1,Q01974,ROR2_HUMAN,,"Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)",Homo sapiens (Human),27.3,264.0,1.5e-16,90.5,sp|Q01974|ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens OX=9606 GN=ROR2 PE=1 SV=2,GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0015026; GO:0016055; GO:0017147; GO:0030335; GO:0030424; GO:0030669; GO:0031435; GO:0043235; GO:0046872,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; positive regulation of cell migration [GO:0030335]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; clathrin-coated endocytic vesicle membrane [GO:0030669]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0016740; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; transferase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_06508,1.3287476082566878,FUN_029305-T1,Peve_00040807,Pocillopora_meandrina_HIv1___RNAseq.g12584.t1,three_way,70.46983333333334,FUN_029305-T1,P51049,,,,,27.9,315.0,5.7e-28,126.7,sp|P51049|MR1BB_DANRE Melatonin receptor type 1B-B OS=Danio rerio OX=7955 GN=mtnr1bb PE=2 SV=2,,,,,,
OG_06509,1.282585968157929,FUN_029306-T2,Peve_00040799,Pocillopora_meandrina_HIv1___RNAseq.g12583.t1,three_way,74.93816666666666,FUN_029306-T2,O55164,MPDZ_RAT,,Multiple PDZ domain protein (Multi-PDZ domain protein 1),Rattus norvegicus (Rat),35.8,2259.0,2.8000000000000002e-304,1047.0,sp|O55164|MPDZ_RAT Multiple PDZ domain protein OS=Rattus norvegicus OX=10116 GN=Mpdz PE=1 SV=1,GO:0005737; GO:0005886; GO:0005923; GO:0006886; GO:0007155; GO:0012505; GO:0014069; GO:0016324; GO:0016327; GO:0016358; GO:0030425; GO:0031410; GO:0035003; GO:0035556; GO:0042552; GO:0043220; GO:0045177; GO:0045202; GO:0098978; GO:0120192,cell adhesion [GO:0007155]; dendrite development [GO:0016358]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; myelination [GO:0042552]; tight junction assembly [GO:0120192],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; subapical complex [GO:0035003]; synapse [GO:0045202],,GO:0005886; GO:0006886; GO:0007155; GO:0031410; GO:0034330; GO:0043226; GO:0048856,plasma membrane; intracellular protein transport; cell adhesion; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development
OG_06512,1.3205674358500674,FUN_029309-T1,Peve_00038265,Pocillopora_meandrina_HIv1___RNAseq.g12582.t1,three_way,42.67516666666667,FUN_029309-T1,Q921R4,,,,,33.1,314.0,3e-36,155.6,sp|Q921R4|DJC14_MOUSE DnaJ homolog subfamily C member 14 OS=Mus musculus OX=10090 GN=Dnajc14 PE=2 SV=2,,,,,,
OG_06513,1.6247509753921725,FUN_029310-T1,Peve_00038264,Pocillopora_meandrina_HIv1___RNAseq.g12579.t1,three_way,89.39833333333333,FUN_029310-T1,O00139,KIF2A_HUMAN,,Kinesin-like protein KIF2A (Kinesin-2) (hK2),Homo sapiens (Human),53.7,709.0,1.3e-187,657.9,sp|O00139|KIF2A_HUMAN Kinesin-like protein KIF2A OS=Homo sapiens OX=9606 GN=KIF2A PE=1 SV=3,GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0030154; GO:0030334; GO:0036064; GO:0051301; GO:0072686; GO:0090307; GO:0120103,cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334],centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005654; GO:0005730; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleoplasm; nucleolus; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; cell differentiation; organelle; anatomical structure development; ATP-dependent activity
OG_06516,1.598722137581181,FUN_029317-T1,Peve_00038259,Pocillopora_meandrina_HIv1___RNAseq.g12575.t1,three_way,56.52,FUN_029317-T1,Q8IY67,,,,,37.9,269.0,1.4e-40,169.9,sp|Q8IY67|RAVR1_HUMAN Ribonucleoprotein PTB-binding 1 OS=Homo sapiens OX=9606 GN=RAVER1 PE=1 SV=1,,,,,,
OG_06520,1.238912209631451,FUN_029330-T1,Peve_00010682,Pocillopora_meandrina_HIv1___TS.g2875.t1,three_way,40.08233333333333,FUN_029330-T1,Q9VC47,TOK_DROME,,Protein tolkin (EC 3.4.24.-) (Tolloid-related protein) (Tolloid-related protein 1),Drosophila melanogaster (Fruit fly),26.6,218.0,6.4e-11,70.1,sp|Q9VC47|TOK_DROME Protein tolkin OS=Drosophila melanogaster OX=7227 GN=tok PE=1 SV=1,GO:0004222; GO:0005509; GO:0005615; GO:0007411; GO:0007415; GO:0008045; GO:0008270; GO:0008586; GO:0009953; GO:0016485; GO:0030424; GO:0030513; GO:0032927; GO:0043204,axon guidance [GO:0007411]; defasciculation of motor neuron axon [GO:0007415]; dorsal/ventral pattern formation [GO:0009953]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; motor neuron axon guidance [GO:0008045]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485],axon [GO:0030424]; extracellular space [GO:0005615]; perikaryon [GO:0043204],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_06522,3.1591267317190788,FUN_029339-T1,Peve_00023361,Pocillopora_meandrina_HIv1___RNAseq.g17301.t1,three_way,61.434333333333335,FUN_029339-T1,Q01973,ROR1_HUMAN,,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",Homo sapiens (Human),31.6,773.0,1.1000000000000001e-118,429.1,sp|Q01973|ROR1_HUMAN Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens OX=9606 GN=ROR1 PE=1 SV=2,GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0015026; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092,astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_06526,1.4886258256771452,FUN_029345-T1,Peve_00023375,Pocillopora_meandrina_HIv1___RNAseq.g17294.t1,three_way,65.33866666666667,FUN_029345-T1,Q6PB03,PLD3_XENLA,,5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3),Xenopus laevis (African clawed frog),48.3,445.0,6.4e-117,422.5,sp|Q6PB03|PLD3_XENLA 5'-3' exonuclease PLD3 OS=Xenopus laevis OX=8355 GN=pld3 PE=2 SV=1,GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0014902; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015,immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015],early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202],single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145],GO:0002376; GO:0003824; GO:0006954; GO:0016787; GO:0030154; GO:0140097,"immune system process; catalytic activity; inflammatory response; hydrolase activity; cell differentiation; catalytic activity, acting on DNA"
OG_06528,1.9375191133048209,FUN_029357-T1,Peve_00023328,Pocillopora_meandrina_HIv1___RNAseq.g17291.t1,three_way,87.65433333333334,FUN_029357-T1,Q9UIJ7,KAD3_HUMAN,,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)",Homo sapiens (Human),57.9,209.0,2.1e-67,256.9,"sp|Q9UIJ7|KAD3_HUMAN GTP:AMP phosphotransferase AK3, mitochondrial OS=Homo sapiens OX=9606 GN=AK3 PE=1 SV=4",GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0016874; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899,ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; ligase activity [GO:0016874]; nucleoside triphosphate adenylate kinase activity [GO:0046899],GO:0003824; GO:0005739; GO:0016740; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; transferase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_06530,1.3392076639348651,FUN_029360-T1,Peve_00044526,Pocillopora_meandrina_HIv1___RNAseq.g17132.t3,three_way,79.10799999999999,FUN_029360-T1,B2GV50,RFX2_RAT,,DNA-binding protein RFX2 (Regulatory factor X 2),Rattus norvegicus (Rat),57.0,604.0,1.9e-176,620.9,sp|B2GV50|RFX2_RAT DNA-binding protein RFX2 OS=Rattus norvegicus OX=10116 GN=Rfx2 PE=1 SV=1,GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001675; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007286; GO:0045944; GO:0060271; GO:1990830; GO:1990837,acrosome assembly [GO:0001675]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; cilium organization; anatomical structure development; transcription regulator activity
OG_06533,1.619373518424357,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,55.2,87.0,8.5e-18,94.4,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06533,1.619373518424357,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,56.2,48.0,2e-06,56.6,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06536,1.519293495715444,FUN_029396-T1,Peve_00044520,Pocillopora_meandrina_HIv1___RNAseq.g17138.t1,three_way,63.98033333333333,FUN_029396-T1,Q7SZC5,,,,,32.8,673.0,7.2e-84,313.2,sp|Q7SZC5|NDC1_DANRE Nucleoporin NDC1 OS=Danio rerio OX=7955 GN=ndc1 PE=2 SV=1,,,,,,
OG_06538,1.6917183844124046,FUN_029400-T1,Peve_00044529,Pocillopora_meandrina_HIv1___RNAseq.g17141.t1,three_way,71.86333333333333,FUN_029400-T1,Q7T3H9,,,,,41.9,265.0,5.600000000000001e-59,229.2,sp|Q7T3H9|HYI_DANRE Putative hydroxypyruvate isomerase OS=Danio rerio OX=7955 GN=hyi PE=2 SV=2,,,,,,
OG_06539,2.1116968032038512,FUN_029401-T1,Peve_00044530,Pocillopora_meandrina_HIv1___RNAseq.g17142.t1,three_way,73.958,,,,,,,,,,,,,,,,,
OG_06540,1.3174963900490475,FUN_029404-T2,Peve_00044518,Pocillopora_meandrina_HIv1___RNAseq.g17143.t1,three_way,73.2395,FUN_029404-T2,Q5ZLX5,,,,,66.9,136.0,1.8e-50,200.7,sp|Q5ZLX5|ZRAB2_CHICK Zinc finger Ran-binding domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ZRANB2 PE=2 SV=1,,,,,,
OG_06541,1.853909210258085,FUN_029405-T1,Peve_00035059,Pocillopora_meandrina_HIv1___RNAseq.g17144.t1,three_way,85.84700000000001,FUN_029405-T1,Q3MHG1,SPTC1_BOVIN,,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),Bos taurus (Bovine),57.5,463.0,4.2e-156,552.7,sp|Q3MHG1|SPTC1_BOVIN Serine palmitoyltransferase 1 OS=Bos taurus OX=9913 GN=SPTLC1 PE=2 SV=1,GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0017059; GO:0030170; GO:0046512; GO:0046513; GO:1904649,ceramide biosynthetic process [GO:0046513]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_06550,1.659988308016481,FUN_029422-T1,Peve_00005721,Pocillopora_meandrina_HIv1___RNAseq.g17177.t2,three_way,42.010666666666665,,,,,,,,,,,,,,,,,
OG_06555,1.2797963697414056,FUN_029434-T1,Peve_00039460,Pocillopora_meandrina_HIv1___RNAseq.g17170.t1,three_way,82.005,FUN_029434-T1,Q2TA24,VATO_BOVIN,,V-type proton ATPase 21 kDa proteolipid subunit c'' (V-ATPase 21 kDa proteolipid subunit c'') (Vacuolar proton pump 21 kDa proteolipid subunit c''),Bos taurus (Bovine),62.9,197.0,5.8e-62,238.8,sp|Q2TA24|VATO_BOVIN V-type proton ATPase 21 kDa proteolipid subunit c'' OS=Bos taurus OX=9913 GN=ATP6V0B PE=1 SV=1,GO:0000220; GO:0005768; GO:0016020; GO:0030665; GO:0045851; GO:0046961; GO:1902600,pH reduction [GO:0045851]; proton transmembrane transport [GO:1902600],"clathrin-coated vesicle membrane [GO:0030665]; endosome [GO:0005768]; membrane [GO:0016020]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005768; GO:0031410; GO:0043226; GO:0055085; GO:0140657,transporter activity; endosome; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_06556,2.23692164498811,FUN_029438-T1,Peve_00028188,Pocillopora_meandrina_HIv1___RNAseq.g17152.t1,three_way,76.8055,FUN_029438-T1,Q8IZF0,NALCN_HUMAN,,Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1),Homo sapiens (Human),41.8,1604.0,0.0,1137.9,sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1,GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805,"calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]",monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06557,1.6073965100203702,FUN_029439-T1,Peve_00028189,Pocillopora_meandrina_HIv1___RNAseq.g17153.t1,three_way,82.17283333333333,FUN_029439-T1,Q91X83,,,,,67.5,381.0,1.1e-154,547.7,sp|Q91X83|METK1_MOUSE S-adenosylmethionine synthase isoform type-1 OS=Mus musculus OX=10090 GN=Mat1a PE=1 SV=1,,,,,,
OG_06558,2.270370717472753,FUN_029440-T1,Peve_00028190,Pocillopora_meandrina_HIv1___RNAseq.g17154.t1,three_way,63.96833333333333,FUN_029440-T1,Q8TDY2,,,,,32.0,596.0,2.7e-76,288.9,sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3,,,,,,
OG_06566,1.2811496635930315,FUN_029473-T1,Peve_00028195,Pocillopora_meandrina_HIv1___RNAseq.g17147.t1,three_way,66.37633333333333,FUN_029473-T1,Q8IWX8,CHERP_HUMAN,,Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6),Homo sapiens (Human),43.1,933.0,6.6e-63,243.8,sp|Q8IWX8|CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3,GO:0003723; GO:0005654; GO:0005737; GO:0006396; GO:0006874; GO:0007399; GO:0008285; GO:0016020; GO:0033017; GO:0044325; GO:0048471; GO:0051209; GO:0070886,intracellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396],cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017],RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325],GO:0003723; GO:0005654; GO:0048856; GO:0055085,RNA binding; nucleoplasm; anatomical structure development; transmembrane transport
OG_06568,1.3207812722900651,FUN_029475-T1,Peve_00028203,Pocillopora_meandrina_HIv1___RNAseq.g17149.t1,three_way,80.37583333333333,FUN_029475-T1,Q5F3F5,,,,,45.8,690.0,1.3e-158,561.6,sp|Q5F3F5|LMBD2_CHICK G-protein coupled receptor-associated protein LMBRD2 OS=Gallus gallus OX=9031 GN=LMBRD2 PE=2 SV=1,,,,,,
OG_06571,1.0494831977739711,FUN_029484-T1,Peve_00017245,Pocillopora_meandrina_HIv1___RNAseq.g17128.t1,three_way,64.353,FUN_029484-T1,Q8NEA6,GLIS3_HUMAN,,Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515),Homo sapiens (Human),64.3,70.0,4.8e-23,110.9,sp|Q8NEA6|GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens OX=9606 GN=GLIS3 PE=1 SV=5,GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0045944,negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_06574,1.3636977498975358,FUN_029519-T1,Peve_00022876,Pocillopora_meandrina_HIv1___TS.g2888.t1,three_way,93.70616666666666,FUN_029519-T1,Q9JHU4,DYHC1_MOUSE,,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",Mus musculus (Mouse),73.3,4665.0,0.0,6825.7,sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2,GO:0003341; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0008569; GO:0016887; GO:0030175; GO:0030286; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1905832,cell division [GO:0051301]; cilium movement [GO:0003341]; establishment of spindle localization [GO:0051293]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; filopodium [GO:0030175]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0016787; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; hydrolase activity; isomerase activity; ATP-dependent activity
OG_06575,1.3601397530837993,FUN_029520-T1,Peve_00028644,Pocillopora_meandrina_HIv1___RNAseq.g17115.t1,three_way,95.12166666666668,FUN_029520-T1,Q8MQI6,,,,,74.4,82.0,6.9e-32,137.5,sp|Q8MQI6|ELOF1_DROME Transcription elongation factor 1 homolog OS=Drosophila melanogaster OX=7227 GN=CG40228 PE=3 SV=1,,,,,,
OG_06576,2.8421078751042463,FUN_029521-T2,Peve_00028580,Pocillopora_meandrina_HIv1___RNAseq.g17111.t1,three_way,61.62799999999999,FUN_029521-T2,P0DN10,,,,,63.5,52.0,2.7e-14,83.6,sp|P0DN10|VKT6_ANEVI U-actitoxin-Avd3i OS=Anemonia viridis OX=51769 PE=3 SV=1,,,,,,
OG_06577,3.2086103154639183,FUN_029524-T1,Peve_00010676,Pocillopora_meandrina_HIv1___RNAseq.g17110.t1,three_way,64.472,,,,,,,,,,,,,,,,,
OG_06581,1.2816302084648503,FUN_029538-T1,Peve_00012818,Pocillopora_meandrina_HIv1___RNAseq.g2589.t1,three_way,73.36083333333333,,,,,,,,,,,,,,,,,
OG_06584,1.7749860383444984,FUN_029556-T1,Peve_00023360,Pocillopora_meandrina_HIv1___TS.g3028.t1,three_way,49.354,,,,,,,,,,,,,,,,,
OG_06588,1.5311233666754267,FUN_029570-T1,Peve_00018824,Pocillopora_meandrina_HIv1___RNAseq.g17256.t1,three_way,51.34166666666667,,,,,,,,,,,,,,,,,
OG_06592,1.0587681220571177,FUN_029640-T1,Peve_00037895,Pocillopora_meandrina_HIv1___RNAseq.g17204.t1,three_way,61.37616666666666,FUN_029640-T1,A2ARV4,LRP2_MOUSE,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Mus musculus (Mouse),38.1,428.0,4.3e-50,201.4,sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1,GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0016020; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0034311; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045177; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1904888,aorta development [GO:0035904]; cell population proliferation [GO:0008283]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006629; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; lipid metabolic process; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_06598,1.3968220023241131,FUN_029671-T2,Peve_00038757,Pocillopora_meandrina_HIv1___RNAseq.g17306.t1,three_way,45.8935,FUN_029671-T2,Q8N3J2,METL4_HUMAN,,N(6)-adenine-specific methyltransferase METTL4 (Methyltransferase-like protein 4) (N(6)-adenine-specific DNA methyltransferase METTL4) (EC 2.1.1.72) (snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4) (EC 2.1.1.-),Homo sapiens (Human),28.4,507.0,6.9e-56,219.9,sp|Q8N3J2|METL4_HUMAN N(6)-adenine-specific methyltransferase METTL4 OS=Homo sapiens OX=9606 GN=METTL4 PE=1 SV=3,GO:0003676; GO:0005634; GO:0005759; GO:0005829; GO:0008173; GO:0009007; GO:0032259; GO:0036396; GO:0043484; GO:0045814; GO:0090296; GO:0106347; GO:0120049; GO:1903108; GO:1990204,"methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]",cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity [GO:0106347],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006355; GO:0016073; GO:0016740; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; cytosol; chromatin organization; regulation of DNA-templated transcription; snRNA metabolic process; transferase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_06599,2.5041787918099208,FUN_029673-T1,Peve_00038759,Pocillopora_meandrina_HIv1___RNAseq.g17212.t1,three_way,61.962,FUN_029673-T1,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),38.7,310.0,4.200000000000001e-58,228.0,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_06606,1.222685253719711,FUN_029754-T1,Peve_00019513,Pocillopora_meandrina_HIv1___RNAseq.g17315.t1,three_way,73.25083333333333,FUN_029754-T1,D3ZYR1,FCHO2_RAT,,F-BAR domain only protein 2,Rattus norvegicus (Rat),35.2,1026.0,1.2e-117,426.0,sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1,GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793,clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]",GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0065003; GO:0072659,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; protein-containing complex assembly; protein localization to plasma membrane
OG_06610,1.3511169379098107,FUN_029760-T1,Peve_00019501,Pocillopora_meandrina_HIv1___RNAseq.g17234.t1,three_way,80.53166666666667,FUN_029760-T1,Q8NBS3,,,,,44.5,815.0,1.7000000000000001e-178,627.9,sp|Q8NBS3|S4A11_HUMAN Solute carrier family 4 member 11 OS=Homo sapiens OX=9606 GN=SLC4A11 PE=1 SV=3,,,,,,
OG_06612,1.4973933542495652,FUN_029763-T1,Peve_00019504,Pocillopora_meandrina_HIv1___RNAseq.g17323.t1,three_way,61.1925,FUN_029763-T1,Q6PCS4,,,,,36.2,716.0,2.9e-92,342.0,sp|Q6PCS4|RHG29_DANRE Rho GTPase-activating protein 29 OS=Danio rerio OX=7955 GN=arhgap29 PE=2 SV=1,,,,,,
OG_06613,1.4453307768732049,FUN_029767-T1,Peve_00019505,Pocillopora_meandrina_HIv1___RNAseq.g17324.t1,three_way,60.8995,,,,,,,,,,,,,,,,,
OG_06616,1.544371432508985,FUN_029772-T1,Peve_00013611,Pocillopora_meandrina_HIv1___RNAseq.g17328.t1a,three_way,49.64566666666666,FUN_029772-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),21.8,458.0,5e-18,94.7,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06621,1.070290391569378,FUN_029882-T1,Peve_00024289,Pocillopora_meandrina_HIv1___RNAseq.g17341.t1,three_way,72.087,FUN_029882-T1,Q9BT73,,,,,34.5,119.0,2.2e-13,76.6,sp|Q9BT73|PSMG3_HUMAN Proteasome assembly chaperone 3 OS=Homo sapiens OX=9606 GN=PSMG3 PE=1 SV=1,,,,,,
OG_06635,1.03286044140204,FUN_030183-T1,Peve_00004642,Pocillopora_meandrina_HIv1___RNAseq.g17361.t1,three_way,86.83633333333333,FUN_030183-T1,Q4ZIN3,MBRL_HUMAN,,Membralin (Transmembrane protein 259),Homo sapiens (Human),57.5,454.0,1.4999999999999998e-127,458.0,sp|Q4ZIN3|MBRL_HUMAN Membralin OS=Homo sapiens OX=9606 GN=TMEM259 PE=1 SV=1,GO:0005783; GO:0005789; GO:0034976; GO:1904294,positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0005783; GO:0043226,endoplasmic reticulum; organelle
OG_06639,1.165203327510416,FUN_030196-T1,Peve_00004645,Pocillopora_meandrina_HIv1___RNAseq.g17363.t1,three_way,66.36449999999999,FUN_030196-T1,Q8BH88,,,,,31.6,554.0,1.5e-64,248.8,sp|Q8BH88|DEP1B_MOUSE DEP domain-containing protein 1B OS=Mus musculus OX=10090 GN=Depdc1b PE=2 SV=1,,,,,,
OG_06641,1.2404120405370307,FUN_030202-T1,Peve_00017913,Pocillopora_meandrina_HIv1___RNAseq.g17365.t1,three_way,75.41716666666666,FUN_030202-T1,Q96SU4,OSBL9_HUMAN,,Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9),Homo sapiens (Human),43.4,491.0,4.6e-91,336.7,sp|Q96SU4|OSBL9_HUMAN Oxysterol-binding protein-related protein 9 OS=Homo sapiens OX=9606 GN=OSBPL9 PE=1 SV=2,GO:0005794; GO:0005829; GO:0006699; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0120015,bile acid biosynthetic process [GO:0006699],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020],sterol binding [GO:0032934]; sterol transfer activity [GO:0120015],GO:0005215; GO:0005794; GO:0005829; GO:0006629; GO:0008289; GO:0043226,transporter activity; Golgi apparatus; cytosol; lipid metabolic process; lipid binding; organelle
OG_06643,1.2767938989770868,FUN_030655-T1,Peve_00043685,Pocillopora_meandrina_HIv1___RNAseq.g30310.t1,three_way,62.553666666666665,FUN_030655-T1,Q80T85,DCAF5_MOUSE,,DDB1- and CUL4-associated factor 5 (WD repeat-containing protein 22),Mus musculus (Mouse),49.2,445.0,8.699999999999999e-107,389.4,sp|Q80T85|DCAF5_MOUSE DDB1- and CUL4-associated factor 5 OS=Mus musculus OX=10090 GN=Dcaf5 PE=1 SV=2,GO:0005739; GO:0016567; GO:0080008,protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; mitochondrion [GO:0005739],,GO:0005739; GO:0043226,mitochondrion; organelle
OG_06654,1.316123246476852,FUN_030679-T1,Peve_00028159,Pocillopora_meandrina_HIv1___RNAseq.g30326.t1,three_way,92.19966666666669,FUN_030679-T1,Q7TN83,SYT16_MOUSE,,Synaptotagmin-16 (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein),Mus musculus (Mouse),44.2,303.0,5.6e-64,246.5,sp|Q7TN83|SYT16_MOUSE Synaptotagmin-16 OS=Mus musculus OX=10090 GN=Syt16 PE=1 SV=1,GO:0005543; GO:0016020; GO:0042802,,membrane [GO:0016020],identical protein binding [GO:0042802]; phospholipid binding [GO:0005543],GO:0008289,lipid binding
OG_06658,1.0032434974638107,FUN_030874-T1,Peve_00043625,Pocillopora_meandrina_HIv1___RNAseq.g30289.t1,three_way,83.54933333333334,FUN_030874-T1,Q9P2D3,HTR5B_HUMAN,,HEAT repeat-containing protein 5B,Homo sapiens (Human),50.9,2060.0,0.0,1933.7,sp|Q9P2D3|HTR5B_HUMAN HEAT repeat-containing protein 5B OS=Homo sapiens OX=9606 GN=HEATR5B PE=1 SV=2,GO:0005654; GO:0005794; GO:0005829; GO:0006897; GO:0008104; GO:0015031; GO:0016020; GO:0030136; GO:0030139; GO:0042147; GO:0043231; GO:0048471,"endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],,GO:0005654; GO:0005794; GO:0005829; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; Golgi apparatus; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06660,1.2409912837083663,FUN_030876-T1,Peve_00043621,Pocillopora_meandrina_HIv1___RNAseq.g30292.t1,three_way,68.59583333333333,FUN_030876-T1,Q96F63,,,,,38.8,289.0,4.3e-33,143.3,sp|Q96F63|CCD97_HUMAN Coiled-coil domain-containing protein 97 OS=Homo sapiens OX=9606 GN=CCDC97 PE=1 SV=1,,,,,,
OG_06663,1.1007813051964774,FUN_031054-T1,Peve_00028185,Pocillopora_meandrina_HIv1___RNAseq.g30322.t1,three_way,84.973,FUN_031054-T1,Q8CIB5,FERM2_MOUSE,,Fermitin family homolog 2 (Kindlin-2) (Pleckstrin homology domain-containing family C member 1),Mus musculus (Mouse),47.4,694.0,4.1000000000000004e-170,599.7,sp|Q8CIB5|FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus OX=10090 GN=Fermt2 PE=1 SV=1,GO:0001725; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0005938; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009898; GO:0009986; GO:0010718; GO:0016055; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035025; GO:0043116; GO:0043539; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0070374; GO:0072657; GO:0120283; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691,"adherens junction maintenance [GO:0034334]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]",adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725],"actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]",GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0007155; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,circulatory system process; nucleus; nucleoplasm; cytosol; cell adhesion; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_06669,2.180232500920846,FUN_031068-T1,Peve_00028133,Pocillopora_meandrina_HIv1___RNAseq.g30321.t1,three_way,84.0175,FUN_031068-T1,P05094,,,,,65.8,876.0,0.0,1176.4,sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3,,,,,,
OG_06670,1.8079604319095035,FUN_031070-T1,Peve_00025081,Pocillopora_meandrina_HIv1___RNAseq.g6195.t1,three_way,68.65666666666667,FUN_031070-T1,Q93VC9,,,,,40.9,320.0,1.6e-60,234.6,sp|Q93VC9|CATB2_ARATH Cathepsin B-like protease 2 OS=Arabidopsis thaliana OX=3702 GN=CATHB2 PE=2 SV=1,,,,,,
OG_06676,2.151496070800317,FUN_031079-T1,Peve_00028146,Pocillopora_meandrina_HIv1___RNAseq.27627_t,three_way,61.867666666666665,,,,,,,,,,,,,,,,,
OG_06679,1.8023779495169616,FUN_031085-T1,Peve_00025083,Pocillopora_meandrina_HIv1___RNAseq.g5957.t1,three_way,74.02966666666667,FUN_031085-T1,Q6PB93,GALT2_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],Mus musculus (Mouse),51.6,580.0,2.8e-175,616.7,sp|Q6PB93|GALT2_MOUSE Polypeptide N-acetylgalactosaminyltransferase 2 OS=Mus musculus OX=10090 GN=Galnt2 PE=1 SV=1,GO:0002639; GO:0004653; GO:0005576; GO:0005796; GO:0006493; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0051604,O-glycan processing [GO:0016266]; positive regulation of immunoglobulin production [GO:0002639]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005576; GO:0009101; GO:0016740; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; extracellular region; glycoprotein biosynthetic process; transferase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06680,2.467231710891012,FUN_031176-T1,Peve_00016087,Pocillopora_meandrina_HIv1___TS.g23938.t1b,three_way,56.30883333333333,,,,,,,,,,,,,,,,,
OG_06681,1.354774966254258,FUN_031184-T1,Peve_00016090,Pocillopora_meandrina_HIv1___RNAseq.g5221.t1,three_way,48.904,,,,,,,,,,,,,,,,,
OG_06683,1.113367654036476,FUN_031186-T1,Peve_00041875,Pocillopora_meandrina_HIv1___RNAseq.g5214.t1,three_way,69.12466666666667,FUN_031186-T1,P25500,,,,,64.8,491.0,5.8e-181,636.0,sp|P25500|PAPOA_BOVIN Poly(A) polymerase alpha OS=Bos taurus OX=9913 GN=PAPOLA PE=1 SV=3,,,,,,
OG_06685,2.13203718640796,FUN_031206-T1,Peve_00041864,Pocillopora_meandrina_HIv1___RNAseq.g5212.t1,three_way,67.21766666666666,,,,,,,,,,,,,,,,,
OG_06688,1.3994940538662295,FUN_031220-T1,Peve_00032142,Pocillopora_meandrina_HIv1___RNAseq.g5199.t1,three_way,54.43183333333333,,,,,,,,,,,,,,,,,
OG_06690,1.9781095598399547,FUN_031234-T1,Peve_00040979,Pocillopora_meandrina_HIv1___RNAseq.g22662.t1,three_way,68.60033333333334,FUN_031234-T1,Q9ULQ1,,,,,45.7,750.0,3.3e-152,540.4,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_06692,2.391190792311519,FUN_031240-T1,Peve_00043069,Pocillopora_meandrina_HIv1___RNAseq.g5193.t1,three_way,67.849,FUN_031240-T1,P42335,,,,,50.9,399.0,9.1e-107,389.0,sp|P42335|IP3KB_RAT Inositol-trisphosphate 3-kinase B OS=Rattus norvegicus OX=10116 GN=Itpkb PE=1 SV=3,,,,,,
OG_06698,1.3100498094478774,FUN_031263-T1,Peve_00001470,Pocillopora_meandrina_HIv1___RNAseq.g5187.t1,three_way,67.0335,,,,,,,,,,,,,,,,,
OG_06702,2.459072565741922,FUN_031269-T1,Peve_00036737,Pocillopora_meandrina_HIv1___TS.g23896.t1,three_way,69.62383333333334,FUN_031269-T1,Q3T906,GNPTA_HUMAN,,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta],Homo sapiens (Human),39.7,1334.0,1e-257,891.7,sp|Q3T906|GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens OX=9606 GN=GNPTAB PE=1 SV=1,GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835,carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976],GO:0003824; GO:0005794; GO:0005975; GO:0007040; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; carbohydrate metabolic process; lysosome organization; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_06705,2.086014176908978,FUN_031276-T1,Peve_00036741,Pocillopora_meandrina_HIv1___RNAseq.g5175.t1,three_way,49.56583333333333,FUN_031276-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),47.1,70.0,5.9e-10,67.8,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_06706,1.0524754726115828,FUN_031286-T1,Peve_00036747,Pocillopora_meandrina_HIv1___RNAseq.g5173.t1,three_way,73.2735,FUN_031286-T1,Q8CHB8,TTLL5_MOUSE,,Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 5),Mus musculus (Mouse),44.1,870.0,1.4999999999999998e-189,665.2,sp|Q8CHB8|TTLL5_MOUSE Tubulin polyglutamylase TTLL5 OS=Mus musculus OX=10090 GN=Ttll5 PE=1 SV=3,GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0030317; GO:0036064; GO:0036211; GO:0046872; GO:0060041; GO:0070740; GO:0097731; GO:0106437; GO:0106438,fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283],9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005634; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; ligase activity; reproductive process; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_06707,1.0060283294664227,FUN_031287-T1,Peve_00036748,Pocillopora_meandrina_HIv1___RNAseq.g5172.t1,three_way,87.3345,FUN_031287-T1,Q8BFX3,,,,,64.2,653.0,1.1999999999999999e-235,817.4,sp|Q8BFX3|KCTD3_MOUSE BTB/POZ domain-containing protein KCTD3 OS=Mus musculus OX=10090 GN=Kctd3 PE=1 SV=1,,,,,,
OG_06712,1.923071019116516,FUN_031304-T1,Peve_00026516,Pocillopora_meandrina_HIv1___TS.g23876.t1,three_way,80.76050000000001,FUN_031304-T1,Q2XVR6,SC4AB_TAKRU,,Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b),Takifugu rubripes (Japanese pufferfish) (Fugu rubripes),36.0,1773.0,3.2e-262,907.1,sp|Q2XVR6|SC4AB_TAKRU Sodium channel protein type 4 subunit alpha B OS=Takifugu rubripes OX=31033 GN=scn4ab PE=3 SV=1,GO:0001518; GO:0005248; GO:0019228; GO:0086010,membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228],voltage-gated sodium channel complex [GO:0001518],voltage-gated sodium channel activity [GO:0005248],GO:0005215,transporter activity
OG_06717,2.3516877104961247,FUN_031467-T1,Peve_00026558,Pocillopora_meandrina_HIv1___RNAseq.g5084.t2,three_way,78.09566666666667,FUN_031467-T1,Q5RDQ2,PALS1_PONAB,,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),46.4,576.0,2.3e-140,501.5,sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1,GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204,central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204],ATP binding [GO:0005524],GO:0005794; GO:0043226; GO:0048856,Golgi apparatus; organelle; anatomical structure development
OG_06719,1.2884409893226252,FUN_031470-T1,Peve_00026552,Pocillopora_meandrina_HIv1___RNAseq.g5082.t1,three_way,68.5885,FUN_031470-T1,Q9JLC8,,,,,30.2,4722.0,0.0,1872.1,sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2,,,,,,
OG_06720,1.0942263005176167,FUN_031471-T1,Peve_00026551,Pocillopora_meandrina_HIv1___RNAseq.g5081.t1,three_way,81.32666666666667,FUN_031471-T1,P97376,,,,,43.9,214.0,1.7e-44,181.0,sp|P97376|FRG1_MOUSE Protein FRG1 OS=Mus musculus OX=10090 GN=Frg1 PE=1 SV=2,,,,,,
OG_06723,1.2408753296495192,FUN_031489-T1,Peve_00026539,Pocillopora_meandrina_HIv1___RNAseq.g5078.t1,three_way,87.43599999999999,FUN_031489-T1,O82018,,,,,70.5,146.0,1.3e-29,131.0,sp|O82018|CALM_MOUSC Calmodulin OS=Mougeotia scalaris OX=13158 PE=2 SV=3,,,,,,
OG_06725,1.2756287261480963,FUN_031497-T1,Peve_00044299,Pocillopora_meandrina_HIv1___RNAseq.g5099.t1,three_way,61.17183333333333,FUN_031497-T1,Q5T197,DCST1_HUMAN,,E3 ubiquitin-protein ligase DCST1 (EC 2.3.2.27) (DC-STAMP domain-containing protein 1) (RING-type E3 ubiquitin transferase),Homo sapiens (Human),26.0,338.0,8.3e-13,77.8,sp|Q5T197|DCST1_HUMAN E3 ubiquitin-protein ligase DCST1 OS=Homo sapiens OX=9606 GN=DCST1 PE=1 SV=1,GO:0002080; GO:0005886; GO:0006511; GO:0007342; GO:0008270; GO:0016567; GO:0035036; GO:0045087; GO:0060339; GO:0061630,fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein ubiquitination [GO:0016567]; sperm-egg recognition [GO:0035036]; ubiquitin-dependent protein catabolic process [GO:0006511],acrosomal membrane [GO:0002080]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005886; GO:0016740; GO:0022414; GO:0061024; GO:0098542; GO:0140096,"immune system process; catalytic activity; plasma membrane; transferase activity; reproductive process; membrane organization; defense response to other organism; catalytic activity, acting on a protein"
OG_06728,1.211423696005242,FUN_031501-T1,Peve_00044288,Pocillopora_meandrina_HIv1___RNAseq.g5104.t1,three_way,66.48166666666667,FUN_031501-T1,O58320,,,,,47.3,292.0,1.0000000000000001e-60,235.3,sp|O58320|GYAR_PYRHO Glyoxylate reductase OS=Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) OX=70601 GN=gyaR PE=1 SV=2,,,,,,
OG_06730,1.256258719965237,FUN_031507-T1,Peve_00004813,Pocillopora_meandrina_HIv1___RNAseq.g5114.t1,three_way,62.814,FUN_031507-T1,H3ZPL1,,,,,29.4,394.0,3.1e-48,194.1,sp|H3ZPL1|ARAT1_THELN Aromatic-amino-acid aminotransferase 1 OS=Thermococcus litoralis (strain ATCC 51850 / DSM 5473 / JCM 8560 / NS-C) OX=523849 GN=OCC_04335 PE=1 SV=1,,,,,,
OG_06734,1.3551163893998552,FUN_031518-T1,Peve_00045248,Pocillopora_meandrina_HIv1___RNAseq.g5120.t1,three_way,47.7075,FUN_031518-T1,D0PRN3,,,,,27.2,463.0,3.3000000000000003e-34,148.3,sp|D0PRN3|NRX3A_CHICK Neurexin-3 OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06735,1.5779910314036574,FUN_031519-T1,Peve_00045247,Pocillopora_meandrina_HIv1___RNAseq.g5126.t1,three_way,70.90833333333333,,,,,,,,,,,,,,,,,
OG_06738,1.6048851236606858,FUN_031525-T1,Peve_00022761,Pocillopora_meandrina_HIv1___TS.g23851.t1,three_way,69.21566666666666,FUN_031525-T1,O75445,USH2A_HUMAN,,Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein),Homo sapiens (Human),31.2,5403.0,0.0,2352.8,sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3,GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696,establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696],collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022],GO:0005576; GO:0005815; GO:0008092; GO:0030154; GO:0030312; GO:0031012; GO:0050877,extracellular region; microtubule organizing center; cytoskeletal protein binding; cell differentiation; external encapsulating structure; extracellular matrix; nervous system process
OG_06742,1.4670715570654336,FUN_031548-T1,Peve_00022768,Pocillopora_meandrina_HIv1___RNAseq.g5141.t1,three_way,49.17633333333333,FUN_031548-T1,A3KMW7,,,,,26.0,519.0,1.2e-11,73.6,sp|A3KMW7|MAP10_BOVIN Microtubule-associated protein 10 OS=Bos taurus OX=9913 GN=MAP10 PE=2 SV=1,,,,,,
OG_06747,1.0125802159231962,FUN_031556-T1,Peve_00022778,Pocillopora_meandrina_HIv1___RNAseq.g5088.t1,three_way,56.9495,FUN_031556-T1,Q6DD45,ZCHC8_XENLA,,Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8),Xenopus laevis (African clawed frog),35.5,389.0,7.999999999999999e-53,209.9,sp|Q6DD45|ZCHC8_XENLA Zinc finger CCHC domain-containing protein 8 OS=Xenopus laevis OX=8355 GN=zcchc8 PE=2 SV=1,GO:0003723; GO:0005654; GO:0006396; GO:0008270; GO:0031124; GO:0071013,mRNA 3'-end processing [GO:0031124]; RNA processing [GO:0006396],catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0016071,RNA binding; nucleoplasm; mRNA metabolic process
OG_06751,1.5666919278742162,FUN_031560-T1,Peve_00032864,Pocillopora_meandrina_HIv1___TS.g23795.t1,three_way,47.11333333333334,FUN_031560-T1,B1H349,,,,,42.6,68.0,1.3e-06,57.4,sp|B1H349|SOX6_XENTR Transcription factor Sox-6 OS=Xenopus tropicalis OX=8364 GN=sox6 PE=2 SV=1,,,,,,
OG_06754,3.250447132964484,FUN_031565-T1,Peve_00021513,Pocillopora_meandrina_HIv1___RNAseq.g5072.t1,three_way,87.24600000000001,FUN_031565-T1,Q01728,,,,,54.5,932.0,1.8e-266,920.2,sp|Q01728|NAC1_RAT Sodium/calcium exchanger 1 OS=Rattus norvegicus OX=10116 GN=Slc8a1 PE=1 SV=3,,,,,,
OG_06757,1.5554376558780425,FUN_031570-T1,Peve_00021507,Pocillopora_meandrina_HIv1___RNAseq.g5065.t1,three_way,57.521,FUN_031570-T1,D4A218,,,,,32.0,303.0,1.1e-26,122.5,sp|D4A218|DMRT3_RAT Doublesex and mab-3 related transcription factor 3 OS=Rattus norvegicus OX=10116 GN=Dmrt3 PE=3 SV=1,,,,,,
OG_06758,1.451626914601535,FUN_031589-T1,Peve_00021514,Pocillopora_meandrina_HIv1___RNAseq.g5069.t1,three_way,86.82000000000001,FUN_031589-T1,Q561L1,,,,,61.0,438.0,3.8e-161,569.3,sp|Q561L1|PUA1A_XENLA Adenylosuccinate synthetase isozyme 1 A OS=Xenopus laevis OX=8355 GN=adss1-a PE=2 SV=1,,,,,,
OG_06759,2.4313798411430274,FUN_031590-T1,Peve_00012525,Pocillopora_meandrina_HIv1___RNAseq.g5062.t1,three_way,79.86133333333333,FUN_031590-T1,Q86VP3,PACS2_HUMAN,,Phosphofurin acidic cluster sorting protein 2 (PACS-2) (PACS1-like protein),Homo sapiens (Human),37.8,886.0,1.1e-132,475.7,sp|Q86VP3|PACS2_HUMAN Phosphofurin acidic cluster sorting protein 2 OS=Homo sapiens OX=9606 GN=PACS2 PE=1 SV=3,GO:0000045; GO:0005739; GO:0005783; GO:0006915; GO:0032469; GO:0034497; GO:0044325; GO:0072659; GO:1990456,apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],transmembrane transporter binding [GO:0044325],GO:0005739; GO:0005783; GO:0012501; GO:0043226; GO:0072659,mitochondrion; endoplasmic reticulum; programmed cell death; organelle; protein localization to plasma membrane
OG_06761,1.6065365126701567,FUN_031592-T1,Peve_00012523,Pocillopora_meandrina_HIv1___RNAseq.g5060.t1,three_way,68.10383333333334,FUN_031592-T1,P41823,,,,,25.5,165.0,2.3e-09,64.3,sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2,,,,,,
OG_06766,1.18946109278538,FUN_031605-T1,Peve_00012514,Pocillopora_meandrina_HIv1___RNAseq.g5989.t1,three_way,84.85766666666667,FUN_031605-T1,Q6PB93,GALT2_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],Mus musculus (Mouse),62.1,493.0,2.2999999999999998e-192,673.3,sp|Q6PB93|GALT2_MOUSE Polypeptide N-acetylgalactosaminyltransferase 2 OS=Mus musculus OX=10090 GN=Galnt2 PE=1 SV=1,GO:0002639; GO:0004653; GO:0005576; GO:0005796; GO:0006493; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0051604,O-glycan processing [GO:0016266]; positive regulation of immunoglobulin production [GO:0002639]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005576; GO:0009101; GO:0016740; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; extracellular region; glycoprotein biosynthetic process; transferase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06767,1.7081680413235167,FUN_031606-T1,Peve_00012513,Pocillopora_meandrina_HIv1___RNAseq.g5968.t1,three_way,73.351,FUN_031606-T1,Q9HBF4,ZFYV1_HUMAN,,Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1),Homo sapiens (Human),53.5,708.0,2.7999999999999996e-217,756.5,sp|Q9HBF4|ZFYV1_HUMAN Zinc finger FYVE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZFYVE1 PE=1 SV=1,GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0044829; GO:0048471; GO:0097629; GO:0140042; GO:1990462,cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; positive regulation by host of viral genome replication [GO:0044829],autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407],"1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]",GO:0005739; GO:0005773; GO:0005783; GO:0005794; GO:0005811; GO:0006914; GO:0008289; GO:0043226,mitochondrion; vacuole; endoplasmic reticulum; Golgi apparatus; lipid droplet; autophagy; lipid binding; organelle
OG_06769,1.5577579321885402,FUN_031627-T1,Peve_00019757,Pocillopora_meandrina_HIv1___RNAseq.g5964.t1,three_way,88.16233333333334,,,,,,,,,,,,,,,,,
OG_06771,1.8051551369249152,FUN_031635-T1,Peve_00032682,Pocillopora_meandrina_HIv1___RNAseq.g5688.t1,three_way,60.882666666666665,FUN_031635-T1,Q9DBY8,NVL_MOUSE,,Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein),Mus musculus (Mouse),44.8,562.0,1.9e-102,374.8,sp|Q9DBY8|NVL_MOUSE Nuclear valosin-containing protein-like OS=Mus musculus OX=10090 GN=Nvl PE=1 SV=1,GO:0000176; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0032206; GO:0042254; GO:0042273; GO:1904749; GO:1905323; GO:1990275,positive regulation of protein binding [GO:0032092]; positive regulation of telomere maintenance [GO:0032206]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; telomerase holoenzyme complex assembly [GO:1905323],nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0042254; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; ribosome biogenesis; organelle; protein-containing complex assembly
OG_06772,1.5641184450649042,FUN_031637-T1,Peve_00032681,Pocillopora_meandrina_HIv1___RNAseq.g5689.t1,three_way,76.88733333333333,FUN_031637-T1,Q5HZE0,S2529_RAT,,Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29),Rattus norvegicus (Rat),52.4,288.0,1.7e-80,300.8,sp|Q5HZE0|S2529_RAT Mitochondrial basic amino acids transporter OS=Rattus norvegicus OX=10116 GN=Slc25a29 PE=2 SV=1,GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0015174; GO:0015227; GO:0015822; GO:0089709; GO:1903401; GO:1903826; GO:1990575,L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity L-arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_06773,1.452114025756303,FUN_031638-T1,Peve_00032680,Pocillopora_meandrina_HIv1___TS.g24410.t3a,three_way,91.53766666666668,FUN_031638-T1,P25490,TYY1_HUMAN,,Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1),Homo sapiens (Human),88.5,113.0,4.1e-58,226.5,sp|P25490|TYY1_HUMAN Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2,GO:0000122; GO:0000400; GO:0000723; GO:0000724; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005677; GO:0006275; GO:0006282; GO:0006338; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010628; GO:0010629; GO:0016363; GO:0030183; GO:0031011; GO:0031519; GO:0032688; GO:0033044; GO:0034644; GO:0034696; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0046332; GO:0048593; GO:0051726; GO:0060382; GO:0061052; GO:0071347; GO:0071707; GO:0140297; GO:1902894; GO:1904507; GO:1990837,anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723],chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0140110,immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; telomere organization; organelle; transcription regulator activity
OG_06775,1.0876852315680274,FUN_031641-T1,Peve_00032677,Pocillopora_meandrina_HIv1___TS.g24411.t1,three_way,53.80883333333333,FUN_031641-T1,P18168,SERR_DROME,,Protein serrate (Protein beaded),Drosophila melanogaster (Fruit fly),31.2,337.0,1e-34,149.8,sp|P18168|SERR_DROME Protein serrate OS=Drosophila melanogaster OX=7227 GN=Ser PE=1 SV=3,GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0007423; GO:0007435; GO:0007436; GO:0007476; GO:0007480; GO:0008587; GO:0009986; GO:0014009; GO:0016324; GO:0016330; GO:0030673; GO:0030718; GO:0035017; GO:0035167; GO:0035204; GO:0035214; GO:0036011; GO:0042688; GO:0043208; GO:0045179; GO:0046331; GO:0048018; GO:0048100; GO:0048749,compound eye development [GO:0048749]; crystal cell differentiation [GO:0042688]; cuticle pattern formation [GO:0035017]; eye-antennal disc development [GO:0035214]; germ-line stem cell population maintenance [GO:0030718]; glial cell proliferation [GO:0014009]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; larval lymph gland hemopoiesis [GO:0035167]; larval salivary gland morphogenesis [GO:0007436]; lateral inhibition [GO:0046331]; negative regulation of lamellocyte differentiation [GO:0035204]; Notch signaling pathway [GO:0007219]; salivary gland morphogenesis [GO:0007435]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; wing disc anterior/posterior pattern formation [GO:0048100],apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; cell surface [GO:0009986]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; glycosphingolipid binding [GO:0043208]; Notch binding [GO:0005112]; receptor ligand activity [GO:0048018],GO:0000278; GO:0002376; GO:0005886; GO:0008289; GO:0023052; GO:0030154; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; immune system process; plasma membrane; lipid binding; signaling; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06777,1.307925481320989,FUN_031643-T1,Peve_00043580,Pocillopora_meandrina_HIv1___RNAseq.g5686.t1,three_way,83.8815,FUN_031643-T1,Q14738,2A5D_HUMAN,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),Homo sapiens (Human),65.9,548.0,3.3e-205,716.1,sp|Q14738|2A5D_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform OS=Homo sapiens OX=9606 GN=PPP2R5D PE=1 SV=1,GO:0000159; GO:0005634; GO:0005654; GO:0005829; GO:0007165; GO:0007399; GO:0019888; GO:0051177; GO:0072542,meiotic sister chromatid cohesion [GO:0051177]; nervous system development [GO:0007399]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159],protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005654; GO:0005829; GO:0043226; GO:0048856; GO:0098772,nucleus; nucleoplasm; cytosol; organelle; anatomical structure development; molecular function regulator activity
OG_06778,2.354880677095141,FUN_031644-T1,Peve_00043582,Pocillopora_meandrina_HIv1___RNAseq.g5685.t1,three_way,76.86,FUN_031644-T1,Q3EBF7,SLD2_ARATH,,Delta(8)-fatty-acid desaturase 2 (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase 2) (Sphingoid long-chain base desaturase 2) (Sphingoid LCB desaturase 2) (Sphingolipid 8-(E/Z)-desaturase 2),Arabidopsis thaliana (Mouse-ear cress),41.9,451.0,8.5e-100,365.5,sp|Q3EBF7|SLD2_ARATH Delta(8)-fatty-acid desaturase 2 OS=Arabidopsis thaliana OX=3702 GN=SLD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0030148; GO:0046872; GO:0052631; GO:0070417,cellular response to cold [GO:0070417]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; sphingolipid 8-(E/Z)-desaturase activity [GO:0052631],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_06779,1.4866962688252423,FUN_031646-T1,Peve_00043571,Pocillopora_meandrina_HIv1___RNAseq.g5683.t1,three_way,65.723,FUN_031646-T1,A6H7B1,,,,,54.9,144.0,2.7e-34,146.4,sp|A6H7B1|TOM20_BOVIN Mitochondrial import receptor subunit TOM20 homolog OS=Bos taurus OX=9913 GN=TOMM20 PE=2 SV=1,,,,,,
OG_06782,1.3876284809016874,FUN_031649-T1,Peve_00043575,Pocillopora_meandrina_HIv1___TS.g24400.t2a,three_way,66.82783333333333,FUN_031649-T1,Q96PN7,TREF1_HUMAN,,Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132),Homo sapiens (Human),29.4,486.0,4e-39,165.6,sp|Q96PN7|TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens OX=9606 GN=TRERF1 PE=1 SV=1,GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0008270; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0050847; GO:0071393,cellular response to progesterone stimulus [GO:0071393]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; nuclear progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_06784,1.6401909986351062,FUN_031651-T1,Peve_00017754,Pocillopora_meandrina_HIv1___RNAseq.g5677.t1,three_way,75.48266666666667,FUN_031651-T1,Q9NQX3,GEPH_HUMAN,,Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)],Homo sapiens (Human),46.9,721.0,2.5e-174,614.4,sp|Q9NQX3|GEPH_HUMAN Gephyrin OS=Homo sapiens OX=9606 GN=GPHN PE=1 SV=1,GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006777; GO:0007416; GO:0007529; GO:0008940; GO:0009898; GO:0010038; GO:0014069; GO:0030425; GO:0030674; GO:0032324; GO:0042802; GO:0043197; GO:0043546; GO:0045184; GO:0045211; GO:0046872; GO:0060077; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098982; GO:0099091; GO:0099572; GO:0099645,establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to metal ion [GO:0010038]; synapse assembly [GO:0007416],"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization, intracellular component [GO:0099091]; synaptic membrane [GO:0097060]",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005856; GO:0005886; GO:0016491; GO:0016740; GO:0034330; GO:0043226; GO:0060090,catalytic activity; cytosol; cytoskeleton; plasma membrane; oxidoreductase activity; transferase activity; cell junction organization; organelle; molecular adaptor activity
OG_06792,1.8793565947470563,FUN_031678-T1,Peve_00012833,Pocillopora_meandrina_HIv1___RNAseq.g5745.t1,three_way,69.84783333333333,FUN_031678-T1,Q5R4I2,RNF8_PONAB,,E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),29.4,446.0,2.1e-21,105.5,sp|Q5R4I2|RNF8_PONAB E3 ubiquitin-protein ligase RNF8 OS=Pongo abelii OX=9601 GN=RNF8 PE=2 SV=1,GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168,cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_06794,1.3777586839158769,FUN_031681-T1,Peve_00012830,Pocillopora_meandrina_HIv1___RNAseq.g5749.t1,three_way,56.66333333333333,,,,,,,,,,,,,,,,,
OG_06796,1.0968667360915405,FUN_031684-T1,Peve_00013836,Pocillopora_meandrina_HIv1___RNAseq.g5778.t1,three_way,57.97633333333333,,,,,,,,,,,,,,,,,
OG_06805,1.8662769578306544,FUN_031703-T1,Peve_00018219,Pocillopora_meandrina_HIv1___RNAseq.g5760.t1,three_way,62.979,FUN_031703-T1,Q9H1A4,APC1_HUMAN,,Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein),Homo sapiens (Human),31.9,1180.0,1.5000000000000001e-145,518.8,sp|Q9H1A4|APC1_HUMAN Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1,GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070936; GO:0070979; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],molecular adaptor activity [GO:0060090],GO:0005654; GO:0005829; GO:0030163; GO:0060090,nucleoplasm; cytosol; protein catabolic process; molecular adaptor activity
OG_06807,1.07169390577498,FUN_031706-T1,Peve_00022014,Pocillopora_meandrina_HIv1___TS.g24476.t1b,three_way,67.46533333333333,,,,,,,,,,,,,,,,,
OG_06812,1.812816116276851,FUN_031712-T1,Peve_00002661,Pocillopora_meandrina_HIv1___RNAseq.g5450.t1,three_way,83.29866666666666,FUN_031712-T1,M9PH32,,,,,46.4,69.0,3.2e-08,62.0,sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1,,,,,,
OG_06813,1.463501565405133,FUN_031713-T1,Peve_00002672,Pocillopora_meandrina_HIv1___RNAseq.g5451.t1,three_way,71.65333333333334,,,,,,,,,,,,,,,,,
OG_06814,1.1876181218309283,FUN_031714-T1,Peve_00025698,Pocillopora_meandrina_HIv1___RNAseq.g5452.t1,three_way,40.220666666666666,FUN_031714-T1,P16581,LYAM2_HUMAN,,E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E),Homo sapiens (Human),25.8,260.0,2.1e-11,72.4,sp|P16581|LYAM2_HUMAN E-selectin OS=Homo sapiens OX=9606 GN=SELE PE=1 SV=1,GO:0002092; GO:0002523; GO:0002687; GO:0004888; GO:0005615; GO:0005886; GO:0005901; GO:0005905; GO:0006954; GO:0007157; GO:0007159; GO:0007200; GO:0009897; GO:0019722; GO:0030029; GO:0030863; GO:0032496; GO:0033691; GO:0034097; GO:0034612; GO:0043274; GO:0045121; GO:0046872; GO:0048471; GO:0050727; GO:0050901; GO:0070492; GO:0070555; GO:1903238,actin filament-based process [GO:0030029]; calcium-mediated signaling [GO:0019722]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration involved in inflammatory response [GO:0002523]; leukocyte tethering or rolling [GO:0050901]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of receptor internalization [GO:0002092]; regulation of inflammatory response [GO:0050727]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612],caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492]; phospholipase binding [GO:0043274]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888],GO:0002376; GO:0005615; GO:0005856; GO:0005886; GO:0006954; GO:0007155; GO:0043226; GO:0048870; GO:0060089,immune system process; extracellular space; cytoskeleton; plasma membrane; inflammatory response; cell adhesion; organelle; cell motility; molecular transducer activity
OG_06817,1.228474030772849,FUN_031723-T1,Peve_00040627,Pocillopora_meandrina_HIv1___RNAseq.g5482.t1,three_way,60.10466666666667,FUN_031723-T1,Q8BH86,,,,,37.3,510.0,3.3e-76,287.3,"sp|Q8BH86|GLUCM_MOUSE D-glutamate cyclase, mitochondrial OS=Mus musculus OX=10090 GN=Dglucy PE=1 SV=1",,,,,,
OG_06819,1.38983944812239,FUN_031725-T1,Peve_00040632,Pocillopora_meandrina_HIv1___RNAseq.g5493.t1,three_way,86.41283333333334,FUN_031725-T1,Q6P2K6,P4R3A_MOUSE,,Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1),Mus musculus (Mouse),62.4,675.0,1.2e-239,830.9,sp|Q6P2K6|P4R3A_MOUSE Serine/threonine-protein phosphatase 4 regulatory subunit 3A OS=Mus musculus OX=10090 GN=Ppp4r3a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006094; GO:0016607; GO:0019888; GO:0030289; GO:0045722,gluconeogenesis [GO:0006094]; positive regulation of gluconeogenesis [GO:0045722],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289],protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005815; GO:0005829; GO:0005975; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; carbohydrate metabolic process; organelle; molecular function regulator activity
OG_06823,1.5787703107372608,FUN_031733-T1,Peve_00029893,Pocillopora_meandrina_HIv1___RNAseq.g5510.t1,three_way,68.32266666666666,FUN_031733-T1,Q3UDE2,,,,,24.0,492.0,1.4000000000000002e-23,113.2,sp|Q3UDE2|TTL12_MOUSE Tubulin--tyrosine ligase-like protein 12 OS=Mus musculus OX=10090 GN=Ttll12 PE=1 SV=1,,,,,,
OG_06824,1.0627268809086146,FUN_031734-T1,Peve_00043416,Pocillopora_meandrina_HIv1___RNAseq.g5511.t1,three_way,50.765,FUN_031734-T1,Q60HG2,TOR1A_MACFA,,Torsin-1A (Dystonia 1 protein) (Torsin ATPase 1) (EC 3.6.4.-) (Torsin family 1 member A),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),40.1,284.0,9.500000000000001e-58,226.5,sp|Q60HG2|TOR1A_MACFA Torsin-1A OS=Macaca fascicularis OX=9541 GN=TOR1A PE=2 SV=1,GO:0000338; GO:0005524; GO:0005635; GO:0005788; GO:0005789; GO:0005856; GO:0006998; GO:0007155; GO:0008021; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0036503; GO:0042802; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051085; GO:0051584; GO:0061077; GO:0071763; GO:0140662; GO:1900244; GO:2000008,"cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ERAD pathway [GO:0036503]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]",cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; growth cone [GO:0030426]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894],GO:0003824; GO:0005635; GO:0005856; GO:0007010; GO:0007155; GO:0008092; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048870; GO:0061024; GO:0140657,catalytic activity; nuclear envelope; cytoskeleton; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; cell motility; membrane organization; ATP-dependent activity
OG_06828,1.2151859774752267,FUN_031739-T1,Peve_00043412,Pocillopora_meandrina_HIv1___RNAseq.g5514.t1,three_way,71.18233333333333,,,,,,,,,,,,,,,,,
OG_06834,1.0143665071407717,FUN_031752-T1,Peve_00023214,Pocillopora_meandrina_HIv1___RNAseq.g5535.t1,three_way,68.37466666666667,,,,,,,,,,,,,,,,,
OG_06835,1.1264010898590195,FUN_031753-T1,Peve_00023213,Pocillopora_meandrina_HIv1___RNAseq.g5536.t1,three_way,55.97633333333333,,,,,,,,,,,,,,,,,
OG_06836,2.1949372080933958,FUN_031754-T1,Peve_00023210,Pocillopora_meandrina_HIv1___RNAseq.g5542.t1,three_way,70.37316666666666,FUN_031754-T1,Q8R9T6,,,,,32.9,246.0,1.1e-20,104.0,sp|Q8R9T6|PKN1_CALS4 Probable serine/threonine-protein kinase Sps1 OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=sps1 PE=3 SV=1,,,,,,
OG_06839,1.976221511467529,FUN_031779-T1,Peve_00026557,Pocillopora_meandrina_HIv1___RNAseq.g5548.t1a,three_way,38.97683333333333,,,,,,,,,,,,,,,,,
OG_06841,1.0614473915833895,FUN_031781-T1,Peve_00010425,Pocillopora_meandrina_HIv1___TS.g24284.t1,three_way,64.70833333333333,,,,,,,,,,,,,,,,,
OG_06846,1.5103917734640564,FUN_031787-T1,Peve_00019324,Pocillopora_meandrina_HIv1___RNAseq.g5568.t1,three_way,65.77866666666667,FUN_031787-T1,A7Z026,,,,,44.6,294.0,6.300000000000001e-65,250.4,sp|A7Z026|PPR37_BOVIN Protein phosphatase 1 regulatory subunit 37 OS=Bos taurus OX=9913 GN=PPP1R37 PE=2 SV=1,,,,,,
OG_06849,1.0935295844714532,FUN_031790-T1,Peve_00019330,Pocillopora_meandrina_HIv1___TS.g24291.t1,three_way,72.05833333333334,,,,,,,,,,,,,,,,,
OG_06850,2.7657924980029707,FUN_031791-T1,Peve_00019321,Pocillopora_meandrina_HIv1___RNAseq.g5572.t1,three_way,73.44166666666666,FUN_031791-T1,K7VCB9,,,,,43.1,232.0,1e-38,161.8,sp|K7VCB9|THIM_MAIZE Hydroxyethylthiazole kinase OS=Zea mays OX=4577 GN=THIM PE=1 SV=1,,,,,,
OG_06851,1.6306454759800644,FUN_031800-T1,Peve_00019322,Pocillopora_meandrina_HIv1___RNAseq.g5573.t1,three_way,74.092,FUN_031800-T1,Q99986,VRK1_HUMAN,,Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1),Homo sapiens (Human),53.3,336.0,1.4000000000000001e-101,371.3,sp|Q99986|VRK1_HUMAN Serine/threonine-protein kinase VRK1 OS=Homo sapiens OX=9606 GN=VRK1 PE=1 SV=1,GO:0000785; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005829; GO:0006338; GO:0006468; GO:0006974; GO:0007077; GO:0007165; GO:0015030; GO:0016301; GO:0019901; GO:0030576; GO:0031175; GO:0031492; GO:0035175; GO:0042393; GO:0046777; GO:0051301; GO:0072354; GO:0090166; GO:0106310; GO:0120187; GO:0141003; GO:2001222,Cajal body organization [GO:0030576]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; mitotic nuclear membrane disassembly [GO:0007077]; neuron projection development [GO:0031175]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of neuron migration [GO:2001222]; signal transduction [GO:0007165],Cajal body [GO:0015030]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AX kinase activity [GO:0141003]; histone H3S10 kinase activity [GO:0035175]; histone H3T3 kinase activity [GO:0072354]; kinase activity [GO:0016301]; nucleosomal DNA binding [GO:0031492]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0016740; GO:0042393; GO:0043226; GO:0061024; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; transferase activity; histone binding; organelle; membrane organization; catalytic activity, acting on a protein"
OG_06853,2.3005864758872843,FUN_031802-T1,Peve_00030270,Pocillopora_meandrina_HIv1___RNAseq.g5589.t1,three_way,72.05866666666667,FUN_031802-T1,Q0V9J5,,,,,66.4,107.0,1.6999999999999999e-35,150.6,sp|Q0V9J5|EIF1A_XENTR Probable RNA-binding protein EIF1AD OS=Xenopus tropicalis OX=8364 GN=eif1ad PE=2 SV=1,,,,,,
OG_06859,1.1676661849979544,FUN_031849-T1,Peve_00030292,Pocillopora_meandrina_HIv1___RNAseq.g5608.t1,three_way,82.18233333333333,FUN_031849-T1,Q8BX37,,,,,55.5,402.0,4.6e-141,502.7,sp|Q8BX37|ACP7_MOUSE Acid phosphatase type 7 OS=Mus musculus OX=10090 GN=Acp7 PE=2 SV=2,,,,,,
OG_06862,1.2080172555705877,FUN_031854-T1,Peve_00038987,Pocillopora_meandrina_HIv1___RNAseq.g5616.t1,three_way,84.778,FUN_031854-T1,O70333,,,,,71.8,78.0,3.9000000000000004e-27,122.1,sp|O70333|CRIPT_MOUSE Cysteine-rich PDZ-binding protein OS=Mus musculus OX=10090 GN=Cript PE=1 SV=1,,,,,,
OG_06864,1.7425744844542237,FUN_031860-T1,Peve_00011073,Pocillopora_meandrina_HIv1___RNAseq.g5631.t4,three_way,80.47416666666668,FUN_031860-T1,Q86UA1,,,,,44.6,579.0,9.1e-144,512.3,sp|Q86UA1|PRP39_HUMAN Pre-mRNA-processing factor 39 OS=Homo sapiens OX=9606 GN=PRPF39 PE=1 SV=3,,,,,,
OG_06869,1.2192292248038148,FUN_031869-T1,Peve_00010191,Pocillopora_meandrina_HIv1___RNAseq.g5647.t1,three_way,60.89966666666667,,,,,,,,,,,,,,,,,
OG_06871,1.3140217118262454,FUN_031874-T1,Peve_00012650,Pocillopora_meandrina_HIv1___RNAseq.g5445.t1b,three_way,69.66433333333333,FUN_031874-T1,A5D6U8,ACP7_DANRE,,Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form),Danio rerio (Zebrafish) (Brachydanio rerio),57.7,414.0,1.5e-144,514.2,sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1,GO:0003993; GO:0005576; GO:0046872,,extracellular region [GO:0005576],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_06874,2.013876861359853,FUN_031877-T1,Peve_00012644,Pocillopora_meandrina_HIv1___RNAseq.g5447.t1,three_way,82.98033333333333,FUN_031877-T1,Q9VT65,CANB_DROME,,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],Drosophila melanogaster (Fruit fly),40.7,685.0,5.4e-154,546.2,sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2,GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; membrane [GO:0016020],calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198],GO:0003824; GO:0016787; GO:0048870; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_06875,1.76767757030109,FUN_031878-T1,Peve_00031835,Pocillopora_meandrina_HIv1___TS.g24761.t1,three_way,73.57633333333334,FUN_031878-T1,Q05973,,,,,36.1,1564.0,1.8000000000000003e-248,861.3,sp|Q05973|SCN1_HETBL Sodium channel protein 1 brain OS=Heterololigo bleekeri OX=1423826 PE=2 SV=1,,,,,,
OG_06876,1.510430101122551,FUN_031888-T1,Peve_00031832,Pocillopora_meandrina_HIv1___RNAseq.g6051.t1,three_way,66.68083333333333,FUN_031888-T1,P23913,,,,,45.3,417.0,4.9e-103,376.7,sp|P23913|LBR_CHICK Delta(14)-sterol reductase LBR OS=Gallus gallus OX=9031 GN=LBR PE=1 SV=1,,,,,,
OG_06882,1.5042685630312864,FUN_031903-T1,Peve_00037702,Pocillopora_meandrina_HIv1___RNAseq.g30040.t1,three_way,82.041,FUN_031903-T1,Q7ZXY0,,,,,73.9,506.0,4.6e-220,765.4,sp|Q7ZXY0|INO1A_XENLA Inositol-3-phosphate synthase 1-A OS=Xenopus laevis OX=8355 GN=isyna1-a PE=2 SV=1,,,,,,
OG_06885,1.0646020941177372,FUN_031908-T1,Peve_00037696,Pocillopora_meandrina_HIv1___RNAseq.g30045.t1,three_way,57.48116666666667,FUN_031908-T1,Q9Z2E9,,,,,45.7,221.0,1.5e-52,209.1,sp|Q9Z2E9|BSCL2_MOUSE Seipin OS=Mus musculus OX=10090 GN=Bscl2 PE=1 SV=2,,,,,,
OG_06887,1.20983715990617,FUN_031921-T1,Peve_00040661,Pocillopora_meandrina_HIv1___RNAseq.g30046.t1,three_way,57.22266666666666,FUN_031921-T1,Q3LU38,,,,,36.1,183.0,3.9e-15,83.6,sp|Q3LU38|PROP1_ALOBE Homeobox protein prophet of Pit-1 OS=Alouatta belzebul OX=30590 GN=PROP1 PE=3 SV=1,,,,,,
OG_06890,1.2196324476364129,FUN_031929-T1,Peve_00004239,Pocillopora_meandrina_HIv1___RNAseq.g18236.t1,three_way,51.3345,FUN_031929-T1,A0A061IR73,,,,,46.3,749.0,3.1e-175,617.5,sp|A0A061IR73|PEX6_CRIGR Peroxisomal ATPase PEX6 OS=Cricetulus griseus OX=10029 GN=PEX6 PE=3 SV=1,,,,,,
OG_06891,1.341635389837573,FUN_031930-T1,Peve_00004237,Pocillopora_meandrina_HIv1___RNAseq.g18237.t1,three_way,54.86833333333333,,,,,,,,,,,,,,,,,
OG_06895,1.960617444767612,FUN_031937-T1,Peve_00024805,Pocillopora_meandrina_HIv1___RNAseq.g18211.t1,three_way,52.65616666666666,,,,,,,,,,,,,,,,,
OG_06896,1.897012099273446,FUN_031938-T1,Peve_00024799,Pocillopora_meandrina_HIv1___RNAseq.g18210.t1,three_way,53.64366666666667,,,,,,,,,,,,,,,,,
OG_06903,1.449279865582611,FUN_031949-T1,Peve_00031822,Pocillopora_meandrina_HIv1___RNAseq.g6063.t2,three_way,64.09533333333334,FUN_031949-T1,P81439,,,,,40.1,187.0,5.8e-32,141.7,sp|P81439|EQSTC_ACTEQ Equistatin OS=Actinia equina OX=6106 PE=1 SV=2,,,,,,
OG_06908,1.7287870004926202,FUN_031966-T1,Peve_00043673,Pocillopora_meandrina_HIv1___RNAseq.g30203.t1,three_way,76.01766666666667,FUN_031966-T1,Q8UWA5,,,,,36.9,274.0,3.3e-36,153.7,sp|Q8UWA5|CAH2_PSEHK Carbonic anhydrase 2 OS=Pseudaspius hakonensis OX=3004147 GN=ca2 PE=2 SV=3,,,,,,
OG_06919,1.643268223831602,FUN_031983-T1,Peve_00028814,Pocillopora_meandrina_HIv1___RNAseq.g30258.t1,three_way,74.83933333333334,FUN_031983-T1,Q8NBN7,RDH13_HUMAN,,Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3),Homo sapiens (Human),55.7,298.0,1e-85,318.2,sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2,GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650,eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_06922,2.01027981245829,FUN_032012-T1,Peve_00028791,Pocillopora_meandrina_HIv1___RNAseq.g30267.t1,three_way,74.29599999999999,FUN_032012-T1,Q20191,,,,,44.3,228.0,1.5e-45,185.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_06924,1.941550923091223,FUN_032014-T1,Peve_00041128,Pocillopora_meandrina_HIv1___RNAseq.g30270.t1,three_way,57.59433333333333,FUN_032014-T1,P14824,ANXA6_MOUSE,,Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70),Mus musculus (Mouse),25.3,292.0,1.3e-17,92.0,sp|P14824|ANXA6_MOUSE Annexin A6 OS=Mus musculus OX=10090 GN=Anxa6 PE=1 SV=3,GO:0005509; GO:0005525; GO:0005544; GO:0005739; GO:0005765; GO:0005829; GO:0006816; GO:0006937; GO:0015276; GO:0015485; GO:0016020; GO:0031902; GO:0042470; GO:0042802; GO:0048306; GO:0048471; GO:0051560; GO:0062023; GO:0097190,apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; mitochondrial calcium ion homeostasis [GO:0051560]; regulation of muscle contraction [GO:0006937],collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005739; GO:0005829; GO:0008289; GO:0031410; GO:0043226,transporter activity; mitochondrion; cytosol; lipid binding; cytoplasmic vesicle; organelle
OG_06926,1.029358108593864,FUN_032016-T2,Peve_00041123,Pocillopora_meandrina_HIv1___RNAseq.27584_t,three_way,52.10083333333333,FUN_032016-T2,Q1G7G9,TALD3_CHICK,,TALPID3 protein,Gallus gallus (Chicken),25.3,663.0,1.1000000000000002e-28,131.3,sp|Q1G7G9|TALD3_CHICK TALPID3 protein OS=Gallus gallus OX=9031 GN=TALPID3 PE=2 SV=2,GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271,centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; smoothened signaling pathway [GO:0007224],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737],,GO:0005815; GO:0043226; GO:0044782,microtubule organizing center; organelle; cilium organization
OG_06928,1.1458938057384722,FUN_032018-T1,Peve_00041130,Pocillopora_meandrina_HIv1___RNAseq.g30276.t1,three_way,85.556,,,,,,,,,,,,,,,,,
OG_06929,1.2482789038787854,FUN_032019-T1,Peve_00041125,Pocillopora_meandrina_HIv1___TS.g22573.t1,three_way,74.76366666666667,FUN_032019-T1,Q55E31,RB32B_DICDI,,Ras-related protein Rab-32B,Dictyostelium discoideum (Social amoeba),61.0,182.0,6.3999999999999996e-62,238.8,sp|Q55E31|RB32B_DICDI Ras-related protein Rab-32B OS=Dictyostelium discoideum OX=44689 GN=rab32B PE=3 SV=1,GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0012505; GO:0016192; GO:0031982; GO:0032438,intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192],endomembrane system [GO:0012505]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0006886; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; intracellular protein transport; vesicle-mediated transport; hydrolase activity; organelle
OG_06935,1.1813652163161357,FUN_032040-T1,Peve_00013552,Pocillopora_meandrina_HIv1___RNAseq.g5930.t1,three_way,82.90566666666666,FUN_032040-T1,Q6PA06,ATLA2_MOUSE,,Atlastin-2 (EC 3.6.5.-),Mus musculus (Mouse),61.0,490.0,2.9e-179,629.8,sp|Q6PA06|ATLA2_MOUSE Atlastin-2 OS=Mus musculus OX=10090 GN=Atl2 PE=1 SV=1,GO:0005525; GO:0016320; GO:0071346; GO:0098826; GO:0140523; GO:1990809,cellular response to type II interferon [GO:0071346]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum tubular network membrane organization [GO:1990809],endoplasmic reticulum tubular network membrane [GO:0098826],GTP binding [GO:0005525]; GTPase-dependent fusogenic activity [GO:0140523],GO:0003824; GO:0003924; GO:0016787; GO:0061024,catalytic activity; GTPase activity; hydrolase activity; membrane organization
OG_06942,1.7082966283688648,FUN_032052-T1,Peve_00012445,Pocillopora_meandrina_HIv1___RNAseq.g6026.t1,three_way,72.548,FUN_032052-T1,Q96NT5,,,,,28.5,445.0,2.6e-38,161.4,sp|Q96NT5|PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens OX=9606 GN=SLC46A1 PE=1 SV=1,,,,,,
OG_06948,1.4519402564390549,FUN_032061-T2,Peve_00040453,Pocillopora_meandrina_HIv1___RNAseq.g6047.t1,three_way,65.65933333333334,FUN_032061-T2,P39428,TRAF1_MOUSE,,TNF receptor-associated factor 1,Mus musculus (Mouse),31.4,264.0,1.1000000000000001e-27,125.9,sp|P39428|TRAF1_MOUSE TNF receptor-associated factor 1 OS=Mus musculus OX=10090 GN=Traf1 PE=1 SV=2,GO:0005164; GO:0005737; GO:0006915; GO:0007165; GO:0008270; GO:0031625; GO:0031996; GO:0042802; GO:2001236,apoptotic process [GO:0006915]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; signal transduction [GO:0007165],cytoplasm [GO:0005737],identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0012501,programmed cell death
OG_06950,1.8221368192569585,FUN_032063-T1,Peve_00024739,Pocillopora_meandrina_HIv1___RNAseq.g6045.t1,three_way,41.4025,,,,,,,,,,,,,,,,,
OG_06955,1.7913035750643134,FUN_032074-T1,Peve_00018829,Pocillopora_meandrina_HIv1___RNAseq.g6016.t1,three_way,67.94316666666667,FUN_032074-T1,P78504,JAG1_HUMAN,,Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339),Homo sapiens (Human),41.2,204.0,9.5e-42,174.5,sp|P78504|JAG1_HUMAN Protein jagged-1 OS=Homo sapiens OX=9606 GN=JAG1 PE=1 SV=3,GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737,angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; molecular adaptor activity [GO:0060090]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198],GO:0002376; GO:0005198; GO:0005576; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0048018; GO:0048856; GO:0060090; GO:0098772,immune system process; structural molecule activity; extracellular region; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_06956,2.0081218225291817,FUN_032081-T1,Peve_00039910,Pocillopora_meandrina_HIv1___RNAseq.g5227.t1,three_way,79.99466666666666,FUN_032081-T1,Q5RE98,AOFB_PONAB,,Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.7,486.0,1.1000000000000001e-130,468.4,sp|Q5RE98|AOFB_PONAB Amine oxidase [flavin-containing] B OS=Pongo abelii OX=9601 GN=MAOB PE=2 SV=3,GO:0005739; GO:0005741; GO:0008131; GO:0050660; GO:0097621,,mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_06958,1.3782903192087728,FUN_032087-T1,Peve_00026034,Pocillopora_meandrina_HIv1___RNAseq.g5298.t1,three_way,38.37983333333334,,,,,,,,,,,,,,,,,
OG_06961,1.526671680437844,FUN_032091-T1,Peve_00012819,Pocillopora_meandrina_HIv1___RNAseq.g5277.t1,three_way,71.29066666666667,FUN_032091-T1,Q00IB7,,,,,40.9,952.0,1.5e-190,668.7,sp|Q00IB7|PKHH1_DANRE Pleckstrin homology domain-containing family H member 1 OS=Danio rerio OX=7955 GN=plekhh1 PE=2 SV=1,,,,,,
OG_06962,1.2153574729915806,FUN_032092-T1,Peve_00012820,Pocillopora_meandrina_HIv1___RNAseq.g5276.t1,three_way,74.64983333333333,,,,,,,,,,,,,,,,,
OG_06966,1.3278859123096671,FUN_032098-T1,Peve_00035667,Pocillopora_meandrina_HIv1___RNAseq.g5302.t1,three_way,77.37366666666667,FUN_032098-T1,Q9Y256,FACE2_HUMAN,,CAAX prenyl protease 2 (EC 3.4.26.1) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1),Homo sapiens (Human),47.3,292.0,1.5e-65,251.1,sp|Q9Y256|FACE2_HUMAN CAAX prenyl protease 2 OS=Homo sapiens OX=9606 GN=RCE1 PE=1 SV=1,GO:0000165; GO:0004175; GO:0004197; GO:0004222; GO:0005789; GO:0005829; GO:0005886; GO:0008238; GO:0016020; GO:0018342; GO:0071586,CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; cytosol; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_06967,1.4886780587080888,FUN_032099-T1,Peve_00035662,Pocillopora_meandrina_HIv1___RNAseq.g5303.t1,three_way,74.34366666666666,FUN_032099-T1,P98192,GNPAT_MOUSE,,Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase),Mus musculus (Mouse),36.0,659.0,1.3e-94,349.0,sp|P98192|GNPAT_MOUSE Dihydroxyacetone phosphate acyltransferase OS=Mus musculus OX=10090 GN=Gnpat PE=1 SV=1,GO:0003824; GO:0005777; GO:0005778; GO:0005782; GO:0006650; GO:0007416; GO:0008611; GO:0016287; GO:0021587; GO:0030054; GO:0030913; GO:0042552; GO:0061024,cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; synapse assembly [GO:0007416],cell junction [GO:0030054]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287],GO:0003824; GO:0005777; GO:0006629; GO:0016740; GO:0034330; GO:0043226; GO:0061024,catalytic activity; peroxisome; lipid metabolic process; transferase activity; cell junction organization; organelle; membrane organization
OG_06972,1.2118613042756885,FUN_032106-T1,Peve_00030222,Pocillopora_meandrina_HIv1___RNAseq.g5395.t1,three_way,94.85066666666668,FUN_032106-T1,P53451,,,,,75.0,539.0,3.9000000000000003e-224,778.9,sp|P53451|TCPD_TAKRU T-complex protein 1 subunit delta OS=Takifugu rubripes OX=31033 GN=cct4 PE=2 SV=1,,,,,,
OG_06973,2.925064945300367,FUN_032108-T1,Peve_00030224,Pocillopora_meandrina_HIv1___RNAseq.g5393.t1,three_way,58.33233333333333,FUN_032108-T1,Q8IWX5,SGPP2_HUMAN,,Sphingosine-1-phosphate phosphatase 2 (SPPase2) (Spp2) (hSPP2) (EC 3.1.3.-) (Sphingosine-1-phosphatase 2),Homo sapiens (Human),34.5,403.0,2.3e-56,221.1,sp|Q8IWX5|SGPP2_HUMAN Sphingosine-1-phosphate phosphatase 2 OS=Homo sapiens OX=9606 GN=SGPP2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0006670; GO:0030149; GO:0042392; GO:0046839; GO:0061469; GO:0070780,phospholipid dephosphorylation [GO:0046839]; regulation of type B pancreatic cell proliferation [GO:0061469]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392],GO:0003824; GO:0005783; GO:0006629; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; hydrolase activity; organelle
OG_06974,1.3876764022694534,FUN_032109-T1,Peve_00030225,Pocillopora_meandrina_HIv1___RNAseq.g5392.t1,three_way,77.26299999999999,FUN_032109-T1,F1RAX8,,,,,55.6,444.0,2.5e-134,480.3,"sp|F1RAX8|COQ6_DANRE Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial OS=Danio rerio OX=7955 GN=coq6 PE=2 SV=1",,,,,,
OG_06979,1.1789150732472609,FUN_032115-T1,Peve_00030231,Pocillopora_meandrina_HIv1___RNAseq.g5383.t1,three_way,75.76333333333334,,,,,,,,,,,,,,,,,
OG_06980,1.4634128164392783,FUN_032117-T1,Peve_00030232,Pocillopora_meandrina_HIv1___TS.g24094.t1,three_way,95.08266666666668,FUN_032117-T1,Q80U96,XPO1_RAT,,Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog),Rattus norvegicus (Rat),78.0,1074.0,0.0,1682.5,sp|Q80U96|XPO1_RAT Exportin-1 OS=Rattus norvegicus OX=10116 GN=Xpo1 PE=1 SV=1,GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0005829; GO:0006406; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0071401; GO:0140297; GO:1902075; GO:1990904,cellular response to salt [GO:1902075]; cellular response to triglyceride [GO:0071401]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254],annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],DNA-binding transcription factor binding [GO:0140297]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006886; GO:0006913; GO:0042254; GO:0043226; GO:0140104,RNA binding; nucleus; nucleolus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; ribosome biogenesis; organelle; molecular carrier activity
OG_06981,2.317151178292306,FUN_032118-T1,Peve_00030238,Pocillopora_meandrina_HIv1___RNAseq.g5380.t1,three_way,76.23633333333333,FUN_032118-T1,Q5ZL91,INT7_CHICK,,Integrator complex subunit 7 (Int7),Gallus gallus (Chicken),45.5,927.0,3.2e-212,740.3,sp|Q5ZL91|INT7_CHICK Integrator complex subunit 7 OS=Gallus gallus OX=9031 GN=INTS7 PE=2 SV=1,GO:0005634; GO:0005694; GO:0005737; GO:0006974; GO:0032039; GO:0034472; GO:0160232; GO:0160240,DNA damage response [GO:0006974]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472],chromosome [GO:0005694]; cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634],,GO:0005634; GO:0005694; GO:0016073; GO:0043226,nucleus; chromosome; snRNA metabolic process; organelle
OG_06985,1.7374287504131654,FUN_032124-T1,Peve_00040714,Pocillopora_meandrina_HIv1___TS.g24079.t3,three_way,68.271,FUN_032124-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),24.2,715.0,4.2e-45,184.9,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_06986,1.4390292159508993,FUN_032125-T1,Peve_00040713,Pocillopora_meandrina_HIv1___RNAseq.g5366.t1,three_way,78.05966666666667,FUN_032125-T1,Q6DF57,,,,,46.3,95.0,4e-16,85.9,sp|Q6DF57|GPT11_XENTR G patch domain-containing protein 11 OS=Xenopus tropicalis OX=8364 GN=gpatch11 PE=2 SV=1,,,,,,
OG_06987,1.5734671584059516,FUN_032128-T1,Peve_00040717,Pocillopora_meandrina_HIv1___RNAseq.g5363.t1,three_way,49.11266666666667,,,,,,,,,,,,,,,,,
OG_06991,1.7449269417074216,FUN_032133-T1,Peve_00029139,Pocillopora_meandrina_HIv1___RNAseq.g5353.t1,three_way,78.61566666666667,FUN_032133-T1,Q9ULQ1,,,,,28.8,552.0,2.7000000000000004e-44,181.8,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_06992,1.298494234373946,FUN_032137-T1,Peve_00007914,Pocillopora_meandrina_HIv1___RNAseq.g5357.t1,three_way,65.0305,FUN_032137-T1,Q3MIT2,PUS10_HUMAN,,tRNA pseudouridine synthase Pus10 (Hup10) (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase),Homo sapiens (Human),46.1,347.0,1.3e-77,291.6,sp|Q3MIT2|PUS10_HUMAN tRNA pseudouridine synthase Pus10 OS=Homo sapiens OX=9606 GN=PUS10 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029; GO:0160148,primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine(55) synthase activity [GO:0160148],GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006399; GO:0016853; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mitochondrion; tRNA metabolic process; isomerase activity; organelle; catalytic activity, acting on RNA"
OG_06993,2.9915632467739184,FUN_032139-T1,Peve_00007913,Pocillopora_meandrina_HIv1___TS.g24062.t1,three_way,49.26766666666666,,,,,,,,,,,,,,,,,
OG_06995,1.5823920463755758,FUN_032143-T1,Peve_00007909,Pocillopora_meandrina_HIv1___RNAseq.g5346.t1,three_way,75.438,FUN_032143-T1,Q9H0R1,AP5M1_HUMAN,,AP-5 complex subunit mu-1 (Adaptor-related protein complex 5 subunit mu-1) (Mu5) (Mu-2-related death-inducing protein) (MuD) (Putative HIV-1 infection-related protein),Homo sapiens (Human),34.8,515.0,1.2e-78,295.4,sp|Q9H0R1|AP5M1_HUMAN AP-5 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP5M1 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016020; GO:0016192; GO:0016197; GO:0030119; GO:0031902; GO:0044599,endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],,GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06996,2.236494285239796,FUN_032145-T1,Peve_00007916,Pocillopora_meandrina_HIv1___TS.g24057.t1,three_way,48.8235,,,,,,,,,,,,,,,,,
OG_06997,1.4397455601959634,FUN_032146-T1,Peve_00007915,Pocillopora_meandrina_HIv1___RNAseq.g5343.t1,three_way,60.750166666666665,,,,,,,,,,,,,,,,,
OG_07003,1.4061542869052333,FUN_032155-T1,Peve_00003240,Pocillopora_meandrina_HIv1___RNAseq.g5324.t1,three_way,81.494,FUN_032155-T1,Q80U44,,,,,40.9,88.0,2.1e-14,80.9,sp|Q80U44|ZFY16_MOUSE Zinc finger FYVE domain-containing protein 16 OS=Mus musculus OX=10090 GN=Zfyve16 PE=1 SV=2,,,,,,
OG_07004,1.943680281344463,FUN_032156-T1,Peve_00003241,Pocillopora_meandrina_HIv1___RNAseq.g5323.t1,three_way,54.30733333333333,,,,,,,,,,,,,,,,,
OG_07007,1.4083621876789427,FUN_032160-T1,Peve_00005389,Pocillopora_meandrina_HIv1___RNAseq.g5308.t1,three_way,84.28083333333333,FUN_032160-T1,Q9BX10,GTPB2_HUMAN,,GTP-binding protein 2,Homo sapiens (Human),61.1,535.0,2.7e-191,669.8,sp|Q9BX10|GTPB2_HUMAN GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=GTPBP2 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:0070966; GO:0072344; GO:1904678,"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]",extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093],alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802],GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0016071; GO:0016787,RNA binding; catalytic activity; GTPase activity; extracellular region; mRNA metabolic process; hydrolase activity
OG_07009,1.533748863351333,FUN_032162-T1,Peve_00038631,Pocillopora_meandrina_HIv1___RNAseq.g5313.t1,three_way,99.18466666666669,FUN_032162-T1,Q6GQL2,PP1B_XENLA,,Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16),Xenopus laevis (African clawed frog),94.5,325.0,3.300000000000001e-186,652.1,sp|Q6GQL2|PP1B_XENLA Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Xenopus laevis OX=8355 GN=ppp1cb PE=2 SV=1,GO:0004722; GO:0005634; GO:0005737; GO:0005977; GO:0030155; GO:0032922; GO:0042752; GO:0046872; GO:0050115; GO:0051301; GO:0072357,cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752],cytoplasm [GO:0005737]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357],metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005975; GO:0006091; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; carbohydrate metabolic process; generation of precursor metabolites and energy; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07010,1.413137649075886,FUN_032163-T1,Peve_00038632,Pocillopora_meandrina_HIv1___RNAseq.g5314.t1,three_way,95.89,FUN_032163-T1,Q561P5,MCM5_XENTR,,DNA replication licensing factor mcm5 (EC 3.6.4.12),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),72.9,735.0,0.0,1084.7,sp|Q561P5|MCM5_XENTR DNA replication licensing factor mcm5 OS=Xenopus tropicalis OX=8364 GN=mcm5 PE=2 SV=1,GO:0000785; GO:0003688; GO:0004386; GO:0005524; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162,cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; regulation of DNA-templated DNA replication initiation [GO:0030174],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA replication origin binding [GO:0003688]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0006260; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; DNA replication; hydrolase activity; isomerase activity; ATP-dependent activity
OG_07013,1.057761253792918,FUN_032166-T1,Peve_00038634,Pocillopora_meandrina_HIv1___RNAseq.g5319.t2,three_way,83.15083333333334,FUN_032166-T1,Q6DFF9,,,,,47.4,610.0,1.9e-158,560.8,sp|Q6DFF9|MABP1_XENLA Mitogen-activated protein kinase-binding protein 1 OS=Xenopus laevis OX=8355 GN=mapkbp1 PE=2 SV=1,,,,,,
OG_07014,1.5884830984845633,FUN_032167-T1,Peve_00012811,Pocillopora_meandrina_HIv1___RNAseq.g5306.t1,three_way,90.62433333333334,FUN_032167-T1,P18074,ERCC2_HUMAN,,General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 5.6.2.3) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA 5'-3' helicase XPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein),Homo sapiens (Human),72.6,731.0,0.0,1078.9,sp|P18074|ERCC2_HUMAN General transcription and DNA repair factor IIH helicase subunit XPD OS=Homo sapiens OX=9606 GN=ERCC2 PE=1 SV=1,GO:0000439; GO:0000462; GO:0001666; GO:0001701; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0005737; GO:0005819; GO:0005829; GO:0006283; GO:0006289; GO:0006357; GO:0006362; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0007059; GO:0008340; GO:0009650; GO:0009791; GO:0016887; GO:0021510; GO:0030198; GO:0030282; GO:0030674; GO:0032289; GO:0035264; GO:0035315; GO:0040016; GO:0043139; GO:0043249; GO:0045951; GO:0046872; GO:0048009; GO:0048568; GO:0048820; GO:0051539; GO:0060218; GO:0070516; GO:0071425; GO:0071817; GO:0072332; GO:1901990,"apoptotic process [GO:0006915]; bone mineralization [GO:0030282]; central nervous system myelin formation [GO:0032289]; chromosome segregation [GO:0007059]; determination of adult lifespan [GO:0008340]; embryonic cleavage [GO:0040016]; embryonic organ development [GO:0048568]; erythrocyte maturation [GO:0043249]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; hair follicle maturation [GO:0048820]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; in utero embryonic development [GO:0001701]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; positive regulation of mitotic recombination [GO:0045951]; post-embryonic development [GO:0009791]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]",CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006351; GO:0006355; GO:0007059; GO:0012501; GO:0016787; GO:0016853; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; chromosome segregation; programmed cell death; hydrolase activity; isomerase activity; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07015,1.637200040970065,FUN_032191-T1,Peve_00020048,Pocillopora_meandrina_HIv1___RNAseq.g24664.t1,three_way,75.42333333333333,FUN_032191-T1,Q0V9A9,,,,,59.2,284.0,1.1e-90,334.7,sp|Q0V9A9|LACB2_XENTR Endoribonuclease LACTB2 OS=Xenopus tropicalis OX=8364 GN=lactb2 PE=2 SV=1,,,,,,
OG_07018,1.4903000200090342,FUN_032194-T1,Peve_00017482,Pocillopora_meandrina_HIv1___RNAseq.g24398.t1,three_way,85.27199999999999,FUN_032194-T1,P48506,GSH1_HUMAN,,Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase),Homo sapiens (Human),62.3,628.0,4.5e-227,788.9,sp|P48506|GSH1_HUMAN Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens OX=9606 GN=GCLC PE=1 SV=2,GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237,blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877],GO:0003013; GO:0003824; GO:0005739; GO:0005829; GO:0005975; GO:0006355; GO:0006520; GO:0006575; GO:0006790; GO:0007005; GO:0016874; GO:0043226; GO:0061024,circulatory system process; catalytic activity; mitochondrion; cytosol; carbohydrate metabolic process; regulation of DNA-templated transcription; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; mitochondrion organization; ligase activity; organelle; membrane organization
OG_07020,1.030830944011732,FUN_032196-T1,Peve_00017487,Pocillopora_meandrina_HIv1___RNAseq.g24408.t1,three_way,64.211,FUN_032196-T1,D3ZAT9,,,,,33.5,239.0,5.8e-38,159.5,sp|D3ZAT9|FAXC_RAT Failed axon connections homolog OS=Rattus norvegicus OX=10116 GN=Faxc PE=3 SV=1,,,,,,
OG_07023,1.484176582027782,FUN_032204-T1,Peve_00013799,Pocillopora_meandrina_HIv1___RNAseq.g24269.t1,three_way,60.29666666666667,FUN_032204-T1,Q9UBU6,,,,,33.3,201.0,1.1e-22,109.0,sp|Q9UBU6|FA8A1_HUMAN Protein FAM8A1 OS=Homo sapiens OX=9606 GN=FAM8A1 PE=1 SV=1,,,,,,
OG_07025,1.3779856797349812,FUN_032217-T1,Peve_00015500,Pocillopora_meandrina_HIv1___RNAseq.g24278.t1,three_way,88.01366666666667,,,,,,,,,,,,,,,,,
OG_07026,1.2420301044173037,FUN_032218-T1,Peve_00015505,Pocillopora_meandrina_HIv1___RNAseq.g24279.t1,three_way,81.62233333333333,FUN_032218-T1,Q5F477,,,,,37.9,285.0,3.4e-45,183.7,sp|Q5F477|LDAH_CHICK Lipid droplet-associated hydrolase OS=Gallus gallus OX=9031 GN=LDAH PE=2 SV=2,,,,,,
OG_07027,1.2576263145256683,FUN_032219-T1,Peve_00015512,Pocillopora_meandrina_HIv1___RNAseq.g24280.t1,three_way,65.81,FUN_032219-T1,A3KP40,,,,,24.7,461.0,2.2e-09,65.5,sp|A3KP40|CH034_DANRE Uncharacterized protein C8orf34 homolog OS=Danio rerio OX=7955 GN=zgc:162928 PE=2 SV=1,,,,,,
OG_07028,1.8723451328325933,FUN_032220-T1,Peve_00015518,Pocillopora_meandrina_HIv1___RNAseq.g24281.t1,three_way,76.94216666666667,FUN_032220-T1,P08461,,,,,60.7,443.0,2.7e-132,473.8,"sp|P08461|ODP2_RAT Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial OS=Rattus norvegicus OX=10116 GN=Dlat PE=1 SV=3",,,,,,
OG_07030,1.807850936869882,FUN_032222-T1,Peve_00015538,Pocillopora_meandrina_HIv1___RNAseq.g24283.t1,three_way,63.73566666666667,FUN_032222-T1,Q8BVA5,LDAH_MOUSE,,Lipid droplet-associated hydrolase (EC 3.1.1.13) (Lipid droplet-associated serine hydrolase) (mLDAH),Mus musculus (Mouse),39.9,288.0,2.1e-50,201.1,sp|Q8BVA5|LDAH_MOUSE Lipid droplet-associated hydrolase OS=Mus musculus OX=10090 GN=Ldah PE=1 SV=1,GO:0004771; GO:0005783; GO:0005811; GO:0019915; GO:0035356; GO:0042632; GO:0090077; GO:0160077,cholesterol homeostasis [GO:0042632]; foam cell differentiation [GO:0090077]; intracellular triglyceride homeostasis [GO:0035356]; lipid droplet fusion [GO:0160077]; lipid storage [GO:0019915],endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811],sterol ester esterase activity [GO:0004771],GO:0003824; GO:0005783; GO:0005811; GO:0016787; GO:0030154; GO:0043226,catalytic activity; endoplasmic reticulum; lipid droplet; hydrolase activity; cell differentiation; organelle
OG_07033,1.1390392353197738,FUN_032225-T1,Peve_00043436,Pocillopora_meandrina_HIv1___RNAseq.g24827.t1,three_way,72.54,FUN_032225-T1,Q5HZI9,S2551_MOUSE,,Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (Mitochondrial NAD(+) transporter SLC25A51) (Mitochondrial carrier triple repeat protein 1) (Solute carrier family 25 member 51),Mus musculus (Mouse),51.1,266.0,4.2e-74,279.6,sp|Q5HZI9|S2551_MOUSE Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 OS=Mus musculus OX=10090 GN=Slc25a51 PE=1 SV=1,GO:0005739; GO:0005743; GO:0006741; GO:0008514; GO:0019646; GO:0051724; GO:1990549,aerobic electron transport chain [GO:0019646]; mitochondrial NAD transmembrane transport [GO:1990549]; NADP biosynthetic process [GO:0006741],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],NAD transmembrane transporter activity [GO:0051724]; organic anion transmembrane transporter activity [GO:0008514],GO:0005215; GO:0005739; GO:0006091; GO:0043226; GO:0055085; GO:0055086,transporter activity; mitochondrion; generation of precursor metabolites and energy; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process
OG_07042,1.3149948162485166,FUN_032241-T1,Peve_00023301,Pocillopora_meandrina_HIv1___TS.g12785.t1,three_way,77.97733333333333,FUN_032241-T1,Q9JLT4,TRXR2_MOUSE,,"Thioredoxin reductase 2, mitochondrial (EC 1.8.1.9) (Thioredoxin reductase TR3)",Mus musculus (Mouse),64.1,493.0,1.2e-193,677.6,"sp|Q9JLT4|TRXR2_MOUSE Thioredoxin reductase 2, mitochondrial OS=Mus musculus OX=10090 GN=Txnrd2 PE=1 SV=4",GO:0000305; GO:0004791; GO:0005739; GO:0007507; GO:0030097; GO:0042803; GO:0045454; GO:0050660,cell redox homeostasis [GO:0045454]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; response to oxygen radical [GO:0000305],mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005739; GO:0016209; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; antioxidant activity; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07046,1.4117090990432235,FUN_032249-T1,Peve_00042108,Pocillopora_meandrina_HIv1___TS.g12806.t2,three_way,79.56116666666667,FUN_032249-T1,Q4H4B6,SCRIB_DANRE,,Protein scribble homolog (Scribble1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,938.0,2.3e-130,468.8,sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1,GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887,"activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944]",adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793],protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0005886; GO:0006886; GO:0007010; GO:0007155; GO:0007163; GO:0012501; GO:0016192; GO:0043226; GO:0048856; GO:0048870; GO:0072659,plasma membrane; intracellular protein transport; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; programmed cell death; vesicle-mediated transport; organelle; anatomical structure development; cell motility; protein localization to plasma membrane
OG_07047,1.4463699953920028,FUN_032252-T1,Peve_00042110,Pocillopora_meandrina_HIv1___RNAseq.g24907.t1a,three_way,67.65599999999999,FUN_032252-T1,Q92539,LPIN2_HUMAN,,Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2),Homo sapiens (Human),37.9,927.0,2.0999999999999998e-129,464.9,sp|Q92539|LPIN2_HUMAN Phosphatidate phosphatase LPIN2 OS=Homo sapiens OX=9606 GN=LPIN2 PE=1 SV=1,GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944,cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0006629; GO:0016787; GO:0043226; GO:0060090; GO:0140110,catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; lipid metabolic process; hydrolase activity; organelle; molecular adaptor activity; transcription regulator activity
OG_07049,1.8216602075879424,FUN_032255-T1,Peve_00014264,Pocillopora_meandrina_HIv1___RNAseq.g24905.t1,three_way,70.49433333333333,FUN_032255-T1,O43909,EXTL3_HUMAN,,Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3),Homo sapiens (Human),46.1,855.0,2.3e-207,723.8,sp|O43909|EXTL3_HUMAN Exostosin-like 3 OS=Homo sapiens OX=9606 GN=EXTL3 PE=1 SV=1,GO:0000287; GO:0001888; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006486; GO:0010838; GO:0015012; GO:0016500; GO:0016757; GO:0030307; GO:0045617; GO:0050728; GO:0051897; GO:0106015; GO:1900016; GO:2000972,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; positive regulation of cell growth [GO:0030307]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein glycosylation [GO:0006486],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886],glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500],GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:0060089; GO:1901135,catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; plasma membrane; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; molecular transducer activity; carbohydrate derivative metabolic process
OG_07051,2.617116772749674,FUN_032271-T1,Peve_00030007,Pocillopora_meandrina_HIv1___RNAseq.g24973.t1,three_way,77.01566666666666,FUN_032271-T1,A5PJJ7,,,,,49.8,301.0,1.8999999999999998e-82,307.8,sp|A5PJJ7|S16C6_BOVIN Short-chain dehydrogenase/reductase family 16C member 6 OS=Bos taurus OX=9913 GN=SDR16C6 PE=2 SV=1,,,,,,
OG_07052,3.009416703960736,FUN_032274-T1,Peve_00011763,Pocillopora_meandrina_HIv1___RNAseq.g24974.t1,three_way,68.399,FUN_032274-T1,A8E7N9,,,,,31.6,370.0,2.9e-44,181.0,sp|A8E7N9|GDF6B_DANRE Growth/differentiation factor 6-B OS=Danio rerio OX=7955 GN=gdf6b PE=2 SV=1,,,,,,
OG_07055,1.705747811962446,FUN_032278-T1,Peve_00011758,Pocillopora_meandrina_HIv1___RNAseq.g24978.t1,three_way,81.38966666666667,FUN_032278-T1,Q8N584,,,,,40.9,587.0,4.1e-121,436.8,sp|Q8N584|TT39C_HUMAN Tetratricopeptide repeat protein 39C OS=Homo sapiens OX=9606 GN=TTC39C PE=1 SV=2,,,,,,
OG_07056,1.311268809668375,FUN_032281-T1,Peve_00015549,Pocillopora_meandrina_HIv1___RNAseq.g24293.t1,three_way,73.47583333333333,FUN_032281-T1,P13264,GLSK_RAT,,"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]",Rattus norvegicus (Rat),52.4,517.0,1.8000000000000002e-158,560.8,"sp|P13264|GLSK_RAT Glutaminase kidney isoform, mitochondrial OS=Rattus norvegicus OX=10116 GN=Gls PE=1 SV=2",GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0045202; GO:0051289; GO:0090461,chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; intracellular glutamate homeostasis [GO:0090461]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202],glutaminase activity [GO:0004359],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016787; GO:0023052; GO:0043226; GO:0050877; GO:0065003,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; hydrolase activity; signaling; organelle; nervous system process; protein-containing complex assembly
OG_07061,1.1013773028137213,FUN_032287-T1,Peve_00015513,Pocillopora_meandrina_HIv1___RNAseq.g24298.t1,three_way,80.58466666666666,FUN_032287-T1,O60942,MCE1_HUMAN,,mRNA-capping enzyme (HCAP1) (HCE) [Includes: mRNA 5'-triphosphate monophosphatase (EC 3.6.1.74) (mRNA 5'-phosphatase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)],Homo sapiens (Human),49.5,566.0,5.900000000000001e-162,572.4,sp|O60942|MCE1_HUMAN mRNA-capping enzyme OS=Homo sapiens OX=9606 GN=RNGTT PE=1 SV=1,GO:0004484; GO:0004651; GO:0004721; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0006370; GO:0006396; GO:0008192; GO:0050355; GO:0140818,7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; GTP binding [GO:0005525]; inorganic triphosphate phosphatase activity [GO:0050355]; mRNA 5'-triphosphate monophosphatase activity [GO:0140818]; mRNA guanylyltransferase activity [GO:0004484]; phosphoprotein phosphatase activity [GO:0004721]; polynucleotide 5'-phosphatase activity [GO:0004651]; RNA guanylyltransferase activity [GO:0008192],GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016740; GO:0016787; GO:0043226; GO:0140096; GO:0140098,"catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_07063,1.3907875526893254,FUN_032289-T1,Peve_00015510,Pocillopora_meandrina_HIv1___TS.g12261.t1,three_way,71.52666666666667,FUN_032289-T1,Q54SR7,FKBP2_DICDI,,FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase),Dictyostelium discoideum (Social amoeba),50.8,132.0,2.3000000000000002e-30,133.7,sp|Q54SR7|FKBP2_DICDI FK506-binding protein 2 OS=Dictyostelium discoideum OX=44689 GN=fkbp2 PE=3 SV=1,GO:0003755; GO:0005783; GO:0061077,chaperone-mediated protein folding [GO:0061077],endoplasmic reticulum [GO:0005783],peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0005783; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_07066,3.0662630861225533,FUN_032299-T1,Peve_00020128,Pocillopora_meandrina_HIv1___RNAseq.g24900.t1,three_way,50.632333333333335,FUN_032299-T1,Q3ZT31,SNX25_MOUSE,,Sorting nexin-25,Mus musculus (Mouse),27.2,125.0,1.3e-07,60.8,sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3,GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091,negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008],phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005768; GO:0008289; GO:0031410; GO:0043226,endosome; lipid binding; cytoplasmic vesicle; organelle
OG_07071,1.226753136591714,FUN_032307-T1,Peve_00001538,Pocillopora_meandrina_HIv1___RNAseq.g24762.t2,three_way,70.71366666666667,FUN_032307-T1,Q3U0J8,,,,,48.1,480.0,9.9e-126,452.6,sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2,,,,,,
OG_07073,1.0356974161545944,FUN_032309-T1,Peve_00009101,Pocillopora_meandrina_HIv1___RNAseq.g24764.t1,three_way,78.17133333333334,FUN_032309-T1,A7RZS0,BL1S2_NEMVE,,Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2),Nematostella vectensis (Starlet sea anemone),53.8,104.0,2.7e-21,103.2,sp|A7RZS0|BL1S2_NEMVE Biogenesis of lysosome-related organelles complex 1 subunit 2 OS=Nematostella vectensis OX=45351 GN=bloc1s2 PE=3 SV=1,GO:0000930; GO:0005765; GO:0005813; GO:0016197; GO:0031083; GO:0032418; GO:0043015; GO:0099078,endosomal transport [GO:0016197]; lysosome localization [GO:0032418],BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; centrosome [GO:0005813]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765],gamma-tubulin binding [GO:0043015],GO:0005815; GO:0008092; GO:0016192,microtubule organizing center; cytoskeletal protein binding; vesicle-mediated transport
OG_07075,1.084912870925976,FUN_032312-T1,Peve_00002566,Pocillopora_meandrina_HIv1___RNAseq.g24785.t1,three_way,58.21183333333333,,,,,,,,,,,,,,,,,
OG_07079,1.8440733954113333,FUN_032317-T1,Peve_00031925,Pocillopora_meandrina_HIv1___RNAseq.g24788.t1,three_way,48.4895,FUN_032317-T1,Q3ULM6,,,,,29.3,300.0,2.1e-30,135.6,sp|Q3ULM6|USPL1_MOUSE SUMO-specific isopeptidase USPL1 OS=Mus musculus OX=10090 GN=Uspl1 PE=2 SV=2,,,,,,
OG_07086,1.2471910049163917,FUN_032343-T1,Peve_00043851,Pocillopora_meandrina_HIv1___RNAseq.g29795.t1,three_way,70.73383333333334,FUN_032343-T1,Q9VCA2,,,,,31.8,528.0,2.3999999999999997e-61,238.0,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_07087,1.7427131208662798,FUN_032344-T1,Peve_00021401,Pocillopora_meandrina_HIv1___RNAseq.g29796.t1,three_way,74.12733333333334,FUN_032344-T1,Q9H3R1,,,,,40.3,749.0,4.3000000000000005e-161,570.1,sp|Q9H3R1|NDST4_HUMAN Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 OS=Homo sapiens OX=9606 GN=NDST4 PE=1 SV=1,,,,,,
OG_07088,2.3563523498021386,FUN_032345-T1,Peve_00021405,Pocillopora_meandrina_HIv1___RNAseq.g29797.t2,three_way,70.41966666666667,FUN_032345-T1,Q9V3L1,NDST_DROME,,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)],Drosophila melanogaster (Fruit fly),46.3,901.0,9.6e-236,818.1,sp|Q9V3L1|NDST_DROME Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase OS=Drosophila melanogaster OX=7227 GN=sfl PE=1 SV=1,GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008543; GO:0008587; GO:0015012; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140,"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]",endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139],deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate N-sulfotransferase activity [GO:0015016],GO:0003824; GO:0005783; GO:0005794; GO:0006790; GO:0009101; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; hydrolase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_07093,1.167316559301605,FUN_032350-T1,Peve_00012758,Pocillopora_meandrina_HIv1___RNAseq.g29802.t1,three_way,54.929,FUN_032350-T1,Q5BJT4,TXD15_RAT,,Thioredoxin domain-containing protein 15,Rattus norvegicus (Rat),40.4,198.0,3.1999999999999997e-29,130.6,sp|Q5BJT4|TXD15_RAT Thioredoxin domain-containing protein 15 OS=Rattus norvegicus OX=10116 GN=Txndc15 PE=2 SV=1,GO:0005929; GO:0045880; GO:0060170; GO:0060271,cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880],ciliary membrane [GO:0060170]; cilium [GO:0005929],,GO:0005929; GO:0043226; GO:0044782,cilium; organelle; cilium organization
OG_07098,1.0948691986479864,FUN_032356-T1,Peve_00001943,Pocillopora_meandrina_HIv1___RNAseq.g29814.t1,three_way,72.94966666666667,FUN_032356-T1,O95876,FRITZ_HUMAN,,WD repeat-containing and planar cell polarity effector protein fritz homolog (hFRTZ) (Bardet-Biedl syndrome 15 protein) (WD repeat-containing and planar cell polarity effector protein),Homo sapiens (Human),42.2,720.0,3.6e-153,543.5,sp|O95876|FRITZ_HUMAN WD repeat-containing and planar cell polarity effector protein fritz homolog OS=Homo sapiens OX=9606 GN=WDPCP PE=1 SV=2,GO:0001736; GO:0001822; GO:0002093; GO:0005886; GO:0005929; GO:0005930; GO:0007224; GO:0007399; GO:0010762; GO:0016476; GO:0021915; GO:0032185; GO:0032880; GO:0035091; GO:0042073; GO:0042733; GO:0043010; GO:0043587; GO:0044782; GO:0045184; GO:0051893; GO:0055123; GO:0060021; GO:0060271; GO:0060541; GO:0072359; GO:0090521; GO:0097541; GO:1900027; GO:1902017; GO:2000114,auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; podocyte cell migration [GO:0090521]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587],axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886],phosphatidylinositol binding [GO:0035091],GO:0005886; GO:0005929; GO:0007010; GO:0007018; GO:0008289; GO:0043226; GO:0044782; GO:0048856; GO:0048870,plasma membrane; cilium; cytoskeleton organization; microtubule-based movement; lipid binding; organelle; cilium organization; anatomical structure development; cell motility
OG_07101,1.304671683675808,FUN_032361-T1,Peve_00045028,Pocillopora_meandrina_HIv1___RNAseq.g29818.t1,three_way,57.91883333333333,FUN_032361-T1,Q8C3S2,,,,,33.1,1162.0,1.7e-147,525.4,sp|Q8C3S2|TNG6_MOUSE Transport and Golgi organization protein 6 homolog OS=Mus musculus OX=10090 GN=Tango6 PE=1 SV=1,,,,,,
OG_07102,2.6735436289042744,FUN_032363-T1,Peve_00045030,Pocillopora_meandrina_HIv1___RNAseq.g29819.t1,three_way,59.871500000000005,FUN_032363-T1,Q6N021,TET2_HUMAN,,Methylcytosine dioxygenase TET2 (EC 1.14.11.80),Homo sapiens (Human),32.8,825.0,5.8e-99,364.4,sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3,GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579; GO:0141167,"chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]",chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0009101; GO:0016491; GO:0030154; GO:0043226; GO:0140097; GO:1901135,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; glycoprotein biosynthetic process; oxidoreductase activity; cell differentiation; organelle; catalytic activity, acting on DNA; carbohydrate derivative metabolic process"
OG_07103,3.893688661989071,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_07108,1.6658254292385029,FUN_032378-T1,Peve_00041776,Pocillopora_meandrina_HIv1___RNAseq.7604_t,three_way,89.479,FUN_032378-T1,Q5R7J8,TP4A1_PONAB,,Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),64.7,167.0,1.4000000000000001e-59,230.7,sp|Q5R7J8|TP4A1_PONAB Protein tyrosine phosphatase type IVA 1 OS=Pongo abelii OX=9601 GN=PTP4A1 PE=2 SV=1,GO:0004725; GO:0005634; GO:0005769; GO:0005783; GO:0005819; GO:0005886,,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819],protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005768; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07110,1.0744240661341196,FUN_032381-T1,Peve_00041787,Pocillopora_meandrina_HIv1___RNAseq.g24369.t2,three_way,58.79066666666667,FUN_032381-T1,Q0VGT4,ZGRF1_MOUSE,,5'-3' DNA helicase ZGRF1 (EC 5.6.2.3) (GRF-type zinc finger domain-containing protein 1),Mus musculus (Mouse),49.1,846.0,3.2e-210,734.2,sp|Q0VGT4|ZGRF1_MOUSE 5'-3' DNA helicase ZGRF1 OS=Mus musculus OX=10090 GN=Zgrf1 PE=1 SV=2,GO:0000725; GO:0005524; GO:0005634; GO:0008270; GO:0016787; GO:0043139,recombinational repair [GO:0000725],nucleus [GO:0005634],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07116,1.354288032943611,FUN_032392-T1,Peve_00023247,Pocillopora_meandrina_HIv1___RNAseq.g29740.t1,three_way,68.81316666666666,FUN_032392-T1,Q641M3,,,,,38.8,134.0,3.6e-23,109.4,sp|Q641M3|TMM18_DANRE Transmembrane protein 18 OS=Danio rerio OX=7955 GN=tmem18 PE=2 SV=1,,,,,,
OG_07123,1.4258989514564486,FUN_032422-T1,Peve_00009161,Pocillopora_meandrina_HIv1___RNAseq.g21126.t1,three_way,56.91133333333333,,,,,,,,,,,,,,,,,
OG_07129,1.578373820383227,FUN_032429-T1,Peve_00027369,Pocillopora_meandrina_HIv1___RNAseq.g24121.t1,three_way,86.55766666666666,FUN_032429-T1,O95847,UCP4_HUMAN,,Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27),Homo sapiens (Human),60.4,303.0,4.3e-103,375.9,sp|O95847|UCP4_HUMAN Mitochondrial uncoupling protein 4 OS=Homo sapiens OX=9606 GN=SLC25A27 PE=1 SV=1,GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0015078; GO:0015108; GO:0022857; GO:0031966; GO:0035356; GO:0042803; GO:0043025; GO:0043524; GO:0045177; GO:0046324; GO:0048839; GO:0051562,inner ear development [GO:0048839]; intracellular triglyceride homeostasis [GO:0035356]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; regulation of D-glucose import [GO:0046324]; response to cold [GO:0009409],apical part of cell [GO:0045177]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025],chloride transmembrane transporter activity [GO:0015108]; protein homodimerization activity [GO:0042803]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005739; GO:0043226; GO:0048856,transporter activity; mitochondrion; organelle; anatomical structure development
OG_07131,1.288607705785923,FUN_032432-T1,Peve_00038723,Pocillopora_meandrina_HIv1___RNAseq.g24125.t1,three_way,82.28133333333334,FUN_032432-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),32.3,431.0,5.6e-52,206.8,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_07132,1.4254611065437073,FUN_032433-T1,Peve_00038721,Pocillopora_meandrina_HIv1___RNAseq.g20796.t1b,three_way,50.24216666666667,FUN_032433-T1,Q12789,TF3C1_HUMAN,,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),Homo sapiens (Human),25.0,1605.0,2.7e-101,372.9,sp|Q12789|TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens OX=9606 GN=GTF3C1 PE=1 SV=4,GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904,5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127],DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995],GO:0003677; GO:0005654; GO:0005730; GO:0006351; GO:0006399; GO:0043226; GO:0140223,DNA binding; nucleoplasm; nucleolus; DNA-templated transcription; tRNA metabolic process; organelle; general transcription initiation factor activity
OG_07134,1.0430388625233673,FUN_032459-T1,Peve_00009149,Pocillopora_meandrina_HIv1___RNAseq.g24151.t1,three_way,75.24633333333333,,,,,,,,,,,,,,,,,
OG_07136,1.8171214443401933,FUN_032461-T1,Peve_00009147,Pocillopora_meandrina_HIv1___RNAseq.g24160.t1,three_way,52.884,FUN_032461-T1,G5ECX0,LPLT2_CAEEL,,Latrophilin-like protein LAT-2,Caenorhabditis elegans,35.2,369.0,3.4e-52,208.0,sp|G5ECX0|LPLT2_CAEEL Latrophilin-like protein LAT-2 OS=Caenorhabditis elegans OX=6239 GN=lat-2 PE=2 SV=1,GO:0004175; GO:0004930; GO:0005886; GO:0007166; GO:0030246; GO:0097264,cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264],plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930],GO:0003824; GO:0005886; GO:0016787; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_07138,1.5441758480793202,FUN_032464-T1,Peve_00009180,Pocillopora_meandrina_HIv1___TS.g12111.t1,three_way,65.44783333333334,FUN_032464-T1,E1BB03,ZRAB3_BOVIN,,DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)],Bos taurus (Bovine),45.5,521.0,7.4999999999999995e-115,416.0,sp|E1BB03|ZRAB3_BOVIN DNA annealing helicase and endonuclease ZRANB3 OS=Bos taurus OX=9913 GN=ZRANB3 PE=3 SV=3,GO:0004386; GO:0004520; GO:0005524; GO:0006281; GO:0006974; GO:0008270; GO:0009411; GO:0031297; GO:0036310; GO:0043596; GO:0070530,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; replication fork processing [GO:0031297]; response to UV [GO:0009411],nuclear replication fork [GO:0043596],ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA endonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006281; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA repair; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07147,1.2589533564465265,FUN_032482-T1,Peve_00045320,Pocillopora_meandrina_HIv1___RNAseq.g24339.t1,three_way,75.098,FUN_032482-T1,Q866A2,,,,,39.7,312.0,4.7e-52,206.5,sp|Q866A2|ACHA7_MACMU Neuronal acetylcholine receptor subunit alpha-7 OS=Macaca mulatta OX=9544 GN=CHRNA7 PE=2 SV=1,,,,,,
OG_07150,1.0554746807134368,FUN_032503-T1,Peve_00042404,Pocillopora_meandrina_HIv1___TS.g12263.t1,three_way,58.67733333333334,FUN_032503-T1,Q20191,,,,,47.1,204.0,5.400000000000001e-44,181.0,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_07153,1.1629548446405675,FUN_032526-T1,Peve_00000682,Pocillopora_meandrina_HIv1___RNAseq.g24734.t1,three_way,53.52583333333333,,,,,,,,,,,,,,,,,
OG_07157,1.3637679436991854,FUN_032542-T1,Peve_00000698,Pocillopora_meandrina_HIv1___TS.g12666.t1,three_way,53.22266666666667,FUN_032542-T1,Q6P4Y6,,,,,31.6,465.0,2.0000000000000003e-48,195.7,sp|Q6P4Y6|IRS1_XENTR Insulin receptor substrate 1 OS=Xenopus tropicalis OX=8364 GN=irs1 PE=2 SV=1,,,,,,
OG_07158,1.16854889237391,FUN_032568-T1,Peve_00000699,Pocillopora_meandrina_HIv1___RNAseq.g24716.t1b,three_way,85.37066666666666,FUN_032568-T1,F1M8G0,,,,,33.0,764.0,2.5e-102,374.4,sp|F1M8G0|PHTF1_RAT Protein PHTF1 OS=Rattus norvegicus OX=10116 GN=Phtf1 PE=1 SV=1,,,,,,
OG_07159,2.0288261600670703,FUN_032569-T1,Peve_00000700,Pocillopora_meandrina_HIv1___RNAseq.g24716.t1a,three_way,75.09,FUN_032569-T1,Q5FWL4,EST2A_XENLA,,Extended synaptotagmin-2-A (E-Syt2-A),Xenopus laevis (African clawed frog),28.4,855.0,1.4000000000000001e-89,332.4,sp|Q5FWL4|EST2A_XENLA Extended synaptotagmin-2-A OS=Xenopus laevis OX=8355 GN=esyt2-a PE=2 SV=1,GO:0005509; GO:0005544; GO:0005789; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268,endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091],GO:0008289; GO:0016192,lipid binding; vesicle-mediated transport
OG_07160,2.7841924613291407,FUN_032571-T1,Peve_00000701,Pocillopora_meandrina_HIv1___RNAseq.g24714.t1,three_way,68.33,FUN_032571-T1,O95497,VNN1_HUMAN,,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1),Homo sapiens (Human),45.2,496.0,7.1e-112,406.0,sp|O95497|VNN1_HUMAN Pantetheinase OS=Homo sapiens OX=9606 GN=VNN1 PE=1 SV=2,GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015938; GO:0015939; GO:0016020; GO:0017159; GO:0033089; GO:0035577; GO:0045087; GO:0098552; GO:0098609; GO:1902177,acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; coenzyme A catabolic process [GO:0015938]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pantothenate metabolic process [GO:0015939]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979],azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],pantetheine hydrolase activity [GO:0017159],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0006575; GO:0006790; GO:0006954; GO:0007155; GO:0016787; GO:0055086; GO:0098542,immune system process; catalytic activity; extracellular region; plasma membrane; modified amino acid metabolic process; sulfur compound metabolic process; inflammatory response; cell adhesion; hydrolase activity; nucleobase-containing small molecule metabolic process; defense response to other organism
OG_07161,2.6340050514857305,FUN_032573-T1,Peve_00020057,Pocillopora_meandrina_HIv1___RNAseq.g24657.t1,three_way,46.22766666666666,FUN_032573-T1,Q90876,,,,,34.0,153.0,5.600000000000001e-23,109.4,sp|Q90876|IRF1_CHICK Interferon regulatory factor 1 OS=Gallus gallus OX=9031 GN=IRF1 PE=2 SV=1,,,,,,
OG_07162,1.6807900255331647,FUN_032574-T1,Peve_00020059,Pocillopora_meandrina_HIv1___RNAseq.g24656.t1,three_way,65.90716666666667,FUN_032574-T1,P23906,,,,,51.3,117.0,2.3999999999999999e-35,150.6,sp|P23906|IRF2_MOUSE Interferon regulatory factor 2 OS=Mus musculus OX=10090 GN=Irf2 PE=1 SV=1,,,,,,
OG_07165,1.177371372652124,FUN_032583-T1,Peve_00026847,Pocillopora_meandrina_HIv1___RNAseq.g24648.t1,three_way,42.123333333333335,,,,,,,,,,,,,,,,,
OG_07166,1.2395484195547326,FUN_032584-T1,Peve_00024132,Pocillopora_meandrina_HIv1___TS.g12593.t1,three_way,79.44666666666666,FUN_032584-T1,A3KPN8,,,,,50.9,456.0,4.1e-137,489.6,sp|A3KPN8|TTC38_DANRE Tetratricopeptide repeat protein 38 OS=Danio rerio OX=7955 GN=ttc38 PE=3 SV=1,,,,,,
OG_07167,1.6543290182157666,FUN_032602-T1,Peve_00001527,Pocillopora_meandrina_HIv1___RNAseq.g24628.t1,three_way,85.47983333333333,FUN_032602-T1,Q9Y2J2,E41L3_HUMAN,,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",Homo sapiens (Human),51.7,348.0,4e-95,349.7,sp|Q9Y2J2|E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens OX=9606 GN=EPB41L3 PE=1 SV=2,GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005929; GO:0006915; GO:0008360; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0036064; GO:0043217; GO:0044224; GO:0048812; GO:0071205; GO:0072659; GO:0098696; GO:0098794; GO:0098978; GO:0106006,actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696],cell junction [GO:0030054]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],actin binding [GO:0003779]; cytoskeletal protein-membrane anchor activity [GO:0106006]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007010; GO:0008092; GO:0012501; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659,structural molecule activity; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeleton organization; cytoskeletal protein binding; programmed cell death; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane
OG_07173,1.5109589773945225,FUN_032611-T1,Peve_00026810,Pocillopora_meandrina_HIv1___RNAseq.g29794.t1,three_way,66.65333333333334,FUN_032611-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),42.2,393.0,4.2e-78,293.5,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_07177,1.8846513425821632,FUN_032628-T1,Peve_00033703,Pocillopora_meandrina_HIv1___RNAseq.g29789.t1,three_way,82.41583333333334,FUN_032628-T1,Q9EQW7,KI13A_MOUSE,,Kinesin-like protein KIF13A,Mus musculus (Mouse),47.9,1454.0,0.0,1170.6,sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1,GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005874; GO:0006886; GO:0008017; GO:0008333; GO:0010008; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383,cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459],centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016853; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; protein localization to plasma membrane; ATP-dependent activity
OG_07178,1.672594962604371,FUN_032629-T1,Peve_00033684,Pocillopora_meandrina_HIv1___RNAseq.g24118.t1,three_way,65.04233333333333,FUN_032629-T1,Q91175,,,,,32.9,316.0,2.3000000000000002e-33,144.4,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_07179,1.8653677730320568,FUN_032632-T1,Peve_00033689,Pocillopora_meandrina_HIv1___RNAseq.g24117.t1,three_way,60.99433333333333,FUN_032632-T1,Q5ZIJ9,,,,,45.3,1029.0,1.5e-112,409.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_07183,2.6629174494130083,FUN_032641-T1,Peve_00015953,Pocillopora_meandrina_HIv1___RNAseq.g24113.t1,three_way,69.64766666666667,FUN_032641-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.4,2239.0,9.5e-255,882.9,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_07185,2.75106228460336,FUN_032676-T1,Peve_00015960,Pocillopora_meandrina_HIv1___RNAseq.g24112.t1,three_way,78.02799999999999,FUN_032676-T1,Q4KMZ8,NKAI1_HUMAN,,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 1) (Protein FAM77C),Homo sapiens (Human),45.9,205.0,1.6e-45,184.1,sp|Q4KMZ8|NKAI1_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 OS=Homo sapiens OX=9606 GN=NKAIN1 PE=2 SV=3,GO:0002028; GO:0005886; GO:0051117,regulation of sodium ion transport [GO:0002028],plasma membrane [GO:0005886],ATPase binding [GO:0051117],GO:0005886,plasma membrane
OG_07198,1.2360734048037827,FUN_032706-T1,Peve_00029923,Pocillopora_meandrina_HIv1___RNAseq.g29870.t1,three_way,82.68833333333333,FUN_032706-T1,Q63ZI0,,,,,51.8,257.0,2.8e-65,250.4,sp|Q63ZI0|KCNK9_XENLA Potassium channel subfamily K member 9 OS=Xenopus laevis OX=8355 GN=kcnk9 PE=2 SV=1,,,,,,
OG_07203,1.5983417989902242,FUN_032738-T1,Peve_00029918,Pocillopora_meandrina_HIv1___RNAseq.g29876.t1,three_way,86.90433333333334,FUN_032738-T1,P49739,,,,,65.5,823.0,6e-285,981.5,sp|P49739|MCM3M_XENLA Maternal DNA replication licensing factor mcm3 OS=Xenopus laevis OX=8355 GN=mmcm3 PE=1 SV=2,,,,,,
OG_07205,1.7117185038000544,FUN_032745-T1,Peve_00029929,Pocillopora_meandrina_HIv1___RNAseq.g29880.t1,three_way,55.068333333333335,FUN_032745-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),29.8,540.0,7.7e-54,213.8,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_07206,1.1388432441487268,FUN_032747-T1,Peve_00006280,Pocillopora_meandrina_HIv1___RNAseq.g29883.t1,three_way,65.71983333333333,FUN_032747-T1,Q8CJG0,AGO2_MOUSE,,Protein argonaute-2 (Argonaute2) (mAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Piwi/argonaute family protein meIF2C2) (Protein slicer),Mus musculus (Mouse),49.0,851.0,2.2e-220,767.3,sp|Q8CJG0|AGO2_MOUSE Protein argonaute-2 OS=Mus musculus OX=10090 GN=Ago2 PE=1 SV=3,GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0009791; GO:0010467; GO:0010586; GO:0010628; GO:0016442; GO:0030154; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0033962; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035925; GO:0043489; GO:0045727; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090128; GO:0090624; GO:0090625; GO:0098794; GO:0098808; GO:0098978; GO:1900153; GO:1901165; GO:1990904,"cell differentiation [GO:0030154]; gene expression [GO:0010467]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of translational initiation [GO:0045947]; P-body assembly [GO:0033962]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of synapse maturation [GO:0090128]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RISC complex assembly [GO:0070922]; RNA stabilization [GO:0043489]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578],"core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0031047; GO:0043226; GO:0065003; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_07213,1.03407866312374,FUN_032772-T1,Peve_00017712,Pocillopora_meandrina_HIv1___RNAseq.g29730.t1,three_way,60.71333333333333,,,,,,,,,,,,,,,,,
OG_07215,1.8592450893175547,FUN_032774-T1,Peve_00010354,Pocillopora_meandrina_HIv1___RNAseq.g29728.t1,three_way,61.269333333333336,,,,,,,,,,,,,,,,,
OG_07218,2.4041950091878537,FUN_032790-T1,Peve_00010373,Pocillopora_meandrina_HIv1___RNAseq.g29721.t1,three_way,55.391333333333336,FUN_032790-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),38.8,456.0,1.5999999999999999e-83,312.8,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07221,1.5040234178036938,FUN_032814-T1,Peve_00014511,Pocillopora_meandrina_HIv1___RNAseq.g29708.t1,three_way,72.67099999999999,FUN_032814-T1,A7SCH8,KYNU_NEMVE,,Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase),Nematostella vectensis (Starlet sea anemone),58.9,472.0,1.2e-166,587.8,sp|A7SCH8|KYNU_NEMVE Kynureninase OS=Nematostella vectensis OX=45351 GN=kynu PE=3 SV=1,GO:0005737; GO:0019441; GO:0019805; GO:0030170; GO:0030429; GO:0034354; GO:0043420; GO:0097053,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; L-tryptophan catabolic process to kynurenine [GO:0019441]; quinolinate biosynthetic process [GO:0019805],cytoplasm [GO:0005737],kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0006520; GO:0016787; GO:0055086,catalytic activity; amino acid metabolic process; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_07223,1.748605302232629,FUN_032817-T1,Peve_00014521,Pocillopora_meandrina_HIv1___RNAseq.g29683.t2,three_way,71.64333333333333,FUN_032817-T1,Q8K0Q5,,,,,40.2,540.0,1.3e-92,342.4,sp|Q8K0Q5|RHG18_MOUSE Rho GTPase-activating protein 18 OS=Mus musculus OX=10090 GN=Arhgap18 PE=1 SV=1,,,,,,
OG_07224,1.0537951219379662,FUN_032825-T1,Peve_00014525,Pocillopora_meandrina_HIv1___TS.g24937.t1a,three_way,59.772,FUN_032825-T1,A1ZAY1,DLISH_DROME,,SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains),Drosophila melanogaster (Fruit fly),55.6,63.0,2.3e-14,81.6,sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1,GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219,establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251],apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219],cadherin binding [GO:0045296],GO:0005929; GO:0007163; GO:0043226,cilium; establishment or maintenance of cell polarity; organelle
OG_07229,1.824948311666922,FUN_032885-T1,Peve_00001722,Pocillopora_meandrina_HIv1___RNAseq.g29858.t1,three_way,52.5095,,,,,,,,,,,,,,,,,
OG_07233,1.650585743923278,FUN_032906-T1,Peve_00014529,Pocillopora_meandrina_HIv1___RNAseq.g24991.t1,three_way,83.96633333333334,FUN_032906-T1,Q14671,,,,,46.1,1272.0,9e-53,210.7,sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3,,,,,,
OG_07234,1.1325845927197635,FUN_032907-T1,Peve_00014530,Pocillopora_meandrina_HIv1___RNAseq.g24992.t1,three_way,79.497,FUN_032907-T1,Q5PQ53,PEF1_XENLA,,Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1),Xenopus laevis (African clawed frog),49.1,165.0,3.699999999999999e-43,176.4,sp|Q5PQ53|PEF1_XENLA Peflin OS=Xenopus laevis OX=8355 GN=pef1 PE=1 SV=1,GO:0005509; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0031463; GO:0048208; GO:0048306; GO:1902527; GO:1990756,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527],COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; endoplasmic reticulum [GO:0005783],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0065003,endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_07235,1.2726622310921556,FUN_032908-T1,Peve_00014533,Pocillopora_meandrina_HIv1___RNAseq.g24988.t1,three_way,75.6895,FUN_032908-T1,Q9JKP8,,,,,42.9,105.0,2.1e-16,86.7,sp|Q9JKP8|CHRC1_MOUSE Chromatin accessibility complex protein 1 OS=Mus musculus OX=10090 GN=Chrac1 PE=1 SV=1,,,,,,
OG_07236,1.3748757393004405,FUN_032909-T1,Peve_00014534,Pocillopora_meandrina_HIv1___TS.g12926.t1,three_way,60.93333333333333,,,,,,,,,,,,,,,,,
OG_07238,1.0863608010679704,FUN_032958-T1,Peve_00014537,Pocillopora_meandrina_HIv1___RNAseq.g24985.t1,three_way,92.142,FUN_032958-T1,Q16204,CCDC6_HUMAN,,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),Homo sapiens (Human),66.4,369.0,7.5e-39,162.9,sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2,GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802,,cytoskeleton [GO:0005856]; cytosol [GO:0005829],identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005829; GO:0005856; GO:0043226,structural molecule activity; cytosol; cytoskeleton; organelle
OG_07241,1.819310783445849,FUN_032971-T1,Peve_00017817,Pocillopora_meandrina_HIv1___RNAseq.g29687.t1,three_way,75.51633333333334,FUN_032971-T1,Q8IX29,,,,,52.3,214.0,1.3e-58,228.4,sp|Q8IX29|FBX16_HUMAN F-box only protein 16 OS=Homo sapiens OX=9606 GN=FBXO16 PE=1 SV=1,,,,,,
OG_07243,1.330920970997183,FUN_032973-T1,Peve_00015586,Pocillopora_meandrina_HIv1___RNAseq.g29689.t1,three_way,85.39766666666667,FUN_032973-T1,Q4QRK0,MAP11_DANRE,,Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1),Danio rerio (Zebrafish) (Brachydanio rerio),68.7,380.0,8.099999999999999e-160,564.7,sp|Q4QRK0|MAP11_DANRE Methionine aminopeptidase 1 OS=Danio rerio OX=7955 GN=metap1 PE=2 SV=2,GO:0004239; GO:0005829; GO:0006882; GO:0008270; GO:0016485; GO:0022626; GO:0070006,intracellular zinc ion homeostasis [GO:0006882]; protein processing [GO:0016485],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626],initiator methionyl aminopeptidase activity [GO:0004239]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005840; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; cytosol; ribosome; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_07244,1.8402017358686484,FUN_032974-T1,Peve_00017818,Pocillopora_meandrina_HIv1___RNAseq.g29686.t1,three_way,48.894,,,,,,,,,,,,,,,,,
OG_07245,1.0777733061993109,FUN_032975-T1,Peve_00014556,Pocillopora_meandrina_HIv1___RNAseq.g24981.t1,three_way,41.4585,,,,,,,,,,,,,,,,,
OG_07248,1.5260478205974393,FUN_032987-T2,Peve_00014549,Pocillopora_meandrina_HIv1___RNAseq.g24997.t1,three_way,40.58166666666667,,,,,,,,,,,,,,,,,
OG_07255,1.1595140058225883,FUN_033022-T1,Peve_00017508,Pocillopora_meandrina_HIv1___RNAseq.g24456.t1,three_way,78.04766666666666,FUN_033022-T1,Q99835,SMO_HUMAN,,Protein smoothened (Protein Gx),Homo sapiens (Human),48.7,435.0,2.7000000000000003e-126,453.8,sp|Q99835|SMO_HUMAN Protein smoothened OS=Homo sapiens OX=9606 GN=SMO PE=1 SV=1,GO:0000122; GO:0001570; GO:0001649; GO:0001701; GO:0001708; GO:0001755; GO:0001933; GO:0001947; GO:0002052; GO:0002053; GO:0003140; GO:0003323; GO:0004862; GO:0004930; GO:0005113; GO:0005770; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005886; GO:0005929; GO:0006606; GO:0006915; GO:0007224; GO:0007371; GO:0007389; GO:0007405; GO:0007417; GO:0007494; GO:0008142; GO:0009952; GO:0010467; GO:0010628; GO:0010629; GO:0021513; GO:0021542; GO:0021696; GO:0021794; GO:0021904; GO:0021953; GO:0021987; GO:0030335; GO:0030425; GO:0030666; GO:0030857; GO:0031069; GO:0034236; GO:0035264; GO:0040018; GO:0042307; GO:0042475; GO:0043066; GO:0043231; GO:0043392; GO:0045880; GO:0045944; GO:0046622; GO:0048143; GO:0048741; GO:0048745; GO:0048853; GO:0048873; GO:0050673; GO:0050679; GO:0050821; GO:0051451; GO:0051799; GO:0060170; GO:0060242; GO:0060413; GO:0060644; GO:0060684; GO:0061053; GO:0061113; GO:0070062; GO:0070986; GO:0071397; GO:0071542; GO:0071679; GO:0072285; GO:0090190; GO:0097542; GO:0097731; GO:0140311; GO:1902140; GO:1904672; GO:2000826,anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial cell proliferation [GO:0050673]; epithelial-mesenchymal cell signaling [GO:0060684]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; pattern specification process [GO:0007389]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of heart morphogenesis [GO:2000826]; regulation of somatic stem cell population maintenance [GO:1904672]; response to inositol [GO:1902140]; skeletal muscle fiber development [GO:0048741]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371],9+0 non-motile cilium [GO:0097731]; centriole [GO:0005814]; ciliary membrane [GO:0060170]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; plasma membrane [GO:0005886],cAMP-dependent protein kinase inhibitor activity [GO:0004862]; G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]; patched binding [GO:0005113]; protein kinase A catalytic subunit binding [GO:0034236]; protein sequestering activity [GO:0140311],GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006355; GO:0006886; GO:0006913; GO:0008289; GO:0012501; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0098772; GO:0140313,endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; cilium; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; lipid binding; programmed cell death; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; molecular function regulator activity; molecular sequestering activity
OG_07257,1.232323827418876,FUN_033025-T1,Peve_00017504,Pocillopora_meandrina_HIv1___RNAseq.g24453.t1,three_way,59.50533333333333,,,,,,,,,,,,,,,,,
OG_07258,1.2981336395202934,FUN_033035-T1,Peve_00017503,Pocillopora_meandrina_HIv1___RNAseq.g24452.t1,three_way,61.70483333333333,,,,,,,,,,,,,,,,,
OG_07259,1.117705921467186,FUN_033036-T1,Peve_00017502,Pocillopora_meandrina_HIv1___RNAseq.g24450.t1,three_way,76.906,FUN_033036-T1,Q96QG7,,,,,53.2,329.0,2.6e-101,370.2,sp|Q96QG7|MTMR9_HUMAN Myotubularin-related protein 9 OS=Homo sapiens OX=9606 GN=MTMR9 PE=1 SV=1,,,,,,
OG_07261,1.53694335710811,FUN_033038-T1,Peve_00017501,Pocillopora_meandrina_HIv1___RNAseq.g24448.t1,three_way,84.66233333333334,FUN_033038-T1,Q5ZM55,,,,,46.0,624.0,7.899999999999999e-83,309.7,sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1,,,,,,
OG_07262,2.2517253853687675,FUN_033039-T1,Peve_00017500,Pocillopora_meandrina_HIv1___RNAseq.g24445.t1,three_way,64.32033333333334,FUN_033039-T1,O94766,,,,,45.2,303.0,1.9e-65,251.1,sp|O94766|B3GA3_HUMAN Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Homo sapiens OX=9606 GN=B3GAT3 PE=1 SV=2,,,,,,
OG_07266,1.87828693490254,FUN_033114-T1,Peve_00019518,Pocillopora_meandrina_HIv1___RNAseq.g24261.t1,three_way,54.964666666666666,FUN_033114-T1,Q1EG27,MYO3B_MOUSE,,Myosin-IIIb (EC 2.7.11.1),Mus musculus (Mouse),33.6,769.0,3.6e-116,421.4,sp|Q1EG27|MYO3B_MOUSE Myosin-IIIb OS=Mus musculus OX=10090 GN=Myo3b PE=1 SV=2,GO:0000146; GO:0001750; GO:0001917; GO:0003779; GO:0004674; GO:0005524; GO:0005829; GO:0007601; GO:0007605; GO:0016459; GO:0030832; GO:0032426; GO:0032433; GO:0051491; GO:0060088; GO:0090103; GO:0106310,auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytosol [GO:0005829]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0005829; GO:0008092; GO:0016740; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytosol; cytoskeletal protein binding; transferase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07268,1.767623222994487,FUN_033119-T1,Peve_00013204,Pocillopora_meandrina_HIv1___TS.g25013.t2,three_way,69.678,FUN_033119-T1,Q9R1R2,TRIM3_MOUSE,,Tripartite motif-containing protein 3 (EC 2.3.2.27) (RING finger protein 22) (RING finger protein HAC1),Mus musculus (Mouse),23.2,482.0,3.9e-23,111.7,sp|Q9R1R2|TRIM3_MOUSE Tripartite motif-containing protein 3 OS=Mus musculus OX=10090 GN=Trim3 PE=1 SV=1,GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0034141; GO:0042802; GO:0061351; GO:0061630; GO:0070534,neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein K63-linked ubiquitination [GO:0070534]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07271,1.5504191096667592,FUN_033127-T1,Peve_00043508,Pocillopora_meandrina_HIv1___RNAseq.g29764.t1,three_way,64.51100000000001,FUN_033127-T1,P0C152,MKS3_RAT,,Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67),Rattus norvegicus (Rat),39.0,1006.0,3.6e-183,643.7,sp|P0C152|MKS3_RAT Meckelin OS=Rattus norvegicus OX=10116 GN=Tmem67 PE=1 SV=1,GO:0001822; GO:0005789; GO:0005813; GO:0005930; GO:0007368; GO:0007507; GO:0010826; GO:0030659; GO:0031005; GO:0035567; GO:0035845; GO:0035869; GO:0036038; GO:0036503; GO:0048754; GO:0051082; GO:0051787; GO:0060170; GO:0060271; GO:0060322; GO:0060441; GO:1902857; GO:1904294,branching morphogenesis of an epithelial tube [GO:0048754]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERAD pathway [GO:0036503]; head development [GO:0060322]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of centrosome duplication [GO:0010826]; non-canonical Wnt signaling pathway [GO:0035567]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of non-motile cilium assembly [GO:1902857],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; MKS complex [GO:0036038],filamin binding [GO:0031005]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082],GO:0005815; GO:0008092; GO:0030163; GO:0044782; GO:0048856,microtubule organizing center; cytoskeletal protein binding; protein catabolic process; cilium organization; anatomical structure development
OG_07272,1.0491050902065868,FUN_033210-T1,Peve_00043517,Pocillopora_meandrina_HIv1___RNAseq.g29763.t1,three_way,93.34833333333331,FUN_033210-T1,P63328,PP2BA_MOUSE,,Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform),Mus musculus (Mouse),80.6,407.0,2.1e-201,703.0,sp|P63328|PP2BA_MOUSE Protein phosphatase 3 catalytic subunit alpha OS=Mus musculus OX=10090 GN=Ppp3ca PE=1 SV=1,GO:0000082; GO:0004721; GO:0004723; GO:0005516; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008287; GO:0008544; GO:0009898; GO:0010613; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0019722; GO:0023057; GO:0030018; GO:0030216; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0042104; GO:0042383; GO:0043197; GO:0045669; GO:0045672; GO:0045807; GO:0045944; GO:0046872; GO:0046878; GO:0046983; GO:0048741; GO:0048813; GO:0050774; GO:0050804; GO:0051117; GO:0051592; GO:0060079; GO:0061006; GO:0070886; GO:0090193; GO:0097205; GO:0098685; GO:0098978; GO:0099170; GO:0110062; GO:1903244; GO:1905205; GO:1905665; GO:1905949,calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy in response to stress [GO:0014898]; dendrite morphogenesis [GO:0048813]; epidermis development [GO:0008544]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiotensin-activated signaling pathway [GO:0110062]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of signaling [GO:0023057]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of saliva secretion [GO:0046878]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; regulation of cell proliferation involved in kidney morphogenesis [GO:0061006]; renal filtration [GO:0097205]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein serine/threonine phosphatase complex [GO:0008287]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018],ATPase binding [GO:0051117]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein dimerization activity [GO:0046983],GO:0003012; GO:0003014; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"muscle system process; renal system process; catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07273,1.0551928408346334,FUN_033212-T1,Peve_00043513,Pocillopora_meandrina_HIv1___RNAseq.g29767.t1,three_way,73.36633333333333,FUN_033212-T1,Q99NA2,ATOH8_MOUSE,,Transcription factor Atoh8 (Helix-loop-helix protein mATH-6) (mATH6) (Okadin) (Protein atonal homolog 8),Mus musculus (Mouse),47.4,116.0,4.5e-17,89.4,sp|Q99NA2|ATOH8_MOUSE Transcription factor Atoh8 OS=Mus musculus OX=10090 GN=Atoh8 PE=1 SV=1,GO:0001704; GO:0001937; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0008134; GO:0010595; GO:0010629; GO:0016607; GO:0030154; GO:0035148; GO:0045603; GO:0045892; GO:0045893; GO:0046983; GO:0051450; GO:0060391; GO:0070888; GO:0140297; GO:1902895,cell differentiation [GO:0030154]; formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; tube formation [GO:0035148],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07284,1.5325085915949923,FUN_033608-T1,Peve_00041752,Pocillopora_meandrina_HIv1___RNAseq.g24385.t1,three_way,81.65133333333334,FUN_033608-T1,Q9QUR6,,,,,66.5,708.0,4.9e-299,1028.1,sp|Q9QUR6|PPCE_MOUSE Prolyl endopeptidase OS=Mus musculus OX=10090 GN=Prep PE=1 SV=1,,,,,,
OG_07286,1.018639650559898,FUN_033666-T1,Peve_00006805,Pocillopora_meandrina_HIv1___RNAseq.g28824.t1,three_way,56.083,,,,,,,,,,,,,,,,,
OG_07289,1.1398112934153697,FUN_033670-T1,Peve_00037062,Pocillopora_meandrina_HIv1___RNAseq.g28727.t1,three_way,77.678,,,,,,,,,,,,,,,,,
OG_07290,1.2153891120513771,FUN_033671-T1,Peve_00037059,Pocillopora_meandrina_HIv1___RNAseq.g28729.t1,three_way,39.33133333333333,FUN_033671-T1,A2APV2,,,,,42.6,237.0,1.1e-43,179.9,sp|A2APV2|FMNL2_MOUSE Formin-like protein 2 OS=Mus musculus OX=10090 GN=Fmnl2 PE=1 SV=2,,,,,,
OG_07291,1.0320317779610386,FUN_033672-T1,Peve_00037093,Pocillopora_meandrina_HIv1___RNAseq.g25923.t1,three_way,75.25266666666667,FUN_033672-T1,O05218,,,,,36.4,549.0,6.5e-89,329.7,sp|O05218|YWRD_BACSU Glutathione hydrolase-like YwrD proenzyme OS=Bacillus subtilis (strain 168) OX=224308 GN=ywrD PE=1 SV=1,,,,,,
OG_07293,1.1463512297069582,FUN_033675-T1,Peve_00006808,Pocillopora_meandrina_HIv1___TS.g8603.t2,three_way,61.733,FUN_033675-T1,Q8R1N4,,,,,33.3,360.0,2.1e-53,211.1,sp|Q8R1N4|NUDC3_MOUSE NudC domain-containing protein 3 OS=Mus musculus OX=10090 GN=Nudcd3 PE=1 SV=3,,,,,,
OG_07311,1.0375925438357485,FUN_033700-T1,Peve_00027581,Pocillopora_meandrina_HIv1___RNAseq.g28769.t1,three_way,83.841,FUN_033700-T1,Q2HZX7,FUZZY_XENTR,,Protein fuzzy homolog (Xfy),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),47.5,417.0,1.0999999999999999e-107,391.7,sp|Q2HZX7|FUZZY_XENTR Protein fuzzy homolog OS=Xenopus tropicalis OX=8364 GN=fuz PE=1 SV=1,GO:0001736; GO:0001843; GO:0005737; GO:0005856; GO:0008589; GO:0010172; GO:0015031; GO:0016192; GO:0042995; GO:0048704; GO:0060271,cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; neural tube closure [GO:0001843]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],,GO:0005856; GO:0016192; GO:0043226; GO:0044782,cytoskeleton; vesicle-mediated transport; organelle; cilium organization
OG_07315,1.1958807116132215,FUN_033707-T1,Peve_00042846,Pocillopora_meandrina_HIv1___TS.g18650.t1,three_way,55.01383333333333,FUN_033707-T1,Q6S5C2,GNPTG_MOUSE,,N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (M6PR domain-containing protein 1) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma),Mus musculus (Mouse),40.2,276.0,7.9e-49,196.1,sp|Q6S5C2|GNPTG_MOUSE N-acetylglucosamine-1-phosphotransferase subunit gamma OS=Mus musculus OX=10090 GN=Gnptg PE=1 SV=1,GO:0005576; GO:0005794; GO:0042803; GO:0046835,carbohydrate phosphorylation [GO:0046835],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],protein homodimerization activity [GO:0042803],GO:0005576; GO:0005794; GO:0005975; GO:0043226,extracellular region; Golgi apparatus; carbohydrate metabolic process; organelle
OG_07318,1.1682233186972562,FUN_033711-T1,Peve_00014636,Pocillopora_meandrina_HIv1___RNAseq.g28838.t1,three_way,71.58500000000001,FUN_033711-T1,O00418,EF2K_HUMAN,,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),Homo sapiens (Human),45.3,695.0,2.2e-155,550.8,sp|O00418|EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2,GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637,cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]",GO:0003824; GO:0005829; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07319,1.7013471516513294,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),34.7,404.0,4.399999999999997e-47,191.8,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07319,1.7013471516513294,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),36.6,243.0,1.1e-37,160.6,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07323,1.2252871711854671,FUN_033717-T1,Peve_00017865,Pocillopora_meandrina_HIv1___RNAseq.g25848.t1,three_way,68.39483333333334,FUN_033717-T1,Q8CHU3,EPN2_MOUSE,,Epsin-2 (EPS-15-interacting protein 2) (Intersectin-EH-binding protein 2) (Ibp2),Mus musculus (Mouse),47.6,361.0,7.300000000000001e-74,279.6,sp|Q8CHU3|EPN2_MOUSE Epsin-2 OS=Mus musculus OX=10090 GN=Epn2 PE=1 SV=1,GO:0001701; GO:0005737; GO:0006897; GO:0007219; GO:0008289; GO:0048568,embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; Notch signaling pathway [GO:0007219],cytoplasm [GO:0005737],lipid binding [GO:0008289],GO:0008289; GO:0016192; GO:0048856,lipid binding; vesicle-mediated transport; anatomical structure development
OG_07326,1.1920653791912497,FUN_033720-T1,Peve_00027572,Pocillopora_meandrina_HIv1___RNAseq.g25888.t1,three_way,75.48283333333333,FUN_033720-T1,Q8VDL4,ADPGK_MOUSE,,ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147),Mus musculus (Mouse),32.2,428.0,2.5e-49,198.0,sp|Q8VDL4|ADPGK_MOUSE ADP-dependent glucokinase OS=Mus musculus OX=10090 GN=Adpgk PE=1 SV=2,GO:0005576; GO:0006006; GO:0006096; GO:0043843; GO:0046872,glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096],extracellular region [GO:0005576],ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0005975; GO:0006091; GO:0016740; GO:0055086; GO:1901135,catalytic activity; extracellular region; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07329,1.3199214496481204,FUN_033730-T1,Peve_00027615,Pocillopora_meandrina_HIv1___RNAseq.g28784.t1,three_way,68.86500000000001,FUN_033730-T1,Q96RR1,PEO1_HUMAN,,"Twinkle mtDNA helicase (EC 5.6.2.3) (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)",Homo sapiens (Human),40.6,611.0,5.2e-118,426.8,sp|Q96RR1|PEO1_HUMAN Twinkle mtDNA helicase OS=Homo sapiens OX=9606 GN=TWNK PE=1 SV=1,GO:0000262; GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006261; GO:0006264; GO:0006390; GO:0008289; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139,DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214],mitochondrial chromosome [GO:0000262]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005694; GO:0005739; GO:0006260; GO:0006351; GO:0008289; GO:0016787; GO:0016853; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"DNA binding; catalytic activity; chromosome; mitochondrion; DNA replication; DNA-templated transcription; lipid binding; hydrolase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07334,1.349731479278282,FUN_033738-T1,Peve_00027592,Pocillopora_meandrina_HIv1___RNAseq.g28761.t1,three_way,77.64833333333334,FUN_033738-T1,Q3ZBH3,,,,,37.7,244.0,3e-46,186.8,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07336,1.2537408187792236,FUN_033740-T1,Peve_00027590,Pocillopora_meandrina_HIv1___TS.g8552.t1c,three_way,74.79316666666666,FUN_033740-T1,Q3ZBH3,,,,,33.3,192.0,1.9e-26,120.9,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07337,1.0479847912132003,FUN_033741-T1,Peve_00027596,Pocillopora_meandrina_HIv1___RNAseq.g26636.t1,three_way,45.35183333333333,FUN_033741-T1,Q16322,KCA10_HUMAN,,Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8),Homo sapiens (Human),31.0,116.0,4.5e-06,54.3,sp|Q16322|KCA10_HUMAN Potassium voltage-gated channel subfamily A member 10 OS=Homo sapiens OX=9606 GN=KCNA10 PE=1 SV=2,GO:0001508; GO:0005221; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016020; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_07339,2.120526881713877,FUN_033744-T1,Peve_00004928,Pocillopora_meandrina_HIv1___RNAseq.g28756.t1,three_way,54.52616666666667,FUN_033744-T1,O61735,,,,,28.5,362.0,1.4e-35,152.5,sp|O61735|CLOCK_DROME Circadian locomoter output cycles protein kaput OS=Drosophila melanogaster OX=7227 GN=Clk PE=1 SV=3,,,,,,
OG_07340,2.577438293347644,FUN_033745-T1,Peve_00004929,Pocillopora_meandrina_HIv1___RNAseq.g28757.t1,three_way,54.01,FUN_033745-T1,Q8QGQ6,CLOCK_CHICK,,Circadian locomoter output cycles protein kaput,Gallus gallus (Chicken),37.6,367.0,2.7000000000000002e-58,228.0,sp|Q8QGQ6|CLOCK_CHICK Circadian locomoter output cycles protein kaput OS=Gallus gallus OX=9031 GN=CLOCK PE=1 SV=2,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005829; GO:0006357; GO:0006473; GO:0006974; GO:0032922; GO:0046983; GO:0051775; GO:0070888; GO:1990513,circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; protein acetylation [GO:0006473]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775],CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07341,1.4594169125673202,FUN_033746-T1,Peve_00004930,Pocillopora_meandrina_HIv1___RNAseq.g16445.t1,three_way,68.84733333333334,,,,,,,,,,,,,,,,,
OG_07342,1.6817936729688243,FUN_033747-T1,Peve_00004931,Pocillopora_meandrina_HIv1___RNAseq.g28755.t1,three_way,74.33666666666667,FUN_033747-T1,Q9DCK3,,,,,40.9,220.0,1.4e-37,157.9,sp|Q9DCK3|TSN4_MOUSE Tetraspanin-4 OS=Mus musculus OX=10090 GN=Tspan4 PE=1 SV=1,,,,,,
OG_07344,1.9413457093438264,FUN_033751-T1,Peve_00004933,Pocillopora_meandrina_HIv1___TS.g8542.t1,three_way,79.90966666666667,FUN_033751-T1,O95461,,,,,60.2,689.0,6.4e-254,878.2,sp|O95461|LARG1_HUMAN Xylosyl- and glucuronyltransferase LARGE1 OS=Homo sapiens OX=9606 GN=LARGE1 PE=1 SV=1,,,,,,
OG_07347,1.0468229499774326,FUN_033754-T1,Peve_00004912,Pocillopora_meandrina_HIv1___TS.g8539.t2,three_way,70.884,FUN_033754-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),48.5,371.0,5.8e-94,345.9,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_07349,3.1163052831378675,FUN_033756-T1,Peve_00004915,Pocillopora_meandrina_HIv1___RNAseq.g28747.t1,three_way,85.5945,FUN_033756-T1,Q13136,LIPA1_HUMAN,,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),Homo sapiens (Human),45.4,1218.0,1.3e-187,658.7,sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1,GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077,cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444],,GO:0005829; GO:0007010; GO:0007155; GO:0034330; GO:0043226,cytosol; cytoskeleton organization; cell adhesion; cell junction organization; organelle
OG_07350,1.641935647691066,FUN_033757-T1,Peve_00004916,Pocillopora_meandrina_HIv1___RNAseq.g28746.t2,three_way,69.06666666666666,FUN_033757-T1,Q8IYG6,LRC56_HUMAN,,Leucine-rich repeat-containing protein 56,Homo sapiens (Human),35.6,413.0,1.5000000000000001e-30,136.0,sp|Q8IYG6|LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens OX=9606 GN=LRRC56 PE=1 SV=1,GO:0005929; GO:0030030,cell projection organization [GO:0030030],cilium [GO:0005929],,GO:0005929; GO:0043226,cilium; organelle
OG_07351,3.811731833505157,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_07354,1.4972269898219654,FUN_033762-T1,Peve_00009249,Pocillopora_meandrina_HIv1___TS.g8524.t1,three_way,86.10033333333332,FUN_033762-T1,Q9VFC8,GYS_DROME,,Glycogen [starch] synthase (EC 2.4.1.11) (Glycogen synthase),Drosophila melanogaster (Fruit fly),60.9,627.0,8e-232,804.7,sp|Q9VFC8|GYS_DROME Glycogen [starch] synthase OS=Drosophila melanogaster OX=7227 GN=Glys PE=1 SV=2,GO:0004373; GO:0005737; GO:0005776; GO:0005829; GO:0005978; GO:0009267; GO:0009744; GO:0031410; GO:0071329,cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; response to sucrose [GO:0009744],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829],"alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity [GO:0004373]",GO:0003824; GO:0005773; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0031410; GO:0043226,catalytic activity; vacuole; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; cytoplasmic vesicle; organelle
OG_07355,1.655723466395001,FUN_033763-T1,Peve_00009255,Pocillopora_meandrina_HIv1___RNAseq.g28734.t1,three_way,65.53633333333333,FUN_033763-T1,Q6NRZ1,,,,,29.8,1444.0,1.4e-132,476.1,sp|Q6NRZ1|BLT3B_XENLA Bridge-like lipid transfer protein family member 3B OS=Xenopus laevis OX=8355 GN=bltp3b PE=2 SV=1,,,,,,
OG_07357,1.2692646601097546,FUN_033767-T1,Peve_00005709,Pocillopora_meandrina_HIv1___RNAseq.g25936.t1,three_way,59.3455,,,,,,,,,,,,,,,,,
OG_07358,1.577531781476926,FUN_033769-T1,Peve_00006493,Pocillopora_meandrina_HIv1___RNAseq.g26662.t1,three_way,67.60866666666666,FUN_033769-T1,Q6B9X6,VWKA_DICDI,,Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase),Dictyostelium discoideum (Social amoeba),35.0,137.0,1.1e-14,82.4,sp|Q6B9X6|VWKA_DICDI Alpha-protein kinase vwkA OS=Dictyostelium discoideum OX=44689 GN=vwkA PE=1 SV=1,GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006971; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177; GO:0106310,contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005773; GO:0005829; GO:0007010; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"cytokinesis; catalytic activity; vacuole; cytosol; cytoskeleton organization; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07359,1.5745626759776992,FUN_033770-T1,Peve_00006489,Pocillopora_meandrina_HIv1___RNAseq.g26661.t1,three_way,47.22,FUN_033770-T1,P10733,,,,,27.9,204.0,1.2e-17,92.4,sp|P10733|SEVE_DICDI Severin OS=Dictyostelium discoideum OX=44689 GN=sevA PE=1 SV=1,,,,,,
OG_07360,1.953877303704027,FUN_033771-T1,Peve_00006491,Pocillopora_meandrina_HIv1___RNAseq.g26660.t1,three_way,47.66133333333333,FUN_033771-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),34.7,340.0,7.799999999999999e-49,196.1,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_07362,1.8299292630735209,FUN_033774-T1,Peve_00005278,Pocillopora_meandrina_HIv1___RNAseq.g26656.t1,three_way,62.04566666666667,,,,,,,,,,,,,,,,,
OG_07363,1.1619919333230673,FUN_033775-T1,Peve_00005277,Pocillopora_meandrina_HIv1___RNAseq.g26655.t1,three_way,73.41866666666667,FUN_033775-T1,Q64127,TIF1A_MOUSE,,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24),Mus musculus (Mouse),28.5,1018.0,1.7e-86,322.4,sp|Q64127|TIF1A_MOUSE Transcription intermediary factor 1-alpha OS=Mus musculus OX=10090 GN=Trim24 PE=1 SV=1,GO:0000791; GO:0001673; GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0008270; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043434; GO:0043565; GO:0045892; GO:0045893; GO:0050673; GO:0050680; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796,calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell proliferation [GO:0050673]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; response to peptide hormone [GO:0043434],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726],chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07372,1.185778716524205,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,43.9,214.0,1.7e-40,169.9,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07372,1.185778716524205,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,30.4,171.0,0.00058,48.5,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07375,1.463569947269279,FUN_033797-T1,Peve_00029703,Pocillopora_meandrina_HIv1___RNAseq.g26319.t1,three_way,67.2325,FUN_033797-T1,O95071,,,,,39.0,318.0,1.5e-52,211.1,sp|O95071|UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2,,,,,,
OG_07376,1.597800080497965,FUN_033798-T1,Peve_00029699,Pocillopora_meandrina_HIv1___TS.g19067.t1,three_way,72.4535,FUN_033798-T1,Q8R0S4,CACB4_MOUSE,,Voltage-dependent L-type calcium channel subunit beta-4 (CAB4) (Calcium channel voltage-dependent subunit beta 4),Mus musculus (Mouse),47.8,251.0,2.2999999999999998e-55,218.0,sp|Q8R0S4|CACB4_MOUSE Voltage-dependent L-type calcium channel subunit beta-4 OS=Mus musculus OX=10090 GN=Cacnb4 PE=1 SV=2,GO:0005245; GO:0005886; GO:0005891; GO:0006816; GO:0007214; GO:0007528; GO:0007628; GO:0008285; GO:0008331; GO:0014051; GO:0016607; GO:0019227; GO:0019901; GO:0035249; GO:0042391; GO:0046058; GO:0048536; GO:0048538; GO:0048541; GO:0050852; GO:0050877; GO:0050908; GO:0055001; GO:0098793; GO:0098978; GO:0099626; GO:1904751; GO:1990830; GO:2000134; GO:2000300,"adult walking behavior [GO:0007628]; calcium ion transport [GO:0006816]; cAMP metabolic process [GO:0046058]; cellular response to leukemia inhibitory factor [GO:1990830]; detection of light stimulus involved in visual perception [GO:0050908]; gamma-aminobutyric acid secretion [GO:0014051]; gamma-aminobutyric acid signaling pathway [GO:0007214]; muscle cell development [GO:0055001]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuronal action potential propagation [GO:0019227]; Peyer's patch development [GO:0048541]; positive regulation of protein localization to nucleolus [GO:1904751]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spleen development [GO:0048536]; synaptic transmission, glutamatergic [GO:0035249]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]",glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; voltage-gated calcium channel complex [GO:0005891],high voltage-gated calcium channel activity [GO:0008331]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626],GO:0002376; GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:1901135,immune system process; transporter activity; plasma membrane; signaling; cell junction organization; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07377,1.083890288543771,FUN_033799-T2,Peve_00007573,Pocillopora_meandrina_HIv1___RNAseq.g26317.t1,three_way,61.620666666666665,,,,,,,,,,,,,,,,,
OG_07382,1.1060487723997607,FUN_033804-T1,Peve_00009713,Pocillopora_meandrina_HIv1___RNAseq.g26323.t1,three_way,76.55666666666666,FUN_033804-T1,Q90341,,,,,52.7,91.0,6.4e-15,83.2,sp|Q90341|MYC1_CYPCA Transcriptional regulator Myc-1 OS=Cyprinus carpio OX=7962 GN=myca PE=3 SV=1,,,,,,
OG_07385,1.185047802759486,FUN_033812-T1,Peve_00028718,Pocillopora_meandrina_HIv1___RNAseq.g26345.t1,three_way,82.21633333333334,FUN_033812-T1,Q9C040,TRIM2_HUMAN,,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2),Homo sapiens (Human),28.2,550.0,1.4000000000000001e-59,232.6,sp|Q9C040|TRIM2_HUMAN Tripartite motif-containing protein 2 OS=Homo sapiens OX=9606 GN=TRIM2 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_07386,1.094494608268752,FUN_033813-T1,Peve_00028719,Pocillopora_meandrina_HIv1___RNAseq.g26346.t1,three_way,86.456,FUN_033813-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,533.0,2.9e-60,235.0,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07389,1.050779183552713,FUN_033818-T1,Peve_00028736,Pocillopora_meandrina_HIv1___RNAseq.g26354.t1,three_way,55.74516666666667,FUN_033818-T1,B3EWY6,,,,,96.4,386.0,1.3e-160,567.4,sp|B3EWY6|SAAR1_ACRMI Skeletal aspartic acid-rich protein 1 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_07391,1.027927552186013,FUN_033820-T1,Peve_00028743,Pocillopora_meandrina_HIv1___RNAseq.g26352.t1,three_way,71.83,FUN_033820-T1,Q80VW5,WHRN_MOUSE,,Whirlin,Mus musculus (Mouse),32.1,324.0,3.8000000000000004e-36,154.5,sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005829; GO:0005884; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032421; GO:0032426; GO:0036064; GO:0042802; GO:0043005; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005829; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; cytosol; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_07393,1.741690153643607,FUN_033823-T1,Peve_00028748,Pocillopora_meandrina_HIv1___RNAseq.g26350.t1,three_way,70.8005,,,,,,,,,,,,,,,,,
OG_07395,1.742696313229552,FUN_033834-T1,Peve_00028775,Pocillopora_meandrina_HIv1___RNAseq.g26359.t1,three_way,52.308,FUN_033834-T1,Q6L9W6,B4GN3_HUMAN,,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",Homo sapiens (Human),32.0,328.0,2e-52,208.8,"sp|Q6L9W6|B4GN3_HUMAN Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=B4GALNT3 PE=1 SV=2",GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231,,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0005794; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; transferase activity; organelle
OG_07403,1.6829685210651382,FUN_033845-T1,Peve_00039879,Pocillopora_meandrina_HIv1___RNAseq.g26135.t1,three_way,74.83,FUN_033845-T1,P50430,,,,,43.8,525.0,6.2e-118,426.0,sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2,,,,,,
OG_07404,2.1117690154934734,FUN_033855-T1,Peve_00039888,Pocillopora_meandrina_HIv1___RNAseq.g28422.t1,three_way,68.755,FUN_033855-T1,O75581,LRP6_HUMAN,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Homo sapiens (Human),46.7,1685.0,2.9e-254,880.6,sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2,GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909,canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851],coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005576; GO:0005783; GO:0005886; GO:0006355; GO:0007155; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0060089; GO:0072659; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; cell adhesion; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; molecular transducer activity; protein localization to plasma membrane; molecular function regulator activity
OG_07405,1.2134364639153865,FUN_033856-T2,Peve_00043300,Pocillopora_meandrina_HIv1___TS.g8205.t2,three_way,77.4,FUN_033856-T2,Q96KP4,CNDP2_HUMAN,,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase),Homo sapiens (Human),65.4,474.0,6.799999999999999e-188,658.3,sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2,GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573,proteolysis [GO:0006508],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07408,2.109494233276392,FUN_033861-T1,Peve_00043296,Pocillopora_meandrina_HIv1___RNAseq.g28415.t1,three_way,63.10766666666667,FUN_033861-T1,Q95JR6,,,,,28.8,295.0,3.5e-27,124.8,sp|Q95JR6|CNBD2_MACFA Cyclic nucleotide-binding domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=CNBD2 PE=2 SV=1,,,,,,
OG_07409,1.5219859261786914,FUN_033862-T1,Peve_00043295,Pocillopora_meandrina_HIv1___RNAseq.g28416.t1,three_way,77.74766666666666,,,,,,,,,,,,,,,,,
OG_07420,2.172324106822644,FUN_033882-T1,Peve_00043308,Pocillopora_meandrina_HIv1___RNAseq.g28395.t1,three_way,83.125,FUN_033882-T1,P08510,,,,,61.8,395.0,1.9e-120,434.5,sp|P08510|KCNAS_DROME Potassium voltage-gated channel protein Shaker OS=Drosophila melanogaster OX=7227 GN=Sh PE=1 SV=3,,,,,,
OG_07421,1.3061610016385492,FUN_033883-T1,Peve_00043307,Pocillopora_meandrina_HIv1___RNAseq.g28394.t1,three_way,75.87733333333333,FUN_033883-T1,P28739,,,,,55.2,377.0,4.1e-107,390.6,sp|P28739|KLPA_EMENI Kinesin-like protein klpA OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=klpA PE=2 SV=3,,,,,,
OG_07422,1.8882866246851149,FUN_033884-T1,Peve_00043305,Pocillopora_meandrina_HIv1___RNAseq.g28393.t1,three_way,52.554,,,,,,,,,,,,,,,,,
OG_07425,1.879354418100304,FUN_033890-T1,Peve_00035943,Pocillopora_meandrina_HIv1___RNAseq.g28382.t1,three_way,42.425,,,,,,,,,,,,,,,,,
OG_07428,1.5278882086917671,FUN_033913-T1,Peve_00032110,Pocillopora_meandrina_HIv1___RNAseq.g28372.t2,three_way,56.92033333333333,FUN_033913-T1,Q5R4A6,,,,,31.1,344.0,9.1e-40,166.8,sp|Q5R4A6|AMZ2_PONAB Archaemetzincin-2 OS=Pongo abelii OX=9601 GN=AMZ2 PE=2 SV=1,,,,,,
OG_07429,1.4833094036301404,FUN_033915-T1,Peve_00022636,Pocillopora_meandrina_HIv1___RNAseq.g26598.t1,three_way,74.89316666666667,FUN_033915-T1,E7EY42,PTSS2_DANRE,,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),Danio rerio (Zebrafish) (Brachydanio rerio),61.7,366.0,2.1e-146,520.4,sp|E7EY42|PTSS2_DANRE Phosphatidylserine synthase 2 OS=Danio rerio OX=7955 GN=ptdss2 PE=3 SV=1,GO:0005789; GO:0006659; GO:0106245,phosphatidylserine biosynthetic process [GO:0006659],endoplasmic reticulum membrane [GO:0005789],L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245],GO:0003824; GO:0006575; GO:0006629; GO:0016740,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity
OG_07430,1.812452567931208,FUN_033917-T1,Peve_00022631,Pocillopora_meandrina_HIv1___TS.g19347.t2a,three_way,44.82383333333333,,,,,,,,,,,,,,,,,
OG_07433,1.2963557061207849,FUN_033921-T1,Peve_00022625,Pocillopora_meandrina_HIv1___RNAseq.g26594.t1,three_way,72.53766666666667,FUN_033921-T1,Q8IUH5,ZDH17_HUMAN,,Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Acyltransferase ZDHHC17) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17) (DHHC17) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17),Homo sapiens (Human),50.0,564.0,7.8e-130,465.7,sp|Q8IUH5|ZDH17_HUMAN Palmitoyltransferase ZDHHC17 OS=Homo sapiens OX=9606 GN=ZDHHC17 PE=1 SV=2,GO:0000139; GO:0005102; GO:0005794; GO:0007409; GO:0016409; GO:0018345; GO:0019705; GO:0019706; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0042995; GO:0043067; GO:0043123; GO:0043231; GO:0051386; GO:0070372; GO:0098978; GO:0098987; GO:0140240; GO:0140439; GO:0150051,"axonogenesis [GO:0007409]; lipoprotein transport [GO:0042953]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein palmitoylation [GO:0018345]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of modification of synapse structure, modulating synaptic transmission [GO:0098987]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; regulation of programmed cell death [GO:0043067]",cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; intracellular membrane-bounded organelle [GO:0043231]; perforant pathway to dendrate granule cell synapse [GO:0140240]; postsynaptic Golgi apparatus [GO:0150051]; presynaptic membrane [GO:0042734],identical protein binding [GO:0042802]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07436,1.131824917409833,FUN_033926-T1,Peve_00022622,Pocillopora_meandrina_HIv1___TS.g19337.t1,three_way,74.93,,,,,,,,,,,,,,,,,
OG_07438,1.206879573375602,FUN_033928-T1,Peve_00022640,Pocillopora_meandrina_HIv1___RNAseq.g26589.t1,three_way,76.85166666666666,FUN_033928-T1,A6H8T2,,,,,34.0,712.0,1.4e-110,402.1,sp|A6H8T2|DNAI7_DANRE Dynein axonemal intermediate chain 7 OS=Danio rerio OX=7955 GN=dnai7 PE=2 SV=2,,,,,,
OG_07439,1.0407562928011131,FUN_033929-T1,Peve_00022639,Pocillopora_meandrina_HIv1___TS.g19340.t1,three_way,41.10216666666667,,,,,,,,,,,,,,,,,
OG_07441,4.0259688693230045,FUN_033933-T1,Peve_00020980,Pocillopora_meandrina_HIv1___RNAseq.g26583.t1,three_way,86.51866666666666,FUN_033933-T1,Q15915,ZIC1_HUMAN,,Zinc finger protein ZIC 1 (Zinc finger protein 201) (Zinc finger protein of the cerebellum 1),Homo sapiens (Human),37.8,249.0,1.7e-36,155.2,sp|Q15915|ZIC1_HUMAN Zinc finger protein ZIC 1 OS=Homo sapiens OX=9606 GN=ZIC1 PE=1 SV=2,GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007389; GO:0007417; GO:0007420; GO:0007628; GO:0008270; GO:0008589; GO:0010467; GO:0021510; GO:0021766; GO:0021772; GO:0030154; GO:0042307; GO:0042472; GO:0045893; GO:0098727; GO:1990837,adult walking behavior [GO:0007628]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; inner ear morphogenesis [GO:0042472]; maintenance of cell number [GO:0098727]; olfactory bulb development [GO:0021772]; pattern specification process [GO:0007389]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07442,2.294795893270276,FUN_033934-T1,Peve_00020984,Pocillopora_meandrina_HIv1___RNAseq.g26581.t1,three_way,92.2815,FUN_033934-T1,Q9IB89,,,,,45.0,169.0,3.2000000000000005e-33,144.4,sp|Q9IB89|ZIC5_XENLA Zinc finger protein ZIC 5 OS=Xenopus laevis OX=8355 GN=zic5 PE=2 SV=1,,,,,,
OG_07443,1.4556681358375505,FUN_033935-T1,Peve_00020986,Pocillopora_meandrina_HIv1___RNAseq.g26580.t1,three_way,84.01316666666666,FUN_033935-T1,Q6DJQ6,,,,,35.6,281.0,6.4e-32,140.2,sp|Q6DJQ6|ZIC3_XENTR Zinc finger protein ZIC 3 OS=Xenopus tropicalis OX=8364 GN=zic3 PE=2 SV=1,,,,,,
OG_07444,1.5346843094936855,FUN_033936-T1,Peve_00020989,Pocillopora_meandrina_HIv1___RNAseq.g26579.t1,three_way,66.17033333333333,FUN_033936-T1,Q9IB89,,,,,50.6,83.0,2.4e-20,101.7,sp|Q9IB89|ZIC5_XENLA Zinc finger protein ZIC 5 OS=Xenopus laevis OX=8355 GN=zic5 PE=2 SV=1,,,,,,
OG_07448,1.8722882854830256,FUN_033942-T1,Peve_00020994,Pocillopora_meandrina_HIv1___RNAseq.g26574.t1,three_way,64.84833333333333,FUN_033942-T1,P48733,,,,,43.3,127.0,1.1000000000000002e-28,131.3,sp|P48733|UROM_BOVIN Uromodulin OS=Bos taurus OX=9913 GN=UMOD PE=2 SV=1,,,,,,
OG_07449,2.4636381518032997,FUN_033943-T1,Peve_00020995,Pocillopora_meandrina_HIv1___RNAseq.g26573.t1,three_way,65.91733333333333,FUN_033943-T1,Q8WVB3,,,,,40.2,460.0,1.3e-86,322.0,sp|Q8WVB3|HEXD_HUMAN Hexosaminidase D OS=Homo sapiens OX=9606 GN=HEXD PE=1 SV=3,,,,,,
OG_07455,1.8332574956269807,FUN_033951-T1,Peve_00032117,Pocillopora_meandrina_HIv1___RNAseq.g28360.t1,three_way,65.717,,,,,,,,,,,,,,,,,
OG_07464,2.413862357755414,FUN_033968-T1,Peve_00015220,Pocillopora_meandrina_HIv1___RNAseq.g28549.t1,three_way,90.424,FUN_033968-T1,Q9Y2H1,ST38L_HUMAN,,Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2),Homo sapiens (Human),71.3,442.0,1.3e-188,660.6,sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens OX=9606 GN=STK38L PE=1 SV=3,GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0010507; GO:0015629; GO:0016020; GO:0035556; GO:0051128; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005829; GO:0005856; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07466,1.4005280266376772,FUN_033970-T2,Peve_00015222,Pocillopora_meandrina_HIv1___RNAseq.g26371.t1,three_way,71.7745,FUN_033970-T2,Q4V7B1,,,,,32.9,639.0,3.6999999999999998e-56,221.5,sp|Q4V7B1|CF20D_RAT Protein CFAP20DC OS=Rattus norvegicus OX=10116 GN=Cfap20dc PE=2 SV=1,,,,,,
OG_07467,1.3818731371762372,FUN_033971-T3,Peve_00015223,Pocillopora_meandrina_HIv1___RNAseq.g26370.t1,three_way,66.31200000000001,FUN_033971-T3,Q5E9H2,,,,,39.4,419.0,1.4e-85,318.5,sp|Q5E9H2|1A1L1_BOVIN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Bos taurus OX=9913 GN=ACCS PE=2 SV=1,,,,,,
OG_07469,1.8445142117017408,FUN_033979-T1,Peve_00004846,Pocillopora_meandrina_HIv1___RNAseq.g26111.t1,three_way,80.1855,FUN_033979-T1,O70247,,,,,40.7,570.0,5.3000000000000004e-111,403.3,sp|O70247|SC5A6_RAT Sodium-dependent multivitamin transporter OS=Rattus norvegicus OX=10116 GN=Slc5a6 PE=1 SV=1,,,,,,
OG_07471,1.122947447618183,FUN_033981-T1,Peve_00004845,Pocillopora_meandrina_HIv1___RNAseq.g26109.t1,three_way,70.14966666666666,FUN_033981-T1,A7S4N4,,,,,30.2,378.0,5.1e-38,160.2,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_07476,1.0089186852904573,FUN_033998-T2,Peve_00000499,Pocillopora_meandrina_HIv1___RNAseq.g26093.t2,three_way,69.55316666666667,FUN_033998-T2,Q8CDK2,,,,,49.7,734.0,1.8e-192,674.9,sp|Q8CDK2|CBPC2_MOUSE Cytosolic carboxypeptidase 2 OS=Mus musculus OX=10090 GN=Agbl2 PE=1 SV=1,,,,,,
OG_07483,1.4969886396852905,FUN_034008-T1,Peve_00033154,Pocillopora_meandrina_HIv1___RNAseq.g26086.t1,three_way,63.45133333333334,FUN_034008-T1,P46023,,,,,46.7,347.0,3.7e-84,314.7,sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_07491,1.796106676370524,FUN_034018-T1,Peve_00024700,Pocillopora_meandrina_HIv1___RNAseq.g26076.t1,three_way,64.037,FUN_034018-T1,Q9Z2E3,,,,,35.4,401.0,2.3e-51,206.5,sp|Q9Z2E3|ERN2_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Mus musculus OX=10090 GN=Ern2 PE=2 SV=2,,,,,,
OG_07495,1.0195272463191236,FUN_034026-T1,Peve_00034136,Pocillopora_meandrina_HIv1___RNAseq.g25924.t1,three_way,61.47733333333333,FUN_034026-T1,Q3ZBH3,,,,,35.5,242.0,6.9999999999999995e-40,165.6,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07499,1.0099817312007022,FUN_034036-T1,Peve_00019782,Pocillopora_meandrina_HIv1___RNAseq.g26045.t1b,three_way,76.29766666666667,FUN_034036-T1,Q95L46,,,,,39.6,793.0,4.6999999999999995e-143,510.0,sp|Q95L46|IF4G2_BOVIN Eukaryotic translation initiation factor 4 gamma 2 OS=Bos taurus OX=9913 GN=EIF4G2 PE=2 SV=2,,,,,,
OG_07500,1.9916724902539653,FUN_034039-T1,Peve_00023160,Pocillopora_meandrina_HIv1___RNAseq.17737_t,three_way,94.59466666666668,FUN_034039-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),80.3,188.0,1.6999999999999999e-84,313.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_07502,1.2213250405387288,FUN_034042-T1,Peve_00023162,Pocillopora_meandrina_HIv1___RNAseq.g26042.t1,three_way,74.04383333333334,FUN_034042-T1,Q9H0F5,,,,,39.1,207.0,1.7000000000000003e-28,128.6,sp|Q9H0F5|RNF38_HUMAN E3 ubiquitin-protein ligase RNF38 OS=Homo sapiens OX=9606 GN=RNF38 PE=1 SV=4,,,,,,
OG_07507,1.4468312012801436,FUN_034049-T1,Peve_00022955,Pocillopora_meandrina_HIv1___RNAseq.g26034.t2,three_way,61.748,FUN_034049-T1,Q9JIH2,NUP50_MOUSE,,Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50),Mus musculus (Mouse),30.3,478.0,2.7e-38,161.0,sp|Q9JIH2|NUP50_MOUSE Nuclear pore complex protein Nup50 OS=Mus musculus OX=10090 GN=Nup50 PE=1 SV=3,GO:0001841; GO:0005635; GO:0005643; GO:0005654; GO:0006913; GO:0015031; GO:0031965; GO:0051028; GO:1990904,mRNA transport [GO:0051028]; neural tube formation [GO:0001841]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904],,GO:0005635; GO:0005654; GO:0006913,nuclear envelope; nucleoplasm; nucleocytoplasmic transport
OG_07511,1.1746863735066804,FUN_034054-T1,Peve_00009943,Pocillopora_meandrina_HIv1___RNAseq.g26029.t1,three_way,82.816,FUN_034054-T1,Q9I829,,,,,52.2,385.0,3.7999999999999997e-90,333.6,sp|Q9I829|KCNA1_ONCMY Shaker-related potassium channel tsha2 OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_07512,1.6622960943446443,FUN_034055-T1,Peve_00015322,Pocillopora_meandrina_HIv1___RNAseq.g26028.t2,three_way,81.44633333333333,FUN_034055-T1,O08873,MADD_RAT,,MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP),Rattus norvegicus (Rat),38.5,1719.0,1.8e-285,984.2,sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1,GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236,anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483],axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0007018; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; microtubule-based movement; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_07519,2.512148833320514,FUN_034088-T1,Peve_00037071,Pocillopora_meandrina_HIv1___RNAseq.g26059.t1,three_way,77.17566666666667,FUN_034088-T1,Q4V920,PACN1_DANRE,,Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1),Danio rerio (Zebrafish) (Brachydanio rerio),36.1,449.0,4.1e-70,266.9,sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006,actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; ruffle membrane [GO:0032587]; synapse [GO:0045202],phospholipid binding [GO:0005543],GO:0005768; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0044782; GO:0061024,endosome; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; cilium organization; membrane organization
OG_07520,1.7747153818863128,FUN_034090-T1,Peve_00037070,Pocillopora_meandrina_HIv1___RNAseq.g26061.t1,three_way,75.31133333333334,FUN_034090-T1,Q9I9H8,,,,,36.6,1258.0,6.2000000000000005e-146,520.4,sp|Q9I9H8|APAF_DANRE Apoptotic protease-activating factor 1 OS=Danio rerio OX=7955 GN=apaf1 PE=2 SV=1,,,,,,
OG_07523,1.4285377357182458,FUN_034093-T1,Peve_00037067,Pocillopora_meandrina_HIv1___RNAseq.g26065.t1,three_way,65.31416666666668,FUN_034093-T1,Q641G4,,,,,38.5,642.0,2.6e-94,347.8,sp|Q641G4|CNDH2_XENLA Condensin-2 complex subunit H2 OS=Xenopus laevis OX=8355 GN=ncaph2 PE=1 SV=1,,,,,,
OG_07526,1.8937874960564824,FUN_034096-T1,Peve_00006468,Pocillopora_meandrina_HIv1___TS.g18816.t1b,three_way,49.18933333333333,FUN_034096-T1,E7F211,TTC17_DANRE,,Tetratricopeptide repeat protein 17 (TPR repeat protein 17),Danio rerio (Zebrafish) (Brachydanio rerio),26.7,1249.0,1.1e-72,276.9,sp|E7F211|TTC17_DANRE Tetratricopeptide repeat protein 17 OS=Danio rerio OX=7955 GN=ttc17 PE=3 SV=1,GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371,actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005856; GO:0005886; GO:0043226; GO:0044782; GO:0065003,cytoskeleton; plasma membrane; organelle; cilium organization; protein-containing complex assembly
OG_07528,1.0166025233872933,FUN_034098-T1,Peve_00042343,Pocillopora_meandrina_HIv1___RNAseq.g26070.t1,three_way,59.001,FUN_034098-T1,Q9NQ36,SCUB2_HUMAN,,"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)",Homo sapiens (Human),41.2,85.0,1.9e-12,75.9,"sp|Q9NQ36|SCUB2_HUMAN Signal peptide, CUB and EGF-like domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCUBE2 PE=1 SV=3",GO:0005509; GO:0005576; GO:0005615; GO:0007165; GO:0008289; GO:0009986,signal transduction [GO:0007165],cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; lipid binding [GO:0008289],GO:0005576; GO:0005615; GO:0008289,extracellular region; extracellular space; lipid binding
OG_07532,1.3567938605231813,FUN_034108-T1,Peve_00035268,Pocillopora_meandrina_HIv1___RNAseq.g25963.t1,three_way,83.90533333333333,FUN_034108-T1,P17972,KCNAW_DROME,,Potassium voltage-gated channel protein Shaw (Shaw2),Drosophila melanogaster (Fruit fly),49.9,433.0,1.8e-110,401.4,sp|P17972|KCNAW_DROME Potassium voltage-gated channel protein Shaw OS=Drosophila melanogaster OX=7227 GN=Shaw PE=2 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431],axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_07533,1.5988898226270738,FUN_034109-T1,Peve_00034853,Pocillopora_meandrina_HIv1___RNAseq.g25962.t1,three_way,67.35366666666667,FUN_034109-T1,P55265,DSRAD_HUMAN,,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),Homo sapiens (Human),33.4,739.0,5.6e-90,334.0,sp|P55265|DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens OX=9606 GN=ADAR PE=1 SV=4,GO:0001649; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016020; GO:0016553; GO:0030218; GO:0031054; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0097284; GO:0098586; GO:1900369; GO:1903944,adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; hepatocyte apoptotic process [GO:0097284]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530],DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006886; GO:0006913; GO:0012501; GO:0016071; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098542; GO:0140098,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; intracellular protein transport; nucleocytoplasmic transport; programmed cell death; mRNA metabolic process; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA"
OG_07536,1.134009857413697,FUN_034112-T1,Peve_00034854,Pocillopora_meandrina_HIv1___RNAseq.g25957.t1,three_way,95.99733333333332,FUN_034112-T1,P61211,,,,,86.2,181.0,9.1e-85,314.3,sp|P61211|ARL1_MOUSE ADP-ribosylation factor-like protein 1 OS=Mus musculus OX=10090 GN=Arl1 PE=1 SV=1,,,,,,
OG_07538,1.1087593118828316,FUN_034114-T1,Peve_00034856,Pocillopora_meandrina_HIv1___RNAseq.g25955.t1,three_way,88.02533333333334,FUN_034114-T1,O54747,DPOD1_RAT,,DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-),Rattus norvegicus (Rat),65.3,1059.0,0.0,1419.8,sp|O54747|DPOD1_RAT DNA polymerase delta catalytic subunit OS=Rattus norvegicus OX=10116 GN=Pold1 PE=2 SV=1,GO:0000109; GO:0000166; GO:0000731; GO:0000781; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0006261; GO:0006287; GO:0006297; GO:0008270; GO:0008296; GO:0008408; GO:0019899; GO:0034644; GO:0043625; GO:0045004; GO:0051539; GO:0055089; GO:0070987; GO:0071897,"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]","chromosome, telomeric region [GO:0000781]; delta DNA polymerase complex [GO:0043625]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]","3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_07539,1.1344281021065188,FUN_034120-T1,Peve_00039587,Pocillopora_meandrina_HIv1___RNAseq.g25948.t2,three_way,82.97233333333334,FUN_034120-T1,A0A0G2K047,ACSS3_RAT,,"Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Acyl-CoA synthetase short-chain family member 3) (Propionate--CoA ligase) (EC 6.2.1.17)",Rattus norvegicus (Rat),54.1,625.0,2.0000000000000002e-212,740.3,"sp|A0A0G2K047|ACSS3_RAT Acyl-CoA synthetase short-chain family member 3, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acss3 PE=1 SV=1",GO:0003987; GO:0005524; GO:0005759; GO:0006629; GO:0031956; GO:0050218,lipid metabolic process [GO:0006629],mitochondrial matrix [GO:0005759],acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0006629; GO:0016874; GO:0140657,catalytic activity; lipid metabolic process; ligase activity; ATP-dependent activity
OG_07547,1.226411066110747,FUN_034129-T1,Peve_00006387,Pocillopora_meandrina_HIv1___RNAseq.g25940.t1,three_way,75.964,FUN_034129-T1,O02703,BAX_BOVIN,,Apoptosis regulator BAX,Bos taurus (Bovine),37.1,140.0,9.6e-19,95.1,sp|O02703|BAX_BOVIN Apoptosis regulator BAX OS=Bos taurus OX=9913 GN=BAX PE=2 SV=1,GO:0001783; GO:0001836; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0008053; GO:0008289; GO:0008630; GO:0008637; GO:0009636; GO:0010248; GO:0010917; GO:0015267; GO:0031334; GO:0032091; GO:0032976; GO:0042803; GO:0042981; GO:0043065; GO:0043525; GO:0043653; GO:0046930; GO:0051434; GO:0051881; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:2001244,apoptotic mitochondrial changes [GO:0008637]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein binding [GO:0032091]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to toxic substance [GO:0009636],BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930],BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0007005; GO:0008289; GO:0012501; GO:0043226; GO:0055085,transporter activity; nucleus; mitochondrion; endoplasmic reticulum; cytosol; mitochondrion organization; lipid binding; programmed cell death; organelle; transmembrane transport
OG_07548,1.780605997643081,FUN_034130-T1,Peve_00006386,Pocillopora_meandrina_HIv1___RNAseq.g26664.t1,three_way,57.29133333333333,,,,,,,,,,,,,,,,,
OG_07553,1.9496109257799084,FUN_034144-T1,Peve_00018769,Pocillopora_meandrina_HIv1___RNAseq.g26305.t1,three_way,57.939,FUN_034144-T1,Q9UPZ3,HPS5_HUMAN,,BLOC-2 complex member HPS5 (Alpha-integrin-binding protein 63) (Hermansky-Pudlak syndrome 5 protein) (Ruby-eye protein 2 homolog) (Ru2),Homo sapiens (Human),32.0,425.0,2.9e-54,216.1,sp|Q9UPZ3|HPS5_HUMAN BLOC-2 complex member HPS5 OS=Homo sapiens OX=9606 GN=HPS5 PE=1 SV=2,GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232,blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155],BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769],,GO:0005768; GO:0005829; GO:0031410; GO:0043226,endosome; cytosol; cytoplasmic vesicle; organelle
OG_07554,3.996073532799239,FUN_034149-T1,Peve_00026010,Pocillopora_meandrina_HIv1___TS.g23718.t1b,three_way,50.663833333333336,,,,,,,,,,,,,,,,,
OG_07555,1.2103335882991109,FUN_034159-T1,Peve_00018778,Pocillopora_meandrina_HIv1___RNAseq.g26287.t1,three_way,78.49566666666666,FUN_034159-T1,Q8CFE4,SCYL2_MOUSE,,SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa),Mus musculus (Mouse),55.5,600.0,1.7e-193,677.9,sp|Q8CFE4|SCYL2_MOUSE SCY1-like protein 2 OS=Mus musculus OX=10090 GN=Scyl2 PE=1 SV=1,GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0031623; GO:0072583; GO:0090090,brain development [GO:0007420]; clathrin-dependent endocytosis [GO:0072583]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; pyramidal neuron development [GO:0021860]; receptor internalization [GO:0031623],clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005794; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07557,1.4547271995394309,FUN_034162-T1,Peve_00039725,Pocillopora_meandrina_HIv1___RNAseq.g26285.t1,three_way,67.07516666666666,FUN_034162-T1,Q9TRY0,,,,,48.3,402.0,1.3e-98,361.7,sp|Q9TRY0|FKBP4_BOVIN Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Bos taurus OX=9913 GN=FKBP4 PE=1 SV=4,,,,,,
OG_07559,1.18319610774505,FUN_034173-T1,Peve_00006812,Pocillopora_meandrina_HIv1___RNAseq.g26278.t1,three_way,85.85433333333333,FUN_034173-T1,Q6UPE0,CHDH_RAT,,"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)",Rattus norvegicus (Rat),63.8,450.0,6.7e-177,621.7,"sp|Q6UPE0|CHDH_RAT Choline dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Chdh PE=1 SV=1",GO:0005743; GO:0008812; GO:0019285; GO:0050660,glycine betaine biosynthetic process from choline [GO:0019285],mitochondrial inner membrane [GO:0005743],choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660],GO:0003824; GO:0006575; GO:0016491,catalytic activity; modified amino acid metabolic process; oxidoreductase activity
OG_07563,1.022519875812883,FUN_034209-T1,Peve_00027534,Pocillopora_meandrina_HIv1___RNAseq.g26169.t1,three_way,56.48,,,,,,,,,,,,,,,,,
OG_07567,1.9317939989512352,FUN_034229-T1,Peve_00040765,Pocillopora_meandrina_HIv1___RNAseq.g28437.t1,three_way,83.228,FUN_034229-T1,Q8IWQ3,BRSK2_HUMAN,,Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A),Homo sapiens (Human),50.3,650.0,3.4999999999999997e-169,596.7,sp|Q8IWQ3|BRSK2_HUMAN Serine/threonine-protein kinase BRSK2 OS=Homo sapiens OX=9606 GN=BRSK2 PE=1 SV=3,GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0019901; GO:0021953; GO:0030010; GO:0030036; GO:0030182; GO:0036503; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0106310; GO:0150034; GO:1904152; GO:2000807,"actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell division [GO:0051301]; central nervous system neuron differentiation [GO:0021953]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005783; GO:0005815; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endoplasmic reticulum; microtubule organizing center; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07569,1.5651512521862367,FUN_034231-T1,Peve_00000637,Pocillopora_meandrina_HIv1___RNAseq.g28439.t1,three_way,80.96333333333334,FUN_034231-T1,Q8VI63,,,,,46.2,212.0,1.0999999999999999e-47,191.4,sp|Q8VI63|MOB2_MOUSE MOB kinase activator 2 OS=Mus musculus OX=10090 GN=Mob2 PE=1 SV=1,,,,,,
OG_07570,1.1272628756135192,FUN_034232-T1,Peve_00000638,Pocillopora_meandrina_HIv1___RNAseq.g28440.t1,three_way,77.614,FUN_034232-T1,Q7ZXF5,FACR1_XENLA,,Fatty acyl-CoA reductase 1 (Far1) (EC 1.2.1.84),Xenopus laevis (African clawed frog),46.0,506.0,1e-133,478.4,sp|Q7ZXF5|FACR1_XENLA Fatty acyl-CoA reductase 1 OS=Xenopus laevis OX=8355 GN=far1 PE=2 SV=1,GO:0005777; GO:0005778; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965,ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025],peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],alcohol-forming long-chain fatty acyl-CoA reductase activity [GO:0102965]; alcohol-forming very long-chain fatty acyl-CoA reductase activity [GO:0080019],GO:0003824; GO:0005777; GO:0006629; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; peroxisome; lipid metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07577,1.616478453503852,FUN_034258-T1,Peve_00009313,Pocillopora_meandrina_HIv1___RNAseq.g26618.t1,three_way,57.11,FUN_034258-T1,A0A386CAB9,NLRP1_DANRE,,"NACHT, LRR and PYD domains-containing protein 1 homolog (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1, C-terminus (NLRP1-CT); NACHT, LRR and PYD domains-containing protein 1, N-terminus (NLRP1-NT)]",Danio rerio (Zebrafish) (Brachydanio rerio),23.4,402.0,5e-16,88.6,"sp|A0A386CAB9|NLRP1_DANRE NACHT, LRR and PYD domains-containing protein 1 homolog OS=Danio rerio OX=7955 GN=nlrp1 PE=1 SV=1",GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0006954; GO:0008233; GO:0012501; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0061702; GO:0072558,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981],canonical inflammasome complex [GO:0061702]; cytoplasm [GO:0005737]; NLRP1 inflammasome complex [GO:0072558],ATP binding [GO:0005524]; peptidase activity [GO:0008233],GO:0002376; GO:0003824; GO:0006954; GO:0012501; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; inflammatory response; programmed cell death; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07579,1.121172898759898,FUN_034260-T1,Peve_00009311,Pocillopora_meandrina_HIv1___RNAseq.g26620.t1,three_way,74.869,FUN_034260-T1,Q9H2X6,HIPK2_HUMAN,,Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1),Homo sapiens (Human),49.5,662.0,4.4e-159,563.9,sp|Q9H2X6|HIPK2_HUMAN Homeodomain-interacting protein kinase 2 OS=Homo sapiens OX=9606 GN=HIPK2 PE=1 SV=2,GO:0000122; GO:0001654; GO:0003016; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007179; GO:0007224; GO:0007628; GO:0008283; GO:0008284; GO:0009952; GO:0010467; GO:0010494; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0030182; GO:0030218; GO:0030330; GO:0030511; GO:0030514; GO:0030578; GO:0030878; GO:0040029; GO:0042771; GO:0043524; GO:0045766; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051402; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0060425; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059,"adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; gene expression [GO:0010467]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; lung morphogenesis [GO:0060425]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of JNK cascade [GO:0046330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; respiratory system process [GO:0003016]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790],GO:0003016; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140096; GO:0140110,"respiratory system process; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07581,1.1909005127420105,FUN_034265-T2,Peve_00039352,Pocillopora_meandrina_HIv1___RNAseq.g26635.t1,three_way,82.47233333333334,FUN_034265-T2,O15992,,,,,76.4,700.0,0.0,1118.6,sp|O15992|KARG_ANTJA Arginine kinase OS=Anthopleura japonica OX=67755 PE=1 SV=1,,,,,,
OG_07590,1.3148697051930474,FUN_034294-T1,Peve_00013952,Pocillopora_meandrina_HIv1___RNAseq.g28509.t1,three_way,53.21816666666667,,,,,,,,,,,,,,,,,
OG_07593,2.0605939072588484,FUN_034298-T1,Peve_00013945,Pocillopora_meandrina_HIv1___RNAseq.g28503.t1,three_way,77.514,FUN_034298-T1,P28285,,,,,30.0,217.0,3.3e-14,80.9,sp|P28285|5HT2A_DROME 5-hydroxytryptamine receptor 2A OS=Drosophila melanogaster OX=7227 GN=5-HT1A PE=2 SV=2,,,,,,
OG_07594,2.5831772790874936,FUN_034300-T1,Peve_00013958,Pocillopora_meandrina_HIv1___RNAseq.g28501.t1,three_way,80.99333333333334,FUN_034300-T1,Q86WG5,MTMRD_HUMAN,,Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2),Homo sapiens (Human),39.3,2002.0,0.0,1303.1,sp|Q86WG5|MTMRD_HUMAN Myotubularin-related protein 13 OS=Homo sapiens OX=9606 GN=SBF2 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005774; GO:0005829; GO:0006914; GO:0010008; GO:0016020; GO:0019208; GO:0019902; GO:0030424; GO:0035091; GO:0042552; GO:0042802; GO:0048471,autophagy [GO:0006914]; myelination [GO:0042552],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006914; GO:0008289; GO:0098772,cytosol; autophagy; lipid binding; molecular function regulator activity
OG_07595,1.5794961066212043,FUN_034301-T1,Peve_00019147,Pocillopora_meandrina_HIv1___RNAseq.g28498.t1,three_way,69.90066666666667,FUN_034301-T1,Q803M5,,,,,33.4,392.0,1.2e-47,192.6,sp|Q803M5|SAAL1_DANRE Protein saal1 OS=Danio rerio OX=7955 GN=saal1 PE=2 SV=2,,,,,,
OG_07596,2.5278022717617668,FUN_034303-T1,Peve_00019148,Pocillopora_meandrina_HIv1___RNAseq.g28500.t1,three_way,76.81366666666666,FUN_034303-T1,Q15256,,,,,35.3,544.0,8.4e-69,263.1,sp|Q15256|PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens OX=9606 GN=PTPRR PE=1 SV=2,,,,,,
OG_07598,1.0782593200650537,FUN_034312-T1,Peve_00011305,Pocillopora_meandrina_HIv1___RNAseq.g28493.t1,three_way,91.465,FUN_034312-T1,Q9VSF3,UBC2M_DROME,,Nedd8-conjugating enzyme UbcE2M (EC 2.3.2.34) (Nedd8 carrier protein),Drosophila melanogaster (Fruit fly),74.9,179.0,1.4e-77,290.4,sp|Q9VSF3|UBC2M_DROME Nedd8-conjugating enzyme UbcE2M OS=Drosophila melanogaster OX=7227 GN=UbcE2M PE=1 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0036211; GO:0045116; GO:0045879; GO:0061059; GO:0061654,negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein modification process [GO:0036211]; protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07602,1.222161434636339,FUN_034319-T1,Peve_00016715,Pocillopora_meandrina_HIv1___RNAseq.g28486.t1,three_way,86.86533333333334,FUN_034319-T1,Q501I9,,,,,33.9,445.0,1.6000000000000006e-59,231.9,sp|Q501I9|DIRC2_XENTR Solute carrier family 49 member 4 homolog OS=Xenopus tropicalis OX=8364 GN=slc49a4 PE=2 SV=1,,,,,,
OG_07605,1.560729649838226,FUN_034322-T1,Peve_00015003,Pocillopora_meandrina_HIv1___RNAseq.g28482.t1,three_way,81.48233333333333,FUN_034322-T1,Q14008,,,,,45.2,2083.0,0.0,1544.3,sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3,,,,,,
OG_07606,2.1849257701445417,FUN_034323-T1,Peve_00015002,Pocillopora_meandrina_HIv1___RNAseq.g28481.t1,three_way,65.10766666666666,FUN_034323-T1,Q3UR85,MYRF_MOUSE,,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]",Mus musculus (Mouse),54.0,404.0,1.5000000000000001e-117,425.6,sp|Q3UR85|MYRF_MOUSE Myelin regulatory factor OS=Mus musculus OX=10090 GN=Myrf PE=1 SV=2,GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0043565; GO:0045893; GO:0048709; GO:0048714,central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0061024; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein maturation; membrane organization; catalytic activity, acting on a protein; transcription regulator activity"
OG_07608,1.1803857878826314,FUN_034327-T1,Peve_00019143,Pocillopora_meandrina_HIv1___RNAseq.g28477.t1,three_way,46.769666666666666,,,,,,,,,,,,,,,,,
OG_07619,1.088181901300848,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),37.4,417.0,4.7e-65,251.9,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07619,1.088181901300848,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),56.3,158.0,7.6e-15,85.1,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07622,1.279601189932007,FUN_034367-T1,Peve_00036158,Pocillopora_meandrina_HIv1___RNAseq.g26130.t1,three_way,71.85166666666667,FUN_034367-T1,Q6IV56,,,,,34.6,243.0,5.799999999999999e-31,136.0,sp|Q6IV56|RN141_DANRE RING finger protein 141 OS=Danio rerio OX=7955 GN=rnf141 PE=2 SV=2,,,,,,
OG_07628,1.3003509769077937,FUN_034376-T1,Peve_00027168,Pocillopora_meandrina_HIv1___RNAseq.g26154.t1,three_way,68.84483333333333,FUN_034376-T1,E7FAG6,AMR1A_DANRE,,Activating molecule in BECN1-regulated autophagy protein 1A,Danio rerio (Zebrafish) (Brachydanio rerio),26.3,954.0,1.9e-61,238.8,sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2,GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0006914; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0043231; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; chordate embryonic development [GO:0043009]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741],autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634],protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005856; GO:0006914; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; mitochondrion; vacuole; endoplasmic reticulum; cytosol; cytoskeleton; autophagy; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_07631,1.839108761831855,FUN_034387-T1,Peve_00027164,Pocillopora_meandrina_HIv1___TS.g18900.t1,three_way,70.562,FUN_034387-T1,Q95K73,ELOV4_MACFA,,Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),52.3,279.0,3e-77,290.0,sp|Q95K73|ELOV4_MACFA Very long chain fatty acid elongase 4 OS=Macaca fascicularis OX=9541 GN=ELOVL4 PE=2 SV=1,GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07632,1.8326054802814968,FUN_034388-T1,Peve_00027163,Pocillopora_meandrina_HIv1___RNAseq.g26149.t2,three_way,73.248,FUN_034388-T1,Q9EQC4,ELOV4_MOUSE,,Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),Mus musculus (Mouse),44.2,258.0,3.2e-57,223.4,sp|Q9EQC4|ELOV4_MOUSE Very long chain fatty acid elongase 4 OS=Mus musculus OX=10090 GN=Elovl4 PE=1 SV=2,GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07638,1.2125821318846457,FUN_034397-T1,Peve_00002472,Pocillopora_meandrina_HIv1___RNAseq.g28581.t1,three_way,61.739,FUN_034397-T1,Q20191,,,,,45.7,188.0,3.3e-39,163.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_07641,1.1605877520718653,FUN_034420-T1,Peve_00021291,Pocillopora_meandrina_HIv1___RNAseq.g28575.t1,three_way,76.00066666666666,FUN_034420-T1,Q32LP4,S4A10_BOVIN,,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Bos taurus (Bovine),48.4,1093.0,1.6000000000000002e-273,944.1,sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1,GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982,bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_07649,1.0148611878787093,FUN_034481-T1,Peve_00010882,Pocillopora_meandrina_HIv1___RNAseq.g28844.t1,three_way,80.02866666666667,FUN_034481-T1,P80147,GABT_PIG,,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)",Sus scrofa (Pig),53.6,459.0,4.2e-148,526.2,"sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2",GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537,gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877],4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016740; GO:0043226; GO:0050877,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; transferase activity; organelle; nervous system process
OG_07652,1.3037431681539766,FUN_034486-T1,Peve_00043236,Pocillopora_meandrina_HIv1___RNAseq.g28569.t1,three_way,78.29433333333334,FUN_034486-T1,Q13613,,,,,45.0,387.0,6.2e-98,360.5,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_07658,1.4119441998883375,FUN_034602-T1,Peve_00039727,Pocillopora_meandrina_HIv1___RNAseq.g25885.t1,three_way,43.3945,,,,,,,,,,,,,,,,,
OG_07663,2.3758662979185816,FUN_034717-T1,Peve_00014893,Pocillopora_meandrina_HIv1___RNAseq.g28725.t1,three_way,59.878,FUN_034717-T1,Q91754,GCKR_XENLA,,Glucokinase regulatory protein (GKRP) (Glucokinase regulator),Xenopus laevis (African clawed frog),39.5,582.0,8.800000000000001e-111,402.5,sp|Q91754|GCKR_XENLA Glucokinase regulatory protein OS=Xenopus laevis OX=8355 GN=gckr PE=1 SV=1,GO:0001678; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0009750; GO:0019210; GO:0019899; GO:0030246; GO:0033132; GO:0034504; GO:0070095; GO:0141089; GO:1901135,carbohydrate derivative metabolic process [GO:1901135]; intracellular glucose homeostasis [GO:0001678]; negative regulation of glucokinase activity [GO:0033132]; protein localization to nucleus [GO:0034504]; response to fructose [GO:0009750],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; fructose-6-phosphate binding [GO:0070095]; glucose sensor activity [GO:0141089]; kinase inhibitor activity [GO:0019210],GO:0005654; GO:0005739; GO:0005829; GO:0043226; GO:0098772; GO:0140299; GO:1901135,nucleoplasm; mitochondrion; cytosol; organelle; molecular function regulator activity; molecular sensor activity; carbohydrate derivative metabolic process
OG_07664,1.964925976320236,FUN_034718-T1,Peve_00033270,Pocillopora_meandrina_HIv1___RNAseq.g28724.t1,three_way,70.42683333333333,FUN_034718-T1,Q6NUQ1,RINT1_HUMAN,,RAD50-interacting protein 1 (RAD50 interactor 1) (HsRINT-1) (RINT-1),Homo sapiens (Human),38.7,771.0,2e-149,531.2,sp|Q6NUQ1|RINT1_HUMAN RAD50-interacting protein 1 OS=Homo sapiens OX=9606 GN=RINT1 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0006890; GO:0007095; GO:0015031; GO:0060628; GO:0070939,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0005783; GO:0005829; GO:0016192; GO:0043226,endoplasmic reticulum; cytosol; vesicle-mediated transport; organelle
OG_07665,1.209778049250715,FUN_034720-T1,Peve_00033269,Pocillopora_meandrina_HIv1___RNAseq.g28723.t1,three_way,62.28366666666667,FUN_034720-T1,P82094,TMF1_HUMAN,,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Homo sapiens (Human),40.1,685.0,2.8999999999999997e-43,179.1,sp|P82094|TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens OX=9606 GN=TMF1 PE=1 SV=2,GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0007018; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; regulation of DNA-templated transcription; microtubule-based movement; programmed cell death; reproductive process; cell differentiation; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_07670,1.1679187189557372,FUN_034727-T1,Peve_00033249,Pocillopora_meandrina_HIv1___RNAseq.g28714.t1,three_way,89.599,FUN_034727-T1,Q93009,UBP7_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7),Homo sapiens (Human),59.7,1090.0,0.0,1328.5,sp|Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=2,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006283; GO:0006307; GO:0006508; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0042752; GO:0044027; GO:0045721; GO:0048511; GO:0050821; GO:0051090; GO:0070203; GO:0075342; GO:0101005; GO:1901796; GO:1904262; GO:1904353; GO:1905279; GO:1990380,"DNA alkylation repair [GO:0006307]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of TORC1 signaling [GO:1904262]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of establishment of protein localization to telomere [GO:0070203]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; symbiont-mediated disruption of host cell PML body [GO:0075342]; transcription-coupled nucleotide-excision repair [GO:0006283]",chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07671,1.4934800854248356,FUN_034738-T1,Peve_00010863,Pocillopora_meandrina_HIv1___RNAseq.g25891.t1,three_way,58.40533333333333,,,,,,,,,,,,,,,,,
OG_07672,1.3455922482476776,FUN_034779-T1,Peve_00043699,Pocillopora_meandrina_HIv1___RNAseq.g6184.t1,three_way,61.442,FUN_034779-T1,Q6P3X3,,,,,35.9,830.0,6.2999999999999996e-136,486.5,sp|Q6P3X3|TTC27_HUMAN Tetratricopeptide repeat protein 27 OS=Homo sapiens OX=9606 GN=TTC27 PE=1 SV=1,,,,,,
OG_07675,1.8088447279063105,FUN_034783-T1,Peve_00029734,Pocillopora_meandrina_HIv1___RNAseq.g12279.t1,three_way,75.0925,FUN_034783-T1,Q8TF05,,,,,43.2,940.0,1.8999999999999999e-171,604.7,sp|Q8TF05|PP4R1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Homo sapiens OX=9606 GN=PPP4R1 PE=1 SV=1,,,,,,
OG_07676,1.165913770733428,FUN_034785-T1,Peve_00029735,Pocillopora_meandrina_HIv1___RNAseq.g12280.t2,three_way,53.20216666666666,FUN_034785-T1,O08699,PGDH_RAT,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Rattus norvegicus (Rat),39.5,205.0,1.4e-37,157.9,sp|O08699|PGDH_RAT 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Rattus norvegicus OX=10116 GN=Hpgd PE=1 SV=2,GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654],"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957]",GO:0003824; GO:0005615; GO:0005654; GO:0005829; GO:0006629; GO:0016491; GO:0022414; GO:0048856; GO:0060089,catalytic activity; extracellular space; nucleoplasm; cytosol; lipid metabolic process; oxidoreductase activity; reproductive process; anatomical structure development; molecular transducer activity
OG_07677,1.036573786758562,FUN_034795-T1,Peve_00007519,Pocillopora_meandrina_HIv1___RNAseq.g12295.t1,three_way,68.32300000000001,FUN_034795-T1,Q5RFU0,,,,,42.2,500.0,3.2999999999999996e-114,413.7,sp|Q5RFU0|SIAE_PONAB Sialate O-acetylesterase OS=Pongo abelii OX=9601 GN=SIAE PE=2 SV=1,,,,,,
OG_07679,3.299854021881578,FUN_034797-T1,Peve_00007517,Pocillopora_meandrina_HIv1___RNAseq.g12297.t1,three_way,79.21333333333334,FUN_034797-T1,D3ZDI6,MYLIP_RAT,,E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP),Rattus norvegicus (Rat),43.0,440.0,5.1e-96,353.2,sp|D3ZDI6|MYLIP_RAT E3 ubiquitin-protein ligase MYLIP OS=Rattus norvegicus OX=10116 GN=Mylip PE=2 SV=1,GO:0004842; GO:0005737; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0008270; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0061630,cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886],cytoskeletal protein binding [GO:0008092]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07683,1.1348673333625587,FUN_034801-T1,Peve_00007555,Pocillopora_meandrina_HIv1___RNAseq.g12302.t1,three_way,39.9515,,,,,,,,,,,,,,,,,
OG_07689,1.021876795331104,FUN_034812-T1,Peve_00003622,Pocillopora_meandrina_HIv1___TS.g3642.t1,three_way,57.64416666666666,FUN_034812-T1,Q9BQ04,RBM4B_HUMAN,,RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30),Homo sapiens (Human),48.0,75.0,5.9e-13,75.9,sp|Q9BQ04|RBM4B_HUMAN RNA-binding protein 4B OS=Homo sapiens OX=9606 GN=RBM4B PE=1 SV=1,GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006397; GO:0006417; GO:0007623; GO:0008270; GO:0008380; GO:0010628; GO:0016607; GO:0032922; GO:0032991; GO:0043153,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA processing [GO:0006397]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0016071; GO:0043226,RNA binding; nucleoplasm; nucleolus; cytosol; mRNA metabolic process; organelle
OG_07696,1.5920838270873128,FUN_034829-T1,Peve_00040555,Pocillopora_meandrina_HIv1___RNAseq.g27179.t1,three_way,62.16466666666667,,,,,,,,,,,,,,,,,
OG_07698,1.4026118678776978,FUN_034832-T1,Peve_00006740,Pocillopora_meandrina_HIv1___TS.g14528.t1,three_way,88.521,FUN_034832-T1,O35242,,,,,46.1,921.0,1.3e-227,791.2,sp|O35242|FAN_MOUSE Protein FAN OS=Mus musculus OX=10090 GN=Nsmaf PE=1 SV=2,,,,,,
OG_07699,1.6750135177180798,FUN_034833-T1,Peve_00010451,Pocillopora_meandrina_HIv1___RNAseq.g27185.t1,three_way,51.098,,,,,,,,,,,,,,,,,
OG_07701,1.1957900684598768,FUN_034835-T1,Peve_00007812,Pocillopora_meandrina_HIv1___RNAseq.g27183.t1,three_way,81.74166666666667,FUN_034835-T1,Q8N4L2,PP4P2_HUMAN,,"Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 2 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase II) (Transmembrane protein 55A)",Homo sapiens (Human),49.7,197.0,3.5e-48,193.4,"sp|Q8N4L2|PP4P2_HUMAN Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase OS=Homo sapiens OX=9606 GN=PIP4P2 PE=1 SV=1",GO:0005765; GO:0005886; GO:0030670; GO:0031902; GO:0034597; GO:0046856; GO:0050765,negative regulation of phagocytosis [GO:0050765]; phosphatidylinositol dephosphorylation [GO:0046856],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886],"phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]",GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_07705,1.6588366494068365,FUN_034843-T1,Peve_00037378,Pocillopora_meandrina_HIv1___RNAseq.g27195.t1,three_way,68.62916666666666,FUN_034843-T1,A5D8S5,SH3R1_DANRE,,E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),39.0,77.0,6.6e-06,53.9,sp|A5D8S5|SH3R1_DANRE E3 ubiquitin-protein ligase SH3RF1 OS=Danio rerio OX=7955 GN=sh3rf1 PE=2 SV=2,GO:0001764; GO:0005078; GO:0005794; GO:0008270; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043370; GO:0046330; GO:0048471; GO:0051865; GO:0061630; GO:2000564,"negative regulation of apoptotic process [GO:0043066]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]",Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471],MAP-kinase scaffold activity [GO:0005078]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0016740; GO:0043226; GO:0048870; GO:0060090; GO:0140096,"catalytic activity; Golgi apparatus; transferase activity; organelle; cell motility; molecular adaptor activity; catalytic activity, acting on a protein"
OG_07711,1.391226180435772,FUN_034859-T1,Peve_00008084,Pocillopora_meandrina_HIv1___RNAseq.g12156.t1,three_way,75.80933333333333,FUN_034859-T1,Q80V03,,,,,50.4,538.0,3.3e-152,540.0,sp|Q80V03|ADCK5_MOUSE Uncharacterized aarF domain-containing protein kinase 5 OS=Mus musculus OX=10090 GN=Adck5 PE=2 SV=2,,,,,,
OG_07714,2.6706467135806182,FUN_034867-T1,Peve_00005778,Pocillopora_meandrina_HIv1___RNAseq.g27146.t1,three_way,75.34383333333334,FUN_034867-T1,Q28193,FURIN_BOVIN,,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin),Bos taurus (Bovine),49.8,616.0,5.7e-165,582.8,sp|Q28193|FURIN_BOVIN Furin OS=Bos taurus OX=9913 GN=FURIN PE=1 SV=1,GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0008201; GO:0010008; GO:0016486; GO:0046872; GO:0140447; GO:1904399,cytokine precursor processing [GO:0140447]; peptide hormone processing [GO:0016486],endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_07716,1.215727995717213,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_07722,1.0556625263641692,FUN_034878-T1,Peve_00005698,Pocillopora_meandrina_HIv1___TS.g14511.t1,three_way,82.43299999999999,FUN_034878-T1,Q8NDA8,,,,,34.0,1657.0,1.1e-290,1001.5,sp|Q8NDA8|MROH1_HUMAN Maestro heat-like repeat-containing protein family member 1 OS=Homo sapiens OX=9606 GN=MROH1 PE=1 SV=3,,,,,,
OG_07723,1.8887433181987,FUN_034880-T1,Peve_00005696,Pocillopora_meandrina_HIv1___RNAseq.g27166.t1,three_way,80.42966666666666,FUN_034880-T1,Q0VC84,C1GLT_BOVIN,,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)",Bos taurus (Bovine),47.3,332.0,1.3999999999999998e-82,308.1,sp|Q0VC84|C1GLT_BOVIN Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Bos taurus OX=9913 GN=C1GALT1 PE=2 SV=1,GO:0000166; GO:0001525; GO:0001822; GO:0006486; GO:0016020; GO:0016263; GO:0030154; GO:0046872,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; kidney development [GO:0001822]; protein glycosylation [GO:0006486],membrane [GO:0016020],glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166],GO:0003824; GO:0006486; GO:0016740; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; protein glycosylation; transferase activity; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_07725,1.8995368586974903,FUN_034884-T1,Peve_00011623,Pocillopora_meandrina_HIv1___TS.g14516.t1,three_way,73.757,FUN_034884-T1,Q97MV3,,,,,41.7,72.0,3.9e-08,59.3,sp|Q97MV3|MSRA_CLOAB Peptide methionine sulfoxide reductase MsrA OS=Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / IAM 19013 / LMG 5710 / NBRC 13948 / NRRL B-527 / VKM B-1787 / 2291 / W) OX=272562 GN=msrA PE=3 SV=1,,,,,,
OG_07727,1.6226673944290428,FUN_034888-T1,Peve_00023804,Pocillopora_meandrina_HIv1___RNAseq.g27810.t1,three_way,82.89466666666667,FUN_034888-T1,A7RRG3,AKTIP_NEMVE,,Protein AKTIP homolog (Fused toes protein homolog),Nematostella vectensis (Starlet sea anemone),69.6,306.0,1e-120,434.5,sp|A7RRG3|AKTIP_NEMVE Protein AKTIP homolog OS=Nematostella vectensis OX=45351 GN=v1g232160 PE=3 SV=1,,,,,,
OG_07729,1.294969345339308,FUN_034890-T1,Peve_00037340,Pocillopora_meandrina_HIv1___TS.g15152.t1,three_way,81.66833333333334,FUN_034890-T1,O61585,,,,,55.5,714.0,5.000000000000001e-80,300.4,sp|O61585|KTNB1_STRPU Katanin p80 WD40 repeat-containing subunit B1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNB1 PE=1 SV=1,,,,,,
OG_07730,1.9128060909686555,FUN_034891-T1,Peve_00037339,Pocillopora_meandrina_HIv1___TS.g15151.t2,three_way,94.67133333333334,FUN_034891-T1,Q13951,,,,,57.1,170.0,1.1e-48,194.5,sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2,,,,,,
OG_07731,1.9707986837485123,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_07732,1.472969898187943,FUN_034893-T1,Peve_00037337,Pocillopora_meandrina_HIv1___RNAseq.g27805.t1,three_way,60.900333333333336,FUN_034893-T1,Q8R4E9,CDT1_MOUSE,,DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein),Mus musculus (Mouse),32.5,449.0,1.2e-50,203.0,sp|Q8R4E9|CDT1_MOUSE DNA replication factor Cdt1 OS=Mus musculus OX=10090 GN=Cdt1 PE=1 SV=1,GO:0000076; GO:0000776; GO:0003677; GO:0003682; GO:0005634; GO:0016604; GO:0030174; GO:0033262; GO:0051315; GO:0071163; GO:0072708; GO:2000104; GO:2000105,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; DNA replication checkpoint signaling [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of DNA-templated DNA replication [GO:2000104]; positive regulation of DNA-templated DNA replication [GO:2000105]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708],kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0043226; GO:0065003,DNA binding; nucleus; organelle; protein-containing complex assembly
OG_07736,1.655630075744425,FUN_034913-T1,Peve_00039132,Pocillopora_meandrina_HIv1___RNAseq.g12143.t1,three_way,89.33033333333333,FUN_034913-T1,Q21305,SOX2_CAEEL,,Transcription factor sox-2,Caenorhabditis elegans,71.1,90.0,2.6000000000000002e-30,134.0,sp|Q21305|SOX2_CAEEL Transcription factor sox-2 OS=Caenorhabditis elegans OX=6239 GN=sox-2 PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0005634; GO:0007420; GO:0030182; GO:0036498; GO:0045944; GO:0048665,brain development [GO:0007420]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07737,1.646197015603665,FUN_034914-T1,Peve_00009290,Pocillopora_meandrina_HIv1___RNAseq.g27121.t1,three_way,69.19466666666666,FUN_034914-T1,B5X4H8,,,,,41.4,452.0,1.5e-80,301.6,sp|B5X4H8|RFT2_SALSA Riboflavin transporter 2 OS=Salmo salar OX=8030 GN=rft2 PE=2 SV=1,,,,,,
OG_07740,1.1503576048553104,FUN_034919-T1,Peve_00039137,Pocillopora_meandrina_HIv1___TS.g3478.t2,three_way,88.44266666666667,FUN_034919-T1,Q5R7R6,COG4_PONAB,,Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),53.4,761.0,1.5e-213,744.2,sp|Q5R7R6|COG4_PONAB Conserved oligomeric Golgi complex subunit 4 OS=Pongo abelii OX=9601 GN=COG4 PE=2 SV=1,GO:0000139; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119,"Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119],,GO:0005829; GO:0016192,cytosol; vesicle-mediated transport
OG_07742,1.2002151737757982,FUN_034925-T1,Peve_00009317,Pocillopora_meandrina_HIv1___RNAseq.g27813.t1,three_way,63.78083333333333,FUN_034925-T1,P29119,,,,,41.9,558.0,2.1e-121,438.0,sp|P29119|FURI1_XENLA Furin-1 OS=Xenopus laevis OX=8355 GN=furin PE=2 SV=1,,,,,,
OG_07748,1.9230457317680227,FUN_034937-T1,Peve_00018033,Pocillopora_meandrina_HIv1___RNAseq.g27831.t1,three_way,59.422666666666665,FUN_034937-T1,Q7Z614,SNX20_HUMAN,,Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1),Homo sapiens (Human),34.4,224.0,2.3e-17,91.3,sp|Q7Z614|SNX20_HUMAN Sorting nexin-20 OS=Homo sapiens OX=9606 GN=SNX20 PE=1 SV=1,GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981,protein transport [GO:0015031],early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005654; GO:0005886; GO:0008289,nucleoplasm; plasma membrane; lipid binding
OG_07760,2.193831097940451,FUN_034954-T1,Peve_00036673,Pocillopora_meandrina_HIv1___RNAseq.g27838.t1,three_way,81.57233333333333,FUN_034954-T1,Q9NXC2,GFOD1_HUMAN,,Glucose-fructose oxidoreductase domain-containing protein 1 (Gfo/Idh/MocA-like oxidoreductase domain-containing protein 1),Homo sapiens (Human),45.3,371.0,7.8e-92,339.0,sp|Q9NXC2|GFOD1_HUMAN Glucose-fructose oxidoreductase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GFOD1 PE=1 SV=1,GO:0000166; GO:0005576; GO:0016491; GO:0042802,,extracellular region [GO:0005576],identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005576; GO:0016491,catalytic activity; extracellular region; oxidoreductase activity
OG_07761,1.0166182496527174,FUN_034955-T1,Peve_00036678,Pocillopora_meandrina_HIv1___RNAseq.g27837.t1,three_way,88.89633333333333,FUN_034955-T1,Q75WB5,,,,,64.3,1304.0,0.0,1668.7,sp|Q75WB5|OPLA_BOVIN 5-oxoprolinase OS=Bos taurus OX=9913 GN=OPLAH PE=1 SV=2,,,,,,
OG_07762,3.272586156137826,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_07764,1.5386249167263748,FUN_034958-T1,Peve_00036684,Pocillopora_meandrina_HIv1___RNAseq.g27833.t1,three_way,75.85683333333333,FUN_034958-T1,Q8IXH6,T53I2_HUMAN,,Tumor protein p53-inducible nuclear protein 2 (Diabetes and obesity-regulated gene) (p53-inducible protein U) (PIG-U),Homo sapiens (Human),47.5,80.0,5.2e-12,72.8,sp|Q8IXH6|T53I2_HUMAN Tumor protein p53-inducible nuclear protein 2 OS=Homo sapiens OX=9606 GN=TP53INP2 PE=1 SV=2,GO:0000045; GO:0001649; GO:0001894; GO:0005634; GO:0005776; GO:0005829; GO:0006511; GO:0008104; GO:0016605; GO:0031410; GO:0043130; GO:0045893; GO:1903828,autophagosome assembly [GO:0000045]; negative regulation of protein localization [GO:1903828]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization [GO:0008104]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511],autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605],ubiquitin binding [GO:0043130],GO:0005634; GO:0005773; GO:0005829; GO:0006355; GO:0030154; GO:0031410; GO:0043226,nucleus; vacuole; cytosol; regulation of DNA-templated transcription; cell differentiation; cytoplasmic vesicle; organelle
OG_07766,1.6688133532898677,FUN_034961-T1,Peve_00028347,Pocillopora_meandrina_HIv1___RNAseq.g12173.t1,three_way,58.9135,FUN_034961-T1,P0C7T6,ATX1L_MOUSE,,Ataxin-1-like (Brother of ataxin-1),Mus musculus (Mouse),46.0,150.0,1.8e-30,135.6,sp|P0C7T6|ATX1L_MOUSE Ataxin-1-like OS=Mus musculus OX=10090 GN=Atxn1l PE=1 SV=1,GO:0000122; GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006366; GO:0007420; GO:0007612; GO:0007613; GO:0030198; GO:0030425; GO:0031208; GO:0035176; GO:0048286; GO:1902035,brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; social behavior [GO:0035176]; transcription by RNA polymerase II [GO:0006366],dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006351; GO:0006355; GO:0030198; GO:0043226; GO:0048856; GO:0050877,DNA binding; RNA binding; nucleoplasm; nucleolus; DNA-templated transcription; regulation of DNA-templated transcription; extracellular matrix organization; organelle; anatomical structure development; nervous system process
OG_07769,1.246477608928268,FUN_034972-T1,Peve_00028365,Pocillopora_meandrina_HIv1___RNAseq.g12164.t1,three_way,71.28216666666667,FUN_034972-T1,Q91820,AURAA_XENLA,,Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265),Xenopus laevis (African clawed frog),63.3,341.0,1.5e-121,437.6,sp|Q91820|AURAA_XENLA Aurora kinase A-A OS=Xenopus laevis OX=8355 GN=aurka-a PE=1 SV=1,GO:0000212; GO:0000776; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0007052; GO:0007100; GO:0008017; GO:0018105; GO:0019894; GO:0032133; GO:0032465; GO:0046777; GO:0051233; GO:0051301; GO:0090307; GO:0106310,cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_07771,1.2471964887615283,FUN_034974-T1,Peve_00028360,Pocillopora_meandrina_HIv1___RNAseq.g12162.t1,three_way,65.07733333333333,FUN_034974-T1,Q8K4T5,DUS19_MOUSE,,Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1),Mus musculus (Mouse),43.9,198.0,3.4e-40,166.4,sp|Q8K4T5|DUS19_MOUSE Dual specificity protein phosphatase 19 OS=Mus musculus OX=10090 GN=Dusp19 PE=2 SV=1,GO:0004722; GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0007254; GO:0008138; GO:0008330; GO:0008579; GO:0030295; GO:0031434; GO:0031435; GO:0043409; GO:0043410; GO:0046329; GO:0046330,JNK cascade [GO:0007254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410],cytoplasm [GO:0005737],JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0016787; GO:0060090; GO:0098772; GO:0140096,"catalytic activity; hydrolase activity; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07779,1.495900354679245,FUN_034996-T1,Peve_00024602,Pocillopora_meandrina_HIv1___RNAseq.g12126.t1,three_way,68.37866666666666,FUN_034996-T1,Q923X6,,,,,27.8,299.0,3.7e-18,94.0,sp|Q923X6|TAA7E_RAT Trace amine-associated receptor 7e OS=Rattus norvegicus OX=10116 GN=Taar7e PE=3 SV=1,,,,,,
OG_07782,1.034675225641339,FUN_035002-T1,Peve_00024598,Pocillopora_meandrina_HIv1___RNAseq.g12128.t1,three_way,74.33966666666667,FUN_035002-T1,Q9NRW4,,,,,54.7,172.0,8e-51,201.8,sp|Q9NRW4|DUS22_HUMAN Dual specificity protein phosphatase 22 OS=Homo sapiens OX=9606 GN=DUSP22 PE=1 SV=1,,,,,,
OG_07784,1.210531061140324,FUN_035004-T2,Peve_00024592,Pocillopora_meandrina_HIv1___RNAseq.g12131.t1,three_way,65.9825,FUN_035004-T2,Q6DFQ7,TM198_XENTR,,Transmembrane protein 198,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),21.0,205.0,6.7e-09,63.2,sp|Q6DFQ7|TM198_XENTR Transmembrane protein 198 OS=Xenopus tropicalis OX=8364 GN=tmem198 PE=1 SV=1,GO:0005886; GO:0012506; GO:0016055; GO:0031410,Wnt signaling pathway [GO:0016055],cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506],,GO:0005886; GO:0031410; GO:0043226,plasma membrane; cytoplasmic vesicle; organelle
OG_07790,2.077040597297586,FUN_035011-T1,Peve_00024584,Pocillopora_meandrina_HIv1___RNAseq.g27784.t1,three_way,86.16116666666666,FUN_035011-T1,A1L252,RANB9_DANRE,,Ran-binding protein 9 (RanBP9),Danio rerio (Zebrafish) (Brachydanio rerio),57.7,503.0,5.9e-155,548.9,sp|A1L252|RANB9_DANRE Ran-binding protein 9 OS=Danio rerio OX=7955 GN=ranbp9 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0007010; GO:0060041,cytoskeleton organization [GO:0007010]; retina development in camera-type eye [GO:0060041],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005886; GO:0007010; GO:0043226; GO:0048856,nucleus; plasma membrane; cytoskeleton organization; organelle; anatomical structure development
OG_07797,1.1543353595402592,FUN_035032-T1,Peve_00024626,Pocillopora_meandrina_HIv1___RNAseq.g27760.t1,three_way,96.02833333333334,FUN_035032-T1,P68399,CSK21_BOVIN,,Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1),Bos taurus (Bovine),89.2,269.0,4.8e-146,518.5,sp|P68399|CSK21_BOVIN Casein kinase II subunit alpha OS=Bos taurus OX=9913 GN=CSNK2A1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005956; GO:0006302; GO:0006915; GO:0008284; GO:0016055; GO:0030177; GO:0030307; GO:0045732; GO:0048511; GO:0051726; GO:0106310; GO:1905337; GO:1905818; GO:2000042; GO:2001234,apoptotic process [GO:0006915]; double-strand break repair [GO:0006302]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of aggrephagy [GO:1905337]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; DNA repair; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07801,1.0452945147356578,FUN_035036-T1,Peve_00024636,Pocillopora_meandrina_HIv1___RNAseq.g27754.t1,three_way,63.75233333333333,FUN_035036-T1,Q9VKA4,,,,,27.3,538.0,1e-52,209.9,sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3,,,,,,
OG_07817,2.208457321203376,FUN_035069-T1,Peve_00026039,Pocillopora_meandrina_HIv1___RNAseq.g27720.t1,three_way,65.01733333333334,FUN_035069-T1,Q6DEL1,S38A7_DANRE,,Sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7),Danio rerio (Zebrafish) (Brachydanio rerio),41.4,406.0,1.6000000000000001e-80,301.6,sp|Q6DEL1|S38A7_DANRE Sodium-coupled neutral amino acid transporter 7 OS=Danio rerio OX=7955 GN=slc38a7 PE=2 SV=1,GO:0003333; GO:0005765; GO:0006867; GO:0006868; GO:0015182; GO:0015186; GO:0016020; GO:0030424; GO:0140901; GO:0140902,amino acid transmembrane transport [GO:0003333]; asparagine transport [GO:0006867]; glutamine transport [GO:0006868],axon [GO:0030424]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],L-asparagine transmembrane transporter activity [GO:0015182]; L-asparagine:sodium symporter activity [GO:0140901]; L-glutamine transmembrane transporter activity [GO:0015186]; L-glutamine:sodium symporter activity [GO:0140902],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_07818,1.0453493483266567,FUN_035070-T1,Peve_00031377,Pocillopora_meandrina_HIv1___RNAseq.g27719.t1,three_way,82.29666666666667,FUN_035070-T1,Q7ZT01,PSF3_XENLA,,DNA replication complex GINS protein PSF3 (GINS complex subunit 3),Xenopus laevis (African clawed frog),43.1,197.0,9.3e-49,194.9,sp|Q7ZT01|PSF3_XENLA DNA replication complex GINS protein PSF3 OS=Xenopus laevis OX=8355 GN=gins3 PE=1 SV=1,GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902975,DNA replication [GO:0006260]; mitotic DNA replication initiation [GO:1902975],CMG complex [GO:0071162]; GINS complex [GO:0000811],chromatin binding [GO:0003682],GO:0006260,DNA replication
OG_07820,1.6984035953081895,FUN_035088-T1,Peve_00037967,Pocillopora_meandrina_HIv1___TS.g15056.t2,three_way,81.78233333333334,FUN_035088-T1,Q92508,PIEZ1_HUMAN,,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),Homo sapiens (Human),32.0,2582.0,4.8e-312,1072.8,sp|Q92508|PIEZ1_HUMAN Piezo-type mechanosensitive ion channel component 1 OS=Homo sapiens OX=9606 GN=PIEZO1 PE=1 SV=4,GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0031258; GO:0032420; GO:0032437; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260; GO:0140135,cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391],cuticular plate [GO:0032437]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; stereocilium [GO:0032420],mechanosensitive monoatomic cation channel activity [GO:0140135]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005783; GO:0005886; GO:0043226,transporter activity; endoplasmic reticulum; plasma membrane; organelle
OG_07822,1.6739486932445533,FUN_035090-T2,Peve_00037965,Pocillopora_meandrina_HIv1___RNAseq.g27709.t1,three_way,52.48183333333333,FUN_035090-T2,Q0V8T6,CTP5A_RAT,,Contactin-associated protein like 5-1 (Cell recognition molecule Caspr5-1) (Cell recognition molecule Caspr5a) (Contactin-associated protein-like 5a),Rattus norvegicus (Rat),29.9,626.0,1.1e-68,263.1,sp|Q0V8T6|CTP5A_RAT Contactin-associated protein like 5-1 OS=Rattus norvegicus OX=10116 GN=Cntnap5a PE=2 SV=1,GO:0007155; GO:0016020; GO:0030054,cell adhesion [GO:0007155],cell junction [GO:0030054]; membrane [GO:0016020],,GO:0007155,cell adhesion
OG_07825,1.1882489188099736,FUN_035121-T1,Peve_00005906,Pocillopora_meandrina_HIv1___RNAseq.g27643.t1,three_way,58.49466666666667,FUN_035121-T1,Q86HG9,,,,,32.5,246.0,1e-24,116.3,sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0271682 PE=3 SV=2,,,,,,
OG_07828,1.8397511469111223,FUN_035130-T3,Peve_00005902,Pocillopora_meandrina_HIv1___TS.g14990.t1,three_way,58.65316666666666,FUN_035130-T3,Q8TEP8,,,,,32.3,871.0,3.2e-116,422.5,sp|Q8TEP8|CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens OX=9606 GN=CEP192 PE=1 SV=3,,,,,,
OG_07829,1.201166200169087,FUN_035131-T3,Peve_00005900,Pocillopora_meandrina_HIv1___RNAseq.g27639.t1,three_way,66.834,FUN_035131-T3,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),29.1,983.0,1.9e-97,359.8,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_07835,2.859636097727673,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_07836,2.023816401974577,FUN_035166-T1,Peve_00036194,Pocillopora_meandrina_HIv1___RNAseq.g27915.t1,three_way,52.95516666666667,FUN_035166-T1,Q29477,TRFL_CAPHI,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-),Capra hircus (Goat),35.5,366.0,2.5e-42,174.5,sp|Q29477|TRFL_CAPHI Lactotransferrin OS=Capra hircus OX=9925 GN=LTF PE=1 SV=1,GO:0001503; GO:0001817; GO:0002227; GO:0005615; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0008236; GO:0019731; GO:0019732; GO:0031665; GO:0032680; GO:0033690; GO:0042581; GO:0043066; GO:0045669; GO:0046872; GO:0055037; GO:0060349; GO:1900159; GO:1900229; GO:1902732; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; bone morphogenesis [GO:0060349]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule [GO:0042581],metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236],GO:0002376; GO:0003824; GO:0005615; GO:0005768; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; endosome; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_07842,1.3580907934671569,FUN_035177-T1,Peve_00036192,Pocillopora_meandrina_HIv1___RNAseq.g27936.t1,three_way,89.8475,FUN_035177-T1,Q14703,MBTP1_HUMAN,,Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1),Homo sapiens (Human),63.6,1006.0,0.0,1305.4,sp|Q14703|MBTP1_HUMAN Membrane-bound transcription factor site-1 protease OS=Homo sapiens OX=9606 GN=MBTPS1 PE=1 SV=1,GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0007095; GO:0008203; GO:0016485; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0051604; GO:0060627,ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein import into nucleus [GO:0006606]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005794; GO:0006629; GO:0006886; GO:0006913; GO:0007040; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; Golgi apparatus; lipid metabolic process; intracellular protein transport; nucleocytoplasmic transport; lysosome organization; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_07844,1.7310605708185305,FUN_035182-T1,Peve_00021488,Pocillopora_meandrina_HIv1___RNAseq.g27944.t1,three_way,78.65466666666667,FUN_035182-T1,Q8NBX0,,,,,49.1,424.0,1.2e-111,404.8,sp|Q8NBX0|SCPDL_HUMAN Saccharopine dehydrogenase-like oxidoreductase OS=Homo sapiens OX=9606 GN=SCCPDH PE=1 SV=1,,,,,,
OG_07847,1.253173503954021,FUN_035185-T1,Peve_00036893,Pocillopora_meandrina_HIv1___RNAseq.g27955.t1,three_way,75.83783333333334,FUN_035185-T1,P07090,,,,,41.6,262.0,1.6e-43,177.9,sp|P07090|CALB2_CHICK Calretinin OS=Gallus gallus OX=9031 GN=CALB2 PE=2 SV=3,,,,,,
OG_07854,1.4140590552370378,FUN_035208-T1,Peve_00027694,Pocillopora_meandrina_HIv1___RNAseq.g27632.t1,three_way,78.51983333333334,FUN_035208-T1,Q21920,,,,,31.1,132.0,2.1e-08,61.6,sp|Q21920|ANKHM_CAEEL Ankyrin repeat and KH domain-containing protein mask-1 OS=Caenorhabditis elegans OX=6239 GN=mask-1 PE=3 SV=3,,,,,,
OG_07855,1.9453621044632337,FUN_035210-T1,Peve_00027693,Pocillopora_meandrina_HIv1___RNAseq.g27630.t1,three_way,70.29866666666666,,,,,,,,,,,,,,,,,
OG_07861,2.699840394518861,FUN_035216-T2,Peve_00035892,Pocillopora_meandrina_HIv1___RNAseq.g27615.t1,three_way,70.04816666666666,FUN_035216-T2,Q503Z8,IRX6A_DANRE,,Iroquois homeobox protein 6a,Danio rerio (Zebrafish) (Brachydanio rerio),47.6,233.0,1.9e-40,168.3,sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0048468,cell development [GO:0048468]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07862,1.3292375416682614,FUN_035217-T1,Peve_00035882,Pocillopora_meandrina_HIv1___TS.g14965.t1,three_way,86.42566666666667,FUN_035217-T1,O43747,,,,,62.9,851.0,9.3e-281,967.6,sp|O43747|AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens OX=9606 GN=AP1G1 PE=1 SV=5,,,,,,
OG_07864,2.280829340162569,FUN_035221-T1,Peve_00035886,Pocillopora_meandrina_HIv1___RNAseq.g27610.t1,three_way,84.449,FUN_035221-T1,Q6DE14,E2F4_XENLA,,Transcription factor E2F4 (E2F-4),Xenopus laevis (African clawed frog),54.9,368.0,1.1e-96,354.8,sp|Q6DE14|E2F4_XENLA Transcription factor E2F4 OS=Xenopus laevis OX=8355 GN=e2f4 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003700; GO:0006357; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251,centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0006355; GO:0030154; GO:0044782; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; cilium organization; transcription regulator activity
OG_07865,2.6664961782634755,FUN_035222-T1,Peve_00035887,Pocillopora_meandrina_HIv1___RNAseq.g27609.t1,three_way,55.40566666666666,FUN_035222-T1,Q501V0,KPSH1_DANRE,,Serine/threonine-protein kinase H1 homolog (EC 2.7.11.1),Danio rerio (Zebrafish) (Brachydanio rerio),66.9,323.0,4.8e-116,419.9,sp|Q501V0|KPSH1_DANRE Serine/threonine-protein kinase H1 homolog OS=Danio rerio OX=7955 GN=pskh1 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005737; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_07873,1.5827654940730862,FUN_035233-T1,Peve_00044494,Pocillopora_meandrina_HIv1___RNAseq.g27904.t1,three_way,73.75433333333334,FUN_035233-T1,Q3T0C2,PGDH_BOVIN,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Bos taurus (Bovine),40.9,257.0,7.100000000000001e-48,192.2,sp|Q3T0C2|PGDH_BOVIN 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Bos taurus OX=9913 GN=HPGD PE=2 SV=1,GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957],GO:0003824; GO:0006629; GO:0016491; GO:0022414; GO:0060089,catalytic activity; lipid metabolic process; oxidoreductase activity; reproductive process; molecular transducer activity
OG_07877,1.2676718980613535,FUN_035239-T2,Peve_00042235,Pocillopora_meandrina_HIv1___RNAseq.g27898.t1,three_way,66.54466666666667,FUN_035239-T2,P54278,PMS2_HUMAN,,Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2),Homo sapiens (Human),48.0,891.0,7.499999999999999e-217,755.4,sp|P54278|PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens OX=9606 GN=PMS2 PE=1 SV=2,GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006298; GO:0009410; GO:0016446; GO:0016447; GO:0016887; GO:0032138; GO:0032389; GO:0048298; GO:0048304; GO:0140664,mismatch repair [GO:0006298]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; response to xenobiotic stimulus [GO:0009410]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447],cytosol [GO:0005829]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_07881,1.1968269267825935,FUN_035244-T1,Peve_00042234,Pocillopora_meandrina_HIv1___RNAseq.g27892.t1b,three_way,69.50633333333333,FUN_035244-T1,O32210,,,,,44.7,262.0,5.5e-61,236.1,sp|O32210|GR_BACSU Glyoxal reductase OS=Bacillus subtilis (strain 168) OX=224308 GN=yvgN PE=1 SV=1,,,,,,
OG_07883,1.9406691086619472,FUN_035260-T1,Peve_00032643,Pocillopora_meandrina_HIv1___RNAseq.g27881.t1,three_way,64.38783333333333,FUN_035260-T1,O88738,BIRC6_MOUSE,,Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),Mus musculus (Mouse),43.8,267.0,4.8e-62,241.9,sp|O88738|BIRC6_MOUSE Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Mus musculus OX=10090 GN=Birc6 PE=1 SV=2,GO:0000922; GO:0001890; GO:0004869; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237,apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; placenta development [GO:0001890]; positive regulation of cell population proliferation [GO:0008284]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712],centrosome [GO:0005813]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802],cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005768; GO:0005815; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; endosome; microtubule organizing center; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07887,2.825489604380392,FUN_035265-T1,Peve_00032654,Pocillopora_meandrina_HIv1___RNAseq.g27870.t1,three_way,70.16533333333334,FUN_035265-T1,Q2LKW6,NL1B1_MOUSE,,"NACHT, LRR and PYD domains-containing protein 1b allele 1 (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1b, C-terminus (Nlrp1b1-CT); NACHT, LRR and PYD domains-containing protein 1b, N-terminus (Nlrp1b1-NT)]",Mus musculus (Mouse),24.6,346.0,2.5e-09,65.9,"sp|Q2LKW6|NL1B1_MOUSE NACHT, LRR and PYD domains-containing protein 1b allele 1 OS=Mus musculus OX=10090 GN=Nlrp1b PE=1 SV=1",GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0008233; GO:0012501; GO:0016020; GO:0030163; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0070269; GO:0072558,innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; pyroptotic inflammatory response [GO:0070269]; regulation of apoptotic process [GO:0042981],cytoplasm [GO:0005737]; membrane [GO:0016020]; NLRP1 inflammasome complex [GO:0072558],ATP binding [GO:0005524]; peptidase activity [GO:0008233],GO:0002376; GO:0003824; GO:0006954; GO:0012501; GO:0016787; GO:0030163; GO:0098542; GO:0140096,"immune system process; catalytic activity; inflammatory response; programmed cell death; hydrolase activity; protein catabolic process; defense response to other organism; catalytic activity, acting on a protein"
OG_07891,1.3136163213925054,FUN_035270-T1,Peve_00029230,Pocillopora_meandrina_HIv1___RNAseq.g27866.t1,three_way,78.87733333333333,FUN_035270-T1,Q32KJ8,ARSI_RAT,,Arylsulfatase I (ASI) (EC 3.1.6.-),Rattus norvegicus (Rat),53.0,485.0,1.4e-154,547.7,sp|Q32KJ8|ARSI_RAT Arylsulfatase I OS=Rattus norvegicus OX=10116 GN=Arsi PE=2 SV=1,GO:0005576; GO:0005783; GO:0008484; GO:0046872,,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005576; GO:0005783; GO:0016787; GO:0043226,catalytic activity; extracellular region; endoplasmic reticulum; hydrolase activity; organelle
OG_07893,1.571008240728218,FUN_035272-T1,Peve_00044991,Pocillopora_meandrina_HIv1___RNAseq.g27864.t1,three_way,73.48066666666666,FUN_035272-T1,Q6NRC9,,,,,41.0,1022.0,1.9e-99,365.5,sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1,,,,,,
OG_07895,1.0274908656867712,FUN_035274-T1,Peve_00044989,Pocillopora_meandrina_HIv1___RNAseq.g27861.t1,three_way,96.17166666666668,FUN_035274-T1,Q6PGV1,VA0D1_DANRE,,V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (Vacuolar proton pump subunit d 1),Danio rerio (Zebrafish) (Brachydanio rerio),80.6,350.0,8.699999999999999e-172,604.4,sp|Q6PGV1|VA0D1_DANRE V-type proton ATPase subunit d 1 OS=Danio rerio OX=7955 GN=atp6v0d1 PE=1 SV=1,GO:0001947; GO:0003406; GO:0005765; GO:0005769; GO:0006879; GO:0007034; GO:0007035; GO:0008057; GO:0016471; GO:0032438; GO:0033179; GO:0033181; GO:0035675; GO:0036295; GO:0039022; GO:0045176; GO:0046688; GO:0046961; GO:0060041; GO:0060271; GO:0070986,apical protein localization [GO:0045176]; cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; eye pigment granule organization [GO:0008057]; heart looping [GO:0001947]; intracellular iron ion homeostasis [GO:0006879]; left/right axis specification [GO:0070986]; melanosome organization [GO:0032438]; neuromast hair cell development [GO:0035675]; pronephric duct development [GO:0039022]; response to copper ion [GO:0046688]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034],"early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005768; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0140657,transporter activity; endosome; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; ATP-dependent activity
OG_07898,1.903471973013846,FUN_035279-T1,Peve_00001128,Pocillopora_meandrina_HIv1___RNAseq.g10444.t1,three_way,76.0005,FUN_035279-T1,Q9Z2W0,,,,,60.3,441.0,8.4e-151,535.0,sp|Q9Z2W0|DNPEP_MOUSE Aspartyl aminopeptidase OS=Mus musculus OX=10090 GN=Dnpep PE=1 SV=2,,,,,,
OG_07904,1.4173785129840677,FUN_035341-T1,Peve_00029661,Pocillopora_meandrina_HIv1___TS.g3597.t1,three_way,81.158,FUN_035341-T1,Q3URV1,BROMI_MOUSE,,Protein broad-minded (TBC1 domain family member 32),Mus musculus (Mouse),41.3,269.0,9.2e-49,195.3,sp|Q3URV1|BROMI_MOUSE Protein broad-minded OS=Mus musculus OX=10090 GN=Tbc1d32 PE=1 SV=2,GO:0001822; GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007224; GO:0007368; GO:0007507; GO:0021532; GO:0021915; GO:0035082; GO:0042733; GO:0043010; GO:0060021; GO:0060041; GO:0060271; GO:0060831; GO:0061512; GO:1905515,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; neural tube development [GO:0021915]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005929; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cilium; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_07905,1.183377480809964,FUN_035346-T1,Peve_00036057,Pocillopora_meandrina_HIv1___RNAseq.g12858.t1,three_way,36.35866666666666,,,,,,,,,,,,,,,,,
OG_07918,1.4503769198024246,FUN_035403-T1,Peve_00002640,Pocillopora_meandrina_HIv1___TS.g3526.t1,three_way,88.887,,,,,,,,,,,,,,,,,
OG_07919,1.0532583599307248,FUN_035404-T1,Peve_00002644,Pocillopora_meandrina_HIv1___TS.g3527.t2,three_way,68.768,FUN_035404-T1,Q9WYX8,,,,,49.4,172.0,3.9e-43,176.4,sp|Q9WYX8|Y508_THEMA Uncharacterized protein TM_0508 OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0508 PE=3 SV=1,,,,,,
OG_07920,1.0240408115437594,FUN_035405-T1,Peve_00002645,Pocillopora_meandrina_HIv1___RNAseq.g12189.t1,three_way,73.37433333333333,,,,,,,,,,,,,,,,,
OG_07921,1.2475953876669168,FUN_035406-T1,Peve_00002646,Pocillopora_meandrina_HIv1___TS.g3529.t1,three_way,75.06933333333333,FUN_035406-T1,O43312,,,,,48.1,239.0,4.2000000000000004e-60,234.2,sp|O43312|MTSS1_HUMAN Protein MTSS 1 OS=Homo sapiens OX=9606 GN=MTSS1 PE=1 SV=2,,,,,,
OG_07923,1.036920008107094,FUN_035409-T1,Peve_00039846,Pocillopora_meandrina_HIv1___RNAseq.g12196.t1,three_way,78.21966666666667,FUN_035409-T1,A2RT91,,,,,34.3,306.0,3.9e-42,174.9,sp|A2RT91|ANKAR_MOUSE Ankyrin and armadillo repeat-containing protein OS=Mus musculus OX=10090 GN=Ankar PE=2 SV=1,,,,,,
OG_07925,2.045748520622663,FUN_035413-T1,Peve_00039843,Pocillopora_meandrina_HIv1___RNAseq.g27561.t1,three_way,72.32216666666666,FUN_035413-T1,Q9BVG8,,,,,62.9,383.0,8.400000000000001e-134,479.6,sp|Q9BVG8|KIFC3_HUMAN Kinesin-like protein KIFC3 OS=Homo sapiens OX=9606 GN=KIFC3 PE=1 SV=4,,,,,,
OG_07929,2.37424318752296,FUN_035418-T1,Peve_00039851,Pocillopora_meandrina_HIv1___RNAseq.g27566.t1,three_way,69.55066666666667,FUN_035418-T1,B8AJ09,,,,,28.2,312.0,1.7e-16,88.6,"sp|B8AJ09|BASS4_ORYSI Probable sodium/metabolite cotransporter BASS4, chloroplastic OS=Oryza sativa subsp. indica OX=39946 GN=BASS4 PE=3 SV=1",,,,,,
OG_07941,1.119750311253073,FUN_035450-T2,Peve_00001658,Pocillopora_meandrina_HIv1___RNAseq.g25308.t1,three_way,52.35066666666667,FUN_035450-T2,A2BGU9,,,,,34.3,303.0,9.8e-42,172.2,sp|A2BGU9|SERHL_DANRE Serine hydrolase-like protein OS=Danio rerio OX=7955 GN=serhl PE=2 SV=1,,,,,,
OG_07942,2.131388467896922,FUN_035456-T1,Peve_00012138,Pocillopora_meandrina_HIv1___RNAseq.g26976.t1,three_way,62.52466666666667,FUN_035456-T1,F4KGU4,,,,,33.2,1498.0,1.7000000000000002e-214,748.4,"sp|F4KGU4|DEAHC_ARATH ATP-dependent RNA helicase DEAH12, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=At5g10370 PE=3 SV=1",,,,,,
OG_07944,1.707402510768648,FUN_035462-T1,Peve_00012136,Pocillopora_meandrina_HIv1___RNAseq.g27041.t1,three_way,72.29833333333333,FUN_035462-T1,Q9SY73,PTALR_ARATH,,NADPH-dependent pterin aldehyde reductase (EC 1.1.1.-),Arabidopsis thaliana (Mouse-ear cress),45.1,224.0,2e-55,217.2,sp|Q9SY73|PTALR_ARATH NADPH-dependent pterin aldehyde reductase OS=Arabidopsis thaliana OX=3702 GN=At1g10310 PE=1 SV=1,GO:0005829; GO:0006760; GO:0016616,folic acid-containing compound metabolic process [GO:0006760],cytosol [GO:0005829],"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0005829; GO:0006575; GO:0016491,catalytic activity; cytosol; modified amino acid metabolic process; oxidoreductase activity
OG_07950,1.073523532575125,FUN_035473-T1,Peve_00033973,Pocillopora_meandrina_HIv1___RNAseq.g26982.t1,three_way,62.86833333333333,FUN_035473-T1,A4ZNR5,NKD2L_DANRE,,Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B),Danio rerio (Zebrafish) (Brachydanio rerio),30.5,236.0,1.9e-14,82.0,sp|A4ZNR5|NKD2L_DANRE Protein naked cuticle homolog 2-like OS=Danio rerio OX=7955 GN=nkd2l PE=2 SV=1,GO:0005509; GO:0005737; GO:0005886; GO:0016055; GO:0030178; GO:0090090,negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886,plasma membrane
OG_07951,1.7975258417699018,FUN_035476-T1,Peve_00033971,Pocillopora_meandrina_HIv1___TS.g14334.t1b,three_way,75.7615,FUN_035476-T1,Q58EX7,PKHG4_HUMAN,,Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1),Homo sapiens (Human),31.9,906.0,1.4e-119,433.0,sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056,axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0098772,cytosol; plasma membrane; molecular function regulator activity
OG_07952,1.1290406119849647,FUN_035478-T1,Peve_00033970,Pocillopora_meandrina_HIv1___TS.g14339.t1,three_way,81.2215,FUN_035478-T1,P08487,,,,,46.2,825.0,3.7e-203,709.9,"sp|P08487|PLCG1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Bos taurus OX=9913 GN=PLCG1 PE=1 SV=1",,,,,,
OG_07953,1.1642332534094313,FUN_035490-T1,Peve_00033965,Pocillopora_meandrina_HIv1___RNAseq.g26985.t1,three_way,91.537,,,,,,,,,,,,,,,,,
OG_07954,1.8817328650143432,FUN_035494-T1,Peve_00033964,Pocillopora_meandrina_HIv1___RNAseq.g26989.t1,three_way,76.04083333333334,FUN_035494-T1,P52171,,,,,53.8,240.0,1.4e-69,265.4,sp|P52171|IMA1_XENLA Importin subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kpna2 PE=1 SV=2,,,,,,
OG_07955,1.3769680428687685,FUN_035498-T1,Peve_00033959,Pocillopora_meandrina_HIv1___RNAseq.g26992.t1,three_way,53.365833333333335,,,,,,,,,,,,,,,,,
OG_07956,4.127542737065862,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_07958,1.1175140940923274,FUN_035508-T1,Peve_00039971,Pocillopora_meandrina_HIv1___TS.g14356.t2,three_way,47.306,FUN_035508-T1,Q9V5N8,,,,,34.5,592.0,2.5e-66,256.5,sp|Q9V5N8|STAN_DROME Protocadherin-like wing polarity protein stan OS=Drosophila melanogaster OX=7227 GN=stan PE=1 SV=4,,,,,,
OG_07960,1.2746909361029193,FUN_035513-T1,Peve_00039975,Pocillopora_meandrina_HIv1___RNAseq.g26972.t1,three_way,86.628,FUN_035513-T1,Q0P5Y3,TPPP2_MOUSE,,Tubulin polymerization-promoting protein family member 2,Mus musculus (Mouse),45.7,164.0,1.1000000000000002e-28,127.9,sp|Q0P5Y3|TPPP2_MOUSE Tubulin polymerization-promoting protein family member 2 OS=Mus musculus OX=10090 GN=Tppp2 PE=2 SV=1,GO:0005829; GO:0007283; GO:0015631; GO:0030154; GO:0036126; GO:0046785; GO:1901317,cell differentiation [GO:0030154]; microtubule polymerization [GO:0046785]; regulation of flagellated sperm motility [GO:1901317]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; sperm flagellum [GO:0036126],tubulin binding [GO:0015631],GO:0005829; GO:0005929; GO:0007010; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0065003,cytosol; cilium; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; protein-containing complex assembly
OG_07961,1.2104261783018615,FUN_035519-T1,Peve_00007927,Pocillopora_meandrina_HIv1___RNAseq.g26966.t1,three_way,53.88283333333334,FUN_035519-T1,A3KMR8,MAFA_DANRE,,Transcription factor MafAa (Somite Maf1) (SMaf1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,97.0,4.2e-09,63.2,sp|A3KMR8|MAFA_DANRE Transcription factor MafAa OS=Danio rerio OX=7955 GN=mafaa PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07963,1.295916600882745,FUN_035524-T1,Peve_00020842,Pocillopora_meandrina_HIv1___RNAseq.g26954.t1,three_way,73.49983333333333,FUN_035524-T1,O54975,XPP1_RAT,,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",Rattus norvegicus (Rat),44.4,626.0,4.6e-150,533.1,sp|O54975|XPP1_RAT Xaa-Pro aminopeptidase 1 OS=Rattus norvegicus OX=10116 GN=Xpnpep1 PE=1 SV=1,GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016787; GO:0140096,"catalytic activity; cytosol; hydrolase activity; catalytic activity, acting on a protein"
OG_07966,1.0992166328550592,FUN_035535-T1,Peve_00021382,Pocillopora_meandrina_HIv1___RNAseq.g27998.t1,three_way,79.72866666666667,,,,,,,,,,,,,,,,,
OG_07967,1.1655103478837672,FUN_035536-T1,Peve_00026593,Pocillopora_meandrina_HIv1___RNAseq.g27999.t1,three_way,59.93233333333333,FUN_035536-T1,Q9N121,,,,,56.3,126.0,8.6e-37,154.8,"sp|Q9N121|GCSH_RABIT Glycine cleavage system H protein, mitochondrial OS=Oryctolagus cuniculus OX=9986 GN=GCSH PE=2 SV=1",,,,,,
OG_07975,1.0470659428727327,FUN_035552-T1,Peve_00036916,Pocillopora_meandrina_HIv1___RNAseq.g28024.t1,three_way,68.95633333333333,FUN_035552-T1,Q7M767,UB2V2_RAT,,Ubiquitin-conjugating enzyme E2 variant 2 (Ubiquitin-conjugating enzyme variant MMS2),Rattus norvegicus (Rat),69.6,138.0,2.3e-51,203.0,sp|Q7M767|UB2V2_RAT Ubiquitin-conjugating enzyme E2 variant 2 OS=Rattus norvegicus OX=10116 GN=Ube2v2 PE=1 SV=3,GO:0000729; GO:0005634; GO:0006301; GO:0010976; GO:0031371; GO:0031372; GO:0032436; GO:0042275; GO:0043524; GO:0045739; GO:0051965; GO:0070534; GO:1902523; GO:2000781,DNA double-strand break processing [GO:0000729]; error-free postreplication DNA repair [GO:0042275]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of synapse assembly [GO:0051965]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534],nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371],,GO:0005634; GO:0006281; GO:0043226,nucleus; DNA repair; organelle
OG_07976,2.049910683100605,FUN_035554-T2,Peve_00036915,Pocillopora_meandrina_HIv1___TS.g15372.t1,three_way,93.07433333333334,FUN_035554-T2,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),67.4,4652.0,0.0,6165.9,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_07977,1.7339298197460016,FUN_035598-T2,Peve_00027482,Pocillopora_meandrina_HIv1___TS.g15377.t1,three_way,86.6325,FUN_035598-T2,Q92620,PRP16_HUMAN,,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38),Homo sapiens (Human),76.7,951.0,0.0,1411.7,sp|Q92620|PRP16_HUMAN Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Homo sapiens OX=9606 GN=DHX38 PE=1 SV=2,GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0016020; GO:0016887; GO:0034458; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_07981,1.114616908302099,FUN_035603-T1,Peve_00027476,Pocillopora_meandrina_HIv1___RNAseq.g28041.t1,three_way,72.97933333333333,FUN_035603-T1,Q92556,ELMO1_HUMAN,,Engulfment and cell motility protein 1 (Protein ced-12 homolog),Homo sapiens (Human),43.4,726.0,1.6e-169,597.8,sp|Q92556|ELMO1_HUMAN Engulfment and cell motility protein 1 OS=Homo sapiens OX=9606 GN=ELMO1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870; GO:0098794; GO:0098978; GO:0150052,"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],SH3 domain binding [GO:0017124],GO:0005829; GO:0005886; GO:0007010; GO:0012501; GO:0048870; GO:0061024,cytosol; plasma membrane; cytoskeleton organization; programmed cell death; cell motility; membrane organization
OG_07982,1.7896242030161216,FUN_035607-T2,Peve_00025644,Pocillopora_meandrina_HIv1___RNAseq.g28044.t1,three_way,64.08733333333333,,,,,,,,,,,,,,,,,
OG_07983,1.101337586368138,FUN_035608-T1,Peve_00031575,Pocillopora_meandrina_HIv1___RNAseq.g28045.t1,three_way,61.36366666666667,,,,,,,,,,,,,,,,,
OG_07986,1.2113964236503345,FUN_035613-T1,Peve_00029657,Pocillopora_meandrina_HIv1___RNAseq.g28081.t1,three_way,73.11133333333333,FUN_035613-T1,P53454,,,,,34.0,329.0,2e-36,154.8,sp|P53454|DRD5L_TAKRU D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1,,,,,,
OG_07987,1.2197040521439366,FUN_035615-T1,Peve_00029654,Pocillopora_meandrina_HIv1___RNAseq.g28080.t1,three_way,72.06366666666666,FUN_035615-T1,P35404,,,,,33.6,348.0,1.1e-32,142.5,sp|P35404|5HT1B_DIDVI 5-hydroxytryptamine receptor 1B OS=Didelphis virginiana OX=9267 GN=HTR1B PE=2 SV=1,,,,,,
OG_07988,1.111582016749314,FUN_035618-T1,Peve_00029653,Pocillopora_meandrina_HIv1___TS.g15425.t1,three_way,87.45883333333333,FUN_035618-T1,Q9Y5B9,,,,,59.7,937.0,0.0,1174.5,sp|Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,,,,,,
OG_07996,2.0126305997071667,FUN_035637-T1,Peve_00029721,Pocillopora_meandrina_HIv1___RNAseq.g28085.t1,three_way,59.298,,,,,,,,,,,,,,,,,
OG_07999,1.5487598839794527,FUN_035640-T1,Peve_00020462,Pocillopora_meandrina_HIv1___RNAseq.g28090.t1,three_way,58.150333333333336,FUN_035640-T1,Q58L91,FA5V_OXYSU,,Venom prothrombin activator oscutarin-C non-catalytic subunit (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Oscutarin-C non-catalytic subunit heavy chain; Oscutarin-C non-catalytic subunit light chain],Oxyuranus scutellatus (Coastal taipan),40.5,163.0,8.3e-24,113.2,sp|Q58L91|FA5V_OXYSU Venom prothrombin activator oscutarin-C non-catalytic subunit OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1,GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729,venom-mediated blood coagulation [GO:0044469],extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729],GO:0005576; GO:0005886; GO:0060089; GO:0090729; GO:0098772,extracellular region; plasma membrane; molecular transducer activity; toxin activity; molecular function regulator activity
OG_08001,2.247791151320789,FUN_035647-T1,Peve_00022820,Pocillopora_meandrina_HIv1___RNAseq.g28097.t1,three_way,46.10966666666667,,,,,,,,,,,,,,,,,
OG_08002,2.039587593155231,FUN_035648-T1,Peve_00022818,Pocillopora_meandrina_HIv1___RNAseq.g28098.t1,three_way,65.012,FUN_035648-T1,P53668,LIMK1_MOUSE,,LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (KIZ-1),Mus musculus (Mouse),32.9,210.0,5.1e-23,110.2,sp|P53668|LIMK1_MOUSE LIM domain kinase 1 OS=Mus musculus OX=10090 GN=Limk1 PE=1 SV=1,GO:0001673; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0016020; GO:0016607; GO:0030027; GO:0031072; GO:0031625; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051496; GO:0098794; GO:0098978; GO:0106310; GO:1990948,axon extension [GO:0048675]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; stress fiber assembly [GO:0043149],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08003,1.3469800394383586,FUN_035652-T1,Peve_00022825,Pocillopora_meandrina_HIv1___RNAseq.g28106.t1,three_way,72.28066666666666,FUN_035652-T1,Q80ZW0,,,,,30.1,335.0,1.1000000000000001e-27,125.6,sp|Q80ZW0|STK35_MOUSE Serine/threonine-protein kinase 35 OS=Mus musculus OX=10090 GN=Stk35 PE=1 SV=3,,,,,,
OG_08004,1.8134138856833264,FUN_035653-T1,Peve_00028212,Pocillopora_meandrina_HIv1___RNAseq.g28108.t1,three_way,78.766,FUN_035653-T1,Q568Z7,CIB2_RAT,,Calcium and integrin-binding family member 2,Rattus norvegicus (Rat),52.7,188.0,6.2e-54,213.0,sp|Q568Z7|CIB2_RAT Calcium and integrin-binding family member 2 OS=Rattus norvegicus OX=10116 GN=Cib2 PE=1 SV=1,GO:0000287; GO:0001750; GO:0001917; GO:0005178; GO:0005509; GO:0005737; GO:0005829; GO:0005927; GO:0007204; GO:0031594; GO:0032420; GO:0032437; GO:0042383; GO:0042803; GO:0044877; GO:0045494; GO:0055074; GO:0071318; GO:0071944,calcium ion homeostasis [GO:0055074]; cellular response to ATP [GO:0071318]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cytosolic calcium ion concentration [GO:0007204],cell periphery [GO:0071944]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; sarcolemma [GO:0042383]; stereocilium [GO:0032420],calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0005829; GO:0005886,cytosol; plasma membrane
OG_08005,2.0064347795346653,FUN_035654-T1,Peve_00028213,Pocillopora_meandrina_HIv1___RNAseq.g28110.t1,three_way,80.874,FUN_035654-T1,Q9H063,MAF1_HUMAN,,Repressor of RNA polymerase III transcription MAF1 homolog,Homo sapiens (Human),50.8,254.0,2.7999999999999997e-63,243.4,sp|Q9H063|MAF1_HUMAN Repressor of RNA polymerase III transcription MAF1 homolog OS=Homo sapiens OX=9606 GN=MAF1 PE=1 SV=2,GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0016479; GO:0016480; GO:0030424; GO:0030425; GO:0048471; GO:0050811; GO:0060077,negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle
OG_08008,1.699565222583972,FUN_035660-T1,Peve_00020774,Pocillopora_meandrina_HIv1___RNAseq.g28116.t1,three_way,60.16833333333333,,,,,,,,,,,,,,,,,
OG_08010,1.3432380497587846,FUN_035663-T1,Peve_00038557,Pocillopora_meandrina_HIv1___RNAseq.g28119.t3,three_way,87.50766666666667,FUN_035663-T1,O75081,MTG16_HUMAN,,Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein) (hMTG16) (Zinc finger MYND domain-containing protein 4),Homo sapiens (Human),42.8,549.0,6.600000000000001e-80,299.7,sp|O75081|MTG16_HUMAN Protein CBFA2T3 OS=Homo sapiens OX=9606 GN=CBFA2T3 PE=1 SV=2,GO:0000139; GO:0001666; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008270; GO:0008285; GO:0030851; GO:0032436; GO:0045820; GO:0045892; GO:1903715,DNA-templated transcription [GO:0006351]; granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glycolytic process [GO:0045820]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666],Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; nucleolus; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_08012,1.8013528107306405,FUN_035665-T1,Peve_00002788,Pocillopora_meandrina_HIv1___RNAseq.g28121.t1,three_way,70.55033333333334,FUN_035665-T1,Q9NRH2,,,,,66.7,330.0,4.4e-126,453.8,sp|Q9NRH2|SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=SNRK PE=1 SV=2,,,,,,
OG_08013,1.5220825484958591,FUN_035667-T1,Peve_00002800,Pocillopora_meandrina_HIv1___RNAseq.g28123.t1,three_way,73.54066666666667,FUN_035667-T1,Q86V88,,,,,52.3,155.0,1.1e-44,181.0,sp|Q86V88|MGDP1_HUMAN Magnesium-dependent phosphatase 1 OS=Homo sapiens OX=9606 GN=MDP1 PE=1 SV=1,,,,,,
OG_08017,1.242454920631523,FUN_035671-T1,Peve_00002792,Pocillopora_meandrina_HIv1___RNAseq.g28139.t1,three_way,83.45733333333334,FUN_035671-T1,Q561X0,,,,,57.4,122.0,3.5000000000000004e-32,139.0,sp|Q561X0|NEPR1_DANRE Nuclear envelope phosphatase-regulatory subunit 1 OS=Danio rerio OX=7955 GN=cnep1r1 PE=2 SV=1,,,,,,
OG_08020,1.0963369008728676,FUN_035675-T1,Peve_00002795,Pocillopora_meandrina_HIv1___RNAseq.g28142.t1,three_way,59.38916666666667,FUN_035675-T1,Q6NZL6,TONSL_MOUSE,,Tonsoku-like protein (Inhibitor of kappa B-related protein) (I-kappa-B-related protein) (IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2),Mus musculus (Mouse),29.1,1503.0,7.8e-97,357.5,sp|Q6NZL6|TONSL_MOUSE Tonsoku-like protein OS=Mus musculus OX=10090 GN=Tonsl PE=1 SV=2,GO:0000724; GO:0005737; GO:0031297; GO:0035861; GO:0042393; GO:0043596; GO:0140566,double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; site of double-strand break [GO:0035861],histone binding [GO:0042393]; histone reader activity [GO:0140566],GO:0006281; GO:0006310; GO:0042393; GO:0060090,DNA repair; DNA recombination; histone binding; molecular adaptor activity
OG_08022,1.6193969075932422,FUN_035677-T1,Peve_00002799,Pocillopora_meandrina_HIv1___RNAseq.g28144.t1,three_way,61.552,FUN_035677-T1,Q96I34,PP16A_HUMAN,,Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3),Homo sapiens (Human),37.7,371.0,1.2e-26,123.2,sp|Q96I34|PP16A_HUMAN Protein phosphatase 1 regulatory subunit 16A OS=Homo sapiens OX=9606 GN=PPP1R16A PE=1 SV=1,GO:0004857; GO:0005737; GO:0005886; GO:0017020,,cytoplasm [GO:0005737]; plasma membrane [GO:0005886],enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_08023,1.2255837177833548,FUN_035678-T1,Peve_00033237,Pocillopora_meandrina_HIv1___TS.g15489.t1,three_way,88.24733333333333,FUN_035678-T1,A7SXZ6,OSGEP_NEMVE,,Probable tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgep) (tRNA threonylcarbamoyladenosine biosynthesis protein osgep),Nematostella vectensis (Starlet sea anemone),88.9,334.0,1.2e-175,617.1,sp|A7SXZ6|OSGEP_NEMVE Probable tRNA N6-adenosine threonylcarbamoyltransferase OS=Nematostella vectensis OX=45351 GN=osgep PE=3 SV=1,GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0046872; GO:0061711,tRNA threonylcarbamoyladenosine modification [GO:0002949],cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634],metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711],GO:0003824; GO:0005634; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_08024,1.051030081985688,FUN_035679-T1,Peve_00025446,Pocillopora_meandrina_HIv1___RNAseq.g28146.t1,three_way,82.66166666666666,FUN_035679-T1,Q15024,EXOS7_HUMAN,,Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8),Homo sapiens (Human),60.1,291.0,4e-98,359.4,sp|Q15024|EXOS7_HUMAN Exosome complex component RRP42 OS=Homo sapiens OX=9606 GN=EXOSC7 PE=1 SV=3,GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0071028; GO:0071035; GO:0071038; GO:0101019,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]",cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_08028,1.1993280949856415,FUN_035683-T1,Peve_00041296,Pocillopora_meandrina_HIv1___RNAseq.g11803.t1,three_way,70.305,FUN_035683-T1,P20456,IMPA1_BOVIN,,Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1),Bos taurus (Bovine),55.4,271.0,2.1e-80,300.4,sp|P20456|IMPA1_BOVIN Inositol monophosphatase 1 OS=Bos taurus OX=9913 GN=IMPA1 PE=1 SV=1,GO:0000287; GO:0004346; GO:0005737; GO:0006020; GO:0006021; GO:0007165; GO:0008877; GO:0008934; GO:0030145; GO:0031403; GO:0046854; GO:0047954; GO:0052832; GO:0052833; GO:0052834; GO:0103026,inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165],cytoplasm [GO:0005737],fructose-1-phosphatase activity [GO:0103026]; glucose-1-phosphatase activity [GO:0008877]; glucose-6-phosphatase activity [GO:0004346]; glycerol-2-phosphatase activity [GO:0047954]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_08031,1.9235505029707312,FUN_035689-T1,Peve_00041293,Pocillopora_meandrina_HIv1___RNAseq.g11805.t1,three_way,90.49,FUN_035689-T1,Q13884,SNTB1_HUMAN,,Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43),Homo sapiens (Human),47.2,527.0,2.4e-127,457.2,sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3,GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202,muscle contraction [GO:0006936],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198],GO:0003012; GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0043226,muscle system process; structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_08034,1.3715788399186126,FUN_035694-T1,Peve_00033765,Pocillopora_meandrina_HIv1___RNAseq.g11819.t1,three_way,79.92699999999999,FUN_035694-T1,Q8BQM4,,,,,35.3,680.0,4.0999999999999996e-92,340.5,sp|Q8BQM4|HEAT3_MOUSE HEAT repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Heatr3 PE=1 SV=1,,,,,,
OG_08042,1.4525032596672771,FUN_035719-T1,Peve_00044099,Pocillopora_meandrina_HIv1___RNAseq.g11850.t2,three_way,78.6335,FUN_035719-T1,Q3US41,,,,,38.6,681.0,3.3e-122,440.7,sp|Q3US41|ESRP1_MOUSE Epithelial splicing regulatory protein 1 OS=Mus musculus OX=10090 GN=Esrp1 PE=1 SV=2,,,,,,
OG_08043,1.2201114889220126,FUN_035720-T1,Peve_00044100,Pocillopora_meandrina_HIv1___RNAseq.g11851.t1,three_way,80.81633333333333,FUN_035720-T1,E2RDZ6,,,,,67.2,265.0,2.5e-105,383.3,"sp|E2RDZ6|SIR5_CANLF NAD-dependent protein deacylase sirtuin-5, mitochondrial OS=Canis lupus familiaris OX=9615 GN=SIRT5 PE=3 SV=1",,,,,,
OG_08046,2.8076636265308905,FUN_035734-T1,Peve_00044083,Pocillopora_meandrina_HIv1___RNAseq.g11861.t1,three_way,58.831,FUN_035734-T1,Q8C080,,,,,51.9,162.0,2.9e-41,171.0,sp|Q8C080|SNX16_MOUSE Sorting nexin-16 OS=Mus musculus OX=10090 GN=Snx16 PE=1 SV=2,,,,,,
OG_08047,1.7244567821891263,FUN_035735-T1,Peve_00044084,Pocillopora_meandrina_HIv1___RNAseq.g11862.t1,three_way,61.315000000000005,FUN_035735-T1,P57769,SNX16_RAT,,Sorting nexin-16,Rattus norvegicus (Rat),44.3,149.0,4.9000000000000005e-27,124.0,sp|P57769|SNX16_RAT Sorting nexin-16 OS=Rattus norvegicus OX=10116 GN=Snx16 PE=1 SV=2,GO:0001881; GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022,early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]; receptor recycling [GO:0001881],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_08049,1.3359891635639414,FUN_035737-T1,Peve_00044088,Pocillopora_meandrina_HIv1___RNAseq.g11864.t1,three_way,77.52216666666666,FUN_035737-T1,Q8BYH8,CHD9_MOUSE,,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.-) (ATP-dependent helicase CHD9) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),Mus musculus (Mouse),43.2,2161.0,0.0,1496.1,sp|Q8BYH8|CHD9_MOUSE Chromodomain-helicase-DNA-binding protein 9 OS=Mus musculus OX=10090 GN=Chd9 PE=1 SV=2,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005829; GO:0006325; GO:0016887,chromatin organization [GO:0006325],cytosol [GO:0005829]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; nucleoplasm; cytosol; chromatin organization; hydrolase activity; isomerase activity; ATP-dependent activity
OG_08057,1.6831328097554434,FUN_035752-T1,Peve_00044203,Pocillopora_meandrina_HIv1___RNAseq.g11880.t1,three_way,86.57133333333333,FUN_035752-T1,Q64701,RBL1_MOUSE,,Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1),Mus musculus (Mouse),50.0,1056.0,2.6e-275,949.9,sp|Q64701|RBL1_MOUSE Retinoblastoma-like protein 1 OS=Mus musculus OX=10090 GN=Rbl1 PE=1 SV=3,GO:0000122; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0010629; GO:0051726; GO:1990841; GO:2000773,chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],promoter-specific chromatin binding [GO:1990841],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_08058,1.3001724361969016,FUN_035753-T1,Peve_00044191,Pocillopora_meandrina_HIv1___RNAseq.g11881.t1,three_way,66.50783333333334,,,,,,,,,,,,,,,,,
OG_08059,1.6208228526900572,FUN_035754-T1,Peve_00044192,Pocillopora_meandrina_HIv1___RNAseq.g11883.t1,three_way,63.23283333333333,FUN_035754-T1,Q5NDE7,PMGT2_XENLA,,"Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGnT2) (EC 2.4.1.312) (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2)",Xenopus laevis (African clawed frog),45.0,524.0,2.7e-140,500.4,"sp|Q5NDE7|PMGT2_XENLA Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 OS=Xenopus laevis OX=8355 GN=pomgnt2 PE=2 SV=1",GO:0001764; GO:0005783; GO:0005789; GO:0006493; GO:0008375; GO:0035269; GO:0097363,neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],acetylglucosaminyltransferase activity [GO:0008375]; protein O-acetylglucosaminyltransferase activity [GO:0097363],GO:0003824; GO:0005783; GO:0009101; GO:0016740; GO:0043226; GO:0048870; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; transferase activity; organelle; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_08063,1.1161206486192754,FUN_035761-T1,Peve_00033438,Pocillopora_meandrina_HIv1___RNAseq.g11890.t1,three_way,66.28783333333334,FUN_035761-T1,O70220,,,,,66.0,94.0,2.7e-33,144.1,sp|O70220|FOXQ1_MOUSE Forkhead box protein Q1 OS=Mus musculus OX=10090 GN=Foxq1 PE=2 SV=3,,,,,,
OG_08065,1.5669979563363936,FUN_035765-T1,Peve_00033443,Pocillopora_meandrina_HIv1___RNAseq.g11894.t1,three_way,90.73666666666666,FUN_035765-T1,Q6GL41,MCM4_XENTR,,DNA replication licensing factor mcm4 (EC 3.6.4.12) (Minichromosome maintenance protein 4),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),68.7,836.0,0.0,1105.1,sp|Q6GL41|MCM4_XENTR DNA replication licensing factor mcm4 OS=Xenopus tropicalis OX=8364 GN=mcm4 PE=2 SV=1,GO:0000785; GO:0001878; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0006270; GO:0008270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162,cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; regulation of DNA-templated DNA replication initiation [GO:0030174]; response to yeast [GO:0001878],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006260; GO:0016787; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA replication; hydrolase activity; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_08066,1.5192207734064107,FUN_035767-T1,Peve_00033444,Pocillopora_meandrina_HIv1___RNAseq.g11895.t1,three_way,83.33766666666666,FUN_035767-T1,Q8VI75,,,,,41.1,443.0,5.400000000000001e-89,330.1,sp|Q8VI75|IPO4_MOUSE Importin-4 OS=Mus musculus OX=10090 GN=Ipo4 PE=1 SV=1,,,,,,
OG_08067,1.0927450021079153,FUN_035770-T1,Peve_00027765,Pocillopora_meandrina_HIv1___RNAseq.g11896.t1,three_way,75.35533333333333,FUN_035770-T1,A2VDS1,SCLY_BOVIN,,Selenocysteine lyase (EC 4.4.1.16),Bos taurus (Bovine),57.0,407.0,1.2999999999999999e-129,464.5,sp|A2VDS1|SCLY_BOVIN Selenocysteine lyase OS=Bos taurus OX=9913 GN=SCLY PE=2 SV=1,GO:0005829; GO:0009000; GO:0016740,,cytosol [GO:0005829],selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740],GO:0003824; GO:0005829; GO:0016740; GO:0016829,catalytic activity; cytosol; transferase activity; lyase activity
OG_08070,1.645222269671848,FUN_035775-T1,Peve_00017724,Pocillopora_meandrina_HIv1___RNAseq.g11904.t1,three_way,71.4095,FUN_035775-T1,Q1LUT1,,,,,33.8,1359.0,3e-127,458.4,sp|Q1LUT1|EDC4_DANRE Enhancer of mRNA-decapping protein 4 OS=Danio rerio OX=7955 GN=edc4 PE=3 SV=1,,,,,,
OG_08071,1.085937784065139,FUN_035776-T1,Peve_00017723,Pocillopora_meandrina_HIv1___RNAseq.g11903.t1,three_way,63.2255,FUN_035776-T1,Q7TSG2,CTDP1_MOUSE,,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),Mus musculus (Mouse),33.5,714.0,1.6e-88,328.9,sp|Q7TSG2|CTDP1_MOUSE RNA polymerase II subunit A C-terminal domain phosphatase OS=Mus musculus OX=10090 GN=Ctdp1 PE=1 SV=1,GO:0000922; GO:0001096; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006470; GO:0008420; GO:0010458; GO:0030496; GO:0030957; GO:0032991; GO:0043923; GO:0051233; GO:0051301; GO:0061052,cell division [GO:0051301]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096],GO:0003824; GO:0005654; GO:0005815; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08073,1.0396886411595343,FUN_035778-T1,Peve_00027195,Pocillopora_meandrina_HIv1___RNAseq.g11901.t1,three_way,76.41,FUN_035778-T1,Q9BWW7,SCRT1_HUMAN,,Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (hScrt),Homo sapiens (Human),76.7,86.0,1.5e-16,88.2,sp|Q9BWW7|SCRT1_HUMAN Transcriptional repressor scratch 1 OS=Homo sapiens OX=9606 GN=SCRT1 PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0006355; GO:0008270; GO:0016604; GO:0043565; GO:1990837; GO:2001222,negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron migration [GO:2001222],nuclear body [GO:0016604],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0006355; GO:0043226; GO:0140110,DNA binding; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_08074,1.0011562674449506,FUN_035779-T1,Peve_00027194,Pocillopora_meandrina_HIv1___RNAseq.g11900.t1,three_way,82.8665,FUN_035779-T1,Q9CWL8,CTBL1_MOUSE,,Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP),Mus musculus (Mouse),62.4,479.0,1.4e-168,594.3,sp|Q9CWL8|CTBL1_MOUSE Beta-catenin-like protein 1 OS=Mus musculus OX=10090 GN=Ctnnbl1 PE=1 SV=1,GO:0000398; GO:0000974; GO:0002250; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016445; GO:0019899; GO:0043065,"adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]",centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681],enzyme binding [GO:0019899],GO:0002376; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0012501; GO:0016071; GO:0043226,immune system process; nucleus; nucleoplasm; microtubule organizing center; cytosol; programmed cell death; mRNA metabolic process; organelle
OG_08076,1.7079339315290474,FUN_035800-T1,Peve_00015196,Pocillopora_meandrina_HIv1___RNAseq.g11910.t1a,three_way,62.337,FUN_035800-T1,O13076,,,,,29.1,313.0,8e-19,96.3,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_08080,1.586536308210587,FUN_035804-T1,Peve_00017708,Pocillopora_meandrina_HIv1___RNAseq.g11921.t1,three_way,69.93833333333333,FUN_035804-T1,Q8NCN5,,,,,39.3,819.0,1e-170,602.1,"sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2",,,,,,
OG_08083,2.565774874626583,FUN_035810-T1,Peve_00037792,Pocillopora_meandrina_HIv1___RNAseq.g11929.t1,three_way,63.96066666666667,FUN_035810-T1,O15943,CADN_DROME,,Neural-cadherin (Cadherin-N) (dN-cadherin),Drosophila melanogaster (Fruit fly),31.2,2035.0,2.2e-241,838.2,sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2,GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016020; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609,axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803],GO:0005886; GO:0007155; GO:0048856,plasma membrane; cell adhesion; anatomical structure development
OG_08084,1.4791150546979828,FUN_035813-T1,Peve_00037805,Pocillopora_meandrina_HIv1___RNAseq.g11928.t1,three_way,74.87766666666667,FUN_035813-T1,Q969N2,PIGT_HUMAN,,GPI-anchor transamidase component PIGT (Phosphatidylinositol-glycan biosynthesis class T protein),Homo sapiens (Human),45.6,553.0,4.1e-142,506.5,sp|Q969N2|PIGT_HUMAN GPI-anchor transamidase component PIGT OS=Homo sapiens OX=9606 GN=PIGT PE=1 SV=1,GO:0005789; GO:0006506; GO:0016020; GO:0016255; GO:0030182; GO:0031410; GO:0034235; GO:0042765; GO:0051402; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020],GPI anchor binding [GO:0034235],GO:0006629; GO:0008289; GO:0012501; GO:0030154; GO:0031410; GO:0043226; GO:0051604; GO:1901135,lipid metabolic process; lipid binding; programmed cell death; cell differentiation; cytoplasmic vesicle; organelle; protein maturation; carbohydrate derivative metabolic process
OG_08086,1.5183367577518574,FUN_035818-T1,Peve_00037796,Pocillopora_meandrina_HIv1___RNAseq.g11926.t1,three_way,85.777,FUN_035818-T1,Q6ZQ89,,,,,69.6,573.0,3.7e-215,749.2,sp|Q6ZQ89|MARH6_MOUSE E3 ubiquitin-protein ligase MARCHF6 OS=Mus musculus OX=10090 GN=Marchf6 PE=2 SV=2,,,,,,
OG_08087,1.038720195097275,FUN_035819-T1,Peve_00037795,Pocillopora_meandrina_HIv1___RNAseq.g11925.t1,three_way,66.42033333333333,FUN_035819-T1,Q9CVD2,ATX3_MOUSE,,Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1 homolog),Mus musculus (Mouse),53.3,152.0,9.399999999999999e-39,161.8,sp|Q9CVD2|ATX3_MOUSE Ataxin-3 OS=Mus musculus OX=10090 GN=Atxn3 PE=1 SV=2,GO:0000226; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005765; GO:0005789; GO:0005829; GO:0005886; GO:0006511; GO:0006515; GO:0010810; GO:0016363; GO:0030036; GO:0031625; GO:0031966; GO:0034198; GO:0034605; GO:0035520; GO:0035640; GO:0042405; GO:0042802; GO:0043161; GO:0045104; GO:0051117; GO:0061578; GO:0070536; GO:0071108; GO:0071218; GO:1904262; GO:1904294; GO:1904327; GO:1990380; GO:2000060,actin cytoskeleton organization [GO:0030036]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; exploration behavior [GO:0035640]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex [GO:1904327]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0007010; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; plasma membrane; cytoskeleton organization; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_08090,2.288409654948259,FUN_035822-T1,Peve_00037801,Pocillopora_meandrina_HIv1___RNAseq.g11932.t1,three_way,75.45,FUN_035822-T1,Q6PJI9,WDR59_HUMAN,,GATOR2 complex protein WDR59 (WD repeat-containing protein 59),Homo sapiens (Human),39.0,885.0,8.999999999999999e-151,535.8,sp|Q6PJI9|WDR59_HUMAN GATOR2 complex protein WDR59 OS=Homo sapiens OX=9606 GN=WDR59 PE=1 SV=2,GO:0005765; GO:0005774; GO:0005829; GO:0008270; GO:0031669; GO:0034198; GO:0035591; GO:0035859; GO:0043231; GO:0061700; GO:1904262; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774],signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270],GO:0005829; GO:0043226; GO:0060090,cytosol; organelle; molecular adaptor activity
OG_08091,2.826453236271011,FUN_035824-T1,Peve_00037802,Pocillopora_meandrina_HIv1___RNAseq.g11933.t1,three_way,90.67833333333334,FUN_035824-T1,P08239,,,,,72.6,354.0,3e-148,526.2,sp|P08239|GNAO_BOVIN Guanine nucleotide-binding protein G(o) subunit alpha OS=Bos taurus OX=9913 GN=GNAO1 PE=1 SV=4,,,,,,
OG_08093,1.5509584885043928,FUN_035828-T1,Peve_00002588,Pocillopora_meandrina_HIv1___RNAseq.g11936.t1,three_way,67.353,FUN_035828-T1,Q60751,IGF1R_MOUSE,,Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain],Mus musculus (Mouse),48.0,275.0,4.300000000000001e-71,271.6,sp|Q60751|IGF1R_MOUSE Insulin-like growth factor 1 receptor OS=Mus musculus OX=10090 GN=Igf1r PE=1 SV=3,GO:0000165; GO:0004713; GO:0005010; GO:0005198; GO:0005520; GO:0005524; GO:0005886; GO:0007420; GO:0008544; GO:0009887; GO:0016020; GO:0030238; GO:0030315; GO:0030325; GO:0030879; GO:0031017; GO:0032869; GO:0043235; GO:0043409; GO:0043410; GO:0043491; GO:0043548; GO:0043560; GO:0045840; GO:0045893; GO:0046777; GO:0048009; GO:0048639; GO:0051446; GO:0051897; GO:0051898; GO:0060740; GO:0071333; GO:0098794; GO:0098978; GO:0099170; GO:0120162; GO:0140014,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; insulin-like growth factor receptor signaling pathway [GO:0048009]; male sex determination [GO:0030238]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; mitotic nuclear division [GO:0140014]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; prostate gland epithelium morphogenesis [GO:0060740]; protein autophosphorylation [GO:0046777],glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]; T-tubule [GO:0030315],ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198],GO:0003824; GO:0005198; GO:0005886; GO:0006355; GO:0016740; GO:0022414; GO:0048856; GO:0060089; GO:0140014; GO:0140096,"catalytic activity; structural molecule activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; reproductive process; anatomical structure development; molecular transducer activity; mitotic nuclear division; catalytic activity, acting on a protein"
OG_08095,2.4565825026800043,FUN_035833-T1,Peve_00002593,Pocillopora_meandrina_HIv1___RNAseq.g11963.t1,three_way,82.79166666666667,FUN_035833-T1,O74212,,,,,49.9,443.0,1.9999999999999999e-128,460.7,sp|O74212|D5FAD_MORAP Acyl-lipid (8-3)-desaturase OS=Mortierella alpina OX=64518 GN=DES1 PE=1 SV=1,,,,,,
OG_08104,1.12609788119795,FUN_035850-T1,Peve_00032508,Pocillopora_meandrina_HIv1___RNAseq.g11951.t1,three_way,80.12583333333333,,,,,,,,,,,,,,,,,
OG_08108,1.1637903988280789,FUN_035859-T2,Peve_00035389,Pocillopora_meandrina_HIv1___RNAseq.g11944.t1,three_way,59.82066666666666,FUN_035859-T2,Q8CHP0,ZC3H3_MOUSE,,Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor),Mus musculus (Mouse),54.4,169.0,1.6e-16,89.7,sp|Q8CHP0|ZC3H3_MOUSE Zinc finger CCCH domain-containing protein 3 OS=Mus musculus OX=10090 GN=Zc3h3 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005847; GO:0008270; GO:0031124; GO:0032927; GO:0046332; GO:0051028; GO:0070412,mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927],mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634],DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0016071; GO:0043226,DNA binding; nucleus; mRNA metabolic process; organelle
OG_08112,1.194454130767569,FUN_035865-T1,Peve_00012613,Pocillopora_meandrina_HIv1___RNAseq.g11977.t1,three_way,77.13466666666666,FUN_035865-T1,Q8TEL6,TP4AP_HUMAN,,Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS),Homo sapiens (Human),37.4,768.0,3.2e-131,470.7,sp|Q8TEL6|TP4AP_HUMAN Short transient receptor potential channel 4-associated protein OS=Homo sapiens OX=9606 GN=TRPC4AP PE=1 SV=2,GO:0005262; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0070588; GO:0080008; GO:0140627; GO:1990756,calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005215; GO:0005829; GO:0005886; GO:0030163; GO:0055085; GO:0060090,transporter activity; cytosol; plasma membrane; protein catabolic process; transmembrane transport; molecular adaptor activity
OG_08113,1.0382653337440364,FUN_035867-T1,Peve_00012616,Pocillopora_meandrina_HIv1___RNAseq.g11976.t1,three_way,85.703,FUN_035867-T1,Q642Q1,,,,,69.7,287.0,2e-117,423.7,sp|Q642Q1|SAE2A_XENLA SUMO-activating enzyme subunit 2-A OS=Xenopus laevis OX=8355 GN=uba2-a PE=2 SV=1,,,,,,
OG_08117,1.2872551511227586,FUN_035871-T1,Peve_00012622,Pocillopora_meandrina_HIv1___RNAseq.g11971.t1,three_way,62.25533333333333,FUN_035871-T1,O35218,,,,,52.0,269.0,2.1e-71,271.9,sp|O35218|CPSF2_MOUSE Cleavage and polyadenylation specificity factor subunit 2 OS=Mus musculus OX=10090 GN=Cpsf2 PE=1 SV=1,,,,,,
OG_08118,1.343832076318677,FUN_035872-T1,Peve_00014418,Pocillopora_meandrina_HIv1___RNAseq.g11987.t1,three_way,91.452,FUN_035872-T1,Q10568,,,,,69.1,181.0,3.2e-69,262.7,sp|Q10568|CPSF2_BOVIN Cleavage and polyadenylation specificity factor subunit 2 OS=Bos taurus OX=9913 GN=CPSF2 PE=1 SV=1,,,,,,
OG_08121,2.053674059640723,FUN_035878-T1,Peve_00014423,Pocillopora_meandrina_HIv1___RNAseq.g11992.t1,three_way,81.17266666666667,FUN_035878-T1,Q01650,LAT1_HUMAN,,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),Homo sapiens (Human),47.3,412.0,9.6e-108,392.1,sp|Q01650|LAT1_HUMAN Large neutral amino acids transporter small subunit 1 OS=Homo sapiens OX=9606 GN=SLC7A5 PE=1 SV=2,GO:0002720; GO:0003333; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010507; GO:0010629; GO:0014850; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015297; GO:0015349; GO:0015804; GO:0015818; GO:0015820; GO:0015821; GO:0015823; GO:0015824; GO:0015827; GO:0015828; GO:0015829; GO:0016020; GO:0016323; GO:0016324; GO:0031528; GO:0032328; GO:0032729; GO:0032740; GO:0032753; GO:0042149; GO:0042605; GO:0042908; GO:0043231; GO:0055093; GO:0060252; GO:0070062; GO:0070327; GO:0071222; GO:0089718; GO:0097421; GO:0098591; GO:0150104; GO:1902024; GO:1903577; GO:1903801; GO:1904556; GO:1905460; GO:1905534; GO:1990184,alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; cellular response to glucose starvation [GO:0042149]; cellular response to L-arginine [GO:1903577]; cellular response to lipopolysaccharide [GO:0071222]; isoleucine transport [GO:0015818]; L-histidine transport [GO:1902024]; L-leucine import across plasma membrane [GO:1903801]; L-leucine transport [GO:0015820]; L-tryptophan transmembrane transport [GO:1904556]; liver regeneration [GO:0097421]; methionine transport [GO:0015821]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of L-leucine import across plasma membrane [GO:1905534]; positive regulation of type II interferon production [GO:0032729]; proline transport [GO:0015824]; response to hyperoxia [GO:0055093]; response to muscle activity [GO:0014850]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828]; valine transport [GO:0015829]; xenobiotic transport [GO:0042908],amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349],GO:0003013; GO:0005215; GO:0005829; GO:0005886; GO:0043226; GO:0048856; GO:0055085,circulatory system process; transporter activity; cytosol; plasma membrane; organelle; anatomical structure development; transmembrane transport
OG_08127,1.0454314463830896,FUN_035886-T1,Peve_00029402,Pocillopora_meandrina_HIv1___RNAseq.g12004.t1,three_way,81.07366666666667,FUN_035886-T1,O75340,PDCD6_HUMAN,,Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2),Homo sapiens (Human),52.7,167.0,2.5e-50,199.9,sp|O75340|PDCD6_HUMAN Programmed cell death protein 6 OS=Homo sapiens OX=9606 GN=PDCD6 PE=1 SV=1,GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043065; GO:0043495; GO:0045766; GO:0046982; GO:0046983; GO:0048208; GO:0048306; GO:0048471; GO:0051592; GO:0051898; GO:0070062; GO:0070971; GO:0097190; GO:1902527; GO:1990756,angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005829; GO:0006886; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0065003,nucleus; nucleoplasm; endosome; endoplasmic reticulum; cytosol; intracellular protein transport; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_08130,1.0701961155531825,FUN_035890-T2,Peve_00029398,Pocillopora_meandrina_HIv1___RNAseq.g12007.t1,three_way,73.41116666666667,FUN_035890-T2,Q8TEB1,DCA11_HUMAN,,DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23),Homo sapiens (Human),51.1,493.0,1.3e-147,524.6,sp|Q8TEB1|DCA11_HUMAN DDB1- and CUL4-associated factor 11 OS=Homo sapiens OX=9606 GN=DCAF11 PE=1 SV=1,GO:0003016; GO:0005654; GO:0006979; GO:0007613; GO:0010467; GO:0016567; GO:0035640; GO:0043161; GO:0050821; GO:0080008,exploration behavior [GO:0035640]; gene expression [GO:0010467]; memory [GO:0007613]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; respiratory system process [GO:0003016]; response to oxidative stress [GO:0006979],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654],,GO:0003016; GO:0005654; GO:0030163; GO:0050877,respiratory system process; nucleoplasm; protein catabolic process; nervous system process
OG_08131,2.182606954938968,FUN_035891-T1,Peve_00029395,Pocillopora_meandrina_HIv1___RNAseq.g12008.t1,three_way,81.82483333333333,FUN_035891-T1,Q9WUU6,,,,,68.0,325.0,9.9e-122,438.3,sp|Q9WUU6|HNF4G_MOUSE Hepatocyte nuclear factor 4-gamma OS=Mus musculus OX=10090 GN=Hnf4g PE=2 SV=2,,,,,,
OG_08132,1.1855398360134517,FUN_035892-T1,Peve_00029394,Pocillopora_meandrina_HIv1___RNAseq.g12009.t1,three_way,77.4455,FUN_035892-T1,Q8BH79,,,,,42.9,631.0,1.1e-140,501.9,sp|Q8BH79|ANO10_MOUSE Anoctamin-10 OS=Mus musculus OX=10090 GN=Ano10 PE=1 SV=1,,,,,,
OG_08133,1.5584147068791157,FUN_035894-T1,Peve_00029391,Pocillopora_meandrina_HIv1___RNAseq.g12010.t1,three_way,84.60600000000001,FUN_035894-T1,Q9NYG2,,,,,45.2,252.0,8.5e-50,198.7,sp|Q9NYG2|ZDHC3_HUMAN Palmitoyltransferase ZDHHC3 OS=Homo sapiens OX=9606 GN=ZDHHC3 PE=1 SV=2,,,,,,
OG_08139,1.5939970949751106,FUN_035901-T1,Peve_00006712,Pocillopora_meandrina_HIv1___RNAseq.g12026.t1,three_way,63.80683333333334,FUN_035901-T1,Q96H35,,,,,44.4,160.0,6.5e-30,132.1,sp|Q96H35|RBM18_HUMAN Probable RNA-binding protein 18 OS=Homo sapiens OX=9606 GN=RBM18 PE=1 SV=1,,,,,,
OG_08142,1.9457353087616591,FUN_035907-T1,Peve_00006737,Pocillopora_meandrina_HIv1___RNAseq.g12031.t1,three_way,87.19116666666667,FUN_035907-T1,Q5RE09,DC1L2_PONAB,,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),51.2,477.0,2.9e-122,440.3,sp|Q5RE09|DC1L2_PONAB Cytoplasmic dynein 1 light intermediate chain 2 OS=Pongo abelii OX=9601 GN=DYNC1LI2 PE=2 SV=1,GO:0000226; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045504,microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874],ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504],GO:0005815; GO:0007010; GO:0007018,microtubule organizing center; cytoskeleton organization; microtubule-based movement
OG_08143,2.3616958523428404,FUN_035908-T1,Peve_00006733,Pocillopora_meandrina_HIv1___TS.g3371.t1,three_way,92.83516666666668,,,,,,,,,,,,,,,,,
OG_08144,1.985157419841426,FUN_035913-T1,Peve_00006734,Pocillopora_meandrina_HIv1___RNAseq.g12035.t1,three_way,56.841,,,,,,,,,,,,,,,,,
OG_08145,1.3058563354001829,FUN_035914-T1,Peve_00006728,Pocillopora_meandrina_HIv1___TS.g3385.t1,three_way,55.639,FUN_035914-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),29.7,1194.0,1.5999999999999999e-96,356.3,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_08146,1.0591578911062136,FUN_035915-T1,Peve_00006727,Pocillopora_meandrina_HIv1___RNAseq.24982_t,three_way,54.92366666666666,,,,,,,,,,,,,,,,,
OG_08148,1.7328642889711996,FUN_035917-T1,Peve_00006725,Pocillopora_meandrina_HIv1___TS.g3382.t1,three_way,58.83166666666667,FUN_035917-T1,Q3ZBF3,,,,,41.2,245.0,2.2e-49,197.6,sp|Q3ZBF3|RM38_BOVIN Large ribosomal subunit protein mL38 OS=Bos taurus OX=9913 GN=MRPL38 PE=1 SV=2,,,,,,
OG_08158,1.99607338987946,FUN_035936-T1,Peve_00036627,Pocillopora_meandrina_HIv1___RNAseq.g12073.t1,three_way,53.47433333333333,FUN_035936-T1,Q4UB16,,,,,28.3,191.0,4.2e-12,73.2,sp|Q4UB16|RAB1_THEAN Ras-related protein Rab-1 OS=Theileria annulata OX=5874 GN=rab1 PE=3 SV=1,,,,,,
OG_08159,1.372604113498975,FUN_035940-T1,Peve_00036628,Pocillopora_meandrina_HIv1___RNAseq.g12074.t1,three_way,50.0505,FUN_035940-T1,Q86JC8,,,,,30.0,150.0,1.5e-06,54.7,sp|Q86JC8|RABH_DICDI Ras-related protein RabH OS=Dictyostelium discoideum OX=44689 GN=rabH PE=3 SV=1,,,,,,
OG_08160,1.516612020747539,FUN_035941-T1,Peve_00036629,Pocillopora_meandrina_HIv1___RNAseq.g12076.t1,three_way,64.244,FUN_035941-T1,P36861,,,,,37.7,175.0,9.300000000000001e-27,122.1,sp|P36861|YPTV2_VOLCA GTP-binding protein yptV2 OS=Volvox carteri OX=3067 GN=YPTV2 PE=3 SV=1,,,,,,
OG_08161,1.3969428972606497,FUN_035942-T1,Peve_00036630,Pocillopora_meandrina_HIv1___RNAseq.g12075.t1,three_way,70.11566666666667,FUN_035942-T1,P36410,RAB14_DICDI,,Ras-related protein Rab-14 (EC 3.6.5.2) (Rab4-like GTPase),Dictyostelium discoideum (Social amoeba),37.9,169.0,2.2000000000000004e-28,127.1,sp|P36410|RAB14_DICDI Ras-related protein Rab-14 OS=Dictyostelium discoideum OX=44689 GN=rab14 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005764; GO:0005765; GO:0005769; GO:0005802; GO:0005811; GO:0005829; GO:0006886; GO:0006895; GO:0006970; GO:0006971; GO:0012505; GO:0031164; GO:0032456; GO:0033298; GO:0042742; GO:0045335; GO:0048548; GO:0055037; GO:0062160; GO:0090382; GO:0140220; GO:1905364,contractile vacuole organization [GO:0033298]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; Golgi to endosome transport [GO:0006895]; hypotonic response [GO:0006971]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of pinocytosis [GO:0048548]; response to osmotic stress [GO:0006970],contractile vacuolar membrane [GO:0031164]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; pathogen-containing vacuole [GO:0140220]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; spongiome [GO:0062160]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_08164,1.14116811991469,FUN_035947-T1,Peve_00036635,Pocillopora_meandrina_HIv1___RNAseq.g12350.t1,three_way,62.132666666666665,FUN_035947-T1,Q99KW9,,,,,39.8,606.0,8.400000000000001e-111,402.5,sp|Q99KW9|TIP_MOUSE T-cell immunomodulatory protein OS=Mus musculus OX=10090 GN=Itfg1 PE=1 SV=2,,,,,,
OG_08170,2.480590277321152,FUN_035976-T1,Peve_00006611,Pocillopora_meandrina_HIv1___RNAseq.g12335.t1,three_way,78.89066666666666,FUN_035976-T1,Q8BVR6,,,,,56.2,489.0,3e-152,540.0,sp|Q8BVR6|RSPRY_MOUSE RING finger and SPRY domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rspry1 PE=1 SV=1,,,,,,
OG_08171,1.2319841873149164,FUN_035978-T1,Peve_00045087,Pocillopora_meandrina_HIv1___RNAseq.g12340.t1,three_way,89.63966666666667,FUN_035978-T1,Q9Y2E8,SL9A8_HUMAN,,Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8),Homo sapiens (Human),56.9,568.0,1.0999999999999999e-166,588.2,sp|Q9Y2E8|SL9A8_HUMAN Sodium/hydrogen exchanger 8 OS=Homo sapiens OX=9606 GN=SLC9A8 PE=1 SV=4,GO:0000139; GO:0001669; GO:0001675; GO:0006811; GO:0015385; GO:0015386; GO:0016324; GO:0032585; GO:0032588; GO:0035725; GO:0051453; GO:0071805; GO:1902600; GO:1905526,acrosome assembly [GO:0001675]; monoatomic ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; sodium ion transmembrane transport [GO:0035725],acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; multivesicular body membrane [GO:0032585]; trans-Golgi network membrane [GO:0032588],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0022414; GO:0031410; GO:0043226; GO:0055085,transporter activity; reproductive process; cytoplasmic vesicle; organelle; transmembrane transport
OG_08176,1.5430123182910551,FUN_035998-T1,Peve_00041845,Pocillopora_meandrina_HIv1___RNAseq.g12328.t1b,three_way,73.96566666666666,FUN_035998-T1,Q5EAC2,GSHB_BOVIN,,Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase),Bos taurus (Bovine),44.9,472.0,1.8e-108,394.4,sp|Q5EAC2|GSHB_BOVIN Glutathione synthetase OS=Bos taurus OX=9913 GN=GSS PE=2 SV=1,GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0042803; GO:0043295,,cytosol [GO:0005829],ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016874,catalytic activity; cytosol; ligase activity
OG_08178,1.279465213246165,FUN_036002-T1,Peve_00041842,Pocillopora_meandrina_HIv1___RNAseq.g12326.t1,three_way,67.96933333333334,FUN_036002-T1,O16099,,,,,43.3,506.0,4.3e-112,406.8,sp|O16099|MAL2_DROVI Maltase 2 OS=Drosophila virilis OX=7244 GN=Mal-B2 PE=3 SV=2,,,,,,
OG_08179,1.3561581311018596,FUN_036003-T1,Peve_00041841,Pocillopora_meandrina_HIv1___RNAseq.g12325.t1,three_way,75.89933333333333,FUN_036003-T1,Q0VCJ8,METL9_BOVIN,,Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (Methyltransferase-like protein 9),Bos taurus (Bovine),51.5,262.0,1.7e-76,287.7,sp|Q0VCJ8|METL9_BOVIN Protein-L-histidine N-pros-methyltransferase OS=Bos taurus OX=9913 GN=METTL9 PE=2 SV=1,GO:0005739; GO:0005783; GO:0032259; GO:0106370,methylation [GO:0032259],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],protein-L-histidine N-pros-methyltransferase activity [GO:0106370],GO:0003824; GO:0005739; GO:0005783; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; endoplasmic reticulum; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08192,1.7004673181470078,FUN_036035-T1,Peve_00011097,Pocillopora_meandrina_HIv1___TS.g14605.t2,three_way,50.55033333333333,FUN_036035-T1,Q0V8S9,,,,,27.5,641.0,1.3e-62,243.4,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_08198,1.4163700543841218,FUN_036042-T1,Peve_00011145,Pocillopora_meandrina_HIv1___RNAseq.g27346.t1,three_way,70.13033333333333,FUN_036042-T1,O00750,P3C2B_HUMAN,,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta),Homo sapiens (Human),40.2,1439.0,5.8e-287,989.2,sp|O00750|P3C2B_HUMAN Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta OS=Homo sapiens OX=9606 GN=PIK3C2B PE=1 SV=2,GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0009267; GO:0016303; GO:0016477; GO:0030139; GO:0031965; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037,autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091],GO:0003824; GO:0005654; GO:0005783; GO:0005829; GO:0005886; GO:0006629; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0048870,catalytic activity; nucleoplasm; endoplasmic reticulum; cytosol; plasma membrane; lipid metabolic process; lipid binding; transferase activity; cytoplasmic vesicle; organelle; cell motility
OG_08199,1.8995423258625883,FUN_036043-T1,Peve_00011144,Pocillopora_meandrina_HIv1___RNAseq.g27347.t1,three_way,70.165,,,,,,,,,,,,,,,,,
OG_08200,1.0809376188974025,FUN_036044-T1,Peve_00011142,Pocillopora_meandrina_HIv1___RNAseq.g27348.t1,three_way,84.868,FUN_036044-T1,F1QXM5,,,,,66.1,449.0,1e-178,627.9,"sp|F1QXM5|LDHD_DANRE Probable D-lactate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=ldhd PE=2 SV=1",,,,,,
OG_08201,1.4496209908197837,FUN_036046-T1,Peve_00029868,Pocillopora_meandrina_HIv1___RNAseq.g27386.t1,three_way,42.30983333333333,FUN_036046-T1,Q6UB98,ANR12_HUMAN,,Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein),Homo sapiens (Human),36.3,113.0,2.4e-08,62.8,sp|Q6UB98|ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ANKRD12 PE=1 SV=3,GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_08216,1.622881064482157,FUN_036074-T3,Peve_00018966,Pocillopora_meandrina_HIv1___RNAseq.g27412.t1,three_way,78.726,FUN_036074-T3,Q8CG73,FTM_MOUSE,,Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein),Mus musculus (Mouse),37.4,1341.0,1.0999999999999998e-198,695.7,sp|Q8CG73|FTM_MOUSE Protein fantom OS=Mus musculus OX=10090 GN=Rpgrip1l PE=1 SV=2,GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0007420; GO:0008589; GO:0016607; GO:0021532; GO:0021537; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0035108; GO:0035115; GO:0035116; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0060039; GO:0060271; GO:0060322; GO:0090102; GO:1905515,brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; telencephalon development [GO:0021537],axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],thromboxane A2 receptor binding [GO:0031870],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007163; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytosol; plasma membrane; cilium; establishment or maintenance of cell polarity; organelle; cilium organization; anatomical structure development
OG_08218,1.1944253012689103,FUN_036079-T1,Peve_00018984,Pocillopora_meandrina_HIv1___RNAseq.g27415.t1,three_way,56.51533333333333,,,,,,,,,,,,,,,,,
OG_08219,1.7394838378909945,FUN_036081-T1,Peve_00018988,Pocillopora_meandrina_HIv1___RNAseq.g27414.t1,three_way,75.69716666666666,,,,,,,,,,,,,,,,,
OG_08220,1.0809432886882184,FUN_036082-T1,Peve_00018968,Pocillopora_meandrina_HIv1___RNAseq.g27416.t1,three_way,86.618,FUN_036082-T1,P56812,,,,,59.5,126.0,4.5000000000000004e-30,132.1,sp|P56812|PDCD5_MOUSE Programmed cell death protein 5 OS=Mus musculus OX=10090 GN=Pdcd5 PE=1 SV=3,,,,,,
OG_08222,2.5934394052613268,FUN_036093-T1,Peve_00032189,Pocillopora_meandrina_HIv1___RNAseq.g27441.t1,three_way,76.63133333333333,FUN_036093-T1,Q68DA7,FMN1_HUMAN,,Formin-1 (Limb deformity protein homolog),Homo sapiens (Human),33.3,471.0,1.5e-63,246.1,sp|Q68DA7|FMN1_HUMAN Formin-1 OS=Homo sapiens OX=9606 GN=FMN1 PE=1 SV=3,GO:0003779; GO:0005634; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0030036; GO:0045010,actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010],actin filament [GO:0005884]; adherens junction [GO:0005912]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0005634; GO:0005886; GO:0007010; GO:0008092; GO:0043226,nucleus; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08224,1.0767780951646095,FUN_036095-T1,Peve_00032192,Pocillopora_meandrina_HIv1___RNAseq.g27439.t1,three_way,90.405,FUN_036095-T1,Q9EQH3,VPS35_MOUSE,,Vacuolar protein sorting-associated protein 35 (Maternal-embryonic 3) (Vesicle protein sorting 35),Mus musculus (Mouse),69.9,800.0,0.0,1120.5,sp|Q9EQH3|VPS35_MOUSE Vacuolar protein sorting-associated protein 35 OS=Mus musculus OX=10090 GN=Vps35 PE=1 SV=1,GO:0005737; GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006624; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0016020; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032456; GO:0032463; GO:0033365; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0045202; GO:0045732; GO:0048471; GO:0050728; GO:0050804; GO:0050882; GO:0060161; GO:0061357; GO:0090128; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098691; GO:0098793; GO:0098794; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:0150052; GO:1902823; GO:1902950; GO:1903181; GO:1903828; GO:1904377; GO:1905166; GO:2000331,"endocytic recycling [GO:0032456]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; protein localization to organelle [GO:0033365]; regulation of dendritic spine maintenance [GO:1902950]; regulation of postsynapse assembly [GO:0150052]; regulation of synapse maturation [GO:0090128]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056]; vacuolar protein processing [GO:0006624]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; synapse [GO:0045202]; tubular endosome [GO:0097422]",D1 dopamine receptor binding [GO:0031748],GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006886; GO:0007005; GO:0007040; GO:0016192; GO:0031410; GO:0043226; GO:0050877; GO:0051604; GO:0072659,mitochondrion; lysosome; endosome; vacuole; cytosol; intracellular protein transport; mitochondrion organization; lysosome organization; vesicle-mediated transport; cytoplasmic vesicle; organelle; nervous system process; protein maturation; protein localization to plasma membrane
OG_08225,1.1963578440929097,FUN_036096-T1,Peve_00032193,Pocillopora_meandrina_HIv1___RNAseq.g27438.t1,three_way,74.27666666666667,FUN_036096-T1,Q9NP78,ABCB9_HUMAN,,ABC-type oligopeptide transporter ABCB9 (EC 7.4.2.6) (ATP-binding cassette sub-family B member 9) (ATP-binding cassette transporter 9) (ABC transporter 9 protein) (hABCB9) (TAP-like protein) (TAPL),Homo sapiens (Human),47.3,731.0,6.000000000000002e-181,636.0,sp|Q9NP78|ABCB9_HUMAN ABC-type oligopeptide transporter ABCB9 OS=Homo sapiens OX=9606 GN=ABCB9 PE=1 SV=1,GO:0005524; GO:0005764; GO:0005765; GO:0005789; GO:0006518; GO:0015031; GO:0015421; GO:0015440; GO:0015833; GO:0016020; GO:0016887; GO:0022857; GO:0042803; GO:0043231; GO:0055085,peptide metabolic process [GO:0006518]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],ABC-type oligopeptide transporter activity [GO:0015421]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857],GO:0003824; GO:0005215; GO:0005764; GO:0005773; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; lysosome; vacuole; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_08226,3.0223506550066133,FUN_036097-T2,Peve_00032194,Pocillopora_meandrina_HIv1___RNAseq.g27437.t1,three_way,61.02516666666666,FUN_036097-T2,Q801E2,ANLN_XENLA,,Anillin,Xenopus laevis (African clawed frog),34.7,432.0,4.6e-56,221.5,sp|Q801E2|ANLN_XENLA Anillin OS=Xenopus laevis OX=8355 GN=anln PE=1 SV=1,GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005826; GO:0005938; GO:0031106; GO:0032059; GO:1904172,actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; septin ring organization [GO:0031106],actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; nucleus [GO:0005634],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0007010; GO:0008092; GO:0043226,cytokinesis; nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08227,2.8252195848572184,FUN_036099-T1,Peve_00032195,Pocillopora_meandrina_HIv1___RNAseq.g27436.t1,three_way,72.92099999999999,FUN_036099-T1,Q66JZ4,,,,,33.3,475.0,4.2000000000000004e-60,233.8,"sp|Q66JZ4|TCAIM_MOUSE T-cell activation inhibitor, mitochondrial OS=Mus musculus OX=10090 GN=TCAIM PE=1 SV=1",,,,,,
OG_08230,1.698802859385124,FUN_036103-T1,Peve_00003702,Pocillopora_meandrina_HIv1___RNAseq.g27433.t1,three_way,73.634,FUN_036103-T1,P82160,,,,,38.8,147.0,1.8000000000000001e-22,107.8,"sp|P82160|MLE3_CHERA Myosin light chain 3, skeletal muscle isoform OS=Chelon ramada OX=30804 PE=1 SV=1",,,,,,
OG_08231,2.4215308737307395,FUN_036106-T1,Peve_00003695,Pocillopora_meandrina_HIv1___RNAseq.g27429.t1,three_way,71.5815,FUN_036106-T1,Q68D86,C102B_HUMAN,,Coiled-coil domain-containing protein 102B,Homo sapiens (Human),37.2,390.0,5.6e-42,173.7,sp|Q68D86|C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens OX=9606 GN=CCDC102B PE=1 SV=4,GO:0005737; GO:0005814; GO:0010457; GO:0120283,centriole-centriole cohesion [GO:0010457],centriole [GO:0005814]; cytoplasm [GO:0005737],protein serine/threonine kinase binding [GO:0120283],GO:0043226,organelle
OG_08233,1.2535624809265091,FUN_036109-T1,Peve_00003699,Pocillopora_meandrina_HIv1___RNAseq.g27427.t1,three_way,71.93266666666666,FUN_036109-T1,Q330K2,NDUF6_HUMAN,,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (Putative phytoene synthase)",Homo sapiens (Human),51.8,301.0,2.4e-85,317.0,"sp|Q330K2|NDUF6_HUMAN NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 OS=Homo sapiens OX=9606 GN=NDUFAF6 PE=1 SV=2",GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0009058; GO:0032981,biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634],,GO:0005634; GO:0005739; GO:0043226; GO:0065003,nucleus; mitochondrion; organelle; protein-containing complex assembly
OG_08237,1.3600994362755368,FUN_036116-T1,Peve_00000283,Pocillopora_meandrina_HIv1___RNAseq.g27423.t1,three_way,63.0515,FUN_036116-T1,O34313,NTPES_BACSU,,"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]",Bacillus subtilis (strain 168),27.1,510.0,4.6e-36,154.8,sp|O34313|NTPES_BACSU Trifunctional nucleotide phosphoesterase protein YfkN OS=Bacillus subtilis (strain 168) OX=224308 GN=yfkN PE=1 SV=1,GO:0000166; GO:0005576; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872,nucleotide catabolic process [GO:0009166],extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288],"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]",GO:0003824; GO:0005576; GO:0016787; GO:0055086,catalytic activity; extracellular region; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_08239,1.150591860066592,FUN_036119-T1,Peve_00000289,Pocillopora_meandrina_HIv1___RNAseq.g27453.t1,three_way,78.82766666666666,FUN_036119-T1,Q6Q0C0,TRAF7_HUMAN,,E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7),Homo sapiens (Human),37.1,523.0,1.3999999999999998e-41,172.6,sp|Q6Q0C0|TRAF7_HUMAN E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1,GO:0000151; GO:0004842; GO:0005634; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0035519; GO:0043231; GO:0043410; GO:0043525; GO:0061630; GO:0070372; GO:2000060; GO:2001235,apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372],cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005886; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_08240,1.945833204600807,FUN_036124-T1,Peve_00000288,Pocillopora_meandrina_HIv1___RNAseq.g27452.t1,three_way,65.2255,FUN_036124-T1,Q9UK23,NAGPA_HUMAN,,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase),Homo sapiens (Human),47.2,369.0,3.6e-90,334.0,sp|Q9UK23|NAGPA_HUMAN N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGPA PE=1 SV=2,GO:0003944; GO:0005975; GO:0006486; GO:0006622; GO:0007040; GO:0016020; GO:0032580; GO:0033299; GO:0036211,carbohydrate metabolic process [GO:0005975]; lysosome organization [GO:0007040]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020],N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [GO:0003944],GO:0003824; GO:0005975; GO:0006486; GO:0006886; GO:0007040; GO:0016787,catalytic activity; carbohydrate metabolic process; protein glycosylation; intracellular protein transport; lysosome organization; hydrolase activity
OG_08241,1.312287253028789,FUN_036143-T1,Peve_00000292,Pocillopora_meandrina_HIv1___TS.g14803.t1,three_way,87.003,FUN_036143-T1,Q13885,TBB2A_HUMAN,,Tubulin beta-2A chain (Tubulin beta class IIa),Homo sapiens (Human),69.0,432.0,1.8e-185,650.2,sp|Q13885|TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapiens OX=9606 GN=TUBB2A PE=1 SV=1,GO:0000226; GO:0000278; GO:0001764; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0021987; GO:0045171; GO:0046872; GO:0070062; GO:0072686; GO:1903561,cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0003824; GO:0003924; GO:0005198; GO:0005634; GO:0005856; GO:0007010; GO:0016787; GO:0043226; GO:0048856; GO:0048870,mitotic cell cycle; catalytic activity; GTPase activity; structural molecule activity; nucleus; cytoskeleton; cytoskeleton organization; hydrolase activity; organelle; anatomical structure development; cell motility
OG_08243,1.0495010093098105,FUN_036150-T2,Peve_00000296,Pocillopora_meandrina_HIv1___RNAseq.g27459.t1,three_way,82.88,FUN_036150-T2,Q9NTJ5,SAC1_HUMAN,,Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein),Homo sapiens (Human),56.5,591.0,2.1e-194,680.2,sp|Q9NTJ5|SAC1_HUMAN Phosphatidylinositol-3-phosphatase SAC1 OS=Homo sapiens OX=9606 GN=SACM1L PE=1 SV=2,GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0006661; GO:0016791; GO:0032281; GO:0034596; GO:0043812; GO:0046856; GO:0098967; GO:0098978; GO:0099003; GO:0140268,exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; vesicle-mediated transport in synapse [GO:0099003],AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],phosphatase activity [GO:0016791]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812],GO:0003824; GO:0005783; GO:0005794; GO:0006629; GO:0016192; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; Golgi apparatus; lipid metabolic process; vesicle-mediated transport; hydrolase activity; organelle
OG_08255,1.5832349440411866,FUN_036165-T1,Peve_00027201,Pocillopora_meandrina_HIv1___RNAseq.g27500.t1,three_way,70.53633333333333,FUN_036165-T1,C7G3A0,,,,,48.3,383.0,1e-99,365.2,sp|C7G3A0|MPPE1_CRIGR Metallophosphoesterase 1 OS=Cricetulus griseus OX=10029 GN=MPPE1 PE=2 SV=1,,,,,,
OG_08258,2.279066385793368,FUN_036169-T2,Peve_00027206,Pocillopora_meandrina_HIv1___TS.g14852.t1,three_way,74.27483333333333,FUN_036169-T2,Q9XS59,,,,,42.6,611.0,6.1e-141,503.1,sp|Q9XS59|S6A15_BOVIN Sodium-dependent neutral amino acid transporter B(0)AT2 OS=Bos taurus OX=9913 GN=SLC6A15 PE=2 SV=1,,,,,,
OG_08259,1.903512762987523,FUN_036171-T4,Peve_00027208,Pocillopora_meandrina_HIv1___RNAseq.g27504.t1,three_way,57.3255,FUN_036171-T4,Q7TN88,,,,,26.0,1910.0,4.8e-157,558.5,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08266,1.375877040054095,FUN_036178-T1,Peve_00027217,Pocillopora_meandrina_HIv1___RNAseq.g27512.t1,three_way,66.12366666666667,FUN_036178-T1,Q3ZBX6,,,,,42.9,282.0,2.9e-56,220.7,sp|Q3ZBX6|RM03_BOVIN Large ribosomal subunit protein uL3m OS=Bos taurus OX=9913 GN=MRPL3 PE=1 SV=1,,,,,,
OG_08267,1.0985168546302992,FUN_036179-T1,Peve_00027218,Pocillopora_meandrina_HIv1___RNAseq.g27513.t1,three_way,49.457,FUN_036179-T1,O94763,,,,,33.3,249.0,4.4e-29,130.6,sp|O94763|RMP_HUMAN Unconventional prefoldin RPB5 interactor 1 OS=Homo sapiens OX=9606 GN=URI1 PE=1 SV=3,,,,,,
OG_08268,1.1529777513888435,FUN_036180-T1,Peve_00015591,Pocillopora_meandrina_HIv1___RNAseq.g27514.t1,three_way,71.41016666666667,FUN_036180-T1,Q5R4M2,,,,,37.6,1344.0,2.1e-234,814.3,sp|Q5R4M2|ULK4_PONAB Serine/threonine-protein kinase ULK4 OS=Pongo abelii OX=9601 GN=ULK4 PE=2 SV=1,,,,,,
OG_08271,1.2068056975132335,FUN_036183-T1,Peve_00015587,Pocillopora_meandrina_HIv1___RNAseq.g27377.t1,three_way,72.55316666666667,FUN_036183-T1,Q8R422,CD109_MOUSE,,CD109 antigen (GPI-anchored alpha-2 macroglobulin-related protein) (CD antigen CD109),Mus musculus (Mouse),33.9,1471.0,4.4000000000000005e-193,677.2,sp|Q8R422|CD109_MOUSE CD109 antigen OS=Mus musculus OX=10090 GN=Cd109 PE=1 SV=1,GO:0001942; GO:0004867; GO:0005615; GO:0005829; GO:0005886; GO:0010839; GO:0030512; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647,hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089],cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005615; GO:0005829; GO:0005886; GO:0048856; GO:0098772,extracellular space; cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_08274,1.102822589126128,FUN_036189-T1,Peve_00038735,Pocillopora_meandrina_HIv1___RNAseq.g27372.t1,three_way,67.0075,FUN_036189-T1,P42674,,,,,42.8,208.0,8.1e-39,164.1,sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1,,,,,,
OG_08275,1.1775006565993265,FUN_036192-T1,Peve_00011127,Pocillopora_meandrina_HIv1___RNAseq.g27369.t1,three_way,85.32933333333334,FUN_036192-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,536.0,3.7e-101,370.9,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08276,1.8921378588995887,FUN_036193-T1,Peve_00011114,Pocillopora_meandrina_HIv1___RNAseq.g27368.t2,three_way,60.47933333333333,,,,,,,,,,,,,,,,,
OG_08277,1.4946864176961396,FUN_036195-T1,Peve_00011109,Pocillopora_meandrina_HIv1___RNAseq.g27367.t1,three_way,72.57383333333334,FUN_036195-T1,Q3UMR0,ANR27_MOUSE,,Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein),Mus musculus (Mouse),42.3,787.0,1.5999999999999999e-96,355.9,sp|Q3UMR0|ANR27_MOUSE Ankyrin repeat domain-containing protein 27 OS=Mus musculus OX=10090 GN=Ankrd27 PE=1 SV=2,GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422,early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031],cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,lysosome; endosome; vacuole; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08278,1.1842704251751708,FUN_036196-T1,Peve_00025812,Pocillopora_meandrina_HIv1___RNAseq.g27366.t1,three_way,85.65133333333334,FUN_036196-T1,Q3UMM4,CDK10_MOUSE,,Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10),Mus musculus (Mouse),65.4,358.0,4.4e-137,489.2,sp|Q3UMM4|CDK10_MOUSE Cyclin-dependent kinase 10 OS=Mus musculus OX=10090 GN=Cdk10 PE=1 SV=1,GO:0000307; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0007346; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0097472; GO:0106310; GO:1902018; GO:1902749,cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of mitotic cell cycle [GO:0007346],ciliary basal body [GO:0036064]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08286,1.7266391354118302,FUN_036221-T1,Peve_00025940,Pocillopora_meandrina_HIv1___RNAseq.g27543.t1,three_way,83.386,FUN_036221-T1,F1MM41,ZNRF1_BOVIN,,E3 ubiquitin-protein ligase ZNRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1),Bos taurus (Bovine),57.0,93.0,2.6e-26,120.2,sp|F1MM41|ZNRF1_BOVIN E3 ubiquitin-protein ligase ZNRF1 OS=Bos taurus OX=9913 GN=ZNRF1 PE=3 SV=2,GO:0004842; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0008270; GO:0016020; GO:0030672; GO:0034145; GO:0043161; GO:0043231; GO:0061630; GO:0070936; GO:0160177,positive regulation of autophagosome-lysosome fusion [GO:0160177]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; synaptic vesicle membrane [GO:0030672],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; cytosol; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_08287,1.110379433077464,FUN_036222-T1,Peve_00025942,Pocillopora_meandrina_HIv1___RNAseq.g27544.t1,three_way,56.418,FUN_036222-T1,Q8IZU8,,,,,33.9,921.0,1.2e-134,482.3,sp|Q8IZU8|DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens OX=9606 GN=DSEL PE=1 SV=2,,,,,,
OG_08294,1.3430657704574909,FUN_036232-T1,Peve_00015682,Pocillopora_meandrina_HIv1___RNAseq.g27553.t2,three_way,83.43166666666666,FUN_036232-T1,O75131,CPNE3_HUMAN,,Copine-3 (Copine III),Homo sapiens (Human),56.6,525.0,3.6e-177,622.9,sp|O75131|CPNE3_HUMAN Copine-3 OS=Homo sapiens OX=9606 GN=CPNE3 PE=1 SV=1,GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0046872; GO:0048306; GO:0070062; GO:0071277; GO:0071363,cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335],azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0008289; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; plasma membrane; lipid binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08299,1.4996540906550642,FUN_036248-T1,Peve_00045282,Pocillopora_meandrina_HIv1___TS.g14942.t1,three_way,59.625,,,,,,,,,,,,,,,,,
OG_08303,1.3832794375622053,FUN_036255-T1,Peve_00045292,Pocillopora_meandrina_HIv1___TS.g14937.t1,three_way,66.72966666666667,FUN_036255-T1,Q8BYI6,PCAT2_MOUSE,,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1),Mus musculus (Mouse),38.1,491.0,7.4e-84,312.8,sp|Q8BYI6|PCAT2_MOUSE Lysophosphatidylcholine acyltransferase 2 OS=Mus musculus OX=10090 GN=Lpcat2 PE=1 SV=1,GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005795; GO:0005811; GO:0005886; GO:0006663; GO:0016020; GO:0036151; GO:0047159; GO:0047184; GO:0047192; GO:0061024,membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0047159],GO:0003824; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0016740; GO:0043226; GO:0061024,catalytic activity; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; transferase activity; organelle; membrane organization
OG_08305,2.2750496840257566,FUN_036260-T1,Peve_00012320,Pocillopora_meandrina_HIv1___RNAseq.g27582.t1,three_way,82.303,FUN_036260-T1,Q8WXH2,JPH3_HUMAN,,Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein),Homo sapiens (Human),66.7,57.0,9.9e-20,99.4,sp|Q8WXH2|JPH3_HUMAN Junctophilin-3 OS=Homo sapiens OX=9606 GN=JPH3 PE=1 SV=2,GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0010880; GO:0010882; GO:0014701; GO:0016020; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060402,calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic plasticity [GO:0048167],endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886],,GO:0005886; GO:0050877; GO:0055085,plasma membrane; nervous system process; transmembrane transport
OG_08310,1.3177298691221708,FUN_036335-T1,Peve_00031401,Pocillopora_meandrina_HIv1___RNAseq.g12101.t1,three_way,84.46183333333333,FUN_036335-T1,A0A0R4IC37,,,,,53.9,778.0,5.1e-235,815.5,sp|A0A0R4IC37|CPSF1_DANRE Cleavage and polyadenylation specificity factor subunit 1 OS=Danio rerio OX=7955 GN=cpsf1 PE=3 SV=2,,,,,,
OG_08311,1.0509212096712608,FUN_036338-T1,Peve_00031393,Pocillopora_meandrina_HIv1___RNAseq.g12116.t1,three_way,98.718,FUN_036338-T1,Q6PBJ2,CFA20_DANRE,,Cilia- and flagella-associated protein 20,Danio rerio (Zebrafish) (Brachydanio rerio),98.1,156.0,3e-84,312.4,sp|Q6PBJ2|CFA20_DANRE Cilia- and flagella-associated protein 20 OS=Danio rerio OX=7955 GN=cfap20 PE=2 SV=1,GO:0001895; GO:0005634; GO:0005814; GO:0005879; GO:0005929; GO:0014807; GO:0018095; GO:0031514; GO:0036064; GO:0048570; GO:0060271; GO:0060296; GO:0061371; GO:0065001; GO:1901207; GO:2000147; GO:2000253,cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; notochord morphogenesis [GO:0048570]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of heart looping [GO:1901207]; regulation of somitogenesis [GO:0014807]; retina homeostasis [GO:0001895]; specification of axis polarity [GO:0065001],axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; motile cilium [GO:0031514]; nucleus [GO:0005634],,GO:0005634; GO:0005815; GO:0005929; GO:0043226; GO:0044782,nucleus; microtubule organizing center; cilium; organelle; cilium organization
OG_08313,1.4034968303487898,FUN_036513-T1,Peve_00031408,Pocillopora_meandrina_HIv1___RNAseq.g27052.t1,three_way,58.79833333333333,FUN_036513-T1,A0A8I3PDQ1,CASL_CANLF,,Enhancer of filamentation 1 (CRK-associated substrate-related protein) (CAS-L) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (p105),Canis lupus familiaris (Dog) (Canis familiaris),22.2,968.0,2.6e-26,122.5,sp|A0A8I3PDQ1|CASL_CANLF Enhancer of filamentation 1 OS=Canis lupus familiaris OX=9615 GN=NEDD9 PE=1 SV=1,GO:0000922; GO:0001772; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0005938; GO:0007155; GO:0007169; GO:0007611; GO:0016323; GO:0016477; GO:0030027; GO:0030336; GO:0032956; GO:0036064; GO:0045672; GO:0051301; GO:0061523; GO:0072686; GO:0097021; GO:0140131; GO:1900026; GO:1902952; GO:1903829; GO:1990782; GO:2000522,cell adhesion [GO:0007155]; cell division [GO:0051301]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium disassembly [GO:0061523]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956],basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0007155; GO:0043226; GO:0044782; GO:0048870; GO:0050877,immune system process; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; cell adhesion; organelle; cilium organization; cell motility; nervous system process
OG_08314,1.8453371905441167,FUN_036524-T1,Peve_00031406,Pocillopora_meandrina_HIv1___RNAseq.g12097.t1,three_way,72.94333333333334,FUN_036524-T1,Q8NG66,NEK11_HUMAN,,Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11),Homo sapiens (Human),37.1,631.0,1.6e-98,361.7,sp|Q8NG66|NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens OX=9606 GN=NEK11 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006468; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990,intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08319,1.5654327186020296,FUN_036746-T1,Peve_00018099,Pocillopora_meandrina_HIv1___TS.g3451.t1,three_way,67.292,FUN_036746-T1,Q29IC2,RIC8_DROPS,,Chaperone Ric-8 (Synembryn),Drosophila pseudoobscura pseudoobscura (Fruit fly),32.0,565.0,2.9e-63,244.6,sp|Q29IC2|RIC8_DROPS Chaperone Ric-8 OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=ric8a PE=3 SV=1,GO:0001965; GO:0005085; GO:0005737; GO:0005938; GO:0007163; GO:0007186; GO:0008104; GO:0008356; GO:0010004; GO:0040001; GO:0042995; GO:0050821; GO:0055057; GO:0098793,asymmetric cell division [GO:0008356]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation involving germ band extension [GO:0010004]; neuroblast division [GO:0055057]; protein localization [GO:0008104]; protein stabilization [GO:0050821],cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; presynapse [GO:0098793],G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0007010; GO:0007163; GO:0098772,cytoskeleton organization; establishment or maintenance of cell polarity; molecular function regulator activity
OG_08324,1.291691598938412,FUN_036753-T1,Peve_00001060,Pocillopora_meandrina_HIv1___RNAseq.g12113.t1,three_way,78.39483333333332,FUN_036753-T1,Q2V2M9,FHOD3_HUMAN,,FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2),Homo sapiens (Human),42.2,1460.0,2.6000000000000004e-214,747.7,sp|Q2V2M9|FHOD3_HUMAN FH1/FH2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FHOD3 PE=1 SV=2,GO:0005737; GO:0005856; GO:0030018; GO:0030866; GO:0045214; GO:0051015; GO:0055003,cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; sarcomere organization [GO:0045214],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018],actin filament binding [GO:0051015],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08325,1.3395147046851212,FUN_036755-T1,Peve_00027843,Pocillopora_meandrina_HIv1___RNAseq.g27068.t1,three_way,83.454,FUN_036755-T1,Q9CY50,,,,,53.3,197.0,9.4e-56,218.4,sp|Q9CY50|SSRA_MOUSE Translocon-associated protein subunit alpha OS=Mus musculus OX=10090 GN=Ssr1 PE=1 SV=1,,,,,,
OG_08326,1.8380070226008327,FUN_036756-T1,Peve_00001059,Pocillopora_meandrina_HIv1___RNAseq.g27066.t1,three_way,84.369,FUN_036756-T1,Q08CH8,,,,,50.0,340.0,3.7e-95,349.7,sp|Q08CH8|ZTRF1_DANRE Zinc finger TRAF-type-containing protein 1 OS=Danio rerio OX=7955 GN=zftraf1 PE=2 SV=2,,,,,,
OG_08328,1.002027769843943,FUN_036764-T1,Peve_00006972,Pocillopora_meandrina_HIv1___RNAseq.g10638.t1,three_way,53.79416666666667,,,,,,,,,,,,,,,,,
OG_08329,1.0875636335612182,FUN_036767-T1,Peve_00006967,Pocillopora_meandrina_HIv1___RNAseq.g10634.t1,three_way,71.927,FUN_036767-T1,F1N2K1,,,,,39.2,452.0,1.2999999999999999e-83,312.0,sp|F1N2K1|PCYOX_BOVIN Prenylcysteine oxidase 1 OS=Bos taurus OX=9913 GN=PCYOX1 PE=1 SV=2,,,,,,
OG_08331,1.268056261636728,FUN_036817-T1,Peve_00006527,Pocillopora_meandrina_HIv1___RNAseq.g10617.t1,three_way,69.63,FUN_036817-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.5,2060.0,1.3e-224,782.3,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_08332,1.1819984018028151,FUN_036826-T1,Peve_00006971,Pocillopora_meandrina_HIv1___TS.g13145.t5b,three_way,63.583666666666666,FUN_036826-T1,O15111,IKKA_HUMAN,,Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK-1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16),Homo sapiens (Human),35.9,754.0,3.8999999999999995e-129,463.8,sp|O15111|IKKA_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens OX=9606 GN=CHUK PE=1 SV=2,GO:0003009; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008384; GO:0008385; GO:0009410; GO:0009615; GO:0009636; GO:0009653; GO:0009898; GO:0010034; GO:0032088; GO:0032727; GO:0033194; GO:0033209; GO:0034142; GO:0035631; GO:0038061; GO:0042803; GO:0043123; GO:0043200; GO:0044877; GO:0045087; GO:0045944; GO:0046982; GO:0051092; GO:0051146; GO:0061847; GO:0071356; GO:0097110; GO:0098586; GO:1990459,anatomical structure morphogenesis [GO:0009653]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to acetate [GO:0010034]; response to amino acid [GO:0043200]; response to cholecystokinin [GO:0061847]; response to hydroperoxide [GO:0033194]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle contraction [GO:0003009]; striated muscle cell differentiation [GO:0051146]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; transferrin receptor binding [GO:1990459],GO:0002376; GO:0003012; GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0006954; GO:0016740; GO:0030154; GO:0098542; GO:0140096,"immune system process; muscle system process; catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; inflammatory response; transferase activity; cell differentiation; defense response to other organism; catalytic activity, acting on a protein"
OG_08335,1.3928353520690198,FUN_036831-T1,Peve_00006966,Pocillopora_meandrina_HIv1___RNAseq.g10632.t1,three_way,76.47966666666666,FUN_036831-T1,O95470,SGPL1_HUMAN,,Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase),Homo sapiens (Human),52.1,94.0,7.9e-25,114.4,sp|O95470|SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3,GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190,androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117],GO:0003824; GO:0005783; GO:0006629; GO:0016829; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870,catalytic activity; endoplasmic reticulum; lipid metabolic process; lyase activity; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility
OG_08336,1.0462693167540746,FUN_036841-T1,Peve_00006959,Pocillopora_meandrina_HIv1___TS.g13168.t1,three_way,71.919,FUN_036841-T1,P80457,XDH_BOVIN,,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],Bos taurus (Bovine),33.5,1310.0,3.4e-197,690.6,sp|P80457|XDH_BOVIN Xanthine dehydrogenase/oxidase OS=Bos taurus OX=9913 GN=XDH PE=1 SV=4,GO:0002197; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0009115; GO:0030151; GO:0042803; GO:0043546; GO:0050660; GO:0051537; GO:0071949,xanthine catabolic process [GO:0009115],extracellular space [GO:0005615]; peroxisome [GO:0005777]; xanthine dehydrogenase complex [GO:0002197],"2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]",GO:0003824; GO:0005615; GO:0005777; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; peroxisome; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_08337,1.7972385021674766,FUN_036850-T1,Peve_00036530,Pocillopora_meandrina_HIv1___RNAseq.g10652.t1,three_way,46.763666666666666,,,,,,,,,,,,,,,,,
OG_08338,1.4619355902588451,FUN_036852-T1,Peve_00036539,Pocillopora_meandrina_HIv1___RNAseq.g10654.t1,three_way,83.33333333333333,FUN_036852-T1,A0A7U2MMF3,ADHB_ASPFN,,Zinc-type alcohol dehydrogenase B (EC 1.1.1.1),Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167),27.4,296.0,3.4e-19,97.4,sp|A0A7U2MMF3|ADHB_ASPFN Zinc-type alcohol dehydrogenase B OS=Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) OX=332952 GN=adhB PE=1 SV=1,GO:0008270; GO:0016491,,,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08339,1.1953740760264175,FUN_036853-T1,Peve_00036532,Pocillopora_meandrina_HIv1___RNAseq.g10656.t1,three_way,73.08466666666666,FUN_036853-T1,P21765,,,,,43.4,143.0,7.7e-27,121.7,sp|P21765|GPX5_MOUSE Epididymal secretory glutathione peroxidase OS=Mus musculus OX=10090 GN=Gpx5 PE=2 SV=3,,,,,,
OG_08340,2.452286287009066,FUN_036857-T1,Peve_00001064,Pocillopora_meandrina_HIv1___RNAseq.g27062.t1,three_way,73.51566666666666,FUN_036857-T1,Q8BTI7,,,,,29.1,158.0,2.6e-07,58.9,sp|Q8BTI7|ANR52_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Mus musculus OX=10090 GN=Ankrd52 PE=1 SV=1,,,,,,
OG_08341,1.1076524765767286,FUN_036858-T1,Peve_00001065,Pocillopora_meandrina_HIv1___RNAseq.g27061.t1,three_way,76.1845,FUN_036858-T1,P22412,,,,,50.9,369.0,1.1e-104,381.7,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_08343,1.6431897932123702,FUN_036868-T1,Peve_00004118,Pocillopora_meandrina_HIv1___RNAseq.g10621.t1,three_way,60.080666666666666,FUN_036868-T1,P46616,,,,,28.6,308.0,2.1e-10,68.2,sp|P46616|AA2AR_CAVPO Adenosine receptor A2a OS=Cavia porcellus OX=10141 GN=ADORA2A PE=2 SV=1,,,,,,
OG_08345,1.4736299312184364,FUN_036872-T1,Peve_00039758,Pocillopora_meandrina_HIv1___TS.g13142.t1,three_way,53.678333333333335,FUN_036872-T1,O08710,THYG_MOUSE,,Thyroglobulin (Tg),Mus musculus (Mouse),21.6,1359.0,7.8e-40,168.7,sp|O08710|THYG_MOUSE Thyroglobulin OS=Mus musculus OX=10090 GN=Tg PE=1 SV=3,GO:0005179; GO:0005615; GO:0006590; GO:0015705; GO:0030878; GO:0031641; GO:0042403; GO:0042446; GO:0042802,hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403],extracellular space [GO:0005615],hormone activity [GO:0005179]; identical protein binding [GO:0042802],GO:0005615; GO:0006575; GO:0048018; GO:0048856; GO:0098772,extracellular space; modified amino acid metabolic process; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_08348,1.095471929627295,FUN_036882-T1,Peve_00018386,Pocillopora_meandrina_HIv1___RNAseq.g10797.t1,three_way,61.394666666666666,FUN_036882-T1,Q9H0R5,GBP3_HUMAN,,Guanylate-binding protein 3 (EC 3.6.5.-) (GTP-binding protein 3) (GBP-3) (Guanine nucleotide-binding protein 3),Homo sapiens (Human),26.4,405.0,1e-20,103.2,sp|Q9H0R5|GBP3_HUMAN Guanylate-binding protein 3 OS=Homo sapiens OX=9606 GN=GBP3 PE=1 SV=3,GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0031410; GO:0042742; GO:0042802; GO:0042803; GO:0048471; GO:0051607; GO:0051715; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0140639,cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cytolysis in another organism [GO:0051715]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; positive regulation of pyroptotic inflammatory response [GO:0140639],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; cytosol; hydrolase activity; cytoplasmic vesicle; organelle
OG_08350,1.3134857548570495,FUN_036889-T1,Peve_00018383,Pocillopora_meandrina_HIv1___RNAseq.g10792.t1,three_way,77.267,FUN_036889-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),42.6,251.0,1e-55,218.4,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_08351,2.471230191510867,FUN_036892-T1,Peve_00018381,Pocillopora_meandrina_HIv1___RNAseq.g10791.t1,three_way,49.0455,FUN_036892-T1,Q6P1Z5,,,,,37.6,282.0,9.5e-45,183.3,sp|Q6P1Z5|PED1A_MOUSE PC-esterase domain-containing protein 1A OS=Mus musculus OX=10090 GN=Pced1a PE=2 SV=2,,,,,,
OG_08354,1.2024144214854005,FUN_036898-T1,Peve_00018372,Pocillopora_meandrina_HIv1___RNAseq.g10780.t1,three_way,90.75833333333333,FUN_036898-T1,Q6XUZ5,,,,,79.5,409.0,2.4e-189,662.9,sp|Q6XUZ5|IDHC_SHEEP Isocitrate dehydrogenase [NADP] cytoplasmic OS=Ovis aries OX=9940 GN=IDH1 PE=2 SV=1,,,,,,
OG_08358,1.2040474042744944,FUN_036907-T1,Peve_00018423,Pocillopora_meandrina_HIv1___RNAseq.g10812.t1,three_way,90.18,FUN_036907-T1,P61962,DCAF7_HUMAN,,DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog),Homo sapiens (Human),88.8,338.0,2.6e-189,662.5,sp|P61962|DCAF7_HUMAN DDB1- and CUL4-associated factor 7 OS=Homo sapiens OX=9606 GN=DCAF7 PE=1 SV=1,GO:0005654; GO:0005737; GO:0005829; GO:0016363; GO:0016567; GO:0016604; GO:0030674; GO:0032991; GO:0080008,protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],protein-macromolecule adaptor activity [GO:0030674],GO:0005654; GO:0005829; GO:0043226; GO:0060090,nucleoplasm; cytosol; organelle; molecular adaptor activity
OG_08361,2.2424846447437665,FUN_036910-T1,Peve_00018417,Pocillopora_meandrina_HIv1___RNAseq.g10815.t1,three_way,60.812666666666665,,,,,,,,,,,,,,,,,
OG_08363,1.2684860387450387,FUN_036912-T1,Peve_00018402,Pocillopora_meandrina_HIv1___RNAseq.g10818.t1,three_way,83.19500000000001,FUN_036912-T1,Q5ZLY5,,,,,72.2,223.0,1.2e-94,347.8,sp|Q5ZLY5|PKHF2_CHICK Pleckstrin homology domain-containing family F member 2 OS=Gallus gallus OX=9031 GN=PLEKHF2 PE=2 SV=1,,,,,,
OG_08368,1.1270676044598804,FUN_036921-T1,Peve_00018424,Pocillopora_meandrina_HIv1___RNAseq.g10826.t1,three_way,86.99816666666666,FUN_036921-T1,Q6NV04,HACL2_DANRE,,2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein),Danio rerio (Zebrafish) (Brachydanio rerio),70.3,609.0,1.0999999999999999e-259,897.1,sp|Q6NV04|HACL2_DANRE 2-hydroxyacyl-CoA lyase 2 OS=Danio rerio OX=7955 GN=ilvbl PE=2 SV=1,GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016829; GO:0030976; GO:0048701; GO:0050660,embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; L-valine biosynthetic process [GO:0009099],acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789],acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0006520; GO:0006629; GO:0016740; GO:0016829,catalytic activity; amino acid metabolic process; lipid metabolic process; transferase activity; lyase activity
OG_08370,1.3341575229182194,FUN_036923-T2,Peve_00026097,Pocillopora_meandrina_HIv1___RNAseq.g10834.t1,three_way,80.37633333333333,FUN_036923-T2,Q3UR70,,,,,41.3,855.0,6.4e-187,656.0,sp|Q3UR70|TGFA1_MOUSE Transforming growth factor-beta receptor-associated protein 1 OS=Mus musculus OX=10090 GN=Tgfbrap1 PE=1 SV=1,,,,,,
OG_08371,1.3174661422086753,FUN_036924-T1,Peve_00026098,Pocillopora_meandrina_HIv1___RNAseq.g10835.t1,three_way,85.29133333333333,FUN_036924-T1,Q9D6Y9,GLGB_MOUSE,,"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)",Mus musculus (Mouse),64.1,674.0,6.4e-272,937.9,"sp|Q9D6Y9|GLGB_MOUSE 1,4-alpha-glucan-branching enzyme OS=Mus musculus OX=10090 GN=Gbe1 PE=1 SV=1",GO:0003844; GO:0004553; GO:0005829; GO:0005978; GO:0030246; GO:0043169; GO:0043524,glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524],cytosol [GO:0005829],"1,4-alpha-glucan branching enzyme activity [GO:0003844]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]",GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0016787,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; hydrolase activity
OG_08372,1.9206556832007269,FUN_036925-T1,Peve_00040016,Pocillopora_meandrina_HIv1___TS.g13354.t1,three_way,76.31133333333334,FUN_036925-T1,Q91618,PMYT1_XENLA,,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase),Xenopus laevis (African clawed frog),38.5,550.0,3.8e-86,320.5,sp|Q91618|PMYT1_XENLA Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Xenopus laevis OX=8355 GN=pkmyt1 PE=1 SV=1,GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0007088; GO:0010972; GO:0046872; GO:0051321; GO:0106310; GO:0110031,meiotic cell cycle [GO:0051321]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031]; regulation of mitotic nuclear division [GO:0007088],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_08373,1.991799806558784,FUN_036934-T1,Peve_00040009,Pocillopora_meandrina_HIv1___RNAseq.g10839.t1,three_way,68.39766666666667,,,,,,,,,,,,,,,,,
OG_08374,1.113864966562261,FUN_036939-T1,Peve_00040037,Pocillopora_meandrina_HIv1___TS.g13373.t2,three_way,65.984,FUN_036939-T1,A0A2R8QF68,GRIK2_DANRE,,"Glutamate receptor ionotropic, kainate 2 (GluK2)",Danio rerio (Zebrafish) (Brachydanio rerio),26.9,878.0,3.2999999999999996e-90,334.7,"sp|A0A2R8QF68|GRIK2_DANRE Glutamate receptor ionotropic, kainate 2 OS=Danio rerio OX=7955 GN=grik2 PE=3 SV=1",GO:0005886; GO:0015277; GO:0022849; GO:0032983; GO:0035249; GO:0042734; GO:0050804; GO:0098839; GO:1904315,"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]",kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734],glutamate-gated calcium ion channel activity [GO:0022849]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0060089,transporter activity; plasma membrane; signaling; molecular transducer activity
OG_08375,1.021517409829023,FUN_036940-T1,Peve_00040036,Pocillopora_meandrina_HIv1___RNAseq.g10861.t1,three_way,62.068666666666665,,,,,,,,,,,,,,,,,
OG_08378,1.3508466202886755,FUN_036955-T1,Peve_00040029,Pocillopora_meandrina_HIv1___RNAseq.g10865.t1,three_way,80.931,FUN_036955-T1,Q9DFS6,IF4EA_DANRE,,Eukaryotic translation initiation factor 4E-1A (eIF4E-1A) (mRNA cap-binding protein),Danio rerio (Zebrafish) (Brachydanio rerio),62.2,196.0,3.3e-73,276.2,sp|Q9DFS6|IF4EA_DANRE Eukaryotic translation initiation factor 4E-1A OS=Danio rerio OX=7955 GN=eif4ea PE=1 SV=1,GO:0000340; GO:0003743; GO:0005634; GO:0005737; GO:0006406; GO:0006413; GO:0006417; GO:0016281; GO:0016607,mRNA export from nucleus [GO:0006406]; regulation of translation [GO:0006417]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nuclear speck [GO:0016607]; nucleus [GO:0005634],RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0005634; GO:0006913; GO:0043226,RNA binding; nucleus; nucleocytoplasmic transport; organelle
OG_08379,1.1503470979340025,FUN_036956-T1,Peve_00040028,Pocillopora_meandrina_HIv1___RNAseq.g10866.t1,three_way,55.576,FUN_036956-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),26.9,357.0,2.3e-32,142.1,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_08382,1.546274241743281,FUN_036967-T1,Peve_00040021,Pocillopora_meandrina_HIv1___RNAseq.g10880.t1,three_way,57.36033333333334,FUN_036967-T1,Q8NBR6,MINY2_HUMAN,,Ubiquitin carboxyl-terminal hydrolase MINDY-2 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-2) (Protein FAM63B),Homo sapiens (Human),57.9,328.0,8.6e-100,365.9,sp|Q8NBR6|MINY2_HUMAN Ubiquitin carboxyl-terminal hydrolase MINDY-2 OS=Homo sapiens OX=9606 GN=MINDY2 PE=1 SV=2,GO:0004843; GO:0005654; GO:0006508; GO:0016807; GO:0036435; GO:0070530; GO:0071795; GO:0071796; GO:1990380,proteolysis [GO:0006508],nucleoplasm [GO:0005654],cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type deubiquitinase activity [GO:0004843]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked deubiquitinase activity [GO:1990380]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530],GO:0003824; GO:0005654; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; catalytic activity, acting on a protein"
OG_08384,1.7427446835302571,FUN_036983-T1,Peve_00003610,Pocillopora_meandrina_HIv1___RNAseq.g26799.t1,three_way,71.97066666666667,FUN_036983-T1,P18293,ANPRA_MOUSE,,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),Mus musculus (Mouse),38.7,1036.0,8.099999999999999e-189,662.5,sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2,GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0007168; GO:0008217; GO:0010753; GO:0016020; GO:0016941; GO:0017046; GO:0019934; GO:0042417; GO:0043235; GO:0048662; GO:0097746; GO:1990620,blood vessel diameter maintenance [GO:0097746]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217],ANPR-A receptor complex [GO:1990620]; membrane [GO:0016020]; receptor complex [GO:0043235],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672],GO:0003013; GO:0003824; GO:0009975; GO:0016740; GO:0016829; GO:0060089; GO:0140096,"circulatory system process; catalytic activity; cyclase activity; transferase activity; lyase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_08385,1.588665619638192,FUN_036984-T1,Peve_00002155,Pocillopora_meandrina_HIv1___RNAseq.g26705.t1,three_way,55.851333333333336,FUN_036984-T1,O95948,ONEC2_HUMAN,,One cut domain family member 2 (Hepatocyte nuclear factor 6-beta) (HNF-6-beta) (One cut homeobox 2) (Transcription factor ONECUT-2) (OC-2),Homo sapiens (Human),56.5,154.0,9.3e-42,172.6,sp|O95948|ONEC2_HUMAN One cut domain family member 2 OS=Homo sapiens OX=9606 GN=ONECUT2 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0001952; GO:0002064; GO:0005634; GO:0005654; GO:0006357; GO:0007179; GO:0009887; GO:0015629; GO:0030512; GO:0031018; GO:0045165; GO:0045944; GO:0048935; GO:0060271; GO:1905319; GO:1905322; GO:1990837,animal organ morphogenesis [GO:0009887]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; mesenchymal stem cell migration [GO:1905319]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; transforming growth factor beta receptor signaling pathway [GO:0007179],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005856; GO:0006355; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; nucleoplasm; cytoskeleton; regulation of DNA-templated transcription; organelle; cilium organization; anatomical structure development; cell motility; transcription regulator activity
OG_08387,1.75622400696898,FUN_036995-T1,Peve_00002140,Pocillopora_meandrina_HIv1___RNAseq.9756_t,three_way,45.89866666666667,FUN_036995-T1,Q9DEQ4,,,,,26.8,317.0,3.5e-20,100.5,sp|Q9DEQ4|SFRP1_CHICK Secreted frizzled-related protein 1 OS=Gallus gallus OX=9031 GN=SFRP1 PE=2 SV=1,,,,,,
OG_08388,1.4795183027623535,FUN_036996-T1,Peve_00002148,Pocillopora_meandrina_HIv1___RNAseq.g26772.t1,three_way,73.63133333333333,FUN_036996-T1,O43826,G6PT1_HUMAN,,Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19),Homo sapiens (Human),40.1,421.0,3.3000000000000003e-80,300.4,sp|O43826|G6PT1_HUMAN Glucose-6-phosphate exchanger SLC37A4 OS=Homo sapiens OX=9606 GN=SLC37A4 PE=1 SV=1,GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0015152; GO:0015760; GO:0016020; GO:0035435; GO:0042593; GO:0061513,gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],glucose 6-phosphate:phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152],GO:0005215; GO:0005783; GO:0005975; GO:0043226; GO:0055085,transporter activity; endoplasmic reticulum; carbohydrate metabolic process; organelle; transmembrane transport
OG_08390,1.090847613333071,FUN_036999-T1,Peve_00002150,Pocillopora_meandrina_HIv1___TS.g14072.t1,three_way,67.99333333333334,FUN_036999-T1,Q17QR6,,,,,30.8,390.0,1.4e-45,185.7,sp|Q17QR6|MOT13_BOVIN Monocarboxylate transporter 13 OS=Bos taurus OX=9913 GN=SLC16A13 PE=2 SV=1,,,,,,
OG_08391,1.990153408271934,FUN_037001-T1,Peve_00002157,Pocillopora_meandrina_HIv1___RNAseq.g26679.t1,three_way,50.65266666666667,,,,,,,,,,,,,,,,,
OG_08392,2.207961360945367,FUN_037004-T1,Peve_00002158,Pocillopora_meandrina_HIv1___RNAseq.g26681.t1,three_way,58.53766666666667,FUN_037004-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),35.2,267.0,1.5999999999999998e-41,172.9,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08393,1.5853873589651613,FUN_037005-T1,Peve_00032342,Pocillopora_meandrina_HIv1___RNAseq.g26694.t1,three_way,58.15716666666667,FUN_037005-T1,Q9NZM4,BICRA_HUMAN,,BRD4-interacting chromatin-remodeling complex-associated protein (Glioma tumor suppressor candidate region gene 1 protein),Homo sapiens (Human),50.0,118.0,1.2e-22,110.5,sp|Q9NZM4|BICRA_HUMAN BRD4-interacting chromatin-remodeling complex-associated protein OS=Homo sapiens OX=9606 GN=BICRA PE=1 SV=2,GO:0000785; GO:0005634; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0045893; GO:0140288; GO:0140537; GO:1902459,chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],transcription regulator activator activity [GO:0140537],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0098772,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_08396,1.941796403141914,FUN_037010-T1,Peve_00032338,Pocillopora_meandrina_HIv1___RNAseq.g26698.t1,three_way,85.58966666666667,FUN_037010-T1,Q8N2G6,,,,,56.0,234.0,5.3e-63,242.7,sp|Q8N2G6|ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ZCCHC24 PE=1 SV=1,,,,,,
OG_08398,1.300634493833951,FUN_037046-T1,Peve_00032332,Pocillopora_meandrina_HIv1___RNAseq.g26796.t1,three_way,71.37566666666666,FUN_037046-T1,Q5T7P8,SYT6_HUMAN,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Homo sapiens (Human),41.5,311.0,2.6999999999999997e-55,217.6,sp|Q5T7P8|SYT6_HUMAN Synaptotagmin-6 OS=Homo sapiens OX=9606 GN=SYT6 PE=1 SV=3,GO:0000149; GO:0005829; GO:0005886; GO:0007268; GO:0009898; GO:0016020; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0046872; GO:0060478; GO:0061891; GO:0070382; GO:0097038,acrosomal vesicle exocytosis [GO:0060478]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion sensor activity [GO:0061891]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0098772; GO:0140299,cytosol; plasma membrane; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_08407,1.831225691956708,FUN_037058-T1,Peve_00018392,Pocillopora_meandrina_HIv1___RNAseq.g26774.t2,three_way,52.75666666666667,,,,,,,,,,,,,,,,,
OG_08410,1.4666998056527911,FUN_037061-T1,Peve_00018395,Pocillopora_meandrina_HIv1___RNAseq.g26778.t1,three_way,63.92483333333333,FUN_037061-T1,Q5U2U2,CRKL_RAT,,Crk-like protein,Rattus norvegicus (Rat),37.5,293.0,5.8e-46,186.0,sp|Q5U2U2|CRKL_RAT Crk-like protein OS=Rattus norvegicus OX=10116 GN=Crkl PE=1 SV=1,GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0002685; GO:0003151; GO:0005654; GO:0005737; GO:0005829; GO:0006629; GO:0007167; GO:0007283; GO:0007338; GO:0007389; GO:0007507; GO:0008284; GO:0008543; GO:0008584; GO:0009887; GO:0009952; GO:0010468; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0043410; GO:0045202; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0060392; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0071774; GO:0086100; GO:0095500; GO:0098698; GO:0098749; GO:0098761; GO:0098890; GO:0160093; GO:1900026; GO:1903977; GO:1904393; GO:1904395; GO:1904888; GO:2000404,acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of gene expression [GO:0010468]; regulation of leukocyte migration [GO:0002685]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; response to fibroblast growth factor [GO:0071774]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; synapse [GO:0045202],identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591],GO:0002376; GO:0005654; GO:0005829; GO:0006629; GO:0007163; GO:0012501; GO:0022414; GO:0048856; GO:0048870; GO:0060090,immune system process; nucleoplasm; cytosol; lipid metabolic process; establishment or maintenance of cell polarity; programmed cell death; reproductive process; anatomical structure development; cell motility; molecular adaptor activity
OG_08414,1.1267786744056207,FUN_037070-T1,Peve_00004738,Pocillopora_meandrina_HIv1___RNAseq.g26782.t2,three_way,48.457166666666666,FUN_037070-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),28.6,706.0,1.4999999999999998e-62,242.7,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_08415,1.2875920193974233,FUN_037071-T1,Peve_00004736,Pocillopora_meandrina_HIv1___RNAseq.g26783.t1,three_way,86.73233333333333,FUN_037071-T1,Q99973,TEP1_HUMAN,,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),Homo sapiens (Human),26.9,577.0,1.6999999999999998e-43,179.9,sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2,GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904,telomere maintenance via recombination [GO:0000722],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0006310; GO:0016740; GO:0032200; GO:0140097,"RNA binding; catalytic activity; DNA recombination; transferase activity; telomere organization; catalytic activity, acting on DNA"
OG_08417,1.5214007158902008,FUN_037075-T1,Peve_00004732,Pocillopora_meandrina_HIv1___RNAseq.g26676.t1,three_way,77.25566666666667,FUN_037075-T1,Q6ZT07,,,,,45.3,1328.0,2.4e-304,1046.6,sp|Q6ZT07|TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens OX=9606 GN=TBC1D9 PE=1 SV=2,,,,,,
OG_08419,2.155359414426937,FUN_037077-T1,Peve_00004730,Pocillopora_meandrina_HIv1___RNAseq.g11154.t1,three_way,74.945,FUN_037077-T1,Q8WV41,SNX33_HUMAN,,Sorting nexin-33 (SH3 and PX domain-containing protein 3),Homo sapiens (Human),39.2,576.0,3.0000000000000003e-107,390.6,sp|Q8WV41|SNX33_HUMAN Sorting nexin-33 OS=Homo sapiens OX=9606 GN=SNX33 PE=1 SV=1,GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010,cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038],cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0000910; GO:0005829; GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,cytokinesis; cytosol; plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_08421,1.1142303472053552,FUN_037079-T1,Peve_00004727,Pocillopora_meandrina_HIv1___TS.g13651.t2,three_way,79.86733333333333,FUN_037079-T1,Q5F362,CC50A_CHICK,,Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A),Gallus gallus (Chicken),52.8,339.0,4.2e-97,356.3,sp|Q5F362|CC50A_CHICK Cell cycle control protein 50A OS=Gallus gallus OX=9031 GN=TMEM30A PE=2 SV=1,GO:0001750; GO:0001917; GO:0005783; GO:0005794; GO:0005886; GO:0016324; GO:0030658; GO:0045332; GO:1990531,phospholipid translocation [GO:0045332],apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; phospholipid-translocating ATPase complex [GO:1990531]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658],,GO:0005783; GO:0005794; GO:0005886; GO:0043226; GO:0061024,endoplasmic reticulum; Golgi apparatus; plasma membrane; organelle; membrane organization
OG_08422,1.2527636900509391,FUN_037080-T1,Peve_00004726,Pocillopora_meandrina_HIv1___RNAseq.g11151.t1,three_way,82.979,FUN_037080-T1,Q5I0J5,,,,,53.9,232.0,3.1e-69,263.5,sp|Q5I0J5|MITD1_RAT MIT domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Mitd1 PE=2 SV=1,,,,,,
OG_08424,1.207306296568187,FUN_037083-T1,Peve_00004720,Pocillopora_meandrina_HIv1___TS.g13397.t1,three_way,58.36266666666667,,,,,,,,,,,,,,,,,
OG_08426,3.069071700068709,FUN_037087-T1,Peve_00004772,Pocillopora_meandrina_HIv1___RNAseq.g11102.t1,three_way,80.21233333333333,FUN_037087-T1,Q8IVV2,,,,,26.6,2021.0,6.8e-184,647.5,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08427,1.97210889594178,FUN_037089-T1,Peve_00004758,Pocillopora_meandrina_HIv1___RNAseq.g11095.t1,three_way,84.80416666666667,FUN_037089-T1,Q9NQ94,,,,,49.9,583.0,6.8e-140,499.2,sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1,,,,,,
OG_08433,1.046371439071936,FUN_037167-T1,Peve_00003254,Pocillopora_meandrina_HIv1___RNAseq.g11080.t1,three_way,59.40383333333333,,,,,,,,,,,,,,,,,
OG_08437,2.5150287644650287,FUN_037196-T1,Peve_00004715,Pocillopora_meandrina_HIv1___RNAseq.g11075.t2,three_way,81.52866666666667,FUN_037196-T1,Q15111,PLCL1_HUMAN,,Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP),Homo sapiens (Human),49.5,1043.0,1.4e-302,1040.4,sp|Q15111|PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens OX=9606 GN=PLCL1 PE=1 SV=3,GO:0004435; GO:0004629; GO:0005737; GO:0007214; GO:0032228; GO:0035556; GO:0046488; GO:0048015; GO:0051209; GO:0120163,"gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209]",cytoplasm [GO:0005737],"phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]",GO:0003824; GO:0006629; GO:0016787; GO:0023052; GO:0055085,catalytic activity; lipid metabolic process; hydrolase activity; signaling; transmembrane transport
OG_08438,1.1408356430788371,FUN_037197-T1,Peve_00004751,Pocillopora_meandrina_HIv1___RNAseq.g11073.t1,three_way,80.64233333333334,FUN_037197-T1,O88818,,,,,54.1,628.0,4.1e-185,649.4,sp|O88818|PLST_CRIGR Plastin-3 OS=Cricetulus griseus OX=10029 GN=PLS3 PE=2 SV=3,,,,,,
OG_08440,2.0601491438231463,FUN_037199-T1,Peve_00004724,Pocillopora_meandrina_HIv1___RNAseq.g11071.t1,three_way,64.9865,FUN_037199-T1,F1M3L7,EPS8_RAT,,Epidermal growth factor receptor kinase substrate 8,Rattus norvegicus (Rat),31.0,826.0,2.5e-71,272.3,sp|F1M3L7|EPS8_RAT Epidermal growth factor receptor kinase substrate 8 OS=Rattus norvegicus OX=10116 GN=Eps8 PE=1 SV=2,GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030036; GO:0030426; GO:0030832; GO:0031267; GO:0032420; GO:0032421; GO:0032426; GO:0032587; GO:0035023; GO:0036336; GO:0045202; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830,actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],brush border [GO:0005903]; cell cortex [GO:0005938]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202],actin binding [GO:0003779]; small GTPase binding [GO:0031267],GO:0002376; GO:0005886; GO:0007010; GO:0008092; GO:0043226; GO:0048870,immune system process; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle; cell motility
OG_08449,1.8576362189658069,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),43.2,586.0,1.7999999999999998e-127,459.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08449,1.8576362189658069,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),49.5,105.0,7.2e-15,85.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08450,1.0825713817777896,FUN_037214-T1,Peve_00012947,Pocillopora_meandrina_HIv1___RNAseq.g11059.t1,three_way,90.98433333333334,,,,,,,,,,,,,,,,,
OG_08451,2.5240760511131675,FUN_037216-T1,Peve_00006684,Pocillopora_meandrina_HIv1___RNAseq.g11058.t1,three_way,62.538,FUN_037216-T1,P55302,AMRP_MOUSE,,Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Heparin-binding protein 44) (HBP-44) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP),Mus musculus (Mouse),33.9,316.0,3e-27,124.0,sp|P55302|AMRP_MOUSE Alpha-2-macroglobulin receptor-associated protein OS=Mus musculus OX=10090 GN=Lrpap1 PE=1 SV=1,GO:0002091; GO:0005768; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0008201; GO:0009986; GO:0010916; GO:0031904; GO:0035473; GO:0048018; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0070326; GO:0150093; GO:1900222,amyloid-beta clearance by transcytosis [GO:0150093]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; regulation of receptor-mediated endocytosis [GO:0048259],cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237],heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; very-low-density lipoprotein particle receptor binding [GO:0070326],GO:0005768; GO:0005794; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0048018; GO:0098772,endosome; Golgi apparatus; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_08452,1.20339714347219,FUN_037217-T2,Peve_00006683,Pocillopora_meandrina_HIv1___RNAseq.g11057.t1,three_way,61.09466666666667,FUN_037217-T2,Q8BFR2,,,,,25.6,789.0,5.4e-64,247.3,sp|Q8BFR2|FSTL5_MOUSE Follistatin-related protein 5 OS=Mus musculus OX=10090 GN=Fstl5 PE=2 SV=1,,,,,,
OG_08454,1.4812024770837555,FUN_037221-T1,Peve_00044303,Pocillopora_meandrina_HIv1___RNAseq.g11044.t1,three_way,87.619,FUN_037221-T1,Q9Z120,TRMB_MOUSE,,tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase),Mus musculus (Mouse),65.6,250.0,5.6e-93,342.0,sp|Q9Z120|TRMB_MOUSE tRNA (guanine-N(7)-)-methyltransferase OS=Mus musculus OX=10090 GN=Mettl1 PE=1 SV=1,GO:0000049; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006400; GO:0008176; GO:0033554; GO:0036416; GO:0106004; GO:0106143; GO:0160090,cellular response to stress [GO:0033554]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m7G46) methyltransferase complex [GO:0106143],internal mRNA (guanine-N7-)-methyltransferase activity [GO:0160090]; tRNA (guanine(46)-N7)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_08456,1.9459080182331032,FUN_037224-T1,Peve_00044309,Pocillopora_meandrina_HIv1___RNAseq.g11042.t1,three_way,59.601333333333336,,,,,,,,,,,,,,,,,
OG_08458,1.3263883069918152,FUN_037227-T1,Peve_00044302,Pocillopora_meandrina_HIv1___RNAseq.g11036.t1,three_way,72.9805,FUN_037227-T1,Q68F99,,,,,26.3,278.0,2.8000000000000004e-22,108.6,sp|Q68F99|STAC3_XENTR SH3 and cysteine-rich domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=stac3 PE=2 SV=1,,,,,,
OG_08462,1.450012070315071,FUN_037231-T1,Peve_00006214,Pocillopora_meandrina_HIv1___RNAseq.g11018.t1,three_way,95.307,FUN_037231-T1,P61092,SIA1A_MOUSE,,E3 ubiquitin-protein ligase SIAH1A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1A) (Seven in absentia homolog 1a) (Siah-1a) (Siah1a) (mSiah-1a),Mus musculus (Mouse),84.6,266.0,2.4e-135,483.0,sp|P61092|SIA1A_MOUSE E3 ubiquitin-protein ligase SIAH1A OS=Mus musculus OX=10090 GN=Siah1a PE=1 SV=1,GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007141; GO:0007283; GO:0008270; GO:0009791; GO:0016567; GO:0019005; GO:0030154; GO:0040014; GO:0042803; GO:0043161; GO:0051402; GO:0060070; GO:0061630; GO:0097718,canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],disordered domain specific binding [GO:0097718]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"catalytic activity; nucleus; cytosol; programmed cell death; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_08464,1.0796672061532795,FUN_037233-T1,Peve_00034021,Pocillopora_meandrina_HIv1___RNAseq.g14907.t1,three_way,41.4985,FUN_037233-T1,Q7JK24,,,,,27.4,292.0,3.9e-25,117.5,"sp|Q7JK24|B3GT1_GORGO Beta-1,3-galactosyltransferase 1 OS=Gorilla gorilla gorilla OX=9595 GN=B3GALT1 PE=3 SV=1",,,,,,
OG_08469,1.8593744633986151,FUN_037281-T1,Peve_00001634,Pocillopora_meandrina_HIv1___RNAseq.g26881.t1,three_way,79.723,,,,,,,,,,,,,,,,,
OG_08473,1.0661725947619929,FUN_037290-T1,Peve_00032665,Pocillopora_meandrina_HIv1___RNAseq.g10674.t1,three_way,91.80166666666666,FUN_037290-T1,A7SWD3,,,,,71.6,215.0,1.3999999999999999e-83,310.8,sp|A7SWD3|GID8_NEMVE Glucose-induced degradation protein 8 homolog OS=Nematostella vectensis OX=45351 GN=v1g247787 PE=3 SV=1,,,,,,
OG_08478,1.913859068219884,FUN_037305-T1,Peve_00045269,Pocillopora_meandrina_HIv1___RNAseq.g10723.t1,three_way,44.54433333333333,,,,,,,,,,,,,,,,,
OG_08482,2.91127427645917,FUN_037313-T1,Peve_00006178,Pocillopora_meandrina_HIv1___RNAseq.g10707.t1,three_way,74.689,FUN_037313-T1,Q32PP9,,,,,66.0,94.0,6.7e-27,122.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_08484,1.0400384146562929,FUN_037320-T1,Peve_00006220,Pocillopora_meandrina_HIv1___RNAseq.g10703.t1,three_way,66.359,FUN_037320-T1,A2VE04,FRRS1_BOVIN,,Ferric-chelate reductase 1 (EC 1.-.-.-),Bos taurus (Bovine),29.7,202.0,6.1e-07,57.4,sp|A2VE04|FRRS1_BOVIN Ferric-chelate reductase 1 OS=Bos taurus OX=9913 GN=FRRS1 PE=2 SV=1,GO:0006879; GO:0016020; GO:0016722; GO:0046872,intracellular iron ion homeostasis [GO:0006879],membrane [GO:0016020],"metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08485,1.6905239084413688,FUN_037321-T1,Peve_00006223,Pocillopora_meandrina_HIv1___RNAseq.g10702.t1,three_way,81.63366666666667,FUN_037321-T1,A4IFE4,,,,,53.6,440.0,2.4e-126,454.1,sp|A4IFE4|RGF1B_BOVIN Ras-GEF domain-containing family member 1B OS=Bos taurus OX=9913 GN=RASGEF1B PE=2 SV=1,,,,,,
OG_08488,1.81990525699582,FUN_037324-T1,Peve_00006231,Pocillopora_meandrina_HIv1___RNAseq.g10699.t1,three_way,65.4175,FUN_037324-T1,Q8CF97,VCIP1_RAT,,Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein),Rattus norvegicus (Rat),47.3,994.0,4.7e-244,846.3,sp|Q8CF97|VCIP1_RAT Deubiquitinating protein VCPIP1 OS=Rattus norvegicus OX=10116 GN=Vcpip1 PE=1 SV=2,GO:0004843; GO:0005634; GO:0005783; GO:0005795; GO:0006508; GO:0006974; GO:0007030; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0045202; GO:0071108; GO:0090168; GO:0106300; GO:1905634,DNA damage response [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; regulation of protein localization to chromatin [GO:1905634],endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; synapse [GO:0045202],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0005783; GO:0006281; GO:0016787; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; DNA repair; hydrolase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_08491,1.408562382287458,FUN_037330-T1,Peve_00006234,Pocillopora_meandrina_HIv1___RNAseq.g10692.t1,three_way,60.120000000000005,FUN_037330-T1,Q8IVV2,,,,,39.6,273.0,5.8e-47,192.2,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08499,1.0484592128908246,FUN_037383-T2,Peve_00006197,Pocillopora_meandrina_HIv1___TS.g13502.t1,three_way,59.019,FUN_037383-T2,Q99MU3,,,,,44.6,505.0,7.2e-106,387.1,sp|Q99MU3|DSRAD_MOUSE Double-stranded RNA-specific adenosine deaminase OS=Mus musculus OX=10090 GN=Adar PE=1 SV=2,,,,,,
OG_08505,1.3723848092215127,FUN_037404-T1,Peve_00028554,Pocillopora_meandrina_HIv1___RNAseq.g10936.t1,three_way,65.14683333333333,FUN_037404-T1,Q8R2Q6,TECT3_MOUSE,,Tectonic-3,Mus musculus (Mouse),30.9,556.0,8.399999999999998e-55,216.5,sp|Q8R2Q6|TECT3_MOUSE Tectonic-3 OS=Mus musculus OX=10090 GN=Tctn3 PE=1 SV=1,GO:0005634; GO:0006915; GO:0007224; GO:0016020; GO:0043065; GO:0060271,apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; positive regulation of apoptotic process [GO:0043065]; smoothened signaling pathway [GO:0007224],membrane [GO:0016020]; nucleus [GO:0005634],,GO:0005634; GO:0012501; GO:0043226; GO:0044782,nucleus; programmed cell death; organelle; cilium organization
OG_08507,1.2589009601229446,FUN_037415-T1,Peve_00028254,Pocillopora_meandrina_HIv1___RNAseq.g10939.t1,three_way,73.82433333333333,FUN_037415-T1,A5PJF6,,,,,47.9,303.0,2.3000000000000002e-73,277.3,sp|A5PJF6|HSDL1_BOVIN Inactive hydroxysteroid dehydrogenase-like protein 1 OS=Bos taurus OX=9913 GN=HSDL1 PE=2 SV=1,,,,,,
OG_08508,1.576591545062321,FUN_037416-T2,Peve_00028857,Pocillopora_meandrina_HIv1___RNAseq.g10945.t1,three_way,60.57983333333333,FUN_037416-T2,Q569T7,,,,,33.2,400.0,7.700000000000001e-48,193.0,sp|Q569T7|MFS4B_XENLA Sodium-dependent glucose transporter 1 OS=Xenopus laevis OX=8355 GN=mfsd4b PE=2 SV=1,,,,,,
OG_08509,1.6368660418612573,FUN_037422-T1,Peve_00000594,Pocillopora_meandrina_HIv1___RNAseq.g10949.t1,three_way,81.52333333333333,FUN_037422-T1,Q6QA33,,,,,49.3,306.0,1.5e-71,271.2,sp|Q6QA33|DH12B_DANRE Very-long-chain 3-oxoacyl-CoA reductase-B OS=Danio rerio OX=7955 GN=hsd17b12b PE=2 SV=2,,,,,,
OG_08510,1.7507532345750825,FUN_037424-T1,Peve_00000597,Pocillopora_meandrina_HIv1___RNAseq.g10952.t1a,three_way,54.638333333333335,,,,,,,,,,,,,,,,,
OG_08511,1.1033004015872885,FUN_037425-T2,Peve_00014237,Pocillopora_meandrina_HIv1___RNAseq.g10955.t1,three_way,83.41216666666666,FUN_037425-T2,P31266,,,,,75.5,440.0,3.4e-193,676.0,sp|P31266|SUH_MOUSE Recombining binding protein suppressor of hairless OS=Mus musculus OX=10090 GN=Rbpj PE=1 SV=1,,,,,,
OG_08512,1.633847905998547,FUN_037430-T2,Peve_00014228,Pocillopora_meandrina_HIv1___RNAseq.g10960.t1,three_way,48.326,,,,,,,,,,,,,,,,,
OG_08513,1.67879610425922,FUN_037439-T1,Peve_00014239,Pocillopora_meandrina_HIv1___RNAseq.g10962.t1,three_way,78.76766666666666,FUN_037439-T1,P97393,RHG05_MOUSE,,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),Mus musculus (Mouse),30.1,1790.0,6.2e-194,680.2,sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3,GO:0002053; GO:0005096; GO:0005783; GO:0005829; GO:0005886; GO:0007165; GO:0008361; GO:0010631; GO:0010634; GO:0016477; GO:0030879; GO:0042169,cell migration [GO:0016477]; epithelial cell migration [GO:0010631]; mammary gland development [GO:0030879]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; signal transduction [GO:0007165],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; SH2 domain binding [GO:0042169],GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0048856; GO:0048870; GO:0098772,endoplasmic reticulum; cytosol; plasma membrane; organelle; anatomical structure development; cell motility; molecular function regulator activity
OG_08514,1.3339179143429076,FUN_037440-T1,Peve_00014235,Pocillopora_meandrina_HIv1___RNAseq.22823_t,three_way,64.086,FUN_037440-T1,Q9M9E8,,,,,30.9,269.0,4.400000000000001e-28,127.1,sp|Q9M9E8|JMJ21_ARATH Lysine-specific demethylase JMJ21 OS=Arabidopsis thaliana OX=3702 GN=JMJ21 PE=2 SV=3,,,,,,
OG_08519,2.3540827822683847,FUN_037451-T1,Peve_00044121,Pocillopora_meandrina_HIv1___RNAseq.g1365.t1,three_way,62.06366666666667,,,,,,,,,,,,,,,,,
OG_08520,3.3105447319678465,FUN_037452-T1,Peve_00044119,Pocillopora_meandrina_HIv1___RNAseq.g1368.t1,three_way,59.91483333333333,FUN_037452-T1,Q9IA95,,,,,32.7,266.0,2.4e-45,184.1,sp|Q9IA95|SFRP3_CHICK Secreted frizzled-related protein 3 OS=Gallus gallus OX=9031 GN=FRZB PE=2 SV=1,,,,,,
OG_08521,1.8776841353963551,FUN_037454-T1,Peve_00044133,Pocillopora_meandrina_HIv1___RNAseq.g1366.t1,three_way,42.83116666666667,,,,,,,,,,,,,,,,,
OG_08525,1.2454440750108018,FUN_037458-T2,Peve_00036027,Pocillopora_meandrina_HIv1___RNAseq.g1372.t1,three_way,51.31883333333333,,,,,,,,,,,,,,,,,
OG_08530,1.6834568174842142,FUN_037477-T1,Peve_00020433,Pocillopora_meandrina_HIv1___RNAseq.g1391.t1,three_way,71.99733333333333,FUN_037477-T1,Q3TDN2,FAF2_MOUSE,,FAS-associated factor 2 (UBX domain-containing protein 8),Mus musculus (Mouse),45.3,267.0,3.1e-59,230.3,sp|Q3TDN2|FAF2_MOUSE FAS-associated factor 2 OS=Mus musculus OX=10090 GN=Faf2 PE=1 SV=2,GO:0005783; GO:0005811; GO:0006986; GO:0030674; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0035617; GO:0036503; GO:0043130; GO:0043161; GO:0055102,"ERAD pathway [GO:0036503]; lipid droplet organization [GO:0034389]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]",endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005783; GO:0005811; GO:0006886; GO:0030163; GO:0043226; GO:0060090; GO:0098772,endoplasmic reticulum; lipid droplet; intracellular protein transport; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_08533,1.2583880601951425,FUN_037483-T1,Peve_00020422,Pocillopora_meandrina_HIv1___RNAseq.g1397.t1,three_way,72.69066666666667,,,,,,,,,,,,,,,,,
OG_08535,1.6830195786764,FUN_037485-T2,Peve_00020418,Pocillopora_meandrina_HIv1___RNAseq.g1299.t1,three_way,72.62033333333333,FUN_037485-T2,Q8CHC4,SYNJ1_MOUSE,,"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)",Mus musculus (Mouse),54.1,1036.0,0.0,1097.0,sp|Q8CHC4|SYNJ1_MOUSE Synaptojanin-1 OS=Mus musculus OX=10090 GN=Synj1 PE=1 SV=3,GO:0003723; GO:0004439; GO:0006836; GO:0007612; GO:0012506; GO:0016082; GO:0016191; GO:0030117; GO:0030118; GO:0030132; GO:0034595; GO:0043195; GO:0046488; GO:0046856; GO:0048015; GO:0048471; GO:0048488; GO:0048489; GO:0097060; GO:0098685; GO:0098978; GO:0099149; GO:1903423,learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of synaptic vesicle recycling [GO:1903423]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; perinuclear region of cytoplasm [GO:0048471]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506],"phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; RNA binding [GO:0003723]",GO:0003723; GO:0003824; GO:0006629; GO:0016192; GO:0016787; GO:0050877; GO:0065003,RNA binding; catalytic activity; lipid metabolic process; vesicle-mediated transport; hydrolase activity; nervous system process; protein-containing complex assembly
OG_08536,2.4634711485959864,FUN_037486-T1,Peve_00020414,Pocillopora_meandrina_HIv1___RNAseq.g1300.t1,three_way,64.04466666666667,FUN_037486-T1,Q6TLI7,AA2AR_HORSE,,Adenosine receptor A2a,Equus caballus (Horse),24.3,296.0,4.7e-07,57.0,sp|Q6TLI7|AA2AR_HORSE Adenosine receptor A2a OS=Equus caballus OX=9796 GN=ADORA2A PE=2 SV=1,GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005886; GO:0007189; GO:0007626; GO:0008289; GO:0014074; GO:0019899; GO:0032230; GO:0042755; GO:0042802; GO:0046636; GO:0050728; GO:0060080; GO:0097190; GO:0098794; GO:2001235,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic signaling pathway [GO:0097190]; eating behavior [GO:0042755]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; response to purine-containing compound [GO:0014074]; synaptic transmission, dopaminergic [GO:0001963]",plasma membrane [GO:0005886]; postsynapse [GO:0098794],calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],GO:0005886; GO:0008289; GO:0023052; GO:0060089,plasma membrane; lipid binding; signaling; molecular transducer activity
OG_08540,1.7115122630730937,FUN_037491-T1,Peve_00028570,Pocillopora_meandrina_HIv1___RNAseq.g1307.t1,three_way,88.51766666666667,FUN_037491-T1,P31153,METK2_HUMAN,,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),Homo sapiens (Human),79.0,381.0,3.6e-177,622.5,sp|P31153|METK2_HUMAN S-adenosylmethionine synthase isoform type-2 OS=Homo sapiens OX=9606 GN=MAT2A PE=1 SV=1,GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0036094; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0061431; GO:1904263; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to methionine [GO:0061431]; one-carbon metabolic process [GO:0006730]; positive regulation of TORC1 signaling [GO:1904263]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556],cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; small molecule binding [GO:0036094],GO:0003824; GO:0005829; GO:0006790; GO:0016740; GO:0065003,catalytic activity; cytosol; sulfur compound metabolic process; transferase activity; protein-containing complex assembly
OG_08541,1.0574476824571843,FUN_037492-T1,Peve_00028569,Pocillopora_meandrina_HIv1___RNAseq.g1308.t1,three_way,98.157,FUN_037492-T1,Q7L9L4,MOB1B_HUMAN,,MOB kinase activator 1B (Mob1 homolog 1A) (Mob1A) (Mob1B) (Mps one binder kinase activator-like 1A),Homo sapiens (Human),87.5,216.0,3.6e-112,405.6,sp|Q7L9L4|MOB1B_HUMAN MOB kinase activator 1B OS=Homo sapiens OX=9606 GN=MOB1B PE=1 SV=3,GO:0005634; GO:0005737; GO:0005829; GO:0019209; GO:0019900; GO:0030295; GO:0031952; GO:0035329; GO:0043539; GO:0046872; GO:0070062,hippo signaling [GO:0035329]; regulation of protein autophosphorylation [GO:0031952],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],kinase activator activity [GO:0019209]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005634; GO:0005829; GO:0043226; GO:0098772,nucleus; cytosol; organelle; molecular function regulator activity
OG_08543,2.0601569524117798,FUN_037496-T1,Peve_00028565,Pocillopora_meandrina_HIv1___RNAseq.g1312.t1,three_way,79.1105,FUN_037496-T1,P36895,BMR1A_MOUSE,,Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (BMP-2/BMP-4 receptor) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292),Mus musculus (Mouse),53.0,487.0,2.7e-145,516.9,sp|P36895|BMR1A_MOUSE Bone morphogenetic protein receptor type-1A OS=Mus musculus OX=10090 GN=Bmpr1a PE=1 SV=1,GO:0001525; GO:0001649; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003007; GO:0003148; GO:0003151; GO:0003161; GO:0003171; GO:0003183; GO:0003186; GO:0003203; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0004674; GO:0005025; GO:0005524; GO:0005901; GO:0006955; GO:0007179; GO:0007389; GO:0007398; GO:0007399; GO:0007492; GO:0007507; GO:0009897; GO:0009950; GO:0009952; GO:0009953; GO:0009986; GO:0010629; GO:0014032; GO:0014912; GO:0021953; GO:0021983; GO:0021998; GO:0030324; GO:0030425; GO:0030501; GO:0030509; GO:0032915; GO:0035019; GO:0035137; GO:0035912; GO:0036122; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048339; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0048598; GO:0048863; GO:0050673; GO:0050679; GO:0050768; GO:0051148; GO:0051216; GO:0060021; GO:0060043; GO:0060045; GO:0060391; GO:0060412; GO:0060896; GO:0060914; GO:0060928; GO:0061626; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:2000772,angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; atrioventricular node cell development [GO:0060928]; atrioventricular valve development [GO:0003171]; BMP signaling pathway [GO:0030509]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cartilage development [GO:0051216]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic morphogenesis [GO:0048598]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endoderm development [GO:0007492]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart development [GO:0007507]; heart formation [GO:0060914]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; neural plate pattern specification [GO:0060896]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm structural organization [GO:0048352]; pattern specification process [GO:0007389]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell differentiation [GO:0048863]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],caveola [GO:0005901]; cell surface [GO:0009986]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025],"ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]",GO:0002376; GO:0003824; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0060089; GO:0140096,"immune system process; catalytic activity; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_08545,2.2655820999769345,FUN_037499-T1,Peve_00028563,Pocillopora_meandrina_HIv1___RNAseq.g1314.t1,three_way,52.762,FUN_037499-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),26.9,750.0,3.7e-53,211.8,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_08553,1.3511383607933496,FUN_037529-T1,Peve_00018745,Pocillopora_meandrina_HIv1___RNAseq.g10587.t1,three_way,78.19266666666667,FUN_037529-T1,P97479,,,,,53.2,485.0,6.6e-146,518.8,sp|P97479|MYO7A_MOUSE Unconventional myosin-VIIa OS=Mus musculus OX=10090 GN=Myo7a PE=1 SV=2,,,,,,
OG_08555,1.458194604432114,FUN_037537-T2,Peve_00032233,Pocillopora_meandrina_HIv1___RNAseq.g1638.t1,three_way,66.20966666666666,,,,,,,,,,,,,,,,,
OG_08562,1.0835473651472285,FUN_037555-T2,Peve_00044142,Pocillopora_meandrina_HIv1___RNAseq.g1623.t3,three_way,81.39433333333334,FUN_037555-T2,Q8TEU7,,,,,43.2,1168.0,7.5e-253,875.5,sp|Q8TEU7|RPGF6_HUMAN Rap guanine nucleotide exchange factor 6 OS=Homo sapiens OX=9606 GN=RAPGEF6 PE=1 SV=2,,,,,,
OG_08564,1.2399296719041677,FUN_037564-T1,Peve_00017811,Pocillopora_meandrina_HIv1___RNAseq.g1620.t1,three_way,60.96666666666667,FUN_037564-T1,Q8CFX1,G6PE_MOUSE,,GDH/6PGL endoplasmic bifunctional protein [Includes: Hexose-6-phosphate dehydrogenase (Glucose 1-dehydrogenase) (EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase) (EC 1.1.1.363); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)],Mus musculus (Mouse),42.7,784.0,1.5e-169,598.2,sp|Q8CFX1|G6PE_MOUSE GDH/6PGL endoplasmic bifunctional protein OS=Mus musculus OX=10090 GN=H6pd PE=1 SV=2,GO:0004345; GO:0005783; GO:0005788; GO:0006006; GO:0006098; GO:0009051; GO:0016529; GO:0017057; GO:0030246; GO:0031667; GO:0047934; GO:0047935; GO:0050661; GO:0097305; GO:2000064,"glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; regulation of cortisol biosynthetic process [GO:2000064]; response to alcohol [GO:0097305]; response to nutrient levels [GO:0031667]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; sarcoplasmic reticulum [GO:0016529],6-phosphogluconolactonase activity [GO:0017057]; carbohydrate binding [GO:0030246]; glucose 1-dehydrogenase (NAD+) activity [GO:0047934]; glucose 1-dehydrogenase (NADP+) activity [GO:0047935]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661],GO:0003824; GO:0005783; GO:0005975; GO:0006091; GO:0016491; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08567,1.8501317985548864,FUN_037568-T1,Peve_00035302,Pocillopora_meandrina_HIv1___RNAseq.g1585.t1,three_way,85.8415,FUN_037568-T1,A7SFP1,,,,,81.5,578.0,2.3e-41,171.8,sp|A7SFP1|SHOC2_NEMVE Leucine-rich repeat protein soc-2 homolog OS=Nematostella vectensis OX=45351 GN=v1g189306 PE=3 SV=1,,,,,,
OG_08568,1.3303135648298507,FUN_037569-T1,Peve_00035301,Pocillopora_meandrina_HIv1___RNAseq.g1586.t1,three_way,72.47983333333333,FUN_037569-T1,Q9D168,,,,,31.7,259.0,2.5000000000000002e-22,107.8,sp|Q9D168|INT12_MOUSE Integrator complex subunit 12 OS=Mus musculus OX=10090 GN=Ints12 PE=1 SV=1,,,,,,
OG_08575,1.3536955710316938,FUN_037586-T1,Peve_00035294,Pocillopora_meandrina_HIv1___RNAseq.g1594.t1,three_way,57.32,FUN_037586-T1,Q2TBA3,MALT1_MOUSE,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase),Mus musculus (Mouse),30.2,394.0,3.9e-35,151.4,sp|Q2TBA3|MALT1_MOUSE Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog OS=Mus musculus OX=10090 GN=Malt1 PE=1 SV=2,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0061133; GO:0071222; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; protease binding [GO:0002020]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08576,1.367897414261158,FUN_037588-T1,Peve_00035293,Pocillopora_meandrina_HIv1___RNAseq.g1595.t1,three_way,69.3425,FUN_037588-T1,P38935,SMBP2_HUMAN,,DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2),Homo sapiens (Human),52.6,831.0,1.4e-215,751.1,sp|P38935|SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens OX=9606 GN=IGHMBP2 PE=1 SV=3,GO:0000049; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0003727; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008094; GO:0008186; GO:0008270; GO:0016020; GO:0016604; GO:0016887; GO:0030424; GO:0030426; GO:0032574; GO:0036121; GO:0042802; GO:0043022; GO:0043139; GO:0140296; GO:1990904,,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA helicase activity [GO:0036121]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08577,1.6719410257698593,FUN_037589-T1,Peve_00035292,Pocillopora_meandrina_HIv1___RNAseq.g1596.t1,three_way,82.638,FUN_037589-T1,P70032,,,,,57.4,608.0,4.1e-204,712.6,sp|P70032|PLK1_XENLA Serine/threonine-protein kinase PLK1 OS=Xenopus laevis OX=8355 GN=plk1 PE=1 SV=1,,,,,,
OG_08578,1.5678768705570731,FUN_037681-T1,Peve_00042426,Pocillopora_meandrina_HIv1___RNAseq.g1611.t1,three_way,55.60116666666666,,,,,,,,,,,,,,,,,
OG_08579,1.5730828234968397,FUN_037682-T1,Peve_00042425,Pocillopora_meandrina_HIv1___RNAseq.g1612.t1,three_way,55.28383333333333,,,,,,,,,,,,,,,,,
OG_08580,1.1533637452202845,FUN_037683-T1,Peve_00042424,Pocillopora_meandrina_HIv1___RNAseq.g1613.t1,three_way,49.037333333333336,,,,,,,,,,,,,,,,,
OG_08583,1.4308851612897735,FUN_037687-T1,Peve_00042417,Pocillopora_meandrina_HIv1___RNAseq.g1616.t1,three_way,68.82533333333333,FUN_037687-T1,A0A0G2KQY6,S39AE_DANRE,,Metal cation symporter ZIP14 (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14),Danio rerio (Zebrafish) (Brachydanio rerio),38.7,473.0,2.6e-78,294.3,sp|A0A0G2KQY6|S39AE_DANRE Metal cation symporter ZIP14 OS=Danio rerio OX=7955 GN=slc39a14 PE=2 SV=1,GO:0005381; GO:0005384; GO:0005385; GO:0005765; GO:0005886; GO:0006829; GO:0006882; GO:0015086; GO:0015296; GO:0016323; GO:0016324; GO:0030003; GO:0031901; GO:0031902; GO:0032869; GO:0033212; GO:0034755; GO:0045745; GO:0055071; GO:0071333; GO:0071421; GO:0071577; GO:0071578; GO:0098662; GO:0098739; GO:0140410,cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; import across plasma membrane [GO:0098739]; inorganic cation transmembrane transport [GO:0098662]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; manganese ion transmembrane transport [GO:0071421]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; monoatomic anion:monoatomic cation symporter activity [GO:0015296]; monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_08585,1.246331164366702,FUN_037689-T1,Peve_00001249,Pocillopora_meandrina_HIv1___RNAseq.g1580.t1,three_way,63.23266666666667,FUN_037689-T1,Q5XI67,FBX30_RAT,,F-box only protein 30,Rattus norvegicus (Rat),28.3,703.0,2.900000000000001e-71,271.2,sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1,GO:0006325; GO:0007059; GO:0008270; GO:0010467; GO:0016567; GO:0030261; GO:0061630,chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; protein ubiquitination [GO:0016567],,ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0006325; GO:0007059; GO:0016740; GO:0140096,"catalytic activity; chromatin organization; chromosome segregation; transferase activity; catalytic activity, acting on a protein"
OG_08586,1.0271979227987806,FUN_037690-T1,Peve_00001242,Pocillopora_meandrina_HIv1___RNAseq.g1579.t1,three_way,69.16366666666667,FUN_037690-T1,Q8TEM1,PO210_HUMAN,,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),Homo sapiens (Human),34.5,1584.0,2.7e-254,880.9,sp|Q8TEM1|PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens OX=9606 GN=NUP210 PE=1 SV=3,GO:0005635; GO:0005643; GO:0005789; GO:0006913; GO:0015031; GO:0016020; GO:0031965; GO:0051028,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643],,GO:0005635; GO:0006913,nuclear envelope; nucleocytoplasmic transport
OG_08591,1.446764638682963,FUN_037700-T1,Peve_00044123,Pocillopora_meandrina_HIv1___RNAseq.g1360.t1,three_way,70.3135,FUN_037700-T1,Q6DCC6,,,,,41.9,434.0,6.4e-86,319.7,sp|Q6DCC6|GTPB6_XENLA Putative GTP-binding protein 6 OS=Xenopus laevis OX=8355 GN=gtpbp6 PE=2 SV=1,,,,,,
OG_08594,1.6028805161988628,FUN_037709-T1,Peve_00027437,Pocillopora_meandrina_HIv1___RNAseq.g1402.t1,three_way,58.09033333333333,FUN_037709-T1,E7F1U2,DNMBP_DANRE,,Dynamin-binding protein (Scaffold protein Tuba),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,728.0,7.8e-103,377.5,sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1,GO:0001822; GO:0005085; GO:0005737; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005794; GO:0005856; GO:0043226; GO:0044782; GO:0048856; GO:0098772,Golgi apparatus; cytoskeleton; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_08597,1.0910116036662136,FUN_037739-T1,Peve_00037364,Pocillopora_meandrina_HIv1___RNAseq.g1330.t1,three_way,79.21866666666666,FUN_037739-T1,Q8T293,,,,,40.8,353.0,1.5e-70,268.1,sp|Q8T293|DIAC2_DICDI Probable di-N-acetylchitobiase 2 OS=Dictyostelium discoideum OX=44689 GN=ctbs2 PE=3 SV=1,,,,,,
OG_08598,2.0169467034434025,FUN_037740-T1,Peve_00037367,Pocillopora_meandrina_HIv1___RNAseq.g1331.t2,three_way,82.32733333333333,,,,,,,,,,,,,,,,,
OG_08599,1.4779874946230374,FUN_037741-T1,Peve_00037358,Pocillopora_meandrina_HIv1___RNAseq.g1334.t1,three_way,67.00733333333334,,,,,,,,,,,,,,,,,
OG_08603,1.193508277813668,FUN_037746-T1,Peve_00037365,Pocillopora_meandrina_HIv1___RNAseq.g1336.t1,three_way,86.29599999999999,FUN_037746-T1,P12003,,,,,38.8,1139.0,2.9999999999999998e-182,640.6,sp|P12003|VINC_CHICK Vinculin OS=Gallus gallus OX=9031 GN=VCL PE=1 SV=4,,,,,,
OG_08604,1.2225675702354608,FUN_037750-T1,Peve_00038308,Pocillopora_meandrina_HIv1___TS.g22747.t1,three_way,55.69183333333333,FUN_037750-T1,Q5HYC2,,,,,33.3,420.0,9.399999999999999e-55,217.6,sp|Q5HYC2|BRD10_HUMAN Uncharacterized bromodomain-containing protein 10 OS=Homo sapiens OX=9606 GN=BRD10 PE=1 SV=2,,,,,,
OG_08606,2.3546530946424515,FUN_037752-T1,Peve_00038306,Pocillopora_meandrina_HIv1___RNAseq.g1340.t1,three_way,82.766,FUN_037752-T1,A2BGM5,FOXN4_DANRE,,Forkhead box protein N4,Danio rerio (Zebrafish) (Brachydanio rerio),68.4,117.0,7.3e-42,172.9,sp|A2BGM5|FOXN4_DANRE Forkhead box protein N4 OS=Danio rerio OX=7955 GN=foxn4 PE=1 SV=1,GO:0000981; GO:0000987; GO:0001947; GO:0003170; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0035881; GO:0036302; GO:0043565; GO:0045893; GO:0045944; GO:0060579,amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; heart looping [GO:0001947]; heart valve development [GO:0003170]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of heart contraction [GO:0008016]; retina layer formation [GO:0010842]; ventral spinal cord interneuron fate commitment [GO:0060579],nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08607,1.397386619896962,FUN_037753-T1,Peve_00038304,Pocillopora_meandrina_HIv1___RNAseq.g1341.t1,three_way,59.559333333333335,FUN_037753-T1,A7SKJ3,DPH2_NEMVE,,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2),Nematostella vectensis (Starlet sea anemone),44.1,313.0,3.200000000000001e-65,250.4,sp|A7SKJ3|DPH2_NEMVE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 OS=Nematostella vectensis OX=45351 GN=dph2 PE=3 SV=1,GO:0017183; GO:0046872; GO:0051539; GO:0090560; GO:0120513,protein histidyl modification to diphthamide [GO:0017183],2-(3-amino-3-carboxypropyl)histidine synthase complex [GO:0120513],"2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_08615,1.058688871129127,FUN_037763-T1,Peve_00014331,Pocillopora_meandrina_HIv1___RNAseq.g1494.t1,three_way,49.86833333333333,FUN_037763-T1,Q5ZJX4,,,,,57.6,92.0,4.4e-26,120.2,sp|Q5ZJX4|RBM38_CHICK RNA-binding protein 38 OS=Gallus gallus OX=9031 GN=RBM38 PE=2 SV=1,,,,,,
OG_08617,1.82043912238219,FUN_037768-T1,Peve_00014328,Pocillopora_meandrina_HIv1___RNAseq.g1480.t1,three_way,79.92966666666668,FUN_037768-T1,O35552,F263_RAT,,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain-type isozyme) (RB2K) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",Rattus norvegicus (Rat),53.4,440.0,1.1000000000000001e-130,468.4,"sp|O35552|F263_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 OS=Rattus norvegicus OX=10116 GN=Pfkfb3 PE=2 SV=1",GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006096; GO:0006110; GO:0006915; GO:0010001; GO:0061744,"apoptotic process [GO:0006915]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; motor behavior [GO:0061744]; regulation of glycolytic process [GO:0006110]",cytosol [GO:0005829]; nucleoplasm [GO:0005654],"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]",GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; programmed cell death; transferase activity; hydrolase activity; cell differentiation; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08618,1.1601189162018335,FUN_037769-T1,Peve_00014327,Pocillopora_meandrina_HIv1___RNAseq.g1481.t1,three_way,74.75533333333334,FUN_037769-T1,O95147,,,,,47.9,167.0,1.2999999999999998e-43,177.6,sp|O95147|DUS14_HUMAN Dual specificity protein phosphatase 14 OS=Homo sapiens OX=9606 GN=DUSP14 PE=1 SV=1,,,,,,
OG_08619,1.3526982435639472,FUN_037772-T1,Peve_00014348,Pocillopora_meandrina_HIv1___RNAseq.g1505.t1,three_way,75.424,FUN_037772-T1,Q32P28,P3H1_HUMAN,,Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1),Homo sapiens (Human),33.7,692.0,1e-99,365.9,sp|Q32P28|P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens OX=9606 GN=P3H1 PE=1 SV=2,GO:0005506; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0008285; GO:0010976; GO:0016020; GO:0018126; GO:0019797; GO:0030199; GO:0030278; GO:0030308; GO:0031418; GO:0032963; GO:0032991; GO:0050708; GO:0050821; GO:0060348; GO:0061077; GO:0070062; GO:1901874,bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of post-translational protein modification [GO:1901874]; positive regulation of neuron projection development [GO:0010976]; protein folding [GO:0006457]; protein hydroxylation [GO:0018126]; protein stabilization [GO:0050821]; regulation of ossification [GO:0030278]; regulation of protein secretion [GO:0050708],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797],GO:0003824; GO:0005634; GO:0005783; GO:0006457; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; protein folding; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08620,1.3612611686700695,FUN_037775-T1,Peve_00040704,Pocillopora_meandrina_HIv1___RNAseq.g1512.t1,three_way,79.25166666666667,FUN_037775-T1,P48630,,,,,49.3,377.0,7.5e-100,365.5,"sp|P48630|FD6E1_SOYBN Omega-6 fatty acid desaturase, endoplasmic reticulum isozyme 1 OS=Glycine max OX=3847 GN=FAD2-1 PE=2 SV=1",,,,,,
OG_08621,2.276328991930184,FUN_037776-T1,Peve_00040706,Pocillopora_meandrina_HIv1___RNAseq.g1509.t1,three_way,81.93966666666667,,,,,,,,,,,,,,,,,
OG_08625,1.4074848816808283,FUN_037791-T1,Peve_00026138,Pocillopora_meandrina_HIv1___RNAseq.g10947.t1,three_way,61.035,FUN_037791-T1,Q9Z0E8,,,,,29.9,532.0,1.3e-54,215.7,sp|Q9Z0E8|S22A5_MOUSE Organic cation/carnitine transporter 2 OS=Mus musculus OX=10090 GN=Slc22a5 PE=1 SV=1,,,,,,
OG_08627,2.2430879238330217,FUN_037795-T1,Peve_00026136,Pocillopora_meandrina_HIv1___RNAseq.g1555.t3,three_way,71.708,FUN_037795-T1,P51960,,,,,33.6,758.0,4.3e-85,317.4,sp|P51960|MYBA_MOUSE Myb-related protein A OS=Mus musculus OX=10090 GN=Mybl1 PE=1 SV=2,,,,,,
OG_08628,1.2973127968106577,FUN_037796-T1,Peve_00026135,Pocillopora_meandrina_HIv1___RNAseq.g1556.t1,three_way,91.083,FUN_037796-T1,Q9CWF6,BBS2_MOUSE,,BBSome complex member BBS2 (Bardet-Biedl syndrome 2 protein homolog),Mus musculus (Mouse),66.9,718.0,8.9e-285,980.7,sp|Q9CWF6|BBS2_MOUSE BBSome complex member BBS2 OS=Mus musculus OX=10090 GN=Bbs2 PE=1 SV=1,GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034451; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515,adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0003012; GO:0003013; GO:0005815; GO:0005929; GO:0007010; GO:0016192; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0072659,muscle system process; circulatory system process; microtubule organizing center; cilium; cytoskeleton organization; vesicle-mediated transport; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein localization to plasma membrane
OG_08629,1.2715006357505867,FUN_037798-T1,Peve_00026125,Pocillopora_meandrina_HIv1___RNAseq.g1558.t1,three_way,81.751,,,,,,,,,,,,,,,,,
OG_08633,2.7594142634379635,FUN_037802-T1,Peve_00026129,Pocillopora_meandrina_HIv1___RNAseq.g1562.t1,three_way,59.398,,,,,,,,,,,,,,,,,
OG_08635,2.6340840207996377,FUN_037806-T1,Peve_00003980,Pocillopora_meandrina_HIv1___RNAseq.g1566.t1,three_way,45.65533333333333,,,,,,,,,,,,,,,,,
OG_08638,1.671684173421777,FUN_037810-T1,Peve_00028101,Pocillopora_meandrina_HIv1___RNAseq.g1572.t1,three_way,58.22133333333333,,,,,,,,,,,,,,,,,
OG_08639,1.89134839598061,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08643,1.1253152329336364,FUN_037834-T1,Peve_00029596,Pocillopora_meandrina_HIv1___RNAseq.g1455.t1,three_way,63.28266666666666,FUN_037834-T1,P05423,RPC4_HUMAN,,DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog),Homo sapiens (Human),40.7,413.0,3.7e-38,160.6,sp|P05423|RPC4_HUMAN DNA-directed RNA polymerase III subunit RPC4 OS=Homo sapiens OX=9606 GN=POLR3D PE=1 SV=2,GO:0003677; GO:0003682; GO:0005654; GO:0005666; GO:0005829; GO:0032728; GO:0042797; GO:0045087; GO:0045089; GO:0051607,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666],chromatin binding [GO:0003682]; DNA binding [GO:0003677],GO:0002376; GO:0003677; GO:0005654; GO:0005829; GO:0006351; GO:0006399; GO:0098542,immune system process; DNA binding; nucleoplasm; cytosol; DNA-templated transcription; tRNA metabolic process; defense response to other organism
OG_08644,2.8485945291024155,FUN_037835-T1,Peve_00000571,Pocillopora_meandrina_HIv1___RNAseq.g1459.t1,three_way,87.0945,FUN_037835-T1,A0JNC1,CDS2_BOVIN,,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),Bos taurus (Bovine),57.1,410.0,3.5e-138,493.0,sp|A0JNC1|CDS2_BOVIN Phosphatidate cytidylyltransferase 2 OS=Bos taurus OX=9913 GN=CDS2 PE=2 SV=1,GO:0004605; GO:0005783; GO:0005789; GO:0016020; GO:0016024; GO:0140042,CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],phosphatidate cytidylyltransferase activity [GO:0004605],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_08645,1.6392203521256234,FUN_037836-T1,Peve_00000570,Pocillopora_meandrina_HIv1___RNAseq.g1460.t1,three_way,80.37733333333334,FUN_037836-T1,P12004,PCNA_HUMAN,,Proliferating cell nuclear antigen (PCNA) (Cyclin),Homo sapiens (Human),65.3,259.0,5e-100,365.5,sp|P12004|PCNA_HUMAN Proliferating cell nuclear antigen OS=Homo sapiens OX=9606 GN=PCNA PE=1 SV=1,GO:0000122; GO:0000307; GO:0000701; GO:0000781; GO:0000785; GO:0001673; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006287; GO:0006298; GO:0006325; GO:0007507; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030894; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032355; GO:0032405; GO:0034644; GO:0035035; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0044877; GO:0045739; GO:0045740; GO:0046686; GO:0070062; GO:0070182; GO:0070301; GO:0070557; GO:0071466; GO:0071548; GO:0097421; GO:1900264; GO:1902065; GO:1902990,"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]","centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]",chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; nuclear estrogen receptor binding [GO:0030331]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0048856; GO:0098772; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; reproductive process; cell differentiation; telomere organization; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA"
OG_08651,1.540616997312238,FUN_037847-T1,Peve_00023799,Pocillopora_meandrina_HIv1___RNAseq.g1440.t1,three_way,86.37266666666667,FUN_037847-T1,P59015,VPS18_DANRE,,Vacuolar protein sorting-associated protein 18 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),45.1,987.0,1.5e-247,857.4,sp|P59015|VPS18_DANRE Vacuolar protein sorting-associated protein 18 homolog OS=Danio rerio OX=7955 GN=vps18 PE=2 SV=2,GO:0005765; GO:0005768; GO:0006886; GO:0006904; GO:0007032; GO:0007040; GO:0007634; GO:0008270; GO:0008333; GO:0015721; GO:0030674; GO:0030897; GO:0031902; GO:0043485; GO:0045176; GO:0048069; GO:0048284; GO:0048757; GO:0060036,apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; organelle fusion [GO:0048284]; pigment granule maturation [GO:0048757]; vesicle docking involved in exocytosis [GO:0006904],endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270],GO:0005768; GO:0006886; GO:0007040; GO:0016192; GO:0031410; GO:0043226; GO:0060090,endosome; intracellular protein transport; lysosome organization; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_08657,1.0899511403030857,FUN_037867-T2,Peve_00024529,Pocillopora_meandrina_HIv1___RNAseq.g1412.t1,three_way,72.27066666666667,FUN_037867-T2,Q9C0H5,,,,,58.9,384.0,1.7000000000000002e-133,478.4,sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2,,,,,,
OG_08657,1.0899511403030857,FUN_037867-T2,Peve_00024529,Pocillopora_meandrina_HIv1___RNAseq.g1412.t1,three_way,72.27066666666667,FUN_037867-T2,Q9C0H5,,,,,68.3,82.0,2.2e-08,62.8,sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2,,,,,,
OG_08658,1.7405011638606946,FUN_037870-T1,Peve_00024531,Pocillopora_meandrina_HIv1___RNAseq.g1409.t1,three_way,93.36216666666668,FUN_037870-T1,P08642,,,,,80.5,174.0,5.3e-75,282.0,sp|P08642|RASH_CHICK GTPase HRas OS=Gallus gallus OX=9031 GN=HRAS PE=1 SV=1,,,,,,
OG_08660,1.4364965995162464,FUN_037875-T1,Peve_00005853,Pocillopora_meandrina_HIv1___RNAseq.g10665.t1,three_way,84.873,FUN_037875-T1,O86938,,,,,32.4,376.0,3.4e-48,194.1,sp|O86938|PPD_STRVT Phosphonopyruvate decarboxylase OS=Streptomyces viridochromogenes (strain DSM 40736 / JCM 4977 / BCRC 1201 / Tue 494) OX=591159 GN=ppd PE=1 SV=1,,,,,,
OG_08663,2.351517513145133,FUN_037896-T1,Peve_00028733,Pocillopora_meandrina_HIv1___TS.g8473.t1,three_way,53.025666666666666,FUN_037896-T1,Q7TN88,,,,,25.8,1720.0,6.2e-137,491.9,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08664,1.105218901321674,FUN_037898-T1,Peve_00028732,Pocillopora_meandrina_HIv1___RNAseq.g28683.t1,three_way,62.17966666666667,FUN_037898-T1,Q8CBH5,,,,,22.7,569.0,1.1e-22,109.8,sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1,,,,,,
OG_08667,1.6201290862626152,FUN_037903-T1,Peve_00028717,Pocillopora_meandrina_HIv1___RNAseq.g28653.t1,three_way,61.3495,FUN_037903-T1,Q5XK85,,,,,25.0,1134.0,1.4e-34,150.2,sp|Q5XK85|KATIP_XENLA Protein KATNIP homolog OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_08671,1.5879148687734268,FUN_037907-T1,Peve_00004641,Pocillopora_meandrina_HIv1___RNAseq.g17360.t1,three_way,85.071,FUN_037907-T1,Q0VFT9,,,,,56.3,423.0,5.6e-120,432.6,sp|Q0VFT9|TPC13_XENTR Trafficking protein particle complex subunit 13 OS=Xenopus tropicalis OX=8364 GN=trappc13 PE=2 SV=1,,,,,,
OG_08674,2.307981088449211,FUN_037910-T1,Peve_00004651,Pocillopora_meandrina_HIv1___TS.g5680.t1,three_way,79.7845,FUN_037910-T1,Q8IV35,,,,,30.2,865.0,1.6e-100,369.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_08680,1.4345124123942234,FUN_037920-T1,Peve_00010402,Pocillopora_meandrina_HIv1___RNAseq.g26500.t1,three_way,76.47983333333333,FUN_037920-T1,Q8BIF2,RFOX3_MOUSE,,RNA binding protein fox-1 homolog 3 (Fox-1 homolog C) (Hexaribonucleotide-binding protein 3) (Fox-3) (Neuronal nuclei antigen) (NeuN antigen),Mus musculus (Mouse),58.4,149.0,1.5e-33,144.8,sp|Q8BIF2|RFOX3_MOUSE RNA binding protein fox-1 homolog 3 OS=Mus musculus OX=10090 GN=Rbfox3 PE=1 SV=2,GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0007399; GO:0008380; GO:0043025; GO:0043204,"mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0048856,DNA binding; RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; anatomical structure development
OG_08685,1.2035087529364026,FUN_037926-T1,Peve_00005837,Pocillopora_meandrina_HIv1___RNAseq.g26224.t1,three_way,74.24433333333334,FUN_037926-T1,A0A0G2K1Q8,ABCA3_RAT,,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],Rattus norvegicus (Rat),46.9,1760.0,0.0,1404.0,sp|A0A0G2K1Q8|ABCA3_RAT Phospholipid-transporting ATPase ABCA3 OS=Rattus norvegicus OX=10116 GN=Abca3 PE=1 SV=1,GO:0005319; GO:0005524; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032368; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140,lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid transport [GO:0032368]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019],GO:0003824; GO:0005215; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_08687,1.9154390099964127,FUN_037929-T1,Peve_00005835,Pocillopora_meandrina_HIv1___RNAseq.g26222.t1,three_way,56.6,,,,,,,,,,,,,,,,,
OG_08688,2.332668283214638,FUN_037931-T1,Peve_00015637,Pocillopora_meandrina_HIv1___RNAseq.g26217.t1,three_way,82.56883333333333,FUN_037931-T1,A7M7B9,NTH_CHICK,,Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase),Gallus gallus (Chicken),64.4,225.0,3.1999999999999997e-85,316.6,sp|A7M7B9|NTH_CHICK Endonuclease III-like protein 1 OS=Gallus gallus OX=9031 GN=NTHL1 PE=2 SV=1,GO:0000703; GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006289; GO:0046872; GO:0051539; GO:0140078,"base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair [GO:0006289]",mitochondrion [GO:0005739]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]",GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_08689,1.3425329521592675,FUN_037932-T1,Peve_00015636,Pocillopora_meandrina_HIv1___RNAseq.g26216.t1,three_way,64.56266666666667,FUN_037932-T1,F4KFT7,TENAC_ARATH,,"Bifunctional TH2 protein, mitochondrial (THIAMINE REQUIRING 2) [Includes: Thiamine phosphate phosphatase (EC 3.1.3.100); Aminopyrimidine aminohydrolase (EC 3.5.99.2)]",Arabidopsis thaliana (Mouse-ear cress),27.5,298.0,3.8999999999999995e-28,127.1,"sp|F4KFT7|TENAC_ARATH Bifunctional TH2 protein, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=TH2 PE=1 SV=1",GO:0005739; GO:0005829; GO:0009228; GO:0042131; GO:0050334,thiamine biosynthetic process [GO:0009228],cytosol [GO:0005829]; mitochondrion [GO:0005739],thiaminase activity [GO:0050334]; thiamine phosphate phosphatase activity [GO:0042131],GO:0003824; GO:0005739; GO:0005829; GO:0006766; GO:0006790; GO:0016787; GO:0043226,catalytic activity; mitochondrion; cytosol; vitamin metabolic process; sulfur compound metabolic process; hydrolase activity; organelle
OG_08691,1.5494211881897046,FUN_037935-T1,Peve_00015640,Pocillopora_meandrina_HIv1___RNAseq.g26204.t1,three_way,78.68583333333333,,,,,,,,,,,,,,,,,
OG_08694,1.4369448944502192,FUN_037938-T1,Peve_00027269,Pocillopora_meandrina_HIv1___RNAseq.g26201.t1,three_way,89.87166666666667,FUN_037938-T1,Q76MZ1,,,,,68.1,282.0,7.8e-115,414.8,sp|Q76MZ1|CYH1_CHLAE Cytohesin-1 OS=Chlorocebus aethiops OX=9534 GN=CYTH1 PE=2 SV=1,,,,,,
OG_08703,1.2644389644106615,FUN_037952-T1,Peve_00040734,Pocillopora_meandrina_HIv1___RNAseq.g26514.t2,three_way,73.35300000000001,FUN_037952-T1,Q6PIF6,MYO7B_HUMAN,,Unconventional myosin-VIIb,Homo sapiens (Human),26.7,797.0,3.1000000000000003e-66,255.4,sp|Q6PIF6|MYO7B_HUMAN Unconventional myosin-VIIb OS=Homo sapiens OX=9606 GN=MYO7B PE=1 SV=2,GO:0000146; GO:0005524; GO:0005737; GO:0005902; GO:0005903; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016459; GO:0030048; GO:0030154; GO:0051015; GO:0090651; GO:1904970,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory perception of sound [GO:0007605],actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146],GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0016853; GO:0030154; GO:0043226; GO:0050877; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; isomerase activity; cell differentiation; organelle; nervous system process; ATP-dependent activity
OG_08704,2.1567435611282915,FUN_037953-T1,Peve_00040733,Pocillopora_meandrina_HIv1___RNAseq.g26512.t1,three_way,50.168,FUN_037953-T1,Q91905,,,,,68.3,60.0,4.7e-18,92.8,sp|Q91905|FXI1B_XENLA Forkhead box protein I1-B OS=Xenopus laevis OX=8355 GN=foxi1-b PE=2 SV=1,,,,,,
OG_08705,2.202367697594083,FUN_037955-T1,Peve_00040732,Pocillopora_meandrina_HIv1___TS.g19261.t1,three_way,55.23566666666667,FUN_037955-T1,Q9PVY9,,,,,40.6,217.0,5.7000000000000006e-36,153.3,sp|Q9PVY9|FXC2A_XENLA Forkhead box protein C2-A OS=Xenopus laevis OX=8355 GN=foxc2-a PE=2 SV=1,,,,,,
OG_08713,1.2700256540926231,FUN_037965-T1,Peve_00009707,Pocillopora_meandrina_HIv1___RNAseq.g26234.t1,three_way,48.86333333333334,,,,,,,,,,,,,,,,,
OG_08715,2.285760980773785,FUN_037967-T1,Peve_00012656,Pocillopora_meandrina_HIv1___RNAseq.g26236.t1,three_way,59.54,FUN_037967-T1,Q09630,,,,,24.1,906.0,2.2e-38,162.5,sp|Q09630|GRM1_CAEEL Probable metabotropic glutamate receptor mgl-1 OS=Caenorhabditis elegans OX=6239 GN=mgl-1 PE=3 SV=1,,,,,,
OG_08718,1.2748491821891186,FUN_037970-T1,Peve_00032390,Pocillopora_meandrina_HIv1___RNAseq.g9858.t1a,three_way,78.12766666666666,FUN_037970-T1,D4D448,,,,,26.9,458.0,2.1999999999999996e-24,115.2,sp|D4D448|EASE_TRIVH FAD-linked oxidoreductase easE OS=Trichophyton verrucosum (strain HKI 0517) OX=663202 GN=easE PE=3 SV=1,,,,,,
OG_08722,2.477381407272852,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),36.1,280.0,6.1e-42,174.9,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08722,2.477381407272852,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),43.2,148.0,5.4e-22,108.6,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08725,1.3484972249745706,FUN_037978-T1,Peve_00019558,Pocillopora_meandrina_HIv1___RNAseq.g26187.t1,three_way,70.464,FUN_037978-T1,Q9UTA8,,,,,32.4,262.0,8.2e-29,129.0,sp|Q9UTA8|YL8A_SCHPO Uncharacterized methyltransferase-like C25B8.10 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC25B8.10 PE=3 SV=1,,,,,,
OG_08728,1.6030375772552672,FUN_037983-T1,Peve_00026785,Pocillopora_meandrina_HIv1___RNAseq.g26190.t1,three_way,60.70233333333333,FUN_037983-T1,Q8BTK5,SMYD4_MOUSE,,Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4),Mus musculus (Mouse),28.3,600.0,9.799999999999999e-55,216.5,sp|Q8BTK5|SMYD4_MOUSE Protein-lysine N-methyltransferase SMYD4 OS=Mus musculus OX=10090 GN=Smyd4 PE=2 SV=2,GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0008270; GO:0032259,heart development [GO:0007507]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; transferase activity; organelle; anatomical structure development
OG_08731,2.578310132131674,FUN_037988-T1,Peve_00025059,Pocillopora_meandrina_HIv1___RNAseq.g26272.t1,three_way,38.300666666666665,,,,,,,,,,,,,,,,,
OG_08733,1.2678593719656293,FUN_037990-T1,Peve_00023488,Pocillopora_meandrina_HIv1___RNAseq.g26269.t1,three_way,90.14733333333334,FUN_037990-T1,A5PKG7,,,,,68.2,198.0,5.2e-73,275.4,sp|A5PKG7|KCTD5_BOVIN BTB/POZ domain-containing protein KCTD5 OS=Bos taurus OX=9913 GN=KCTD5 PE=2 SV=1,,,,,,
OG_08735,2.239715622055678,FUN_037992-T1,Peve_00023490,Pocillopora_meandrina_HIv1___RNAseq.g26267.t1,three_way,59.86366666666667,,,,,,,,,,,,,,,,,
OG_08737,1.120153928569809,FUN_037996-T1,Peve_00021252,Pocillopora_meandrina_HIv1___RNAseq.g26261.t1,three_way,74.359,FUN_037996-T1,B4F7A1,,,,,45.2,84.0,7.5e-15,81.3,sp|B4F7A1|LYRM7_RAT Complex III assembly factor LYRM7 OS=Rattus norvegicus OX=10116 GN=Lyrm7 PE=3 SV=1,,,,,,
OG_08741,1.4019377051937725,FUN_038000-T1,Peve_00021256,Pocillopora_meandrina_HIv1___RNAseq.g26257.t1,three_way,91.26966666666668,FUN_038000-T1,Q6GR34,,,,,50.0,164.0,1.5e-41,170.6,sp|Q6GR34|CP52A_XENLA Uncharacterized protein C16orf52 homolog A OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_08750,1.2489664656749024,FUN_038017-T1,Peve_00009818,Pocillopora_meandrina_HIv1___RNAseq.g26530.t2,three_way,84.67783333333334,FUN_038017-T1,A6NCI4,VWA3A_HUMAN,,von Willebrand factor A domain-containing protein 3A,Homo sapiens (Human),37.6,1172.0,1.8000000000000002e-227,791.2,sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3,GO:0005576,,extracellular region [GO:0005576],,GO:0005576,extracellular region
OG_08751,2.499308175447835,FUN_038018-T1,Peve_00022791,Pocillopora_meandrina_HIv1___RNAseq.g26531.t1,three_way,70.62033333333333,FUN_038018-T1,A7UA95,RADIL_DANRE,,Ras-associating and dilute domain-containing protein,Danio rerio (Zebrafish) (Brachydanio rerio),28.0,1225.0,3e-109,398.7,sp|A7UA95|RADIL_DANRE Ras-associating and dilute domain-containing protein OS=Danio rerio OX=7955 GN=radil PE=2 SV=1,GO:0001755; GO:0005874; GO:0007165; GO:0034446; GO:0051020,neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],microtubule [GO:0005874],GTPase binding [GO:0051020],GO:0007155; GO:0048870,cell adhesion; cell motility
OG_08754,1.5351230014796364,FUN_038023-T1,Peve_00018114,Pocillopora_meandrina_HIv1___RNAseq.g26535.t1,three_way,57.67633333333333,FUN_038023-T1,Q8BKN6,,,,,55.4,260.0,1.5e-77,291.6,sp|Q8BKN6|HS3SA_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 OS=Mus musculus OX=10090 GN=Hs3st3a1 PE=2 SV=1,,,,,,
OG_08757,1.2785554617879744,FUN_038028-T1,Peve_00002131,Pocillopora_meandrina_HIv1___TS.g19287.t1a,three_way,79.5965,FUN_038028-T1,Q80U30,CL16A_MOUSE,,Protein CLEC16A,Mus musculus (Mouse),42.5,1092.0,9.9e-206,718.8,sp|Q80U30|CL16A_MOUSE Protein CLEC16A OS=Mus musculus OX=10090 GN=Clec16a PE=1 SV=2,GO:0006914; GO:0031648; GO:0032434; GO:0032435; GO:0036020; GO:0043161; GO:1901098; GO:1901525,autophagy [GO:0006914]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],endolysosome membrane [GO:0036020],,GO:0006914; GO:0030163,autophagy; protein catabolic process
OG_08765,1.5258983613617911,FUN_038040-T1,Peve_00024877,Pocillopora_meandrina_HIv1___RNAseq.g26549.t1,three_way,88.22833333333332,FUN_038040-T1,Q5DU02,UBP22_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22),Mus musculus (Mouse),61.3,530.0,6.3e-179,628.6,sp|Q5DU02|UBP22_MOUSE Ubiquitin carboxyl-terminal hydrolase 22 OS=Mus musculus OX=10090 GN=Usp22 PE=1 SV=2,GO:0000086; GO:0000124; GO:0003713; GO:0004843; GO:0005737; GO:0006282; GO:0006357; GO:0006511; GO:0008270; GO:0010485; GO:0016579; GO:0019899; GO:0032481; GO:0033276; GO:0043484; GO:0045893; GO:0045931; GO:0140936; GO:0140950,G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of type I interferon production [GO:0032481]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],cysteine-type deubiquitinase activity [GO:0004843]; enzyme binding [GO:0019899]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; histone H4 acetyltransferase activity [GO:0010485]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0006355; GO:0016740; GO:0016787; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; regulation of DNA-templated transcription; transferase activity; hydrolase activity; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_08766,1.954819658173892,FUN_038041-T1,Peve_00024876,Pocillopora_meandrina_HIv1___RNAseq.g26550.t1,three_way,79.8755,FUN_038041-T1,Q0VA03,,,,,44.2,674.0,1.0999999999999999e-148,528.5,sp|Q0VA03|SUZ12_XENTR Polycomb protein suz12 OS=Xenopus tropicalis OX=8364 GN=suz12 PE=2 SV=1,,,,,,
OG_08770,1.1657183804030449,FUN_038053-T1,Peve_00018147,Pocillopora_meandrina_HIv1___TS.g5311.t1,three_way,63.9905,,,,,,,,,,,,,,,,,
OG_08771,1.339840494074118,FUN_038055-T1,Peve_00018151,Pocillopora_meandrina_HIv1___TS.g5314.t1,three_way,87.48233333333333,FUN_038055-T1,Q3UJZ3,,,,,44.1,170.0,8.999999999999999e-32,138.3,sp|Q3UJZ3|ARMC7_MOUSE Armadillo repeat-containing protein 7 OS=Mus musculus OX=10090 GN=Armc7 PE=1 SV=2,,,,,,
OG_08774,2.407815669827615,FUN_038058-T1,Peve_00000945,Pocillopora_meandrina_HIv1___RNAseq.g798.t1,three_way,76.90766666666667,,,,,,,,,,,,,,,,,
OG_08775,1.328966885022096,FUN_038060-T1,Peve_00000948,Pocillopora_meandrina_HIv1___RNAseq.g795.t1,three_way,78.47183333333334,FUN_038060-T1,Q70CQ4,UBP31_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31),Homo sapiens (Human),42.1,537.0,7.000000000000003e-110,399.4,sp|Q70CQ4|UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens OX=9606 GN=USP31 PE=1 SV=2,GO:0004843; GO:0005634; GO:0006508; GO:0016579,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08779,1.5162639545530932,FUN_038065-T1,Peve_00010941,Pocillopora_meandrina_HIv1___RNAseq.g789.t1,three_way,67.371,FUN_038065-T1,O66515,,,,,27.3,388.0,2.3e-27,125.9,sp|O66515|AMT_AQUAE Ammonium transporter OS=Aquifex aeolicus (strain VF5) OX=224324 GN=amt PE=1 SV=1,,,,,,
OG_08782,1.29233305636066,FUN_038068-T1,Peve_00030105,Pocillopora_meandrina_HIv1___RNAseq.g786.t1,three_way,71.34216666666667,FUN_038068-T1,Q5HZH2,TSR3_MOUSE,,18S rRNA aminocarboxypropyltransferase (EC 2.5.1.157) (20S S rRNA accumulation protein 3 homolog),Mus musculus (Mouse),58.3,175.0,4.9e-51,202.2,sp|Q5HZH2|TSR3_MOUSE 18S rRNA aminocarboxypropyltransferase OS=Mus musculus OX=10090 GN=Tsr3 PE=1 SV=1,GO:0000455; GO:0005737; GO:0106388; GO:1904047,enzyme-directed rRNA pseudouridine synthesis [GO:0000455],cytoplasm [GO:0005737],18S rRNA aminocarboxypropyltransferase activity [GO:0106388]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0016740; GO:0140098,"catalytic activity; transferase activity; catalytic activity, acting on RNA"
OG_08783,1.0407225018404542,FUN_038072-T1,Peve_00000952,Pocillopora_meandrina_HIv1___TS.g5330.t1,three_way,63.88366666666666,FUN_038072-T1,A2A870,,,,,41.9,74.0,6.3e-06,55.5,sp|A2A870|FBF1_MOUSE Fas-binding factor 1 OS=Mus musculus OX=10090 GN=Fbf1 PE=1 SV=1,,,,,,
OG_08785,1.2644053602455034,FUN_038074-T1,Peve_00000950,Pocillopora_meandrina_HIv1___RNAseq.g801.t1,three_way,77.11666666666666,FUN_038074-T1,A7MBC2,,,,,36.1,660.0,2.4e-110,401.4,sp|A7MBC2|PDXD1_BOVIN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PDXDC1 PE=2 SV=1,,,,,,
OG_08791,1.4005160576395348,FUN_038087-T1,Peve_00036442,Pocillopora_meandrina_HIv1___TS.g5341.t2,three_way,72.54633333333332,,,,,,,,,,,,,,,,,
OG_08792,1.050230669301763,FUN_038088-T1,Peve_00007106,Pocillopora_meandrina_HIv1___RNAseq.g815.t1,three_way,76.33416666666666,FUN_038088-T1,P54922,ADPRH_HUMAN,,ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase) (hARH1),Homo sapiens (Human),57.1,350.0,2.3e-116,420.2,sp|P54922|ADPRH_HUMAN ADP-ribosylhydrolase ARH1 OS=Homo sapiens OX=9606 GN=ADPRH PE=1 SV=1,GO:0000287; GO:0003875; GO:0005615; GO:0030955; GO:0036211; GO:0051725,protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211],extracellular space [GO:0005615],ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_08799,1.1642071789045771,FUN_038101-T2,Peve_00009167,Pocillopora_meandrina_HIv1___RNAseq.g25708.t1,three_way,60.379666666666665,,,,,,,,,,,,,,,,,
OG_08800,2.154559354893676,FUN_038103-T1,Peve_00025353,Pocillopora_meandrina_HIv1___RNAseq.g837.t1,three_way,71.89616666666667,FUN_038103-T1,Q4R7U0,,,,,32.1,701.0,1.2e-85,319.3,sp|Q4R7U0|TMC7_MACFA Transmembrane channel-like protein 7 OS=Macaca fascicularis OX=9541 GN=TMC7 PE=2 SV=1,,,,,,
OG_08802,1.3982375880075342,FUN_038118-T1,Peve_00025357,Pocillopora_meandrina_HIv1___RNAseq.g836.t1,three_way,55.861,,,,,,,,,,,,,,,,,
OG_08806,1.891840966321521,FUN_038127-T1,Peve_00003031,Pocillopora_meandrina_HIv1___RNAseq.g770.t1,three_way,67.37616666666666,FUN_038127-T1,Q9FKY3,,,,,25.2,373.0,1.3999999999999999e-24,115.9,sp|Q9FKY3|AVT3A_ARATH Amino acid transporter AVT3A OS=Arabidopsis thaliana OX=3702 GN=AVT3A PE=1 SV=1,,,,,,
OG_08813,1.318531984153459,FUN_038139-T1,Peve_00043370,Pocillopora_meandrina_HIv1___RNAseq.g761.t1,three_way,73.74383333333333,FUN_038139-T1,Q12767,,,,,33.1,1424.0,3.2e-177,624.4,sp|Q12767|TMM94_HUMAN Transmembrane protein 94 OS=Homo sapiens OX=9606 GN=TMEM94 PE=1 SV=1,,,,,,
OG_08816,1.8158598618456867,FUN_038143-T1,Peve_00026425,Pocillopora_meandrina_HIv1___RNAseq.g754.t1,three_way,89.606,FUN_038143-T1,Q96AX2,RAB37_HUMAN,,Ras-related protein Rab-37 (EC 3.6.5.2),Homo sapiens (Human),68.2,201.0,5.6e-78,292.0,sp|Q96AX2|RAB37_HUMAN Ras-related protein Rab-37 OS=Homo sapiens OX=9606 GN=RAB37 PE=1 SV=3,GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005793; GO:0005794; GO:0005886; GO:0010508; GO:0015031; GO:0017157; GO:0032391; GO:0035577; GO:0035579; GO:0042478,positive regulation of autophagy [GO:0010508]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of eye photoreceptor cell development [GO:0042478],azurophil granule membrane [GO:0035577]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098772,catalytic activity; GTPase activity; endosome; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08817,1.0122943053076303,FUN_038145-T1,Peve_00026423,Pocillopora_meandrina_HIv1___RNAseq.g753.t1,three_way,57.66566666666667,FUN_038145-T1,Q4V9P9,,,,,22.8,762.0,2.6999999999999997e-31,138.7,sp|Q4V9P9|NOL11_DANRE Nucleolar protein 11-like OS=Danio rerio OX=7955 GN=nol11 PE=2 SV=1,,,,,,
OG_08824,1.199935381187469,FUN_038161-T1,Peve_00033052,Pocillopora_meandrina_HIv1___RNAseq.g1154.t1,three_way,72.33833333333334,FUN_038161-T1,Q8BHY8,SNX14_MOUSE,,Sorting nexin-14,Mus musculus (Mouse),35.9,892.0,3e-144,514.2,sp|Q8BHY8|SNX14_MOUSE Sorting nexin-14 OS=Mus musculus OX=10090 GN=Snx14 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0030425; GO:0031902; GO:0045202; GO:0080025; GO:0097352; GO:0098794; GO:0099170,autophagosome maturation [GO:0097352]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein transport [GO:0015031],cytosol [GO:0005829]; dendrite [GO:0030425]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; postsynapse [GO:0098794]; synapse [GO:0045202],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]",GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0008289; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; lipid binding; cytoplasmic vesicle; organelle
OG_08825,1.047351862433737,FUN_038162-T1,Peve_00038319,Pocillopora_meandrina_HIv1___RNAseq.g1076.t1,three_way,58.09933333333333,,,,,,,,,,,,,,,,,
OG_08828,1.644121061923544,FUN_038165-T1,Peve_00025795,Pocillopora_meandrina_HIv1___RNAseq.g1068.t1,three_way,82.789,FUN_038165-T1,P04047,,,,,61.3,173.0,8.000000000000002e-57,221.5,"sp|P04047|KITH_CHICK Thymidine kinase, cytosolic OS=Gallus gallus OX=9031 GN=TK1 PE=1 SV=1",,,,,,
OG_08829,1.0012214130713106,FUN_038166-T1,Peve_00025794,Pocillopora_meandrina_HIv1___RNAseq.g1069.t1,three_way,75.97183333333332,FUN_038166-T1,P85037,FOXK1_HUMAN,,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),Homo sapiens (Human),48.9,499.0,9.7e-110,399.1,sp|P85037|FOXK1_HUMAN Forkhead box protein K1 OS=Homo sapiens OX=9606 GN=FOXK1 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007517; GO:0010507; GO:0010906; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837,canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; intracellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005975; GO:0006091; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140110; GO:1901135,DNA binding; nucleus; nucleoplasm; carbohydrate metabolic process; generation of precursor metabolites and energy; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; transcription regulator activity; carbohydrate derivative metabolic process
OG_08830,1.7305530755153984,FUN_038167-T1,Peve_00025790,Pocillopora_meandrina_HIv1___RNAseq.g1070.t1,three_way,91.073,FUN_038167-T1,P23098,,,,,73.8,4465.0,0.0,6623.9,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_08831,1.4766809398165444,FUN_038168-T1,Peve_00025789,Pocillopora_meandrina_HIv1___RNAseq.g1071.t1,three_way,77.63566666666667,,,,,,,,,,,,,,,,,
OG_08832,1.1213229967221308,FUN_038170-T1,Peve_00025787,Pocillopora_meandrina_HIv1___RNAseq.g1073.t1,three_way,75.25566666666666,FUN_038170-T1,Q71RS6,NCKX5_HUMAN,,Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5),Homo sapiens (Human),38.0,440.0,2.3e-83,312.0,sp|Q71RS6|NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 OS=Homo sapiens OX=9606 GN=SLC24A5 PE=1 SV=1,GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0032588; GO:0034220; GO:0042438; GO:0042470; GO:0048022; GO:0070509; GO:0070588,calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; melanin biosynthetic process [GO:0042438]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of melanin biosynthetic process [GO:0048022],melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0031410; GO:0043226; GO:0055085,transporter activity; cytoplasmic vesicle; organelle; transmembrane transport
OG_08834,1.031596925865277,FUN_038174-T1,Peve_00010077,Pocillopora_meandrina_HIv1___RNAseq.g1157.t1,three_way,76.404,FUN_038174-T1,C3YWU0,FUCO_BRAFL,,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),Branchiostoma floridae (Florida lancelet) (Amphioxus),67.4,448.0,4.8e-191,668.7,sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2,GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139,fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],extracellular region [GO:0005576]; lysosome [GO:0005764],alpha-L-fucosidase activity [GO:0004560],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005975; GO:0016787; GO:0043226; GO:1901135,catalytic activity; extracellular region; lysosome; vacuole; carbohydrate metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_08835,2.433884966941733,FUN_038179-T1,Peve_00009439,Pocillopora_meandrina_HIv1___RNAseq.g965.t1,three_way,67.80166666666668,FUN_038179-T1,Q9Y4F3,,,,,28.7,1454.0,1.1e-132,476.9,sp|Q9Y4F3|MARF1_HUMAN Meiosis regulator and mRNA stability factor 1 OS=Homo sapiens OX=9606 GN=MARF1 PE=1 SV=6,,,,,,
OG_08842,3.614813639516881,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_08849,1.3484566479430584,FUN_038210-T1,Peve_00038842,Pocillopora_meandrina_HIv1___TS.g5429.t1,three_way,51.66433333333333,FUN_038210-T1,Q7TN88,,,,,27.8,967.0,4.1e-93,344.7,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08850,1.9983861087132209,FUN_038213-T1,Peve_00038850,Pocillopora_meandrina_HIv1___RNAseq.g897.t1,three_way,68.68866666666666,FUN_038213-T1,Q7Z402,,,,,32.1,639.0,1e-79,299.7,sp|Q7Z402|TMC7_HUMAN Transmembrane channel-like protein 7 OS=Homo sapiens OX=9606 GN=TMC7 PE=1 SV=1,,,,,,
OG_08851,1.0702874117073642,FUN_038214-T1,Peve_00038839,Pocillopora_meandrina_HIv1___RNAseq.g898.t1,three_way,50.641666666666666,,,,,,,,,,,,,,,,,
OG_08852,3.0595874859471683,FUN_038217-T1,Peve_00038841,Pocillopora_meandrina_HIv1___RNAseq.g901.t2,three_way,66.15016666666666,FUN_038217-T1,Q9UKN7,,,,,32.5,2688.0,0.0,1096.6,sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2,,,,,,
OG_08853,1.5448035967770826,FUN_038218-T1,Peve_00038844,Pocillopora_meandrina_HIv1___RNAseq.g902.t1,three_way,77.83533333333334,FUN_038218-T1,Q08BA6,ALKB5_DANRE,,RNA demethylase ALKBH5 (EC 1.14.11.53) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5),Danio rerio (Zebrafish) (Brachydanio rerio),59.5,222.0,1.7999999999999994e-68,260.8,sp|Q08BA6|ALKB5_DANRE RNA demethylase ALKBH5 OS=Danio rerio OX=7955 GN=alkbh5 PE=1 SV=1,GO:0001666; GO:0005634; GO:0006397; GO:0006417; GO:0007283; GO:0010793; GO:0016607; GO:0016706; GO:0035515; GO:0042382; GO:0046872; GO:0050684; GO:0061157; GO:0140693; GO:0140694; GO:1990931,membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283],nuclear speck [GO:0016607]; nucleus [GO:0005634]; paraspeckles [GO:0042382],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515],GO:0003824; GO:0005634; GO:0016071; GO:0016491; GO:0022414; GO:0043226; GO:0060090; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; oxidoreductase activity; reproductive process; organelle; molecular adaptor activity; catalytic activity, acting on RNA"
OG_08856,2.44262417145594,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_08857,1.2268602101293864,FUN_038243-T1,Peve_00029667,Pocillopora_meandrina_HIv1___TS.g5440.t1,three_way,80.75166666666667,FUN_038243-T1,P12389,ACHA2_RAT,,Neuronal acetylcholine receptor subunit alpha-2,Rattus norvegicus (Rat),36.7,436.0,2.8999999999999996e-68,260.8,sp|P12389|ACHA2_RAT Neuronal acetylcholine receptor subunit alpha-2 OS=Rattus norvegicus OX=10116 GN=Chrna2 PE=1 SV=2,GO:0005654; GO:0005886; GO:0005892; GO:0007165; GO:0007271; GO:0007274; GO:0015464; GO:0022848; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0043005; GO:0045171; GO:0045202; GO:0045211; GO:0050997; GO:0051899; GO:0071316; GO:0071944; GO:0095500; GO:0098828; GO:0098878; GO:0120111; GO:1901363; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; cellular response to nicotine [GO:0071316]; membrane depolarization [GO:0051899]; modulation of inhibitory postsynaptic potential [GO:0098828]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cell periphery [GO:0071944]; intercellular bridge [GO:0045171]; neuron projection [GO:0043005]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synapse [GO:0045202],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; nucleoplasm; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_08859,3.45216379577666,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_08860,1.2646936194544185,FUN_038246-T1,Peve_00007987,Pocillopora_meandrina_HIv1___RNAseq.g924.t1,three_way,77.44533333333334,FUN_038246-T1,Q9UBH6,S53A1_HUMAN,,Solute carrier family 53 member 1 (Phosphate exporter SLC53A1) (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor) (Xenotropic and polytropic retrovirus receptor 1),Homo sapiens (Human),44.3,395.0,5.400000000000001e-89,329.7,sp|Q9UBH6|S53A1_HUMAN Solute carrier family 53 member 1 OS=Homo sapiens OX=9606 GN=XPR1 PE=1 SV=1,GO:0000822; GO:0001618; GO:0005315; GO:0005886; GO:0006817; GO:0009615; GO:0015562; GO:0016036; GO:0030643; GO:0035435,cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615],plasma membrane [GO:0005886],efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate transmembrane transporter activity [GO:0005315]; virus receptor activity [GO:0001618],GO:0001618; GO:0005215; GO:0005886; GO:0055085,virus receptor activity; transporter activity; plasma membrane; transmembrane transport
OG_08863,1.1714715198702088,FUN_038255-T1,Peve_00007991,Pocillopora_meandrina_HIv1___RNAseq.g920.t1,three_way,62.71116666666666,FUN_038255-T1,Q91ZW6,TMLH_RAT,,"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)",Rattus norvegicus (Rat),39.7,358.0,4.9e-73,276.6,"sp|Q91ZW6|TMLH_RAT Trimethyllysine dioxygenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Tmlhe PE=1 SV=2",GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353,carnitine biosynthetic process [GO:0045329],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]",GO:0003824; GO:0005739; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_08865,1.1431306929825944,FUN_038257-T1,Peve_00007993,Pocillopora_meandrina_HIv1___RNAseq.g918.t1,three_way,71.358,FUN_038257-T1,Q7YR75,,,,,46.6,161.0,9.300000000000001e-27,121.7,sp|Q7YR75|RM12_BOVIN Large ribosomal subunit protein bL12m OS=Bos taurus OX=9913 GN=MRPL12 PE=1 SV=1,,,,,,
OG_08866,1.2814411560307537,FUN_038258-T1,Peve_00007994,Pocillopora_meandrina_HIv1___RNAseq.g917.t1,three_way,77.65366666666667,FUN_038258-T1,P51798,CLCN7_HUMAN,,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),Homo sapiens (Human),54.4,803.0,4.5999999999999997e-237,822.4,sp|P51798|CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens OX=9606 GN=CLCN7 PE=1 SV=2,GO:0005254; GO:0005524; GO:0005765; GO:0009268; GO:0015108; GO:0016020; GO:0030321; GO:0034707; GO:0043231; GO:0062158,response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321],chloride channel complex [GO:0034707]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; chloride:proton antiporter activity [GO:0062158],GO:0005215; GO:0043226,transporter activity; organelle
OG_08871,1.929630980664146,FUN_038268-T1,Peve_00008000,Pocillopora_meandrina_HIv1___TS.g5412.t1,three_way,67.79916666666666,FUN_038268-T1,Q8N5R6,,,,,28.3,782.0,1.1e-70,270.0,sp|Q8N5R6|CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens OX=9606 GN=CCDC33 PE=1 SV=3,,,,,,
OG_08873,1.847313149500024,FUN_038270-T1,Peve_00007980,Pocillopora_meandrina_HIv1___TS.g21499.t1,three_way,66.01583333333333,FUN_038270-T1,Q8NCG7,DGLB_HUMAN,,Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta),Homo sapiens (Human),36.5,698.0,2.7e-105,384.4,sp|Q8NCG7|DGLB_HUMAN Diacylglycerol lipase-beta OS=Homo sapiens OX=9606 GN=DAGLB PE=1 SV=2,GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0006640; GO:0007405; GO:0010898; GO:0016298; GO:0019369; GO:0022008; GO:0046340; GO:0046872; GO:0047372; GO:0050727; GO:1901696,arachidonate metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727],lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lipase activity [GO:0016298]; metal ion binding [GO:0046872]; monoacylglycerol lipase activity [GO:0047372]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005654; GO:0005886; GO:0006629; GO:0016787; GO:0030154,catalytic activity; nucleoplasm; plasma membrane; lipid metabolic process; hydrolase activity; cell differentiation
OG_08882,1.1438951366611907,FUN_038284-T1,Peve_00041720,Pocillopora_meandrina_HIv1___RNAseq.g28310.t1,three_way,75.99766666666667,FUN_038284-T1,Q60631,GRB2_MOUSE,,Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2),Mus musculus (Mouse),62.0,213.0,1.7000000000000002e-74,280.4,sp|Q60631|GRB2_MOUSE Growth factor receptor-bound protein 2 OS=Mus musculus OX=10090 GN=Grb2 PE=1 SV=1,GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031623; GO:0035987; GO:0038133; GO:0042110; GO:0042267; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0045953; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:2000379,actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110],cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506],ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; molecular adaptor activity [GO:0060090]; neurotrophin TRKA receptor binding [GO:0005168]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0002376; GO:0005634; GO:0005768; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0007010; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0098772,immune system process; nucleus; endosome; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cytoskeleton organization; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_08883,1.126722787100032,FUN_038285-T1,Peve_00041722,Pocillopora_meandrina_HIv1___RNAseq.g28309.t1a,three_way,84.59233333333333,FUN_038285-T1,A7SE05,UBE2S_NEMVE,,Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (Ubiquitin carrier protein S) (Ubiquitin-protein ligase S),Nematostella vectensis (Starlet sea anemone),74.8,206.0,2.1e-82,306.6,sp|A7SE05|UBE2S_NEMVE Ubiquitin-conjugating enzyme E2 S OS=Nematostella vectensis OX=45351 GN=v1g237158 PE=3 SV=1,GO:0000209; GO:0005524; GO:0005634; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0031145; GO:0051301; GO:0061631; GO:0070979; GO:1904668,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08884,1.266432406693895,FUN_038286-T1,Peve_00041723,Pocillopora_meandrina_HIv1___RNAseq.g28308.t1,three_way,69.07466666666667,FUN_038286-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),52.2,69.0,7.9e-14,81.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_08888,1.1290619737642034,FUN_038294-T1,Peve_00041731,Pocillopora_meandrina_HIv1___RNAseq.g28300.t1,three_way,63.32116666666666,FUN_038294-T1,Q7YR76,,,,,24.8,440.0,1.6e-15,86.7,sp|Q7YR76|MYCD_PIG Myocardin OS=Sus scrofa OX=9823 GN=MYOCD PE=2 SV=1,,,,,,
OG_08895,1.8580807123095435,FUN_038302-T1,Peve_00000035,Pocillopora_meandrina_HIv1___RNAseq.g28304.t1,three_way,90.22033333333331,FUN_038302-T1,F8WK50,,,,,59.3,1273.0,2.6e-295,1016.5,sp|F8WK50|FLII_DANRE Protein flightless-1 homolog OS=Danio rerio OX=7955 GN=flii PE=1 SV=1,,,,,,
OG_08896,1.579142980903713,FUN_038303-T1,Peve_00000042,Pocillopora_meandrina_HIv1___RNAseq.g28305.t1,three_way,74.95766666666667,FUN_038303-T1,Q60631,GRB2_MOUSE,,Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2),Mus musculus (Mouse),52.4,212.0,9e-63,241.5,sp|Q60631|GRB2_MOUSE Growth factor receptor-bound protein 2 OS=Mus musculus OX=10090 GN=Grb2 PE=1 SV=1,GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031623; GO:0035987; GO:0038133; GO:0042110; GO:0042267; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0045953; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:2000379,actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110],cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506],ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; molecular adaptor activity [GO:0060090]; neurotrophin TRKA receptor binding [GO:0005168]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0002376; GO:0005634; GO:0005768; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0007010; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0098772,immune system process; nucleus; endosome; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cytoskeleton organization; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_08898,1.1879746018742317,FUN_038311-T1,Peve_00020693,Pocillopora_meandrina_HIv1___RNAseq.g1142.t1,three_way,76.04366666666667,FUN_038311-T1,Q8R5K6,,,,,43.3,217.0,3.7999999999999996e-39,163.3,sp|Q8R5K6|TOB1_RAT Protein Tob1 OS=Rattus norvegicus OX=10116 GN=Tob1 PE=1 SV=1,,,,,,
OG_08901,1.1993093872891083,FUN_038315-T1,Peve_00035853,Pocillopora_meandrina_HIv1___RNAseq.g1120.t1,three_way,66.31266666666666,FUN_038315-T1,Q8NDV7,,,,,34.4,224.0,3.4e-17,93.2,sp|Q8NDV7|TNR6A_HUMAN Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens OX=9606 GN=TNRC6A PE=1 SV=2,,,,,,
OG_08903,3.010253111081743,FUN_038332-T1,Peve_00023107,Pocillopora_meandrina_HIv1___RNAseq.g1118.t1,three_way,64.6005,FUN_038332-T1,Q6ZPJ0,,,,,28.1,720.0,3.7e-42,175.3,sp|Q6ZPJ0|TEX2_MOUSE Testis-expressed protein 2 OS=Mus musculus OX=10090 GN=Tex2 PE=1 SV=2,,,,,,
OG_08906,1.0217958097578903,FUN_038337-T1,Peve_00000101,Pocillopora_meandrina_HIv1___RNAseq.g1113.t1,three_way,71.11383333333333,FUN_038337-T1,Q553D3,,,,,30.7,212.0,2.5e-20,102.4,sp|Q553D3|GXCJJ_DICDI Rac guanine nucleotide exchange factor JJ OS=Dictyostelium discoideum OX=44689 GN=gxcJJ PE=1 SV=1,,,,,,
OG_08907,2.3245016740724544,FUN_038338-T1,Peve_00000098,Pocillopora_meandrina_HIv1___RNAseq.g1110.t1,three_way,67.40100000000001,,,,,,,,,,,,,,,,,
OG_08910,1.3827541108988892,FUN_038344-T1,Peve_00030150,Pocillopora_meandrina_HIv1___TS.g5636.t1,three_way,69.94033333333333,,,,,,,,,,,,,,,,,
OG_08918,1.4568224114874144,FUN_038374-T1,Peve_00000080,Pocillopora_meandrina_HIv1___RNAseq.g1093.t1,three_way,64.227,FUN_038374-T1,Q9YHV3,,,,,38.1,176.0,5.8999999999999994e-31,136.0,sp|Q9YHV3|NOGG3_DANRE Noggin-3 OS=Danio rerio OX=7955 GN=nog3 PE=1 SV=1,,,,,,
OG_08919,1.866901193308545,FUN_038375-T2,Peve_00000078,Pocillopora_meandrina_HIv1___RNAseq.g1091.t1,three_way,51.34516666666666,,,,,,,,,,,,,,,,,
OG_08925,2.4181331477980623,FUN_038382-T1,Peve_00000067,Pocillopora_meandrina_HIv1___RNAseq.g28293.t1,three_way,74.66466666666666,FUN_038382-T1,O09118,NET1_MOUSE,,Netrin-1,Mus musculus (Mouse),49.0,571.0,1.2000000000000005e-167,591.3,sp|O09118|NET1_MOUSE Netrin-1 OS=Mus musculus OX=10090 GN=Ntn1 PE=1 SV=3,GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008283; GO:0014009; GO:0015629; GO:0030334; GO:0030517; GO:0030879; GO:0032488; GO:0033564; GO:0042472; GO:0045202; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147,"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]",actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; synapse [GO:0045202],,GO:0005576; GO:0005654; GO:0005829; GO:0005856; GO:0007155; GO:0012501; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870,extracellular region; nucleoplasm; cytosol; cytoskeleton; cell adhesion; programmed cell death; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility
OG_08927,1.1400093303711931,FUN_038385-T1,Peve_00000064,Pocillopora_meandrina_HIv1___RNAseq.g28289.t1,three_way,68.722,FUN_038385-T1,Q7JQ32,GC76C_DROME,,Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1),Drosophila melanogaster (Fruit fly),39.3,1091.0,6.199999999999997e-206,719.9,sp|Q7JQ32|GC76C_DROME Receptor-type guanylate cyclase Gyc76C OS=Drosophila melanogaster OX=7227 GN=Gyc76C PE=1 SV=1,GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872; GO:0050830,"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]",plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023],GO:0003824; GO:0005886; GO:0009975; GO:0016829; GO:0030198; GO:0048856; GO:0055086; GO:0060089; GO:1901135,catalytic activity; plasma membrane; cyclase activity; lyase activity; extracellular matrix organization; anatomical structure development; nucleobase-containing small molecule metabolic process; molecular transducer activity; carbohydrate derivative metabolic process
OG_08928,2.2860528313514306,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08930,3.063927215886661,FUN_038392-T1,Peve_00000048,Pocillopora_meandrina_HIv1___RNAseq.g28264.t1,three_way,76.04899999999999,FUN_038392-T1,P16065,,,,,36.6,998.0,4.3999999999999996e-160,567.0,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08931,1.0921489372476838,FUN_038393-T1,Peve_00000047,Pocillopora_meandrina_HIv1___RNAseq.g28265.t1,three_way,73.06066666666668,FUN_038393-T1,P22570,ADRO_HUMAN,,"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase) (EC 1.18.1.-)",Homo sapiens (Human),57.3,464.0,8.3e-144,511.9,"sp|P22570|ADRO_HUMAN NADPH:adrenodoxin oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=FDXR PE=1 SV=3",GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006744; GO:0008203,cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ferredoxin-NADP+ reductase activity [GO:0004324],GO:0003824; GO:0005739; GO:0006091; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; oxidoreductase activity; organelle
OG_08932,1.5119446021825969,FUN_038394-T1,Peve_00000046,Pocillopora_meandrina_HIv1___RNAseq.g28266.t1,three_way,82.16016666666667,FUN_038394-T1,Q9HCN4,,,,,64.7,317.0,5.600000000000002e-111,402.5,sp|Q9HCN4|GPN1_HUMAN GPN-loop GTPase 1 OS=Homo sapiens OX=9606 GN=GPN1 PE=1 SV=1,,,,,,
OG_08934,1.4151199451763357,FUN_038396-T1,Peve_00000044,Pocillopora_meandrina_HIv1___RNAseq.g28268.t1,three_way,67.62233333333333,FUN_038396-T1,P52189,KCNJ4_MOUSE,,"Inward rectifier potassium channel 4 (Inward rectifier K(+) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4)",Mus musculus (Mouse),44.0,357.0,2.8999999999999997e-75,283.9,sp|P52189|KCNJ4_MOUSE Inward rectifier potassium channel 4 OS=Mus musculus OX=10090 GN=Kcnj4 PE=1 SV=1,GO:0005242; GO:0030659; GO:0034702; GO:0045211; GO:0098978,,cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211],inward rectifier potassium channel activity [GO:0005242],GO:0005215,transporter activity
OG_08935,1.4209079345611315,FUN_038398-T1,Peve_00000041,Pocillopora_meandrina_HIv1___RNAseq.g28273.t1,three_way,71.20833333333333,FUN_038398-T1,Q4TZY1,KCJ12_BOVIN,,"ATP-sensitive inward rectifier potassium channel 12 (Potassium channel, inwardly rectifying subfamily J member 12)",Bos taurus (Bovine),44.9,381.0,2.6e-85,317.4,sp|Q4TZY1|KCJ12_BOVIN ATP-sensitive inward rectifier potassium channel 12 OS=Bos taurus OX=9913 GN=KCNJ12 PE=2 SV=1,GO:0005242; GO:0005886; GO:0006813; GO:0016020; GO:0034702; GO:0034765; GO:0046872; GO:0051289; GO:1990573,potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of monoatomic ion transmembrane transport [GO:0034765],membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],inward rectifier potassium channel activity [GO:0005242]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_08936,1.178663186624175,FUN_038400-T1,Peve_00000036,Pocillopora_meandrina_HIv1___RNAseq.g28274.t1,three_way,75.47866666666667,FUN_038400-T1,Q6P5D8,SMHD1_MOUSE,,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-),Mus musculus (Mouse),23.5,2075.0,6.200000000000001e-86,321.6,sp|Q6P5D8|SMHD1_MOUSE Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Mus musculus OX=10090 GN=Smchd1 PE=1 SV=2,GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034,chromosome organization [GO:0051276]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],"Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006325; GO:0016787; GO:0043226; GO:0048856,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; chromatin organization; hydrolase activity; organelle; anatomical structure development
OG_08939,1.8710632188466063,FUN_038404-T1,Peve_00000024,Pocillopora_meandrina_HIv1___RNAseq.g28278.t1,three_way,76.78699999999999,FUN_038404-T1,P9WM78,,,,,42.5,365.0,1e-80,302.0,sp|P9WM78|Y0574_MYCTO Probable polyglutamine synthesis accessory protein MT0602 OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=MT0602 PE=2 SV=1,,,,,,
OG_08940,1.1045329545112343,FUN_038405-T1,Peve_00000017,Pocillopora_meandrina_HIv1___RNAseq.g28279.t1,three_way,71.28666666666668,FUN_038405-T1,Q6PHN1,,,,,25.6,1091.0,7.9000000000000025e-59,230.7,sp|Q6PHN1|CCD57_MOUSE Coiled-coil domain-containing protein 57 OS=Mus musculus OX=10090 GN=Ccdc57 PE=1 SV=1,,,,,,
OG_08942,1.4131903555751824,FUN_038415-T1,Peve_00000011,Pocillopora_meandrina_HIv1___RNAseq.g1190.t1,three_way,60.18366666666667,FUN_038415-T1,Q9NZS9,,,,,33.4,416.0,1.4e-60,235.3,sp|Q9NZS9|BFAR_HUMAN Bifunctional apoptosis regulator OS=Homo sapiens OX=9606 GN=BFAR PE=1 SV=1,,,,,,
OG_08945,1.0678519578606305,FUN_038418-T1,Peve_00000006,Pocillopora_meandrina_HIv1___RNAseq.g1186.t1,three_way,79.584,FUN_038418-T1,P17844,DDX5_HUMAN,,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),Homo sapiens (Human),68.1,470.0,2.1999999999999997e-192,673.7,sp|P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1,GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003729; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016607; GO:0016887; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0031053; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1990841; GO:1990904; GO:2001014,"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; primary miRNA processing [GO:0031053]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08946,1.629898324744809,FUN_038419-T1,Peve_00000005,Pocillopora_meandrina_HIv1___RNAseq.g1185.t2,three_way,81.85316666666667,FUN_038419-T1,Q5E9X2,MP2K6_BOVIN,,Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6),Bos taurus (Bovine),59.4,342.0,1e-108,394.8,sp|Q5E9X2|MP2K6_BOVIN Dual specificity mitogen-activated protein kinase kinase 6 OS=Bos taurus OX=9913 GN=MAP2K6 PE=2 SV=1,GO:0000165; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006915; GO:0106310,apoptotic process [GO:0006915]; MAPK cascade [GO:0000165],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005856; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08947,1.4412498858525378,FUN_038420-T1,Peve_00000003,Pocillopora_meandrina_HIv1___RNAseq.g1183.t1,three_way,75.96466666666667,FUN_038420-T1,P49005,DPOD2_HUMAN,,DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50),Homo sapiens (Human),55.6,457.0,3.6e-136,486.5,sp|P49005|DPOD2_HUMAN DNA polymerase delta subunit 2 OS=Homo sapiens OX=9606 GN=POLD2 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006261; GO:0006271; GO:0016035; GO:0042276; GO:0043625; GO:0071897,DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276],delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA replication; DNA repair; organelle
OG_08950,1.0616507402478312,FUN_038423-T2,Peve_00000121,Pocillopora_meandrina_HIv1___RNAseq.g1180.t1,three_way,68.95383333333334,FUN_038423-T2,B2RS91,RRN3_MOUSE,,RNA polymerase I-specific transcription initiation factor RRN3,Mus musculus (Mouse),41.0,575.0,1.8e-113,411.4,sp|B2RS91|RRN3_MOUSE RNA polymerase I-specific transcription initiation factor RRN3 OS=Mus musculus OX=10090 GN=Rrn3 PE=1 SV=1,GO:0001164; GO:0001181; GO:0001701; GO:0005730; GO:0006352; GO:0006361; GO:0007000; GO:0007028; GO:0010976; GO:0042254; GO:0045893; GO:0048144; GO:0048872; GO:0070063; GO:0072332; GO:1902254; GO:2000142,cytoplasm organization [GO:0007028]; DNA-templated transcription initiation [GO:0006352]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection development [GO:0010976]; regulation of DNA-templated transcription initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation at RNA polymerase I promoter [GO:0006361],nucleolus [GO:0005730],RNA polymerase binding [GO:0070063]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181],GO:0003677; GO:0005730; GO:0006355; GO:0042254; GO:0043226; GO:0048856; GO:0140223,DNA binding; nucleolus; regulation of DNA-templated transcription; ribosome biogenesis; organelle; anatomical structure development; general transcription initiation factor activity
OG_08953,1.1524050488861073,FUN_038427-T1,Peve_00000113,Pocillopora_meandrina_HIv1___RNAseq.g1177.t1,three_way,70.89833333333333,FUN_038427-T1,Q86XK2,FBX11_HUMAN,,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),Homo sapiens (Human),41.5,82.0,9.1e-08,59.3,sp|Q86XK2|FBX11_HUMAN F-box only protein 11 OS=Homo sapiens OX=9606 GN=FBXO11 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0036211; GO:0042981; GO:0043161; GO:1990756,negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0050877; GO:0060090; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; transferase activity; protein catabolic process; organelle; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_08956,1.661964131115832,FUN_038431-T1,Peve_00000107,Pocillopora_meandrina_HIv1___RNAseq.g1060.t1,three_way,80.83533333333334,FUN_038431-T1,Q8IX18,,,,,54.5,730.0,2.7000000000000003e-223,776.5,sp|Q8IX18|DHX40_HUMAN Probable ATP-dependent RNA helicase DHX40 OS=Homo sapiens OX=9606 GN=DHX40 PE=1 SV=2,,,,,,
OG_08958,1.0127433146543254,FUN_038436-T1,Peve_00029448,Pocillopora_meandrina_HIv1___TS.g5415.t2,three_way,79.24033333333334,FUN_038436-T1,Q2TBW2,COQ7_BOVIN,,"NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial (EC 1.14.13.253) (3-demethoxyubiquinone 3-hydroxylase (NADH)) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)",Bos taurus (Bovine),67.6,173.0,7.099999999999999e-62,238.4,"sp|Q2TBW2|COQ7_BOVIN NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial OS=Bos taurus OX=9913 GN=COQ7 PE=2 SV=1",GO:0005634; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0031314; GO:0046872; GO:0110142; GO:0160224; GO:2000377,determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142],3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; 3-demethoxyubiquinone 3-hydroxylase (NADH) activity [GO:0160224]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0016491; GO:0043226,catalytic activity; nucleus; oxidoreductase activity; organelle
OG_08959,1.1619628611304178,FUN_038437-T2,Peve_00029447,Pocillopora_meandrina_HIv1___RNAseq.25797_t,three_way,40.388666666666666,,,,,,,,,,,,,,,,,
OG_08960,1.440897785617094,FUN_038438-T1,Peve_00029444,Pocillopora_meandrina_HIv1___RNAseq.g885.t1,three_way,75.46883333333334,FUN_038438-T1,O43670,ZN207_HUMAN,,BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (hBuGZ) (Zinc finger protein 207),Homo sapiens (Human),86.7,90.0,2.7e-43,177.9,sp|O43670|ZN207_HUMAN BUB3-interacting and GLEBS motif-containing protein ZNF207 OS=Homo sapiens OX=9606 GN=ZNF207 PE=1 SV=1,GO:0000070; GO:0000776; GO:0001578; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008201; GO:0008270; GO:0008608; GO:0046785; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047,attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983],cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047],DNA binding [GO:0003677]; heparin binding [GO:0008201]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0007010; GO:0007059; GO:0008092; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; nucleolus; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_08975,1.9666698680486367,FUN_038482-T1,Peve_00013523,Pocillopora_meandrina_HIv1___RNAseq.g6991.t1,three_way,43.61266666666667,,,,,,,,,,,,,,,,,
OG_08977,1.8690574963522144,FUN_038488-T1,Peve_00013519,Pocillopora_meandrina_HIv1___TS.g8002.t1a,three_way,57.826,FUN_038488-T1,Q8JHF2,,,,,52.1,263.0,1.5e-77,291.6,"sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2",,,,,,
OG_08978,1.094512872030197,FUN_038489-T1,Peve_00013518,Pocillopora_meandrina_HIv1___RNAseq.g28213.t1,three_way,49.112,,,,,,,,,,,,,,,,,
OG_08982,2.237353100029772,FUN_038500-T1,Peve_00013485,Pocillopora_meandrina_HIv1___RNAseq.g28194.t1,three_way,84.38300000000001,FUN_038500-T1,Q8K4R4,,,,,65.7,251.0,8.2e-100,364.8,sp|Q8K4R4|PITC1_MOUSE Cytoplasmic phosphatidylinositol transfer protein 1 OS=Mus musculus OX=10090 GN=Pitpnc1 PE=1 SV=1,,,,,,
OG_08983,2.834797631770287,FUN_038502-T1,Peve_00013538,Pocillopora_meandrina_HIv1___RNAseq.g28192.t1,three_way,75.99333333333333,FUN_038502-T1,Q7RTV0,PHF5A_HUMAN,,PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b),Homo sapiens (Human),97.1,104.0,8.6e-59,229.9,sp|Q7RTV0|PHF5A_HUMAN PHD finger-like domain-containing protein 5A OS=Homo sapiens OX=9606 GN=PHF5A PE=1 SV=1,GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011; GO:1903241,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of DNA-templated transcription [GO:0045893]; stem cell differentiation [GO:0048863]; U2-type prespliceosome assembly [GO:1903241]",nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0030154; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_08985,1.0204410709535807,FUN_038504-T1,Peve_00041693,Pocillopora_meandrina_HIv1___TS.g7946.t1,three_way,87.35516666666666,FUN_038504-T1,Q9Y5X2,SNX8_HUMAN,,Sorting nexin-8,Homo sapiens (Human),46.6,399.0,4.6e-97,356.7,sp|Q9Y5X2|SNX8_HUMAN Sorting nexin-8 OS=Homo sapiens OX=9606 GN=SNX8 PE=1 SV=1,GO:0005829; GO:0006886; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231,early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0043226,cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; organelle
OG_08987,1.1533812721838297,FUN_038507-T2,Peve_00041684,Pocillopora_meandrina_HIv1___RNAseq.g28173.t1,three_way,75.75433333333334,FUN_038507-T2,Q4R7R1,,,,,61.6,357.0,4.3e-122,439.5,sp|Q4R7R1|D42E1_MACFA Short-chain dehydrogenase/reductase family 42E member 1 OS=Macaca fascicularis OX=9541 GN=SDR42E1 PE=2 SV=1,,,,,,
OG_08990,1.596114855490816,FUN_038512-T1,Peve_00041679,Pocillopora_meandrina_HIv1___RNAseq.20620_t,three_way,87.99716666666667,FUN_038512-T1,Q6P1M3,L2GL2_HUMAN,,LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2),Homo sapiens (Human),41.5,959.0,1.6e-203,711.4,sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0043231; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716,branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_08993,1.1455227129602494,FUN_038523-T1,Peve_00041676,Pocillopora_meandrina_HIv1___RNAseq.g28185.t1,three_way,88.359,FUN_038523-T1,P0C0A3,CHMP6_MOUSE,,Charged multivesicular body protein 6 (Chromatin-modifying protein 6),Mus musculus (Mouse),62.5,168.0,7.5e-51,201.8,sp|P0C0A3|CHMP6_MOUSE Charged multivesicular body protein 6 OS=Mus musculus OX=10090 GN=Chmp6 PE=1 SV=2,GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005828; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0015031; GO:0030496; GO:0031468; GO:0032585; GO:0036258; GO:0039702; GO:0042176; GO:0043162; GO:0044877; GO:0046761; GO:0051469; GO:0061763; GO:0061952; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904930,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886],protein-containing complex binding [GO:0044877],GO:0005886; GO:0006914; GO:0016192; GO:0043226; GO:0061024,plasma membrane; autophagy; vesicle-mediated transport; organelle; membrane organization
OG_08994,2.674661821822556,FUN_038524-T1,Peve_00041750,Pocillopora_meandrina_HIv1___RNAseq.g28186.t1,three_way,79.337,FUN_038524-T1,Q8BKX6,SMG1_MOUSE,,Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1),Mus musculus (Mouse),37.7,3713.0,0.0,2274.6,sp|Q8BKX6|SMG1_MOUSE Serine/threonine-protein kinase SMG1 OS=Mus musculus OX=10090 GN=Smg1 PE=1 SV=3,GO:0000184; GO:0004674; GO:0005524; GO:0005654; GO:0006281; GO:0032204; GO:0033391; GO:0042162; GO:0046854; GO:0046872; GO:0106310,"DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of telomere maintenance [GO:0032204]",chromatoid body [GO:0033391]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005654; GO:0006281; GO:0006629; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleoplasm; DNA repair; lipid metabolic process; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08997,1.912608384508269,FUN_038533-T1,Peve_00013531,Pocillopora_meandrina_HIv1___RNAseq.g28191.t1,three_way,83.86566666666667,FUN_038533-T1,O00116,ADAS_HUMAN,,"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)",Homo sapiens (Human),58.7,623.0,3.6e-226,785.8,"sp|O00116|ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Homo sapiens OX=9606 GN=AGPS PE=1 SV=1",GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0071949,ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; transferase activity; organelle
OG_08998,1.0482962495688186,FUN_038535-T1,Peve_00009817,Pocillopora_meandrina_HIv1___TS.g7943.t1,three_way,65.10233333333333,FUN_038535-T1,Q9JIA7,SPHK2_MOUSE,,Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91),Mus musculus (Mouse),34.2,547.0,3.6e-73,277.3,sp|Q9JIA7|SPHK2_MOUSE Sphingosine kinase 2 OS=Mus musculus OX=10090 GN=Sphk2 PE=1 SV=2,GO:0000786; GO:0001568; GO:0002720; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006669; GO:0006670; GO:0007420; GO:0007565; GO:0008283; GO:0008284; GO:0008481; GO:0016020; GO:0017050; GO:0030308; GO:0032736; GO:0032755; GO:0032760; GO:0033008; GO:0035556; GO:0038036; GO:0042393; GO:0043065; GO:0043122; GO:0043306; GO:0045815; GO:0046512; GO:1903426; GO:1904628; GO:1904959; GO:2000304; GO:2001169,blood vessel development [GO:0001568]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; female pregnancy [GO:0007565]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ATP biosynthetic process [GO:2001169]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; transcription initiation-coupled chromatin remodeling [GO:0045815],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; histone binding [GO:0042393]; sphingosine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006325; GO:0006629; GO:0016740; GO:0022414; GO:0042393; GO:0043226; GO:0048856; GO:0060089,catalytic activity; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; cytosol; plasma membrane; chromatin organization; lipid metabolic process; transferase activity; reproductive process; histone binding; organelle; anatomical structure development; molecular transducer activity
OG_08999,1.4194297283322377,FUN_038540-T1,Peve_00009816,Pocillopora_meandrina_HIv1___RNAseq.g28156.t1,three_way,75.49133333333333,FUN_038540-T1,Q9CQY1,ATG12_MOUSE,,Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like),Mus musculus (Mouse),46.2,130.0,8.7e-29,127.9,sp|Q9CQY1|ATG12_MOUSE Ubiquitin-like protein ATG12 OS=Mus musculus OX=10090 GN=Atg12 PE=1 SV=1,GO:0000045; GO:0005654; GO:0005776; GO:0005829; GO:0006914; GO:0016020; GO:0016236; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0045824; GO:0050687; GO:1901096; GO:1904973; GO:1990234,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; regulation of autophagosome maturation [GO:1901096],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234],,GO:0005654; GO:0005773; GO:0005829; GO:0006914; GO:0043226,nucleoplasm; vacuole; cytosol; autophagy; organelle
OG_09003,1.2488928952992673,FUN_038548-T1,Peve_00037483,Pocillopora_meandrina_HIv1___RNAseq.g1036.t1,three_way,61.59066666666666,FUN_038548-T1,Q9Z0Y8,CAC1I_RAT,,Voltage-dependent T-type calcium channel subunit alpha-1I (CaVT.3) (Voltage-gated calcium channel subunit alpha Cav3.3),Rattus norvegicus (Rat),37.5,1870.0,1.6e-259,898.3,sp|Q9Z0Y8|CAC1I_RAT Voltage-dependent T-type calcium channel subunit alpha-1I OS=Rattus norvegicus OX=10116 GN=Cacna1i PE=1 SV=3,GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0006816; GO:0008332; GO:0019228; GO:0030431; GO:0042391; GO:0043005; GO:0045956; GO:0060402; GO:0070509; GO:0086010,calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of membrane potential [GO:0042391]; sleep [GO:0030431],neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518],low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_09009,1.892607816870976,FUN_038568-T1,Peve_00020181,Pocillopora_meandrina_HIv1___RNAseq.g1018.t1,three_way,78.31666666666666,FUN_038568-T1,A2AHL1,ANO3_MOUSE,,Anoctamin-3 (Transmembrane protein 16C),Mus musculus (Mouse),39.6,847.0,1.3e-160,568.5,sp|A2AHL1|ANO3_MOUSE Anoctamin-3 OS=Mus musculus OX=10090 GN=Ano3 PE=1 SV=1,GO:0005886; GO:0016048; GO:0017128; GO:0046983; GO:0050982; GO:0051649; GO:0061590; GO:0061591,calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; establishment of localization in cell [GO:0051649],plasma membrane [GO:0005886],phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0061024,transporter activity; plasma membrane; membrane organization
OG_09011,1.2009095024992178,FUN_038571-T2,Peve_00020178,Pocillopora_meandrina_HIv1___RNAseq.g1016.t1,three_way,72.84416666666667,FUN_038571-T2,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.9,821.0,8.6e-166,585.9,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_09013,1.118689587641208,FUN_038574-T1,Peve_00020171,Pocillopora_meandrina_HIv1___RNAseq.g1013.t1,three_way,55.36533333333333,FUN_038574-T1,Q10660,DXO_CAEEL,,Decapping nuclease dom-3 (EC 3.6.1.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase dom-3) (DeNADding enzyme dom-3) (EC 3.6.1.-),Caenorhabditis elegans,26.4,254.0,2.9e-12,75.1,sp|Q10660|DXO_CAEEL Decapping nuclease dom-3 OS=Caenorhabditis elegans OX=6239 GN=dom-3 PE=2 SV=1,GO:0000166; GO:0000956; GO:0003723; GO:0004518; GO:0005634; GO:0005829; GO:0034353; GO:0046872; GO:0110152; GO:0110155,NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956],cytosol [GO:0005829]; nucleus [GO:0005634],metal ion binding [GO:0046872]; mRNA 5'-diphosphatase activity [GO:0034353]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA NAD+-cap (NAD+-forming) hydrolase activity [GO:0110152],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09014,1.563813738353361,FUN_038576-T1,Peve_00012106,Pocillopora_meandrina_HIv1___RNAseq.g1012.t1,three_way,84.76333333333334,FUN_038576-T1,Q17QF0,AGT2_BOVIN,,"Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (EC 2.6.1.18) (D-3-aminoisobutyrate-pyruvate aminotransferase) (D-AIBAT) (D-beta-aminoisobutyrate-pyruvate aminotransferase)",Bos taurus (Bovine),57.4,462.0,1.3e-163,577.8,"sp|Q17QF0|AGT2_BOVIN Alanine--glyoxylate aminotransferase 2, mitochondrial OS=Bos taurus OX=9913 GN=AGXT2 PE=2 SV=1",GO:0005739; GO:0008453; GO:0009436; GO:0016223; GO:0019481; GO:0030170; GO:0047305; GO:2001299,"glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; N(omega),N(omega)-dimethyl-L-arginine catabolic process [GO:2001299]",mitochondrion [GO:0005739],(R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; beta-alanine:pyruvate transaminase activity [GO:0016223]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0006520; GO:0006575; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; transferase activity; organelle
OG_09016,1.7615035119540643,FUN_038578-T1,Peve_00012102,Pocillopora_meandrina_HIv1___TS.g5540.t1,three_way,63.539,FUN_038578-T1,Q9Z207,DIAP3_MOUSE,,Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (p134mDIA2) (mDIA2),Mus musculus (Mouse),27.2,290.0,2e-21,105.1,sp|Q9Z207|DIAP3_MOUSE Protein diaphanous homolog 3 OS=Mus musculus OX=10090 GN=Diaph3 PE=1 SV=1,GO:0000226; GO:0000813; GO:0000922; GO:0001701; GO:0003779; GO:0005634; GO:0005737; GO:0005815; GO:0007010; GO:0007015; GO:0007026; GO:0007059; GO:0007229; GO:0007605; GO:0008017; GO:0008092; GO:0010467; GO:0016197; GO:0030010; GO:0030030; GO:0030036; GO:0030041; GO:0030182; GO:0030218; GO:0030225; GO:0031267; GO:0031941; GO:0032154; GO:0032432; GO:0034367; GO:0042803; GO:0043131; GO:0045010; GO:0046785; GO:0051017; GO:0051764; GO:0060113; GO:0060322; GO:0061909; GO:0071800; GO:0097470; GO:1990427,actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; autophagosome-lysosome fusion [GO:0061909]; cell projection organization [GO:0030030]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; endosomal transport [GO:0016197]; erythrocyte differentiation [GO:0030218]; erythrocyte enucleation [GO:0043131]; establishment of cell polarity [GO:0030010]; gene expression [GO:0010467]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; inner ear receptor cell differentiation [GO:0060113]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron differentiation [GO:0030182]; podosome assembly [GO:0071800]; protein-containing complex remodeling [GO:0034367]; sensory perception of sound [GO:0007605],actin filament bundle [GO:0032432]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; ESCRT I complex [GO:0000813]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ribbon synapse [GO:0097470]; spindle pole [GO:0000922]; stereocilia tip-link density [GO:1990427],actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],GO:0005634; GO:0005815; GO:0007010; GO:0007059; GO:0007163; GO:0008092; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0061024; GO:0065003,nucleus; microtubule organizing center; cytoskeleton organization; chromosome segregation; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; nervous system process; membrane organization; protein-containing complex assembly
OG_09019,1.3527347349630725,FUN_038607-T1,Peve_00005402,Pocillopora_meandrina_HIv1___TS.g5522.t2,three_way,74.475,FUN_038607-T1,Q8BJ51,,,,,48.3,379.0,6.799999999999997e-91,335.9,sp|Q8BJ51|MFS11_MOUSE UNC93-like protein MFSD11 OS=Mus musculus OX=10090 GN=Mfsd11 PE=1 SV=1,,,,,,
OG_09022,1.1228789112971056,FUN_038611-T1,Peve_00044574,Pocillopora_meandrina_HIv1___RNAseq.g9728.t2,three_way,43.10066666666667,,,,,,,,,,,,,,,,,
OG_09024,2.263336479793589,FUN_038614-T1,Peve_00002807,Pocillopora_meandrina_HIv1___RNAseq.g972.t1,three_way,69.6525,FUN_038614-T1,Q9Z0Y8,CAC1I_RAT,,Voltage-dependent T-type calcium channel subunit alpha-1I (CaVT.3) (Voltage-gated calcium channel subunit alpha Cav3.3),Rattus norvegicus (Rat),43.5,1698.0,3.2999999999999997e-299,1030.0,sp|Q9Z0Y8|CAC1I_RAT Voltage-dependent T-type calcium channel subunit alpha-1I OS=Rattus norvegicus OX=10116 GN=Cacna1i PE=1 SV=3,GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0006816; GO:0008332; GO:0019228; GO:0030431; GO:0042391; GO:0043005; GO:0045956; GO:0060402; GO:0070509; GO:0086010,calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of membrane potential [GO:0042391]; sleep [GO:0030431],neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518],low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_09029,2.531652172345886,FUN_038622-T1,Peve_00042048,Pocillopora_meandrina_HIv1___RNAseq.g1159.t1,three_way,78.449,FUN_038622-T1,P22448,,,,,31.8,349.0,7.2e-41,169.5,sp|P22448|RARB_CHICK Retinoic acid receptor beta OS=Gallus gallus OX=9031 GN=RARB PE=2 SV=2,,,,,,
OG_09033,1.2396099709432011,FUN_038633-T1,Peve_00013497,Pocillopora_meandrina_HIv1___RNAseq.g26495.t1,three_way,75.706,FUN_038633-T1,Q5EAE5,JOS1_BOVIN,,Josephin-1 (EC 3.4.19.12) (Josephin domain-containing protein 1),Bos taurus (Bovine),47.4,175.0,6.499999999999999e-43,175.3,sp|Q5EAE5|JOS1_BOVIN Josephin-1 OS=Bos taurus OX=9913 GN=JOSD1 PE=2 SV=1,GO:0004843; GO:0005737; GO:0005886; GO:0006508; GO:0006897; GO:0016579; GO:0044091; GO:0048870; GO:0061024,cell motility [GO:0048870]; endocytosis [GO:0006897]; membrane biogenesis [GO:0044091]; membrane organization [GO:0061024]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005886; GO:0016192; GO:0016787; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; vesicle-mediated transport; hydrolase activity; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_09039,1.9236161625128136,FUN_038685-T1,Peve_00013482,Pocillopora_meandrina_HIv1___TS.g19231.t1,three_way,85.41833333333334,FUN_038685-T1,Q96QU8,,,,,53.9,1170.0,0.0,1206.0,sp|Q96QU8|XPO6_HUMAN Exportin-6 OS=Homo sapiens OX=9606 GN=XPO6 PE=1 SV=1,,,,,,
OG_09042,1.948565036462225,FUN_038695-T1,Peve_00013474,Pocillopora_meandrina_HIv1___RNAseq.g26473.t1,three_way,63.010333333333335,,,,,,,,,,,,,,,,,
OG_09048,1.01284816606855,FUN_038727-T1,Peve_00017651,Pocillopora_meandrina_HIv1___RNAseq.g26440.t1,three_way,92.25766666666668,FUN_038727-T1,P21265,,,,,75.8,454.0,5e-204,711.8,sp|P21265|PUR8_CHICK Adenylosuccinate lyase OS=Gallus gallus OX=9031 GN=ADSL PE=2 SV=2,,,,,,
OG_09050,1.5287653297723918,FUN_038730-T1,Peve_00016753,Pocillopora_meandrina_HIv1___RNAseq.g26437.t1,three_way,53.7555,,,,,,,,,,,,,,,,,
OG_09059,1.392787069534006,FUN_038742-T1,Peve_00009051,Pocillopora_meandrina_HIv1___RNAseq.g26426.t1,three_way,86.85000000000001,FUN_038742-T1,Q8TB05,,,,,74.4,86.0,2.5e-28,125.9,sp|Q8TB05|UBAD1_HUMAN UBA-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBALD1 PE=1 SV=1,,,,,,
OG_09062,1.838777410792504,FUN_038769-T1,Peve_00022730,Pocillopora_meandrina_HIv1___RNAseq.g26408.t1,three_way,76.67533333333333,,,,,,,,,,,,,,,,,
OG_09070,1.980141441984013,FUN_038795-T1,Peve_00007232,Pocillopora_meandrina_HIv1___RNAseq.g26384.t1,three_way,72.97933333333333,FUN_038795-T1,P09848,LPH_HUMAN,,Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)],Homo sapiens (Human),49.1,489.0,1.3e-139,498.0,sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3,GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892,cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733],external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886],beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005886; GO:0005975; GO:0006629; GO:0016787; GO:1901135,catalytic activity; plasma membrane; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_09071,1.4480438253211854,FUN_038799-T1,Peve_00007230,Pocillopora_meandrina_HIv1___RNAseq.g26382.t1,three_way,59.84366666666666,,,,,,,,,,,,,,,,,
OG_09074,1.5730811959372466,FUN_038803-T1,Peve_00007224,Pocillopora_meandrina_HIv1___RNAseq.g28545.t1,three_way,82.41499999999999,FUN_038803-T1,Q8BL48,UNK_MOUSE,,RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5),Mus musculus (Mouse),46.5,778.0,5.4999999999999996e-160,567.0,sp|Q8BL48|UNK_MOUSE RING finger protein unkempt homolog OS=Mus musculus OX=10090 GN=Unk PE=1 SV=1,GO:0001701; GO:0001764; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766,cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764],cytoplasm [GO:0005737],mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270],GO:0003723; GO:0048856; GO:0048870,RNA binding; anatomical structure development; cell motility
OG_09086,1.5664107341237667,FUN_038833-T1,Peve_00028686,Pocillopora_meandrina_HIv1___RNAseq.21094_t,three_way,62.954166666666666,FUN_038833-T1,O15169,AXIN1_HUMAN,,Axin-1 (Axis inhibition protein 1) (hAxin),Homo sapiens (Human),27.2,904.0,3.3e-52,208.4,sp|O15169|AXIN1_HUMAN Axin-1 OS=Homo sapiens OX=9606 GN=AXIN1 PE=1 SV=2,GO:0000209; GO:0001701; GO:0002039; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0010629; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060,apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605],beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0006325; GO:0006355; GO:0006913; GO:0007010; GO:0012501; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0065003; GO:0098772,nucleus; nucleolus; cytosol; cytoskeleton; plasma membrane; chromatin organization; regulation of DNA-templated transcription; nucleocytoplasmic transport; cytoskeleton organization; programmed cell death; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity
OG_09088,1.2600588724622737,FUN_038886-T1,Peve_00028696,Pocillopora_meandrina_HIv1___RNAseq.g28678.t1,three_way,74.4045,FUN_038886-T1,Q9CZT4,,,,,39.5,714.0,3.8e-131,470.3,sp|Q9CZT4|RPC5_MOUSE DNA-directed RNA polymerase III subunit RPC5 OS=Mus musculus OX=10090 GN=Polr3e PE=1 SV=2,,,,,,
OG_09093,2.074124315410372,FUN_038891-T1,Peve_00028706,Pocillopora_meandrina_HIv1___RNAseq.g28660.t1,three_way,59.693333333333335,FUN_038891-T1,Q8CBY3,,,,,44.1,488.0,6.6999999999999995e-90,333.6,sp|Q8CBY3|LENG8_MOUSE Leukocyte receptor cluster member 8 homolog OS=Mus musculus OX=10090 GN=Leng8 PE=1 SV=1,,,,,,
OG_09096,1.5488383469513298,FUN_038901-T1,Peve_00028737,Pocillopora_meandrina_HIv1___TS.g8477.t1a,three_way,68.12616666666666,FUN_038901-T1,Q6NU40,,,,,42.3,1032.0,7.199999999999999e-189,662.5,sp|Q6NU40|CTF18_XENLA Chromosome transmission fidelity protein 18 homolog OS=Xenopus laevis OX=8355 GN=chtf18 PE=2 SV=1,,,,,,
OG_09098,1.4159426385330047,FUN_038913-T1,Peve_00006149,Pocillopora_meandrina_HIv1___RNAseq.g1175.t1,three_way,65.38966666666666,FUN_038913-T1,Q504A5,,,,,36.9,198.0,3.2e-30,133.7,sp|Q504A5|TPMT_DANRE Probable thiopurine S-methyltransferase OS=Danio rerio OX=7955 GN=tpmt PE=2 SV=1,,,,,,
OG_09100,1.128090706278557,FUN_038917-T1,Peve_00004515,Pocillopora_meandrina_HIv1___RNAseq.g1080.t1,three_way,61.212,,,,,,,,,,,,,,,,,
OG_09102,1.3221970168696469,FUN_038919-T1,Peve_00023621,Pocillopora_meandrina_HIv1___RNAseq.g1058.t1,three_way,88.84166666666667,FUN_038919-T1,Q9R1C6,DGKE_MOUSE,,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),Mus musculus (Mouse),48.7,487.0,5.8999999999999995e-148,525.8,sp|Q9R1C6|DGKE_MOUSE Diacylglycerol kinase epsilon OS=Mus musculus OX=10090 GN=Dgke PE=1 SV=1,GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006654; GO:0006661; GO:0007200; GO:0008270; GO:0016020; GO:0046339; GO:0046834; GO:0050804; GO:0098978,diacylglycerol metabolic process [GO:0046339]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016740,catalytic activity; nucleoplasm; cytosol; lipid metabolic process; transferase activity
OG_09106,1.7766704289196873,FUN_038933-T1,Peve_00043963,Pocillopora_meandrina_HIv1___TS.g5573.t1,three_way,82.23966666666666,FUN_038933-T1,S4R2P9,NAC3_MOUSE,,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),Mus musculus (Mouse),37.2,888.0,1.1e-137,492.3,sp|S4R2P9|NAC3_MOUSE Sodium/calcium exchanger 3 OS=Mus musculus OX=10090 GN=Slc8a3 PE=1 SV=1,GO:0002244; GO:0005432; GO:0005516; GO:0005654; GO:0005741; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0098815; GO:1902532; GO:1905060; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of intracellular signal transduction [GO:1902532]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; telencephalon development [GO:0021537],anchoring junction [GO:0070161]; axon terminus [GO:0043679]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202],calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0005215; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0055085,transporter activity; nucleoplasm; microtubule organizing center; cytosol; plasma membrane; cell differentiation; cell junction organization; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_09107,1.4251180706289843,FUN_038934-T1,Peve_00043964,Pocillopora_meandrina_HIv1___RNAseq.g1039.t1,three_way,93.333,FUN_038934-T1,Q5ZLL1,KC1E_CHICK,,Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1),Gallus gallus (Chicken),76.2,420.0,1.2e-178,627.5,sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus OX=9031 GN=CSNK1E PE=2 SV=2,GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006897; GO:0007165; GO:0032436; GO:0048511; GO:0090263; GO:0106310,endocytosis [GO:0006897]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; rhythmic process [GO:0048511]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016192; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vesicle-mediated transport; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09110,1.787646260718256,FUN_039036-T1,Peve_00028756,Pocillopora_meandrina_HIv1___RNAseq.g28692.t1,three_way,82.128,FUN_039036-T1,Q8N8E3,,,,,40.0,442.0,1.5e-65,251.9,sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2,,,,,,
OG_09117,2.154919731885036,FUN_039101-T1,Peve_00028755,Pocillopora_meandrina_HIv1___RNAseq.g28705.t1,three_way,90.875,FUN_039101-T1,P27600,GNA12_MOUSE,,Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12),Mus musculus (Mouse),67.3,349.0,4.800000000000001e-130,465.7,sp|P27600|GNA12_MOUSE Guanine nucleotide-binding protein subunit alpha-12 OS=Mus musculus OX=10090 GN=Gna12 PE=1 SV=3,GO:0001701; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005834; GO:0007186; GO:0007266; GO:0008217; GO:0008360; GO:0009410; GO:0010762; GO:0016328; GO:0030154; GO:0031526; GO:0031683; GO:0031752; GO:0032006; GO:0032434; GO:0035556; GO:0042733; GO:0043005; GO:0043025; GO:0046872; GO:0051721; GO:0072542; GO:0160221; GO:1904706; GO:1904753,cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],D5 dopamine receptor binding [GO:0031752]; G protein activity [GO:0003925]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase activator activity [GO:0072542],GO:0003824; GO:0003924; GO:0016787; GO:0030154; GO:0048856; GO:0098772,catalytic activity; GTPase activity; hydrolase activity; cell differentiation; anatomical structure development; molecular function regulator activity
OG_09121,1.4714009696844963,FUN_039269-T1,Peve_00002766,Pocillopora_meandrina_HIv1___RNAseq.14855_t,three_way,50.418,FUN_039269-T1,P15384,,,,,32.5,428.0,1e-50,202.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_09126,1.4868691566700605,FUN_039319-T2,Peve_00037934,Pocillopora_meandrina_HIv1___TS.g2591.t1,three_way,56.69116666666667,FUN_039319-T2,Q9JJP2,P73_MOUSE,,Tumor protein p73 (p53-like transcription factor) (p53-related protein),Mus musculus (Mouse),35.0,369.0,2.7e-50,201.4,sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0001836; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005886; GO:0006954; GO:0006974; GO:0007346; GO:0009410; GO:0009791; GO:0010468; GO:0019901; GO:0021766; GO:0030054; GO:0030900; GO:0033326; GO:0036064; GO:0042771; GO:0042802; GO:0043410; GO:0043523; GO:0043524; GO:0045665; GO:0045793; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0048666; GO:0048714; GO:0051262; GO:0060044; GO:0061629; GO:0097371; GO:1901248; GO:1902167; GO:2001235,cerebrospinal fluid secretion [GO:0033326]; digestive tract morphogenesis [GO:0048546]; DNA damage response [GO:0006974]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein tetramerization [GO:0051262]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron apoptotic process [GO:0043523]; release of cytochrome c from mitochondria [GO:0001836]; response to xenobiotic stimulus [GO:0009410],cell junction [GO:0030054]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005886; GO:0006355; GO:0006954; GO:0007005; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; plasma membrane; regulation of DNA-templated transcription; inflammatory response; mitochondrion organization; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_09129,2.5801498178204785,FUN_039435-T1,Peve_00012694,Pocillopora_meandrina_HIv1___RNAseq.g15606.t1,three_way,76.65166666666667,FUN_039435-T1,O57321,,,,,48.3,466.0,6.6e-113,409.5,sp|O57321|EAA1_AMBTI Excitatory amino acid transporter 1 OS=Ambystoma tigrinum OX=8305 GN=SLC1A3 PE=1 SV=1,,,,,,
OG_09136,1.1052008306786745,FUN_039774-T1,Peve_00030564,Pocillopora_meandrina_HIv1___RNAseq.g7453.t1,three_way,59.15083333333333,FUN_039774-T1,Q810V0,,,,,40.6,702.0,1.4999999999999998e-68,262.3,sp|Q810V0|MPP10_MOUSE U3 small nucleolar ribonucleoprotein protein MPP10 OS=Mus musculus OX=10090 GN=Mphosph10 PE=1 SV=2,,,,,,
OG_09137,1.5089290519830525,FUN_039776-T1,Peve_00017576,Pocillopora_meandrina_HIv1___RNAseq.g7455.t1,three_way,87.746,FUN_039776-T1,O14775,GNB5_HUMAN,,Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5),Homo sapiens (Human),61.0,344.0,9.299999999999999e-94,345.1,sp|O14775|GNB5_HUMAN Guanine nucleotide-binding protein subunit beta-5 OS=Homo sapiens OX=9606 GN=GNB5 PE=1 SV=2,GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0007165; GO:0007212; GO:0030159; GO:0030425; GO:0031682; GO:0036367; GO:0042734; GO:0043547; GO:0045211; GO:0051087; GO:0051286; GO:0098688; GO:1901386; GO:1902773; GO:1990603,dark adaptation [GO:1990603]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],cell tip [GO:0051286]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein-folding chaperone binding [GO:0051087]; signaling receptor complex adaptor activity [GO:0030159],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0060090; GO:0098772,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; molecular adaptor activity; molecular function regulator activity
OG_09138,2.238522130699633,FUN_039777-T1,Peve_00017586,Pocillopora_meandrina_HIv1___TS.g1210.t1,three_way,63.503,,,,,,,,,,,,,,,,,
OG_09140,1.9989824171470365,FUN_039779-T1,Peve_00017588,Pocillopora_meandrina_HIv1___RNAseq.g7461.t1,three_way,84.48583333333333,FUN_039779-T1,O95263,,,,,46.7,904.0,5.4e-218,759.2,"sp|O95263|PDE8B_HUMAN High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B OS=Homo sapiens OX=9606 GN=PDE8B PE=1 SV=2",,,,,,
OG_09145,1.6191112282914644,FUN_039793-T1,Peve_00017607,Pocillopora_meandrina_HIv1___RNAseq.g7472.t1,three_way,87.68633333333334,FUN_039793-T1,Q6AZN6,PK3C3_XENLA,,Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3),Xenopus laevis (African clawed frog),66.7,884.0,0.0,1166.0,sp|Q6AZN6|PK3C3_XENLA Phosphatidylinositol 3-kinase catalytic subunit type 3 OS=Xenopus laevis OX=8355 GN=pik3c3 PE=2 SV=1,GO:0000045; GO:0000407; GO:0000425; GO:0005524; GO:0005737; GO:0005768; GO:0005777; GO:0006897; GO:0016020; GO:0016303; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0036092; GO:0048015; GO:0051301,autophagosome assembly [GO:0000045]; cell division [GO:0051301]; endocytosis [GO:0006897]; pexophagy [GO:0000425]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465],"cytoplasm [GO:0005737]; endosome [GO:0005768]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]",1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524],GO:0003824; GO:0005768; GO:0005777; GO:0006629; GO:0006914; GO:0016192; GO:0016740; GO:0031410; GO:0043226,catalytic activity; endosome; peroxisome; lipid metabolic process; autophagy; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle
OG_09157,2.152495916327542,FUN_039816-T3,Peve_00039070,Pocillopora_meandrina_HIv1___TS.g1258.t1,three_way,80.97083333333333,FUN_039816-T3,Q9BZC7,ABCA2_HUMAN,,ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2),Homo sapiens (Human),45.9,2470.0,0.0,1970.7,sp|Q9BZC7|ABCA2_HUMAN ATP-binding cassette sub-family A member 2 OS=Homo sapiens OX=9606 GN=ABCA2 PE=1 SV=4,GO:0000166; GO:0001573; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006629; GO:0006684; GO:0006687; GO:0006869; GO:0007626; GO:0009410; GO:0010008; GO:0016020; GO:0016887; GO:0019218; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0045939; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0140359; GO:0150104; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905601; GO:2000008,central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; intracellular sphingolipid homeostasis [GO:0090156]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104],ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166],GO:0003013; GO:0003824; GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005815; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0055085; GO:0061024; GO:0098772; GO:0140657; GO:1901135,circulatory system process; catalytic activity; transporter activity; lysosome; endosome; vacuole; microtubule organizing center; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; transmembrane transport; membrane organization; molecular function regulator activity; ATP-dependent activity; carbohydrate derivative metabolic process
OG_09158,1.1062085560523565,FUN_039817-T1,Peve_00039024,Pocillopora_meandrina_HIv1___RNAseq.g7505.t1,three_way,89.61566666666667,FUN_039817-T1,Q9Z1Q9,,,,,66.3,991.0,0.0,1398.6,sp|Q9Z1Q9|SYVC_MOUSE Valine--tRNA ligase OS=Mus musculus OX=10090 GN=Vars1 PE=1 SV=1,,,,,,
OG_09169,1.0436685396390293,FUN_039835-T1,Peve_00005154,Pocillopora_meandrina_HIv1___RNAseq.4974_t,three_way,57.41133333333333,,,,,,,,,,,,,,,,,
OG_09170,1.079309425943686,FUN_039836-T1,Peve_00006312,Pocillopora_meandrina_HIv1___RNAseq.g7301.t1,three_way,84.05966666666666,FUN_039836-T1,Q5R971,HEM2_PONAB,,Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),66.0,326.0,4.3e-125,449.1,sp|Q5R971|HEM2_PONAB Delta-aminolevulinic acid dehydratase OS=Pongo abelii OX=9601 GN=ALAD PE=2 SV=2,GO:0004655; GO:0005829; GO:0006782; GO:0006783; GO:0008270,heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],cytosol [GO:0005829],porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016829,catalytic activity; cytosol; lyase activity
OG_09173,1.983720203025967,FUN_039849-T1,Peve_00006320,Pocillopora_meandrina_HIv1___RNAseq.g7298.t1,three_way,70.33566666666667,FUN_039849-T1,A8WQK3,,,,,33.2,506.0,8.5e-67,256.5,sp|A8WQK3|ACH1_CAEBR Acetylcholine receptor subunit alpha-type acr-16 OS=Caenorhabditis briggsae OX=6238 GN=acr-16 PE=3 SV=2,,,,,,
OG_09175,1.28220793201383,FUN_039851-T1,Peve_00002763,Pocillopora_meandrina_HIv1___RNAseq.g7297.t1a,three_way,73.80716666666667,FUN_039851-T1,Q5RAN1,,,,,44.1,933.0,7.1e-188,659.4,sp|Q5RAN1|RBGP1_PONAB Rab GTPase-activating protein 1 OS=Pongo abelii OX=9601 GN=RABGAP1 PE=2 SV=1,,,,,,
OG_09177,1.7312659755891333,FUN_039853-T1,Peve_00020651,Pocillopora_meandrina_HIv1___RNAseq.g7295.t2,three_way,71.36883333333333,FUN_039853-T1,Q8QFV0,,,,,43.4,1143.0,3.4999999999999996e-251,869.8,sp|Q8QFV0|KCNT1_CHICK Potassium channel subfamily T member 1 OS=Gallus gallus OX=9031 GN=KCNT1 PE=1 SV=1,,,,,,
OG_09179,1.1868713597102771,FUN_039859-T1,Peve_00014928,Pocillopora_meandrina_HIv1___TS.g1031.t1,three_way,39.94166666666667,,,,,,,,,,,,,,,,,
OG_09180,1.6138456535260148,FUN_039860-T1,Peve_00014924,Pocillopora_meandrina_HIv1___TS.g1030.t3,three_way,76.61816666666667,,,,,,,,,,,,,,,,,
OG_09189,1.8169923581141112,FUN_039871-T1,Peve_00011726,Pocillopora_meandrina_HIv1___RNAseq.g7376.t1,three_way,52.6305,FUN_039871-T1,Q54PX0,Y4251_DICDI,,Probable serine/threonine-protein kinase DDB_G0284251 (EC 2.7.11.1),Dictyostelium discoideum (Social amoeba),27.9,201.0,3e-07,58.2,sp|Q54PX0|Y4251_DICDI Probable serine/threonine-protein kinase DDB_G0284251 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0284251 PE=3 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0046872; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09191,1.2570452504317249,FUN_039873-T1,Peve_00011728,Pocillopora_meandrina_HIv1___RNAseq.g7374.t1,three_way,85.6805,FUN_039873-T1,A2AJ77,PRD12_MOUSE,,PR domain zinc finger protein 12 (PR domain-containing protein 12),Mus musculus (Mouse),45.0,289.0,1.8e-61,238.0,sp|A2AJ77|PRD12_MOUSE PR domain zinc finger protein 12 OS=Mus musculus OX=10090 GN=Prdm12 PE=2 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0008168; GO:0008270; GO:0019233; GO:0022008; GO:0031175; GO:0032259; GO:0050965; GO:0140713; GO:1990226,detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; sensory perception of pain [GO:0019233],nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone chaperone activity [GO:0140713]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0050877; GO:0140104,DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; nervous system process; molecular carrier activity
OG_09195,2.0358961962368163,FUN_039878-T1,Peve_00004939,Pocillopora_meandrina_HIv1___RNAseq.g7349.t1,three_way,88.2645,FUN_039878-T1,Q9Z325,DPM2_RAT,,Dolichol phosphate-mannose biosynthesis regulatory protein (Dolichol-phosphate mannose synthase subunit 2) (DPM synthase subunit 2),Rattus norvegicus (Rat),52.4,82.0,1.3e-17,90.1,sp|Q9Z325|DPM2_RAT Dolichol phosphate-mannose biosynthesis regulatory protein OS=Rattus norvegicus OX=10116 GN=Dpm2 PE=1 SV=3,GO:0000506; GO:0004582; GO:0005783; GO:0005789; GO:0006486; GO:0006506; GO:0008047; GO:0019348; GO:0030234; GO:0031647; GO:0033185; GO:0048471; GO:0180047,dolichol metabolic process [GO:0019348]; dolichol phosphate mannose biosynthetic process [GO:0180047]; GPI anchor biosynthetic process [GO:0006506]; protein glycosylation [GO:0006486]; regulation of protein stability [GO:0031647],dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; perinuclear region of cytoplasm [GO:0048471],dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234],GO:0003824; GO:0005783; GO:0006486; GO:0006629; GO:0016740; GO:0043226; GO:0098772; GO:1901135,catalytic activity; endoplasmic reticulum; protein glycosylation; lipid metabolic process; transferase activity; organelle; molecular function regulator activity; carbohydrate derivative metabolic process
OG_09198,1.4322473935430364,FUN_039883-T1,Peve_00011734,Pocillopora_meandrina_HIv1___RNAseq.g7356.t1,three_way,74.50316666666667,FUN_039883-T1,Q6GQB9,EDEM3_XENLA,,"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)",Xenopus laevis (African clawed frog),59.0,761.0,5.3e-264,912.1,sp|Q6GQB9|EDEM3_XENLA ER degradation-enhancing alpha-mannosidase-like protein 3 OS=Xenopus laevis OX=8355 GN=edem3 PE=2 SV=2,GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006058; GO:0006486; GO:0016020; GO:0030968; GO:0044322; GO:0097466; GO:1904380,carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005975; GO:0006486; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; protein glycosylation; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_09200,1.0749444931535546,FUN_039885-T1,Peve_00021850,Pocillopora_meandrina_HIv1___TS.g1125.t1,three_way,87.84066666666666,FUN_039885-T1,D3Z902,FBXW7_RAT,,F-box/WD repeat-containing protein 7,Rattus norvegicus (Rat),61.1,216.0,4.6000000000000004e-73,277.3,sp|D3Z902|FBXW7_RAT F-box/WD repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Fbxw7 PE=1 SV=2,GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],chromosome [GO:0005694]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005634; GO:0005694; GO:0005730; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; chromosome; nucleolus; mitochondrion; endoplasmic reticulum; Golgi apparatus; DNA repair; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_09210,1.0561671758622149,FUN_039923-T1,Peve_00010141,Pocillopora_meandrina_HIv1___RNAseq.g7340.t1,three_way,61.899,,,,,,,,,,,,,,,,,
OG_09211,1.164096626412374,FUN_039924-T1,Peve_00010142,Pocillopora_meandrina_HIv1___RNAseq.g7338.t1,three_way,76.45366666666666,FUN_039924-T1,P58389,PTPA_MOUSE,,"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')",Mus musculus (Mouse),64.7,295.0,3.3e-115,416.4,sp|P58389|PTPA_MOUSE Serine/threonine-protein phosphatase 2A activator OS=Mus musculus OX=10090 GN=Ptpa PE=1 SV=1,GO:0000159; GO:0003755; GO:0004721; GO:0005102; GO:0005524; GO:0005654; GO:0005737; GO:0008160; GO:0019888; GO:0034704; GO:0042803; GO:0043065; GO:0046872; GO:0051721; GO:1904949,positive regulation of apoptotic process [GO:0043065],ATPase complex [GO:1904949]; calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005654; GO:0016787; GO:0016853; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; isomerase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09212,1.00985671285103,FUN_039928-T1,Peve_00002279,Pocillopora_meandrina_HIv1___TS.g307.t1,three_way,71.687,,,,,,,,,,,,,,,,,
OG_09214,1.8850951472609256,FUN_039931-T1,Peve_00036243,Pocillopora_meandrina_HIv1___RNAseq.g7332.t1,three_way,58.890166666666666,FUN_039931-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),40.3,578.0,1.5999999999999999e-96,355.9,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_09216,1.062521529107105,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_09225,1.4370573339373698,FUN_039947-T1,Peve_00039029,Pocillopora_meandrina_HIv1___RNAseq.g7508.t1,three_way,78.4495,FUN_039947-T1,Q5T280,SPOUT_HUMAN,,28S rRNA (uridine-N(3))-methyltransferase (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (Methyltransferase C9orf114) (Ribosomal RNA methyltransferase SPOUT1) (SPOUT domain-containing methyltransferase 1),Homo sapiens (Human),60.8,237.0,1.3e-79,297.7,sp|Q5T280|SPOUT_HUMAN 28S rRNA (uridine-N(3))-methyltransferase OS=Homo sapiens OX=9606 GN=SPOUT1 PE=1 SV=3,GO:0000776; GO:0003723; GO:0005737; GO:0010608; GO:0031616; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0070042; GO:0070475; GO:0072686; GO:1904047,cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608]; rRNA base methylation [GO:0070475],cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616],miRNA binding [GO:0035198]; RNA binding [GO:0003723]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003723; GO:0003824; GO:0005815; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09228,1.1921094429736827,FUN_039965-T1,Peve_00039032,Pocillopora_meandrina_HIv1___RNAseq.g7516.t1,three_way,86.89633333333333,FUN_039965-T1,P28700,RXRA_MOUSE,,Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha),Mus musculus (Mouse),37.9,340.0,1.9999999999999998e-53,211.1,sp|P28700|RXRA_MOUSE Retinoic acid receptor RXR-alpha OS=Mus musculus OX=10090 GN=Rxra PE=1 SV=1,GO:0000122; GO:0000977; GO:0000978; GO:0001162; GO:0001223; GO:0001701; GO:0001890; GO:0001893; GO:0002157; GO:0003007; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0006355; GO:0006357; GO:0007507; GO:0007566; GO:0008270; GO:0009755; GO:0010467; GO:0010629; GO:0030501; GO:0031490; GO:0042789; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0045994; GO:0048384; GO:0055007; GO:0055010; GO:0055012; GO:0060038; GO:0060485; GO:0060528; GO:0060687; GO:0060978; GO:0061032; GO:0070564; GO:0090575,angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; camera-type eye development [GO:0043010]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; embryo implantation [GO:0007566]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; hormone-mediated signaling pathway [GO:0009755]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; mesenchyme development [GO:0060485]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of thyroid hormone receptor signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational initiation by iron [GO:0045994]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral serous pericardium development [GO:0061032],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667],chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006351; GO:0006355; GO:0016071; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_09232,1.1100683100473292,FUN_039973-T1,Peve_00000409,Pocillopora_meandrina_HIv1___RNAseq.g7541.t1,three_way,75.81366666666666,FUN_039973-T1,A0A1L8GVF0,RA50S_XENLA,,DNA repair protein RAD50.S (EC 3.6.-.-),Xenopus laevis (African clawed frog),38.8,1313.0,5.3e-182,640.2,sp|A0A1L8GVF0|RA50S_XENLA DNA repair protein RAD50.S OS=Xenopus laevis OX=8355 GN=rad50.S PE=1 SV=1,GO:0000722; GO:0000729; GO:0000781; GO:0000794; GO:0003691; GO:0005524; GO:0006302; GO:0007004; GO:0016887; GO:0030870; GO:0035861; GO:0043047; GO:0043539; GO:0046872; GO:0051310; GO:0051880; GO:0062176; GO:0070192; GO:0110025,chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; metaphase chromosome alignment [GO:0051310]; R-loop processing [GO:0062176]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004],"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; Mre11 complex [GO:0030870]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; protein serine/threonine kinase activator activity [GO:0043539]; single-stranded telomeric DNA binding [GO:0043047],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0098772,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; molecular function regulator activity
OG_09233,2.972259214614548,FUN_039977-T1,Peve_00029897,Pocillopora_meandrina_HIv1___RNAseq.g7542.t1,three_way,56.55166666666666,FUN_039977-T1,Q9ULJ7,,,,,25.1,427.0,1.1e-26,124.8,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_09237,2.375179587171347,FUN_039990-T1,Peve_00004422,Pocillopora_meandrina_HIv1___RNAseq.g7562.t1,three_way,81.36533333333333,FUN_039990-T1,Q96CN4,EVI5L_HUMAN,,EVI5-like protein (Ecotropic viral integration site 5-like protein),Homo sapiens (Human),45.3,516.0,1.2e-114,415.2,sp|Q96CN4|EVI5L_HUMAN EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1,GO:0005096; GO:0031267; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],,GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0098772,molecular function regulator activity
OG_09241,2.405039078093118,FUN_040029-T1,Peve_00025977,Pocillopora_meandrina_HIv1___RNAseq.g8448.t1,three_way,44.02483333333333,FUN_040029-T1,Q8BZ20,,,,,27.0,711.0,1.1e-55,220.7,sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3,,,,,,
OG_09246,1.0775045218052512,FUN_040036-T1,Peve_00040432,Pocillopora_meandrina_HIv1___RNAseq.g8455.t1,three_way,69.15733333333333,,,,,,,,,,,,,,,,,
OG_09247,1.9592353012694448,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09249,1.0989533942142191,FUN_040039-T1,Peve_00040428,Pocillopora_meandrina_HIv1___RNAseq.g8458.t1,three_way,71.936,FUN_040039-T1,Q4R7W3,,,,,46.6,567.0,3.6999999999999997e-121,436.8,sp|Q4R7W3|RGPS2_MACFA Ras-specific guanine nucleotide-releasing factor RalGPS2 OS=Macaca fascicularis OX=9541 GN=RALGPS2 PE=2 SV=1,,,,,,
OG_09251,2.077758636717241,FUN_040041-T1,Peve_00040425,Pocillopora_meandrina_HIv1___TS.g20197.t1,three_way,47.19116666666667,,,,,,,,,,,,,,,,,
OG_09252,1.4286519337547594,FUN_040042-T1,Peve_00032519,Pocillopora_meandrina_HIv1___RNAseq.g8461.t1,three_way,62.42433333333334,FUN_040042-T1,Q7ZWG9,SGMR1_DANRE,,Sigma non-opioid intracellular receptor 1 (Sigma 1-type opioid receptor) (Sigma1-receptor) (Sigma1R),Danio rerio (Zebrafish) (Brachydanio rerio),51.8,197.0,2.0000000000000002e-60,233.8,sp|Q7ZWG9|SGMR1_DANRE Sigma non-opioid intracellular receptor 1 OS=Danio rerio OX=7955 GN=sigmar1 PE=2 SV=1,GO:0005637; GO:0005640; GO:0005783; GO:0005789; GO:0006869; GO:0009611; GO:0016020; GO:0031410; GO:0036269; GO:0043457; GO:0046548; GO:1905897,lipid transport [GO:0006869]; regulation of cellular respiration [GO:0043457]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; swimming behavior [GO:0036269],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640],,GO:0005783; GO:0031410; GO:0043226; GO:0048856,endoplasmic reticulum; cytoplasmic vesicle; organelle; anatomical structure development
OG_09254,1.5337111423550307,FUN_040053-T1,Peve_00016113,Pocillopora_meandrina_HIv1___RNAseq.g8469.t1,three_way,77.773,,,,,,,,,,,,,,,,,
OG_09255,1.5876837537591828,FUN_040054-T1,Peve_00016114,Pocillopora_meandrina_HIv1___RNAseq.g8468.t1,three_way,76.35666666666667,FUN_040054-T1,O09172,GSH0_MOUSE,,Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit),Mus musculus (Mouse),40.4,275.0,1.6000000000000002e-48,194.5,sp|O09172|GSH0_MOUSE Glutamate--cysteine ligase regulatory subunit OS=Mus musculus OX=10090 GN=Gclm PE=1 SV=1,GO:0004357; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007584; GO:0008637; GO:0009410; GO:0014823; GO:0017109; GO:0035226; GO:0035729; GO:0035733; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237,apoptotic mitochondrial changes [GO:0008637]; blood vessel diameter maintenance [GO:0097746]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],glutamate-cysteine ligase complex [GO:0017109],glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877],GO:0003013; GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0007005; GO:0016874,circulatory system process; catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; mitochondrion organization; ligase activity
OG_09262,1.270147074587969,FUN_040067-T1,Peve_00033898,Pocillopora_meandrina_HIv1___RNAseq.g7701.t2,three_way,60.609,FUN_040067-T1,A8VU90,ANKL1_MOUSE,,Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3),Mus musculus (Mouse),45.4,251.0,4.0999999999999996e-53,210.7,sp|A8VU90|ANKL1_MOUSE Ankyrin repeat and LEM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankle1 PE=2 SV=1,GO:0004519; GO:0005654; GO:0005829; GO:0006611; GO:0045950; GO:1905453; GO:1905456,negative regulation of mitotic recombination [GO:0045950]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453],cytosol [GO:0005829]; nucleoplasm [GO:0005654],endonuclease activity [GO:0004519],GO:0003824; GO:0005654; GO:0005829; GO:0006886; GO:0006913,catalytic activity; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_09266,1.4894038660057936,FUN_040071-T1,Peve_00021006,Pocillopora_meandrina_HIv1___RNAseq.g7693.t1,three_way,74.35883333333334,FUN_040071-T1,P17439,GBA1_MOUSE,,Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase),Mus musculus (Mouse),48.2,500.0,5.999999999999999e-140,499.2,sp|P17439|GBA1_MOUSE Lysosomal acid glucosylceramidase OS=Mus musculus OX=10090 GN=Gba1 PE=1 SV=1,GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0042391; GO:0043161; GO:0043202; GO:0043409; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:1901805; GO:1903052; GO:1904457; GO:1905037; GO:1905091; GO:1905146,antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021],endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295],GO:0002376; GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0006091; GO:0006629; GO:0006914; GO:0007005; GO:0007040; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:1901135,immune system process; catalytic activity; extracellular space; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; generation of precursor metabolites and energy; lipid metabolic process; autophagy; mitochondrion organization; lysosome organization; programmed cell death; transferase activity; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; cell motility; nervous system process; carbohydrate derivative metabolic process
OG_09269,2.2002539483986783,FUN_040075-T1,Peve_00021003,Pocillopora_meandrina_HIv1___RNAseq.g7690.t1,three_way,38.61383333333333,,,,,,,,,,,,,,,,,
OG_09270,1.205553887592488,FUN_040076-T1,Peve_00011678,Pocillopora_meandrina_HIv1___RNAseq.g7621.t1,three_way,86.5475,FUN_040076-T1,A0JMA9,,,,,57.6,564.0,2.1999999999999998e-169,597.0,sp|A0JMA9|KATL2_XENTR Katanin p60 ATPase-containing subunit A-like 2 OS=Xenopus tropicalis OX=8364 GN=katnal2 PE=2 SV=1,,,,,,
OG_09282,1.7547135742989757,FUN_040097-T1,Peve_00037195,Pocillopora_meandrina_HIv1___RNAseq.g7573.t1,three_way,68.70466666666667,,,,,,,,,,,,,,,,,
OG_09283,1.7808064767681984,FUN_040102-T1,Peve_00037277,Pocillopora_meandrina_HIv1___RNAseq.g8727.t1,three_way,80.4645,FUN_040102-T1,O02810,PI4KB_BOVIN,,Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67),Bos taurus (Bovine),46.0,496.0,2e-98,361.3,sp|O02810|PI4KB_BOVIN Phosphatidylinositol 4-kinase beta OS=Bos taurus OX=9913 GN=PI4KB PE=1 SV=2,GO:0000139; GO:0004430; GO:0005524; GO:0005737; GO:0005741; GO:0016020; GO:0030867; GO:0046854; GO:0048015; GO:0048839; GO:0071889,inner ear development [GO:0048839]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015],cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867],1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524],GO:0003824; GO:0006629; GO:0016740; GO:0048856,catalytic activity; lipid metabolic process; transferase activity; anatomical structure development
OG_09284,1.1752498450488829,FUN_040103-T1,Peve_00037278,Pocillopora_meandrina_HIv1___TS.15901_t,three_way,92.47733333333332,FUN_040103-T1,Q5M786,,,,,79.0,324.0,5.5e-22,106.7,sp|Q5M786|WDR5_XENTR WD repeat-containing protein 5 OS=Xenopus tropicalis OX=8364 GN=wdr5 PE=2 SV=1,,,,,,
OG_09285,1.6903577485242574,FUN_040106-T1,Peve_00037279,Pocillopora_meandrina_HIv1___RNAseq.g8725.t1,three_way,92.27733333333332,FUN_040106-T1,Q9R1A8,COP1_MOUSE,,E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2),Mus musculus (Mouse),62.3,648.0,1.5e-230,800.4,sp|Q9R1A8|COP1_MOUSE E3 ubiquitin-protein ligase COP1 OS=Mus musculus OX=10090 GN=Cop1 PE=1 SV=2,GO:0000139; GO:0008270; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0061630,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212],Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09289,1.0794023606067509,FUN_040116-T1,Peve_00043154,Pocillopora_meandrina_HIv1___RNAseq.g8711.t1,three_way,56.97933333333333,FUN_040116-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),35.8,545.0,3.1999999999999997e-85,317.4,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09292,1.0269253804252565,FUN_040137-T1,Peve_00038117,Pocillopora_meandrina_HIv1___RNAseq.g6687.t1,three_way,85.08683333333333,FUN_040137-T1,Q9DC33,HM20A_MOUSE,,High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein HMGX1) (Inhibitor of BRAF35) (iBRAF),Mus musculus (Mouse),39.6,386.0,2.9e-64,247.7,sp|Q9DC33|HM20A_MOUSE High mobility group protein 20A OS=Mus musculus OX=10090 GN=Hmg20a PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0006325; GO:0033234; GO:0042802; GO:0045665,chromatin organization [GO:0006325]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122],nucleus [GO:0005634],DNA binding [GO:0003677]; identical protein binding [GO:0042802],GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0043226,DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle
OG_09294,1.2066356928967543,FUN_040140-T1,Peve_00038114,Pocillopora_meandrina_HIv1___RNAseq.g8514.t1,three_way,65.46633333333334,FUN_040140-T1,Q66LN0,PGES2_BOVIN,,Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form],Bos taurus (Bovine),47.7,176.0,2.8e-42,173.7,sp|Q66LN0|PGES2_BOVIN Prostaglandin E synthase 2 OS=Bos taurus OX=9913 GN=PTGES2 PE=1 SV=3,GO:0001516; GO:0005739; GO:0005783; GO:0016020; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220,prostaglandin biosynthetic process [GO:0001516],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739],12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220],GO:0003824; GO:0005739; GO:0005783; GO:0006629; GO:0016491; GO:0016829; GO:0016853; GO:0043226,catalytic activity; mitochondrion; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; lyase activity; isomerase activity; organelle
OG_09297,1.2263773649950784,FUN_040150-T1,Peve_00038146,Pocillopora_meandrina_HIv1___TS.g20237.t1,three_way,63.22716666666667,FUN_040150-T1,Q7Z591,AKNA_HUMAN,,Microtubule organization protein AKNA (AT-hook-containing transcription factor),Homo sapiens (Human),27.6,254.0,1.3e-09,67.4,sp|Q7Z591|AKNA_HUMAN Microtubule organization protein AKNA OS=Homo sapiens OX=9606 GN=AKNA PE=1 SV=2,GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234,delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654],DNA binding [GO:0003677],GO:0003677; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0030154; GO:0043226,DNA binding; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle
OG_09304,1.7885325484027754,FUN_040172-T1,Peve_00038126,Pocillopora_meandrina_HIv1___RNAseq.g7734.t1,three_way,59.11516666666667,FUN_040172-T1,Q6NZ18,,,,,43.9,374.0,1.3999999999999999e-61,239.2,sp|Q6NZ18|KHDC4_DANRE KH homology domain-containing protein 4 OS=Danio rerio OX=7955 GN=khdc4 PE=2 SV=1,,,,,,
OG_09305,1.1235145884145608,FUN_040173-T1,Peve_00038124,Pocillopora_meandrina_HIv1___RNAseq.g7732.t2,three_way,76.989,FUN_040173-T1,Q9HAD4,,,,,29.1,433.0,1.6e-50,201.8,sp|Q9HAD4|WDR41_HUMAN WD repeat-containing protein 41 OS=Homo sapiens OX=9606 GN=WDR41 PE=1 SV=3,,,,,,
OG_09306,1.3453624269969198,FUN_040203-T1,Peve_00038111,Pocillopora_meandrina_HIv1___TS.g1483.t1,three_way,55.532,,,,,,,,,,,,,,,,,
OG_09308,1.2909678448312865,FUN_040205-T1,Peve_00038142,Pocillopora_meandrina_HIv1___RNAseq.g7738.t1,three_way,81.12466666666667,FUN_040205-T1,Q8AXU9,,,,,51.1,356.0,5.9e-88,325.9,sp|Q8AXU9|SH3G3_CHICK Endophilin-A3 OS=Gallus gallus OX=9031 GN=SH3GL3 PE=1 SV=1,,,,,,
OG_09309,1.2457001090058513,FUN_040206-T1,Peve_00038134,Pocillopora_meandrina_HIv1___RNAseq.g7739.t1,three_way,73.89966666666666,FUN_040206-T1,Q5EA19,,,,,50.3,181.0,5.1e-47,189.1,sp|Q5EA19|ARL15_BOVIN ADP-ribosylation factor-like protein 15 OS=Bos taurus OX=9913 GN=ARL15 PE=2 SV=1,,,,,,
OG_09312,1.4750236709515003,FUN_040217-T1,Peve_00023451,Pocillopora_meandrina_HIv1___RNAseq.g7756.t1,three_way,77.917,FUN_040217-T1,H2FLJ1,,,,,69.5,302.0,1.4e-88,328.2,sp|H2FLJ1|STML1_CAEEL Stomatin-like protein stl-1 OS=Caenorhabditis elegans OX=6239 GN=stl-1 PE=2 SV=1,,,,,,
OG_09313,1.02226740104674,FUN_040220-T1,Peve_00023452,Pocillopora_meandrina_HIv1___RNAseq.g7757.t1,three_way,57.968833333333336,FUN_040220-T1,Q64264,5HT1A_MOUSE,,5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A),Mus musculus (Mouse),23.7,396.0,4.7e-13,77.4,sp|Q64264|5HT1A_MOUSE 5-hydroxytryptamine receptor 1A OS=Mus musculus OX=10090 GN=Htr1a PE=2 SV=2,GO:0001586; GO:0001662; GO:0004993; GO:0005886; GO:0007198; GO:0007210; GO:0007214; GO:0014062; GO:0019229; GO:0030425; GO:0035640; GO:0042053; GO:0042428; GO:0046883; GO:0050795; GO:0090722; GO:0099589,adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; behavioral fear response [GO:0001662]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of behavior [GO:0050795]; regulation of dopamine metabolic process [GO:0042053]; regulation of hormone secretion [GO:0046883]; regulation of serotonin secretion [GO:0014062]; regulation of vasoconstriction [GO:0019229]; serotonin metabolic process [GO:0042428]; serotonin receptor signaling pathway [GO:0007210],dendrite [GO:0030425]; plasma membrane [GO:0005886],G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; receptor-receptor interaction [GO:0090722]; serotonin receptor activity [GO:0099589],GO:0003013; GO:0005886; GO:0023052; GO:0060089,circulatory system process; plasma membrane; signaling; molecular transducer activity
OG_09315,1.037295528369579,FUN_040222-T1,Peve_00023454,Pocillopora_meandrina_HIv1___RNAseq.g7759.t1,three_way,64.82433333333333,FUN_040222-T1,Q7TN31,AGGF1_MOUSE,,Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q),Mus musculus (Mouse),45.0,300.0,1.7e-60,235.3,sp|Q7TN31|AGGF1_MOUSE Angiogenic factor with G patch and FHA domains 1 OS=Mus musculus OX=10090 GN=Aggf1 PE=2 SV=1,GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0042802; GO:0045766; GO:0048471,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471],identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676],GO:0005576; GO:0007155; GO:0030154,extracellular region; cell adhesion; cell differentiation
OG_09329,1.7650372175555151,FUN_040263-T1,Peve_00029137,Pocillopora_meandrina_HIv1___RNAseq.g7788.t1,three_way,72.762,,,,,,,,,,,,,,,,,
OG_09331,1.187292591708258,FUN_040267-T1,Peve_00014979,Pocillopora_meandrina_HIv1___RNAseq.g7811.t1,three_way,61.712,FUN_040267-T1,Q5M824,SHC1_RAT,,SHC-transforming protein 1 (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1),Rattus norvegicus (Rat),35.5,541.0,3.7e-73,277.3,sp|Q5M824|SHC1_RAT SHC-transforming protein 1 OS=Rattus norvegicus OX=10116 GN=Shc1 PE=1 SV=1,GO:0001525; GO:0001666; GO:0001784; GO:0005068; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005829; GO:0005886; GO:0005925; GO:0006940; GO:0007173; GO:0007507; GO:0008284; GO:0008286; GO:0010008; GO:0030036; GO:0030182; GO:0030971; GO:0031100; GO:0031175; GO:0032868; GO:0032869; GO:0035094; GO:0035556; GO:0042127; GO:0042742; GO:0043066; GO:0043410; GO:0044877; GO:0045892; GO:0045893; GO:0045907; GO:0046875; GO:0048009; GO:0048408; GO:0048661; GO:0051219; GO:0051384; GO:0051721; GO:0070301; GO:0070374; GO:0070435; GO:0071363; GO:0097237; GO:0098609; GO:1904628; GO:1990839,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to insulin stimulus [GO:0032869]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to toxic substance [GO:0097237]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094],cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435],ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0003013; GO:0005829; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0030154; GO:0048856; GO:0060090,circulatory system process; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; cell differentiation; anatomical structure development; molecular adaptor activity
OG_09334,1.075247574896208,FUN_040273-T1,Peve_00014971,Pocillopora_meandrina_HIv1___RNAseq.g9069.t1,three_way,63.76,FUN_040273-T1,Q3ZBH3,,,,,27.7,242.0,9e-19,95.5,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_09336,2.50711911468921,FUN_040299-T1,Peve_00038649,Pocillopora_meandrina_HIv1___TS.g20792.t1,three_way,42.627833333333335,FUN_040299-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),24.5,4769.0,0.0,1096.6,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_09338,1.9886633992226863,FUN_040301-T1,Peve_00038647,Pocillopora_meandrina_HIv1___RNAseq.g9075.t1,three_way,65.522,FUN_040301-T1,Q80T21,ATL4_MOUSE,,ADAMTS-like protein 4 (ADAMTSL-4) (Thrombospondin repeat-containing protein 1),Mus musculus (Mouse),33.5,731.0,7.7e-109,396.4,sp|Q80T21|ATL4_MOUSE ADAMTS-like protein 4 OS=Mus musculus OX=10090 GN=Adamtsl4 PE=2 SV=1,GO:0002020; GO:0002064; GO:0005576; GO:0005614; GO:0006915; GO:0030198; GO:0031012; GO:0043065; GO:0070285,apoptotic process [GO:0006915]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; pigment cell development [GO:0070285]; positive regulation of apoptotic process [GO:0043065],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614],protease binding [GO:0002020],GO:0005576; GO:0012501; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; programmed cell death; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09345,2.083887339780758,FUN_040328-T1,Peve_00025748,Pocillopora_meandrina_HIv1___RNAseq.g9085.t1,three_way,73.42633333333333,,,,,,,,,,,,,,,,,
OG_09347,1.0673784927959409,FUN_040402-T1,Peve_00014984,Pocillopora_meandrina_HIv1___RNAseq.g6531.t1,three_way,64.912,FUN_040402-T1,P19137,LAMA1_MOUSE,,Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha),Mus musculus (Mouse),22.5,3355.0,9.5e-78,295.0,sp|P19137|LAMA1_MOUSE Laminin subunit alpha-1 OS=Mus musculus OX=10090 GN=Lama1 PE=1 SV=2,GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046,branching involved in salivary gland morphogenesis [GO:0060445]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888],basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; signaling receptor binding [GO:0005102],GO:0005198; GO:0005576; GO:0005615; GO:0007155; GO:0007163; GO:0008289; GO:0030154; GO:0030312; GO:0031012; GO:0048856,structural molecule activity; extracellular region; extracellular space; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09353,1.0765491991733742,FUN_040424-T1,Peve_00004009,Pocillopora_meandrina_HIv1___RNAseq.g6508.t1,three_way,80.8135,FUN_040424-T1,Q13367,,,,,64.1,1065.0,1.8e-297,1023.5,sp|Q13367|AP3B2_HUMAN AP-3 complex subunit beta-2 OS=Homo sapiens OX=9606 GN=AP3B2 PE=1 SV=2,,,,,,
OG_09354,1.3114260513311546,FUN_040425-T1,Peve_00004010,Pocillopora_meandrina_HIv1___RNAseq.g6509.t1,three_way,76.108,,,,,,,,,,,,,,,,,
OG_09357,1.2573863487016703,FUN_040443-T1,Peve_00004016,Pocillopora_meandrina_HIv1___RNAseq.g6517.t1,three_way,78.62,FUN_040443-T1,Q8BUY9,,,,,58.1,344.0,1.7e-114,414.1,sp|Q8BUY9|PGTB1_MOUSE Geranylgeranyl transferase type-1 subunit beta OS=Mus musculus OX=10090 GN=Pggt1b PE=1 SV=1,,,,,,
OG_09361,1.0623513785053016,FUN_040473-T1,Peve_00004019,Pocillopora_meandrina_HIv1___TS.g256.t1,three_way,67.65716666666667,FUN_040473-T1,Q68ED7,CRTC1_MOUSE,,CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1 homolog) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1),Mus musculus (Mouse),36.4,132.0,1.2e-08,62.4,sp|Q68ED7|CRTC1_MOUSE CREB-regulated transcription coactivator 1 OS=Mus musculus OX=10090 GN=Crtc1 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007613; GO:0008140; GO:0016604; GO:0032793; GO:0043153; GO:0045944; GO:0048511; GO:0051289; GO:0097009; GO:1902631,energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886],cAMP response element binding protein binding [GO:0008140],GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0050877; GO:0065003,nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; nervous system process; protein-containing complex assembly
OG_09362,1.443796882667235,FUN_040477-T1,Peve_00015410,Pocillopora_meandrina_HIv1___RNAseq.g6522.t1,three_way,73.125,FUN_040477-T1,Q3UHD6,SNX27_MOUSE,,Sorting nexin-27,Mus musculus (Mouse),49.7,503.0,5.2e-142,506.1,sp|Q3UHD6|SNX27_MOUSE Sorting nexin-27 OS=Mus musculus OX=10090 GN=Snx27 PE=1 SV=2,GO:0001772; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0071203; GO:0090128; GO:0098685; GO:0098794; GO:0098837; GO:0098842; GO:0098978; GO:0099072,endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; postsynapse [GO:0098794]; postsynaptic early endosome [GO:0098842]; postsynaptic recycling endosome [GO:0098837]; retromer complex [GO:0030904]; Schaffer collateral - CA1 synapse [GO:0098685]; WASH complex [GO:0071203],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0005768; GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09369,1.545412383855013,FUN_040493-T1,Peve_00015398,Pocillopora_meandrina_HIv1___RNAseq.g6529.t1,three_way,81.2965,FUN_040493-T1,Q69ZF3,GBA2_MOUSE,,Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase) (EC 3.2.1.46) (Non-lysosomal glycosylceramidase),Mus musculus (Mouse),52.7,827.0,2.4e-249,863.2,sp|Q69ZF3|GBA2_MOUSE Non-lysosomal glucosylceramidase OS=Mus musculus OX=10090 GN=Gba2 PE=1 SV=2,GO:0000139; GO:0004336; GO:0004348; GO:0005789; GO:0005829; GO:0005975; GO:0006680; GO:0008203; GO:0008422; GO:0016139; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0046527; GO:0050295; GO:0097035,carbohydrate metabolic process [GO:0005975]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295],GO:0003824; GO:0005829; GO:0005975; GO:0006629; GO:0016740; GO:0016787; GO:0048856; GO:0061024; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; lipid metabolic process; transferase activity; hydrolase activity; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_09372,1.1969625565756226,FUN_040547-T1,Peve_00015401,Pocillopora_meandrina_HIv1___RNAseq.g6506.t1,three_way,82.78766666666667,FUN_040547-T1,P46940,IQGA1_HUMAN,,Ras GTPase-activating-like protein IQGAP1 (p195),Homo sapiens (Human),54.6,1653.0,0.0,1496.9,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0009898; GO:0010761; GO:0016323; GO:0016324; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031267; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0070836; GO:0071277; GO:0071364; GO:0072015; GO:1903479; GO:1990138; GO:1990904,caveola assembly [GO:0070836]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; mitotic actomyosin contractile ring assembly actin filament organization [GO:1903479]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165],actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057],"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]",GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0061024; GO:0098772,nucleus; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; organelle; anatomical structure development; cell motility; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_09379,2.502136784219449,FUN_040615-T1,Peve_00015411,Pocillopora_meandrina_HIv1___RNAseq.g6470.t1,three_way,87.62333333333333,FUN_040615-T1,E9PV86,,,,,44.3,711.0,1.7e-153,544.7,sp|E9PV86|MCTP1_MOUSE Multiple C2 and transmembrane domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mctp1 PE=1 SV=1,,,,,,
OG_09380,2.1009491336482413,FUN_040663-T1,Peve_00015413,Pocillopora_meandrina_HIv1___RNAseq.g6468.t1,three_way,48.03816666666667,,,,,,,,,,,,,,,,,
OG_09383,2.077817102573735,FUN_040672-T1,Peve_00015418,Pocillopora_meandrina_HIv1___RNAseq.g6459.t1,three_way,56.578833333333336,,,,,,,,,,,,,,,,,
OG_09384,1.7387116639115177,FUN_040673-T1,Peve_00015420,Pocillopora_meandrina_HIv1___RNAseq.g6458.t1,three_way,49.12566666666667,,,,,,,,,,,,,,,,,
OG_09387,1.092163021355839,FUN_040680-T1,Peve_00009589,Pocillopora_meandrina_HIv1___RNAseq.g6447.t1,three_way,74.92949999999999,FUN_040680-T1,Q13972,RGRF1_HUMAN,,Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25),Homo sapiens (Human),40.1,1471.0,1.8e-260,901.0,sp|Q13972|RGRF1_HUMAN Ras-specific guanine nucleotide-releasing factor 1 OS=Homo sapiens OX=9606 GN=RASGRF1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035022; GO:0035254; GO:0043005; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168,long-term memory [GO:0007616]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0050877; GO:0098772,cytosol; plasma membrane; nervous system process; molecular function regulator activity
OG_09396,1.7550962513940505,FUN_040694-T1,Peve_00029582,Pocillopora_meandrina_HIv1___TS.g20808.t2,three_way,54.065333333333335,FUN_040694-T1,Q24322,SEM1A_DROME,,Semaphorin-1A (Semaphorin-I) (Sema I),Drosophila melanogaster (Fruit fly),31.1,550.0,8.8e-52,206.8,sp|Q24322|SEM1A_DROME Semaphorin-1A OS=Drosophila melanogaster OX=7227 GN=Sema1a PE=1 SV=3,GO:0005886; GO:0007411; GO:0007416; GO:0008039; GO:0008045; GO:0008201; GO:0016020; GO:0016199; GO:0030215; GO:0030335; GO:0045499; GO:0045792; GO:0048813; GO:0050919; GO:0071526; GO:0072499,axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of cell size [GO:0045792]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039],membrane [GO:0016020]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; heparin binding [GO:0008201]; semaphorin receptor binding [GO:0030215],GO:0005886; GO:0034330; GO:0048018; GO:0098772,plasma membrane; cell junction organization; receptor ligand activity; molecular function regulator activity
OG_09404,1.29255549155684,FUN_040784-T1,Peve_00042932,Pocillopora_meandrina_HIv1___RNAseq.g17859.t1,three_way,80.83433333333333,FUN_040784-T1,Q9LMI7,,,,,34.0,664.0,2.5e-87,324.7,"sp|Q9LMI7|ACO32_ARATH Putative acyl-coenzyme A oxidase 3.2, peroxisomal OS=Arabidopsis thaliana OX=3702 GN=ACX3.2 PE=3 SV=1",,,,,,
OG_09409,1.900005313729025,FUN_040861-T1,Peve_00002298,Pocillopora_meandrina_HIv1___RNAseq.g6554.t1,three_way,84.35516666666666,FUN_040861-T1,Q5RE70,,,,,41.1,995.0,2.5e-211,737.3,sp|Q5RE70|INT3_PONAB Integrator complex subunit 3 OS=Pongo abelii OX=9601 GN=INTS3 PE=2 SV=1,,,,,,
OG_09416,1.7866647456436917,FUN_040957-T1,Peve_00031410,Pocillopora_meandrina_HIv1___RNAseq.g27053.t1,three_way,76.98966666666666,FUN_040957-T1,Q9CQ02,,,,,59.0,188.0,2.6000000000000004e-57,223.8,sp|Q9CQ02|COMD4_MOUSE COMM domain-containing protein 4 OS=Mus musculus OX=10090 GN=Commd4 PE=1 SV=1,,,,,,
OG_09417,1.208960984875424,FUN_040958-T1,Peve_00031409,Pocillopora_meandrina_HIv1___RNAseq.g27054.t1,three_way,67.29966666666667,,,,,,,,,,,,,,,,,
OG_09424,1.9473627444368915,FUN_041213-T1,Peve_00021335,Pocillopora_meandrina_HIv1___RNAseq.g16095.t1,three_way,68.873,FUN_041213-T1,Q5R6R1,EYS_PONAB,,Protein eyes shut homolog (Epidermal growth factor-like protein 10) (EGF-like protein 10) (Epidermal growth factor-like protein 11) (EGF-like protein 11) (Protein spacemaker homolog),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,243.0,2.9e-16,89.0,sp|Q5R6R1|EYS_PONAB Protein eyes shut homolog OS=Pongo abelii OX=9601 GN=EYS PE=2 SV=3,GO:0001750; GO:0005509; GO:0005576; GO:0005737; GO:0005813; GO:0005886; GO:0007157; GO:0032991; GO:0033165; GO:0043403; GO:0045197; GO:0050908,detection of light stimulus involved in visual perception [GO:0050908]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; skeletal muscle tissue regeneration [GO:0043403],centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],calcium ion binding [GO:0005509],GO:0005576; GO:0005815; GO:0005886; GO:0007155; GO:0007163; GO:0030312; GO:0031012; GO:0048856,extracellular region; microtubule organizing center; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09427,1.6752002829296533,FUN_041311-T1,Peve_00036795,Pocillopora_meandrina_HIv1___RNAseq.g16009.t1,three_way,64.30933333333334,FUN_041311-T1,A7MFZ8,,,,,30.6,288.0,3.9e-34,147.1,sp|A7MFZ8|GHRA_CROS8 Glyoxylate/hydroxypyruvate reductase A OS=Cronobacter sakazakii (strain ATCC BAA-894) OX=290339 GN=ghrA PE=3 SV=1,,,,,,
OG_09430,1.1446512582169917,FUN_041368-T1,Peve_00037822,Pocillopora_meandrina_HIv1___RNAseq.g16110.t1,three_way,54.66166666666667,FUN_041368-T1,Q92622,RUBIC_HUMAN,,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron),Homo sapiens (Human),31.9,973.0,2.4e-104,381.7,sp|Q92622|RUBIC_HUMAN Run domain Beclin-1-interacting and cysteine-rich domain-containing protein OS=Homo sapiens OX=9606 GN=RUBCN PE=1 SV=4,GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006909; GO:0006914; GO:0010507; GO:0043231; GO:0045806; GO:0051898; GO:0071985; GO:0141039; GO:1901097; GO:1901981,autophagy [GO:0006914]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phagocytosis [GO:0006909],cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol phosphate binding [GO:1901981],GO:0002376; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006914; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772,immune system process; nucleoplasm; lysosome; endosome; vacuole; cytosol; autophagy; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09432,1.2261235784274869,FUN_041389-T1,Peve_00044211,Pocillopora_meandrina_HIv1___RNAseq.g15715.t1,three_way,84.4495,FUN_041389-T1,Q32PP9,,,,,49.8,245.0,5.5e-50,199.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_09434,2.146257956206374,FUN_041404-T1,Peve_00020588,Pocillopora_meandrina_HIv1___RNAseq.g15720.t1,three_way,81.456,,,,,,,,,,,,,,,,,
OG_09438,1.8904158397436392,FUN_041410-T1,Peve_00017540,Pocillopora_meandrina_HIv1___RNAseq.g15731.t1,three_way,64.53566666666667,FUN_041410-T1,Q95241,A4_SAISC,,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],Saimiri sciureus (Common squirrel monkey),24.4,737.0,3.4e-45,184.5,sp|Q95241|A4_SAISC Amyloid-beta precursor protein OS=Saimiri sciureus OX=9521 GN=APP PE=2 SV=1,GO:0003677; GO:0004867; GO:0005102; GO:0005576; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005905; GO:0006417; GO:0006878; GO:0006897; GO:0006915; GO:0007155; GO:0007219; GO:0007409; GO:0007417; GO:0007617; GO:0007626; GO:0008088; GO:0008201; GO:0008344; GO:0008542; GO:0009986; GO:0016020; GO:0016199; GO:0016322; GO:0016358; GO:0030198; GO:0030424; GO:0030426; GO:0030546; GO:0031175; GO:0035235; GO:0040014; GO:0043204; GO:0045121; GO:0045931; GO:0046914; GO:0048669; GO:0050803; GO:0055037,adult locomotory behavior [GO:0008344]; apoptotic process [GO:0006915]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; collateral sprouting in absence of injury [GO:0048669]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; intracellular copper ion homeostasis [GO:0006878]; ionotropic glutamate receptor signaling pathway [GO:0035235]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of multicellular organism growth [GO:0040014]; regulation of synapse structure or activity [GO:0050803]; regulation of translation [GO:0006417]; visual learning [GO:0008542],axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],DNA binding [GO:0003677]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914],GO:0003677; GO:0005576; GO:0005634; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0007018; GO:0007155; GO:0012501; GO:0016192; GO:0022414; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0098772,DNA binding; extracellular region; nucleus; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; microtubule-based movement; cell adhesion; programmed cell death; vesicle-mediated transport; reproductive process; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_09442,1.1198252002033022,FUN_041431-T1,Peve_00008988,Pocillopora_meandrina_HIv1___RNAseq.g15733.t1,three_way,55.95633333333333,FUN_041431-T1,Q1LZD0,,,,,27.8,309.0,1.9e-09,65.1,sp|Q1LZD0|AA2BR_BOVIN Adenosine receptor A2b OS=Bos taurus OX=9913 GN=ADORA2B PE=2 SV=1,,,,,,
OG_09445,1.11293474309287,FUN_041437-T1,Peve_00007743,Pocillopora_meandrina_HIv1___RNAseq.g15744.t2,three_way,80.71600000000001,FUN_041437-T1,Q96MT8,,,,,30.8,240.0,5.7e-19,97.1,sp|Q96MT8|CEP63_HUMAN Centrosomal protein of 63 kDa OS=Homo sapiens OX=9606 GN=CEP63 PE=1 SV=1,,,,,,
OG_09452,1.20205238479383,FUN_041460-T1,Peve_00007409,Pocillopora_meandrina_HIv1___RNAseq.g15692.t1,three_way,85.84066666666666,FUN_041460-T1,Q68FP9,,,,,56.8,628.0,1e-207,724.5,sp|Q68FP9|COG6_RAT Conserved oligomeric Golgi complex subunit 6 OS=Rattus norvegicus OX=10116 GN=Cog6 PE=2 SV=1,,,,,,
OG_09455,1.6486148486417167,FUN_041463-T1,Peve_00013687,Pocillopora_meandrina_HIv1___RNAseq.g15689.t1,three_way,54.7395,FUN_041463-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),36.6,2110.0,7.4e-199,697.2,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09456,1.657846282269005,FUN_041464-T1,Peve_00013686,Pocillopora_meandrina_HIv1___RNAseq.g15688.t1,three_way,73.06016666666666,FUN_041464-T1,Q06AU2,RAP2A_PIG,,Ras-related protein Rap-2a (EC 3.6.5.2),Sus scrofa (Pig),43.6,165.0,3.2999999999999997e-29,130.6,sp|Q06AU2|RAP2A_PIG Ras-related protein Rap-2a OS=Sus scrofa OX=9823 GN=RAP2A PE=2 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005829; GO:0005886; GO:0005923; GO:0008104; GO:0019003; GO:0019904; GO:0030036; GO:0030336; GO:0030496; GO:0031954; GO:0032486; GO:0044291; GO:0045121; GO:0046328; GO:0048814; GO:0055038; GO:0070062; GO:0070527,actin cytoskeleton organization [GO:0030036]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; positive regulation of protein autophosphorylation [GO:0031954]; protein localization [GO:0008104]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328],bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904],GO:0003824; GO:0003924; GO:0005829; GO:0005886; GO:0007010; GO:0007155; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; cytosol; plasma membrane; cytoskeleton organization; cell adhesion; hydrolase activity; organelle; molecular function regulator activity
OG_09458,1.3121676461097675,FUN_041466-T1,Peve_00028293,Pocillopora_meandrina_HIv1___RNAseq.g15685.t1,three_way,68.417,FUN_041466-T1,Q6NYE7,,,,,35.5,231.0,5.700000000000001e-30,132.9,sp|Q6NYE7|TM192_DANRE Transmembrane protein 192 OS=Danio rerio OX=7955 GN=tmem192 PE=2 SV=1,,,,,,
OG_09462,1.735122572725699,FUN_041481-T1,Peve_00015167,Pocillopora_meandrina_HIv1___RNAseq.g15673.t1,three_way,81.04583333333333,FUN_041481-T1,Q6NVN0,SOX2_XENTR,,Transcription factor Sox-2 (SRY (sex determining region Y)-box 2),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.8,271.0,2.8e-42,174.1,sp|Q6NVN0|SOX2_XENTR Transcription factor Sox-2 OS=Xenopus tropicalis OX=8364 GN=sox2 PE=2 SV=1,GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0008283; GO:0021522; GO:0021538; GO:0021982; GO:0031101; GO:0043565; GO:0045893; GO:0045944; GO:0048592; GO:0060119; GO:0071599; GO:1905040; GO:1905812,cell population proliferation [GO:0008283]; epithalamus development [GO:0021538]; eye morphogenesis [GO:0048592]; fin regeneration [GO:0031101]; inner ear receptor cell development [GO:0060119]; nervous system development [GO:0007399]; otic placode development [GO:1905040]; otic vesicle development [GO:0071599]; pineal gland development [GO:0021982]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of motor neuron axon guidance [GO:1905812]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09469,1.09344972459198,FUN_041494-T2,Peve_00017071,Pocillopora_meandrina_HIv1___RNAseq.g15664.t2,three_way,87.778,FUN_041494-T2,Q14409,,,,,63.3,542.0,7e-203,708.4,sp|Q14409|GLPK3_HUMAN Glycerol kinase 3 OS=Homo sapiens OX=9606 GN=GK3 PE=1 SV=2,,,,,,
OG_09471,1.8590439437381936,FUN_041497-T1,Peve_00017073,Pocillopora_meandrina_HIv1___RNAseq.g15661.t1,three_way,80.51666666666667,FUN_041497-T1,P62046,,,,,32.5,711.0,2.7e-36,155.2,sp|P62046|LRCH1_MOUSE Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrch1 PE=1 SV=2,,,,,,
OG_09473,1.881539585761888,FUN_041499-T1,Peve_00007701,Pocillopora_meandrina_HIv1___RNAseq.g15656.t1,three_way,76.57366666666667,FUN_041499-T1,Q8WY91,THAP4_HUMAN,,Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric Homo sapiens nitrobindin) (Hs-Nb(III)) (THAP domain-containing protein 4),Homo sapiens (Human),39.2,166.0,1.3000000000000001e-33,144.4,sp|Q8WY91|THAP4_HUMAN Peroxynitrite isomerase THAP4 OS=Homo sapiens OX=9606 GN=THAP4 PE=1 SV=2,GO:0003677; GO:0005654; GO:0005829; GO:0006570; GO:0008270; GO:0020037; GO:0042126; GO:0042802; GO:0062213; GO:0070026,nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570],cytosol [GO:0005829]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006520; GO:0016853,DNA binding; catalytic activity; nucleoplasm; cytosol; amino acid metabolic process; isomerase activity
OG_09474,1.8533026955355147,FUN_041501-T1,Peve_00028685,Pocillopora_meandrina_HIv1___RNAseq.g15660.t1,three_way,84.75066666666666,FUN_041501-T1,P70191,TRAF5_MOUSE,,TNF receptor-associated factor 5,Mus musculus (Mouse),38.3,193.0,2.8e-32,141.0,sp|P70191|TRAF5_MOUSE TNF receptor-associated factor 5 OS=Mus musculus OX=10090 GN=Traf5 PE=1 SV=1,GO:0005164; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0023035; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043123; GO:0048255; GO:0051092; GO:0061630; GO:0097400,apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829],identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0006355; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; regulation of DNA-templated transcription; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_09477,1.5939062340765475,FUN_041504-T1,Peve_00021429,Pocillopora_meandrina_HIv1___RNAseq.g15966.t1,three_way,72.34566666666666,FUN_041504-T1,Q9WU81,,,,,54.1,495.0,5.3e-144,512.7,sp|Q9WU81|G6PT3_MOUSE Glucose-6-phosphate exchanger SLC37A2 OS=Mus musculus OX=10090 GN=Slc37a2 PE=1 SV=1,,,,,,
OG_09484,1.0709065514608929,FUN_041516-T1,Peve_00021419,Pocillopora_meandrina_HIv1___RNAseq.g16018.t1,three_way,81.921,FUN_041516-T1,Q5RF33,,,,,65.7,213.0,1.2000000000000001e-80,300.8,sp|Q5RF33|VP26C_PONAB Vacuolar protein sorting-associated protein 26C OS=Pongo abelii OX=9601 GN=VPS26C PE=2 SV=1,,,,,,
OG_09486,1.777560704066747,FUN_041519-T1,Peve_00024151,Pocillopora_meandrina_HIv1___RNAseq.g15592.t1,three_way,58.06766666666667,FUN_041519-T1,P27393,,,,,62.9,224.0,9e-84,314.3,sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1,,,,,,
OG_09487,1.154477647641391,FUN_041521-T2,Peve_00024136,Pocillopora_meandrina_HIv1___RNAseq.g15591.t1,three_way,53.47683333333333,FUN_041521-T2,Q7SIB2,CO4A1_BOVIN,,Collagen alpha-1(IV) chain [Cleaved into: Arresten],Bos taurus (Bovine),66.8,226.0,2.6e-91,339.3,sp|Q7SIB2|CO4A1_BOVIN Collagen alpha-1(IV) chain OS=Bos taurus OX=9913 GN=COL4A1 PE=1 SV=2,GO:0005581; GO:0005604; GO:0005615; GO:0030020; GO:0062023,,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],extracellular matrix structural constituent conferring tensile strength [GO:0030020],GO:0005198; GO:0005615; GO:0030312; GO:0031012,structural molecule activity; extracellular space; external encapsulating structure; extracellular matrix
OG_09489,1.4667159907037308,FUN_041524-T1,Peve_00000980,Pocillopora_meandrina_HIv1___RNAseq.g15379.t1,three_way,54.44833333333333,FUN_041524-T1,O43933,,,,,28.6,255.0,4.9e-20,100.5,sp|O43933|PEX1_HUMAN Peroxisomal ATPase PEX1 OS=Homo sapiens OX=9606 GN=PEX1 PE=1 SV=1,,,,,,
OG_09493,1.0498348205328216,FUN_041532-T1,Peve_00017081,Pocillopora_meandrina_HIv1___RNAseq.g15376.t1,three_way,72.252,FUN_041532-T1,Q60525,TCAB1_MESAU,,Telomerase Cajal body protein 1 (Guanine nucleotide-binding protein beta 5) (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog),Mesocricetus auratus (Golden hamster),49.7,346.0,6.4e-92,339.7,sp|Q60525|TCAB1_MESAU Telomerase Cajal body protein 1 OS=Mesocricetus auratus OX=10036 GN=Wrap53 PE=2 SV=1,GO:0000781; GO:0003723; GO:0005697; GO:0005829; GO:0006281; GO:0007004; GO:0015030; GO:0030576; GO:0031625; GO:0032203; GO:0032212; GO:0034337; GO:0035861; GO:0042393; GO:0042802; GO:0044877; GO:0045739; GO:0051087; GO:0070034; GO:0090666; GO:0090671; GO:0140597; GO:0140691; GO:1904851; GO:1904867; GO:1905168; GO:2000781; GO:2001034,Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004],"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]",histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; RNA folding chaperone [GO:0140691]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005829; GO:0006281; GO:0032200; GO:0042393; GO:0043226; GO:0140104,RNA binding; cytosol; DNA repair; telomere organization; histone binding; organelle; molecular carrier activity
OG_09494,2.008722869158556,FUN_041533-T1,Peve_00017080,Pocillopora_meandrina_HIv1___RNAseq.g15375.t1,three_way,44.41416666666667,,,,,,,,,,,,,,,,,
OG_09498,1.0817462663959625,FUN_041540-T1,Peve_00007703,Pocillopora_meandrina_HIv1___RNAseq.g15651.t1,three_way,66.28366666666666,FUN_041540-T1,P51521,OVO_DROME,,Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)],Drosophila melanogaster (Fruit fly),66.4,128.0,4.1e-08,60.8,sp|P51521|OVO_DROME Transcriptional regulator ovo OS=Drosophila melanogaster OX=7227 GN=ovo PE=1 SV=2,GO:0000122; GO:0000978; GO:0000981; GO:0001223; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007010; GO:0008270; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0032196; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048067; GO:0048477; GO:1990837,adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]; transposition [GO:0032196],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007010; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09499,1.0921408599958111,FUN_041543-T1,Peve_00021435,Pocillopora_meandrina_HIv1___RNAseq.g15962.t2,three_way,59.63633333333333,,,,,,,,,,,,,,,,,
OG_09501,1.505324166688334,FUN_041545-T1,Peve_00000890,Pocillopora_meandrina_HIv1___RNAseq.g15994.t2,three_way,60.269666666666666,FUN_041545-T1,Q80TI0,ASTRB_MOUSE,,Protein Aster-B (GRAM domain-containing protein 1B),Mus musculus (Mouse),34.0,679.0,3.2e-86,321.2,sp|Q80TI0|ASTRB_MOUSE Protein Aster-B OS=Mus musculus OX=10090 GN=Gramd1b PE=1 SV=2,GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268,cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786],GO:0005215; GO:0005886; GO:0008289,transporter activity; plasma membrane; lipid binding
OG_09502,1.2563973156834962,FUN_041546-T1,Peve_00023189,Pocillopora_meandrina_HIv1___RNAseq.g15991.t1,three_way,94.7,FUN_041546-T1,Q5TTG1,,,,,84.8,613.0,1.2e-309,1063.1,sp|Q5TTG1|VATA_ANOGA V-type proton ATPase catalytic subunit A OS=Anopheles gambiae OX=7165 GN=Vha68-2 PE=3 SV=1,,,,,,
OG_09503,1.3485210279019313,FUN_041547-T1,Peve_00023190,Pocillopora_meandrina_HIv1___RNAseq.g15992.t1,three_way,62.568,FUN_041547-T1,Q6DE06,,,,,52.5,202.0,6.7e-57,222.2,sp|Q6DE06|TM2D3_XENLA TM2 domain-containing protein 3 OS=Xenopus laevis OX=8355 GN=tm2d3 PE=2 SV=1,,,,,,
OG_09506,1.208811018419101,FUN_041551-T1,Peve_00025197,Pocillopora_meandrina_HIv1___RNAseq.g16000.t2,three_way,86.78033333333333,FUN_041551-T1,Q62829,PAK3_RAT,,Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (p21-activated kinase 3) (PAK-3) (p65-PAK),Rattus norvegicus (Rat),65.6,547.0,2.1e-185,650.2,sp|Q62829|PAK3_RAT Serine/threonine-protein kinase PAK 3 OS=Rattus norvegicus OX=10116 GN=Pak3 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0007409; GO:0009267; GO:0010763; GO:0010975; GO:0014069; GO:0016358; GO:0016477; GO:0017124; GO:0030833; GO:0031267; GO:0032956; GO:0035556; GO:0043408; GO:0043525; GO:0046872; GO:0050770; GO:0051020; GO:0060996; GO:0060997; GO:0061003; GO:0098978; GO:0099175; GO:0106310; GO:2000573,axonogenesis [GO:0007409]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; dendrite development [GO:0016358]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175],cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],GO:0003824; GO:0005768; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; endosome; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_09507,1.183992843485496,FUN_041552-T1,Peve_00025202,Pocillopora_meandrina_HIv1___RNAseq.g15999.t1,three_way,89.03266666666666,FUN_041552-T1,Q8NBZ7,,,,,78.6,243.0,1.1e-113,411.0,sp|Q8NBZ7|UXS1_HUMAN UDP-glucuronic acid decarboxylase 1 OS=Homo sapiens OX=9606 GN=UXS1 PE=1 SV=1,,,,,,
OG_09508,1.5645211985762255,FUN_041556-T1,Peve_00033126,Pocillopora_meandrina_HIv1___RNAseq.g16080.t1,three_way,62.22316666666666,FUN_041556-T1,Q6P549,SHIP2_MOUSE,,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)",Mus musculus (Mouse),30.0,330.0,1.1e-19,99.0,"sp|Q6P549|SHIP2_MOUSE Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 OS=Mus musculus OX=10090 GN=Inppl1 PE=1 SV=1",GO:0000132; GO:0000922; GO:0001958; GO:0002376; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006006; GO:0006629; GO:0006661; GO:0006897; GO:0006915; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0009925; GO:0010467; GO:0010629; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0032880; GO:0034485; GO:0042169; GO:0043491; GO:0046856; GO:0070371; GO:0097178; GO:0110053,actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; lipid metabolic process [GO:0006629]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of actin filament organization [GO:0110053]; regulation of protein localization [GO:0032880]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],"actin binding [GO:0003779]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]",GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006629; GO:0007010; GO:0007155; GO:0008092; GO:0012501; GO:0016192; GO:0016787; GO:0043226,immune system process; catalytic activity; nucleus; Golgi apparatus; cytosol; plasma membrane; carbohydrate metabolic process; lipid metabolic process; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; programmed cell death; vesicle-mediated transport; hydrolase activity; organelle
OG_09509,1.2645742009961516,FUN_041557-T1,Peve_00033125,Pocillopora_meandrina_HIv1___RNAseq.g16079.t1,three_way,82.36866666666667,FUN_041557-T1,F1LP64,TRIPC_RAT,,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),Rattus norvegicus (Rat),52.2,1669.0,0.0,1587.8,sp|F1LP64|TRIPC_RAT E3 ubiquitin-protein ligase TRIP12 OS=Rattus norvegicus OX=10116 GN=Trip12 PE=1 SV=1,GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0033696; GO:0043161; GO:0045995; GO:0046966; GO:0061630; GO:0140861,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09510,1.3555535217119887,FUN_041562-T1,Peve_00033130,Pocillopora_meandrina_HIv1___RNAseq.g16036.t1,three_way,88.02866666666667,FUN_041562-T1,Q93008,USP9X_HUMAN,,"Ubiquitin carboxyl-terminal hydrolase 9X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)",Homo sapiens (Human),61.0,2508.0,0.0,2993.4,sp|Q93008|USP9X_HUMAN Ubiquitin carboxyl-terminal hydrolase 9X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4,GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006307; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016562; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0031647; GO:0032092; GO:0032435; GO:0035520; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0060271; GO:0061578; GO:0061824; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:0140313; GO:0180017; GO:1904515; GO:1990000; GO:1990380,"amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; DNA alkylation repair [GO:0006307]; female gamete generation [GO:0007292]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]",centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634],co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; K11-linked deubiquitinase activity [GO:0180017]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; molecular sequestering activity [GO:0140313],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006281; GO:0006355; GO:0007059; GO:0016787; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140096; GO:0140313,"catalytic activity; nucleus; microtubule organizing center; cytosol; cilium; DNA repair; regulation of DNA-templated transcription; chromosome segregation; hydrolase activity; reproductive process; organelle; cilium organization; cell motility; catalytic activity, acting on a protein; molecular sequestering activity"
OG_09511,1.085796517200497,FUN_041565-T1,Peve_00033117,Pocillopora_meandrina_HIv1___RNAseq.g15976.t1,three_way,84.76766666666667,FUN_041565-T1,O70589,,,,,55.9,942.0,1.7e-296,1020.0,sp|O70589|CSKP_MOUSE Peripheral plasma membrane protein CASK OS=Mus musculus OX=10090 GN=Cask PE=1 SV=2,,,,,,
OG_09513,1.7233678668907275,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,27.8,752.0,2.7e-39,166.4,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09513,1.7233678668907275,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,36.9,187.0,1.8e-19,100.5,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09514,1.835343410489929,FUN_041569-T1,Peve_00033110,Pocillopora_meandrina_HIv1___RNAseq.g15980.t1,three_way,70.16366666666667,FUN_041569-T1,Q5U239,,,,,48.1,399.0,5.6e-110,399.4,sp|Q5U239|TM145_XENLA Transmembrane protein 145 OS=Xenopus laevis OX=8355 GN=tmem145 PE=2 SV=1,,,,,,
OG_09518,1.0204866857963757,FUN_041578-T1,Peve_00028459,Pocillopora_meandrina_HIv1___TS.g10950.t2,three_way,69.42166666666667,FUN_041578-T1,Q6GPD0,,,,,44.5,659.0,2.9e-150,534.3,sp|Q6GPD0|RHG32_XENLA Rho GTPase-activating protein 32 OS=Xenopus laevis OX=8355 GN=arhgap32 PE=2 SV=1,,,,,,
OG_09524,1.1462744802701663,FUN_041586-T1,Peve_00028474,Pocillopora_meandrina_HIv1___RNAseq.g15266.t1,three_way,66.81083333333333,FUN_041586-T1,Q4VSN4,DUSTY_CANLF,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Canis lupus familiaris (Dog) (Canis familiaris),27.4,893.0,3.3000000000000003e-80,301.6,sp|Q4VSN4|DUSTY_CANLF Dual serine/threonine and tyrosine protein kinase OS=Canis lupus familiaris OX=9615 GN=DSTYK PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09527,1.849319663143936,FUN_041595-T1,Peve_00036094,Pocillopora_meandrina_HIv1___RNAseq.g15283.t1,three_way,62.94383333333334,FUN_041595-T1,A2AQH4,,,,,38.7,331.0,1.8e-09,67.0,sp|A2AQH4|BCORL_MOUSE BCL-6 corepressor-like protein 1 OS=Mus musculus OX=10090 GN=Bcorl1 PE=2 SV=1,,,,,,
OG_09530,1.2907901209760853,FUN_041607-T1,Peve_00026860,Pocillopora_meandrina_HIv1___RNAseq.g15307.t1,three_way,78.76933333333334,FUN_041607-T1,P49748,ACADV_HUMAN,,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)",Homo sapiens (Human),64.5,595.0,5.3e-212,738.8,"sp|P49748|ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADVL PE=1 SV=1",GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0042802; GO:0045717; GO:0046322; GO:0050660; GO:0090181,energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099],GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0006091; GO:0006629; GO:0008289; GO:0016491; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; nucleolus; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; lipid binding; oxidoreductase activity; cell differentiation; organelle
OG_09535,2.524538818964611,FUN_041622-T1,Peve_00036084,Pocillopora_meandrina_HIv1___TS.g10312.t1b,three_way,81.132,FUN_041622-T1,P41247,PLPL4_HUMAN,,Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2),Homo sapiens (Human),48.4,248.0,4.7999999999999995e-61,236.1,sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3,GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088,lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739],"acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806]",GO:0003824; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_09539,1.165191685965007,FUN_041633-T1,Peve_00023646,Pocillopora_meandrina_HIv1___RNAseq.g14223.t1,three_way,72.00033333333333,FUN_041633-T1,Q47898,ASPG_ELIMR,,N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain],Elizabethkingia miricola (Chryseobacterium miricola),40.3,119.0,4.7e-17,89.0,sp|Q47898|ASPG_ELIMR N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase OS=Elizabethkingia miricola OX=172045 PE=1 SV=1,GO:0003948; GO:0005737; GO:0006508; GO:0008233; GO:0042597,proteolysis [GO:0006508],cytoplasm [GO:0005737]; periplasmic space [GO:0042597],N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_09540,1.3144575818076925,FUN_041634-T1,Peve_00023645,Pocillopora_meandrina_HIv1___RNAseq.g14222.t1,three_way,82.26466666666667,FUN_041634-T1,Q9H0K1,SIK2_HUMAN,,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),Homo sapiens (Human),46.9,631.0,4.8999999999999996e-135,483.4,sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310,intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09546,1.95984111323356,FUN_041644-T1,Peve_00037268,Pocillopora_meandrina_HIv1___RNAseq.g14206.t1,three_way,62.803333333333335,FUN_041644-T1,Q10751,ACE_CHICK,,Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II),Gallus gallus (Chicken),41.6,587.0,1.4e-125,451.8,sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2,GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573,angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030154; GO:0048856; GO:0050886; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; cell differentiation; anatomical structure development; endocrine process; protein maturation; catalytic activity, acting on a protein"
OG_09549,1.3337266419972515,FUN_041648-T1,Peve_00000476,Pocillopora_meandrina_HIv1___TS.g11937.t1,three_way,62.53166666666666,FUN_041648-T1,B1KHT1,,,,,36.7,120.0,1.2e-13,78.6,sp|B1KHT1|TPMT_SHEWM Thiopurine S-methyltransferase OS=Shewanella woodyi (strain ATCC 51908 / MS32) OX=392500 GN=tpm PE=3 SV=1,,,,,,
OG_09551,2.020008507567802,FUN_041651-T1,Peve_00000466,Pocillopora_meandrina_HIv1___RNAseq.g14153.t1,three_way,42.71266666666666,,,,,,,,,,,,,,,,,
OG_09555,1.1383924746540093,FUN_041658-T1,Peve_00033089,Pocillopora_meandrina_HIv1___RNAseq.g13859.t2,three_way,82.45566666666667,FUN_041658-T1,Q5XGI1,KMCP1_XENTR,,Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),57.3,293.0,1.7999999999999999e-93,344.0,sp|Q5XGI1|KMCP1_XENTR Kidney mitochondrial carrier protein 1 OS=Xenopus tropicalis OX=8364 GN=slc25a30 PE=2 SV=1,GO:0005452; GO:0005743; GO:0015698,inorganic anion transport [GO:0015698],mitochondrial inner membrane [GO:0005743],solute:inorganic anion antiporter activity [GO:0005452],GO:0005215,transporter activity
OG_09556,1.765570597412191,FUN_041659-T1,Peve_00033090,Pocillopora_meandrina_HIv1___RNAseq.g13858.t1,three_way,62.041,FUN_041659-T1,P39963,,,,,55.5,274.0,1e-79,298.9,sp|P39963|CCNB3_CHICK G2/mitotic-specific cyclin-B3 OS=Gallus gallus OX=9031 GN=CCNB3 PE=2 SV=1,,,,,,
OG_09560,1.3898752034631847,FUN_041669-T1,Peve_00031770,Pocillopora_meandrina_HIv1___RNAseq.g13997.t1,three_way,78.03516666666667,FUN_041669-T1,Q32NT4,,,,,52.5,118.0,7.100000000000001e-28,126.3,sp|Q32NT4|LRC58_XENLA Leucine-rich repeat-containing protein 58 OS=Xenopus laevis OX=8355 GN=lrrc58 PE=2 SV=1,,,,,,
OG_09562,1.923336408707527,FUN_041672-T1,Peve_00007760,Pocillopora_meandrina_HIv1___RNAseq.g14001.t1,three_way,59.1795,,,,,,,,,,,,,,,,,
OG_09566,2.286459774394552,FUN_041688-T1,Peve_00041074,Pocillopora_meandrina_HIv1___RNAseq.25430_t,three_way,47.72233333333333,,,,,,,,,,,,,,,,,
OG_09569,1.6836564926522732,FUN_041700-T1,Peve_00004374,Pocillopora_meandrina_HIv1___RNAseq.g13955.t1,three_way,80.44200000000001,FUN_041700-T1,P49585,PCY1A_HUMAN,,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),Homo sapiens (Human),42.7,375.0,6.1e-72,272.7,sp|P49585|PCY1A_HUMAN Choline-phosphate cytidylyltransferase A OS=Homo sapiens OX=9606 GN=PCYT1A PE=1 SV=2,GO:0004105; GO:0005516; GO:0005634; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006656; GO:0006657; GO:0031210; GO:0042100; GO:0042587; GO:0042802; GO:0042803; GO:0045190; GO:0140678,B cell proliferation [GO:0042100]; CDP-choline pathway [GO:0006657]; isotype switching [GO:0045190]; phosphatidylcholine biosynthetic process [GO:0006656],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634],calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003824; GO:0005634; GO:0005635; GO:0005783; GO:0005829; GO:0006310; GO:0006629; GO:0008289; GO:0016740; GO:0043226; GO:0098772,immune system process; catalytic activity; nucleus; nuclear envelope; endoplasmic reticulum; cytosol; DNA recombination; lipid metabolic process; lipid binding; transferase activity; organelle; molecular function regulator activity
OG_09572,1.899527173922311,FUN_041703-T1,Peve_00004371,Pocillopora_meandrina_HIv1___RNAseq.g13969.t1,three_way,83.44083333333333,FUN_041703-T1,Q9R062,,,,,48.6,329.0,7.9e-90,332.0,sp|Q9R062|GLYG_MOUSE Glycogenin-1 OS=Mus musculus OX=10090 GN=Gyg1 PE=1 SV=3,,,,,,
OG_09574,1.1796238593028254,FUN_041706-T2,Peve_00001479,Pocillopora_meandrina_HIv1___RNAseq.g13974.t1,three_way,47.231,FUN_041706-T2,Q8BQ48,CE295_MOUSE,,Centrosomal protein of 295 kDa,Mus musculus (Mouse),29.4,452.0,1.2e-32,144.1,sp|Q8BQ48|CE295_MOUSE Centrosomal protein of 295 kDa OS=Mus musculus OX=10090 GN=Cep295 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0008017; GO:0010825; GO:0030030; GO:1901985; GO:1903724; GO:1904951; GO:1990498,cell projection organization [GO:0030030]; centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle microtubule [GO:1990498],microtubule binding [GO:0008017],GO:0005815; GO:0008092; GO:0043226,microtubule organizing center; cytoskeletal protein binding; organelle
OG_09576,1.468898378472299,FUN_041711-T1,Peve_00034441,Pocillopora_meandrina_HIv1___RNAseq.g13977.t1,three_way,99.00466666666668,FUN_041711-T1,Q9VC49,,,,,95.5,67.0,5.1e-33,141.0,"sp|Q9VC49|RPAB5_DROME DNA-directed RNA polymerases I, II, and III subunit RPABC5 OS=Drosophila melanogaster OX=7227 GN=Polr2L PE=1 SV=1",,,,,,
OG_09580,1.2495298229136371,FUN_041718-T1,Peve_00024454,Pocillopora_meandrina_HIv1___RNAseq.g13944.t1,three_way,59.919,FUN_041718-T1,Q92542,NICA_HUMAN,,Nicastrin,Homo sapiens (Human),35.0,718.0,6.4e-110,399.8,sp|Q92542|NICA_HUMAN Nicastrin OS=Homo sapiens OX=9606 GN=NCSTN PE=1 SV=2,GO:0000139; GO:0002262; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0016020; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042734; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0050673; GO:0051117; GO:0051402; GO:0061133; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:1900271; GO:1990926,adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; epithelial cell proliferation [GO:0050673]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098],azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; ATPase binding [GO:0051117]; endopeptidase activator activity [GO:0061133]; growth factor receptor binding [GO:0070851]; protein-macromolecule adaptor activity [GO:0030674]",GO:0002376; GO:0003824; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0012501; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0051604; GO:0060090; GO:0098772; GO:0140096,"immune system process; catalytic activity; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; programmed cell death; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; protein maturation; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09582,1.1526865144792284,FUN_041720-T1,Peve_00020366,Pocillopora_meandrina_HIv1___RNAseq.g13942.t1,three_way,60.73533333333334,FUN_041720-T1,O45830,,,,,44.8,105.0,3.3e-19,97.1,sp|O45830|NDX1_CAEEL Putative nudix hydrolase 1 OS=Caenorhabditis elegans OX=6239 GN=ndx-1 PE=3 SV=1,,,,,,
OG_09591,2.0075753715310167,FUN_041734-T1,Peve_00024444,Pocillopora_meandrina_HIv1___RNAseq.6485_t,three_way,58.46866666666666,FUN_041734-T1,Q7Z7M0,MEGF8_HUMAN,,Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4),Homo sapiens (Human),33.1,2861.0,0.0,1367.4,sp|Q7Z7M0|MEGF8_HUMAN Multiple epidermal growth factor-like domains protein 8 OS=Homo sapiens OX=9606 GN=MEGF8 PE=1 SV=2,GO:0000151; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0070062; GO:0071907; GO:0097094; GO:0097155; GO:1990403,aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224],extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],calcium ion binding [GO:0005509],GO:0005634; GO:0043226; GO:0048856; GO:0048870; GO:0065003,nucleus; organelle; anatomical structure development; cell motility; protein-containing complex assembly
OG_09592,1.0207636068747443,FUN_041737-T1,Peve_00002192,Pocillopora_meandrina_HIv1___RNAseq.g15780.t1,three_way,71.5,FUN_041737-T1,Q61070,EI24_MOUSE,,Etoposide-induced protein 2.4 (p53-induced gene 8 protein),Mus musculus (Mouse),40.5,309.0,4.4e-56,219.9,sp|Q61070|EI24_MOUSE Etoposide-induced protein 2.4 OS=Mus musculus OX=10090 GN=Ei24 PE=1 SV=3,GO:0005789; GO:0005794; GO:0005829; GO:0006914; GO:0008630; GO:0009410; GO:0030308; GO:0031965; GO:0042308; GO:0050885; GO:0061676; GO:0071494; GO:2001244,autophagy [GO:0006914]; cellular response to UV-C [GO:0071494]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cell growth [GO:0030308]; negative regulation of protein import into nucleus [GO:0042308]; neuromuscular process controlling balance [GO:0050885]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965],importin-alpha family protein binding [GO:0061676],GO:0005794; GO:0005829; GO:0006914; GO:0043226; GO:0050877,Golgi apparatus; cytosol; autophagy; organelle; nervous system process
OG_09593,2.3244577833997377,FUN_041738-T1,Peve_00002190,Pocillopora_meandrina_HIv1___RNAseq.g15782.t1,three_way,65.286,FUN_041738-T1,Q766D5,,,,,40.6,320.0,1.8e-71,271.9,sp|Q766D5|B4GN4_MOUSE N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1,,,,,,
OG_09595,1.6284836806047749,FUN_041741-T2,Peve_00002194,Pocillopora_meandrina_HIv1___TS.g10807.t1,three_way,87.13516666666666,FUN_041741-T2,Q9WVF7,DPOE1_MOUSE,,DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A),Mus musculus (Mouse),61.3,2303.0,0.0,2863.2,sp|Q9WVF7|DPOE1_MOUSE DNA polymerase epsilon catalytic subunit A OS=Mus musculus OX=10090 GN=Pole PE=1 SV=3,GO:0000082; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005654; GO:0005886; GO:0006261; GO:0006287; GO:0006297; GO:0008270; GO:0008622; GO:0016787; GO:0048568; GO:0051539,"base-excision repair, gap-filling [GO:0006287]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; nucleotide-excision repair, DNA gap filling [GO:0006297]",epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005654; GO:0005886; GO:0006260; GO:0016740; GO:0016787; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleoplasm; plasma membrane; DNA replication; transferase activity; hydrolase activity; anatomical structure development; catalytic activity, acting on DNA"
OG_09596,3.00173175689642,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_09597,2.357704922521818,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_09598,3.190367349443379,FUN_041745-T1,Peve_00000338,Pocillopora_meandrina_HIv1___RNAseq.g15790.t1,three_way,56.4945,,,,,,,,,,,,,,,,,
OG_09599,1.463605289519018,FUN_041749-T1,Peve_00042718,Pocillopora_meandrina_HIv1___RNAseq.g15090.t1,three_way,53.022333333333336,,,,,,,,,,,,,,,,,
OG_09604,1.087731532747256,FUN_041758-T1,Peve_00041570,Pocillopora_meandrina_HIv1___RNAseq.g15101.t1,three_way,70.423,FUN_041758-T1,Q90416,RXRGA_DANRE,,Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A),Danio rerio (Zebrafish) (Brachydanio rerio),33.6,357.0,6.5e-52,206.5,sp|Q90416|RXRGA_DANRE Retinoic acid receptor RXR-gamma-A OS=Danio rerio OX=7955 GN=rxrga PE=2 SV=2,GO:0003700; GO:0003707; GO:0004879; GO:0007399; GO:0008270; GO:0030154; GO:0044323; GO:0045893; GO:0045944; GO:0048384; GO:0090575,cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384],RNA polymerase II transcription regulator complex [GO:0090575],DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; zinc ion binding [GO:0008270],GO:0003677; GO:0006355; GO:0030154; GO:0048856; GO:0060089; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_09605,1.3032001481205344,FUN_041759-T1,Peve_00041567,Pocillopora_meandrina_HIv1___RNAseq.g15102.t1,three_way,88.23033333333333,FUN_041759-T1,Q7XMK8,,,,,72.9,402.0,1.1e-173,610.9,sp|Q7XMK8|RH6_ORYSJ DEAD-box ATP-dependent RNA helicase 6 OS=Oryza sativa subsp. japonica OX=39947 GN=Os04g0533000 PE=2 SV=1,,,,,,
OG_09606,1.885550190380211,FUN_041760-T1,Peve_00041568,Pocillopora_meandrina_HIv1___RNAseq.g15241.t1,three_way,74.42366666666666,FUN_041760-T1,A6H7H7,FBX3_BOVIN,,F-box only protein 3,Bos taurus (Bovine),45.3,391.0,5.5e-96,352.8,sp|A6H7H7|FBX3_BOVIN F-box only protein 3 OS=Bos taurus OX=9913 GN=FBXO3 PE=2 SV=1,GO:0005634; GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032496; GO:1990756,protein ubiquitination [GO:0016567]; response to lipopolysaccharide [GO:0032496]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0030163; GO:0043226; GO:0060090,nucleus; protein catabolic process; organelle; molecular adaptor activity
OG_09609,1.7579160317526918,FUN_041767-T1,Peve_00041572,Pocillopora_meandrina_HIv1___RNAseq.g15244.t1,three_way,57.924,FUN_041767-T1,Q6WRH9,,,,,29.6,406.0,5.6000000000000005e-28,128.6,sp|Q6WRH9|IGS10_RAT Immunoglobulin superfamily member 10 OS=Rattus norvegicus OX=10116 GN=Igsf10 PE=1 SV=1,,,,,,
OG_09610,1.2027045216618717,FUN_041768-T1,Peve_00041573,Pocillopora_meandrina_HIv1___RNAseq.g15245.t1,three_way,58.71716666666667,FUN_041768-T1,Q641Q2,WAC2A_HUMAN,,WASH complex subunit 2A,Homo sapiens (Human),43.1,202.0,2.6000000000000002e-37,159.8,sp|Q641Q2|WAC2A_HUMAN WASH complex subunit 2A OS=Homo sapiens OX=9606 GN=WASHC2A PE=1 SV=3,GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0036010; GO:0042147; GO:0043231; GO:0071203; GO:1901981; GO:1905394,"endosomal transport [GO:0016197]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203],phosphatidylinositol phosphate binding [GO:1901981]; retromer complex binding [GO:1905394],GO:0005730; GO:0005768; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleolus; endosome; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09611,2.2189468436224096,FUN_041769-T1,Peve_00041575,Pocillopora_meandrina_HIv1___RNAseq.g15246.t1,three_way,89.10266666666666,,,,,,,,,,,,,,,,,
OG_09613,1.0217939986188278,FUN_041771-T1,Peve_00021185,Pocillopora_meandrina_HIv1___RNAseq.g15894.t1,three_way,85.66066666666667,FUN_041771-T1,P17870,ARRB1_BOVIN,,Beta-arrestin-1 (Arrestin beta-1) (Arrestin-2),Bos taurus (Bovine),64.8,341.0,1.1000000000000001e-118,427.9,sp|P17870|ARRB1_BOVIN Beta-arrestin-1 OS=Bos taurus OX=9913 GN=ARRB1 PE=1 SV=1,GO:0000822; GO:0001664; GO:0001934; GO:0002029; GO:0002031; GO:0002092; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0007165; GO:0015031; GO:0030132; GO:0030276; GO:0031143; GO:0031410; GO:0031623; GO:0032050; GO:0033130; GO:0035612; GO:0036094; GO:0045746; GO:0060090; GO:0070374; GO:0072583,clathrin-dependent endocytosis [GO:0072583]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],"acetylcholine receptor binding [GO:0033130]; AP-2 adaptor complex binding [GO:0035612]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; G protein-coupled receptor binding [GO:0001664]; inositol hexakisphosphate binding [GO:0000822]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small molecule binding [GO:0036094]",GO:0005634; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0060090,nucleus; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_09619,1.3974530925241626,FUN_041779-T1,Peve_00042838,Pocillopora_meandrina_HIv1___RNAseq.g15878.t1,three_way,82.13516666666666,FUN_041779-T1,P23098,,,,,25.2,3572.0,0.0,1097.8,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_09622,1.1022610259124388,FUN_041786-T1,Peve_00038537,Pocillopora_meandrina_HIv1___RNAseq.g15774.t1,three_way,61.81633333333333,FUN_041786-T1,Q01887,,,,,38.8,624.0,3.9e-114,413.7,sp|Q01887|RYK_MOUSE Tyrosine-protein kinase RYK OS=Mus musculus OX=10090 GN=Ryk PE=1 SV=2,,,,,,
OG_09623,1.2902050955658328,FUN_041787-T1,Peve_00038538,Pocillopora_meandrina_HIv1___RNAseq.g15773.t1,three_way,47.7465,FUN_041787-T1,Q9UT40,,,,,34.3,105.0,4.5e-10,67.0,"sp|Q9UT40|YIQ3_SCHPO Uncharacterized protein C824.03c, mitochondrial OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC824.03c PE=4 SV=1",,,,,,
OG_09624,2.097320382809782,FUN_041788-T1,Peve_00038539,Pocillopora_meandrina_HIv1___RNAseq.g15771.t1,three_way,71.78066666666666,FUN_041788-T1,Q8BX90,FND3A_MOUSE,,Fibronectin type-III domain-containing protein 3A,Mus musculus (Mouse),35.3,996.0,1.6e-163,578.6,sp|Q8BX90|FND3A_MOUSE Fibronectin type-III domain-containing protein 3A OS=Mus musculus OX=10090 GN=Fndc3a PE=1 SV=3,GO:0000139; GO:0001669; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0031410; GO:0060009; GO:0098609,cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; vesicle membrane [GO:0012506],,GO:0005829; GO:0007155; GO:0022414; GO:0031410; GO:0043226; GO:0048856,cytosol; cell adhesion; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development
OG_09628,1.6908654145584658,FUN_041799-T1,Peve_00025729,Pocillopora_meandrina_HIv1___RNAseq.g15850.t2,three_way,48.657,FUN_041799-T1,Q4VSN1,DUSTY_DANRE,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Danio rerio (Zebrafish) (Brachydanio rerio),33.2,265.0,3.3e-27,125.6,sp|Q4VSN1|DUSTY_DANRE Dual serine/threonine and tyrosine protein kinase OS=Danio rerio OX=7955 GN=dstyk PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0043066; GO:0044344; GO:0045743; GO:0048568; GO:0048570; GO:0060036; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; embryonic organ development [GO:0048568]; negative regulation of apoptotic process [GO:0043066]; notochord cell vacuolation [GO:0060036]; notochord morphogenesis [GO:0048570]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_09632,1.2654611729079923,FUN_041818-T2,Peve_00025199,Pocillopora_meandrina_HIv1___RNAseq.g15802.t1,three_way,72.51433333333334,FUN_041818-T2,Q1L8W0,ZBT18_DANRE,,Zinc finger and BTB domain-containing protein 18 (Zinc finger protein 238),Danio rerio (Zebrafish) (Brachydanio rerio),38.6,70.0,6.9e-06,54.3,sp|Q1L8W0|ZBT18_DANRE Zinc finger and BTB domain-containing protein 18 OS=Danio rerio OX=7955 GN=zbtb18 PE=2 SV=1,GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_09633,2.630509487700556,FUN_041820-T1,Peve_00025198,Pocillopora_meandrina_HIv1___RNAseq.g15803.t1,three_way,68.35566666666666,FUN_041820-T1,P47793,WNT4A_DANRE,,Protein Wnt-4a,Danio rerio (Zebrafish) (Brachydanio rerio),43.4,334.0,3.1000000000000003e-76,287.0,sp|P47793|WNT4A_DANRE Protein Wnt-4a OS=Danio rerio OX=7955 GN=wnt4a PE=2 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0007507; GO:0021986; GO:0030182; GO:0042074; GO:0045165; GO:0045893; GO:0048703; GO:0048841; GO:0060070; GO:0070654,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell migration involved in gastrulation [GO:0042074]; embryonic viscerocranium morphogenesis [GO:0048703]; habenula development [GO:0021986]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of axon extension involved in axon guidance [GO:0048841]; sensory epithelium regeneration [GO:0070654],extracellular space [GO:0005615],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0006355; GO:0030154; GO:0048018; GO:0048856; GO:0048870; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell differentiation; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09634,1.1423146014167518,FUN_041821-T1,Peve_00025187,Pocillopora_meandrina_HIv1___RNAseq.g15804.t1,three_way,89.15533333333333,FUN_041821-T1,P42325,NCAH_DROME,,Neurocalcin homolog (DrosNCa),Drosophila melanogaster (Fruit fly),50.3,187.0,4e-46,186.0,sp|P42325|NCAH_DROME Neurocalcin homolog OS=Drosophila melanogaster OX=7227 GN=Nca PE=1 SV=2,GO:0005509; GO:0009966; GO:0045938; GO:1902848,"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; regulation of signal transduction [GO:0009966]",,calcium ion binding [GO:0005509],,
OG_09635,1.3877642472184974,FUN_041824-T1,Peve_00039128,Pocillopora_meandrina_HIv1___RNAseq.g15806.t1,three_way,95.95933333333332,FUN_041824-T1,P0C6F1,DYH2_MOUSE,,Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2),Mus musculus (Mouse),72.9,2852.0,0.0,4229.9,sp|P0C6F1|DYH2_MOUSE Dynein axonemal heavy chain 2 OS=Mus musculus OX=10090 GN=Dnah2 PE=1 SV=1,GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0008569; GO:0016887; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285,cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_09636,2.3359033323307705,FUN_041827-T1,Peve_00039124,Pocillopora_meandrina_HIv1___RNAseq.g15809.t1,three_way,78.95666666666666,FUN_041827-T1,Q9UL03,,,,,53.7,536.0,5.9e-156,552.4,sp|Q9UL03|INT6_HUMAN Integrator complex subunit 6 OS=Homo sapiens OX=9606 GN=INTS6 PE=1 SV=1,,,,,,
OG_09640,1.9125715548092912,FUN_041835-T1,Peve_00009638,Pocillopora_meandrina_HIv1___RNAseq.g15085.t1,three_way,89.23433333333334,FUN_041835-T1,Q2HJ40,BACE1_BOVIN,,Beta-secretase 1 (EC 3.4.23.46) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2),Bos taurus (Bovine),47.6,429.0,8.5e-117,422.2,sp|Q2HJ40|BACE1_BOVIN Beta-secretase 1 OS=Bos taurus OX=9913 GN=BACE1 PE=2 SV=1,GO:0004175; GO:0004190; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0009986; GO:0030424; GO:0030425; GO:0030659; GO:0045121; GO:0050435; GO:0055037,amyloid-beta metabolic process [GO:0050435]; membrane protein ectodomain proteolysis [GO:0006509]; proteolysis [GO:0006508],axon [GO:0030424]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_09642,1.0062313913422367,FUN_041837-T1,Peve_00009647,Pocillopora_meandrina_HIv1___RNAseq.g15083.t1,three_way,77.079,FUN_041837-T1,Q676U5,A16L1_HUMAN,,Autophagy-related protein 16-1 (APG16-like 1),Homo sapiens (Human),34.9,601.0,7.8e-79,296.2,sp|Q676U5|A16L1_HUMAN Autophagy-related protein 16-1 OS=Homo sapiens OX=9606 GN=ATG16L1 PE=1 SV=2,GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0019787; GO:0021766; GO:0022038; GO:0030424; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0043495; GO:0051020; GO:0051607; GO:0097225; GO:0098792; GO:0098930; GO:0098978; GO:0120095; GO:0140059; GO:1903860,autophagosome assembly [GO:0000045]; axonal transport [GO:0098930]; C-terminal protein lipidation [GO:0006501]; corpus callosum development [GO:0022038]; defense response to virus [GO:0051607]; dendrite arborization [GO:0140059]; hippocampus development [GO:0021766]; macroautophagy [GO:0016236]; microautophagy [GO:0016237]; negative regulation of dendrite extension [GO:1903860]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095],GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like protein transferase activity [GO:0019787],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0007018; GO:0016740; GO:0043226; GO:0048856; GO:0060090; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; microtubule-based movement; transferase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein"
OG_09651,1.2693939791305673,FUN_041850-T1,Peve_00010479,Pocillopora_meandrina_HIv1___RNAseq.g15071.t1,three_way,44.224500000000006,FUN_041850-T1,P11279,LAMP1_HUMAN,,Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a),Homo sapiens (Human),28.6,231.0,2.1e-08,62.0,sp|P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,GO:0000421; GO:0001618; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005829; GO:0005886; GO:0007042; GO:0008021; GO:0008200; GO:0009897; GO:0010008; GO:0016020; GO:0019899; GO:0019904; GO:0031902; GO:0035577; GO:0042383; GO:0042470; GO:0043323; GO:0044754; GO:0045954; GO:0048471; GO:0050821; GO:0061474; GO:0070062; GO:0072594; GO:0090160; GO:0101003; GO:0101004; GO:0140507; GO:1902513,establishment of protein localization to organelle [GO:0072594]; Golgi to lysosome transport [GO:0090160]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; lysosomal lumen acidification [GO:0007042]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; protein stabilization [GO:0050821]; regulation of organelle transport along microtubule [GO:1902513],autolysosome [GO:0044754]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; cytolytic granule membrane [GO:0101004]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagolysosome membrane [GO:0061474]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021],enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein domain specific binding [GO:0019904]; virus receptor activity [GO:0001618],GO:0001618; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,virus receptor activity; lysosome; endosome; vacuole; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09653,1.2328070632164287,FUN_041854-T1,Peve_00025833,Pocillopora_meandrina_HIv1___RNAseq.g15067.t2,three_way,60.3945,FUN_041854-T1,Q8N137,CNTRB_HUMAN,,Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8),Homo sapiens (Human),35.5,242.0,1.8e-21,106.7,sp|Q8N137|CNTRB_HUMAN Centrobin OS=Homo sapiens OX=9606 GN=CNTROB PE=1 SV=1,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0036064; GO:0051299; GO:1902017; GO:1902410,centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],protein domain specific binding [GO:0019904],GO:0005815; GO:0005829; GO:0043226,microtubule organizing center; cytosol; organelle
OG_09654,1.5445510832438751,FUN_041857-T1,Peve_00025834,Pocillopora_meandrina_HIv1___RNAseq.g15066.t2,three_way,58.90233333333333,FUN_041857-T1,Q5EA49,,,,,30.3,185.0,2.1e-14,80.9,sp|Q5EA49|MIS12_BOVIN Protein MIS12 homolog OS=Bos taurus OX=9913 GN=MIS12 PE=2 SV=1,,,,,,
OG_09655,1.4720214107123033,FUN_041860-T1,Peve_00030446,Pocillopora_meandrina_HIv1___RNAseq.g15125.t1,three_way,65.9885,FUN_041860-T1,Q9D099,ACER3_MOUSE,,Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC),Mus musculus (Mouse),45.8,249.0,9.999999999999999e-57,221.9,sp|Q9D099|ACER3_MOUSE Alkaline ceramidase 3 OS=Mus musculus OX=10090 GN=Acer3 PE=1 SV=1,GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602,ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270],GO:0003824; GO:0006629; GO:0006954; GO:0016787,catalytic activity; lipid metabolic process; inflammatory response; hydrolase activity
OG_09657,1.4217959684857482,FUN_041862-T1,Peve_00030448,Pocillopora_meandrina_HIv1___RNAseq.g15123.t1,three_way,78.17916666666666,FUN_041862-T1,A0A8C0TYJ0,DLG1_CANLF,,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97),Canis lupus familiaris (Dog) (Canis familiaris),54.7,959.0,1.8e-266,920.2,sp|A0A8C0TYJ0|DLG1_CANLF Disks large homolog 1 OS=Canis lupus familiaris OX=9615 GN=DLG1 PE=3 SV=1,GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0005604; GO:0005634; GO:0005789; GO:0005794; GO:0005874; GO:0005923; GO:0007268; GO:0008284; GO:0008360; GO:0009898; GO:0010669; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019900; GO:0019902; GO:0030041; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031579; GO:0031594; GO:0031641; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042982; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0098609; GO:0098911; GO:0098915; GO:0098919; GO:0098978; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903764; GO:2000134,actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; epithelial structure maintenance [GO:0010669]; establishment of centrosome localization [GO:0051660]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell projection membrane [GO:0031253]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060],kinase binding [GO:0019900]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0005198; GO:0005634; GO:0005794; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0022414; GO:0023052; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003; GO:0072659; GO:0098772,immune system process; muscle system process; structural molecule activity; nucleus; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; reproductive process; signaling; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly; protein localization to plasma membrane; molecular function regulator activity
OG_09662,1.9149325401380528,FUN_041873-T1,Peve_00040565,Pocillopora_meandrina_HIv1___TS.g10137.t1b,three_way,58.01883333333333,FUN_041873-T1,Q5R9Y1,,,,,42.6,282.0,1.7000000000000002e-58,228.0,sp|Q5R9Y1|FSTL1_PONAB Follistatin-related protein 1 OS=Pongo abelii OX=9601 GN=FSTL1 PE=2 SV=2,,,,,,
OG_09663,1.462409619308946,FUN_041874-T1,Peve_00040563,Pocillopora_meandrina_HIv1___RNAseq.g15106.t3,three_way,72.21516666666666,FUN_041874-T1,P49959,MRE11_HUMAN,,Double-strand break repair protein MRE11 (EC 3.1.-.-) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A),Homo sapiens (Human),55.2,538.0,4.6e-166,586.3,sp|P49959|MRE11_HUMAN Double-strand break repair protein MRE11 OS=Homo sapiens OX=9606 GN=MRE11 PE=1 SV=3,GO:0000014; GO:0000019; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003690; GO:0004518; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007004; GO:0007062; GO:0007095; GO:0007129; GO:0007131; GO:0008283; GO:0008296; GO:0008408; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0032206; GO:0035825; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0044818; GO:0045296; GO:0062176; GO:0070533; GO:0097552; GO:0098687; GO:0110025; GO:2000781; GO:2001033,cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; R-loop processing [GO:0062176]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860],"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; cadherin binding [GO:0045296]; DNA endonuclease activity [GO:0004520]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; catalytic activity, acting on DNA"
OG_09664,1.429493036635448,FUN_041875-T1,Peve_00040575,Pocillopora_meandrina_HIv1___RNAseq.g15107.t1,three_way,97.13533333333334,FUN_041875-T1,P49841,GSK3B_HUMAN,,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),Homo sapiens (Human),88.7,212.0,1.4000000000000005e-111,403.7,sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens OX=9606 GN=GSK3B PE=1 SV=2,GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0003170; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007005; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010629; GO:0010719; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0019082; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030154; GO:0030336; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031398; GO:0031625; GO:0032007; GO:0032092; GO:0032436; GO:0032886; GO:0034236; GO:0034452; GO:0034976; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043161; GO:0043525; GO:0045597; GO:0045668; GO:0045719; GO:0045724; GO:0045732; GO:0046777; GO:0046825; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060070; GO:0060079; GO:0061629; GO:0070507; GO:0070885; GO:0071109; GO:0071300; GO:0090090; GO:0097110; GO:0097191; GO:0097192; GO:0098793; GO:0098794; GO:0098978; GO:0099171; GO:0106027; GO:0106310; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1902042; GO:1903566; GO:1903940; GO:1904339; GO:1904646; GO:1904781; GO:1990909; GO:2000077; GO:2000466; GO:2000740,canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glycogen metabolic process [GO:0005977]; heart valve development [GO:0003170]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC2 signaling [GO:1903940]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of protein-containing complex assembly [GO:0031334]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; response to endoplasmic reticulum stress [GO:0034976]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Wnt signalosome [GO:1990909],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0007005; GO:0007163; GO:0008092; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0061024; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; mitochondrion organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; membrane organization; catalytic activity, acting on a protein"
OG_09665,1.214940417326461,FUN_041877-T1,Peve_00000883,Pocillopora_meandrina_HIv1___TS.g10136.t1,three_way,95.18533333333332,FUN_041877-T1,B5DF89,CUL3_RAT,,Cullin-3,Rattus norvegicus (Rat),75.7,760.0,0.0,1124.4,sp|B5DF89|CUL3_RAT Cullin-3 OS=Rattus norvegicus OX=10116 GN=Cul3 PE=1 SV=2,GO:0000122; GO:0000209; GO:0000278; GO:0000902; GO:0000922; GO:0001701; GO:0001822; GO:0001831; GO:0005112; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005827; GO:0005886; GO:0006357; GO:0006511; GO:0006513; GO:0006888; GO:0006954; GO:0007080; GO:0007229; GO:0007369; GO:0010467; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030163; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0032480; GO:0034599; GO:0035024; GO:0036126; GO:0040016; GO:0042802; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0061630; GO:0070936; GO:0071230; GO:0071630; GO:0072576; GO:0072686; GO:0098794; GO:0098978; GO:0140252; GO:0160072; GO:1900076; GO:1901992; GO:1904263,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cellular response to amino acid stimulus [GO:0071230]; cellular response to oxidative stress [GO:0034599]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; gastrulation [GO:0007369]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; liver morphogenesis [GO:0072576]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon production [GO:0032480]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation protein catabolic process at postsynapse [GO:0140252]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0003824; GO:0005634; GO:0005794; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0006954; GO:0007010; GO:0012501; GO:0016192; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0065003; GO:0140096,"mitotic cell cycle; catalytic activity; nucleus; Golgi apparatus; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; inflammatory response; cytoskeleton organization; programmed cell death; vesicle-mediated transport; transferase activity; protein catabolic process; organelle; anatomical structure development; cell motility; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_09667,1.2471894729944195,FUN_041884-T1,Peve_00012643,Pocillopora_meandrina_HIv1___RNAseq.g15395.t1,three_way,72.869,FUN_041884-T1,F4IF36,FGT1_ARATH,,Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135),Arabidopsis thaliana (Mouse-ear cress),38.7,1090.0,1.2e-201,705.7,sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1,GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841,chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408],nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_09671,1.0519261900150296,FUN_041889-T1,Peve_00033396,Pocillopora_meandrina_HIv1___RNAseq.g15418.t1,three_way,84.536,FUN_041889-T1,A7MBP4,IFT46_DANRE,,Intraflagellar transport protein 46 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),61.5,364.0,1.1999999999999999e-92,341.7,sp|A7MBP4|IFT46_DANRE Intraflagellar transport protein 46 homolog OS=Danio rerio OX=7955 GN=ift46 PE=2 SV=2,GO:0005737; GO:0005815; GO:0030992; GO:0031514; GO:0036064; GO:0042073; GO:0048264; GO:0048793; GO:0060041; GO:0060271,cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_09677,1.270374907987759,FUN_041901-T1,Peve_00017951,Pocillopora_meandrina_HIv1___RNAseq.g15357.t1,three_way,67.588,FUN_041901-T1,Q0P5B7,AAAD_BOVIN,,Arylacetamide deacetylase (EC 3.1.1.3),Bos taurus (Bovine),35.9,337.0,8.299999999999997e-41,169.5,sp|Q0P5B7|AAAD_BOVIN Arylacetamide deacetylase OS=Bos taurus OX=9913 GN=AADAC PE=2 SV=1,GO:0004806; GO:0005789; GO:0006629; GO:0010898; GO:0017171,lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898],endoplasmic reticulum membrane [GO:0005789],serine hydrolase activity [GO:0017171]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_09679,1.1312364239771409,FUN_041903-T1,Peve_00030474,Pocillopora_meandrina_HIv1___RNAseq.g15367.t1,three_way,66.04633333333334,FUN_041903-T1,Q80W94,MOGT2_MOUSE,,2-acylglycerol O-acyltransferase 2 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 1-like) (Monoacylglycerol O-acyltransferase 2),Mus musculus (Mouse),40.6,315.0,1.3000000000000002e-60,235.0,sp|Q80W94|MOGT2_MOUSE 2-acylglycerol O-acyltransferase 2 OS=Mus musculus OX=10090 GN=Mogat2 PE=1 SV=1,GO:0003846; GO:0004144; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0016407; GO:0019432; GO:0046462; GO:0050892; GO:1990578,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; monoacylglycerol metabolic process [GO:0046462]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum membrane [GO:1990578],2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005783; GO:0005975; GO:0006629; GO:0016740; GO:0022600; GO:0043226,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; lipid metabolic process; transferase activity; digestive system process; organelle
OG_09683,2.1532096531986693,FUN_041908-T1,Peve_00007888,Pocillopora_meandrina_HIv1___RNAseq.g15648.t1,three_way,83.73049999999999,FUN_041908-T1,Q17QZ4,,,,,57.2,383.0,2e-95,351.3,sp|Q17QZ4|TFDP1_BOVIN Transcription factor Dp-1 OS=Bos taurus OX=9913 GN=TFDP1 PE=2 SV=1,,,,,,
OG_09689,1.4279479308161616,FUN_041917-T1,Peve_00007877,Pocillopora_meandrina_HIv1___RNAseq.g15639.t1,three_way,79.75916666666667,FUN_041917-T1,Q33E94,RFX4_HUMAN,,Transcription factor RFX4 (Regulatory factor X 4) (Testis development protein NYD-SP10),Homo sapiens (Human),50.0,494.0,4.500000000000001e-130,466.8,sp|Q33E94|RFX4_HUMAN Transcription factor RFX4 OS=Homo sapiens OX=9606 GN=RFX4 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0021537; GO:0045879; GO:0045944; GO:0060271; GO:0070613; GO:1990837,cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0044782; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cilium organization; anatomical structure development; transcription regulator activity
OG_09692,1.5204956780962635,FUN_041921-T1,Peve_00007872,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1a,three_way,76.00366666666666,FUN_041921-T1,Q68F70,,,,,40.3,1001.0,6.6e-185,649.4,sp|Q68F70|INT4_XENLA Integrator complex subunit 4 OS=Xenopus laevis OX=8355 GN=ints4 PE=2 SV=1,,,,,,
OG_09695,1.2203304396401422,FUN_041924-T1,Peve_00007863,Pocillopora_meandrina_HIv1___TS.g10650.t1,three_way,81.45066666666666,FUN_041924-T1,Q9H8V3,,,,,44.9,864.0,3.6e-184,646.7,sp|Q9H8V3|ECT2_HUMAN Protein ECT2 OS=Homo sapiens OX=9606 GN=ECT2 PE=1 SV=4,,,,,,
OG_09696,1.9336226472738067,FUN_041927-T1,Peve_00025329,Pocillopora_meandrina_HIv1___RNAseq.g15250.t1,three_way,59.38166666666667,FUN_041927-T1,Q3UPY5,,,,,44.6,630.0,8.2e-144,512.3,sp|Q3UPY5|GLBL2_MOUSE Beta-galactosidase-1-like protein 2 OS=Mus musculus OX=10090 GN=Glb1l2 PE=1 SV=1,,,,,,
OG_09697,1.0699164773084022,FUN_041928-T1,Peve_00022682,Pocillopora_meandrina_HIv1___RNAseq.g15696.t1,three_way,66.166,FUN_041928-T1,Q8BG19,TMTC4_MOUSE,,Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4),Mus musculus (Mouse),52.0,481.0,5.7e-131,469.9,sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1,GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584,endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169],GO:0003824; GO:0005783; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0050877; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; nervous system process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_09698,1.951593171573263,FUN_041929-T1,Peve_00022681,Pocillopora_meandrina_HIv1___RNAseq.g15697.t1,three_way,59.108,FUN_041929-T1,Q6AYB8,GO45_RAT,,Golgin-45 (Basic leucine zipper nuclear factor 1),Rattus norvegicus (Rat),29.6,422.0,1.5e-25,119.0,sp|Q6AYB8|GO45_RAT Golgin-45 OS=Rattus norvegicus OX=10116 GN=Blzf1 PE=1 SV=1,GO:0000139; GO:0005634; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001,Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005794; GO:0016192; GO:0043226; GO:0072659,nucleus; Golgi apparatus; vesicle-mediated transport; organelle; protein localization to plasma membrane
OG_09702,1.0028689647981104,FUN_041933-T1,Peve_00023581,Pocillopora_meandrina_HIv1___RNAseq.g15700.t1,three_way,61.377,FUN_041933-T1,P52594,AGFG1_HUMAN,,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),Homo sapiens (Human),57.9,183.0,3.4e-54,214.9,sp|P52594|AGFG1_HUMAN Arf-GAP domain and FG repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=AGFG1 PE=1 SV=2,GO:0001675; GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005737; GO:0005829; GO:0006406; GO:0007289; GO:0008270; GO:0031410; GO:0042995; GO:0043025; GO:0043231; GO:0045109,acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nuclear pore [GO:0005643],DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005829; GO:0006913; GO:0007010; GO:0022414; GO:0031410; GO:0043226; GO:0098772,DNA binding; RNA binding; cytosol; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09703,1.1816295355362796,FUN_041935-T1,Peve_00023583,Pocillopora_meandrina_HIv1___RNAseq.g15701.t2,three_way,79.72516666666667,FUN_041935-T1,Q9ES28,,,,,36.5,902.0,1.6e-131,471.9,sp|Q9ES28|ARHG7_MOUSE Rho guanine nucleotide exchange factor 7 OS=Mus musculus OX=10090 GN=Arhgef7 PE=1 SV=2,,,,,,
OG_09704,1.4742432436699666,FUN_041938-T1,Peve_00023588,Pocillopora_meandrina_HIv1___TS.g10732.t1,three_way,61.260666666666665,FUN_041938-T1,P05619,,,,,35.9,376.0,1.1e-65,252.3,sp|P05619|ILEU_HORSE Leukocyte elastase inhibitor OS=Equus caballus OX=9796 GN=SERPINB1 PE=1 SV=3,,,,,,
OG_09707,1.9708956480118511,FUN_041944-T1,Peve_00023595,Pocillopora_meandrina_HIv1___RNAseq.g15636.t1,three_way,61.59033333333333,FUN_041944-T1,P25169,,,,,28.7,293.0,1.3e-21,105.1,sp|P25169|AT1B1_ARTSF Sodium/potassium-transporting ATPase subunit beta OS=Artemia franciscana OX=6661 PE=2 SV=1,,,,,,
OG_09709,1.205455170483134,FUN_041947-T1,Peve_00007871,Pocillopora_meandrina_HIv1___TS.g10659.t1,three_way,67.32600000000001,,,,,,,,,,,,,,,,,
OG_09710,2.028863175707356,FUN_041950-T1,Peve_00025328,Pocillopora_meandrina_HIv1___RNAseq.g15251.t1,three_way,82.19333333333333,FUN_041950-T1,Q6PBU5,,,,,49.8,325.0,8.4e-92,338.6,sp|Q6PBU5|GRT1A_DANRE Growth hormone-regulated TBC protein 1-A OS=Danio rerio OX=7955 GN=grtp1a PE=2 SV=1,,,,,,
OG_09711,1.3593529876059058,FUN_041951-T1,Peve_00022248,Pocillopora_meandrina_HIv1___RNAseq.g15252.t1,three_way,67.0045,FUN_041951-T1,Q498F0,,,,,52.2,592.0,2.6e-153,544.3,sp|Q498F0|WDR44_XENLA WD repeat-containing protein 44 OS=Xenopus laevis OX=8355 GN=wdr44 PE=2 SV=1,,,,,,
OG_09714,1.2326876000951006,FUN_041959-T1,Peve_00043500,Pocillopora_meandrina_HIv1___RNAseq.g15157.t1,three_way,69.572,FUN_041959-T1,P91891,,,,,66.1,336.0,8.800000000000001e-118,424.9,sp|P91891|MO25_DROME Protein Mo25 OS=Drosophila melanogaster OX=7227 GN=Mo25 PE=2 SV=2,,,,,,
OG_09715,1.0723954038927566,FUN_041961-T1,Peve_00043496,Pocillopora_meandrina_HIv1___RNAseq.g15155.t1,three_way,54.928,,,,,,,,,,,,,,,,,
OG_09716,1.3316379453528713,FUN_041962-T1,Peve_00043495,Pocillopora_meandrina_HIv1___RNAseq.g15154.t1,three_way,93.26933333333334,FUN_041962-T1,P20340,RAB6A_HUMAN,,Ras-related protein Rab-6A (Rab-6) (EC 3.6.5.2),Homo sapiens (Human),85.4,205.0,1.1e-94,347.4,sp|P20340|RAB6A_HUMAN Ras-related protein Rab-6A OS=Homo sapiens OX=9606 GN=RAB6A PE=1 SV=3,GO:0000139; GO:0002080; GO:0003924; GO:0005525; GO:0005654; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0016020; GO:0018125; GO:0019882; GO:0019904; GO:0030667; GO:0031175; GO:0031410; GO:0031489; GO:0032588; GO:0034067; GO:0034498; GO:0036064; GO:0042147; GO:0070062; GO:0070381; GO:0072385; GO:1903292,"antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; minus-end-directed organelle transport along microtubule [GO:0072385]; neuron projection development [GO:0031175]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; protein localization to Golgi membrane [GO:1903292]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",acrosomal membrane [GO:0002080]; ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0043226,immune system process; catalytic activity; GTPase activity; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_09724,1.843231028790301,FUN_041970-T1,Peve_00028273,Pocillopora_meandrina_HIv1___RNAseq.g15920.t1,three_way,90.77,FUN_041970-T1,P39825,,,,,38.0,129.0,2e-17,90.1,sp|P39825|PROF_SCHPO Profilin OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=cdc3 PE=1 SV=1,,,,,,
OG_09727,2.800572699605609,FUN_041980-T1,Peve_00001545,Pocillopora_meandrina_HIv1___RNAseq.g15256.t1,three_way,86.63666666666666,FUN_041980-T1,Q14644,RASA3_HUMAN,,Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein),Homo sapiens (Human),47.9,821.0,2.6000000000000004e-211,736.9,sp|Q14644|RASA3_HUMAN Ras GTPase-activating protein 3 OS=Homo sapiens OX=9606 GN=RASA3 PE=1 SV=3,GO:0005096; GO:0005246; GO:0005829; GO:0007165; GO:0008270; GO:0009898; GO:0030168; GO:0035556; GO:0046580,intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; platelet activation [GO:0030168]; signal transduction [GO:0007165],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829],calcium channel regulator activity [GO:0005246]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_09728,1.761591035615798,FUN_041981-T1,Peve_00001546,Pocillopora_meandrina_HIv1___RNAseq.g15162.t1,three_way,54.784666666666666,FUN_041981-T1,P06400,RB_HUMAN,,Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110),Homo sapiens (Human),27.8,857.0,8.2e-74,280.0,sp|P06400|RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens OX=9606 GN=RB1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000785; GO:0000977; GO:0001894; GO:0002062; GO:0003180; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006338; GO:0006355; GO:0006366; GO:0006469; GO:0007224; GO:0007265; GO:0007283; GO:0007346; GO:0010629; GO:0014009; GO:0016514; GO:0016605; GO:0019900; GO:0030154; GO:0030308; GO:0031134; GO:0031175; GO:0031507; GO:0031625; GO:0032869; GO:0034088; GO:0034349; GO:0035189; GO:0035914; GO:0042551; GO:0042802; GO:0043353; GO:0043433; GO:0043550; GO:0045445; GO:0045651; GO:0045786; GO:0045842; GO:0045879; GO:0045892; GO:0045944; GO:0048565; GO:0048667; GO:0050673; GO:0050680; GO:0050728; GO:0051146; GO:0051219; GO:0051276; GO:0051301; GO:0051402; GO:0051726; GO:0060090; GO:0060253; GO:0061629; GO:0061676; GO:0061793; GO:0071459; GO:0071466; GO:0090230; GO:0097284; GO:0097718; GO:0120163; GO:0140297; GO:1903055; GO:1903944; GO:1904028; GO:1904761; GO:2000134; GO:2000679; GO:2001234,"aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; chromosome organization [GO:0051276]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell proliferation [GO:0050673]; G1/S transition of mitotic cell cycle [GO:0000082]; glial cell apoptotic process [GO:0034349]; glial cell proliferation [GO:0014009]; hepatocyte apoptotic process [GO:0097284]; heterochromatin formation [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of DNA-templated transcription [GO:0006355]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]",chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514],disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_09731,1.75508912085606,FUN_041989-T1,Peve_00010446,Pocillopora_meandrina_HIv1___RNAseq.g15231.t1,three_way,48.022,,,,,,,,,,,,,,,,,
OG_09732,2.3412320634514865,FUN_041991-T1,Peve_00020704,Pocillopora_meandrina_HIv1___RNAseq.g15229.t1,three_way,48.99766666666667,,,,,,,,,,,,,,,,,
OG_09734,1.4360051457266223,FUN_041993-T1,Peve_00014041,Pocillopora_meandrina_HIv1___RNAseq.g15227.t1,three_way,47.711666666666666,,,,,,,,,,,,,,,,,
OG_09736,1.5078430621103605,FUN_041995-T1,Peve_00023725,Pocillopora_meandrina_HIv1___RNAseq.g15224.t1,three_way,92.50633333333332,FUN_041995-T1,Q7ZXB1,MCM7B_XENLA,,DNA replication licensing factor mcm7-B (EC 3.6.4.12) (CDC47 homolog B) (CDC47-2p) (Minichromosome maintenance protein 7-B) (xMCM7-B),Xenopus laevis (African clawed frog),74.5,718.0,1.4e-309,1063.1,sp|Q7ZXB1|MCM7B_XENLA DNA replication licensing factor mcm7-B OS=Xenopus laevis OX=8355 GN=mcm7-b PE=1 SV=1,GO:0000727; GO:0000785; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006270; GO:0006271; GO:0008270; GO:0016887; GO:0017116; GO:0030174; GO:0042555; GO:0071162,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_09737,1.8157400182424817,FUN_041999-T3,Peve_00034150,Pocillopora_meandrina_HIv1___RNAseq.g15222.t1,three_way,51.45166666666667,FUN_041999-T3,Q9ERU9,RBP2_MOUSE,,E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2),Mus musculus (Mouse),23.6,3401.0,5.800000000000001e-178,628.2,sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2,GO:0001975; GO:0003723; GO:0003755; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723,centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975],annulate lamellae [GO:0005642]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068],kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005635; GO:0005654; GO:0005829; GO:0006457; GO:0006886; GO:0006913; GO:0016740; GO:0016853; GO:0098772; GO:0140096,"RNA binding; catalytic activity; nuclear envelope; nucleoplasm; cytosol; protein folding; intracellular protein transport; nucleocytoplasmic transport; transferase activity; isomerase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09738,1.1504502269395234,FUN_042000-T1,Peve_00016463,Pocillopora_meandrina_HIv1___RNAseq.g15221.t1,three_way,69.44083333333333,,,,,,,,,,,,,,,,,
OG_09740,2.068339732017692,FUN_042002-T1,Peve_00016466,Pocillopora_meandrina_HIv1___RNAseq.g15218.t1,three_way,89.01233333333333,FUN_042002-T1,Q96GG9,DCNL1_HUMAN,,DCN1-like protein 1 (DCNL1) (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene),Homo sapiens (Human),68.3,259.0,8.2e-106,385.2,sp|Q96GG9|DCNL1_HUMAN DCN1-like protein 1 OS=Homo sapiens OX=9606 GN=DCUN1D1 PE=1 SV=1,GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0031396; GO:0031624; GO:0032182; GO:0045116; GO:0097602; GO:2000434; GO:2000436,positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]; regulation of protein ubiquitination [GO:0031396],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182],GO:0005634; GO:0005654; GO:0005829; GO:0043226,nucleus; nucleoplasm; cytosol; organelle
OG_09743,1.9296480400776528,FUN_042009-T1,Peve_00031038,Pocillopora_meandrina_HIv1___RNAseq.g15212.t1,three_way,48.658166666666666,,,,,,,,,,,,,,,,,
OG_09744,1.017641130162623,FUN_042010-T1,Peve_00035507,Pocillopora_meandrina_HIv1___RNAseq.g15214.t1,three_way,59.618,,,,,,,,,,,,,,,,,
OG_09748,1.773509817839837,FUN_042017-T1,Peve_00044151,Pocillopora_meandrina_HIv1___RNAseq.g15194.t1,three_way,79.5055,FUN_042017-T1,B5FXE5,FSP1_TAEGU,,Ferroptosis suppressor protein 1 (FSP1) (EC 1.6.5.-) (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death) (AMID) (p53-responsive gene 3 protein),Taeniopygia guttata (Zebra finch) (Poephila guttata),39.4,373.0,2.0999999999999998e-70,267.7,sp|B5FXE5|FSP1_TAEGU Ferroptosis suppressor protein 1 OS=Taeniopygia guttata OX=59729 GN=AIFM2 PE=2 SV=1,GO:0004174; GO:0005634; GO:0005811; GO:0005886; GO:0008637; GO:0016655; GO:0031966; GO:0042373; GO:0043065; GO:0050660,apoptotic mitochondrial changes [GO:0008637]; positive regulation of apoptotic process [GO:0043065]; vitamin K metabolic process [GO:0042373],lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]",GO:0003824; GO:0005634; GO:0005811; GO:0005886; GO:0007005; GO:0016491; GO:0043226,catalytic activity; nucleus; lipid droplet; plasma membrane; mitochondrion organization; oxidoreductase activity; organelle
OG_09754,1.5222736712966765,FUN_042025-T1,Peve_00030370,Pocillopora_meandrina_HIv1___RNAseq.g15170.t1,three_way,94.194,FUN_042025-T1,G3MZY8,RPB1_BOVIN,,DNA-directed RNA polymerase II subunit RPB1 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),Bos taurus (Bovine),77.4,1533.0,0.0,2438.7,sp|G3MZY8|RPB1_BOVIN DNA-directed RNA polymerase II subunit RPB1 OS=Bos taurus OX=9913 GN=POLR2A PE=1 SV=2,GO:0000287; GO:0000791; GO:0001046; GO:0003899; GO:0003968; GO:0005665; GO:0005739; GO:0006366; GO:0008270; GO:0016787; GO:0071667,transcription by RNA polymerase II [GO:0006366],"euchromatin [GO:0000791]; mitochondrion [GO:0005739]; RNA polymerase II, core complex [GO:0005665]",core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005739; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; catalytic activity; mitochondrion; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09755,1.5813887135439182,FUN_042027-T1,Peve_00025064,Pocillopora_meandrina_HIv1___RNAseq.g15172.t1,three_way,61.967,,,,,,,,,,,,,,,,,
OG_09756,1.6454498306406693,FUN_042028-T1,Peve_00025065,Pocillopora_meandrina_HIv1___RNAseq.g15173.t1,three_way,82.21866666666666,FUN_042028-T1,Q9VUX2,MIB_DROME,,E3 ubiquitin-protein ligase mind-bomb (EC 2.3.2.27) (Mind bomb homolog) (D-mib) (RING-type E3 ubiquitin transferase mind-bomb),Drosophila melanogaster (Fruit fly),41.3,75.0,1.5e-08,62.4,sp|Q9VUX2|MIB_DROME E3 ubiquitin-protein ligase mind-bomb OS=Drosophila melanogaster OX=7227 GN=mib1 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006897; GO:0007219; GO:0007423; GO:0008104; GO:0008270; GO:0008593; GO:0016567; GO:0045179; GO:0045747; GO:0045807; GO:0046331; GO:0061630,endocytosis [GO:0006897]; lateral inhibition [GO:0046331]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593]; sensory organ development [GO:0007423],apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016192; GO:0016740; GO:0023052; GO:0048856; GO:0140096,"catalytic activity; cytosol; vesicle-mediated transport; transferase activity; signaling; anatomical structure development; catalytic activity, acting on a protein"
OG_09757,3.0848258003107047,FUN_042029-T1,Peve_00025063,Pocillopora_meandrina_HIv1___RNAseq.g15174.t1,three_way,47.64533333333333,FUN_042029-T1,Q9QYM2,,,,,31.9,354.0,1.1e-38,163.7,sp|Q9QYM2|PARG_RAT Poly(ADP-ribose) glycohydrolase OS=Rattus norvegicus OX=10116 GN=Parg PE=1 SV=1,,,,,,
OG_09762,1.630885137418059,FUN_042036-T1,Peve_00025426,Pocillopora_meandrina_HIv1___RNAseq.g15187.t1,three_way,89.87166666666667,FUN_042036-T1,O00410,IPO5_HUMAN,,Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5),Homo sapiens (Human),54.7,1080.0,0.0,1178.7,sp|O00410|IPO5_HUMAN Importin-5 OS=Homo sapiens OX=9606 GN=IPO5 PE=1 SV=4,GO:0002753; GO:0003723; GO:0005095; GO:0005634; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0016020; GO:0031267; GO:0031965; GO:0042307; GO:0045786; GO:0061608; GO:0071230,cellular response to amino acid stimulus [GO:0071230]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; negative regulation of cell cycle [GO:0045786]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0002376; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0098772; GO:0140104,immune system process; RNA binding; nucleus; nucleoplasm; nucleolus; Golgi apparatus; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular function regulator activity; molecular carrier activity
OG_09763,1.7294486467246193,FUN_042040-T1,Peve_00025408,Pocillopora_meandrina_HIv1___RNAseq.g15182.t1,three_way,54.059333333333335,FUN_042040-T1,Q63155,DCC_RAT,,Netrin receptor DCC (Tumor suppressor protein DCC),Rattus norvegicus (Rat),29.4,687.0,1.7e-55,219.2,sp|Q63155|DCC_RAT Netrin receptor DCC OS=Rattus norvegicus OX=10116 GN=Dcc PE=1 SV=2,GO:0001764; GO:0001975; GO:0003713; GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0009986; GO:0010976; GO:0021554; GO:0021965; GO:0021987; GO:0022038; GO:0030424; GO:0032584; GO:0033563; GO:0033564; GO:0042802; GO:0061564; GO:0070374; GO:0098609; GO:0098685; GO:0098839; GO:0099170,anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon development [GO:0061564]; axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; optic nerve development [GO:0021554]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron projection development [GO:0010976]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; response to amphetamine [GO:0001975]; spinal cord ventral commissure morphogenesis [GO:0021965],axon [GO:0030424]; cell surface [GO:0009986]; growth cone membrane [GO:0032584]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685],identical protein binding [GO:0042802]; netrin receptor activity [GO:0005042]; transcription coactivator activity [GO:0003713],GO:0005886; GO:0007155; GO:0012501; GO:0048856; GO:0048870; GO:0060089; GO:0060090; GO:0140110,plasma membrane; cell adhesion; programmed cell death; anatomical structure development; cell motility; molecular transducer activity; molecular adaptor activity; transcription regulator activity
OG_09764,1.4735619582296595,FUN_042043-T1,Peve_00025406,Pocillopora_meandrina_HIv1___RNAseq.g15137.t1,three_way,85.81366666666666,FUN_042043-T1,Q70VZ7,MOGT1_BOVIN,,2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Monoacylglycerol O-acyltransferase 1),Bos taurus (Bovine),56.3,332.0,2.7e-106,386.7,sp|Q70VZ7|MOGT1_BOVIN 2-acylglycerol O-acyltransferase 1 OS=Bos taurus OX=9913 GN=MOGAT1 PE=2 SV=1,GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0019432,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum membrane [GO:0005789],2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005975; GO:0006629; GO:0016740,catalytic activity; carbohydrate metabolic process; lipid metabolic process; transferase activity
OG_09767,1.8467368833302875,FUN_042048-T1,Peve_00025414,Pocillopora_meandrina_HIv1___RNAseq.g15142.t1,three_way,77.533,FUN_042048-T1,Q8BH01,,,,,43.5,666.0,3.1e-136,487.3,sp|Q8BH01|TMCO3_MOUSE Transmembrane and coiled-coil domain-containing protein 3 OS=Mus musculus OX=10090 GN=Tmco3 PE=2 SV=1,,,,,,
OG_09768,1.6265735759558502,FUN_042049-T1,Peve_00025415,Pocillopora_meandrina_HIv1___RNAseq.g15143.t1,three_way,63.039,,,,,,,,,,,,,,,,,
OG_09770,1.1360363592886915,FUN_042051-T1,Peve_00025418,Pocillopora_meandrina_HIv1___RNAseq.g15145.t1,three_way,44.09616666666667,FUN_042051-T1,Q8BHR2,,,,,29.9,294.0,1.7e-33,146.4,sp|Q8BHR2|ENOX1_MOUSE Ecto-NOX disulfide-thiol exchanger 1 OS=Mus musculus OX=10090 GN=Enox1 PE=2 SV=1,,,,,,
OG_09774,1.2608521672501067,FUN_042060-T1,Peve_00019715,Pocillopora_meandrina_HIv1___RNAseq.g22263.t1,three_way,39.5205,,,,,,,,,,,,,,,,,
OG_09777,1.079937513317,FUN_042107-T1,Peve_00009513,Pocillopora_meandrina_HIv1___RNAseq.g21779.t1,three_way,95.49616666666668,FUN_042107-T1,Q6GQ52,,,,,67.9,84.0,1.4000000000000001e-28,126.7,sp|Q6GQ52|TI10B_XENLA Mitochondrial import inner membrane translocase subunit Tim10-B OS=Xenopus laevis OX=8355 GN=timm10-b PE=3 SV=1,,,,,,
OG_09779,1.1460122979108118,FUN_042125-T1,Peve_00009509,Pocillopora_meandrina_HIv1___RNAseq.g19349.t1,three_way,54.792,,,,,,,,,,,,,,,,,
OG_09787,1.195512134269604,FUN_042589-T1,Peve_00012671,Pocillopora_meandrina_HIv1___RNAseq.g16875.t1,three_way,61.26133333333333,FUN_042589-T1,P25122,KCNC1_RAT,,Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (RAW2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4),Rattus norvegicus (Rat),43.0,461.0,4.9e-93,344.0,sp|P25122|KCNC1_RAT Voltage-gated potassium channel KCNC1 OS=Rattus norvegicus OX=10116 GN=Kcnc1 PE=1 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030425; GO:0030673; GO:0032589; GO:0032590; GO:0032809; GO:0034765; GO:0034767; GO:0035864; GO:0042734; GO:0043025; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0046872; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901379; GO:1901381; GO:1990089,action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of monoatomic ion transmembrane transport [GO:0034767]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of potassium ion transmembrane transport [GO:1901379]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636],axolemma [GO:0030673]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; neuron projection membrane [GO:0032589]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0008092; GO:0048856; GO:0055085; GO:0065003,transporter activity; cytoskeletal protein binding; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_09789,2.594687491501229,FUN_042591-T1,Peve_00012673,Pocillopora_meandrina_HIv1___RNAseq.g16869.t1,three_way,79.75733333333334,FUN_042591-T1,Q87PP5,,,,,36.3,535.0,8.499999999999999e-92,339.7,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_09791,1.4205151977780948,FUN_042593-T1,Peve_00008128,Pocillopora_meandrina_HIv1___RNAseq.g16867.t1,three_way,79.72,FUN_042593-T1,Q80TC6,,,,,50.6,1158.0,2.7e-309,1062.8,sp|Q80TC6|ZSWM5_MOUSE Zinc finger SWIM domain-containing protein 5 OS=Mus musculus OX=10090 GN=Zswim5 PE=2 SV=2,,,,,,
OG_09792,1.6055493495477475,FUN_042594-T1,Peve_00008122,Pocillopora_meandrina_HIv1___RNAseq.g16865.t1,three_way,78.67766666666667,FUN_042594-T1,Q9D531,NXNL2_MOUSE,,Nucleoredoxin-like protein 2 (Rod-derived cone viability factor 2) (RdCVF2),Mus musculus (Mouse),47.3,146.0,7.7e-34,145.2,sp|Q9D531|NXNL2_MOUSE Nucleoredoxin-like protein 2 OS=Mus musculus OX=10090 GN=Nxnl2 PE=1 SV=1,GO:0007601; GO:0007608; GO:0045494,photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601],,,GO:0050877,nervous system process
OG_09793,1.1333159122403464,FUN_042595-T1,Peve_00008123,Pocillopora_meandrina_HIv1___RNAseq.g16864.t1,three_way,83.503,FUN_042595-T1,Q8T3X9,,,,,67.9,131.0,2.0999999999999997e-43,176.4,"sp|Q8T3X9|ISCA1_DROME Iron-sulfur cluster assembly 1 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=MagR PE=1 SV=1",,,,,,
OG_09794,1.430860192611532,FUN_042597-T1,Peve_00008125,Pocillopora_meandrina_HIv1___RNAseq.g16860.t1,three_way,82.09866666666666,FUN_042597-T1,Q8BGV9,ATG4D_MOUSE,,"Cysteine protease ATG4D (EC 3.4.22.-) (AUT-like 4 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 4) (Autophagin-4) (Autophagy-related protein 4 homolog D) [Cleaved into: Cysteine protease ATG4D, mitochondrial]",Mus musculus (Mouse),44.8,402.0,5.1e-100,366.3,sp|Q8BGV9|ATG4D_MOUSE Cysteine protease ATG4D OS=Mus musculus OX=10090 GN=Atg4d PE=1 SV=1,GO:0000423; GO:0005654; GO:0005759; GO:0006508; GO:0006914; GO:0006915; GO:0008234; GO:0015031; GO:0019786; GO:0034497; GO:0051697,apoptotic process [GO:0006915]; autophagy [GO:0006914]; mitophagy [GO:0000423]; protein delipidation [GO:0051697]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; proteolysis [GO:0006508],mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654],cysteine-type peptidase activity [GO:0008234]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786],GO:0003824; GO:0005654; GO:0006914; GO:0012501; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; autophagy; programmed cell death; hydrolase activity; catalytic activity, acting on a protein"
OG_09795,1.0827466902779106,FUN_042602-T1,Peve_00034908,Pocillopora_meandrina_HIv1___RNAseq.g16851.t1,three_way,67.051,FUN_042602-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),26.5,701.0,3.2999999999999996e-62,241.9,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_09798,1.0442090403279276,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000003e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_09803,2.259690632527825,FUN_042614-T1,Peve_00034928,Pocillopora_meandrina_HIv1___RNAseq.g17030.t1,three_way,75.631,FUN_042614-T1,A0A1D5PXA5,TRPV4_CHICK,,Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Vanilloid receptor-related osmotically activated channel) (VR-OAC),Gallus gallus (Chicken),20.4,313.0,1.5e-08,63.2,sp|A0A1D5PXA5|TRPV4_CHICK Transient receptor potential cation channel subfamily V member 4 OS=Gallus gallus OX=9031 GN=TRPV4 PE=1 SV=1,GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005886; GO:0005912; GO:0005929; GO:0006874; GO:0007015; GO:0007231; GO:0008289; GO:0016324; GO:0017124; GO:0035091; GO:0046872; GO:0098703,actin filament organization [GO:0007015]; calcium ion import across plasma membrane [GO:0098703]; intracellular calcium ion homeostasis [GO:0006874]; osmosensory signaling pathway [GO:0007231],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; monoatomic cation channel activity [GO:0005261]; phosphatidylinositol binding [GO:0035091]; SH3 domain binding [GO:0017124],GO:0005215; GO:0005886; GO:0005929; GO:0008289; GO:0043226; GO:0055085,transporter activity; plasma membrane; cilium; lipid binding; organelle; transmembrane transport
OG_09804,1.1471044902798018,FUN_042622-T1,Peve_00029438,Pocillopora_meandrina_HIv1___RNAseq.g11513.t1,three_way,76.01333333333334,FUN_042622-T1,A7YWD2,,,,,36.5,941.0,1.5e-175,618.2,sp|A7YWD2|IPO13_BOVIN Importin-13 OS=Bos taurus OX=9913 GN=IPO13 PE=2 SV=1,,,,,,
OG_09806,3.0124862650416224,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09807,1.791159942274586,FUN_042628-T1,Peve_00016195,Pocillopora_meandrina_HIv1___RNAseq.g11508.t1,three_way,45.25,FUN_042628-T1,O95390,GDF11_HUMAN,,Growth/differentiation factor 11 (GDF-11) (Bone morphogenetic protein 11) (BMP-11),Homo sapiens (Human),29.0,372.0,2.3000000000000002e-33,144.8,sp|O95390|GDF11_HUMAN Growth/differentiation factor 11 OS=Homo sapiens OX=9606 GN=GDF11 PE=1 SV=1,GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005615; GO:0007399; GO:0007498; GO:0008083; GO:0008283; GO:0008285; GO:0021512; GO:0032924; GO:0032991; GO:0035881; GO:0048593; GO:0060021; GO:0060391; GO:0072560; GO:1902870,activin receptor signaling pathway [GO:0032924]; amacrine cell differentiation [GO:0035881]; camera-type eye morphogenesis [GO:0048593]; cell population proliferation [GO:0008283]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of SMAD protein signal transduction [GO:0060391]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; spinal cord anterior/posterior patterning [GO:0021512]; type B pancreatic cell maturation [GO:0072560]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; protein-containing complex [GO:0032991],cytokine activity [GO:0005125]; growth factor activity [GO:0008083],GO:0005615; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_09809,1.8095283532868909,FUN_042631-T1,Peve_00030043,Pocillopora_meandrina_HIv1___RNAseq.g11506.t1,three_way,73.376,FUN_042631-T1,Q5VTB9,RN220_HUMAN,,E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220),Homo sapiens (Human),33.0,657.0,3.9999999999999997e-63,244.2,sp|Q5VTB9|RN220_HUMAN E3 ubiquitin-protein ligase RNF220 OS=Homo sapiens OX=9606 GN=RNF220 PE=1 SV=1,GO:0003358; GO:0004842; GO:0005634; GO:0005652; GO:0005654; GO:0005737; GO:0006513; GO:0008013; GO:0008270; GO:0016567; GO:0021904; GO:0032991; GO:0051091; GO:0051865; GO:0061630; GO:0090263; GO:0098794; GO:0098978; GO:0099149; GO:2000677,dorsal/ventral neural tube patterning [GO:0021904]; noradrenergic neuron development [GO:0003358]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of transcription regulatory region DNA binding [GO:2000677],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],beta-catenin binding [GO:0008013]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09811,1.0955788448388448,FUN_042633-T1,Peve_00030033,Pocillopora_meandrina_HIv1___RNAseq.19516_t,three_way,82.042,FUN_042633-T1,P08651,NFIC_HUMAN,,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),Homo sapiens (Human),48.2,390.0,3.2e-79,297.7,sp|P08651|NFIC_HUMAN Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0006366; GO:0042475; GO:0045944; GO:1990837,DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA replication; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_09814,1.6877142102539795,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),49.4,1473.0,0.0,1337.0,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09814,1.6877142102539795,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),30.0,247.0,2.5e-08,63.9,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09820,1.8769049140013696,FUN_042653-T1,Peve_00038268,Pocillopora_meandrina_HIv1___RNAseq.g16812.t1,three_way,75.381,FUN_042653-T1,Q8R4F0,MCLN3_MOUSE,,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),Mus musculus (Mouse),39.9,491.0,5.2000000000000004e-89,330.1,sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1,GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171,inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171],lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289; GO:0030154,transporter activity; plasma membrane; lipid binding; cell differentiation
OG_09821,1.0103183876695576,FUN_042654-T1,Peve_00031585,Pocillopora_meandrina_HIv1___RNAseq.g4912.t1,three_way,68.26350000000001,FUN_042654-T1,Q9JJP2,P73_MOUSE,,Tumor protein p73 (p53-like transcription factor) (p53-related protein),Mus musculus (Mouse),45.5,266.0,9.2e-51,202.6,sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0001836; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005886; GO:0006954; GO:0006974; GO:0007346; GO:0009410; GO:0009791; GO:0010468; GO:0019901; GO:0021766; GO:0030054; GO:0030900; GO:0033326; GO:0036064; GO:0042771; GO:0042802; GO:0043410; GO:0043523; GO:0043524; GO:0045665; GO:0045793; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0048666; GO:0048714; GO:0051262; GO:0060044; GO:0061629; GO:0097371; GO:1901248; GO:1902167; GO:2001235,cerebrospinal fluid secretion [GO:0033326]; digestive tract morphogenesis [GO:0048546]; DNA damage response [GO:0006974]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein tetramerization [GO:0051262]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron apoptotic process [GO:0043523]; release of cytochrome c from mitochondria [GO:0001836]; response to xenobiotic stimulus [GO:0009410],cell junction [GO:0030054]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005886; GO:0006355; GO:0006954; GO:0007005; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; plasma membrane; regulation of DNA-templated transcription; inflammatory response; mitochondrion organization; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_09822,1.2807298332790895,FUN_042655-T1,Peve_00031586,Pocillopora_meandrina_HIv1___RNAseq.g4911.t2,three_way,59.10533333333333,FUN_042655-T1,Q8R4F0,MCLN3_MOUSE,,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),Mus musculus (Mouse),39.7,546.0,7.899999999999999e-99,362.8,sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1,GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171,inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171],lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289; GO:0030154,transporter activity; plasma membrane; lipid binding; cell differentiation
OG_09826,1.0026178565377015,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_09830,1.830990979230679,FUN_042807-T1,Peve_00003076,Pocillopora_meandrina_HIv1___RNAseq.g7424.t1,three_way,78.86633333333333,FUN_042807-T1,P41240,CSK_HUMAN,,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),Homo sapiens (Human),56.1,442.0,8.4e-143,508.4,sp|P41240|CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens OX=9606 GN=CSK PE=1 SV=1,GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0034236; GO:0034332; GO:0035556; GO:0042802; GO:0042997; GO:0045779; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0050860; GO:0050868; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375; GO:1990782,adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; oligodendrocyte differentiation [GO:0048709]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; transferase activity; cell differentiation; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_09831,1.1133132794467957,FUN_042808-T1,Peve_00003077,Pocillopora_meandrina_HIv1___RNAseq.g7425.t1,three_way,92.786,FUN_042808-T1,Q5F448,GPHR_CHICK,,Golgi pH regulator (Protein GPR89),Gallus gallus (Chicken),68.6,455.0,9.7e-176,617.8,sp|Q5F448|GPHR_CHICK Golgi pH regulator OS=Gallus gallus OX=9031 GN=GPR89 PE=2 SV=1,GO:0000139; GO:0008308; GO:0015031; GO:0030217; GO:0030660; GO:0032580; GO:0034702; GO:0043588; GO:0051452,intracellular pH reduction [GO:0051452]; protein transport [GO:0015031]; skin development [GO:0043588]; T cell differentiation [GO:0030217],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; monoatomic ion channel complex [GO:0034702],voltage-gated monoatomic anion channel activity [GO:0008308],GO:0002376; GO:0005215; GO:0030154; GO:0048856,immune system process; transporter activity; cell differentiation; anatomical structure development
OG_09839,1.992410026123266,FUN_042820-T1,Peve_00019572,Pocillopora_meandrina_HIv1___RNAseq.g7438.t1,three_way,89.72666666666667,FUN_042820-T1,P40424,PBX1_HUMAN,,Pre-B-cell leukemia transcription factor 1 (Homeobox protein PBX1) (Homeobox protein PRL),Homo sapiens (Human),69.0,407.0,9.8e-132,471.9,sp|P40424|PBX1_HUMAN Pre-B-cell leukemia transcription factor 1 OS=Homo sapiens OX=9606 GN=PBX1 PE=1 SV=1,GO:0000086; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001222; GO:0001228; GO:0001654; GO:0001655; GO:0001658; GO:0001779; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006694; GO:0007420; GO:0007548; GO:0009887; GO:0009952; GO:0009954; GO:0010971; GO:0030278; GO:0030325; GO:0030326; GO:0035162; GO:0043433; GO:0045665; GO:0045944; GO:0048536; GO:0048538; GO:0048568; GO:0048666; GO:0048706; GO:0072089; GO:0090575; GO:0140297; GO:1990837; GO:2000648,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; G2/M transition of mitotic cell cycle [GO:0000086]; natural killer cell differentiation [GO:0001779]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006629; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; lipid metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09840,1.887415105005542,FUN_042821-T1,Peve_00019575,Pocillopora_meandrina_HIv1___RNAseq.g7439.t2,three_way,61.8725,FUN_042821-T1,A2RV61,,,,,30.5,1466.0,5.5e-152,540.4,sp|A2RV61|GAPD1_XENLA GTPase-activating protein and VPS9 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gapvd1 PE=2 SV=1,,,,,,
OG_09841,1.1506441788799666,FUN_042822-T2,Peve_00019576,Pocillopora_meandrina_HIv1___TS.g1194.t1,three_way,82.61283333333333,FUN_042822-T2,Q28WQ1,KIF1A_DROPS,,Kinesin-like protein unc-104,Drosophila pseudoobscura pseudoobscura (Fruit fly),47.8,1673.0,0.0,1395.2,sp|Q28WQ1|KIF1A_DROPS Kinesin-like protein unc-104 OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=unc-104 PE=3 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005875; GO:0008017; GO:0047496; GO:0048489,synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0007018; GO:0008092; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule-based movement; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_09843,1.2070335411047308,FUN_042828-T1,Peve_00041828,Pocillopora_meandrina_HIv1___RNAseq.g7273.t1,three_way,72.41866666666667,FUN_042828-T1,Q5IS35,,,,,48.6,315.0,4e-78,293.1,sp|Q5IS35|TPC_MACFA Mitochondrial thiamine pyrophosphate carrier OS=Macaca fascicularis OX=9541 GN=SLC25A19 PE=2 SV=1,,,,,,
OG_09844,1.0511660724107252,FUN_042829-T1,Peve_00041827,Pocillopora_meandrina_HIv1___RNAseq.g7272.t1,three_way,75.69333333333333,,,,,,,,,,,,,,,,,
OG_09845,1.149195982737402,FUN_042830-T1,Peve_00041826,Pocillopora_meandrina_HIv1___RNAseq.g7271.t1,three_way,92.688,FUN_042830-T1,P62915,TF2B_MOUSE,,Transcription initiation factor IIB (EC 2.3.1.48) (General transcription factor TFIIB) (RNA polymerase II alpha initiation factor),Mus musculus (Mouse),79.1,316.0,4.3e-135,482.3,sp|P62915|TF2B_MOUSE Transcription initiation factor IIB OS=Mus musculus OX=10090 GN=Gtf2b PE=1 SV=1,GO:0000776; GO:0000793; GO:0000979; GO:0000993; GO:0001174; GO:0003677; GO:0004402; GO:0005634; GO:0005669; GO:0005694; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0010467; GO:0016251; GO:0016407; GO:0016604; GO:0017025; GO:0019083; GO:0032153; GO:0032993; GO:0042585; GO:0046966; GO:0051123; GO:0051177; GO:0051225; GO:0051276; GO:1990114; GO:1990841,chromosome organization [GO:0051276]; gene expression [GO:0010467]; meiotic sister chromatid cohesion [GO:0051177]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083],cell division site [GO:0032153]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; germinal vesicle [GO:0042585]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription factor TFIID complex [GO:0005669],acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; nuclear thyroid hormone receptor binding [GO:0046966]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006351; GO:0007010; GO:0016740; GO:0043226; GO:0065003; GO:0140096; GO:0140223,"DNA binding; catalytic activity; nucleus; chromosome; DNA-templated transcription; cytoskeleton organization; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; general transcription initiation factor activity"
OG_09847,1.1412992586391904,FUN_042837-T1,Peve_00007263,Pocillopora_meandrina_HIv1___RNAseq.g7264.t1,three_way,78.92983333333333,FUN_042837-T1,Q32S26,BRD2_BOVIN,,Bromodomain-containing protein 2,Bos taurus (Bovine),50.9,737.0,1.5e-137,492.3,sp|Q32S26|BRD2_BOVIN Bromodomain-containing protein 2 OS=Bos taurus OX=9913 GN=BRD2 PE=3 SV=1,GO:0000785; GO:0005634; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0070577; GO:0071168; GO:0140012; GO:0140588; GO:2000330,chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; nucleosome assembly [GO:0006334]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein localization to chromatin [GO:0071168]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],histone H4K5ac reader activity [GO:0140012]; lysine-acetylated histone binding [GO:0070577],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0065003,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly
OG_09849,1.7288593713276323,FUN_042840-T1,Peve_00007266,Pocillopora_meandrina_HIv1___RNAseq.g7261.t1,three_way,47.549,,,,,,,,,,,,,,,,,
OG_09854,1.565437927606052,FUN_042847-T1,Peve_00023278,Pocillopora_meandrina_HIv1___RNAseq.g7253.t2,three_way,70.20666666666666,FUN_042847-T1,Q924L9,,,,,46.9,557.0,1.5e-131,471.5,"sp|Q924L9|FOLC_CRIGR Folylpolyglutamate synthase, mitochondrial OS=Cricetulus griseus OX=10029 GN=FPGS PE=2 SV=1",,,,,,
OG_09857,1.7904435920854949,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,47.2,733.0,1.3e-174,616.7,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09857,1.7904435920854949,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,26.6,466.0,1.1e-35,155.2,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09862,2.2322311598143454,FUN_042871-T1,Peve_00023282,Pocillopora_meandrina_HIv1___RNAseq.g7234.t1,three_way,64.53166666666667,FUN_042871-T1,Q8CAE2,HENMT_MOUSE,,Small RNA 2'-O-methyltransferase (EC 2.1.1.386) (HEN1 methyltransferase homolog 1) (mHEN1),Mus musculus (Mouse),36.6,366.0,2.9e-54,214.5,sp|Q8CAE2|HENMT_MOUSE Small RNA 2'-O-methyltransferase OS=Mus musculus OX=10090 GN=Henmt1 PE=1 SV=1,GO:0001510; GO:0003723; GO:0005829; GO:0008171; GO:0008173; GO:0034587; GO:0043186; GO:0046872; GO:0090486,piRNA processing [GO:0034587]; RNA methylation [GO:0001510],cytosol [GO:0005829]; P granule [GO:0043186],metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486],GO:0003723; GO:0003824; GO:0005829; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; cytosol; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09874,1.861071016607576,FUN_042912-T1,Peve_00019289,Pocillopora_meandrina_HIv1___RNAseq.g7196.t1,three_way,79.65833333333333,FUN_042912-T1,B0KWE9,,,,,51.6,225.0,4.9e-63,242.7,sp|B0KWE9|DOPP1_CALJA Dolichyldiphosphatase 1 OS=Callithrix jacchus OX=9483 GN=DOLPP1 PE=3 SV=1,,,,,,
OG_09881,1.3120039220824151,FUN_042949-T1,Peve_00019972,Pocillopora_meandrina_HIv1___TS.g886.t1,three_way,68.23983333333334,FUN_042949-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),34.1,560.0,6.8e-78,293.1,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09885,1.039972822369653,FUN_042958-T1,Peve_00039055,Pocillopora_meandrina_HIv1___RNAseq.g7122.t1,three_way,87.16766666666666,FUN_042958-T1,Q9HD20,,,,,56.8,1187.0,0.0,1261.5,sp|Q9HD20|AT131_HUMAN Endoplasmic reticulum transmembrane helix translocase OS=Homo sapiens OX=9606 GN=ATP13A1 PE=1 SV=2,,,,,,
OG_09888,2.32479567239845,FUN_042963-T1,Peve_00039045,Pocillopora_meandrina_HIv1___RNAseq.4783_t,three_way,65.88283333333334,FUN_042963-T1,Q4VGL6,RC3H1_MOUSE,,Roquin-1 (Roquin) (EC 2.3.2.27) (Protein Sanroque) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1),Mus musculus (Mouse),60.2,523.0,1.3e-165,585.5,sp|Q4VGL6|RC3H1_MOUSE Roquin-1 OS=Mus musculus OX=10090 GN=Rc3h1 PE=1 SV=1,GO:0000184; GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003725; GO:0003729; GO:0003730; GO:0004842; GO:0005737; GO:0008270; GO:0010468; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0071347; GO:1900151; GO:1901224; GO:1905762; GO:2000320; GO:2000628,"3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932],CCR4-NOT complex binding [GO:1905762]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; RNA binding; catalytic activity; mRNA metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09893,1.898732496755388,FUN_042972-T1,Peve_00039022,Pocillopora_meandrina_HIv1___RNAseq.g7104.t1,three_way,74.01466666666667,FUN_042972-T1,A5PMR2,UBP33_DANRE,,Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33),Danio rerio (Zebrafish) (Brachydanio rerio),44.1,884.0,6.5e-205,715.7,sp|A5PMR2|UBP33_DANRE Ubiquitin carboxyl-terminal hydrolase 33 OS=Danio rerio OX=7955 GN=usp33 PE=2 SV=1,GO:0004197; GO:0004843; GO:0005813; GO:0006508; GO:0006897; GO:0007399; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108,axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],centrosome [GO:0005813]; perinuclear region of cytoplasm [GO:0048471],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0016192; GO:0016787; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; microtubule organizing center; vesicle-mediated transport; hydrolase activity; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_09895,1.4429418254549202,FUN_042989-T1,Peve_00031072,Pocillopora_meandrina_HIv1___RNAseq.g7089.t1,three_way,80.24966666666667,FUN_042989-T1,Q8BS35,,,,,54.4,397.0,1.2e-125,451.4,sp|Q8BS35|ALKMO_MOUSE Alkylglycerol monooxygenase OS=Mus musculus OX=10090 GN=Agmo PE=1 SV=1,,,,,,
OG_09905,1.8569744940524284,FUN_043002-T1,Peve_00017780,Pocillopora_meandrina_HIv1___RNAseq.g7026.t1,three_way,77.39216666666667,FUN_043002-T1,P46209,,,,,33.0,179.0,6.8e-14,79.3,sp|P46209|USF_AQUPY Protein usf OS=Aquifex pyrophilus OX=2714 GN=usf PE=4 SV=1,,,,,,
OG_09906,1.691301737305841,FUN_043003-T1,Peve_00017777,Pocillopora_meandrina_HIv1___RNAseq.g7027.t1,three_way,86.71766666666667,FUN_043003-T1,Q66L49,SCMC1_DANRE,,Mitochondrial adenyl nucleotide antiporter SLC25A24 (Small calcium-binding mitochondrial carrier protein 1) (SCaMC-1) (Solute carrier family 25 member 24),Danio rerio (Zebrafish) (Brachydanio rerio),54.6,467.0,1e-146,521.5,sp|Q66L49|SCMC1_DANRE Mitochondrial adenyl nucleotide antiporter SLC25A24 OS=Danio rerio OX=7955 GN=slc25a24 PE=2 SV=1,GO:0000295; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0015866; GO:0015867; GO:0016020; GO:0051503; GO:0071277; GO:0140987; GO:0140988; GO:1990544,adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; mitochondrial ATP transmembrane transport [GO:1990544],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_09908,1.3303477849240766,FUN_043005-T1,Peve_00017775,Pocillopora_meandrina_HIv1___RNAseq.g7029.t1,three_way,70.90416666666667,FUN_043005-T1,Q90416,RXRGA_DANRE,,Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A),Danio rerio (Zebrafish) (Brachydanio rerio),36.4,365.0,1.1999999999999999e-61,239.2,sp|Q90416|RXRGA_DANRE Retinoic acid receptor RXR-gamma-A OS=Danio rerio OX=7955 GN=rxrga PE=2 SV=2,GO:0003700; GO:0003707; GO:0004879; GO:0007399; GO:0008270; GO:0030154; GO:0044323; GO:0045893; GO:0045944; GO:0048384; GO:0090575,cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384],RNA polymerase II transcription regulator complex [GO:0090575],DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; zinc ion binding [GO:0008270],GO:0003677; GO:0006355; GO:0030154; GO:0048856; GO:0060089; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_09909,1.3715138487681178,FUN_043007-T1,Peve_00017772,Pocillopora_meandrina_HIv1___RNAseq.4691_t,three_way,55.84033333333333,FUN_043007-T1,A3BF39,HMA2_ORYSJ,,Cadmium/zinc-transporting ATPase HMA2 (EC 7.2.2.12) (EC 7.2.2.21) (Protein HEAVY METAL ATPASE 2) (OsHMA2),Oryza sativa subsp. japonica (Rice),39.4,746.0,3.1e-123,444.9,sp|A3BF39|HMA2_ORYSJ Cadmium/zinc-transporting ATPase HMA2 OS=Oryza sativa subsp. japonica OX=39947 GN=HMA2 PE=1 SV=1,GO:0005524; GO:0005886; GO:0008551; GO:0016020; GO:0016463; GO:0016887; GO:0022857; GO:0046872; GO:0055085,transmembrane transport [GO:0055085],membrane [GO:0016020]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type cadmium transporter activity [GO:0008551]; P-type zinc transporter activity [GO:0016463]; transmembrane transporter activity [GO:0022857],GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085; GO:0140657,catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_09910,1.1121713183883508,FUN_043008-T1,Peve_00017770,Pocillopora_meandrina_HIv1___RNAseq.g7032.t1,three_way,89.62533333333333,FUN_043008-T1,Q9JKK1,STX6_MOUSE,,Syntaxin-6,Mus musculus (Mouse),50.4,232.0,1.3e-55,218.0,sp|Q9JKK1|STX6_MOUSE Syntaxin-6 OS=Mus musculus OX=10090 GN=Stx6 PE=1 SV=1,GO:0000139; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0016020; GO:0019905; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048471; GO:0055037; GO:0055038,"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]",cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905],GO:0005654; GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; endosome; Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization
OG_09912,2.421983829278679,FUN_043010-T1,Peve_00017768,Pocillopora_meandrina_HIv1___RNAseq.g7034.t1,three_way,65.28,FUN_043010-T1,Q8CGF6,WDR47_MOUSE,,WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin),Mus musculus (Mouse),31.1,1178.0,1.9e-103,379.0,sp|Q8CGF6|WDR47_MOUSE WD repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Wdr47 PE=1 SV=2,GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168,adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],protein-containing complex binding [GO:0044877],GO:0006914; GO:0007010; GO:0048856; GO:0048870,autophagy; cytoskeleton organization; anatomical structure development; cell motility
OG_09914,1.4401726520727782,FUN_043014-T1,Peve_00017765,Pocillopora_meandrina_HIv1___RNAseq.g7037.t1,three_way,69.486,FUN_043014-T1,Q4R3Y4,S27A4_MACFA,,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),48.2,627.0,1.8e-170,600.9,sp|Q4R3Y4|S27A4_MACFA Long-chain fatty acid transport protein 4 OS=Macaca fascicularis OX=9541 GN=SLC27A4 PE=2 SV=2,GO:0000166; GO:0001579; GO:0005324; GO:0005789; GO:0005886; GO:0031957; GO:0044539; GO:0047676; GO:0090434,long-chain fatty acid import into cell [GO:0044539]; medium-chain fatty acid transport [GO:0001579],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; oleoyl-CoA ligase activity [GO:0090434]; very long-chain fatty acid-CoA ligase activity [GO:0031957],GO:0003824; GO:0005215; GO:0005886; GO:0016874; GO:0140657,catalytic activity; transporter activity; plasma membrane; ligase activity; ATP-dependent activity
OG_09917,1.822926191905304,FUN_043027-T1,Peve_00026962,Pocillopora_meandrina_HIv1___TS.g790.t1,three_way,57.98016666666667,FUN_043027-T1,Q8AYG3,TTK_DANRE,,Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap),Danio rerio (Zebrafish) (Brachydanio rerio),30.7,960.0,1.6999999999999998e-92,342.4,sp|Q8AYG3|TTK_DANRE Dual specificity protein kinase Ttk OS=Danio rerio OX=7955 GN=ttk PE=1 SV=2,GO:0000776; GO:0001100; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0007059; GO:0007060; GO:0007094; GO:0016321; GO:0031101; GO:0033316; GO:0034501; GO:0042246; GO:0046872; GO:0051301; GO:0060249; GO:0106310,anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of exit from mitosis [GO:0001100]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246],kinetochore [GO:0000776]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09919,1.0341006297803226,FUN_043030-T1,Peve_00026964,Pocillopora_meandrina_HIv1___RNAseq.g7058.t1,three_way,69.98333333333333,FUN_043030-T1,Q0P5A6,,,,,35.4,491.0,1.2e-81,305.4,sp|Q0P5A6|PSMD5_BOVIN 26S proteasome non-ATPase regulatory subunit 5 OS=Bos taurus OX=9913 GN=PSMD5 PE=2 SV=1,,,,,,
OG_09920,1.3978532365409069,FUN_043031-T1,Peve_00026965,Pocillopora_meandrina_HIv1___TS.g793.t1,three_way,52.451,FUN_043031-T1,Q9FN03,,,,,28.7,334.0,5.500000000000001e-28,129.0,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_09921,1.0399406407244356,FUN_043033-T1,Peve_00026967,Pocillopora_meandrina_HIv1___TS.g794.t2,three_way,75.653,FUN_043033-T1,Q9P1Z9,,,,,29.7,851.0,7.199999999999999e-95,350.9,sp|Q9P1Z9|CC180_HUMAN Coiled-coil domain-containing protein 180 OS=Homo sapiens OX=9606 GN=CCDC180 PE=1 SV=3,,,,,,
OG_09923,1.840394564517256,FUN_043035-T1,Peve_00026975,Pocillopora_meandrina_HIv1___RNAseq.g7043.t1,three_way,57.261,FUN_043035-T1,Q9UBN4,,,,,29.3,744.0,3.7999999999999996e-68,261.2,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_09928,1.3709621869393198,FUN_043084-T1,Peve_00026456,Pocillopora_meandrina_HIv1___RNAseq.g7081.t1,three_way,62.529833333333336,FUN_043084-T1,Q9UBN4,,,,,30.1,742.0,4.2e-83,310.8,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_09930,1.4933230323117617,FUN_043086-T1,Peve_00001644,Pocillopora_meandrina_HIv1___TS.g825.t1,three_way,66.956,FUN_043086-T1,Q501I9,,,,,35.5,445.0,2.3000000000000002e-74,281.2,sp|Q501I9|DIRC2_XENTR Solute carrier family 49 member 4 homolog OS=Xenopus tropicalis OX=8364 GN=slc49a4 PE=2 SV=1,,,,,,
OG_09931,1.403175919181992,FUN_043087-T1,Peve_00001643,Pocillopora_meandrina_HIv1___RNAseq.g7088.t2,three_way,65.04733333333333,FUN_043087-T1,Q8N9H8,,,,,31.9,793.0,2e-93,345.5,sp|Q8N9H8|MUT7_HUMAN Exonuclease mut-7 homolog OS=Homo sapiens OX=9606 GN=EXD3 PE=1 SV=3,,,,,,
OG_09933,1.3407430051841762,FUN_043091-T1,Peve_00001653,Pocillopora_meandrina_HIv1___RNAseq.g6995.t1,three_way,75.982,FUN_043091-T1,O95870,ABHGA_HUMAN,,Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5) (hBAT5) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23) (Protein G5),Homo sapiens (Human),43.3,563.0,5.9e-132,472.6,sp|O95870|ABHGA_HUMAN Phosphatidylserine lipase ABHD16A OS=Homo sapiens OX=9606 GN=ABHD16A PE=1 SV=3,GO:0004620; GO:0006660; GO:0016020; GO:0047372; GO:0052651; GO:1905344,monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344],membrane [GO:0016020],monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620],GO:0003824; GO:0006575; GO:0006629; GO:0016787,catalytic activity; modified amino acid metabolic process; lipid metabolic process; hydrolase activity
OG_09934,1.3461727890506705,FUN_043092-T2,Peve_00038925,Pocillopora_meandrina_HIv1___RNAseq.g6998.t1,three_way,64.206,FUN_043092-T2,P55268,LAMB2_HUMAN,,Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta),Homo sapiens (Human),29.3,844.0,9.599999999999999e-61,238.0,sp|P55268|LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens OX=9606 GN=LAMB2 PE=1 SV=2,GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0005788; GO:0007155; GO:0007411; GO:0007528; GO:0007601; GO:0014002; GO:0014044; GO:0031594; GO:0043083; GO:0043260; GO:0045785; GO:0048677; GO:0051149; GO:0060041; GO:0062023; GO:0070062; GO:0072249; GO:0072274; GO:0098637; GO:0110011; GO:0150043; GO:2001046,astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; metanephric glomerular basement membrane development [GO:0072274]; metanephric podocyte development [GO:0072249]; neuromuscular junction development [GO:0007528]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; visual perception [GO:0007601],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083],extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural constituent of synapse-associated extracellular matrix [GO:0150043]; structural molecule activity [GO:0005198],GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0050877,structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; nervous system process
OG_09935,2.0766812115321613,FUN_043094-T1,Peve_00038927,Pocillopora_meandrina_HIv1___RNAseq.g7010.t1,three_way,77.438,FUN_043094-T1,Q7XP59,,,,,24.4,475.0,3.8e-18,95.9,sp|Q7XP59|GLR31_ORYSJ Glutamate receptor 3.1 OS=Oryza sativa subsp. japonica OX=39947 GN=GLR3.1 PE=1 SV=1,,,,,,
OG_09937,2.4895226729435653,FUN_043097-T2,Peve_00033762,Pocillopora_meandrina_HIv1___RNAseq.g7007.t1,three_way,79.86333333333333,FUN_043097-T2,Q6DD44,XPR1_XENLA,,Xenotropic and polytropic retrovirus receptor 1 homolog,Xenopus laevis (African clawed frog),51.0,700.0,4.5e-193,676.0,sp|Q6DD44|XPR1_XENLA Xenotropic and polytropic retrovirus receptor 1 homolog OS=Xenopus laevis OX=8355 GN=xpr1 PE=2 SV=1,GO:0000822; GO:0005315; GO:0005794; GO:0005886; GO:0006817; GO:0015562; GO:0016036; GO:0030643; GO:0035435,cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817],Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate transmembrane transporter activity [GO:0005315],GO:0005215; GO:0005794; GO:0005886; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; plasma membrane; organelle; transmembrane transport
OG_09939,1.6251279615193188,FUN_043099-T1,Peve_00026300,Pocillopora_meandrina_HIv1___RNAseq.g7004.t1,three_way,80.35766666666666,FUN_043099-T1,Q92540,SMG7_HUMAN,,Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog) (hSMG-7),Homo sapiens (Human),43.2,475.0,1.8e-94,348.6,sp|Q92540|SMG7_HUMAN Nonsense-mediated mRNA decay factor SMG7 OS=Homo sapiens OX=9606 GN=SMG7 PE=1 SV=2,GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0035303; GO:0042162; GO:0051721; GO:0070034,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0006913; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; cytosol; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_09947,1.1636837834909688,FUN_043114-T1,Peve_00026299,Pocillopora_meandrina_HIv1___RNAseq.g7891.t2,three_way,80.283,,,,,,,,,,,,,,,,,
OG_09948,2.398791828030343,FUN_043115-T2,Peve_00026298,Pocillopora_meandrina_HIv1___RNAseq.g7890.t1,three_way,78.194,FUN_043115-T2,Q9NQH7,XPP3_HUMAN,,Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),Homo sapiens (Human),46.0,461.0,1.6e-124,448.0,sp|Q9NQH7|XPP3_HUMAN Xaa-Pro aminopeptidase 3 OS=Homo sapiens OX=9606 GN=XPNPEP3 PE=1 SV=1,GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006,glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003014; GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"renal system process; catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09949,2.7249264063848377,FUN_043116-T1,Peve_00026297,Pocillopora_meandrina_HIv1___RNAseq.g7889.t1,three_way,69.772,FUN_043116-T1,O77633,,,,,35.3,744.0,1.4000000000000001e-117,425.2,sp|O77633|ADA10_PIG Disintegrin and metalloproteinase domain-containing protein 10 OS=Sus scrofa OX=9823 GN=ADAM10 PE=2 SV=2,,,,,,
OG_09951,1.5702292259678028,FUN_043118-T1,Peve_00026295,Pocillopora_meandrina_HIv1___RNAseq.g7887.t1,three_way,78.261,FUN_043118-T1,P08081,CLCA_RAT,,Clathrin light chain A (Lca),Rattus norvegicus (Rat),34.8,221.0,5.9e-23,109.0,sp|P08081|CLCA_RAT Clathrin light chain A OS=Rattus norvegicus OX=10116 GN=Clta PE=1 SV=1,GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0006897; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0048488; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978,cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488],clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672],clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198],GO:0005198; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0065003,structural molecule activity; lysosome; endosome; vacuole; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_09956,1.4054490968990974,FUN_043126-T1,Peve_00013593,Pocillopora_meandrina_HIv1___TS.g1627.t1,three_way,55.45466666666667,FUN_043126-T1,Q1LZE9,,,,,32.7,275.0,1.4e-27,125.2,sp|Q1LZE9|PRS23_BOVIN Serine protease 23 OS=Bos taurus OX=9913 GN=PRSS23 PE=2 SV=1,,,,,,
OG_09967,1.6548941782701645,FUN_043148-T1,Peve_00044685,Pocillopora_meandrina_HIv1___RNAseq.g6855.t1,three_way,81.35900000000001,FUN_043148-T1,A4QNE9,,,,,54.8,115.0,1.3e-07,57.4,sp|A4QNE9|VATG3_XENTR V-type proton ATPase subunit G 3 OS=Xenopus tropicalis OX=8364 GN=atp6v1g3 PE=3 SV=1,,,,,,
OG_09972,1.2358293263230025,FUN_043155-T1,Peve_00011378,Pocillopora_meandrina_HIv1___RNAseq.g6836.t1,three_way,39.551,,,,,,,,,,,,,,,,,
OG_09980,2.2599545171642346,FUN_043169-T1,Peve_00025850,Pocillopora_meandrina_HIv1___RNAseq.g6792.t1,three_way,52.61283333333333,,,,,,,,,,,,,,,,,
OG_09981,1.431798600723147,FUN_043171-T1,Peve_00025849,Pocillopora_meandrina_HIv1___RNAseq.g6793.t1,three_way,67.71433333333333,,,,,,,,,,,,,,,,,
OG_09983,1.844333349614447,FUN_043175-T1,Peve_00025846,Pocillopora_meandrina_HIv1___RNAseq.g6800.t1,three_way,71.23483333333334,FUN_043175-T1,Q28036,SL9A1_BOVIN,,Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1),Bos taurus (Bovine),47.8,557.0,4.8999999999999995e-141,503.4,sp|Q28036|SL9A1_BOVIN Sodium/hydrogen exchanger 1 OS=Bos taurus OX=9913 GN=SLC9A1 PE=2 SV=2,GO:0005516; GO:0005543; GO:0005654; GO:0005737; GO:0005886; GO:0006883; GO:0006885; GO:0010447; GO:0010613; GO:0010882; GO:0015385; GO:0015386; GO:0016323; GO:0016324; GO:0030346; GO:0035994; GO:0036376; GO:0042802; GO:0045121; GO:0045944; GO:0048306; GO:0048863; GO:0051259; GO:0051453; GO:0055007; GO:0070886; GO:0071468; GO:0071805; GO:0071872; GO:0086092; GO:0090533; GO:0098719; GO:0098735,cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to epinephrine stimulus [GO:0071872]; intracellular sodium ion homeostasis [GO:0006883]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; stem cell differentiation [GO:0048863],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005654; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0055085; GO:0065003,transporter activity; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; transmembrane transport; protein-containing complex assembly
OG_09984,1.103769713124427,FUN_043176-T1,Peve_00025845,Pocillopora_meandrina_HIv1___RNAseq.g6801.t1,three_way,80.18466666666667,FUN_043176-T1,Q6YP21,KAT3_HUMAN,,Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III),Homo sapiens (Human),55.5,411.0,1.1999999999999999e-132,474.6,sp|Q6YP21|KAT3_HUMAN Kynurenine--oxoglutarate transaminase 3 OS=Homo sapiens OX=9606 GN=KYAT3 PE=1 SV=1,GO:0003723; GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189; GO:0097053,2-oxoglutarate metabolic process [GO:0006103]; amino acid metabolic process [GO:0006520]; biosynthetic process [GO:0009058]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0016829; GO:0043226,RNA binding; catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; lyase activity; organelle
OG_09986,1.208235419538381,FUN_043179-T1,Peve_00025843,Pocillopora_meandrina_HIv1___TS.g546.t1,three_way,66.02266666666667,FUN_043179-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),33.3,1426.0,9.8e-216,753.1,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_09988,1.2855207542104268,FUN_043182-T1,Peve_00043027,Pocillopora_meandrina_HIv1___RNAseq.g6806.t1,three_way,59.36083333333333,FUN_043182-T1,Q9Z136,,,,,38.8,361.0,3.4e-62,241.9,sp|Q9Z136|TSC1_RAT Hamartin OS=Rattus norvegicus OX=10116 GN=Tsc1 PE=1 SV=1,,,,,,
OG_09997,1.3235188925714143,FUN_043222-T1,Peve_00007691,Pocillopora_meandrina_HIv1___RNAseq.g6774.t1a,three_way,69.872,FUN_043222-T1,Q22885,,,,,27.1,362.0,1.3e-21,105.5,sp|Q22885|BROX_CAEEL BRO1 domain-containing protein BROX homolog OS=Caenorhabditis elegans OX=6239 GN=B0507.2 PE=3 SV=2,,,,,,
OG_09998,1.495754400046263,FUN_043224-T1,Peve_00007692,Pocillopora_meandrina_HIv1___RNAseq.g6773.t1,three_way,90.942,FUN_043224-T1,Q5ZKU5,RAB14_CHICK,,Ras-related protein Rab-14 (EC 3.6.5.2),Gallus gallus (Chicken),80.5,215.0,6.4e-93,341.7,sp|Q5ZKU5|RAB14_CHICK Ras-related protein Rab-14 OS=Gallus gallus OX=9031 GN=RAB14 PE=2 SV=3,GO:0000139; GO:0001845; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005802; GO:0005829; GO:0006886; GO:0006895; GO:0008543; GO:0012505; GO:0031901; GO:0032456; GO:0042742; GO:0045335; GO:0045995; GO:0055037,defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly [GO:0001845]; regulation of embryonic development [GO:0045995],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0006886; GO:0007040; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0098772,catalytic activity; GTPase activity; endosome; cytosol; intracellular protein transport; lysosome organization; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09999,1.7366589437300162,FUN_043231-T1,Peve_00019451,Pocillopora_meandrina_HIv1___TS.g505.t1,three_way,79.51733333333333,FUN_043231-T1,Q8TDX7,NEK7_HUMAN,,Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7),Homo sapiens (Human),83.6,280.0,5.0999999999999996e-138,491.9,sp|Q8TDX7|NEK7_HUMAN Serine/threonine-protein kinase Nek7 OS=Homo sapiens OX=9606 GN=NEK7 PE=1 SV=1,GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032206; GO:0035865; GO:0046872; GO:0051225; GO:0106310; GO:0140677; GO:1900227,cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10001,1.3848314516001037,FUN_043234-T1,Peve_00001448,Pocillopora_meandrina_HIv1___RNAseq.g6754.t1,three_way,72.01266666666666,FUN_043234-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),39.5,309.0,3.7e-52,207.2,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_10005,1.2500768547248775,FUN_043240-T1,Peve_00001439,Pocillopora_meandrina_HIv1___RNAseq.g6713.t1,three_way,70.26633333333334,FUN_043240-T1,P28304,,,,,38.9,319.0,9.5e-54,212.2,sp|P28304|QOR1_ECOLI Quinone oxidoreductase 1 OS=Escherichia coli (strain K12) OX=83333 GN=qorA PE=1 SV=1,,,,,,
OG_10010,1.3442981442677318,FUN_043245-T1,Peve_00001456,Pocillopora_meandrina_HIv1___TS.g20570.t1,three_way,67.59233333333333,FUN_043245-T1,Q60695,,,,,39.4,754.0,3.9e-110,400.6,sp|Q60695|RGL1_MOUSE Ral guanine nucleotide dissociation stimulator-like 1 OS=Mus musculus OX=10090 GN=Rgl1 PE=1 SV=2,,,,,,
OG_10017,1.5520380411557233,FUN_043254-T1,Peve_00030637,Pocillopora_meandrina_HIv1___RNAseq.g8858.t1,three_way,79.7325,,,,,,,,,,,,,,,,,
OG_10020,1.4075556900238324,FUN_043261-T1,Peve_00032607,Pocillopora_meandrina_HIv1___RNAseq.g8893.t1,three_way,65.95816666666667,FUN_043261-T1,Q7Z7G8,VP13B_HUMAN,,Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B),Homo sapiens (Human),28.7,4270.0,0.0,1449.5,sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2,GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168,acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0008289; GO:0016192; GO:0022414; GO:0048856; GO:0050877,lipid binding; vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process
OG_10021,1.2677154504906714,FUN_043262-T1,Peve_00032608,Pocillopora_meandrina_HIv1___RNAseq.g8892.t1,three_way,72.44983333333333,FUN_043262-T1,Q9Z0H0,,,,,35.1,559.0,3.6e-82,307.4,sp|Q9Z0H0|CDC7_MOUSE Cell division cycle 7-related protein kinase OS=Mus musculus OX=10090 GN=Cdc7 PE=1 SV=2,,,,,,
OG_10022,1.6201125647500878,FUN_043264-T1,Peve_00032613,Pocillopora_meandrina_HIv1___RNAseq.g8889.t1,three_way,60.43216666666667,FUN_043264-T1,P79795,NRP1_CHICK,,Neuropilin-1 (A5 protein),Gallus gallus (Chicken),28.2,255.0,3.2e-12,75.9,sp|P79795|NRP1_CHICK Neuropilin-1 OS=Gallus gallus OX=9031 GN=NRP1 PE=2 SV=1,GO:0001570; GO:0001755; GO:0002040; GO:0005021; GO:0005886; GO:0005925; GO:0007155; GO:0007411; GO:0008201; GO:0009611; GO:0010595; GO:0017154; GO:0022035; GO:0030424; GO:0030947; GO:0031966; GO:0032584; GO:0038085; GO:0043679; GO:0044295; GO:0046872; GO:0048010; GO:0048729; GO:0051491; GO:0070852; GO:0098743,axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell aggregation [GO:0098743]; neural crest cell migration [GO:0001755]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to wounding [GO:0009611]; rhombomere cell migration [GO:0022035]; sprouting angiogenesis [GO:0002040]; tissue morphogenesis [GO:0048729]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570],axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell body fiber [GO:0070852]; focal adhesion [GO:0005925]; growth cone membrane [GO:0032584]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886],heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0030154; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; cell differentiation; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10026,1.822833505398291,FUN_043279-T1,Peve_00007455,Pocillopora_meandrina_HIv1___RNAseq.g8875.t1,three_way,77.92,FUN_043279-T1,Q08832,GBRB3_DROME,,Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor),Drosophila melanogaster (Fruit fly),34.6,457.0,7.399999999999999e-75,282.7,sp|Q08832|GBRB3_DROME Gamma-aminobutyric acid receptor subunit beta-like OS=Drosophila melanogaster OX=7227 GN=Lcch3 PE=1 SV=2,GO:0004890; GO:0005886; GO:0022851; GO:0034707; GO:0045211; GO:1902476; GO:1902711,chloride transmembrane transport [GO:1902476],chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_10027,1.00358109566134,FUN_043281-T1,Peve_00007453,Pocillopora_meandrina_HIv1___TS.g20595.t1c,three_way,70.7575,FUN_043281-T1,Q8IYH5,ZZZ3_HUMAN,,ZZ-type zinc finger-containing protein 3,Homo sapiens (Human),45.6,450.0,2.1e-88,328.2,sp|Q8IYH5|ZZZ3_HUMAN ZZ-type zinc finger-containing protein 3 OS=Homo sapiens OX=9606 GN=ZZZ3 PE=1 SV=1,GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140672,chromatin organization [GO:0006325]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357],ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_10028,1.344112868079777,FUN_043283-T1,Peve_00007451,Pocillopora_meandrina_HIv1___RNAseq.g8872.t1,three_way,45.01633333333333,,,,,,,,,,,,,,,,,
OG_10031,1.5680979038242222,FUN_043286-T1,Peve_00007448,Pocillopora_meandrina_HIv1___RNAseq.g8869.t1,three_way,90.06933333333333,FUN_043286-T1,Q5ZKN1,CDK9_CHICK,,Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9),Gallus gallus (Chicken),71.5,375.0,2.3e-151,536.6,sp|Q5ZKN1|CDK9_CHICK Cyclin-dependent kinase 9 OS=Gallus gallus OX=9031 GN=CDK9 PE=2 SV=1,GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0008353; GO:0032968; GO:0045944; GO:0070691; GO:0106310; GO:0120187,positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634]; P-TEFb complex [GO:0070691],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_10039,3.7185353718172496,FUN_043309-T1,Peve_00007495,Pocillopora_meandrina_HIv1___RNAseq.g8924.t1,three_way,66.18766666666667,FUN_043309-T1,P33450,FAT_DROME,,Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito],Drosophila melanogaster (Fruit fly),27.1,816.0,1.3e-70,270.0,sp|P33450|FAT_DROME Cadherin-related tumor suppressor OS=Drosophila melanogaster OX=7227 GN=ft PE=1 SV=3,GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0090175; GO:0090176; GO:0090251; GO:0098609,"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]",apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509],GO:0005739; GO:0005886; GO:0007010; GO:0007155; GO:0007163; GO:0043226; GO:0048856,mitochondrion; plasma membrane; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; organelle; anatomical structure development
OG_10041,1.3942137831995731,FUN_043312-T1,Peve_00007499,Pocillopora_meandrina_HIv1___RNAseq.g8928.t1,three_way,77.94933333333333,FUN_043312-T1,P36916,,,,,53.7,488.0,4.9e-143,509.6,sp|P36916|GNL1_MOUSE Guanine nucleotide-binding protein-like 1 OS=Mus musculus OX=10090 GN=Gnl1 PE=1 SV=4,,,,,,
OG_10045,1.1456503153989737,FUN_043317-T1,Peve_00007503,Pocillopora_meandrina_HIv1___RNAseq.g8932.t2b,three_way,56.23733333333333,FUN_043317-T1,O60462,NRP2_HUMAN,,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),Homo sapiens (Human),27.6,315.0,8.3e-18,93.2,sp|O60462|NRP2_HUMAN Neuropilin-2 OS=Homo sapiens OX=9606 GN=NRP2 PE=1 SV=3,GO:0001525; GO:0001938; GO:0002116; GO:0003148; GO:0005021; GO:0005576; GO:0005886; GO:0007155; GO:0007411; GO:0008201; GO:0010595; GO:0016020; GO:0017154; GO:0019838; GO:0019955; GO:0021612; GO:0021637; GO:0021649; GO:0021675; GO:0021785; GO:0021828; GO:0030424; GO:0036486; GO:0038023; GO:0042802; GO:0045211; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0071526; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1903375; GO:1904835; GO:1990830,angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116],cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005576; GO:0005886; GO:0007155; GO:0016740; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; extracellular region; plasma membrane; cell adhesion; transferase activity; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10048,1.4084934275460348,FUN_043322-T1,Peve_00007511,Pocillopora_meandrina_HIv1___RNAseq.g8949.t1,three_way,57.72333333333333,FUN_043322-T1,Q03146,DDR1_MOUSE,,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),Mus musculus (Mouse),49.6,373.0,3.5e-93,344.7,sp|Q03146|DDR1_MOUSE Epithelial discoidin domain-containing receptor 1 OS=Mus musculus OX=10090 GN=Ddr1 PE=2 SV=2,GO:0001558; GO:0001952; GO:0005518; GO:0005524; GO:0005886; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0014909; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138,"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]",plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0022414; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; reproductive process; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10050,1.3600486906043534,FUN_043324-T1,Peve_00036591,Pocillopora_meandrina_HIv1___RNAseq.g8951.t1,three_way,74.779,FUN_043324-T1,Q59228,,,,,31.3,361.0,3.9e-44,181.0,sp|Q59228|AAT_GEOSE Aspartate aminotransferase OS=Geobacillus stearothermophilus OX=1422 GN=aspC PE=3 SV=1,,,,,,
OG_10053,1.166332271399618,FUN_043327-T1,Peve_00043037,Pocillopora_meandrina_HIv1___RNAseq.g8955.t1,three_way,55.082,FUN_043327-T1,D6WMX4,PINK1_TRICA,,"Serine/threonine-protein kinase Pink1, mitochondrial (EC 2.7.11.1) (PTEN-induced putative kinase 1)",Tribolium castaneum (Red flour beetle),36.7,450.0,9.499999999999999e-69,262.7,"sp|D6WMX4|PINK1_TRICA Serine/threonine-protein kinase Pink1, mitochondrial OS=Tribolium castaneum OX=7070 GN=Pink1 PE=1 SV=1",GO:0000422; GO:0004674; GO:0005524; GO:0005739; GO:0005741; GO:0005743; GO:0005829; GO:0031398; GO:0031625; GO:0042981; GO:0046777; GO:0046872; GO:0090141; GO:1904544,autophagy of mitochondrion [GO:0000422]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein ubiquitination [GO:0031398]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005739; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; cytosol; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_10055,1.7848335843906542,FUN_043349-T1,Peve_00043040,Pocillopora_meandrina_HIv1___TS.g20680.t2,three_way,60.5675,FUN_043349-T1,P20909,,,,,33.1,236.0,3.2e-34,149.4,sp|P20909|COBA1_RAT Collagen alpha-1(XI) chain OS=Rattus norvegicus OX=10116 GN=Col11a1 PE=1 SV=2,,,,,,
OG_10059,1.6925118988604904,FUN_043355-T1,Peve_00016650,Pocillopora_meandrina_HIv1___TS.g20685.t1a,three_way,62.21816666666667,FUN_043355-T1,A1L1H3,,,,,26.3,758.0,1.4e-48,196.4,sp|A1L1H3|TDRD5_XENLA Tudor domain-containing protein 5 OS=Xenopus laevis OX=8355 GN=tdrd5 PE=2 SV=1,,,,,,
OG_10063,1.1700952181972075,FUN_043363-T1,Peve_00016658,Pocillopora_meandrina_HIv1___RNAseq.g8970.t1,three_way,82.36583333333333,FUN_043363-T1,Q8C4Y3,NELFB_MOUSE,,Negative elongation factor B (NELF-B) (Cofactor of BRCA1),Mus musculus (Mouse),45.5,587.0,1.2e-135,485.0,sp|Q8C4Y3|NELFB_MOUSE Negative elongation factor B OS=Mus musculus OX=10090 GN=Nelfb PE=1 SV=2,GO:0003723; GO:0005741; GO:0005829; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737,cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; stem cell differentiation [GO:0048863],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021],RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0006355; GO:0030154,RNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation
OG_10066,1.130741057917595,FUN_043370-T1,Peve_00004904,Pocillopora_meandrina_HIv1___RNAseq.g8975.t1,three_way,68.366,,,,,,,,,,,,,,,,,
OG_10067,1.9615954758541945,FUN_043371-T1,Peve_00004903,Pocillopora_meandrina_HIv1___RNAseq.g8976.t1,three_way,72.36966666666666,FUN_043371-T1,Q8VHQ9,ACO11_MOUSE,,Acyl-coenzyme A thioesterase 11 (Acyl-CoA thioesterase 11) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 11) (Adipose-associated thioesterase) (Brown fat-inducible thioesterase) (BFIT) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2),Mus musculus (Mouse),44.0,550.0,4.4e-114,413.3,sp|Q8VHQ9|ACO11_MOUSE Acyl-coenzyme A thioesterase 11 OS=Mus musculus OX=10090 GN=Acot11 PE=1 SV=1,GO:0005737; GO:0005759; GO:0005829; GO:0006631; GO:0008289; GO:0009266; GO:0009409; GO:0035556; GO:0047617; GO:0052689; GO:0052816; GO:0120163,fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759],carboxylic ester hydrolase activity [GO:0052689]; fatty acyl-CoA hydrolase activity [GO:0047617]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816],GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity
OG_10069,1.399246158194983,FUN_043374-T1,Peve_00004909,Pocillopora_meandrina_HIv1___RNAseq.g8978.t1,three_way,63.316,,,,,,,,,,,,,,,,,
OG_10070,1.499640728773937,FUN_043375-T1,Peve_00004908,Pocillopora_meandrina_HIv1___RNAseq.g8979.t1,three_way,59.082,FUN_043375-T1,Q7T320,,,,,39.1,192.0,1.5e-23,112.1,sp|Q7T320|GORAB_DANRE RAB6-interacting golgin OS=Danio rerio OX=7955 GN=gorab PE=2 SV=1,,,,,,
OG_10073,1.09002948626985,FUN_043379-T1,Peve_00027430,Pocillopora_meandrina_HIv1___RNAseq.g8985.t1,three_way,83.51266666666666,FUN_043379-T1,Q5F3K4,WDR48_CHICK,,WD repeat-containing protein 48 (USP1-associated factor 1),Gallus gallus (Chicken),62.4,697.0,1.0999999999999999e-189,664.8,sp|Q5F3K4|WDR48_CHICK WD repeat-containing protein 48 OS=Gallus gallus OX=9031 GN=WDR48 PE=2 SV=1,GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005764; GO:0005770; GO:0006974; GO:0007283; GO:0007338; GO:0035264; GO:0035800; GO:0043130; GO:0043588; GO:0046427; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1905168,DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283],late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634],deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130],GO:0003677; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0006281; GO:0006310; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0098772,DNA binding; nucleus; lysosome; endosome; vacuole; DNA repair; DNA recombination; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_10077,1.0969326410269382,FUN_043385-T1,Peve_00024254,Pocillopora_meandrina_HIv1___RNAseq.g8996.t1,three_way,60.781666666666666,FUN_043385-T1,Q90923,,,,,32.9,474.0,3e-58,229.6,sp|Q90923|NET3_CHICK Netrin-3 (Fragment) OS=Gallus gallus OX=9031 GN=NTN3 PE=2 SV=1,,,,,,
OG_10079,1.097190851436897,FUN_043389-T1,Peve_00024250,Pocillopora_meandrina_HIv1___RNAseq.g9000.t1,three_way,64.57716666666667,FUN_043389-T1,Q64322,,,,,41.2,131.0,5.3e-15,83.6,sp|Q64322|NPDC1_MOUSE Neural proliferation differentiation and control protein 1 OS=Mus musculus OX=10090 GN=Npdc1 PE=2 SV=2,,,,,,
OG_10085,1.4653210337899452,FUN_043403-T1,Peve_00007567,Pocillopora_meandrina_HIv1___RNAseq.g9068.t1,three_way,45.621,,,,,,,,,,,,,,,,,
OG_10087,3.8309075985691377,FUN_043414-T1,Peve_00045005,Pocillopora_meandrina_HIv1___RNAseq.g7825.t1,three_way,56.5365,FUN_043414-T1,Q69Z28,ATS16_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Mus musculus (Mouse),30.5,1138.0,9.8e-129,463.0,sp|Q69Z28|ATS16_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Mus musculus OX=10090 GN=Adamts16 PE=2 SV=2,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; catalytic activity, acting on a protein"
OG_10088,1.8909123509912893,FUN_043417-T1,Peve_00026858,Pocillopora_meandrina_HIv1___RNAseq.g7829.t1,three_way,78.89,FUN_043417-T1,Q28DG7,,,,,43.1,390.0,3.9e-66,253.4,sp|Q28DG7|UBAC1_XENTR Ubiquitin-associated domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=ubac1 PE=2 SV=1,,,,,,
OG_10089,2.3676215077766294,FUN_043418-T1,Peve_00026856,Pocillopora_meandrina_HIv1___RNAseq.g7830.t1,three_way,78.10233333333333,,,,,,,,,,,,,,,,,
OG_10090,1.97702995712958,FUN_043420-T1,Peve_00005576,Pocillopora_meandrina_HIv1___TS.g1600.t1,three_way,92.59866666666667,FUN_043420-T1,Q13813,,,,,59.0,2468.0,0.0,2752.6,"sp|Q13813|SPTN1_HUMAN Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=1 SV=3",,,,,,
OG_10093,1.8112599329711232,FUN_043424-T1,Peve_00022202,Pocillopora_meandrina_HIv1___RNAseq.g7845.t1,three_way,57.81816666666666,,,,,,,,,,,,,,,,,
OG_10095,1.1586017788842475,FUN_043427-T1,Peve_00041803,Pocillopora_meandrina_HIv1___RNAseq.g7840.t1,three_way,67.638,,,,,,,,,,,,,,,,,
OG_10097,1.2827179378418352,FUN_043429-T1,Peve_00028846,Pocillopora_meandrina_HIv1___RNAseq.g7837.t1,three_way,59.028,,,,,,,,,,,,,,,,,
OG_10100,1.1272330070644352,FUN_043438-T1,Peve_00028841,Pocillopora_meandrina_HIv1___RNAseq.g7850.t1,three_way,48.59733333333333,FUN_043438-T1,F6RRD7,,,,,49.2,181.0,8.9e-38,159.8,sp|F6RRD7|RPAP2_BOVIN Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 OS=Bos taurus OX=9913 GN=RPAP2 PE=2 SV=1,,,,,,
OG_10101,1.459717291153367,FUN_043439-T1,Peve_00028851,Pocillopora_meandrina_HIv1___RNAseq.g7000.t1,three_way,91.469,FUN_043439-T1,P62167,,,,,65.2,158.0,4.7e-58,225.7,sp|P62167|NCS1_CHICK Neuronal calcium sensor 1 OS=Gallus gallus OX=9031 GN=NCS1 PE=1 SV=2,,,,,,
OG_10102,1.1857914012315256,FUN_043440-T1,Peve_00028850,Pocillopora_meandrina_HIv1___RNAseq.g7001.t1,three_way,87.993,FUN_043440-T1,P62167,,,,,77.4,190.0,1.3999999999999999e-83,310.5,sp|P62167|NCS1_CHICK Neuronal calcium sensor 1 OS=Gallus gallus OX=9031 GN=NCS1 PE=1 SV=2,,,,,,
OG_10104,1.150932707682427,FUN_043446-T1,Peve_00028845,Pocillopora_meandrina_HIv1___TS.g1655.t1,three_way,49.04,FUN_043446-T1,O60241,AGRB2_HUMAN,,Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2),Homo sapiens (Human),30.9,175.0,8.7e-11,70.5,sp|O60241|AGRB2_HUMAN Adhesion G protein-coupled receptor B2 OS=Homo sapiens OX=9606 GN=ADGRB2 PE=1 SV=2,GO:0004930; GO:0005576; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007422; GO:0016020; GO:0016525; GO:0033173; GO:0051965; GO:0098978,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422]; positive regulation of synapse assembly [GO:0051965],extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005576; GO:0005886; GO:0048856; GO:0060089,extracellular region; plasma membrane; anatomical structure development; molecular transducer activity
OG_10105,1.0087958730756044,FUN_043447-T1,Peve_00015294,Pocillopora_meandrina_HIv1___RNAseq.g7900.t1,three_way,62.12,FUN_043447-T1,Q9Z148,EHMT2_MOUSE,,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a),Mus musculus (Mouse),35.3,538.0,2.6e-88,328.6,sp|Q9Z148|EHMT2_MOUSE Histone-lysine N-methyltransferase EHMT2 OS=Mus musculus OX=10090 GN=Ehmt2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0006357; GO:0007130; GO:0007286; GO:0008270; GO:0009267; GO:0009566; GO:0016279; GO:0016607; GO:0018027; GO:0035265; GO:0036166; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140947; GO:1902902; GO:1990841,behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130],chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9me2 methyltransferase activity [GO:0140947]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10108,1.5270219531083007,FUN_043456-T1,Peve_00031070,Pocillopora_meandrina_HIv1___RNAseq.g7904.t1,three_way,80.63666666666667,FUN_043456-T1,Q9JM13,RABX5_MOUSE,,Rab5 GDP/GTP exchange factor (Rabex-5),Mus musculus (Mouse),40.0,468.0,2.6e-94,347.4,sp|Q9JM13|RABX5_MOUSE Rab5 GDP/GTP exchange factor OS=Mus musculus OX=10090 GN=Rabgef1 PE=1 SV=1,GO:0002686; GO:0003677; GO:0005085; GO:0005730; GO:0005769; GO:0005829; GO:0006612; GO:0006898; GO:0007265; GO:0008270; GO:0015031; GO:0030425; GO:0031267; GO:0031982; GO:0032715; GO:0032764; GO:0033004; GO:0038109; GO:0043303; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0051649; GO:0055037; GO:0060368; GO:0061630; GO:0097531; GO:0098830; GO:0098935; GO:1900235,dendritic transport [GO:0098935]; establishment of localization in cell [GO:0051649]; Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; nucleolus [GO:0005730]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037]; vesicle [GO:0031982],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005730; GO:0005768; GO:0005829; GO:0007018; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0048870; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleolus; endosome; cytosol; microtubule-based movement; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10109,1.952857262315869,FUN_043479-T1,Peve_00021731,Pocillopora_meandrina_HIv1___RNAseq.g7915.t1,three_way,47.53266666666666,,,,,,,,,,,,,,,,,
OG_10110,3.1900399466854084,FUN_043480-T1,Peve_00021725,Pocillopora_meandrina_HIv1___RNAseq.g7918.t1,three_way,87.28833333333333,FUN_043480-T1,Q8UVR3,,,,,49.4,237.0,7.3e-58,226.1,sp|Q8UVR3|LMX1B_XENLA LIM homeobox transcription factor 1-beta.1 OS=Xenopus laevis OX=8355 GN=lmx1b.1 PE=2 SV=1,,,,,,
OG_10111,1.5717394039546526,FUN_043481-T1,Peve_00021726,Pocillopora_meandrina_HIv1___RNAseq.g7917.t1,three_way,78.01516666666667,FUN_043481-T1,Q6GLQ4,,,,,30.6,710.0,2.3999999999999998e-39,165.6,sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1,,,,,,
OG_10113,3.1868532541447,FUN_043483-T1,Peve_00021710,Pocillopora_meandrina_HIv1___RNAseq.g7933.t1,three_way,81.26899999999999,FUN_043483-T1,Q96E35,,,,,48.1,241.0,4.4e-58,226.1,sp|Q96E35|ZMY19_HUMAN Zinc finger MYND domain-containing protein 19 OS=Homo sapiens OX=9606 GN=ZMYND19 PE=1 SV=1,,,,,,
OG_10119,1.576749995621825,FUN_043495-T1,Peve_00024915,Pocillopora_meandrina_HIv1___TS.g1707.t3,three_way,64.6395,FUN_043495-T1,Q7Z7A1,CNTRL_HUMAN,,Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110),Homo sapiens (Human),33.3,916.0,5.599999999999997e-29,132.9,sp|Q7Z7A1|CNTRL_HUMAN Centriolin OS=Homo sapiens OX=9606 GN=CNTRL PE=1 SV=2,GO:0001822; GO:0003281; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0005886; GO:0016020; GO:0034451; GO:0035904; GO:0036064; GO:0048471; GO:0051301; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103,aorta development [GO:0035904]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; ventricular septum development [GO:0003281],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],,GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0048856,Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; organelle; anatomical structure development
OG_10121,1.99614751904492,FUN_043499-T1,Peve_00024907,Pocillopora_meandrina_HIv1___RNAseq.g7964.t1,three_way,56.86333333333334,FUN_043499-T1,P82279,CRUM1_HUMAN,,Protein crumbs homolog 1,Homo sapiens (Human),23.8,741.0,3.6e-48,196.4,sp|P82279|CRUM1_HUMAN Protein crumbs homolog 1 OS=Homo sapiens OX=9606 GN=CRB1 PE=1 SV=2,GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386,blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; protein localization [GO:0008104]; retina layer formation [GO:0010842],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003],calcium ion binding [GO:0005509],GO:0005576; GO:0005886; GO:0007155; GO:0007163; GO:0023052; GO:0030154; GO:0048856; GO:0061024,extracellular region; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; signaling; cell differentiation; anatomical structure development; membrane organization
OG_10133,1.384293850721754,FUN_043517-T1,Peve_00017256,Pocillopora_meandrina_HIv1___RNAseq.g8028.t1,three_way,92.006,FUN_043517-T1,O61491,,,,,66.1,419.0,1.6e-84,314.7,sp|O61491|FLOT1_DROME Flotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1,,,,,,
OG_10137,1.3299173600770378,FUN_043522-T1,Peve_00015611,Pocillopora_meandrina_HIv1___RNAseq.g8037.t1,three_way,57.667,FUN_043522-T1,P63157,BARH1_MOUSE,,BarH-like 1 homeobox protein (Bar-class homeodomain protein MBH2) (BarH-related homeobox protein 1),Mus musculus (Mouse),43.9,132.0,9.9e-17,88.6,sp|P63157|BARH1_MOUSE BarH-like 1 homeobox protein OS=Mus musculus OX=10090 GN=Barhl1 PE=2 SV=1,GO:0001228; GO:0001764; GO:0005634; GO:0007605; GO:0030901; GO:0043524; GO:0045944; GO:0051402; GO:1905584; GO:1905586; GO:1990837,midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of outer hair cell apoptotic process [GO:1905586]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; outer hair cell apoptotic process [GO:1905584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of sound [GO:0007605],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_10138,1.3045256022989384,FUN_043525-T1,Peve_00027815,Pocillopora_meandrina_HIv1___RNAseq.g8035.t1,three_way,75.3475,FUN_043525-T1,P53547,,,,,61.0,59.0,2e-11,70.9,sp|P53547|HM01_CAEEL Homeobox protein ceh-1 (Fragment) OS=Caenorhabditis elegans OX=6239 GN=ceh-1 PE=3 SV=1,,,,,,
OG_10139,2.501436278235823,FUN_043526-T1,Peve_00011962,Pocillopora_meandrina_HIv1___RNAseq.g8034.t1,three_way,58.651,FUN_043526-T1,Q9NY43,,,,,44.1,118.0,1.7e-15,84.3,sp|Q9NY43|BARH2_HUMAN BarH-like 2 homeobox protein OS=Homo sapiens OX=9606 GN=BARHL2 PE=1 SV=2,,,,,,
OG_10140,1.368922353461351,FUN_043529-T1,Peve_00011972,Pocillopora_meandrina_HIv1___RNAseq.g8039.t1,three_way,62.42733333333334,FUN_043529-T1,P22933,GBRD_MOUSE,,Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) (GABAAR subunit delta),Mus musculus (Mouse),32.4,417.0,2.1e-53,211.5,sp|P22933|GBRD_MOUSE Gamma-aminobutyric acid receptor subunit delta OS=Mus musculus OX=10090 GN=Gabrd PE=2 SV=1,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0030424; GO:0030425; GO:0034707; GO:0043025; GO:0045211; GO:0051932; GO:0098978; GO:0098982; GO:1902711; GO:1904315,"gamma-aminobutyric acid signaling pathway [GO:0007214]; synaptic transmission, GABAergic [GO:0051932]",axon [GO:0030424]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0060089,transporter activity; plasma membrane; signaling; molecular transducer activity
OG_10145,1.143780931109501,FUN_043535-T1,Peve_00016667,Pocillopora_meandrina_HIv1___RNAseq.g8056.t1,three_way,80.87466666666667,FUN_043535-T1,O14733,,,,,44.9,256.0,1.8e-48,194.5,sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP2K7 PE=1 SV=2,,,,,,
OG_10148,1.5820961918899497,FUN_043539-T1,Peve_00012551,Pocillopora_meandrina_HIv1___TS.g1775.t1,three_way,61.17516666666667,FUN_043539-T1,Q9DBQ9,,,,,27.4,592.0,6.5e-46,187.6,sp|Q9DBQ9|SWT1_MOUSE Transcriptional protein SWT1 OS=Mus musculus OX=10090 GN=Swt1 PE=2 SV=3,,,,,,
OG_10149,1.2122076778842412,FUN_043541-T1,Peve_00011556,Pocillopora_meandrina_HIv1___TS.g1771.t2,three_way,54.464666666666666,FUN_043541-T1,P07307,ASGR2_HUMAN,,Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2),Homo sapiens (Human),30.1,153.0,7.5e-13,76.6,sp|P07307|ASGR2_HUMAN Asialoglycoprotein receptor 2 OS=Homo sapiens OX=9606 GN=ASGR2 PE=1 SV=2,GO:0004873; GO:0005537; GO:0005886; GO:0006897; GO:0006955; GO:0007166; GO:0009897; GO:0038187; GO:0042806; GO:0044322; GO:0048471,cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; immune response [GO:0006955],endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],asialoglycoprotein receptor activity [GO:0004873]; D-mannose binding [GO:0005537]; fucose binding [GO:0042806]; pattern recognition receptor activity [GO:0038187],GO:0002376; GO:0005886; GO:0016192; GO:0038024; GO:0060089,immune system process; plasma membrane; vesicle-mediated transport; cargo receptor activity; molecular transducer activity
OG_10152,1.1215550441344304,FUN_043545-T1,Peve_00011554,Pocillopora_meandrina_HIv1___RNAseq.g8015.t1,three_way,81.398,FUN_043545-T1,Q3TQI7,,,,,46.6,262.0,7.4e-50,199.1,sp|Q3TQI7|TLS1_MOUSE Splicing factor C9orf78 homolog OS=Mus musculus OX=10090 PE=1 SV=2,,,,,,
OG_10153,1.0310947896552438,FUN_043546-T1,Peve_00011555,Pocillopora_meandrina_HIv1___RNAseq.g8014.t1,three_way,78.13083333333334,,,,,,,,,,,,,,,,,
OG_10154,1.033834565732364,FUN_043549-T1,Peve_00011559,Pocillopora_meandrina_HIv1___RNAseq.g8013.t1,three_way,40.39266666666667,,,,,,,,,,,,,,,,,
OG_10155,1.180333968850909,FUN_043550-T1,Peve_00009532,Pocillopora_meandrina_HIv1___RNAseq.g8005.t3,three_way,70.52333333333333,FUN_043550-T1,Q5XJS0,,,,,31.4,544.0,1.1000000000000004e-59,232.6,sp|Q5XJS0|MIGA1_DANRE Mitoguardin 1 OS=Danio rerio OX=7955 GN=miga1 PE=2 SV=1,,,,,,
OG_10158,1.5554238170989887,FUN_043553-T1,Peve_00009529,Pocillopora_meandrina_HIv1___RNAseq.g8042.t1,three_way,85.187,FUN_043553-T1,Q8NE28,,,,,26.2,443.0,8.100000000000001e-38,160.2,sp|Q8NE28|STKL1_HUMAN Serine/threonine kinase-like domain-containing protein STKLD1 OS=Homo sapiens OX=9606 GN=STKLD1 PE=1 SV=5,,,,,,
OG_10160,1.6742682601956946,FUN_043558-T1,Peve_00022071,Pocillopora_meandrina_HIv1___RNAseq.g8044.t1,three_way,60.96266666666666,,,,,,,,,,,,,,,,,
OG_10161,1.3644518912978356,FUN_043559-T1,Peve_00022066,Pocillopora_meandrina_HIv1___RNAseq.g8043.t1,three_way,42.258833333333335,,,,,,,,,,,,,,,,,
OG_10170,1.2452530698362132,FUN_043573-T1,Peve_00011698,Pocillopora_meandrina_HIv1___TS.g1621.t2,three_way,82.74133333333333,FUN_043573-T1,Q5ZIR1,,,,,52.2,364.0,7.2e-94,345.5,sp|Q5ZIR1|SHLB1_CHICK Endophilin-B1 OS=Gallus gallus OX=9031 GN=SH3GLB1 PE=2 SV=1,,,,,,
OG_10171,1.5569348968033538,FUN_043574-T1,Peve_00011699,Pocillopora_meandrina_HIv1___RNAseq.g7870.t2,three_way,82.55833333333334,FUN_043574-T1,Q5ZKK5,,,,,31.7,703.0,1.4e-15,86.7,sp|Q5ZKK5|ODFP2_CHICK Outer dense fiber protein 2 OS=Gallus gallus OX=9031 GN=ODF2 PE=2 SV=1,,,,,,
OG_10175,1.0348313290325557,FUN_043584-T1,Peve_00045195,Pocillopora_meandrina_HIv1___RNAseq.g6988.t1,three_way,66.09083333333334,FUN_043584-T1,P21180,CO2_MOUSE,,Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)],Mus musculus (Mouse),25.1,491.0,5.4e-29,131.0,sp|P21180|CO2_MOUSE Complement C2 OS=Mus musculus OX=10090 GN=C2 PE=1 SV=2,GO:0004252; GO:0005615; GO:0006508; GO:0006958; GO:0007584; GO:0032496; GO:0045087; GO:0046872; GO:0097066; GO:2000427,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; proteolysis [GO:0006508]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to thyroid hormone [GO:0097066]",extracellular space [GO:0005615],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003824; GO:0005615; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_10176,2.4285554583577302,FUN_043585-T1,Peve_00045227,Pocillopora_meandrina_HIv1___RNAseq.g6986.t1,three_way,56.91216666666666,FUN_043585-T1,Q9BYX4,IFIH1_HUMAN,,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),Homo sapiens (Human),27.6,1184.0,1.0000000000000001e-88,330.1,sp|Q9BYX4|IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IFIH1 PE=1 SV=3,GO:0002753; GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0038187; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051259; GO:0051607; GO:0060337; GO:0060760; GO:0071360; GO:0098586; GO:0140374,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0065003; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; hydrolase activity; isomerase activity; organelle; molecular transducer activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10177,1.1362506964509431,FUN_043586-T1,Peve_00045222,Pocillopora_meandrina_HIv1___RNAseq.g6984.t1,three_way,54.448,,,,,,,,,,,,,,,,,
OG_10184,1.3592100876615605,FUN_043599-T1,Peve_00007612,Pocillopora_meandrina_HIv1___RNAseq.g6951.t1,three_way,61.132,FUN_043599-T1,Q68CP4,HGNAT_HUMAN,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Homo sapiens (Human),42.6,591.0,3.1e-113,410.6,sp|Q68CP4|HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens OX=9606 GN=HGSNAT PE=1 SV=2,GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0005886; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; plasma membrane; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10189,1.1076978568343103,FUN_043608-T1,Peve_00040378,Pocillopora_meandrina_HIv1___RNAseq.g6946.t1,three_way,60.33733333333333,FUN_043608-T1,Q5TZ07,PLPP6_DANRE,,Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 (EC 3.1.3.-) (EC 3.6.1.-) (EC 3.6.1.68) (Phosphatidic acid phosphatase type 2 domain-containing protein 2) (Phospholipid phosphatase 6),Danio rerio (Zebrafish) (Brachydanio rerio),44.4,180.0,2.8e-34,147.1,sp|Q5TZ07|PLPP6_DANRE Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 OS=Danio rerio OX=7955 GN=plpp6 PE=2 SV=1,GO:0005637; GO:0005789; GO:0016020; GO:0018342; GO:0031965; GO:0033383; GO:0042392; GO:0045339; GO:0046839; GO:1902247,farnesyl diphosphate catabolic process [GO:0045339]; geranyl diphosphate metabolic process [GO:0033383]; geranylgeranyl diphosphate catabolic process [GO:1902247]; phospholipid dephosphorylation [GO:0046839]; protein prenylation [GO:0018342],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],sphingosine-1-phosphate phosphatase activity [GO:0042392],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_10192,1.3728141437440322,FUN_043612-T1,Peve_00040372,Pocillopora_meandrina_HIv1___RNAseq.4603_t,three_way,52.043,FUN_043612-T1,P48970,,,,,38.5,104.0,1.5e-19,98.6,sp|P48970|UNIV_STRPU Univin OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2,,,,,,
OG_10194,2.4458260892079418,FUN_043618-T2,Peve_00008246,Pocillopora_meandrina_HIv1___RNAseq.g6933.t1,three_way,53.74066666666667,FUN_043618-T2,P34821,BMP8A_MOUSE,,Bone morphogenetic protein 8A (BMP-8A) (Osteogenic protein 2) (OP-2),Mus musculus (Mouse),32.2,345.0,3.1000000000000002e-34,147.5,sp|P34821|BMP8A_MOUSE Bone morphogenetic protein 8A OS=Mus musculus OX=10090 GN=Bmp8a PE=2 SV=1,GO:0001649; GO:0005125; GO:0005615; GO:0007179; GO:0007281; GO:0007283; GO:0008083; GO:0051216,cartilage development [GO:0051216]; germ cell development [GO:0007281]; osteoblast differentiation [GO:0001649]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179],extracellular space [GO:0005615],cytokine activity [GO:0005125]; growth factor activity [GO:0008083],GO:0005615; GO:0022414; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; reproductive process; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_10195,1.9061475061665023,FUN_043619-T1,Peve_00008225,Pocillopora_meandrina_HIv1___RNAseq.g6932.t1,three_way,88.456,FUN_043619-T1,Q6DJ06,,,,,63.2,125.0,1e-48,194.5,sp|Q6DJ06|LMO42_XENTR LIM domain transcription factor LMO4.2 OS=Xenopus tropicalis OX=8364 GN=lmo4.2 PE=2 SV=1,,,,,,
OG_10196,1.7235321415677007,FUN_043620-T1,Peve_00008227,Pocillopora_meandrina_HIv1___RNAseq.g6930.t1,three_way,51.489333333333335,,,,,,,,,,,,,,,,,
OG_10197,1.013554536774902,FUN_043621-T1,Peve_00008231,Pocillopora_meandrina_HIv1___RNAseq.g6929.t1,three_way,80.29433333333333,,,,,,,,,,,,,,,,,
OG_10198,3.1309745719159845,FUN_043622-T1,Peve_00008234,Pocillopora_meandrina_HIv1___RNAseq.g6927.t1,three_way,76.94266666666667,FUN_043622-T1,Q9VUX3,NOTUM_DROME,,Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (Protein Notum) (Protein wingful) (dNOTUM),Drosophila melanogaster (Fruit fly),28.2,347.0,8.8e-26,119.8,sp|Q9VUX3|NOTUM_DROME Palmitoleoyl-protein carboxylesterase NOTUM OS=Drosophila melanogaster OX=7227 GN=Notum PE=1 SV=3,GO:0005615; GO:0007419; GO:0009986; GO:0016055; GO:0035220; GO:0035222; GO:0045880; GO:0048076; GO:0048190; GO:0048546; GO:0090090; GO:1990697; GO:1990699,digestive tract morphogenesis [GO:0048546]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; extracellular space [GO:0005615],palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005615; GO:0016787; GO:0030163; GO:0048856,catalytic activity; extracellular space; hydrolase activity; protein catabolic process; anatomical structure development
OG_10200,1.123354958003013,FUN_043628-T1,Peve_00008239,Pocillopora_meandrina_HIv1___TS.g640.t1b,three_way,64.35733333333333,FUN_043628-T1,Q504Y2,PKDCC_HUMAN,,"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)",Homo sapiens (Human),40.7,243.0,2.7e-47,190.3,sp|Q504Y2|PKDCC_HUMAN Extracellular tyrosine-protein kinase PKDCC OS=Homo sapiens OX=9606 GN=PKDCC PE=1 SV=2,GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021,bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672],GO:0003824; GO:0005576; GO:0005794; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular region; Golgi apparatus; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10202,1.0628785023891292,FUN_043630-T1,Peve_00008241,Pocillopora_meandrina_HIv1___RNAseq.g6906.t1,three_way,61.4405,FUN_043630-T1,D3ZWZ9,,,,,57.8,339.0,5.1e-111,403.3,sp|D3ZWZ9|GP107_RAT Protein GPR107 OS=Rattus norvegicus OX=10116 GN=Gpr107 PE=1 SV=1,,,,,,
OG_10204,1.826317514647667,FUN_043636-T1,Peve_00008249,Pocillopora_meandrina_HIv1___RNAseq.g6909.t1,three_way,53.50783333333334,FUN_043636-T1,Q8NDA2,,,,,26.3,753.0,7.9000000000000025e-59,231.5,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_10216,1.9875970069751605,FUN_043662-T1,Peve_00001429,Pocillopora_meandrina_HIv1___RNAseq.g7395.t2,three_way,79.739,FUN_043662-T1,P98198,AT8B2_HUMAN,,Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2),Homo sapiens (Human),52.5,1179.0,0.0,1144.4,sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2,GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531,Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
OG_10221,1.270294083518115,FUN_043835-T1,Peve_00041794,Pocillopora_meandrina_HIv1___TS.g12323.t1,three_way,54.1065,,,,,,,,,,,,,,,,,
OG_10222,1.2676834270751325,FUN_044275-T2,Peve_00026564,Pocillopora_meandrina_HIv1___TS.g27908.t1,three_way,73.819,FUN_044275-T2,Q9PT84,,,,,52.5,472.0,4.3e-137,490.0,sp|Q9PT84|KCNH6_CHICK Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Gallus gallus OX=9031 GN=KCNH6 PE=2 SV=2,,,,,,
